Citrus Sinensis ID: 043524
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 314 | 2.2.26 [Sep-21-2011] | |||||||
| Q9M092 | 786 | Wall-associated receptor | no | no | 0.961 | 0.384 | 0.310 | 3e-42 | |
| Q9LSV3 | 433 | Putative wall-associated | no | no | 0.926 | 0.672 | 0.319 | 4e-42 | |
| Q0WNY5 | 793 | Wall-associated receptor | no | no | 0.961 | 0.380 | 0.313 | 2e-41 | |
| Q9LMT9 | 764 | Putative wall-associated | no | no | 0.939 | 0.386 | 0.305 | 1e-39 | |
| Q8RY17 | 751 | Wall-associated receptor | no | no | 0.878 | 0.367 | 0.339 | 3e-39 | |
| Q7X8C5 | 748 | Wall-associated receptor | no | no | 0.878 | 0.368 | 0.339 | 5e-39 | |
| Q9S9M3 | 730 | Wall-associated receptor | no | no | 0.878 | 0.378 | 0.316 | 6e-39 | |
| Q9S9M2 | 761 | Wall-associated receptor | no | no | 0.904 | 0.373 | 0.322 | 6e-39 | |
| Q9LMN8 | 741 | Wall-associated receptor | no | no | 0.904 | 0.383 | 0.305 | 4e-38 | |
| Q9LN59 | 788 | Putative wall-associated | no | no | 0.958 | 0.381 | 0.322 | 4e-38 |
| >sp|Q9M092|WAKLM_ARATH Wall-associated receptor kinase-like 17 OS=Arabidopsis thaliana GN=WAKL17 PE=3 SV=2 | Back alignment and function desciption |
|---|
Score = 172 bits (436), Expect = 3e-42, Method: Compositional matrix adjust.
Identities = 106/341 (31%), Positives = 175/341 (51%), Gaps = 39/341 (11%)
Query: 3 WILRKFKLWSKGKRTLMIG---NGASVLQELIASSNGKYIPYRIFSAQELKQETNNYDQK 59
W LRKF + + + NG +LQ+ + + G RIF+++EL++ T N+ +
Sbjct: 388 WWLRKFLVKRRMAKRKKKFFKRNGGLLLQQELNTRQGVVEKARIFTSKELEKATENFSEN 447
Query: 60 NGFWH------------------------------ESCINNVTYAAQMSHDHILKLIGCC 89
H + IN V +Q++H H++KL+GCC
Sbjct: 448 RVLGHGGQGTVYKGMLVDGRTVAVKKSKVIDEDKLQEFINEVVILSQINHRHVVKLLGCC 507
Query: 90 LETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPI 149
LET + ILV+E++ +G L+ I + ++ RL+ AVD A AL+YLH PI
Sbjct: 508 LETEVPILVYEFIINGNLFKHIHEEEADDYT-MIWGMRLRIAVDIAGALSYLHSAASSPI 566
Query: 150 VFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEK 209
RD K+++IL E+ K+ DF S S+ +TH T + GT G++ P+Y + ++EK
Sbjct: 567 YHRDIKSTNILLDEKYRAKVADFGTSRSVTIDQTHWTTVISGTVGYVDPEYYRSSQYTEK 626
Query: 210 LDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSC 269
DVYSFG L+EL+TG + +V++ +++ E+ + ++ R ++I+D I D
Sbjct: 627 SDVYSFGVILAELITGDKPVIMVQNTQEII-ALAEHFRVAMKERRLSDIMDARIRDD--- 682
Query: 270 TEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310
K +Q+ A A L +CL+ +RP M +V L +IC S
Sbjct: 683 -SKPEQVMAVANLAMKCLSSRGRNRPNMREVFTELERICTS 722
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9LSV3|WAKLS_ARATH Putative wall-associated receptor kinase-like 16 OS=Arabidopsis thaliana GN=WAKL16 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 171 bits (434), Expect = 4e-42, Method: Compositional matrix adjust.
Identities = 108/338 (31%), Positives = 177/338 (52%), Gaps = 47/338 (13%)
Query: 5 LRKFKLWSKGKRTLMI-GNGASVLQELIASSNGKYIPYRIFSAQELKQETNNYD-----Q 58
+RK + +K +R L NG +L E ++ + I ++IF+ +++K+ TN YD
Sbjct: 56 IRKHQKDTKIQRQLFFEKNGGGMLIERLSGAGSSNIDFKIFTEEDMKEATNGYDVSRILG 115
Query: 59 KNGFWH-------------------------ESCINNVTYAAQMSHDHILKLIGCCLETP 93
+ G W E IN V +Q++H +++KL+GCCLET
Sbjct: 116 QGGQWTVYKGILPDNSIVAIKKTRLGDNNQVEQFINEVLVLSQINHRNVVKLLGCCLETE 175
Query: 94 IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRD 153
+ +LV+E++ G+L+D + G+ L + RL+ A++ A A+AYLH G PI+ RD
Sbjct: 176 VPLLVYEFITGGSLFDHLHGS--MFVSSLTWEHRLEIAIEVAGAIAYLHSGASIPIIHRD 233
Query: 154 FKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVY 213
KT +IL E K+ DF S P + +T V GT G+L P+Y TT +EK DVY
Sbjct: 234 IKTENILLDENLTAKVADFGASKLKPMDKEQLTTMVQGTLGYLDPEYYTTWLLNEKSDVY 293
Query: 214 SFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF----EDNRFTEIVDPIIVQDLSC 269
SFG L EL++G+ L R +++L +YF ++NR EI+D ++ +
Sbjct: 294 SFGVVLMELISGQKALCFERP------ETSKHLVSYFVLATKENRLHEIIDDQVLNE--- 344
Query: 270 TEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQI 307
E ++++H +A++ EC +RP M++VA L +
Sbjct: 345 -ENQREIHEAARVAVECTRLKGEERPRMIEVAAELETL 381
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q0WNY5|WAKLN_ARATH Wall-associated receptor kinase-like 18 OS=Arabidopsis thaliana GN=WAKL18 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 169 bits (429), Expect = 2e-41, Method: Compositional matrix adjust.
Identities = 107/341 (31%), Positives = 176/341 (51%), Gaps = 39/341 (11%)
Query: 3 WILRKF---KLWSKGKRTLMIGNGASVLQELIASSNGKYIPYRIFSAQELKQETNNYDQK 59
W LRKF + +K K+ NG +L + + + G R+F+++EL++ T N+ +
Sbjct: 397 WWLRKFLIKRRITKRKKKFFKRNGGLLLLQELNTREGYVEKTRVFNSRELEKATENFSEN 456
Query: 60 NGFWH------------------------------ESCINNVTYAAQMSHDHILKLIGCC 89
H + IN V +Q++H H++KL+GCC
Sbjct: 457 RVLGHGGQGTVYKGMLVDGRTVAVKKSKVIDEDKLQEFINEVVILSQINHRHVVKLLGCC 516
Query: 90 LETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPI 149
LET + +LV+E++ +G L+ I + +L RL+ AVD A AL+YLH PI
Sbjct: 517 LETEVPMLVYEFIINGNLFKHIHEEESDDY-TMLWGMRLRIAVDIAGALSYLHSSASSPI 575
Query: 150 VFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEK 209
RD K+++IL E+ K+ DF S S+ +TH T + GT G++ P+Y + ++EK
Sbjct: 576 YHRDIKSTNILLDEKYRAKVADFGTSRSVTIDQTHWTTVISGTVGYVDPEYYQSSQYTEK 635
Query: 210 LDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSC 269
DVYSFG L+EL+TG + +V++ ++V E+ + ++ R T+I+D I D
Sbjct: 636 SDVYSFGVILAELITGDKPVIMVQNTQEIV-ALAEHFRVAMKEKRLTDIIDARIRNDC-- 692
Query: 270 TEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310
K +Q+ A A++ +CL+ RP M +V L +IC S
Sbjct: 693 --KPEQVMAVAKVAMKCLSSKGKKRPNMREVFTELERICTS 731
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMT9|WAKLL_ARATH Putative wall-associated receptor kinase-like 13 OS=Arabidopsis thaliana GN=WAKL13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 163 bits (413), Expect = 1e-39, Method: Compositional matrix adjust.
Identities = 103/337 (30%), Positives = 171/337 (50%), Gaps = 42/337 (12%)
Query: 4 ILRKFKLWSKGKRTLMIGNGASVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFW 63
+LRK ++ ++ KR NG +LQ+ + ++ G+ ++FS++EL++ T+N++
Sbjct: 403 LLRKRRMTNR-KRKFFKRNGGLLLQQQLNTTQGRVEKTKLFSSRELEKATDNFNDNRVIG 461
Query: 64 H------------------------------ESCINNVTYAAQMSHDHILKLIGCCLETP 93
+ IN V +Q++H H++KL+GCCLET
Sbjct: 462 QGGQGTVYKGMLVDGRSVAVKKSNVVDEDKLQEFINEVIILSQINHRHVVKLLGCCLETE 521
Query: 94 IAILVFEYVQHGTLWDRILGAPQTHFE--PLLLKRRLKDAVDAANALAYLHFGFPRPIVF 151
+ ILV+E++ +G L+ + F+ L R++ AVD + A +YLH PI
Sbjct: 522 VPILVYEFIPNGNLFQHL----HEEFDDYTALWGVRMRIAVDISGAFSYLHTAACSPIYH 577
Query: 152 RDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLD 211
RD K+++IL E+ K+ DF S S+ TH T + GT G++ P+Y + F+EK D
Sbjct: 578 RDIKSTNILLDEKYRAKVSDFGTSRSVSIDHTHWTTVISGTVGYVDPEYYGSSHFTEKSD 637
Query: 212 VYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTE 271
VYSFG L EL+TG + + + ++ +Y + +NR EI+D I D
Sbjct: 638 VYSFGVVLVELITGEKPVITLSETQEIT-GLADYFRLAMRENRLFEIIDARIRNDC---- 692
Query: 272 KEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQIC 308
K +Q+ A A L CL ++ RP M +V+ L +IC
Sbjct: 693 KLEQVIAVANLALRCLKKTGKTRPDMREVSTALERIC 729
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8RY17|WAKLI_ARATH Wall-associated receptor kinase-like 22 OS=Arabidopsis thaliana GN=WAKL22 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 162 bits (411), Expect = 3e-39, Method: Compositional matrix adjust.
Identities = 108/318 (33%), Positives = 165/318 (51%), Gaps = 42/318 (13%)
Query: 22 NGASVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWH----------------- 64
NG +L++ + + G +IFS++EL++ T+N++
Sbjct: 387 NGGLLLKQQLTTRGGNVQSSKIFSSKELEKATDNFNMNRVLGQGGQGTVYKGMLVDGRIV 446
Query: 65 -------------ESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRI 111
E IN V +Q++H +I+KL+GCCLET + ILV+E++ +G L+ R+
Sbjct: 447 AVKRSKVLDEDKVEEFINEVGVLSQINHRNIVKLMGCCLETEVPILVYEHIPNGDLFKRL 506
Query: 112 LGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171
+ + RL+ +V+ A ALAYLH P+ RD KT++IL E+ K+ D
Sbjct: 507 HHDSDDY--TMTWDVRLRISVEIAGALAYLHSAASTPVYHRDVKTTNILLDEKYRAKVSD 564
Query: 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDL 231
F S SI +TH+T V GT+G+L P+Y T F++K DVYSFG L EL+TG +
Sbjct: 565 FGTSRSINVDQTHLTTLVAGTFGYLDPEYFQTSQFTDKSDVYSFGVVLVELITGEKPFSV 624
Query: 232 VR--DAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNE 289
+R + LV FNE +K NR +IVD I + CT +Q+ A A+L CL+
Sbjct: 625 MRPEENRGLVSHFNEAMKQ----NRVLDIVDSRIKE--GCT--LEQVLAVAKLARRCLSL 676
Query: 290 SPIDRPTMVDVARRLRQI 307
RP M +V+ L +I
Sbjct: 677 KGKKRPNMREVSVELERI 694
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Required during plant's response to pathogen infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q7X8C5|WAKLB_ARATH Wall-associated receptor kinase-like 2 OS=Arabidopsis thaliana GN=WAKL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 161 bits (408), Expect = 5e-39, Method: Compositional matrix adjust.
Identities = 108/318 (33%), Positives = 158/318 (49%), Gaps = 42/318 (13%)
Query: 22 NGASVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWH----------------- 64
NG +L++ +A G RIFS+ EL++ T+N+++
Sbjct: 382 NGGMLLKQQLARKEGNVEMSRIFSSHELEKATDNFNKNRVLGQGGQGTVYKGMLVDGRIV 441
Query: 65 -------------ESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRI 111
E IN V AQ++H +I+KL+GCCLET + +LV+E+V +G L R+
Sbjct: 442 AVKRSKAVDEDRVEEFINEVVVLAQINHRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRL 501
Query: 112 LGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171
+ + + RL A++ A AL+YLH PI RD KT++IL E N K+ D
Sbjct: 502 HDESDDY--TMTWEVRLHIAIEIAGALSYLHSAASFPIYHRDIKTTNILLDERNRAKVSD 559
Query: 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDL 231
F S S+ +TH+T V GT+G++ P+Y + F+EK DVYSFG L ELLTG
Sbjct: 560 FGTSRSVTIDQTHLTTQVAGTFGYVDPEYFQSSKFTEKSDVYSFGVVLVELLTGEKPSSR 619
Query: 232 VRDAHD--LVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNE 289
VR + L F E +K +NR +IVD I + + Q+ + A L CLN
Sbjct: 620 VRSEENRGLAAHFVEAVK----ENRVLDIVDDRIKDECNM----DQVMSVANLARRCLNR 671
Query: 290 SPIDRPTMVDVARRLRQI 307
RP M +V+ L I
Sbjct: 672 KGKKRPNMREVSIELEMI 689
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M3|WAKLC_ARATH Wall-associated receptor kinase-like 3 OS=Arabidopsis thaliana GN=WAKL3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 161 bits (408), Expect = 6e-39, Method: Compositional matrix adjust.
Identities = 100/316 (31%), Positives = 163/316 (51%), Gaps = 40/316 (12%)
Query: 22 NGASVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWH----------------- 64
NG +L++ + + +G +IFS++EL++ T+N+
Sbjct: 394 NGGLLLKQQLTTKDGSVEMSKIFSSRELEKATDNFSIDRVLGQGGQGTVYKRMLVDGSIV 453
Query: 65 -------------ESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRI 111
E IN + +Q++H +I+KL+GCCLET + ILV+EY+ +G L+ R+
Sbjct: 454 AVKRSKVVDEDKMEEFINEIVLLSQINHRNIVKLLGCCLETEVPILVYEYIPNGDLFKRL 513
Query: 112 LGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171
+ + + RL+ AV+ A AL+Y+H PI RD KT++IL E+ K+ D
Sbjct: 514 HDEYDDYM--MTWEVRLRIAVEIAGALSYMHSAASFPIFHRDIKTTNILLDEKYRAKISD 571
Query: 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDL 231
F S S+ +TH+T V GT+G++ P+Y + ++ K DVYSFG L EL+TG +
Sbjct: 572 FGTSRSVATDQTHLTTLVAGTFGYMDPEYFLSSQYTHKSDVYSFGVVLVELITGEKPMSR 631
Query: 232 VRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESP 291
VR + Y ++NR +I+D I ++D S +Q+ A A+L CLN
Sbjct: 632 VRSEEGI--GLATYFLEAMKENRAVDIID-IRIKDES-----KQVMAVAKLARRCLNRKG 683
Query: 292 IDRPTMVDVARRLRQI 307
RP M +V+ +L +I
Sbjct: 684 NKRPNMREVSIKLERI 699
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M2|WAKLD_ARATH Wall-associated receptor kinase-like 4 OS=Arabidopsis thaliana GN=WAKL4 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 161 bits (407), Expect = 6e-39, Method: Compositional matrix adjust.
Identities = 104/322 (32%), Positives = 161/322 (50%), Gaps = 38/322 (11%)
Query: 16 RTLMIGNGASVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWH----------- 64
R NG +L++ +A G +IFS+ EL++ T+N++
Sbjct: 384 RVFFRRNGGMLLKQQLARKEGNVEMSKIFSSNELEKATDNFNTNRVLGQGGQGTVYKGML 443
Query: 65 -------------------ESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHG 105
E IN V AQ++H +I+KL+GCCLET + +LV+E+V +G
Sbjct: 444 VDGRIVAVKRSKAMDEDKVEEFINEVVVLAQINHRNIVKLLGCCLETEVPVLVYEFVPNG 503
Query: 106 TLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN 165
L R+ + + + RL A++ A AL+YLH PI RD KT++IL E+
Sbjct: 504 DLCKRLRDECDDYI--MTWEVRLHIAIEIAGALSYLHSAASFPIYHRDIKTTNILLDEKY 561
Query: 166 VVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225
VK+ DF S S+ +TH+T V GT+G++ P+Y + F++K DVYSFG L EL+TG
Sbjct: 562 QVKVSDFGTSRSVTIDQTHLTTQVAGTFGYVDPEYFQSSKFTDKSDVYSFGVVLVELITG 621
Query: 226 RGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFE 285
+ V+ + F + ++NRF +IVD I + + Q+ A A+L
Sbjct: 622 KNPSSRVQSEEN--RGFAAHFVAAVKENRFLDIVDERIKDECNL----DQVMAVAKLAKR 675
Query: 286 CLNESPIDRPTMVDVARRLRQI 307
CLN RP M +V+ L +I
Sbjct: 676 CLNRKGKKRPNMREVSVELERI 697
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Plays a role in plant mineral nutrients response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMN8|WAK3_ARATH Wall-associated receptor kinase 3 OS=Arabidopsis thaliana GN=WAK3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 159 bits (401), Expect = 4e-38, Method: Compositional matrix adjust.
Identities = 104/340 (30%), Positives = 172/340 (50%), Gaps = 56/340 (16%)
Query: 7 KFKLWSKGKRTLMIGNGASVLQELIASSNGKYIPYRIFSAQELKQETNNYD--------- 57
K + ++K +R NG +L + ++ + I ++IF+ + +K+ TN YD
Sbjct: 366 KQRKYTKLRRQFFEQNGGGMLIQRLSGAGLSNIDFKIFTEEGMKEATNGYDESRILGQGG 425
Query: 58 --------------------------QKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91
Q + F HE V +Q++H +++K++GCCLE
Sbjct: 426 QGTVYKGILPDNTIVAIKKARLADSRQVDQFIHE-----VLVLSQINHRNVVKILGCCLE 480
Query: 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVF 151
T + +LV+E++ +GTL+D + G+ L + RL+ A++ A LAYLH PI+
Sbjct: 481 TEVPLLVYEFITNGTLFDHLHGS--IFDSSLTWEHRLRIAIEVAGTLAYLHSSASIPIIH 538
Query: 152 RDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLD 211
RD KT++IL E K+ DF S IP + +T V GT G+L P+Y TT +EK D
Sbjct: 539 RDIKTANILLDENLTAKVADFGASKLIPMDKEQLTTMVQGTLGYLDPEYYTTGLLNEKSD 598
Query: 212 VYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF----EDNRFTEIVDPIIVQDL 267
VYSFG L ELL+G+ L R +++L +YF E+NR EI+D ++ +
Sbjct: 599 VYSFGVVLMELLSGQKALCFERPQA------SKHLVSYFVSATEENRLHEIIDDQVLNE- 651
Query: 268 SCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQI 307
+ +++ +A++ EC +RP M +VA +L +
Sbjct: 652 ---DNLKEIQEAARIAAECTRLMGEERPRMKEVAAKLEAL 688
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LN59|WAKLK_ARATH Putative wall-associated receptor kinase-like 11 OS=Arabidopsis thaliana GN=WAKL11 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 158 bits (400), Expect = 4e-38, Method: Compositional matrix adjust.
Identities = 110/341 (32%), Positives = 169/341 (49%), Gaps = 40/341 (11%)
Query: 3 WILRKF---KLWSKGKRTLMIGNGASVLQELIASSNGKYIPYRIFSAQELKQETNNYDQK 59
W LRKF + SK KR NG +LQ+ + ++ G RIFS++EL++ T+N+ +
Sbjct: 395 WWLRKFLKKRRMSKRKRKFFKRNGGLLLQQQLNTNKGNVEKTRIFSSRELEKATDNFSES 454
Query: 60 NGFWH------------------------------ESCINNVTYAAQMSHDHILKLIGCC 89
E IN V +Q++H H++KL+GCC
Sbjct: 455 RILGQGGQGTVYKGMLVDGRTVAVKKSKVVDEDKLEEFINEVVILSQINHRHVVKLLGCC 514
Query: 90 LETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPI 149
LET + LV+E++ +G L+ I + + + RL+ AVD A AL+YLH PI
Sbjct: 515 LETEVPTLVYEFIPNGNLFQHIHEESDDYTKTWGM--RLRIAVDIAGALSYLHSAASSPI 572
Query: 150 VFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEK 209
RD K+++IL E+ K+ DF S S+ TH T + GT G++ P+Y + +++K
Sbjct: 573 YHRDIKSTNILLDEKYRTKVSDFGTSRSVTIDHTHWTTVISGTVGYVDPEYYGSSQYTDK 632
Query: 210 LDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSC 269
DVYSFG L EL+TG + V ++ + + ++ + ++NRF EI+D I
Sbjct: 633 SDVYSFGVVLVELITGEKPVITVSNSQE-IRGLADHFRVAMKENRFFEIMDARIRDGC-- 689
Query: 270 TEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310
K +Q+ A A L CLN RP M V L +I S
Sbjct: 690 --KPEQVMAVANLARRCLNSKGKKRPCMRKVFTDLEKILAS 728
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 314 | ||||||
| 255582635 | 331 | receptor protein kinase, putative [Ricin | 0.910 | 0.864 | 0.444 | 5e-68 | |
| 224123144 | 344 | predicted protein [Populus trichocarpa] | 0.945 | 0.863 | 0.416 | 1e-63 | |
| 255542656 | 331 | serine-threonine protein kinase, plant-t | 0.920 | 0.873 | 0.422 | 5e-58 | |
| 255542662 | 330 | serine-threonine protein kinase, plant-t | 0.926 | 0.881 | 0.406 | 6e-58 | |
| 255542658 | 356 | serine-threonine protein kinase, plant-t | 0.894 | 0.789 | 0.392 | 3e-56 | |
| 255542668 | 307 | serine-threonine protein kinase, plant-t | 0.901 | 0.921 | 0.429 | 5e-55 | |
| 359495254 | 331 | PREDICTED: wall-associated receptor kina | 0.910 | 0.864 | 0.375 | 4e-47 | |
| 297740943 | 321 | unnamed protein product [Vitis vinifera] | 0.910 | 0.890 | 0.375 | 5e-47 | |
| 22331843 | 355 | putative protein kinase [Arabidopsis tha | 0.891 | 0.788 | 0.369 | 9e-46 | |
| 4678274 | 352 | putative protein [Arabidopsis thaliana] | 0.891 | 0.795 | 0.369 | 9e-46 |
| >gi|255582635|ref|XP_002532098.1| receptor protein kinase, putative [Ricinus communis] gi|223528232|gb|EEF30288.1| receptor protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 263 bits (673), Expect = 5e-68, Method: Compositional matrix adjust.
Identities = 140/315 (44%), Positives = 197/315 (62%), Gaps = 29/315 (9%)
Query: 22 NGASVLQELIASSNGKYIPYRIFSAQELKQETNNYDQK------------NGFWHES--- 66
NG +L++LIAS +G+ P RIFSA EL + T++YD + NG HE
Sbjct: 15 NGRMLLEKLIASCDGRCNPIRIFSADELSRATDDYDPRKIITQDSGYKLYNGLLHERTIS 74
Query: 67 -------------CINNVTYAAQMS-HDHILKLIGCCLETPIAILVFEYVQHGTLWDRIL 112
C N++ +A QMS H + LKL+GCCLET I +LVFE +++GTL R+
Sbjct: 75 VKKFKDKSEQYKYCYNDIMFATQMSKHKNFLKLLGCCLETQIPVLVFEPIEYGTLAGRLY 134
Query: 113 GAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF 172
G +T ++PLL + RLK AV+ ANA++YLH F RPIVFR+ K +I E +V KL DF
Sbjct: 135 GPNKTLYQPLLWRHRLKIAVEIANAVSYLHTAFSRPIVFRNIKPLNIFLDECHVAKLSDF 194
Query: 173 SLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLV 232
SL++SIPEGE+H+ D + G +G +AP+Y T F+E DVY+FG FL LLTG+ ++D
Sbjct: 195 SLAVSIPEGESHVKDMLAGAWGLIAPEYAKTSCFNESQDVYNFGVFLLMLLTGQKVVDSY 254
Query: 233 RDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPI 292
R +++K + D+RF E VD II+ + S EK+QQL A L+F C++E+
Sbjct: 255 RPQAGEELGLVDHVKKFIADDRFYETVDSIILGEGSLPEKDQQLQAFTLLSFRCISEADE 314
Query: 293 DRPTMVDVARRLRQI 307
DRP M+DVA+ LR+I
Sbjct: 315 DRPMMIDVAKELRKI 329
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224123144|ref|XP_002319005.1| predicted protein [Populus trichocarpa] gi|222857381|gb|EEE94928.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 249 bits (637), Expect = 1e-63, Method: Compositional matrix adjust.
Identities = 137/329 (41%), Positives = 201/329 (61%), Gaps = 32/329 (9%)
Query: 15 KRTLMIGNGASVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKN------------GF 62
K T I NG+ +L++L+ +GK R FSA ELK+ TNNYD + GF
Sbjct: 15 KETAFIKNGSKLLEKLVDICDGKCNSIRSFSATELKKATNNYDPQKILTGDSGYKLYKGF 74
Query: 63 W----------------HESCINNVTYAAQMS-HDHILKLIGCCLETPIAILVFEYVQHG 105
+E C N++ YA++MS H +KL+GCCLE I ILVFEYV
Sbjct: 75 LQGRPVSVKKFKDDDEQYEYCFNDIVYASKMSVHKSFMKLLGCCLEARIPILVFEYVGDW 134
Query: 106 TLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN 165
TL D + G+ + +PLL R K A+D ANA+A+LH F +PIVFR+ K +IL + +
Sbjct: 135 TLSDFLWGSEEARCQPLLWIPRSKIAMDMANAVAFLHAAFSKPIVFRNIKPLNILLDDNH 194
Query: 166 VVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225
KL DFS+SISIP+GE+H+ D+V G G +AP+Y+TT +F+EK DV++FG FL LL+G
Sbjct: 195 EAKLSDFSISISIPKGESHVRDSVAGATGLIAPEYLTTGNFNEKQDVFNFGVFLLVLLSG 254
Query: 226 RGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFE 285
+ ++D R +++ +++K ED+RF +++D I+ + + KEQQL A L+
Sbjct: 255 QMVVDFSRPEKEIL--LQDHVKKCIEDDRFNKVIDSTIIAEGTWPGKEQQLQAYTALSLR 312
Query: 286 CLNESPIDRPTMVDVARRLRQICCS-LSC 313
C++E DRPTM+DV++ LR+I S +SC
Sbjct: 313 CISELAEDRPTMIDVSKELRKIYWSAISC 341
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255542656|ref|XP_002512391.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548352|gb|EEF49843.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 230 bits (587), Expect = 5e-58, Method: Compositional matrix adjust.
Identities = 140/331 (42%), Positives = 188/331 (56%), Gaps = 42/331 (12%)
Query: 12 SKGKRTLMIGNGASVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFW-------- 63
SK ++ LM NG S+L++ +A +NG+ P R FS +EL+ TN+Y Q N F+
Sbjct: 8 SKYEKALM-RNGRSLLEKSVALNNGRGNPVRCFSVKELQNATNSYSQHNVFYIDGTCRLY 66
Query: 64 -------------------HESCINNVTYAAQMS-HDHILKLIGCCLETPIAILVFEYVQ 103
E ++++ A++MS H ++LKL+GCCLE+ I I VFEY +
Sbjct: 67 KGLIRDRPVIVKKYDYKHPSEDPVSDIVIASEMSVHRNVLKLLGCCLESEIPIPVFEYAE 126
Query: 104 HGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSE 163
GTL D + LL K RLK AVD A+ +AYLH FPRPIV RD + IL E
Sbjct: 127 KGTLEDYVQKTA------LLWKDRLKIAVDVASVIAYLHTAFPRPIVHRDISLASILLDE 180
Query: 164 ENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELL 223
+ K+ FSLSISIPEGETHI D V GT G++AP+Y F+EK+DVYSFG L LL
Sbjct: 181 DCAAKVTGFSLSISIPEGETHIEDEVAGTIGYVAPEYFMKRMFNEKIDVYSFGVVLLVLL 240
Query: 224 TGRGIL---DLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASA 280
TG G + ++H LV +KN RF EI+DP I+++ EKEQQL +
Sbjct: 241 TGHGPILRSPTTNESHALVVFVEAKIKN----ERFNEIIDPAILEEGPWPEKEQQLKSFL 296
Query: 281 QLTFECLNESPIDRPTMVDVARRLRQICCSL 311
L +C + DRP + DVA++LR I SL
Sbjct: 297 TLAMQCTRKDEEDRPEITDVAKQLRHIYHSL 327
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255542662|ref|XP_002512394.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548355|gb|EEF49846.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 230 bits (587), Expect = 6e-58, Method: Compositional matrix adjust.
Identities = 130/320 (40%), Positives = 183/320 (57%), Gaps = 29/320 (9%)
Query: 22 NGASVLQELIASSNGKYIPYRIFSAQELKQETNNYDQK------------NGFWHES--- 66
NG+ +L++ +A NG+ P R FS++EL++ T NY++K GF +
Sbjct: 10 NGSKLLEKSVAFCNGRCNPIRNFSSEELEKATRNYNEKQVLKLDGYFELYKGFLQDRPVI 69
Query: 67 ------------CINNVTYAAQMS-HDHILKLIGCCLETPIAILVFEYVQHGTLWDRILG 113
IN + YA+ MS H + +KL+GCCLETP ILVFE + TL DRI+
Sbjct: 70 VKKFLEVGVEQLAINEIVYASAMSVHINSIKLLGCCLETPSPILVFESAKEKTLADRIID 129
Query: 114 APQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFS 173
HFEP+ K RLK D AN + Y+H FPRPIV R+ K S+IL E+ V KL DFS
Sbjct: 130 RNDDHFEPVKWKLRLKIVADIANVVVYIHTAFPRPIVHRNIKASNILLDEDYVAKLSDFS 189
Query: 174 LSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVR 233
L +SIPEG++ + D + GT G +A + + T F+EK DVYSFG L +LTG+ D R
Sbjct: 190 LCVSIPEGKSRVRDIMAGTMGLIASESLATGYFNEKSDVYSFGVVLLVVLTGQRSFDFSR 249
Query: 234 DAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPID 293
+ ++K + E F E+VDPIIV + + K Q+L L C+++S +
Sbjct: 250 TETGEQFLLVNHVKKHIETGGFKEMVDPIIVAEEAGNRKGQELEDFRDLALRCIHDSAEE 309
Query: 294 RPTMVDVARRLRQICCSLSC 313
RPTM++VA++LR I S SC
Sbjct: 310 RPTMIEVAKQLRHIYLS-SC 328
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255542658|ref|XP_002512392.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548353|gb|EEF49844.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 225 bits (573), Expect = 3e-56, Method: Compositional matrix adjust.
Identities = 139/354 (39%), Positives = 186/354 (52%), Gaps = 73/354 (20%)
Query: 17 TLMIGNGASVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKN----GFWH-------- 64
T ++ NG +L++ IA +NG+ P R FS EL+ TN+Y Q N G WH
Sbjct: 14 TALMRNGGILLEKSIAFNNGRGNPIRWFSVDELQTATNSYSQNNVIYEGGWHTLYKGFLR 73
Query: 65 ---------------ESC-INNVTYAAQMS-HDHILKLIGCCLETPIAILVFEYVQHGTL 107
C IN++ +A++MS H ++LKL+GCCLE+ I ILVFEY + G L
Sbjct: 74 DRPVIVKRYRNNIHERVCPINDIVFASEMSRHKNVLKLLGCCLESEIPILVFEYAEKGKL 133
Query: 108 WDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVV 167
D I F PLL K RLK AVDAAN +AYLH PRP+V RD S+I E+ V
Sbjct: 134 QDYIYKTDSASFRPLLWKSRLKIAVDAANVIAYLHTACPRPVVHRDITLSNIWLDEDYVA 193
Query: 168 KLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRG 227
K+ DF++S+SI EGETHI D V+GT G+ AP+YV + F+EK+DV+SFG L LLT +
Sbjct: 194 KVTDFTVSMSILEGETHIEDFVLGTCGYAAPEYVRSGIFNEKIDVFSFGVLLLVLLTDQK 253
Query: 228 ILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIV---------------------------- 259
PF +N +D RF EI+
Sbjct: 254 -------------PFQGNWENILKDARFDEIIGSLIVEKGLWSEKEQLETFLTRTRQKLD 300
Query: 260 ---DPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310
DPIIV++ EKEQQL A L +C++ +RP + DVA++LR S
Sbjct: 301 LTIDPIIVEEGPWPEKEQQLKAFLMLGVQCIDPDEENRPEITDVAKQLRHFYLS 354
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255542668|ref|XP_002512397.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548358|gb|EEF49849.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 221 bits (562), Expect = 5e-55, Method: Compositional matrix adjust.
Identities = 131/305 (42%), Positives = 186/305 (60%), Gaps = 22/305 (7%)
Query: 13 KGKR--TLMIGNGASVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINN 70
KGK+ T+++ NG+ +L++ IA +NG+ I + + A ++ E IN+
Sbjct: 21 KGKKDETVLLRNGSRLLEKSIALNNGRVIVKKYYWASDM---------------EDPIND 65
Query: 71 VTYAAQMS-HDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLK 129
+ +A++MS H ++LKL+GCCLE+ I ILVFE Q G L D +T LL + RL+
Sbjct: 66 IVFASEMSVHKNVLKLLGCCLESKIPILVFECAQKGILKDYFY---KTDSASLLWQIRLR 122
Query: 130 DAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTV 189
AVD A+ ++YLH FPRPIV RD S+IL E+ + K+ FSLS+SIPEG+THI D V
Sbjct: 123 IAVDVASVISYLHSAFPRPIVHRDITLSNILLDEDYIAKVTGFSLSMSIPEGKTHIEDEV 182
Query: 190 MGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNY 249
+GT G+LAP Y T F+EK+DVYSFG L LLTG+ + L Y ++K
Sbjct: 183 VGTPGYLAPAYFKTLMFNEKIDVYSFGVLLLVLLTGQQPI-LHSPTTTARYSLVNFVKEK 241
Query: 250 FEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICC 309
ED RF EI+DP+I+++ EKE+QL L +C +E+ DRP + DVA++LR I
Sbjct: 242 IEDERFDEIIDPVILEEGPWPEKERQLEIFLTLAMQCTHENEEDRPEITDVAKQLRHIYH 301
Query: 310 SLSCN 314
SL N
Sbjct: 302 SLISN 306
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359495254|ref|XP_002271826.2| PREDICTED: wall-associated receptor kinase-like 8-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 194 bits (493), Expect = 4e-47, Method: Compositional matrix adjust.
Identities = 121/322 (37%), Positives = 173/322 (53%), Gaps = 36/322 (11%)
Query: 15 KRTLMIGNGASVLQELIASSNGKYI-PYRIFSAQELKQETNNY--------DQKNGFWH- 64
K+ M+ NG+ +L+E I+ NGKY P R F +EL+ T++Y D N W+
Sbjct: 10 KKESMLKNGSLLLKERISYFNGKYFNPIRSFCMKELQNATDDYNTGLIFDHDVGNCIWYK 69
Query: 65 ------------------ESCINNVTYAAQMS-HDHILKLIGCCLETPIAILVFEYVQHG 105
E IN + A+QMS H + LKL+GCCLET I ILV+E+ G
Sbjct: 70 GSLEGRTISVRTNFYEGVEMAINEIVIASQMSAHKNALKLLGCCLETRIPILVYEFPSGG 129
Query: 106 TLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN 165
+L DRI P PL K RL+ A D AN +AYLH FPR I+ D K S ++
Sbjct: 130 SLIDRIFSPPN----PLSWKSRLRIAYDIANVIAYLHIAFPRSIIHTDIKPSSFFLDQDC 185
Query: 166 VVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225
KL DFSLSI++PEGE H+ D + GT+G+LAP+ + + ++EK DV+SFG L ELL G
Sbjct: 186 AAKLSDFSLSITLPEGEMHVEDEIRGTFGYLAPETLISGVYTEKNDVFSFGILLLELLIG 245
Query: 226 RGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFE 285
+ ++ H+ +Y +++ IVDPII+ +E Q A L
Sbjct: 246 KRAHSIM---HEERASIQDYAQSFVNTYDINGIVDPIILAQPRGIHEELQFQAIFDLAMR 302
Query: 286 CLNESPIDRPTMVDVARRLRQI 307
C + +RPT+V+ A+ +R+I
Sbjct: 303 CSMKDMDERPTIVNAAKEVRRI 324
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297740943|emb|CBI31255.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 194 bits (492), Expect = 5e-47, Method: Compositional matrix adjust.
Identities = 121/322 (37%), Positives = 173/322 (53%), Gaps = 36/322 (11%)
Query: 15 KRTLMIGNGASVLQELIASSNGKYI-PYRIFSAQELKQETNNY--------DQKNGFWH- 64
K+ M+ NG+ +L+E I+ NGKY P R F +EL+ T++Y D N W+
Sbjct: 2 KKESMLKNGSLLLKERISYFNGKYFNPIRSFCMKELQNATDDYNTGLIFDHDVGNCIWYK 61
Query: 65 ------------------ESCINNVTYAAQMS-HDHILKLIGCCLETPIAILVFEYVQHG 105
E IN + A+QMS H + LKL+GCCLET I ILV+E+ G
Sbjct: 62 GSLEGRTISVRTNFYEGVEMAINEIVIASQMSAHKNALKLLGCCLETRIPILVYEFPSGG 121
Query: 106 TLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN 165
+L DRI P PL K RL+ A D AN +AYLH FPR I+ D K S ++
Sbjct: 122 SLIDRIFSPPN----PLSWKSRLRIAYDIANVIAYLHIAFPRSIIHTDIKPSSFFLDQDC 177
Query: 166 VVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225
KL DFSLSI++PEGE H+ D + GT+G+LAP+ + + ++EK DV+SFG L ELL G
Sbjct: 178 AAKLSDFSLSITLPEGEMHVEDEIRGTFGYLAPETLISGVYTEKNDVFSFGILLLELLIG 237
Query: 226 RGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFE 285
+ ++ H+ +Y +++ IVDPII+ +E Q A L
Sbjct: 238 KRAHSIM---HEERASIQDYAQSFVNTYDINGIVDPIILAQPRGIHEELQFQAIFDLAMR 294
Query: 286 CLNESPIDRPTMVDVARRLRQI 307
C + +RPT+V+ A+ +R+I
Sbjct: 295 CSMKDMDERPTIVNAAKEVRRI 316
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|22331843|ref|NP_191332.2| putative protein kinase [Arabidopsis thaliana] gi|18086365|gb|AAL57644.1| AT3g57730/F15B8_80 [Arabidopsis thaliana] gi|21700831|gb|AAM70539.1| AT3g57730/F15B8_80 [Arabidopsis thaliana] gi|332646170|gb|AEE79691.1| putative protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 190 bits (482), Expect = 9e-46, Method: Compositional matrix adjust.
Identities = 119/322 (36%), Positives = 172/322 (53%), Gaps = 42/322 (13%)
Query: 22 NGASVLQELIASSNGKYIPYRIFSAQELKQETNNYD-----QKNGF--WHESCINNVTY- 73
NG+ L+ELI NGK IP R F++ ++++ T N+D + GF W++ I + +Y
Sbjct: 33 NGSIFLKELIVDCNGKSIPIRSFTSSQIRKATKNFDLSCFVAEEGFYIWYKGVIEDRSYM 92
Query: 74 -----------------------AAQMS-HDHILKLIGCCLETPIAILVFEYVQHGTLWD 109
+A+MS H++ LKL+GCCLE P +LVFE+ +HG L
Sbjct: 93 IKRFSEYKVTDYRVSEVYKDIVLSARMSNHNNFLKLLGCCLEFPFPVLVFEFAEHGVLNY 152
Query: 110 RILGAPQTHFEPLL-LKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVK 168
R G E LL L RLK + ANALAYLH FP+ I++RD K H+ K
Sbjct: 153 R-GGITVNGEESLLPLSLRLKIGKEIANALAYLHMAFPKIIIYRDVKPLHVFLDNNWTAK 211
Query: 169 LFDFSLSISIPEGETHI-TDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRG 227
L D S SIS+ EG++ I + V+GTYG+L P Y T +E DVYSFG FL ++TG
Sbjct: 212 LSDLSFSISLEEGKSQIEAEDVLGTYGYLDPLYFATRIVTEYTDVYSFGVFLMVVITGIS 271
Query: 228 ILDLVRDAHDLVYPFN--EYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFE 285
+ D YP Y+K E+ + EIV P+I+++++ ++ Q+ A L
Sbjct: 272 VYFTGSDG----YPVGILGYMKGLAENGKLNEIVYPMIMKEMTSAQR-LQVEACVLLALR 326
Query: 286 CLNESPIDRPTMVDVARRLRQI 307
C E DRP M+ VA+ L++I
Sbjct: 327 CCEERVEDRPKMIQVAKELKRI 348
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|4678274|emb|CAB41182.1| putative protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 189 bits (481), Expect = 9e-46, Method: Compositional matrix adjust.
Identities = 119/322 (36%), Positives = 172/322 (53%), Gaps = 42/322 (13%)
Query: 22 NGASVLQELIASSNGKYIPYRIFSAQELKQETNNYD-----QKNGF--WHESCINNVTY- 73
NG+ L+ELI NGK IP R F++ ++++ T N+D + GF W++ I + +Y
Sbjct: 30 NGSIFLKELIVDCNGKSIPIRSFTSSQIRKATKNFDLSCFVAEEGFYIWYKGVIEDRSYM 89
Query: 74 -----------------------AAQMS-HDHILKLIGCCLETPIAILVFEYVQHGTLWD 109
+A+MS H++ LKL+GCCLE P +LVFE+ +HG L
Sbjct: 90 IKRFSEYKVTDYRVSEVYKDIVLSARMSNHNNFLKLLGCCLEFPFPVLVFEFAEHGVLNY 149
Query: 110 RILGAPQTHFEPLL-LKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVK 168
R G E LL L RLK + ANALAYLH FP+ I++RD K H+ K
Sbjct: 150 R-GGITVNGEESLLPLSLRLKIGKEIANALAYLHMAFPKIIIYRDVKPLHVFLDNNWTAK 208
Query: 169 LFDFSLSISIPEGETHI-TDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRG 227
L D S SIS+ EG++ I + V+GTYG+L P Y T +E DVYSFG FL ++TG
Sbjct: 209 LSDLSFSISLEEGKSQIEAEDVLGTYGYLDPLYFATRIVTEYTDVYSFGVFLMVVITGIS 268
Query: 228 ILDLVRDAHDLVYPFN--EYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFE 285
+ D YP Y+K E+ + EIV P+I+++++ ++ Q+ A L
Sbjct: 269 VYFTGSDG----YPVGILGYMKGLAENGKLNEIVYPMIMKEMTSAQR-LQVEACVLLALR 323
Query: 286 CLNESPIDRPTMVDVARRLRQI 307
C E DRP M+ VA+ L++I
Sbjct: 324 CCEERVEDRPKMIQVAKELKRI 345
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 314 | ||||||
| TAIR|locus:2076671 | 355 | AT3G57730 [Arabidopsis thalian | 0.738 | 0.653 | 0.403 | 2.3e-48 | |
| TAIR|locus:2076586 | 351 | AT3G57710 [Arabidopsis thalian | 0.796 | 0.712 | 0.367 | 4.7e-48 | |
| TAIR|locus:2076681 | 359 | AT3G57720 [Arabidopsis thalian | 0.748 | 0.654 | 0.370 | 3.3e-45 | |
| TAIR|locus:2094468 | 433 | AT3G25490 [Arabidopsis thalian | 0.735 | 0.533 | 0.360 | 1.2e-43 | |
| TAIR|locus:2126316 | 786 | AT4G31100 [Arabidopsis thalian | 0.754 | 0.301 | 0.362 | 3.2e-43 | |
| TAIR|locus:2126271 | 793 | AT4G31110 [Arabidopsis thalian | 0.754 | 0.298 | 0.370 | 8.4e-43 | |
| TAIR|locus:2076596 | 340 | AT3G57700 [Arabidopsis thalian | 0.789 | 0.729 | 0.348 | 8.5e-43 | |
| TAIR|locus:2016377 | 788 | AT1G19390 [Arabidopsis thalian | 0.761 | 0.303 | 0.365 | 2.1e-41 | |
| TAIR|locus:2200552 | 730 | WAKL1 "wall associated kinase- | 0.742 | 0.319 | 0.379 | 1.1e-40 | |
| TAIR|locus:2019893 | 751 | RFO1 "RESISTANCE TO FUSARIUM O | 0.742 | 0.310 | 0.404 | 3e-40 |
| TAIR|locus:2076671 AT3G57730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 420 (152.9 bits), Expect = 2.3e-48, Sum P(2) = 2.3e-48
Identities = 98/243 (40%), Positives = 139/243 (57%)
Query: 70 NVTYAAQMS-HDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLL-LKRR 127
++ +A+MS H++ LKL+GCCLE P +LVFE+ +HG L R G E LL L R
Sbjct: 112 DIVLSARMSNHNNFLKLLGCCLEFPFPVLVFEFAEHGVLNYRG-GITVNGEESLLPLSLR 170
Query: 128 LKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHI-T 186
LK + ANALAYLH FP+ I++RD K H+ KL D S SIS+ EG++ I
Sbjct: 171 LKIGKEIANALAYLHMAFPKIIIYRDVKPLHVFLDNNWTAKLSDLSFSISLEEGKSQIEA 230
Query: 187 DTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFN--E 244
+ V+GTYG+L P Y T +E DVYSFG FL ++TG + D YP
Sbjct: 231 EDVLGTYGYLDPLYFATRIVTEYTDVYSFGVFLMVVITGISVYFTGSDG----YPVGILG 286
Query: 245 YLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRL 304
Y+K E+ + EIV P+I+++++ ++ Q+ A L C E DRP M+ VA+ L
Sbjct: 287 YMKGLAENGKLNEIVYPMIMKEMTSAQR-LQVEACVLLALRCCEERVEDRPKMIQVAKEL 345
Query: 305 RQI 307
++I
Sbjct: 346 KRI 348
|
|
| TAIR|locus:2076586 AT3G57710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 416 (151.5 bits), Expect = 4.7e-48, Sum P(2) = 4.7e-48
Identities = 96/261 (36%), Positives = 147/261 (56%)
Query: 57 DQKNGFWH--ESCINNVTYAAQMS-HDHILKLIGCCLETPIAILVFEYVQHGTLWDRILG 113
D+ G H + N++ +A+MS H + L+L+GCCLE P +LVFE+ +HG + R G
Sbjct: 92 DEITGKRHRVKEVYNDIVLSARMSNHSNFLQLLGCCLEFPFPVLVFEFAEHGAMNQR--G 149
Query: 114 APQTHFEPLLL--KRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171
+ E LL RLK + ANA+ YLH FP+ I+ RD K H+ + KL D
Sbjct: 150 GVIVNGEESLLPWSVRLKIGKEIANAVTYLHTAFPKIIIHRDVKPMHVFLDKNWTAKLSD 209
Query: 172 FSLSISIPEGETHI-TDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILD 230
S SIS+PEG++ I + V+GT+G++ P Y TC +E DVYSFG L ++TG+ +
Sbjct: 210 LSFSISLPEGKSRIEAEWVLGTFGYIDPLYHKTCFVTEYTDVYSFGICLLVIITGKPAIM 269
Query: 231 LVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNES 290
+ D DL ++ E+ + E++DP +++D++ ++ Q+ A L C E
Sbjct: 270 TISDG-DL-QGILSLVRELCENGKLDEVIDPRLMKDITSGQR-LQVEACVVLALRCCKER 326
Query: 291 PIDRPTMVDVARRLRQICCSL 311
DRP M+ VA+ L+QI SL
Sbjct: 327 DEDRPKMIQVAKELKQIEASL 347
|
|
| TAIR|locus:2076681 AT3G57720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 399 (145.5 bits), Expect = 3.3e-45, Sum P(2) = 3.3e-45
Identities = 90/243 (37%), Positives = 137/243 (56%)
Query: 69 NNVTYAAQMS-HDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLL--K 125
N + +A+MS H++ LKLIG CLE + +LVFEY +HG L R G + E ++L
Sbjct: 114 NEIVLSARMSNHNNFLKLIGFCLEFSLPVLVFEYAEHGVLNHR--GGVIVNGEEVILPLS 171
Query: 126 RRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHI 185
RLK + ANA+ YLH FP+ ++ R K ++ E KL DFS+SI++PEG++ I
Sbjct: 172 LRLKIGKEIANAVTYLHMAFPKILIHRHIKPRNVFLDENWTPKLSDFSISINLPEGKSRI 231
Query: 186 -TDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNE 244
+ V GT G+L P Y TT +E DVYSFG FL +LTG+ L D +
Sbjct: 232 EVECVQGTIGYLDPVYYTTKMVTEYTDVYSFGVFLMVILTGKPALASTSSDGDYKH-IAS 290
Query: 245 YLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRL 304
Y+K + E+ + ++DP +++D++ +K + A L C +RP M+ +A+ L
Sbjct: 291 YVKGFHENGQLDGVIDPKVMEDITSAQKVH-VEACVVLALRCCELRDENRPKMIQIAKEL 349
Query: 305 RQI 307
+QI
Sbjct: 350 KQI 352
|
|
| TAIR|locus:2094468 AT3G25490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 398 (145.2 bits), Expect = 1.2e-43, Sum P(2) = 1.2e-43
Identities = 89/247 (36%), Positives = 142/247 (57%)
Query: 65 ESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLL 124
E IN V +Q++H +++KL+GCCLET + +LV+E++ G+L+D + G+ L
Sbjct: 147 EQFINEVLVLSQINHRNVVKLLGCCLETEVPLLVYEFITGGSLFDHLHGS--MFVSSLTW 204
Query: 125 KRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETH 184
+ RL+ A++ A A+AYLH G PI+ RD KT +IL E K+ DF S P +
Sbjct: 205 EHRLEIAIEVAGAIAYLHSGASIPIIHRDIKTENILLDENLTAKVADFGASKLKPMDKEQ 264
Query: 185 ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNE 244
+T V GT G+L P+Y TT +EK DVYSFG L EL++G+ L R ++
Sbjct: 265 LTTMVQGTLGYLDPEYYTTWLLNEKSDVYSFGVVLMELISGQKALCFERPET------SK 318
Query: 245 YLKNYF----EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDV 300
+L +YF ++NR EI+D ++ + E ++++H +A++ EC +RP M++V
Sbjct: 319 HLVSYFVLATKENRLHEIIDDQVLNE----ENQREIHEAARVAVECTRLKGEERPRMIEV 374
Query: 301 ARRLRQI 307
A L +
Sbjct: 375 AAELETL 381
|
|
| TAIR|locus:2126316 AT4G31100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 407 (148.3 bits), Expect = 3.2e-43, Sum P(2) = 3.2e-43
Identities = 88/243 (36%), Positives = 142/243 (58%)
Query: 68 INNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRR 127
IN V +Q++H H++KL+GCCLET + ILV+E++ +G L+ I + ++ R
Sbjct: 486 INEVVILSQINHRHVVKLLGCCLETEVPILVYEFIINGNLFKHIHEEEADDYT-MIWGMR 544
Query: 128 LKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITD 187
L+ AVD A AL+YLH PI RD K+++IL E+ K+ DF S S+ +TH T
Sbjct: 545 LRIAVDIAGALSYLHSAASSPIYHRDIKSTNILLDEKYRAKVADFGTSRSVTIDQTHWTT 604
Query: 188 TVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLK 247
+ GT G++ P+Y + ++EK DVYSFG L+EL+TG + +V++ +++ E+ +
Sbjct: 605 VISGTVGYVDPEYYRSSQYTEKSDVYSFGVILAELITGDKPVIMVQNTQEII-ALAEHFR 663
Query: 248 NYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQI 307
++ R ++I+D I D K +Q+ A A L +CL+ +RP M +V L +I
Sbjct: 664 VAMKERRLSDIMDARIRDD----SKPEQVMAVANLAMKCLSSRGRNRPNMREVFTELERI 719
Query: 308 CCS 310
C S
Sbjct: 720 CTS 722
|
|
| TAIR|locus:2126271 AT4G31110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 413 (150.4 bits), Expect = 8.4e-43, Sum P(2) = 8.4e-43
Identities = 90/243 (37%), Positives = 143/243 (58%)
Query: 68 INNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRR 127
IN V +Q++H H++KL+GCCLET + +LV+E++ +G L+ I + +L R
Sbjct: 495 INEVVILSQINHRHVVKLLGCCLETEVPMLVYEFIINGNLFKHIHEEESDDYT-MLWGMR 553
Query: 128 LKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITD 187
L+ AVD A AL+YLH PI RD K+++IL E+ K+ DF S S+ +TH T
Sbjct: 554 LRIAVDIAGALSYLHSSASSPIYHRDIKSTNILLDEKYRAKVADFGTSRSVTIDQTHWTT 613
Query: 188 TVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLK 247
+ GT G++ P+Y + ++EK DVYSFG L+EL+TG + +V++ ++V E+ +
Sbjct: 614 VISGTVGYVDPEYYQSSQYTEKSDVYSFGVILAELITGDKPVIMVQNTQEIV-ALAEHFR 672
Query: 248 NYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQI 307
++ R T+I+D I D C K +Q+ A A++ +CL+ RP M +V L +I
Sbjct: 673 VAMKEKRLTDIIDARIRND--C--KPEQVMAVAKVAMKCLSSKGKKRPNMREVFTELERI 728
Query: 308 CCS 310
C S
Sbjct: 729 CTS 731
|
|
| TAIR|locus:2076596 AT3G57700 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 364 (133.2 bits), Expect = 8.5e-43, Sum P(2) = 8.5e-43
Identities = 91/261 (34%), Positives = 138/261 (52%)
Query: 51 QETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDR 110
Q+ + +D N F+ + ++++ SH ++LKL+GCCLE P +LV EY +HG L
Sbjct: 85 QDCSVFDADN-FYRDIAVSSL----MSSHKNVLKLLGCCLEFPRPVLVCEYPEHGALNCI 139
Query: 111 ILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170
G P + RL+ A + A+A+AYLH FPR I+ RD K ++I E KL
Sbjct: 140 RCGKEGVRSFPWNV--RLRIAKEIADAVAYLHTEFPRTIIHRDLKLANIFLDENWSAKLS 197
Query: 171 DFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILD 230
FSLSI +PEGET + D V T ++ P Y T +E +D+YS G + +LTG+ +
Sbjct: 198 SFSLSIVLPEGETGVNDMVCRTSSYIEPDYFNTGLVTENVDIYSLGIIMLIILTGKSEYN 257
Query: 231 LVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCT---EKEQQLHASAQLTFECL 287
+ V P Y+ + E TE++DP I+ S Q+ A +L F C+
Sbjct: 258 SEVAVYLPVLPV--YVGKFLERGLLTELIDPSILDSTSDDIPKHSRLQMEAFIELAFRCV 315
Query: 288 NESPIDR-PTMVDVARRLRQI 307
P + P M+DVA+ L++I
Sbjct: 316 RFRPGENVPRMIDVAKELKKI 336
|
|
| TAIR|locus:2016377 AT1G19390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 379 (138.5 bits), Expect = 2.1e-41, Sum P(2) = 2.1e-41
Identities = 90/246 (36%), Positives = 137/246 (55%)
Query: 65 ESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLL 124
E IN V +Q++H H++KL+GCCLET + LV+E++ +G L+ I + + +
Sbjct: 490 EEFINEVVILSQINHRHVVKLLGCCLETEVPTLVYEFIPNGNLFQHIHEESDDYTKTWGM 549
Query: 125 KRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETH 184
RL+ AVD A AL+YLH PI RD K+++IL E+ K+ DF S S+ TH
Sbjct: 550 --RLRIAVDIAGALSYLHSAASSPIYHRDIKSTNILLDEKYRTKVSDFGTSRSVTIDHTH 607
Query: 185 ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNE 244
T + GT G++ P+Y + +++K DVYSFG L EL+TG + V ++ + + +
Sbjct: 608 WTTVISGTVGYVDPEYYGSSQYTDKSDVYSFGVVLVELITGEKPVITVSNSQE-IRGLAD 666
Query: 245 YLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRL 304
+ + ++NRF EI+D I +D C K +Q+ A A L CLN RP M V L
Sbjct: 667 HFRVAMKENRFFEIMDARI-RD-GC--KPEQVMAVANLARRCLNSKGKKRPCMRKVFTDL 722
Query: 305 RQICCS 310
+I S
Sbjct: 723 EKILAS 728
|
|
| TAIR|locus:2200552 WAKL1 "wall associated kinase-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 401 (146.2 bits), Expect = 1.1e-40, Sum P(2) = 1.1e-40
Identities = 93/245 (37%), Positives = 143/245 (58%)
Query: 65 ESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLL 124
E IN + +Q++H +I+KL+GCCLET + ILV+EY+ +G L+ R+ + +
Sbjct: 468 EEFINEIVLLSQINHRNIVKLLGCCLETEVPILVYEYIPNGDLFKRLHDESDDY--TMTW 525
Query: 125 KRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETH 184
+ RL+ A++ A AL Y+H PI RD KT++IL E+ K+ DF S S+ +TH
Sbjct: 526 EVRLRIAIEIAGALTYMHSAASFPIFHRDIKTTNILLDEKYRAKVSDFGTSRSVTLDQTH 585
Query: 185 ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVR--DAHDLVYPF 242
+T V GT+G++ P+Y + ++ K DVYSFG L EL+TG L VR + L F
Sbjct: 586 LTTLVAGTFGYMDPEYFLSSQYTHKSDVYSFGVVLVELITGEKPLSRVRSEEGRGLATHF 645
Query: 243 NEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302
E +K +NR +I+D I ++D S K +Q+ A A+L +CLN +RP M +V+
Sbjct: 646 LEAMK----ENRVIDIID-IRIKDES---KLEQVMAVAKLARKCLNRKGKNRPNMKEVSN 697
Query: 303 RLRQI 307
L +I
Sbjct: 698 ELERI 702
|
|
| TAIR|locus:2019893 RFO1 "RESISTANCE TO FUSARIUM OXYSPORUM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 394 (143.8 bits), Expect = 3.0e-40, Sum P(2) = 3.0e-40
Identities = 99/245 (40%), Positives = 141/245 (57%)
Query: 65 ESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLL 124
E IN V +Q++H +I+KL+GCCLET + ILV+E++ +G L+ R+ + +
Sbjct: 460 EEFINEVGVLSQINHRNIVKLMGCCLETEVPILVYEHIPNGDLFKRLHHDSDDY--TMTW 517
Query: 125 KRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETH 184
RL+ +V+ A ALAYLH P+ RD KT++IL E+ K+ DF S SI +TH
Sbjct: 518 DVRLRISVEIAGALAYLHSAASTPVYHRDVKTTNILLDEKYRAKVSDFGTSRSINVDQTH 577
Query: 185 ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHD--LVYPF 242
+T V GT+G+L P+Y T F++K DVYSFG L EL+TG ++R + LV F
Sbjct: 578 LTTLVAGTFGYLDPEYFQTSQFTDKSDVYSFGVVLVELITGEKPFSVMRPEENRGLVSHF 637
Query: 243 NEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302
NE +K NR +IVD I + CT EQ L A A+L CL+ RP M +V+
Sbjct: 638 NEAMKQ----NRVLDIVDSRIKE--GCT-LEQVL-AVAKLARRCLSLKGKKRPNMREVSV 689
Query: 303 RLRQI 307
L +I
Sbjct: 690 ELERI 694
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pm.C_LG_XIII000087 | hypothetical protein (344 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 314 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-26 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-24 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-24 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-23 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-22 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-19 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-18 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-16 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-14 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-13 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-13 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-12 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-12 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-12 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-12 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-12 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-12 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-12 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-11 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-11 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-10 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-10 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-10 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-10 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-10 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-09 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-09 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-09 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-09 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-09 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-09 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-09 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-09 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-09 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-09 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-09 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-09 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-09 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-09 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-09 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-09 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-09 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 9e-09 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-09 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-08 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-08 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-08 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-08 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-08 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-08 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-08 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-08 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-08 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-08 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-08 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-08 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-08 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-08 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-08 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-07 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-07 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-07 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-07 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-07 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-07 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-07 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-07 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-07 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-07 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-07 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-07 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-07 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-07 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-07 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-07 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-07 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-07 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-07 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-07 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-07 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-07 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 9e-07 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-06 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-06 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-06 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-06 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-06 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-06 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-06 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-06 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-06 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-06 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-06 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-06 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-06 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-06 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-06 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-06 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-06 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-06 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-06 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-06 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-06 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-06 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-06 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-06 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-06 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-06 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-06 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-06 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-06 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-06 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-06 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-06 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 9e-06 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-05 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-05 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-05 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-05 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-05 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-05 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-05 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-05 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-05 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-05 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-05 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-05 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-05 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-05 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-05 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-05 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-05 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 6e-05 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-05 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-05 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 9e-05 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 9e-05 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-04 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-04 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-04 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-04 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-04 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-04 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-04 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-04 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-04 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-04 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-04 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-04 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-04 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-04 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-04 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-04 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-04 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-04 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-04 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-04 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 7e-04 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-04 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 8e-04 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-04 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 0.001 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 0.001 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 0.001 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 0.001 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 0.001 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 0.001 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 0.001 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 0.001 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 0.001 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 0.001 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.001 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 0.001 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 0.002 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.002 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 0.002 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 0.002 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 0.002 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 0.003 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 0.003 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 0.003 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 0.003 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.003 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.004 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 0.004 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 9e-26
Identities = 57/232 (24%), Positives = 93/232 (40%), Gaps = 32/232 (13%)
Query: 75 AQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA 134
++ H +++KL+G C E +V EY++ G L + + + L L L A+
Sbjct: 56 RKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL----RKNRPKLSLSDLLSFALQI 111
Query: 135 ANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYG 194
A + YL + + RD + L E VVK+ DF LS + + + +
Sbjct: 112 ARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR 168
Query: 195 HLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPF--NEYLKNYFED 252
+AP+ + F+ K DV+SFG L E+ T G YP NE + Y ++
Sbjct: 169 WMAPESLKEGKFTSKSDVWSFGVLLWEIFT-LGEQP---------YPGMSNEEVLEYLKN 218
Query: 253 NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRL 304
+C + L +C E P DRPT ++ L
Sbjct: 219 GYRLPQPP-------NCPPE------LYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 4e-24
Identities = 58/232 (25%), Positives = 91/232 (39%), Gaps = 31/232 (13%)
Query: 75 AQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA 134
++ H +I+KL+G C E ++V EY+ G L L + L L L A+
Sbjct: 56 RKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDL-LDYLRKNRPKE--LSLSDLLSFALQI 112
Query: 135 ANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYG 194
A + YL + + RD + L E VVK+ DF LS + + + +
Sbjct: 113 ARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR 169
Query: 195 HLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPF--NEYLKNYFED 252
+AP+ + F+ K DV+SFG L E+ T G YP N + Y +
Sbjct: 170 WMAPESLKEGKFTSKSDVWSFGVLLWEIFT-LGEEP---------YPGMSNAEVLEYLKK 219
Query: 253 NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRL 304
+C + +L +C E P DRPT ++ L
Sbjct: 220 GYRLPKPP-------NCPPE------LYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 5e-24
Identities = 65/238 (27%), Positives = 101/238 (42%), Gaps = 45/238 (18%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAA 135
++SH +I++L+G C + +V EY+ G L D + + H E L LK L+ A+ A
Sbjct: 57 KLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL----RKHGEKLTLKDLLQMALQIA 112
Query: 136 NALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGH 195
+ YL + V RD + L +E VVK+ DF LS I E + G
Sbjct: 113 KGMEYLES---KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDY----YRKRGGGK 165
Query: 196 L-----APQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPF----NEYL 246
L AP+ + F+ K DV+SFG L E+ T P+ NE +
Sbjct: 166 LPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQ------------PYPGMSNEEV 213
Query: 247 KNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRL 304
ED + + +C + +L+ +L +C P DRPT ++ L
Sbjct: 214 LELLEDGY-------RLPRPENCPD---ELY---ELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 4e-23
Identities = 50/178 (28%), Positives = 83/178 (46%), Gaps = 13/178 (7%)
Query: 58 QKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQT 117
+ + E + + +++H +I+KL G + LV EY + G+L D + +
Sbjct: 29 EDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLL----KE 84
Query: 118 HFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN-VVKLFDFSLSI 176
+ L L+ + L YLH I+ RD K +IL +N VKL DF LS
Sbjct: 85 NEGKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSK 141
Query: 177 SIPEGETHITDTVMGTYGHLAP-QYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVR 233
+ + + T++GT ++AP + +SEK D++S G L EL + DL+R
Sbjct: 142 LLTSDK-SLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---PELKDLIR 195
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 3e-22
Identities = 65/244 (26%), Positives = 100/244 (40%), Gaps = 47/244 (19%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWD----RILGAPQTHFEPLLLKRRLKDA 131
++ H ++++L+G C E LV EY++ G L D P L LK L A
Sbjct: 52 KLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFA 111
Query: 132 VDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMG 191
+ A + YL + V RD + L E+ VVK+ DF LS + + +
Sbjct: 112 IQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD----YYRKK 164
Query: 192 TYGHL-----APQYVTTCDFSEKLDVYSFGAFLSELLT-GR----GILDLVRDAHDLVYP 241
T G L AP+ + F+ K DV+SFG L E+ T G G+ +++
Sbjct: 165 TGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL-----SNEEVL-- 217
Query: 242 FNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVA 301
EYL+ R + + C ++ +L S C P DRPT ++
Sbjct: 218 --EYLRK---GYR--------LPKPEYCPDELYELMLS------CWQLDPEDRPTFSELV 258
Query: 302 RRLR 305
RL
Sbjct: 259 ERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-19
Identities = 66/266 (24%), Positives = 106/266 (39%), Gaps = 43/266 (16%)
Query: 42 RIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEY 101
+I + + LK+ + + E I ++SH +I++LI + LV EY
Sbjct: 25 KIVAVKILKKRSEKSKKDQTARREIRIL-----RRLSHPNIVRLIDAFEDKDHLYLVMEY 79
Query: 102 VQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILF 161
+ G L+D + K+ + L YLH I+ RD K +IL
Sbjct: 80 CEGGDLFDYLS--RGGPLSEDEAKKIALQIL---RGLEYLH---SNGIIHRDLKPENILL 131
Query: 162 SEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAP-QYVTTCDFSEKLDVYSFGAFLS 220
E VVK+ DF L+ + T +GT ++AP + + K+DV+S G L
Sbjct: 132 DENGVVKIADFGLA-KKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILY 190
Query: 221 ELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCT-----EKEQQ 275
ELLTG+ PF +N ++ +I + L K
Sbjct: 191 ELLTGK-------------PPF-------SGENILDQLQ--LIRRILGPPLEFDEPKWSS 228
Query: 276 LHASAQ-LTFECLNESPIDRPTMVDV 300
A+ L +CLN+ P RPT ++
Sbjct: 229 GSEEAKDLIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-18
Identities = 59/239 (24%), Positives = 100/239 (41%), Gaps = 26/239 (10%)
Query: 77 MSHDHILKLIGCCLET--PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA 134
+ H++I+K G C + L+ EY+ G+L D + Q H + + LKR L +
Sbjct: 63 LDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL----QRHRDQINLKRLLLFSSQI 118
Query: 135 ANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHIT-----DTV 189
+ YL + + RD +IL E++VK+ DF L+ +PE + + ++
Sbjct: 119 CKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESP 175
Query: 190 MGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNY 249
+ Y AP+ + T FS DV+SFG L EL T G A L +
Sbjct: 176 IFWY---APECLRTSKFSSASDVWSFGVTLYELFT-YGDPSQSPPAEFLRMIGIAQGQMI 231
Query: 250 FEDNRFTEIVDPIIVQDLSCTEK-EQQLHASAQLTFECLNESPIDRPTMVDVARRLRQI 307
R E++ + L +++ L C P DRP+ D+ + ++
Sbjct: 232 VT--RLLELLKE--GERLPRPPSCPDEVY---DLMKLCWEAEPQDRPSFADLILIVDRL 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 81.4 bits (202), Expect = 6e-18
Identities = 46/151 (30%), Positives = 75/151 (49%), Gaps = 10/151 (6%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAA 135
++ H +I++L + LV EY + G L+D + + + L+ +
Sbjct: 53 KLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLK--KRGRLSEDEARFYLRQILS-- 108
Query: 136 NALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGH 195
AL YLH + IV RD K +IL E+ VKL DF L+ + GE T +GT +
Sbjct: 109 -ALEYLH---SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK--LTTFVGTPEY 162
Query: 196 LAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
+AP+ + + + +D++S G L ELLTG+
Sbjct: 163 MAPEVLLGKGYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 7e-16
Identities = 57/238 (23%), Positives = 100/238 (42%), Gaps = 29/238 (12%)
Query: 68 INNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRR 127
+N + + + H +I+ ++ ++ EY GTL+D+I+ FE ++
Sbjct: 47 LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWY 106
Query: 128 LKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITD 187
L V +A++Y+H I+ RD KT +I ++ ++KL DF +S I E + +
Sbjct: 107 LFQIV---SAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGIS-KILGSEYSMAE 159
Query: 188 TVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLK 247
TV+GT +++P+ ++ K D+++ G L ELLT LK
Sbjct: 160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLT---------------------LK 198
Query: 248 NYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLR 305
F+ +V IVQ L L + P RPT +V +
Sbjct: 199 RTFDATNPLNLVVK-IVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 2e-14
Identities = 48/165 (29%), Positives = 76/165 (46%), Gaps = 15/165 (9%)
Query: 65 ESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLL- 123
E IN + + H +I+K G L+ +V E+ G+L D + QT E +
Sbjct: 42 EKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIA 101
Query: 124 --LKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEG 181
K LK L YLH I+ RD K ++IL + + VKL DF LS + +
Sbjct: 102 YVCKELLK-------GLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151
Query: 182 ETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
+ +T++GT +AP+ + + K D++S G EL G+
Sbjct: 152 KA--RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 1e-13
Identities = 43/156 (27%), Positives = 75/156 (48%), Gaps = 15/156 (9%)
Query: 76 QMSHDHILKLIGCCL-ETPIAILVF-EYVQHGTLWDRI--LGAPQTHFEPLLLKRRLKDA 131
+ H +I++ G E + +F EYV G+L + G ++++ +
Sbjct: 55 SLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGK----LPEPVIRKYTRQI 110
Query: 132 VDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGET-HITDTVM 190
++ LAYLH IV RD K ++IL + VVKL DF + + + ET T +V
Sbjct: 111 LEG---LAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVR 164
Query: 191 GTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
GT +AP+ + ++ D++S G + E+ TG+
Sbjct: 165 GTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 5e-13
Identities = 49/170 (28%), Positives = 77/170 (45%), Gaps = 14/170 (8%)
Query: 60 NGFWHESC-INNVTYAAQMSHDHILKLIGCCLET--PIAILVFEYVQHGTLWDRILGAPQ 116
G + S + + H++I+K GCC E L+ EYV G+L D + P+
Sbjct: 45 CGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL---PK 101
Query: 117 THFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176
L L + L A +AYLH + + RD ++L + +VK+ DF L+
Sbjct: 102 HK---LNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 155
Query: 177 SIPEGETH--ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT 224
++PEG + + + A + + FS DV+SFG L ELLT
Sbjct: 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 5e-13
Identities = 47/173 (27%), Positives = 77/173 (44%), Gaps = 29/173 (16%)
Query: 77 MSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAAN 136
+ H+++++L G L P+ ++V E G+L DR+ + L+ AV AN
Sbjct: 53 LDHENLIRLYGVVLTHPL-MMVTELAPLGSLLDRL---RKDALGHFLISTLCDYAVQIAN 108
Query: 137 ALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHL 196
+ YL + + RD +IL + ++ VK+ DF L ++P+ E H HL
Sbjct: 109 GMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEE-----HL 160
Query: 197 -------APQYVTTCDFSEKLDVYSFGAFLSEL----------LTGRGILDLV 232
AP+ + T FS DV+ FG L E+ L+G IL +
Sbjct: 161 KVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 5e-13
Identities = 62/229 (27%), Positives = 96/229 (41%), Gaps = 19/229 (8%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAA 135
++ H +I+KLIG C A L+ EY++ L + + L +RR K A+ A
Sbjct: 739 KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIA 790
Query: 136 NALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGH 195
AL +LH +V + I+ ++ L +S+P G + +
Sbjct: 791 KALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL-----RLSLP-GLLCTDTKCFISSAY 844
Query: 196 LAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRF 255
+AP+ T D +EK D+Y FG L ELLTG+ D H + + Y + D
Sbjct: 845 VAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYC---YSDCHL 901
Query: 256 TEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRL 304
+DP I D+S + E + L C P RP DV + L
Sbjct: 902 DMWIDPSIRGDVSVNQNE--IVEVMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 1e-12
Identities = 45/179 (25%), Positives = 84/179 (46%), Gaps = 13/179 (7%)
Query: 49 LKQ-ETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTL 107
+KQ ++ +S + + + H +I+K IG + ++ EY ++G+L
Sbjct: 30 IKQISLEKIKEEA---LKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSL 86
Query: 108 WDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVV 167
I F L+ + + LAYLH + ++ RD K ++IL +++ VV
Sbjct: 87 RQII--KKFGPFPESLVAVYVYQVLQG---LAYLH---EQGVIHRDIKAANILTTKDGVV 138
Query: 168 KLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
KL DF ++ + + + +V+GT +AP+ + S D++S G + ELLTG
Sbjct: 139 KLADFGVATKLND-VSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-12
Identities = 68/299 (22%), Positives = 111/299 (37%), Gaps = 61/299 (20%)
Query: 21 GNGASVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHD 80
GN SV++ + +GK + + + LKQE +K F E+ + AQ+ H
Sbjct: 6 GNFGSVVKGVYLMKSGKEVEVAV---KTLKQEHIAAGKKE-FLREASV-----MAQLDHP 56
Query: 81 HILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAY 140
I++LIG C P+ +LV E G L + + L A A +AY
Sbjct: 57 CIVRLIGVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDLKEL-----AHQVAMGMAY 110
Query: 141 L---HFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTY--GH 195
L HF V RD ++L + K+ DF +S ++ G + T G +
Sbjct: 111 LESKHF------VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKW 164
Query: 196 LAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRF 255
AP+ + FS K DV+S+G L E + + +
Sbjct: 165 YAPECINYGKFSSKSDVWSYGVTLWEAFS-------------------------YGAKPY 199
Query: 256 TEIVDPIIVQDLSCTEKEQQLHASA-------QLTFECLNESPIDRPTMVDVARRLRQI 307
E+ ++ L E ++L + C P DRPT ++ R+
Sbjct: 200 GEMKGAEVIAML---ESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 66.7 bits (161), Expect = 2e-12
Identities = 61/231 (26%), Positives = 95/231 (41%), Gaps = 24/231 (10%)
Query: 78 SHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANA 137
+I+KL + LV EYV G+L D + PL L +A
Sbjct: 56 HPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLL--KKIGRKGPLSESEALFILAQILSA 113
Query: 138 LAYLHFGFPRPIVFRDFKTSHILFSEE-NVVKLFDFSLSISIPEGETH-----ITDTVMG 191
L YLH + I+ RD K +IL + VVKL DF L+ +P+ + + T +G
Sbjct: 114 LEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVG 170
Query: 192 TYGHLAPQYVT---TCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKN 248
T G++AP+ + S D++S G L ELLTG + ++ LK
Sbjct: 171 TPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGL----PPFEGEKNSSATSQTLKI 226
Query: 249 YFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVD 299
E+ P + LS + E A++ L + L + P +R +
Sbjct: 227 ------ILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSS 271
|
Length = 384 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-12
Identities = 57/229 (24%), Positives = 94/229 (41%), Gaps = 30/229 (13%)
Query: 80 DHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALA 139
+I+ G L + E++ G+L DRI P+ ++ K AV L
Sbjct: 63 PYIVSFYGAFLNENNICMCMEFMDCGSL-DRIY----KKGGPIPVEILGKIAVAVVEGLT 117
Query: 140 YLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGE--THITDTVMGTYGHLA 197
YL+ I+ RD K S+IL + +KL DF +S GE I DT +GT +++
Sbjct: 118 YLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVS-----GELINSIADTFVGTSTYMS 170
Query: 198 PQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTE 257
P+ + ++ K DV+S G + EL G+ +PF + +
Sbjct: 171 PERIQGGKYTVKSDVWSLGISIIELALGK-------------FPFAFSNIDDDGQDDPMG 217
Query: 258 IVDPI--IVQDLSCTEKEQQLHASAQLTFE-CLNESPIDRPTMVDVARR 303
I+D + IVQ+ + + CL + P +RPT +
Sbjct: 218 ILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-12
Identities = 51/181 (28%), Positives = 83/181 (45%), Gaps = 23/181 (12%)
Query: 51 QETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET-PIAILVFEYVQHGTLWD 109
+ T D K F E+ I Q H +I+KLIG C++ PI I V E V G+L
Sbjct: 28 RSTLPPDLKRKFLQEAEI-----LKQYDHPNIVKLIGVCVQKQPIYI-VMELVPGGSLLT 81
Query: 110 RILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKL 169
+ + L +K+ L+ ++DAA + YL + + RD + L E NV+K+
Sbjct: 82 FL----RKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKI 134
Query: 170 FDFSLSISIPEGETHITD-----TVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT 224
DF +S G ++D + T AP+ + ++ + DV+S+G L E +
Sbjct: 135 SDFGMSREEEGGIYTVSDGLKQIPIKWT----APEALNYGRYTSESDVWSYGILLWETFS 190
Query: 225 G 225
Sbjct: 191 L 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-12
Identities = 39/165 (23%), Positives = 79/165 (47%), Gaps = 13/165 (7%)
Query: 65 ESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRI---LGAPQTHFEP 121
E I+ A++ +I++ L+ +V EY ++G L + G P E
Sbjct: 44 EEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLP--ED 101
Query: 122 LLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEG 181
+ + ++ + LA+LH + I+ RD K+ ++ + VK+ D ++ + +
Sbjct: 102 QVWRFFIQILL----GLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD- 153
Query: 182 ETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
T+ +T++GT +L+P+ ++EK DV++ G L E TG+
Sbjct: 154 NTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-12
Identities = 47/163 (28%), Positives = 74/163 (45%), Gaps = 22/163 (13%)
Query: 77 MSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGA--PQTHF---------EPLLLK 125
+ H HI++ G C E ++VFEY++HG L +R L + P L L
Sbjct: 64 LQHQHIVRFYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAPGQLTLG 122
Query: 126 RRLKDAVDAANALAY---LHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGE 182
+ L A A+ + Y LHF V RD T + L + VVK+ DF +S I +
Sbjct: 123 QMLAIASQIASGMVYLASLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 176
Query: 183 TH-ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT 224
+ + M + P+ + F+ + D++SFG L E+ T
Sbjct: 177 YYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 5e-12
Identities = 44/152 (28%), Positives = 73/152 (48%), Gaps = 11/152 (7%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAA 135
+ H ++++L+G L+ +V EY+ G+L D + + L ++L A+D
Sbjct: 56 TLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVIT---LAQQLGFALDVC 112
Query: 136 NALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGH 195
+ YL + V RD ++L SE+ V K+ DF L+ +G+ V T
Sbjct: 113 EGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT--- 166
Query: 196 LAPQYVTTCDFSEKLDVYSFGAFLSELLT-GR 226
AP+ + FS K DV+SFG L E+ + GR
Sbjct: 167 -APEALREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 8e-12
Identities = 48/163 (29%), Positives = 75/163 (46%), Gaps = 19/163 (11%)
Query: 75 AQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWD---------RILGAPQTHFEPLLLK 125
H++I+K G C E I+VFEY++HG L L +P + L L
Sbjct: 63 TNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLS 122
Query: 126 RRLKDAVDAANALAYL---HFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGE 182
+ L+ AV A+ + YL HF V RD T + L + VVK+ DF +S + +
Sbjct: 123 QLLQIAVQIASGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTD 176
Query: 183 TH-ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT 224
+ + M + P+ + F+ + DV+SFG L E+ T
Sbjct: 177 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 3e-11
Identities = 49/162 (30%), Positives = 70/162 (43%), Gaps = 31/162 (19%)
Query: 78 SHDHILKLIGCCL---ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRR------- 127
+I+K G L + I I + EY + G+L D I + KR
Sbjct: 57 KSPYIVKYYGAFLDESSSSIGIAM-EYCEGGSL-DSIYKK--------VKKRGGRIGEKV 106
Query: 128 -LKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGE--TH 184
K A L+YLH R I+ RD K S+IL + + VKL DF +S GE
Sbjct: 107 LGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVS-----GELVNS 158
Query: 185 ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
+ T GT ++AP+ + +S DV+S G L E+ R
Sbjct: 159 LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-11
Identities = 69/293 (23%), Positives = 114/293 (38%), Gaps = 60/293 (20%)
Query: 38 YIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAIL 97
Y P+ + + + LK+E + D + F E+ + A+ H +I+KL+G C L
Sbjct: 32 YEPFTMVAVKMLKEEASA-DMQADFQREAAL-----MAEFDHPNIVKLLGVCAVGKPMCL 85
Query: 98 VFEYVQHGTL-----------------WDRILGAPQTHFEPLLLKRRLKDAVDAANALAY 140
+FEY+ +G L + PL +L A A +AY
Sbjct: 86 LFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAY 145
Query: 141 LHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAP-- 198
L R V RD T + L E VVK+ DF LS +I + D + P
Sbjct: 146 LS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNI-----YSADYYKASENDAIPIR 197
Query: 199 ----QYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNR 254
+ + ++ + DV+++G L E+ + G+ AH+ V Y D
Sbjct: 198 WMPPESIFYNRYTTESDVWAYGVVLWEIFS-YGMQPYYGMAHEEVI-------YYVRDGN 249
Query: 255 FTEIVDPIIVQDLSCTEK-EQQLHASAQLTFECLNESPIDRPTMVDVARRLRQ 306
LSC + +L+ L C ++ P DRP+ + R L++
Sbjct: 250 V-----------LSCPDNCPLELYN---LMRLCWSKLPSDRPSFASINRILQR 288
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-11
Identities = 47/164 (28%), Positives = 75/164 (45%), Gaps = 23/164 (14%)
Query: 77 MSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRIL------------GAPQTHFEPLLL 124
+ H+HI+K G C + I+VFEY++HG L ++ L G P+ L L
Sbjct: 64 LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPRQAKGELGL 122
Query: 125 KRRLKDAVDAANALAYL---HFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEG 181
+ L A A+ + YL HF V RD T + L +VK+ DF +S +
Sbjct: 123 SQMLHIASQIASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYST 176
Query: 182 ETH-ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT 224
+ + + M + P+ + F+ + DV+SFG L E+ T
Sbjct: 177 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 40/178 (22%), Positives = 73/178 (41%), Gaps = 19/178 (10%)
Query: 75 AQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA 134
A + H H+++L+G CL + + L+ + + G L + + + L L V
Sbjct: 64 ASVDHPHVVRLLGICLSSQVQ-LITQLMPLGCL-LDYVRNHKDNIGSQYL---LNWCVQI 118
Query: 135 ANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETH-ITDTVMGTY 193
A ++YL + +V RD ++L VK+ DF L+ + E +
Sbjct: 119 AKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPI 175
Query: 194 GHLAPQYVTTCDFSEKLDVYSFGAFLSELLT----------GRGILDLVRDAHDLVYP 241
+A + + ++ K DV+S+G + EL+T I DL+ L P
Sbjct: 176 KWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQP 233
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 2e-10
Identities = 44/148 (29%), Positives = 65/148 (43%), Gaps = 8/148 (5%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAA 135
Q H HI+KLIG E P+ I V E G L + Q + L L + + +
Sbjct: 63 QFDHPHIVKLIGVITENPVWI-VMELAPLGELRSYL----QVNKYSLDLASLILYSYQLS 117
Query: 136 NALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGH 195
ALAYL + V RD ++L S + VKL DF LS + + +
Sbjct: 118 TALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKW 174
Query: 196 LAPQYVTTCDFSEKLDVYSFGAFLSELL 223
+AP+ + F+ DV+ FG + E+L
Sbjct: 175 MAPESINFRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 3e-10
Identities = 53/171 (30%), Positives = 75/171 (43%), Gaps = 32/171 (18%)
Query: 74 AAQMS---HDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEP--LLLKRRL 128
A MS H +I+KL+G CL ++ E ++ G L + A F P L LK L
Sbjct: 50 AHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELL 109
Query: 129 KDAVDAANALAYL---HFGFPRPIVFRDFKTSHILFSEEN-----VVKLFDFSLSISI-- 178
+D A YL HF + RD + L SE+ VVK+ DF L+ I
Sbjct: 110 DICLDVAKGCVYLEQMHF------IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK 163
Query: 179 -----PEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT 224
EGE + M AP+ + F+ + DV+SFG + E+LT
Sbjct: 164 SDYYRKEGEGLLPVRWM------APESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 4e-10
Identities = 63/238 (26%), Positives = 103/238 (43%), Gaps = 43/238 (18%)
Query: 76 QMSHDHILKLIGCCLE-TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA 134
++SH +++L G C E +PI LVFE+++HG L D L A + F L L +D
Sbjct: 55 KLSHPKLVQLYGVCTERSPIC-LVFEFMEHGCLSD-YLRAQRGKFSQETL---LGMCLDV 109
Query: 135 ANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS-ISIPEGETHITDTVMGTY 193
+AYL ++ RD + L E VVK+ DF ++ + + T T T
Sbjct: 110 CEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK 166
Query: 194 GHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDN 253
+P+ + +S K DV+SFG + E+ F+E Y +N
Sbjct: 167 WS-SPEVFSFSKYSSKSDVWSFGVLMWEV-------------------FSEGKTPY--EN 204
Query: 254 RFTEIVDPIIVQDLSCTEKEQQLHASAQLTFE----CLNESPIDRPTMVDVARRLRQI 307
R V V+ ++ + + ++Q +E C E P DRP+ + L Q+
Sbjct: 205 RSNSEV----VETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSF---SLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 6e-10
Identities = 43/166 (25%), Positives = 68/166 (40%), Gaps = 31/166 (18%)
Query: 77 MSHDHILKLIG---------CCLETPIAI-LVFEYVQHGTLW-----DRILGAPQTHFEP 121
M+ +L L G C +T + V EYV G L P+ F
Sbjct: 43 MTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFY- 101
Query: 122 LLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI-SIPE 180
A + L +LH R I++RD K ++L E +K+ DF + I
Sbjct: 102 ---------AAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG 149
Query: 181 GETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
G T T T GT ++AP+ ++ + +D ++ G L E+L G+
Sbjct: 150 GVT--TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 7e-10
Identities = 48/170 (28%), Positives = 81/170 (47%), Gaps = 12/170 (7%)
Query: 59 KNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQT 117
KN ++ + + Q+ H ++++L+G +E + +V EY+ G+L D + ++
Sbjct: 38 KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS 97
Query: 118 HFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSIS 177
L LK ++D A+ YL V RD ++L SE+NV K+ DF L+
Sbjct: 98 ---VLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLT-- 149
Query: 178 IPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GR 226
+ + DT AP+ + FS K DV+SFG L E+ + GR
Sbjct: 150 --KEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 7e-10
Identities = 45/153 (29%), Positives = 74/153 (48%), Gaps = 11/153 (7%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAA 135
Q+ H++I+ L LVFEYV+ L +L A P ++ + +
Sbjct: 56 QLRHENIVNLKEAFRRKGRLYLVFEYVERTLL--ELLEASPGGLPPDAVRSYIWQLL--- 110
Query: 136 NALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEG-ETHITDTVMGTYG 194
A+AY H I+ RD K +IL SE V+KL DF + ++ + +TD V T
Sbjct: 111 QAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRW 166
Query: 195 HLAPQ-YVTTCDFSEKLDVYSFGAFLSELLTGR 226
+ AP+ V ++ + +DV++ G ++ELL G
Sbjct: 167 YRAPELLVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 1e-09
Identities = 47/160 (29%), Positives = 72/160 (45%), Gaps = 18/160 (11%)
Query: 77 MSHDHILKLIGCCLETPIAILVFEYVQHGTL--------WDRILGAPQTHFEPLLLKRRL 128
+ H+HI+K G C+E I+VFEY++HG L D +L A L + L
Sbjct: 64 LQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQML 123
Query: 129 KDAVDAANALAYL---HFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETH- 184
A A + YL HF V RD T + L E +VK+ DF +S + + +
Sbjct: 124 HIAQQIAAGMVYLASQHF------VHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYR 177
Query: 185 ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT 224
+ M + P+ + F+ + DV+S G L E+ T
Sbjct: 178 VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-09
Identities = 40/155 (25%), Positives = 71/155 (45%), Gaps = 18/155 (11%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAA 135
++ H ++++L+G C P ++ E++ +G L D + + ++L L A +
Sbjct: 58 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQIS 114
Query: 136 NALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGH 195
+A+ YL + + RD + L E ++VK+ DF LS + DT G
Sbjct: 115 SAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG------DTYTAHAGA 165
Query: 196 ------LAPQYVTTCDFSEKLDVYSFGAFLSELLT 224
AP+ + FS K DV++FG L E+ T
Sbjct: 166 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 1e-09
Identities = 43/164 (26%), Positives = 74/164 (45%), Gaps = 14/164 (8%)
Query: 65 ESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEP--- 121
E IN + H +I+ L +V EY+ G+L D I EP
Sbjct: 60 ELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIA 119
Query: 122 LLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEG 181
+ + L+ L YLH + ++ RD K+ +IL S++ VKL DF + + +
Sbjct: 120 YVCREVLQ-------GLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169
Query: 182 ETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225
++ +V+GT +AP+ + D+ K+D++S G E+ G
Sbjct: 170 KSKRN-SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 2e-09
Identities = 40/138 (28%), Positives = 62/138 (44%), Gaps = 25/138 (18%)
Query: 97 LVFEYVQHGTLWDRI-----LGAPQTHF---EPLLLKRRLKDAVDAANALAYLHFGFPRP 148
LV EY G L+ + + F E +L AL YLH
Sbjct: 70 LVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVL-------------ALEYLH---SLG 113
Query: 149 IVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSE 208
I++RD K +IL + +KL DF L+ + + T+T GT +LAP+ + + +
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR-TNTFCGTPEYLAPEVLLGKGYGK 172
Query: 209 KLDVYSFGAFLSELLTGR 226
+D +S G L E+LTG+
Sbjct: 173 AVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 40/151 (26%), Positives = 68/151 (45%), Gaps = 9/151 (5%)
Query: 76 QMSHDHILKLIGCCLET-PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA 134
++SH ++++L G C + PI I V EY+ +G L + + + L + L D
Sbjct: 55 KLSHPNLVQLYGVCTKQRPIFI-VTEYMANGCLLNYL----RERKGKLGTEWLLDMCSDV 109
Query: 135 ANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYG 194
A+ YL + RD + L E+NVVK+ DF L+ + + + +
Sbjct: 110 CEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVK 166
Query: 195 HLAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225
P+ FS K DV+SFG + E+ +
Sbjct: 167 WAPPEVFDYSRFSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 50/156 (32%), Positives = 73/156 (46%), Gaps = 15/156 (9%)
Query: 76 QMSHDHILKLIGCCLET-PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA 134
++ HD +++L C E PI I V EY+ G+L D L + + L L + + A
Sbjct: 57 KLRHDKLVQLYAVCSEEEPIYI-VTEYMSKGSLLD-FLKSGEGKK--LRLPQLVDMAAQI 112
Query: 135 ANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYG 194
A +AYL R + RD +IL E V K+ DF L+ I E G
Sbjct: 113 AEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLI---EDDEYTAREGAKF 166
Query: 195 HL---APQYVTTCDFSEKLDVYSFGAFLSELLT-GR 226
+ AP+ F+ K DV+SFG L+E++T GR
Sbjct: 167 PIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 67/249 (26%), Positives = 103/249 (41%), Gaps = 45/249 (18%)
Query: 77 MSHDHILKLIGCCLET--PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA 134
+ HD+I+K G C LV EY+ +G+L D + Q H E L ++ L A
Sbjct: 62 LQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL----QKHRERLDHRKLLLYASQI 117
Query: 135 ANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGT-- 192
+ YL + V RD T +IL EN VK+ DF L+ +P+ + + G
Sbjct: 118 CKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESP 174
Query: 193 ---YGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT--------GRGILDLV---RDAHDL 238
Y AP+ +T FS DV+SFG L EL T + ++ + +
Sbjct: 175 IFWY---APESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMI 231
Query: 239 VYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMV 298
VY E LKN + C + ++A + EC N P RP+
Sbjct: 232 VYHLIELLKNNGR-----------LPAPPGCPAE---IYA---IMKECWNNDPSQRPSFS 274
Query: 299 DVARRLRQI 307
++A ++ I
Sbjct: 275 ELALQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 62/261 (23%), Positives = 98/261 (37%), Gaps = 66/261 (25%)
Query: 79 HDHILKLIGCCL-ETPIAILVFEYVQHGTLW-----------DRILGAPQTHFEPLLLKR 126
H +I+ L+G C E P+ ++V EY G L D + E L K
Sbjct: 77 HKNIINLLGVCTQEGPLYVIV-EYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 127 RLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHIT 186
+ A A + YL R + RD ++L +E+NV+K+ DF L+ G I
Sbjct: 136 LVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLA----RGVHDID 188
Query: 187 DTVMGTYGHL-----APQYVTTCDFSEKLDVYSFGAFLSELLTGRG----------ILDL 231
+ G L AP+ + ++ + DV+SFG + E+ T G + L
Sbjct: 189 YYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL 248
Query: 232 VRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESP 291
+R+ H + P N CT H L EC + P
Sbjct: 249 LREGHRMDKPSN-------------------------CT------HELYMLMRECWHAVP 277
Query: 292 IDRPTMVDVARRLRQICCSLS 312
RPT + L ++ ++S
Sbjct: 278 TQRPTFKQLVEALDKVLAAVS 298
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-09
Identities = 42/161 (26%), Positives = 79/161 (49%), Gaps = 23/161 (14%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRI--LGAPQTHFEPLLLKRRLKDAVD 133
++ H++I++ +G L+ + EYV G++ + GA FE L++ ++ +
Sbjct: 62 ELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA----FEETLVRNFVRQIL- 116
Query: 134 AANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDT----- 188
L YLH R I+ RD K ++IL + +K+ DF +S + E + T
Sbjct: 117 --KGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL---EANSLSTKTNGA 168
Query: 189 ---VMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
+ G+ +AP+ V ++ K D++S G + E+LTG+
Sbjct: 169 RPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-09
Identities = 46/173 (26%), Positives = 79/173 (45%), Gaps = 23/173 (13%)
Query: 58 QKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQT 117
Q+ F E+ I Q H +I++L G ++ +++ EY+++G+L D+ L
Sbjct: 48 QRLDFLTEASI-----MGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSL-DKFLRENDG 101
Query: 118 HFEPLLLKRRLKDAVDAANALAYL-HFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176
F L L+ A+ + YL + V RD +IL + V K+ DF LS
Sbjct: 102 KFTVGQLVGMLR---GIASGMKYLSEMNY----VHRDLAARNILVNSNLVCKVSDFGLSR 154
Query: 177 SIPEGETHITDTVMGTYGHL-----APQYVTTCDFSEKLDVYSFGAFLSELLT 224
+ + E T T G G + AP+ + F+ DV+SFG + E+++
Sbjct: 155 RLEDSEA--TYTTKG--GKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 3e-09
Identities = 43/160 (26%), Positives = 73/160 (45%), Gaps = 17/160 (10%)
Query: 76 QMSHDHILKLIGCCLETPIA--ILVFEYVQHGTLWD--RILGAPQTHFEPLLLKRRLKDA 131
++ H +I++L +VFEY+ H D +L +P+ F +K +K
Sbjct: 54 KLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH----DLTGLLDSPEVKFTESQIKCYMKQL 109
Query: 132 VDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISI-PEGETHITDTVM 190
L YLH I+ RD K S+IL + + V+KL DF L+ T+ V+
Sbjct: 110 ---LEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI 163
Query: 191 GTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGRGIL 229
T + P+ + + ++D++S G L+EL G+ I
Sbjct: 164 -TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-09
Identities = 56/233 (24%), Positives = 95/233 (40%), Gaps = 34/233 (14%)
Query: 65 ESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFE-PLL 123
E +T +Q ++ K G L+ ++ EY+ G+ D + P F+ +
Sbjct: 47 EDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATM 106
Query: 124 LKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGET 183
LK LK L YLH + RD K +++L SE+ VKL DF ++ + + +
Sbjct: 107 LKEILK-------GLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156
Query: 184 HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFN 243
+T +GT +AP+ + + K D++S G EL G + ++P
Sbjct: 157 K-RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKG-------EPPNSDMHP-- 206
Query: 244 EYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPT 296
++ F + P + + S KE CLN+ P RPT
Sbjct: 207 --MRVLFLIPKNNP---PTLTGEFSKPFKE--------FIDACLNKDPSFRPT 246
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-09
Identities = 43/152 (28%), Positives = 76/152 (50%), Gaps = 8/152 (5%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAA 135
Q+ H +++L + PI I + EY+++G+L D L P+ L + + + A A
Sbjct: 57 QLQHPRLVRLYAVVTQEPIYI-ITEYMENGSLVD-FLKTPEGI--KLTINKLIDMAAQIA 112
Query: 136 NALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGH 195
+A++ + + RD + ++IL SE K+ DF L+ I + E +
Sbjct: 113 EGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKW 169
Query: 196 LAPQYVTTCDFSEKLDVYSFGAFLSELLT-GR 226
AP+ + F+ K DV+SFG L+E++T GR
Sbjct: 170 TAPEAINYGTFTIKSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 3e-09
Identities = 51/190 (26%), Positives = 79/190 (41%), Gaps = 31/190 (16%)
Query: 49 LKQ-ETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTL 107
LK+ + +N +K E +N V +++H +I+K E +V EY G L
Sbjct: 30 LKEIDLSNMSEKE---REDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDL 86
Query: 108 WDRIL--GAPQTHFEP---------LLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKT 156
+I F L L AL YLH R I+ RD K
Sbjct: 87 SQKIKKQKKEGKPFPEEQILDWFVQLCL------------ALKYLH---SRKILHRDIKP 131
Query: 157 SHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFG 216
+I + +VKL DF +S + + TV+GT +L+P+ ++ K D++S G
Sbjct: 132 QNIFLTSNGLVKLGDFGIS-KVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLG 190
Query: 217 AFLSELLTGR 226
L EL T +
Sbjct: 191 CVLYELCTLK 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-09
Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 19/178 (10%)
Query: 49 LKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLW 108
+K+ + + Q N W + I V + Q+ H + ++ GC L+ A LV EY G+
Sbjct: 51 VKKMSYSGKQTNEKWQD-IIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSAS 108
Query: 109 DRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVK 168
D + + H +PL A LAYLH ++ RD K +IL +E VK
Sbjct: 109 DLL----EVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVK 161
Query: 169 LFDF-SLSISIPEGETHITDTVMGTYGHLAPQYVTTCD---FSEKLDVYSFGAFLSEL 222
L DF S S S P ++ +GT +AP+ + D + K+DV+S G EL
Sbjct: 162 LADFGSASKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-09
Identities = 43/149 (28%), Positives = 68/149 (45%), Gaps = 7/149 (4%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAA 135
Q H +I+KLIG C + +V E V G L + + L K+ +K A+DAA
Sbjct: 48 QYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF----LSFLRKKKDELKTKQLVKFALDAA 103
Query: 136 NALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGH 195
+AYL + + RD + L E NV+K+ DF +S +G +
Sbjct: 104 AGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKW 160
Query: 196 LAPQYVTTCDFSEKLDVYSFGAFLSELLT 224
AP+ + +S + DV+S+G L E +
Sbjct: 161 TAPEALNYGRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 5e-09
Identities = 58/231 (25%), Positives = 95/231 (41%), Gaps = 20/231 (8%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAA 135
Q+ H++++ LI LVFE+V H T+ D + P L R K
Sbjct: 56 QLRHENLVNLIEVFRRKKRLYLVFEFVDH-TVLDDLEKYPNG----LDESRVRKYLFQIL 110
Query: 136 NALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGH 195
+ + H I+ RD K +IL S+ VVKL DF + ++ TD V T +
Sbjct: 111 RGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-ATRWY 166
Query: 196 LAPQY-VTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVY-------PFNEYLK 247
AP+ V + +D+++ G ++E+LTG + D D +Y +
Sbjct: 167 RAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI-DQLYHIIKCLGNLIPRHQ 225
Query: 248 NYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTF--ECLNESPIDRPT 296
F+ N + V+++ EK + L +CL P DRP+
Sbjct: 226 EIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 5e-09
Identities = 28/96 (29%), Positives = 48/96 (50%), Gaps = 5/96 (5%)
Query: 131 AVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVM 190
+ AL YLH + I+ RD K +IL E+ V + DF+++ + +T +
Sbjct: 106 ICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTS 160
Query: 191 GTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
GT G++AP+ + +S +D +S G E L G+
Sbjct: 161 GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGK 196
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 7e-09
Identities = 33/90 (36%), Positives = 50/90 (55%), Gaps = 6/90 (6%)
Query: 137 ALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL-SISIPEGETHITDTVMGTYGH 195
AL +LH + I++RD K +IL + VKL DF L SI EG +T T GT +
Sbjct: 112 ALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--VTHTFCGTIEY 166
Query: 196 LAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225
+AP+ + + +D +S GA + ++LTG
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 7e-09
Identities = 51/179 (28%), Positives = 80/179 (44%), Gaps = 27/179 (15%)
Query: 51 QETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDR 110
+ET D K F E+ I Q SH +I++LIG C + +V E VQ G
Sbjct: 29 RETLPPDLKAKFLQEARI-----LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF--- 80
Query: 111 ILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170
L +T L +K ++ +AA + YL + + RD + L +E+NV+K+
Sbjct: 81 -LTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKIS 136
Query: 171 DFSLSISIPEGETHITDTVMGTYGHL--------APQYVTTCDFSEKLDVYSFGAFLSE 221
DF +S +G V + G + AP+ + +S + DV+SFG L E
Sbjct: 137 DFGMSREEEDG-------VYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 8e-09
Identities = 52/195 (26%), Positives = 89/195 (45%), Gaps = 20/195 (10%)
Query: 42 RIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEY 101
RI++ + +K+E N D ++ W ++ + +H ++ L C V EY
Sbjct: 21 RIYAMKVVKKELVN-DDEDIDWVQT--EKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY 77
Query: 102 VQHGTLW---DRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSH 158
V G L R P+ H R A + + AL YLH R I++RD K +
Sbjct: 78 VNGGDLMFHMQRQRKLPEEH-------ARFYSA-EISLALNYLH---ERGIIYRDLKLDN 126
Query: 159 ILFSEENVVKLFDFSLSIS-IPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGA 217
+L E +KL D+ + + G+T T T GT ++AP+ + D+ +D ++ G
Sbjct: 127 VLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEILRGEDYGFSVDWWALGV 184
Query: 218 FLSELLTGRGILDLV 232
+ E++ GR D+V
Sbjct: 185 LMFEMMAGRSPFDIV 199
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 9e-09
Identities = 53/251 (21%), Positives = 92/251 (36%), Gaps = 59/251 (23%)
Query: 65 ESCINNVTYAAQMSHDHILK-----LIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHF 119
E +N + A ++H +I+ L G L +V EY G L I +
Sbjct: 44 EDAVNEIRILASVNHPNIISYKEAFLDGNKL-----CIVMEYAPFGDLSKAISKRKKK-- 96
Query: 120 EPLLLKRRLKD------AVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFS 173
++ + + + L LH + I+ RD K+++IL ++VK+ D
Sbjct: 97 -----RKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLG 148
Query: 174 LSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVR 233
+S + + + T +GT ++AP+ +S K D++S G L E+ T
Sbjct: 149 ISKVLKKN---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA------- 198
Query: 234 DAHDLVYPFN----EYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNE 289
PF + L+ + ++ I PI QDL L
Sbjct: 199 ------PPFEARSMQDLRYKVQRGKYPPI-PPIYSQDLQ------------NFIRSMLQV 239
Query: 290 SPIDRPTMVDV 300
P RP +
Sbjct: 240 KPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 9e-09
Identities = 43/151 (28%), Positives = 74/151 (49%), Gaps = 8/151 (5%)
Query: 77 MSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAAN 136
+ HD ++KL + PI I+ E++ G+L D L + + +PL + + + A
Sbjct: 58 LQHDKLVKLHAVVTKEPIYIIT-EFMAKGSLLD-FLKSDEGSKQPL--PKLIDFSAQIAE 113
Query: 137 ALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHL 196
+A++ R + RD + ++IL S V K+ DF L+ I + E +
Sbjct: 114 GMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT 170
Query: 197 APQYVTTCDFSEKLDVYSFGAFLSELLT-GR 226
AP+ + F+ K DV+SFG L E++T GR
Sbjct: 171 APEAINFGSFTIKSDVWSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-08
Identities = 53/185 (28%), Positives = 83/185 (44%), Gaps = 19/185 (10%)
Query: 45 SAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE---TPIAILVFEY 101
+ + LK E+ + E I Y H++I+K G C E I L+ E+
Sbjct: 37 AVKSLKPESGG-NHIADLKKEIEILRNLY-----HENIVKYKGICTEDGGNGIK-LIMEF 89
Query: 102 VQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILF 161
+ G+L + + P+ + LK++LK AV + YL R V RD ++L
Sbjct: 90 LPSGSLKEYL---PRNK-NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLV 142
Query: 162 SEENVVKLFDFSLSISIPEGETHIT--DTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFL 219
E+ VK+ DF L+ +I + + T D + AP+ + F DV+SFG L
Sbjct: 143 ESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTL 202
Query: 220 SELLT 224
ELLT
Sbjct: 203 YELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-08
Identities = 59/221 (26%), Positives = 90/221 (40%), Gaps = 40/221 (18%)
Query: 65 ESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLL 124
E+ + ++ H+ +++L E PI I V EY+ G+L D + G + L L
Sbjct: 46 EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKY---LRL 101
Query: 125 KRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETH 184
+ + A A+ +AY+ V RD + ++IL E V K+ DF L+ I + E
Sbjct: 102 PQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158
Query: 185 ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT----------GRGILDLVRD 234
AP+ F+ K DV+SFG L+EL T R +LD V
Sbjct: 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 218
Query: 235 A-------------HDLVY----------PFNEYLKNYFED 252
HDL+ P EYL+ + ED
Sbjct: 219 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 1e-08
Identities = 46/150 (30%), Positives = 72/150 (48%), Gaps = 9/150 (6%)
Query: 79 HDHILKLIGCC-LETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANA 137
H +++L C LE PI I V E +++G+L + + G L L + + A A+
Sbjct: 60 HPKLIQLYAVCTLEEPIYI-VTELMKYGSLLEYLQGGAGRA---LKLPQLIDMAAQVASG 115
Query: 138 LAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLA 197
+AYL + + RD ++L E N+ K+ DF L+ I E + A
Sbjct: 116 MAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTA 172
Query: 198 PQYVTTCDFSEKLDVYSFGAFLSELLT-GR 226
P+ FS K DV+SFG L+E++T GR
Sbjct: 173 PEAALYNRFSIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 45/168 (26%), Positives = 77/168 (45%), Gaps = 18/168 (10%)
Query: 76 QMSHDHILKLIGCCLETPIAI-LVFEYVQHGTLW---DRILGAPQTHFEPLLLKRRLKDA 131
Q S + L + C +T + LV EYV G L R P+ H A
Sbjct: 51 QASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFY--------A 102
Query: 132 VDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSIS-IPEGETHITDTVM 190
+ AL +LH R I++RD K ++L + +KL D+ + + G+T T T
Sbjct: 103 AEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TSTFC 157
Query: 191 GTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDL 238
GT ++AP+ + ++ +D ++ G + E++ GR D++ D D+
Sbjct: 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM 205
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 1e-08
Identities = 54/178 (30%), Positives = 81/178 (45%), Gaps = 19/178 (10%)
Query: 49 LKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLW 108
+K+ + + Q N W + I V + ++ H + ++ GC L A LV EY G+
Sbjct: 45 IKKMSYSGKQSNEKWQD-IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSAS 102
Query: 109 DRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVK 168
D + + H +PL A LAYLH ++ RD K +IL SE +VK
Sbjct: 103 DLL----EVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVK 155
Query: 169 LFDF-SLSISIPEGETHITDTVMGTYGHLAPQYVTTCD---FSEKLDVYSFGAFLSEL 222
L DF S SI P + +GT +AP+ + D + K+DV+S G EL
Sbjct: 156 LGDFGSASIMAP------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 1e-08
Identities = 53/224 (23%), Positives = 101/224 (45%), Gaps = 26/224 (11%)
Query: 10 LWSKGKRTLMIGNGASVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCIN 69
W+KG+ ++G GA ++ G+ I + ++++ +T+N +E
Sbjct: 1 EWTKGE---VLGKGAYGTVYCGLTNQGQLI-----AVKQVELDTSNVLAAEK-EYEKLQE 51
Query: 70 NVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLK--RR 127
V + H +I++ +G CL+ + E+V G++ IL EP+ K ++
Sbjct: 52 EVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSI-SSILNRFGPLPEPVFCKYTKQ 110
Query: 128 LKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITD 187
+ D V AYLH +V RD K ++++ ++KL DF + + H T
Sbjct: 111 ILDGV------AYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTH 161
Query: 188 TVM-----GTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
+ M GT +AP+ + + K D++S G + E+ TG+
Sbjct: 162 SNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 3e-08
Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 14/153 (9%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLL-LKRRLKDAVDA 134
++ H ++++L+G L + I V E + G L + + +T L+ + + L+ ++D
Sbjct: 55 KLHHKNLVRLLGVILHNGLYI-VMELMSKGNLVNFL----RTRGRALVSVIQLLQFSLDV 109
Query: 135 ANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYG 194
A + YL + +V RD +IL SE+ V K+ DF L+ G D
Sbjct: 110 AEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----VDNSKLPVK 162
Query: 195 HLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GR 226
AP+ + FS K DV+S+G L E+ + GR
Sbjct: 163 WTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (130), Expect = 3e-08
Identities = 45/157 (28%), Positives = 72/157 (45%), Gaps = 20/157 (12%)
Query: 76 QMSHDHILKLIG-CCLETPIAILVFEYVQHGTLWD--RILGAPQTHFEPLLLKRRLKDAV 132
++ H +I+KL+ E + LVFEY D + L P L+K + +
Sbjct: 54 ELKHPNIVKLLDVIHTERKL-YLVFEYCDM----DLKKYLDKRPGPLSPNLIKSIMYQLL 108
Query: 133 DAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS--ISIPEGETHITDTVM 190
LAY H I+ RD K +IL + + V+KL DF L+ IP T V+
Sbjct: 109 ---RGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIP--LRTYTHEVV 160
Query: 191 GTYGHLAPQYVTTCDF-SEKLDVYSFGAFLSELLTGR 226
T + AP+ + S +D++S G +E++TG+
Sbjct: 161 -TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-08
Identities = 54/226 (23%), Positives = 97/226 (42%), Gaps = 38/226 (16%)
Query: 76 QMSHDHILKLIGCCL-ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA 134
++SH+ +++L G C + PI I V EY+ +G L + L F+P L KD +
Sbjct: 55 KLSHEKLVQLYGVCTKQRPIYI-VTEYMSNGCLLN-YLREHGKRFQPSQLLEMCKDVCEG 112
Query: 135 ANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYG 194
+AYL + + RD + L ++ VK+ DF LS + + E + +G+
Sbjct: 113 ---MAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY---TSSVGSKF 163
Query: 195 HL---APQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYF 250
+ P+ + FS K DV++FG + E+ + G+ P+ +
Sbjct: 164 PVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGK-------------MPYERF----- 205
Query: 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPT 296
+N +E V+ + Q L + + C +E +RPT
Sbjct: 206 -NN--SETVEKVS-QGLRLYRPHLASEKVYAIMYSCWHEKAEERPT 247
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 3e-08
Identities = 50/152 (32%), Positives = 74/152 (48%), Gaps = 15/152 (9%)
Query: 78 SHDHILKLIGCCL-ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAAN 136
+ +I+ G I+I + EY+ G+L D+IL Q +L K AV
Sbjct: 57 NSPYIVGFYGAFYNNGDISICM-EYMDGGSL-DKILKEVQGRIPERILG---KIAVAVLK 111
Query: 137 ALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGE--THITDTVMGTYG 194
L YLH I+ RD K S+IL + +KL DF +S G+ + T +GT
Sbjct: 112 GLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVS-----GQLVNSLAKTFVGTSS 164
Query: 195 HLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
++AP+ + D+S K D++S G L EL TGR
Sbjct: 165 YMAPERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 3e-08
Identities = 53/178 (29%), Positives = 82/178 (46%), Gaps = 19/178 (10%)
Query: 49 LKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLW 108
+K+ + + Q N W + I V + ++ H + ++ GC L A LV EY G+
Sbjct: 55 IKKMSYSGKQSNEKWQD-IIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSAS 112
Query: 109 DRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVK 168
D + + H +PL A LAYLH ++ RD K +IL +E VK
Sbjct: 113 DLL----EVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVK 165
Query: 169 LFDF-SLSISIPEGETHITDTVMGTYGHLAPQYVTTCD---FSEKLDVYSFGAFLSEL 222
L DF S SI+ P ++ +GT +AP+ + D + K+DV+S G EL
Sbjct: 166 LADFGSASIASP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 4e-08
Identities = 53/172 (30%), Positives = 79/172 (45%), Gaps = 25/172 (14%)
Query: 58 QKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQT 117
Q N W + I V + Q+ H + ++ GC L A LV EY G+ D + +
Sbjct: 54 QSNEKWQD-IIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDIL----EV 107
Query: 118 HFEPLLLKRRLKDAV---DAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF-S 173
H +PL + ++ A A LAYLH + RD K +IL +E VKL DF S
Sbjct: 108 HKKPL---QEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGS 161
Query: 174 LSISIPEGETHITDTVMGTYGHLAPQYVTTCD---FSEKLDVYSFGAFLSEL 222
S+ P ++ +GT +AP+ + D + K+DV+S G EL
Sbjct: 162 ASLVSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-08
Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 19/216 (8%)
Query: 15 KRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTY 73
KR ++G+GA + + I G+ + +I A ++ ET F E+ I
Sbjct: 10 KRVKVLGSGAFGTVYKGIWVPEGETV--KIPVAIKILNETTGPKANVEFMDEALI----- 62
Query: 74 AAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVD 133
A M H H+++L+G CL +P LV + + HG L D + H + + + L V
Sbjct: 63 MASMDHPHLVRLLGVCL-SPTIQLVTQLMPHGCLLDYV----HEHKDNIGSQLLLNWCVQ 117
Query: 134 AANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTY 193
A + YL R +V RD ++L N VK+ DF L+ + EG+ + G
Sbjct: 118 IAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLA-RLLEGDEKEYNADGGKM 173
Query: 194 --GHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRG 227
+A + + F+ + DV+S+G + EL+T G
Sbjct: 174 PIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGG 209
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 5e-08
Identities = 59/242 (24%), Positives = 97/242 (40%), Gaps = 34/242 (14%)
Query: 65 ESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLL 124
E+ V A+M H +I+ E +V EY G L RI F
Sbjct: 44 EASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSE--- 100
Query: 125 KRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVV-KLFDFSLSISIPEGET 183
+ L V + L ++H R I+ RD K+ +I S+ +V KL DF ++ + +
Sbjct: 101 DQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND-SM 156
Query: 184 HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFN 243
+ T +GT +L+P+ ++ K D++S G L EL T
Sbjct: 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCT------------------- 197
Query: 244 EYLKNYFEDNRFTEIVDPIIVQDLSCTEK--EQQLHASAQLTFECLNESPIDRPTMVDVA 301
LK+ FE N ++V I + + L + F+ SP DRP++ +
Sbjct: 198 --LKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFKV---SPRDRPSITSIL 252
Query: 302 RR 303
+R
Sbjct: 253 KR 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 5e-08
Identities = 48/191 (25%), Positives = 81/191 (42%), Gaps = 33/191 (17%)
Query: 79 HDHILKLIGCCLETPIAILVFEYVQHGTLWDRI-----------LGAPQTHFEPLLLKRR 127
H +I+ L+G C + +V EY HG L D + P+ E L K
Sbjct: 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 128 LKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITD 187
+ A A + +L + + RD ++L +E++V+K+ DF L+ I HI
Sbjct: 135 VSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDI----HHIDY 187
Query: 188 TVMGTYGHL-----APQYVTTCDFSEKLDVYSFGAFLSELLTGRG----------ILDLV 232
T G L AP+ + ++ + DV+SFG L E+ T G + L+
Sbjct: 188 YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL 247
Query: 233 RDAHDLVYPFN 243
++ + + P N
Sbjct: 248 KEGYRMEKPQN 258
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 6e-08
Identities = 45/163 (27%), Positives = 74/163 (45%), Gaps = 8/163 (4%)
Query: 65 ESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLL 124
E+ + ++ HD ++ L E PI I V E++ G+L D + + L L
Sbjct: 46 EAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYI-VTEFMGKGSLLDFLKEGDGKY---LKL 101
Query: 125 KRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETH 184
+ + A A+ +AY+ + RD + ++IL + V K+ DF L+ I + E
Sbjct: 102 PQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158
Query: 185 ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GR 226
AP+ F+ K DV+SFG L+EL+T GR
Sbjct: 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 8e-08
Identities = 52/266 (19%), Positives = 101/266 (37%), Gaps = 72/266 (27%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTL---------------------WDRILGA 114
Q++H H++KL G C + +L+ EY ++G+L L
Sbjct: 59 QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118
Query: 115 PQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL 174
P L + + A + + YL +V RD ++L +E +K+ DF L
Sbjct: 119 PDE--RALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGL 173
Query: 175 SISIPEGETHIT---DTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRG---- 227
S + E ++++ + + +A + + ++ + DV+SFG L E++T G
Sbjct: 174 SRDVYEEDSYVKRSKGRIPVKW--MAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 231
Query: 228 ------ILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQ 281
+ +L++ + + P N C+E
Sbjct: 232 GIAPERLFNLLKTGYRMERPEN-------------------------CSE------EMYN 260
Query: 282 LTFECLNESPIDRPTMVDVARRLRQI 307
L C + P RPT D+++ L ++
Sbjct: 261 LMLTCWKQEPDKRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 1e-07
Identities = 42/160 (26%), Positives = 74/160 (46%), Gaps = 9/160 (5%)
Query: 66 SCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLK 125
+ N +SH +I++ LE ++V EY GTL + I + +
Sbjct: 45 AAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDE---D 101
Query: 126 RRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSE-ENVVKLFDFSLSISIPEGETH 184
L V AL ++H + I+ RD KT +IL + + VVK+ DF +S +
Sbjct: 102 TILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL--SSKS 156
Query: 185 ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT 224
TV+GT +++P+ +++K D+++ G L EL +
Sbjct: 157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 45/170 (26%), Positives = 76/170 (44%), Gaps = 16/170 (9%)
Query: 58 QKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQT 117
Q+ F E+ I Q SH +I++L G + A+++ EY+++G L D+ L
Sbjct: 49 QRQDFLSEASI-----MGQFSHHNIIRLEGVVTKFKPAMIITEYMENGAL-DKYLRDHDG 102
Query: 118 HFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSIS 177
F L L+ L+ +++ V RD +IL + K+ DF LS
Sbjct: 103 EFSSYQLVGMLRGIAAGMKYLSDMNY------VHRDLAARNILVNSNLECKVSDFGLSRV 156
Query: 178 I---PEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT 224
+ PEG T+ T AP+ + F+ DV+SFG + E+++
Sbjct: 157 LEDDPEG-TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 1e-07
Identities = 64/271 (23%), Positives = 106/271 (39%), Gaps = 49/271 (18%)
Query: 51 QETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL-ETPIAILVFEYVQHGTLWD 109
+E + F E + + H +I+ L+G C E P +L FEY+ HG L +
Sbjct: 44 KENAEPKVQQEFRQE-----AELMSDLQHPNIVCLLGVCTKEQPTCML-FEYLAHGDLHE 97
Query: 110 -RILGAPQTHFEPLLLKRRLKDAVDAANAL-------AYLHFGFPRPIVFRDFKTSHILF 161
+ +P + +K ++D ++ L A + + V RD + L
Sbjct: 98 FLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV 157
Query: 162 SEENVVKLFDFSLSISIPEGETHITDTVMGT----YGHLAPQYVTTCDFSEKLDVYSFGA 217
E VK+ DF LS I + + V + P+ + F+ + D++SFG
Sbjct: 158 GEGLTVKISDFGLSRDIYSADYY---RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGV 214
Query: 218 FLSELLTGRGILDLVRDAHDLVYPFNEYLKNY--FEDNRFTEIVDPIIVQDLSCTEK-EQ 274
L E+ F+ L+ Y F + E++ + L C E
Sbjct: 215 VLWEI-------------------FSYGLQPYYGFSNQEVIEMIRSRQL--LPCPEDCPA 253
Query: 275 QLHASAQLTFECLNESPIDRPTMVDVARRLR 305
+++A L EC NE P RP D+ RLR
Sbjct: 254 RVYA---LMIECWNEIPARRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-07
Identities = 44/183 (24%), Positives = 88/183 (48%), Gaps = 27/183 (14%)
Query: 122 LLLKRRLKD-AVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPE 180
LL + ++ + V A AL YLH + I+ RD KT ++ + N++K+ D ++ + E
Sbjct: 98 LLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIA-RVLE 153
Query: 181 GETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVY 240
+ + T++GT +++P+ + ++ K DV++ G + E+ T + + +D + LVY
Sbjct: 154 NQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN-AKDMNSLVY 212
Query: 241 PFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDV 300
R E P + +D S +L +L L++ P RP++ +
Sbjct: 213 -------------RIIEGKLPPMPKDYS-----PEL---GELIATMLSKRPEKRPSVKSI 251
Query: 301 ARR 303
R+
Sbjct: 252 LRQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 5/91 (5%)
Query: 136 NALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGH 195
A YLH R I++RD K ++L VKL DF + + G+ T T GT +
Sbjct: 104 LAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK--TWTFCGTPEY 158
Query: 196 LAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
+AP+ + + +D +S G L ELLTGR
Sbjct: 159 VAPEIILNKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 44/171 (25%), Positives = 83/171 (48%), Gaps = 20/171 (11%)
Query: 66 SCINNVTYAAQMSHDHILKL----IGCCLETPIAILVFEYVQH--GTLWDRILGAPQTHF 119
S + +T + H +I++L +G L++ LV EY + +L D + P +
Sbjct: 52 SSLREITLLLNLRHPNIVELKEVVVGKHLDS--IFLVMEYCEQDLASLLDN-MPTPFSES 108
Query: 120 EPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIP 179
+ L +L L YLH F I+ RD K S++L +++ +K+ DF L+ +
Sbjct: 109 QVKCLMLQL------LRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159
Query: 180 EGETHITDTVMGTYGHLAPQYVTTCD-FSEKLDVYSFGAFLSELLTGRGIL 229
+T V+ T + AP+ + C ++ +D+++ G L+ELL + +L
Sbjct: 160 LPAKPMTPKVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLL 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-07
Identities = 26/78 (33%), Positives = 46/78 (58%), Gaps = 2/78 (2%)
Query: 149 IVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSE 208
IV+RD K +IL + +++ D L++ +PEG+T I V GT G++AP+ V ++
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNERYTF 180
Query: 209 KLDVYSFGAFLSELLTGR 226
D ++ G L E++ G+
Sbjct: 181 SPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 41/162 (25%), Positives = 72/162 (44%), Gaps = 12/162 (7%)
Query: 65 ESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLL 124
E IN + ++ + +I+ + L +V EY+ G+L D + + +
Sbjct: 61 ELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAV 120
Query: 125 KRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISI-PEGET 183
R + AL +LH ++ RD K+ ++L + VKL DF I PE
Sbjct: 121 CR------ECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171
Query: 184 HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225
T++GT +AP+ VT + K+D++S G E++ G
Sbjct: 172 R--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 54/219 (24%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 15 KRTLMIGNGASVLQELIASSNGKYIPY-RIFSAQELKQETNNYDQKNGFWHESCINNVTY 73
+R +IG GA A GK++P R+ + + + +T + D + E V
Sbjct: 4 QRLELIGRGA-----YGAVYRGKHVPTGRVVALKIINLDTPDDDVSD-IQRE-----VAL 52
Query: 74 AAQMSHD---HILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEP---LLLKRR 127
+Q+ +I K G L+ P ++ EY + G++ R L E ++++
Sbjct: 53 LSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSV--RTLMKAGPIAEKYISVIIREV 110
Query: 128 LKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITD 187
L AL Y+H ++ RD K ++IL + VKL DF ++ + + + +
Sbjct: 111 LV-------ALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRS- 159
Query: 188 TVMGTYGHLAPQYVTT-CDFSEKLDVYSFGAFLSELLTG 225
T +GT +AP+ +T + K D++S G + E+ TG
Sbjct: 160 TFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 41/140 (29%), Positives = 64/140 (45%), Gaps = 29/140 (20%)
Query: 97 LVFEYVQHGTLW-----DRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVF 151
V EYV G L+ +R+ +T F + +AL YLH G IV+
Sbjct: 72 FVMEYVNGGELFFHLSRERVFSEDRTRFY----------GAEIVSALDYLHSG---KIVY 118
Query: 152 RDFKTSHILFSEENVVKLFDFSLSISIPEGETHITD-----TVMGTYGHLAPQYVTTCDF 206
RD K +++ ++ +K+ DF L EG ITD T GT +LAP+ + D+
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGLC---KEG---ITDAATMKTFCGTPEYLAPEVLEDNDY 172
Query: 207 SEKLDVYSFGAFLSELLTGR 226
+D + G + E++ GR
Sbjct: 173 GRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 30/91 (32%), Positives = 42/91 (46%), Gaps = 5/91 (5%)
Query: 137 ALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHL 196
AL +LH I++RD K +IL E V L DF LS E + GT ++
Sbjct: 117 ALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYM 173
Query: 197 APQYVTTCD--FSEKLDVYSFGAFLSELLTG 225
AP+ + + +D +S G ELLTG
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 40/159 (25%), Positives = 64/159 (40%), Gaps = 20/159 (12%)
Query: 79 HDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRR----------- 127
H +I+ L+G C + EY +G L D + + +P K
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 128 LKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITD 187
L+ A D A + YL + + RD ++L E K+ DF LS GE
Sbjct: 122 LQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLS----RGEEVYVK 174
Query: 188 TVMGTYG--HLAPQYVTTCDFSEKLDVYSFGAFLSELLT 224
MG +A + + ++ K DV+SFG L E+++
Sbjct: 175 KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 50/171 (29%), Positives = 74/171 (43%), Gaps = 24/171 (14%)
Query: 65 ESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWD-------RILGAPQT 117
ES + ++ HD +++L E PI I V EY+ G+L D R L P
Sbjct: 46 ESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKDGEGRALKLPN- 103
Query: 118 HFEPLLLKRRLKD-AVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176
L D A A +AY+ + RD ++++IL + V K+ DF L+
Sbjct: 104 ----------LVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLAR 150
Query: 177 SIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GR 226
I + E AP+ F+ K DV+SFG L+EL+T GR
Sbjct: 151 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 54/213 (25%), Positives = 88/213 (41%), Gaps = 35/213 (16%)
Query: 20 IGNGASVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSH 79
IG GAS Y + + QE+ + N Q+ E IN + + H
Sbjct: 27 IGQGAS---------GTVYTAIDVATGQEVAIKQMNLQQQPK--KELIINEILVMRENKH 75
Query: 80 DHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAA---- 135
+I+ + L +V EY+ G+L D ++ + + + AA
Sbjct: 76 PNIVNYLDSYLVGDELWVVMEYLAGGSLTD------------VVTETCMDEGQIAAVCRE 123
Query: 136 --NALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISI-PEGETHITDTVMGT 192
AL +LH ++ RD K+ +IL + VKL DF I PE T++GT
Sbjct: 124 CLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGT 178
Query: 193 YGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225
+AP+ VT + K+D++S G E++ G
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-07
Identities = 41/155 (26%), Positives = 73/155 (47%), Gaps = 24/155 (15%)
Query: 89 CLETPIAI-LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKD------AVDAANALAYL 141
C +T + V E+V G L H + +R+L + + + + AL +L
Sbjct: 64 CFQTESRLFFVIEFVSGGDL--------MFHMQR---QRKLPEEHARFYSAEISLALNFL 112
Query: 142 HFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL-SISIPEGETHITDTVMGTYGHLAPQY 200
H R I++RD K ++L E +KL D+ + I G+T T T GT ++AP+
Sbjct: 113 H---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT--TSTFCGTPNYIAPEI 167
Query: 201 VTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDA 235
+ D+ +D ++ G + E++ GR D+V +
Sbjct: 168 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMS 202
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 34/92 (36%), Positives = 49/92 (53%), Gaps = 6/92 (6%)
Query: 135 ANALAYLH-FGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTY 193
A AL +LH G I++RD K +IL EE +KL DF LS + E + GT
Sbjct: 108 ALALDHLHSLG----IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK-AYSFCGTV 162
Query: 194 GHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225
++AP+ V ++ D +SFG + E+LTG
Sbjct: 163 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-07
Identities = 39/156 (25%), Positives = 75/156 (48%), Gaps = 13/156 (8%)
Query: 75 AQMSHDHILKLIGCCLETPIAILVF-EYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVD 133
+ H +I++ +G T + +F EYV G++ L FE L++ + ++
Sbjct: 63 KDLDHLNIVQYLGF-ETTEEYLSIFLEYVPGGSI-GSCLRTY-GRFEEQLVRFFTEQVLE 119
Query: 134 AANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVM-GT 192
LAYLH + I+ RD K ++L + + K+ DF +S + + + M G+
Sbjct: 120 G---LAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGS 173
Query: 193 YGHLAPQYVTT--CDFSEKLDVYSFGAFLSELLTGR 226
+AP+ + + +S K+D++S G + E+ GR
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 24/78 (30%), Positives = 44/78 (56%), Gaps = 2/78 (2%)
Query: 149 IVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSE 208
IV+RD K +IL + +++ D L++ IPEGET +GT G++AP+ + ++
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRVGTVGYMAPEVINNEKYTF 180
Query: 209 KLDVYSFGAFLSELLTGR 226
D + G + E++ G+
Sbjct: 181 SPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-07
Identities = 25/90 (27%), Positives = 46/90 (51%), Gaps = 5/90 (5%)
Query: 138 LAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLA 197
L +LH R IV+RD K ++L + V++ D L++ + G+ GT G++A
Sbjct: 108 LEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYMA 162
Query: 198 PQYVTTCDFSEKLDVYSFGAFLSELLTGRG 227
P+ + + +D ++ G L E++ GR
Sbjct: 163 PEVLQGEVYDFSVDWFALGCTLYEMIAGRS 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 4e-07
Identities = 54/221 (24%), Positives = 93/221 (42%), Gaps = 29/221 (13%)
Query: 11 WSKGKRTLMIGNGASVLQELIASSNGK-YIPYRIFSAQEL--KQ-ETNNYDQKNGFWHES 66
W +GK ++G GA G+ Y+ Y + + +EL KQ + + +
Sbjct: 4 WRRGK---LLGQGAF----------GRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNA 50
Query: 67 CINNVTYAAQMSHDHILKLIGCCLETPIAILVF-EYVQHGTLWDRILGAPQTHFEPLLLK 125
+ + H+ I++ GC L + +F EY+ G++ D++ + L
Sbjct: 51 LECEIQLLKNLQHERIVQYYGC-LRDDETLSIFMEYMPGGSVKDQL-----KAYGALTET 104
Query: 126 RRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHI 185
K + YLH IV RD K ++IL VKL DF S + +
Sbjct: 105 VTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161
Query: 186 T--DTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT 224
T +V GT ++P+ ++ + K DV+S G + E+LT
Sbjct: 162 TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 4e-07
Identities = 33/99 (33%), Positives = 46/99 (46%), Gaps = 14/99 (14%)
Query: 136 NALAYLH-FGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS--------ISIPEGETHIT 186
AL YLH G I+ RD K +IL +KL DF LS I++ + E
Sbjct: 104 LALEYLHSNG----IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK 159
Query: 187 DTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225
V GT ++AP+ + S+ +D +S G L E L G
Sbjct: 160 RIV-GTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 4e-07
Identities = 42/157 (26%), Positives = 69/157 (43%), Gaps = 22/157 (14%)
Query: 81 HILKLIGCCLETPIAI-LVFEYVQHGTLWDRI-----LGAPQTHFEPLLLKRRLKDAVDA 134
L + C +T + V EYV G L I P F A +
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFY----------AAEI 110
Query: 135 ANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL-SISIPEGETHITDTVMGTY 193
A L +LH + I++RD K +++ E +K+ DF + +I G+T T T GT
Sbjct: 111 AIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT--TRTFCGTP 165
Query: 194 GHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILD 230
++AP+ + + + +D ++FG L E+L G+ D
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 5e-07
Identities = 41/159 (25%), Positives = 65/159 (40%), Gaps = 20/159 (12%)
Query: 79 HDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEP-----------LLLKRR 127
H +I+ L+G C L EY HG L D + + +P L ++
Sbjct: 55 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114
Query: 128 LKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITD 187
L A D A + YL + + RD +IL E V K+ DF LS G+
Sbjct: 115 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLS----RGQEVYVK 167
Query: 188 TVMGTYG--HLAPQYVTTCDFSEKLDVYSFGAFLSELLT 224
MG +A + + ++ DV+S+G L E+++
Sbjct: 168 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 5e-07
Identities = 40/149 (26%), Positives = 71/149 (47%), Gaps = 8/149 (5%)
Query: 77 MSHDHILKLIGCCL-ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAA 135
+ HD +++L E PI I+ EY+ G+L D + +LL + + + A
Sbjct: 58 LQHDKLVRLYAVVTKEEPIYIIT-EYMAKGSLLDFLKSDEGGK---VLLPKLIDFSAQIA 113
Query: 136 NALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGH 195
+AY+ + + RD + +++L SE + K+ DF L+ I + E +
Sbjct: 114 EGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKW 170
Query: 196 LAPQYVTTCDFSEKLDVYSFGAFLSELLT 224
AP+ + F+ K DV+SFG L E++T
Sbjct: 171 TAPEAINFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 5e-07
Identities = 45/155 (29%), Positives = 63/155 (40%), Gaps = 16/155 (10%)
Query: 74 AAQMSHDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAV 132
A H ++ L C +T + V EY G L I H + R + A
Sbjct: 56 ANSERHPFLVNLF-ACFQTEDHVCFVMEYAAGGDLMMHI------HTDVFSEPRAVFYAA 108
Query: 133 DAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETH--ITDTVM 190
L YLH IV+RD K ++L E VK+ DF L EG T T
Sbjct: 109 CVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLC---KEGMGFGDRTSTFC 162
Query: 191 GTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225
GT LAP+ +T ++ +D + G + E+L G
Sbjct: 163 GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 5e-07
Identities = 42/157 (26%), Positives = 68/157 (43%), Gaps = 13/157 (8%)
Query: 75 AQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRIL----GAPQTHFEPLLLKRRLKD 130
++SH ++++L+G C E ++ EY G L + + PL K+++
Sbjct: 63 RKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVAL 122
Query: 131 AVDAA---NALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITD 187
A + L+ F V RD + L S + VK+ SLS + E +
Sbjct: 123 CTQIALGMDHLSNARF------VHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLR 176
Query: 188 TVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT 224
+ LAP+ V DFS K DV+SFG + E+ T
Sbjct: 177 NALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 49/191 (25%), Positives = 80/191 (41%), Gaps = 33/191 (17%)
Query: 79 HDHILKLIGCCLETPIAILVFEYVQHGTLWD--RILGAPQTHF---------EPLLLKRR 127
H +I+ L+G C + ++ EY G L + R P + E L K
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 128 LKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITD 187
+ A A + YL + + RD ++L +E+NV+K+ DF L+ I HI
Sbjct: 143 VSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDI----HHIDY 195
Query: 188 TVMGTYGHL-----APQYVTTCDFSEKLDVYSFGAFLSELLTGRG----------ILDLV 232
T G L AP+ + ++ + DV+SFG L E+ T G + L+
Sbjct: 196 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 255
Query: 233 RDAHDLVYPFN 243
++ H + P N
Sbjct: 256 KEGHRMDKPSN 266
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 6e-07
Identities = 41/134 (30%), Positives = 59/134 (44%), Gaps = 19/134 (14%)
Query: 97 LVFEYVQHGTLW-----DRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVF 151
V +YV G L+ +R P+ F A + A+A+ YLH I++
Sbjct: 73 FVLDYVNGGELFFHLQRERCFLEPRARFY----------AAEVASAIGYLH---SLNIIY 119
Query: 152 RDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLD 211
RD K +IL + V L DF L E E T T GT +LAP+ + + +D
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTSTFCGTPEYLAPEVLRKEPYDRTVD 178
Query: 212 VYSFGAFLSELLTG 225
+ GA L E+L G
Sbjct: 179 WWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 6e-07
Identities = 55/234 (23%), Positives = 94/234 (40%), Gaps = 36/234 (15%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRI--LGAPQTHFEPLLLKRRLKDAVD 133
Q+ H +I++ LE +V + ++ L + L + F +R V
Sbjct: 65 QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTE---ERIWNIFVQ 121
Query: 134 AANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTY 193
AL YLH + IV RD ++I+ E++ V + DF L+ + +V+GT
Sbjct: 122 MVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQ--KQPESKLTSVVGTI 177
Query: 194 GHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDN 253
+ P+ V + EK DV++FG L ++ T L PF Y N +
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQMCT-------------LQPPF--YSTNML--S 220
Query: 254 RFTEIVDPIIVQDLSCTEKEQQLHASAQLTF---ECLNESPIDRPTMVDVARRL 304
T+IV+ + E + S +T CL RP ++ V+ +
Sbjct: 221 LATKIVEAVY-------EPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 7e-07
Identities = 28/94 (29%), Positives = 43/94 (45%), Gaps = 4/94 (4%)
Query: 133 DAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGT 192
L YLH + RD K +IL +EE KL DF +S +TV+GT
Sbjct: 107 QTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVS-GQLTDTMAKRNTVIGT 162
Query: 193 YGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
+AP+ + ++ K D++S G E+ G+
Sbjct: 163 PFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 7e-07
Identities = 49/195 (25%), Positives = 83/195 (42%), Gaps = 14/195 (7%)
Query: 32 ASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91
+S Y I + QE+ + N Q+ E IN + + + +I+ + L
Sbjct: 30 GASGTVYTAIDIATGQEVAIKQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLV 87
Query: 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVF 151
+V EY+ G+L D + + + R A+D +LH ++
Sbjct: 88 GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALD------FLH---SNQVIH 138
Query: 152 RDFKTSHILFSEENVVKLFDFSLSISI-PEGETHITDTVMGTYGHLAPQYVTTCDFSEKL 210
RD K+ +IL + VKL DF I PE T++GT +AP+ VT + K+
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKV 196
Query: 211 DVYSFGAFLSELLTG 225
D++S G E++ G
Sbjct: 197 DIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 8e-07
Identities = 37/157 (23%), Positives = 66/157 (42%), Gaps = 14/157 (8%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAA 135
+ H +++K G + + EY GTL + + + R +
Sbjct: 55 LLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEH---GRILDEHVIRVY--TLQLL 109
Query: 136 NALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITD---TVMGT 192
LAYLH IV RD K ++I V+KL DF ++ + T + + ++ GT
Sbjct: 110 EGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGT 166
Query: 193 YGHLAPQYVTTCDFSEKL---DVYSFGAFLSELLTGR 226
++AP+ +T D++S G + E+ TG+
Sbjct: 167 PAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGK 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 8e-07
Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 25/158 (15%)
Query: 77 MSHDH-ILKLIGCCLETPIAIL-VFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKD---- 130
++ +H L + CC +TP + V E+V G L I + RR +
Sbjct: 51 LARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKS-----------RRFDEARAR 99
Query: 131 --AVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL-SISIPEGETHITD 187
A + +AL +LH + I++RD K ++L E KL DF + I G+T T
Sbjct: 100 FYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TS 154
Query: 188 TVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225
T GT ++AP+ + + +D ++ G L E+L G
Sbjct: 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 9e-07
Identities = 37/155 (23%), Positives = 72/155 (46%), Gaps = 9/155 (5%)
Query: 71 VTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKD 130
V + M H +I++ E +V +Y + G L+ +I F + ++ D
Sbjct: 50 VAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFP----EDQILD 105
Query: 131 -AVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTV 189
V AL ++H R I+ RD K+ +I +++ +KL DF ++ + + T
Sbjct: 106 WFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIA-RVLNSTVELARTC 161
Query: 190 MGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT 224
+GT +L+P+ ++ K D+++ G L E+ T
Sbjct: 162 IGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 9e-07
Identities = 24/78 (30%), Positives = 44/78 (56%), Gaps = 2/78 (2%)
Query: 149 IVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSE 208
V+RD K +IL + +++ D L++ IPEGE+ I V GT G++AP+ + ++
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-IRGRV-GTVGYMAPEVLNNQRYTL 180
Query: 209 KLDVYSFGAFLSELLTGR 226
D + G + E++ G+
Sbjct: 181 SPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 35/135 (25%), Positives = 60/135 (44%), Gaps = 21/135 (15%)
Query: 98 VFEYVQHGTLW-----DRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFR 152
V EY G L+ +R+ + F + +AL YLH +V+R
Sbjct: 73 VMEYANGGELFFHLSRERVFSEDRARFY----------GAEIVSALGYLH---SCDVVYR 119
Query: 153 DFKTSHILFSEENVVKLFDFSL-SISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLD 211
D K +++ ++ +K+ DF L I +G T T GT +LAP+ + D+ +D
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVD 177
Query: 212 VYSFGAFLSELLTGR 226
+ G + E++ GR
Sbjct: 178 WWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 1e-06
Identities = 39/179 (21%), Positives = 64/179 (35%), Gaps = 57/179 (31%)
Query: 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAAN-------ALAYLHFGFPRPI 149
V EY +G L + K D AL YLH + I
Sbjct: 79 FVLEYAPNGELLQ------------YIRKYGSLDEKCTRFYAAEILLALEYLH---SKGI 123
Query: 150 VFRDFKTSHILFSEENVVKLFDF---------SLSISIPEGETHI----------TDTVM 190
+ RD K +IL ++ +K+ DF S S T+I + +
Sbjct: 124 IHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFV 183
Query: 191 GTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPF---NEYL 246
GT +++P+ + + D+++ G + ++LTG+ PF NEYL
Sbjct: 184 GTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK-------------PPFRGSNEYL 229
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 44/195 (22%), Positives = 82/195 (42%), Gaps = 21/195 (10%)
Query: 31 IASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90
I + K + +I +E + E + Q+ +T +Q ++ K G L
Sbjct: 24 IDNRTQKVVAIKIIDLEEAEDEIEDIQQE-----------ITVLSQCDSPYVTKYYGSYL 72
Query: 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIV 150
+ ++ EY+ G+ D + P + + R + +D YLH +
Sbjct: 73 KDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLD------YLH---SEKKI 123
Query: 151 FRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKL 210
RD K +++L SE VKL DF ++ + + + +T +GT +AP+ + + K
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RNTFVGTPFWMAPEVIKQSAYDSKA 182
Query: 211 DVYSFGAFLSELLTG 225
D++S G EL G
Sbjct: 183 DIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 53/197 (26%), Positives = 85/197 (43%), Gaps = 40/197 (20%)
Query: 74 AAQM---SHDHILKLIGCCLET------PIAILVFEYVQHGTL-----WDRILGAPQTHF 119
AA M H +++KLIG C E P +++ +++HG L + R+ G P+
Sbjct: 52 AACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEK-- 109
Query: 120 EPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIP 179
L L+ LK VD A + YL R + RD + + E+ V + DF LS I
Sbjct: 110 --LPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIY 164
Query: 180 EG----ETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRG-------- 227
G + I + +A + + ++ K DV++FG + E+ T RG
Sbjct: 165 SGDYYRQGRIAKMPV---KWIAIESLADRVYTSKSDVWAFGVTMWEIAT-RGQTPYPGVE 220
Query: 228 ---ILDLVRDAHDLVYP 241
I D +R + L P
Sbjct: 221 NHEIYDYLRHGNRLKQP 237
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 27/78 (34%), Positives = 45/78 (57%), Gaps = 2/78 (2%)
Query: 149 IVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSE 208
IV+RD K +IL + +++ D L++ IPEGET I V GT G++AP+ V ++
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGYMAPEVVKNERYTF 180
Query: 209 KLDVYSFGAFLSELLTGR 226
D + G + E++ G+
Sbjct: 181 SPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 35/136 (25%), Positives = 61/136 (44%), Gaps = 20/136 (14%)
Query: 97 LVFEYVQHGTLW-----DRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVF 151
V EY G L+ +R+ + F + +AL YLH + +V+
Sbjct: 72 FVMEYANGGELFFHLSRERVFSEDRARFY----------GAEIVSALDYLHS--EKNVVY 119
Query: 152 RDFKTSHILFSEENVVKLFDFSLSIS-IPEGETHITDTVMGTYGHLAPQYVTTCDFSEKL 210
RD K +++ ++ +K+ DF L I +G T T GT +LAP+ + D+ +
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCGTPEYLAPEVLEDNDYGRAV 177
Query: 211 DVYSFGAFLSELLTGR 226
D + G + E++ GR
Sbjct: 178 DWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 1e-06
Identities = 41/150 (27%), Positives = 69/150 (46%), Gaps = 7/150 (4%)
Query: 79 HDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANAL 138
H H++ L C ++ E ++ G+L L +P+ + L + + A A +
Sbjct: 61 HKHLISLFAVCSVGEPVYIITELMEKGSLLA-FLRSPEG--QVLPVASLIDMACQVAEGM 117
Query: 139 AYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAP 198
AYL + + RD +IL E+ V K+ DF L+ I E + +++ Y AP
Sbjct: 118 AYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE-DVYLSSDKKIPYKWTAP 173
Query: 199 QYVTTCDFSEKLDVYSFGAFLSELLTGRGI 228
+ + FS K DV+SFG L E+ T +
Sbjct: 174 EAASHGTFSTKSDVWSFGILLYEMFTYGQV 203
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 28/93 (30%), Positives = 49/93 (52%), Gaps = 1/93 (1%)
Query: 134 AANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTY 193
AA + L F + I++RD K ++L ++ +K+ DF + GE T GT
Sbjct: 102 AAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG-KASTFCGTP 160
Query: 194 GHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
++AP+ + ++E +D +SFG L E+L G+
Sbjct: 161 DYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 25/90 (27%), Positives = 49/90 (54%), Gaps = 4/90 (4%)
Query: 138 LAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLA 197
L +LH R I++RD K ++L + V++ D L++ + +G++ T GT G +A
Sbjct: 110 LEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMA 165
Query: 198 PQYVTTCDFSEKLDVYSFGAFLSELLTGRG 227
P+ + ++ +D ++ G L E++ RG
Sbjct: 166 PELLQGEEYDFSVDYFALGVTLYEMIAARG 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 41/162 (25%), Positives = 73/162 (45%), Gaps = 12/162 (7%)
Query: 65 ESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAP-QTHFEPLL 123
E +T +Q +I + G L+ ++ EY+ G+ D + P + + +
Sbjct: 47 EDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATI 106
Query: 124 LKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGET 183
L+ LK L YLH + RD K +++L SE+ VKL DF ++ + + +
Sbjct: 107 LREILK-------GLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156
Query: 184 HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225
+T +GT +AP+ + + K D++S G EL G
Sbjct: 157 K-RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 1e-06
Identities = 33/95 (34%), Positives = 46/95 (48%), Gaps = 4/95 (4%)
Query: 131 AVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVM 190
A + A+AL YLH I++RD K +IL + V L DF L E T T
Sbjct: 102 AAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK-TTSTFC 157
Query: 191 GTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225
GT +LAP+ + + +D + GA L E+L G
Sbjct: 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 29/93 (31%), Positives = 48/93 (51%), Gaps = 1/93 (1%)
Query: 134 AANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTY 193
AA + L F + IV+RD K +IL + +K+ DF + G+ T T GT
Sbjct: 102 AAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-TCTFCGTP 160
Query: 194 GHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
++AP+ + ++ +D +SFG L E+L G+
Sbjct: 161 DYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 55/256 (21%), Positives = 103/256 (40%), Gaps = 42/256 (16%)
Query: 65 ESCINNVTYAAQMSHDHILKLIGCCLET------PIAILVFEYVQHGTLWDRILGAPQTH 118
E + + H +++KLIG L + PI +++ +++HG L +L +
Sbjct: 46 EEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL-MSRIG 104
Query: 119 FEPLLLKRR--LKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176
EP L + ++ +D A+ + YL + + RD + + +E V + DF LS
Sbjct: 105 EEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSK 161
Query: 177 SIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKL-----DVYSFGAFLSELLTGRGILDL 231
I G+ + G L +++ ++ + DV++FG + E++T RG
Sbjct: 162 KIYSGDYY----RQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT-RGQTPY 216
Query: 232 VRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESP 291
+ +Y YL + NR Q C E +L +C + P
Sbjct: 217 AGVENSEIY---NYL---IKGNRLK--------QPPDCLED------VYELMCQCWSPEP 256
Query: 292 IDRPTMVDVARRLRQI 307
RP+ + +L I
Sbjct: 257 KCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 41/155 (26%), Positives = 72/155 (46%), Gaps = 17/155 (10%)
Query: 76 QMSHDHILKLIGCCL-ETPIAILVFEYVQHGTLWDRILGAPQTHFEPL--LLKRRLKDAV 132
++ H +I++ +G E + I + E V G+L ++L + EP+ L R++
Sbjct: 58 KLQHPNIVQYLGTEREEDNLYIFL-ELVPGGSL-AKLLKKYGSFPEPVIRLYTRQILLG- 114
Query: 133 DAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGT 192
L YLH R V RD K ++IL VVKL DF ++ + E + G+
Sbjct: 115 -----LEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF--AKSFKGS 164
Query: 193 YGHLAPQYVTTCD-FSEKLDVYSFGAFLSELLTGR 226
+AP+ + + D++S G + E+ TG+
Sbjct: 165 PYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 61/260 (23%), Positives = 106/260 (40%), Gaps = 43/260 (16%)
Query: 56 YDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAP 115
+D + CI + Q++H +++K +E +V E G L I
Sbjct: 38 FDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMI---- 93
Query: 116 QTHFEPLLLKRRL-------KDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVK 168
HF+ ++RL K V +AL ++H R ++ RD K +++ + VVK
Sbjct: 94 -KHFKK---QKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVK 146
Query: 169 LFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGI 228
L D L +T +++GT +++P+ + ++ K D++S G L E+
Sbjct: 147 LGDLGLG-RFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA---- 201
Query: 229 LDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVD-PIIVQDLSCTEKEQQLHASAQLTFECL 287
L PF N + + E D P + D ++L QL C+
Sbjct: 202 ---------LQSPFYGDKMNLYSLCKKIEQCDYPPLPSD----HYSEELR---QLVNMCI 245
Query: 288 NESPIDRPTMV---DVARRL 304
N P RP + DVA+R+
Sbjct: 246 NPDPEKRPDITYVYDVAKRM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-06
Identities = 62/238 (26%), Positives = 99/238 (41%), Gaps = 40/238 (16%)
Query: 78 SHDHILKLIGCCLETP-IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAV---- 132
SH ++L L+G CL + ++V Y++HG L + I +TH P +KD +
Sbjct: 54 SHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFI--RSETH-NP-----TVKDLIGFGL 105
Query: 133 DAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGE---THITDTV 189
A + YL + V RD + + E VK+ DF L+ I + E H
Sbjct: 106 QVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGA 162
Query: 190 MGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNY 249
+A + + T F+ K DV+SFG L EL+T RG + V F+ + Y
Sbjct: 163 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGA-----PPYPDVDSFD--ITVY 214
Query: 250 FEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQI 307
R ++Q C + ++ C + P RPT ++ R+ QI
Sbjct: 215 LLQGRR-------LLQPEYCPD------PLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 2e-06
Identities = 46/194 (23%), Positives = 81/194 (41%), Gaps = 12/194 (6%)
Query: 32 ASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91
+S Y + + QE+ N Q+ E IN + + + +I+ + L
Sbjct: 31 GASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLV 88
Query: 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVF 151
+V EY+ G+L D + + + R + AL +LH ++
Sbjct: 89 GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR------ECLQALEFLH---SNQVIH 139
Query: 152 RDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLD 211
RD K+ +IL + VKL DF I ++ + V GT +AP+ VT + K+D
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 198
Query: 212 VYSFGAFLSELLTG 225
++S G E++ G
Sbjct: 199 IWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 48/168 (28%), Positives = 77/168 (45%), Gaps = 24/168 (14%)
Query: 75 AQMSHDHILKLI--GCCLETPIAIL--VFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKD 130
A++ H +I+ L+ G E P +L VFEYV TL + + A R +
Sbjct: 33 ARLYHPNIVALLDSG---EAPPGLLFAVFEYVPGRTLREVL--AADGALPAGETGRLMLQ 87
Query: 131 AVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENV---VKLFDFSLSISIP----EGET 183
+D ALA H + IV RD K +I+ S+ V K+ DF + +P
Sbjct: 88 VLD---ALACAH---NQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVA 141
Query: 184 HITDT--VMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGIL 229
+T T V+GT + AP+ + + D+Y++G E LTG+ ++
Sbjct: 142 TLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 55/241 (22%), Positives = 101/241 (41%), Gaps = 34/241 (14%)
Query: 76 QMSHDHILKLIGCCLET------PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRL- 128
+ H ++++LIG CL+T P +++ +++HG L +L + + P L ++
Sbjct: 56 EFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYS-RLGDCPQYLPTQML 114
Query: 129 -KDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITD 187
K D A+ + YL + + RD + + +E V + DF LS I G+ +
Sbjct: 115 VKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQG 171
Query: 188 TVMGT-YGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYL 246
+ +A + + ++ K DV+SFG + E+ T RG + +Y +YL
Sbjct: 172 RIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT-RGQTPYPGVENSEIY---DYL 227
Query: 247 KNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQ 306
+ + NR + D C L L C +P DRP+ + L +
Sbjct: 228 R---QGNRLKQPPD--------C------LDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270
Query: 307 I 307
Sbjct: 271 A 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 74/305 (24%), Positives = 125/305 (40%), Gaps = 59/305 (19%)
Query: 27 LQELIASSNGK------YIP----YRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQ 76
++EL + GK Y+P ++ + + LK + NN Q F E+ + A+
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLK-DINNPQQWGEFQQEASL-----MAE 63
Query: 77 MSHDHILKLIGCCLETPIAILVFEYVQHGTLWD-RILGAPQTHF-----EPLLLKRRLKD 130
+ H +I+ L+G + ++FEY+ G L + I+ +P + E +K L
Sbjct: 64 LHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDH 123
Query: 131 ------AVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETH 184
A+ A + YL F V +D +IL E+ VK+ D LS I + +
Sbjct: 124 GDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYY 180
Query: 185 -ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFN 243
+ + + P+ + FS D++SFG L E+ F+
Sbjct: 181 RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEI-------------------FS 221
Query: 244 EYLKNY--FEDNRFTEIVDPIIVQDLSCTEK-EQQLHASAQLTFECLNESPIDRPTMVDV 300
L+ Y F + E+V Q L C+E ++++ L EC E P RP D+
Sbjct: 222 FGLQPYYGFSNQEVIEMVRK--RQLLPCSEDCPPRMYS---LMTECWQEGPSRRPRFKDI 276
Query: 301 ARRLR 305
RLR
Sbjct: 277 HTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 43/156 (27%), Positives = 72/156 (46%), Gaps = 11/156 (7%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRI-LGAPQTHFEPLLLKRRLKDAVDA 134
Q +H +++K + LV Y+ G+L D + P+ + ++ LK+ +
Sbjct: 55 QCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVL-- 112
Query: 135 ANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEG---ETHITDTVMG 191
L YLH + RD K +IL E+ VK+ DF +S S+ +G + T +G
Sbjct: 113 -KGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVG 168
Query: 192 TYGHLAPQYVTTCD-FSEKLDVYSFGAFLSELLTGR 226
T +AP+ + + K D++SFG EL TG
Sbjct: 169 TPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-06
Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 11/93 (11%)
Query: 138 LAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS------ISIPEGETHITDTVMG 191
L +H + ++ RD K+++IL +VKL DF S +S G T G
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT-----FCG 207
Query: 192 TYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT 224
T ++AP+ +S+K D++S G L ELLT
Sbjct: 208 TPYYVAPEIWRRKPYSKKADMFSLGVLLYELLT 240
|
Length = 496 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 38/162 (23%), Positives = 74/162 (45%), Gaps = 22/162 (13%)
Query: 76 QMSHDHILKLIGCCLETPIA--------ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRR 127
+ H++++ LI C LVFE+ +H +L F +K+
Sbjct: 67 LLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLA--GLLSNKNVKFTLSEIKKV 124
Query: 128 LKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS--ISIPEGE--T 183
+K + N L Y+H I+ RD K ++IL +++ ++KL DF L+ S+ +
Sbjct: 125 MKMLL---NGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPN 178
Query: 184 HITDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLT 224
T+ V+ T + P+ + D+ +D++ G ++E+ T
Sbjct: 179 RYTNRVV-TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 38/140 (27%), Positives = 63/140 (45%), Gaps = 21/140 (15%)
Query: 97 LVFEYVQHGTLWDRI-----LGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVF 151
V EYV G L I PQ F A + + L +LH R I++
Sbjct: 78 FVMEYVNGGDLMYHIQQVGKFKEPQAVFY----------AAEISVGLFFLH---RRGIIY 124
Query: 152 RDFKTSHILFSEENVVKLFDFSL-SISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKL 210
RD K +++ E +K+ DF + + +G T T T GT ++AP+ + + + +
Sbjct: 125 RDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT--TRTFCGTPDYIAPEIIAYQPYGKSV 182
Query: 211 DVYSFGAFLSELLTGRGILD 230
D +++G L E+L G+ D
Sbjct: 183 DWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 35/158 (22%), Positives = 73/158 (46%), Gaps = 5/158 (3%)
Query: 65 ESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLL 124
+ C+ + Q+ H +++K + +E +V E G L R++ + +
Sbjct: 47 QDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDL-SRMIKHFKKQKRLIPE 105
Query: 125 KRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETH 184
+ K V +AL ++H + I+ RD K +++ + VVKL D L +T
Sbjct: 106 RTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLG-RFFSSKTT 161
Query: 185 ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSEL 222
+++GT +++P+ + ++ K D++S G L E+
Sbjct: 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 35/153 (22%), Positives = 64/153 (41%), Gaps = 13/153 (8%)
Query: 77 MSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRI--LGAPQTHFEPLLLKRRLKDAVDA 134
H +++KL+ +LV EY+ L + + P + R L V
Sbjct: 56 CQHPYVVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLLKGVAY 114
Query: 135 ANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYG 194
+A +H RD K +++L S + V+K+ DF L+ E E + + T
Sbjct: 115 MHANGIMH---------RDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRW 165
Query: 195 HLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGR 226
+ AP+ + + +D+++ G +ELL G
Sbjct: 166 YRAPELLYGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-06
Identities = 37/165 (22%), Positives = 76/165 (46%), Gaps = 19/165 (11%)
Query: 65 ESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLL 124
+ C+ + Q++H +++K + +E +V E G L I +F+
Sbjct: 47 QDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIK-----YFKK--- 98
Query: 125 KRRL-------KDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSIS 177
++RL K V +A+ ++H R ++ RD K +++ + VVKL D L
Sbjct: 99 QKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLG-R 154
Query: 178 IPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSEL 222
+T +++GT +++P+ + ++ K D++S G L E+
Sbjct: 155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 4e-06
Identities = 40/134 (29%), Positives = 58/134 (43%), Gaps = 19/134 (14%)
Query: 97 LVFEYVQHGTLW-----DRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVF 151
V +Y+ G L+ +R P+ F A + A+AL YLH IV+
Sbjct: 73 FVLDYINGGELFYHLQRERCFLEPRARFY----------AAEIASALGYLH---SLNIVY 119
Query: 152 RDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLD 211
RD K +IL + + L DF L E T T GT +LAP+ + + +D
Sbjct: 120 RDLKPENILLDSQGHIVLTDFGLCKENIE-HNGTTSTFCGTPEYLAPEVLHKQPYDRTVD 178
Query: 212 VYSFGAFLSELLTG 225
+ GA L E+L G
Sbjct: 179 WWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-06
Identities = 22/78 (28%), Positives = 44/78 (56%), Gaps = 2/78 (2%)
Query: 149 IVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSE 208
IV+RD K ++L ++ +L D L++ + +G+T GT G++AP+ + +S
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEPYSY 173
Query: 209 KLDVYSFGAFLSELLTGR 226
+D ++ G + E++ GR
Sbjct: 174 PVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 4e-06
Identities = 27/92 (29%), Positives = 42/92 (45%), Gaps = 3/92 (3%)
Query: 137 ALAYLHFG-FPRPIVF-RDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYG 194
AL H P V RD K ++I N VKL DF L+ + + T +GT
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD-SSFAKTYVGTPY 175
Query: 195 HLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
+++P+ + + EK D++S G + EL
Sbjct: 176 YMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 5e-06
Identities = 38/134 (28%), Positives = 58/134 (43%), Gaps = 28/134 (20%)
Query: 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAV------DAANALAYLHFGFPRPIV 150
LV E G++ D + G +RLK+ + LAYLH ++
Sbjct: 86 LVMELCGGGSVTDLVKGL-------RKKGKRLKEEWIAYILRETLRGLAYLH---ENKVI 135
Query: 151 FRDFKTSHILFSEENVVKLFDFSLS--ISIPEGETHITDTVMGTYGHLAPQYVTTCD--- 205
RD K +IL ++ VKL DF +S + G + T +GT +AP+ V CD
Sbjct: 136 HRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRN---TFIGTPYWMAPE-VIACDEQP 191
Query: 206 ---FSEKLDVYSFG 216
+ + DV+S G
Sbjct: 192 DASYDARSDVWSLG 205
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 5e-06
Identities = 41/174 (23%), Positives = 78/174 (44%), Gaps = 15/174 (8%)
Query: 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKT 156
LVFEYV+ L +L P ++ + + A +H+ IV RD K
Sbjct: 77 LVFEYVEKNML--ELLEEMPNGVPPEKVRSYIYQLIKA------IHWCHKNDIVHRDIKP 128
Query: 157 SHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFG 216
++L S +V+KL DF + ++ EG + T + +P+ + + + +D++S G
Sbjct: 129 ENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVG 188
Query: 217 AFLSELLTGRGI------LDLVRDAHDLVYPF-NEYLKNYFEDNRFTEIVDPII 263
L EL G+ + +D + ++ P E +K ++ + RF + P +
Sbjct: 189 CILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAV 242
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 5e-06
Identities = 41/156 (26%), Positives = 66/156 (42%), Gaps = 19/156 (12%)
Query: 79 HDHILKLIGCCLETPIAILVFEYVQHGTLWDRI---LGAPQTHFEPLLLKRRLKDAVDAA 135
H +I+ L ++ E+ G L D I L T + + R++ +A
Sbjct: 61 HPNIVGLYEAYFYENKLWILIEFCDGGAL-DSIMLELERGLTEPQIRYVCRQMLEA---- 115
Query: 136 NALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGH 195
L +LH ++ RD K +IL + + VKL DF +S + + DT +GT
Sbjct: 116 --LNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVS-AKNKSTLQKRDTFIGTPYW 169
Query: 196 LAPQYVTTCDFSE-----KLDVYSFGAFLSELLTGR 226
+AP+ V F + K D++S G L EL
Sbjct: 170 MAPEVVACETFKDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 5e-06
Identities = 44/191 (23%), Positives = 78/191 (40%), Gaps = 33/191 (17%)
Query: 79 HDHILKLIGCCLETPIAILVFEYVQHGTL--WDRILGAPQTHF---------EPLLLKRR 127
H +I+ L+G C + ++ EY G L + R P + E + K
Sbjct: 80 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139
Query: 128 LKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITD 187
+ A + YL + + RD ++L +E NV+K+ DF L+ + +I
Sbjct: 140 VSCTYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDV----NNIDY 192
Query: 188 TVMGTYGHL-----APQYVTTCDFSEKLDVYSFGAFLSELLTGRG----------ILDLV 232
T G L AP+ + ++ + DV+SFG + E+ T G + L+
Sbjct: 193 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 252
Query: 233 RDAHDLVYPFN 243
++ H + P N
Sbjct: 253 KEGHRMDKPAN 263
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 5e-06
Identities = 42/135 (31%), Positives = 61/135 (45%), Gaps = 21/135 (15%)
Query: 97 LVFEYVQHGTLW-----DRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVF 151
V ++V G L+ +R P+ F A + A+AL YLH IV+
Sbjct: 73 FVLDFVNGGELFFHLQRERSFPEPRARFY----------AAEIASALGYLH---SINIVY 119
Query: 152 RDFKTSHILFSEENVVKLFDFSLSIS-IPEGETHITDTVMGTYGHLAPQYVTTCDFSEKL 210
RD K +IL + V L DF L I + +T T T GT +LAP+ + + +
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYLAPEVIRKQPYDNTV 177
Query: 211 DVYSFGAFLSELLTG 225
D + GA L E+L G
Sbjct: 178 DWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 5e-06
Identities = 43/160 (26%), Positives = 66/160 (41%), Gaps = 21/160 (13%)
Query: 76 QMSHD--HILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVD 133
SHD +I+K G + + E + T D++L Q +L K V
Sbjct: 68 LKSHDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILG---KMTVA 122
Query: 134 AANALAYL---HFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVM 190
AL YL H ++ RD K S+IL VKL DF +S + + +
Sbjct: 123 IVKALHYLKEKH-----GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSA 175
Query: 191 GTYGHLAPQYVT----TCDFSEKLDVYSFGAFLSELLTGR 226
G ++AP+ + + + DV+S G L EL TG+
Sbjct: 176 GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 7e-06
Identities = 32/91 (35%), Positives = 43/91 (47%), Gaps = 5/91 (5%)
Query: 137 ALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHL 196
AL +LH I++RD K +IL V L DF LS E E + GT ++
Sbjct: 117 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM 173
Query: 197 APQYVTTCD--FSEKLDVYSFGAFLSELLTG 225
AP V D + +D +S G + ELLTG
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 7e-06
Identities = 29/92 (31%), Positives = 49/92 (53%), Gaps = 6/92 (6%)
Query: 136 NALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSIS-IPEGETHITDTVMGTYG 194
+AL YLH R +V+RD K +++ ++ +K+ DF L I +G T T GT
Sbjct: 106 SALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPE 160
Query: 195 HLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
+LAP+ + D+ +D + G + E++ GR
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 8e-06
Identities = 31/96 (32%), Positives = 46/96 (47%), Gaps = 6/96 (6%)
Query: 131 AVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVM 190
AV L YL + I+ RD K S++L + VKL DF +S + I T +
Sbjct: 101 AVAVVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYV 154
Query: 191 GTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
GT ++AP+ ++ + DV+S G EL GR
Sbjct: 155 GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 8e-06
Identities = 36/161 (22%), Positives = 75/161 (46%), Gaps = 10/161 (6%)
Query: 65 ESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLL 124
E N V H++++ + L +V E+++ G L D + TH +
Sbjct: 64 ELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIV-----THTR-MNE 117
Query: 125 KRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETH 184
++ + AL+YLH + ++ RD K+ IL + + +KL DF + + E
Sbjct: 118 EQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK-EVP 173
Query: 185 ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225
+++GT +AP+ ++ + ++D++S G + E++ G
Sbjct: 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 8e-06
Identities = 25/93 (26%), Positives = 48/93 (51%), Gaps = 1/93 (1%)
Query: 134 AANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTY 193
AA + L F + I++RD K +++ + +K+ DF + G+ + T GT
Sbjct: 102 AAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAS-TFCGTP 160
Query: 194 GHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
++AP+ + ++ +D +SFG L E+L G+
Sbjct: 161 DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 8e-06
Identities = 40/141 (28%), Positives = 66/141 (46%), Gaps = 12/141 (8%)
Query: 88 CCLETPIAIL-VFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFP 146
CC +T + V EYV G L +I + + F+ R A + AL +LH
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQRSRK--FDE---PRSRFYAAEVTLALMFLH---R 114
Query: 147 RPIVFRDFKTSHILFSEENVVKLFDFSL-SISIPEGETHITDTVMGTYGHLAPQYVTTCD 205
+++RD K +IL E KL DF + I G T T T GT ++AP+ + +
Sbjct: 115 HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYIAPEILQELE 172
Query: 206 FSEKLDVYSFGAFLSELLTGR 226
+ +D ++ G + E++ G+
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 9e-06
Identities = 49/193 (25%), Positives = 82/193 (42%), Gaps = 37/193 (19%)
Query: 79 HDHILKLIGCCLET-PIAILVFEYVQHGTLWD--RILGAPQTHF---------EPLLLKR 126
H +I+ L+G C + P+ +LV EY G L + R P + E L K
Sbjct: 77 HKNIINLLGACTQDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 127 RLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHIT 186
+ A A + YL + + RD ++L +E+NV+K+ DF L+ + H
Sbjct: 136 LVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDV-----HNI 187
Query: 187 DTVMGTYGH------LAPQYVTTCDFSEKLDVYSFGAFLSELLTGRG----------ILD 230
D T +AP+ + ++ + DV+SFG L E+ T G +
Sbjct: 188 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 247
Query: 231 LVRDAHDLVYPFN 243
L+++ H + P N
Sbjct: 248 LLKEGHRMDKPAN 260
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 41/152 (26%), Positives = 70/152 (46%), Gaps = 10/152 (6%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAA 135
+++H +I+KL+ LVFE++ +++ Q L+K L +
Sbjct: 54 ELNHPNIIKLLDVFRHKGDLYLVFEFMDTDLY--KLIKDRQRGLPESLIKSYLYQLL--- 108
Query: 136 NALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGH 195
LA+ H I+ RD K ++L + E V+KL DF L+ S T V+ T +
Sbjct: 109 QGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-TRWY 164
Query: 196 LAPQYVTTCDF-SEKLDVYSFGAFLSELLTGR 226
AP+ + S +D++S G +ELL+ R
Sbjct: 165 RAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 36/130 (27%), Positives = 66/130 (50%), Gaps = 10/130 (7%)
Query: 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKT 156
+ E++ G+L D++L + E +L K ++ LAYL I+ RD K
Sbjct: 80 ICMEHMDGGSL-DQVLKEAKRIPEEILGKV----SIAVLRGLAYLRE--KHQIMHRDVKP 132
Query: 157 SHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFG 216
S+IL + +KL DF +S + + + ++ +GT +++P+ + +S + D++S G
Sbjct: 133 SNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMG 189
Query: 217 AFLSELLTGR 226
L EL GR
Sbjct: 190 LSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 38/159 (23%), Positives = 76/159 (47%), Gaps = 14/159 (8%)
Query: 69 NNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPL--LLKR 126
N V H +I+++ L +V E+++ G L D I+ + + E + +
Sbjct: 65 NEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLA 123
Query: 127 RLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHIT 186
LK AL++LH + ++ RD K+ IL + + VKL DF + + E
Sbjct: 124 VLK-------ALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK-EVPRR 172
Query: 187 DTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225
+++GT +AP+ ++ + ++D++S G + E++ G
Sbjct: 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-05
Identities = 51/230 (22%), Positives = 92/230 (40%), Gaps = 30/230 (13%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAA 135
++SH +++L G C + +V E++++G L + L Q +L L D
Sbjct: 55 KLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLN-YLRQRQGKLSKDML---LSMCQDVC 110
Query: 136 NALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGH 195
+ YL + RD + L S VVK+ DF ++ + + E +
Sbjct: 111 EGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKW 167
Query: 196 LAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFEDNR 254
P+ +S K DV+SFG + E+ T G+ PF + NY
Sbjct: 168 SPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGK-------------MPFEKK-SNY----- 208
Query: 255 FTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRL 304
E+V+ +I + + ++ + C +E P RPT ++ R +
Sbjct: 209 --EVVE-MISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 28/97 (28%), Positives = 53/97 (54%), Gaps = 6/97 (6%)
Query: 131 AVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL-SISIPEGETHITDTV 189
A + A L +LH + I++RD K +++ E +K+ DF + ++ +G T T T
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT--TKTF 161
Query: 190 MGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
GT ++AP+ + + + +D ++FG L E+L G+
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 1e-05
Identities = 32/90 (35%), Positives = 44/90 (48%), Gaps = 4/90 (4%)
Query: 137 ALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHL 196
AL +LH IV+RD K +IL E V L DF LS E T + GT ++
Sbjct: 117 ALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYM 173
Query: 197 APQYV-TTCDFSEKLDVYSFGAFLSELLTG 225
AP+ + + +D +S G + ELLTG
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-05
Identities = 37/167 (22%), Positives = 75/167 (44%), Gaps = 22/167 (13%)
Query: 65 ESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLL 124
E N V H++++++ L +V E+++ G L D + TH
Sbjct: 62 ELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV-----TH------ 110
Query: 125 KRRLKD------AVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISI 178
R+ + + AL+ LH + ++ RD K+ IL + + VKL DF +
Sbjct: 111 -TRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 166
Query: 179 PEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225
+ E +++GT +AP+ ++ + ++D++S G + E++ G
Sbjct: 167 SK-EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 1e-05
Identities = 49/247 (19%), Positives = 82/247 (33%), Gaps = 52/247 (21%)
Query: 75 AQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWD--RILGAPQTHFEPLLLKRRLKDAV 132
++ +H +I++LIG E ++ E + G L R L +K L A
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 133 DAANALAYLH-FGFPRPIVFRDFKTSHILFS---EENVVKLFDFSLSISIPEGETH-ITD 187
D A YL F + RD + L + V K+ DF ++ I +
Sbjct: 124 DVAKGCKYLEENHF----IHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGG 179
Query: 188 TVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELL----------TGRGILDLVRDAHD 237
M + P+ F+ K DV+SFG L E+ T + +++ V
Sbjct: 180 RAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGR 239
Query: 238 LVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTM 297
L P P+ ++ +C +P DRP
Sbjct: 240 LDPP--------------KGCPGPVY-----------------RIMTDCWQHTPEDRPNF 268
Query: 298 VDVARRL 304
+ R+
Sbjct: 269 ATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 41/162 (25%), Positives = 68/162 (41%), Gaps = 25/162 (15%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAA 135
+ H +I++ +G E + E V G+L + ++ + P LKD
Sbjct: 61 YLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALL----RSKWGP------LKDNEQTI 110
Query: 136 N--------ALAYLHFGFPRPIVFRDFKTSHILFSE-ENVVKLFDFSLSISIPEGETHIT 186
L YLH IV RD K ++L + VVK+ DF S + G T
Sbjct: 111 IFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA-GINPCT 166
Query: 187 DTVMGTYGHLAPQYVTTC--DFSEKLDVYSFGAFLSELLTGR 226
+T GT ++AP+ + + D++S G + E+ TG+
Sbjct: 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 35/151 (23%), Positives = 72/151 (47%), Gaps = 13/151 (8%)
Query: 78 SHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANA 137
+H++I+ L+G C +++ EY +G L + + ++ L L+ L + A
Sbjct: 97 NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESF---LTLEDLLSFSYQVAKG 153
Query: 138 LAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGT----Y 193
+A+L + + RD ++L + +VK+ DF L+ I ++ V G
Sbjct: 154 MAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV---VKGNARLPV 207
Query: 194 GHLAPQYVTTCDFSEKLDVYSFGAFLSELLT 224
+AP+ + C ++ + DV+S+G L E+ +
Sbjct: 208 KWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 23/80 (28%), Positives = 44/80 (55%), Gaps = 7/80 (8%)
Query: 149 IVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETH--ITDTVMGTYGHLAPQYVTTCDF 206
I+ RD K S+IL + +KL DF +S G+ + ++ +GT +++P+ + +
Sbjct: 121 IMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGTHY 175
Query: 207 SEKLDVYSFGAFLSELLTGR 226
+ + D++S G L E+ GR
Sbjct: 176 TVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 36/162 (22%), Positives = 75/162 (46%), Gaps = 12/162 (7%)
Query: 65 ESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLL 124
E N V H +++++ L ++ E++Q G L D + + L
Sbjct: 63 ELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIV-------SQTRLN 115
Query: 125 KRRLKDAVDAA-NALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGET 183
+ ++ ++ AL YLH + ++ RD K+ IL + + VKL DF I + +
Sbjct: 116 EEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK-DV 171
Query: 184 HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225
+++GT +AP+ ++ + ++D++S G + E++ G
Sbjct: 172 PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 2e-05
Identities = 35/130 (26%), Positives = 61/130 (46%), Gaps = 8/130 (6%)
Query: 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKT 156
+V EY+ G+L D + +L + + L YLH R I+ RD K
Sbjct: 76 IVLEYMDGGSLADLL--KKVGKIPEPVLAYIARQILKG---LDYLHT--KRHIIHRDIKP 128
Query: 157 SHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFG 216
S++L + + VK+ DF +S + E +T +GT +++P+ + +S D++S G
Sbjct: 129 SNLLINSKGEVKIADFGISKVL-ENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLG 187
Query: 217 AFLSELLTGR 226
L E G+
Sbjct: 188 LTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 55/264 (20%), Positives = 102/264 (38%), Gaps = 68/264 (25%)
Query: 68 INNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTL--WDRIL--------GAPQT 117
+N + + H+++L+G + ++V E + HG L + R L G P
Sbjct: 57 LNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP-- 114
Query: 118 HFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSIS 177
P L+ ++ A + A+ +AYL+ + V RD + + + + VK+ DF ++
Sbjct: 115 ---PPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRD 168
Query: 178 IPEGETHITDTVMGTYGHL-----APQYVTTCDFSEKLDVYSFGAFLSEL---------- 222
I E + + G G L AP+ + F+ D++SFG L E+
Sbjct: 169 IYETDYYRK----GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG 224
Query: 223 LTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQL 282
L+ +L V D L P N C +++ ++
Sbjct: 225 LSNEQVLKFVMDGGYLDQPDN-------------------------C---PERVTDLMRM 256
Query: 283 TFECLNESPIDRPTMVDVARRLRQ 306
C +P RPT +++ L+
Sbjct: 257 ---CWQFNPKMRPTFLEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 41/159 (25%), Positives = 65/159 (40%), Gaps = 20/159 (12%)
Query: 79 HDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEP-----------LLLKRR 127
H +I+ L+G C L EY HG L D + + +P L ++
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 128 LKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITD 187
L A D A + YL + + RD +IL E V K+ DF LS G+
Sbjct: 127 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLS----RGQEVYVK 179
Query: 188 TVMGTYG--HLAPQYVTTCDFSEKLDVYSFGAFLSELLT 224
MG +A + + ++ DV+S+G L E+++
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 4e-05
Identities = 31/124 (25%), Positives = 56/124 (45%), Gaps = 18/124 (14%)
Query: 147 RPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTT-CD 205
R +V+RD K ++IL E V++ D L+ + + H + +GT+G++AP+ +
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPEVLQKGVA 172
Query: 206 FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEY-LKNYFEDNRFTEIVDPIIV 264
+ D +S G L +LL G PF ++ K+ E +R T + +
Sbjct: 173 YDSSADWFSLGCMLFKLLRGH-------------SPFRQHKTKDKHEIDRMTLTMAVELP 219
Query: 265 QDLS 268
S
Sbjct: 220 DSFS 223
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 4e-05
Identities = 39/167 (23%), Positives = 77/167 (46%), Gaps = 17/167 (10%)
Query: 68 INNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILG-APQTHFEPLL--- 123
+N + + + H+++L+G + +++ E + G L + P+ P+
Sbjct: 57 LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPP 116
Query: 124 -LKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGE 182
LK+ ++ A + A+ +AYL+ V RD + + +E+ VK+ DF ++ I E +
Sbjct: 117 SLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 173
Query: 183 THITDTVMGTYGHL-----APQYVTTCDFSEKLDVYSFGAFLSELLT 224
+ G G L +P+ + F+ DV+SFG L E+ T
Sbjct: 174 YYRK----GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 4e-05
Identities = 26/89 (29%), Positives = 46/89 (51%), Gaps = 7/89 (7%)
Query: 137 ALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHL 196
A YLH + I++RD K ++L + VK+ DF + +P+ T T+ GT +L
Sbjct: 130 AFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR----TFTLCGTPEYL 182
Query: 197 APQYVTTCDFSEKLDVYSFGAFLSELLTG 225
AP+ + + + +D ++ G L E + G
Sbjct: 183 APEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 5e-05
Identities = 25/90 (27%), Positives = 39/90 (43%), Gaps = 8/90 (8%)
Query: 136 NALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGH 195
+ LH R I+ RD K ++L + +KL DF LS + +GT +
Sbjct: 108 LGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG-----LENKKFVGTPDY 159
Query: 196 LAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225
LAP+ + + D +S G + E L G
Sbjct: 160 LAPETILGVGDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 6e-05
Identities = 41/154 (26%), Positives = 72/154 (46%), Gaps = 17/154 (11%)
Query: 81 HILKLIGCCLETPIAILVFEYVQHGTLWDRILGA-PQTHFEPLL----LKRRLKDAVDAA 135
H+++L+G ++V E + G L + P+ P L L++ ++ A + A
Sbjct: 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129
Query: 136 NALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGH 195
+ +AYL + V RD + + +E+ VK+ DF ++ I E + + G G
Sbjct: 130 DGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYY----RKGGKGL 182
Query: 196 L-----APQYVTTCDFSEKLDVYSFGAFLSELLT 224
L AP+ + F+ K DV+SFG L E+ T
Sbjct: 183 LPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 6e-05
Identities = 23/77 (29%), Positives = 42/77 (54%), Gaps = 1/77 (1%)
Query: 149 IVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSE 208
+++RD K +IL + + L DF L + + T+T GT +LAP+ + +++
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLC-KLNMKDDDKTNTFCGTPEYLAPELLLGHGYTK 172
Query: 209 KLDVYSFGAFLSELLTG 225
+D ++ G L E+LTG
Sbjct: 173 AVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 6e-05
Identities = 37/133 (27%), Positives = 59/133 (44%), Gaps = 12/133 (9%)
Query: 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKT 156
LV ++ + G LW I + +KR A + AL LH IV RD
Sbjct: 62 LVLQHAEGGKLWSHIS--KFLNIPEECVKRW---AAEMVVALDALH---REGIVCRDLNP 113
Query: 157 SHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFG 216
++IL + ++L FS + + + + V Y AP+ + +E D +S G
Sbjct: 114 NNILLDDRGHIQLTYFSRWSEVED--SCDGEAVENMY--CAPEVGGISEETEACDWWSLG 169
Query: 217 AFLSELLTGRGIL 229
A L ELLTG+ ++
Sbjct: 170 AILFELLTGKTLV 182
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 6e-05
Identities = 55/221 (24%), Positives = 92/221 (41%), Gaps = 42/221 (19%)
Query: 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLK--RRLKDAVDAANALAYLHFGFPRPIVFRDF 154
LVFEY H T+ + + P+ E L+ K + AV+ + +H RD
Sbjct: 77 LVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIH---------RDV 126
Query: 155 KTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQY-VTTCDFSEKLDVY 213
K +IL +++ +KL DF + + TD V T + AP+ V + +DV+
Sbjct: 127 KPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPELLVGDTQYGPPVDVW 185
Query: 214 SFGAFLSELLTGRGI---------LDLVRDA-------HDLVYPFNEYLKNYFEDNRFTE 257
+ G +ELLTG+ + L L+R H ++ N++ K
Sbjct: 186 AIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL-------S 238
Query: 258 IVDPIIVQDLSCTEKEQQLHASAQLTF--ECLNESPIDRPT 296
I +P + L E + +S L+F CL P +R +
Sbjct: 239 IPEPETREPL---ESKFPNISSPALSFLKGCLQMDPTERLS 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 6e-05
Identities = 43/152 (28%), Positives = 69/152 (45%), Gaps = 14/152 (9%)
Query: 78 SHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANA 137
H +I+KL E VFEY++ G L+ + F +++ +
Sbjct: 56 EHPNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQI---LQG 111
Query: 138 LAYLH-FGFPRPIVF-RDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGH 195
LA++H GF F RD K ++L S VVK+ DF L+ I + TD V T +
Sbjct: 112 LAHIHKHGF-----FHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-TDYV-STRWY 164
Query: 196 LAPQYVTTCDF-SEKLDVYSFGAFLSELLTGR 226
AP+ + S +D+++ G ++EL T R
Sbjct: 165 RAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 9e-05
Identities = 51/215 (23%), Positives = 96/215 (44%), Gaps = 23/215 (10%)
Query: 15 KRTLMIGNGA--SVLQEL-IASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNV 71
K+ ++G+GA +V + L I IP I +EL++ T+ K ++
Sbjct: 10 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAI---KELREATSPKANK------EILDEA 60
Query: 72 TYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDA 131
A + + H+ +L+G CL + + L+ + + G L D + + H + + + L
Sbjct: 61 YVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV----REHKDNIGSQYLLNWC 115
Query: 132 VDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS--ISIPEGETHITDTV 189
V A + YL R +V RD ++L VK+ DF L+ + E E H +
Sbjct: 116 VQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYH-AEGG 171
Query: 190 MGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT 224
+A + + ++ + DV+S+G + EL+T
Sbjct: 172 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 9e-05
Identities = 42/160 (26%), Positives = 72/160 (45%), Gaps = 27/160 (16%)
Query: 75 AQMSHDHILKLIGCCLETPIAILVFEYVQHGTL------WDRILGAPQTHFEPLLLKRRL 128
A +H +I+KL+G ++ E+ G + DR L PQ ++ ++ L
Sbjct: 64 ATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ---VICRQML 120
Query: 129 KDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDT 188
+ AL YLH I+ RD K ++L + + +KL DF +S + D+
Sbjct: 121 E-------ALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK-TLQRRDS 169
Query: 189 VMGTYGHLAPQYVTTCD------FSEKLDVYSFGAFLSEL 222
+GT +AP+ V C+ + K D++S G L E+
Sbjct: 170 FIGTPYWMAPE-VVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 26/90 (28%), Positives = 47/90 (52%), Gaps = 7/90 (7%)
Query: 137 ALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHL 196
L ++H F +V+RD K ++IL E V++ D L+ + + H + +GT+G++
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYM 162
Query: 197 APQYVTT-CDFSEKLDVYSFGAFLSELLTG 225
AP+ + + D +S G L +LL G
Sbjct: 163 APEVLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 42/156 (26%), Positives = 71/156 (45%), Gaps = 24/156 (15%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKD----- 130
++SH I++L + ++ EYV G L F L R +
Sbjct: 57 EVSHPFIIRLFWTEHDQRFLYMLMEYVPGGEL-----------FSYLRNSGRFSNSTGLF 105
Query: 131 -AVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTV 189
A + AL YLH + IV+RD K +IL +E +KL DF + + + T T+
Sbjct: 106 YASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----TWTL 158
Query: 190 MGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225
GT +LAP+ + + ++ +D ++ G + E+L G
Sbjct: 159 CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 23/78 (29%), Positives = 44/78 (56%), Gaps = 3/78 (3%)
Query: 149 IVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSE 208
I+ RD K S+IL + +KL DF +S + + + ++ +GT +++P+ + +S
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSV 181
Query: 209 KLDVYSFGAFLSELLTGR 226
+ D++S G L E+ GR
Sbjct: 182 QSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 1e-04
Identities = 36/158 (22%), Positives = 68/158 (43%), Gaps = 24/158 (15%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAA 135
Q+ + +I+++IG C E +LV E G L ++ L KD + +
Sbjct: 51 QLDNPYIVRMIGVC-EAEALMLVMEMASGGPL-NKFLSGK-------------KDEITVS 95
Query: 136 NALAYLH---FGFP----RPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDT 188
N + +H G + V RD ++L ++ K+ DF LS ++ +++
Sbjct: 96 NVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155
Query: 189 VMGTY--GHLAPQYVTTCDFSEKLDVYSFGAFLSELLT 224
G + AP+ + FS + DV+S+G + E +
Sbjct: 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 25/79 (31%), Positives = 42/79 (53%), Gaps = 1/79 (1%)
Query: 147 RPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGET-HITDTVMGTYGHLAPQYVTTCD 205
R ++ RD K+++I ++KL DF S + + + + GT +LAP+
Sbjct: 188 RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKR 247
Query: 206 FSEKLDVYSFGAFLSELLT 224
+S+K D++S G L ELLT
Sbjct: 248 YSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 1e-04
Identities = 32/95 (33%), Positives = 45/95 (47%), Gaps = 16/95 (16%)
Query: 137 ALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTV------M 190
L YLH + RD K ++IL SEE VKL DF +S +T T+ +
Sbjct: 110 GLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVS-------GQLTSTMSKRNTFV 159
Query: 191 GTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225
GT +AP+ + + EK D++S G EL G
Sbjct: 160 GTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 1e-04
Identities = 29/97 (29%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 136 NALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGH 195
+ +AYLH R IV RD K S++L + VK+ DF +S + + +V GT +
Sbjct: 179 SGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAY 234
Query: 196 LAPQYVTTCDFSEKL------DVYSFGAFLSELLTGR 226
++P+ + T D + D++S G + E GR
Sbjct: 235 MSPERINT-DLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 2e-04
Identities = 43/172 (25%), Positives = 75/172 (43%), Gaps = 20/172 (11%)
Query: 58 QKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQT 117
Q+ F E+ I Q H +I+ L G ++ ++V EY+++G+L D L
Sbjct: 48 QRRDFLSEASI-----MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSL-DAFLRKHDG 101
Query: 118 HFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSIS 177
F + L L+ L+ + + V RD +IL + V K+ DF LS
Sbjct: 102 QFTVIQLVGMLRGIASGMKYLSDMGY------VHRDLAARNILVNSNLVCKVSDFGLS-R 154
Query: 178 IPEGETHITDTVMGTYGHL-----APQYVTTCDFSEKLDVYSFGAFLSELLT 224
+ E + T G G + AP+ + F+ DV+S+G + E+++
Sbjct: 155 VLEDDPEAAYTTRG--GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 3e-04
Identities = 58/209 (27%), Positives = 89/209 (42%), Gaps = 46/209 (22%)
Query: 75 AQMSHDHILKLIGCCL-ETPIAILVFEYVQHGTL------WDRILGAPQTHFEPLLLKRR 127
A H +I+KL+ E + IL+ E+ G + +R L PQ ++ K+
Sbjct: 57 ASCDHPNIVKLLDAFYYENNLWILI-EFCAGGAVDAVMLELERPLTEPQIR---VVCKQT 112
Query: 128 LKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITD 187
L+ AL YLH I+ RD K +ILF+ + +KL DF +S D
Sbjct: 113 LE-------ALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR-TIQRRD 161
Query: 188 TVMGTYGHLAPQYVTTCDFSE------KLDVYSFGAFL----------SELLTGRGILDL 231
+ +GT +AP+ V C+ S+ K DV+S G L EL R +L +
Sbjct: 162 SFIGTPYWMAPE-VVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKI 220
Query: 232 VR-DAHDLVYP------FNEYLKNYFEDN 253
+ + L P F ++LK E N
Sbjct: 221 AKSEPPTLAQPSRWSSEFKDFLKKCLEKN 249
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 46/163 (28%), Positives = 71/163 (43%), Gaps = 24/163 (14%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHF----EPLLLKRRLKDA 131
Q+ H +IL + + +V + +G+ D + +THF L + LKD
Sbjct: 55 QLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL----KTHFPEGLPELAIAFILKDV 110
Query: 132 VDAANALAYLH-FGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSIS-IPEGETH--ITD 187
+ NAL Y+H GF + R K SHIL S + V L S+S I G+ + D
Sbjct: 111 L---NALDYIHSKGF----IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163
Query: 188 TVMGTYGHL---APQ--YVTTCDFSEKLDVYSFGAFLSELLTG 225
+ +L +P+ ++EK D+YS G EL G
Sbjct: 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 38/162 (23%), Positives = 68/162 (41%), Gaps = 20/162 (12%)
Query: 75 AQMSHDHILKLIGCCLETPIAILVFEYVQHGTL-----------WDRILGAPQTHFEPLL 123
+++S +I +L+G C P ++ EY+++G L + F LL
Sbjct: 74 SRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLL 133
Query: 124 LKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGET 183
A A+ + YL V RD T + L + +K+ DF +S ++ +
Sbjct: 134 YM-----ATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDY 185
Query: 184 H-ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT 224
+ + +A + V F+ K DV++FG L E+LT
Sbjct: 186 YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 29/95 (30%), Positives = 44/95 (46%), Gaps = 13/95 (13%)
Query: 131 AVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVM 190
AVDA + L Y+H RD K + L +KL DF LS I ++V+
Sbjct: 113 AVDALHELGYIH---------RDLKPENFLIDASGHIKLTDFGLSKGIVT----YANSVV 159
Query: 191 GTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225
G+ ++AP+ + + +D +S G L E L G
Sbjct: 160 GSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 4e-04
Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 22/103 (21%)
Query: 136 NALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGH 195
AL Y+H G ++ RD K S+IL + + VKL DF L+ S+ E E + + V+ T
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVL-TD-- 171
Query: 196 LAPQYVTT------------CDFSEKLDVYSFGAFLSELLTGR 226
YV T +++ +D++S G L E+L G+
Sbjct: 172 ----YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 4e-04
Identities = 27/92 (29%), Positives = 49/92 (53%), Gaps = 5/92 (5%)
Query: 136 NALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGH 195
+ +A+LH I+ RD KTS++L + ++K+ DF L+ T V+ T +
Sbjct: 117 SGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWY 172
Query: 196 LAPQ-YVTTCDFSEKLDVYSFGAFLSELLTGR 226
AP+ + ++S +D++S G +ELLT +
Sbjct: 173 RAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 4e-04
Identities = 40/171 (23%), Positives = 72/171 (42%), Gaps = 20/171 (11%)
Query: 58 QKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQT 117
Q+ GF E+ Q H +I++L G ++V EY+ +G L D L +
Sbjct: 49 QRRGFLAEALT-----LGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGAL-DSFL---RK 99
Query: 118 HFEPLLLKRRLKDAVDAANALAYL-HFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176
H L+ + + A+ + YL G+ V + +L + + V K+ F
Sbjct: 100 HEGQLVAGQLMGMLPGLASGMKYLSEMGY----VHKGLAAHKVLVNSDLVCKISGFR--- 152
Query: 177 SIPEGETHITDTVMGTYGHL---APQYVTTCDFSEKLDVYSFGAFLSELLT 224
+ E ++ T M + AP+ + FS DV+SFG + E+++
Sbjct: 153 RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 5e-04
Identities = 33/112 (29%), Positives = 53/112 (47%), Gaps = 16/112 (14%)
Query: 120 EPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISI- 178
EPL L+ + + A + +L R + RD +IL SE NVVK+ DF L+ I
Sbjct: 168 EPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIY 224
Query: 179 --PE----GETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT 224
P+ G+ + M AP+ + ++ + DV+SFG L E+ +
Sbjct: 225 KDPDYVRKGDARLPLKWM------APESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 5e-04
Identities = 36/134 (26%), Positives = 58/134 (43%), Gaps = 22/134 (16%)
Query: 97 LVFEYVQHGTLWDRI-----LGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVF 151
LV EYV G L+ + P F A AL YLH IV+
Sbjct: 78 LVMEYVPGGELFSHLRKSGRFPEPVARFY----------AAQVVLALEYLH---SLDIVY 124
Query: 152 RDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLD 211
RD K ++L + +K+ DF + + T T+ GT +LAP+ + + + + +D
Sbjct: 125 RDLKPENLLLDSDGYIKITDFGFAKRVKGR----TYTLCGTPEYLAPEIILSKGYGKAVD 180
Query: 212 VYSFGAFLSELLTG 225
++ G + E+L G
Sbjct: 181 WWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 5e-04
Identities = 43/154 (27%), Positives = 69/154 (44%), Gaps = 16/154 (10%)
Query: 77 MSHDHILKLIGCCL---ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVD 133
+ HD I++ GC E ++I V EY+ G++ D++ + L +
Sbjct: 61 LRHDRIVQYYGCLRDPEEKKLSIFV-EYMPGGSIKDQLKA-----YGALTENVTRRYTRQ 114
Query: 134 AANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPE---GETHITDTVM 190
++YLH IV RD K ++IL VKL DF S I T I +V
Sbjct: 115 ILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIK-SVT 170
Query: 191 GTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT 224
GT ++P+ ++ + K DV+S + E+LT
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 5e-04
Identities = 45/179 (25%), Positives = 79/179 (44%), Gaps = 21/179 (11%)
Query: 75 AQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA 134
A + ++ +L+G CL + + LV + + +G L D + + + + + + L V
Sbjct: 64 AGVGSPYVCRLLGICLTSTVQ-LVTQLMPYGCLLDYV----RENKDRIGSQDLLNWCVQI 118
Query: 135 ANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS--ISIPEGETHITDTVMGT 192
A ++YL +V RD ++L N VK+ DF L+ + I E E H D
Sbjct: 119 AKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYH-ADGGKVP 174
Query: 193 YGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT----------GRGILDLVRDAHDLVYP 241
+A + + F+ + DV+S+G + EL+T R I DL+ L P
Sbjct: 175 IKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQP 233
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 5e-04
Identities = 40/173 (23%), Positives = 75/173 (43%), Gaps = 20/173 (11%)
Query: 58 QKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQT 117
Q+ F E+ I Q H +I+ L G ++ +++ E++++G L D L
Sbjct: 48 QRRDFLSEASI-----MGQFDHPNIIHLEGVVTKSRPVMIITEFMENGAL-DSFLRQNDG 101
Query: 118 HFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSIS 177
F + L L+ L+ +++ V RD +IL + V K+ DF LS
Sbjct: 102 QFTVIQLVGMLRGIAAGMKYLSEMNY------VHRDLAARNILVNSNLVCKVSDFGLSRF 155
Query: 178 IPEGETHITDTVMGTYGH------LAPQYVTTCDFSEKLDVYSFGAFLSELLT 224
+ + + T T + G AP+ + F+ DV+S+G + E+++
Sbjct: 156 LEDDTSDPTYT--SSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 6e-04
Identities = 39/153 (25%), Positives = 68/153 (44%), Gaps = 14/153 (9%)
Query: 79 HDHILKLIGCCLETPIAIL--VFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAAN 136
H+ I++ GC + L E++ G++ D++ + L K
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-----KSYGALTENVTRKYTRQILE 117
Query: 137 ALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS---ISIPEGETHITDTVMGTY 193
++YLH IV RD K ++IL VKL DF S +I T + +V GT
Sbjct: 118 GVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMK-SVTGTP 173
Query: 194 GHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
++P+ ++ + K D++S G + E+LT +
Sbjct: 174 YWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 6e-04
Identities = 32/149 (21%), Positives = 71/149 (47%), Gaps = 9/149 (6%)
Query: 77 MSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAAN 136
+ H +I++L+G C + LV + G+L D + + H + L +R L V A
Sbjct: 66 LDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHV----RQHRDSLDPQRLLNWCVQIAK 120
Query: 137 ALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS-ISIPEGETHITDTVMGTYGH 195
+ YL +V R+ +IL +++V++ DF ++ + P+ + +
Sbjct: 121 GMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKW 177
Query: 196 LAPQYVTTCDFSEKLDVYSFGAFLSELLT 224
+A + + ++ + DV+S+G + E+++
Sbjct: 178 MALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 6e-04
Identities = 29/101 (28%), Positives = 44/101 (43%), Gaps = 17/101 (16%)
Query: 136 NALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGH 195
L YLH + I+ RD K +++L + + V+KL DF L+ S +T V+ T +
Sbjct: 113 RGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWY 168
Query: 196 LAP-------QYVTTCDFSEKLDVYSFGAFLSELLTGRGIL 229
AP Y D++S G +ELL L
Sbjct: 169 RAPELLFGARHYGVGV------DMWSVGCIFAELLLRVPFL 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 7e-04
Identities = 21/77 (27%), Positives = 42/77 (54%), Gaps = 4/77 (5%)
Query: 149 IVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSE 208
IV+RD K ++L ++ +K+ DF + + + T+ T+ GT ++AP+ + +
Sbjct: 152 IVYRDLKPENLLLDKDGFIKMTDFGFA-KVVDTRTY---TLCGTPEYIAPEILLNVGHGK 207
Query: 209 KLDVYSFGAFLSELLTG 225
D ++ G F+ E+L G
Sbjct: 208 AADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 7e-04
Identities = 42/204 (20%), Positives = 84/204 (41%), Gaps = 37/204 (18%)
Query: 49 LKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETP--------IAILVFE 100
LK+ +++K+GF + + + ++ H +++ LI +E P +V
Sbjct: 38 LKKILM-HNEKDGF-PITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTP 95
Query: 101 YVQH---GTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTS 157
Y+ H G +L P +K + ++ + YLH I+ RD K +
Sbjct: 96 YMDHDLSG-----LLENPSVKLTESQIKCYMLQLLEG---INYLH---ENHILHRDIKAA 144
Query: 158 HILFSEENVVKLFDFSLSISI-----------PEGETHITDTVMGTYGHLAPQYVT-TCD 205
+IL + ++K+ DF L+ G T+ V+ T + P+ +
Sbjct: 145 NILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVV-TRWYRPPELLLGERR 203
Query: 206 FSEKLDVYSFGAFLSELLTGRGIL 229
++ +D++ G +E+ T R IL
Sbjct: 204 YTTAVDIWGIGCVFAEMFTRRPIL 227
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 7e-04
Identities = 28/94 (29%), Positives = 49/94 (52%), Gaps = 14/94 (14%)
Query: 137 ALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMG---TY 193
L Y+H I+ RD K S++ +E+ +K+ DF L+ H D + G T
Sbjct: 132 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA-------RHTDDEMTGYVATR 181
Query: 194 GHLAPQYVTT-CDFSEKLDVYSFGAFLSELLTGR 226
+ AP+ + +++ +D++S G ++ELLTGR
Sbjct: 182 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 7e-04
Identities = 43/156 (27%), Positives = 71/156 (45%), Gaps = 16/156 (10%)
Query: 77 MSHDHILKLIGCCL---ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVD 133
+ H+ I++ GC E + I + EY+ G++ D++ + L K
Sbjct: 61 LQHERIVQYYGCLRDRAEKTLTIFM-EYMPGGSVKDQLKA-----YGALTESVTRKYTRQ 114
Query: 134 AANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI---SIPEGETHITDTVM 190
++YLH IV RD K ++IL VKL DF S +I T I +V
Sbjct: 115 ILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIR-SVT 170
Query: 191 GTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
GT ++P+ ++ + K DV+S G + E+LT +
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 8e-04
Identities = 30/119 (25%), Positives = 46/119 (38%), Gaps = 33/119 (27%)
Query: 137 ALAYLH-FGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI-----------------SI 178
AL YLH G IV+RD K +IL E + L DF LS
Sbjct: 115 ALEYLHLLG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRR 170
Query: 179 PEGETHITDTV-----------MGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
+ ++T +GT ++AP+ ++ +D ++ G L E+L G
Sbjct: 171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 8e-04
Identities = 36/171 (21%), Positives = 75/171 (43%), Gaps = 22/171 (12%)
Query: 65 ESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRI--LGAPQTHFEPL 122
E+ + A+++H HI++++G E L E++ G++ + GA F+
Sbjct: 48 EALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA----FKEA 103
Query: 123 LLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILF-SEENVVKLFDFSLSISIPEG 181
++ + + L+YLH I+ RD K +++L S +++ DF + +
Sbjct: 104 VIINYTEQLL---RGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARL--- 154
Query: 182 ETHITDT------VMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
T ++GT +AP+ + + DV+S G + E+ T +
Sbjct: 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 9e-04
Identities = 25/85 (29%), Positives = 43/85 (50%), Gaps = 1/85 (1%)
Query: 141 LHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITD-TVMGTYGHLAPQ 199
+ F R + RD +IL SE NVVK+ DF L+ I + ++ + +AP+
Sbjct: 187 MEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPE 246
Query: 200 YVTTCDFSEKLDVYSFGAFLSELLT 224
+ ++ + DV+SFG L E+ +
Sbjct: 247 SIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.001
Identities = 43/155 (27%), Positives = 69/155 (44%), Gaps = 18/155 (11%)
Query: 76 QMSHDHILKLIGCCL------ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLK 129
H +I++L+ C ET + LVFE+V L + P P L +K
Sbjct: 58 AFDHPNIVRLMDVCATSRTDRETKVT-LVFEHVDQ-DLRTYLDKVP----PPGLPAETIK 111
Query: 130 DAVDA-ANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDT 188
D + L +LH IV RD K +IL + VKL DF L+ I + +T
Sbjct: 112 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA-RIYSCQMALTPV 167
Query: 189 VMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELL 223
V+ T + AP+ + ++ +D++S G +E+
Sbjct: 168 VV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.001
Identities = 39/161 (24%), Positives = 71/161 (44%), Gaps = 27/161 (16%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAA 135
+++H +I++L+ LVFE++ L + +P T +P L+K L +
Sbjct: 54 ELNHPNIVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQG- 111
Query: 136 NALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL--SISIPEGETHITDTVMGTY 193
+AY H ++ RD K ++L E +KL DF L + +P + TY
Sbjct: 112 --IAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP----------VRTY 156
Query: 194 GH-------LAPQYVTTC-DFSEKLDVYSFGAFLSELLTGR 226
H AP+ + +S +D++S G +E++ R
Sbjct: 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.001
Identities = 42/164 (25%), Positives = 79/164 (48%), Gaps = 13/164 (7%)
Query: 68 INNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRR 127
I ++ +++H +I+KL+ LVFE++ H L + +P + L+K
Sbjct: 47 IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSY 105
Query: 128 LKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL--SISIPEGETHI 185
L + LA+ H ++ RD K ++L + E +KL DF L + +P T+
Sbjct: 106 LFQLL---QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYT 158
Query: 186 TDTVMGTYGHLAPQYVTTCDF-SEKLDVYSFGAFLSELLTGRGI 228
+ V T + AP+ + C + S +D++S G +E++T R +
Sbjct: 159 HEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.001
Identities = 34/107 (31%), Positives = 50/107 (46%), Gaps = 18/107 (16%)
Query: 129 KDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDT 188
K AV AL YLH ++ RD K S++L + VKL DF +S ++ D+
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGIS-------GYLVDS 157
Query: 189 V-----MGTYGHLAPQYV----TTCDFSEKLDVYSFGAFLSELLTGR 226
V G ++AP+ + + K DV+S G + EL TGR
Sbjct: 158 VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 28/91 (30%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 138 LAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS-ISIPEGETHITDTVMGTYGHL 196
L YLH I+ RD K ++L + V+K+ DF L+ + P+ H+T V+ Y +
Sbjct: 116 LKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YR 171
Query: 197 APQYVTTC-DFSEKLDVYSFGAFLSELLTGR 226
AP+ + ++ +D++S G +ELL R
Sbjct: 172 APEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 0.001
Identities = 26/94 (27%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 137 ALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISI---PEGETHITDTVMGTY 193
L YLH ++ RD K S+IL + +K+ DF L+ + + + +T+ V+ T
Sbjct: 115 GLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV-TR 170
Query: 194 GHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGR 226
+ AP+ + + +++ +D++S G +ELLT +
Sbjct: 171 WYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.001
Identities = 22/101 (21%), Positives = 49/101 (48%), Gaps = 13/101 (12%)
Query: 149 IVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSE 208
I+ RD K S+I+ + +K+ DF L+ + G + + + T + AP+ + + E
Sbjct: 140 IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKE 197
Query: 209 KLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNY 249
+D++S G + E++ H +++P +Y+ +
Sbjct: 198 NVDIWSVGCIMGEMVR-----------HKILFPGRDYIDQW 227
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.001
Identities = 39/159 (24%), Positives = 68/159 (42%), Gaps = 28/159 (17%)
Query: 75 AQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRI---------LGAPQT--HFEPLL 123
+++ H I+K LE ++ EY + L ++ L Q F LL
Sbjct: 57 SKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLL 116
Query: 124 LKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGET 183
L + Y+H R I+ RD K +I F + N++K+ DF +S + G
Sbjct: 117 L------------GVHYMH---QRRILHRDLKAKNI-FLKNNLLKIGDFGVS-RLLMGSC 159
Query: 184 HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSEL 222
+ T GT +++P+ + + K D++S G L E+
Sbjct: 160 DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 24/89 (26%), Positives = 46/89 (51%), Gaps = 3/89 (3%)
Query: 149 IVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSE 208
I+ RD K S+I+ + +K+ DF L+ + G + + + T + AP+ + + E
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKE 204
Query: 209 KLDVYSFGAFLSELLTGRGILDLVRDAHD 237
+D++S G + E++ G G+L D D
Sbjct: 205 NVDIWSVGCIMGEMIKG-GVLFPGTDHID 232
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.001
Identities = 45/176 (25%), Positives = 79/176 (44%), Gaps = 18/176 (10%)
Query: 49 LKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLW 108
LK + N+ K+ E+ NV Q+ + +I+++IG C E +LV E + G L
Sbjct: 30 LKNDNNDPALKDELLREA---NVM--QQLDNPYIVRMIGIC-EAESWMLVMELAELGPL- 82
Query: 109 DRILGAPQTHFEPLLLKRRLKDAVDAAN-ALAYLHFGFPRPIVFRDFKTSHILFSEENVV 167
++ L H + ++ + + V + + YL V RD ++L ++
Sbjct: 83 NKFL-QKNKH----VTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYA 134
Query: 168 KLFDFSLSISIPEGETHITDTVMGTY--GHLAPQYVTTCDFSEKLDVYSFGAFLSE 221
K+ DF LS ++ E + G + AP+ + FS K DV+SFG + E
Sbjct: 135 KISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.001
Identities = 64/231 (27%), Positives = 95/231 (41%), Gaps = 61/231 (26%)
Query: 88 CCLETPIAI-LVFEYVQHG---TLWDRILGAP----QTHFEPLLLKRRLKDAVDAANALA 139
C ET + +V EYV+ G TL I P + +F +L AL
Sbjct: 68 CSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVL------------ALE 115
Query: 140 YLH-FGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS------ISIPEGETHI-TDT--- 188
YLH +G IV RD K ++L + +KL DF LS ++ E HI DT
Sbjct: 116 YLHNYG----IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREF 171
Query: 189 ----VMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNE 244
V GT ++AP+ + + + +D ++ G L E L G PF
Sbjct: 172 LDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG-------------CVPF-- 216
Query: 245 YLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQ-LTFECLNESPIDR 294
F D E+ +I D+ E ++ L A AQ L L ++P++R
Sbjct: 217 -----FGDTP-EELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLER 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.001
Identities = 39/134 (29%), Positives = 65/134 (48%), Gaps = 11/134 (8%)
Query: 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKT 156
LVFEY+ H + +L + HF +K +K ++ L Y H + + RD K
Sbjct: 93 LVFEYMDHDLM--GLLESGLVHFSEDHIKSFMKQLLEG---LNYCH---KKNFLHRDIKC 144
Query: 157 SHILFSEENVVKLFDFSLS-ISIPEGETHITDTVMGTYGHLAPQYVTTCD-FSEKLDVYS 214
S+IL + + +KL DF L+ + E T+ V+ T + P+ + + + +DV+S
Sbjct: 145 SNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWS 203
Query: 215 FGAFLSELLTGRGI 228
G L EL T + I
Sbjct: 204 CGCILGELFTKKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.002
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 7/91 (7%)
Query: 137 ALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS-ISIPEGETHITDTVMGTYGH 195
AL +LH IV+RD K +IL + L DF LS ++ + +T T+T GT +
Sbjct: 108 ALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEY 162
Query: 196 LAPQ-YVTTCDFSEKLDVYSFGAFLSELLTG 225
LAP+ + +++ +D +S G + E+ G
Sbjct: 163 LAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 41/166 (24%), Positives = 66/166 (39%), Gaps = 23/166 (13%)
Query: 141 LHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHIT--DTVMGTYGHLAP 198
+ F R + RD +IL SE NVVK+ DF L+ I + ++ D + +AP
Sbjct: 192 MEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-PLKWMAP 250
Query: 199 QYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEI 258
+ + ++ + DV+SFG L E I L + V E+ + E R
Sbjct: 251 ETIFDRVYTIQSDVWSFGVLLWE------IFSLGASPYPGVKIDEEFCRRLKEGTRMR-- 302
Query: 259 VDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRL 304
D + E Q + +C + P RPT ++ L
Sbjct: 303 -----APDYTTPEMYQTM-------LDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 24/85 (28%), Positives = 42/85 (49%), Gaps = 10/85 (11%)
Query: 149 IVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTY----GHLAPQYVTTC 204
I+ RD K S+I+ + +K+ DF L+ T T+ +M Y + AP+ +
Sbjct: 144 IIHRDLKPSNIVVKSDCTLKILDFGLA------RTACTNFMMTPYVVTRYYRAPEVILGM 197
Query: 205 DFSEKLDVYSFGAFLSELLTGRGIL 229
+ E +D++S G + EL+ G I
Sbjct: 198 GYKENVDIWSVGCIMGELVKGSVIF 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.002
Identities = 37/160 (23%), Positives = 70/160 (43%), Gaps = 19/160 (11%)
Query: 77 MSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHF----EPLLLKRRLKDAV 132
++H ++L+ +G C+E+ +LV E+ G L L + + + +L+R A
Sbjct: 52 LNHPNVLQCLGQCIESIPYLLVLEFCPLGDL-KNYLRSNRGMVAQMAQKDVLQRM---AC 107
Query: 133 DAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSIS-IPEGETHITDTVMG 191
+ A+ L +LH + D + + + VK+ D+ L++ PE D
Sbjct: 108 EVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV 164
Query: 192 TYGHLAPQYVT-------TCDFSEKLDVYSFGAFLSELLT 224
LAP+ V D ++K +++S G + EL T
Sbjct: 165 PLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.002
Identities = 22/82 (26%), Positives = 40/82 (48%), Gaps = 10/82 (12%)
Query: 149 IVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTY----GHLAPQYVTTC 204
I+ RD K S+I+ + +K+ DF L+ T T +M Y + AP+ +
Sbjct: 139 IIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRYYRAPEVILGM 192
Query: 205 DFSEKLDVYSFGAFLSELLTGR 226
+ E +D++S G + E++ G
Sbjct: 193 GYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.003
Identities = 44/166 (26%), Positives = 72/166 (43%), Gaps = 18/166 (10%)
Query: 66 SCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHG--TLWDRILGAPQTHFEPLL 123
+ I V+ + H +I+ L LVFEY+ D + H L
Sbjct: 50 TAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLF 109
Query: 124 LKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL--SISIPEG 181
L + L+ L Y H R ++ RD K ++L +E +KL DF L + SIP
Sbjct: 110 LFQLLR-------GLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 158
Query: 182 ETHITDTVMGTYGHLAPQYVT-TCDFSEKLDVYSFGAFLSELLTGR 226
+T+ + V T + P + + D+S ++D++ G E+ TGR
Sbjct: 159 KTYSNEVV--TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 25/99 (25%), Positives = 49/99 (49%), Gaps = 13/99 (13%)
Query: 131 AVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVM 190
A+DA +++ ++H RD K ++L + +KL DF + + + DT +
Sbjct: 154 ALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 204
Query: 191 GTYGHLAPQYVTTCD----FSEKLDVYSFGAFLSELLTG 225
GT +++P+ + + + + D +S G FL E+L G
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.003
Identities = 25/99 (25%), Positives = 48/99 (48%), Gaps = 13/99 (13%)
Query: 131 AVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVM 190
A+DA +++ ++H RD K ++L + +KL DF + + DT +
Sbjct: 154 ALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV 204
Query: 191 GTYGHLAPQYVTT----CDFSEKLDVYSFGAFLSELLTG 225
GT +++P+ + + + + D +S G FL E+L G
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.003
Identities = 39/158 (24%), Positives = 67/158 (42%), Gaps = 36/158 (22%)
Query: 149 IVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSE 208
I+ RD K +++L + VKL DF +S ++ + T +G ++AP+ + + ++
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNL---VASLAKTNIGCQSYMAPERIKSGGPNQ 180
Query: 209 KL------DVYSFGAFLSELLTGRGILDLVRDAHDLVYPF-NEYLKNYFEDNRFTEIVD- 260
DV+S G + E+ GR YP+ E N F + + IVD
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGR-------------YPYPPETYANIF--AQLSAIVDG 225
Query: 261 --PIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPT 296
P + S ++ +CLN+ P RPT
Sbjct: 226 DPPTLPSGYSDDAQD--------FVAKCLNKIPNRRPT 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.003
Identities = 38/158 (24%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 97 LVFEYVQHGTLWD--RILGAPQTHFEPLLLKRRLKDAV--DAANALAYLHFGFPRPIVFR 152
L+F+Y +H LW + A + + +P+ L R + ++ + + YLH + ++ R
Sbjct: 77 LLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHR 132
Query: 153 DFKTSHILF----SEENVVKLFD--FSLSISIPEGETHITDTVMGTYGHLAPQYVTTC-D 205
D K ++IL E VK+ D F+ + P D V+ T+ + AP+ +
Sbjct: 133 DLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARH 192
Query: 206 FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFN 243
+++ +D+++ G +ELLT I ++ PF+
Sbjct: 193 YTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFH 230
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.004
Identities = 61/232 (26%), Positives = 93/232 (40%), Gaps = 51/232 (21%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAA 135
Q+SH HI+ L G C+ I+V E+V+ G L D + + L + K A A
Sbjct: 60 QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPL-DLFM---HRKSDVLTTPWKFKVAKQLA 115
Query: 136 NALAYLHFGFPRPIVFRDFKTSHILFSEENV-------VKLFDFSLSISIPEGETHITDT 188
+AL+YL + +V + T +IL + E + +KL D + I++ + +
Sbjct: 116 SALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERI 172
Query: 189 VMGTYGHLAPQYVT-TCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLK 247
+AP+ V + + S D +SFG L E+ I P + K
Sbjct: 173 PW-----IAPECVEDSKNLSIAADKWSFGTTLWEICYNGEI------------PLKD--K 213
Query: 248 NYFEDNRFTE----IVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRP 295
E RF E +V P SC E A L C+N P RP
Sbjct: 214 TLAEKERFYEGQCMLVTP------SCKE-------LADLMTHCMNYDPNQRP 252
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.004
Identities = 51/209 (24%), Positives = 86/209 (41%), Gaps = 31/209 (14%)
Query: 35 NGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPI 94
NGK + ++ QE +E + + I + + H +I+ L
Sbjct: 29 NGKLVALKVIRLQE--EEGTPF---------TAIREASLLKGLKHANIVLLHDIIHTKET 77
Query: 95 AILVFEYVQHGTL---WDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVF 151
LVFEYV H L D+ G L L + L+ L+Y+H R I+
Sbjct: 78 LTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLR-------GLSYIH---QRYILH 126
Query: 152 RDFKTSHILFSEENVVKLFDFSL--SISIPEGETHITDTVMGTYGHLAPQYVT-TCDFSE 208
RD K ++L S+ +KL DF L + S+P +H + T + P + + ++S
Sbjct: 127 RDLKPQNLLISDTGELKLADFGLARAKSVP---SHTYSNEVVTLWYRPPDVLLGSTEYST 183
Query: 209 KLDVYSFGAFLSELLTGRGILDLVRDAHD 237
LD++ G E++ G ++D D
Sbjct: 184 CLDMWGVGCIFVEMIQGVAAFPGMKDIQD 212
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.004
Identities = 32/101 (31%), Positives = 50/101 (49%), Gaps = 9/101 (8%)
Query: 138 LAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL--SISIPEGETHITDTVMGTYGH 195
LAY+H + I+ RD K ++L S +KL DF L + SIP +T+ ++ V T +
Sbjct: 116 LAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP-SQTYSSEVV--TLWY 169
Query: 196 LAPQYVT-TCDFSEKLDVYSFGAFLSELLTGRGILDLVRDA 235
P + D+S LD++ G E+L G+ V D
Sbjct: 170 RPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV 210
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 314 | |||
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.87 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.79 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.77 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.77 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.76 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.75 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.72 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.7 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.68 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.65 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.65 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.64 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.61 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.61 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.59 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.55 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.5 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.48 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.39 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.38 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.35 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.26 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.16 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.11 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.07 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.02 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.01 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.91 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.9 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.9 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.81 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.77 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.65 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.63 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.59 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.53 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.52 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.28 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.2 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.18 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.17 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.02 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.93 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.82 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.8 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.41 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.36 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.15 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.15 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 96.99 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 96.86 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 96.74 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.49 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 96.31 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.78 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 95.3 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.1 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.01 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.69 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 94.66 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 93.08 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 92.15 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 91.5 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 90.5 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 90.28 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 90.16 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 90.08 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 89.39 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 88.97 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 88.38 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 87.56 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 86.25 | |
| PTZ00384 | 383 | choline kinase; Provisional | 86.23 | |
| PLN02236 | 344 | choline kinase | 85.97 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 85.95 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 84.79 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 83.36 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 82.34 | |
| KOG4720 | 391 | consensus Ethanolamine kinase [Lipid transport and | 82.21 | |
| COG4499 | 434 | Predicted membrane protein [Function unknown] | 81.09 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 81.02 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 80.07 |
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-51 Score=368.63 Aligned_cols=250 Identities=22% Similarity=0.348 Sum_probs=215.9
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|.++..+|+|| ..+|.+.+..+|+.||+|++.++.+.+.... +.+.+||++.+.|+|||||+++++|+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~r---------eKv~~EIeIHr~L~HpnIV~f~~~FE 88 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQR---------EKVLNEIEIHRSLKHPNIVQFYHFFE 88 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchH---------HHHHHHHHHHHhcCCCcEEeeeeEee
Confidence 5688889999999 8899998889999999999999887665433 78899999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
+.+++|||+|+|.+++|..+++.. .++.+.+++.++.||+.||.||| +++|+|||||..|++++.+..+||+
T Consensus 89 Ds~nVYivLELC~~~sL~el~Krr-----k~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIg 160 (592)
T KOG0575|consen 89 DSNNVYIVLELCHRGSLMELLKRR-----KPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIG 160 (592)
T ss_pred cCCceEEEEEecCCccHHHHHHhc-----CCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEec
Confidence 999999999999999998888744 46899999999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhh
Q 043524 171 DFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 171 dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
|||+|..+.... +...+.+|||.|.|||++.....+..+||||+||++|.|+.|++||+.-.
T Consensus 161 DFGLAt~le~~~-Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~----------------- 222 (592)
T KOG0575|consen 161 DFGLATQLEYDG-ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT----------------- 222 (592)
T ss_pred ccceeeeecCcc-cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-----------------
Confidence 999998875432 34568899999999999999899999999999999999999999997322
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
..+..+.+.......+. ..+.++.+||.++|+.||.+|||+++|+.
T Consensus 223 ----vkety~~Ik~~~Y~~P~--~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 223 ----VKETYNKIKLNEYSMPS--HLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ----HHHHHHHHHhcCccccc--ccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11222222222322222 56678899999999999999999999985
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-51 Score=351.14 Aligned_cols=251 Identities=21% Similarity=0.281 Sum_probs=209.3
Q ss_pred cccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCC
Q 043524 15 KRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETP 93 (314)
Q Consensus 15 ~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (314)
.+...+|+|. ++|+++.+..+++.+|.|.+.... ..+ ..+++.+|+++++..+|||||++||.|....
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~-~~~----------~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~ 150 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNI-DPA----------LQKQILRELEILRSCQSPYIVGFYGAFYSNG 150 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccC-CHH----------HHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence 3455688887 899999999999999999984331 111 1267899999999999999999999999988
Q ss_pred -eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccc
Q 043524 94 -IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 94 -~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~df 172 (314)
.+.|+||||.+|||.+++...+ .+++...-.++.+++.||.|||. +.+|+||||||+|+|++..|.+||+||
T Consensus 151 ~~isI~mEYMDgGSLd~~~k~~g-----~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDF 223 (364)
T KOG0581|consen 151 EEISICMEYMDGGSLDDILKRVG-----RIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDF 223 (364)
T ss_pred ceEEeehhhcCCCCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccc
Confidence 4999999999999999987653 58899999999999999999993 499999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhcc
Q 043524 173 SLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFED 252 (314)
Q Consensus 173 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (314)
|.++.+..+ ...+++||..|||||-+.+..|+.++||||||++++|+++|++||...... .
T Consensus 224 GVS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~----------------~ 284 (364)
T KOG0581|consen 224 GVSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP----------------Y 284 (364)
T ss_pred cccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC----------------C
Confidence 999877544 467899999999999999999999999999999999999999998654111 1
Q ss_pred CCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 253 NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
..+-++++.+..++.+......+++++++|+..||++||.+|||+.|+++
T Consensus 285 ~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 285 LDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 12233344444433333333258899999999999999999999999986
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-51 Score=355.74 Aligned_cols=256 Identities=21% Similarity=0.308 Sum_probs=208.9
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
..|.-...+|.|+ +.|.+++...+|+.||||+++++............ ..+.+|+++|.+|+|||||+++++|+
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~-----~~v~~EieILkkL~HP~IV~~~d~f~ 246 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKT-----RDVQNEIEILKKLSHPNIVRIKDFFE 246 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccch-----hhhHHHHHHHHhcCCCCEEEEeeeee
Confidence 3344555789988 99999999999999999999998765533210000 22579999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCC---Cce
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEE---NVV 167 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~---~~~ 167 (314)
.....||||||++||+|.+++.... .+....-..++.|++.|+.||| +.||+||||||+|||+..+ ..+
T Consensus 247 ~~ds~YmVlE~v~GGeLfd~vv~nk-----~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~ll 318 (475)
T KOG0615|consen 247 VPDSSYMVLEYVEGGELFDKVVANK-----YLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLL 318 (475)
T ss_pred cCCceEEEEEEecCccHHHHHHhcc-----ccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEE
Confidence 9999999999999999999998764 4666777889999999999999 9999999999999999876 678
Q ss_pred EEcccccceecCCCCcccccccccccccccCcccccCC---CCcccchHHHHHHHHHHHhCCCCcccccCccccccchHH
Q 043524 168 KLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCD---FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNE 244 (314)
Q Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 244 (314)
||+|||+|+..+.. ..+.+++||+.|.|||++.... +..++|+||+||++|-+++|.+||.......
T Consensus 319 KItDFGlAK~~g~~--sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-------- 388 (475)
T KOG0615|consen 319 KITDFGLAKVSGEG--SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-------- 388 (475)
T ss_pred Eecccchhhccccc--eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--------
Confidence 99999999987643 4588999999999999998765 3458899999999999999999997443322
Q ss_pred HHHhhhccCCcccccChhhhcc--CCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 245 YLKNYFEDNRFTEIVDPIIVQD--LSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.+.+.+..+. +.++.....+++.++||..||..||++|||+.|+|+
T Consensus 389 ------------sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 389 ------------SLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred ------------cHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 0111222222 223344477889999999999999999999999986
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-50 Score=331.73 Aligned_cols=257 Identities=19% Similarity=0.285 Sum_probs=213.1
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEe-EEEe
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIG-CCLE 91 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~-~~~~ 91 (314)
+.....+|.|+ +.|+++....+|..+|.|.+....+.... .+.+..|+.+|++|+|||||++++ .+..
T Consensus 21 y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~----------rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~ 90 (375)
T KOG0591|consen 21 YQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKA----------RQDCVKEISLLKQLNHPNIVQYYAHSFIE 90 (375)
T ss_pred HHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHH----------HHHHHHHHHHHHhcCCchHHHHHHHhhhc
Confidence 34445699999 99999999999999999998876554332 267899999999999999999998 5666
Q ss_pred CCe-eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCC--CC--ceeccCCCCCeeecCCCc
Q 043524 92 TPI-AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFP--RP--IVFRDFKTSHILFSEENV 166 (314)
Q Consensus 92 ~~~-~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~--~~--i~H~dlk~~nil~~~~~~ 166 (314)
++. ++||||+|.+|+|...++...+.. ..++...++.++.|++.||.+|| + .+ |+||||||.||+++.+|.
T Consensus 91 ~~evlnivmE~c~~GDLsqmIk~~K~qk-r~ipE~~Vwk~f~QL~~AL~~cH---~~~~r~~VmHRDIKPaNIFl~~~gv 166 (375)
T KOG0591|consen 91 DNEVLNIVMELCDAGDLSQMIKHFKKQK-RLIPEKTVWKYFVQLCRALYHCH---SKIPRGTVMHRDIKPANIFLTANGV 166 (375)
T ss_pred cchhhHHHHHhhcccCHHHHHHHHHhcc-ccCchHHHHHHHHHHHHHHHHHh---ccccccceeeccCcchheEEcCCCc
Confidence 665 899999999999999887543221 46899999999999999999999 6 44 899999999999999999
Q ss_pred eEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHH
Q 043524 167 VKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYL 246 (314)
Q Consensus 167 ~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 246 (314)
+||+|||+++.+.... ....+.+|||.||+||.+....|+.++||||+||++|||+.-++||.+.
T Consensus 167 vKLGDfGL~r~l~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-------------- 231 (375)
T KOG0591|consen 167 VKLGDFGLGRFLSSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-------------- 231 (375)
T ss_pred eeeccchhHhHhcchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc--------------
Confidence 9999999999885543 3466789999999999999999999999999999999999999998642
Q ss_pred HhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHH
Q 043524 247 KNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQ 306 (314)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 306 (314)
+..++..++..++.++-....++.++..|+..|+..||+.||+...++..+..
T Consensus 232 -------n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 232 -------NLLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred -------cHHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 22233444455555544445889999999999999999999986666655543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-48 Score=331.40 Aligned_cols=195 Identities=26% Similarity=0.418 Sum_probs=176.5
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeEE
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAIL 97 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i 97 (314)
.+|.|+ ++||++.++.+|..||||.+.++.+.... .+.+..|+++|+.++|||||++++++.+++.+|+
T Consensus 17 ~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~----------~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 17 EIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKL----------VELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred hccCcceEEEEEeEeccCCceEEeeeehhhccCHHH----------HHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 399999 99999999999999999999988643322 1567899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCC------CceEEcc
Q 043524 98 VFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEE------NVVKLFD 171 (314)
Q Consensus 98 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~------~~~kl~d 171 (314)
|||||.||||.+++...+ .+++..++.++.|++.|+.+|| +++|+||||||.|||++.. -.+||+|
T Consensus 87 VMEyC~gGDLs~yi~~~~-----~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIAD 158 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRRG-----RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIAD 158 (429)
T ss_pred EEEeCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecc
Confidence 999999999999998864 5889999999999999999999 9999999999999999875 4689999
Q ss_pred cccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCccccc
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVR 233 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 233 (314)
||+|+.+..... ..+.+|++.|||||++...+|+.|+|+||+|+++|+|++|+.||+...
T Consensus 159 FGfAR~L~~~~~--a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 159 FGFARFLQPGSM--AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred cchhhhCCchhH--HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 999999865433 668899999999999999999999999999999999999999998544
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=335.07 Aligned_cols=252 Identities=27% Similarity=0.453 Sum_probs=201.8
Q ss_pred ccCch-hHHHHHHHhcCCcc-cccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCC-eeE
Q 043524 20 IGNGA-SVLQELIASSNGKY-IPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETP-IAI 96 (314)
Q Consensus 20 ~G~g~-~~~~~~~~~~~g~~-~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~ 96 (314)
+|.|+ +.|+.+ ...|.. ||+|++...+..... .++|.+|+.+|.+++|||||+++|+|.+.. ..+
T Consensus 49 iG~G~~g~V~~~--~~~g~~~vavK~~~~~~~~~~~----------~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~ 116 (362)
T KOG0192|consen 49 LGSGSFGTVYKG--KWRGTDVVAVKIISDPDFDDES----------RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLC 116 (362)
T ss_pred cccCCceeEEEE--EeCCceeEEEEEecchhcChHH----------HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceE
Confidence 77777 556533 445565 999999876643332 268999999999999999999999999887 799
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCC-ceeccCCCCCeeecCCC-ceEEccccc
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRP-IVFRDFKTSHILFSEEN-VVKLFDFSL 174 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~-i~H~dlk~~nil~~~~~-~~kl~dfg~ 174 (314)
+||||+++|+|.+++....+ ..+++..++.++.||+.|+.||| +++ |+||||||+|+|++..+ .+||+|||+
T Consensus 117 iVtEy~~~GsL~~~l~~~~~---~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGl 190 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKRK---RKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGL 190 (362)
T ss_pred EEEEeCCCCcHHHHHhhccc---CCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCcc
Confidence 99999999999999977411 46899999999999999999999 899 99999999999999997 999999999
Q ss_pred ceecCCCCcccccccccccccccCcccc--cCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhcc
Q 043524 175 SISIPEGETHITDTVMGTYGHLAPQYVT--TCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFED 252 (314)
Q Consensus 175 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (314)
++....... ......||+.|||||++. ...|+.++||||||+++|||+||..||....... . .
T Consensus 191 sr~~~~~~~-~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~-~-------~------ 255 (362)
T KOG0192|consen 191 SREKVISKT-SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ-V-------A------ 255 (362)
T ss_pred ceeeccccc-cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH-H-------H------
Confidence 987654321 133368999999999999 5589999999999999999999999997655311 0 0
Q ss_pred CCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhc
Q 043524 253 NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSL 311 (314)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 311 (314)
.....+...+..+..++..+..|+..||+.||+.||++.+++..|+.+....
T Consensus 256 -------~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 256 -------SAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred -------HHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 0000011111111135667899999999999999999999999999887643
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=342.88 Aligned_cols=250 Identities=21% Similarity=0.278 Sum_probs=212.2
Q ss_pred hhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEE
Q 043524 11 WSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCC 89 (314)
Q Consensus 11 ~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 89 (314)
..+|.....+|+|+ +.|+.+....+++.||||.+........ +-+++|+.+|+..+|+|||.+++.|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k------------eLilnEi~Vm~~~~H~NiVnfl~Sy 339 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKK------------ELLLNEILVMRDLHHPNIVNFLDSY 339 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCch------------hhhHHHHHHHHhccchHHHHHHHHh
Confidence 45566667799999 8888899999999999999886653322 5678999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEE
Q 043524 90 LETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKL 169 (314)
Q Consensus 90 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl 169 (314)
.-++.+|+||||++||+|.|.+... .+.+.++..+..+++.||+||| .++|+|||||.+||+++.+|.+||
T Consensus 340 lv~deLWVVMEym~ggsLTDvVt~~------~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKl 410 (550)
T KOG0578|consen 340 LVGDELWVVMEYMEGGSLTDVVTKT------RMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKL 410 (550)
T ss_pred cccceeEEEEeecCCCchhhhhhcc------cccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEE
Confidence 9999999999999999999999764 3789999999999999999999 999999999999999999999999
Q ss_pred cccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhh
Q 043524 170 FDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNY 249 (314)
Q Consensus 170 ~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (314)
+|||++..+.... .+..+.+||++|||||++....|+.++||||||++++||+.|.+||-... ++.....-
T Consensus 411 tDFGFcaqi~~~~-~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~-------PlrAlyLI- 481 (550)
T KOG0578|consen 411 TDFGFCAQISEEQ-SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN-------PLRALYLI- 481 (550)
T ss_pred eeeeeeecccccc-CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC-------hHHHHHHH-
Confidence 9999998775543 35778899999999999999999999999999999999999999985311 11111110
Q ss_pred hccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 250 FEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
...+......+...+..+++|+.+||..|+++||||.|||+
T Consensus 482 ------------a~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 482 ------------ATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred ------------hhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 11223333444477888999999999999999999999997
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=321.55 Aligned_cols=240 Identities=23% Similarity=0.325 Sum_probs=202.3
Q ss_pred ccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCe
Q 043524 16 RTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPI 94 (314)
Q Consensus 16 ~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 94 (314)
....+|.|+ +.|+.+.+..+|+.+|.|+++++.+-..... +...+|..+|..++||+||++.-.|.+...
T Consensus 29 ~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~---------~~~~~Er~IL~~v~hPFiv~l~ysFQt~~k 99 (357)
T KOG0598|consen 29 ILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEV---------RHTKAERNILSKIKHPFIVKLIYSFQTEEK 99 (357)
T ss_pred eeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhH---------HHHHHHHHHHHhCCCCcEeeeEEecccCCe
Confidence 345689999 8899999999999999999999877554322 567899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccc
Q 043524 95 AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL 174 (314)
Q Consensus 95 ~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~ 174 (314)
+|+|+||+.||+|...+.+.+ .+++..+..++.+|+.||.||| ++||+||||||+|||++..|.++|+|||+
T Consensus 100 LylVld~~~GGeLf~hL~~eg-----~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL 171 (357)
T KOG0598|consen 100 LYLVLDYLNGGELFYHLQREG-----RFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGL 171 (357)
T ss_pred EEEEEeccCCccHHHHHHhcC-----CcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEecccc
Confidence 999999999999999998764 4889999999999999999999 99999999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCC
Q 043524 175 SISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNR 254 (314)
Q Consensus 175 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (314)
++...... ....+++||+.|||||++.+..|+..+|.||+|+++|||++|.+||......
T Consensus 172 ~k~~~~~~-~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~------------------- 231 (357)
T KOG0598|consen 172 CKEDLKDG-DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK------------------- 231 (357)
T ss_pred chhcccCC-CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH-------------------
Confidence 98653332 2366789999999999999999999999999999999999999999744321
Q ss_pred cccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCC
Q 043524 255 FTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRP 295 (314)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp 295 (314)
+..+.+..+....+ +...+.++++++..+|..||++|.
T Consensus 232 --~~~~~I~~~k~~~~-p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 232 --KMYDKILKGKLPLP-PGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred --HHHHHHhcCcCCCC-CccCCHHHHHHHHHHhccCHHHhc
Confidence 12222222221111 114567789999999999999995
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=315.33 Aligned_cols=271 Identities=20% Similarity=0.290 Sum_probs=209.4
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
+|.+...+|+|+ ++|+++.++.+|+.||||.|...+-. ..+.+-.++|+++|++++|+|+|.+.++|..
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd----------~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr 72 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDD----------PVVKKIALREIRMLKQLKHENLVNLIEVFRR 72 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCcc----------HHHHHHHHHHHHHHHhcccchHHHHHHHHHh
Confidence 445556699999 99999999999999999998654321 1133567899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
...+++|+|||.. ++.+-+...+ ..++...+..+++|++.|+.||| +++++||||||+|||++..+.+||+|
T Consensus 73 krklhLVFE~~dh-TvL~eLe~~p----~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCD 144 (396)
T KOG0593|consen 73 KRKLHLVFEYCDH-TVLHELERYP----NGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCD 144 (396)
T ss_pred cceeEEEeeecch-HHHHHHHhcc----CCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEecc
Confidence 9999999999965 7778787766 35888999999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccc-CCCCcccchHHHHHHHHHHHhCCCCcccccCccccc------cchHH
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTT-CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLV------YPFNE 244 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~------~~~~~ 244 (314)
||+|+.+..... .-...+.|.+|.|||++.+ .+|+.++||||+||++.||++|.+.|.+.++.+.+. +.+..
T Consensus 145 FGFAR~L~~pgd-~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~p 223 (396)
T KOG0593|consen 145 FGFARTLSAPGD-NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIP 223 (396)
T ss_pred chhhHhhcCCcc-hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCH
Confidence 999998764221 2335578999999999987 689999999999999999999999998766654321 12222
Q ss_pred HHHhhhccC-CcccccChhhhccCCch-hHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 245 YLKNYFEDN-RFTEIVDPIIVQDLSCT-EKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 245 ~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
...+.|..+ -+..+.-|....+.+.. .-+..+.-+.+|++.||+.||.+|++-+|++.
T Consensus 224 rhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 224 RHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred HHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 222233221 11111111111111110 01134556899999999999999999999875
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-46 Score=329.71 Aligned_cols=248 Identities=21% Similarity=0.289 Sum_probs=207.6
Q ss_pred cccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeEEEeC
Q 043524 15 KRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGCCLET 92 (314)
Q Consensus 15 ~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 92 (314)
+=+..+|.|+ +.|+.+.+..+++.||||++.++-+.+..+. +-+..|-.+|.+| .||.||+++-.|.+.
T Consensus 76 ~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~Kv---------kYV~~Ek~~l~~L~~hPgivkLy~TFQD~ 146 (604)
T KOG0592|consen 76 KFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKV---------KYVTREKEALTQLSGHPGIVKLYFTFQDE 146 (604)
T ss_pred chhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhccc---------chhhHHHHHHHHhhCCCCeEEEEEEeecc
Confidence 3345699999 9999999999999999999999977665443 3455788889999 799999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~df 172 (314)
..+|+|+||+++|+|.++|...+ .++....+.++.+|+.||+||| ++|||||||||+|||++.++.++|+||
T Consensus 147 ~sLYFvLe~A~nGdll~~i~K~G-----sfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDF 218 (604)
T KOG0592|consen 147 ESLYFVLEYAPNGDLLDLIKKYG-----SFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDF 218 (604)
T ss_pred cceEEEEEecCCCcHHHHHHHhC-----cchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeec
Confidence 99999999999999999998764 5889999999999999999999 999999999999999999999999999
Q ss_pred ccceecCCCCcc------------cccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCcccccc
Q 043524 173 SLSISIPEGETH------------ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVY 240 (314)
Q Consensus 173 g~~~~~~~~~~~------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~ 240 (314)
|.|+.+.+.... ...+++||-.|.+||++.....+..+|+|+|||++|+|+.|.+||.....
T Consensus 219 GsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne------ 292 (604)
T KOG0592|consen 219 GSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE------ 292 (604)
T ss_pred cccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH------
Confidence 999987653211 12458999999999999999999999999999999999999999853221
Q ss_pred chHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 241 PFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
..+++.++.-+...+. ..++.+.+|+++.|..||.+|+|+.||.+
T Consensus 293 ---------------yliFqkI~~l~y~fp~--~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 293 ---------------YLIFQKIQALDYEFPE--GFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred ---------------HHHHHHHHHhcccCCC--CCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 1122233222222111 44567899999999999999999988765
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=328.00 Aligned_cols=270 Identities=37% Similarity=0.615 Sum_probs=219.9
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCC-e
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETP-I 94 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~ 94 (314)
...+|.|+ +.||++ ...+|..||||.+....... ..+|.+|+.++.+++|||+|+++|+|.+++ +
T Consensus 80 ~~~ig~Ggfg~VYkG-~l~~~~~vAVK~~~~~~~~~------------~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~ 146 (361)
T KOG1187|consen 80 SNLIGEGGFGTVYKG-VLSDGTVVAVKRLSSNSGQG------------EREFLNEVEILSRLRHPNLVKLLGYCLEGGEH 146 (361)
T ss_pred hcceecCCCeEEEEE-EECCCCEEEEEEecCCCCcc------------hhHHHHHHHHHhcCCCcCcccEEEEEecCCce
Confidence 34688888 555544 44555899999655432210 156999999999999999999999999988 5
Q ss_pred eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccc
Q 043524 95 AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL 174 (314)
Q Consensus 95 ~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~ 174 (314)
.++|+||+++|+|.+.+...... +++|..++.++.+++.||+|||..+...|+|||||+.|||+|.+..+||+|||+
T Consensus 147 ~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGL 223 (361)
T KOG1187|consen 147 RLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGL 223 (361)
T ss_pred EEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccC
Confidence 99999999999999999876532 789999999999999999999976566799999999999999999999999999
Q ss_pred ceecCC-CCccccccc-ccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhcc
Q 043524 175 SISIPE-GETHITDTV-MGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFED 252 (314)
Q Consensus 175 ~~~~~~-~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (314)
|+..+. ... .... .||.+|+|||+......+.++||||||+++.|+++|+.+.+...... ...+..|.+.....
T Consensus 224 a~~~~~~~~~--~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~--~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 224 AKLGPEGDTS--VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRG--ELSLVEWAKPLLEE 299 (361)
T ss_pred cccCCccccc--eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcc--cccHHHHHHHHHHC
Confidence 977654 221 2222 79999999999998899999999999999999999998887654222 23378888888888
Q ss_pred CCcccccChhhhc-cCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHh
Q 043524 253 NRFTEIVDPIIVQ-DLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICC 309 (314)
Q Consensus 253 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 309 (314)
....+++|+.+.. ..... .....+..+...|++.+|++||++.|+++.|+.+..
T Consensus 300 ~~~~eiiD~~l~~~~~~~~---~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDE---KEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred cchhheeCCCccCCCCChH---HHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 8999999998763 33221 344568899999999999999999999999976653
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=331.71 Aligned_cols=248 Identities=25% Similarity=0.362 Sum_probs=202.2
Q ss_pred ccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeEEE
Q 043524 20 IGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILV 98 (314)
Q Consensus 20 ~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~iv 98 (314)
+|+|- +.|+....+. ...||+|.+....... +.|.+|+++|++|+|+|||+++++|..+..+|||
T Consensus 214 LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~-------------~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIV 279 (468)
T KOG0197|consen 214 LGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSP-------------EAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIV 279 (468)
T ss_pred hcCCccceEEEEEEcC-CCcccceEEeccccCh-------------hHHHHHHHHHHhCcccCeEEEEEEEecCCceEEE
Confidence 67766 5555553332 2378999876553221 6789999999999999999999999998899999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccceec
Q 043524 99 FEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISI 178 (314)
Q Consensus 99 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~ 178 (314)
|||++.|+|.+++..... ..+...+.+.++.|||+|++||. ++++|||||.+.|||++.++.+||+|||+|+..
T Consensus 280 tE~m~~GsLl~yLr~~~~---~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~ 353 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRTREG---GLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLI 353 (468)
T ss_pred EEecccCcHHHHhhhcCC---CccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEccccccccc
Confidence 999999999999987333 45788999999999999999999 999999999999999999999999999999966
Q ss_pred CCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhccCCccc
Q 043524 179 PEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTE 257 (314)
Q Consensus 179 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (314)
.+..........-+..|+|||.+....|+.++|||||||+|+||+| |+.|+......+ .+.
T Consensus 354 ~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e--------v~~---------- 415 (468)
T KOG0197|consen 354 GDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE--------VLE---------- 415 (468)
T ss_pred CCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH--------HHH----------
Confidence 5555444455556788999999999999999999999999999999 777876433221 111
Q ss_pred ccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHh
Q 043524 258 IVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICC 309 (314)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 309 (314)
.+......+.+..+|.++-+++..||+.+|++|||++.+...|+++..
T Consensus 416 ----~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 416 ----LLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred ----HHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 122223333444677889999999999999999999999999998865
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=316.46 Aligned_cols=260 Identities=21% Similarity=0.282 Sum_probs=210.0
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
.|+-...+|.|. .+|+.++-..+++.||||++...+..... +.+.+|+..++.++||||++++..|..
T Consensus 27 ~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~l-----------d~l~kE~~~msl~~HPNIv~~~~sFvv 95 (516)
T KOG0582|consen 27 DYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDL-----------DALRKEVQTMSLIDHPNIVTYHCSFVV 95 (516)
T ss_pred ceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhH-----------HHHHHHHHHhhhcCCCCcceEEEEEEe
Confidence 344556789888 89999999999999999999988876542 678899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
+..+|+||.||.+||+.+++..... ..+.+..+..++.+++.||.||| .+|.+|||+|+.||||+.+|.++|+|
T Consensus 96 ~~~LWvVmpfMa~GS~ldIik~~~~---~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLad 169 (516)
T KOG0582|consen 96 DSELWVVMPFMAGGSLLDIIKTYYP---DGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLAD 169 (516)
T ss_pred cceeEEeehhhcCCcHHHHHHHHcc---ccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcC
Confidence 9999999999999999999987654 34788899999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCccc--c-cccccccccccCcccccC--CCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHH
Q 043524 172 FSLSISIPEGETHI--T-DTVMGTYGHLAPQYVTTC--DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYL 246 (314)
Q Consensus 172 fg~~~~~~~~~~~~--~-~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 246 (314)
||.+..+-.+.... . .++.||++|||||++... .|+.|+||||||++.+|+++|+.||..... .....
T Consensus 170 Fgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP-------mkvLl 242 (516)
T KOG0582|consen 170 FGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP-------MKVLL 242 (516)
T ss_pred ceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh-------HHHHH
Confidence 99987665543221 2 567999999999996544 499999999999999999999999964321 11111
Q ss_pred HhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 247 KNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
..+-...-.. . ....+-......+..++.++..||.+||.+||||+++++
T Consensus 243 ~tLqn~pp~~--~----t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 243 LTLQNDPPTL--L----TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred HHhcCCCCCc--c----cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 1111110000 0 111222333456678999999999999999999999987
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-46 Score=335.04 Aligned_cols=249 Identities=20% Similarity=0.282 Sum_probs=209.4
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.-++-+..+|.|+ +.|..+.+..||+.+|||++.+..-.. +. ....+-+|+.+|+-+.||||++++++|+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s------~s---~~~~IerEIviMkLi~HpnVl~LydVwe 82 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELS------SS---QPAGIEREIVIMKLIEHPNVLRLYDVWE 82 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccc------cc---cccchhhhhHHHHHhcCCCeeeeeeeec
Confidence 3455567788888 889999999999999999998763111 10 1144668999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
+..++|+|.||+++|.|++++...+ +++..+...++.||+.|+.||| ..+|+||||||+|+|++..+.+||+
T Consensus 83 ~~~~lylvlEyv~gGELFdylv~kG-----~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIA 154 (786)
T KOG0588|consen 83 NKQHLYLVLEYVPGGELFDYLVRKG-----PLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIA 154 (786)
T ss_pred cCceEEEEEEecCCchhHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeee
Confidence 9999999999999999999998874 6899999999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCcccccCCC-CcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhh
Q 043524 171 DFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDF-SEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNY 249 (314)
Q Consensus 171 dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (314)
|||+|..-..+ ...++.+|+++|.|||++.+.+| +.++||||+|||||.+++|+.||+.
T Consensus 155 DFGMAsLe~~g--klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD------------------ 214 (786)
T KOG0588|consen 155 DFGMASLEVPG--KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD------------------ 214 (786)
T ss_pred ccceeecccCC--ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC------------------
Confidence 99999654332 34778899999999999999998 5889999999999999999999972
Q ss_pred hccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 250 FEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.++..++.+...+.+..+ ...+.++++|++.||..||++|.|.+||++
T Consensus 215 ---dNir~LLlKV~~G~f~MP--s~Is~eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 215 ---DNIRVLLLKVQRGVFEMP--SNISSEAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred ---ccHHHHHHHHHcCcccCC--CcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence 222233333333444333 366778999999999999999999999986
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=301.91 Aligned_cols=271 Identities=18% Similarity=0.199 Sum_probs=212.2
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
+|.+...+|+|. ++|+++.+..+|+.||||.+...+.+. + +....++|+++|+.++|+||+.+.++|.+
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd---G-------i~~talREIK~Lqel~h~nIi~LiD~F~~ 72 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD---G-------INRTALREIKLLQELKHPNIIELIDVFPH 72 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc---C-------ccHHHHHHHHHHHHccCcchhhhhhhccC
Confidence 455666799999 999999999999999999988764321 1 11467899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
.+.+-+|+||++. +|...++... ..+....+..++.+++.|++||| ++.|+||||||+|+|++.+|.+|++|
T Consensus 73 ~~~l~lVfEfm~t-dLe~vIkd~~----i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiAD 144 (318)
T KOG0659|consen 73 KSNLSLVFEFMPT-DLEVVIKDKN----IILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIAD 144 (318)
T ss_pred CCceEEEEEeccc-cHHHHhcccc----cccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeec
Confidence 9999999999975 9999998765 56889999999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCcccccCC-CCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhh
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTTCD-FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
||+++.+...... ....+-|..|.|||++.+.+ |+..+|+||.||++.||+-|.+.|.+..+.+....-|...-....
T Consensus 145 FGLAr~f~~p~~~-~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~ 223 (318)
T KOG0659|consen 145 FGLARFFGSPNRI-QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTP 223 (318)
T ss_pred ccchhccCCCCcc-cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCc
Confidence 9999988654332 22236799999999998876 999999999999999999999999887776654443333221111
Q ss_pred -ccCCcccccChhh----hccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 251 -EDNRFTEIVDPII----VQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 251 -~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.++++..+-|-.. ..+.....-+.++..+.+|+.+||.+||.+|+|++|+++
T Consensus 224 ~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~ 280 (318)
T KOG0659|consen 224 DQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK 280 (318)
T ss_pred ccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence 0111111111100 000000011245667799999999999999999999986
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=326.37 Aligned_cols=253 Identities=25% Similarity=0.337 Sum_probs=206.7
Q ss_pred hhhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC-CCceeeeEe
Q 043524 10 LWSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS-HDHILKLIG 87 (314)
Q Consensus 10 ~~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~ 87 (314)
...+|.....+|.|+ +.|+.+.+..+|+.||+|++..+...... .. ..+.+.+|+.+++.++ ||||+++++
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~----~~---~~~~i~rEi~~~~~~~~HpnI~~l~e 87 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKS----QK---LDELIKREISILRRLRSHPNIIRLLE 87 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccc----cc---cchhhHHHHHHHHHhccCCCEeEEEE
Confidence 345677777899998 88999989999999999987765221110 00 1144558999999999 999999999
Q ss_pred EEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCC-Cc
Q 043524 88 CCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEE-NV 166 (314)
Q Consensus 88 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~-~~ 166 (314)
++.....+|+|||||.+|+|.+.+... .++.+..+..++.|+++|++||| ++||+||||||+|++++.+ +.
T Consensus 88 v~~t~~~~~ivmEy~~gGdL~~~i~~~-----g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~ 159 (370)
T KOG0583|consen 88 VFATPTKIYIVMEYCSGGDLFDYIVNK-----GRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGN 159 (370)
T ss_pred EEecCCeEEEEEEecCCccHHHHHHHc-----CCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCC
Confidence 999999999999999999999999884 35788999999999999999999 9999999999999999999 99
Q ss_pred eEEcccccceecCCCCcccccccccccccccCcccccCC-CC-cccchHHHHHHHHHHHhCCCCcccccCccccccchHH
Q 043524 167 VKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCD-FS-EKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNE 244 (314)
Q Consensus 167 ~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~-~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 244 (314)
+||+|||++.... .......+.+||+.|+|||++.+.. |+ .++||||+|++||-|++|+.||+.....
T Consensus 160 ~Kl~DFG~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~--------- 229 (370)
T KOG0583|consen 160 LKLSDFGLSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP--------- 229 (370)
T ss_pred EEEeccccccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH---------
Confidence 9999999998773 2222367889999999999999987 85 8899999999999999999999752211
Q ss_pred HHHhhhccCCcccccChhhhccCCchhHHHH-HHHHHHHHhHhccCCCCCCCCHHHHH
Q 043524 245 YLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQ-LHASAQLTFECLNESPIDRPTMVDVA 301 (314)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~cl~~dp~~Rps~~ell 301 (314)
.....+..+....+. .. +.++.+|+..||..||.+|+|+.+|+
T Consensus 230 ------------~l~~ki~~~~~~~p~--~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 230 ------------NLYRKIRKGEFKIPS--YLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred ------------HHHHHHhcCCccCCC--CcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 111112223333322 22 67889999999999999999999998
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=319.62 Aligned_cols=252 Identities=21% Similarity=0.274 Sum_probs=199.9
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
.+.+...+|.|+ +.|+++....+|+..|||.+...+... .+.+.+|+.+|++++|||||+++|....
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~------------~~~l~~Ei~iL~~l~~p~IV~~~G~~~~ 85 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT------------SESLEREIRILSRLNHPNIVQYYGSSSS 85 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh------------HHHHHHHHHHHHhCCCCCEEeeCCcccc
Confidence 356677899999 888888888889999999887763211 1567899999999999999999998554
Q ss_pred CC--eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecC-CCceE
Q 043524 92 TP--IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSE-ENVVK 168 (314)
Q Consensus 92 ~~--~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~-~~~~k 168 (314)
.. .++++|||+++|+|.+.+...+. .++...++.+..|++.||+||| ++|++||||||+|||++. ++.+|
T Consensus 86 ~~~~~~~i~mEy~~~GsL~~~~~~~g~----~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~K 158 (313)
T KOG0198|consen 86 RENDEYNIFMEYAPGGSLSDLIKRYGG----KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVK 158 (313)
T ss_pred ccCeeeEeeeeccCCCcHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEE
Confidence 44 69999999999999999988652 4899999999999999999999 999999999999999999 69999
Q ss_pred EcccccceecCC--CCcccccccccccccccCcccccC-CCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHH
Q 043524 169 LFDFSLSISIPE--GETHITDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEY 245 (314)
Q Consensus 169 l~dfg~~~~~~~--~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 245 (314)
|+|||.++.... ..........||+.|||||++... ..+.++||||+||++.||+||.+||...... ....
T Consensus 159 laDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~------~~~~ 232 (313)
T KOG0198|consen 159 LADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEE------AEAL 232 (313)
T ss_pred eccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcch------HHHH
Confidence 999999977653 122224467899999999999863 2345999999999999999999998643100 0000
Q ss_pred HHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 043524 246 LKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARR 303 (314)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 303 (314)
...... ...+..+...++++.+|+..|+..||++||||.++|+.
T Consensus 233 ~~ig~~--------------~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h 276 (313)
T KOG0198|consen 233 LLIGRE--------------DSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH 276 (313)
T ss_pred HHHhcc--------------CCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence 110000 00112222567789999999999999999999999974
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=322.33 Aligned_cols=269 Identities=19% Similarity=0.239 Sum_probs=206.1
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
+.+...||+|. +.||++++..+|+.||+|.+.....+.. ...-..+||.+|++|.|||||++.+..++.
T Consensus 119 feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~----------~~~t~~REI~ILr~l~HpNIikL~eivt~~ 188 (560)
T KOG0600|consen 119 FEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEG----------FPITAIREIKILRRLDHPNIIKLEEIVTSK 188 (560)
T ss_pred HHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCc----------chHHHHHHHHHHHhcCCCcccceeeEEEec
Confidence 34455699999 9999999999999999999886553221 113457999999999999999999999876
Q ss_pred --CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 93 --PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 93 --~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
..+|+|+|||++ ||..++.... -.+...++..++.|++.||+||| ++||+|||||++||||+++|.+||+
T Consensus 189 ~~~siYlVFeYMdh-DL~GLl~~p~----vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKia 260 (560)
T KOG0600|consen 189 LSGSIYLVFEYMDH-DLSGLLSSPG----VKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIA 260 (560)
T ss_pred CCceEEEEEecccc-hhhhhhcCCC----cccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEec
Confidence 789999999976 9988887654 35889999999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCcccccC-CCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhh
Q 043524 171 DFSLSISIPEGETHITDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNY 249 (314)
Q Consensus 171 dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (314)
|||+|++............+-|.+|.|||++++. .|+..+|+||.|||+.||+.|+++|++....+.+-.-|.-+- .
T Consensus 261 DFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcG--S 338 (560)
T KOG0600|consen 261 DFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCG--S 338 (560)
T ss_pred cccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhC--C
Confidence 9999998766544335566789999999999986 499999999999999999999999986554332211111000 0
Q ss_pred hccCCcc--cccChhhhccCCc------hhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 250 FEDNRFT--EIVDPIIVQDLSC------TEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 250 ~~~~~~~--~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.....|. ++-......+... ......+..+.+|+..+|..||.+|.||.++|+
T Consensus 339 P~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 339 PTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 0011111 0000000000000 001244567899999999999999999999885
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=320.83 Aligned_cols=248 Identities=21% Similarity=0.288 Sum_probs=209.3
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
.+.+...+|.|+ +.||++.+..+++.||+|++.....+... +.+..|+.+|.+++++||.++|+.+..
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deI-----------ediqqei~~Ls~~~~~~it~yygsyl~ 82 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEI-----------EDIQQEISVLSQCDSPNITEYYGSYLK 82 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhh-----------HHHHHHHHHHHhcCcchHHhhhhheee
Confidence 445557799999 99999999999999999999887655433 557789999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
+..+|++||||.||++.+.+.... .+....+..++.+++.|+.|+| ..+.+|||||+.||++...|.+|++|
T Consensus 83 g~~LwiiMey~~gGsv~~lL~~~~-----~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~D 154 (467)
T KOG0201|consen 83 GTKLWIIMEYCGGGSVLDLLKSGN-----ILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLAD 154 (467)
T ss_pred cccHHHHHHHhcCcchhhhhccCC-----CCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEe
Confidence 999999999999999999987653 3467777888999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhc
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFE 251 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (314)
||++.++..... ...+++||+.|||||++....|+.++||||||++.+||++|.+|+...+...
T Consensus 155 fgVa~ql~~~~~-rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr--------------- 218 (467)
T KOG0201|consen 155 FGVAGQLTNTVK-RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR--------------- 218 (467)
T ss_pred cceeeeeechhh-ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce---------------
Confidence 999988765443 3588999999999999998899999999999999999999999986544311
Q ss_pred cCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 252 DNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
..-+ +....++.....++..+++|+..||.+||+.||||.++++
T Consensus 219 ---vlfl----Ipk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 219 ---VLFL----IPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ---EEEe----ccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 0011 1111222222266777999999999999999999999987
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=320.22 Aligned_cols=267 Identities=19% Similarity=0.273 Sum_probs=204.2
Q ss_pred hhhhhhhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC-CCcee
Q 043524 6 RKFKLWSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS-HDHIL 83 (314)
Q Consensus 6 ~~~~~~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv 83 (314)
.+|+..++ +|.|+ +.|+++....+|+.||||.+..+-..-.. --=++|++.|++|+ |||||
T Consensus 10 ~RY~~i~k------lGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee-----------~~nLREvksL~kln~hpnii 72 (538)
T KOG0661|consen 10 DRYTVIRK------LGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE-----------CMNLREVKSLRKLNPHPNII 72 (538)
T ss_pred HHHHHHHH------hcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH-----------HHHHHHHHHHHhcCCCCcch
Confidence 35555555 89998 99999999999999999977654321110 01258999999998 99999
Q ss_pred eeEeEEEeCC-eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeec
Q 043524 84 KLIGCCLETP-IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFS 162 (314)
Q Consensus 84 ~~~~~~~~~~-~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~ 162 (314)
++.+++.+.+ .+|+||||| .++|.++++..+ .+++...++.++.||+.||+|+| .+|+.|||+||+|||+.
T Consensus 73 kL~Evi~d~~~~L~fVfE~M-d~NLYqLmK~R~----r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~ 144 (538)
T KOG0661|consen 73 KLKEVIRDNDRILYFVFEFM-DCNLYQLMKDRN----RLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILIS 144 (538)
T ss_pred hhHHHhhccCceEeeeHHhh-hhhHHHHHhhcC----CcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEec
Confidence 9999999877 999999999 579999998875 57999999999999999999999 99999999999999999
Q ss_pred CCCceEEcccccceecCCCCcccccccccccccccCcccccCC-CCcccchHHHHHHHHHHHhCCCCcccccCccccccc
Q 043524 163 EENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCD-FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYP 241 (314)
Q Consensus 163 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~ 241 (314)
....+||+|||+|+....... -...+.|++|.|||+++... |+.+.|+|++||+++|+++-++.|.+....++.. .
T Consensus 145 ~~~~iKiaDFGLARev~SkpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~-K 221 (538)
T KOG0661|consen 145 GNDVIKIADFGLAREVRSKPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIY-K 221 (538)
T ss_pred ccceeEecccccccccccCCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHH-H
Confidence 888999999999998765543 23457899999999998654 8999999999999999999999997665544221 1
Q ss_pred hHHHHHhhhccCCccc---ccC------hhhhc-cCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 242 FNEYLKNYFEDNRFTE---IVD------PIIVQ-DLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 242 ~~~~~~~~~~~~~~~~---~~~------~~~~~-~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
..+.+...-. ..+.+ +.. +...+ ++..-. +.++.++.+||.+||.+||++||||.|+++
T Consensus 222 Ic~VLGtP~~-~~~~eg~~La~~mnf~~P~~~~~~l~~L~-p~~s~~~~~li~~ll~WDP~kRpTA~~al~ 290 (538)
T KOG0661|consen 222 ICEVLGTPDK-DSWPEGYNLASAMNFRFPQVKPSPLKDLL-PNASSEAASLIERLLAWDPDKRPTASQALQ 290 (538)
T ss_pred HHHHhCCCcc-ccchhHHHHHHHhccCCCcCCCCChHHhC-cccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence 1111110000 00000 000 00000 111111 146788999999999999999999999987
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=298.28 Aligned_cols=238 Identities=21% Similarity=0.313 Sum_probs=204.8
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
+.+...+|.|+ +.|-+++++.+|..+|.|+.+++++-+.+.. +...+|..+|..++||+++++++.|.+.
T Consensus 46 fe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQv---------eH~~nEk~vL~~v~~PFlv~l~~t~~d~ 116 (355)
T KOG0616|consen 46 FERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQV---------EHTHNEKRVLKAVSHPFLVKLYGTFKDN 116 (355)
T ss_pred hhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHH---------HHHhhHHHHHhhccCceeEEEEEeeccC
Confidence 34455788888 8888899999999999999999987554432 5678999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~df 172 (314)
+.+|+||||.+||.|..++++.+ .++...++.++.+|+.||+||| +++|++|||||+|||+|.+|.+||+||
T Consensus 117 ~~lymvmeyv~GGElFS~Lrk~~-----rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDF 188 (355)
T KOG0616|consen 117 SNLYMVMEYVPGGELFSYLRKSG-----RFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDF 188 (355)
T ss_pred CeEEEEEeccCCccHHHHHHhcC-----CCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEec
Confidence 99999999999999999998764 5889999999999999999999 999999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhcc
Q 043524 173 SLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFED 252 (314)
Q Consensus 173 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (314)
|.|+..... ..+.+||+-|+|||++....|+.++|.||||+++|||+.|.+||.....
T Consensus 189 GFAK~v~~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~------------------ 246 (355)
T KOG0616|consen 189 GFAKRVSGR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP------------------ 246 (355)
T ss_pred cceEEecCc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh------------------
Confidence 999887443 4578999999999999999999999999999999999999999975442
Q ss_pred CCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCC
Q 043524 253 NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRP 295 (314)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp 295 (314)
..+.++++.+....+ +..+.++.+|+...|+.|-.+|.
T Consensus 247 ---~~iY~KI~~~~v~fP--~~fs~~~kdLl~~LL~vD~t~R~ 284 (355)
T KOG0616|consen 247 ---IQIYEKILEGKVKFP--SYFSSDAKDLLKKLLQVDLTKRF 284 (355)
T ss_pred ---HHHHHHHHhCcccCC--cccCHHHHHHHHHHHhhhhHhhh
Confidence 122333443333322 26667889999999999999983
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-45 Score=323.21 Aligned_cols=247 Identities=20% Similarity=0.272 Sum_probs=207.9
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
+|.....+|+|+ +.||+..++.+++.||+|.+.+....... .+.+.+|+++++.++|||||.++++|++
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~----------l~~l~~ev~i~r~lkHpniv~m~esfEt 72 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKE----------LKNLRQEVRILRSLKHPNIVEMLESFET 72 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHH----------HHHHHHHHHHHHhcCCcchhhHHHhhcc
Confidence 344456799999 99999999999999999998876432211 1457899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
..++|+|+|||.| +|..++.... .++++.+..++.+++.||.||| +++|+|||+||.|||++..+.+|++|
T Consensus 73 ~~~~~vVte~a~g-~L~~il~~d~-----~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~Klcd 143 (808)
T KOG0597|consen 73 SAHLWVVTEYAVG-DLFTILEQDG-----KLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCD 143 (808)
T ss_pred cceEEEEehhhhh-hHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeech
Confidence 9999999999976 9999998764 5899999999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhc
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFE 251 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (314)
||+|+.+..+ +.......||+-|||||++.+.+|+..+|.||+||++||+++|++||.... +.
T Consensus 144 Fg~Ar~m~~~-t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s--------i~-------- 206 (808)
T KOG0597|consen 144 FGLARAMSTN-TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS--------IT-------- 206 (808)
T ss_pred hhhhhhcccC-ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH--------HH--------
Confidence 9999987554 334566789999999999999999999999999999999999999995221 11
Q ss_pred cCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 252 DNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
+++..+...+..++. ..+..+.+|+...|.+||..|.|+.+++.
T Consensus 207 -----~Lv~~I~~d~v~~p~--~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 207 -----QLVKSILKDPVKPPS--TASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred -----HHHHHHhcCCCCCcc--cccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 122222222222222 67778999999999999999999999875
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=315.14 Aligned_cols=251 Identities=23% Similarity=0.305 Sum_probs=210.9
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
|.....+|.|+ +..++..++.+++.+++|.+......... .+...+|+.++++++|||||.+.+.|..+
T Consensus 6 Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~----------r~~A~~E~~lis~~~hP~iv~y~ds~~~~ 75 (426)
T KOG0589|consen 6 YEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE----------RRSAIQEMDLLSKLLHPNIVEYKDSFEED 75 (426)
T ss_pred hhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh----------hHHHHHHHHHHHhccCCCeeeeccchhcC
Confidence 34445689999 88888999999999999998766532221 14568999999999999999999999988
Q ss_pred Ce-eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 93 PI-AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 93 ~~-~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
+. ++|||+||+||++.+.+....+ ..++.+.+..|+.|++.|+.||| +++|+|||||+.||+++.++.++|+|
T Consensus 76 ~~~l~Ivm~Y~eGg~l~~~i~~~k~---~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgD 149 (426)
T KOG0589|consen 76 GQLLCIVMEYCEGGDLAQLIKEQKG---VLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGD 149 (426)
T ss_pred CceEEEEEeecCCCCHHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecc
Confidence 88 9999999999999999988663 45789999999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhc
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFE 251 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (314)
||+|+.+.... ....+..||+.|++||++.+.+|+.++||||+||++|||++-+++|+...
T Consensus 150 fGlaK~l~~~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~------------------ 210 (426)
T KOG0589|consen 150 FGLAKILNPED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN------------------ 210 (426)
T ss_pred hhhhhhcCCch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc------------------
Confidence 99999875543 23667899999999999999999999999999999999999998886432
Q ss_pred cCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 043524 252 DNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARR 303 (314)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 303 (314)
+..++.++...... +.+..++.++..|+..||..+|..||++.++|..
T Consensus 211 ---m~~Li~ki~~~~~~-Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 211 ---MSELILKINRGLYS-PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ---hHHHHHHHhhccCC-CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 33333333333322 2223667889999999999999999999999985
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=291.38 Aligned_cols=260 Identities=23% Similarity=0.329 Sum_probs=212.4
Q ss_pred hhhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC-CCceeeeEe
Q 043524 10 LWSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS-HDHILKLIG 87 (314)
Q Consensus 10 ~~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~ 87 (314)
++.++.....+|.|+ ++|..+.++.+|..+|+|++.... +..++.....+.++-..|+.+|+++. ||||+++.+
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~a----t~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D 90 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTA----TTESGETPYEMREATRQEISILRQVMGHPYIIDLQD 90 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecc----cccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeee
Confidence 445666667788777 999999999999999999986432 23333444456688889999999985 999999999
Q ss_pred EEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCce
Q 043524 88 CCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVV 167 (314)
Q Consensus 88 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~ 167 (314)
+|+++...++|+|.|+.|.|.|++.+.- .++.++.+.++.|+..|++||| .++||||||||+|||++++..+
T Consensus 91 ~yes~sF~FlVFdl~prGELFDyLts~V-----tlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i 162 (411)
T KOG0599|consen 91 VYESDAFVFLVFDLMPRGELFDYLTSKV-----TLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNI 162 (411)
T ss_pred eccCcchhhhhhhhcccchHHHHhhhhe-----eecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccce
Confidence 9999999999999999999999997653 5899999999999999999999 9999999999999999999999
Q ss_pred EEcccccceecCCCCcccccccccccccccCcccc------cCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccc
Q 043524 168 KLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVT------TCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYP 241 (314)
Q Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~ 241 (314)
+|+|||++..++.+. +....+||++|+|||.+. ...|+..+|+|++|+++|.++.|.+||..-+...
T Consensus 163 ~isDFGFa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml----- 235 (411)
T KOG0599|consen 163 KISDFGFACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML----- 235 (411)
T ss_pred EEeccceeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH-----
Confidence 999999999886654 366789999999999874 2348889999999999999999999997433211
Q ss_pred hHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 242 FNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.++....+ +-.+..++..+.+....+||.+||+.||.+|.|++|+|.
T Consensus 236 ---MLR~ImeG-----------kyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 236 ---MLRMIMEG-----------KYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred ---HHHHHHhc-----------ccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 11111110 011223333466777899999999999999999999886
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=310.42 Aligned_cols=264 Identities=24% Similarity=0.282 Sum_probs=209.0
Q ss_pred hhhhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCCh--hHHHHHHHHHHHhcCCCCceeee
Q 043524 9 KLWSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGF--WHESCINNVTYAAQMSHDHILKL 85 (314)
Q Consensus 9 ~~~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~ 85 (314)
+....|.....+|+|. +.|.++++..+++.||+|++.+....+...-..+.... =.+.+.+|+.+|+++.|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 3344556667799999 99999999999999999999998876544322222111 12689999999999999999999
Q ss_pred EeEEEe--CCeeEEEEeecCCCCHHHHHhcCCCCCCCc-ccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeec
Q 043524 86 IGCCLE--TPIAILVFEYVQHGTLWDRILGAPQTHFEP-LLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFS 162 (314)
Q Consensus 86 ~~~~~~--~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~-l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~ 162 (314)
+++..+ .+.+|||+|||..|.+...= . ..+ +...+++.++.+++.||+||| .+||+||||||+|+|++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p-~-----d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~ 244 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP-P-----DKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLS 244 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC-C-----CcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEc
Confidence 999976 56799999999998884421 1 133 889999999999999999999 99999999999999999
Q ss_pred CCCceEEcccccceecCCCC----cccccccccccccccCcccccCC----CCcccchHHHHHHHHHHHhCCCCcccccC
Q 043524 163 EENVVKLFDFSLSISIPEGE----THITDTVMGTYGHLAPQYVTTCD----FSEKLDVYSFGAFLSELLTGRGILDLVRD 234 (314)
Q Consensus 163 ~~~~~kl~dfg~~~~~~~~~----~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DiwslG~~l~el~~g~~p~~~~~~ 234 (314)
.+|.+||+|||.+..+..+. ........||+.|+|||++.... .+.+.||||+||+||.|+.|+.||-..
T Consensus 245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~-- 322 (576)
T KOG0585|consen 245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD-- 322 (576)
T ss_pred CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc--
Confidence 99999999999997663321 11233468999999999998733 357889999999999999999998421
Q ss_pred ccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 235 AHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
...++.++++..++..+..+...+.+.+||+.||.+||+.|.+..+|..
T Consensus 323 -------------------~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 323 -------------------FELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred -------------------hHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 2223444555555555555566788999999999999999999988864
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=303.95 Aligned_cols=249 Identities=20% Similarity=0.285 Sum_probs=208.3
Q ss_pred hhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEE
Q 043524 11 WSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCC 89 (314)
Q Consensus 11 ~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 89 (314)
.-+|.-...+|.|. +.|.++.....|+.||||.+.+..++....- -.+.+|+++|+.|+||||+.++++|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDl---------vhIRREIeIMSsLNHPhII~IyEVF 122 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDL---------VHIRREIEIMSSLNHPHIIQIYEVF 122 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHH---------HHHHHHHHHHhhcCCCceeehhhhh
Confidence 34455556799999 8899999999999999999988877654321 4567999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEE
Q 043524 90 LETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKL 169 (314)
Q Consensus 90 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl 169 (314)
+..+.+.|||||..+|+|.|++...+ .++..+.+.++.||++|+.||| .++++|||||.+|||+|.++.+||
T Consensus 123 ENkdKIvivMEYaS~GeLYDYiSer~-----~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKI 194 (668)
T KOG0611|consen 123 ENKDKIVIVMEYASGGELYDYISERG-----SLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKI 194 (668)
T ss_pred cCCceEEEEEEecCCccHHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeee
Confidence 99999999999999999999998875 5899999999999999999999 999999999999999999999999
Q ss_pred cccccceecCCCCcccccccccccccccCcccccCCC-CcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHh
Q 043524 170 FDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDF-SEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKN 248 (314)
Q Consensus 170 ~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (314)
+|||++..+.... ...+++|++-|.+||++.+.+| ++.+|.||+|++||.+..|.-||++... ...+++
T Consensus 195 ADFGLSNly~~~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh--------k~lvrQ 264 (668)
T KOG0611|consen 195 ADFGLSNLYADKK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH--------KRLVRQ 264 (668)
T ss_pred eccchhhhhcccc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH--------HHHHHH
Confidence 9999997765443 2678899999999999999998 5889999999999999999999986442 122222
Q ss_pred hhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 249 YFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.. .+....+ ..+..+.-||+.||..||++|.|+.+|..
T Consensus 265 Is-------------~GaYrEP---~~PSdA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 265 IS-------------RGAYREP---ETPSDASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred hh-------------cccccCC---CCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence 21 1221111 12234667999999999999999999864
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=324.96 Aligned_cols=257 Identities=25% Similarity=0.371 Sum_probs=208.5
Q ss_pred cccCch-hHHHHHHHhcC-----CcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 19 MIGNGA-SVLQELIASSN-----GKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~-----g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
.+|+|. +.|+++.-..- -..||||........++ .++|.+|+.++..++|||||+++|+|..+
T Consensus 493 eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~-----------~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 493 ELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQA-----------RQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred hhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHH-----------HHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 477777 66666643322 23699997765544332 27899999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCC---------CCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecC
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQT---------HFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSE 163 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~---------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~ 163 (314)
+..|+|+|||..|||..++...... ...++...+.+.++.||+.|+.||. ++++|||||-++|+|++.
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceecc
Confidence 9999999999999999999853221 1234889999999999999999999 999999999999999999
Q ss_pred CCceEEcccccceecCCCCccccc-ccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccc
Q 043524 164 ENVVKLFDFSLSISIPEGETHITD-TVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYP 241 (314)
Q Consensus 164 ~~~~kl~dfg~~~~~~~~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~ 241 (314)
...+||+|||+++..-..+.++.. ...-+.+|||||.+...+|++++|||||||+|||+++ |..||.+..+.+
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E----- 713 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE----- 713 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-----
Confidence 999999999999887666555433 4456889999999999999999999999999999998 889987666543
Q ss_pred hHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhc
Q 043524 242 FNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSL 311 (314)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 311 (314)
+++-+..+.. .+.+..+|.++.+|+..||+.+|++|||++||..+|+.....-
T Consensus 714 ----------------VIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 714 ----------------VIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred ----------------HHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 1122222222 2333477788999999999999999999999999999886643
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=311.35 Aligned_cols=262 Identities=20% Similarity=0.352 Sum_probs=195.6
Q ss_pred CcccccccCch-hHHHHHH-----HhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeE
Q 043524 14 GKRTLMIGNGA-SVLQELI-----ASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLI 86 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~-----~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~ 86 (314)
+.....+|.|+ +.|+++. ...+++.||+|++........ .+.+.+|+.++..+ +||||++++
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~E~~~l~~l~~h~niv~~~ 77 (338)
T cd05102 9 LRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASE-----------HKALMSELKILIHIGNHLNVVNLL 77 (338)
T ss_pred ceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHH-----------HHHHHHHHHHHHHhccCcceeeEE
Confidence 33344588888 7777664 234567899998764322111 15688999999999 899999999
Q ss_pred eEEEeC-CeeEEEEeecCCCCHHHHHhcCCCC------------------------------------------------
Q 043524 87 GCCLET-PIAILVFEYVQHGTLWDRILGAPQT------------------------------------------------ 117 (314)
Q Consensus 87 ~~~~~~-~~~~iv~e~~~~g~L~~~l~~~~~~------------------------------------------------ 117 (314)
+++... ..++++|||+++|+|.+++......
T Consensus 78 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (338)
T cd05102 78 GACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGST 157 (338)
T ss_pred eEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccc
Confidence 998764 4689999999999999988753210
Q ss_pred ---------CCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccceecCCCCcc-ccc
Q 043524 118 ---------HFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETH-ITD 187 (314)
Q Consensus 118 ---------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~ 187 (314)
...++....+..++.|++.||.||| +++|+||||||+||+++.++.++|+|||+++........ ...
T Consensus 158 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~ 234 (338)
T cd05102 158 NPPQETDDLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 234 (338)
T ss_pred ccchhccccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhccc
Confidence 0124677888899999999999999 999999999999999999999999999999765332211 122
Q ss_pred ccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhccCCcccccChhhhcc
Q 043524 188 TVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQD 266 (314)
Q Consensus 188 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (314)
...++..|+|||++.+..++.++||||||+++|||++ |..||........ .... ......
T Consensus 235 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-------~~~~-~~~~~~----------- 295 (338)
T cd05102 235 SARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-------FCQR-LKDGTR----------- 295 (338)
T ss_pred CCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-------HHHH-HhcCCC-----------
Confidence 3346678999999988889999999999999999997 9999865332110 0011 111000
Q ss_pred CCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 267 LSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 267 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
...+...+..+.+++..||+.||++|||+.|+++.|+++..+
T Consensus 296 --~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 296 --MRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred --CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 000113345688999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=282.70 Aligned_cols=246 Identities=24% Similarity=0.334 Sum_probs=202.0
Q ss_pred ccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCe
Q 043524 16 RTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPI 94 (314)
Q Consensus 16 ~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 94 (314)
-...+|+|. ++|+.+.+..+|+.+|+|++..+.+... -.+.+.+|+++.+.|+||||+++.+.+.+...
T Consensus 15 l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~----------~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~ 84 (355)
T KOG0033|consen 15 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR----------DFQKLEREARICRKLQHPNIVRLHDSIQEESF 84 (355)
T ss_pred HHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc----------cHHHHHHHHHHHHhcCCCcEeehhhhhcccce
Confidence 344588888 9999999999999999999987765443 23778899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCC---CceEEcc
Q 043524 95 AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEE---NVVKLFD 171 (314)
Q Consensus 95 ~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~---~~~kl~d 171 (314)
.|+|+|++.|++|..-|-.. ...+...+-.++.||+.+|.||| +++|+|||+||+|+++.+. .-+|++|
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~ 156 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLAD 156 (355)
T ss_pred eEEEEecccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecc
Confidence 99999999999996555332 23566677788999999999999 9999999999999998543 4589999
Q ss_pred cccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhc
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFE 251 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (314)
||++.....+ ..-..+.|||.|||||++...+|+.++|||+.|+++|-++.|.+||.+....
T Consensus 157 FGvAi~l~~g--~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---------------- 218 (355)
T KOG0033|consen 157 FGLAIEVNDG--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---------------- 218 (355)
T ss_pred cceEEEeCCc--cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH----------------
Confidence 9999988633 3355778999999999999999999999999999999999999999753322
Q ss_pred cCCcccccChhhhcc--CCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 252 DNRFTEIVDPIIVQD--LSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 252 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.+.+.++.+. .+.+.....++++.+|++.||..||++|.|+.|.|+
T Consensus 219 -----rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 219 -----RLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred -----HHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 1222222222 222233366788999999999999999999999875
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=305.36 Aligned_cols=248 Identities=18% Similarity=0.246 Sum_probs=192.6
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe----C
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE----T 92 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~ 92 (314)
..+|+|+ +.|+.+. .+|+.||+|.+........ .+.+.+.+|+.+|.+++||||+++++++.+ .
T Consensus 26 ~~i~~g~~~~v~~~~--~~~~~vavK~~~~~~~~~~---------~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~ 94 (283)
T PHA02988 26 VLIKENDQNSIYKGI--FNNKEVIIRTFKKFHKGHK---------VLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94 (283)
T ss_pred eEEeeCCceEEEEEE--ECCEEEEEEeccccccccH---------HHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCC
Confidence 5677777 5555543 4789999999875432111 122667899999999999999999999877 4
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCC-CCceeccCCCCCeeecCCCceEEcc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFP-RPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~-~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
...++||||+++|+|.+++.... .++......++.+++.|+.||| + .+++||||||+||+++.++.+|++|
T Consensus 95 ~~~~lv~Ey~~~g~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~kl~d 166 (283)
T PHA02988 95 PRLSLILEYCTRGYLREVLDKEK-----DLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKLKIIC 166 (283)
T ss_pred CceEEEEEeCCCCcHHHHHhhCC-----CCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcEEEcc
Confidence 57899999999999999997643 4778888999999999999999 6 4889999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccc--CCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhh
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTT--CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNY 249 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (314)
||+++..... .....++..|+|||++.+ ..++.++|||||||++|||++|..||...... +.....
T Consensus 167 fg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~--------~~~~~i 234 (283)
T PHA02988 167 HGLEKILSSP----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK--------EIYDLI 234 (283)
T ss_pred cchHhhhccc----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH--------HHHHHH
Confidence 9998765332 123467899999999876 57899999999999999999999999743211 111111
Q ss_pred hccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHh
Q 043524 250 FEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICC 309 (314)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 309 (314)
... ...+..+..++..+.+|+.+||+.||++|||+.|+++.|+.++.
T Consensus 235 ~~~-------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 235 INK-------------NNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred Hhc-------------CCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 110 00011111345678999999999999999999999999998763
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=305.36 Aligned_cols=247 Identities=20% Similarity=0.290 Sum_probs=208.5
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
|--...+|.|- .+|.++.+-.+|..||||++.+..+..... ..++.|+++|..++|||||++|++..++
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st----------~hlfqEVRCMKLVQHpNiVRLYEViDTQ 89 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLST----------GHLFQEVRCMKLVQHPNIVRLYEVIDTQ 89 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhh----------hHHHHHHHHHHHhcCcCeeeeeehhccc
Confidence 33444678887 889999999999999999999887654332 4578999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeec-CCCceEEcc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFS-EENVVKLFD 171 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~-~~~~~kl~d 171 (314)
..+|+|+|+-.+|+|.|+|..+. ..+......+++.||+.|+.||| ..++|||||||+|+++. .-|-+||.|
T Consensus 90 TKlyLiLELGD~GDl~DyImKHe----~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTD 162 (864)
T KOG4717|consen 90 TKLYLILELGDGGDLFDYIMKHE----EGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTD 162 (864)
T ss_pred ceEEEEEEecCCchHHHHHHhhh----ccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeee
Confidence 99999999999999999998876 56889999999999999999999 99999999999999764 567899999
Q ss_pred cccceecCCCCcccccccccccccccCcccccCCCC-cccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhh
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFS-EKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
||++..+.++. +..+.+|+..|-|||++++..|+ +++||||+|++||.+.+|+.||+.-.+.+.
T Consensus 163 FGFSNkf~PG~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET------------- 227 (864)
T KOG4717|consen 163 FGFSNKFQPGK--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET------------- 227 (864)
T ss_pred ccccccCCCcc--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh-------------
Confidence 99998776554 37788999999999999999997 678999999999999999999975443331
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
+..++..... .+...+.++++||..||..||++|.|.+||..
T Consensus 228 --------LTmImDCKYt--vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 228 --------LTMIMDCKYT--VPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred --------hhhhhccccc--CchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 1112222222 22377899999999999999999999999864
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=294.09 Aligned_cols=242 Identities=20% Similarity=0.313 Sum_probs=208.3
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeEE
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAIL 97 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i 97 (314)
.+|+|+ +.|+++.++.+|..+|+|.+....-. ++++.|+.++.+++.+++|++||.|.....+||
T Consensus 40 KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDL--------------QEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWI 105 (502)
T KOG0574|consen 40 KLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDL--------------QEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWI 105 (502)
T ss_pred HhcCCcchHHHHHHHhccCcEEEEEecCccchH--------------HHHHHHHHHHHHcCCchhhhhhhhhccCCceEe
Confidence 489999 99999999999999999987655322 567899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccccee
Q 043524 98 VFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSIS 177 (314)
Q Consensus 98 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~ 177 (314)
|||||..|++.|+++... .++...++..++.+.+.||.||| ...-+|||||..|||++.+|..||+|||.+.+
T Consensus 106 VMEYCGAGSiSDI~R~R~----K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQ 178 (502)
T KOG0574|consen 106 VMEYCGAGSISDIMRARR----KPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQ 178 (502)
T ss_pred ehhhcCCCcHHHHHHHhc----CCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccch
Confidence 999999999999998776 57999999999999999999999 88889999999999999999999999999977
Q ss_pred cCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCccc
Q 043524 178 IPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTE 257 (314)
Q Consensus 178 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (314)
+.+.. -+.++..||+.|||||++..-.|+..+||||+|++..||+.|++||...+... .
T Consensus 179 LTDTM-AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR--------------------A 237 (502)
T KOG0574|consen 179 LTDTM-AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR--------------------A 237 (502)
T ss_pred hhhhH-HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc--------------------e
Confidence 75543 24678899999999999999999999999999999999999999997555322 1
Q ss_pred ccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 258 IVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
++.--..++....-+...+.++.+++++||..+|++|-||.++++
T Consensus 238 IFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 238 IFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred eEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 111111222223344578899999999999999999999999887
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=303.56 Aligned_cols=250 Identities=18% Similarity=0.302 Sum_probs=197.7
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCee
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIA 95 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (314)
...+|+|+ +.|+++....+|+.+|+|.+........... ..+.+|+.++..++|+||+++.+++.+++..
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~---------~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~ 75 (285)
T cd05631 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE---------AMALNEKRILEKVNSRFVVSLAYAYETKDAL 75 (285)
T ss_pred EEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhH---------HHHHHHHHHHHhcCCCcEEEEEEEEccCCeE
Confidence 34578888 8888888888999999999887665433211 4577999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
++|+||+++|+|.+.+..... ..++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+|||++
T Consensus 76 ~lv~e~~~~g~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~ 149 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYNMGN---PGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLA 149 (285)
T ss_pred EEEEEecCCCcHHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCc
Confidence 999999999999888764332 35788899999999999999999 999999999999999999999999999999
Q ss_pred eecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCc
Q 043524 176 ISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRF 255 (314)
Q Consensus 176 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (314)
........ .....||..|+|||++.+..++.++||||+||++|+|++|+.||........ ..........
T Consensus 150 ~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-----~~~~~~~~~~--- 219 (285)
T cd05631 150 VQIPEGET--VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-----REEVDRRVKE--- 219 (285)
T ss_pred EEcCCCCe--ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-----HHHHHHHhhc---
Confidence 77543322 2345789999999999988999999999999999999999999975432210 0000000000
Q ss_pred ccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCC-----HHHHHH
Q 043524 256 TEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPT-----MVDVAR 302 (314)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps-----~~ell~ 302 (314)
.. ...+...+..+.+|+.+||+.||++||+ ++++++
T Consensus 220 ---------~~--~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 220 ---------DQ--EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ---------cc--ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 00 0011134567889999999999999997 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=311.47 Aligned_cols=237 Identities=24% Similarity=0.385 Sum_probs=194.3
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeEE
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAIL 97 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i 97 (314)
=+|.|+ +.|+.. ...++.||||.+. +++ ..+++.|++|+|||||.|.|+|....-+||
T Consensus 131 WlGSGaQGAVF~G--rl~netVAVKKV~--elk-----------------ETdIKHLRkLkH~NII~FkGVCtqsPcyCI 189 (904)
T KOG4721|consen 131 WLGSGAQGAVFLG--RLHNETVAVKKVR--ELK-----------------ETDIKHLRKLKHPNIITFKGVCTQSPCYCI 189 (904)
T ss_pred hhccCcccceeee--eccCceehhHHHh--hhh-----------------hhhHHHHHhccCcceeeEeeeecCCceeEE
Confidence 367777 555444 2335789998654 222 257999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccccee
Q 043524 98 VFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSIS 177 (314)
Q Consensus 98 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~ 177 (314)
|||||..|.|...++... ++.......|..+|+.|+.||| .+.|+|||||.-||||+.+..+||+|||.++.
T Consensus 190 iMEfCa~GqL~~VLka~~-----~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e 261 (904)
T KOG4721|consen 190 IMEFCAQGQLYEVLKAGR-----PITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKE 261 (904)
T ss_pred eeeccccccHHHHHhccC-----ccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHh
Confidence 999999999999998753 5778899999999999999999 99999999999999999999999999999987
Q ss_pred cCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCccc
Q 043524 178 IPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTE 257 (314)
Q Consensus 178 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (314)
..+.. ..-.+.||..|||||++...+.+.++|||||||+||||+||..||...........
T Consensus 262 ~~~~S--TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwG----------------- 322 (904)
T KOG4721|consen 262 LSDKS--TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWG----------------- 322 (904)
T ss_pred hhhhh--hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEe-----------------
Confidence 65442 24467899999999999999999999999999999999999999875443321000
Q ss_pred ccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHH
Q 043524 258 IVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQI 307 (314)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~ 307 (314)
+- .+.+..+.+..+++.+.-|+++||+..|..||++++|+.-|+=.
T Consensus 323 VG----sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 323 VG----SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred cc----CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 00 11233444457888899999999999999999999999887643
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=309.79 Aligned_cols=243 Identities=18% Similarity=0.286 Sum_probs=194.5
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeEE
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAIL 97 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i 97 (314)
.+|+|+ +.|+++.+..+|+.+|+|++.......... ...+.+|+.++..++||||+++++++..++.+|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~---------~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~l 72 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDE---------VAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCF 72 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHH---------HHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEE
Confidence 367887 888888888899999999998654322111 1457789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccccee
Q 043524 98 VFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSIS 177 (314)
Q Consensus 98 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~ 177 (314)
||||+++|+|.+.+... ..++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+|||+++.
T Consensus 73 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~ 144 (323)
T cd05571 73 VMEYANGGELFFHLSRE-----RVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKE 144 (323)
T ss_pred EEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcc
Confidence 99999999999988754 34788899999999999999999 99999999999999999999999999999875
Q ss_pred cCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCccc
Q 043524 178 IPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTE 257 (314)
Q Consensus 178 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (314)
..... .......||+.|+|||++.+..++.++||||+||++|+|++|..||...... ........
T Consensus 145 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--------~~~~~~~~------ 209 (323)
T cd05571 145 GISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLFELILM------ 209 (323)
T ss_pred cccCC-CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH--------HHHHHHHc------
Confidence 32221 1233457999999999999888999999999999999999999999643211 10111000
Q ss_pred ccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCC-----CHHHHHH
Q 043524 258 IVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRP-----TMVDVAR 302 (314)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 302 (314)
..... +...+.++.+|+.+||+.||++|| ++.++++
T Consensus 210 -------~~~~~--p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 210 -------EEIRF--PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred -------CCCCC--CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 00000 113456789999999999999999 7998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=303.77 Aligned_cols=270 Identities=17% Similarity=0.203 Sum_probs=195.7
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
+|.....+|.|+ +.|+++.+..+++.||+|.+........ ...+.+|+.+++.++||||+++++++.+
T Consensus 6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (288)
T cd07871 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA-----------PCTAIREVSLLKNLKHANIVTLHDIIHT 74 (288)
T ss_pred cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCc-----------chhHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 445555688888 8888888888999999998864321110 1456799999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
++..++||||++ |+|.+.+.... ..++...+..++.|++.||.||| +++|+||||||+||+++.++.+||+|
T Consensus 75 ~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~D 146 (288)
T cd07871 75 ERCLTLVFEYLD-SDLKQYLDNCG----NLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLAD 146 (288)
T ss_pred CCeEEEEEeCCC-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECc
Confidence 999999999996 59988886543 34678889999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccc-CCCCcccchHHHHHHHHHHHhCCCCcccccCcccccc-------chH
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTT-CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVY-------PFN 243 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~-------~~~ 243 (314)
||+++....... ......+++.|+|||++.+ ..++.++||||+||++|+|++|+.||........... +..
T Consensus 147 fG~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 225 (288)
T cd07871 147 FGLARAKSVPTK-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTE 225 (288)
T ss_pred CcceeeccCCCc-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 999876533221 1234467899999998875 4588999999999999999999999965432211000 000
Q ss_pred HHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 244 EYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
+..........+.....+..............+.++.+|+.+||..||.+|||++|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 226 ETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred HHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 10000000001111111100000000001123456889999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=306.16 Aligned_cols=242 Identities=20% Similarity=0.284 Sum_probs=192.6
Q ss_pred ccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeEEE
Q 043524 20 IGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILV 98 (314)
Q Consensus 20 ~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~iv 98 (314)
+|+|+ +.|+++.+..+|+.+|+|++.......... ...+.+|+.++..++||||+++++++.+++..|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~---------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 71 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSE---------VTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLV 71 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhH---------HHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEE
Confidence 57777 888888888899999999987654322211 15678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccceec
Q 043524 99 FEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISI 178 (314)
Q Consensus 99 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~ 178 (314)
|||+++|+|.+.+.... .++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+|||+++..
T Consensus 72 ~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~ 143 (312)
T cd05585 72 LAFINGGELFHHLQREG-----RFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLN 143 (312)
T ss_pred EcCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccC
Confidence 99999999999987643 4788899999999999999999 999999999999999999999999999998754
Q ss_pred CCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcccc
Q 043524 179 PEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEI 258 (314)
Q Consensus 179 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (314)
.... .......||+.|+|||++.+..++.++||||+||++|+|++|..||..... .........
T Consensus 144 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~--------~~~~~~~~~------- 207 (312)
T cd05585 144 MKDD-DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV--------NEMYRKILQ------- 207 (312)
T ss_pred ccCC-CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH--------HHHHHHHHc-------
Confidence 3222 123455789999999999988899999999999999999999999964321 111111111
Q ss_pred cChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCC---HHHHHH
Q 043524 259 VDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPT---MVDVAR 302 (314)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps---~~ell~ 302 (314)
.+...+ ...+..+.+|+.+||+.||++||+ +.|++.
T Consensus 208 ------~~~~~~--~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 208 ------EPLRFP--DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred ------CCCCCC--CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 111111 134466889999999999999985 566654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=302.75 Aligned_cols=244 Identities=21% Similarity=0.294 Sum_probs=196.3
Q ss_pred cccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCC
Q 043524 15 KRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETP 93 (314)
Q Consensus 15 ~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (314)
.....+|.|+ +.|+++.+..+|+.+|+|++.......... .+.+.+|+.++..++||||+++++++.+++
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~---------~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 74 (291)
T cd05612 4 ERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQ---------EQHVHNEKRVLKEVSHPFIIRLFWTEHDQR 74 (291)
T ss_pred eeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHH---------HHHHHHHHHHHHhCCCCcHhhhHhhhccCC
Confidence 3345688888 888888888899999999998765432211 156789999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccc
Q 043524 94 IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFS 173 (314)
Q Consensus 94 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg 173 (314)
.+|+||||+++|+|.+++.... .++......++.|++.||.||| +++|+||||||+||+++.++.++|+|||
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg 146 (291)
T cd05612 75 FLYMLMEYVPGGELFSYLRNSG-----RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFG 146 (291)
T ss_pred eEEEEEeCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecC
Confidence 9999999999999999987643 4788888999999999999999 9999999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccC
Q 043524 174 LSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDN 253 (314)
Q Consensus 174 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (314)
+++..... .....|++.|+|||++.+..++.++||||+||++|+|++|..||....... .......
T Consensus 147 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~--------~~~~i~~-- 212 (291)
T cd05612 147 FAKKLRDR----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG--------IYEKILA-- 212 (291)
T ss_pred cchhccCC----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHh--
Confidence 98765332 224568999999999988889999999999999999999999986432111 1111110
Q ss_pred CcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCC-----HHHHHH
Q 043524 254 RFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPT-----MVDVAR 302 (314)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps-----~~ell~ 302 (314)
+....+ ...+..+.+|+.+||+.||.+||+ +.++++
T Consensus 213 -----------~~~~~~--~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 213 -----------GKLEFP--RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred -----------CCcCCC--ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 110011 123456889999999999999995 888775
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=306.29 Aligned_cols=246 Identities=18% Similarity=0.275 Sum_probs=197.1
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
.+.....+|.|+ +.|+.+....+|+.+|+|++.......... .+.+.+|+.++..++||||+++++++.+
T Consensus 19 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~---------~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 89 (329)
T PTZ00263 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQ---------VQHVAQEKSILMELSHPFIVNMMCSFQD 89 (329)
T ss_pred heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhh---------HHHHHHHHHHHHhCCCCCCCcEEEEEEc
Confidence 344455688888 888888888899999999998765433211 2568899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
++..|+||||+++|+|.+.+.... .++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+|
T Consensus 90 ~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~D 161 (329)
T PTZ00263 90 ENRVYFLLEFVVGGELFTHLRKAG-----RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTD 161 (329)
T ss_pred CCEEEEEEcCCCCChHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEee
Confidence 999999999999999999987643 4778888899999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhc
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFE 251 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (314)
||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...... ........
T Consensus 162 fg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--------~~~~~i~~ 229 (329)
T PTZ00263 162 FGFAKKVPDR----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF--------RIYEKILA 229 (329)
T ss_pred ccCceEcCCC----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH--------HHHHHHhc
Confidence 9999765432 22457899999999999888999999999999999999999999643211 00111110
Q ss_pred cCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCC-----HHHHHH
Q 043524 252 DNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPT-----MVDVAR 302 (314)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps-----~~ell~ 302 (314)
+....+ ...+..+.+|+..||+.||++||+ +.+++.
T Consensus 230 -------------~~~~~p--~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 230 -------------GRLKFP--NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred -------------CCcCCC--CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 000000 123456789999999999999997 577764
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=302.75 Aligned_cols=263 Identities=18% Similarity=0.262 Sum_probs=198.0
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
+.....+|.|+ +.|+++.+..+|..+|+|++....... ..+.+.+|++++..++||||+++++++..+
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 75 (331)
T cd06649 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPA-----------IRNQIIRELQVLHECNSPYIVGFYGAFYSD 75 (331)
T ss_pred ceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHH-----------HHHHHHHHHHHHHHCCCCCCCeEEEEEEEC
Confidence 34445588888 888888888899999999887542111 125688999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCC-CceeccCCCCCeeecCCCceEEcc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPR-PIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~-~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
+..++||||+++|+|.+++.... .++...+..++.|++.||.||| ++ +|+|+||||+||+++.++.++|+|
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~D 147 (331)
T cd06649 76 GEISICMEHMDGGSLDQVLKEAK-----RIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCD 147 (331)
T ss_pred CEEEEEeecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEcc
Confidence 99999999999999999987643 4788889999999999999999 75 699999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHh-hh
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKN-YF 250 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~ 250 (314)
||++....... .....|++.|+|||++.+..++.++||||+||++|+|++|+.||....... +...... ..
T Consensus 148 fg~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~-----~~~~~~~~~~ 219 (331)
T cd06649 148 FGVSGQLIDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE-----LEAIFGRPVV 219 (331)
T ss_pred Ccccccccccc---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHhccccc
Confidence 99987653322 334578999999999998889999999999999999999999996432211 0000000 00
Q ss_pred ccC--C---------------------------cccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHH
Q 043524 251 EDN--R---------------------------FTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVA 301 (314)
Q Consensus 251 ~~~--~---------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell 301 (314)
... . ..+..+.......+.......+.++.+|+.+||+.||++|||+.|++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell 299 (331)
T cd06649 220 DGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLM 299 (331)
T ss_pred ccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHh
Confidence 000 0 00000000001111111113566789999999999999999999998
Q ss_pred HH
Q 043524 302 RR 303 (314)
Q Consensus 302 ~~ 303 (314)
+.
T Consensus 300 ~h 301 (331)
T cd06649 300 NH 301 (331)
T ss_pred cC
Confidence 73
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=296.13 Aligned_cols=250 Identities=18% Similarity=0.297 Sum_probs=194.1
Q ss_pred ccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeEEE
Q 043524 20 IGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILV 98 (314)
Q Consensus 20 ~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~iv 98 (314)
+|.|+ +.|+++....+|+.+|+|.+........... ..+..|+++++.++||||+++.+++.++...|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~---------~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv 71 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGE---------KMALLEKEILEKVNSPFIVNLAYAFESKTHLCLV 71 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhh---------HHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEE
Confidence 47777 7888888888999999999876654332111 3456799999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccceec
Q 043524 99 FEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISI 178 (314)
Q Consensus 99 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~ 178 (314)
|||+++++|.+.+..... ..++...+..++.|++.||.||| +++++|+||||+||+++.++.++|+|||++...
T Consensus 72 ~e~~~g~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~ 145 (277)
T cd05607 72 MSLMNGGDLKYHIYNVGE---RGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVEL 145 (277)
T ss_pred EecCCCCCHHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeec
Confidence 999999999888865432 34778888999999999999999 999999999999999999999999999998765
Q ss_pred CCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcccc
Q 043524 179 PEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEI 258 (314)
Q Consensus 179 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (314)
..... .....|+..|+|||++....++.++|+||+||++|+|++|..||........ .........
T Consensus 146 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~----~~~~~~~~~-------- 211 (277)
T cd05607 146 KDGKT--ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA----KEELKRRTL-------- 211 (277)
T ss_pred CCCce--eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh----HHHHHHHhh--------
Confidence 43321 2344689999999999888899999999999999999999999864332110 001111100
Q ss_pred cChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHH
Q 043524 259 VDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRL 304 (314)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 304 (314)
....... ....+.++.+|+..||+.||++||++.|+++.+
T Consensus 212 -----~~~~~~~-~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 212 -----EDEVKFE-HQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred -----ccccccc-cccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 0000000 013456689999999999999999997766443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=286.94 Aligned_cols=268 Identities=18% Similarity=0.226 Sum_probs=207.4
Q ss_pred hhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEE
Q 043524 11 WSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCC 89 (314)
Q Consensus 11 ~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 89 (314)
...+.+.-.|++|+ ++||.+.++.+++.||.|.+.... .+..|. =.-++|+.+|..++|||||.+.++.
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek---ek~GFP-------ItsLREIniLl~~~H~NIV~vkEVV 144 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK---EKEGFP-------ITSLREINILLKARHPNIVEVKEVV 144 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc---ccCCCc-------chhHHHHHHHHhcCCCCeeeeEEEE
Confidence 34444555689999 999999999999999999988765 223333 2347999999999999999999998
Q ss_pred Ee--CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCce
Q 043524 90 LE--TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVV 167 (314)
Q Consensus 90 ~~--~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~ 167 (314)
.. -+.+|+|||||+. +|...+..-. +++...++..++.|++.|++||| ++.|+|||||++|+|++..|.+
T Consensus 145 vG~~~d~iy~VMe~~Eh-DLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~l 216 (419)
T KOG0663|consen 145 VGSNMDKIYIVMEYVEH-DLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGIL 216 (419)
T ss_pred eccccceeeeeHHHHHh-hHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcE
Confidence 75 3579999999976 9999988765 57899999999999999999999 9999999999999999999999
Q ss_pred EEcccccceecCCCCcccccccccccccccCcccccCC-CCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHH
Q 043524 168 KLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCD-FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYL 246 (314)
Q Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 246 (314)
||+|||+|+...... ......+-|.+|.|||++++.. |+++.|+||+|||+.||+++++.|.+....+....-|...-
T Consensus 217 KiaDFGLAR~ygsp~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llG 295 (419)
T KOG0663|consen 217 KIADFGLAREYGSPL-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLG 295 (419)
T ss_pred EecccchhhhhcCCc-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhC
Confidence 999999999886542 2344567899999999999886 99999999999999999999999986665443222111110
Q ss_pred HhhhccCCcccccC--------------hhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 247 KNYFEDNRFTEIVD--------------PIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 247 ~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
......|..+.. ..+.+.+... ..++...+|+..+|.+||.+|.||+|.|+
T Consensus 296 --tPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~---~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 296 --TPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGAL---SLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred --CCccccCCCccccchhhccccCCCCchhhhhhcccc---ccchhHHHHHHHHhccCccccccHHHhhc
Confidence 001111111110 1111112111 14567889999999999999999999875
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=303.68 Aligned_cols=243 Identities=19% Similarity=0.290 Sum_probs=193.9
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeEE
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAIL 97 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i 97 (314)
.+|+|+ +.|+++.+..+|+.+|+|++......... ....+.+|++++..++||||+++.+++...+..|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~---------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 72 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKD---------EVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCF 72 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhh---------HHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEE
Confidence 367777 88888888889999999999865432211 11567899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccccee
Q 043524 98 VFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSIS 177 (314)
Q Consensus 98 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~ 177 (314)
||||+++|+|.+.+... ..++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+|||+++.
T Consensus 73 v~Ey~~~g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~ 144 (328)
T cd05593 73 VMEYVNGGELFFHLSRE-----RVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKE 144 (328)
T ss_pred EEeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCcc
Confidence 99999999998888654 24788899999999999999999 99999999999999999999999999999875
Q ss_pred cCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCccc
Q 043524 178 IPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTE 257 (314)
Q Consensus 178 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (314)
..... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||...... ........
T Consensus 145 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~--------~~~~~~~~------ 209 (328)
T cd05593 145 GITDA-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLFELILM------ 209 (328)
T ss_pred CCCcc-cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH--------HHHHHhcc------
Confidence 32221 1233457899999999998888999999999999999999999999643211 11111000
Q ss_pred ccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCC-----CHHHHHH
Q 043524 258 IVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRP-----TMVDVAR 302 (314)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 302 (314)
..... +...+.++.+|+..||..||++|| ++.|+++
T Consensus 210 -------~~~~~--p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 210 -------EDIKF--PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred -------CCccC--CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 00000 013345688999999999999997 8999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=302.54 Aligned_cols=250 Identities=18% Similarity=0.243 Sum_probs=202.3
Q ss_pred cccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCC
Q 043524 15 KRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETP 93 (314)
Q Consensus 15 ~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (314)
.-...||.|+ +.|+++..+.+|+.+|+|++.+.+....... +-+..|-.+|....+|+||+++-.|.+..
T Consensus 144 e~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv---------~hV~aERdiL~~~ds~~vVKLyYsFQD~~ 214 (550)
T KOG0605|consen 144 ELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQV---------EHVRAERDILAEVDSPWVVKLYYSFQDKE 214 (550)
T ss_pred hhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhH---------HHHHHHHHHhhhcCCCcEEEEEEEecCCC
Confidence 3445799999 9999999999999999999999976554332 56789999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccc
Q 043524 94 IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFS 173 (314)
Q Consensus 94 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg 173 (314)
.+|+||||++||++..++...+ .|+...+..++.+++.|+..+| ..|++||||||+|+|||..|.+||+|||
T Consensus 215 ~LYLiMEylPGGD~mTLL~~~~-----~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFG 286 (550)
T KOG0605|consen 215 YLYLIMEYLPGGDMMTLLMRKD-----TLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFG 286 (550)
T ss_pred eeEEEEEecCCccHHHHHHhcC-----cCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeecccc
Confidence 9999999999999999998764 6899999999999999999999 9999999999999999999999999999
Q ss_pred cceecCCC-----------------------Ccc---c--------------------ccccccccccccCcccccCCCC
Q 043524 174 LSISIPEG-----------------------ETH---I--------------------TDTVMGTYGHLAPQYVTTCDFS 207 (314)
Q Consensus 174 ~~~~~~~~-----------------------~~~---~--------------------~~~~~g~~~y~aPE~~~~~~~~ 207 (314)
+++.+... ... . ....+|||-|+|||++.+..|+
T Consensus 287 Ls~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~ 366 (550)
T KOG0605|consen 287 LSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG 366 (550)
T ss_pred ccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC
Confidence 98643210 000 0 1134899999999999999999
Q ss_pred cccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhc
Q 043524 208 EKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECL 287 (314)
Q Consensus 208 ~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl 287 (314)
..+|.||+|||+|||+.|.+||......+. .+....+ ...+..+.....+.++.|||..||
T Consensus 367 ~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T--------~rkI~nw-----------r~~l~fP~~~~~s~eA~DLI~rll 427 (550)
T KOG0605|consen 367 KECDWWSLGCIMYEMLVGYPPFCSETPQET--------YRKIVNW-----------RETLKFPEEVDLSDEAKDLITRLL 427 (550)
T ss_pred ccccHHHHHHHHHHHHhCCCCCCCCCHHHH--------HHHHHHH-----------hhhccCCCcCcccHHHHHHHHHHh
Confidence 999999999999999999999975543221 1111111 011111222244578899999999
Q ss_pred cCCCCCCCC---HHHHH
Q 043524 288 NESPIDRPT---MVDVA 301 (314)
Q Consensus 288 ~~dp~~Rps---~~ell 301 (314)
. ||++|.- +.||.
T Consensus 428 ~-d~~~RLG~~G~~EIK 443 (550)
T KOG0605|consen 428 C-DPENRLGSKGAEEIK 443 (550)
T ss_pred c-CHHHhcCcccHHHHh
Confidence 9 9999985 55554
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=297.51 Aligned_cols=271 Identities=20% Similarity=0.270 Sum_probs=197.1
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
|.....+|.|+ +.|+++.+..+++.+|+|++....... ...+.+.+|+.+++.++||||+++++++..+
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~----------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 72 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE----------EVKETTLRELKMLRTLKQENIVELKEAFRRR 72 (287)
T ss_pred ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccc----------cchhhHHHHHHHHHhCCCccccchhhhEecC
Confidence 33445578887 788888888899999999886432111 1125678999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~df 172 (314)
+..|+||||++++.+..+.. .. ..++...+..++.|++.||.||| +.+++|+||||+||+++.++.++|+||
T Consensus 73 ~~~~lv~e~~~~~~l~~~~~-~~----~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Df 144 (287)
T cd07848 73 GKLYLVFEYVEKNMLELLEE-MP----NGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDF 144 (287)
T ss_pred CEEEEEEecCCCCHHHHHHh-cC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeec
Confidence 99999999998876654433 22 34788899999999999999999 999999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccc------cchH-HH
Q 043524 173 SLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLV------YPFN-EY 245 (314)
Q Consensus 173 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~------~~~~-~~ 245 (314)
|+++..............|++.|+|||++.+..++.++|+||+||++|+|++|+.||.......... .+.. ..
T Consensus 145 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 224 (287)
T cd07848 145 GFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQ 224 (287)
T ss_pred cCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHH
Confidence 9997764433222334568999999999988889999999999999999999999997543221100 0000 00
Q ss_pred HHhhhccCCcccccChhhhccCC--chhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 246 LKNYFEDNRFTEIVDPIIVQDLS--CTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
...............+....... .......+..+.+|+.+||+.||++|||++|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 225 MKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred HHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11111111111110000000000 0001124567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=302.33 Aligned_cols=243 Identities=18% Similarity=0.294 Sum_probs=193.2
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeEE
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAIL 97 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i 97 (314)
.+|+|+ +.|+++.+..+|+.||+|++.......... ...+.+|++++..++||||+++++++...+..|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~---------~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~l 72 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE---------VAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 72 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHH---------HHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEE
Confidence 367777 888888888899999999998754322111 1456789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccccee
Q 043524 98 VFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSIS 177 (314)
Q Consensus 98 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~ 177 (314)
||||+++|+|...+.... .++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+|||+++.
T Consensus 73 v~E~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~ 144 (323)
T cd05595 73 VMEYANGGELFFHLSRER-----VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKE 144 (323)
T ss_pred EEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhcc
Confidence 999999999988886542 4788999999999999999999 99999999999999999999999999999865
Q ss_pred cCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCccc
Q 043524 178 IPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTE 257 (314)
Q Consensus 178 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (314)
..... .......||+.|+|||++.+..++.++||||+||++|+|++|..||....... .......
T Consensus 145 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~--------~~~~~~~------ 209 (323)
T cd05595 145 GISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--------LFELILM------ 209 (323)
T ss_pred ccCCC-CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH--------HHHHHhc------
Confidence 32221 12334578999999999988889999999999999999999999986432111 0011000
Q ss_pred ccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCC-----CHHHHHH
Q 043524 258 IVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRP-----TMVDVAR 302 (314)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 302 (314)
.....+ ...+..+.+|+..||+.||++|| ++.++++
T Consensus 210 -------~~~~~p--~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 210 -------EEIRFP--RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred -------CCCCCC--CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 000000 13446688999999999999998 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=292.67 Aligned_cols=254 Identities=17% Similarity=0.202 Sum_probs=193.8
Q ss_pred CcccccccCch-hHHHHHHHh---cCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEE
Q 043524 14 GKRTLMIGNGA-SVLQELIAS---SNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCC 89 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~---~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 89 (314)
++-...+|+|+ +.|+.+... ..+..+|+|.+........ .+.+.+|+.++..++||||+++++++
T Consensus 7 ~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~iv~~~~~~ 75 (266)
T cd05064 7 IKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQ-----------RRGFLAEALTLGQFDHSNIVRLEGVI 75 (266)
T ss_pred eEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHH-----------HHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence 33444588887 666655332 4556899998764321111 15688999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEE
Q 043524 90 LETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKL 169 (314)
Q Consensus 90 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl 169 (314)
..++..++||||+++|+|.+++.... ..+++..++.++.|++.||+||| +++++||||||+||+++.++.+++
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l 148 (266)
T cd05064 76 TRGNTMMIVTEYMSNGALDSFLRKHE----GQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKI 148 (266)
T ss_pred ecCCCcEEEEEeCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEE
Confidence 99999999999999999999887643 35788999999999999999999 999999999999999999999999
Q ss_pred cccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHh
Q 043524 170 FDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKN 248 (314)
Q Consensus 170 ~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 248 (314)
+|||.+...............++..|+|||.+....++.++||||+||++|++++ |..||...... +....
T Consensus 149 ~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--------~~~~~ 220 (266)
T cd05064 149 SGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--------DVIKA 220 (266)
T ss_pred CCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHH
Confidence 9999875532222111222345678999999988889999999999999999775 99998643221 11111
Q ss_pred hhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHH
Q 043524 249 YFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQI 307 (314)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~ 307 (314)
.. ... ..+.+..++..+.+++.+||+.+|++|||+.+|++.|.++
T Consensus 221 ~~-~~~-------------~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 221 VE-DGF-------------RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HH-CCC-------------CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 10 000 0011123456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=302.23 Aligned_cols=253 Identities=17% Similarity=0.191 Sum_probs=200.0
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
|.....+|.|+ +.|+.+.+..+|+.||+|++.......... .+.+.+|+.++..++||||+++++++..+
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~---------~~~~~~e~~~l~~~~h~~iv~~~~~~~~~ 73 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNE---------VRHVLTERDILTTTKSEWLVKLLYAFQDD 73 (333)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhH---------HHHHHHHHHHHHhCCCCCCccEEEEEEcC
Confidence 34455688888 888888888899999999998765432211 15678999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~df 172 (314)
+..|+||||+++|+|.+++.... .++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+||
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Df 145 (333)
T cd05600 74 EYLYLAMEYVPGGDFRTLLNNLG-----VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDF 145 (333)
T ss_pred CEEEEEEeCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeC
Confidence 99999999999999999986543 4788889999999999999999 999999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhcc
Q 043524 173 SLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFED 252 (314)
Q Consensus 173 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (314)
|+++.... ......||+.|+|||++.+..++.++||||+||++|+|++|..||......+ ........
T Consensus 146 g~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--------~~~~i~~~ 213 (333)
T cd05600 146 GLSKGIVT----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE--------TWENLKYW 213 (333)
T ss_pred cCCccccc----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH--------HHHHHHhc
Confidence 99876533 2345678999999999998899999999999999999999999996433211 11111000
Q ss_pred CCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 253 NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
..... .+.........+.++.+|+.+||..+|.+|||+.++++
T Consensus 214 ---~~~~~----~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~ 256 (333)
T cd05600 214 ---KETLQ----RPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKN 256 (333)
T ss_pred ---ccccc----CCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHh
Confidence 00000 00000000134567899999999999999999999986
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=293.42 Aligned_cols=250 Identities=20% Similarity=0.296 Sum_probs=194.9
Q ss_pred ccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeEEE
Q 043524 20 IGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILV 98 (314)
Q Consensus 20 ~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~iv 98 (314)
+|.|+ +.|+.+.+..+|+.+|+|.+......... ..+.+..|+++++.++|+||+++.+++..+...|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~---------~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv 71 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRK---------GYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLV 71 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhH---------HHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEE
Confidence 47777 78888888889999999998876543321 125678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccceec
Q 043524 99 FEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISI 178 (314)
Q Consensus 99 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~ 178 (314)
|||+++|+|.+.+...... ...++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+|||.+...
T Consensus 72 ~e~~~~g~L~~~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 147 (280)
T cd05608 72 MTIMNGGDLRYHIYNVDEE-NPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVEL 147 (280)
T ss_pred EeCCCCCCHHHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceec
Confidence 9999999998877542211 135788999999999999999999 999999999999999999999999999999765
Q ss_pred CCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcccc
Q 043524 179 PEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEI 258 (314)
Q Consensus 179 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (314)
..... ......||+.|+|||++.+..++.++|+||+|+++|+|++|+.||........ ......
T Consensus 148 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~----~~~~~~----------- 211 (280)
T cd05608 148 KDGQS-KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE----NKELKQ----------- 211 (280)
T ss_pred CCCCc-cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh----HHHHHH-----------
Confidence 44322 23345789999999999998999999999999999999999999964332110 000000
Q ss_pred cChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCC-----CHHHHHH
Q 043524 259 VDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRP-----TMVDVAR 302 (314)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 302 (314)
.....+. ..+...+..+.+++.+||+.||++|| |++++++
T Consensus 212 --~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 212 --RILNDSV--TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred --hhcccCC--CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 0000110 11113456789999999999999999 6777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=289.19 Aligned_cols=269 Identities=18% Similarity=0.215 Sum_probs=199.1
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHH--HHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQ--ELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGC 88 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~--~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 88 (314)
+++.....+|.|+ ++|..+.+..+|+.||+|.+... ....+ ++..+|+++|+.++|+|||.+.++
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~a------------kRtlRElklLr~~~HeNIi~l~di 89 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDA------------KRTLRELKLLRHLRHENIIGLLDI 89 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHH------------HHHHHHHHHHHHhcCCCcceEEee
Confidence 3344456799999 88889999999999999987722 22112 567899999999999999999999
Q ss_pred EEe-----CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecC
Q 043524 89 CLE-----TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSE 163 (314)
Q Consensus 89 ~~~-----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~ 163 (314)
+.. -+.+|+|+|+| +.+|...++... .+....+...++|++.||.|+| +-+|+||||||.|++++.
T Consensus 90 ~~p~~~~~f~DvYiV~elM-etDL~~iik~~~-----~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~ 160 (359)
T KOG0660|consen 90 FRPPSRDKFNDVYLVFELM-ETDLHQIIKSQQ-----DLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNA 160 (359)
T ss_pred cccccccccceeEEehhHH-hhHHHHHHHcCc-----cccHHHHHHHHHHHHHhcchhh---cccccccccchhheeecc
Confidence 875 45689999999 569999887753 4888899999999999999999 999999999999999999
Q ss_pred CCceEEcccccceecCCCC-cccccccccccccccCcccccC-CCCcccchHHHHHHHHHHHhCCCCcccccCcccc---
Q 043524 164 ENVVKLFDFSLSISIPEGE-THITDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDL--- 238 (314)
Q Consensus 164 ~~~~kl~dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~--- 238 (314)
+..+||+|||+|+...... .......+.|.+|.|||++... .|+...||||.||++.||++|++.|.+....+..
T Consensus 161 ~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI 240 (359)
T KOG0660|consen 161 DCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLI 240 (359)
T ss_pred CCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHH
Confidence 9999999999999875431 1113455789999999988654 5999999999999999999999999754432211
Q ss_pred ---ccchHHHHHhhhccCCcccccChh---hhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 239 ---VYPFNEYLKNYFEDNRFTEIVDPI---IVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 239 ---~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.+...+..............+... ...++. ..-+..+..+.+|+.+||..||.+|+|++|.|+
T Consensus 241 ~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~-~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 241 LELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFS-SIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHH-HHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 111111111111111111111100 000000 011144567899999999999999999999986
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=275.69 Aligned_cols=261 Identities=19% Similarity=0.277 Sum_probs=202.6
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
+|+....+|+|| +-|+......+++.||+|.+.....+.. +..++|++..+.++|||+++++++...
T Consensus 22 Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~------------e~~~rEid~~rkf~s~~vl~l~dh~l~ 89 (302)
T KOG2345|consen 22 RYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDI------------EEALREIDNHRKFNSPNVLRLVDHQLR 89 (302)
T ss_pred eEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHH------------HHHHHHHHHHHhhCCcchHHHHHHHHH
Confidence 444555688888 7777777888999999999887764433 567899999999999999999988764
Q ss_pred C-----CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCC--ceeccCCCCCeeecCC
Q 043524 92 T-----PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRP--IVFRDFKTSHILFSEE 164 (314)
Q Consensus 92 ~-----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~--i~H~dlk~~nil~~~~ 164 (314)
+ ...|++++|...|+|.+.+......+ ..++..+++.++.+++.||.+|| +.. +.||||||.||+++..
T Consensus 90 ~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg-~~~sE~~iL~if~gic~gL~~lH---~~~~~yAH~DiKP~NILls~~ 165 (302)
T KOG2345|consen 90 EEKDGKHEAYLLLPYYKRGSLLDEIERLKIKG-NFVSEAQILWIFLGICRGLEALH---EKEPPYAHRDIKPANILLSDS 165 (302)
T ss_pred hhccCceeEEEEeehhccccHHHHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHHh---ccCCcccccCCCcceeEecCC
Confidence 3 34899999999999999987643321 35889999999999999999999 777 9999999999999999
Q ss_pred CceEEcccccceecCCCCccc--------ccccccccccccCcccc---cCCCCcccchHHHHHHHHHHHhCCCCccccc
Q 043524 165 NVVKLFDFSLSISIPEGETHI--------TDTVMGTYGHLAPQYVT---TCDFSEKLDVYSFGAFLSELLTGRGILDLVR 233 (314)
Q Consensus 165 ~~~kl~dfg~~~~~~~~~~~~--------~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 233 (314)
+.+++.|||.+...+..-... -..-..|..|.|||++. +...+.++|||||||++|.|+.|..||+..-
T Consensus 166 ~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~ 245 (302)
T KOG2345|consen 166 GLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY 245 (302)
T ss_pred CceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh
Confidence 999999999987654321000 00125689999999885 3447899999999999999999999997432
Q ss_pred CccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHH
Q 043524 234 DAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQIC 308 (314)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~ 308 (314)
... ++...-+.. +....+.....++.+.++++.||+.||.+||++.+++..++++.
T Consensus 246 ~~G---------------gSlaLAv~n----~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 246 QQG---------------GSLALAVQN----AQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred hcC---------------CeEEEeeec----cccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 211 011111122 22223333357788999999999999999999999999998874
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=290.31 Aligned_cols=249 Identities=19% Similarity=0.309 Sum_probs=197.2
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeE
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAI 96 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (314)
..+|.|+ +.|+++....+++.+|+|.+...... .+.+.+|+++++.++|+||+++++++..++.++
T Consensus 12 ~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~-------------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (263)
T cd05052 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-------------VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 78 (263)
T ss_pred eecCCcccceEEEEEEecCCceEEEEEecCCchH-------------HHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence 4578777 78888888888999999987643221 146789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
++|||+++++|.+.+..... ..++...++.++.|++.||+||| +++++|+||||+||+++.++.++|+|||.+.
T Consensus 79 lv~e~~~~~~L~~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~ 152 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNR---QEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSR 152 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCcccc
Confidence 99999999999999865432 34788889999999999999999 9999999999999999999999999999987
Q ss_pred ecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhccCCc
Q 043524 177 SIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFEDNRF 255 (314)
Q Consensus 177 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (314)
..............++..|+|||.+.+..++.++||||||+++|+|++ |..||...... +........ .
T Consensus 153 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--------~~~~~~~~~--~ 222 (263)
T cd05052 153 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------QVYELLEKG--Y 222 (263)
T ss_pred ccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHHCC--C
Confidence 664433222223344678999999988889999999999999999998 88888643211 111111000 0
Q ss_pred ccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHH
Q 043524 256 TEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQI 307 (314)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~ 307 (314)
....+...+.++.+++.+||..||++|||+.++++.|+++
T Consensus 223 ------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 223 ------------RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0001113456789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=299.30 Aligned_cols=269 Identities=20% Similarity=0.261 Sum_probs=193.8
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
+|.....+|.|+ +.|+.+.+..+|+.+|+|++........ ...+.+|+.+++.++||||+++++++.+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (303)
T cd07869 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-----------PFTAIREASLLKGLKHANIVLLHDIIHT 74 (303)
T ss_pred cceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccccc-----------chhHHHHHHHHhhCCCCCcCeEEEEEec
Confidence 444555688888 8888888888999999999864321110 1356789999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
+...|+||||++ ++|.+.+.... ..++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+|
T Consensus 75 ~~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~D 146 (303)
T cd07869 75 KETLTLVFEYVH-TDLCQYMDKHP----GGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLAD 146 (303)
T ss_pred CCeEEEEEECCC-cCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECC
Confidence 999999999995 68888886543 34788889999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCcccccC-CCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhh
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
||+++...... .......+++.|+|||++.+. .++.++||||+||++|+|++|..||....+..+........... .
T Consensus 147 fg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~ 224 (303)
T cd07869 147 FGLARAKSVPS-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGT-P 224 (303)
T ss_pred CCcceeccCCC-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCC-C
Confidence 99987543222 112345688999999988754 47889999999999999999999997543321100000000000 0
Q ss_pred ccCCccc-----ccCh-hhh--ccCCch---hHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 251 EDNRFTE-----IVDP-IIV--QDLSCT---EKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 251 ~~~~~~~-----~~~~-~~~--~~~~~~---~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
....+.. ...+ ... .+.... .....+..+.+|+..||+.||++|||+.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 225 NEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000000 0000 000 000000 00012356789999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=304.04 Aligned_cols=260 Identities=19% Similarity=0.347 Sum_probs=194.5
Q ss_pred CcccccccCch-hHHHHHHHh-----cCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeE
Q 043524 14 GKRTLMIGNGA-SVLQELIAS-----SNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLI 86 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~-----~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~ 86 (314)
+.-...+|.|+ +.|+++.+. .++..||+|.+........ .+.+.+|+++++.+ +|+|||+++
T Consensus 40 ~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~E~~il~~l~~h~nIv~~~ 108 (374)
T cd05106 40 LQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDE-----------REALMSELKILSHLGQHKNIVNLL 108 (374)
T ss_pred ceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHH-----------HHHHHHHHHHHHhhccCCceeeEe
Confidence 33445588888 677666533 3345799998864322111 15678999999999 899999999
Q ss_pred eEEEeCCeeEEEEeecCCCCHHHHHhcCCC--------------------------------------------------
Q 043524 87 GCCLETPIAILVFEYVQHGTLWDRILGAPQ-------------------------------------------------- 116 (314)
Q Consensus 87 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~-------------------------------------------------- 116 (314)
+++..+...++|||||++|+|.+++.....
T Consensus 109 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (374)
T cd05106 109 GACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS 188 (374)
T ss_pred eEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence 999999999999999999999998854211
Q ss_pred ---------------CCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccceecCCC
Q 043524 117 ---------------THFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEG 181 (314)
Q Consensus 117 ---------------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~ 181 (314)
....+++...++.++.|++.||.||| +++|+||||||+||+++.++.++|+|||+++.....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~ 265 (374)
T cd05106 189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265 (374)
T ss_pred ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCC
Confidence 00124677888999999999999999 999999999999999999999999999998765332
Q ss_pred Ccc-cccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhccCCccccc
Q 043524 182 ETH-ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIV 259 (314)
Q Consensus 182 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (314)
... ......++..|+|||++....++.++||||+||++|+|++ |..||........ +... .... .
T Consensus 266 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~----~~~~----~~~~-~---- 332 (374)
T cd05106 266 SNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK----FYKM----VKRG-Y---- 332 (374)
T ss_pred cceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH----HHHH----HHcc-c----
Confidence 211 1222345678999999988889999999999999999997 9999864332110 0000 0000 0
Q ss_pred ChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHH
Q 043524 260 DPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQIC 308 (314)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~ 308 (314)
....+...+.++.+++.+||+.||++|||+.++++.|+++.
T Consensus 333 --------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 333 --------QMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred --------CccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 00000122456889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=293.51 Aligned_cols=263 Identities=19% Similarity=0.313 Sum_probs=190.9
Q ss_pred CcccccccCch-hHHHHHHH----------------hcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhc
Q 043524 14 GKRTLMIGNGA-SVLQELIA----------------SSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQ 76 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~----------------~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 76 (314)
++....+|.|+ +.|+.+.. ..++..||+|++........ ...+.+|++++..
T Consensus 7 ~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~~E~~~l~~ 75 (304)
T cd05096 7 LLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNA-----------RNDFLKEVKILSR 75 (304)
T ss_pred CeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHH-----------HHHHHHHHHHHhh
Confidence 33344588888 66665532 23445799998765322111 1568899999999
Q ss_pred CCCCceeeeEeEEEeCCeeEEEEeecCCCCHHHHHhcCCC--------------CCCCcccHHHHHHHHHHHHHHHHHhh
Q 043524 77 MSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQ--------------THFEPLLLKRRLKDAVDAANALAYLH 142 (314)
Q Consensus 77 l~h~niv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~--------------~~~~~l~~~~~~~~~~~i~~~l~~lH 142 (314)
++||||+++++++.+.+..+++|||+++|+|.+++..... .....+++..+..++.|++.||.|||
T Consensus 76 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH 155 (304)
T cd05096 76 LKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS 155 (304)
T ss_pred cCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999998865321 11123677888999999999999999
Q ss_pred cCCCCCceeccCCCCCeeecCCCceEEcccccceecCCCCc-ccccccccccccccCcccccCCCCcccchHHHHHHHHH
Q 043524 143 FGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGET-HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSE 221 (314)
Q Consensus 143 ~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~e 221 (314)
+++|+|+||||+||+++.++.++|+|||+++....... .......++..|+|||++....++.++||||||+++|+
T Consensus 156 ---~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~e 232 (304)
T cd05096 156 ---SLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWE 232 (304)
T ss_pred ---HCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHH
Confidence 99999999999999999999999999999976533321 11223456788999999988889999999999999999
Q ss_pred HHh--CCCCcccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHH
Q 043524 222 LLT--GRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVD 299 (314)
Q Consensus 222 l~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~e 299 (314)
|++ +..||....... ........+.... .... ...+ ..++..+.+|+.+||..||++|||+.|
T Consensus 233 l~~~~~~~p~~~~~~~~-----~~~~~~~~~~~~~-~~~~---~~~~------~~~~~~~~~li~~cl~~~p~~RPs~~~ 297 (304)
T cd05096 233 ILMLCKEQPYGELTDEQ-----VIENAGEFFRDQG-RQVY---LFRP------PPCPQGLYELMLQCWSRDCRERPSFSD 297 (304)
T ss_pred HHHccCCCCCCcCCHHH-----HHHHHHHHhhhcc-cccc---ccCC------CCCCHHHHHHHHHHccCCchhCcCHHH
Confidence 987 456665433211 1111111111000 0000 0000 123456899999999999999999999
Q ss_pred HHHHHH
Q 043524 300 VARRLR 305 (314)
Q Consensus 300 ll~~L~ 305 (314)
|.+.|+
T Consensus 298 i~~~l~ 303 (304)
T cd05096 298 IHAFLT 303 (304)
T ss_pred HHHHHh
Confidence 998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=287.59 Aligned_cols=248 Identities=23% Similarity=0.312 Sum_probs=204.7
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeEE
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAIL 97 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i 97 (314)
.+|.|. +.||++....++..+|+|++.+..+...++- .++..|-++|..++||.++.+|..++++...|+
T Consensus 84 ~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl---------~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 84 RLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKL---------KRAQTEREILSLLDHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred HcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHH---------HHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence 389888 8999998888889999999999887654322 667889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccccee
Q 043524 98 VFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSIS 177 (314)
Q Consensus 98 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~ 177 (314)
+||||+||+|....+.++. ..++...++.++.+++.||+||| -.|||.|||||+|||+-.+|.+.|+||-++..
T Consensus 155 ~meyCpGGdL~~LrqkQp~---~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQPG---KRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred EEecCCCccHHHHHhhCCC---CccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeecccccc
Confidence 9999999999988877665 56889999999999999999999 99999999999999999999999999987543
Q ss_pred cCC---------------------------------C-C---------------------cccccccccccccccCcccc
Q 043524 178 IPE---------------------------------G-E---------------------THITDTVMGTYGHLAPQYVT 202 (314)
Q Consensus 178 ~~~---------------------------------~-~---------------------~~~~~~~~g~~~y~aPE~~~ 202 (314)
... . . ......++||..|+|||++.
T Consensus 229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~ 308 (459)
T KOG0610|consen 229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR 308 (459)
T ss_pred CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence 210 0 0 01123568999999999999
Q ss_pred cCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHH
Q 043524 203 TCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQL 282 (314)
Q Consensus 203 ~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 282 (314)
+...+.++|.|+|||++|||+.|..||.+..+.+.. . .++..+...+.....+..++||
T Consensus 309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl----~-----------------NIv~~~l~Fp~~~~vs~~akDL 367 (459)
T KOG0610|consen 309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETL----R-----------------NIVGQPLKFPEEPEVSSAAKDL 367 (459)
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhH----H-----------------HHhcCCCcCCCCCcchhHHHHH
Confidence 999999999999999999999999999876654421 1 1222222223223566789999
Q ss_pred HhHhccCCCCCCCC----HHHHHH
Q 043524 283 TFECLNESPIDRPT----MVDVAR 302 (314)
Q Consensus 283 i~~cl~~dp~~Rps----~~ell~ 302 (314)
|+..|.+||.+|.. |.||.+
T Consensus 368 Ir~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 368 IRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred HHHHhccChhhhhccccchHHhhc
Confidence 99999999999997 777754
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=303.42 Aligned_cols=260 Identities=18% Similarity=0.318 Sum_probs=194.8
Q ss_pred cCcccccccCch-hHHHHHH-----HhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeee
Q 043524 13 KGKRTLMIGNGA-SVLQELI-----ASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKL 85 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~-----~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~ 85 (314)
++.....+|.|+ +.|+++. +..++..||+|++........ .+.+.+|+.++..+ +||||+++
T Consensus 36 ~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~-----------~~~~~~Ei~il~~l~~HpnIv~l 104 (375)
T cd05104 36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTE-----------REALMSELKVLSYLGNHINIVNL 104 (375)
T ss_pred HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHH-----------HHHHHHHHHHHHHhcCCcceeee
Confidence 445556688888 6665442 345667899998864321111 15678999999999 89999999
Q ss_pred EeEEEeCCeeEEEEeecCCCCHHHHHhcCCCC------------------------------------------------
Q 043524 86 IGCCLETPIAILVFEYVQHGTLWDRILGAPQT------------------------------------------------ 117 (314)
Q Consensus 86 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~------------------------------------------------ 117 (314)
++++..++..++|||||++|+|.+++......
T Consensus 105 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 184 (375)
T cd05104 105 LGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKAD 184 (375)
T ss_pred eeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccc
Confidence 99999999999999999999999988653210
Q ss_pred ----------------------CCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 118 ----------------------HFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 118 ----------------------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
....+++..+..++.|++.||.||| +++|+||||||+||+++.++.++|+|||++
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a 261 (375)
T cd05104 185 KRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLA 261 (375)
T ss_pred cccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccc
Confidence 0014677888999999999999999 999999999999999999999999999999
Q ss_pred eecCCCCccc-ccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhccC
Q 043524 176 ISIPEGETHI-TDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFEDN 253 (314)
Q Consensus 176 ~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (314)
+......... .....++..|+|||++....++.++||||||+++|+|++ |..||....... .... .....
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-------~~~~-~~~~~ 333 (375)
T cd05104 262 RDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-------KFYK-MIKEG 333 (375)
T ss_pred eeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-------HHHH-HHHhC
Confidence 7654332111 122345677999999998889999999999999999998 888886433211 0111 11110
Q ss_pred CcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHH
Q 043524 254 RFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQI 307 (314)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~ 307 (314)
. . ...+...+.++.+|+..||+.||++|||+.|+++.|++.
T Consensus 334 ~-~------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 334 Y-R------------MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred c-c------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0 0 000012245688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=301.69 Aligned_cols=263 Identities=16% Similarity=0.110 Sum_probs=193.8
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
+|.....+|.|+ +.|+++.+..+++.||+|.... +.+.+|+++++.++|||||++++++..
T Consensus 93 ~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------------------~~~~~E~~il~~l~HpnIv~~~~~~~~ 154 (391)
T PHA03212 93 GFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------------------GGTATEAHILRAINHPSIIQLKGTFTY 154 (391)
T ss_pred CcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------------------hhhHHHHHHHHhCCCCCCCCEeEEEEE
Confidence 455556688888 8888999999999999995431 235689999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
+...++++|++. ++|...+.... .++...++.++.|++.||.||| +++|+||||||+||+++..+.++|+|
T Consensus 155 ~~~~~lv~e~~~-~~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~D 225 (391)
T PHA03212 155 NKFTCLILPRYK-TDLYCYLAAKR-----NIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGD 225 (391)
T ss_pred CCeeEEEEecCC-CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEe
Confidence 999999999995 68988886542 4788899999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCcccc---ccchHHHHHh
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDL---VYPFNEYLKN 248 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~---~~~~~~~~~~ 248 (314)
||+++..............||+.|+|||++.+..++.++||||+||++|+|++|..||......... ...+......
T Consensus 226 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~ 305 (391)
T PHA03212 226 FGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRR 305 (391)
T ss_pred CCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHH
Confidence 9998654332222233457999999999999888999999999999999999999876432211100 0000000000
Q ss_pred hhcc-CC--------ccccc----ChhhhccC---CchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 249 YFED-NR--------FTEIV----DPIIVQDL---SCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 249 ~~~~-~~--------~~~~~----~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.-.. .. ..... ......+. ........+.++.+|+.+||+.||++||||.|+++
T Consensus 306 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 306 SGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000 00 00000 00000000 01111234667899999999999999999999985
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=304.92 Aligned_cols=253 Identities=18% Similarity=0.244 Sum_probs=197.7
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
.+.....+|.|+ +.|+++.+..+|+.+|+|++.......... .+.+.+|+.++..++||||+++++++.+
T Consensus 44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~---------~~~~~~e~~il~~~~h~~iv~~~~~~~~ 114 (370)
T cd05596 44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSD---------SAFFWEERDIMAHANSEWIVQLHYAFQD 114 (370)
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhh---------HHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 445556688888 888888888899999999997654332211 1456789999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
++..|+||||+++|+|.+++... .++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+|
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~D 185 (370)
T cd05596 115 DKYLYMVMEYMPGGDLVNLMSNY------DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLAD 185 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEe
Confidence 99999999999999999988653 3677888889999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCcccccC----CCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHH
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTTC----DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLK 247 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (314)
||++...............||+.|+|||++... .++.++||||+||++|+|++|..||...... ....
T Consensus 186 fG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--------~~~~ 257 (370)
T cd05596 186 FGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--------GTYS 257 (370)
T ss_pred ccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH--------HHHH
Confidence 999976644332223456799999999988653 3788999999999999999999999643311 1111
Q ss_pred hhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCC--CCCHHHHHH
Q 043524 248 NYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPID--RPTMVDVAR 302 (314)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~--Rps~~ell~ 302 (314)
....... ....+.....+.++.+|+..||..+|++ |||+.|+++
T Consensus 258 ~i~~~~~-----------~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 258 KIMDHKN-----------SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred HHHcCCC-----------cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 1111100 0001111134567899999999999998 999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=290.29 Aligned_cols=254 Identities=22% Similarity=0.341 Sum_probs=194.3
Q ss_pred cccccCch-hHHHHHHHhcCC-----cccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 17 TLMIGNGA-SVLQELIASSNG-----KYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g-----~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
...+|.|+ +.|+.+.....+ ..+|+|.+....... ..+++.+|+.++..++||||+++++++.
T Consensus 10 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~-----------~~~~~~~ei~~l~~l~h~~i~~~~~~~~ 78 (283)
T cd05048 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPK-----------VQQEFRQEAELMSDLQHPNIVCLLGVCT 78 (283)
T ss_pred hhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHH-----------HHHHHHHHHHHHHhcCCcccceEEEEEc
Confidence 34478777 677666544333 578888775332111 1256889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCC-----------CcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCe
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHF-----------EPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHI 159 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~-----------~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~ni 159 (314)
.....|+++||+++|+|.+++........ ..++...+..++.|++.||.||| +++++|+||||+||
T Consensus 79 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Ni 155 (283)
T cd05048 79 KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNC 155 (283)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceE
Confidence 99999999999999999999876432111 34778889999999999999999 99999999999999
Q ss_pred eecCCCceEEcccccceecCCCCc-ccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccc
Q 043524 160 LFSEENVVKLFDFSLSISIPEGET-HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHD 237 (314)
Q Consensus 160 l~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~ 237 (314)
+++.++.++|+|||+++....... .......+++.|+|||.+....++.++|||||||++|||++ |..||.......
T Consensus 156 l~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~- 234 (283)
T cd05048 156 LVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE- 234 (283)
T ss_pred EEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH-
Confidence 999999999999999876533221 11233456788999999988889999999999999999998 999986433211
Q ss_pred cccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHH
Q 043524 238 LVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQ 306 (314)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 306 (314)
.... ... +.. ...+..++.++.+|+..||+.||++|||+.||++.|++
T Consensus 235 -------~~~~-i~~------------~~~-~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 235 -------VIEM-IRS------------RQL-LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -------HHHH-HHc------------CCc-CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1110 000 000 01112456789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=292.25 Aligned_cols=251 Identities=20% Similarity=0.283 Sum_probs=197.1
Q ss_pred ccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCe
Q 043524 16 RTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPI 94 (314)
Q Consensus 16 ~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 94 (314)
....+|+|+ +.|+++....+|+.||+|++.......... ...+.+|+.+++.++||||+++++.+..++.
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 74 (285)
T cd05605 4 HYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG---------EAMALNEKQILEKVNSRFVVSLAYAYETKDA 74 (285)
T ss_pred EEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhh---------HHHHHHHHHHHHhcCCCCEeeeeeeecCCCe
Confidence 344578888 788888888889999999987765443221 1456789999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccc
Q 043524 95 AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL 174 (314)
Q Consensus 95 ~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~ 174 (314)
.|+||||+++|+|.+.+..... ..++...+..++.|++.||.||| +++++|+||||+||+++.++.++|+|||+
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~ 148 (285)
T cd05605 75 LCLVLTLMNGGDLKFHIYNMGN---PGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGL 148 (285)
T ss_pred EEEEEeccCCCcHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCC
Confidence 9999999999999988865432 35788999999999999999999 99999999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCC
Q 043524 175 SISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNR 254 (314)
Q Consensus 175 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (314)
+........ .....|++.|+|||++.+..++.++||||+|+++|+|++|..||....... ........ .
T Consensus 149 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~----~~~~~~~~-~---- 217 (285)
T cd05605 149 AVEIPEGET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV----KREEVERR-V---- 217 (285)
T ss_pred ceecCCCCc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh----HHHHHHHH-h----
Confidence 877543322 234578999999999988889999999999999999999999997433211 00000000 0
Q ss_pred cccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCC-----CHHHHHH
Q 043524 255 FTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRP-----TMVDVAR 302 (314)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 302 (314)
..... ..+...+..+.+|+..||..||++|| ++.+++.
T Consensus 218 --------~~~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 218 --------KEDQE--EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred --------hhccc--ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 00000 01113456788999999999999999 8888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=301.81 Aligned_cols=243 Identities=17% Similarity=0.292 Sum_probs=192.9
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeEE
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAIL 97 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i 97 (314)
.+|+|+ +.|+.+.+..+|+.+|+|++.......... ...+.+|++++..++||||+++.+++...+..|+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~---------~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~l 72 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE---------VAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 72 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhH---------HHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEE
Confidence 367777 888888888899999999998754322111 1456789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCC-CCceeccCCCCCeeecCCCceEEcccccce
Q 043524 98 VFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFP-RPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 98 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~-~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
||||+++|+|...+... ..++...+..++.|++.||.||| + ++|+||||||+||+++.++.++|+|||+++
T Consensus 73 v~E~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~ 144 (325)
T cd05594 73 VMEYANGGELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 144 (325)
T ss_pred EEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCe
Confidence 99999999998888654 24788899999999999999999 7 799999999999999999999999999987
Q ss_pred ecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcc
Q 043524 177 SIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFT 256 (314)
Q Consensus 177 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (314)
....... ......||+.|+|||++.+..++.++||||+||++|+|++|..||....... .......
T Consensus 145 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~--------~~~~i~~----- 210 (325)
T cd05594 145 EGIKDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--------LFELILM----- 210 (325)
T ss_pred ecCCCCc-ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH--------HHHHHhc-----
Confidence 5432221 1334569999999999988889999999999999999999999996432111 0010000
Q ss_pred cccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCC-----CHHHHHH
Q 043524 257 EIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRP-----TMVDVAR 302 (314)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 302 (314)
..... +...+.++.+|+..||+.||++|+ ++.++++
T Consensus 211 --------~~~~~--p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 211 --------EEIRF--PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred --------CCCCC--CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 00000 012345688999999999999997 8999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=298.91 Aligned_cols=238 Identities=19% Similarity=0.313 Sum_probs=189.5
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeEEEeCCeeE
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGCCLETPIAI 96 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 96 (314)
.+|.|+ +.|+.+....+|+.||+|++.......... .+.+..|..++..+ +||||+++++++.+.+.+|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~---------~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~ 72 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDD---------VECTMTEKRILSLARNHPFLTQLYCCFQTPDRLF 72 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccH---------HHHHHHHHHHHHhccCCCchhceeeEEEcCCEEE
Confidence 367787 888888888899999999998664322211 15567888888876 6999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
+||||+++|+|.+.+.... .++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+|||+++
T Consensus 73 iv~Ey~~~g~L~~~i~~~~-----~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~ 144 (320)
T cd05590 73 FVMEFVNGGDLMFHIQKSR-----RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK 144 (320)
T ss_pred EEEcCCCCchHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCe
Confidence 9999999999998886543 4788899999999999999999 9999999999999999999999999999987
Q ss_pred ecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcc
Q 043524 177 SIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFT 256 (314)
Q Consensus 177 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (314)
....... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||...... .........
T Consensus 145 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--------~~~~~i~~~---- 211 (320)
T cd05590 145 EGIFNGK-TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED--------DLFEAILND---- 211 (320)
T ss_pred ecCcCCC-cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--------HHHHHHhcC----
Confidence 5432221 233457899999999999888999999999999999999999999643321 111111110
Q ss_pred cccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCH
Q 043524 257 EIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTM 297 (314)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 297 (314)
.... +...+.++.+++..||+.||++||++
T Consensus 212 ---------~~~~--~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 212 ---------EVVY--PTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred ---------CCCC--CCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 0000 01234568899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=311.65 Aligned_cols=251 Identities=20% Similarity=0.206 Sum_probs=194.8
Q ss_pred CcccccccCch-hHHHHHHHhcC-CcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 14 GKRTLMIGNGA-SVLQELIASSN-GKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~-g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
|.....+|.|+ +.|+.+.+..+ ++.+|+|.+...+.... ..+.+|+.++..++|||||++++++..
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~------------~~~~~E~~~l~~l~Hpniv~~~~~~~~ 136 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQA------------AYARSELHCLAACDHFGIVKHFDDFKS 136 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHH------------HHHHHHHHHHHhCCCCCEeEEEEEEEE
Confidence 44555678877 77777777777 67888887644332221 456789999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
++..|+||||+++|+|.+.+...... ..+++...+..++.|++.||.||| +++|+||||||+||+++..+.++|+|
T Consensus 137 ~~~~~lv~E~~~gg~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~D 212 (478)
T PTZ00267 137 DDKLLLIMEYGSGGDLNKQIKQRLKE-HLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGD 212 (478)
T ss_pred CCEEEEEEECCCCCCHHHHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEe
Confidence 99999999999999999877542211 135788889999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCc-ccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhh
Q 043524 172 FSLSISIPEGET-HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 172 fg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
||+++....... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||...... +......
T Consensus 213 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~--------~~~~~~~ 284 (478)
T PTZ00267 213 FGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR--------EIMQQVL 284 (478)
T ss_pred CcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHH
Confidence 999987643321 1234456999999999998888999999999999999999999998643211 1111111
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.+... +.+...+..+.+++..||..||++|||+.+++.
T Consensus 285 -------------~~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 285 -------------YGKYD-PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -------------hCCCC-CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 11100 001134466899999999999999999999875
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=297.69 Aligned_cols=196 Identities=19% Similarity=0.286 Sum_probs=165.8
Q ss_pred cccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCC
Q 043524 15 KRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETP 93 (314)
Q Consensus 15 ~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (314)
.....+|.|+ +.|+++.+..+|..+|+|.+....... ..+.+.+|++++..++||||+++++++.+++
T Consensus 8 ~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (333)
T cd06650 8 EKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPA-----------IRNQIIRELQVLHECNSPYIVGFYGAFYSDG 76 (333)
T ss_pred heeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHH-----------HHHHHHHHHHHHHHCCCCcccceeEEEEECC
Confidence 3344578877 888888888899999999876532111 1156889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCC-CceeccCCCCCeeecCCCceEEccc
Q 043524 94 IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPR-PIVFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 94 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~-~i~H~dlk~~nil~~~~~~~kl~df 172 (314)
..|+||||+++|+|.+++.... .++...+..++.+++.||.||| ++ +++|+||||+||+++.++.++|+||
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~Df 148 (333)
T cd06650 77 EISICMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDF 148 (333)
T ss_pred EEEEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEeeC
Confidence 9999999999999999987643 4778888999999999999999 64 7999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccc
Q 043524 173 SLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLV 232 (314)
Q Consensus 173 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 232 (314)
|++....... .....|+..|+|||++.+..++.++|+||+||++|+|++|+.||...
T Consensus 149 g~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 149 GVSGQLIDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred Ccchhhhhhc---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 9986543221 23456899999999998888999999999999999999999999643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=300.86 Aligned_cols=246 Identities=16% Similarity=0.225 Sum_probs=194.2
Q ss_pred cCcccccccCch-hHHHHHHHhcCC-cccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNG-KYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g-~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+.....+|.|+ +.|+++....++ ..+|+|.+.......... .+.+.+|+.++..++||||+++++++.
T Consensus 31 ~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~---------~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 101 (340)
T PTZ00426 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQ---------VDHVFSERKILNYINHPFCVNLYGSFK 101 (340)
T ss_pred hcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhh---------HHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence 344455688888 777777644444 689999987765432211 156789999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
+++..|+||||+++|+|.+++.... .++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+
T Consensus 102 ~~~~~~lv~Ey~~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~ 173 (340)
T PTZ00426 102 DESYLYLVLEFVIGGEFFTFLRRNK-----RFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMT 173 (340)
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEe
Confidence 9999999999999999999987643 4788889999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhh
Q 043524 171 DFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 171 dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
|||+++..... .....||+.|+|||++.+..++.++|+||+||++|+|++|..||....... ......
T Consensus 174 DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~--------~~~~i~ 241 (340)
T PTZ00426 174 DFGFAKVVDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL--------IYQKIL 241 (340)
T ss_pred cCCCCeecCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH--------HHHHHh
Confidence 99999765332 235578999999999988889999999999999999999999996433210 011111
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCC-----CHHHHHH
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRP-----TMVDVAR 302 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 302 (314)
.. .... +...+..+.+++.+||+.||++|+ |+.++++
T Consensus 242 ~~-------------~~~~--p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 242 EG-------------IIYF--PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred cC-------------CCCC--CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 00 0000 012345678999999999999995 7888875
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=287.99 Aligned_cols=262 Identities=19% Similarity=0.249 Sum_probs=201.6
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
+.....+|.|+ +.|+.+....+|+.+|+|.+......... ....+.+|+++++.++||||+++++++.+.
T Consensus 4 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (267)
T cd08228 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAK---------ARQDCVKEIDLLKQLNHPNVIKYLDSFIED 74 (267)
T ss_pred eeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHH---------HHHHHHHHHHHHHhCCCcceeeeeeeEEEC
Confidence 33445578887 78888888889999999976543211110 115678999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~df 172 (314)
+..++++||+++++|.+++...... ...++...+..++.|++.||.||| +++++|+||+|+||+++.++.++++||
T Consensus 75 ~~~~~v~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~ 150 (267)
T cd08228 75 NELNIVLELADAGDLSQMIKYFKKQ-KRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred CeEEEEEEecCCCcHHHHHHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECcc
Confidence 9999999999999998888542211 134678889999999999999999 999999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhcc
Q 043524 173 SLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFED 252 (314)
Q Consensus 173 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (314)
|.+........ ......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||....... ...... ...
T Consensus 151 g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~------~~~~~~-~~~ 222 (267)
T cd08228 151 GLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL------FSLCQK-IEQ 222 (267)
T ss_pred ccceeccchhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH------HHHHHH-Hhc
Confidence 99876643321 1234568889999999988888999999999999999999999985332110 111111 000
Q ss_pred CCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHH
Q 043524 253 NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQIC 308 (314)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~ 308 (314)
...+.......+..+.+++.+||..+|++|||+.++++.++++.
T Consensus 223 ------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 223 ------------CDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred ------------CCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 00111111245567899999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=309.52 Aligned_cols=248 Identities=21% Similarity=0.343 Sum_probs=206.0
Q ss_pred cccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCC
Q 043524 15 KRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETP 93 (314)
Q Consensus 15 ~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (314)
.....+|+|. ++||.+++..+....|||.+..++-+.. +-+.+|+.+.++|+|.|||++.|.+.+++
T Consensus 578 ~ervVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~------------QPLhEEIaLH~~LrHkNIVrYLGs~senG 645 (1226)
T KOG4279|consen 578 NERVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREV------------QPLHEEIALHSTLRHKNIVRYLGSVSENG 645 (1226)
T ss_pred CceEEeecCceeEEEeeccccceeEEEeeecccccchhh------------ccHHHHHHHHHHHhhHhHHHHhhccCCCC
Confidence 4567899999 9999999999999999998876654332 45789999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhcCCCCCCCcc--cHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecC-CCceEEc
Q 043524 94 IAILVFEYVQHGTLWDRILGAPQTHFEPL--LLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSE-ENVVKLF 170 (314)
Q Consensus 94 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~l--~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~-~~~~kl~ 170 (314)
++-|.||-.+||||.+.++..= +|+ .....-.+..||++||.||| ++.|||||||.+|+|++. .|.+||+
T Consensus 646 f~kIFMEqVPGGSLSsLLrskW----GPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKIS 718 (1226)
T KOG4279|consen 646 FFKIFMEQVPGGSLSSLLRSKW----GPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKIS 718 (1226)
T ss_pred eEEEEeecCCCCcHHHHHHhcc----CCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEec
Confidence 9999999999999999997643 455 67788889999999999999 999999999999999974 5899999
Q ss_pred ccccceecCCCCcccccccccccccccCcccccCC--CCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHh
Q 043524 171 DFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCD--FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKN 248 (314)
Q Consensus 171 dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (314)
|||.++.+. +-+.+.+++.||.-|||||++...+ |+.++|||||||++.||+||++||-...+...+.
T Consensus 719 DFGTsKRLA-ginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM--------- 788 (1226)
T KOG4279|consen 719 DFGTSKRLA-GINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM--------- 788 (1226)
T ss_pred ccccchhhc-cCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh---------
Confidence 999998773 3344578999999999999998765 8999999999999999999999996444322110
Q ss_pred hhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 249 YFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
|+-+ ..+.. ++.+...+.++..+|..|+.+||-+||+|.++|+
T Consensus 789 -FkVG--------myKvH--P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 789 -FKVG--------MYKVH--PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred -hhhc--------ceecC--CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 1100 01111 2334478889999999999999999999999986
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=297.73 Aligned_cols=252 Identities=19% Similarity=0.289 Sum_probs=193.8
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeEEEeCCeeE
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGCCLETPIAI 96 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 96 (314)
.+|.|+ +.|+.+.+..+|+.||+|++......... ..+.+..|..++..+ +||||+++++++.+.+.+|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~---------~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~ 72 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDE---------DIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLF 72 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhh---------HHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEE
Confidence 367777 88888888889999999999876433221 114577899999888 6999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
+||||+++|+|.+.+... ..++...+..++.|++.||.||| +++++||||||+||+++.++.++|+|||+++
T Consensus 73 lv~e~~~~g~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~ 144 (329)
T cd05588 73 FVIEFVSGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK 144 (329)
T ss_pred EEEeCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCcccc
Confidence 999999999998888654 35889999999999999999999 9999999999999999999999999999986
Q ss_pred ecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcc
Q 043524 177 SIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFT 256 (314)
Q Consensus 177 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (314)
...... .......||+.|+|||++.+..++.++|+||+||++|+|++|+.||+..............+......
T Consensus 145 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~----- 218 (329)
T cd05588 145 EGIRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVIL----- 218 (329)
T ss_pred ccccCC-CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHH-----
Confidence 532211 12335578999999999998889999999999999999999999997433221111111111111111
Q ss_pred cccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCC------HHHHHH
Q 043524 257 EIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPT------MVDVAR 302 (314)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps------~~ell~ 302 (314)
......+ ...+..+.+++.+||+.||++||| +.++++
T Consensus 219 -------~~~~~~p--~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 219 -------EKQIRIP--RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred -------cCCCCCC--CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 1111111 123456889999999999999997 566653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=305.90 Aligned_cols=241 Identities=24% Similarity=0.346 Sum_probs=200.6
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeEE
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAIL 97 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i 97 (314)
-||.|+ +.||.+.+..+.+.||||.++...-+...++ +.++.||+.|.+++|||+|.+.|+|......|+
T Consensus 33 EIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKW---------qDIlKEVrFL~~l~HPntieYkgCyLre~TaWL 103 (948)
T KOG0577|consen 33 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW---------QDILKEVRFLRQLRHPNTIEYKGCYLREHTAWL 103 (948)
T ss_pred HhcCCccceeEEeeccCccceeeeeeccccccccHHHH---------HHHHHHHHHHHhccCCCcccccceeeccchHHH
Confidence 488888 8899999999999999999887654444333 778999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccccee
Q 043524 98 VFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSIS 177 (314)
Q Consensus 98 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~ 177 (314)
||||| -||-.|++.... .++-..++..+..+.+.||+||| +.+.+|||||..|||++..|.+||+|||.+..
T Consensus 104 VMEYC-lGSAsDlleVhk----KplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi 175 (948)
T KOG0577|consen 104 VMEYC-LGSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASI 175 (948)
T ss_pred HHHHH-hccHHHHHHHHh----ccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhh
Confidence 99999 569999998776 46888899999999999999999 99999999999999999999999999999855
Q ss_pred cCCCCcccccccccccccccCcccccC---CCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCC
Q 043524 178 IPEGETHITDTVMGTYGHLAPQYVTTC---DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNR 254 (314)
Q Consensus 178 ~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (314)
.. ..++++|||+|||||+++.+ .|+.++||||+|+++.|++..++|+-.. .....-+-
T Consensus 176 ~~-----PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM----------NAMSALYH---- 236 (948)
T KOG0577|consen 176 MA-----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM----------NAMSALYH---- 236 (948)
T ss_pred cC-----chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc----------hHHHHHHH----
Confidence 42 35689999999999998754 5999999999999999999999986311 11111000
Q ss_pred cccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 255 FTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
+..++.+......++..+.+|+..||+.-|.+|||..+++.
T Consensus 237 -------IAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 237 -------IAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred -------HHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 11112222223378899999999999999999999999886
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=303.84 Aligned_cols=252 Identities=15% Similarity=0.185 Sum_probs=193.8
Q ss_pred cccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCC
Q 043524 15 KRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETP 93 (314)
Q Consensus 15 ~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (314)
.....+|.|+ +.|+++.+..+|+.+|+|++.......... .+.+.+|++++..++||||+++++++.+++
T Consensus 4 ~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~---------~~~~~~E~~il~~l~h~~iv~l~~~~~~~~ 74 (381)
T cd05626 4 VKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQ---------VAHVKAERDILAEADNEWVVKLYYSFQDKD 74 (381)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHH---------HHHHHHHHHHHHhcCCCCeeeeEEEEecCC
Confidence 3445689888 888899899999999999998765432211 156889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccc
Q 043524 94 IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFS 173 (314)
Q Consensus 94 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg 173 (314)
.+|+|||||++|+|.+++.... .++...+..++.|++.||.||| +++|+||||||+||+++..+.++|+|||
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFG 146 (381)
T cd05626 75 NLYFVMDYIPGGDMMSLLIRME-----VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFG 146 (381)
T ss_pred EEEEEEecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCc
Confidence 9999999999999999987643 4788888899999999999999 9999999999999999999999999999
Q ss_pred cceecCCCCc----------------------------------------------ccccccccccccccCcccccCCCC
Q 043524 174 LSISIPEGET----------------------------------------------HITDTVMGTYGHLAPQYVTTCDFS 207 (314)
Q Consensus 174 ~~~~~~~~~~----------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~ 207 (314)
+++....... .......||+.|+|||++.+..++
T Consensus 147 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~ 226 (381)
T cd05626 147 LCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT 226 (381)
T ss_pred CCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC
Confidence 9754311000 001235799999999999888899
Q ss_pred cccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhc
Q 043524 208 EKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECL 287 (314)
Q Consensus 208 ~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl 287 (314)
.++||||+||++|||++|..||........ ......... ....+.....+.++.+|+.+|+
T Consensus 227 ~~~DiwSlG~il~elltG~~Pf~~~~~~~~--------~~~i~~~~~-----------~~~~~~~~~~s~~~~dli~~ll 287 (381)
T cd05626 227 QLCDWWSVGVILFEMLVGQPPFLAPTPTET--------QLKVINWEN-----------TLHIPPQVKLSPEAVDLITKLC 287 (381)
T ss_pred CccceeehhhHHHHHHhCCCCCcCCCHHHH--------HHHHHcccc-----------ccCCCCCCCCCHHHHHHHHHHc
Confidence 999999999999999999999965332110 000000000 0001111123456788998844
Q ss_pred --cCCCCCCCCHHHHHH
Q 043524 288 --NESPIDRPTMVDVAR 302 (314)
Q Consensus 288 --~~dp~~Rps~~ell~ 302 (314)
..+|..||++.+++.
T Consensus 288 ~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 288 CSAEERLGRNGADDIKA 304 (381)
T ss_pred cCcccccCCCCHHHHhc
Confidence 556666999999986
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=296.24 Aligned_cols=244 Identities=20% Similarity=0.291 Sum_probs=189.4
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHH---hcCCCCceeeeEeEEEeC
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYA---AQMSHDHILKLIGCCLET 92 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~ 92 (314)
...+|.|+ +.|+.+....+|+.||+|++.......... .+.+.+|++++ ..++||||+++++++.++
T Consensus 4 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~---------~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~ 74 (324)
T cd05589 4 LAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDE---------VESLMCEKRIFETANSERHPFLVNLFACFQTE 74 (324)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhH---------HHHHHHHHHHHHhccccCCCChhceeeEEEcC
Confidence 34578877 788888888899999999998765322211 14556666554 567799999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~df 172 (314)
+..|+||||+++|+|...+.. ..++...+..++.|++.||.||| +++++||||||+||+++.++.++|+||
T Consensus 75 ~~~~lv~E~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Df 145 (324)
T cd05589 75 DHVCFVMEYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADF 145 (324)
T ss_pred CEEEEEEcCCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcc
Confidence 999999999999999888754 34788999999999999999999 999999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhcc
Q 043524 173 SLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFED 252 (314)
Q Consensus 173 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (314)
|+++...... .......|++.|+|||++.+..++.++||||+||++|+|++|..||....... .......
T Consensus 146 g~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~--------~~~~i~~- 215 (324)
T cd05589 146 GLCKEGMGFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE--------VFDSIVN- 215 (324)
T ss_pred cCCccCCCCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHh-
Confidence 9986532221 12345678999999999998889999999999999999999999996433111 1111111
Q ss_pred CCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCC-----CHHHHHH
Q 043524 253 NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRP-----TMVDVAR 302 (314)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 302 (314)
.....+ ...+..+.+++.+||+.||++|| ++.++++
T Consensus 216 ------------~~~~~p--~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 216 ------------DEVRYP--RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ------------CCCCCC--CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 000000 12345678999999999999999 5666665
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=284.14 Aligned_cols=247 Identities=22% Similarity=0.299 Sum_probs=190.9
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeEE
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAIL 97 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i 97 (314)
.+|+|+ +.|+.+....+|+.+|+|.+....... ....+.+|+++++.++||||+++++++......++
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 70 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPD-----------LKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 70 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHH-----------HHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEE
Confidence 367777 788888888889999999875332111 12568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccccee
Q 043524 98 VFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSIS 177 (314)
Q Consensus 98 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~ 177 (314)
|+||+++++|.+++.... ..+++..+..++.|++.||.||| +++++|+||||+||+++.++.++++|||++..
T Consensus 71 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 143 (252)
T cd05084 71 VMELVQGGDFLTFLRTEG----PRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSRE 143 (252)
T ss_pred EEeeccCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcc
Confidence 999999999999986543 34788899999999999999999 99999999999999999999999999999865
Q ss_pred cCCCCccc-ccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhccCCc
Q 043524 178 IPEGETHI-TDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFEDNRF 255 (314)
Q Consensus 178 ~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (314)
........ ......+..|+|||.+....++.++|+||+|+++|+|++ |..||....... ........
T Consensus 144 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~---------~~~~~~~~-- 212 (252)
T cd05084 144 EEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ---------TREAIEQG-- 212 (252)
T ss_pred cccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH---------HHHHHHcC--
Confidence 43221110 111123456999999988889999999999999999998 888885332111 00111000
Q ss_pred ccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHH
Q 043524 256 TEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLR 305 (314)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~ 305 (314)
.....+...+..+.+++.+||..||++|||+.++++.|+
T Consensus 213 -----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 213 -----------VRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred -----------CCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 000011133457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=299.02 Aligned_cols=239 Identities=22% Similarity=0.301 Sum_probs=187.8
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHH-HHhcCCCCceeeeEeEEEeCCeeE
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVT-YAAQMSHDHILKLIGCCLETPIAI 96 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~ 96 (314)
.+|.|+ +.|+++.+..+|+.+|+|++.......... ...+.+|.. ++..++||||+++++++..++..|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~---------~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~ 72 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKE---------QKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLY 72 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhH---------HHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEE
Confidence 367777 888889888999999999998765432211 134555554 557899999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
+||||+++|+|...+... ..++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+|||+++
T Consensus 73 lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~ 144 (323)
T cd05575 73 FVLDYVNGGELFFHLQRE-----RSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK 144 (323)
T ss_pred EEEcCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCc
Confidence 999999999999888654 34788889999999999999999 9999999999999999999999999999986
Q ss_pred ecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcc
Q 043524 177 SIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFT 256 (314)
Q Consensus 177 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (314)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||..... .+.......
T Consensus 145 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~----- 210 (323)
T cd05575 145 EGIEHS-KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT--------AEMYDNILN----- 210 (323)
T ss_pred ccccCC-CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH--------HHHHHHHHc-----
Confidence 542221 123345789999999999988899999999999999999999999964321 111111111
Q ss_pred cccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHH
Q 043524 257 EIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMV 298 (314)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ 298 (314)
...... ...+..+.+++.+||+.||++||++.
T Consensus 211 --------~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 211 --------KPLRLK--PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred --------CCCCCC--CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 110000 12345688999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=284.19 Aligned_cols=262 Identities=20% Similarity=0.285 Sum_probs=203.1
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
+.....+|.|+ +.++.+....+|+.+|+|.+......... ..+.+.+|++++++++|+||+++++.+..+
T Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~---------~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~ 74 (267)
T cd08224 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAK---------ARQDCLKEIDLLKQLDHPNVIKYLASFIEN 74 (267)
T ss_pred eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchh---------hHHHHHHHHHHHHhCCCCCeeeeeeeeecC
Confidence 33444578877 88888888889999999987643321111 115688999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~df 172 (314)
+..+++|||+++++|.+.+...... ...++...+..++.+++.|+.||| +.+++|+||+|+||+++.++.++++||
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~ 150 (267)
T cd08224 75 NELNIVLELADAGDLSRMIKHFKKQ-KRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred CeEEEEEecCCCCCHHHHHHHhccc-CCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEecc
Confidence 9999999999999999988653211 134788899999999999999999 999999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhcc
Q 043524 173 SLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFED 252 (314)
Q Consensus 173 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (314)
|.+........ ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...... ........
T Consensus 151 ~~~~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~--- 220 (267)
T cd08224 151 GLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKKI--- 220 (267)
T ss_pred ceeeeccCCCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc------HHHHHhhh---
Confidence 99876543322 123446888999999998888999999999999999999999998533211 11111110
Q ss_pred CCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHH
Q 043524 253 NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQIC 308 (314)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~ 308 (314)
..+..........+..+.+++.+||..+|++|||+.+|++.|+++.
T Consensus 221 ----------~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 221 ----------EKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ----------hcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0011111111245567899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=297.30 Aligned_cols=243 Identities=18% Similarity=0.290 Sum_probs=192.0
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeEEEeCCeeE
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGCCLETPIAI 96 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 96 (314)
.+|.|+ +.|+.+.+..+|+.+|+|++.......... .+.+..|.+++..+ +||||+++++++.+++.+|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~---------~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~ 72 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDD---------VDCTMTEKRILALAAKHPFLTALHCCFQTKDRLF 72 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhH---------HHHHHHHHHHHHhccCCCCccceeeEEEcCCeEE
Confidence 367777 888888888889999999998754322211 14567889888866 7999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
+||||+++|+|.+.+.... .++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+|||+++
T Consensus 73 lv~E~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~ 144 (321)
T cd05591 73 FVMEYVNGGDLMFQIQRSR-----KFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCK 144 (321)
T ss_pred EEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccce
Confidence 9999999999998886543 4778888999999999999999 9999999999999999999999999999987
Q ss_pred ecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcc
Q 043524 177 SIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFT 256 (314)
Q Consensus 177 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (314)
....... ......||+.|+|||++....++.++||||+||++|+|++|+.||....... ........
T Consensus 145 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~--------~~~~i~~~---- 211 (321)
T cd05591 145 EGILNGV-TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD--------LFESILHD---- 211 (321)
T ss_pred ecccCCc-cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH--------HHHHHHcC----
Confidence 5432221 2334568999999999988889999999999999999999999996433211 11111110
Q ss_pred cccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCC-------CHHHHHH
Q 043524 257 EIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRP-------TMVDVAR 302 (314)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-------s~~ell~ 302 (314)
....+ ...+.++.+++..||+.||++|| ++.++++
T Consensus 212 ---------~~~~p--~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 212 ---------DVLYP--VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred ---------CCCCC--CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 00000 12345688999999999999999 7787764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=306.77 Aligned_cols=238 Identities=22% Similarity=0.333 Sum_probs=200.8
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC-CCceeeeEeEEEeCCee
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS-HDHILKLIGCCLETPIA 95 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 95 (314)
..+|.|+ +.|.++-.+.+++.+|||+..+.++...... +..+.|.+++.... ||.++.++..|.+.+++
T Consensus 374 ~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~V---------e~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 374 AVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEV---------ESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred EEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccH---------HHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 4688998 8888888899999999999988876554332 67788999998775 99999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
|+||||+.||++..+... ..++...+..++..++.||.||| +++|++||||.+|||+|.+|.+||+|||++
T Consensus 445 ~fvmey~~Ggdm~~~~~~------~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlc 515 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIHT------DVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLC 515 (694)
T ss_pred EEEEEecCCCcEEEEEec------ccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccc
Confidence 999999999996554433 35899999999999999999999 999999999999999999999999999999
Q ss_pred eecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCc
Q 043524 176 ISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRF 255 (314)
Q Consensus 176 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (314)
+..--... ...+++||+-|+|||++.+..|+..+|.|||||++|||+.|..||.+...
T Consensus 516 Ke~m~~g~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE--------------------- 573 (694)
T KOG0694|consen 516 KEGMGQGD-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE--------------------- 573 (694)
T ss_pred cccCCCCC-ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH---------------------
Confidence 87543332 47789999999999999999999999999999999999999999864332
Q ss_pred ccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCH
Q 043524 256 TEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTM 297 (314)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 297 (314)
.++++.++..+...+ ...+.++.++++.+|.+||++|.-+
T Consensus 574 ee~FdsI~~d~~~yP--~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 574 EEVFDSIVNDEVRYP--RFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHHHHhcCCCCCC--CcccHHHHHHHHHHhccCcccccCC
Confidence 344444443332222 2667889999999999999999843
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=304.49 Aligned_cols=252 Identities=18% Similarity=0.218 Sum_probs=199.6
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
|.....+|.|+ +.|+++.+..+|+.||+|++......... ..+.+.+|++++..++||||+++++++.++
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~---------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 73 (350)
T cd05573 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRN---------QIAHVRAERDILADADSPWIVKLYYSFQDE 73 (350)
T ss_pred ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhcc---------HHHHHHHHHHHHHhcCCCCccchhhheecC
Confidence 33445688888 88888888889999999999876543211 125678999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~df 172 (314)
+..|+||||+++++|.+++... ..++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+||
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Df 145 (350)
T cd05573 74 EHLYLVMEYMPGGDLMNLLIRK-----DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADF 145 (350)
T ss_pred CeEEEEEcCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecC
Confidence 9999999999999999998765 24788999999999999999999 999999999999999999999999999
Q ss_pred ccceecCCCC----------------------------cccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh
Q 043524 173 SLSISIPEGE----------------------------THITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT 224 (314)
Q Consensus 173 g~~~~~~~~~----------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~ 224 (314)
|+++...... ........||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~ 225 (350)
T cd05573 146 GLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLY 225 (350)
T ss_pred CCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhcc
Confidence 9987654332 112334578999999999999899999999999999999999
Q ss_pred CCCCcccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCC-HHHHHH
Q 043524 225 GRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPT-MVDVAR 302 (314)
Q Consensus 225 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps-~~ell~ 302 (314)
|+.||....... ........ . .....+.....+..+.+|+.+||. ||.+||+ +.++++
T Consensus 226 g~~Pf~~~~~~~--------~~~~i~~~---~--------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 226 GFPPFYSDTLQE--------TYNKIINW---K--------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred CCCCCCCCCHHH--------HHHHHhcc---C--------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 999996443111 11111110 0 000000001245678899999997 9999999 999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=297.58 Aligned_cols=250 Identities=22% Similarity=0.311 Sum_probs=207.9
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC-CCceeeeEeEEEe
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS-HDHILKLIGCCLE 91 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~ 91 (314)
|.-...+|.|. ++|+.+....+|+.+|+|++.+....... ..+.+.+|+.+|++++ |||||.++++|++
T Consensus 37 Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~---------~~~~v~~Ev~il~~l~~hpniv~l~~~~e~ 107 (382)
T KOG0032|consen 37 YELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKE---------DREDVRREVAILQQLSGHPNIVQLKDAFED 107 (382)
T ss_pred EEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccc---------cHHHHHHHHHHHHhccCCCCEEEEEEEEEc
Confidence 33335688888 89999999999999999999988765432 1256889999999998 9999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCC----Cce
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEE----NVV 167 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~----~~~ 167 (314)
...+++|||+|.||+|.+.+... .++...+..++.|++.++.||| +.||+|||+||+|+|+... +.+
T Consensus 108 ~~~~~lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~i 178 (382)
T KOG0032|consen 108 PDSVYLVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRI 178 (382)
T ss_pred CCeEEEEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcE
Confidence 99999999999999999999765 1788999999999999999999 9999999999999998654 379
Q ss_pred EEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHH
Q 043524 168 KLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLK 247 (314)
Q Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (314)
+++|||++..... .......+||+.|+|||++....|+..+|+||+|+++|.|++|.+||.......... .
T Consensus 179 k~~DFGla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~----~--- 249 (382)
T KOG0032|consen 179 KLIDFGLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL----A--- 249 (382)
T ss_pred EEeeCCCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH----H---
Confidence 9999999988765 334667899999999999999999999999999999999999999998666433111 0
Q ss_pred hhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 248 NYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.. ..++ .+..+.....+..+.++++.||..||.+|+||.++|+
T Consensus 250 -i~-~~~~----------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 250 -IL-RGDF----------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred -HH-cCCC----------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 00 0010 1122222356778999999999999999999999987
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=286.08 Aligned_cols=249 Identities=19% Similarity=0.308 Sum_probs=193.5
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCee
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIA 95 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (314)
...+|.|+ +.|+++. ..++..+|+|.+...... .+.+.+|+.+++.++|+||+++++.+..++..
T Consensus 11 ~~~lg~g~~g~v~~~~-~~~~~~v~iK~~~~~~~~-------------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05072 11 VKKLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMS-------------VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPI 76 (261)
T ss_pred eeecCCcCCceEEEEE-ecCCceEEEEEccCCchh-------------HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 34478877 6666655 345677999976543221 15688999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
++++||+++++|.+++..... ..++...+..++.+++.||.||| +++++|+||||+||+++.++.++++|||.+
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~ 150 (261)
T cd05072 77 YIITEYMAKGSLLDFLKSDEG---GKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLA 150 (261)
T ss_pred EEEEecCCCCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccc
Confidence 999999999999999875432 34678888999999999999999 999999999999999999999999999999
Q ss_pred eecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhccCC
Q 043524 176 ISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFEDNR 254 (314)
Q Consensus 176 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (314)
...............++..|+|||.+....++.++||||+|+++|+|++ |..||....... ..... ....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--------~~~~~-~~~~ 221 (261)
T cd05072 151 RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD--------VMSAL-QRGY 221 (261)
T ss_pred eecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH--------HHHHH-HcCC
Confidence 8765433222233456778999999988889999999999999999998 899986432111 11111 0000
Q ss_pred cccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHH
Q 043524 255 FTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQI 307 (314)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~ 307 (314)
..+.....+.++.+++.+||+.||++|||++++.+.|+++
T Consensus 222 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 222 -------------RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred -------------CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 0011113445688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=296.38 Aligned_cols=247 Identities=20% Similarity=0.304 Sum_probs=190.2
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeEEEeCCeeE
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGCCLETPIAI 96 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 96 (314)
.+|+|+ +.|+++....+++.+|+|++......... ..+.+.+|+.++..+ +||||+++++++.+++..|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~---------~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~ 72 (329)
T cd05618 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDE---------DIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 72 (329)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchh---------HHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEE
Confidence 478888 88888888889999999999865432211 114567888888776 7999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
+||||+++|+|...+... ..++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+|||+++
T Consensus 73 lv~E~~~~~~L~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~ 144 (329)
T cd05618 73 FVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK 144 (329)
T ss_pred EEEeCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccc
Confidence 999999999998888654 34788999999999999999999 9999999999999999999999999999987
Q ss_pred ecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcc
Q 043524 177 SIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFT 256 (314)
Q Consensus 177 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (314)
....... ......||+.|+|||++.+..++.++|+||+||++|+|++|..||...............+......
T Consensus 145 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~----- 218 (329)
T cd05618 145 EGLRPGD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL----- 218 (329)
T ss_pred cccCCCC-ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHh-----
Confidence 5322211 2334578999999999998889999999999999999999999996433221111111111111110
Q ss_pred cccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCH
Q 043524 257 EIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTM 297 (314)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 297 (314)
......+ ...+..+.+++.+||+.||++|||+
T Consensus 219 -------~~~~~~p--~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 219 -------EKQIRIP--RSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred -------cCCCCCC--CCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 0111111 1334567899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=285.26 Aligned_cols=259 Identities=20% Similarity=0.260 Sum_probs=201.8
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCee
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIA 95 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (314)
...+|.|+ +.|+++....+|+.+|+|.+...+..... ..+++.+|+++++.++|+||+++++++..++..
T Consensus 7 ~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~---------~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 77 (267)
T cd08229 7 EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAK---------ARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 77 (267)
T ss_pred hhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHH---------HHHHHHHHHHHHHHccCCchhhhhheeEeCCeE
Confidence 34578777 77888888889999999987654322211 115688999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
++++||+++++|.+.+...... ...++...+..++.+++.|+.||| +++++|+||+|+||+++.++.++++|||.+
T Consensus 78 ~~v~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~ 153 (267)
T cd08229 78 NIVLELADAGDLSRMIKHFKKQ-KRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred EEEEEecCCCCHHHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhh
Confidence 9999999999999988642211 135788899999999999999999 999999999999999999999999999998
Q ss_pred eecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCc
Q 043524 176 ISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRF 255 (314)
Q Consensus 176 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (314)
........ ......++..|+|||.+....++.++|+||+|+++|+|++|..||....... ........
T Consensus 154 ~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~----- 221 (267)
T cd08229 154 RFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL------YSLCKKIE----- 221 (267)
T ss_pred hccccCCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH------HHHhhhhh-----
Confidence 76543322 1234568899999999988888999999999999999999999985432110 00000000
Q ss_pred ccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHH
Q 043524 256 TEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQIC 308 (314)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~ 308 (314)
....+.......+..+.+++.+||..||++|||+.+|++.++++.
T Consensus 222 --------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 222 --------QCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred --------cCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 000011111245667899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=301.53 Aligned_cols=254 Identities=19% Similarity=0.255 Sum_probs=196.2
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
.+.....+|.|+ +.|+.+.+..+++.+|+|++.+........ .+.+.+|+.++..++||||+++++++.+
T Consensus 44 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~---------~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (370)
T cd05621 44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSD---------SAFFWEERDIMAFANSPWVVQLFCAFQD 114 (370)
T ss_pred HCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhh---------HHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 445555789988 888888888899999999997654322211 1457789999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
+...|+|||||++|+|.+++... .++...+..++.|++.||.||| +++|+||||||+||+++.++.+||+|
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~D 185 (370)
T cd05621 115 DKYLYMVMEYMPGGDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLAD 185 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEe
Confidence 99999999999999999988643 3678888999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCcccccCC----CCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHH
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTTCD----FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLK 247 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (314)
||+++..............||+.|+|||++.... ++.++|+||+||++|+|++|..||...... +...
T Consensus 186 FG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~--------~~~~ 257 (370)
T cd05621 186 FGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV--------GTYS 257 (370)
T ss_pred cccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH--------HHHH
Confidence 9999876443322234567999999999987543 788999999999999999999999643211 1111
Q ss_pred hhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCC--CCCHHHHHHH
Q 043524 248 NYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPID--RPTMVDVARR 303 (314)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~--Rps~~ell~~ 303 (314)
....... ....+.....+..+.+++..||..+|.+ |+|+.|+++.
T Consensus 258 ~i~~~~~-----------~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 258 KIMDHKN-----------SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HHHhCCc-----------ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1111000 0011111134566889999999866544 8899998873
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=300.16 Aligned_cols=248 Identities=19% Similarity=0.272 Sum_probs=204.7
Q ss_pred cccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCC
Q 043524 15 KRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETP 93 (314)
Q Consensus 15 ~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (314)
....-+|.|+ +.||++..+.++-..|.|++..+.-... +.++-|+.+|..+.||+||++++.|.-.+
T Consensus 35 eIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEEL------------EDylVEIeILa~CdHP~ivkLl~ayy~en 102 (1187)
T KOG0579|consen 35 EIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEEL------------EDYLVEIEILAECDHPVIVKLLSAYYFEN 102 (1187)
T ss_pred HHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHH------------hhhhhhhhhhhcCCChHHHHHHHHHhccC
Confidence 3445678888 9999999999988999998865543322 66889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccc
Q 043524 94 IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFS 173 (314)
Q Consensus 94 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg 173 (314)
.+||+.|||+||.+..++...+ .++...++..+++|++.||.||| +++|+|||||+.|||++.+|.++|+|||
T Consensus 103 kLwiliEFC~GGAVDaimlEL~----r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFG 175 (1187)
T KOG0579|consen 103 KLWILIEFCGGGAVDAIMLELG----RVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFG 175 (1187)
T ss_pred ceEEEEeecCCchHhHHHHHhc----cccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeeccc
Confidence 9999999999999988888766 46889999999999999999999 9999999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCccc-----ccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHh
Q 043524 174 LSISIPEGETHITDTVMGTYGHLAPQYV-----TTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKN 248 (314)
Q Consensus 174 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~-----~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (314)
++..... ...+..+++||++|||||++ ...+|+.++||||||++|.||+.+.+|..... ++...++-
T Consensus 176 VSAKn~~-t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln-------pMRVllKi 247 (1187)
T KOG0579|consen 176 VSAKNKS-TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN-------PMRVLLKI 247 (1187)
T ss_pred ccccchh-HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc-------hHHHHHHH
Confidence 9855422 33357789999999999976 45679999999999999999999999854222 22222111
Q ss_pred hhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 249 YFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
. ...+.....++.++..+.+++..||..||..||++.++++
T Consensus 248 a-------------KSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 248 A-------------KSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred h-------------hcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 1 1122333344578889999999999999999999999986
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=299.48 Aligned_cols=252 Identities=14% Similarity=0.208 Sum_probs=196.0
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
+.....+|.|+ +.|+.+.+..+|+.||+|++......... ....+.+|+.++..++||||+++++++.++
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~---------~~~~~~~E~~il~~l~h~~iv~~~~~~~~~ 73 (364)
T cd05599 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKE---------QVAHVRAERDILAEADNPWVVKLYYSFQDE 73 (364)
T ss_pred ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhh---------HHHHHHHHHHHHHhCCCCCCcceEEEEEcC
Confidence 33445688888 88888888889999999999876533221 114577899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~df 172 (314)
+.+|+|||||++|+|.+++.... .++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+||
T Consensus 74 ~~~~lv~E~~~~g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Df 145 (364)
T cd05599 74 NYLYLIMEYLPGGDMMTLLMKKD-----TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDF 145 (364)
T ss_pred CeEEEEECCCCCcHHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeec
Confidence 99999999999999999987643 4788999999999999999999 999999999999999999999999999
Q ss_pred ccceecCCCCcc-------------------------------------cccccccccccccCcccccCCCCcccchHHH
Q 043524 173 SLSISIPEGETH-------------------------------------ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSF 215 (314)
Q Consensus 173 g~~~~~~~~~~~-------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl 215 (314)
|+++.+...... ......||+.|+|||++....++.++||||+
T Consensus 146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 225 (364)
T cd05599 146 GLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSL 225 (364)
T ss_pred ccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecc
Confidence 998764321100 0112468999999999988889999999999
Q ss_pred HHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCC
Q 043524 216 GAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRP 295 (314)
Q Consensus 216 G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp 295 (314)
||++|+|++|..||....... .......... .. ..+.....++.+.+|+.+||. +|.+|+
T Consensus 226 G~il~el~~G~~Pf~~~~~~~--------~~~~i~~~~~-------~~----~~~~~~~~s~~~~~li~~ll~-~p~~R~ 285 (364)
T cd05599 226 GVIMYEMLVGYPPFCSDNPQE--------TYRKIINWKE-------TL----QFPDEVPLSPEAKDLIKRLCC-EAERRL 285 (364)
T ss_pred hhHHHHhhcCCCCCCCCCHHH--------HHHHHHcCCC-------cc----CCCCCCCCCHHHHHHHHHHcc-CHhhcC
Confidence 999999999999996433211 1111111000 00 000000234567899999996 999999
Q ss_pred C---HHHHHH
Q 043524 296 T---MVDVAR 302 (314)
Q Consensus 296 s---~~ell~ 302 (314)
+ +.|+++
T Consensus 286 ~~~~~~~ll~ 295 (364)
T cd05599 286 GNNGVNEIKS 295 (364)
T ss_pred CCCCHHHHhc
Confidence 8 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=304.29 Aligned_cols=253 Identities=24% Similarity=0.335 Sum_probs=196.1
Q ss_pred cccCch-hHHHHHH-HhcCC--cc-cccccccHHH--HHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 19 MIGNGA-SVLQELI-ASSNG--KY-IPYRIFSAQE--LKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 19 ~~G~g~-~~~~~~~-~~~~g--~~-~a~k~~~~~~--~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
.+|+|+ +.|+... ...++ .. ||+|....+. .+.+ ..+|++|.+++++++|||||+++|+...
T Consensus 164 kLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~-----------~~e~m~EArvMr~l~H~NVVr~yGVa~~ 232 (474)
T KOG0194|consen 164 KLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQ-----------IKEFMKEARVMRQLNHPNVVRFYGVAVL 232 (474)
T ss_pred eeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHH-----------HHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence 456666 4444443 33333 23 7888766411 1111 2789999999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
...+++|||+|+||+|.+++.... ..++..+...++.+.+.||+||| +++++||||-.+|+|++..+.+||+|
T Consensus 233 ~~Pl~ivmEl~~gGsL~~~L~k~~----~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISD 305 (474)
T KOG0194|consen 233 EEPLMLVMELCNGGSLDDYLKKNK----KSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISD 305 (474)
T ss_pred CCccEEEEEecCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCc
Confidence 999999999999999999999876 35889999999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhh
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
||+++....... ......-+..|+|||.+....|+.++|||||||++||+++ |..||.+....+ +.
T Consensus 306 FGLs~~~~~~~~-~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~---------v~--- 372 (474)
T KOG0194|consen 306 FGLSRAGSQYVM-KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE---------VK--- 372 (474)
T ss_pred cccccCCcceee-ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH---------HH---
Confidence 999876531111 1112235789999999999999999999999999999999 788886555332 01
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhc
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSL 311 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 311 (314)
..+.....+.+.+...+..+..++.+||..||++|||+.++.+.|+.+....
T Consensus 373 ---------~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 373 ---------AKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred ---------HHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 1111112222222255667889999999999999999999999999987653
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=299.93 Aligned_cols=251 Identities=16% Similarity=0.245 Sum_probs=191.6
Q ss_pred ccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCe
Q 043524 16 RTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPI 94 (314)
Q Consensus 16 ~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 94 (314)
....+|.|+ +.|+.+.+..+|+.+|+|++.......... .+.+.+|+.++..++|+||+++++.+.++..
T Consensus 5 ~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~---------~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~ 75 (363)
T cd05628 5 SLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQ---------VGHIRAERDILVEADSLWVVKMFYSFQDKLN 75 (363)
T ss_pred EeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhH---------HHHHHHHHHHHHhCCCCCcceEEEEEecCCe
Confidence 344688888 888888888899999999998765432221 1567889999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccc
Q 043524 95 AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL 174 (314)
Q Consensus 95 ~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~ 174 (314)
+|+|||||++|+|.+++... ..++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+|||+
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGl 147 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKK-----DTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccC
Confidence 99999999999999998764 35788999999999999999999 99999999999999999999999999999
Q ss_pred ceecCCCCc----------------------------------ccccccccccccccCcccccCCCCcccchHHHHHHHH
Q 043524 175 SISIPEGET----------------------------------HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLS 220 (314)
Q Consensus 175 ~~~~~~~~~----------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~ 220 (314)
++....... .......||+.|+|||++.+..++.++||||+||++|
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 227 (363)
T cd05628 148 CTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227 (363)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHH
Confidence 875422100 0012347999999999999888999999999999999
Q ss_pred HHHhCCCCcccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhcc--CCCCCCCCHH
Q 043524 221 ELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLN--ESPIDRPTMV 298 (314)
Q Consensus 221 el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~--~dp~~Rps~~ 298 (314)
||++|..||....... .......... .. .. +.....+.++.+++..|+. .++..||++.
T Consensus 228 ell~G~~Pf~~~~~~~--------~~~~i~~~~~--~~---~~------p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ 288 (363)
T cd05628 228 EMLIGYPPFCSETPQE--------TYKKVMNWKE--TL---IF------PPEVPISEKAKDLILRFCCEWEHRIGAPGVE 288 (363)
T ss_pred HHHhCCCCCCCCCHHH--------HHHHHHcCcC--cc---cC------CCcCCCCHHHHHHHHHHcCChhhcCCCCCHH
Confidence 9999999996433111 1111111000 00 00 0000234567788887654 2334568999
Q ss_pred HHHH
Q 043524 299 DVAR 302 (314)
Q Consensus 299 ell~ 302 (314)
||++
T Consensus 289 ei~~ 292 (363)
T cd05628 289 EIKT 292 (363)
T ss_pred HHhC
Confidence 9987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=293.65 Aligned_cols=243 Identities=19% Similarity=0.297 Sum_probs=189.7
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhc-CCCCceeeeEeEEEeCCeeE
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQ-MSHDHILKLIGCCLETPIAI 96 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~ 96 (314)
.+|.|+ +.|+++....+++.||+|++.......... .+.+..|..++.. .+||||+++++++..+...|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~---------~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~ 72 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDD---------VECTMVERRVLALAWEHPFLTHLFCTFQTKEHLF 72 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhh---------HHHHHHHHHHHHhccCCCCccceeeEEEcCCEEE
Confidence 478888 888888888889999999988654322111 1345667777765 47999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
+||||+++|+|.+.+.... .++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+|||+++
T Consensus 73 lv~e~~~gg~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~ 144 (316)
T cd05592 73 FVMEYLNGGDLMFHIQSSG-----RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCK 144 (316)
T ss_pred EEEcCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCe
Confidence 9999999999999886543 4788889999999999999999 9999999999999999999999999999997
Q ss_pred ecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcc
Q 043524 177 SIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFT 256 (314)
Q Consensus 177 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (314)
...... .......||+.|+|||++.+..++.++||||+||++|+|++|..||....... ........
T Consensus 145 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~--------~~~~i~~~---- 211 (316)
T cd05592 145 ENMNGE-GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE--------LFDSILND---- 211 (316)
T ss_pred ECCCCC-CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHcC----
Confidence 643322 22345678999999999998889999999999999999999999996433211 11111100
Q ss_pred cccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHH-HHHH
Q 043524 257 EIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMV-DVAR 302 (314)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~-ell~ 302 (314)
.. ..+...+.++.+|+..||+.||++||++. ++++
T Consensus 212 ---------~~--~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 212 ---------RP--HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred ---------CC--CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 00 00113345678999999999999999864 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=294.93 Aligned_cols=250 Identities=20% Similarity=0.240 Sum_probs=185.9
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC-CCceeeeEeEEEe
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS-HDHILKLIGCCLE 91 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~ 91 (314)
|.+...+|.|| +.|+++.... .+.||+|.+.....-.++ -..|.+|+.+|.+|+ |.+||+++++-..
T Consensus 363 Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qt----------l~gy~nEI~lL~KLkg~~~IIqL~DYEv~ 431 (677)
T KOG0596|consen 363 YEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQT----------LDGYRNEIALLNKLKGHDKIIQLYDYEVT 431 (677)
T ss_pred hhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHH----------HHHHHHHHHHHHHhcCCceEEEEeeeecc
Confidence 44555689888 6777665544 455566554433222221 267899999999996 8999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
++.+|+|||+= ..+|..++..... ..+.-.++.+..|++.++.++| ..||||.||||.|+|+ ..|.+||+|
T Consensus 432 d~~lYmvmE~G-d~DL~kiL~k~~~----~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLl-VkG~LKLID 502 (677)
T KOG0596|consen 432 DGYLYMVMECG-DIDLNKILKKKKS----IDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLL-VKGRLKLID 502 (677)
T ss_pred CceEEEEeecc-cccHHHHHHhccC----CCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEE-EeeeEEeee
Confidence 99999999954 6799999987542 2333477888899999999999 9999999999999988 678999999
Q ss_pred cccceecCCCCccc-ccccccccccccCcccccCC-----------CCcccchHHHHHHHHHHHhCCCCcccccCccccc
Q 043524 172 FSLSISIPEGETHI-TDTVMGTYGHLAPQYVTTCD-----------FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLV 239 (314)
Q Consensus 172 fg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~-----------~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~ 239 (314)
||.|..+...++.. ...-+||+.||+||.+..+. .+.++||||+||+||+|+.|++||....+..
T Consensus 503 FGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~--- 579 (677)
T KOG0596|consen 503 FGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQI--- 579 (677)
T ss_pred echhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHH---
Confidence 99999887665543 44568999999999986443 4579999999999999999999986433211
Q ss_pred cchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 240 YPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.+ +..+.++.-.-+++...+ ..++.++++.||.+||++|||..++|+
T Consensus 580 ------aK-------l~aI~~P~~~Iefp~~~~---~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 580 ------AK-------LHAITDPNHEIEFPDIPE---NDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred ------HH-------HHhhcCCCccccccCCCC---chHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 11 111222211111111111 122889999999999999999999986
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=296.62 Aligned_cols=266 Identities=18% Similarity=0.245 Sum_probs=189.8
Q ss_pred ccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC--
Q 043524 16 RTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET-- 92 (314)
Q Consensus 16 ~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-- 92 (314)
....+|.|+ +.|+.+.+..+|+.||+|.+........ ...++.+|+++++.++||||+++++++...
T Consensus 4 i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 73 (338)
T cd07859 4 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVS----------DATRILREIKLLRLLRHPDIVEIKHIMLPPSR 73 (338)
T ss_pred EEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccch----------hHHHHHHHHHHHHhCCCCCEeeecceEeccCC
Confidence 344578887 8888888888999999998764321100 014578999999999999999999998643
Q ss_pred ---CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEE
Q 043524 93 ---PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKL 169 (314)
Q Consensus 93 ---~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl 169 (314)
..+|+|||||+ ++|.+.+.... .++...+..++.|++.||.||| +++|+||||||+||+++.++.++|
T Consensus 74 ~~~~~~~lv~e~~~-~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL 144 (338)
T cd07859 74 REFKDIYVVFELME-SDLHQVIKAND-----DLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKI 144 (338)
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc-----cCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEE
Confidence 34899999995 69998886543 4788999999999999999999 999999999999999999999999
Q ss_pred cccccceecCCCCcc--cccccccccccccCccccc--CCCCcccchHHHHHHHHHHHhCCCCcccccCccccc------
Q 043524 170 FDFSLSISIPEGETH--ITDTVMGTYGHLAPQYVTT--CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLV------ 239 (314)
Q Consensus 170 ~dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~------ 239 (314)
+|||+++........ ......||+.|+|||++.. ..++.++||||+||++|+|++|+.||..........
T Consensus 145 ~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~ 224 (338)
T cd07859 145 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLL 224 (338)
T ss_pred ccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHh
Confidence 999998764322111 1234578999999998865 568999999999999999999999996533211000
Q ss_pred -cchHHHHHhhhccCCcccccChhhhccCCchhH---HHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 240 -YPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEK---EQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 240 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.+........ ............ ....+.+.. ...+..+.+++.+||+.||++|||++|+++
T Consensus 225 ~~~~~~~~~~i-~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 225 GTPSPETISRV-RNEKARRYLSSM-RKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred CCCCHHHHHHh-hhhhHHHHHHhh-cccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000000000 000000000000 000000000 023456789999999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=298.33 Aligned_cols=246 Identities=18% Similarity=0.249 Sum_probs=187.6
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
+.....+|.|+ +.|+++.+..+|+.||+|++....... ..+.+.+|++++..++|+||+++++++..+
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 144 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDT-----------VRRQICREIEILRDVNHPNVVKCHDMFDHN 144 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHH-----------HHHHHHHHHHHHHhCCCCCcceeeeEeccC
Confidence 33445688888 888888888899999999875432111 125688999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~df 172 (314)
+.+++||||+.+|+|.+.. ......+..++.|++.||.||| +++|+||||||+||+++.++.++|+||
T Consensus 145 ~~~~lv~e~~~~~~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~Df 212 (353)
T PLN00034 145 GEIQVLLEFMDGGSLEGTH---------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADF 212 (353)
T ss_pred CeEEEEEecCCCCcccccc---------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccc
Confidence 9999999999999986532 2456677889999999999999 999999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCcccccC-----CCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHH
Q 043524 173 SLSISIPEGETHITDTVMGTYGHLAPQYVTTC-----DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLK 247 (314)
Q Consensus 173 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (314)
|+++...... .......||..|+|||++... ..+.++|||||||++|+|++|+.||....... +.....
T Consensus 213 G~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-----~~~~~~ 286 (353)
T PLN00034 213 GVSRILAQTM-DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD-----WASLMC 286 (353)
T ss_pred ccceeccccc-ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc-----HHHHHH
Confidence 9997654322 123345789999999987532 23568999999999999999999997322111 111111
Q ss_pred hhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 248 NYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.... .. ........+.++.+|+..||+.||++|||+.|+++
T Consensus 287 ~~~~-------------~~-~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 287 AICM-------------SQ-PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred HHhc-------------cC-CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 00 00011134567899999999999999999999986
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=268.76 Aligned_cols=243 Identities=21% Similarity=0.336 Sum_probs=204.5
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeEE
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAIL 97 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i 97 (314)
.+|.|- +.||.++.++++..+|+|++-++++...... +.+.+|+++-+.|+||||.++|++|.+....|+
T Consensus 29 ~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~---------~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 29 PLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVE---------HQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred cccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcch---------hhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 355544 6899999999999999999998887665433 778999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccccee
Q 043524 98 VFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSIS 177 (314)
Q Consensus 98 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~ 177 (314)
++||.++|++...+..... ..+.......++.|++.|+.||| .++|+||||||+|+|++..+.+|++|||-+..
T Consensus 100 ilEya~~gel~k~L~~~~~---~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~ 173 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRM---KRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVH 173 (281)
T ss_pred EEEecCCchHHHHHHhccc---ccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceee
Confidence 9999999999999985543 35777888899999999999999 99999999999999999999999999999876
Q ss_pred cCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCccc
Q 043524 178 IPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTE 257 (314)
Q Consensus 178 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (314)
.+. ....+.+||.-|++||+..+..++..+|+|++|+..||++.|.+||+.....+ .+.
T Consensus 174 ~p~---~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e----tYk-------------- 232 (281)
T KOG0580|consen 174 APS---NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE----TYK-------------- 232 (281)
T ss_pred cCC---CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH----HHH--------------
Confidence 542 34678899999999999999999999999999999999999999997544221 011
Q ss_pred ccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 258 IVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.+.+.....+ ...+..+.+||..||..+|.+|.+..|+++
T Consensus 233 ---rI~k~~~~~p--~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 233 ---RIRKVDLKFP--STISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred ---HHHHccccCC--cccChhHHHHHHHHhccCccccccHHHHhh
Confidence 1111111111 256677899999999999999999999875
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=283.51 Aligned_cols=266 Identities=23% Similarity=0.332 Sum_probs=193.7
Q ss_pred cccccccCch-hHHHH----HHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEE
Q 043524 15 KRTLMIGNGA-SVLQE----LIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCC 89 (314)
Q Consensus 15 ~~~~~~G~g~-~~~~~----~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 89 (314)
+....+|.|+ +.|+. .....++..+|+|.+........ .+.+.+|+++++.++||||+++++++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~~E~~~l~~l~h~~i~~~~~~~ 75 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQN-----------TSGWKKEINILKTLYHENIVKYKGCC 75 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHH-----------HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 3444577777 55533 33556788999998865422111 15678999999999999999999988
Q ss_pred Ee--CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCce
Q 043524 90 LE--TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVV 167 (314)
Q Consensus 90 ~~--~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~ 167 (314)
.. ....+++|||+++++|.+++... .++...+..++.|++.||.||| +++++|+||||+||+++.++.+
T Consensus 76 ~~~~~~~~~lv~e~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~ 146 (283)
T cd05080 76 SEQGGKGLQLIMEYVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLV 146 (283)
T ss_pred ecCCCceEEEEecCCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcE
Confidence 65 34689999999999999998653 4788999999999999999999 9999999999999999999999
Q ss_pred EEcccccceecCCCCcc--cccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCcc-ccccchHH
Q 043524 168 KLFDFSLSISIPEGETH--ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAH-DLVYPFNE 244 (314)
Q Consensus 168 kl~dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~-~~~~~~~~ 244 (314)
+|+|||+++........ ......++..|+|||.+....++.++||||||+++|+|++|..|+....... +.......
T Consensus 147 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~ 226 (283)
T cd05080 147 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQG 226 (283)
T ss_pred EEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhccccc
Confidence 99999998766432211 1122345667999999988889999999999999999999999986433211 00000000
Q ss_pred HHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHH
Q 043524 245 YLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQIC 308 (314)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~ 308 (314)
........+..+... ..+.+...+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 227 ----~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 227 ----QMTVVRLIELLERGM----RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred ----ccchhhhhhhhhcCC----CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 000000000111000 01111134567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=293.96 Aligned_cols=244 Identities=20% Similarity=0.301 Sum_probs=189.8
Q ss_pred cccCch-hHHHHHHH---hcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCe
Q 043524 19 MIGNGA-SVLQELIA---SSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPI 94 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~---~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 94 (314)
.+|.|+ +.|+.+.. ..+|+.+|+|++.......... ....+.+|+.+++.++||||+++++++..++.
T Consensus 3 ~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~--------~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~ 74 (323)
T cd05584 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQK--------DTAHTKAERNILEAVKHPFIVDLIYAFQTGGK 74 (323)
T ss_pred eeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhh--------hHHHHHHHHHHHHhCCCCchhceeeEEecCCe
Confidence 467777 66665543 3578899999998765432111 01456789999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccc
Q 043524 95 AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL 174 (314)
Q Consensus 95 ~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~ 174 (314)
.|+||||+++++|.+.+.... .++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+|||+
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 146 (323)
T cd05584 75 LYLILEYLSGGELFMHLEREG-----IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGL 146 (323)
T ss_pred EEEEEeCCCCchHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcC
Confidence 999999999999999887543 4677888889999999999999 99999999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCC
Q 043524 175 SISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNR 254 (314)
Q Consensus 175 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (314)
++....... ......||+.|+|||++....++.++||||+|+++|+|++|+.||...... ........
T Consensus 147 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~--------~~~~~~~~--- 214 (323)
T cd05584 147 CKESIHEGT-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK--------KTIDKILK--- 214 (323)
T ss_pred CeecccCCC-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH--------HHHHHHHc---
Confidence 875432221 233457899999999999888999999999999999999999999643311 11111111
Q ss_pred cccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCC-----CHHHHHH
Q 043524 255 FTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRP-----TMVDVAR 302 (314)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 302 (314)
+....+ ...+..+.+|+..||+.||++|| ++.++++
T Consensus 215 ----------~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 215 ----------GKLNLP--PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred ----------CCCCCC--CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 111000 12345688999999999999999 7888766
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=285.90 Aligned_cols=260 Identities=20% Similarity=0.307 Sum_probs=197.5
Q ss_pred CcccccccCch-hHHHHHHH-----hcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEe
Q 043524 14 GKRTLMIGNGA-SVLQELIA-----SSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIG 87 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~-----~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 87 (314)
+.....+|.|+ +.|+.+.. ..++..+|+|.+....... .+.+.+|+.++..++||||+++++
T Consensus 7 ~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~------------~~~~~~e~~~l~~l~h~~i~~~~~ 74 (288)
T cd05093 7 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNA------------RKDFHREAELLTNLQHEHIVKFYG 74 (288)
T ss_pred eeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHH------------HHHHHHHHHHHHhCCCCCcceEEE
Confidence 33444578877 66666542 3345578999876432211 156889999999999999999999
Q ss_pred EEEeCCeeEEEEeecCCCCHHHHHhcCCC--------CCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCe
Q 043524 88 CCLETPIAILVFEYVQHGTLWDRILGAPQ--------THFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHI 159 (314)
Q Consensus 88 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~--------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~ni 159 (314)
++..++..++++||+++++|.+++..... .....+++..+..++.|++.||+||| +++++||||||+||
T Consensus 75 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Ni 151 (288)
T cd05093 75 VCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNC 151 (288)
T ss_pred EEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceE
Confidence 99999999999999999999999875431 11234788999999999999999999 99999999999999
Q ss_pred eecCCCceEEcccccceecCCCCc-ccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccc
Q 043524 160 LFSEENVVKLFDFSLSISIPEGET-HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHD 237 (314)
Q Consensus 160 l~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~ 237 (314)
+++.++.++++|||.++....... .......++..|+|||.+....++.++|+||||+++|+|++ |..||.......
T Consensus 152 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~- 230 (288)
T cd05093 152 LVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE- 230 (288)
T ss_pred EEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-
Confidence 999999999999999876533221 11223345778999999988889999999999999999998 888886433211
Q ss_pred cccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 238 LVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
....... ..... .....+.++.+|+.+||+.||.+|||+.+++..|+++...
T Consensus 231 -------~~~~i~~-~~~~~-------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 231 -------VIECITQ-GRVLQ-------------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred -------HHHHHHc-CCcCC-------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 1111111 00000 0012345689999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=293.65 Aligned_cols=243 Identities=21% Similarity=0.321 Sum_probs=192.2
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeEEEeCCeeE
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGCCLETPIAI 96 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 96 (314)
.+|.|+ +.|+.+.+..+++.+|+|++.......... .+.+..|..++..+ +||||+++++++...+.+|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~---------~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~ 72 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDD---------VECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLF 72 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhH---------HHHHHHHHHHHHhccCCCCccceeeEEEcCCEEE
Confidence 367777 788888888889999999998765332211 14567888888877 6999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
+||||+++|+|.+.+.... .++...+..++.|++.||.||| +++++|+||||+||+++.++.++|+|||+++
T Consensus 73 lv~e~~~~~~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 144 (318)
T cd05570 73 FVMEYVNGGDLMFHIQRSG-----RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCK 144 (318)
T ss_pred EEEcCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCe
Confidence 9999999999998887642 4788999999999999999999 9999999999999999999999999999986
Q ss_pred ecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcc
Q 043524 177 SIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFT 256 (314)
Q Consensus 177 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (314)
....... ......|++.|+|||++.+..++.++|+||+||++|+|++|..||...... .........
T Consensus 145 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~--------~~~~~i~~~---- 211 (318)
T cd05570 145 EGILGGV-TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED--------ELFQSILED---- 211 (318)
T ss_pred ecCcCCC-cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH--------HHHHHHHcC----
Confidence 5322221 133456899999999999989999999999999999999999999643311 111111100
Q ss_pred cccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCH-----HHHHH
Q 043524 257 EIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTM-----VDVAR 302 (314)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~-----~ell~ 302 (314)
.... +...+..+.+|+.+||+.||++|||+ .++++
T Consensus 212 ---------~~~~--~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 212 ---------EVRY--PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred ---------CCCC--CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 0000 01234568899999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=282.03 Aligned_cols=250 Identities=22% Similarity=0.350 Sum_probs=193.8
Q ss_pred ccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCe
Q 043524 16 RTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPI 94 (314)
Q Consensus 16 ~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 94 (314)
-...+|.|+ +.|+++... +++.+|+|.+...... .+.+.+|+.+++.++||||+++++++...+.
T Consensus 10 ~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~-------------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 75 (261)
T cd05068 10 LLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMD-------------PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEP 75 (261)
T ss_pred eEEEecccCCccEEEEEec-CCeEEEEEeeCCCccc-------------HHHHHHHHHHHHHCCCCCccceeEEEecCCC
Confidence 344578877 777776643 4578999987653321 1467899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccc
Q 043524 95 AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL 174 (314)
Q Consensus 95 ~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~ 174 (314)
.|+++||+++++|.+++..... ..++...+..++.+++.|+.+|| +++++|+||||+||+++.++.++|+|||+
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~ 149 (261)
T cd05068 76 IYIVTELMKYGSLLEYLQGGAG---RALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGL 149 (261)
T ss_pred eeeeeecccCCcHHHHHhccCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcce
Confidence 9999999999999999876432 35788999999999999999999 99999999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhccC
Q 043524 175 SISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFEDN 253 (314)
Q Consensus 175 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (314)
++...............+..|+|||.+....++.++|+||||+++|+|++ |+.||....... .... ....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--------~~~~-~~~~ 220 (261)
T cd05068 150 ARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE--------VLQQ-VDQG 220 (261)
T ss_pred EEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH--------HHHH-HHcC
Confidence 98765332211222233467999999988889999999999999999999 998986432111 0000 0000
Q ss_pred CcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHH
Q 043524 254 RFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQI 307 (314)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~ 307 (314)
. ..+.+...+..+.+++.+||+.||++||++.++.+.|+++
T Consensus 221 -~------------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 221 -Y------------RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred -C------------CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 0 0000113346689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=296.22 Aligned_cols=252 Identities=17% Similarity=0.178 Sum_probs=196.9
Q ss_pred cccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCC
Q 043524 15 KRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETP 93 (314)
Q Consensus 15 ~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (314)
.....+|.|+ +.|+++.+..+|+.+|+|++......... ..+.+.+|+.++..++|+||+++++++.+++
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~---------~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~ 74 (330)
T cd05601 4 DVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQE---------TVSFFEEERDILSISNSPWIPQLQYAFQDKD 74 (330)
T ss_pred eEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhh---------HHHHHHHHHHHHHhCCCCCCcceeeEEecCC
Confidence 3345688888 88888888889999999999876542211 1156778999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccc
Q 043524 94 IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFS 173 (314)
Q Consensus 94 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg 173 (314)
..|+||||+++|+|.+++.... ..++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+|||
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg 147 (330)
T cd05601 75 NLYLVMEYQPGGDLLSLLNRYE----DQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFG 147 (330)
T ss_pred eEEEEECCCCCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCC
Confidence 9999999999999999997653 35788899999999999999999 9999999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCcccc------cCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHH
Q 043524 174 LSISIPEGETHITDTVMGTYGHLAPQYVT------TCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLK 247 (314)
Q Consensus 174 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (314)
++...............||+.|+|||++. ...++.++||||+||++|+|++|..||....... ...
T Consensus 148 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~--------~~~ 219 (330)
T cd05601 148 SAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK--------TYN 219 (330)
T ss_pred CCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH--------HHH
Confidence 99876543332233457899999999986 3457889999999999999999999996433211 111
Q ss_pred hhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 248 NYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
......... ..+.....+..+.+|+..||. ||++|||+.+++.
T Consensus 220 ~i~~~~~~~-----------~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 220 NIMNFQRFL-----------KFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred HHHcCCCcc-----------CCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 111110000 000111344568899999998 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=283.31 Aligned_cols=253 Identities=22% Similarity=0.333 Sum_probs=193.8
Q ss_pred ccccCch-hHHHHHHHh-----cCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 18 LMIGNGA-SVLQELIAS-----SNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~-----~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
..+|+|+ +.|+.+... .+++.+|+|.+....... ..+.+.+|++++..++|+||+++++++..
T Consensus 11 ~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 79 (280)
T cd05049 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASND-----------ARKDFEREAELLTNFQHENIVKFYGVCTE 79 (280)
T ss_pred hhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHH-----------HHHHHHHHHHHHHhcCCCCchheeeEEec
Confidence 3488888 777776543 345789999876432211 12578899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCC---------CCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeec
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQ---------THFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFS 162 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~---------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~ 162 (314)
+...|++|||+++++|.+++..... .....++...+..++.|++.|+.||| +++++|+||||+||+++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~ 156 (280)
T cd05049 80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVG 156 (280)
T ss_pred CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEc
Confidence 9999999999999999999976431 11234678888999999999999999 99999999999999999
Q ss_pred CCCceEEcccccceecCCCCcc-cccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCcccccc
Q 043524 163 EENVVKLFDFSLSISIPEGETH-ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVY 240 (314)
Q Consensus 163 ~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~ 240 (314)
.++.++|+|||+++........ ......+++.|+|||++....++.++||||+|+++|+|++ |..||.......
T Consensus 157 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---- 232 (280)
T cd05049 157 YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---- 232 (280)
T ss_pred CCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH----
Confidence 9999999999998764332211 1223345788999999998889999999999999999998 999985433211
Q ss_pred chHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHH
Q 043524 241 PFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQ 306 (314)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 306 (314)
...... . +.... .+...+..+.+++.+||..||++|||+.|+++.|++
T Consensus 233 ----~~~~~~-~------------~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 233 ----VIECIT-Q------------GRLLQ-RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred ----HHHHHH-c------------CCcCC-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 111110 0 00000 011344668999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=303.94 Aligned_cols=253 Identities=15% Similarity=0.184 Sum_probs=194.7
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
+|.....+|.|+ +.|+++.+..+|+.+|+|++.......... .+.+.+|++++..++|+||+++++.+.+
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~---------~~~~~~E~~il~~l~h~~iv~~~~~~~~ 72 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQ---------AAHVKAERDILAEADNEWVVKLYYSFQD 72 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhh---------HHHHHHHHHHHHhCCCCCcceEEEEEEc
Confidence 344556688888 889988888999999999998765433211 1567899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
++.+|+|||||++|+|.+++.... .++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+|
T Consensus 73 ~~~~~lv~E~~~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~D 144 (376)
T cd05598 73 KDNLYFVMDYIPGGDMMSLLIRLG-----IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTD 144 (376)
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEe
Confidence 999999999999999999987643 4678888889999999999999 99999999999999999999999999
Q ss_pred cccceecCCCC------------------------------------------cccccccccccccccCcccccCCCCcc
Q 043524 172 FSLSISIPEGE------------------------------------------THITDTVMGTYGHLAPQYVTTCDFSEK 209 (314)
Q Consensus 172 fg~~~~~~~~~------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~ 209 (314)
||++..+.... ........||+.|+|||++.+..++.+
T Consensus 145 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 224 (376)
T cd05598 145 FGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL 224 (376)
T ss_pred CCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcc
Confidence 99975321000 000113469999999999998889999
Q ss_pred cchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccC
Q 043524 210 LDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNE 289 (314)
Q Consensus 210 ~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~ 289 (314)
+||||+||++|+|++|+.||....... .......... ....+.....+..+.+++.+|+ .
T Consensus 225 ~DiwSlGvilyell~G~~Pf~~~~~~~--------~~~~i~~~~~-----------~~~~~~~~~~s~~~~~li~~l~-~ 284 (376)
T cd05598 225 CDWWSVGVILYEMLVGQPPFLADTPAE--------TQLKVINWET-----------TLHIPSQAKLSREASDLILRLC-C 284 (376)
T ss_pred eeeeeccceeeehhhCCCCCCCCCHHH--------HHHHHhccCc-----------cccCCCCCCCCHHHHHHHHHHh-c
Confidence 999999999999999999997543211 0011100000 0000001123456788888876 5
Q ss_pred CCCCCC---CHHHHHH
Q 043524 290 SPIDRP---TMVDVAR 302 (314)
Q Consensus 290 dp~~Rp---s~~ell~ 302 (314)
+|++|+ |+.|++.
T Consensus 285 ~p~~R~~~~t~~ell~ 300 (376)
T cd05598 285 GAEDRLGKNGADEIKA 300 (376)
T ss_pred CHhhcCCCCCHHHHhC
Confidence 999999 8899875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=292.74 Aligned_cols=242 Identities=18% Similarity=0.288 Sum_probs=189.2
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhc-CCCCceeeeEeEEEeCCeeE
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQ-MSHDHILKLIGCCLETPIAI 96 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~ 96 (314)
.+|.|+ +.|+++.+..+|+.+|+|++.......... .+.+..|..++.. ++||||+++++++.+.+..|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~---------~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~ 72 (316)
T cd05620 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDD---------VECTMVEKRVLALAWENPFLTHLYCTFQTKEHLF 72 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcch---------HHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEE
Confidence 367777 888888888899999999998754321111 1445678888775 48999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
+||||+++|+|.+.+... ..++...+..++.|++.||+||| +++|+||||||+||+++.++.++|+|||+++
T Consensus 73 lv~E~~~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~ 144 (316)
T cd05620 73 FVMEFLNGGDLMFHIQDK-----GRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCK 144 (316)
T ss_pred EEECCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCe
Confidence 999999999999888654 24788889999999999999999 9999999999999999999999999999986
Q ss_pred ecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcc
Q 043524 177 SIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFT 256 (314)
Q Consensus 177 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (314)
....... ......||+.|+|||++.+..++.++||||+||++|+|++|..||...... ........
T Consensus 145 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--------~~~~~~~~----- 210 (316)
T cd05620 145 ENVFGDN-RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--------ELFESIRV----- 210 (316)
T ss_pred ecccCCC-ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHh-----
Confidence 5322211 234567899999999999888999999999999999999999999643211 11111100
Q ss_pred cccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHH-HHH
Q 043524 257 EIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMV-DVA 301 (314)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~-ell 301 (314)
..... +...+.++.+|+.+||+.||++||++. +++
T Consensus 211 --------~~~~~--~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 211 --------DTPHY--PRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred --------CCCCC--CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 00000 012345688999999999999999974 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=319.13 Aligned_cols=258 Identities=23% Similarity=0.361 Sum_probs=201.8
Q ss_pred cccccCch-hHHHH-HHHhcCCcc----cccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 17 TLMIGNGA-SVLQE-LIASSNGKY----IPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 17 ~~~~G~g~-~~~~~-~~~~~~g~~----~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
...+|.|. +.||. .+....|.. ||+|......-.+.. ..|++|..+|+.++|||||+++|++.
T Consensus 697 ~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~-----------~~Fl~Ea~~m~~f~HpNiv~liGv~l 765 (1025)
T KOG1095|consen 697 LRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEV-----------SDFLKEALLMSKFDHPNIVSLIGVCL 765 (1025)
T ss_pred eeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHH-----------HHHHHHHHHHhcCCCcceeeEEEeec
Confidence 34566666 44444 445555652 777765443212211 67999999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCC--CCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceE
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTH--FEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVK 168 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~k 168 (314)
+....+|++|||++|+|..++++...+. ...+.....+.++.||+.|..||+ ++++|||||.++|+|++....+|
T Consensus 766 ~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VK 842 (1025)
T KOG1095|consen 766 DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVK 842 (1025)
T ss_pred CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEE
Confidence 9999999999999999999999873322 246889999999999999999999 99999999999999999999999
Q ss_pred EcccccceecCCCCcccccc-cccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHH
Q 043524 169 LFDFSLSISIPEGETHITDT-VMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYL 246 (314)
Q Consensus 169 l~dfg~~~~~~~~~~~~~~~-~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~ 246 (314)
|+|||+|+.+.......... ..-+..|||||.+....|+.++|||||||++||+++ |..||....+.+..
T Consensus 843 IaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~-------- 914 (1025)
T KOG1095|consen 843 IADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVL-------- 914 (1025)
T ss_pred EcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHH--------
Confidence 99999998554444333222 245678999999999999999999999999999999 88888655443210
Q ss_pred HhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 247 KNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
.....+ ...+.++.+++.+.++|.+||+.+|++||++..|++++.++...
T Consensus 915 ~~~~~g--------------gRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 915 LDVLEG--------------GRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred HHHHhC--------------CccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 001111 12233336777889999999999999999999999999888654
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=298.93 Aligned_cols=255 Identities=18% Similarity=0.249 Sum_probs=196.6
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
..+.....+|.|+ +.|+.+.+..+++.+|+|++.......... .+.+.+|+.++..++||||+++++++.
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~---------~~~~~~e~~i~~~~~hp~iv~~~~~~~ 113 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSD---------SAFFWEERDIMAFANSPWVVQLFYAFQ 113 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHH---------HHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 3455566789888 888888888999999999987654332211 145778999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
+++..|+|||||++|+|.+++... .++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~ 184 (371)
T cd05622 114 DDRYLYMVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLA 184 (371)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEE
Confidence 999999999999999999988653 3677888899999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCcccccCC----CCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHH
Q 043524 171 DFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCD----FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYL 246 (314)
Q Consensus 171 dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 246 (314)
|||+++..............||+.|+|||++.... ++.++||||+||++|+|++|..||..... ....
T Consensus 185 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~ 256 (371)
T cd05622 185 DFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTY 256 (371)
T ss_pred eCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH--------HHHH
Confidence 99999876443332334567999999999987543 78899999999999999999999964321 1111
Q ss_pred HhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCC--CCCHHHHHHH
Q 043524 247 KNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPID--RPTMVDVARR 303 (314)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~--Rps~~ell~~ 303 (314)
........ ....+.....+..+.+++..||..++.+ ||++.|+++.
T Consensus 257 ~~i~~~~~-----------~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 257 SKIMNHKN-----------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred HHHHcCCC-----------cccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 11111100 0111111134567889999999844433 7789988873
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=295.67 Aligned_cols=243 Identities=22% Similarity=0.294 Sum_probs=188.7
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHH-HHHhcCCCCceeeeEeEEEeCCeeE
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNV-TYAAQMSHDHILKLIGCCLETPIAI 96 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~ 96 (314)
.+|.|+ +.|+++.+..+++.+|+|++.......... ...+..|. .+++.++||||+++++++.+++..|
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~---------~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~ 72 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKE---------EKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 72 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhH---------HHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEE
Confidence 478777 888888888899999999998765422211 12344454 4567889999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
+||||+++|+|.+.+.... .++...+..++.|++.||.||| ++||+||||||+||+++.++.++|+|||+++
T Consensus 73 lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~ 144 (325)
T cd05602 73 FVLDYINGGELFYHLQRER-----CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK 144 (325)
T ss_pred EEEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCc
Confidence 9999999999999887543 4677888889999999999999 9999999999999999999999999999987
Q ss_pred ecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcc
Q 043524 177 SIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFT 256 (314)
Q Consensus 177 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (314)
...... .......||+.|+|||++.+..++.++||||+||++|+|++|..||....... .......
T Consensus 145 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--------~~~~i~~----- 210 (325)
T cd05602 145 ENIEHN-GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE--------MYDNILN----- 210 (325)
T ss_pred ccccCC-CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH--------HHHHHHh-----
Confidence 542221 12335579999999999998889999999999999999999999996433211 1111111
Q ss_pred cccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 257 EIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.+... ....+..+.+++..||+.||.+||++.+.+.
T Consensus 211 --------~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 211 --------KPLQL--KPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred --------CCcCC--CCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 00000 0133456889999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=284.13 Aligned_cols=273 Identities=18% Similarity=0.257 Sum_probs=203.0
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCc-eeeeEeEEE
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDH-ILKLIGCCL 90 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~ 90 (314)
.+.+...+|+|+ ++|++++...+|+.||+|.+....-.+ . +....++|+.+|..++|+| ||.+++++.
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~E---G-------~P~taiREisllk~L~~~~~iv~L~dv~~ 81 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEE---G-------VPSTAIREISLLKRLSHANHIVRLHDVIH 81 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccccc---C-------CCchhhHHHHHHHHhCCCcceEEEEeeee
Confidence 344445599999 999999999999999999987654210 0 2245689999999999999 999999999
Q ss_pred eCC------eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCC
Q 043524 91 ETP------IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEE 164 (314)
Q Consensus 91 ~~~------~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~ 164 (314)
+.+ .+++|+||+. .+|.+++....... ..++...+..++.|++.||+||| +++|+||||||.|++++..
T Consensus 82 ~~~~~~~~~~l~lvfe~~d-~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~ 156 (323)
T KOG0594|consen 82 TSNNHRGIGKLYLVFEFLD-RDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSS 156 (323)
T ss_pred ecccccccceEEEEEEeec-ccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCC
Confidence 877 8999999995 59999998765321 24666889999999999999999 9999999999999999999
Q ss_pred CceEEcccccceecCCCCcccccccccccccccCcccccC-CCCcccchHHHHHHHHHHHhCCCCcccccCccccccchH
Q 043524 165 NVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFN 243 (314)
Q Consensus 165 ~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~ 243 (314)
|.+||+|||+|+....... ....-++|..|.|||++.+. .|+...||||+||++.||+++++.|.+....+....-+.
T Consensus 157 G~lKlaDFGlAra~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~ 235 (323)
T KOG0594|consen 157 GVLKLADFGLARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFR 235 (323)
T ss_pred CcEeeeccchHHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHH
Confidence 9999999999986642221 13345789999999999987 599999999999999999999999976655322111111
Q ss_pred HHHHhhhccCCcccccC-hhhhccCC-----chhHH---HHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 043524 244 EYLKNYFEDNRFTEIVD-PIIVQDLS-----CTEKE---QQLHASAQLTFECLNESPIDRPTMVDVARR 303 (314)
Q Consensus 244 ~~~~~~~~~~~~~~~~~-~~~~~~~~-----~~~~~---~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 303 (314)
-. .......|..+.. +..+..+. ..... .......+++.+||+++|.+|.||..+++.
T Consensus 236 ~l--GtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 236 LL--GTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred Hc--CCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 00 0001112222210 00000000 01111 112367899999999999999999999874
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=291.06 Aligned_cols=257 Identities=18% Similarity=0.286 Sum_probs=196.1
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcc----cccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKY----IPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIG 87 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~----~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 87 (314)
.++....+|+|+ +.|+++....+|.. +|+|.+........ .+++.+|+.+++.++||||+++++
T Consensus 8 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~~~g 76 (316)
T cd05108 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-----------NKEILDEAYVMASVDNPHVCRLLG 76 (316)
T ss_pred hceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHH-----------HHHHHHHHHHHHhCCCCCCCeEEE
Confidence 345556688888 78877766555654 88888753321111 156889999999999999999999
Q ss_pred EEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCce
Q 043524 88 CCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVV 167 (314)
Q Consensus 88 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~ 167 (314)
++... ..++++||+++|+|.+.+.... ..++......++.|++.||+||| +++|+||||||+||+++.++.+
T Consensus 77 ~~~~~-~~~~v~e~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~ 148 (316)
T cd05108 77 ICLTS-TVQLITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHV 148 (316)
T ss_pred EEcCC-CceeeeecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcE
Confidence 99764 5679999999999999997654 34778888999999999999999 9999999999999999999999
Q ss_pred EEcccccceecCCCCccc-ccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHH
Q 043524 168 KLFDFSLSISIPEGETHI-TDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEY 245 (314)
Q Consensus 168 kl~dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~ 245 (314)
+|+|||+++......... .....++..|+|||.+....++.++||||||+++|||++ |..||...... ..
T Consensus 149 kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--------~~ 220 (316)
T cd05108 149 KITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------EI 220 (316)
T ss_pred EEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--------HH
Confidence 999999998764432211 122234678999999988889999999999999999997 99998643211 11
Q ss_pred HHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 246 LKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
........ ..+.+..++..+.+++..||..||++|||+.+++..|.++...
T Consensus 221 -~~~~~~~~-------------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 221 -SSILEKGE-------------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred -HHHHhCCC-------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 11111100 0000112345678999999999999999999999999888654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=301.82 Aligned_cols=252 Identities=14% Similarity=0.188 Sum_probs=193.3
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
+.....+|.|+ +.|+++.+..+++.+|+|++.......... .+.+.+|+.++..++|||||++++.+.++
T Consensus 3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~---------~~~~~~E~~il~~~~h~~iv~~~~~~~~~ 73 (382)
T cd05625 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQ---------VAHVKAERDILAEADNEWVVRLYYSFQDK 73 (382)
T ss_pred cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHH---------HHHHHHHHHHHHhCCCCcCCeEEEEEEeC
Confidence 34455688888 888998888999999999998765432211 15678999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~df 172 (314)
+.+|+|||||++|+|.+.+.... .++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+||
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DF 145 (382)
T cd05625 74 DNLYFVMDYIPGGDMMSLLIRMG-----IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDF 145 (382)
T ss_pred CEEEEEEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeEC
Confidence 99999999999999999886542 4778888999999999999999 999999999999999999999999999
Q ss_pred ccceecCCCC----------------------------------------------cccccccccccccccCcccccCCC
Q 043524 173 SLSISIPEGE----------------------------------------------THITDTVMGTYGHLAPQYVTTCDF 206 (314)
Q Consensus 173 g~~~~~~~~~----------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~ 206 (314)
|++..+.... ........||+.|+|||++.+..+
T Consensus 146 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~ 225 (382)
T cd05625 146 GLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGY 225 (382)
T ss_pred CCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCC
Confidence 9975321000 000123468999999999998899
Q ss_pred CcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHh
Q 043524 207 SEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFEC 286 (314)
Q Consensus 207 ~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 286 (314)
+.++||||+||++|||++|+.||....... ......... .....+.....+.++.+++..|
T Consensus 226 ~~~~DiwSlGvil~elltG~~Pf~~~~~~~--------~~~~i~~~~-----------~~~~~p~~~~~s~~~~~li~~l 286 (382)
T cd05625 226 TQLCDWWSVGVILYEMLVGQPPFLAQTPLE--------TQMKVINWQ-----------TSLHIPPQAKLSPEASDLIIKL 286 (382)
T ss_pred CCeeeEEechHHHHHHHhCCCCCCCCCHHH--------HHHHHHccC-----------CCcCCCCcccCCHHHHHHHHHH
Confidence 999999999999999999999996433211 000111000 0000111113345678888887
Q ss_pred ccCCCCCCCC---HHHHHH
Q 043524 287 LNESPIDRPT---MVDVAR 302 (314)
Q Consensus 287 l~~dp~~Rps---~~ell~ 302 (314)
+ .||++|++ +.++++
T Consensus 287 ~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 287 C-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred c-cCHhHcCCCCCHHHHhc
Confidence 6 59999997 888765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=295.95 Aligned_cols=256 Identities=23% Similarity=0.322 Sum_probs=208.2
Q ss_pred cccccccCchhHHHHHHHhc-CCc--ccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 15 KRTLMIGNGASVLQELIASS-NGK--YIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 15 ~~~~~~G~g~~~~~~~~~~~-~g~--~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
++.+|.|.+|.++...+... .|+ .||||..........+ +.|+.|..+++.++|||||+++|+|.+
T Consensus 394 ~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~t-----------ekflqEa~iMrnfdHphIikLIGv~~e 462 (974)
T KOG4257|consen 394 KRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDT-----------EKFLQEASIMRNFDHPHIIKLIGVCVE 462 (974)
T ss_pred HHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhH-----------HHHHHHHHHHHhCCCcchhheeeeeec
Confidence 34556666666665555555 454 5777766543221112 789999999999999999999999954
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
...|||||+++-|.|..++.... ..++......++.|++.+|+||| +++.|||||...|||+.+...+|++|
T Consensus 463 -~P~WivmEL~~~GELr~yLq~nk----~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaD 534 (974)
T KOG4257|consen 463 -QPMWIVMELAPLGELREYLQQNK----DSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLAD 534 (974)
T ss_pred -cceeEEEecccchhHHHHHHhcc----ccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecc
Confidence 67899999999999999998766 46888999999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhh
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
||+++.+.+...++.....-+..|||||.+...+++.++|||.||+.+||++. |..||.+.++.+-
T Consensus 535 FGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV------------- 601 (974)
T KOG4257|consen 535 FGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV------------- 601 (974)
T ss_pred cchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce-------------
Confidence 99999998877766665566788999999999999999999999999999886 9999987776541
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhc
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSL 311 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 311 (314)
+- .+.+...++.++.+++.+..|+.+||.+||.+||++.||...|.+++..-
T Consensus 602 --------I~-~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qee 653 (974)
T KOG4257|consen 602 --------IG-HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEE 653 (974)
T ss_pred --------EE-EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHh
Confidence 11 11122223333467778899999999999999999999999999887643
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=300.82 Aligned_cols=250 Identities=16% Similarity=0.211 Sum_probs=191.5
Q ss_pred ccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCe
Q 043524 16 RTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPI 94 (314)
Q Consensus 16 ~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 94 (314)
....+|.|+ +.|+++.+..+|+.||+|++......... ..+.+.+|++++..++||||+++++++.++..
T Consensus 5 ~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~---------~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~ 75 (377)
T cd05629 5 TVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKD---------QLAHVKAERDVLAESDSPWVVSLYYSFQDAQY 75 (377)
T ss_pred EeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhH---------HHHHHHHHHHHHHhCCCCCcceEEEEEEcCCe
Confidence 344588888 88888888899999999998765432211 12567889999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccc
Q 043524 95 AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL 174 (314)
Q Consensus 95 ~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~ 174 (314)
.|+||||+++|+|.+++... ..++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+|||+
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGl 147 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKY-----DTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGL 147 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeeccc
Confidence 99999999999999998754 34778888999999999999999 99999999999999999999999999999
Q ss_pred ceecCCCCcc----------------------------------------------cccccccccccccCcccccCCCCc
Q 043524 175 SISIPEGETH----------------------------------------------ITDTVMGTYGHLAPQYVTTCDFSE 208 (314)
Q Consensus 175 ~~~~~~~~~~----------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~ 208 (314)
++........ ......||+.|+|||++.+..++.
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 227 (377)
T cd05629 148 STGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQ 227 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCC
Confidence 8643211000 001246899999999998888999
Q ss_pred ccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhcc
Q 043524 209 KLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLN 288 (314)
Q Consensus 209 ~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 288 (314)
++||||+||++|||++|..||....... .......... ....+.....+.++.+|+.+||.
T Consensus 228 ~~DiwSlGvil~elltG~~Pf~~~~~~~--------~~~~i~~~~~-----------~~~~p~~~~~s~~~~dli~~lL~ 288 (377)
T cd05629 228 ECDWWSLGAIMFECLIGWPPFCSENSHE--------TYRKIINWRE-----------TLYFPDDIHLSVEAEDLIRRLIT 288 (377)
T ss_pred ceeeEecchhhhhhhcCCCCCCCCCHHH--------HHHHHHccCC-----------ccCCCCCCCCCHHHHHHHHHHhc
Confidence 9999999999999999999996433211 1111111000 00001111234568899999998
Q ss_pred CCCCCC---CCHHHHHH
Q 043524 289 ESPIDR---PTMVDVAR 302 (314)
Q Consensus 289 ~dp~~R---ps~~ell~ 302 (314)
+|.+| +|+.|++.
T Consensus 289 -~~~~r~~r~~~~~~l~ 304 (377)
T cd05629 289 -NAENRLGRGGAHEIKS 304 (377)
T ss_pred -CHhhcCCCCCHHHHhc
Confidence 67765 59999876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=291.15 Aligned_cols=272 Identities=16% Similarity=0.205 Sum_probs=195.7
Q ss_pred hhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEE
Q 043524 11 WSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCC 89 (314)
Q Consensus 11 ~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 89 (314)
...|.....+|.|+ +.|+++.+..+++.+|+|.+........ ...+.+|+.++..++||||+++++++
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~~E~~~l~~l~h~~iv~~~~~~ 73 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA-----------PCTAIREVSLLKDLKHANIVTLHDIV 73 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCc-----------chhHHHHHHHHHhCCCCCcceEEEEE
Confidence 34455566789888 8888888888899999998864321110 13567899999999999999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEE
Q 043524 90 LETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKL 169 (314)
Q Consensus 90 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl 169 (314)
..++..++||||++ ++|.+.+.... ..++...+..++.|++.||.||| +++|+||||||+||+++.++.++|
T Consensus 74 ~~~~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl 145 (309)
T cd07872 74 HTDKSLTLVFEYLD-KDLKQYMDDCG----NIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKL 145 (309)
T ss_pred eeCCeEEEEEeCCC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEE
Confidence 99999999999996 48888876543 34678888999999999999999 999999999999999999999999
Q ss_pred cccccceecCCCCcccccccccccccccCcccccC-CCCcccchHHHHHHHHHHHhCCCCcccccCcccccc-------c
Q 043524 170 FDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVY-------P 241 (314)
Q Consensus 170 ~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~-------~ 241 (314)
+|||+++....... ......+++.|+|||++.+. .++.++||||+|+++|+|++|+.||......+.... +
T Consensus 146 ~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 224 (309)
T cd07872 146 ADFGLARAKSVPTK-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTP 224 (309)
T ss_pred CccccceecCCCcc-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 99999876433221 12334678999999988654 578999999999999999999999965432211000 0
Q ss_pred hHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 242 FNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
...................+..............+.++.+|+.+||+.||.+|||+.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 225 TEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred CHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0000000000000000000000000000011134567889999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=290.67 Aligned_cols=243 Identities=20% Similarity=0.292 Sum_probs=190.1
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhc-CCCCceeeeEeEEEeCCeeE
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQ-MSHDHILKLIGCCLETPIAI 96 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~ 96 (314)
.+|.|+ +.|+++.+..+++.||+|++.......... .+.+..|..++.. ++||||+++++++.+.+.+|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~---------~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~ 72 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDD---------VECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLF 72 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcch---------HHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEE
Confidence 367777 888888888889999999998764322111 1445677888875 48999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
+||||+++|+|.+.+.... .++......++.|++.||.||| +++|+||||||+||+++.++.++|+|||+++
T Consensus 73 lv~ey~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~ 144 (316)
T cd05619 73 FVMEYLNGGDLMFHIQSCH-----KFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCK 144 (316)
T ss_pred EEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcce
Confidence 9999999999999887542 4778888999999999999999 9999999999999999999999999999987
Q ss_pred ecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcc
Q 043524 177 SIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFT 256 (314)
Q Consensus 177 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (314)
...... .......||+.|+|||++.+..++.++||||+||++|+|++|..||...... .........
T Consensus 145 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--------~~~~~i~~~---- 211 (316)
T cd05619 145 ENMLGD-AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--------ELFQSIRMD---- 211 (316)
T ss_pred ECCCCC-CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhC----
Confidence 542221 1233557899999999998888999999999999999999999999643311 111111000
Q ss_pred cccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHH-HHHH
Q 043524 257 EIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMV-DVAR 302 (314)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~-ell~ 302 (314)
... .+...+.++.+++.+||+.||++||++. ++++
T Consensus 212 ---------~~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 212 ---------NPC--YPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ---------CCC--CCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 000 0012345688999999999999999986 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=281.15 Aligned_cols=252 Identities=20% Similarity=0.274 Sum_probs=193.7
Q ss_pred ccccccCch-hHHHHHHHhcC---CcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 16 RTLMIGNGA-SVLQELIASSN---GKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 16 ~~~~~G~g~-~~~~~~~~~~~---g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
....+|.|+ +.|+.+....+ ...+|+|.+........ ...+.+|+.+++.++||||+++++++.+
T Consensus 8 ~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (266)
T cd05033 8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQ-----------RLDFLTEASIMGQFDHPNIIRLEGVVTK 76 (266)
T ss_pred eeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHH-----------HHHHHHHHHHHHhCCCCCcceEeEEEec
Confidence 344578877 77776655433 45799998764322111 1568899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
++..+++|||+++++|.+++.... ..++...+..++.|++.|+.||| +++|+|+||||+||+++.++.++++|
T Consensus 77 ~~~~~iv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~d 149 (266)
T cd05033 77 SRPVMIITEYMENGSLDKFLREND----GKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSD 149 (266)
T ss_pred CCceEEEEEcCCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECc
Confidence 999999999999999999987644 35788999999999999999999 99999999999999999999999999
Q ss_pred cccceecCCC-CcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhh
Q 043524 172 FSLSISIPEG-ETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNY 249 (314)
Q Consensus 172 fg~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (314)
||+++..... .........++..|+|||.+....++.++||||+|+++|+|++ |..||....... .....
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~--------~~~~~ 221 (266)
T cd05033 150 FGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD--------VIKAV 221 (266)
T ss_pred cchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH--------HHHHH
Confidence 9999876421 1111222344678999999988889999999999999999998 988885322111 11110
Q ss_pred hccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHH
Q 043524 250 FEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQI 307 (314)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~ 307 (314)
.... ..+.+...+..+.+++.+||+.||++||++.|+++.|.++
T Consensus 222 -~~~~-------------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 222 -EDGY-------------RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -HcCC-------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0000 0000113446689999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=296.22 Aligned_cols=256 Identities=21% Similarity=0.345 Sum_probs=201.8
Q ss_pred ccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCe
Q 043524 16 RTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPI 94 (314)
Q Consensus 16 ~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 94 (314)
....||.|. ++|+.+.+.. .||||++.......+. .++|.+||..+++-+|.||+-|.|+|...+.
T Consensus 396 l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~q----------lqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 396 LGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQ----------LQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred ccceeccccccceeeccccc---ceEEEEEecCCCCHHH----------HHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 344588888 7777775554 4899998776543331 2789999999999999999999999988777
Q ss_pred eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccc
Q 043524 95 AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL 174 (314)
Q Consensus 95 ~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~ 174 (314)
.||+.+|+|.+|..++.... ..+.....+.++.|++.|+.||| .++|+|||||..||++.+++++||+|||+
T Consensus 463 -AIiTqwCeGsSLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred -eeeehhccCchhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccc
Confidence 89999999999999997765 46888999999999999999999 99999999999999999999999999999
Q ss_pred ceecCC-CCcccccccccccccccCcccc---cCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhh
Q 043524 175 SISIPE-GETHITDTVMGTYGHLAPQYVT---TCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 175 ~~~~~~-~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
+..... ..........|...|||||++- ..+|+..+||||||+++|||++|..||..........+.-.+++
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l---- 610 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYL---- 610 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEeccccc----
Confidence 855322 1222344567888999999885 44699999999999999999999999983322222111111111
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
.+ .......+++.++.+|+..||.+++++||++.+|+..|+++..+
T Consensus 611 ---------~p-----d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 611 ---------MP-----DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred ---------Cc-----cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 00 01112236778899999999999999999999999999888763
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=281.55 Aligned_cols=249 Identities=22% Similarity=0.333 Sum_probs=196.3
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCee
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIA 95 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (314)
...+|.|+ +.|+.+.... ++.+|+|.+........ +.+.+|+.+++.++|+||+++++++.++...
T Consensus 11 ~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~------------~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 77 (261)
T cd05148 11 ERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQ------------QDFQKEVQALKRLRHKHLISLFAVCSVGEPV 77 (261)
T ss_pred hhhhccCCCccEEEeEecC-CCcEEEEeccccchhhH------------HHHHHHHHHHhcCCCcchhheeeeEecCCCe
Confidence 34478877 7777776666 88999999876543222 4678999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
+++|||+++++|.+.+..... ..++...+..++.+++.||.||| +++++|+||+|+||+++.++.++++|||.+
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~ 151 (261)
T cd05148 78 YIITELMEKGSLLAFLRSPEG---QVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLA 151 (261)
T ss_pred EEEEeecccCCHHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccch
Confidence 999999999999999976432 35788899999999999999999 999999999999999999999999999998
Q ss_pred eecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhccCC
Q 043524 176 ISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFEDNR 254 (314)
Q Consensus 176 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (314)
......... .....++..|+|||.+....++.++|+||||+++|+|++ |..||....... ........
T Consensus 152 ~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~--------~~~~~~~~-- 220 (261)
T cd05148 152 RLIKEDVYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE--------VYDQITAG-- 220 (261)
T ss_pred hhcCCcccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH--------HHHHHHhC--
Confidence 765433221 223446778999999988889999999999999999998 888986433111 11111000
Q ss_pred cccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHH
Q 043524 255 FTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQI 307 (314)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~ 307 (314)
...+.+...+..+.+++.+||..||++|||+.++++.|+.+
T Consensus 221 ------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 221 ------------YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred ------------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 00001113446688999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=280.22 Aligned_cols=247 Identities=18% Similarity=0.322 Sum_probs=187.7
Q ss_pred ccCch-hHHHHHHH--hcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeE
Q 043524 20 IGNGA-SVLQELIA--SSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAI 96 (314)
Q Consensus 20 ~G~g~-~~~~~~~~--~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (314)
+|.|+ +.|+.+.. ..++..+|+|++....... ..+.+.+|+.++++++||||+++++++. ....+
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~ 70 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKS-----------VRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALM 70 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChH-----------HHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeE
Confidence 67777 66665433 2445679999876542211 1256889999999999999999999885 45789
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
+||||+++++|.+++.... ..++...+..++.|++.||.||| +++++|+||||+||+++.++.++++|||+++
T Consensus 71 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~ 143 (257)
T cd05115 71 LVMEMASGGPLNKFLSGKK----DEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSK 143 (257)
T ss_pred EEEEeCCCCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccc
Confidence 9999999999999887543 35788999999999999999999 9999999999999999999999999999987
Q ss_pred ecCCCCcccc--cccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhccC
Q 043524 177 SIPEGETHIT--DTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFEDN 253 (314)
Q Consensus 177 ~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (314)
.......... ....++..|+|||.+....++.++||||||+++|++++ |..||....... ... .....
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------~~~-~~~~~ 214 (257)
T cd05115 144 ALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--------VMS-FIEQG 214 (257)
T ss_pred cccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH--------HHH-HHHCC
Confidence 6543322111 11123568999999888889999999999999999996 999986433211 111 11110
Q ss_pred CcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHH
Q 043524 254 RFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQI 307 (314)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~ 307 (314)
. . ...+...+.++.+++.+||..||++||++.+|.+.|+.+
T Consensus 215 ~-~------------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 215 K-R------------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred C-C------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 0 0 000113456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=282.83 Aligned_cols=259 Identities=20% Similarity=0.324 Sum_probs=197.6
Q ss_pred ccccccCch-hHHHHHHH-----hcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEE
Q 043524 16 RTLMIGNGA-SVLQELIA-----SSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCC 89 (314)
Q Consensus 16 ~~~~~G~g~-~~~~~~~~-----~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 89 (314)
....+|.|+ +.++.+.. ..++..+++|.+........ +.+.+|+.+++.++|+||+++++++
T Consensus 9 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~------------~~~~~e~~~l~~l~h~~i~~~~~~~ 76 (291)
T cd05094 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR------------KDFQREAELLTNLQHEHIVKFYGVC 76 (291)
T ss_pred EeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHH------------HHHHHHHHHHhcCCCCCcceEEEEE
Confidence 344577777 66665542 23455688888765443322 4678999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhcCCCC-----------CCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCC
Q 043524 90 LETPIAILVFEYVQHGTLWDRILGAPQT-----------HFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSH 158 (314)
Q Consensus 90 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~n 158 (314)
..+...++||||+++++|.+++...... ....+++..++.++.|++.|+.||| +++++|+||||+|
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~N 153 (291)
T cd05094 77 GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRN 153 (291)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcce
Confidence 9999999999999999999999754310 1123788899999999999999999 9999999999999
Q ss_pred eeecCCCceEEcccccceecCCCCc-ccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCcc
Q 043524 159 ILFSEENVVKLFDFSLSISIPEGET-HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAH 236 (314)
Q Consensus 159 il~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~ 236 (314)
|+++.++.++|+|||++........ .......++..|+|||.+....++.++||||+|+++|+|++ |..||.......
T Consensus 154 il~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 233 (291)
T cd05094 154 CLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE 233 (291)
T ss_pred EEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999876543221 11223456788999999988889999999999999999998 999985432211
Q ss_pred ccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhc
Q 043524 237 DLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSL 311 (314)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 311 (314)
.... ........ .....+..+.+++.+||+.||++|||+.++++.|.++.+..
T Consensus 234 --------~~~~-~~~~~~~~-------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~ 286 (291)
T cd05094 234 --------VIEC-ITQGRVLE-------------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKAT 286 (291)
T ss_pred --------HHHH-HhCCCCCC-------------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhc
Confidence 1111 11111100 00123456889999999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=293.76 Aligned_cols=239 Identities=22% Similarity=0.312 Sum_probs=186.4
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHH-HHhcCCCCceeeeEeEEEeCCeeE
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVT-YAAQMSHDHILKLIGCCLETPIAI 96 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~ 96 (314)
.+|.|+ +.|+++.+..+|+.+|+|++.......... ...+..|.. +++.++||||+++++++.+.+..|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~---------~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~ 72 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKE---------QNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLY 72 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhH---------HHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEE
Confidence 367777 888888888899999999998765432211 134555554 678899999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
+||||+++|+|...+... ..++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+|||+++
T Consensus 73 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~ 144 (321)
T cd05603 73 FVLDYVNGGELFFHLQRE-----RCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK 144 (321)
T ss_pred EEEcCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCc
Confidence 999999999998888653 24778888899999999999999 9999999999999999999999999999987
Q ss_pred ecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcc
Q 043524 177 SIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFT 256 (314)
Q Consensus 177 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (314)
...... .......||+.|+|||++.+..++.++||||+||++|+|++|..||...... ........
T Consensus 145 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~i~~----- 210 (321)
T cd05603 145 EGVEPE-ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS--------QMYDNILH----- 210 (321)
T ss_pred cCCCCC-CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH--------HHHHHHhc-----
Confidence 532221 1233457899999999998888999999999999999999999999643211 11111110
Q ss_pred cccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHH
Q 043524 257 EIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMV 298 (314)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ 298 (314)
.+...+ ...+..+.+++..||+.||.+||++.
T Consensus 211 --------~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 211 --------KPLQLP--GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred --------CCCCCC--CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 111111 12345678999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=288.02 Aligned_cols=245 Identities=21% Similarity=0.333 Sum_probs=190.8
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeEEEeCCeeE
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGCCLETPIAI 96 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 96 (314)
.+|.|+ +.|+++....+++.+|+|++.......... .+.+.+|+.++..+ +||||+++++++.+.+.+|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~---------~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 72 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDED---------IDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLF 72 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhH---------HHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEE
Confidence 378887 888888888899999999998765432211 14577899999888 5999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
+||||+++|+|...+... ..++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+|||+++
T Consensus 73 lv~e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~ 144 (327)
T cd05617 73 LVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCK 144 (327)
T ss_pred EEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccce
Confidence 999999999998888654 24888999999999999999999 9999999999999999999999999999987
Q ss_pred ecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcc
Q 043524 177 SIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFT 256 (314)
Q Consensus 177 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (314)
...... .......||+.|+|||++.+..++.++||||+||++|+|++|..||+........ ..........
T Consensus 145 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~--~~~~~~~~~~------ 215 (327)
T cd05617 145 EGLGPG-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM--NTEDYLFQVI------ 215 (327)
T ss_pred eccCCC-CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccc--ccHHHHHHHH------
Confidence 532221 1233567999999999999888999999999999999999999999754332211 0111111111
Q ss_pred cccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCH
Q 043524 257 EIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTM 297 (314)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 297 (314)
...+...+ ...+..+.+++.+||+.||++|+++
T Consensus 216 ------~~~~~~~p--~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 216 ------LEKPIRIP--RFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred ------HhCCCCCC--CCCCHHHHHHHHHHhccCHHHcCCC
Confidence 01111111 1334567899999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=289.42 Aligned_cols=259 Identities=21% Similarity=0.363 Sum_probs=193.8
Q ss_pred ccccccCch-hHHHHHHH-----hcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeE
Q 043524 16 RTLMIGNGA-SVLQELIA-----SSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGC 88 (314)
Q Consensus 16 ~~~~~G~g~-~~~~~~~~-----~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~ 88 (314)
....+|.|+ +.|+.+.. ..+++.||+|.+........ .+.+..|+.++.++ +|+||++++++
T Consensus 11 i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~-----------~~~~~~E~~~~~~l~~h~niv~~~~~ 79 (337)
T cd05054 11 LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASE-----------YKALMTELKILIHIGHHLNVVNLLGA 79 (337)
T ss_pred hhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHH-----------HHHHHHHHHHHHhhccCcchhheeee
Confidence 344588888 77766643 23457899998864321111 14577899999999 79999999998
Q ss_pred EEe-CCeeEEEEeecCCCCHHHHHhcCCCCC-------------------------------------------------
Q 043524 89 CLE-TPIAILVFEYVQHGTLWDRILGAPQTH------------------------------------------------- 118 (314)
Q Consensus 89 ~~~-~~~~~iv~e~~~~g~L~~~l~~~~~~~------------------------------------------------- 118 (314)
+.. +..+++++||+++++|.+.+.......
T Consensus 80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 864 567889999999999999886432100
Q ss_pred -------CCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccceecCCCCccc-ccccc
Q 043524 119 -------FEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHI-TDTVM 190 (314)
Q Consensus 119 -------~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~ 190 (314)
..++++..+..++.|++.||.||| +++|+||||||+||+++.++.++|+|||+++......... .....
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~ 236 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 236 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCC
Confidence 025788889999999999999999 9999999999999999999999999999997654332211 22345
Q ss_pred cccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhccCCcccccChhhhccCCc
Q 043524 191 GTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSC 269 (314)
Q Consensus 191 g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (314)
++..|+|||++.+..++.++||||+||++|+|++ |..||......+. .......... .
T Consensus 237 ~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--------~~~~~~~~~~-------------~ 295 (337)
T cd05054 237 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--------FCRRLKEGTR-------------M 295 (337)
T ss_pred CCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--------HHHHHhccCC-------------C
Confidence 6778999999999899999999999999999998 9999864322110 0011111000 0
Q ss_pred hhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHh
Q 043524 270 TEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICC 309 (314)
Q Consensus 270 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 309 (314)
..+...+.++.+++..||+.+|++|||+.|+++.|+++..
T Consensus 296 ~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 296 RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0011334568899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=291.80 Aligned_cols=251 Identities=21% Similarity=0.251 Sum_probs=190.8
Q ss_pred cccccCch-hHHHHHHH---hcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC-CCceeeeEeEEEe
Q 043524 17 TLMIGNGA-SVLQELIA---SSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS-HDHILKLIGCCLE 91 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~---~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~ 91 (314)
...+|.|+ +.|+.+.+ ..+|+.+|+|++.......... ..+.+.+|+.++..++ |+||+++++++..
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~--------~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (332)
T cd05614 5 LKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAK--------TVEHTRTERNVLEHVRQSPFLVTLHYAFQT 76 (332)
T ss_pred EEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhh--------HHHHHHHHHHHHHhccCCCCcccEEEEEec
Confidence 44578887 66665433 3578899999997654322110 1256778999999995 8999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
.+.+++||||+++|+|.+.+.... .++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+|
T Consensus 77 ~~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~D 148 (332)
T cd05614 77 EAKLHLILDYVSGGEMFTHLYQRD-----NFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTD 148 (332)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEee
Confidence 999999999999999999886542 4788899999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCcccccCC-CCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhh
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTTCD-FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
||+++..............||+.|+|||++.+.. ++.++||||+||++|+|++|..||........ .........
T Consensus 149 fG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----~~~~~~~~~ 224 (332)
T cd05614 149 FGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT----QSEVSRRIL 224 (332)
T ss_pred CcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC----HHHHHHHHh
Confidence 9998765433332233457999999999987654 78899999999999999999999964332211 011111111
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCC-----CHHHHHH
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRP-----TMVDVAR 302 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 302 (314)
. ... ..+...+..+.+++..||+.||++|| ++.++++
T Consensus 225 ~-------------~~~--~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 225 K-------------CDP--PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred c-------------CCC--CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 0 000 00112345678999999999999999 7778775
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=291.29 Aligned_cols=240 Identities=20% Similarity=0.319 Sum_probs=188.8
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCC-CceeeeEeEEEeCCe
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSH-DHILKLIGCCLETPI 94 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~ 94 (314)
...+|.|+ +.|+++.+..+++.+|+|++.......... .+.+..|.+++..++| ++|+++++++...+.
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~---------~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~ 75 (324)
T cd05587 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDD---------VECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 75 (324)
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhH---------HHHHHHHHHHHHhcCCCCceeeeEEEEEcCCE
Confidence 44588888 888888888889999999998754322111 1567889999999976 568899999999999
Q ss_pred eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccc
Q 043524 95 AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL 174 (314)
Q Consensus 95 ~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~ 174 (314)
+|+||||+++|+|.+.+.... .++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+|||+
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~ 147 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQVG-----KFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGM 147 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCc
Confidence 999999999999999886543 4778889999999999999999 99999999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCC
Q 043524 175 SISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNR 254 (314)
Q Consensus 175 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (314)
++....... ......||+.|+|||++.+..++.++|+||+||++|+|++|+.||....... .......
T Consensus 148 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~--------~~~~i~~--- 215 (324)
T cd05587 148 CKENIFGGK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--------LFQSIME--- 215 (324)
T ss_pred ceecCCCCC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--------HHHHHHc---
Confidence 865322211 2334578999999999998889999999999999999999999996433211 1111110
Q ss_pred cccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCH
Q 043524 255 FTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTM 297 (314)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 297 (314)
..... +...+.++.+++..||..||.+|+++
T Consensus 216 ----------~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 216 ----------HNVSY--PKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ----------CCCCC--CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 00000 01234568899999999999999975
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=279.92 Aligned_cols=244 Identities=20% Similarity=0.331 Sum_probs=188.2
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeE
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAI 96 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (314)
..+|.|+ +.|+.+. ..++..+|+|.+...... .+.+.+|+.+++.++||||+++++++......+
T Consensus 10 ~~lg~G~~~~vy~~~-~~~~~~~a~K~~~~~~~~-------------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (256)
T cd05114 10 KELGSGQFGVVHLGK-WRAQIKVAIKAINEGAMS-------------EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLY 75 (256)
T ss_pred eEecCCcCceEEEEE-eccCceEEEEecccCCcc-------------HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEE
Confidence 3478777 6666553 445567999976543321 146789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
++|||+++|+|.+.+.... ..++...+..++.+++.||.||| +++++|+||+|+||+++.++.++++|||.++
T Consensus 76 iv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~ 148 (256)
T cd05114 76 IVTEFMENGCLLNYLRQRQ----GKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTR 148 (256)
T ss_pred EEEEcCCCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCcc
Confidence 9999999999999887543 24778889999999999999999 9999999999999999999999999999987
Q ss_pred ecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhccCCc
Q 043524 177 SIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFEDNRF 255 (314)
Q Consensus 177 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (314)
..............++..|+|||.+....++.++|+||+|+++|+|++ |+.||...... +..........
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~--------~~~~~i~~~~~- 219 (256)
T cd05114 149 YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY--------EVVEMISRGFR- 219 (256)
T ss_pred ccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHHCCCC-
Confidence 654332222223345678999999988889999999999999999999 88898543211 11111111000
Q ss_pred ccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHH
Q 043524 256 TEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRL 304 (314)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 304 (314)
. ..+...+..+.+++.+||..||++|||+.++++.|
T Consensus 220 --~-----------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 220 --L-----------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred --C-----------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 0 00012235678999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=286.38 Aligned_cols=250 Identities=20% Similarity=0.305 Sum_probs=195.7
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCee
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIA 95 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (314)
...+|.|+ +.|+++....+++.+|+|.+.......... .+.+.+|+.++..++|+||+.+.+.+.+++..
T Consensus 5 ~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~---------~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~ 75 (285)
T cd05630 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG---------ESMALNEKQILEKVNSRFVVSLAYAYETKDAL 75 (285)
T ss_pred eEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHH---------HHHHHHHHHHHHhCCCCCeeeeeEEEecCCEE
Confidence 34578888 788888888999999999987654332211 14567899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
|+||||+++++|.+.+..... ..++...+..++.|++.||.||| +.+|+|+||||+||+++..+.++++|||++
T Consensus 76 ~lv~e~~~g~~L~~~l~~~~~---~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~ 149 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYHMGE---AGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLA 149 (285)
T ss_pred EEEEEecCCCcHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccce
Confidence 999999999999988864332 34788899999999999999999 999999999999999999999999999998
Q ss_pred eecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCc
Q 043524 176 ISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRF 255 (314)
Q Consensus 176 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (314)
........ .....|+..|+|||++.+..++.++||||+|+++|+|++|..||....... . ..........
T Consensus 150 ~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~----~-~~~~~~~~~~--- 219 (285)
T cd05630 150 VHVPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI----K-REEVERLVKE--- 219 (285)
T ss_pred eecCCCcc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc----h-HHHHHhhhhh---
Confidence 76543322 224478999999999988889999999999999999999999997533211 0 0000000000
Q ss_pred ccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCC-----HHHHHH
Q 043524 256 TEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPT-----MVDVAR 302 (314)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps-----~~ell~ 302 (314)
.... .....+.++.+|+.+||+.||++||| +.|+++
T Consensus 220 ---~~~~--------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 220 ---VQEE--------YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred ---hhhh--------cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 0000 00123456789999999999999999 888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=286.15 Aligned_cols=265 Identities=20% Similarity=0.269 Sum_probs=194.4
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
+.-...+|.|+ ++|+.+.-..+++.+|||.+-....-. -.|+.+|+.++|||||++.-+|...
T Consensus 26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----------------nrEl~im~~l~HpNIV~L~~~f~~~ 89 (364)
T KOG0658|consen 26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----------------NRELQIMRKLDHPNIVRLLYFFSSS 89 (364)
T ss_pred EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----------------cHHHHHHHhcCCcCeeeEEEEEEec
Confidence 33445789999 899999888899999999765433211 2799999999999999998887642
Q ss_pred --C---eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCC-Cc
Q 043524 93 --P---IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEE-NV 166 (314)
Q Consensus 93 --~---~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~-~~ 166 (314)
+ ...+||||++. +|...++..... ...++.-.+.-+..|+..||.||| +.+|+||||||.|+|+|.+ |.
T Consensus 90 ~~~d~~~lnlVleymP~-tL~~~~r~~~~~-~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~ 164 (364)
T KOG0658|consen 90 TESDEVYLNLVLEYMPE-TLYRVIRHYTRA-NQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGV 164 (364)
T ss_pred CCCchhHHHHHHHhchH-HHHHHHHHHhhc-CCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCe
Confidence 2 34589999975 998888742110 034677788899999999999999 9999999999999999976 89
Q ss_pred eEEcccccceecCCCCcccccccccccccccCcccccCC-CCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHH
Q 043524 167 VKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCD-FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEY 245 (314)
Q Consensus 167 ~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 245 (314)
+||+|||.|+.+..+.. ..+...|+.|.|||++.+.. |+.+.||||.||++.||+.|++.|.+....+.+.- ....
T Consensus 165 LKicDFGSAK~L~~~ep--niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~e-Iik~ 241 (364)
T KOG0658|consen 165 LKICDFGSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVE-IIKV 241 (364)
T ss_pred EEeccCCcceeeccCCC--ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHH-HHHH
Confidence 99999999998866554 34667899999999998865 99999999999999999999999987554332211 1100
Q ss_pred H----Hhhhc--cCCcccccChhhhc-cCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 246 L----KNYFE--DNRFTEIVDPIIVQ-DLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 246 ~----~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
+ +.... ..+..+...+.+.. ..........+.++.+|+.++|.++|.+|.++.|++.
T Consensus 242 lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 242 LGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred hCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 0 00000 01111111222221 1111122245577899999999999999999999875
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=279.62 Aligned_cols=252 Identities=20% Similarity=0.257 Sum_probs=195.0
Q ss_pred cccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCC
Q 043524 15 KRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETP 93 (314)
Q Consensus 15 ~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (314)
.....+|.|+ +.++.+....+|+.+|+|.+........... ..+.+.+|+++++.++||||+++++++..+.
T Consensus 5 ~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 77 (263)
T cd06625 5 RRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKK-------EVNALECEIQLLKNLQHERIVQYYGCLRDDE 77 (263)
T ss_pred cccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHH-------HHHHHHHHHHHHHhCCCCCeeeeEEEEccCC
Confidence 3445678877 7788888888999999998764432111000 1146788999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccc
Q 043524 94 IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFS 173 (314)
Q Consensus 94 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg 173 (314)
..++++||+++++|.+.+... ..++......++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||
T Consensus 78 ~~~~v~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg 149 (263)
T cd06625 78 TLSIFMEYMPGGSVKDQLKAY-----GALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFG 149 (263)
T ss_pred eEEEEEEECCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecc
Confidence 999999999999999988754 34778888999999999999999 9999999999999999999999999999
Q ss_pred cceecCCCCcccc--cccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhc
Q 043524 174 LSISIPEGETHIT--DTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFE 251 (314)
Q Consensus 174 ~~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (314)
.++.......... ....++..|+|||.+.+..++.++||||+|+++|+|++|+.||....... ... ....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------~~~-~~~~ 221 (263)
T cd06625 150 ASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA-------AIF-KIAT 221 (263)
T ss_pred cceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH-------HHH-HHhc
Confidence 9876543221111 23457889999999998889999999999999999999999986432211 000 0000
Q ss_pred cCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 252 DNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.. .....+...+..+.+++.+||..||++|||+.++++
T Consensus 222 ~~-------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 222 QP-------------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred cC-------------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 00 000111134456889999999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=279.70 Aligned_cols=245 Identities=20% Similarity=0.334 Sum_probs=189.8
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCee
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIA 95 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (314)
...+|.|+ +.|+++.. .+++.+|+|.+...... .+.+.+|+++++.++||||+++++++...+..
T Consensus 9 ~~~lg~G~~~~v~~~~~-~~~~~~~iK~~~~~~~~-------------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd05059 9 LKELGSGQFGVVHLGKW-RGKIDVAIKMIREGAMS-------------EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPI 74 (256)
T ss_pred hhhhccCCCceEEEeEe-cCCccEEEEEeccCCCC-------------HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCce
Confidence 34477777 66666644 45678999987543221 14678899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
++|+||+++++|.+++.... ..++...+..++.|++.|++||| +++++|+||||+||+++.++.++++|||.+
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~ 147 (256)
T cd05059 75 FIVTEYMANGCLLNYLRERK----GKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLA 147 (256)
T ss_pred EEEEecCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccc
Confidence 99999999999999987543 35788899999999999999999 999999999999999999999999999998
Q ss_pred eecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhccCC
Q 043524 176 ISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFEDNR 254 (314)
Q Consensus 176 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (314)
+..............++..|+|||.+....++.++|+||+|+++|+|++ |..||+...... ........
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------~~~~~~~~-- 217 (256)
T cd05059 148 RYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--------VVESVSAG-- 217 (256)
T ss_pred eecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH--------HHHHHHcC--
Confidence 7654332222222234567999999988889999999999999999999 788886433211 11111000
Q ss_pred cccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHH
Q 043524 255 FTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRL 304 (314)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 304 (314)
. ....+...+.++.+++.+||..+|++|||+.|+++.|
T Consensus 218 ----~--------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 218 ----Y--------RLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred ----C--------cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 0 0001113456789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=280.06 Aligned_cols=246 Identities=18% Similarity=0.316 Sum_probs=189.0
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCee
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIA 95 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (314)
...+|+|+ +.++.+ ...++..+|+|.+...... .+.+.+|+.++..++||||+++++++......
T Consensus 9 ~~~lg~G~~~~vy~~-~~~~~~~~aik~~~~~~~~-------------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (256)
T cd05113 9 LKELGTGQFGVVKYG-KWRGQYDVAIKMIKEGSMS-------------EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPI 74 (256)
T ss_pred eeEecCcccceEEEE-EecCCCcEEEEEcCCCccc-------------HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCc
Confidence 34578887 666555 3334456999987643321 15688999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
+++|||+++|+|.+.+.... ..++...++.++.|++.||.||| +++++|+||||+||+++.++.++++|||.+
T Consensus 75 ~lv~e~~~~~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~ 147 (256)
T cd05113 75 YIVTEYMSNGCLLNYLREHG----KRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLS 147 (256)
T ss_pred EEEEEcCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccc
Confidence 99999999999999987643 24788899999999999999999 999999999999999999999999999998
Q ss_pred eecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhccCC
Q 043524 176 ISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFEDNR 254 (314)
Q Consensus 176 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (314)
+..............++..|+|||.+....++.++||||||+++|+|++ |..||...... ......... .
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~~~-~ 218 (256)
T cd05113 148 RYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--------ETVEKVSQG-L 218 (256)
T ss_pred eecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHHHhcC-C
Confidence 7654432221222345678999999988889999999999999999998 99898643321 111111110 0
Q ss_pred cccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHH
Q 043524 255 FTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLR 305 (314)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~ 305 (314)
. .......+..+.+++.+||+.||++|||+.+|++.|+
T Consensus 219 ~-------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 219 R-------------LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred C-------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0 0000123467899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=284.74 Aligned_cols=262 Identities=19% Similarity=0.291 Sum_probs=195.4
Q ss_pred hhcCcccccccCch-hHHHHHHHhcCCc--ccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeE
Q 043524 11 WSKGKRTLMIGNGA-SVLQELIASSNGK--YIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLI 86 (314)
Q Consensus 11 ~~~~~~~~~~G~g~-~~~~~~~~~~~g~--~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~ 86 (314)
|..+.-...+|.|+ +.|+.+....+|. .+++|.+....... ..+.+.+|+.++.++ +||||++++
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~-----------~~~~~~~E~~~l~~l~~hp~iv~~~ 69 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASEN-----------DHRDFAGELEVLCKLGHHPNIINLL 69 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHH-----------HHHHHHHHHHHHHhhcCCCchhheE
Confidence 34455556789888 7787776666665 35777654211111 115678999999999 799999999
Q ss_pred eEEEeCCeeEEEEeecCCCCHHHHHhcCCCC-----------CCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCC
Q 043524 87 GCCLETPIAILVFEYVQHGTLWDRILGAPQT-----------HFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFK 155 (314)
Q Consensus 87 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk 155 (314)
+++...+.+|+++||+++++|.+++...... ....++...++.++.|++.||+||| +++++|+|||
T Consensus 70 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlk 146 (297)
T cd05089 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLA 146 (297)
T ss_pred EEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCC
Confidence 9999999999999999999999998653211 1124778899999999999999999 9999999999
Q ss_pred CCCeeecCCCceEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccC
Q 043524 156 TSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRD 234 (314)
Q Consensus 156 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~ 234 (314)
|+||+++.++.++|+|||++....... .......+..|+|||.+....++.++|||||||++|+|++ |..||.....
T Consensus 147 p~Nill~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~ 224 (297)
T cd05089 147 ARNVLVGENLASKIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC 224 (297)
T ss_pred cceEEECCCCeEEECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999999999999999985432111 1111233567999999988889999999999999999997 9999854321
Q ss_pred ccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 235 AHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
. ......... .....+...+..+.+|+.+||+.||.+|||+.++++.|+++...
T Consensus 225 ~--------~~~~~~~~~--------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~ 278 (297)
T cd05089 225 A--------ELYEKLPQG--------------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278 (297)
T ss_pred H--------HHHHHHhcC--------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1 111111000 00001113446688999999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=294.54 Aligned_cols=242 Identities=22% Similarity=0.265 Sum_probs=188.2
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHH-HHhcCCCCceeeeEeEEEeCCeeE
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVT-YAAQMSHDHILKLIGCCLETPIAI 96 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~ 96 (314)
.+|.|+ +.|+.+.+..+|+.+|+|++.......... ...+..|.. +++.++||||+++++++..++..|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~---------~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~ 72 (325)
T cd05604 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKE---------QKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLY 72 (325)
T ss_pred ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhH---------HHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEE
Confidence 367777 888888888899999999998764322111 134556655 467789999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
+||||+++|+|...+... ..++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+|||+++
T Consensus 73 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~ 144 (325)
T cd05604 73 FVLDFVNGGELFFHLQRE-----RSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCK 144 (325)
T ss_pred EEEcCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcc
Confidence 999999999998888654 35788999999999999999999 9999999999999999999999999999986
Q ss_pred ecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcc
Q 043524 177 SIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFT 256 (314)
Q Consensus 177 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (314)
....... ......||+.|+|||++.+..++.++||||+||++|+|++|..||...... ........
T Consensus 145 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--------~~~~~~~~----- 210 (325)
T cd05604 145 EGIAQSD-TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA--------EMYDNILH----- 210 (325)
T ss_pred cCCCCCC-CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH--------HHHHHHHc-----
Confidence 5422211 233457899999999999888999999999999999999999999643211 11111111
Q ss_pred cccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHH
Q 043524 257 EIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVA 301 (314)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell 301 (314)
...... ...+..+.+++..||+.||.+||++.+.+
T Consensus 211 --------~~~~~~--~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 211 --------KPLVLR--PGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred --------CCccCC--CCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 000000 02345678999999999999999876433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=305.45 Aligned_cols=250 Identities=20% Similarity=0.244 Sum_probs=197.1
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC-CCceeeeEeEEE-e----
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS-HDHILKLIGCCL-E---- 91 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~-~---- 91 (314)
.|-+|| +.||.+.....|..+|+|.+-..+-... +.+.+||.+|+.|+ |+|||.|++... .
T Consensus 44 vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L------------~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~ 111 (738)
T KOG1989|consen 44 VLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEAL------------NAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN 111 (738)
T ss_pred EEccCCcEEEEEEEecCCCceeeeeeeecCCHHHH------------HHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence 355666 8888888888889999997654443332 67889999999997 999999999432 1
Q ss_pred --CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEE
Q 043524 92 --TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKL 169 (314)
Q Consensus 92 --~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl 169 (314)
..++.|+||||.+|+|-|++....++ .|...+++.|++|+++|+++||.. .-.|+|||||.+|+|++.+|..||
T Consensus 112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~---~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KL 187 (738)
T KOG1989|consen 112 NGVWEVLLLMEYCKGGSLVDFMNTRLQT---RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKL 187 (738)
T ss_pred CceeEEEeehhhccCCcHHHHHHHHHhc---cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEe
Confidence 24578999999999999999866553 388999999999999999999943 555999999999999999999999
Q ss_pred cccccceecCCCCccc--------ccccccccccccCcccc---cCCCCcccchHHHHHHHHHHHhCCCCcccccCcccc
Q 043524 170 FDFSLSISIPEGETHI--------TDTVMGTYGHLAPQYVT---TCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDL 238 (314)
Q Consensus 170 ~dfg~~~~~~~~~~~~--------~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~ 238 (314)
||||.+.......... .-...-|+.|+|||++. +..++.|+|||+|||+||.|+....||+......
T Consensus 188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la-- 265 (738)
T KOG1989|consen 188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA-- 265 (738)
T ss_pred CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee--
Confidence 9999986543222111 01125689999999874 5568999999999999999999999997543222
Q ss_pred ccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHh
Q 043524 239 VYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICC 309 (314)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 309 (314)
++.+....+..+.++..+.+||+.||+.||++||++-|+++.+-++..
T Consensus 266 -----------------------Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 266 -----------------------ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred -----------------------EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 222233333334778889999999999999999999999999988754
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=285.88 Aligned_cols=250 Identities=21% Similarity=0.284 Sum_probs=196.7
Q ss_pred hhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEE
Q 043524 11 WSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCC 89 (314)
Q Consensus 11 ~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 89 (314)
..++.....+|.|+ +.|+.+.+..+|+.+|+|.+........ +.+.+|+.+++.++|+||+++++.+
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~------------~~~~~e~~~l~~~~h~~v~~~~~~~ 86 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK------------ELIINEILVMRENKNPNIVNYLDSY 86 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchH------------HHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 34555555688887 7788888888899999998865443221 5678999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEE
Q 043524 90 LETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKL 169 (314)
Q Consensus 90 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl 169 (314)
..+...|+|+||+++++|.+++... .++...+..++.|++.||.||| +.+++|+||||+||+++.++.++|
T Consensus 87 ~~~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl 157 (296)
T cd06654 87 LVGDELWVVMEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKL 157 (296)
T ss_pred EeCCEEEEeecccCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEE
Confidence 9999999999999999999988642 3678889999999999999999 999999999999999999999999
Q ss_pred cccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhh
Q 043524 170 FDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNY 249 (314)
Q Consensus 170 ~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (314)
+|||.+........ ......+++.|+|||.+....++.++|+|||||++|+|++|..||....... .... .
T Consensus 158 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-------~~~~-~ 228 (296)
T cd06654 158 TDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-------ALYL-I 228 (296)
T ss_pred Cccccchhcccccc-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-------hHHH-H
Confidence 99999865433221 1233468889999999988888999999999999999999999996433211 0000 0
Q ss_pred hccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 250 FEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.... ......+...+..+.+++.+||..||++|||+.++++
T Consensus 229 ~~~~------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 229 ATNG------------TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred hcCC------------CCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 0000 0000011134456889999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=295.50 Aligned_cols=258 Identities=17% Similarity=0.311 Sum_probs=193.2
Q ss_pred cccccCch-hHHHHHHH-----hcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC-CCceeeeEeEE
Q 043524 17 TLMIGNGA-SVLQELIA-----SSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS-HDHILKLIGCC 89 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~-----~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~ 89 (314)
...+|.|+ +.|+++.. ..++..||+|.+........ .+.+.+|++++..+. |||||++++++
T Consensus 42 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~-----------~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 42 GRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSE-----------KQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred hheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHH-----------HHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 34578887 66665443 23345799998864322111 156889999999996 99999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhcCCCC----------------------------------------------------
Q 043524 90 LETPIAILVFEYVQHGTLWDRILGAPQT---------------------------------------------------- 117 (314)
Q Consensus 90 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~---------------------------------------------------- 117 (314)
......|+|||||++|+|.+++......
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 9999999999999999999887643110
Q ss_pred ---------------------------------------CCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCC
Q 043524 118 ---------------------------------------HFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSH 158 (314)
Q Consensus 118 ---------------------------------------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~n 158 (314)
....++...+..++.|++.||.||| +++|+|+||||+|
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~N 267 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARN 267 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHh
Confidence 0023667788899999999999999 9999999999999
Q ss_pred eeecCCCceEEcccccceecCCCCcc-cccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCcc
Q 043524 159 ILFSEENVVKLFDFSLSISIPEGETH-ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAH 236 (314)
Q Consensus 159 il~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~ 236 (314)
|+++.++.++|+|||+++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 99999999999999999765332211 1223456788999999988889999999999999999997 888886432111
Q ss_pred ccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHh
Q 043524 237 DLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICC 309 (314)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 309 (314)
..... ... ......+...+..+.+++.+||..||++|||+.++.+.|+++.+
T Consensus 348 -------~~~~~-~~~-------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 348 -------TFYNK-IKS-------------GYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred -------HHHHH-Hhc-------------CCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 00000 000 00001111345678999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=286.36 Aligned_cols=266 Identities=18% Similarity=0.255 Sum_probs=187.7
Q ss_pred CcccccccCch-hHHHHHHHh-cCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC---CCCceeeeEeE
Q 043524 14 GKRTLMIGNGA-SVLQELIAS-SNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM---SHDHILKLIGC 88 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~-~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~ 88 (314)
|.....+|.|+ +.|+++.+. .+|+.+|+|.+........ ....+.+|+.++..+ +||||++++++
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~~e~~~l~~l~~~~hpniv~~~~~ 72 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG----------MPLSTIREVAVLRHLETFEHPNVVRLFDV 72 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC----------chHHHHHHHHHHHhhcccCCCCcceEEEE
Confidence 33445588888 777777664 4568899998764321100 013445677666655 69999999999
Q ss_pred EE-----eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecC
Q 043524 89 CL-----ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSE 163 (314)
Q Consensus 89 ~~-----~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~ 163 (314)
+. ....+++|+||++ ++|.+++..... ..++...+..++.|++.||.||| +++|+||||||+||+++.
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~ 145 (290)
T cd07862 73 CTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTS 145 (290)
T ss_pred EecccCCCCCcEEEEEccCC-CCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcC
Confidence 86 2456899999996 699998875432 34788899999999999999999 999999999999999999
Q ss_pred CCceEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchH
Q 043524 164 ENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFN 243 (314)
Q Consensus 164 ~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~ 243 (314)
++.++|+|||+++..... .......||+.|+|||++....++.++||||+||++|+|++|.+||......+. +.
T Consensus 146 ~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~----~~ 219 (290)
T cd07862 146 SGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ----LG 219 (290)
T ss_pred CCCEEEccccceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH----HH
Confidence 999999999999765433 123455789999999999888899999999999999999999999975443211 01
Q ss_pred HHHHhh--hccCCcccc---cChhhhccCCc---hhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 244 EYLKNY--FEDNRFTEI---VDPIIVQDLSC---TEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 244 ~~~~~~--~~~~~~~~~---~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
...... .....+... ........... ......+..+.+|+.+||+.||++|||+.|+++
T Consensus 220 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 220 KILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred HHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 100000 000000000 00000000000 001134566789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=278.88 Aligned_cols=247 Identities=17% Similarity=0.216 Sum_probs=194.4
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCee
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIA 95 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (314)
...+|.|+ +.++.+.+..+++.+|+|.+........ .+.+.+|+.+++.++|+||+++.+.+.+++.+
T Consensus 5 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 73 (255)
T cd08219 5 LRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSA-----------VEDSRKEAVLLAKMKHPNIVAFKESFEADGHL 73 (255)
T ss_pred EEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHH-----------HHHHHHHHHHHHhCCCCCcceEEEEEEECCEE
Confidence 34577777 6778888888999999998864322211 15677899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
|+++||+++++|.+.+..... ..++......++.|++.||.||| +++++|+||||+||+++.++.++++|||.+
T Consensus 74 ~lv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~ 147 (255)
T cd08219 74 YIVMEYCDGGDLMQKIKLQRG---KLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSA 147 (255)
T ss_pred EEEEeeCCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcc
Confidence 999999999999998865332 34678889999999999999999 999999999999999999999999999998
Q ss_pred eecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCc
Q 043524 176 ISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRF 255 (314)
Q Consensus 176 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (314)
........ ......++..|+|||++....++.++|+||+|+++|+|++|..||..... ......... ...
T Consensus 148 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~--------~~~~~~~~~-~~~ 217 (255)
T cd08219 148 RLLTSPGA-YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW--------KNLILKVCQ-GSY 217 (255)
T ss_pred eeeccccc-ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH--------HHHHHHHhc-CCC
Confidence 76643322 12345688899999999888899999999999999999999999964221 111111110 000
Q ss_pred ccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 043524 256 TEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARR 303 (314)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 303 (314)
. +.+...+..+.+++.+||+.||++|||+.+++.+
T Consensus 218 ~-------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 218 K-------------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred C-------------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0 0011344568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=280.13 Aligned_cols=257 Identities=16% Similarity=0.271 Sum_probs=193.7
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcc----cccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKY----IPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIG 87 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~----~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 87 (314)
.++....+|.|+ +.|+.+....+|+. +++|.+...... ...+++..|+..+..++||||+++++
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~-----------~~~~~~~~~~~~l~~l~h~~iv~~~~ 76 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGR-----------QTFQEITDHMLAMGSLDHAYIVRLLG 76 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccch-----------HHHHHHHHHHHHHhcCCCCCcceEEE
Confidence 344555688888 77877776667764 566655322111 12256778888999999999999999
Q ss_pred EEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCce
Q 043524 88 CCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVV 167 (314)
Q Consensus 88 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~ 167 (314)
++. +...++++||+++|+|.+++.... ..+++..+..++.|++.||.||| +++++|+||||+||+++.++.+
T Consensus 77 ~~~-~~~~~~i~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~ 148 (279)
T cd05111 77 ICP-GASLQLVTQLSPLGSLLDHVRQHR----DSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIV 148 (279)
T ss_pred EEC-CCccEEEEEeCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcE
Confidence 885 456789999999999999997644 35788999999999999999999 9999999999999999999999
Q ss_pred EEcccccceecCCCCcc-cccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHH
Q 043524 168 KLFDFSLSISIPEGETH-ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEY 245 (314)
Q Consensus 168 kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~ 245 (314)
+++|||.++........ ......++..|+|||.+....++.++||||||+++||+++ |..||....... ..+
T Consensus 149 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-----~~~- 222 (279)
T cd05111 149 QIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-----VPD- 222 (279)
T ss_pred EEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHH-
Confidence 99999999866433221 1223456778999999988889999999999999999998 999986433111 111
Q ss_pred HHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 246 LKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
........ .. + ..++..+.+++..||..||++|||+.|+++.|..+.+.
T Consensus 223 ---~~~~~~~~--~~-----~------~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 223 ---LLEKGERL--AQ-----P------QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred ---HHHCCCcC--CC-----C------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 11111100 00 0 02234568899999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=305.27 Aligned_cols=255 Identities=20% Similarity=0.235 Sum_probs=197.3
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|.....+|.|+ +.|+++.+..+|+.||+|++......... ...+.+|+.++..++|+||+++++.+.
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~----------~~~~~~Ei~~l~~~~h~~iv~~~~~~~ 101 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEAD----------KNRAQAEVCCLLNCDFFSIVKCHEDFA 101 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHH----------HHHHHHHHHHHhcCCCCcEEEeeccee
Confidence 4555566789888 88888888889999999998654321111 145778999999999999999988775
Q ss_pred eCC--------eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeec
Q 043524 91 ETP--------IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFS 162 (314)
Q Consensus 91 ~~~--------~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~ 162 (314)
... .+++||||+++|+|.+.+...... ..+++...+..++.|++.||.||| +++|+||||||+||+++
T Consensus 102 ~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~-~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~ 177 (496)
T PTZ00283 102 KKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKT-NRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLC 177 (496)
T ss_pred cccccCcccceEEEEEEeCCCCCcHHHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEe
Confidence 432 368999999999999988653321 145788899999999999999999 99999999999999999
Q ss_pred CCCceEEcccccceecCCCC-cccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccc
Q 043524 163 EENVVKLFDFSLSISIPEGE-THITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYP 241 (314)
Q Consensus 163 ~~~~~kl~dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~ 241 (314)
.++.++|+|||+++...... ........||+.|+|||++....++.++|||||||++|+|++|+.||.....
T Consensus 178 ~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------- 250 (496)
T PTZ00283 178 SNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM------- 250 (496)
T ss_pred CCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-------
Confidence 99999999999997654321 1123456799999999999988899999999999999999999999964321
Q ss_pred hHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 242 FNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
......... +... +.+...+.++.+++..||+.||++|||+.+++.
T Consensus 251 -~~~~~~~~~-------------~~~~-~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 251 -EEVMHKTLA-------------GRYD-PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred -HHHHHHHhc-------------CCCC-CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 111111111 0000 011134567899999999999999999999986
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=294.19 Aligned_cols=243 Identities=20% Similarity=0.267 Sum_probs=187.0
Q ss_pred ccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC---CCCceeeeEeEEEeCCee
Q 043524 20 IGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM---SHDHILKLIGCCLETPIA 95 (314)
Q Consensus 20 ~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~ 95 (314)
+|.|+ +.|+.+.+..+|+.+|+|++.......... ...+..|..++... .||||+++++++.+++.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~---------~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~ 71 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKE---------VAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDL 71 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhH---------HHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeE
Confidence 57777 888888888899999999998765433211 13455677777655 699999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
|+||||+++|+|.+.+... ..++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+|||++
T Consensus 72 ~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a 143 (330)
T cd05586 72 YLVTDYMSGGELFWHLQKE-----GRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLS 143 (330)
T ss_pred EEEEcCCCCChHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcC
Confidence 9999999999999888654 34788999999999999999999 999999999999999999999999999998
Q ss_pred eecCCCCcccccccccccccccCcccccC-CCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCC
Q 043524 176 ISIPEGETHITDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNR 254 (314)
Q Consensus 176 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (314)
+...... .......||+.|+|||++.+. .++.++||||+||++|+|++|..||...... .........
T Consensus 144 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~--------~~~~~i~~~-- 212 (330)
T cd05586 144 KANLTDN-KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ--------QMYRNIAFG-- 212 (330)
T ss_pred cCCCCCC-CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH--------HHHHHHHcC--
Confidence 6542222 123455799999999998765 4789999999999999999999999643211 111111100
Q ss_pred cccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCC----CHHHHHH
Q 043524 255 FTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRP----TMVDVAR 302 (314)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp----s~~ell~ 302 (314)
....+. ...+..+.+|+..||+.||++|| ++.++++
T Consensus 213 -----------~~~~~~-~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 213 -----------KVRFPK-NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -----------CCCCCC-ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 000000 02345678999999999999998 4666654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=292.88 Aligned_cols=271 Identities=20% Similarity=0.268 Sum_probs=195.4
Q ss_pred hhhhhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeE
Q 043524 8 FKLWSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLI 86 (314)
Q Consensus 8 ~~~~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 86 (314)
+....+|.....+|.|+ +.|+.+.+..+|+.+|+|.+........ ...++.+|+.++..++||||++++
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~~E~~~l~~l~h~niv~~~ 86 (359)
T cd07876 17 FTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQT----------HAKRAYRELVLLKCVNHKNIISLL 86 (359)
T ss_pred hhhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchh----------HHHHHHHHHHHHHhCCCCCEeeee
Confidence 34556677777899998 8888888888999999999864321111 115678999999999999999999
Q ss_pred eEEEeCC------eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCee
Q 043524 87 GCCLETP------IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHIL 160 (314)
Q Consensus 87 ~~~~~~~------~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil 160 (314)
+++.... ..|+||||+++ ++.+.+.. .++...+..++.|++.||.||| +++|+||||||+||+
T Consensus 87 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl 155 (359)
T cd07876 87 NVFTPQKSLEEFQDVYLVMELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIV 155 (359)
T ss_pred eeeccCCCccccceeEEEEeCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEE
Confidence 9987543 57999999964 67666532 3677888899999999999999 999999999999999
Q ss_pred ecCCCceEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCcccc--
Q 043524 161 FSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDL-- 238 (314)
Q Consensus 161 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~-- 238 (314)
++.++.++|+|||+++...... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.........
T Consensus 156 ~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~ 233 (359)
T cd07876 156 VKSDCTLKILDFGLARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNK 233 (359)
T ss_pred ECCCCCEEEecCCCccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999999999999987543221 133457899999999999888999999999999999999999999754321100
Q ss_pred -----ccchHHH-------HHhhhcc-CCc-----ccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHH
Q 043524 239 -----VYPFNEY-------LKNYFED-NRF-----TEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDV 300 (314)
Q Consensus 239 -----~~~~~~~-------~~~~~~~-~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el 300 (314)
..+...+ ...+... ... .+...... .+.........+..+.+|+.+||..||++|||+.|+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~ 312 (359)
T cd07876 234 VIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWI-FPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEA 312 (359)
T ss_pred HHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccc-cccccccccccchhHHHHHHHHhccCcccCCCHHHH
Confidence 0000000 0001000 000 00000000 000000111234668999999999999999999999
Q ss_pred HH
Q 043524 301 AR 302 (314)
Q Consensus 301 l~ 302 (314)
++
T Consensus 313 l~ 314 (359)
T cd07876 313 LR 314 (359)
T ss_pred hc
Confidence 87
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=287.96 Aligned_cols=267 Identities=19% Similarity=0.203 Sum_probs=189.1
Q ss_pred ccCc--h-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeE
Q 043524 20 IGNG--A-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAI 96 (314)
Q Consensus 20 ~G~g--~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (314)
+|.| + ++|+.+.+..+|+.||+|.+........ ..+.+.+|+.+++.++||||+++++++..++..|
T Consensus 6 ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~ 75 (327)
T cd08227 6 IGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNE----------MVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 75 (327)
T ss_pred ccccccceEEEEEEeecccCcEEEEEEechhhccHH----------HHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEE
Confidence 5555 4 6788888999999999999876532111 1145678999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
+|+||+++|+|.+++..... ..++...+..++.|++.||.||| +++|+||||||+||+++.++.++++||+...
T Consensus 76 lv~e~~~~~~l~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~ 149 (327)
T cd08227 76 VVTSFMAYGSAKDLICTHFM---DGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNL 149 (327)
T ss_pred EEEeccCCCcHHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhh
Confidence 99999999999999865432 34788899999999999999999 9999999999999999999999999998654
Q ss_pred ecCCCCcc------cccccccccccccCcccccC--CCCcccchHHHHHHHHHHHhCCCCcccccCccccccchH-----
Q 043524 177 SIPEGETH------ITDTVMGTYGHLAPQYVTTC--DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFN----- 243 (314)
Q Consensus 177 ~~~~~~~~------~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~----- 243 (314)
........ ......++..|+|||++... .++.++||||+||++|+|++|..||..............
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 229 (327)
T cd08227 150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 229 (327)
T ss_pred ccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccc
Confidence 33211110 01223567789999998763 588999999999999999999999964332110000000
Q ss_pred ---------HHHHhhhc----cCCccccc-----ChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 244 ---------EYLKNYFE----DNRFTEIV-----DPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 244 ---------~~~~~~~~----~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
+....... ........ .+........+.....+..+.+|+.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 230 LLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred cccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00000000 00000000 0000000001111234567899999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=275.80 Aligned_cols=246 Identities=21% Similarity=0.310 Sum_probs=189.4
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeEE
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAIL 97 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i 97 (314)
.+|.|+ +.|+++. ..+++.+|+|.+........ ...+.+|++++..++||||+++++++...+..++
T Consensus 2 ~ig~g~~g~vy~~~-~~~~~~~a~K~~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 69 (250)
T cd05085 2 LLGKGNFGEVFKGT-LKDKTPVAVKTCKEDLPQEL-----------KIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYI 69 (250)
T ss_pred ccCCCCCceEEEEE-ecCCcEEEEEecCCcCCHHH-----------HHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEE
Confidence 367777 6666664 45688899998754321111 1467899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccccee
Q 043524 98 VFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSIS 177 (314)
Q Consensus 98 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~ 177 (314)
||||+++++|.+++.... ..+....+..++.+++.+|.|+| +++++|+||+|+||+++.++.++++|||++..
T Consensus 70 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 142 (250)
T cd05085 70 VMELVPGGDFLSFLRKKK----DELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQ 142 (250)
T ss_pred EEECCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCcccee
Confidence 999999999999886543 34678899999999999999999 99999999999999999999999999999876
Q ss_pred cCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhccCCcc
Q 043524 178 IPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFEDNRFT 256 (314)
Q Consensus 178 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (314)
.............++..|+|||++....++.++|+||+|+++|++++ |..||....... .... .....
T Consensus 143 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~--------~~~~-~~~~~-- 211 (250)
T cd05085 143 EDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ--------AREQ-VEKGY-- 211 (250)
T ss_pred ccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH--------HHHH-HHcCC--
Confidence 54332222222344678999999988889999999999999999998 898986432111 0000 00000
Q ss_pred cccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHH
Q 043524 257 EIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLR 305 (314)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~ 305 (314)
. . . .+...+..+.+++.+||..+|++|||+.|+++.|.
T Consensus 212 ---~--~--~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 212 ---R--M--S----CPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred ---C--C--C----CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 0 0 0 00123456899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=287.15 Aligned_cols=255 Identities=15% Similarity=0.191 Sum_probs=193.3
Q ss_pred cccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCC
Q 043524 15 KRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETP 93 (314)
Q Consensus 15 ~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (314)
.....+|.|+ +.|+.+....+++.+|+|++.+.+...... .+.+.+|+.++..++|+||+++++++.+++
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~---------~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 74 (331)
T cd05597 4 EILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAE---------TACFREERDVLVNGDRRWITNLHYAFQDEN 74 (331)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhh---------HHHHHHHHHHHHhCCCCCCCceEEEEecCC
Confidence 3445688888 888888888899999999998654332221 155788999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccc
Q 043524 94 IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFS 173 (314)
Q Consensus 94 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg 173 (314)
.+|+||||+++|+|.+++.... ..++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+|||
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg 147 (331)
T cd05597 75 NLYLVMDYYVGGDLLTLLSKFE----DRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFG 147 (331)
T ss_pred eEEEEEecCCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECC
Confidence 9999999999999999987543 34788889999999999999999 9999999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCccccc-----CCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHh
Q 043524 174 LSISIPEGETHITDTVMGTYGHLAPQYVTT-----CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKN 248 (314)
Q Consensus 174 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (314)
++...............||+.|+|||++.. ..++.++||||+||++|+|++|+.||...... +....
T Consensus 148 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~--------~~~~~ 219 (331)
T cd05597 148 SCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV--------ETYGK 219 (331)
T ss_pred ceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH--------HHHHH
Confidence 987654433222333568999999999863 34788999999999999999999999643211 11111
Q ss_pred hhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCC--CCCHHHHHHH
Q 043524 249 YFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPID--RPTMVDVARR 303 (314)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~--Rps~~ell~~ 303 (314)
........ ..+. .....+..+.+++.+||..++++ ||++.++++.
T Consensus 220 i~~~~~~~---------~~~~-~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 220 IMNHKEHF---------QFPP-DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHcCCCcc---------cCCC-ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 11110000 0000 00124567889999988654443 7899988763
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=277.85 Aligned_cols=247 Identities=19% Similarity=0.281 Sum_probs=188.8
Q ss_pred ccCch-hHHHHHH--HhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeE
Q 043524 20 IGNGA-SVLQELI--ASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAI 96 (314)
Q Consensus 20 ~G~g~-~~~~~~~--~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (314)
+|+|+ +.|+.+. ...++..+|+|++........ ..+++.+|+.++..++||||+++++++. +...+
T Consensus 3 lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~ 71 (257)
T cd05116 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPA----------LKDELLREANVMQQLDNPYIVRMIGICE-AESWM 71 (257)
T ss_pred CCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHH----------HHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcE
Confidence 67777 6666653 345678999998764321111 1267889999999999999999999885 55678
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
+||||+++|+|.+++.... .++......++.|++.||.||| +++++|+||||.||+++.++.++|+|||.++
T Consensus 72 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~ 143 (257)
T cd05116 72 LVMELAELGPLNKFLQKNK-----HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSK 143 (257)
T ss_pred EEEecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCcccc
Confidence 9999999999999986542 4788899999999999999999 9999999999999999999999999999997
Q ss_pred ecCCCCccc--ccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhccC
Q 043524 177 SIPEGETHI--TDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFEDN 253 (314)
Q Consensus 177 ~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (314)
......... .....++..|+|||.+....++.++|+||||+++|||++ |..||....... .... ....
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--------~~~~-i~~~ 214 (257)
T cd05116 144 ALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE--------VTQM-IESG 214 (257)
T ss_pred ccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHH-HHCC
Confidence 664432211 112234578999999888888999999999999999998 999986433211 1111 1110
Q ss_pred CcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHH
Q 043524 254 RFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQI 307 (314)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~ 307 (314)
.. .+ .+...+.++.+++.+||+.||++||++.+|.+.|++.
T Consensus 215 ~~---------~~----~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 215 ER---------ME----CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CC---------CC----CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 00 00 0113446688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=289.06 Aligned_cols=240 Identities=18% Similarity=0.302 Sum_probs=188.7
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeEEEeCCe
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGCCLETPI 94 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 94 (314)
...+|+|+ +.|+++.+..+++.+|+|++.......... .+.+..|..++..+ +|++|+++++++.+.+.
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~---------~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~ 75 (323)
T cd05616 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDD---------VECTMVEKRVLALSGKPPFLTQLHSCFQTMDR 75 (323)
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhH---------HHHHHHHHHHHHhccCCCeEeeEEEEEecCCE
Confidence 44588888 888888888899999999988654322111 14466788888777 58999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccc
Q 043524 95 AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL 174 (314)
Q Consensus 95 ~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~ 174 (314)
+|+||||+++|+|.+.+.... .++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+|||+
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~ 147 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQVG-----RFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGM 147 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCC
Confidence 999999999999998886543 4788899999999999999999 99999999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCC
Q 043524 175 SISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNR 254 (314)
Q Consensus 175 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (314)
++....... ......||+.|+|||++....++.++|+||+||++|+|++|+.||....... .......
T Consensus 148 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~--------~~~~i~~--- 215 (323)
T cd05616 148 CKENMWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--------LFQSIME--- 215 (323)
T ss_pred ceecCCCCC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH--------HHHHHHh---
Confidence 875432221 1334578999999999998889999999999999999999999996433211 0111110
Q ss_pred cccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCH
Q 043524 255 FTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTM 297 (314)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 297 (314)
.....+ ...+.++.+++..||+.||++|+++
T Consensus 216 ----------~~~~~p--~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 216 ----------HNVAYP--KSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ----------CCCCCC--CcCCHHHHHHHHHHcccCHHhcCCC
Confidence 010000 1344668899999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=293.67 Aligned_cols=254 Identities=20% Similarity=0.303 Sum_probs=210.5
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeE
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAI 96 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (314)
..+|+|. +.||..++++..--||||........- ++|+.|..+|..++|||+|+++|+|+....+|
T Consensus 273 hKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMev-------------eEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 273 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-------------EEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred eccCCCcccceeeeeeeccceeeehhhhhhcchhH-------------HHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 3577777 889999999988899999765433221 78999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
||+|||..|+|.+++++... +.++.-..++++.||.+|++||. .++++||||...|+|+..+..+|++|||+++
T Consensus 340 IiTEfM~yGNLLdYLRecnr---~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNR---SEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred EEEecccCccHHHHHHHhch---hhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhh
Confidence 99999999999999998765 45677778899999999999999 9999999999999999999999999999999
Q ss_pred ecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhccCCc
Q 043524 177 SIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFEDNRF 255 (314)
Q Consensus 177 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (314)
.+............-+..|.|||.+..+.++.++|||+||++|||++| |..||.+..-.. .-+.+..-+
T Consensus 414 lMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq-----VY~LLEkgy----- 483 (1157)
T KOG4278|consen 414 LMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----VYGLLEKGY----- 483 (1157)
T ss_pred hhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH-----HHHHHhccc-----
Confidence 987665554555566788999999999999999999999999999998 888886544211 001111000
Q ss_pred ccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhcc
Q 043524 256 TEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSLS 312 (314)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~ 312 (314)
++.++. .|++.+..|++.||+++|.+||++.|+.+.++.+..+-|
T Consensus 484 ------RM~~Pe------GCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sS 528 (1157)
T KOG4278|consen 484 ------RMDGPE------GCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSS 528 (1157)
T ss_pred ------cccCCC------CCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccc
Confidence 122232 555678899999999999999999999999999877654
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=280.63 Aligned_cols=263 Identities=23% Similarity=0.313 Sum_probs=190.1
Q ss_pred cccccCch-hHHHHHH----HhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 17 TLMIGNGA-SVLQELI----ASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~----~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
...+|.|+ +.|+.+. ...+|+.+|+|.+........ +.+.+|++++..++||||+++++++..
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~------------~~~~~e~~~l~~l~h~~iv~~~~~~~~ 76 (284)
T cd05081 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHL------------RDFEREIEILKSLQHDNIVKYKGVCYS 76 (284)
T ss_pred eeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHH------------HHHHHHHHHHHhCCCCCeeEEEEEEcc
Confidence 34577777 6665543 456788999998765432221 567899999999999999999998754
Q ss_pred --CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEE
Q 043524 92 --TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKL 169 (314)
Q Consensus 92 --~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl 169 (314)
...+++|+||+++++|.+++.... ..++...+..++.|++.||.||| +++++|+||||+||+++.++.++|
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l 149 (284)
T cd05081 77 AGRRNLRLVMEYLPYGSLRDYLQKHR----ERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKI 149 (284)
T ss_pred CCCCceEEEEEecCCCCHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEE
Confidence 456899999999999999986543 34788899999999999999999 999999999999999999999999
Q ss_pred cccccceecCCCCccc--ccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHH
Q 043524 170 FDFSLSISIPEGETHI--TDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLK 247 (314)
Q Consensus 170 ~dfg~~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (314)
+|||+++......... .....++..|+|||.+.+..++.++|+||+|++++||++|..++....... ..
T Consensus 150 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---------~~ 220 (284)
T cd05081 150 GDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEF---------MR 220 (284)
T ss_pred CCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhh---------hh
Confidence 9999998664432211 112234456999999988889999999999999999999876653221100 00
Q ss_pred hhhccCCcccccC---hhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHH
Q 043524 248 NYFEDNRFTEIVD---PIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQI 307 (314)
Q Consensus 248 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~ 307 (314)
............. .........+.....+..+.+|+.+||..+|++|||+.|+++.|+++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 221 MMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0000000000000 00000111111123456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=304.38 Aligned_cols=253 Identities=19% Similarity=0.273 Sum_probs=206.3
Q ss_pred cccCch-hHHHHHHHhcCCc---ccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCe
Q 043524 19 MIGNGA-SVLQELIASSNGK---YIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPI 94 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~---~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 94 (314)
.||.|- +.|.....+..|+ .||||.....-..++. ..|+.|..+|.+++||||+++.|+.+....
T Consensus 636 VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gytekqr-----------rdFL~EAsIMGQFdHPNIIrLEGVVTks~P 704 (996)
T KOG0196|consen 636 VIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQR-----------RDFLSEASIMGQFDHPNIIRLEGVVTKSKP 704 (996)
T ss_pred EEecccccceecccccCCCCcceeEEEeeeccCccHHHH-----------hhhhhhhhhcccCCCCcEEEEEEEEecCce
Confidence 455555 5666666666664 6899976544333332 679999999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccc
Q 043524 95 AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL 174 (314)
Q Consensus 95 ~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~ 174 (314)
..||+|||++|+|..+++.+. ..+...+...++.+|+.|+.||. +.++|||||.+.|||++.+..+|++|||+
T Consensus 705 vMIiTEyMENGsLDsFLR~~D----GqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGL 777 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQND----GQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGL 777 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhcC----CceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccc
Confidence 999999999999999998876 45888899999999999999999 99999999999999999999999999999
Q ss_pred ceecCCCCccccccc--ccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhc
Q 043524 175 SISIPEGETHITDTV--MGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFE 251 (314)
Q Consensus 175 ~~~~~~~~~~~~~~~--~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (314)
++.+.+.......+. .-+.+|.|||.+....++.++||||||+++||.++ |..||....+.+
T Consensus 778 SRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd--------------- 842 (996)
T KOG0196|consen 778 SRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--------------- 842 (996)
T ss_pred eeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH---------------
Confidence 998865542222222 23678999999999999999999999999999776 999986554432
Q ss_pred cCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhc
Q 043524 252 DNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSL 311 (314)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 311 (314)
+ -+.+......+.+.+++..+.+|+..||++|-.+||.+.||+..|+++....
T Consensus 843 ------V-IkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 843 ------V-IKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred ------H-HHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 1 1122333444445578888999999999999999999999999999998754
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=282.90 Aligned_cols=259 Identities=21% Similarity=0.320 Sum_probs=193.7
Q ss_pred CcccccccCch-hHHHHHHHhc-----CCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeE
Q 043524 14 GKRTLMIGNGA-SVLQELIASS-----NGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLI 86 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~-----~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~ 86 (314)
+.....+|+|+ +.|+++.... ....+|+|.+........ ..++.+|+.++..+ +|+||++++
T Consensus 14 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~-----------~~~~~~E~~~l~~l~~h~~i~~~~ 82 (293)
T cd05053 14 LTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKD-----------LSDLVSEMEMMKMIGKHKNIINLL 82 (293)
T ss_pred eEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHH-----------HHHHHHHHHHHHhhcCCCCeeeEE
Confidence 33444678877 6666655432 336789998764321111 14578999999999 799999999
Q ss_pred eEEEeCCeeEEEEeecCCCCHHHHHhcCCC-----------CCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCC
Q 043524 87 GCCLETPIAILVFEYVQHGTLWDRILGAPQ-----------THFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFK 155 (314)
Q Consensus 87 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk 155 (314)
+++..++.++++|||+++|+|.+++..... .....++...++.++.|++.||.||| +++++|+|||
T Consensus 83 ~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlk 159 (293)
T cd05053 83 GVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLA 159 (293)
T ss_pred EEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccc
Confidence 999999999999999999999999864310 11245788899999999999999999 9999999999
Q ss_pred CCCeeecCCCceEEcccccceecCCCCccc-ccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCccccc
Q 043524 156 TSHILFSEENVVKLFDFSLSISIPEGETHI-TDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVR 233 (314)
Q Consensus 156 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~ 233 (314)
|+||+++.++.++++|||.++......... .....++..|+|||.+....++.++|||||||++|++++ |..||....
T Consensus 160 p~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 239 (293)
T cd05053 160 ARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 239 (293)
T ss_pred eeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC
Confidence 999999999999999999997654332111 122235678999999988889999999999999999997 888875332
Q ss_pred CccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHH
Q 043524 234 DAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQIC 308 (314)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~ 308 (314)
.. +........ . ....+...+..+.+|+..||..||++|||+.|+++.|+++.
T Consensus 240 ~~--------~~~~~~~~~-~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 240 VE--------ELFKLLKEG-Y-------------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HH--------HHHHHHHcC-C-------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11 111111000 0 00001133456889999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=291.84 Aligned_cols=239 Identities=21% Similarity=0.277 Sum_probs=187.1
Q ss_pred cccCch-hHHHHHHH---hcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCe
Q 043524 19 MIGNGA-SVLQELIA---SSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPI 94 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~---~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 94 (314)
.+|.|+ +.|+.+.+ ..+|+.+|+|++......... ...+.+|++++.+++||||+++++++.+++.
T Consensus 3 ~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 72 (318)
T cd05582 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRD----------RVRTKMERDILAEVNHPFIVKLHYAFQTEGK 72 (318)
T ss_pred eeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhh----------HHHHHHHHHHHHhCCCCCcccEEEEEEcCCE
Confidence 367777 66665433 457899999999876543211 1456789999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccc
Q 043524 95 AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL 174 (314)
Q Consensus 95 ~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~ 174 (314)
.|+||||+++|+|.+.+... ..++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+|||+
T Consensus 73 ~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~ 144 (318)
T cd05582 73 LYLILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGL 144 (318)
T ss_pred EEEEEcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccC
Confidence 99999999999999988654 34788999999999999999999 99999999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCC
Q 043524 175 SISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNR 254 (314)
Q Consensus 175 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (314)
++...... .......|++.|+|||++....++.++||||+||++|+|++|+.||....... .......
T Consensus 145 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--------~~~~i~~--- 212 (318)
T cd05582 145 SKESIDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE--------TMTMILK--- 212 (318)
T ss_pred CcccCCCC-CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH--------HHHHHHc---
Confidence 87653321 12334578999999999988889999999999999999999999996432111 1111110
Q ss_pred cccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHH
Q 043524 255 FTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVD 299 (314)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~e 299 (314)
.....+ ...+..+.+|+.+||+.||++|||+.+
T Consensus 213 ----------~~~~~p--~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 213 ----------AKLGMP--QFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ----------CCCCCC--CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 000000 123456789999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=285.76 Aligned_cols=259 Identities=20% Similarity=0.270 Sum_probs=192.9
Q ss_pred CcccccccCch-hHHHHHHHhcCCcc--cccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeEE
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKY--IPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGCC 89 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~--~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 89 (314)
+.-...+|+|+ +.|+.+.+..+|.. +|+|.+....... ..+.+.+|+.++.++ +|+||+++++++
T Consensus 9 ~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~-----------~~~~~~~Ei~~l~~l~~h~~iv~~~~~~ 77 (303)
T cd05088 9 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD-----------DHRDFAGELEVLCKLGHHPNIINLLGAC 77 (303)
T ss_pred ceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHH-----------HHHHHHHHHHHHHHhcCCCCcceEEEEE
Confidence 33345588888 88888877777764 4666544211111 115678899999999 899999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhcCCCC-----------CCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCC
Q 043524 90 LETPIAILVFEYVQHGTLWDRILGAPQT-----------HFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSH 158 (314)
Q Consensus 90 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~n 158 (314)
..++.+|+++||+++++|.+++...... ....++...++.++.|++.|+.||| +++++||||||+|
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~N 154 (303)
T cd05088 78 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARN 154 (303)
T ss_pred CCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchhe
Confidence 9999999999999999999998754210 0124788899999999999999999 9999999999999
Q ss_pred eeecCCCceEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccc
Q 043524 159 ILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHD 237 (314)
Q Consensus 159 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~ 237 (314)
|+++.++.++|+|||+++...... ......++..|+|||.+....++.++||||||+++|+|++ |..||.......
T Consensus 155 ili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~- 231 (303)
T cd05088 155 ILVGENYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE- 231 (303)
T ss_pred EEecCCCcEEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH-
Confidence 999999999999999986432111 1112234667999999988888999999999999999998 999985432211
Q ss_pred cccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 238 LVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
........ .....+...+..+.+|+.+||+.||++|||+.+++..|.++...
T Consensus 232 -------~~~~~~~~--------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 232 -------LYEKLPQG--------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred -------HHHHHhcC--------------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11111000 00000012345678999999999999999999999999887554
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=282.90 Aligned_cols=253 Identities=19% Similarity=0.368 Sum_probs=192.4
Q ss_pred cccccCch-hHHHHHH-----HhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeEE
Q 043524 17 TLMIGNGA-SVLQELI-----ASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGCC 89 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~-----~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 89 (314)
...+|.|+ +.|+.+. ...++..+|+|.+........ .+.+.+|+++++++ +||||+++++++
T Consensus 40 ~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 40 GKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSE-----------REALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred cceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHH-----------HHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 34577777 5555443 234556899998764422111 15688999999999 799999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEE
Q 043524 90 LETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKL 169 (314)
Q Consensus 90 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl 169 (314)
...+..|+++||+++|+|.+++..... ..++...+..++.+++.||.||| +++++|+||||+||+++.++.+++
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~---~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l 182 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRE---SFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKI 182 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEE
Confidence 999999999999999999999875432 23788999999999999999999 999999999999999999999999
Q ss_pred cccccceecCCCCcc-cccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHH
Q 043524 170 FDFSLSISIPEGETH-ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLK 247 (314)
Q Consensus 170 ~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~ 247 (314)
+|||.++........ ......++..|+|||.+....++.++||||+|+++|+|++ |..||........ +..
T Consensus 183 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~----~~~--- 255 (302)
T cd05055 183 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK----FYK--- 255 (302)
T ss_pred CCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH----HHH---
Confidence 999998765433211 1223346778999999988889999999999999999998 9999864332110 000
Q ss_pred hhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHH
Q 043524 248 NYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQI 307 (314)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~ 307 (314)
..... . ....+...+..+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 256 -~~~~~-~------------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 256 -LIKEG-Y------------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -HHHcC-C------------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 01000 0 0000012345689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=281.65 Aligned_cols=250 Identities=19% Similarity=0.295 Sum_probs=194.8
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCee
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIA 95 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (314)
...+|.|+ +.|+.+....+|+.+|+|.+.......... ...+.+|+++++.++|+||+++.+.+..++..
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~---------~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~ 75 (285)
T cd05632 5 YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKG---------ESMALNEKQILEKVNSQFVVNLAYAYETKDAL 75 (285)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhH---------HHHHHHHHHHHHHcCCcCceeEEEEEecCCEE
Confidence 34578887 788888888899999999987765433211 14567899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
|+++||+++++|.+.+..... ..++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+|||++
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~ 149 (285)
T cd05632 76 CLVLTIMNGGDLKFHIYNMGN---PGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLA 149 (285)
T ss_pred EEEEEeccCccHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcc
Confidence 999999999999888865432 35889999999999999999999 999999999999999999999999999998
Q ss_pred eecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCc
Q 043524 176 ISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRF 255 (314)
Q Consensus 176 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (314)
........ .....|+..|+|||++.+..++.++|+||+|+++|+|++|..||........ ...........
T Consensus 150 ~~~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-----~~~~~~~~~~~-- 220 (285)
T cd05632 150 VKIPEGES--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-----REEVDRRVLET-- 220 (285)
T ss_pred eecCCCCc--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHHhhhcc--
Confidence 66533221 2345789999999999888899999999999999999999999964332110 00000000000
Q ss_pred ccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCC-----HHHHHH
Q 043524 256 TEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPT-----MVDVAR 302 (314)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps-----~~ell~ 302 (314)
.. ......+..+.+|+..||+.||++||| +.+++.
T Consensus 221 ~~------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 221 EE------------VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred cc------------ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 00 001133456789999999999999999 677766
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=278.67 Aligned_cols=252 Identities=19% Similarity=0.242 Sum_probs=193.8
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
.+.....+|.|+ +.|+++....+|+.+|+|++....... ...+.+|+.++..++||||+++++++..
T Consensus 10 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~------------~~~~~~e~~~l~~~~h~~ii~~~~~~~~ 77 (267)
T cd06646 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDD------------FSLIQQEIFMVKECKHCNIVAYFGSYLS 77 (267)
T ss_pred hcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccch------------HHHHHHHHHHHHhcCCCCeeeeeEEEEe
Confidence 444555688888 888888888889999999886432111 1356789999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
++..|+||||+++++|.+++... .+++...+..++.|++.|+.||| +.+|+|+|++|+||+++.++.++++|
T Consensus 78 ~~~~~iv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~d 149 (267)
T cd06646 78 REKLWICMEYCGGGSLQDIYHVT-----GPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLAD 149 (267)
T ss_pred CCEEEEEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECc
Confidence 99999999999999999988653 34788899999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCcccc---cCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHh
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVT---TCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKN 248 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (314)
||++........ ......+++.|+|||.+. ...++.++|+||+|+++|+|++|..||..........
T Consensus 150 fg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~--------- 219 (267)
T cd06646 150 FGVAAKITATIA-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--------- 219 (267)
T ss_pred Cccceeeccccc-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe---------
Confidence 999976543221 123456889999999874 3347789999999999999999999985332111000
Q ss_pred hhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 043524 249 YFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARR 303 (314)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 303 (314)
...... ...+. .......+..+.+++..||..||++|||++++++.
T Consensus 220 ~~~~~~---~~~~~------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 220 LMSKSN---FQPPK------LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred eeecCC---CCCCC------CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 000000 00000 01111345678999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=276.63 Aligned_cols=247 Identities=20% Similarity=0.310 Sum_probs=191.6
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCee
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIA 95 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (314)
...+|.|+ +.|+++. ..+++.+|+|.+...... .+.+.+|+.+++.++|+||+++++++ .....
T Consensus 11 ~~~ig~G~~g~v~~~~-~~~~~~~a~K~~~~~~~~-------------~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~ 75 (260)
T cd05067 11 VKKLGAGQFGEVWMGY-YNGHTKVAIKSLKQGSMS-------------PEAFLAEANLMKQLQHPRLVRLYAVV-TQEPI 75 (260)
T ss_pred eeeeccCccceEEeee-cCCCceEEEEEecCCCCc-------------HHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCc
Confidence 34588887 6777765 456788999987643221 15678999999999999999999987 45678
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
++++||+++++|.+.+..... ..++...+..++.|++.||.||| +.+++|+||||+||+++.++.++++|||.+
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~ 149 (260)
T cd05067 76 YIITEYMENGSLVDFLKTPEG---IKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLA 149 (260)
T ss_pred EEEEEcCCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcce
Confidence 999999999999998865432 35788889999999999999999 999999999999999999999999999999
Q ss_pred eecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhccCC
Q 043524 176 ISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFEDNR 254 (314)
Q Consensus 176 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (314)
...............++..|+|||.+....++.++||||||+++|++++ |+.||....... ........
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~-- 219 (260)
T cd05067 150 RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE--------VIQNLERG-- 219 (260)
T ss_pred eecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH--------HHHHHHcC--
Confidence 7765333222333456778999999988889999999999999999998 999986433111 11111000
Q ss_pred cccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHH
Q 043524 255 FTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQ 306 (314)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 306 (314)
...+.....+.++.+++.+||+.||++|||++++++.|+.
T Consensus 220 ------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 220 ------------YRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ------------CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0000011334568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=275.58 Aligned_cols=246 Identities=20% Similarity=0.324 Sum_probs=196.2
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeE
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAI 96 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (314)
..+|.|+ +.++.+....+|+.+++|.+......... .+++.+|+++++.++||||+++++++.+++..|
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (256)
T cd08529 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRRE----------REEAIDEARVLAKLDSSYIIRYYESFLDKGKLN 75 (256)
T ss_pred EEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHH----------HHHHHHHHHHHHhcCCCCeehheeeeccCCEEE
Confidence 3467776 78888888889999999988654322111 156889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
+|+||+++++|.+++..... ..++...+..++.+++.||.||| +++++|+||+|+||+++.++.++++|||.++
T Consensus 76 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~ 149 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQRG---RPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAK 149 (256)
T ss_pred EEEEeCCCCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccce
Confidence 99999999999999876432 35788889999999999999999 9999999999999999999999999999987
Q ss_pred ecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcc
Q 043524 177 SIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFT 256 (314)
Q Consensus 177 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (314)
........ .....++..|+|||++....++.++|+||||+++++|++|..||....... ......
T Consensus 150 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~------ 214 (256)
T cd08529 150 LLSDNTNF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA--------LILKII------ 214 (256)
T ss_pred eccCccch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHH------
Confidence 76443321 234468889999999988889999999999999999999999986433111 011100
Q ss_pred cccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 257 EIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.+..+ ......+..+.+++.+||+.+|++||++.++++
T Consensus 215 -------~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 215 -------RGVFP-PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred -------cCCCC-CCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 01111 111134567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=280.37 Aligned_cols=256 Identities=20% Similarity=0.322 Sum_probs=192.4
Q ss_pred ccccCch-hHHHHHHHhc-----CCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 18 LMIGNGA-SVLQELIASS-----NGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~-----~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
..+|.|+ +.|+++.... .+..+|+|.+........ .+.+.+|+.++..++||||+++++.+..
T Consensus 6 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~-----------~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (290)
T cd05045 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSE-----------LRDLLSEFNLLKQVNHPHVIKLYGACSQ 74 (290)
T ss_pred ccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHH-----------HHHHHHHHHHHhhCCCCCEeeEEEEEec
Confidence 4577777 6666654332 235688887653321111 1568899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCC-------------------CCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceec
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQT-------------------HFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFR 152 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~-------------------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~ 152 (314)
++..++++||+++++|.+++...... ...+++...++.++.|++.||.||| +++++|+
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~ 151 (290)
T cd05045 75 DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHR 151 (290)
T ss_pred CCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehh
Confidence 99999999999999999988643210 1134778889999999999999999 9999999
Q ss_pred cCCCCCeeecCCCceEEcccccceecCCCCcc-cccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcc
Q 043524 153 DFKTSHILFSEENVVKLFDFSLSISIPEGETH-ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILD 230 (314)
Q Consensus 153 dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~ 230 (314)
||||+||+++.++.++|+|||.++........ ......++..|+|||.+.+..++.++||||||+++++|++ |..||.
T Consensus 152 dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 231 (290)
T cd05045 152 DLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 231 (290)
T ss_pred hhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCC
Confidence 99999999999999999999998765332211 1223345678999999888889999999999999999998 998985
Q ss_pred cccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHh
Q 043524 231 LVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICC 309 (314)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 309 (314)
..... . +........ . ...+...+.++.+++..||+.||++||++.|+++.|+++..
T Consensus 232 ~~~~~--------~-~~~~~~~~~---------~----~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 232 GIAPE--------R-LFNLLKTGY---------R----MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred CCCHH--------H-HHHHHhCCC---------C----CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 43211 1 111111100 0 00011344568899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=286.20 Aligned_cols=272 Identities=17% Similarity=0.207 Sum_probs=195.1
Q ss_pred hhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEE
Q 043524 11 WSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCC 89 (314)
Q Consensus 11 ~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 89 (314)
..+|.....+|.|+ +.|+.+.+..+++.||+|.+....... ....+.+|+.+++.++||||+++++++
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~nI~~~~~~~ 73 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG-----------APCTAIREVSLLKDLKHANIVTLHDII 73 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC-----------chhHHHHHHHHHHhcCCCCcceEEEEE
Confidence 34455556688888 888888888889999999886432111 114567899999999999999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEE
Q 043524 90 LETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKL 169 (314)
Q Consensus 90 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl 169 (314)
..++..++|+||++ ++|.+.+.... ..++...+..++.|++.||.||| +++++|+||||+||+++.++.++|
T Consensus 74 ~~~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl 145 (301)
T cd07873 74 HTEKSLTLVFEYLD-KDLKQYLDDCG----NSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKL 145 (301)
T ss_pred ecCCeEEEEEeccc-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEE
Confidence 99999999999996 59988886543 34778889999999999999999 999999999999999999999999
Q ss_pred cccccceecCCCCcccccccccccccccCcccccC-CCCcccchHHHHHHHHHHHhCCCCcccccCccccc-------cc
Q 043524 170 FDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLV-------YP 241 (314)
Q Consensus 170 ~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~-------~~ 241 (314)
+|||++........ ......+++.|+|||++.+. .++.++||||+|+++|+|++|+.||......+... .+
T Consensus 146 ~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~ 224 (301)
T cd07873 146 ADFGLARAKSIPTK-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTP 224 (301)
T ss_pred CcCcchhccCCCCC-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 99999865432221 12234568899999988654 47889999999999999999999997543211000 00
Q ss_pred hHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 242 FNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
....+........+.....+..............+..+.+|+.+||+.||.+|||+.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 225 TEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000000000000000000000000011133556889999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=275.74 Aligned_cols=248 Identities=22% Similarity=0.297 Sum_probs=190.5
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeE
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAI 96 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (314)
..+|.|+ +.|+.+....+ ..+|+|.+...... .+.+.+|+++++.++||||+++++.+. ....+
T Consensus 12 ~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~-------------~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (262)
T cd05071 12 VKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS-------------PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIY 76 (262)
T ss_pred eecCCCCCCcEEEEEecCC-ceEEEEecccCccC-------------HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcE
Confidence 3478777 67776654443 56999988643321 146789999999999999999999874 45679
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
++|||+++|+|.+++..... ..++...+..++.+++.||.|+| +++++|+||||+||+++.++.++|+|||.++
T Consensus 77 lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~ 150 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMG---KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLAR 150 (262)
T ss_pred EEEEcCCCCcHHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCcee
Confidence 99999999999999975432 34678889999999999999999 9999999999999999999999999999997
Q ss_pred ecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhccCCc
Q 043524 177 SIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFEDNRF 255 (314)
Q Consensus 177 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (314)
..............++..|+|||......++.++|+||+|+++|+|++ |..||....... ........
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~--------~~~~~~~~--- 219 (262)
T cd05071 151 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--------VLDQVERG--- 219 (262)
T ss_pred eccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH--------HHHHHhcC---
Confidence 664433222223456778999999988889999999999999999999 788885432111 01111000
Q ss_pred ccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHH
Q 043524 256 TEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQIC 308 (314)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~ 308 (314)
...+.....+..+.+++.+||+.||++|||+.++++.|++..
T Consensus 220 -----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 220 -----------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred -----------CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 000111244567889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=275.44 Aligned_cols=248 Identities=21% Similarity=0.316 Sum_probs=189.8
Q ss_pred cccCch-hHHHHHHHhcC---CcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCe
Q 043524 19 MIGNGA-SVLQELIASSN---GKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPI 94 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~---g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 94 (314)
.+|.|+ +.|+++..... +..+|+|.+........ .+++.+|+++++.+.|+||+++++++. ++.
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 69 (257)
T cd05060 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAG-----------KKEFLREASVMAQLDHPCIVRLIGVCK-GEP 69 (257)
T ss_pred ccCccCceeEEEeEeeccCCCcceEEEEecccccchHH-----------HHHHHHHHHHHHhcCCCCeeeEEEEEc-CCc
Confidence 367777 66665543333 36899998875543211 256889999999999999999999875 567
Q ss_pred eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccc
Q 043524 95 AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL 174 (314)
Q Consensus 95 ~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~ 174 (314)
.++++||+++|+|.+++.... .++...+..++.|++.|+.||| +.+++|+||||+||+++.++.++|+|||.
T Consensus 70 ~~~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~ 141 (257)
T cd05060 70 LMLVMELAPLGPLLKYLKKRR-----EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGM 141 (257)
T ss_pred eEEEEEeCCCCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccc
Confidence 899999999999999997643 4788999999999999999999 99999999999999999999999999999
Q ss_pred ceecCCCCccccc--ccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhc
Q 043524 175 SISIPEGETHITD--TVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFE 251 (314)
Q Consensus 175 ~~~~~~~~~~~~~--~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (314)
++........... ...++..|+|||.+....++.++||||||+++|+|++ |..||....... +... ..
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~-----~~~~----~~ 212 (257)
T cd05060 142 SRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE-----VIAM----LE 212 (257)
T ss_pred cceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH-----HHHH----HH
Confidence 8766443322111 1223467999999988889999999999999999998 999986433211 1111 11
Q ss_pred cCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHH
Q 043524 252 DNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQIC 308 (314)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~ 308 (314)
.... ...+...+..+.+++.+||..||++|||+.++++.|+++.
T Consensus 213 ~~~~-------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 213 SGER-------------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred cCCc-------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 1000 0001133456889999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=320.80 Aligned_cols=253 Identities=18% Similarity=0.272 Sum_probs=203.3
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
-++.++..+|+|. +.||-+++..+|+..|+|.+.-++... .. .....+|.++|..++|||+|+++|+-.
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~--k~--------~~~i~eEm~vlE~lnHpNlV~YyGVEv 1304 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDH--KT--------FKLIAEEMKVLEGLNHPNLVRYYGVEV 1304 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCcccc--cc--------CcchHHHHHHHHhccCccccccCceee
Confidence 3556778899988 999999999999999999877665441 11 245679999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
+....+|.||||.+|+|.+.+...+ ..+......+..|++.|++||| ++||||||+||.||+++.+|.+|++
T Consensus 1305 HRekv~IFMEyC~~GsLa~ll~~gr-----i~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~ 1376 (1509)
T KOG4645|consen 1305 HREKVYIFMEYCEGGSLASLLEHGR-----IEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYG 1376 (1509)
T ss_pred cHHHHHHHHHHhccCcHHHHHHhcc-----hhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEee
Confidence 9999999999999999999887543 2456666778899999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCcc---cccccccccccccCcccccCC---CCcccchHHHHHHHHHHHhCCCCcccccCccccccchHH
Q 043524 171 DFSLSISIPEGETH---ITDTVMGTYGHLAPQYVTTCD---FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNE 244 (314)
Q Consensus 171 dfg~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~---~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 244 (314)
|||.|.....+... ......||+.|||||++.+.. -..++||||+||++.||+||+.||....+.....
T Consensus 1377 DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIM----- 1451 (1509)
T KOG4645|consen 1377 DFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIM----- 1451 (1509)
T ss_pred cccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHH-----
Confidence 99999877544211 134568999999999998765 5678999999999999999999986544332100
Q ss_pred HHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 043524 245 YLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARR 303 (314)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 303 (314)
++ --.+.. ++.+...+.+..+++..||..||++|+++.|+++-
T Consensus 1452 -----y~----------V~~gh~-Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1452 -----YH----------VAAGHK-PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -----hH----------HhccCC-CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 00 000111 12222477888999999999999999999988863
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=279.83 Aligned_cols=246 Identities=19% Similarity=0.295 Sum_probs=190.7
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeE
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAI 96 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (314)
..+|.|+ +.|+++.+..+++.+|+|.+........ .+++.+|++++.+++||||+++++.+...+..+
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~-----------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 75 (279)
T cd06619 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVEL-----------QKQIMSELEILYKCDSPYIIGFYGAFFVENRIS 75 (279)
T ss_pred eeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHH-----------HHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEE
Confidence 4578877 8888888888999999998864321111 156889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
+|+||+++++|.... .++...+..++.|++.|+.||| +++|+|+||||+||+++.++.++|+|||++.
T Consensus 76 lv~e~~~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~ 143 (279)
T cd06619 76 ICTEFMDGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVST 143 (279)
T ss_pred EEEecCCCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcce
Confidence 999999999985432 3567788899999999999999 9999999999999999999999999999987
Q ss_pred ecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcc
Q 043524 177 SIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFT 256 (314)
Q Consensus 177 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (314)
...... .....++..|+|||.+....++.++|+||+|+++|+|++|..||...........+. ....... ...
T Consensus 144 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~-~~~-- 216 (279)
T cd06619 144 QLVNSI---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPL-QLLQCIV-DED-- 216 (279)
T ss_pred eccccc---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchH-HHHHHHh-ccC--
Confidence 653322 334578999999999998889999999999999999999999996533222111110 1000000 000
Q ss_pred cccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 043524 257 EIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARR 303 (314)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 303 (314)
.+.. .....+.++.+++.+||+.||++||++.|+++.
T Consensus 217 ---~~~~-------~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 217 ---PPVL-------PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred ---CCCC-------CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0000 001234568999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=279.91 Aligned_cols=253 Identities=19% Similarity=0.310 Sum_probs=188.2
Q ss_pred cccccCch-hHHHHHHH-----hcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 17 TLMIGNGA-SVLQELIA-----SSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~-----~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
...+|.|+ +.|+.+.. ..++..+|+|.+........ ..++.+|+.+++.++||||+++++++.
T Consensus 11 ~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~-----------~~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRE-----------RIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred eeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHH-----------HHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 34478777 66665432 23456899998754321111 146889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCC-----CCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCC
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQT-----HFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN 165 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~ 165 (314)
.+...++||||+++|+|.+++...... ....++...+..++.|++.||.||| +.+++|+||||+||+++.++
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~ 156 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDF 156 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCC
Confidence 999999999999999999988653211 0123567788899999999999999 99999999999999999999
Q ss_pred ceEEcccccceecCCCCccc-ccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchH
Q 043524 166 VVKLFDFSLSISIPEGETHI-TDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFN 243 (314)
Q Consensus 166 ~~kl~dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~ 243 (314)
.++++|||+++......... .....++..|+|||.+....++.++||||||+++|+|++ |..||......
T Consensus 157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~-------- 228 (277)
T cd05062 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE-------- 228 (277)
T ss_pred CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--------
Confidence 99999999987654322211 112345778999999988889999999999999999999 67887543211
Q ss_pred HHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHH
Q 043524 244 EYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLR 305 (314)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~ 305 (314)
........ ..... .+...+..+.+++.+||+.||++|||+.|+++.|+
T Consensus 229 ~~~~~~~~-~~~~~-------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 229 QVLRFVME-GGLLD-------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHHHHc-CCcCC-------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 11111110 00000 00123456899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=282.18 Aligned_cols=244 Identities=22% Similarity=0.300 Sum_probs=207.6
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCee
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIA 95 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (314)
...+|.|| +.|..+....+|+.+|+|...++.++..... .-.++|-.+|..++.+.||.+--.|++.+.+
T Consensus 190 ~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge---------~maLnEk~iL~kV~s~FiVslaYAfeTkd~L 260 (591)
T KOG0986|consen 190 YRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGE---------TMALNEKQILEKVSSPFIVSLAYAFETKDAL 260 (591)
T ss_pred eEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhh---------HHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence 34688888 9999999999999999999999988776543 4568999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
|+|+..|.||+|.-.|.+.+. ..++...++.++.+|+.||++|| ..+||.|||||+|||+|+.|.++|+|+|+|
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~---~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLA 334 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGN---PGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLA 334 (591)
T ss_pred EEEEEeecCCceeEEeeccCC---CCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceE
Confidence 999999999999999988765 45889999999999999999999 999999999999999999999999999999
Q ss_pred eecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCc
Q 043524 176 ISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRF 255 (314)
Q Consensus 176 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (314)
..++.+.. ....+||.+|||||++....|+.++|.||+||++|||+.|+.||...+... -
T Consensus 335 vei~~g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv------------------k 394 (591)
T KOG0986|consen 335 VEIPEGKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV------------------K 394 (591)
T ss_pred EecCCCCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh------------------h
Confidence 98877654 335589999999999999999999999999999999999999996433211 1
Q ss_pred ccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCC
Q 043524 256 TEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPT 296 (314)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps 296 (314)
.+-++.++.... ...+...++++.+|.+..|..||++|..
T Consensus 395 ~eEvdrr~~~~~-~ey~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 395 REEVDRRTLEDP-EEYSDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred HHHHHHHHhcch-hhcccccCHHHHHHHHHHHccCHHHhcc
Confidence 112333332222 2222478899999999999999999974
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=279.37 Aligned_cols=255 Identities=21% Similarity=0.300 Sum_probs=190.7
Q ss_pred ccccccCch-hHHHHHHH----hcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 16 RTLMIGNGA-SVLQELIA----SSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 16 ~~~~~G~g~-~~~~~~~~----~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
-...+|+|+ +.|+++.. ..++..+|+|.+........ ...+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~~~~~~~ 77 (283)
T cd05090 9 FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQ-----------WGEFQQEASLMAELHHPNIVCLLGVVT 77 (283)
T ss_pred eeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHH-----------HHHHHHHHHHHhhCCCCCeeeEEEEEe
Confidence 334577777 66766542 34567899988753221111 146788999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCC------------CCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCC
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQ------------THFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSH 158 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~------------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~n 158 (314)
.+...|++|||+++++|.+++..... .....++......++.|++.||.||| +++++|+||||+|
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~n 154 (283)
T cd05090 78 QEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARN 154 (283)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccce
Confidence 99999999999999999998853211 00124678888999999999999999 9999999999999
Q ss_pred eeecCCCceEEcccccceecCCCCc-ccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCcc
Q 043524 159 ILFSEENVVKLFDFSLSISIPEGET-HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAH 236 (314)
Q Consensus 159 il~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~ 236 (314)
|+++.++.++++|||+++....... .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.......
T Consensus 155 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~ 234 (283)
T cd05090 155 ILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE 234 (283)
T ss_pred EEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 9999999999999999976533221 11233445778999999988889999999999999999998 888885432110
Q ss_pred ccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHH
Q 043524 237 DLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQ 306 (314)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 306 (314)
.. ........ .+.+...+..+.+++.+||+.||++||++.+|++.|+.
T Consensus 235 --------~~-~~~~~~~~-------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 --------VI-EMVRKRQL-------------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred --------HH-HHHHcCCc-------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 00 00100000 00111334568899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=291.84 Aligned_cols=257 Identities=19% Similarity=0.296 Sum_probs=194.0
Q ss_pred cccccCch-hHHHHHHH-----hcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC-CCceeeeEeEE
Q 043524 17 TLMIGNGA-SVLQELIA-----SSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS-HDHILKLIGCC 89 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~-----~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~ 89 (314)
...+|+|+ +.|+++.+ ..+++.||+|++........ .+.+++|++++..+. |||||++++++
T Consensus 42 ~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~-----------~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 42 GRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSE-----------KQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred hhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhH-----------HHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 44688888 77776653 33456899999864322111 156889999999997 99999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhcCCCC----------------------------------------------------
Q 043524 90 LETPIAILVFEYVQHGTLWDRILGAPQT---------------------------------------------------- 117 (314)
Q Consensus 90 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~---------------------------------------------------- 117 (314)
......++|+|||++|+|.+++......
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 9999999999999999999998653210
Q ss_pred -----------------------------------------CCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCC
Q 043524 118 -----------------------------------------HFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKT 156 (314)
Q Consensus 118 -----------------------------------------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~ 156 (314)
....++....+.++.|++.||.||| +++++||||||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp 267 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAA 267 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCc
Confidence 0013566778889999999999999 99999999999
Q ss_pred CCeeecCCCceEEcccccceecCCCCcc-cccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccC
Q 043524 157 SHILFSEENVVKLFDFSLSISIPEGETH-ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRD 234 (314)
Q Consensus 157 ~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~ 234 (314)
+||+++..+.++++|||+++........ ......++..|+|||.+....++.++|+||||+++|||++ |..||.....
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 9999999999999999999765322211 1223456788999999988889999999999999999998 8888854332
Q ss_pred ccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHH
Q 043524 235 AHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQIC 308 (314)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~ 308 (314)
.. .......... ....+...+.++.+|+.+||..||.+||++.||++.|+++.
T Consensus 348 ~~--------~~~~~~~~~~-------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 348 NE--------QFYNAIKRGY-------------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred hH--------HHHHHHHcCC-------------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11 0001111000 00001133467899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=311.00 Aligned_cols=265 Identities=17% Similarity=0.230 Sum_probs=200.5
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
|.....+|.|+ +.|+++.+..+|+.||+|.+....... ....+++.+|+++++.++||||+++++++.++
T Consensus 4 YeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~---------e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~ 74 (932)
T PRK13184 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSEN---------PLLKKRFLREAKIAADLIHPGIVPVYSICSDG 74 (932)
T ss_pred eEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccC---------HHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC
Confidence 34445688888 889998888899999999886432110 11236789999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCC------CCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQ------THFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENV 166 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~ 166 (314)
+..|++|||+++|+|.+.+..... ......+...++.++.|++.||.||| +++|+||||||+||+++.++.
T Consensus 75 ~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~ 151 (932)
T PRK13184 75 DPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGE 151 (932)
T ss_pred CEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCC
Confidence 999999999999999998864211 01123456778889999999999999 999999999999999999999
Q ss_pred eEEcccccceecCCCC-----------------cccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCc
Q 043524 167 VKLFDFSLSISIPEGE-----------------THITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGIL 229 (314)
Q Consensus 167 ~kl~dfg~~~~~~~~~-----------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~ 229 (314)
++++|||+++...... ........||+.|+|||.+.+..++.++||||+||++|+|++|..||
T Consensus 152 vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF 231 (932)
T PRK13184 152 VVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231 (932)
T ss_pred EEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCC
Confidence 9999999997652110 00112346899999999999888999999999999999999999999
Q ss_pred ccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCC-CHHHHHHHHHHHH
Q 043524 230 DLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRP-TMVDVARRLRQIC 308 (314)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-s~~ell~~L~~~~ 308 (314)
........ .... ....+. ........+..+.+++.+||+.||++|| ++.++.+.|++..
T Consensus 232 ~~~~~~ki---~~~~------------~i~~P~-----~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l 291 (932)
T PRK13184 232 RRKKGRKI---SYRD------------VILSPI-----EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL 291 (932)
T ss_pred CCcchhhh---hhhh------------hccChh-----hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 65322110 0000 000000 0000113445688999999999999997 5888888888775
Q ss_pred hh
Q 043524 309 CS 310 (314)
Q Consensus 309 ~~ 310 (314)
..
T Consensus 292 q~ 293 (932)
T PRK13184 292 QG 293 (932)
T ss_pred hc
Confidence 43
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=293.35 Aligned_cols=197 Identities=20% Similarity=0.304 Sum_probs=171.2
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC-C-----Cceeee
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS-H-----DHILKL 85 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~~ 85 (314)
+|.....+|+|+ +.|.++.+.++++.||||++..+.. +..+...|+.+|..|+ | -|+|++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-------------f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm 253 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-------------FLRQAQIEIRILELLNKHDPDDKYNIVRM 253 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-------------HHHHHHHHHHHHHHHhccCCCCCeeEEEe
Confidence 566677899999 9999999999999999999875532 1244568999999997 4 389999
Q ss_pred EeEEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCC
Q 043524 86 IGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN 165 (314)
Q Consensus 86 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~ 165 (314)
+++|...+++|||+|.+. -+|.++++.+. +..++...++.++.||+.||.+|| +.+|||+||||+|||+...+
T Consensus 254 ~d~F~fr~HlciVfELL~-~NLYellK~n~---f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~ 326 (586)
T KOG0667|consen 254 LDYFYFRNHLCIVFELLS-TNLYELLKNNK---FRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPK 326 (586)
T ss_pred eeccccccceeeeehhhh-hhHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCC
Confidence 999999999999999995 59999998754 467999999999999999999999 99999999999999997544
Q ss_pred --ceEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCccccc
Q 043524 166 --VVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVR 233 (314)
Q Consensus 166 --~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 233 (314)
.+||+|||.|...... ..+.+.++.|.|||++++.+|+.+.|+||||||+.||++|.+.|.+..
T Consensus 327 r~~vKVIDFGSSc~~~q~----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 327 RSRIKVIDFGSSCFESQR----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred cCceeEEecccccccCCc----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 6899999999765332 226788999999999999999999999999999999999988886543
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=300.08 Aligned_cols=265 Identities=19% Similarity=0.283 Sum_probs=187.3
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
+|.....+|.|+ +.|+++....+|+.||+|.+.... ....+|+.+++.++|||||++++++..
T Consensus 67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----------------~~~~~Ei~il~~l~h~niv~l~~~~~~ 130 (440)
T PTZ00036 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----------------QYKNRELLIMKNLNHINIIFLKDYYYT 130 (440)
T ss_pred eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----------------chHHHHHHHHHhcCCCCCcceeeeEee
Confidence 455566789888 888888888899999999874321 123479999999999999999988753
Q ss_pred C--------CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecC
Q 043524 92 T--------PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSE 163 (314)
Q Consensus 92 ~--------~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~ 163 (314)
. ..+++||||++ +++.+.+...... ...++...+..++.|++.||.||| +++|+||||||+||+++.
T Consensus 131 ~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~-~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~ 205 (440)
T PTZ00036 131 ECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARN-NHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDP 205 (440)
T ss_pred cccccCCCceEEEEEEecCC-ccHHHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcC
Confidence 2 24679999997 4777766532111 135788899999999999999999 999999999999999986
Q ss_pred CC-ceEEcccccceecCCCCcccccccccccccccCcccccC-CCCcccchHHHHHHHHHHHhCCCCcccccCcccccc-
Q 043524 164 EN-VVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVY- 240 (314)
Q Consensus 164 ~~-~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~- 240 (314)
.+ .+||+|||+++....... .....||+.|+|||++.+. .++.++||||+||++|+|++|.+||...........
T Consensus 206 ~~~~vkL~DFGla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i 283 (440)
T PTZ00036 206 NTHTLKLCDFGSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRI 283 (440)
T ss_pred CCCceeeeccccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 64 699999999986643322 2345689999999988764 589999999999999999999999975433211100
Q ss_pred ------chHHHHHhhhccCCcccccChhh-hccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 241 ------PFNEYLKNYFEDNRFTEIVDPII-VQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 241 ------~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
+..+..... ...+.++.-+.. ........+...+.++.+|+.+||.+||.+|||+.|++.
T Consensus 284 ~~~~~~p~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 284 IQVLGTPTEDQLKEM--NPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHhCCCCHHHHHHh--chhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 000000000 000000000000 000000011123567899999999999999999999985
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=278.62 Aligned_cols=258 Identities=20% Similarity=0.291 Sum_probs=194.1
Q ss_pred hhcCcccccccCch-hHHHHHH-----HhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceee
Q 043524 11 WSKGKRTLMIGNGA-SVLQELI-----ASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILK 84 (314)
Q Consensus 11 ~~~~~~~~~~G~g~-~~~~~~~-----~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 84 (314)
|+.+.....+|.|+ +.|+.+. ...++..+|+|.+....... .+.+.+|+++++.++|+||++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~------------~~~~~~e~~~l~~l~h~~i~~ 71 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA------------RQDFQREAELLTVLQHQHIVR 71 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHH------------HHHHHHHHHHHhcCCCCCCce
Confidence 34445556688887 6666553 33456688888765433221 156889999999999999999
Q ss_pred eEeEEEeCCeeEEEEeecCCCCHHHHHhcCCCC----------CCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccC
Q 043524 85 LIGCCLETPIAILVFEYVQHGTLWDRILGAPQT----------HFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDF 154 (314)
Q Consensus 85 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~----------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dl 154 (314)
+++++.++...++++||+++++|.+++...... ....++...++.++.|++.|+.||| +++++|+||
T Consensus 72 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dl 148 (280)
T cd05092 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDL 148 (280)
T ss_pred EEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccc
Confidence 999999999999999999999999998754310 0124778889999999999999999 999999999
Q ss_pred CCCCeeecCCCceEEcccccceecCCCCcc-cccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccc
Q 043524 155 KTSHILFSEENVVKLFDFSLSISIPEGETH-ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLV 232 (314)
Q Consensus 155 k~~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~ 232 (314)
||+||+++.++.++|+|||++......... ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||...
T Consensus 149 kp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 228 (280)
T cd05092 149 ATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL 228 (280)
T ss_pred cHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccC
Confidence 999999999999999999998765332211 1223345678999999988889999999999999999998 88888533
Q ss_pred cCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHH
Q 043524 233 RDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLR 305 (314)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~ 305 (314)
.... .......... ...+...+..+.+++.+||+.||++||++.++++.|+
T Consensus 229 ~~~~--------~~~~~~~~~~--------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 229 SNTE--------AIECITQGRE--------------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred CHHH--------HHHHHHcCcc--------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 2211 0111100000 0000133456789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=282.28 Aligned_cols=266 Identities=20% Similarity=0.307 Sum_probs=198.4
Q ss_pred hcCcccccccCch-hHHHHHHHhc-------CCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCce
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASS-------NGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHI 82 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~-------~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni 82 (314)
.++.....+|+|+ +.|+.+.... ++..+|+|.+........ .+.+.+|+.++..+ +||||
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~-----------~~~~~~e~~~l~~l~~h~~i 86 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKD-----------LSDLISEMEMMKMIGKHKNI 86 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHH-----------HHHHHHHHHHHHHhcCCCCE
Confidence 3445555688888 6676654322 335699998864321111 14678899999999 79999
Q ss_pred eeeEeEEEeCCeeEEEEeecCCCCHHHHHhcCCCC-----------CCCcccHHHHHHHHHHHHHHHHHhhcCCCCCcee
Q 043524 83 LKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQT-----------HFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVF 151 (314)
Q Consensus 83 v~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H 151 (314)
+++++++..++..|+|+||+++|+|.+++...... ....++...++.++.|++.||.||| +++++|
T Consensus 87 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H 163 (307)
T cd05098 87 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIH 163 (307)
T ss_pred eeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence 99999999999999999999999999999764321 0124788899999999999999999 999999
Q ss_pred ccCCCCCeeecCCCceEEcccccceecCCCCccc-ccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCc
Q 043524 152 RDFKTSHILFSEENVVKLFDFSLSISIPEGETHI-TDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGIL 229 (314)
Q Consensus 152 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~ 229 (314)
+||||+||+++.++.++|+|||.++......... .....++..|+|||.+.+..++.++|+||+|+++|+|++ |..||
T Consensus 164 ~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~ 243 (307)
T cd05098 164 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 243 (307)
T ss_pred ccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCC
Confidence 9999999999999999999999987653321111 112234568999999988889999999999999999998 88887
Q ss_pred ccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHh
Q 043524 230 DLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICC 309 (314)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 309 (314)
..... .+..... .... ....+...+.++.+|+.+||..+|++|||+.++++.|.++..
T Consensus 244 ~~~~~--------~~~~~~~-~~~~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 244 PGVPV--------EELFKLL-KEGH-------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred CcCCH--------HHHHHHH-HcCC-------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 53221 1111111 1000 000011334678899999999999999999999999999987
Q ss_pred hccC
Q 043524 310 SLSC 313 (314)
Q Consensus 310 ~~~~ 313 (314)
.-++
T Consensus 302 ~~~~ 305 (307)
T cd05098 302 LTSN 305 (307)
T ss_pred Hhhc
Confidence 6554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=278.44 Aligned_cols=253 Identities=19% Similarity=0.294 Sum_probs=193.4
Q ss_pred ccccccCch-hHHHHHHHhcCCcc----cccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 16 RTLMIGNGA-SVLQELIASSNGKY----IPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 16 ~~~~~G~g~-~~~~~~~~~~~g~~----~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
....+|.|+ +.|+++....+|+. ||+|.+........ .+.+.+|+.++..++||||+++++++.
T Consensus 11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~-----------~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (279)
T cd05109 11 KVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKA-----------NKEILDEAYVMAGVGSPYVCRLLGICL 79 (279)
T ss_pred eeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHH-----------HHHHHHHHHHHHhcCCCCCceEEEEEc
Confidence 344588888 78877766667764 78888754322111 256789999999999999999999987
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
. ...++++||+++|+|.+.+.... ..++...++.++.|++.||.||| +++++|+||||+||+++.++.++|+
T Consensus 80 ~-~~~~l~~~~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~ 151 (279)
T cd05109 80 T-STVQLVTQLMPYGCLLDYVRENK----DRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKIT 151 (279)
T ss_pred C-CCcEEEEEcCCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEEC
Confidence 5 45779999999999999987643 35788999999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCccc-ccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHh
Q 043524 171 DFSLSISIPEGETHI-TDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKN 248 (314)
Q Consensus 171 dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 248 (314)
|||+++......... .....++..|+|||......++.++|||||||++|||++ |..||+...... ...
T Consensus 152 dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-----~~~---- 222 (279)
T cd05109 152 DFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE-----IPD---- 222 (279)
T ss_pred CCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHH----
Confidence 999998764332211 112234678999999988889999999999999999998 888986432111 111
Q ss_pred hhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHh
Q 043524 249 YFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICC 309 (314)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 309 (314)
...... ..+.+...+..+.+++.+||..||++|||+.++++.|+++..
T Consensus 223 ~~~~~~-------------~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 223 LLEKGE-------------RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred HHHCCC-------------cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 111100 000011344568899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=277.21 Aligned_cols=262 Identities=17% Similarity=0.295 Sum_probs=190.5
Q ss_pred ccccccCch-hHHHHHHH----------------hcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC
Q 043524 16 RTLMIGNGA-SVLQELIA----------------SSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS 78 (314)
Q Consensus 16 ~~~~~G~g~-~~~~~~~~----------------~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 78 (314)
-...+|+|+ +.|+.+.. ..++..+|+|.+........ .+.+.+|+++++.++
T Consensus 9 ~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~-----------~~~~~~E~~~l~~l~ 77 (296)
T cd05095 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNA-----------RNDFLKEIKIMSRLK 77 (296)
T ss_pred eeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHH-----------HHHHHHHHHHHHhCC
Confidence 334488888 77766532 22344688888764321111 156889999999999
Q ss_pred CCceeeeEeEEEeCCeeEEEEeecCCCCHHHHHhcCCCCC------CCcccHHHHHHHHHHHHHHHHHhhcCCCCCceec
Q 043524 79 HDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTH------FEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFR 152 (314)
Q Consensus 79 h~niv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~------~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~ 152 (314)
|+||+++++++..++..+++|||+++|+|.+++....... ...++...+..++.|++.||.||| +++++|+
T Consensus 78 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~ 154 (296)
T cd05095 78 DPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHR 154 (296)
T ss_pred CCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecc
Confidence 9999999999999999999999999999999987643211 123667789999999999999999 9999999
Q ss_pred cCCCCCeeecCCCceEEcccccceecCCCCcc-cccccccccccccCcccccCCCCcccchHHHHHHHHHHHh--CCCCc
Q 043524 153 DFKTSHILFSEENVVKLFDFSLSISIPEGETH-ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT--GRGIL 229 (314)
Q Consensus 153 dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~--g~~p~ 229 (314)
||||+||+++.++.++++|||.++........ ......++..|++||......++.++|+|||||++|||++ |..||
T Consensus 155 dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~ 234 (296)
T cd05095 155 DLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPY 234 (296)
T ss_pred cCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCc
Confidence 99999999999999999999998765332211 1222344678999998888889999999999999999998 66787
Q ss_pred ccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHH
Q 043524 230 DLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQ 306 (314)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 306 (314)
........ .......+...... .. . +.+..++..+.+|+.+||+.||++|||+.+|++.|++
T Consensus 235 ~~~~~~~~-----~~~~~~~~~~~~~~-~~---~------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 235 SQLSDEQV-----IENTGEFFRDQGRQ-VY---L------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred cccChHHH-----HHHHHHHHhhcccc-cc---C------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 54332110 00001111110000 00 0 0011234568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=273.17 Aligned_cols=246 Identities=21% Similarity=0.336 Sum_probs=191.6
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeEE
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAIL 97 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i 97 (314)
.+|.|+ +.++.+.... |+.+|+|.+........ .+.+.+|++++++++|+||+++++++.+....++
T Consensus 2 ~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~-----------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 69 (251)
T cd05041 2 KIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDL-----------KRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYI 69 (251)
T ss_pred ccccCCCceEEEEEEeC-CCcEEEEeccccCCHHH-----------HHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEE
Confidence 367777 6777776656 89999998775443211 1568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccccee
Q 043524 98 VFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSIS 177 (314)
Q Consensus 98 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~ 177 (314)
++||+++++|.+++.... ..++...+..++.+++.||.||| +++++|+||+|+||+++.++.++++|||.++.
T Consensus 70 v~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~ 142 (251)
T cd05041 70 VMELVPGGSLLTFLRKKK----NRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRE 142 (251)
T ss_pred EEEcCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeecccccc
Confidence 999999999999986643 34778888999999999999999 99999999999999999999999999999876
Q ss_pred cCCCCcccc-cccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhccCCc
Q 043524 178 IPEGETHIT-DTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFEDNRF 255 (314)
Q Consensus 178 ~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (314)
......... ....++..|+|||.+.+..++.++|+||+|+++|+|++ |..||....... ... .....
T Consensus 143 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~-----~~~----~~~~~-- 211 (251)
T cd05041 143 EEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-----TRE----RIESG-- 211 (251)
T ss_pred ccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH-----HHH----HHhcC--
Confidence 543221111 12234567999999988889999999999999999999 788875433211 000 00000
Q ss_pred ccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHH
Q 043524 256 TEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLR 305 (314)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~ 305 (314)
.....+...+..+.+++.+||..+|++|||+.|+++.|+
T Consensus 212 -----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 212 -----------YRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred -----------CCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 000011134567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=276.67 Aligned_cols=252 Identities=21% Similarity=0.299 Sum_probs=189.0
Q ss_pred cccCch-hHHHHHHHhcCCc--ccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeEEEeCCe
Q 043524 19 MIGNGA-SVLQELIASSNGK--YIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGCCLETPI 94 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~--~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 94 (314)
.+|.|+ +.|+.+....+|. .+++|.+........ .+.+.+|+.++.++ +||||+++++++...+.
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~-----------~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 70 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD-----------HRDFAGELEVLCKLGHHPNIINLLGACEHRGY 70 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHH-----------HHHHHHHHHHHHhhccCCCeeeEEEEEecCCC
Confidence 367777 7777777666665 457776653211111 15678999999999 79999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcCCCC-----------CCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecC
Q 043524 95 AILVFEYVQHGTLWDRILGAPQT-----------HFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSE 163 (314)
Q Consensus 95 ~~iv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~ 163 (314)
.|++|||+++|+|.+++...... ....++...+..++.|++.|+.||| +++++|+||||+||+++.
T Consensus 71 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~ 147 (270)
T cd05047 71 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGE 147 (270)
T ss_pred ceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcC
Confidence 99999999999999998754211 1124778899999999999999999 999999999999999999
Q ss_pred CCceEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccch
Q 043524 164 ENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPF 242 (314)
Q Consensus 164 ~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~ 242 (314)
++.++++|||++....... .......+..|+|||++....++.++|+||||+++|+|++ |..||.....
T Consensus 148 ~~~~kl~dfgl~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-------- 217 (270)
T cd05047 148 NYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-------- 217 (270)
T ss_pred CCeEEECCCCCccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH--------
Confidence 9999999999985322111 1111233567999999988889999999999999999997 9999853221
Q ss_pred HHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHH
Q 043524 243 NEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQIC 308 (314)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~ 308 (314)
.+........ . ........+.++.+++.+||..||.+|||+.+++..|.++.
T Consensus 218 ~~~~~~~~~~-~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 218 AELYEKLPQG-Y-------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred HHHHHHHhCC-C-------------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 1111111100 0 00000123456789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=275.42 Aligned_cols=246 Identities=22% Similarity=0.317 Sum_probs=189.8
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeE
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAI 96 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (314)
..+|+|+ +.|+.+. ..++..+|+|.+...... .+++.+|+.+++.++|+||+++++++. ....+
T Consensus 12 ~~ig~g~~~~v~~~~-~~~~~~~~~k~~~~~~~~-------------~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 12 KKLGNGQFGEVWMGT-WNGNTKVAVKTLKPGTMS-------------PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred heeccccCceEEEEE-ecCCceeEEEEecCCCCC-------------HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence 3488887 6666664 346677999987653321 156889999999999999999999875 56688
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
++|||+++++|.+.+..... ..++...+..++.+++.||.||| +++++|+||||+||+++.++.++++|||.+.
T Consensus 77 lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~ 150 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEG---RALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLAR 150 (260)
T ss_pred EEEEecCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeee
Confidence 99999999999999875432 34788899999999999999999 9999999999999999999999999999997
Q ss_pred ecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhccCCc
Q 043524 177 SIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFEDNRF 255 (314)
Q Consensus 177 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (314)
..............++..|+|||......++.++|+||||+++|+|++ |..||...... +........
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~~~--- 219 (260)
T cd05070 151 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--------EVLEQVERG--- 219 (260)
T ss_pred eccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHHcC---
Confidence 764433222223345678999999888889999999999999999999 88888643211 111111100
Q ss_pred ccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHH
Q 043524 256 TEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQ 306 (314)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 306 (314)
...+.+...+..+.+|+.+||..||++|||+.++.+.|++
T Consensus 220 -----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 220 -----------YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -----------CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0001111345678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=282.66 Aligned_cols=250 Identities=21% Similarity=0.288 Sum_probs=196.6
Q ss_pred hhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEE
Q 043524 11 WSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCC 89 (314)
Q Consensus 11 ~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 89 (314)
+.++.....+|.|+ +.++.+.+..+|+.+++|.+....... .+.+.+|+.+++.++||||+++++++
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~------------~~~~~~e~~~l~~l~h~~iv~~~~~~ 85 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPK------------KELIINEILVMKELKNPNIVNFLDSF 85 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCch------------HHHHHHHHHHHHhcCCCceeeeeeeE
Confidence 34455556788887 778888888899999999886432211 15678999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEE
Q 043524 90 LETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKL 169 (314)
Q Consensus 90 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl 169 (314)
..+...|+|+||+++++|...+... .++...+..++.+++.|+.||| +++++|+||+|+||+++.++.++|
T Consensus 86 ~~~~~~~lv~e~~~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl 156 (296)
T cd06655 86 LVGDELFVVMEYLAGGSLTDVVTET------CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKL 156 (296)
T ss_pred ecCceEEEEEEecCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEE
Confidence 9999999999999999999988642 4788999999999999999999 999999999999999999999999
Q ss_pred cccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhh
Q 043524 170 FDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNY 249 (314)
Q Consensus 170 ~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (314)
+|||++........ ......++..|+|||.+....++.++|+|||||++|+|++|..||....... .. ...
T Consensus 157 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~-------~~-~~~ 227 (296)
T cd06655 157 TDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-------AL-YLI 227 (296)
T ss_pred ccCccchhcccccc-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HH-HHH
Confidence 99999876533221 1233468889999999988889999999999999999999999996543211 00 000
Q ss_pred hccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 250 FEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
... .... ...+...+..+.+++.+||..||++|||+.+++.
T Consensus 228 ~~~-~~~~-----------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 228 ATN-GTPE-----------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred Hhc-CCcc-----------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000 0000 0011134456889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=277.59 Aligned_cols=264 Identities=20% Similarity=0.304 Sum_probs=193.7
Q ss_pred cCcccccccCch-hHHHHHHHhc----------------CCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHh
Q 043524 13 KGKRTLMIGNGA-SVLQELIASS----------------NGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAA 75 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~----------------~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 75 (314)
++.-...+|.|+ +.|+.+.... .+..+|+|.+........ .+.+.+|++++.
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~-----------~~~~~~e~~~l~ 74 (296)
T cd05051 6 PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNA-----------REDFLKEVKILS 74 (296)
T ss_pred hCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHH-----------HHHHHHHHHHHH
Confidence 344445588888 6666544333 334678998765432211 156889999999
Q ss_pred cCCCCceeeeEeEEEeCCeeEEEEeecCCCCHHHHHhcCCCCC------CCcccHHHHHHHHHHHHHHHHHhhcCCCCCc
Q 043524 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTH------FEPLLLKRRLKDAVDAANALAYLHFGFPRPI 149 (314)
Q Consensus 76 ~l~h~niv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~------~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i 149 (314)
.++||||+++++++..+...++++||+++++|.+++....... ...++...+..++.|++.||.||| ++++
T Consensus 75 ~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i 151 (296)
T cd05051 75 RLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNF 151 (296)
T ss_pred hcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCc
Confidence 9999999999999999999999999999999999987643111 125788999999999999999999 9999
Q ss_pred eeccCCCCCeeecCCCceEEcccccceecCCCCc-ccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh--CC
Q 043524 150 VFRDFKTSHILFSEENVVKLFDFSLSISIPEGET-HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT--GR 226 (314)
Q Consensus 150 ~H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~--g~ 226 (314)
+|+||||+||+++.++.++++|||.++....... .......+++.|+|||.+....++.++||||||+++|+|++ |.
T Consensus 152 ~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 231 (296)
T cd05051 152 VHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE 231 (296)
T ss_pred cccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCC
Confidence 9999999999999999999999999876533221 11233456788999999988889999999999999999998 66
Q ss_pred CCcccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHH
Q 043524 227 GILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLR 305 (314)
Q Consensus 227 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~ 305 (314)
.||....... ........+......... ......+.++.+++.+||+.||++|||+.||++.|+
T Consensus 232 ~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 232 QPYEHLTDQQ-----VIENAGHFFRDDGRQIYL----------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CCCCCcChHH-----HHHHHHhccccccccccC----------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 6775332111 000011111110000000 001133467899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=272.67 Aligned_cols=238 Identities=22% Similarity=0.365 Sum_probs=182.2
Q ss_pred cccCch-hHHHHHHHhcCCc-------ccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 19 MIGNGA-SVLQELIASSNGK-------YIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~-------~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|.|+ +.|+++.+...+. .+|+|.+....... .+++.+|+.++..++||||+++++++.
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~------------~~~~~~e~~~l~~~~h~~iv~~~~~~~ 69 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNY------------SESFFEAASMMSQLSHKHLVLNYGVCV 69 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHH------------HHHHHHHHHHHHhCCCCChhheeeEEE
Confidence 367777 8888887765544 37777765433221 257889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCc----
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENV---- 166 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~---- 166 (314)
.+...++||||+++|+|.+++.... ..++......++.|++.||.||| +++|+||||||+||+++.++.
T Consensus 70 ~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~ 142 (258)
T cd05078 70 CGDESIMVQEYVKFGSLDTYLKKNK----NLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTG 142 (258)
T ss_pred eCCCcEEEEecCCCCcHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccC
Confidence 9999999999999999999987654 24678888999999999999999 999999999999999987654
Q ss_pred ----eEEcccccceecCCCCcccccccccccccccCcccccC-CCCcccchHHHHHHHHHHHhCC-CCcccccCcccccc
Q 043524 167 ----VKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGR-GILDLVRDAHDLVY 240 (314)
Q Consensus 167 ----~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~-~p~~~~~~~~~~~~ 240 (314)
++++|||.+..... .....++..|+|||++.+. .++.++||||+|+++|+|++|. .||.......
T Consensus 143 ~~~~~~l~d~g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~---- 213 (258)
T cd05078 143 NPPFIKLSDPGISITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---- 213 (258)
T ss_pred CCceEEecccccccccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH----
Confidence 68999998755432 2234678899999999874 4789999999999999999985 5554222111
Q ss_pred chHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHH
Q 043524 241 PFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRL 304 (314)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 304 (314)
. ...... . ...+. ..+.++.+|+.+||+.||++|||++++++.|
T Consensus 214 ----~-~~~~~~---------~--~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 214 ----K-LQFYED---------R--HQLPA----PKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred ----H-HHHHHc---------c--ccCCC----CCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0 000000 0 00000 1224578999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=281.92 Aligned_cols=198 Identities=19% Similarity=0.303 Sum_probs=156.5
Q ss_pred cccCch-hHHHHHHHh--cCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe--CC
Q 043524 19 MIGNGA-SVLQELIAS--SNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE--TP 93 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~--~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~ 93 (314)
.+|.|+ +.|+++.+. .+++.+|+|.+..... ...+.+|+++++.++||||+++++++.. +.
T Consensus 8 ~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 73 (317)
T cd07868 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--------------SMSACREIALLRELKHPNVISLQKVFLSHADR 73 (317)
T ss_pred ccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--------------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCc
Confidence 578888 778777643 4678899998754321 1346789999999999999999999864 56
Q ss_pred eeEEEEeecCCCCHHHHHhcCCC----CCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeee----cCCC
Q 043524 94 IAILVFEYVQHGTLWDRILGAPQ----THFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILF----SEEN 165 (314)
Q Consensus 94 ~~~iv~e~~~~g~L~~~l~~~~~----~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~----~~~~ 165 (314)
..|+++||++ ++|.+.+..... .....++...+..++.|++.||.||| +++|+||||||+||++ +..+
T Consensus 74 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~ 149 (317)
T cd07868 74 KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERG 149 (317)
T ss_pred EEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcC
Confidence 6899999995 588887753221 11134788899999999999999999 9999999999999999 4557
Q ss_pred ceEEcccccceecCCCCc--ccccccccccccccCcccccC-CCCcccchHHHHHHHHHHHhCCCCcccccC
Q 043524 166 VVKLFDFSLSISIPEGET--HITDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGRGILDLVRD 234 (314)
Q Consensus 166 ~~kl~dfg~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~ 234 (314)
.+||+|||+++....... .......+|+.|+|||++.+. .++.++||||+||++|+|++|++||.....
T Consensus 150 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~ 221 (317)
T cd07868 150 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221 (317)
T ss_pred cEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcc
Confidence 899999999976543221 112345789999999998774 488999999999999999999999975443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=274.53 Aligned_cols=249 Identities=20% Similarity=0.284 Sum_probs=189.9
Q ss_pred cccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCC
Q 043524 15 KRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETP 93 (314)
Q Consensus 15 ~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (314)
.....+|.|+ +.|+.+... .+..+|+|.+..... ..+.+.+|+++++.++|+|++++++++. .+
T Consensus 9 ~~~~~ig~g~~~~v~~~~~~-~~~~~~lK~~~~~~~-------------~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~ 73 (260)
T cd05069 9 RLDVKLGQGCFGEVWMGTWN-GTTKVAIKTLKPGTM-------------MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EE 73 (260)
T ss_pred eeeeeecCcCCCeEEEEEEc-CCceEEEEEcccCCc-------------cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CC
Confidence 3344588888 667666443 345689997654321 1256889999999999999999999875 45
Q ss_pred eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccc
Q 043524 94 IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFS 173 (314)
Q Consensus 94 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg 173 (314)
..+++|||+++++|.+++..... ..++...+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg 147 (260)
T cd05069 74 PIYIVTEFMGKGSLLDFLKEGDG---KYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFG 147 (260)
T ss_pred CcEEEEEcCCCCCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCc
Confidence 68899999999999999975432 34678889999999999999999 9999999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhcc
Q 043524 174 LSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFED 252 (314)
Q Consensus 174 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (314)
.+...............++..|+|||......++.++|+||+|+++|+|++ |..||....... ........
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--------~~~~~~~~ 219 (260)
T cd05069 148 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--------VLEQVERG 219 (260)
T ss_pred cceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcC
Confidence 997664433222223456778999999988889999999999999999999 888886432111 11111100
Q ss_pred CCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHH
Q 043524 253 NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQ 306 (314)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 306 (314)
...+.+...+..+.+++.+||..||++||++.++++.|++
T Consensus 220 --------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 220 --------------YRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --------------CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0000111345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=273.37 Aligned_cols=250 Identities=20% Similarity=0.285 Sum_probs=196.3
Q ss_pred cccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCC
Q 043524 15 KRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETP 93 (314)
Q Consensus 15 ~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (314)
.....+|.|+ +.++.+....+++.+++|++....... .+.+.+|+.+++.++||||+++++++..+.
T Consensus 6 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------------~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 73 (262)
T cd06613 6 ELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDD------------FEIIQQEISMLKECRHPNIVAYFGSYLRRD 73 (262)
T ss_pred EEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhh------------HHHHHHHHHHHHhCCCCChhceEEEEEeCC
Confidence 3344578777 788888888888999999987543221 156789999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccc
Q 043524 94 IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFS 173 (314)
Q Consensus 94 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg 173 (314)
.+|++|||+++++|.+++.... ..++...+..++.|++.|+.||| +++++|+||+|+||+++.++.++++|||
T Consensus 74 ~~~l~~e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g 146 (262)
T cd06613 74 KLWIVMEYCGGGSLQDIYQVTR----GPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFG 146 (262)
T ss_pred EEEEEEeCCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccc
Confidence 9999999999999999887643 35788999999999999999999 9999999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCcccccC---CCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhh
Q 043524 174 LSISIPEGETHITDTVMGTYGHLAPQYVTTC---DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 174 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
.+........ ......++..|+|||.+... .++.++|+||+|+++|+|++|..||....... ... . .
T Consensus 147 ~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~-------~~~-~-~ 216 (262)
T cd06613 147 VSAQLTATIA-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR-------ALF-L-I 216 (262)
T ss_pred cchhhhhhhh-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-------HHH-H-H
Confidence 9876543221 23345688899999998776 78899999999999999999999986433211 000 0 0
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.... .. ..........+.++.+++.+||..||.+|||+.+++.
T Consensus 217 ~~~~----~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 217 SKSN----FP-----PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred Hhcc----CC-----CccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000 00 0001112245677899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=281.04 Aligned_cols=250 Identities=22% Similarity=0.279 Sum_probs=197.7
Q ss_pred hhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEE
Q 043524 11 WSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCC 89 (314)
Q Consensus 11 ~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 89 (314)
..+|.....+|.|+ +.++++....+|+.+|+|.+....... .+.+.+|+.+++.++|+||+++++.+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~------------~~~~~~e~~~l~~~~h~~i~~~~~~~ 85 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK------------KELIINEILVMRENKNPNIVNYLDSY 85 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch------------HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 35555566788888 788888888899999999886533221 15678999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEE
Q 043524 90 LETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKL 169 (314)
Q Consensus 90 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl 169 (314)
..+...|+|+||+++++|.+++... .++...+..++.+++.||.||| +.+++|+||||+||+++.++.+++
T Consensus 86 ~~~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l 156 (297)
T cd06656 86 LVGDELWVVMEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKL 156 (297)
T ss_pred ecCCEEEEeecccCCCCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEE
Confidence 9999999999999999999988653 3678889999999999999999 999999999999999999999999
Q ss_pred cccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhh
Q 043524 170 FDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNY 249 (314)
Q Consensus 170 ~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (314)
+|||.+........ ......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||..........
T Consensus 157 ~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~---------- 225 (297)
T cd06656 157 TDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY---------- 225 (297)
T ss_pred CcCccceEccCCcc-CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee----------
Confidence 99999876543321 1234468889999999988889999999999999999999999996433211000
Q ss_pred hccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 250 FEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
. . ...+......+...+..+.+|+.+||..||++|||+.++++
T Consensus 226 -~------~---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 226 -L------I---ATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred -e------e---ccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0 00000001111234456789999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=275.41 Aligned_cols=254 Identities=23% Similarity=0.338 Sum_probs=191.3
Q ss_pred cccCch-hHHHHHHHhc---CCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCe
Q 043524 19 MIGNGA-SVLQELIASS---NGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPI 94 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~---~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 94 (314)
.+|+|+ +.|+.+.... .+..+|+|.+........ ..+.+.+|+..++.++||||+++++++.....
T Consensus 6 ~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 75 (273)
T cd05035 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYS----------EIEEFLSEAACMKDFDHPNVMKLIGVCFEASS 75 (273)
T ss_pred ccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHH----------HHHHHHHHHHHHHhCCCCCeeeEEeeeccCCc
Confidence 478888 7777665444 346899998764322111 11568899999999999999999999876554
Q ss_pred ------eEEEEeecCCCCHHHHHhcCCC-CCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCce
Q 043524 95 ------AILVFEYVQHGTLWDRILGAPQ-THFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVV 167 (314)
Q Consensus 95 ------~~iv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~ 167 (314)
.++++||+++|+|...+..... .....++......++.|++.||.||| +++++|+||||+||+++.++.+
T Consensus 76 ~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~ 152 (273)
T cd05035 76 LQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTV 152 (273)
T ss_pred cccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeE
Confidence 7999999999999888854321 11135788889999999999999999 9999999999999999999999
Q ss_pred EEcccccceecCCCCccc-ccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHH
Q 043524 168 KLFDFSLSISIPEGETHI-TDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEY 245 (314)
Q Consensus 168 kl~dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~ 245 (314)
+|+|||.++......... .....++..|+|||.+....++.++||||+|+++|||++ |..||....... .
T Consensus 153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~--------~ 224 (273)
T cd05035 153 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE--------I 224 (273)
T ss_pred EECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH--------H
Confidence 999999998764432211 112335678999999988889999999999999999999 888886433211 1
Q ss_pred HHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHH
Q 043524 246 LKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQI 307 (314)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~ 307 (314)
....... . ....+...+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 225 ~~~~~~~-~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 225 YDYLRHG-N-------------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HHHHHcC-C-------------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111110 0 0001113456789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=283.96 Aligned_cols=246 Identities=28% Similarity=0.444 Sum_probs=180.2
Q ss_pred ccCch-hHHHHHHHh----cCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCe
Q 043524 20 IGNGA-SVLQELIAS----SNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPI 94 (314)
Q Consensus 20 ~G~g~-~~~~~~~~~----~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 94 (314)
+|.|. +.|+.+... ..+..|+||.+........ .+.+.+|++.+++++||||++++|++...+.
T Consensus 7 ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~-----------~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~ 75 (259)
T PF07714_consen 7 IGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEE-----------EEEFLNEIQILRKLRHPNIVKLYGFCIENEP 75 (259)
T ss_dssp EEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHH-----------HHHHHHHHHHHHTHSBTTBE-EEEEEESSSS
T ss_pred EccCCCcEEEEEEEEcccCCCCEEEEEEEecccccccc-----------ceeeeeccccccccccccccccccccccccc
Confidence 44444 444443333 3456899999854322211 1678999999999999999999999998888
Q ss_pred eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccc
Q 043524 95 AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL 174 (314)
Q Consensus 95 ~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~ 174 (314)
.++|+|||++|+|.+++..... ..++...+..++.|++.||.||| +++++|+||+++||+++.++.+||+|||+
T Consensus 76 ~~lv~e~~~~g~L~~~L~~~~~---~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~ 149 (259)
T PF07714_consen 76 LFLVMEYCPGGSLDDYLKSKNK---EPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGL 149 (259)
T ss_dssp EEEEEE--TTEBHHHHHHHTCT---TTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTT
T ss_pred cccccccccccccccccccccc---ccccccccccccccccccccccc---ccccccccccccccccccccccccccccc
Confidence 9999999999999999988622 45889999999999999999999 99999999999999999999999999999
Q ss_pred ceecCCCC-cccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhcc
Q 043524 175 SISIPEGE-THITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFED 252 (314)
Q Consensus 175 ~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (314)
+....... .........+..|+|||.+....++.++||||||+++||+++ |..||...... +..... ..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~--------~~~~~~-~~ 220 (259)
T PF07714_consen 150 SRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE--------EIIEKL-KQ 220 (259)
T ss_dssp GEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH--------HHHHHH-HT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--------cccccc-cc
Confidence 97762221 122333457788999999988889999999999999999999 67887533211 111111 11
Q ss_pred CCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHH
Q 043524 253 NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRL 304 (314)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 304 (314)
... ...+..++..+.+++.+||+.||++|||+.++++.|
T Consensus 221 ~~~-------------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 221 GQR-------------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TEE-------------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccc-------------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 000 000113445688999999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=274.42 Aligned_cols=251 Identities=20% Similarity=0.285 Sum_probs=192.6
Q ss_pred cccccCch-hHHHHHHHhcCCc---ccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 17 TLMIGNGA-SVLQELIASSNGK---YIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~---~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
...+|.|+ +.|+++....++. .+|+|.+........ .+.+.+|+++++.++|+||+++.+++.+.
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (268)
T cd05063 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQ-----------RQDFLSEASIMGQFSHHNIIRLEGVVTKF 78 (268)
T ss_pred eeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHH-----------HHHHHHHHHHHhcCCCCCeeEEEEEEccC
Confidence 34578777 7777776655554 689987754321111 15678999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~df 172 (314)
+..+++|||+++++|.+++.... ..++...+..++.|++.|+.||| +.+++|+||||+||+++.++.++++||
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~df 151 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRDHD----GEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDF 151 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCC
Confidence 99999999999999999886543 35788899999999999999999 999999999999999999999999999
Q ss_pred ccceecCCCCcccc--cccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhh
Q 043524 173 SLSISIPEGETHIT--DTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNY 249 (314)
Q Consensus 173 g~~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (314)
|++........... .....+..|+|||++....++.++|+||+|+++|+|++ |..||...... +.....
T Consensus 152 g~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--------~~~~~i 223 (268)
T cd05063 152 GLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--------EVMKAI 223 (268)
T ss_pred ccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--------HHHHHH
Confidence 99876643321111 11223457999999988889999999999999999997 99998543211 111111
Q ss_pred hccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHH
Q 043524 250 FEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQI 307 (314)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~ 307 (314)
... ...+.....+..+.+++.+||..||++||++.++++.|+++
T Consensus 224 ~~~--------------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 224 NDG--------------FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred hcC--------------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 100 00000113345688999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=277.09 Aligned_cols=263 Identities=20% Similarity=0.312 Sum_probs=190.8
Q ss_pred CcccccccCch-hHHHHHHHhcCC--------------cccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNG--------------KYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS 78 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g--------------~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 78 (314)
++-...+|+|+ +.|+.+....++ ..+|+|.+........ .+.+.+|++++..++
T Consensus 7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~ei~~l~~l~ 75 (295)
T cd05097 7 LRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTA-----------RNDFLKEIKIMSRLK 75 (295)
T ss_pred CeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHH-----------HHHHHHHHHHHHhCC
Confidence 33444588888 777766554322 2488998764321111 156889999999999
Q ss_pred CCceeeeEeEEEeCCeeEEEEeecCCCCHHHHHhcCCC-------CCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCcee
Q 043524 79 HDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQ-------THFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVF 151 (314)
Q Consensus 79 h~niv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~-------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H 151 (314)
|+||+++++++...+..++||||+++++|.+++..... .....++...+..++.|++.||.||| +++++|
T Consensus 76 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H 152 (295)
T cd05097 76 NPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVH 152 (295)
T ss_pred CCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeec
Confidence 99999999999999999999999999999998864321 01123677888999999999999999 999999
Q ss_pred ccCCCCCeeecCCCceEEcccccceecCCCCcc-cccccccccccccCcccccCCCCcccchHHHHHHHHHHHh--CCCC
Q 043524 152 RDFKTSHILFSEENVVKLFDFSLSISIPEGETH-ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT--GRGI 228 (314)
Q Consensus 152 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~--g~~p 228 (314)
+||||+||+++.++.++++|||++......... ......++..|+|||.+....++.++|+||||+++|+|++ |..|
T Consensus 153 ~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p 232 (295)
T cd05097 153 RDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQP 232 (295)
T ss_pred cccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999999998765332211 1223345778999999988889999999999999999998 5567
Q ss_pred cccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHH
Q 043524 229 LDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLR 305 (314)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~ 305 (314)
|....... ........+.... ..... .. +...+..+.+|+.+||+.||++|||+.+|++.|+
T Consensus 233 ~~~~~~~~-----~~~~~~~~~~~~~-~~~~~-----~~----~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 233 YSLLSDEQ-----VIENTGEFFRNQG-RQIYL-----SQ----TPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred CcccChHH-----HHHHHHHhhhhcc-ccccC-----CC----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 65433211 0000011111000 00000 00 0023456899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=280.41 Aligned_cols=264 Identities=20% Similarity=0.322 Sum_probs=195.7
Q ss_pred cCcccccccCch-hHHHHHHH-------hcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCcee
Q 043524 13 KGKRTLMIGNGA-SVLQELIA-------SSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHIL 83 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~-------~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 83 (314)
++.....+|.|+ +.|+.+.. ...+..+|+|.+........ ...+.+|++++..+ +||||+
T Consensus 13 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~-----------~~~~~~E~~~l~~l~~h~~iv 81 (314)
T cd05099 13 RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKD-----------LADLISEMELMKLIGKHKNII 81 (314)
T ss_pred HeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHH-----------HHHHHHHHHHHHhccCCCCee
Confidence 334455688888 66666543 22345789998764321111 14678999999999 699999
Q ss_pred eeEeEEEeCCeeEEEEeecCCCCHHHHHhcCCCC-----------CCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceec
Q 043524 84 KLIGCCLETPIAILVFEYVQHGTLWDRILGAPQT-----------HFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFR 152 (314)
Q Consensus 84 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~ 152 (314)
++++++......|+++||+++|+|.+++...... ....++...+..++.|++.||.||| +++++|+
T Consensus 82 ~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~ 158 (314)
T cd05099 82 NLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHR 158 (314)
T ss_pred eEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeec
Confidence 9999999999999999999999999999754210 1134788889999999999999999 9999999
Q ss_pred cCCCCCeeecCCCceEEcccccceecCCCCccc-ccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcc
Q 043524 153 DFKTSHILFSEENVVKLFDFSLSISIPEGETHI-TDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILD 230 (314)
Q Consensus 153 dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~ 230 (314)
||||+||+++.++.++|+|||.++......... .....++..|+|||.+....++.++||||||+++|+|++ |..||.
T Consensus 159 dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~ 238 (314)
T cd05099 159 DLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYP 238 (314)
T ss_pred cccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999997654322111 112234567999999988889999999999999999999 888885
Q ss_pred cccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 231 LVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
..... +...... ..... ..+...+.++.+++.+||..||++|||+.++++.|.++...
T Consensus 239 ~~~~~--------~~~~~~~-~~~~~-------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 239 GIPVE--------ELFKLLR-EGHRM-------------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred CCCHH--------HHHHHHH-cCCCC-------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 43211 1111111 00000 00013345678999999999999999999999999998765
Q ss_pred cc
Q 043524 311 LS 312 (314)
Q Consensus 311 ~~ 312 (314)
.+
T Consensus 297 ~~ 298 (314)
T cd05099 297 VS 298 (314)
T ss_pred hc
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=277.80 Aligned_cols=252 Identities=20% Similarity=0.285 Sum_probs=190.3
Q ss_pred ccccCch-hHHHHHHHhc-----CCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 18 LMIGNGA-SVLQELIASS-----NGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~-----~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
..+|.|+ +.|+.+.... ++..+|+|.+......... ..+.+|+.+++.++|+||+++++++.+
T Consensus 12 ~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~-----------~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDE-----------SDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred eECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHH-----------HHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 3578887 7777776655 6678999977543211111 458899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCC--CCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCC---c
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQT--HFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN---V 166 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~---~ 166 (314)
....+++|||+++++|.+++...... ....+++..++.++.|++.||.||| +++++|+||||+||+++..+ .
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~ 157 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRV 157 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcc
Confidence 99999999999999999998764321 1135788999999999999999999 99999999999999998654 5
Q ss_pred eEEcccccceecCCCCcc-cccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHH
Q 043524 167 VKLFDFSLSISIPEGETH-ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNE 244 (314)
Q Consensus 167 ~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~ 244 (314)
++++|||+++........ .......+..|+|||++.+..++.++|||||||++|+|++ |..||+......
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~-------- 229 (277)
T cd05036 158 AKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE-------- 229 (277)
T ss_pred eEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--------
Confidence 899999998765322211 1112234568999999988889999999999999999997 999986433211
Q ss_pred HHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHH
Q 043524 245 YLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLR 305 (314)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~ 305 (314)
.......... .. .+...+..+.+++.+||+.||++|||+.++++.|.
T Consensus 230 ~~~~~~~~~~----------~~----~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 230 VMEFVTGGGR----------LD----PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHHHHcCCc----------CC----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1111100000 00 01133456889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=278.29 Aligned_cols=244 Identities=21% Similarity=0.278 Sum_probs=190.6
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeEE
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAIL 97 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i 97 (314)
.+|.|+ +.++++....++..+++|.+........ +.+.+|+++++.++||||+++++.+..++..|+
T Consensus 12 ~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~------------~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~ 79 (282)
T cd06643 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEEL------------EDYMVEIDILASCDHPNIVKLLDAFYYENNLWI 79 (282)
T ss_pred hcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHH------------HHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEE
Confidence 477777 7788888888889999998865433222 567899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccccee
Q 043524 98 VFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSIS 177 (314)
Q Consensus 98 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~ 177 (314)
|+||+++++|...+.... .+++...+..++.|++.||.||| +.+++|+||||+||+++.++.++++|||++..
T Consensus 80 v~e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~ 152 (282)
T cd06643 80 LIEFCAGGAVDAVMLELE----RPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAK 152 (282)
T ss_pred EEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccc
Confidence 999999999988776533 35788999999999999999999 99999999999999999999999999999866
Q ss_pred cCCCCcccccccccccccccCcccc-----cCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhcc
Q 043524 178 IPEGETHITDTVMGTYGHLAPQYVT-----TCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFED 252 (314)
Q Consensus 178 ~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (314)
..... .......++..|+|||++. ...++.++|+||+||++|+|++|..||....... ........
T Consensus 153 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--------~~~~~~~~ 223 (282)
T cd06643 153 NTRTI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR--------VLLKIAKS 223 (282)
T ss_pred ccccc-cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH--------HHHHHhhc
Confidence 53322 1233456889999999874 3347789999999999999999999986433111 00111000
Q ss_pred CCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 253 NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
. .+. ...+...+.++.+++..||+.||++|||+.++++
T Consensus 224 -~-----~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 224 -E-----PPT------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred -C-----CCC------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 000 0011134567899999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=275.66 Aligned_cols=251 Identities=19% Similarity=0.259 Sum_probs=191.5
Q ss_pred cccccCch-hHHHHHHHhcCCc---ccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 17 TLMIGNGA-SVLQELIASSNGK---YIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~---~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
...+|.|+ +.|+++....++. .+|+|.+....... ..+.+.+|+.++..++||||+++++++.++
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (267)
T cd05066 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEK-----------QRRDFLSEASIMGQFDHPNIIHLEGVVTKS 77 (267)
T ss_pred eeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHH-----------HHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 34577777 6776665544443 68998775432111 115688999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~df 172 (314)
+..|++|||+++++|.+++.... ..++...+..++.|++.|+.||| +++++|+||||+||+++.++.++++||
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~df 150 (267)
T cd05066 78 KPVMIVTEYMENGSLDAFLRKHD----GQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDF 150 (267)
T ss_pred CccEEEEEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCC
Confidence 99999999999999999997653 35788889999999999999999 999999999999999999999999999
Q ss_pred ccceecCCCCcccc--cccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhh
Q 043524 173 SLSISIPEGETHIT--DTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNY 249 (314)
Q Consensus 173 g~~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (314)
|.+........... ....++..|+|||.+....++.++|+||+|+++|++++ |..||....... .....
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--------~~~~~ 222 (267)
T cd05066 151 GLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--------VIKAI 222 (267)
T ss_pred CcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--------HHHHH
Confidence 99977644322111 11223567999999988889999999999999999886 999986432211 11111
Q ss_pred hccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHH
Q 043524 250 FEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQI 307 (314)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~ 307 (314)
.+. ...+.....+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 223 ~~~--------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 223 EEG--------------YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred hCC--------------CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 100 00001113345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=279.34 Aligned_cols=258 Identities=19% Similarity=0.321 Sum_probs=194.3
Q ss_pred ccccccCch-hHHHHHHH-------hcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeE
Q 043524 16 RTLMIGNGA-SVLQELIA-------SSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLI 86 (314)
Q Consensus 16 ~~~~~G~g~-~~~~~~~~-------~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~ 86 (314)
....+|+|+ +.|+.+.. ..++..+|+|.+........ .+.+.+|+.++..+ +||||++++
T Consensus 19 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~-----------~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 19 LGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKD-----------LSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred ecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHH-----------HHHHHHHHHHHHhhccCCCchhee
Confidence 334578887 66665532 23445799998764322111 15678999999999 799999999
Q ss_pred eEEEeCCeeEEEEeecCCCCHHHHHhcCCCCC-----------CCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCC
Q 043524 87 GCCLETPIAILVFEYVQHGTLWDRILGAPQTH-----------FEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFK 155 (314)
Q Consensus 87 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~-----------~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk 155 (314)
+++......|++|||+++|+|.+++....... ...++...+..++.|++.||.||| +++++|+|||
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlk 164 (304)
T cd05101 88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLA 164 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccc
Confidence 99999999999999999999999987642210 124677888999999999999999 9999999999
Q ss_pred CCCeeecCCCceEEcccccceecCCCCccc-ccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCccccc
Q 043524 156 TSHILFSEENVVKLFDFSLSISIPEGETHI-TDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVR 233 (314)
Q Consensus 156 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~ 233 (314)
|+||+++.++.++|+|||.++......... .....++..|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 165 p~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 165 ARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred cceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 999999999999999999998764332211 222345678999999988889999999999999999998 777875322
Q ss_pred CccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHh
Q 043524 234 DAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICC 309 (314)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 309 (314)
..+.......... ...+...+..+.+|+.+||+.+|++|||+.|+++.|+++..
T Consensus 245 --------~~~~~~~~~~~~~--------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 245 --------VEELFKLLKEGHR--------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred --------HHHHHHHHHcCCc--------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 1111111111100 00011344678899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=275.12 Aligned_cols=252 Identities=22% Similarity=0.259 Sum_probs=192.1
Q ss_pred ccccCch-hHHHHHHHhcC---CcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCC
Q 043524 18 LMIGNGA-SVLQELIASSN---GKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETP 93 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~---g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (314)
..+|.|+ +.|+.+..... ...+|+|.+........ .+.+.+|+.+++.++||||+++++++.+ .
T Consensus 12 ~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~-----------~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~ 79 (270)
T cd05056 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSV-----------REKFLQEAYIMRQFDHPHIVKLIGVITE-N 79 (270)
T ss_pred eeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHH-----------HHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence 3467777 66666654332 34688887764431111 1568899999999999999999999865 5
Q ss_pred eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccc
Q 043524 94 IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFS 173 (314)
Q Consensus 94 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg 173 (314)
..|++|||+++|+|.+++.... ..++...+..++.+++.||.||| +.+++|+||||+||+++..+.++++|||
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g 152 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFG 152 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCc
Confidence 5789999999999999997643 34788999999999999999999 9999999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhcc
Q 043524 174 LSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFED 252 (314)
Q Consensus 174 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (314)
+++..............++..|+|||.+....++.++||||+|+++|++++ |..||....... ........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--------~~~~~~~~ 224 (270)
T cd05056 153 LSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--------VIGRIENG 224 (270)
T ss_pred eeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--------HHHHHHcC
Confidence 987764443222223344568999999888889999999999999999986 999986443211 11111000
Q ss_pred CCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 253 NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
. ....+...+..+.+++.+||..+|++|||+.++++.|+++..+
T Consensus 225 -~-------------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 225 -E-------------RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred -C-------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0 0000113445789999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=293.16 Aligned_cols=250 Identities=14% Similarity=0.220 Sum_probs=191.7
Q ss_pred ccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCe
Q 043524 16 RTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPI 94 (314)
Q Consensus 16 ~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 94 (314)
....+|.|+ +.|+.+....+|+.+|+|++......... ..+.+.+|+.++..++||||+++++.+.+++.
T Consensus 5 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~---------~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 75 (360)
T cd05627 5 SLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKE---------QVAHIRAERDILVEADGAWVVKMFYSFQDKRN 75 (360)
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhh---------hHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 344588888 88888888889999999999866543221 12567889999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccc
Q 043524 95 AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL 174 (314)
Q Consensus 95 ~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~ 174 (314)
+|+|||||++|+|.+.+.... .++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+|||+
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~ 147 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMKKD-----TLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGL 147 (360)
T ss_pred EEEEEeCCCCccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccC
Confidence 999999999999999987643 4788899999999999999999 99999999999999999999999999999
Q ss_pred ceecCCCCc----------------------------------ccccccccccccccCcccccCCCCcccchHHHHHHHH
Q 043524 175 SISIPEGET----------------------------------HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLS 220 (314)
Q Consensus 175 ~~~~~~~~~----------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~ 220 (314)
++....... .......||+.|+|||++.+..++.++|+||+||++|
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvily 227 (360)
T cd05627 148 CTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227 (360)
T ss_pred CcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceee
Confidence 865422100 0011346899999999999989999999999999999
Q ss_pred HHHhCCCCcccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCC---H
Q 043524 221 ELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPT---M 297 (314)
Q Consensus 221 el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps---~ 297 (314)
+|++|..||....... .......... .. ..+.....+.++.+|+.+|+ .||++|++ +
T Consensus 228 el~tG~~Pf~~~~~~~--------~~~~i~~~~~-------~~----~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~ 287 (360)
T cd05627 228 EMLIGYPPFCSETPQE--------TYRKVMNWKE-------TL----VFPPEVPISEKAKDLILRFC-TDSENRIGSNGV 287 (360)
T ss_pred ecccCCCCCCCCCHHH--------HHHHHHcCCC-------ce----ecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCH
Confidence 9999999996433211 1111111000 00 00000023456788998877 49999995 5
Q ss_pred HHHHH
Q 043524 298 VDVAR 302 (314)
Q Consensus 298 ~ell~ 302 (314)
.|+++
T Consensus 288 ~ei~~ 292 (360)
T cd05627 288 EEIKS 292 (360)
T ss_pred HHHhc
Confidence 66654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=281.26 Aligned_cols=264 Identities=20% Similarity=0.258 Sum_probs=187.9
Q ss_pred ccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC---CCCceeeeEeEEEe
Q 043524 16 RTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM---SHDHILKLIGCCLE 91 (314)
Q Consensus 16 ~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~ 91 (314)
....+|.|+ +.|+++.+..+|+.+|+|.+........ ....+.+|+.++..+ +||||+++++++..
T Consensus 4 ~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~ 73 (288)
T cd07863 4 PVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG----------LPLSTVREVALLKRLEAFDHPNIVRLMDVCAT 73 (288)
T ss_pred EeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCC----------CchHHHHHHHHHHHhhhcCCCCeeeeeeeecc
Confidence 344588888 8888888889999999998764321100 012345667666655 69999999999864
Q ss_pred -----CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCc
Q 043524 92 -----TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENV 166 (314)
Q Consensus 92 -----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~ 166 (314)
....++++||++ ++|.+++..... ..++...+..++.|++.||.||| +++++|+||||+||+++.++.
T Consensus 74 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~ 146 (288)
T cd07863 74 SRTDRETKVTLVFEHVD-QDLRTYLDKVPP---PGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQ 146 (288)
T ss_pred ccCCCCceEEEEEcccc-cCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCC
Confidence 345899999997 589888865432 34788999999999999999999 999999999999999999999
Q ss_pred eEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHH
Q 043524 167 VKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYL 246 (314)
Q Consensus 167 ~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 246 (314)
++|+|||+++....... .....++..|+|||++.+..++.++||||+||++|+|++|.+||........ +....
T Consensus 147 ~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~----~~~~~ 220 (288)
T cd07863 147 VKLADFGLARIYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ----LGKIF 220 (288)
T ss_pred EEECccCccccccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH----HHHHH
Confidence 99999999876543221 2345678999999999888899999999999999999999999864432211 11110
Q ss_pred Hhhh--ccCCccccc---ChhhhccCCc---hhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 247 KNYF--EDNRFTEIV---DPIIVQDLSC---TEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 247 ~~~~--~~~~~~~~~---~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.... ....+.... .......... ......+..+.+|+.+||+.||++|||+.|++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 221 DLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred HHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000 000000000 0000000000 000134566889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=287.03 Aligned_cols=255 Identities=15% Similarity=0.182 Sum_probs=193.2
Q ss_pred cccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCC
Q 043524 15 KRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETP 93 (314)
Q Consensus 15 ~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (314)
.....+|.|+ +.|+++....+++.+|+|++.......... .+.+.+|+.++..++|+||+++++++.+.+
T Consensus 4 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~---------~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 74 (332)
T cd05623 4 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAE---------TACFREERDVLVNGDNQWITTLHYAFQDEN 74 (332)
T ss_pred eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhH---------HHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence 3345688888 788888888889999999987654332211 145778999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccc
Q 043524 94 IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFS 173 (314)
Q Consensus 94 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg 173 (314)
.+|+||||+++|+|.+++.... ..++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+|||
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~----~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG 147 (332)
T cd05623 75 NLYLVMDYYVGGDLLTLLSKFE----DRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFG 147 (332)
T ss_pred EEEEEEeccCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecc
Confidence 9999999999999999997643 34788888999999999999999 9999999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCccccc-----CCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHh
Q 043524 174 LSISIPEGETHITDTVMGTYGHLAPQYVTT-----CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKN 248 (314)
Q Consensus 174 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (314)
+++..............||+.|+|||++.. ..++.++||||+||++|+|++|+.||....... ....
T Consensus 148 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~--------~~~~ 219 (332)
T cd05623 148 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE--------TYGK 219 (332)
T ss_pred hheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH--------HHHH
Confidence 987653332222334579999999998863 357889999999999999999999996432111 1111
Q ss_pred hhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCC--CCCHHHHHHH
Q 043524 249 YFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPID--RPTMVDVARR 303 (314)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~--Rps~~ell~~ 303 (314)
...... .. ..+ ......+..+.+|+..||..++++ |+++.|+++.
T Consensus 220 i~~~~~-------~~--~~p-~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 220 IMNHKE-------RF--QFP-AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HhCCCc-------cc--cCC-CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 111000 00 000 001134567889999999765554 6889998764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=277.89 Aligned_cols=258 Identities=21% Similarity=0.307 Sum_probs=191.3
Q ss_pred ccccCch-hHHHHHH----HhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 18 LMIGNGA-SVLQELI----ASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~----~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
..+|+|+ +.|+.+. ...++..+|+|.+........ .+.+.+|+.+++.++||||+++.+++...
T Consensus 10 ~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (284)
T cd05079 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH-----------IADLKKEIEILRNLYHENIVKYKGICTED 78 (284)
T ss_pred eecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHH-----------HHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 3478777 6665443 346778999998764321111 15688999999999999999999998774
Q ss_pred --CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 93 --PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 93 --~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
...+++|||+++++|.+++.... ..++...+..++.|++.||.||| +++++|+||||+||+++.++.++|+
T Consensus 79 ~~~~~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~ 151 (284)
T cd05079 79 GGNGIKLIMEFLPSGSLKEYLPRNK----NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIG 151 (284)
T ss_pred CCCceEEEEEccCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEEC
Confidence 66899999999999999986543 34788899999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCcc--cccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCc-cccc------cc
Q 043524 171 DFSLSISIPEGETH--ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDA-HDLV------YP 241 (314)
Q Consensus 171 dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~-~~~~------~~ 241 (314)
|||+++........ ......++..|+|||.+.+..++.++||||+|+++|+|+++..|+...... .... ..
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd05079 152 DFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMT 231 (284)
T ss_pred CCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhccccccccc
Confidence 99998765433211 122345677899999998888999999999999999999987664321110 0000 00
Q ss_pred hHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHH
Q 043524 242 FNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQI 307 (314)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~ 307 (314)
........ .. ....+.....+..+.+|+.+||+.||++|||+.++++.|+++
T Consensus 232 ~~~~~~~~-~~-------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 232 VTRLVRVL-EE-------------GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHHHH-Hc-------------CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00000000 00 000011113456789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=275.54 Aligned_cols=254 Identities=20% Similarity=0.315 Sum_probs=189.5
Q ss_pred cccCch-hHHHHHHHhcCCc--ccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC---
Q 043524 19 MIGNGA-SVLQELIASSNGK--YIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET--- 92 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~--~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--- 92 (314)
.+|.|+ +.|+.+....++. .+|+|.+........ -.+.+.+|++++..++|+||+++++++...
T Consensus 6 ~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~----------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 75 (272)
T cd05075 6 TLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRS----------EMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVES 75 (272)
T ss_pred ccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHH----------HHHHHHHHHHHHHhCCCCCcceEEEEEccCCcc
Confidence 477777 7777776666665 589987754321111 015678999999999999999999987542
Q ss_pred ---CeeEEEEeecCCCCHHHHHhcCCC-CCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceE
Q 043524 93 ---PIAILVFEYVQHGTLWDRILGAPQ-THFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVK 168 (314)
Q Consensus 93 ---~~~~iv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~k 168 (314)
...++++||+++|+|.+++..... .....++......++.|++.||.||| +++|+||||||+||+++.++.++
T Consensus 76 ~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~k 152 (272)
T cd05075 76 EGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVC 152 (272)
T ss_pred cCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEE
Confidence 246899999999999888753221 11134788899999999999999999 99999999999999999999999
Q ss_pred EcccccceecCCCCccc-ccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHH
Q 043524 169 LFDFSLSISIPEGETHI-TDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYL 246 (314)
Q Consensus 169 l~dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~ 246 (314)
|+|||+++......... .....+++.|++||......++.++||||||+++|+|++ |..||....... ..
T Consensus 153 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--------~~ 224 (272)
T cd05075 153 VADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE--------IY 224 (272)
T ss_pred ECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--------HH
Confidence 99999998764432211 123346778999999998889999999999999999999 788886432211 11
Q ss_pred HhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHH
Q 043524 247 KNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQI 307 (314)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~ 307 (314)
.. ....... . .....+..+.+++.+||..||++|||+.++++.|+++
T Consensus 225 ~~-~~~~~~~---------~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 225 DY-LRQGNRL---------K----QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HH-HHcCCCC---------C----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11 1111000 0 0012345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=277.83 Aligned_cols=253 Identities=21% Similarity=0.330 Sum_probs=191.4
Q ss_pred cccccCch-hHHHHHHHh-----cCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 17 TLMIGNGA-SVLQELIAS-----SNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~-----~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
...+|.|+ +.|+.+... .++..+|+|.+........ ...+.+|+.++..++||||+++++++.
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~-----------~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRE-----------RIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred EeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHH-----------HHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 34578877 666665544 3447899998754321111 146789999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCC-----CCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCC
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQT-----HFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN 165 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~ 165 (314)
.+...++||||+++|+|.+++...... ....+++..+..++.|++.||.||| +++++|+||||+||+++.++
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~ 156 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDL 156 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCC
Confidence 999999999999999999998753321 1123677888999999999999999 99999999999999999999
Q ss_pred ceEEcccccceecCCCCc-ccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchH
Q 043524 166 VVKLFDFSLSISIPEGET-HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFN 243 (314)
Q Consensus 166 ~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~ 243 (314)
.++|+|||.++....... .......++..|+|||.+....++.++||||||+++|++++ |..||.......
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------- 229 (277)
T cd05032 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE------- 229 (277)
T ss_pred CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH-------
Confidence 999999999876543321 11233456788999999988889999999999999999998 888885322111
Q ss_pred HHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHH
Q 043524 244 EYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLR 305 (314)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~ 305 (314)
.... ........ . +...+..+.+++.+||..+|++|||+.++++.|+
T Consensus 230 -~~~~-~~~~~~~~---------~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 230 -VLKF-VIDGGHLD---------L----PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -HHHH-HhcCCCCC---------C----CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 1111 11100000 0 0122467889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=282.14 Aligned_cols=260 Identities=17% Similarity=0.268 Sum_probs=193.4
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCee
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIA 95 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (314)
...+|.|+ +.|+++.+..+|..+|+|.+....... ..+.+.+|++++..++||||+++++.+..++.+
T Consensus 6 ~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 74 (308)
T cd06615 6 LGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPA-----------IRNQIIRELKVLHECNSPYIVGFYGAFYSDGEI 74 (308)
T ss_pred EeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHH-----------HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEE
Confidence 34477777 778888888889999999875431111 125678999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCC-CCceeccCCCCCeeecCCCceEEccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFP-RPIVFRDFKTSHILFSEENVVKLFDFSL 174 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~-~~i~H~dlk~~nil~~~~~~~kl~dfg~ 174 (314)
|+++||+++++|.+++... ..++...+..++.|++.||.||| + .+++|+||||+||+++.++.++++|||+
T Consensus 75 ~lv~ey~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 146 (308)
T cd06615 75 SICMEHMDGGSLDQVLKKA-----GRIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGV 146 (308)
T ss_pred EEEeeccCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCC
Confidence 9999999999999998764 34788889999999999999999 7 5899999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCC
Q 043524 175 SISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNR 254 (314)
Q Consensus 175 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (314)
+....... .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||....... .............
T Consensus 147 ~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~ 218 (308)
T cd06615 147 SGQLIDSM---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE-----LEAMFGRPVSEGE 218 (308)
T ss_pred cccccccc---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh-----HHHhhcCcccccc
Confidence 86543321 234578899999999888889999999999999999999999986432111 0000000000000
Q ss_pred --------------------cccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 043524 255 --------------------FTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARR 303 (314)
Q Consensus 255 --------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 303 (314)
..+..+.......+.......+.++.+|+..||..||++|||+.|+++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 219 AKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred ccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000000000000001245678999999999999999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=274.19 Aligned_cols=244 Identities=22% Similarity=0.302 Sum_probs=195.1
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCee
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIA 95 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (314)
...+|.|+ +.++.+.+..+++.+|+|++........ .+.+.+|+++++.++|+||+++++.+.+++..
T Consensus 9 ~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (277)
T cd06640 9 LERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE-----------IEDIQQEITVLSQCDSPYVTKYYGSYLKGTKL 77 (277)
T ss_pred hhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHH-----------HHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence 34478877 7888888888899999998875432221 15688999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
|+||||+++++|.+++... +++...+..++.+++.|+.||| +++++|+||+|+||+++.++.++++|||++
T Consensus 78 ~lv~e~~~~~~L~~~i~~~------~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~ 148 (277)
T cd06640 78 WIIMEYLGGGSALDLLRAG------PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVA 148 (277)
T ss_pred EEEEecCCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccc
Confidence 9999999999999988642 4678888899999999999999 999999999999999999999999999999
Q ss_pred eecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCc
Q 043524 176 ISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRF 255 (314)
Q Consensus 176 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (314)
........ ......++..|+|||++.+..++.++|+||||+++|+|++|..||........ ... .
T Consensus 149 ~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--------~~~-~----- 213 (277)
T cd06640 149 GQLTDTQI-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV--------LFL-I----- 213 (277)
T ss_pred eeccCCcc-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH--------hhh-h-----
Confidence 76643322 22334678899999999888899999999999999999999999864332110 000 0
Q ss_pred ccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 043524 256 TEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARR 303 (314)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 303 (314)
............+..+.+++..||+.+|++||++.+++..
T Consensus 214 --------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 214 --------PKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred --------hcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 0000011122456778999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=290.04 Aligned_cols=270 Identities=17% Similarity=0.243 Sum_probs=194.6
Q ss_pred hhhhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEe
Q 043524 9 KLWSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIG 87 (314)
Q Consensus 9 ~~~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 87 (314)
....+|.....+|.|+ +.|+.+.+..+++.+|+|.+........ ..+.+.+|+.+++.++||||+++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~E~~~l~~l~h~niv~~~~ 83 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT----------HAKRAYRELVLMKCVNHKNIISLLN 83 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChH----------HHHHHHHHHHHHHHhCCCchhceee
Confidence 4455666667799988 8888888888999999998864321110 1146778999999999999999999
Q ss_pred EEEeC------CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeee
Q 043524 88 CCLET------PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILF 161 (314)
Q Consensus 88 ~~~~~------~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~ 161 (314)
++... ...|++|||++ +++.+.+.. .++...+..++.|++.||.||| +++|+||||||+||++
T Consensus 84 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill 152 (355)
T cd07874 84 VFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVV 152 (355)
T ss_pred eeeccccccccceeEEEhhhhc-ccHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEE
Confidence 98643 35799999996 477776642 3677888899999999999999 9999999999999999
Q ss_pred cCCCceEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccc--
Q 043524 162 SEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLV-- 239 (314)
Q Consensus 162 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~-- 239 (314)
+.++.++|+|||+++...... ......||..|+|||++.+..++.++||||+||++|+|++|+.||..........
T Consensus 153 ~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 230 (355)
T cd07874 153 KSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 230 (355)
T ss_pred CCCCCEEEeeCcccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999999999999997653322 2334578999999999988889999999999999999999999997543211000
Q ss_pred -----cchHHH-------HHhhhcc-CCcccc-----cChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHH
Q 043524 240 -----YPFNEY-------LKNYFED-NRFTEI-----VDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVA 301 (314)
Q Consensus 240 -----~~~~~~-------~~~~~~~-~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell 301 (314)
.+..+. ....... ...... ...... +.........+..+.+|+.+||..||++|||+.|++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell 309 (355)
T cd07874 231 IEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLF-PADSEHNKLKASQARDLLSKMLVIDPAKRISVDEAL 309 (355)
T ss_pred HHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhcccccc-ccccccccccchHHHHHHHHHhcCCchhcCCHHHHh
Confidence 000000 0000000 000000 000000 000011112345678999999999999999999999
Q ss_pred H
Q 043524 302 R 302 (314)
Q Consensus 302 ~ 302 (314)
+
T Consensus 310 ~ 310 (355)
T cd07874 310 Q 310 (355)
T ss_pred c
Confidence 7
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=276.10 Aligned_cols=254 Identities=19% Similarity=0.231 Sum_probs=182.7
Q ss_pred ccCch-hHHHHHHH--hcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeE
Q 043524 20 IGNGA-SVLQELIA--SSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAI 96 (314)
Q Consensus 20 ~G~g~-~~~~~~~~--~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (314)
+|.|+ +.|+++.. ..++..+|+|.+........ ...+.+|+.++++++||||+++++++.+....+
T Consensus 3 lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~-----------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 71 (269)
T cd05087 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQE-----------QMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYL 71 (269)
T ss_pred ccccCCceEEEEEEcCCCCceEEEEEecCCCCChHH-----------HHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcE
Confidence 67777 66665532 33456789987654321111 145788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
+||||+++|+|.+++...........+...+..++.|++.|+.||| +++++|+||||+||+++.++.++++|||.++
T Consensus 72 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~ 148 (269)
T cd05087 72 LVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSH 148 (269)
T ss_pred EEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccc
Confidence 9999999999999987543221124566777888999999999999 9999999999999999999999999999986
Q ss_pred ecCCCCccc-ccccccccccccCcccccC-------CCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHH
Q 043524 177 SIPEGETHI-TDTVMGTYGHLAPQYVTTC-------DFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLK 247 (314)
Q Consensus 177 ~~~~~~~~~-~~~~~g~~~y~aPE~~~~~-------~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~ 247 (314)
......... .....++..|+|||++... .++.++|+||+|+++|+|++ |..||........ ..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--------~~ 220 (269)
T cd05087 149 NKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV--------LT 220 (269)
T ss_pred cccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH--------HH
Confidence 543322111 1234567889999988532 35789999999999999996 9999964332210 00
Q ss_pred hhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHH
Q 043524 248 NYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLR 305 (314)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~ 305 (314)
.... ........+... ...+..+.+++..|| .+|++|||+.||+..|+
T Consensus 221 ~~~~-~~~~~~~~~~~~--------~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 221 YTVR-EQQLKLPKPRLK--------LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred HHhh-cccCCCCCCccC--------CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 0000 000011111110 022345788999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=273.28 Aligned_cols=251 Identities=24% Similarity=0.375 Sum_probs=196.0
Q ss_pred cccCch-hHHHHHHHhcC---CcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCe
Q 043524 19 MIGNGA-SVLQELIASSN---GKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPI 94 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~---g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 94 (314)
.+|.|+ +.++.+..... +..+++|.+........ .+.+.+|++.+..++|+||+++++++..+..
T Consensus 2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~-----------~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 70 (262)
T cd00192 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEE-----------RKDFLKEARVMKKLGHPNVVRLLGVCTEEEP 70 (262)
T ss_pred ccccCCceEEEEEEEecCCCCCceEEeEeeccccchhH-----------HHHHHHHHHHHhhcCCCChheeeeeecCCCc
Confidence 367777 67777666655 78999998876543221 1568899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcCCCC----CCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 95 AILVFEYVQHGTLWDRILGAPQT----HFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 95 ~~iv~e~~~~g~L~~~l~~~~~~----~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
.++++||+++++|.+++...... ....+++..+..++.|++.||.||| +++++|+||+|+||+++.++.++++
T Consensus 71 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~ 147 (262)
T cd00192 71 LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKIS 147 (262)
T ss_pred eEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEc
Confidence 99999999999999998765210 0145889999999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCc-ccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHh
Q 043524 171 DFSLSISIPEGET-HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKN 248 (314)
Q Consensus 171 dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 248 (314)
|||.+........ .......++..|+|||.+....++.++||||+|+++|+|++ |..||...... .....
T Consensus 148 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~ 219 (262)
T cd00192 148 DFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE--------EVLEY 219 (262)
T ss_pred ccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH--------HHHHH
Confidence 9999977654321 11334457889999999988889999999999999999999 68898654211 11111
Q ss_pred hhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHH
Q 043524 249 YFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLR 305 (314)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~ 305 (314)
.... .....+...+.++.+++..||..||++|||+.|+++.|+
T Consensus 220 ~~~~--------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 220 LRKG--------------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHcC--------------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1110 000111133567899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=279.08 Aligned_cols=253 Identities=17% Similarity=0.249 Sum_probs=190.8
Q ss_pred ccccCch-hHHHHHHHh-----cCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 18 LMIGNGA-SVLQELIAS-----SNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~-----~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
..+|.|+ +.|+++... .++..+|+|.+....... ..+.+.+|+.++..++||||+++++++.+
T Consensus 11 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~~e~~~~~~l~h~~iv~~~~~~~~ 79 (283)
T cd05091 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGP-----------LREEFKHEAMMRSRLQHPNIVCLLGVVTK 79 (283)
T ss_pred HHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHH-----------HHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence 3478777 667666433 345789999887432111 12567899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCC-----------CCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCee
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQ-----------THFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHIL 160 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil 160 (314)
....++++||+++++|.+++..... .....++...+..++.|++.||.|+| +++++||||||+||+
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil 156 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVL 156 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheE
Confidence 9999999999999999998853210 01124778888999999999999999 999999999999999
Q ss_pred ecCCCceEEcccccceecCCCCc-ccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCcccc
Q 043524 161 FSEENVVKLFDFSLSISIPEGET-HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDL 238 (314)
Q Consensus 161 ~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~ 238 (314)
++.++.++|+|||+++....... .......+++.|+|||.+....++.++||||+|+++|||++ |..||......
T Consensus 157 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--- 233 (283)
T cd05091 157 VFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--- 233 (283)
T ss_pred ecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH---
Confidence 99999999999999876543321 11233456788999999988889999999999999999998 77787543211
Q ss_pred ccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHH
Q 043524 239 VYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQ 306 (314)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 306 (314)
+....... .... +.+..++..+.+|+.+||+.||++|||+.+|+..|+.
T Consensus 234 -----~~~~~i~~-~~~~-------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 234 -----DVIEMIRN-RQVL-------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -----HHHHHHHc-CCcC-------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11111111 0000 0111445668899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=271.50 Aligned_cols=248 Identities=24% Similarity=0.411 Sum_probs=193.0
Q ss_pred cccCch-hHHHHHHHhc-CCc--ccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCe
Q 043524 19 MIGNGA-SVLQELIASS-NGK--YIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPI 94 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~-~g~--~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 94 (314)
.+|.|+ +.|+++.... +++ .+|+|.+....... ..+++.+|++++++++||||+++++.+.. ..
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~ 69 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSD-----------IMDDFLKEAAIMHSLDHENLIRLYGVVLT-HP 69 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHH-----------HHHHHHHHHHHHhhcCCCCccceeEEEcC-Ce
Confidence 367777 7777776544 333 68999887765531 12678899999999999999999999988 88
Q ss_pred eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccc
Q 043524 95 AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL 174 (314)
Q Consensus 95 ~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~ 174 (314)
.++++||+++++|.+.+..... ..+++..+..++.|++.||.||| +++++|+||+|+||+++.++.++++|||.
T Consensus 70 ~~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~ 143 (257)
T cd05040 70 LMMVTELAPLGSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGL 143 (257)
T ss_pred EEEEEEecCCCcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccc
Confidence 9999999999999999976532 35788999999999999999999 99999999999999999999999999999
Q ss_pred ceecCCCCcc--cccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhc
Q 043524 175 SISIPEGETH--ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFE 251 (314)
Q Consensus 175 ~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (314)
++........ ......++..|+|||.+....++.++||||+|+++|+|++ |..||......+ .......
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--------~~~~~~~ 215 (257)
T cd05040 144 MRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ--------ILKKIDK 215 (257)
T ss_pred cccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHh
Confidence 8776442211 1223456788999999988889999999999999999998 999986432211 1111110
Q ss_pred cCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHH
Q 043524 252 DNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLR 305 (314)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~ 305 (314)
... . ...+...+..+.+++..||..+|++|||+.++++.|.
T Consensus 216 ~~~-------~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 216 EGE-------R------LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred cCC-------c------CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 000 0 0001133456889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=289.36 Aligned_cols=261 Identities=20% Similarity=0.251 Sum_probs=190.3
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCC---
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETP--- 93 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--- 93 (314)
..+|.|+ +.|+++.+..+|+.||+|.+........ ..+++.+|+.+++.++|+||+++++++...+
T Consensus 6 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 75 (372)
T cd07853 6 RPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLV----------SCKRVFRELKMLCFFKHDNVLSALDILQPPHIDP 75 (372)
T ss_pred ceeeeCCCEEEEEEEECCCCCEEEEEeccccccchH----------HHHHHHHHHHHHHhCCCCCcCCHhheecCCCccc
Confidence 4578888 8888888888999999998753211000 1146789999999999999999999998776
Q ss_pred --eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 94 --IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 94 --~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
..|+|+||+. ++|.+.+... ..++...+..++.|++.||.||| +++++||||||+||+++.++.++|+|
T Consensus 76 ~~~~~lv~e~~~-~~l~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~D 146 (372)
T cd07853 76 FEEIYVVTELMQ-SDLHKIIVSP-----QPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICD 146 (372)
T ss_pred cceEEEEeeccc-cCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEecc
Confidence 7899999996 6888877653 35788999999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCcccccCC-CCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhh
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTTCD-FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
||+++..............+++.|+|||++.+.. ++.++||||+||++|+|++|+.||......... . ......
T Consensus 147 fg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~----~-~i~~~~ 221 (372)
T cd07853 147 FGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQL----D-LITDLL 221 (372)
T ss_pred ccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHH----H-HHHHHc
Confidence 9999765433222233446789999999987754 789999999999999999999999754322100 0 000000
Q ss_pred ccCCcccc-------cChhhhccCCch-------hHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 251 EDNRFTEI-------VDPIIVQDLSCT-------EKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 251 ~~~~~~~~-------~~~~~~~~~~~~-------~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
......+. ...........+ .....+.++.+|+.+||+.||++|||+.|+++
T Consensus 222 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 222 GTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred CCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 00000000 000000000000 00123567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=284.37 Aligned_cols=239 Identities=18% Similarity=0.306 Sum_probs=188.4
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC-CCceeeeEeEEEeCCee
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS-HDHILKLIGCCLETPIA 95 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 95 (314)
..+|.|+ +.|+++.+..+|+.||+|++.......... .+.+..|..++..+. |++|+++.+++.+.+.+
T Consensus 6 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~---------~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~ 76 (323)
T cd05615 6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDD---------VECTMVEKRVLALQDKPPFLTQLHSCFQTVDRL 76 (323)
T ss_pred EEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhH---------HHHHHHHHHHHHhccCCCchhheeeEEecCCEE
Confidence 4588888 888888888899999999988654322111 145678888888886 57888999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
|+||||+++|+|.+.+... ..++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+|||++
T Consensus 77 ~lv~Ey~~~g~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~ 148 (323)
T cd05615 77 YFVMEYVNGGDLMYHIQQV-----GKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMC 148 (323)
T ss_pred EEEEcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccc
Confidence 9999999999999988654 34788999999999999999999 999999999999999999999999999998
Q ss_pred eecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCc
Q 043524 176 ISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRF 255 (314)
Q Consensus 176 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (314)
+....... ......||+.|+|||++.+..++.++|+||+||++|+|++|..||....... ......
T Consensus 149 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~--------~~~~i~----- 214 (323)
T cd05615 149 KEHMVDGV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE--------LFQSIM----- 214 (323)
T ss_pred cccCCCCc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH--------HHHHHH-----
Confidence 75432221 2334568999999999988889999999999999999999999996433111 111111
Q ss_pred ccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCH
Q 043524 256 TEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTM 297 (314)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 297 (314)
......+ ...+..+.+++..||+.||.+|+++
T Consensus 215 --------~~~~~~p--~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 215 --------EHNVSYP--KSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred --------hCCCCCC--ccCCHHHHHHHHHHcccCHhhCCCC
Confidence 0111000 1334567899999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=277.45 Aligned_cols=251 Identities=19% Similarity=0.241 Sum_probs=194.3
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|+-...+|.|+ +.|+++.+..+|+.+++|.+........ +.+.+|+++++.++|+||+++++.+.
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~------------~~~~~e~~~l~~l~h~~i~~~~~~~~ 79 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL------------EDYMVEIEILATCNHPYIVKLLGAFY 79 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHH------------HHHHHHHHHHHhCCCCcEeeeEEEEE
Confidence 4444455588888 8888888888899999999875433222 56789999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
.++..|+||||+++++|...+.... ..++...+..++.|++.++.||| +.+++|+||+|+||+++.++.++|+
T Consensus 80 ~~~~~~lv~e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~ 152 (292)
T cd06644 80 WDGKLWIMIEFCPGGAVDAIMLELD----RGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLA 152 (292)
T ss_pred eCCeEEEEEecCCCCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEc
Confidence 9999999999999999988776543 34788999999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCcccc-----cCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHH
Q 043524 171 DFSLSISIPEGETHITDTVMGTYGHLAPQYVT-----TCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEY 245 (314)
Q Consensus 171 dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 245 (314)
|||.+....... .......++..|+|||++. ...++.++|+||+|+++|+|++|..||....... .
T Consensus 153 dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--------~ 223 (292)
T cd06644 153 DFGVSAKNVKTL-QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--------V 223 (292)
T ss_pred cCccceeccccc-cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH--------H
Confidence 999986543221 1123456888999999885 3346789999999999999999999986432111 0
Q ss_pred HHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 246 LKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
....... .. +. ...+...+.++.+++..||..||++||++.++++
T Consensus 224 ~~~~~~~-~~-----~~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 224 LLKIAKS-EP-----PT------LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred HHHHhcC-CC-----cc------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1111100 00 00 0011134456889999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=272.39 Aligned_cols=246 Identities=23% Similarity=0.325 Sum_probs=188.1
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE-e
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL-E 91 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~ 91 (314)
+.-...+|.|+ +.++.+ ...|+.+|+|.+..... .+.+.+|+.+++.++|+|++++++++. .
T Consensus 8 ~~~~~~lg~g~~~~v~~~--~~~~~~~~~k~~~~~~~--------------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd05082 8 LKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKNDAT--------------AQAFLAEASVMTQLRHSNLVQLLGVIVEE 71 (256)
T ss_pred CeeeeeecccCCCeEEEE--EEcCCcEEEEEeCCCch--------------HHHHHHHHHHHHhCCCCCeeeEEEEEEcC
Confidence 33344577777 566554 34578899998753221 146789999999999999999999765 4
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
++..++++||+++++|.+.+..... ..++...+..++.|++.||.||| +++++|+||||+||+++.++.++++|
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~d 145 (256)
T cd05082 72 KGGLYIVTEYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSD 145 (256)
T ss_pred CCceEEEEECCCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecC
Confidence 5678999999999999999876442 34778889999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhh
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
||+++...... ....++..|+|||++....++.++||||+|+++|+|++ |..||.... .........
T Consensus 146 fg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~--------~~~~~~~~~ 213 (256)
T cd05082 146 FGLTKEASSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--------LKDVVPRVE 213 (256)
T ss_pred CccceeccccC----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHh
Confidence 99987543322 23344678999999988889999999999999999997 888885322 111111110
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHH
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQI 307 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~ 307 (314)
.. . ........+..+.+++.+||+.||++|||+.++++.|+++
T Consensus 214 ~~-~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 214 KG-Y-------------KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred cC-C-------------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 00 0 0000113446688999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=274.95 Aligned_cols=253 Identities=18% Similarity=0.280 Sum_probs=192.8
Q ss_pred cccccccCch-hHHHHHHHhcCCc---ccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 15 KRTLMIGNGA-SVLQELIASSNGK---YIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 15 ~~~~~~G~g~-~~~~~~~~~~~g~---~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
+....+|.|+ +.++.+....+|+ .+|+|.+........ .+.|.+|+.+++.++||||+++++++.
T Consensus 7 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~~e~~~l~~l~h~ni~~~~~~~~ 75 (269)
T cd05065 7 KIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQ-----------RRDFLSEASIMGQFDHPNIIHLEGVVT 75 (269)
T ss_pred EEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHH-----------HHHHHHHHHHHHhCCCcCcceEEEEEC
Confidence 3445578887 7777776666554 599998764311111 156889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
++...++||||+++++|.+++.... ..++...++.++.|++.||.||| +++++|+||||+||+++.++.++++
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~ 148 (269)
T cd05065 76 KSRPVMIITEFMENGALDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVS 148 (269)
T ss_pred CCCceEEEEecCCCCcHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEEC
Confidence 9999999999999999999887643 34788899999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCcccc--ccc--ccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHH
Q 043524 171 DFSLSISIPEGETHIT--DTV--MGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEY 245 (314)
Q Consensus 171 dfg~~~~~~~~~~~~~--~~~--~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~ 245 (314)
|||.+........... ... ..+..|+|||.+....++.++||||+|+++||+++ |..||....... .
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~--------~ 220 (269)
T cd05065 149 DFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--------V 220 (269)
T ss_pred CCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH--------H
Confidence 9999876543221111 111 12457999999988889999999999999999886 999986432111 1
Q ss_pred HHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHH
Q 043524 246 LKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQI 307 (314)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~ 307 (314)
....... ...+.+..++..+.+++.+||..+|++||++.+++..|+++
T Consensus 221 ~~~i~~~--------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 221 INAIEQD--------------YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HHHHHcC--------------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1110000 00011113345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=275.35 Aligned_cols=257 Identities=18% Similarity=0.299 Sum_probs=196.1
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCc----ccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGK----YIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLI 86 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~----~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 86 (314)
.++.....+|+|+ +.++++....+|+ .+|+|.......... .+++.+|+.++..++||||++++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~~~ 75 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKA-----------NKEILDEAYVMASVDHPHVVRLL 75 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHH-----------HHHHHHHHHHHHhCCCCCcceEE
Confidence 3444555688888 7777766555554 478887654432111 15688999999999999999999
Q ss_pred eEEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCc
Q 043524 87 GCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENV 166 (314)
Q Consensus 87 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~ 166 (314)
+++.+ ...++++||+++|+|.+.+.... ..++...+..++.|++.||+||| +.+++|+||||+||+++.++.
T Consensus 76 ~~~~~-~~~~~v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~ 147 (279)
T cd05057 76 GICLS-SQVQLITQLMPLGCLLDYVRNHK----DNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQH 147 (279)
T ss_pred EEEec-CceEEEEecCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCe
Confidence 99987 78899999999999999987654 34788999999999999999999 999999999999999999999
Q ss_pred eEEcccccceecCCCCccc-ccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHH
Q 043524 167 VKLFDFSLSISIPEGETHI-TDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNE 244 (314)
Q Consensus 167 ~kl~dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~ 244 (314)
++|+|||.++......... .....++..|+|||.+....++.++|+||+|+++|++++ |..||.......
T Consensus 148 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------- 219 (279)
T cd05057 148 VKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-------- 219 (279)
T ss_pred EEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH--------
Confidence 9999999997764332211 111223567999999988889999999999999999998 999986433111
Q ss_pred HHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHh
Q 043524 245 YLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICC 309 (314)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 309 (314)
.. ....... . .+.+...+..+.+++.+||..||++|||+.++++.|+++.+
T Consensus 220 ~~-~~~~~~~-----------~--~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 220 IP-DLLEKGE-----------R--LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred HH-HHHhCCC-----------C--CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11 1111000 0 00001233457899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=275.28 Aligned_cols=249 Identities=18% Similarity=0.240 Sum_probs=191.7
Q ss_pred cccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCC
Q 043524 15 KRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETP 93 (314)
Q Consensus 15 ~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (314)
.....+|.|+ +.++.+.+..+++.+|+|.+........ ..+.+|+.+++.++||||+++++++..++
T Consensus 12 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~------------~~~~~e~~~~~~l~h~~ii~~~~~~~~~~ 79 (267)
T cd06645 12 ELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDF------------AVVQQEIIMMKDCKHSNIVAYFGSYLRRD 79 (267)
T ss_pred HHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHH------------HHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Confidence 3344578888 7888888888899999998765432211 45678999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccc
Q 043524 94 IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFS 173 (314)
Q Consensus 94 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg 173 (314)
..|+++||+++++|.+++.... .++...+..++.|++.|+.||| +++++|+||||+||+++.++.++|+|||
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg 151 (267)
T cd06645 80 KLWICMEFCGGGSLQDIYHVTG-----PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFG 151 (267)
T ss_pred EEEEEEeccCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcce
Confidence 9999999999999999886543 4788999999999999999999 9999999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCcccc---cCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhh
Q 043524 174 LSISIPEGETHITDTVMGTYGHLAPQYVT---TCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 174 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
++....... .......|+..|+|||++. ...++.++|+||+||++|+|++|..||........ .. ...
T Consensus 152 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-------~~-~~~ 222 (267)
T cd06645 152 VSAQITATI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-------LF-LMT 222 (267)
T ss_pred eeeEccCcc-cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-------HH-hhh
Confidence 987653322 1233457899999999874 34578899999999999999999999853321110 00 000
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.. . ...+..... ...+..+.+++.+||..||++|||+.++++
T Consensus 223 ~~-~---~~~~~~~~~------~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 223 KS-N---FQPPKLKDK------MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cc-C---CCCCccccc------CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 00 0 000000000 023456789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=271.54 Aligned_cols=246 Identities=18% Similarity=0.311 Sum_probs=192.8
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe-CCee
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE-TPIA 95 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~ 95 (314)
..+|.|+ +.++.+.+..+++.+|+|.+......... .+.+.+|+++++.++|+|++++.+.+.. ...+
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~----------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (257)
T cd08223 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRE----------RKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLL 75 (257)
T ss_pred EEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHH----------HHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEE
Confidence 4567777 77888888888999999998754432111 1467899999999999999999998764 4568
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
|+++||+++++|.+++..... ..++...+..++.+++.|+.+|| +++++|+||+|+||+++.++.++|+|||++
T Consensus 76 ~lv~e~~~~~~l~~~l~~~~~---~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~ 149 (257)
T cd08223 76 YIVMGFCEGGDLYHKLKEQKG---KLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIA 149 (257)
T ss_pred EEEecccCCCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccce
Confidence 999999999999999876432 35788999999999999999999 999999999999999999999999999999
Q ss_pred eecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCc
Q 043524 176 ISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRF 255 (314)
Q Consensus 176 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (314)
....... .......+++.|+|||++.+..++.++|+||+|+++++|++|+.||..... .........
T Consensus 150 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~--------~~~~~~~~~---- 216 (257)
T cd08223 150 RVLENQC-DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM--------NSLVYRIIE---- 216 (257)
T ss_pred EEecccC-CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHHh----
Confidence 7764322 223345688999999999888899999999999999999999999863221 111111110
Q ss_pred ccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 256 TEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
+..+ ..+...+..+.+++.+||+.||++|||+.++++
T Consensus 217 ---------~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 217 ---------GKLP-PMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred ---------cCCC-CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000 011145567899999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=271.12 Aligned_cols=220 Identities=22% Similarity=0.342 Sum_probs=169.5
Q ss_pred ccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeEEEEeecCCCCHHHHHhcCCCC
Q 043524 38 YIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQT 117 (314)
Q Consensus 38 ~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~ 117 (314)
.+++|++........ .++.+|+.+++.++||||+++++++..+...++||||+++|+|..++....
T Consensus 46 ~v~~k~~~~~~~~~~------------~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-- 111 (274)
T cd05076 46 RVVLKVLDPSHRDIA------------LAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK-- 111 (274)
T ss_pred eEEEEecChHHHHHH------------HHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC--
Confidence 477887765433221 568889999999999999999999999999999999999999988886543
Q ss_pred CCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCC-------ceEEcccccceecCCCCcccccccc
Q 043524 118 HFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN-------VVKLFDFSLSISIPEGETHITDTVM 190 (314)
Q Consensus 118 ~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~-------~~kl~dfg~~~~~~~~~~~~~~~~~ 190 (314)
..++...+..++.|++.||.||| +++|+||||||+||+++..+ .++++|||.+...... ....
T Consensus 112 --~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~ 181 (274)
T cd05076 112 --GRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR-----EERV 181 (274)
T ss_pred --CCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc-----cccc
Confidence 35788889999999999999999 99999999999999997543 4799999987543221 2235
Q ss_pred cccccccCccccc-CCCCcccchHHHHHHHHHHH-hCCCCcccccCccccccchHHHHHhhhccCCcccccChhhhccCC
Q 043524 191 GTYGHLAPQYVTT-CDFSEKLDVYSFGAFLSELL-TGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLS 268 (314)
Q Consensus 191 g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (314)
++..|+|||.+.. ..++.++|+||||+++||++ +|..||........ ....... ...+
T Consensus 182 ~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---------~~~~~~~-----------~~~~ 241 (274)
T cd05076 182 ERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK---------ERFYEKK-----------HRLP 241 (274)
T ss_pred cCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH---------HHHHHhc-----------cCCC
Confidence 7788999998865 45889999999999999985 68888864332110 0001000 0000
Q ss_pred chhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHH
Q 043524 269 CTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLR 305 (314)
Q Consensus 269 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~ 305 (314)
. .....+.+++.+||+.+|++|||+.++++.|.
T Consensus 242 ~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 242 E----PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred C----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 0 11235789999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=279.65 Aligned_cols=268 Identities=16% Similarity=0.216 Sum_probs=191.3
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCee
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIA 95 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (314)
...+|.|+ +.|+.+....+|..+|+|.+....... ...+.+.+|+.+++.++||||+++++++.+++..
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~----------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (285)
T cd07861 5 IEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEE----------GVPSTAIREISLLKELQHPNIVCLQDVLMQESRL 74 (285)
T ss_pred eeEecccCceEEEEEEECCCCcEEEEEEeccccccC----------CchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeE
Confidence 34577777 788888888889999999876432110 0124677899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
|+|+||++ ++|.+.+...... ..++...+..++.|++.||.||| +++++|+||+|+||+++.++.++|+|||++
T Consensus 75 ~~v~e~~~-~~l~~~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 148 (285)
T cd07861 75 YLIFEFLS-MDLKKYLDSLPKG--QYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLA 148 (285)
T ss_pred EEEEecCC-CCHHHHHhcCCCC--CcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccce
Confidence 99999997 6898888654321 35788999999999999999999 999999999999999999999999999998
Q ss_pred eecCCCCcccccccccccccccCcccccC-CCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHH---Hhhhc
Q 043524 176 ISIPEGETHITDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYL---KNYFE 251 (314)
Q Consensus 176 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~ 251 (314)
....... .......+++.|+|||.+.+. .++.++|+||+|+++|+|++|+.||............+.... ...+.
T Consensus 149 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (285)
T cd07861 149 RAFGIPV-RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWP 227 (285)
T ss_pred eecCCCc-ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Confidence 7553221 112233568899999988654 478899999999999999999999974332111100000000 00000
Q ss_pred ----cCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 252 ----DNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 252 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.......++........ ......+.++.+++.+||..||++|||+.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 228 GVTSLPDYKNTFPKWKKGSLR-SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred cchhhHHHHhhccccCcchhH-HhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000000000 001124567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=270.65 Aligned_cols=246 Identities=21% Similarity=0.326 Sum_probs=196.1
Q ss_pred cccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCC
Q 043524 15 KRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETP 93 (314)
Q Consensus 15 ~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (314)
.....+|.|+ +.++.+....+++.+++|.+..... .+.+.+|+++++.++|+||+++++.+.++.
T Consensus 6 ~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--------------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (256)
T cd06612 6 DILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--------------LQEIIKEISILKQCDSPYIVKYYGSYFKNT 71 (256)
T ss_pred hhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--------------HHHHHHHHHHHHhCCCCcEeeeeeeeecCC
Confidence 3344577777 7777777777889999999875532 156889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccc
Q 043524 94 IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFS 173 (314)
Q Consensus 94 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg 173 (314)
..|+++||+++++|.+.+.... ..++...+..++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~l~~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg 144 (256)
T cd06612 72 DLWIVMEYCGAGSVSDIMKITN----KTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFG 144 (256)
T ss_pred cEEEEEecCCCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccc
Confidence 9999999999999999986544 45789999999999999999999 9999999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccC
Q 043524 174 LSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDN 253 (314)
Q Consensus 174 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (314)
++........ ......++..|+|||++.+..++.++||||+|+++++|++|+.||.......... .. ..
T Consensus 145 ~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~--------~~--~~ 213 (256)
T cd06612 145 VSGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF--------MI--PN 213 (256)
T ss_pred cchhcccCcc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh--------hh--cc
Confidence 9876543321 2334457889999999988889999999999999999999999986433211000 00 00
Q ss_pred CcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 254 RFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
. .......+...+..+.+++..||+.||++|||+.|+++
T Consensus 214 --------~--~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 214 --------K--PPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred --------C--CCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 0 00011112244567899999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=290.84 Aligned_cols=262 Identities=16% Similarity=0.187 Sum_probs=191.3
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
+.....+|.|+ +.|+++.+..+++.||+|.... ..+.+|+++++.++|+|||++++++..+
T Consensus 171 y~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------------------~~~~~E~~iL~~L~HpnIv~l~~~~~~~ 232 (461)
T PHA03211 171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------------------ASSVHEARLLRRLSHPAVLALLDVRVVG 232 (461)
T ss_pred eEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------------------cCHHHHHHHHHHCCCCCCCcEEEEEEEC
Confidence 33444588888 8888988888999999995321 2356899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~df 172 (314)
...++++|++. ++|.+.+.... ..+++..++.++.|++.||.||| +++|+||||||+||+++..+.++|+||
T Consensus 233 ~~~~lv~e~~~-~~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DF 304 (461)
T PHA03211 233 GLTCLVLPKYR-SDLYTYLGARL----RPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDF 304 (461)
T ss_pred CEEEEEEEccC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEccc
Confidence 99999999994 79988886543 35889999999999999999999 999999999999999999999999999
Q ss_pred ccceecCCCCcc-cccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhc
Q 043524 173 SLSISIPEGETH-ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFE 251 (314)
Q Consensus 173 g~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (314)
|+++........ ......||..|+|||++.+..++.++|||||||++|||++|..++........ ..++...+.....
T Consensus 305 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~-~~~~~~~l~~~i~ 383 (461)
T PHA03211 305 GAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDE-RRPYDAQILRIIR 383 (461)
T ss_pred CCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccc-cCCcHHHHHHHHH
Confidence 999765432211 12245699999999999988899999999999999999998765532221110 1111111111111
Q ss_pred cCC-----cccccChhh------------hccCC---chhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 252 DNR-----FTEIVDPII------------VQDLS---CTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 252 ~~~-----~~~~~~~~~------------~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
... +.......+ ..... .......+..+.+|+..||+.||.+|||+.|+|+
T Consensus 384 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 384 QAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred hhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 100 000000000 00000 0000123346889999999999999999999986
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=286.45 Aligned_cols=254 Identities=15% Similarity=0.183 Sum_probs=193.0
Q ss_pred cccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCC
Q 043524 15 KRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETP 93 (314)
Q Consensus 15 ~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (314)
.....+|+|+ +.|+++....+++.+|+|++.......... .+.+.+|+.++..++|+||+++++++.+++
T Consensus 4 ~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~---------~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~ 74 (331)
T cd05624 4 EIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAE---------TACFREERNVLVNGDCQWITTLHYAFQDEN 74 (331)
T ss_pred eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHH---------HHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 3445688888 788888888899999999987654322211 145778999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccc
Q 043524 94 IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFS 173 (314)
Q Consensus 94 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg 173 (314)
..|+||||+++|+|.+++.... ..++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+|||
T Consensus 75 ~~~lv~Ey~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG 147 (331)
T cd05624 75 YLYLVMDYYVGGDLLTLLSKFE----DRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFG 147 (331)
T ss_pred EEEEEEeCCCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEecc
Confidence 9999999999999999997643 34788889999999999999999 9999999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCccccc-----CCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHh
Q 043524 174 LSISIPEGETHITDTVMGTYGHLAPQYVTT-----CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKN 248 (314)
Q Consensus 174 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (314)
+++..............||+.|+|||++.. ..++.++|+||+|+++|+|++|+.||...... +....
T Consensus 148 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--------~~~~~ 219 (331)
T cd05624 148 SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV--------ETYGK 219 (331)
T ss_pred ceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH--------HHHHH
Confidence 997764433322334579999999998875 35788999999999999999999999643211 11111
Q ss_pred hhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCC--CCCHHHHHH
Q 043524 249 YFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPID--RPTMVDVAR 302 (314)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~--Rps~~ell~ 302 (314)
...... .. +.+. .....+..+.+++.+||..++.+ |+++.++++
T Consensus 220 i~~~~~-------~~--~~p~-~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 220 IMNHEE-------RF--QFPS-HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred HHcCCC-------cc--cCCC-ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 111000 00 0000 00134567889999999876654 457888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=289.56 Aligned_cols=270 Identities=16% Similarity=0.245 Sum_probs=194.4
Q ss_pred hhhhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEe
Q 043524 9 KLWSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIG 87 (314)
Q Consensus 9 ~~~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 87 (314)
....+|.....+|+|+ +.|+.+.+..+++.+|+|.+........ ..+.+.+|+.+++.++||||+++++
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~E~~~l~~l~h~~ii~~~~ 90 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT----------HAKRAYRELVLMKCVNHKNIIGLLN 90 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCch----------hHHHHHHHHHHHHhcCCCCccccce
Confidence 3445566667799998 8888888888999999998864321100 1146789999999999999999999
Q ss_pred EEEeC------CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeee
Q 043524 88 CCLET------PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILF 161 (314)
Q Consensus 88 ~~~~~------~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~ 161 (314)
++... ...|+||||++ +++.+.+.. .++...+..++.|++.||.||| +++|+||||||+||++
T Consensus 91 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll 159 (364)
T cd07875 91 VFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVV 159 (364)
T ss_pred eecccccccccCeEEEEEeCCC-CCHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEE
Confidence 88643 35799999996 577777642 3677888899999999999999 9999999999999999
Q ss_pred cCCCceEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccc--
Q 043524 162 SEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLV-- 239 (314)
Q Consensus 162 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~-- 239 (314)
+.++.++|+|||+++...... ......+|..|+|||++.+..++.++||||+||++|+|++|+.||..........
T Consensus 160 ~~~~~~kL~DfG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~ 237 (364)
T cd07875 160 KSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 237 (364)
T ss_pred CCCCcEEEEeCCCccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999999999999997653322 1334578999999999998889999999999999999999999997543211100
Q ss_pred -----cchHHHHH-------hhhcc-CCc-----ccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHH
Q 043524 240 -----YPFNEYLK-------NYFED-NRF-----TEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVA 301 (314)
Q Consensus 240 -----~~~~~~~~-------~~~~~-~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell 301 (314)
.+...... ..... ... .+...... .+.........+..+.+|+.+||+.||.+|||+.|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L 316 (364)
T cd07875 238 IEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVL-FPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316 (364)
T ss_pred HHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCcccc-ccccccccccccHHHHHHHHHhcCcCcccCCCHHHHh
Confidence 00011100 00000 000 00000000 0000111112345688999999999999999999998
Q ss_pred H
Q 043524 302 R 302 (314)
Q Consensus 302 ~ 302 (314)
+
T Consensus 317 ~ 317 (364)
T cd07875 317 Q 317 (364)
T ss_pred c
Confidence 7
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=272.42 Aligned_cols=250 Identities=23% Similarity=0.322 Sum_probs=184.4
Q ss_pred ccCch-hHHHHHHH---hcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE-eCCe
Q 043524 20 IGNGA-SVLQELIA---SSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL-ETPI 94 (314)
Q Consensus 20 ~G~g~-~~~~~~~~---~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~ 94 (314)
+|.|+ +.|+++.. ...+..+|+|.+........ .+.+.+|+.+++.++||||+++++++. .++.
T Consensus 3 lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 71 (262)
T cd05058 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEE-----------VEQFLKEGIIMKDFSHPNVLSLLGICLPSEGS 71 (262)
T ss_pred ccccCCceEEEEEEecCCCceEEEEEEecCccCCHHH-----------HHHHHHHHHHHccCCCCCcceEEEEeecCCCC
Confidence 57777 66665543 23445799997753221111 156789999999999999999999876 4566
Q ss_pred eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccc
Q 043524 95 AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL 174 (314)
Q Consensus 95 ~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~ 174 (314)
.++++||+.+|+|.+++.... .......+..++.|++.||.||| +.+++|+||||+||+++.++.++++|||+
T Consensus 72 ~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~ 144 (262)
T cd05058 72 PLVVLPYMKHGDLRNFIRSET----HNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGL 144 (262)
T ss_pred cEEEEecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccc
Confidence 889999999999999987543 23566778888999999999999 99999999999999999999999999999
Q ss_pred ceecCCCCc---ccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhC-CCCcccccCccccccchHHHHHhhh
Q 043524 175 SISIPEGET---HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG-RGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 175 ~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
++....... .......++..|+|||.+....++.++||||||+++|||++| .+||...... .......
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~--------~~~~~~~ 216 (262)
T cd05058 145 ARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF--------DITVYLL 216 (262)
T ss_pred cccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHh
Confidence 875533211 011123456789999999888899999999999999999995 5555432211 1111111
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHh
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICC 309 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 309 (314)
... ....+...+..+.+++.+||..+|++||++.++++.|+++..
T Consensus 217 ~~~--------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 217 QGR--------------RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred cCC--------------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 100 000011234568899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=278.25 Aligned_cols=258 Identities=19% Similarity=0.253 Sum_probs=196.7
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
++....+|+|+ +.|+.+....+|+.+|+|++....... ..+.+.+|+++++.++||||+++++.+...
T Consensus 7 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (284)
T cd06620 7 LETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSS-----------VRKQILRELQIMHECRSPYIVSFYGAFLNE 75 (284)
T ss_pred HHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcch-----------HHHHHHHHHHHHHHcCCCCcceEeeeEecC
Confidence 33444588888 888888888889999999876432111 125688999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCC-CCceeccCCCCCeeecCCCceEEcc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFP-RPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~-~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
+.+++|+||+++++|.+.+... .+++......++.+++.++.||| + .+++|+||+|+||+++.++.++|+|
T Consensus 76 ~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~d 147 (284)
T cd06620 76 NNICMCMEFMDCGSLDRIYKKG-----GPIPVEILGKIAVAVVEGLTYLY---NVHRIMHRDIKPSNILVNSRGQIKLCD 147 (284)
T ss_pred CEEEEEEecCCCCCHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHH---HhcCeeccCCCHHHEEECCCCcEEEcc
Confidence 9999999999999999888654 34788899999999999999999 6 5899999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhc
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFE 251 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (314)
||++....... .....|+..|+|||++....++.++|+||+||++|++++|..||+......+........
T Consensus 148 ~gl~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~------ 218 (284)
T cd06620 148 FGVSGELINSI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGI------ 218 (284)
T ss_pred CCcccchhhhc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHH------
Confidence 99986542221 234578999999999988889999999999999999999999997544321100000000
Q ss_pred cCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 043524 252 DNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARR 303 (314)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 303 (314)
.+.....+............+..+.+|+..||..||++|||+.|+++.
T Consensus 219 ----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 219 ----LDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred ----HHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 001111111111111111345678999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=270.82 Aligned_cols=246 Identities=23% Similarity=0.363 Sum_probs=192.1
Q ss_pred cccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCC
Q 043524 15 KRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETP 93 (314)
Q Consensus 15 ~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (314)
.....+|.|+ +.|+.+. ..|+.+|+|.+..... . .+++.+|+.+++.++|+||+++++++.++.
T Consensus 9 ~~~~~ig~g~~g~v~~~~--~~~~~v~iK~~~~~~~-~------------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 73 (256)
T cd05039 9 KLGATIGKGEFGDVMLGD--YRGQKVAVKCLKDDST-A------------AQAFLAEASVMTTLRHPNLVQLLGVVLQGN 73 (256)
T ss_pred cceeeeecCCCceEEEEE--ecCcEEEEEEeccchh-H------------HHHHHHHHHHHHhcCCcceeeeEEEEcCCC
Confidence 3344578777 6666554 3478999998865433 1 156889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccc
Q 043524 94 IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFS 173 (314)
Q Consensus 94 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg 173 (314)
..++||||+++++|.+++..... ..++...+..++.|++.||.||| +++++|+||||+||+++.++.++|+|||
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g 147 (256)
T cd05039 74 PLYIVTEYMAKGSLVDYLRSRGR---AVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFG 147 (256)
T ss_pred CeEEEEEecCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccc
Confidence 99999999999999999876542 25788999999999999999999 9999999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhcc
Q 043524 174 LSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFED 252 (314)
Q Consensus 174 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (314)
.++...... .....+..|+|||.+....++.++|+||+|++++++++ |..||...... ..... ...
T Consensus 148 ~~~~~~~~~----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~-~~~ 214 (256)
T cd05039 148 LAKEASQGQ----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--------DVVPH-VEK 214 (256)
T ss_pred ccccccccc----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--------HHHHH-Hhc
Confidence 987653221 12344667999999988889999999999999999997 99888533211 11111 100
Q ss_pred CCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHH
Q 043524 253 NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQI 307 (314)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~ 307 (314)
. .. ...+...+..+.+++.+||..+|++|||+.++++.|+++
T Consensus 215 ~-~~------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 215 G-YR------------MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred C-CC------------CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 0 00 000112346688999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=264.43 Aligned_cols=242 Identities=19% Similarity=0.242 Sum_probs=196.6
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeEEEeC----
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGCCLET---- 92 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~---- 92 (314)
.+|-|. +.|..+.++.+|+.+|+|+..... ...+|+++.-.. .|||||.++++|+..
T Consensus 69 vLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-----------------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 69 VLGAGINGKVVQCVHKRTQEKFALKVLLDSP-----------------KARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred hhccccCCceEEEEeccchhhhHHHHHhcCH-----------------HHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 456555 788889999999999999765322 235788877665 599999999999753
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecC---CCceEE
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSE---ENVVKL 169 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~---~~~~kl 169 (314)
.-+.+|||.++||+|+.++...++ ..+...++..++.||+.|+.||| +.+|.||||||+|+|... +..+||
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~---~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKL 205 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGD---QAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKL 205 (400)
T ss_pred eeeEeeeecccchHHHHHHHHccc---ccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEe
Confidence 346799999999999999998775 56889999999999999999999 999999999999999864 347899
Q ss_pred cccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhh
Q 043524 170 FDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNY 249 (314)
Q Consensus 170 ~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (314)
+|||+|+...... ...+...|+.|.|||++-...|+..+|+||+|+++|-|++|.+||...+...... .+
T Consensus 206 tDfGFAK~t~~~~--~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aisp-gM------- 275 (400)
T KOG0604|consen 206 TDFGFAKETQEPG--DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-GM------- 275 (400)
T ss_pred cccccccccCCCc--cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCCh-hH-------
Confidence 9999998764432 2556778999999999998899999999999999999999999998766533110 00
Q ss_pred hccCCcccccChhhh--ccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 250 FEDNRFTEIVDPIIV--QDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 250 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
...+.. -.++.++....++...++|+.+|..+|.+|.|+.++++
T Consensus 276 ---------k~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 276 ---------KRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred ---------HhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 011112 23455666688999999999999999999999999875
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=270.54 Aligned_cols=249 Identities=20% Similarity=0.325 Sum_probs=196.4
Q ss_pred ccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCe
Q 043524 16 RTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPI 94 (314)
Q Consensus 16 ~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 94 (314)
....+|.|+ +.++......+|+.+++|.+........ ..+++.+|+++++.++|+||+++++++.+.+.
T Consensus 4 ~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----------~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 73 (256)
T cd08221 4 PIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK----------ERRDALNEIVILSLLQHPNIIAYYNHFMDDNT 73 (256)
T ss_pred EeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchh----------HHHHHHHHHHHHHhCCCCCeeEEEeEEecCCe
Confidence 344577776 5666677778899999998765442221 11567899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccc
Q 043524 95 AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL 174 (314)
Q Consensus 95 ~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~ 174 (314)
.++++||+++++|.+.+..... ..++...+..++.|++.|+.||| +.+++|+||+|+||+++.++.++++|||.
T Consensus 74 ~~~~~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~ 147 (256)
T cd08221 74 LLIEMEYANGGTLYDKIVRQKG---QLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGI 147 (256)
T ss_pred EEEEEEecCCCcHHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcc
Confidence 9999999999999999876532 35788899999999999999999 99999999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCC
Q 043524 175 SISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNR 254 (314)
Q Consensus 175 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (314)
+........ ......+++.|+|||.+.+..++.++|+||+|+++++|++|..||..... .+.......
T Consensus 148 ~~~~~~~~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--------~~~~~~~~~--- 215 (256)
T cd08221 148 SKILGSEYS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP--------LNLVVKIVQ--- 215 (256)
T ss_pred eEEcccccc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHc---
Confidence 876644332 23455689999999999888889999999999999999999999864221 111111111
Q ss_pred cccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 043524 255 FTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARR 303 (314)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 303 (314)
+.... .....+..+.+++.+||..||++|||+.++++.
T Consensus 216 ----------~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 216 ----------GNYTP-VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred ----------CCCCC-CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 00000 012445678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=271.86 Aligned_cols=252 Identities=24% Similarity=0.349 Sum_probs=189.2
Q ss_pred cccCch-hHHHHHHHhcCC------cccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 19 MIGNGA-SVLQELIASSNG------KYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g------~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
.+|.|+ +.|+.+.....+ ..+|+|.+........ ...+.+|+.+++.++||||+++++++..
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 70 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE-----------KKEFLKEAHLMSNFNHPNIVKLLGVCLL 70 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhh-----------HHHHHHHHHHHHhcCCCCeeeEeeeecC
Confidence 367777 667666554322 5789997754321111 1568899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCC--CCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCC----
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQT--HFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN---- 165 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~---- 165 (314)
....++++||+++++|.+.+...... ....+++..+..++.|++.||.||| +++++|+||+|+||+++.++
T Consensus 71 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~ 147 (269)
T cd05044 71 NEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDAD 147 (269)
T ss_pred CCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCC
Confidence 99999999999999999998753211 1123678889999999999999999 99999999999999999877
Q ss_pred -ceEEcccccceecCCCCcc-cccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccch
Q 043524 166 -VVKLFDFSLSISIPEGETH-ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPF 242 (314)
Q Consensus 166 -~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~ 242 (314)
.++++|||+++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 148 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~------ 221 (269)
T cd05044 148 RVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE------ 221 (269)
T ss_pred cceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH------
Confidence 8999999998765332211 1223345678999999988889999999999999999998 999986332111
Q ss_pred HHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHH
Q 043524 243 NEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQ 306 (314)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 306 (314)
.... .... .........+..+.+++.+||..+|++|||+.++++.|.+
T Consensus 222 --~~~~-~~~~-------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 222 --VLQH-VTAG-------------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred --HHHH-HhcC-------------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1110 0000 0001111345678899999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=282.62 Aligned_cols=262 Identities=20% Similarity=0.341 Sum_probs=193.5
Q ss_pred cCcccccccCch-hHHHHHH-----HhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeee
Q 043524 13 KGKRTLMIGNGA-SVLQELI-----ASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKL 85 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~-----~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~ 85 (314)
+++....+|.|+ +.|+++. ...+++.||+|.+........ .+.+.+|+.++..+ +||||+++
T Consensus 8 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~E~~~l~~l~~h~niv~~ 76 (343)
T cd05103 8 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-----------HRALMSELKILIHIGHHLNVVNL 76 (343)
T ss_pred HhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHH-----------HHHHHHHHHHHHhccCCccHhhh
Confidence 444555689888 7777765 345678999998864321111 14678999999999 68999999
Q ss_pred EeEEEe-CCeeEEEEeecCCCCHHHHHhcCCCCC----------------------------------------------
Q 043524 86 IGCCLE-TPIAILVFEYVQHGTLWDRILGAPQTH---------------------------------------------- 118 (314)
Q Consensus 86 ~~~~~~-~~~~~iv~e~~~~g~L~~~l~~~~~~~---------------------------------------------- 118 (314)
++++.. +...+++||||++|+|.+++.......
T Consensus 77 ~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (343)
T cd05103 77 LGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEK 156 (343)
T ss_pred cceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCC
Confidence 998865 456889999999999999986532100
Q ss_pred ----------------CCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccceecCCCC
Q 043524 119 ----------------FEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGE 182 (314)
Q Consensus 119 ----------------~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~ 182 (314)
...++...+..++.|++.||.||| +++|+||||||+||+++.++.++++|||++.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~ 233 (343)
T cd05103 157 SLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP 233 (343)
T ss_pred ccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCc
Confidence 013567778889999999999999 9999999999999999999999999999987653322
Q ss_pred cc-cccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhccCCcccccC
Q 043524 183 TH-ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVD 260 (314)
Q Consensus 183 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (314)
.. ......++..|+|||.+....++.++||||||+++|+|++ |..||....... ..... ......
T Consensus 234 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~-~~~~~~----- 300 (343)
T cd05103 234 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-------EFCRR-LKEGTR----- 300 (343)
T ss_pred chhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-------HHHHH-HhccCC-----
Confidence 11 1222345678999999988889999999999999999997 888886432211 00000 000000
Q ss_pred hhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHh
Q 043524 261 PIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICC 309 (314)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 309 (314)
...+...+..+.+++..||+.||++|||+.|+++.|+.+.+
T Consensus 301 --------~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 301 --------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred --------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 00001223467899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=276.50 Aligned_cols=242 Identities=24% Similarity=0.328 Sum_probs=192.4
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeE
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAI 96 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (314)
..+|.|+ +.|+.+....+|..+|+|.+........ .+.+.+|+++++.++||||+++++++..++..|
T Consensus 10 ~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (277)
T cd06642 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE-----------IEDIQQEITVLSQCDSPYITRYYGSYLKGTKLW 78 (277)
T ss_pred HHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHH-----------HHHHHHHHHHHHcCCCCccHhhhcccccCCceE
Confidence 3477777 7888887888899999998764432211 156789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
+|+||+++++|.+.+.. ..++...+..++.+++.|+.||| +++++|+||+|+||+++.++.++++|||++.
T Consensus 79 lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06642 79 IIMEYLGGGSALDLLKP------GPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAG 149 (277)
T ss_pred EEEEccCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccc
Confidence 99999999999998854 24778889999999999999999 9999999999999999999999999999987
Q ss_pred ecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcc
Q 043524 177 SIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFT 256 (314)
Q Consensus 177 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (314)
....... ......++..|+|||.+....++.++|+||||+++++|++|..||........ .. ......
T Consensus 150 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--------~~-~~~~~~-- 217 (277)
T cd06642 150 QLTDTQI-KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV--------LF-LIPKNS-- 217 (277)
T ss_pred cccCcch-hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH--------Hh-hhhcCC--
Confidence 6543221 22344678899999999888899999999999999999999999863321110 00 000000
Q ss_pred cccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 257 EIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.+ ......+..+.+++..||..+|++|||+.+++.
T Consensus 218 ---~~--------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 218 ---PP--------TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred ---CC--------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 00 011134466889999999999999999999997
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=274.44 Aligned_cols=254 Identities=20% Similarity=0.244 Sum_probs=179.5
Q ss_pred ccCch-hHHHHHH--HhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeE
Q 043524 20 IGNGA-SVLQELI--ASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAI 96 (314)
Q Consensus 20 ~G~g~-~~~~~~~--~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (314)
+|+|+ +.|+++. .......+++|.+........ ...+.+|+.+++.++|+||+++++.+.++...|
T Consensus 3 lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~-----------~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~ 71 (269)
T cd05042 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDE-----------QLLFLQEVQPYRELNHPNVLQCLGQCIESIPYL 71 (269)
T ss_pred CCccCCceEEEEEEecCCCCeEEEEeecCccCChHH-----------HHHHHHHHHHHHhCCCCCcceEEEEECCCCceE
Confidence 56666 5555542 222334677776543321111 156789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
+||||+++|+|.+++...........+......++.|++.||.||| +++|+||||||+||+++.++.++++|||++.
T Consensus 72 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 148 (269)
T cd05042 72 LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLAL 148 (269)
T ss_pred EEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEecccccc
Confidence 9999999999999997654321123456778889999999999999 9999999999999999999999999999986
Q ss_pred ecCCCCcc-cccccccccccccCccccc-------CCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHH
Q 043524 177 SIPEGETH-ITDTVMGTYGHLAPQYVTT-------CDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLK 247 (314)
Q Consensus 177 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~-------~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~ 247 (314)
........ ......++..|+|||++.. ..++.++||||+||++|+|++ |..||....... ...
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--------~~~ 220 (269)
T cd05042 149 EQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ--------VLK 220 (269)
T ss_pred ccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH--------HHH
Confidence 53222111 1123345678999998743 346789999999999999999 777875432211 111
Q ss_pred hhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHH
Q 043524 248 NYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLR 305 (314)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~ 305 (314)
....... .+...+ ......+..+.+++..|| .||++|||+.+|++.|.
T Consensus 221 ~~~~~~~-~~~~~~--------~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 221 QVVREQD-IKLPKP--------QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred HHhhccC-ccCCCC--------cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1111100 011111 111134456678899998 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=269.10 Aligned_cols=237 Identities=24% Similarity=0.355 Sum_probs=177.7
Q ss_pred ccCch-hHHHHHHHhcC------------CcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeE
Q 043524 20 IGNGA-SVLQELIASSN------------GKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLI 86 (314)
Q Consensus 20 ~G~g~-~~~~~~~~~~~------------g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 86 (314)
+|.|+ +.|+++..... ...+++|.+....... ...+.+|+.++..++||||++++
T Consensus 3 lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~------------~~~~~~~~~~l~~l~hp~iv~~~ 70 (262)
T cd05077 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDI------------SLAFFETASMMRQVSHKHIVLLY 70 (262)
T ss_pred cccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhH------------HHHHHHHHHHHHhCCCCCEeeEE
Confidence 56666 66666543221 2257888766543221 25678899999999999999999
Q ss_pred eEEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCc
Q 043524 87 GCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENV 166 (314)
Q Consensus 87 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~ 166 (314)
+++......+++|||+++|+|..++.... .+++...++.++.|++.|++||| +++|+||||||+||+++.++.
T Consensus 71 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~ 143 (262)
T cd05077 71 GVCVRDVENIMVEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGI 143 (262)
T ss_pred EEEecCCCCEEEEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCc
Confidence 99999999999999999999988876543 35788889999999999999999 999999999999999986653
Q ss_pred -------eEEcccccceecCCCCcccccccccccccccCcccc-cCCCCcccchHHHHHHHHHHH-hCCCCcccccCccc
Q 043524 167 -------VKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVT-TCDFSEKLDVYSFGAFLSELL-TGRGILDLVRDAHD 237 (314)
Q Consensus 167 -------~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~~l~el~-~g~~p~~~~~~~~~ 237 (314)
++++|||.+..... .....++..|+|||.+. ...++.++||||||+++|+|+ .|..||.......
T Consensus 144 ~~~~~~~~~l~d~g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~- 217 (262)
T cd05077 144 DGECGPFIKLSDPGIPITVLS-----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE- 217 (262)
T ss_pred cCCCCceeEeCCCCCCccccC-----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-
Confidence 89999999865422 22345788999999886 456889999999999999998 5777765322110
Q ss_pred cccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHH
Q 043524 238 LVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRL 304 (314)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 304 (314)
...... .... ... ..+.++.+|+.+||+.||++||++.+|++.+
T Consensus 218 --------~~~~~~-~~~~----------~~~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 218 --------KERFYE-GQCM----------LVT----PSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred --------HHHHHh-cCcc----------CCC----CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 000000 0000 000 1234678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=276.23 Aligned_cols=246 Identities=21% Similarity=0.286 Sum_probs=192.4
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCee
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIA 95 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (314)
...+|.|+ +.|+.+....++..+|+|.+........ +.+.+|+++++.++||||+++++++..+...
T Consensus 10 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~------------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (280)
T cd06611 10 IGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEEL------------EDFMVEIDILSECKHPNIVGLYEAYFYENKL 77 (280)
T ss_pred HHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHH------------HHHHHHHHHHHhCCCCceeEEEEEEecCCeE
Confidence 34478888 8888887777899999999865433222 5678999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
|+||||+++++|.+++.... ..++...+..++.|++.|+.||| +++++|+||+|+||+++.++.++++|||.+
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~ 150 (280)
T cd06611 78 WILIEFCDGGALDSIMLELE----RGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVS 150 (280)
T ss_pred EEEeeccCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccc
Confidence 99999999999999887644 35788999999999999999999 999999999999999999999999999987
Q ss_pred eecCCCCcccccccccccccccCcccc-----cCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhh
Q 043524 176 ISIPEGETHITDTVMGTYGHLAPQYVT-----TCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 176 ~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
........ ......++..|+|||.+. ...++.++|+||+|+++|+|++|+.||....... ......
T Consensus 151 ~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~ 221 (280)
T cd06611 151 AKNKSTLQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--------VLLKIL 221 (280)
T ss_pred hhhccccc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH--------HHHHHh
Confidence 65433221 123456889999999875 3346789999999999999999999986432111 000000
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
. ... +. ...+...+..+.+++..||+.||.+|||+.++++
T Consensus 222 ~-~~~-----~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 222 K-SEP-----PT------LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred c-CCC-----CC------cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 0 000 00 0011134567889999999999999999999986
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=275.23 Aligned_cols=253 Identities=18% Similarity=0.302 Sum_probs=193.2
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCee
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIA 95 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (314)
...+|.|+ +.++.+.+..+++.+|+|.+.......... .......+.+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSK---DRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred cceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchh---HHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 34577777 778888777888999999875432211100 00000225678999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
++++||+++++|.+++... ..++...+..++.|++.||.||| +++++|+||+|+||+++.++.++|+|||.+
T Consensus 82 ~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNY-----GAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred EEEEEecCCCCHHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCC
Confidence 9999999999999999764 34778888899999999999999 999999999999999999999999999998
Q ss_pred eecCCCCc-----ccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhh
Q 043524 176 ISIPEGET-----HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 176 ~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
+....... .......|+..|+|||.+.+..++.++|+||+|+++|+|++|..||....... . .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~-~~~~~ 225 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-------A-IFKIG 225 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-------H-HHHHh
Confidence 76642211 11223457889999999988889999999999999999999999996433211 0 00000
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
. ...+ ..+...+..+.+++.+||+.||++||++.|+++
T Consensus 226 ~------~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 226 E------NASP--------EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred c------cCCC--------cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0 0000 001134567889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=273.06 Aligned_cols=244 Identities=24% Similarity=0.330 Sum_probs=194.4
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCee
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIA 95 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (314)
...+|.|+ +.++++....+|+.+|+|.+........ ...+.+|+++++.++|+||+++.+.+.++...
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (274)
T cd06609 6 LECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-----------IEDIQQEIQFLSQCRSPYITKYYGSFLKGSKL 74 (274)
T ss_pred hhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchH-----------HHHHHHHHHHHHHcCCCCeeeeeEEEEECCeE
Confidence 34477777 8888888888999999999865431111 14578999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
|+|+||+++++|.+++... +++...+..++.|++.|+.||| +++++|+||+|+||+++.++.++++|||++
T Consensus 75 ~~v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~ 145 (274)
T cd06609 75 WIIMEYCGGGSCLDLLKPG------KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVS 145 (274)
T ss_pred EEEEEeeCCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccc
Confidence 9999999999999998653 4788999999999999999999 999999999999999999999999999999
Q ss_pred eecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCc
Q 043524 176 ISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRF 255 (314)
Q Consensus 176 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (314)
+...... .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||....... .... .....
T Consensus 146 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~--------~~~~-~~~~~- 214 (274)
T cd06609 146 GQLTSTM-SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR--------VLFL-IPKNN- 214 (274)
T ss_pred eeecccc-cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH--------HHHH-hhhcC-
Confidence 8765432 22334568889999999988889999999999999999999999986433111 0000 00000
Q ss_pred ccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 256 TEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.+.. . ....+..+.+++.+||..||++|||+++++.
T Consensus 215 ----~~~~------~-~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 215 ----PPSL------E-GNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ----CCCC------c-ccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 0000 0 0014556889999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=274.51 Aligned_cols=252 Identities=25% Similarity=0.414 Sum_probs=197.1
Q ss_pred ccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCe
Q 043524 16 RTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPI 94 (314)
Q Consensus 16 ~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 94 (314)
....+|.|+ +.|+++.+..+++.+|+|++.......... .....|+.++..++||||+++++++.+...
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~----------~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~ 72 (260)
T PF00069_consen 3 LVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEER----------EENIREIKILRRLRHPNIVQILDVFQDDNY 72 (260)
T ss_dssp EEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHH----------HHHHHHHHHHHHHTBTTBCHEEEEEEESSE
T ss_pred EeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccccccc----------chhhhhhhcccccccccccccccccccccc
Confidence 345688888 899999999999999999998876654431 234569999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccc
Q 043524 95 AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL 174 (314)
Q Consensus 95 ~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~ 174 (314)
.+++||++++++|.+++... ..++...+..++.|++.||.+|| +++++|+||||+||+++.++.++|+|||.
T Consensus 73 ~~~v~~~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~ 144 (260)
T PF00069_consen 73 LYIVMEYCPGGSLQDYLQKN-----KPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGS 144 (260)
T ss_dssp EEEEEEEETTEBHHHHHHHH-----SSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTT
T ss_pred cccccccccccccccccccc-----ccccccccccccccccccccccc---ccccccccccccccccccccccccccccc
Confidence 99999999998999999732 35889999999999999999999 99999999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCcccc-cCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccC
Q 043524 175 SISIPEGETHITDTVMGTYGHLAPQYVT-TCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDN 253 (314)
Q Consensus 175 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (314)
+...... ........++..|+|||++. ...++.++|+||+|+++++|++|..||........ .........
T Consensus 145 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~-~~~~~~~~~------ 216 (260)
T PF00069_consen 145 SVKLSEN-NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQ-LEIIEKILK------ 216 (260)
T ss_dssp TEESTST-TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHH-HHHHHHHHH------
T ss_pred ccccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccchhh-hhhhhhccc------
Confidence 9764221 12244567899999999988 77789999999999999999999999875411110 000000000
Q ss_pred CcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 254 RFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
....... .........+.+++..||+.||++|||+.++++
T Consensus 217 -------~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 217 -------RPLPSSS--QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp -------THHHHHT--TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred -------ccccccc--cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000 000011267899999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=286.54 Aligned_cols=246 Identities=19% Similarity=0.280 Sum_probs=199.0
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCe--
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPI-- 94 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-- 94 (314)
..+|.|+ -+||++.+..+|-.||+-.++..++.+... -.++|..|+.+|+.|+|||||+++++|.+...
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~--------~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~ 117 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPE--------ELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKT 117 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChH--------HHHHHHHHHHHHccCCCCceeeeeeheecCCCce
Confidence 3689998 899999999999999999888777654332 12789999999999999999999999997655
Q ss_pred eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecC-CCceEEcccc
Q 043524 95 AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSE-ENVVKLFDFS 173 (314)
Q Consensus 95 ~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~-~~~~kl~dfg 173 (314)
+.+|+|++..|+|..+.++.. ....+.+..|+.||+.||.|||.- +-.|+|||||.+||+|+. .|.+||+|+|
T Consensus 118 in~iTEL~TSGtLr~Y~kk~~-----~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLG 191 (632)
T KOG0584|consen 118 INFITELFTSGTLREYRKKHR-----RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLG 191 (632)
T ss_pred eeeeeecccCCcHHHHHHHhc-----cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchh
Confidence 789999999999999998875 477889999999999999999943 668999999999999974 5799999999
Q ss_pred cceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccC
Q 043524 174 LSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDN 253 (314)
Q Consensus 174 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (314)
+|+...... ....+|||-|||||++- ..|+..+||||||+.++||+|+.+||....+.. ...+....
T Consensus 192 LAtl~r~s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A-------QIYKKV~S-- 258 (632)
T KOG0584|consen 192 LATLLRKSH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA-------QIYKKVTS-- 258 (632)
T ss_pred HHHHhhccc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHH-------HHHHHHHc--
Confidence 998765443 33478999999999886 789999999999999999999999997555432 11111111
Q ss_pred CcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 254 RFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
+-.+.....-..+++++||..||.. .++|||+.|+|.
T Consensus 259 -----------GiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 259 -----------GIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred -----------CCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 1111111112235689999999999 999999999986
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=270.02 Aligned_cols=250 Identities=20% Similarity=0.311 Sum_probs=192.4
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
++-...+|+|+ +.|+++. ...+..+|+|.+...... .+.+.+|+++++.++|+||+++++.+..
T Consensus 8 ~~~~~~lg~g~~~~vy~~~-~~~~~~~~iK~~~~~~~~-------------~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 72 (260)
T cd05073 8 LKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMS-------------VEAFLAEANVMKTLQHDKLVKLHAVVTK- 72 (260)
T ss_pred eeEEeEecCccceEEEEEE-ecCCccEEEEecCCChhH-------------HHHHHHHHHHHHhcCCCCcceEEEEEcC-
Confidence 33444588888 6666664 345667999987643321 1567899999999999999999999877
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~df 172 (314)
...++++||+++++|.+++..... ..++...+..++.+++.||.||| +++++|+||+|+||+++..+.++++||
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~ 146 (260)
T cd05073 73 EPIYIITEFMAKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADF 146 (260)
T ss_pred CCeEEEEEeCCCCcHHHHHHhCCc---cccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCC
Confidence 778999999999999999976432 34677888999999999999999 999999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhc
Q 043524 173 SLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFE 251 (314)
Q Consensus 173 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (314)
|.+...............++..|+|||.+....++.++|+||+|+++|++++ |..||....... .... ..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--------~~~~-~~ 217 (260)
T cd05073 147 GLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--------VIRA-LE 217 (260)
T ss_pred cceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH--------HHHH-Hh
Confidence 9987664433222333456678999999988889999999999999999998 898986432111 0000 00
Q ss_pred cCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHH
Q 043524 252 DNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQ 306 (314)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 306 (314)
.. ...+.....+.++.+++.+||+.||++||++.++++.|+.
T Consensus 218 ~~-------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 218 RG-------------YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CC-------------CCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 00 0001111345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=270.90 Aligned_cols=246 Identities=20% Similarity=0.299 Sum_probs=189.6
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCee
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIA 95 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (314)
...+|+|+ +.|+.+....++..+|+|.+........ +.+.+|+.+++.++|+||+++++++..++..
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~------------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYV------------QPLHEEIALHSYLKHRNIVQYLGSDSENGFF 80 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHH------------HHHHHHHHHHHhcCCCCeeeeeeeeccCCEE
Confidence 34688887 7888887788888999998765433221 5678999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcc--cHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecC-CCceEEccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPL--LLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSE-ENVVKLFDF 172 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l--~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~-~~~~kl~df 172 (314)
++++||+++++|.+.+.... .++ +...+..++.|++.|+.||| +++|+|+||||+||+++. .+.++|+||
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~df 153 (268)
T cd06624 81 KIFMEQVPGGSLSALLRSKW----GPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDF 153 (268)
T ss_pred EEEEecCCCCCHHHHHHHhc----ccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecc
Confidence 99999999999999987543 224 67778888999999999999 999999999999999976 678999999
Q ss_pred ccceecCCCCcccccccccccccccCcccccCC--CCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhh
Q 043524 173 SLSISIPEGETHITDTVMGTYGHLAPQYVTTCD--FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 173 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
|.+........ ......++..|+|||.+.... ++.++|+||+|+++|+|++|..||.......... +
T Consensus 154 g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~----------~ 222 (268)
T cd06624 154 GTSKRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM----------F 222 (268)
T ss_pred hhheecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH----------h
Confidence 99876533221 223345789999999986654 7889999999999999999999986432211000 0
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.. ..... ....+...+.++.+++.+||+.+|++|||+.|+++
T Consensus 223 ~~---------~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 223 KV---------GMFKI-HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred hh---------hhhcc-CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 00 00000 00011134466889999999999999999999975
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=274.39 Aligned_cols=257 Identities=19% Similarity=0.299 Sum_probs=190.5
Q ss_pred cccccccCch-hHHHHHHH-----hcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeE
Q 043524 15 KRTLMIGNGA-SVLQELIA-----SSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGC 88 (314)
Q Consensus 15 ~~~~~~G~g~-~~~~~~~~-----~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 88 (314)
.....+|.|+ +.|+.+.. ...+..+|+|.+........ ...+.+|+.+++.++||||++++++
T Consensus 9 ~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~e~~~l~~l~~~~i~~~~~~ 77 (288)
T cd05061 9 TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE-----------RIEFLNEASVMKGFTCHHVVRLLGV 77 (288)
T ss_pred eeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHH-----------HHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 3344588887 66665432 23455899997653321111 1457899999999999999999999
Q ss_pred EEeCCeeEEEEeecCCCCHHHHHhcCCC-----CCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecC
Q 043524 89 CLETPIAILVFEYVQHGTLWDRILGAPQ-----THFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSE 163 (314)
Q Consensus 89 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~-----~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~ 163 (314)
+..+...+++|||+++|+|.+++..... ..........+..++.|++.||.||| +++++|+||||+||+++.
T Consensus 78 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~ 154 (288)
T cd05061 78 VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAH 154 (288)
T ss_pred EcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcC
Confidence 9999999999999999999999975321 11123456778889999999999999 999999999999999999
Q ss_pred CCceEEcccccceecCCCCcc-cccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccc
Q 043524 164 ENVVKLFDFSLSISIPEGETH-ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYP 241 (314)
Q Consensus 164 ~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~ 241 (314)
++.++++|||+++........ ......++..|+|||.+....++.++|+||+||++|||++ |..||......
T Consensus 155 ~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~------ 228 (288)
T cd05061 155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE------ 228 (288)
T ss_pred CCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH------
Confidence 999999999998755332211 1122345678999999988889999999999999999998 77887543211
Q ss_pred hHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHH
Q 043524 242 FNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQI 307 (314)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~ 307 (314)
+........ .... .+...+..+.+++..||+.||++|||+.++++.|++.
T Consensus 229 --~~~~~~~~~-~~~~-------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 229 --QVLKFVMDG-GYLD-------------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred --HHHHHHHcC-CCCC-------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 111111111 0000 0012345689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=270.58 Aligned_cols=250 Identities=19% Similarity=0.280 Sum_probs=195.7
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
|.....+|.|+ +.++.+....+|+.+|+|.+......... .+++.+|+.+++.++||||+++.+++...
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~----------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKE----------REESRKEVAVLSNMKHPNIVQYQESFEEN 71 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHH----------HHHHHHHHHHHHhCCCCCeeeeEeeecCC
Confidence 33445678877 67777777788999999988765332111 14678999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~df 172 (314)
+..|+|+||+++++|.+.+..... ..++...+..++.|++.|+.||| +++++|+||+|+||+++.++.++++||
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~ 145 (256)
T cd08218 72 GNLYIVMDYCEGGDLYKKINAQRG---VLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDF 145 (256)
T ss_pred CeEEEEEecCCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeec
Confidence 999999999999999998865432 24678889999999999999999 999999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhcc
Q 043524 173 SLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFED 252 (314)
Q Consensus 173 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (314)
|.+........ ......|+..|+|||.+.+..++.++|+||+|+++++|++|..||..... .+.......
T Consensus 146 ~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--------~~~~~~~~~- 215 (256)
T cd08218 146 GIARVLNSTVE-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM--------KNLVLKIIR- 215 (256)
T ss_pred cceeecCcchh-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH--------HHHHHHHhc-
Confidence 99876543322 12234678899999999888889999999999999999999999853221 111111111
Q ss_pred CCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 253 NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
+..+ ..+...+.++.+++.+||+.+|++||++.++++
T Consensus 216 ------------~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 216 ------------GSYP-PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred ------------CCCC-CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1100 011134566899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=273.71 Aligned_cols=259 Identities=18% Similarity=0.261 Sum_probs=195.1
Q ss_pred ccccccCch-hHHHHHHHhc----CCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 16 RTLMIGNGA-SVLQELIASS----NGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 16 ~~~~~G~g~-~~~~~~~~~~----~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
-...+|+|+ +.|+.+.... ++..+++|.+....... ..+.+.+|+.+++.++|+||+++++++.
T Consensus 10 ~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~-----------~~~~~~~e~~~l~~l~h~ni~~~~~~~~ 78 (280)
T cd05043 10 LSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEI-----------QVTLLLQESCLLYGLSHQNILPILHVCI 78 (280)
T ss_pred EeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHH-----------HHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 345578877 7777776554 25788888765321111 1156789999999999999999999877
Q ss_pred e-CCeeEEEEeecCCCCHHHHHhcCCCC---CCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCc
Q 043524 91 E-TPIAILVFEYVQHGTLWDRILGAPQT---HFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENV 166 (314)
Q Consensus 91 ~-~~~~~iv~e~~~~g~L~~~l~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~ 166 (314)
. +...++++||+++++|.+++...... ....++...+..++.+++.||.||| +++++|+||||+||+++.++.
T Consensus 79 ~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~ 155 (280)
T cd05043 79 EDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQ 155 (280)
T ss_pred cCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCc
Confidence 6 57789999999999999988654221 0134788899999999999999999 999999999999999999999
Q ss_pred eEEcccccceecCCCCcc-cccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHH
Q 043524 167 VKLFDFSLSISIPEGETH-ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNE 244 (314)
Q Consensus 167 ~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~ 244 (314)
++++|||+++.+...... ......++..|+|||.+....++.++||||+|+++|++++ |..||....... ...
T Consensus 156 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~~~ 230 (280)
T cd05043 156 VKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE-----MAA 230 (280)
T ss_pred EEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH-----HHH
Confidence 999999999765433221 1223345778999999988889999999999999999998 999986432111 111
Q ss_pred HHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 245 YLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
. .... ........++.++.+++.+||..||++|||+.++++.|.++.+.
T Consensus 231 ~----~~~~-------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 231 Y----LKDG-------------YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred H----HHcC-------------CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 1 1100 00000112345688999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=278.92 Aligned_cols=246 Identities=18% Similarity=0.315 Sum_probs=192.9
Q ss_pred ccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCe
Q 043524 16 RTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPI 94 (314)
Q Consensus 16 ~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 94 (314)
....+|.|+ +.++.+....+++.+|+|.+........ +.+.+|+..++.++|+||+++++.+..++.
T Consensus 26 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~------------~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~ 93 (292)
T cd06658 26 SFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRR------------ELLFNEVVIMRDYHHENVVDMYNSYLVGDE 93 (292)
T ss_pred hhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHH------------HHHHHHHHHHHhCCCCcHHHHHHheecCCe
Confidence 345688887 7777777777899999998765432222 567899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccc
Q 043524 95 AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL 174 (314)
Q Consensus 95 ~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~ 174 (314)
.|+|+||+++++|.+++... .++...+..++.|++.|+.||| +++++|+||||+||+++.++.++|+|||+
T Consensus 94 ~~lv~e~~~~~~L~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~ 164 (292)
T cd06658 94 LWVVMEFLEGGALTDIVTHT------RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGF 164 (292)
T ss_pred EEEEEeCCCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcc
Confidence 99999999999999887542 3678889999999999999999 99999999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCC
Q 043524 175 SISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNR 254 (314)
Q Consensus 175 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (314)
+........ ......++..|+|||.+....++.++|+||+|+++|+|++|..||....... ...... .
T Consensus 165 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--------~~~~~~-~-- 232 (292)
T cd06658 165 CAQVSKEVP-KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ--------AMRRIR-D-- 232 (292)
T ss_pred hhhcccccc-cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHH-h--
Confidence 865433221 2234568899999999988889999999999999999999999986432111 000000 0
Q ss_pred cccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 043524 255 FTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARR 303 (314)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 303 (314)
...+.. ......+..+.+++..||..||++|||+.|+++.
T Consensus 233 ---~~~~~~------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 233 ---NLPPRV------KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ---cCCCcc------ccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 000000 0011334567899999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=271.08 Aligned_cols=247 Identities=23% Similarity=0.348 Sum_probs=192.1
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeE
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAI 96 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (314)
..+|.|+ +.|+++.. .++..+|+|.+...... .+.+.+|+.+++.++|+||+++++++..+...+
T Consensus 12 ~~ig~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~-------------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 12 RKLGAGQFGEVWMGTW-NGTTKVAVKTLKPGTMS-------------PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred eeeccCcceEEEEEEE-cCCceEEEEEecCCccC-------------HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 4577777 67776654 45578999987753321 146789999999999999999999999989999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
+++||+++++|.+.+..... ..++...+..++.+++.|+.||| +++++|+||+|+||+++.++.++++|||.++
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~---~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~ 151 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEG---KKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLAR 151 (261)
T ss_pred EEEeccCCCCHHHHHhcccc---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccce
Confidence 99999999999999976432 34788899999999999999999 9999999999999999999999999999987
Q ss_pred ecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhccCCc
Q 043524 177 SIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFEDNRF 255 (314)
Q Consensus 177 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (314)
..............++..|+|||.+.+..++.++|+||+|+++|++++ |+.||...... ......... .
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--------~~~~~~~~~--~ 221 (261)
T cd05034 152 LIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR--------EVLEQVERG--Y 221 (261)
T ss_pred eccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcC--C
Confidence 764332222223345678999999988889999999999999999998 99998543211 111111100 0
Q ss_pred ccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHH
Q 043524 256 TEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQ 306 (314)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 306 (314)
..+.+...+..+.+++.+||..||++||++.++.+.|+.
T Consensus 222 ------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 222 ------------RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ------------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 000001224568999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=277.34 Aligned_cols=256 Identities=22% Similarity=0.337 Sum_probs=193.1
Q ss_pred CcccccccCch-hHHHHHHHhcCCcc----cccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeE
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKY----IPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGC 88 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~----~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 88 (314)
++....+|+|+ +.||++....+|+. +|+|.+........ ..++.+|+.++..++||||++++++
T Consensus 9 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~~e~~~~~~l~h~niv~~~~~ 77 (303)
T cd05110 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKA-----------NVEFMDEALIMASMDHPHLVRLLGV 77 (303)
T ss_pred ceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHH-----------HHHHHHHHHHHHhCCCCCcccEEEE
Confidence 34445688888 78887777667763 57776653321111 1467899999999999999999999
Q ss_pred EEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceE
Q 043524 89 CLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVK 168 (314)
Q Consensus 89 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~k 168 (314)
+... ..++++||+++|+|.+.+.... ..++...+..++.|++.||.||| +++|+|+||||+||+++.++.+|
T Consensus 78 ~~~~-~~~~v~e~~~~g~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~k 149 (303)
T cd05110 78 CLSP-TIQLVTQLMPHGCLLDYVHEHK----DNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVK 149 (303)
T ss_pred EcCC-CceeeehhcCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceE
Confidence 8754 4679999999999999987643 34778889999999999999999 99999999999999999999999
Q ss_pred EcccccceecCCCCcc-cccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHH
Q 043524 169 LFDFSLSISIPEGETH-ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYL 246 (314)
Q Consensus 169 l~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~ 246 (314)
|+|||+++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ...
T Consensus 150 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-----~~~-- 222 (303)
T cd05110 150 ITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-----IPD-- 222 (303)
T ss_pred EccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHH--
Confidence 9999999765433221 1222345678999999988889999999999999999997 888885432110 111
Q ss_pred HhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 247 KNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
....... . +.+...+..+.+++..||..||++||++.++++.|+++...
T Consensus 223 --~~~~~~~-------~------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 223 --LLEKGER-------L------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred --HHHCCCC-------C------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1111000 0 00012334678999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=282.14 Aligned_cols=264 Identities=16% Similarity=0.201 Sum_probs=190.0
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|.....+|.|+ +.|+.+.+..+++.||+|.+........ ..+.+.+|+++++.++||||+++++++.
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 84 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLI----------HARRTYRELRLLKHMKHENVIGLLDVFT 84 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhH----------HHHHHHHHHHHHHhcCCCchhhhhhhhc
Confidence 3445556688888 8888888888999999998875432111 0145778999999999999999999886
Q ss_pred eC------CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCC
Q 043524 91 ET------PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEE 164 (314)
Q Consensus 91 ~~------~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~ 164 (314)
.. ...|+++|++ +++|.+++.. ..++...+..++.|++.||.||| +++|+||||||+||+++.+
T Consensus 85 ~~~~~~~~~~~~~~~~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~ 154 (343)
T cd07878 85 PATSIENFNEVYLVTNLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNED 154 (343)
T ss_pred ccccccccCcEEEEeecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCC
Confidence 43 4578999988 7799887754 24788999999999999999999 9999999999999999999
Q ss_pred CceEEcccccceecCCCCcccccccccccccccCccccc-CCCCcccchHHHHHHHHHHHhCCCCcccccCcccccc---
Q 043524 165 NVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTT-CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVY--- 240 (314)
Q Consensus 165 ~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~--- 240 (314)
+.++|+|||+++..... .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...........
T Consensus 155 ~~~kl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 230 (343)
T cd07878 155 CELRILDFGLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIME 230 (343)
T ss_pred CCEEEcCCccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 99999999999765432 234578999999999876 4588999999999999999999999964332110000
Q ss_pred ----chHHHHHhhhccCCcccccChhhhccCCchh----HHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 241 ----PFNEYLKNYFEDNRFTEIVDPIIVQDLSCTE----KEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 241 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
+.......... ......... +. ..+... ....+..+.+|+.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~-~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 231 VVGTPSPEVLKKISS-EHARKYIQS-LP-HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HhCCCCHHHHHhcch-hhHHHHhhc-cc-cccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000000 000000000 00 000000 0012345789999999999999999999985
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=272.87 Aligned_cols=258 Identities=22% Similarity=0.292 Sum_probs=193.5
Q ss_pred CcccccccCch-hHHHHHHHhc-----CCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEe
Q 043524 14 GKRTLMIGNGA-SVLQELIASS-----NGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIG 87 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~-----~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 87 (314)
+.....+|.|+ +.|+.+.... +.+.+++|.+....... ..+++.+|++++++++|+||+++++
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~iv~~~~ 75 (275)
T cd05046 7 LQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDEN-----------LQSEFRRELDMFRKLSHKNVVRLLG 75 (275)
T ss_pred ceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchH-----------HHHHHHHHHHHHHhcCCcceeeeEE
Confidence 33444578888 7777766433 34578888765433221 1256889999999999999999999
Q ss_pred EEEeCCeeEEEEeecCCCCHHHHHhcCCCCC----CCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecC
Q 043524 88 CCLETPIAILVFEYVQHGTLWDRILGAPQTH----FEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSE 163 (314)
Q Consensus 88 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~ 163 (314)
++.+....|+||||+++|+|.+++....... ...++...+..++.|++.||.||| +++++|+||||+||+++.
T Consensus 76 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~ 152 (275)
T cd05046 76 LCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSS 152 (275)
T ss_pred EECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeC
Confidence 9999999999999999999999987543110 125789999999999999999999 999999999999999999
Q ss_pred CCceEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccch
Q 043524 164 ENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPF 242 (314)
Q Consensus 164 ~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~ 242 (314)
++.++++|||.++..............++..|+|||.+....++.++||||+|+++|+|++ |..||......
T Consensus 153 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~------- 225 (275)
T cd05046 153 QREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE------- 225 (275)
T ss_pred CCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH-------
Confidence 9999999999986543322222334456788999999888788899999999999999998 77788533211
Q ss_pred HHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHH
Q 043524 243 NEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQ 306 (314)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 306 (314)
........ .... .......+..+.+++.+||+.||++|||+.|++..|.+
T Consensus 226 -~~~~~~~~-~~~~------------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 226 -EVLNRLQA-GKLE------------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred -HHHHHHHc-CCcC------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 11111110 0000 00001234568899999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=285.21 Aligned_cols=247 Identities=21% Similarity=0.278 Sum_probs=208.3
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
.+.-...+|+|. ..|..+.+..+|..||+|++.+....... .+.+.+|++++..|.|||||+++.+.+.
T Consensus 57 ~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~----------~~k~~rev~imk~l~HPnIvkl~~v~~t 126 (596)
T KOG0586|consen 57 LYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSK----------RQKLGREVDIMKSLNHPNIVKLFSVIET 126 (596)
T ss_pred ceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHH----------HHHHHHHHHHHHhcCCcceeeeeeeeee
Confidence 344555688888 88889999999999999999887654332 1457899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
...+|+||||+.+|.+++++...+. ........++.|++++++||| ++.|+|||||++|++++.+..+||+|
T Consensus 127 ~~~lylV~eya~~ge~~~yl~~~gr-----~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaD 198 (596)
T KOG0586|consen 127 EATLYLVMEYASGGELFDYLVKHGR-----MKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIAD 198 (596)
T ss_pred cceeEEEEEeccCchhHHHHHhccc-----chhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeec
Confidence 9999999999999999999988753 445888899999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCcccccCCC-CcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhh
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDF-SEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
||++..+.... ...+++|++.|.|||++.+..| ++.+|+||+|+++|-|+.|..||++..
T Consensus 199 fgfS~~~~~~~--~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~----------------- 259 (596)
T KOG0586|consen 199 FGFSTFFDYGL--MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN----------------- 259 (596)
T ss_pred cccceeecccc--cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc-----------------
Confidence 99999886443 4678899999999999999887 588999999999999999999987433
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
+.++-++-+.+....+. ..+.++.++|+++|..+|.+|++..++.+
T Consensus 260 ----lk~Lr~rvl~gk~rIp~--~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 260 ----LKELRPRVLRGKYRIPF--YMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred ----cccccchheeeeecccc--eeechhHHHHHHhhccCccccCCHHHhhh
Confidence 22333333333333333 45677899999999999999999999875
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=272.90 Aligned_cols=265 Identities=20% Similarity=0.305 Sum_probs=194.7
Q ss_pred ccccCch-hHHHHHHH----hcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe-
Q 043524 18 LMIGNGA-SVLQELIA----SSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE- 91 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~----~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~- 91 (314)
..+|+|+ +.|+.+.. ..+++.+|+|.+....... ..+.+.+|+++++.++|+||+++++++..
T Consensus 10 ~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~-----------~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~ 78 (284)
T cd05038 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQ-----------HRSDFEREIEILRTLDHENIVKYKGVCEKP 78 (284)
T ss_pred eeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchH-----------HHHHHHHHHHHHHhCCCCChheEEeeeecC
Confidence 3477777 66666653 3457899999887543321 12678899999999999999999999887
Q ss_pred -CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 92 -TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 92 -~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
+...++++||+++++|.+++.... ..++...+..++.|++.||.||| +++++|+||||+||+++.++.++++
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~ 151 (284)
T cd05038 79 GGRSLRLIMEYLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKIS 151 (284)
T ss_pred CCCceEEEEecCCCCCHHHHHHhCc----cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEc
Confidence 668899999999999999997654 34788899999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCcc--cccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHh
Q 043524 171 DFSLSISIPEGETH--ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKN 248 (314)
Q Consensus 171 dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (314)
|||.+......... ......++..|++||......++.++|+||||+++++|++|..|+...............
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~---- 227 (284)
T cd05038 152 DFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQ---- 227 (284)
T ss_pred ccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccccc----
Confidence 99999776432111 111233456799999998888999999999999999999999988643321100000000
Q ss_pred hhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHH
Q 043524 249 YFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQI 307 (314)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~ 307 (314)
...........+......+.+..++.++.+++.+||+.||++|||+.|+++.|+++
T Consensus 228 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 228 ---GQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred ---ccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 00000000000011111111123446789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=274.44 Aligned_cols=256 Identities=23% Similarity=0.330 Sum_probs=191.3
Q ss_pred cccccccCch-hHHHHHHH-----hcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeE
Q 043524 15 KRTLMIGNGA-SVLQELIA-----SSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGC 88 (314)
Q Consensus 15 ~~~~~~G~g~-~~~~~~~~-----~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 88 (314)
+....+|.|+ +.|+.+.. ..++..+|+|.+........ .+.+.+|+.++..++||||++++++
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~-----------~~~~~~ei~~l~~l~h~~iv~~~~~ 76 (288)
T cd05050 8 EYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM-----------QADFQREAALMAEFDHPNIVKLLGV 76 (288)
T ss_pred eecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHH-----------HHHHHHHHHHHHhcCCCchheEEEE
Confidence 3344578777 66666543 23677899998764432111 1567899999999999999999999
Q ss_pred EEeCCeeEEEEeecCCCCHHHHHhcCCC-----------------CCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCcee
Q 043524 89 CLETPIAILVFEYVQHGTLWDRILGAPQ-----------------THFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVF 151 (314)
Q Consensus 89 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~-----------------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H 151 (314)
+..+...++++||+++|+|.+++..... .....++...++.++.|++.||.||| +++++|
T Consensus 77 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H 153 (288)
T cd05050 77 CAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVH 153 (288)
T ss_pred EcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeec
Confidence 9999999999999999999999864321 11124678888999999999999999 999999
Q ss_pred ccCCCCCeeecCCCceEEcccccceecCCCCcc-cccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCc
Q 043524 152 RDFKTSHILFSEENVVKLFDFSLSISIPEGETH-ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGIL 229 (314)
Q Consensus 152 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~ 229 (314)
+||||+||+++.++.++++|||.+......... .......+..|+|||.+....++.++|||||||++|+|++ |..||
T Consensus 154 ~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~ 233 (288)
T cd05050 154 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPY 233 (288)
T ss_pred ccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999998765332211 1122345677999999988889999999999999999997 77787
Q ss_pred ccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHH
Q 043524 230 DLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQ 306 (314)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 306 (314)
...... +..... ...... +. +...+.++.+|+.+||..||++|||+.|+++.|++
T Consensus 234 ~~~~~~--------~~~~~~-~~~~~~-----------~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 234 YGMAHE--------EVIYYV-RDGNVL-----------SC--PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred CCCCHH--------HHHHHH-hcCCCC-----------CC--CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 532211 111111 111100 00 01234568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=273.98 Aligned_cols=250 Identities=22% Similarity=0.295 Sum_probs=196.4
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.++.....+|.|+ +.++++....++..+|+|.+....... .+.+.+|+.+++.++||||+++++.+.
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~------------~~~~~~e~~~l~~l~hp~i~~~~~~~~ 86 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPK------------KELIINEILVMRENKHPNIVNYLDSYL 86 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchH------------HHHHHHHHHHHhhcCCCCeeehhheee
Confidence 3444555688887 777777777788999999875433221 156889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
.++..|+|+||+++++|.+++... .++...+..++.+++.|+.||| +++++|+||+|+||+++.++.++|+
T Consensus 87 ~~~~~~lv~e~~~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~ 157 (293)
T cd06647 87 VGDELWVVMEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLT 157 (293)
T ss_pred eCCcEEEEEecCCCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEc
Confidence 999999999999999999988653 3678888999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhh
Q 043524 171 DFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 171 dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
|||++........ ......+++.|++||.+....++.++|+||+|+++|++++|..||........... ..
T Consensus 158 dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~--------~~ 228 (293)
T cd06647 158 DFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL--------IA 228 (293)
T ss_pred cCcceeccccccc-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee--------hh
Confidence 9998865543322 22344688899999999888889999999999999999999999965433221000 00
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARR 303 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 303 (314)
.. +..........+..+.+++.+||..+|++||++.+++..
T Consensus 229 ~~------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 229 TN------------GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred cC------------CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 000011111344568899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=281.51 Aligned_cols=262 Identities=16% Similarity=0.213 Sum_probs=188.7
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
.|.....+|.|+ +.|+++.+..+++.+|+|+.... ....|+.++..++||||+++++++..
T Consensus 67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------------------~~~~E~~~l~~l~h~~iv~~~~~~~~ 128 (357)
T PHA03209 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------------------TTLIEAMLLQNVNHPSVIRMKDTLVS 128 (357)
T ss_pred CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------------------ccHHHHHHHHhCCCCCCcChhheEEe
Confidence 355566788888 88888888888899999974321 23468999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
+...++|+|++. ++|.+++.... ..+++..+..++.|++.||.||| +++|+||||||+||+++..+.++|+|
T Consensus 129 ~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~D 200 (357)
T PHA03209 129 GAITCMVLPHYS-SDLYTYLTKRS----RPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGD 200 (357)
T ss_pred CCeeEEEEEccC-CcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEec
Confidence 999999999994 68888886543 45789999999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCC-cccccCcc-ccccchHHHHHhh
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGI-LDLVRDAH-DLVYPFNEYLKNY 249 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p-~~~~~~~~-~~~~~~~~~~~~~ 249 (314)
||.++...... ......||+.|+|||++.+..++.++||||+||++|||+++..+ |+...... .........+...
T Consensus 201 fG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~ 278 (357)
T PHA03209 201 LGAAQFPVVAP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKI 278 (357)
T ss_pred CccccccccCc--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHH
Confidence 99986532221 12345689999999999998999999999999999999985544 43322110 0000000001000
Q ss_pred hc-----cCCcc-----cccChhh------hcc---CCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 250 FE-----DNRFT-----EIVDPII------VQD---LSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 250 ~~-----~~~~~-----~~~~~~~------~~~---~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.. ...+. ......+ ..+ ..+......+..+.+||.+||+.||++||||.|+++
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~ 350 (357)
T PHA03209 279 ISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN 350 (357)
T ss_pred HHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence 00 00000 0000000 000 001111133456778999999999999999999985
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=266.69 Aligned_cols=244 Identities=22% Similarity=0.341 Sum_probs=187.7
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
+.....+|.|+ +.|+.+ ..+++.+|+|.+..... .+.+.+|+.+++.++||||+++++++...
T Consensus 8 ~~~~~~lg~g~~g~v~~~--~~~~~~~~iK~~~~~~~--------------~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (254)
T cd05083 8 LTLGEIIGEGEFGAVLQG--EYTGQKVAVKNIKCDVT--------------AQAFLEETAVMTKLHHKNLVRLLGVILHN 71 (254)
T ss_pred ceeeeeeccCCCCceEec--ccCCCceEEEeecCcch--------------HHHHHHHHHHHHhCCCCCcCeEEEEEcCC
Confidence 33444578877 666654 35788899998754321 15678999999999999999999998654
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~df 172 (314)
..++++||+++++|.+++..... ..++...+..++.|++.|+.||| +.+++|+||||+||+++.++.++|+||
T Consensus 72 -~~~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Df 144 (254)
T cd05083 72 -GLYIVMELMSKGNLVNFLRTRGR---ALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDF 144 (254)
T ss_pred -CcEEEEECCCCCCHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCC
Confidence 47899999999999999976432 34788889999999999999999 999999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhc
Q 043524 173 SLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFE 251 (314)
Q Consensus 173 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (314)
|.+...... ......+..|+|||.+....++.++|+||+|+++|+|++ |+.||...... +..... .
T Consensus 145 g~~~~~~~~----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~-~ 211 (254)
T cd05083 145 GLARVGSMG----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK--------EVKECV-E 211 (254)
T ss_pred ccceecccc----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH--------HHHHHH-h
Confidence 998764322 112334678999999988889999999999999999997 89898643311 111111 1
Q ss_pred cCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHH
Q 043524 252 DNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQ 306 (314)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 306 (314)
.. . ... .....+..+.+++.+||+.+|++|||+.++++.|++
T Consensus 212 ~~-~--------~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 212 KG-Y--------RME----PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CC-C--------CCC----CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 00 0 000 001344668899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=277.15 Aligned_cols=197 Identities=19% Similarity=0.300 Sum_probs=154.5
Q ss_pred cccCch-hHHHHHHHh--cCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe--CC
Q 043524 19 MIGNGA-SVLQELIAS--SNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE--TP 93 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~--~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~ 93 (314)
.+|.|+ +.|+++... .++..+|+|.+..... ...+.+|+++++.++||||+++++++.. +.
T Consensus 8 ~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 73 (317)
T cd07867 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--------------SMSACREIALLRELKHPNVIALQKVFLSHSDR 73 (317)
T ss_pred EeccCCCeeEEEEEecCCCccceEEEEEecCCCC--------------cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCC
Confidence 478887 777777643 3567899998753221 1356789999999999999999999854 56
Q ss_pred eeEEEEeecCCCCHHHHHhcCCC----CCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeee----cCCC
Q 043524 94 IAILVFEYVQHGTLWDRILGAPQ----THFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILF----SEEN 165 (314)
Q Consensus 94 ~~~iv~e~~~~g~L~~~l~~~~~----~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~----~~~~ 165 (314)
..|+++||++ ++|.+.+..... .....++...+..++.|++.||.||| +++|+||||||+||++ +..+
T Consensus 74 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~ 149 (317)
T cd07867 74 KVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERG 149 (317)
T ss_pred eEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCC
Confidence 7899999996 588777753211 11134788889999999999999999 9999999999999999 4567
Q ss_pred ceEEcccccceecCCCCcc--cccccccccccccCcccccC-CCCcccchHHHHHHHHHHHhCCCCccccc
Q 043524 166 VVKLFDFSLSISIPEGETH--ITDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGRGILDLVR 233 (314)
Q Consensus 166 ~~kl~dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~ 233 (314)
.++|+|||+++........ ......+|+.|+|||++.+. .++.++||||+||++|+|++|.+||....
T Consensus 150 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 150 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred cEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 8999999999765433211 12345689999999998764 47899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=276.03 Aligned_cols=267 Identities=19% Similarity=0.264 Sum_probs=190.6
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
.+.....+|.|+ +.|+++.+..+|+.||+|.+........ ...+.+|+++++.++|+||+++++++.+
T Consensus 6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~-----------~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 74 (291)
T cd07844 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-----------PFTAIREASLLKDLKHANIVTLHDIIHT 74 (291)
T ss_pred ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCC-----------chhHHHHHHHHhhCCCcceeeEEEEEec
Confidence 344555688888 8888888888899999998865331110 1346789999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
+...++||||++ ++|.+++.... ..++...+..++.|++.||.||| +++++|+||||+||+++.++.++|+|
T Consensus 75 ~~~~~lv~e~~~-~~L~~~~~~~~----~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~d 146 (291)
T cd07844 75 KKTLTLVFEYLD-TDLKQYMDDCG----GGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLAD 146 (291)
T ss_pred CCeEEEEEecCC-CCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECc
Confidence 999999999997 59999887544 35788899999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccc-CCCCcccchHHHHHHHHHHHhCCCCcccccCccccc--------cch
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTT-CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLV--------YPF 242 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~--------~~~ 242 (314)
||.++....... ......++..|+|||++.+ ..++.++||||+|+++|+|++|..||.......+.. .+.
T Consensus 147 fg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (291)
T cd07844 147 FGLARAKSVPSK-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPT 225 (291)
T ss_pred cccccccCCCCc-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCC
Confidence 999865432211 1122346788999998875 447899999999999999999999996443211000 000
Q ss_pred HHHHHhhhccCCccc-----ccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 243 NEYLKNYFEDNRFTE-----IVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 243 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.+............. .....+....... .....+.+++.+||+.||++|||+.|++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 226 EETWPGVSSNPEFKPYSFPFYPPRPLINHAPRL---DRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhhhhhhhhccccccccccccCChhHHHhCcCC---CCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000000000000000 0000000000000 11256789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=271.91 Aligned_cols=262 Identities=17% Similarity=0.253 Sum_probs=195.3
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
|.....+|.|+ +.|+.+....+|+.+|+|.+.......... ........+.+.+|+.++..++||||+++++++..+
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~--~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 80 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRH--DSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE 80 (272)
T ss_pred eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhccc--chHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC
Confidence 34455688877 788888888889999999886432211110 000011235678899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~df 172 (314)
+..++|+||+++++|.+.+... ..++...+..++.|++.||.||| +++++|+||+|+||+++.++.++++||
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~ 152 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDF 152 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeec
Confidence 9999999999999999998765 24778888899999999999999 999999999999999999999999999
Q ss_pred ccceecCCCCcc-cccccccccccccCcccccCC--CCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhh
Q 043524 173 SLSISIPEGETH-ITDTVMGTYGHLAPQYVTTCD--FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNY 249 (314)
Q Consensus 173 g~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (314)
|.++........ ......++..|+|||.+.... ++.++|+||+|++++++++|..||....... . ....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-------~-~~~~ 224 (272)
T cd06629 153 GISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA-------A-MFKL 224 (272)
T ss_pred cccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH-------H-HHHh
Confidence 998765332111 123346788999999887654 7899999999999999999999985322111 0 0000
Q ss_pred hccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 250 FEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
... .....+... .....+..+.+++.+||..||++|||+.++++
T Consensus 225 ~~~-~~~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 225 GNK-RSAPPIPPD--------VSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred hcc-ccCCcCCcc--------ccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 000 000001110 11134567899999999999999999999885
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=269.28 Aligned_cols=244 Identities=22% Similarity=0.368 Sum_probs=188.4
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeE
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAI 96 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (314)
..+|.|+ +.|+++... .++.+|+|.+...... .+.+.+|++++++++||||+++++++......+
T Consensus 10 ~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~-------------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05112 10 QEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS-------------EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPIC 75 (256)
T ss_pred eeecCcccceEEEEEEe-CCCeEEEEECCCCCCC-------------HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceE
Confidence 4477777 667666443 4678999987643221 146789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
+++||+++++|.+++.... ..++...+..++.+++.|+.+|| +.+++|+||||+||+++.++.++++|||.++
T Consensus 76 ~v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 148 (256)
T cd05112 76 LVFEFMEHGCLSDYLRAQR----GKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTR 148 (256)
T ss_pred EEEEcCCCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCccee
Confidence 9999999999999887543 34778889999999999999999 9999999999999999999999999999987
Q ss_pred ecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhccCCc
Q 043524 177 SIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFEDNRF 255 (314)
Q Consensus 177 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (314)
..............++..|+|||.+.+..++.++|+||+|+++|+|++ |..||...... ..........
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~-- 218 (256)
T cd05112 149 FVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS--------EVVETINAGF-- 218 (256)
T ss_pred ecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH--------HHHHHHhCCC--
Confidence 654332211223345678999999988889999999999999999998 89998532211 1111111000
Q ss_pred ccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHH
Q 043524 256 TEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRL 304 (314)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 304 (314)
....+ ...+..+.+|+.+||..+|++|||+.++++.|
T Consensus 219 -~~~~~-----------~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 219 -RLYKP-----------RLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred -CCCCC-----------CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 00000 02345688999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=284.34 Aligned_cols=262 Identities=18% Similarity=0.162 Sum_probs=189.2
Q ss_pred CcccccccCch-hHHHHHHH--hcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 14 GKRTLMIGNGA-SVLQELIA--SSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~--~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
|.....+|.|+ +.|+.+.. ..+++.+|+|.+.... .+.+|+++++.++||||+++++++.
T Consensus 94 y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-----------------~~~~E~~il~~l~h~~iv~~~~~~~ 156 (392)
T PHA03207 94 YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-----------------TPGREIDILKTISHRAIINLIHAYR 156 (392)
T ss_pred eEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-----------------cHHHHHHHHHhcCCCCccceeeeEe
Confidence 44555688888 66665543 3455788998765321 2357999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
.....|++||++. ++|.+++... ..++...++.++.|++.||.||| +++|+||||||+||+++..+.++|+
T Consensus 157 ~~~~~~lv~e~~~-~~l~~~l~~~-----~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~ 227 (392)
T PHA03207 157 WKSTVCMVMPKYK-CDLFTYVDRS-----GPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLG 227 (392)
T ss_pred eCCEEEEEehhcC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEc
Confidence 9999999999995 6898888433 35889999999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCcc-cccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhh
Q 043524 171 DFSLSISIPEGETH-ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNY 249 (314)
Q Consensus 171 dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (314)
|||++......... ......||+.|+|||++....++.++||||+||++|+|++|+.||....... ....+....+..
T Consensus 228 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~l~~i~~~~ 306 (392)
T PHA03207 228 DFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS-SSSQLRSIIRCM 306 (392)
T ss_pred cCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCC-cHHHHHHHHHHh
Confidence 99998765443221 1234579999999999998889999999999999999999999996544321 000111111100
Q ss_pred hcc-CCcc-----cc------cChhhhccCCch---hHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 250 FED-NRFT-----EI------VDPIIVQDLSCT---EKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 250 ~~~-~~~~-----~~------~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
-.. .... .+ .......+...+ .....+.++.++|.+||..||++|||+.|++.
T Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 307 QVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred ccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 000 0000 00 000000000000 01123456889999999999999999999986
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=278.10 Aligned_cols=259 Identities=20% Similarity=0.314 Sum_probs=193.0
Q ss_pred cccccccCch-hHHHHHHHhc-------CCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeee
Q 043524 15 KRTLMIGNGA-SVLQELIASS-------NGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKL 85 (314)
Q Consensus 15 ~~~~~~G~g~-~~~~~~~~~~-------~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~ 85 (314)
.-...+|+|+ +.|+.+.+.. .+..+|+|.+........ .+++.+|++++.++ +||||+++
T Consensus 15 ~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~~E~~~l~~l~~h~~iv~~ 83 (334)
T cd05100 15 TLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKD-----------LSDLVSEMEMMKMIGKHKNIINL 83 (334)
T ss_pred eecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHH-----------HHHHHHHHHHHHhhcCCCCeeee
Confidence 3344688887 6676664322 223688997763221111 15678999999999 79999999
Q ss_pred EeEEEeCCeeEEEEeecCCCCHHHHHhcCCCC-----------CCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccC
Q 043524 86 IGCCLETPIAILVFEYVQHGTLWDRILGAPQT-----------HFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDF 154 (314)
Q Consensus 86 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dl 154 (314)
++++..++..++++||+++|+|.+++...... ....++...+..++.|++.||.||| +++++|+||
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dl 160 (334)
T cd05100 84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDL 160 (334)
T ss_pred eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeecccc
Confidence 99999999999999999999999998753210 1134778888999999999999999 999999999
Q ss_pred CCCCeeecCCCceEEcccccceecCCCCccc-ccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccc
Q 043524 155 KTSHILFSEENVVKLFDFSLSISIPEGETHI-TDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLV 232 (314)
Q Consensus 155 k~~nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~ 232 (314)
||+||+++.++.++|+|||.++......... .....++..|+|||++....++.++||||||+++|+|++ |..||...
T Consensus 161 kp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 240 (334)
T cd05100 161 AARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 240 (334)
T ss_pred ccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 9999999999999999999987654332111 112234567999999988889999999999999999998 88887543
Q ss_pred cCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHh
Q 043524 233 RDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICC 309 (314)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 309 (314)
.. .+........ .. ...+...+..+.+++.+||+.+|++|||+.|+++.|+++..
T Consensus 241 ~~--------~~~~~~~~~~-~~-------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 241 PV--------EELFKLLKEG-HR-------------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred CH--------HHHHHHHHcC-CC-------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 21 1111111110 00 00011334568899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=270.52 Aligned_cols=245 Identities=21% Similarity=0.306 Sum_probs=192.5
Q ss_pred ccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeEEE
Q 043524 20 IGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILV 98 (314)
Q Consensus 20 ~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~iv 98 (314)
+|.|+ +.++.+....+++.+|+|++......... ..+.+.+|+++++.++||||+++++.+.+++..+++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 71 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETG---------QQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYML 71 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhh---------HHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEE
Confidence 46666 77888888888999999998765433211 115688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccceec
Q 043524 99 FEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISI 178 (314)
Q Consensus 99 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~ 178 (314)
+||+++++|.+++.... .++...+..++.|++.||.||| +++++|+||+|+||+++.++.++++|||.++..
T Consensus 72 ~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~ 143 (262)
T cd05572 72 MEYCLGGELWTILRDRG-----LFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL 143 (262)
T ss_pred EecCCCCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCccccc
Confidence 99999999999987642 4788889999999999999999 999999999999999999999999999999776
Q ss_pred CCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcccc
Q 043524 179 PEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEI 258 (314)
Q Consensus 179 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (314)
.... ......++..|++||.+....++.++|+||+|+++|+|++|..||....... ..........
T Consensus 144 ~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~------ 209 (262)
T cd05572 144 KSGQ--KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP------MEIYNDILKG------ 209 (262)
T ss_pred Cccc--ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH------HHHHHHHhcc------
Confidence 4432 1234467889999999888889999999999999999999999996543211 1111111100
Q ss_pred cChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCC-----HHHHHH
Q 043524 259 VDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPT-----MVDVAR 302 (314)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps-----~~ell~ 302 (314)
......+...+..+.+++.+||..||++||+ +.|+++
T Consensus 210 -------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 210 -------NGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred -------CCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 0000111122567899999999999999999 777765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=272.13 Aligned_cols=247 Identities=23% Similarity=0.308 Sum_probs=193.7
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeEE
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAIL 97 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i 97 (314)
.+|.|+ +.++.+....+++.+|+|.+....... ..+++.+|+++++.++||||+++++.+..++..++
T Consensus 8 ~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-----------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 76 (265)
T cd06605 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEA-----------IQKQILRELDILHKCNSPYIVGFYGAFYNNGDISI 76 (265)
T ss_pred HhcCCCCeEEEEEEEcCCCcEEEEEEEecccChH-----------HHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEE
Confidence 467776 778888888889999999876542211 12568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCC-CCceeccCCCCCeeecCCCceEEcccccce
Q 043524 98 VFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFP-RPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 98 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~-~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
++||+++++|.+++.... .+++...+..++.|++.|+.|+| + .+++|+||+|+||+++.++.++|+|||.+.
T Consensus 77 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~ 149 (265)
T cd06605 77 CMEYMDGGSLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSG 149 (265)
T ss_pred EEEecCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccch
Confidence 999999999999987653 35788888999999999999999 8 999999999999999999999999999986
Q ss_pred ecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcc
Q 043524 177 SIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFT 256 (314)
Q Consensus 177 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (314)
...... .....++..|+|||.+.+..++.++|+||+|+++++|++|..||........ ..........
T Consensus 150 ~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~------ 217 (265)
T cd06605 150 QLVNSL---AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD---GIFELLQYIV------ 217 (265)
T ss_pred hhHHHH---hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc---cHHHHHHHHh------
Confidence 553221 1226688899999999888899999999999999999999999864432110 0011111111
Q ss_pred cccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 257 EIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
............+.++.++|..||..||++|||+.+++.
T Consensus 218 -------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 218 -------NEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred -------cCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 111000111125667899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=271.20 Aligned_cols=247 Identities=19% Similarity=0.288 Sum_probs=191.6
Q ss_pred ccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeEEE
Q 043524 20 IGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILV 98 (314)
Q Consensus 20 ~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~iv 98 (314)
+|.|+ +.|+.+....+|+.+|+|.+.......... .+.+.+|+++++.++||||+++.+++...+..|+|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~---------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 71 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKG---------EQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLV 71 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhh---------hHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEE
Confidence 46666 778888788899999999987654432211 14567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccceec
Q 043524 99 FEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISI 178 (314)
Q Consensus 99 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~ 178 (314)
+||+++++|.+.+..... ..++...+..++.|++.||.||| +++++|+||+|+||+++.++.++++|||.+...
T Consensus 72 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~ 145 (277)
T cd05577 72 MTLMNGGDLKYHIYNVGE---PGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVEL 145 (277)
T ss_pred EecCCCCcHHHHHHHcCc---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhh
Confidence 999999999999876542 35788899999999999999999 999999999999999999999999999998765
Q ss_pred CCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcccc
Q 043524 179 PEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEI 258 (314)
Q Consensus 179 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (314)
.... ......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||........ .......
T Consensus 146 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~---------- 209 (277)
T cd05577 146 KGGK--KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE----KEELKRR---------- 209 (277)
T ss_pred ccCC--ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc----HHHHHhc----------
Confidence 3321 12344678899999999888899999999999999999999999964432110 0000000
Q ss_pred cChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCC-----CHHHHHH
Q 043524 259 VDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRP-----TMVDVAR 302 (314)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 302 (314)
..... ...+...+..+.+++.+||+.||++|| ++.+++.
T Consensus 210 ---~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 210 ---TLEMA--VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ---ccccc--ccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 00000 001113356789999999999999999 6666764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=277.23 Aligned_cols=262 Identities=18% Similarity=0.210 Sum_probs=189.0
Q ss_pred hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeEEEEeecCC
Q 043524 25 SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQH 104 (314)
Q Consensus 25 ~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~iv~e~~~~ 104 (314)
+.++......+|+.+|+|.+........ ..+.+.+|+++++.++|+||+++++++......++++||+++
T Consensus 14 ~~v~~~~~~~~~~~~avK~~~~~~~~~~----------~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 14 MIVHLAKHKPTNTLVAVKKINLDSCSKE----------DLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred ceEEEEEecCCCCEEEEEEEeccccchh----------HHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 3444555566899999999875421111 115688999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccceecCCCCc-
Q 043524 105 GTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGET- 183 (314)
Q Consensus 105 g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~- 183 (314)
|+|.+++..... ..++...+..++.|++.||.||| +++|+|+||||+||+++.++.++++|||.+........
T Consensus 84 ~~l~~~l~~~~~---~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~ 157 (314)
T cd08216 84 GSCEDLLKTHFP---EGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR 157 (314)
T ss_pred CCHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccc
Confidence 999999876432 24778888999999999999999 99999999999999999999999999998865532211
Q ss_pred -----ccccccccccccccCcccccC--CCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhcc----
Q 043524 184 -----HITDTVMGTYGHLAPQYVTTC--DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFED---- 252 (314)
Q Consensus 184 -----~~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 252 (314)
.......++..|+|||++... .++.++|+||+|+++++|++|..||..............+........
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (314)
T cd08216 158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYP 237 (314)
T ss_pred ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchh
Confidence 012234567789999998764 478999999999999999999999975432211000000000000000
Q ss_pred ---CCccc----ccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 253 ---NRFTE----IVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 253 ---~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
..... ..++..............+.++.+|+..||..||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 00000 111111122223333456678999999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=272.96 Aligned_cols=264 Identities=19% Similarity=0.247 Sum_probs=194.0
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCee
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIA 95 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (314)
...+|.|+ +.++++....+|+.+|+|++........ ..+.+.+|+.+++.++||||+++++++..+...
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~----------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 74 (286)
T cd07832 5 LGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGG----------IPNQALREIKALQACQHPYVVKLLDVFPHGSGF 74 (286)
T ss_pred EeecccCCCcEEEEEEECCCCceEEEEEEEcccccch----------hhHHHHHHHHHHHhCCCCCCcceeeEEecCCee
Confidence 34578777 7788888888899999998875432111 125688999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
++|+||+ +++|.+.+.... .+++...+..++.|++.||.||| +.+++|+||+|+||+++.++.++++|||.+
T Consensus 75 ~~v~e~~-~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~ 146 (286)
T cd07832 75 VLVMEYM-PSDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLA 146 (286)
T ss_pred EEEeccc-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeec
Confidence 9999999 999999887644 45888999999999999999999 999999999999999999999999999998
Q ss_pred eecCCCCcccccccccccccccCcccccCC-CCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhh-----
Q 043524 176 ISIPEGETHITDTVMGTYGHLAPQYVTTCD-FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNY----- 249 (314)
Q Consensus 176 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~----- 249 (314)
...............++..|+|||.+.... ++.++||||+|+++++|++|.+||........ +.......
T Consensus 147 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~----~~~~~~~~~~~~~ 222 (286)
T cd07832 147 RLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ----LAIVFRTLGTPNE 222 (286)
T ss_pred ccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH----HHHHHHHcCCCCh
Confidence 766443321123456889999999886544 68999999999999999999888754332110 00000000
Q ss_pred ------hccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 250 ------FEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 250 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.....+..+..+..............+..+.+|+..||..||++|||+++++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 223 ETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred HHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00000000000000000000000123467899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=306.27 Aligned_cols=256 Identities=19% Similarity=0.265 Sum_probs=192.5
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
..|.....+|.|+ +.||++.+..++..+|+|++........ ....+..|+.++..|+|||||+++++|.
T Consensus 13 ~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~----------~~~~~~~EI~IL~~L~HPNIVrl~d~f~ 82 (1021)
T PTZ00266 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKER----------EKSQLVIEVNVMRELKHKNIVRYIDRFL 82 (1021)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHH----------HHHHHHHHHHHHHHcCCCCcCeEEEEEE
Confidence 4455556688888 8899998889999999999875432211 1156889999999999999999999986
Q ss_pred e--CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCC----CCCceeccCCCCCeeecC-
Q 043524 91 E--TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGF----PRPIVFRDFKTSHILFSE- 163 (314)
Q Consensus 91 ~--~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~----~~~i~H~dlk~~nil~~~- 163 (314)
+ ...+||||||+++|+|.+.+..... ....++...++.++.||+.||.|||... .++|+|+||||+|||++.
T Consensus 83 de~~~~lyIVMEY~~gGSL~~lL~k~~~-~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~ 161 (1021)
T PTZ00266 83 NKANQKLYILMEFCDAGDLSRNIQKCYK-MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTG 161 (1021)
T ss_pred ecCCCEEEEEEeCCCCCcHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecC
Confidence 5 4568999999999999998865321 1135889999999999999999999311 145999999999999964
Q ss_pred ----------------CCceEEcccccceecCCCCcccccccccccccccCcccccC--CCCcccchHHHHHHHHHHHhC
Q 043524 164 ----------------ENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTC--DFSEKLDVYSFGAFLSELLTG 225 (314)
Q Consensus 164 ----------------~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g 225 (314)
...++|+|||+++...... ......||+.|+|||++... .++.++|||||||++|+|++|
T Consensus 162 ~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTG 239 (1021)
T PTZ00266 162 IRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239 (1021)
T ss_pred ccccccccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHC
Confidence 2348999999997654322 13345789999999998653 478999999999999999999
Q ss_pred CCCcccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 226 RGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 226 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
..||...... .......... + ..+. ...+.++.+||..||..+|.+|||+.|++.
T Consensus 240 k~PF~~~~~~-------~qli~~lk~~-------------p-~lpi-~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 240 KTPFHKANNF-------SQLISELKRG-------------P-DLPI-KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCCCCcCCcH-------HHHHHHHhcC-------------C-CCCc-CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 9999643221 1111111100 0 0000 123456889999999999999999999984
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=311.08 Aligned_cols=261 Identities=25% Similarity=0.351 Sum_probs=202.6
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCee
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIA 95 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (314)
...+|.|+ +.||++....+|..||+|.+..... ....|++.+++++|||||++++++.++...
T Consensus 695 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~ 758 (968)
T PLN00113 695 ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----------------IPSSEIADMGKLQHPNIVKLIGLCRSEKGA 758 (968)
T ss_pred ccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----------------ccHHHHHHHhhCCCCCcceEEEEEEcCCCC
Confidence 34688888 8888888888999999997753211 113568889999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
|+||||+++|+|.+++. .+++..+..++.|++.|++|||..++.+|+|||+||+||+++.++..++. ||..
T Consensus 759 ~lv~Ey~~~g~L~~~l~--------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~ 829 (968)
T PLN00113 759 YLIHEYIEGKNLSEVLR--------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLP 829 (968)
T ss_pred EEEEeCCCCCcHHHHHh--------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccc
Confidence 99999999999999984 26788899999999999999996556799999999999999988877765 5554
Q ss_pred eecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCc
Q 043524 176 ISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRF 255 (314)
Q Consensus 176 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (314)
..... .....+|..|+|||++.+..++.++|||||||++|||++|+.||+...... .....|.+........
T Consensus 830 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~ 901 (968)
T PLN00113 830 GLLCT-----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVH---GSIVEWARYCYSDCHL 901 (968)
T ss_pred ccccc-----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCC---CcHHHHHHHhcCccch
Confidence 33211 123367899999999998889999999999999999999999996433222 2334444444433344
Q ss_pred ccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhcc
Q 043524 256 TEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSLS 312 (314)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~ 312 (314)
...+++.+....... .....++.+++.+||+.||++|||+.|+++.|+++.+..+
T Consensus 902 ~~~~~~~~~~~~~~~--~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~ 956 (968)
T PLN00113 902 DMWIDPSIRGDVSVN--QNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956 (968)
T ss_pred hheeCccccCCCCcc--HHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence 445555543332222 2445678899999999999999999999999999977544
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=277.98 Aligned_cols=244 Identities=19% Similarity=0.330 Sum_probs=191.9
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCee
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIA 95 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (314)
...+|.|+ +.++.+....+|+.+|+|.+....... .+.+.+|+.++..++||||+++++.+..++..
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~------------~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~ 93 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR------------RELLFNEVVIMRDYQHQNVVEMYKSYLVGEEL 93 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccch------------HHHHHHHHHHHHhCCCCchhhhhhheeeCCeE
Confidence 34578887 777777777889999999885433211 15678999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
|+++||+++++|...+.. ..++...+..++.|++.||.||| +++++|+||+|+||+++.++.++|+|||++
T Consensus 94 ~iv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~ 164 (297)
T cd06659 94 WVLMEFLQGGALTDIVSQ------TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFC 164 (297)
T ss_pred EEEEecCCCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhH
Confidence 999999999999887754 23678889999999999999999 999999999999999999999999999998
Q ss_pred eecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCc
Q 043524 176 ISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRF 255 (314)
Q Consensus 176 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (314)
........ ......++..|+|||++.+..++.++|+||+|+++|+|++|..||....... ..... ....
T Consensus 165 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--------~~~~~-~~~~- 233 (297)
T cd06659 165 AQISKDVP-KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--------AMKRL-RDSP- 233 (297)
T ss_pred hhcccccc-cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHH-hccC-
Confidence 65533221 2334568899999999988889999999999999999999999986332111 01110 0000
Q ss_pred ccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 256 TEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.+.. ......+..+.+++.+||+.||++|||+.++++
T Consensus 234 ----~~~~------~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 234 ----PPKL------KNAHKISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred ----CCCc------cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 0000 000123456789999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=278.09 Aligned_cols=251 Identities=20% Similarity=0.297 Sum_probs=195.1
Q ss_pred ccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCe
Q 043524 16 RTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPI 94 (314)
Q Consensus 16 ~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 94 (314)
....+|.|+ +.|+.+....+|+.+|+|.+......... ..+.+.+|++++..++|+||+++++.+.++..
T Consensus 5 ~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 75 (316)
T cd05574 5 KIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRN---------KVKRVLTEQEILATLDHPFLPTLYASFQTETY 75 (316)
T ss_pred EeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHH---------HHHHHHHHHHHHHhCCCCCchhheeeeecCCE
Confidence 334578777 78888888888999999998765433211 12568899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccc
Q 043524 95 AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL 174 (314)
Q Consensus 95 ~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~ 174 (314)
.|++|||+.+++|.+++..... ..++......++.|++.||.||| +.+++|+||||+||+++.++.++|+|||+
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~ 149 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQPG---KCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDL 149 (316)
T ss_pred EEEEEEecCCCCHHHHHHhCCC---CccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecch
Confidence 9999999999999998875432 35788889999999999999999 99999999999999999999999999999
Q ss_pred ceecCCCCc----------------------------ccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCC
Q 043524 175 SISIPEGET----------------------------HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226 (314)
Q Consensus 175 ~~~~~~~~~----------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~ 226 (314)
+........ .......|+..|+|||++.+..++.++||||+|+++|+|++|.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~ 229 (316)
T cd05574 150 SKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229 (316)
T ss_pred hhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCC
Confidence 865422110 0112346788999999999888999999999999999999999
Q ss_pred CCcccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCC----HHHHHH
Q 043524 227 GILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPT----MVDVAR 302 (314)
Q Consensus 227 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps----~~ell~ 302 (314)
.||....... ...... + .....+.....+..+.+++.+||..||++||| +.|++.
T Consensus 230 ~pf~~~~~~~--------~~~~~~---------~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 230 TPFKGSNRDE--------TFSNIL---------K----KEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred CCCCCCchHH--------HHHHHh---------c----CCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 9986433211 000000 0 00011111124567899999999999999999 777765
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=271.63 Aligned_cols=244 Identities=19% Similarity=0.271 Sum_probs=187.4
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeEEEeC---
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGCCLET--- 92 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--- 92 (314)
..+|.|+ +.|+.+....+++.+|+|.+...... ...+.+|+.++..+ +|+||+++.+++...
T Consensus 12 ~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~-------------~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (272)
T cd06637 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-------------EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 78 (272)
T ss_pred HheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc-------------HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence 3478777 77888888888999999987643211 14567899999998 699999999998753
Q ss_pred ---CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEE
Q 043524 93 ---PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKL 169 (314)
Q Consensus 93 ---~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl 169 (314)
...|+++||+++++|.+++..... ..++...+..++.|++.|+.||| +++|+|+||+|+||+++.++.++|
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~---~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l 152 (272)
T cd06637 79 GMDDQLWLVMEFCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKL 152 (272)
T ss_pred CCCcEEEEEEEcCCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEE
Confidence 468999999999999999876432 35788889999999999999999 999999999999999999999999
Q ss_pred cccccceecCCCCcccccccccccccccCcccc-----cCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHH
Q 043524 170 FDFSLSISIPEGETHITDTVMGTYGHLAPQYVT-----TCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNE 244 (314)
Q Consensus 170 ~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 244 (314)
+|||++....... .......|+..|+|||++. ...++.++|+||+||++|+|++|..||....... .
T Consensus 153 ~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-------~ 224 (272)
T cd06637 153 VDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-------A 224 (272)
T ss_pred ccCCCceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-------H
Confidence 9999987653322 1234457899999999886 3357889999999999999999999986432111 1
Q ss_pred HHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 245 YLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
... ... ..... ......+..+.+|+.+||..||++|||+.++++
T Consensus 225 ~~~-~~~-~~~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 225 LFL-IPR-NPAPR------------LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HHH-Hhc-CCCCC------------CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 000 000 00000 000123456899999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=272.93 Aligned_cols=243 Identities=21% Similarity=0.308 Sum_probs=194.0
Q ss_pred ccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCe
Q 043524 16 RTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPI 94 (314)
Q Consensus 16 ~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 94 (314)
....+|.|+ +.++.+....+++.+|+|.+.......... .+.+.+|+++++.++||||+++++++..++.
T Consensus 5 ~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 75 (290)
T cd05580 5 FIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ---------VEHVLNEKRILQSIRHPFLVNLYGSFQDDSN 75 (290)
T ss_pred EEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhH---------HHHHHHHHHHHHhCCCCCccceeeEEEcCCe
Confidence 345578777 788888888889999999987655432211 1567899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccc
Q 043524 95 AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL 174 (314)
Q Consensus 95 ~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~ 174 (314)
.|+||||+++++|.+++... ..++...+..++.|++.||.||| +++++|+||+|+||+++.++.++|+|||+
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~ 147 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKS-----GRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGF 147 (290)
T ss_pred EEEEEecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCC
Confidence 99999999999999998765 34788899999999999999999 99999999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCC
Q 043524 175 SISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNR 254 (314)
Q Consensus 175 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (314)
++..... .....+++.|+|||.+....++.++|+||+|+++|+|++|..||...... ........
T Consensus 148 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~--- 212 (290)
T cd05580 148 AKRVKGR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI--------QIYEKILE--- 212 (290)
T ss_pred ccccCCC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHhc---
Confidence 8765433 23446889999999998888889999999999999999999998643311 00111110
Q ss_pred cccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCC-----CHHHHHH
Q 043524 255 FTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRP-----TMVDVAR 302 (314)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 302 (314)
+.... +...+..+.+++.+||..||++|| ++.|+++
T Consensus 213 ----------~~~~~--~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 213 ----------GKVRF--PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ----------CCccC--CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 00000 112345678999999999999999 6777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=276.59 Aligned_cols=265 Identities=15% Similarity=0.173 Sum_probs=189.6
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCee
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIA 95 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (314)
...+|.|+ +.++.+.+..+|+.+|+|.+........ ....+.+|+.+++.++||||+++++++.+....
T Consensus 5 ~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~----------~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 74 (284)
T cd07839 5 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG----------VPSSALREICLLKELKHKNIVRLYDVLHSDKKL 74 (284)
T ss_pred EEEecccCCeEEEEEEECCCCcEEEEEEeeccccccc----------CccchhHHHHHHHhcCCCCeeeHHHHhccCCce
Confidence 34477777 7888888888999999998865321110 114567899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
|+++||++ ++|.+.+.... ..++...+..++.|++.||.||| +++++|+||||+||+++.++.++|+|||.+
T Consensus 75 ~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~ 146 (284)
T cd07839 75 TLVFEYCD-QDLKKYFDSCN----GDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLA 146 (284)
T ss_pred EEEEecCC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchh
Confidence 99999996 58888776543 35789999999999999999999 999999999999999999999999999998
Q ss_pred eecCCCCcccccccccccccccCcccccCC-CCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHH--------H
Q 043524 176 ISIPEGETHITDTVMGTYGHLAPQYVTTCD-FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEY--------L 246 (314)
Q Consensus 176 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~--------~ 246 (314)
+....... ......++..|+|||.+.+.. ++.++||||+|+++|+|++|..|+....+........... .
T Consensus 147 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07839 147 RAFGIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESW 225 (284)
T ss_pred hccCCCCC-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHh
Confidence 76533221 122345788999999887644 7899999999999999999998864322211000000000 0
Q ss_pred HhhhccCCcccccChhhhccCC-chhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 247 KNYFEDNRFTEIVDPIIVQDLS-CTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
........... .. ....... .......+.++.+|+.+||+.||.+|||+.++++
T Consensus 226 ~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 226 PGVSKLPDYKP-YP-MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred HHhhhcccccc-cC-CCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000000000 00 0000000 0001134567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=271.49 Aligned_cols=253 Identities=21% Similarity=0.257 Sum_probs=189.8
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeEEE
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGCCL 90 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 90 (314)
++.....+|.|+ +.|+++.+..+|+.+|+|++...... .+.+.+|+.+++.+ +||||+++++++.
T Consensus 19 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-------------~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 19 TWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI-------------DEEIEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred ceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch-------------HHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence 444455688887 78888888889999999987543211 14567899999999 6999999999884
Q ss_pred -----eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCC
Q 043524 91 -----ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN 165 (314)
Q Consensus 91 -----~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~ 165 (314)
.++..++||||+++++|.+.+...... -..++...+..++.|++.||.||| +++++|+||||+||+++.++
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~ 161 (286)
T cd06638 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKR-GERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEG 161 (286)
T ss_pred ecccCCCCeEEEEEeecCCCCHHHHHHHhhcc-CccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCC
Confidence 356789999999999999887532111 134778888999999999999999 99999999999999999999
Q ss_pred ceEEcccccceecCCCCcccccccccccccccCccccc-----CCCCcccchHHHHHHHHHHHhCCCCcccccCcccccc
Q 043524 166 VVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTT-----CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVY 240 (314)
Q Consensus 166 ~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~ 240 (314)
.++++|||+++....... ......|++.|+|||++.. ..++.++|+||+||++|+|++|..||.......
T Consensus 162 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~---- 236 (286)
T cd06638 162 GVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR---- 236 (286)
T ss_pred CEEEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH----
Confidence 999999999876643321 2234468999999998753 347889999999999999999999986432211
Q ss_pred chHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 043524 241 PFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARR 303 (314)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 303 (314)
... ... . ...+.. ..+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 237 ---~~~-~~~-~-----~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 237 ---ALF-KIP-R-----NPPPTL------HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred ---HHh-hcc-c-----cCCCcc------cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 000 000 0 000000 0011234568899999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=268.59 Aligned_cols=255 Identities=18% Similarity=0.291 Sum_probs=193.9
Q ss_pred ccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCe
Q 043524 16 RTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPI 94 (314)
Q Consensus 16 ~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 94 (314)
....+|+|+ +.++.+....+|+.+|+|++........ ......+.+.+|+++++.++|+||+++++++.+++.
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 77 (268)
T cd06630 4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSS------EQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSH 77 (268)
T ss_pred ccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCch------hHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCe
Confidence 344578887 7788777778899999998864321000 000022678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCC-ceEEcccc
Q 043524 95 AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN-VVKLFDFS 173 (314)
Q Consensus 95 ~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~-~~kl~dfg 173 (314)
.++|+||+++++|.+++... .+++...+..++.|++.||.||| +++++|+||+|+||+++.++ .++|+|||
T Consensus 78 ~~~v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg 149 (268)
T cd06630 78 FNLFVEWMAGGSVSHLLSKY-----GAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFG 149 (268)
T ss_pred EEEEEeccCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEcccc
Confidence 99999999999999998754 35788899999999999999999 99999999999999998765 69999999
Q ss_pred cceecCCCCcc---cccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhh
Q 043524 174 LSISIPEGETH---ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 174 ~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
.+......... ......++..|+|||.+....++.++|+||+|+++++|++|..||....... .... .....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~----~~~~-~~~~~ 224 (268)
T cd06630 150 AAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN----HLAL-IFKIA 224 (268)
T ss_pred cccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc----hHHH-HHHHh
Confidence 98766433111 1223467889999999988888999999999999999999999985332211 0000 00000
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
........+...+.++.+++.+||..||++|||+.++++
T Consensus 225 -------------~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 225 -------------SATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred -------------ccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 000011111245567889999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=266.25 Aligned_cols=247 Identities=25% Similarity=0.371 Sum_probs=191.8
Q ss_pred cccCch-hHHHHHHHhcCC----cccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCC
Q 043524 19 MIGNGA-SVLQELIASSNG----KYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETP 93 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g----~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (314)
.+|.|+ +.++.+.....+ ..+|+|.+........ .+.+.+|+.++..++|+||+++++++.+.+
T Consensus 6 ~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 74 (258)
T smart00219 6 KLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQ-----------IEEFLREARIMRKLDHPNIVKLLGVCTEEE 74 (258)
T ss_pred eeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHH-----------HHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 467777 777777776655 7899998764432111 156789999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccc
Q 043524 94 IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFS 173 (314)
Q Consensus 94 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg 173 (314)
..+++|||+++++|.+.+..... ..++...+..++.|++.||++|| +++++|+||+|+||+++.++.++++|||
T Consensus 75 ~~~~i~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg 148 (258)
T smart00219 75 PLMIVMEYMEGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFG 148 (258)
T ss_pred eeEEEEeccCCCCHHHHHHhhhh---ccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccC
Confidence 99999999999999999876431 11789999999999999999999 9999999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhcc
Q 043524 174 LSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFED 252 (314)
Q Consensus 174 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (314)
.++..............++..|+|||.+....++.++|+||+|+++++|++ |..||..... ..........
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--------~~~~~~~~~~ 220 (258)
T smart00219 149 LSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--------EEVLEYLKKG 220 (258)
T ss_pred CceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHhcC
Confidence 997765442222222346789999999977789999999999999999998 7888764221 1111111100
Q ss_pred CCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHH
Q 043524 253 NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRL 304 (314)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 304 (314)
.. .......+.++.+++.+||..||++|||+.|+++.|
T Consensus 221 -~~-------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 221 -YR-------------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -CC-------------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 00 000112456789999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=263.59 Aligned_cols=236 Identities=22% Similarity=0.383 Sum_probs=181.4
Q ss_pred ccCch-hHHHHHHHhcCCc----------ccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeE
Q 043524 20 IGNGA-SVLQELIASSNGK----------YIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGC 88 (314)
Q Consensus 20 ~G~g~-~~~~~~~~~~~g~----------~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 88 (314)
+|+|+ +.|+++....++. .+++|.+...... ...+.+|+.+++.++||||++++++
T Consensus 3 lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-------------~~~~~~e~~~l~~l~h~~i~~~~~~ 69 (259)
T cd05037 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-------------SLAFFETASLMSQLSHKHLVKLYGV 69 (259)
T ss_pred ccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-------------HHHHHHHHHHHHcCCCcchhheeeE
Confidence 67777 6777776666552 3666665543321 1578899999999999999999999
Q ss_pred EEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCC---
Q 043524 89 CLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN--- 165 (314)
Q Consensus 89 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~--- 165 (314)
+.. ...++|+||+++|+|.+++.... ..++...+..++.|++.||.||| +++++|+||||+||+++.++
T Consensus 70 ~~~-~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~ 141 (259)
T cd05037 70 CVR-DENIMVEEYVKFGPLDVFLHREK----NNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNE 141 (259)
T ss_pred Eec-CCcEEEEEcCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCcccc
Confidence 988 77899999999999999987654 25788889999999999999999 99999999999999999887
Q ss_pred ----ceEEcccccceecCCCCcccccccccccccccCcccccC--CCCcccchHHHHHHHHHHHh-CCCCcccccCcccc
Q 043524 166 ----VVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTC--DFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDL 238 (314)
Q Consensus 166 ----~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~ 238 (314)
.++++|||.+..... .....++..|+|||++... .++.++|+||+|+++++|++ |..||.......
T Consensus 142 ~~~~~~kl~Dfg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~-- 214 (259)
T cd05037 142 GYVPFIKLSDPGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE-- 214 (259)
T ss_pred CCceeEEeCCCCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh--
Confidence 799999999876533 2234567789999998776 68899999999999999999 566765432111
Q ss_pred ccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHH
Q 043524 239 VYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLR 305 (314)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~ 305 (314)
... .+.... ..+.+ ....+.+++.+||..||.+|||+.++++.|+
T Consensus 215 ---~~~----~~~~~~-----------~~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 215 ---KER----FYQDQH-----------RLPMP----DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred ---HHH----HHhcCC-----------CCCCC----CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 000000 00000 0156789999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=267.21 Aligned_cols=248 Identities=22% Similarity=0.313 Sum_probs=193.7
Q ss_pred cccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCC
Q 043524 15 KRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETP 93 (314)
Q Consensus 15 ~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (314)
.....+|.|+ +.++.+....+++.+|+|.+........ ..+.+.+|+++++.++||||+++++.+..++
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 72 (256)
T cd08220 3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKD----------ERLAAQNECQVLKLLSHPNIIEYYENFLEDK 72 (256)
T ss_pred eEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccH----------HHHHHHHHHHHHhhCCCCchhheeeeEecCC
Confidence 3445578777 7788777888899999998865432111 1256889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCC-CceEEccc
Q 043524 94 IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEE-NVVKLFDF 172 (314)
Q Consensus 94 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~-~~~kl~df 172 (314)
..++|+||+++++|.+++..... ..++...+..++.+++.++.||| +++++|+||+|+||+++.+ +.++++||
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~ 146 (256)
T cd08220 73 ALMIVMEYAPGGTLAEYIQKRCN---SLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDF 146 (256)
T ss_pred EEEEEEecCCCCCHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccC
Confidence 99999999999999999976432 34788899999999999999999 9999999999999999855 46899999
Q ss_pred ccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhcc
Q 043524 173 SLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFED 252 (314)
Q Consensus 173 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (314)
|.+........ .....++..|+|||.+....++.++|+||+|+++++|++|..||....... ........
T Consensus 147 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~--------~~~~~~~~ 216 (256)
T cd08220 147 GISKILSSKSK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA--------LVLKIMSG 216 (256)
T ss_pred CCceecCCCcc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH--------HHHHHHhc
Confidence 99977644321 234568889999999988888999999999999999999999986432111 11111100
Q ss_pred CCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 253 NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.... .....+..+.+++.+||..||++|||+.|++.
T Consensus 217 -~~~~-------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 217 -TFAP-------------ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred -CCCC-------------CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 0000 00134556889999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=274.35 Aligned_cols=253 Identities=19% Similarity=0.214 Sum_probs=192.5
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCee
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIA 95 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (314)
...+|.|+ +.++++.+..+++.||+|.+.......... .+.+.+|+++++.++||||+++++.+.+++..
T Consensus 6 ~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~---------~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 76 (305)
T cd05609 6 IKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQ---------IQQVFVERDILTFAENPFVVSMFCSFETKRHL 76 (305)
T ss_pred eeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHH---------HHHHHHHHHHHHhCCCCCeeeeEEEEecCCEE
Confidence 34577777 778888888899999999887664322111 15678999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
++||||+++++|.+++.... +++...+..++.+++.|+.||| +++++|+||||+||+++..+.++++|||.+
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~ 148 (305)
T cd05609 77 CMVMEYVEGGDCATLLKNIG-----ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLS 148 (305)
T ss_pred EEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCc
Confidence 99999999999999986643 4788888899999999999999 999999999999999999999999999998
Q ss_pred eecCCCC--------------cccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccc
Q 043524 176 ISIPEGE--------------THITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYP 241 (314)
Q Consensus 176 ~~~~~~~--------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~ 241 (314)
+...... ........++..|+|||.+....++.++|+||||+++|+|++|..||......
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------ 222 (305)
T cd05609 149 KIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ 222 (305)
T ss_pred cccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------
Confidence 6421110 00111245788899999998888999999999999999999999998632211
Q ss_pred hHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHH
Q 043524 242 FNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQ 306 (314)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 306 (314)
+........ . ...+ ......+..+.+++.+||+.||++||++.++++.|+.
T Consensus 223 --~~~~~~~~~-~---~~~~--------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 223 --ELFGQVISD-D---IEWP--------EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred --HHHHHHHhc-c---cCCC--------CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 111111100 0 0000 0001344568899999999999999997666665544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=268.46 Aligned_cols=253 Identities=20% Similarity=0.245 Sum_probs=177.9
Q ss_pred ccCch-hHHHHHHHhc--CCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeE
Q 043524 20 IGNGA-SVLQELIASS--NGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAI 96 (314)
Q Consensus 20 ~G~g~-~~~~~~~~~~--~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (314)
+|.|+ +.|+++.... ....+++|.+........ .+.+.+|+.+++.++||||+++++.+.+....|
T Consensus 3 lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~-----------~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 71 (268)
T cd05086 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKE-----------QNEFLQQGDPYRILQHPNILQCLGQCVEAIPYL 71 (268)
T ss_pred CCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHH-----------HHHHHHHHHHHhccCCcchhheEEEecCCCccE
Confidence 67776 5565543222 223455665443221111 157899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
+||||+++|+|.+++...... ....+...+..++.|++.||.||| +++++|+||||+||+++.++.++++|||++.
T Consensus 72 lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~ 147 (268)
T cd05086 72 LVFEYCELGDLKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGP 147 (268)
T ss_pred EEEecCCCCcHHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEeccccccc
Confidence 999999999999998764211 134566777889999999999999 9999999999999999999999999999975
Q ss_pred ecCCCC-cccccccccccccccCccccc-------CCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHH
Q 043524 177 SIPEGE-THITDTVMGTYGHLAPQYVTT-------CDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLK 247 (314)
Q Consensus 177 ~~~~~~-~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~ 247 (314)
...... ........++..|+|||++.. ..++.++||||||+++|||++ |..||...... +...
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--------~~~~ 219 (268)
T cd05086 148 SRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR--------EVLN 219 (268)
T ss_pred ccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH--------HHHH
Confidence 432211 111234567889999998743 235788999999999999997 46677533221 1111
Q ss_pred hhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHH
Q 043524 248 NYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLR 305 (314)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~ 305 (314)
..... ......++.+.. ..+..+.+++.+|| .+|++|||+.++++.|.
T Consensus 220 ~~~~~-~~~~~~~~~~~~--------~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 220 HVIKD-QQVKLFKPQLEL--------PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHhh-cccccCCCccCC--------CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 11111 111111211111 23356788999999 68999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=289.40 Aligned_cols=264 Identities=15% Similarity=0.202 Sum_probs=183.8
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC------CCceeee
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS------HDHILKL 85 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~ 85 (314)
+|+....+|.|+ +.||++.+..+++.||+|++....... +.+..|+.++..++ |.+++++
T Consensus 130 ~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~-------------~~~~~e~~~l~~l~~~~~~~~~~i~~i 196 (467)
T PTZ00284 130 RFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYT-------------RDAKIEIQFMEKVRQADPADRFPLMKI 196 (467)
T ss_pred cEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhH-------------HHHHHHHHHHHHHhhcCcccCcceeee
Confidence 344455689988 888888888899999999985321100 22345566655554 4568999
Q ss_pred EeEEEeC-CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCC-CCceeccCCCCCeeecC
Q 043524 86 IGCCLET-PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFP-RPIVFRDFKTSHILFSE 163 (314)
Q Consensus 86 ~~~~~~~-~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~-~~i~H~dlk~~nil~~~ 163 (314)
++++... .++|+|+|++ +++|.+++... ..++...+..++.|++.||.||| + .+|+||||||+|||++.
T Consensus 197 ~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~ 267 (467)
T PTZ00284 197 QRYFQNETGHMCIVMPKY-GPCLLDWIMKH-----GPFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMET 267 (467)
T ss_pred EEEEEcCCceEEEEEecc-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEec
Confidence 9988764 5789999988 67898888654 35788899999999999999999 7 59999999999999987
Q ss_pred CC----------------ceEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCC
Q 043524 164 EN----------------VVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRG 227 (314)
Q Consensus 164 ~~----------------~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~ 227 (314)
.+ .+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~ 343 (467)
T PTZ00284 268 SDTVVDPVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKL 343 (467)
T ss_pred CCcccccccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 65 489999998754221 1335679999999999999899999999999999999999999
Q ss_pred CcccccCcccc------ccchHH-HHH--------hhhcc-CCcccccChh-hhcc--CCchhHHHHHHHHHHHHhHhcc
Q 043524 228 ILDLVRDAHDL------VYPFNE-YLK--------NYFED-NRFTEIVDPI-IVQD--LSCTEKEQQLHASAQLTFECLN 288 (314)
Q Consensus 228 p~~~~~~~~~~------~~~~~~-~~~--------~~~~~-~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~~li~~cl~ 288 (314)
||+........ ...+.. |.. .++.. .......++. +... ............+.+||..||+
T Consensus 344 pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~ 423 (467)
T PTZ00284 344 LYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLH 423 (467)
T ss_pred CCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCC
Confidence 99754432110 000100 100 00000 0000001100 0000 0000001123567899999999
Q ss_pred CCCCCCCCHHHHHH
Q 043524 289 ESPIDRPTMVDVAR 302 (314)
Q Consensus 289 ~dp~~Rps~~ell~ 302 (314)
+||++||||.|+++
T Consensus 424 ~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 424 YDRQKRLNARQMTT 437 (467)
T ss_pred cChhhCCCHHHHhc
Confidence 99999999999986
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=268.56 Aligned_cols=260 Identities=18% Similarity=0.266 Sum_probs=194.2
Q ss_pred cccccCch-hHHHHHHHhc-CCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhc-CCCCceeeeEeEEEeCC
Q 043524 17 TLMIGNGA-SVLQELIASS-NGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQ-MSHDHILKLIGCCLETP 93 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~-~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~ 93 (314)
...+|.|+ +.++.+.... +++.+|+|.+........+.. ........++.+|+.++.. ++||||+++++++.+++
T Consensus 5 ~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~--~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 82 (269)
T cd08528 5 LEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDK--RERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEND 82 (269)
T ss_pred hhhhcCCCCceEEEEEEcCCCCceeeeeEeecccccccccc--ccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCC
Confidence 34578877 7777777666 678999998765433221110 0111122567789988875 79999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCC-CCceeccCCCCCeeecCCCceEEccc
Q 043524 94 IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFP-RPIVFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 94 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~-~~i~H~dlk~~nil~~~~~~~kl~df 172 (314)
..++++||+++++|.+.+...... ...++...++.++.|++.|+.||| + .+++|+||+|+||+++.++.++++||
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh---~~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 83 RLYIVMDLIEGAPLGEHFNSLKEK-KQRFTEERIWNIFVQMVLALRYLH---KEKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred eEEEEEecCCCCcHHHHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHhc---cCCceeecCCCHHHEEECCCCcEEEecc
Confidence 999999999999998887542111 135788899999999999999999 6 67999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhcc
Q 043524 173 SLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFED 252 (314)
Q Consensus 173 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (314)
|.+....... ......++..|+|||.+....++.++|+||||+++|+|++|..||...... ....... .
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~--------~~~~~~~-~ 227 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML--------SLATKIV-E 227 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH--------HHHHHHh-h
Confidence 9997654432 233556889999999998888999999999999999999999998532211 0011100 0
Q ss_pred CCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHH
Q 043524 253 NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLR 305 (314)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~ 305 (314)
.... +......+..+.+++.+||+.||++|||+.|+..+++
T Consensus 228 ~~~~------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 228 AVYE------------PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ccCC------------cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0000 0001123456889999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=266.25 Aligned_cols=253 Identities=23% Similarity=0.331 Sum_probs=194.5
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCee
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIA 95 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (314)
...+|.|+ +.++.+....+|..+|+|++........ .+.+.+|+++++.++|+||+++++.+..++..
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-----------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (267)
T cd06610 6 IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS-----------VDELRKEVQAMSQCNHPNVVKYYTSFVVGDEL 74 (267)
T ss_pred eeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchH-----------HHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEE
Confidence 44577777 7888887777889999998864332211 15678999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
|+++|++++++|.+.+...... ..++...+..++.|++.|+.+|| +.+++|+||+|+||+++.++.++++|||.+
T Consensus 75 ~iv~e~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~ 149 (267)
T cd06610 75 WLVMPYLSGGSLLDIMKSSYPR--GGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVS 149 (267)
T ss_pred EEEEeccCCCcHHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchH
Confidence 9999999999999998754211 24788889999999999999999 999999999999999999999999999998
Q ss_pred eecCCCCcc---cccccccccccccCcccccC-CCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhc
Q 043524 176 ISIPEGETH---ITDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFE 251 (314)
Q Consensus 176 ~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (314)
......... ......++..|+|||.+... .++.++|+||+|+++++|++|..||....... .+.... .
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~----~~~~~~----~ 221 (267)
T cd06610 150 ASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK----VLMLTL----Q 221 (267)
T ss_pred HHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh----hHHHHh----c
Confidence 766443221 12344688999999998776 68899999999999999999999986433211 011110 0
Q ss_pred cCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 252 DNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
. . .+..... ......+..+.+++..||..||++|||+.++++
T Consensus 222 ~-~-----~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 222 N-D-----PPSLETG---ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred C-C-----CCCcCCc---cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0 0 0000000 001144567899999999999999999999985
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=267.97 Aligned_cols=253 Identities=21% Similarity=0.268 Sum_probs=192.5
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGCC 89 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 89 (314)
.+|.....+|.|+ +.++.+....+++.+++|++...... .+.+.+|+.+++.+ .|+||+++++++
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-------------~~~~~~e~~~l~~~~~h~~i~~~~~~~ 72 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-------------EEEIKEEYNILRKYSNHPNIATFYGAF 72 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchh-------------HHHHHHHHHHHHHhcCCCChheEEEEE
Confidence 3444555678777 77888877788899999998754331 14678999999999 699999999999
Q ss_pred EeCC------eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecC
Q 043524 90 LETP------IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSE 163 (314)
Q Consensus 90 ~~~~------~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~ 163 (314)
.... .+|++|||+++++|.+++...... ...++...+..++.|++.||.||| +.+++|+||+|+||+++.
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~ 148 (275)
T cd06608 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKK-GKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTK 148 (275)
T ss_pred EecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEcc
Confidence 7644 489999999999999888653210 135788899999999999999999 999999999999999999
Q ss_pred CCceEEcccccceecCCCCcccccccccccccccCcccccC-----CCCcccchHHHHHHHHHHHhCCCCcccccCcccc
Q 043524 164 ENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTC-----DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDL 238 (314)
Q Consensus 164 ~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~ 238 (314)
++.++++|||.+....... .......++..|+|||++... .++.++||||+|+++|+|++|..||.......
T Consensus 149 ~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-- 225 (275)
T cd06608 149 NAEVKLVDFGVSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-- 225 (275)
T ss_pred CCeEEECCCccceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--
Confidence 9999999999987654322 223345688999999987532 36788999999999999999999986332111
Q ss_pred ccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 239 VYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
. ....... . ..........+..+.+|+.+||..||++|||+.++++
T Consensus 226 -----~-~~~~~~~------~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 226 -----A-LFKIPRN------P------PPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -----H-HHHhhcc------C------CCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0 0000000 0 0011111235667899999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=267.86 Aligned_cols=243 Identities=23% Similarity=0.321 Sum_probs=192.6
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCee
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIA 95 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (314)
...+|.|+ +.|+++....+++.+|+|.+........ .+.+.+|++++..++||||+++++++..+...
T Consensus 9 ~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 77 (277)
T cd06641 9 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-----------IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL 77 (277)
T ss_pred heeEeecCCeEEEEEEECCCCcEEEEEEeccccchHH-----------HHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeE
Confidence 33478777 7888887788899999998764432221 14678999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
|+|+||+++++|.+++... .++...+..++.+++.++.+|| +++++|+||+|+||+++.++.++++|||++
T Consensus 78 ~lv~e~~~~~~l~~~i~~~------~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~ 148 (277)
T cd06641 78 WIIMEYLGGGSALDLLEPG------PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVA 148 (277)
T ss_pred EEEEEeCCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccc
Confidence 9999999999999888642 4788899999999999999999 999999999999999999999999999998
Q ss_pred eecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCc
Q 043524 176 ISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRF 255 (314)
Q Consensus 176 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (314)
....... .......++..|+|||.+....++.++|+||+|+++++|++|..||....... ...... ....
T Consensus 149 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~-~~~~ 218 (277)
T cd06641 149 GQLTDTQ-IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK--------VLFLIP-KNNP 218 (277)
T ss_pred eecccch-hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH--------HHHHHh-cCCC
Confidence 7654322 12334567889999999988888999999999999999999999985432111 000000 0000
Q ss_pred ccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 256 TEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
+. .....+.++.+++..||..+|++||++.+++.
T Consensus 219 -----~~--------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 219 -----PT--------LEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred -----CC--------CCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00 01134466889999999999999999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=270.75 Aligned_cols=247 Identities=20% Similarity=0.269 Sum_probs=189.9
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeE
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAI 96 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (314)
..+|.|+ +.++.+....+|..+|+|.+....... ..+.+.+|+.++..++||||+++++.+...+..|
T Consensus 7 ~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~-----------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 75 (286)
T cd06622 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDES-----------KFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVY 75 (286)
T ss_pred hhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHH-----------HHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEE
Confidence 3478887 888888888889999999875421111 1156789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCC-CCceeccCCCCCeeecCCCceEEcccccc
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFP-RPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~-~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
+|+||+++++|..++..... ...++...+..++.+++.|+.||| + .+++|+||||+||+++.++.++++|||.+
T Consensus 76 lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 150 (286)
T cd06622 76 MCMEYMDAGSLDKLYAGGVA--TEGIPEDVLRRITYAVVKGLKFLK---EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVS 150 (286)
T ss_pred EEEeecCCCCHHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHH---hcCCEeeCCCCHHHEEECCCCCEEEeecCCc
Confidence 99999999999888765321 135788999999999999999999 6 59999999999999999999999999998
Q ss_pred eecCCCCcccccccccccccccCcccccCC------CCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhh
Q 043524 176 ISIPEGETHITDTVMGTYGHLAPQYVTTCD------FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNY 249 (314)
Q Consensus 176 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~------~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (314)
....... .....++..|+|||.+.... ++.++|+||+||++|+|++|..||....... .+ .....
T Consensus 151 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~-~~~~~- 221 (286)
T cd06622 151 GNLVASL---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN----IF-AQLSA- 221 (286)
T ss_pred ccccCCc---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh----HH-HHHHH-
Confidence 6653221 23446788999999885443 4789999999999999999999986432110 00 00000
Q ss_pred hccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 250 FEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
...+.. ...+...+.++.+++.+||..+|++||++.+++.
T Consensus 222 ------------~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 222 ------------IVDGDP-PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred ------------HhhcCC-CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 000000 0111135677899999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=282.48 Aligned_cols=273 Identities=19% Similarity=0.227 Sum_probs=203.5
Q ss_pred cccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCC
Q 043524 15 KRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETP 93 (314)
Q Consensus 15 ~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (314)
.....+|+|+ +.|+..+++.+|+.+|||.+...-..+. .++-..|+++|++++|+|||+++++-++..
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~-----------~e~~~~EieilkKLnh~NIVk~f~iee~~~ 84 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRP-----------RERWCREIEILKKLNHPNIVKLFDIEETKF 84 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhcccch-----------HHHHHHHHHHHHHcCchhhhhhcccCCccc
Confidence 3445689999 8899999999999999998876431111 156789999999999999999999977644
Q ss_pred ------eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecC--CC
Q 043524 94 ------IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSE--EN 165 (314)
Q Consensus 94 ------~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~--~~ 165 (314)
...++||||++|||...+.+.... ..++..+++.++.+++.|+.||| ++||+||||||.||++-. +|
T Consensus 85 ~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~--~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedg 159 (732)
T KOG4250|consen 85 LGLVTRLPVLVMEYCSGGSLRKVLNSPENA--YGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDG 159 (732)
T ss_pred cCcccccceEEEeecCCCcHHHHhcCcccc--cCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCC
Confidence 467999999999999999765432 45999999999999999999999 999999999999998732 23
Q ss_pred --ceEEcccccceecCCCCcccccccccccccccCccccc-CCCCcccchHHHHHHHHHHHhCCCCcccccCccccccch
Q 043524 166 --VVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTT-CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPF 242 (314)
Q Consensus 166 --~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~ 242 (314)
..||+|||.|+.++++. ...+++||..|++||++-. ..|+..+|.|||||++|+++||..||-.........
T Consensus 160 q~IyKLtDfG~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~--- 234 (732)
T KOG4250|consen 160 QSIYKLTDFGAARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNK--- 234 (732)
T ss_pred ceEEeeecccccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccc---
Confidence 57999999999987765 3667899999999999984 679999999999999999999999996444321100
Q ss_pred HHHHHhhh-ccCCcccc-cC-----h-hhhc--cCCchhHHHHHHHHHHHHhHhccCCCCCCC--CHHHHHHHHHHHHh
Q 043524 243 NEYLKNYF-EDNRFTEI-VD-----P-IIVQ--DLSCTEKEQQLHASAQLTFECLNESPIDRP--TMVDVARRLRQICC 309 (314)
Q Consensus 243 ~~~~~~~~-~~~~~~~~-~~-----~-~~~~--~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp--s~~ell~~L~~~~~ 309 (314)
+...... +.+....+ .+ + .... +.+..........+-..+..+|..||.+|. ...+....+..+..
T Consensus 235 -~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 235 -EIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred -hhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 0000000 00000000 00 0 0111 122333334445567788889999999999 78888877777643
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=272.93 Aligned_cols=269 Identities=19% Similarity=0.204 Sum_probs=194.0
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeE
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAI 96 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (314)
..+|.|+ +.++.+....+|+.+|+|.+........ .......+.+|+++++.++|+||+++++++.+++..+
T Consensus 6 ~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~-------~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 78 (298)
T cd07841 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEA-------KDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNIN 78 (298)
T ss_pred eeeeeccccEEEEEEECCCCcEEEEEEEeccccccc-------cchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEE
Confidence 3578777 8888888888899999999876543211 1112256778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
+||||+ +|+|.+++.... ..++...+..++.|++.||.||| +++++|+||+|+||+++.++.++|+|||+++
T Consensus 79 lv~e~~-~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~ 150 (298)
T cd07841 79 LVFEFM-ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLAR 150 (298)
T ss_pred EEEccc-CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeee
Confidence 999999 889999987643 25788999999999999999999 9999999999999999999999999999997
Q ss_pred ecCCCCcccccccccccccccCccccc-CCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHH---Hhhh-c
Q 043524 177 SIPEGETHITDTVMGTYGHLAPQYVTT-CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYL---KNYF-E 251 (314)
Q Consensus 177 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~---~~~~-~ 251 (314)
....... ......+++.|+|||.+.+ ..++.++|+||+||++|+|++|.+||............+.... ...+ .
T Consensus 151 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 151 SFGSPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229 (298)
T ss_pred eccCCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhh
Confidence 7644321 1223356788999998854 3578999999999999999999888764432211100000000 0000 0
Q ss_pred cCCcccccChhhhccCC-chhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 252 DNRFTEIVDPIIVQDLS-CTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 252 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
................+ .......+..+.+++..||..||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 00000000000000000 0001133567899999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=270.10 Aligned_cols=243 Identities=17% Similarity=0.236 Sum_probs=184.0
Q ss_pred ccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHH---HhcCCCCceeeeEeEEEeCCee
Q 043524 20 IGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTY---AAQMSHDHILKLIGCCLETPIA 95 (314)
Q Consensus 20 ~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~---l~~l~h~niv~~~~~~~~~~~~ 95 (314)
+|+|+ +.|+.+.+..+|+.+|+|.+........... ..+.+|..+ +...+||||+.+++++..++..
T Consensus 2 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 72 (279)
T cd05633 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE---------TLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKL 72 (279)
T ss_pred cccCCCeEEEEEEECCCCcEEEEEEEEccccccchHH---------HHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeE
Confidence 67777 7888888888899999998865433211100 223344433 3345799999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
++||||+++++|.+.+... ..++...+..++.|++.||.||| +++++|+||||+||+++.++.++++|||++
T Consensus 73 ~lv~e~~~~~~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~ 144 (279)
T cd05633 73 CFILDLMNGGDLHYHLSQH-----GVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA 144 (279)
T ss_pred EEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcc
Confidence 9999999999999888654 35889999999999999999999 999999999999999999999999999998
Q ss_pred eecCCCCcccccccccccccccCccccc-CCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCC
Q 043524 176 ISIPEGETHITDTVMGTYGHLAPQYVTT-CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNR 254 (314)
Q Consensus 176 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (314)
....... .....|+..|+|||.+.. ..++.++|+||+|+++|+|++|..||....... .........
T Consensus 145 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------~~~~~~~~~--- 212 (279)
T cd05633 145 CDFSKKK---PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD------KHEIDRMTL--- 212 (279)
T ss_pred eeccccC---ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC------HHHHHHHhh---
Confidence 6543322 223468999999998864 558899999999999999999999996543211 000000000
Q ss_pred cccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCC-----CHHHHHH
Q 043524 255 FTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRP-----TMVDVAR 302 (314)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 302 (314)
..+...+...+.++.+++.+||..||++|| |+.|+++
T Consensus 213 -----------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 213 -----------TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred -----------cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 000011113456789999999999999999 5888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=269.48 Aligned_cols=247 Identities=18% Similarity=0.302 Sum_probs=193.5
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
+.....+|+|+ +.++.+....+++.+++|.+........ +.+.+|+.+++.++||||+++++++..+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~------------~~~~~e~~~l~~~~h~~vv~~~~~~~~~ 88 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRR------------ELLFNEVVIMRDYQHPNIVEMYSSYLVG 88 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHH------------HHHHHHHHHHHHcCCCChheEEEEEEcC
Confidence 34455788888 7888777778889999998754332211 4578999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~df 172 (314)
+..++++||+++++|.+.+... .++...+..++.|++.|+.||| +++++|+||+|+||+++.++.++++||
T Consensus 89 ~~~~~v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~ 159 (285)
T cd06648 89 DELWVVMEFLEGGALTDIVTHT------RMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDF 159 (285)
T ss_pred CeEEEEEeccCCCCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEccc
Confidence 9999999999999999988652 3778889999999999999999 999999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhcc
Q 043524 173 SLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFED 252 (314)
Q Consensus 173 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (314)
|.+........ ......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...... .........
T Consensus 160 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~--------~~~~~~~~~ 230 (285)
T cd06648 160 GFCAQVSKEVP-RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL--------QAMKRIRDN 230 (285)
T ss_pred ccchhhccCCc-ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH--------HHHHHHHhc
Confidence 98765433221 223456889999999998888999999999999999999999998532211 111111100
Q ss_pred CCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 253 NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
. .+... .....+..+.+++.+||+.||++|||+.++++
T Consensus 231 -~-----~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 231 -L-----PPKLK------NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred -C-----CCCCc------ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 0 00000 00123456899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=270.42 Aligned_cols=269 Identities=19% Similarity=0.271 Sum_probs=192.7
Q ss_pred cccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCC
Q 043524 15 KRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETP 93 (314)
Q Consensus 15 ~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (314)
.....+|.|+ +.++++....+|+.+|+|.+....... ...+.+.+|+++++.++|+||+++++++..+.
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~----------~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 73 (286)
T cd07847 4 EKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP----------VIKKIALREIRMLKQLKHPNLVNLIEVFRRKR 73 (286)
T ss_pred eeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc----------cccHHHHHHHHHHHhCCCCCEeeeeeEEeeCC
Confidence 3344578887 788888888889999999876432110 01245789999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccc
Q 043524 94 IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFS 173 (314)
Q Consensus 94 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg 173 (314)
..++||||++++++..++... ..++...+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||
T Consensus 74 ~~~~v~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg 145 (286)
T cd07847 74 KLHLVFEYCDHTVLNELEKNP-----RGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFG 145 (286)
T ss_pred EEEEEEeccCccHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccc
Confidence 999999999988887766543 24788999999999999999999 9999999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCccccc-CCCCcccchHHHHHHHHHHHhCCCCcccccCcccccc------chHHHH
Q 043524 174 LSISIPEGETHITDTVMGTYGHLAPQYVTT-CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVY------PFNEYL 246 (314)
Q Consensus 174 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~------~~~~~~ 246 (314)
.+........ ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||......+.... ......
T Consensus 146 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 224 (286)
T cd07847 146 FARILTGPGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRH 224 (286)
T ss_pred cceecCCCcc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHH
Confidence 9977644321 1223457889999998866 4578899999999999999999999975443211000 000000
Q ss_pred HhhhccCCc-ccccChhhhccCCc-hhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 247 KNYFEDNRF-TEIVDPIIVQDLSC-TEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 247 ~~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
...+....+ .....+......+. ......+..+.+|+.+||+.||++|||+.|++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 225 QQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred hhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000000000 00000000000000 001133567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=268.93 Aligned_cols=248 Identities=19% Similarity=0.261 Sum_probs=189.5
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeEEEe
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGCCLE 91 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 91 (314)
+.....+|.|+ +.++.+.+..+++.+|+|++....... ..+..|+.++..+ +|+||+++++++..
T Consensus 18 ~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~-------------~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-------------EEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHH-------------HHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 33445678888 888888888899999999876543211 3567889999988 69999999999863
Q ss_pred ------CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCC
Q 043524 92 ------TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN 165 (314)
Q Consensus 92 ------~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~ 165 (314)
+...|++|||+++|+|.+++..... ..++...+..++.|++.|+.||| +.+++|+||+|+||+++.++
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~ 158 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG---NALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENA 158 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCC
Confidence 4678999999999999998876432 34677888899999999999999 99999999999999999999
Q ss_pred ceEEcccccceecCCCCcccccccccccccccCcccc-----cCCCCcccchHHHHHHHHHHHhCCCCcccccCcccccc
Q 043524 166 VVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVT-----TCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVY 240 (314)
Q Consensus 166 ~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~ 240 (314)
.++|+|||.+........ ......|++.|+|||.+. ...++.++|+||+|+++|+|++|..||..........
T Consensus 159 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~- 236 (282)
T cd06636 159 EVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF- 236 (282)
T ss_pred CEEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh-
Confidence 999999999875532211 233456889999999876 3457889999999999999999999986433211000
Q ss_pred chHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 241 PFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
... ....+ .......+..+.+|+.+||..||.+|||+.||++
T Consensus 237 -------~~~------~~~~~-------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 -------LIP------RNPPP-------KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -------hHh------hCCCC-------CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000 00000 0011134567899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=266.09 Aligned_cols=250 Identities=19% Similarity=0.280 Sum_probs=194.1
Q ss_pred cccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCC
Q 043524 15 KRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETP 93 (314)
Q Consensus 15 ~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (314)
.....+|.|+ +.++.+....+++.+++|.+........ .....+.+.+|+.+++.++|+||+++++++..+.
T Consensus 3 ~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~-------~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 75 (258)
T cd06632 3 RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQT-------GQEAVKQLEQEIALLSKLQHPNIVQYLGTEREED 75 (258)
T ss_pred cccceeeecCCceEEEEEEcCCCcEEEEEEEEEcccccc-------chHHHHHHHHHHHHHHhcCCCCchheeeeEecCC
Confidence 3445578877 7888888888899999998765432110 0011256889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccc
Q 043524 94 IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFS 173 (314)
Q Consensus 94 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg 173 (314)
..++++||+++++|.+.+.... +++...+..++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~ 147 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKYG-----SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFG 147 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCc
Confidence 9999999999999999986542 4778888899999999999999 9999999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCcccccCC-CCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhcc
Q 043524 174 LSISIPEGETHITDTVMGTYGHLAPQYVTTCD-FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFED 252 (314)
Q Consensus 174 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (314)
.+....... ......++..|++||.+.... ++.++|+||+|+++|+|++|+.||....... ........
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~--------~~~~~~~~ 217 (258)
T cd06632 148 MAKQVVEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA--------AVFKIGRS 217 (258)
T ss_pred cceeccccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH--------HHHHHHhc
Confidence 987653332 233456888999999987766 8899999999999999999999986433111 00000000
Q ss_pred CCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 253 NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.... ..+...+..+.+++.+||..||++|||+.+++.
T Consensus 218 ~~~~-------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 218 KELP-------------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ccCC-------------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 0000 001133466789999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=271.74 Aligned_cols=246 Identities=24% Similarity=0.314 Sum_probs=189.7
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
+.....+|.|+ +.++.+....+|+.+|+|.+......... ..+.+.+|+.+++.++||||+++.+++.++
T Consensus 17 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~---------~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~ 87 (307)
T cd06607 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNE---------KWQDIIKEVRFLQQLRHPNTIEYKGCYLRE 87 (307)
T ss_pred hhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHH---------HHHHHHHHHHHHHhCCCCCEEEEEEEEEeC
Confidence 44445588887 77888777788999999987643211110 115678999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~df 172 (314)
+..|+|+||++ |++.+.+.... .+++...+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+||
T Consensus 88 ~~~~lv~e~~~-g~l~~~~~~~~----~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~df 159 (307)
T cd06607 88 HTAWLVMEYCL-GSASDILEVHK----KPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADF 159 (307)
T ss_pred CeEEEEHHhhC-CCHHHHHHHcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeec
Confidence 99999999996 68877775443 35788999999999999999999 999999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCcccc---cCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhh
Q 043524 173 SLSISIPEGETHITDTVMGTYGHLAPQYVT---TCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNY 249 (314)
Q Consensus 173 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (314)
|++...... ....++..|+|||++. ...++.++||||||+++|+|++|..||....... .....
T Consensus 160 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~--------~~~~~ 226 (307)
T cd06607 160 GSASLVSPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHI 226 (307)
T ss_pred CcceecCCC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH--------HHHHH
Confidence 998654322 2446788999999874 3457889999999999999999999985332111 00000
Q ss_pred hccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 250 FEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.. . ..+.......+..+.+++.+||..||++|||+.+++.
T Consensus 227 ~~-~------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 227 AQ-N------------DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred hc-C------------CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00 0 0000011135567899999999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=270.93 Aligned_cols=273 Identities=19% Similarity=0.265 Sum_probs=192.1
Q ss_pred cccccCch-hHHHHHHHhc--CCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC-
Q 043524 17 TLMIGNGA-SVLQELIASS--NGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET- 92 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~--~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~- 92 (314)
...+|+|+ +.++++.... +|+.+|+|.+....... ....+.+.+|+.++..++||||+++++++.+.
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (316)
T cd07842 5 EGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQY---------TGISQSACREIALLRELKHENVVSLVEVFLEHA 75 (316)
T ss_pred EEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccc---------cCccHHHHHHHHHHHhcCCCCccceEEEEeCCC
Confidence 34588877 7888888777 78999999987643200 00125577899999999999999999999988
Q ss_pred -CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecC----CCce
Q 043524 93 -PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSE----ENVV 167 (314)
Q Consensus 93 -~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~----~~~~ 167 (314)
..+|+|+||++ +++.+.+..........++...+..++.|++.||.||| +++++|+||||+||+++. .+.+
T Consensus 76 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~ 151 (316)
T cd07842 76 DKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVV 151 (316)
T ss_pred CceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceE
Confidence 88999999996 47877775433222135788899999999999999999 999999999999999999 8999
Q ss_pred EEcccccceecCCCCc--ccccccccccccccCcccccC-CCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHH
Q 043524 168 KLFDFSLSISIPEGET--HITDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNE 244 (314)
Q Consensus 168 kl~dfg~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 244 (314)
+++|||++........ .......++..|+|||++.+. .++.++|+||+|+++++|++|+.||...........++..
T Consensus 152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 231 (316)
T cd07842 152 KIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQR 231 (316)
T ss_pred EECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHH
Confidence 9999999876543321 112344678899999988764 4789999999999999999999999754432211111000
Q ss_pred -HHHhhh---------------ccCCcccccChhhhccCC-ch----hHH--HHHHHHHHHHhHhccCCCCCCCCHHHHH
Q 043524 245 -YLKNYF---------------EDNRFTEIVDPIIVQDLS-CT----EKE--QQLHASAQLTFECLNESPIDRPTMVDVA 301 (314)
Q Consensus 245 -~~~~~~---------------~~~~~~~~~~~~~~~~~~-~~----~~~--~~~~~~~~li~~cl~~dp~~Rps~~ell 301 (314)
...... ....+....+.......+ .. ... ..+..+.+++.+||+.||++|||+.|++
T Consensus 232 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil 311 (316)
T cd07842 232 DQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEAL 311 (316)
T ss_pred HHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHh
Confidence 000000 000000000000000000 00 000 2345689999999999999999999997
Q ss_pred H
Q 043524 302 R 302 (314)
Q Consensus 302 ~ 302 (314)
+
T Consensus 312 ~ 312 (316)
T cd07842 312 E 312 (316)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=266.53 Aligned_cols=256 Identities=22% Similarity=0.247 Sum_probs=191.5
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe--CCe
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE--TPI 94 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~ 94 (314)
..+|.|+ +.++.+....+++.+|+|.+........ ..++.+|+++++.++||||+++++++.. .+.
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 75 (287)
T cd06621 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDL-----------QKQILRELEINKSCKSPYIVKYYGAFLDESSSS 75 (287)
T ss_pred EEeccCCceEEEEEEECCCCeEEEEEEEecCCchHH-----------HHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCe
Confidence 3578887 7888888888899999998865422111 2568899999999999999999999865 447
Q ss_pred eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccc
Q 043524 95 AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL 174 (314)
Q Consensus 95 ~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~ 174 (314)
+|+||||+++++|.+.+..... ....++...+..++.|++.||.||| +.+++|+||+|+||+++.++.++++|||+
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 151 (287)
T cd06621 76 IGIAMEYCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGV 151 (287)
T ss_pred EEEEEEecCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccc
Confidence 8999999999999887653211 1135778889999999999999999 99999999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCC
Q 043524 175 SISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNR 254 (314)
Q Consensus 175 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (314)
+....... .....++..|+|||.+....++.++|+||+|+++|+|++|..||+....... ...+.... .....
T Consensus 152 ~~~~~~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~-~~~~~ 224 (287)
T cd06621 152 SGELVNSL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL---GPIELLSY-IVNMP 224 (287)
T ss_pred cccccccc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC---ChHHHHHH-HhcCC
Confidence 86543221 2234578889999999888899999999999999999999999975532110 01111111 11100
Q ss_pred cccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 255 FTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
... +... .......+..+.+++.+||+.||++|||+.|+++
T Consensus 225 ~~~-----~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 225 NPE-----LKDE--PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred chh-----hccC--CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 000 0000 0000134567899999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=277.27 Aligned_cols=257 Identities=18% Similarity=0.281 Sum_probs=199.9
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeE
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAI 96 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (314)
..+|+|- +.+.++... .+..||+|.......+.+. .+|..|+++|.+|+|||||+++|+|..++.+|
T Consensus 544 ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r-----------~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 544 EKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNAR-----------NDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred hhhcCcccceeEEEEec-CceEEEEeecCcccchhHH-----------HHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 3467766 555555333 3689999988877655543 67999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
+|+||+++|+|.+++..+.. +.+.......++.||++|++||. +.++||||+.+.|+|++.++.+||+|||+++
T Consensus 612 mI~EYmEnGDLnqFl~ahea---pt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR 685 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHEL---PTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSR 685 (807)
T ss_pred HHHHHHhcCcHHHHHHhccC---cccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCccccc
Confidence 99999999999999988743 12345566779999999999999 9999999999999999999999999999998
Q ss_pred ecCCCCcccc-cccccccccccCcccccCCCCcccchHHHHHHHHHHHh--CCCCcccccCccccccchHHHHHhhhccC
Q 043524 177 SIPEGETHIT-DTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT--GRGILDLVRDAHDLVYPFNEYLKNYFEDN 253 (314)
Q Consensus 177 ~~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (314)
-+-.+..+.. ...+-+.+|||+|.+.-..+++++|+|+||+++||+++ ...||....+.. ..+-....+.++
T Consensus 686 ~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~-----vven~~~~~~~~ 760 (807)
T KOG1094|consen 686 NLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ-----VVENAGEFFRDQ 760 (807)
T ss_pred ccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH-----HHHhhhhhcCCC
Confidence 7766554443 34466889999999999999999999999999999876 677876544322 011111111111
Q ss_pred CcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHH
Q 043524 254 RFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQI 307 (314)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~ 307 (314)
....+ +..+.-++.++.+++..||++|.++|||++++...|.+.
T Consensus 761 ~~~~~----------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 761 GRQVV----------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred Cccee----------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 10000 111224566788999999999999999999999988764
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=265.36 Aligned_cols=253 Identities=18% Similarity=0.268 Sum_probs=195.6
Q ss_pred ccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe--C
Q 043524 16 RTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE--T 92 (314)
Q Consensus 16 ~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~ 92 (314)
....+|.|+ +.++++.+..+|..+|+|.+......... .+.+.+|+++++.++|+||+++++.+.. +
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~----------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (265)
T cd08217 4 VLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKE----------KQQLVSEVNILRELKHPNIVRYYDRIIDRSN 73 (265)
T ss_pred eeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHH----------HHHHHHHHHHHHhcCCCccceeeeeeecCCC
Confidence 334578777 88888888889999999987643321111 1567899999999999999999998764 5
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCC--CCCceeccCCCCCeeecCCCceEEc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGF--PRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
...|+++||+++++|.+++..... ...+++...++.++.+++.||.|||..+ +.+++|+||+|+||+++.++.++++
T Consensus 74 ~~~~~~~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~ 152 (265)
T cd08217 74 QTLYIVMEYCEGGDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLG 152 (265)
T ss_pred CEEEEEehhccCCCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEe
Confidence 568999999999999999865421 1146788999999999999999999543 6789999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhh
Q 043524 171 DFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 171 dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
|||.+........ ......++..|+|||.+....++.++|+||+|+++++|++|..||...... ..... .
T Consensus 153 d~g~~~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~-~ 222 (265)
T cd08217 153 DFGLAKILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL--------QLASK-I 222 (265)
T ss_pred cccccccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH--------HHHHH-H
Confidence 9999987644332 123456899999999998888999999999999999999999998643311 11111 1
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.... . ...+...+..+.+++..||..+|++|||+.+|++
T Consensus 223 ~~~~------------~-~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 223 KEGK------------F-RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred hcCC------------C-CCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 1100 0 0111144567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=263.64 Aligned_cols=251 Identities=20% Similarity=0.256 Sum_probs=188.3
Q ss_pred cccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe--
Q 043524 15 KRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE-- 91 (314)
Q Consensus 15 ~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-- 91 (314)
.....+|.|+ +.++++.+..+|+.+|+|.+......... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 77 (266)
T cd06651 5 RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPET-------SKEVSALECEIQLLKNLQHERIVQYYGCLRDRA 77 (266)
T ss_pred cccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchh-------HHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCC
Confidence 3445678887 78888888888999999987643211000 0011457889999999999999999999875
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
+...++++||+++++|.+.+.... .++......++.|++.||+||| +.+++|+||+|+||+++.++.++|+|
T Consensus 78 ~~~~~l~~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~d 149 (266)
T cd06651 78 EKTLTIFMEYMPGGSVKDQLKAYG-----ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGD 149 (266)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEcc
Confidence 467889999999999999987542 4678888899999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCc--ccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhh
Q 043524 172 FSLSISIPEGET--HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNY 249 (314)
Q Consensus 172 fg~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (314)
||+++....... .......++..|+|||.+....++.++|+||+|+++|+|++|+.||....... . ....
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~-------~-~~~~ 221 (266)
T cd06651 150 FGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA-------A-IFKI 221 (266)
T ss_pred CCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH-------H-HHHH
Confidence 999875432111 11223457889999999988889999999999999999999999986432111 0 0000
Q ss_pred hccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 250 FEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
... ......+...+..+.+++ .||..+|++|||+.|+++
T Consensus 222 ~~~-------------~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 222 ATQ-------------PTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred hcC-------------CCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 000 000111113445677788 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=272.77 Aligned_cols=267 Identities=19% Similarity=0.208 Sum_probs=188.0
Q ss_pred ccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeEEE
Q 043524 20 IGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILV 98 (314)
Q Consensus 20 ~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~iv 98 (314)
.|.|+ +.|+.+.+..+|+.||+|++........ ..+.+.+|+.++..++||||+++++++..++..|+|
T Consensus 8 ~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v 77 (328)
T cd08226 8 RGFCNLTSVYLARHTPTGTLVTVRITDLENCTEE----------HLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVI 77 (328)
T ss_pred CcccCceeEEEEEEcCCCcEEEEEEeccccCCHH----------HHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEE
Confidence 34445 6788888888999999998764321111 125678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccceec
Q 043524 99 FEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISI 178 (314)
Q Consensus 99 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~ 178 (314)
+||+.++++.+.+..... ..++...+..++.|++.||+||| +++++||||||+||+++.++.++++||+.+...
T Consensus 78 ~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~ 151 (328)
T cd08226 78 SPFMAYGSANSLLKTYFP---EGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSL 151 (328)
T ss_pred EecccCCCHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhh
Confidence 999999999998876432 34788888899999999999999 999999999999999999999999999754322
Q ss_pred CCCCcc------cccccccccccccCcccccC--CCCcccchHHHHHHHHHHHhCCCCcccccCcccccc--------ch
Q 043524 179 PEGETH------ITDTVMGTYGHLAPQYVTTC--DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVY--------PF 242 (314)
Q Consensus 179 ~~~~~~------~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~--------~~ 242 (314)
...... ......++..|+|||++.+. .++.++||||+||++|+|++|..||........... ++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd08226 152 VRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPL 231 (328)
T ss_pred hccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCc
Confidence 111100 01112346679999998764 478999999999999999999999964432110000 00
Q ss_pred -----HHHHHhhhcc-CCcc-----cccC-----hhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 243 -----NEYLKNYFED-NRFT-----EIVD-----PIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 243 -----~~~~~~~~~~-~~~~-----~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.......... .... .... .........+.....+..+.+|+..||..||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 232 DITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred cccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0000000000 0000 0000 000011112223356778999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=285.34 Aligned_cols=233 Identities=15% Similarity=0.159 Sum_probs=163.7
Q ss_pred HHHHHHHHHHhcCCCCceeeeEeEEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcC
Q 043524 65 ESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFG 144 (314)
Q Consensus 65 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~ 144 (314)
..+.+|+.+|..++|||||++++++...+..|+++|++. +++...+..................++.|++.||.|||
T Consensus 208 ~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH-- 284 (501)
T PHA03210 208 IQLENEILALGRLNHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH-- 284 (501)
T ss_pred HHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH--
Confidence 567899999999999999999999999999999999994 57877765432111122345667789999999999999
Q ss_pred CCCCceeccCCCCCeeecCCCceEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh
Q 043524 145 FPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT 224 (314)
Q Consensus 145 ~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~ 224 (314)
+++|+||||||+||+++.++.++|+|||+++.+............||..|+|||++.+..++.++|||||||++|||++
T Consensus 285 -~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~ 363 (501)
T PHA03210 285 -DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363 (501)
T ss_pred -hCCeecCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999998765443333345679999999999998889999999999999999999
Q ss_pred CCCCcccccCccccccchHHHHHhhh-ccCCccc-------ccChh-hh---ccC-CchhHHHHHHHHHHHHhHhccCCC
Q 043524 225 GRGILDLVRDAHDLVYPFNEYLKNYF-EDNRFTE-------IVDPI-IV---QDL-SCTEKEQQLHASAQLTFECLNESP 291 (314)
Q Consensus 225 g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-------~~~~~-~~---~~~-~~~~~~~~~~~~~~li~~cl~~dp 291 (314)
|..++........ ...+........ ....+.+ .++.. +. ... ........+..+.+++.+||..||
T Consensus 364 ~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP 442 (501)
T PHA03210 364 HDFCPIGDGGGKP-GKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDW 442 (501)
T ss_pred CCCCCccCCCCCH-HHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCc
Confidence 8754322111100 000000000000 0000000 00000 00 000 000001223457889999999999
Q ss_pred CCCCCHHHHHH
Q 043524 292 IDRPTMVDVAR 302 (314)
Q Consensus 292 ~~Rps~~ell~ 302 (314)
++|||+.|++.
T Consensus 443 ~~Rpsa~elL~ 453 (501)
T PHA03210 443 HLRPGAAELLA 453 (501)
T ss_pred ccCcCHHHHhh
Confidence 99999999986
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=264.29 Aligned_cols=253 Identities=19% Similarity=0.319 Sum_probs=189.5
Q ss_pred cccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCC
Q 043524 15 KRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETP 93 (314)
Q Consensus 15 ~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (314)
.....+|.|+ +.|+.+. ..+|+.+|+|.+......... .....+.+.+|+.+++.++|+||+++.+++.+++
T Consensus 3 ~~~~~ig~g~~~~v~~~~-~~~~~~~avk~~~~~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 75 (265)
T cd06631 3 TKGEVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLA------AEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDN 75 (265)
T ss_pred cccceEeccCCeEEEEEE-EcCCCeEEEEEeecCccchhh------HHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCC
Confidence 3445577777 6666553 457889999987643210000 0001256789999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccc
Q 043524 94 IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFS 173 (314)
Q Consensus 94 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg 173 (314)
..++++||+++++|.+++.... +++...+..++.|++.||.||| +.+++|+||+|+||+++.++.++++|||
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg 147 (265)
T cd06631 76 TISIFMEFVPGGSISSILNRFG-----PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFG 147 (265)
T ss_pred eEEEEEecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccch
Confidence 9999999999999999986542 4678888899999999999999 9999999999999999999999999999
Q ss_pred cceecCCCC-----cccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHh
Q 043524 174 LSISIPEGE-----THITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKN 248 (314)
Q Consensus 174 ~~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (314)
.+....... ........++..|+|||.+.+..++.++|+||+|+++|+|++|..||....... ....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-------~~~~- 219 (265)
T cd06631 148 CARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-------AMFY- 219 (265)
T ss_pred hhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-------HHHH-
Confidence 987543211 111223468889999999988889999999999999999999999996432111 0000
Q ss_pred hhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 249 YFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
....... . + ..+...+..+.+++.+||..||++|||+.+++.
T Consensus 220 ~~~~~~~---~-~--------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 220 IGAHRGL---M-P--------RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred hhhccCC---C-C--------CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000 0 0 001134566889999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=266.07 Aligned_cols=244 Identities=21% Similarity=0.335 Sum_probs=190.6
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC---CCceeeeEeEEEeC
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS---HDHILKLIGCCLET 92 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~ 92 (314)
...+|.|+ +.++.+.+..+|+.+|+|.+........ .+.+.+|+.+++.++ |||++++++++..+
T Consensus 6 ~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~-----------~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~ 74 (277)
T cd06917 6 LELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD-----------VSDIQREVALLSQLRQSQPPNITKYYGSYLKG 74 (277)
T ss_pred hhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchh-----------HHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC
Confidence 34578888 8888888888999999998754321111 145678999998886 99999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~df 172 (314)
...|++|||+++++|.+++... .++...+..++.+++.||.||| +.+++|+||+|+||+++..+.++++||
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~df 145 (277)
T cd06917 75 PRLWIIMEYAEGGSVRTLMKAG------PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDF 145 (277)
T ss_pred CEEEEEEecCCCCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccC
Confidence 9999999999999999988642 4788899999999999999999 999999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCcccccC-CCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhc
Q 043524 173 SLSISIPEGETHITDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFE 251 (314)
Q Consensus 173 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (314)
|.+........ ......|+..|+|||.+... .++.++|+||+|+++|+|++|..||....... .... ..
T Consensus 146 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--------~~~~-~~ 215 (277)
T cd06917 146 GVAALLNQNSS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR--------AMML-IP 215 (277)
T ss_pred CceeecCCCcc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh--------hhhc-cc
Confidence 99877654332 23345688999999988654 46889999999999999999999996433211 0000 00
Q ss_pred cCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 252 DNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
. ...+.+ .. ...+.++.+++..||+.||++|||+.+++.
T Consensus 216 ~-----~~~~~~------~~-~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 216 K-----SKPPRL------ED-NGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred c-----CCCCCC------Cc-ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 0 000000 00 014457889999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=269.06 Aligned_cols=270 Identities=22% Similarity=0.323 Sum_probs=193.7
Q ss_pred cccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCC
Q 043524 15 KRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETP 93 (314)
Q Consensus 15 ~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (314)
.....+|.|+ +.++.+....+++.+|+|.+........ ..+.+.+|+++++.++|+||+++.+++..++
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 73 (288)
T cd07833 4 EVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDED----------VKKTALREVKVLRQLRHENIVNLKEAFRRKG 73 (288)
T ss_pred eEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccccc----------chhHHHHHHHHHHhcCCCCeeehhheEEECC
Confidence 3344578877 7788888888899999998865432111 1257889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccc
Q 043524 94 IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFS 173 (314)
Q Consensus 94 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg 173 (314)
..++++||++++.+....... ..++...+..++.+++.|+.||| +++++|+||+|+||+++.++.++|+|||
T Consensus 74 ~~~iv~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g 145 (288)
T cd07833 74 RLYLVFEYVERTLLELLEASP-----GGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFG 145 (288)
T ss_pred EEEEEEecCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeee
Confidence 999999999876665554432 34788999999999999999999 9999999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCcccccC-CCCcccchHHHHHHHHHHHhCCCCcccccCcccccc------chHHHH
Q 043524 174 LSISIPEGETHITDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVY------PFNEYL 246 (314)
Q Consensus 174 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~------~~~~~~ 246 (314)
.+...............++..|+|||++... .++.++|+||+|+++|+|++|..||........... .+....
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (288)
T cd07833 146 FARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSH 225 (288)
T ss_pred cccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9877654432223345678899999999887 788999999999999999999999864332110000 000000
Q ss_pred Hhhh-ccCCccc--ccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 247 KNYF-EDNRFTE--IVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 247 ~~~~-~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
...+ ....... ..+...........+...+.++.+|+.+||..||++|||++++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 226 QELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred hhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000 0000000 000000000000001123677899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=268.52 Aligned_cols=248 Identities=21% Similarity=0.280 Sum_probs=185.3
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHH-HhcCCCCceeeeEeEEEeCCe
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTY-AAQMSHDHILKLIGCCLETPI 94 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~ 94 (314)
...+|.|+ +.|+++.+..+|+.||+|.+........ ...+..|+.. ++.++||||+++++++..++.
T Consensus 6 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~ 74 (283)
T cd06617 6 IEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-----------QKRLLMDLDISMRSVDCPYTVTFYGALFREGD 74 (283)
T ss_pred EEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-----------HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCc
Confidence 34577777 8888888888999999998765421111 1345556654 566789999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCC-CceeccCCCCCeeecCCCceEEcccc
Q 043524 95 AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPR-PIVFRDFKTSHILFSEENVVKLFDFS 173 (314)
Q Consensus 95 ~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~-~i~H~dlk~~nil~~~~~~~kl~dfg 173 (314)
.|+++||++ |+|.+.+....... ..+++..+..++.|++.|+.||| ++ +++|+||||+||+++.++.++|+|||
T Consensus 75 ~~lv~e~~~-~~l~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg 149 (283)
T cd06617 75 VWICMEVMD-TSLDKFYKKVYDKG-LTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFG 149 (283)
T ss_pred EEEEhhhhc-ccHHHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecc
Confidence 999999996 68887776432211 35789999999999999999999 87 99999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCccccc----CCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhh
Q 043524 174 LSISIPEGETHITDTVMGTYGHLAPQYVTT----CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNY 249 (314)
Q Consensus 174 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (314)
.+........ .....++..|+|||.+.. ..++.++|+||+|+++|+|++|..||...... +.. ....
T Consensus 150 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~-~~~~ 220 (283)
T cd06617 150 ISGYLVDSVA--KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP------FQQ-LKQV 220 (283)
T ss_pred cccccccccc--cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC------HHH-HHHH
Confidence 9876533211 223467889999998865 34688999999999999999999998532211 010 1111
Q ss_pred hccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 250 FEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
... ..........+.++.+++..||..+|++|||+.++++
T Consensus 221 ~~~-------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 221 VEE-------------PSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred Hhc-------------CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 100 0000001134567899999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=268.67 Aligned_cols=269 Identities=20% Similarity=0.219 Sum_probs=189.6
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
|.....+|.|+ +.|+.+....+|+.+|+|.+....... ....+.+|+.+++.++|+||+++++++..+
T Consensus 7 y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-----------~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 75 (291)
T cd07870 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG-----------VPFTAIREASLLKGLKHANIVLLHDIIHTK 75 (291)
T ss_pred eEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC-----------CcHHHHHHHHHHHhcCCCCEeEEEEEEecC
Confidence 44455688888 788888888889999999886432111 013567899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~df 172 (314)
...|+|+||+. +++.+.+.... ..++...+..++.|++.||.||| +++++|+||||+||+++.++.++|+||
T Consensus 76 ~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Df 147 (291)
T cd07870 76 ETLTFVFEYMH-TDLAQYMIQHP----GGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADF 147 (291)
T ss_pred CeEEEEEeccc-CCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEecc
Confidence 99999999995 68877775433 34677788889999999999999 999999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCcccccC-CCCcccchHHHHHHHHHHHhCCCCcccccCcccccc--------chH
Q 043524 173 SLSISIPEGETHITDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVY--------PFN 243 (314)
Q Consensus 173 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~--------~~~ 243 (314)
|+++....... ......+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||+......+... +..
T Consensus 148 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 226 (291)
T cd07870 148 GLARAKSIPSQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTE 226 (291)
T ss_pred ccccccCCCCC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCCh
Confidence 99875433221 12334578899999988754 478899999999999999999999975443211000 000
Q ss_pred HHHHhhhccCCcccccChh-hhccCC-chhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 244 EYLKNYFEDNRFTEIVDPI-IVQDLS-CTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.............+..... ...... .......+..+.+++.+||..||++|||+.|++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 227 DTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000000000000000 000000 0000011356789999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=267.99 Aligned_cols=247 Identities=19% Similarity=0.225 Sum_probs=195.3
Q ss_pred ccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCe
Q 043524 16 RTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPI 94 (314)
Q Consensus 16 ~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 94 (314)
....+|.|+ +.++.+.+..+|+.+|+|++......... ..+.+.+|+++++.++||||+++++.+.++..
T Consensus 4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 74 (258)
T cd05578 4 LLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKG---------SVRNVLNERRILQELNHPFLVNLWYSFQDEEN 74 (258)
T ss_pred EEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchh---------HHHHHHHHHHHHHhCCCCChHHHHHhhcCCCe
Confidence 344578877 88888888888999999999865432211 12678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccc
Q 043524 95 AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL 174 (314)
Q Consensus 95 ~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~ 174 (314)
.++|+||+.+++|.+.+... .+++...+..++.|++.||.||| +++++|+||+|+||+++.++.++++|||.
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~ 146 (258)
T cd05578 75 MYLVVDLLLGGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNI 146 (258)
T ss_pred EEEEEeCCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeeccc
Confidence 99999999999999998764 25788899999999999999999 99999999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCC
Q 043524 175 SISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNR 254 (314)
Q Consensus 175 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (314)
+........ .....++..|+|||.+....++.++|+||+|+++|+|++|..||....... ..........
T Consensus 147 ~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~~-- 216 (258)
T cd05578 147 ATKVTPDTL--TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI------RDQIRAKQET-- 216 (258)
T ss_pred ccccCCCcc--ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH------HHHHHHHhcc--
Confidence 876544321 234567889999999988889999999999999999999999987544210 1111111000
Q ss_pred cccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCH--HHHH
Q 043524 255 FTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTM--VDVA 301 (314)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~--~ell 301 (314)
.....+...+..+.+++.+||..||.+||++ .|++
T Consensus 217 ------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 217 ------------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ------------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0001111344678899999999999999999 6554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=263.79 Aligned_cols=251 Identities=20% Similarity=0.327 Sum_probs=194.0
Q ss_pred cccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCC
Q 043524 15 KRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETP 93 (314)
Q Consensus 15 ~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (314)
.....+|.|+ +.++.+....+++.+++|.+........ ..+.+.+|+.+++.++|+||+++++.+.+.+
T Consensus 3 ~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 72 (264)
T cd06626 3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPK----------TIKEIADEMKVLELLKHPNLVKYYGVEVHRE 72 (264)
T ss_pred eeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchH----------HHHHHHHHHHHHHhCCCCChhheeeeEecCC
Confidence 3445578777 7777777777899999999875543210 1267889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccc
Q 043524 94 IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFS 173 (314)
Q Consensus 94 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg 173 (314)
..++|+||+++++|.+.+.... .++...+..++.+++.|+.||| +.+++|+||+|+||+++.++.++|+|||
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g 144 (264)
T cd06626 73 KVYIFMEYCSGGTLEELLEHGR-----ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFG 144 (264)
T ss_pred EEEEEEecCCCCcHHHHHhhcC-----CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccc
Confidence 9999999999999999987542 3677888899999999999999 9999999999999999999999999999
Q ss_pred cceecCCCCccccc---ccccccccccCcccccCC---CCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHH
Q 043524 174 LSISIPEGETHITD---TVMGTYGHLAPQYVTTCD---FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLK 247 (314)
Q Consensus 174 ~~~~~~~~~~~~~~---~~~g~~~y~aPE~~~~~~---~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (314)
.+............ ...++..|+|||.+.... ++.++||||+|++++++++|..||....... .....
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~------~~~~~ 218 (264)
T cd06626 145 CAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF------QIMFH 218 (264)
T ss_pred cccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH------HHHHH
Confidence 98776543332221 346788999999988766 7899999999999999999999996432111 00000
Q ss_pred hhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 248 NYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
... .. .+ ..+.....+..+.+++..||+.||++|||+.+++.
T Consensus 219 --~~~-~~----~~------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 219 --VGA-GH----KP------PIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred --Hhc-CC----CC------CCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000 00 00 00111123566789999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=265.92 Aligned_cols=262 Identities=23% Similarity=0.257 Sum_probs=186.8
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC-CCceeeeEeEEEeC--C
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS-HDHILKLIGCCLET--P 93 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~ 93 (314)
..+|.|+ +.++.+....+++.+|+|.+........ + ....+|+.++..+. |+||+++++++.++ +
T Consensus 5 ~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-----~------~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 73 (282)
T cd07831 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-----Q------VNNLREIQALRRLSPHPNILRLIEVLFDRKTG 73 (282)
T ss_pred eeccccccceEEEEEEcCCCcEEEEEEehhccCCch-----h------hhHHHHHHHHhhcCCCCCccceEEEEecCCCC
Confidence 3477777 7788888888899999998764321000 0 23457888898885 99999999999987 8
Q ss_pred eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccc
Q 043524 94 IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFS 173 (314)
Q Consensus 94 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg 173 (314)
.+++|+||++ +++.+.+.... ..+++..+..++.|++.||.||| +++++|+||+|+||+++. +.++|+|||
T Consensus 74 ~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg 144 (282)
T cd07831 74 RLALVFELMD-MNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFG 144 (282)
T ss_pred cEEEEEecCC-ccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecc
Confidence 8999999996 58888886543 35788999999999999999999 999999999999999999 999999999
Q ss_pred cceecCCCCcccccccccccccccCccccc-CCCCcccchHHHHHHHHHHHhCCCCcccccCcccc-------ccchHHH
Q 043524 174 LSISIPEGETHITDTVMGTYGHLAPQYVTT-CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDL-------VYPFNEY 245 (314)
Q Consensus 174 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~-------~~~~~~~ 245 (314)
.++....... .....++..|+|||.+.. ..++.++|+||+||++|+|++|..||......+.. ..+...+
T Consensus 145 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 222 (282)
T cd07831 145 SCRGIYSKPP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV 222 (282)
T ss_pred cccccccCCC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 9976543322 223457889999997654 44688999999999999999999999654321100 0000111
Q ss_pred HHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 246 LKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
..............+..............+..+.+++.+||+.||++|||+.++++
T Consensus 223 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 223 -LKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred -HHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00110000000000000000000111244678999999999999999999999985
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=263.23 Aligned_cols=247 Identities=19% Similarity=0.294 Sum_probs=196.9
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeE
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAI 96 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (314)
..+|.|+ +.++++....+|+.+++|.+....... ..+.+.+|+..+..++|+||+++++++..++..+
T Consensus 7 ~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~-----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (264)
T cd06623 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEE-----------FRKQLLRELKTLRSCESPYVVKCYGAFYKEGEIS 75 (264)
T ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchH-----------HHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEE
Confidence 4577766 777888888889999999887653211 1267889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCC-CCceeccCCCCCeeecCCCceEEcccccc
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFP-RPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~-~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
+++||+++++|.+++... .+++......++.|++.|+.||| + .+++|+||+|+||+++.++.++|+|||.+
T Consensus 76 lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~ 147 (264)
T cd06623 76 IVLEYMDGGSLADLLKKV-----GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGIS 147 (264)
T ss_pred EEEEecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccc
Confidence 999999999999998764 35788999999999999999999 8 99999999999999999999999999998
Q ss_pred eecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCc
Q 043524 176 ISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRF 255 (314)
Q Consensus 176 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (314)
......... .....++..|+|||.+....++.++|+||||+++|+|++|..||...... .+.+........
T Consensus 148 ~~~~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-----~~~~~~~~~~~~--- 218 (264)
T cd06623 148 KVLENTLDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP-----SFFELMQAICDG--- 218 (264)
T ss_pred eecccCCCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc-----CHHHHHHHHhcC---
Confidence 776433321 22446788999999998888899999999999999999999998654420 111111111110
Q ss_pred ccccChhhhccCCchhHHH-HHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 043524 256 TEIVDPIIVQDLSCTEKEQ-QLHASAQLTFECLNESPIDRPTMVDVARR 303 (314)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~cl~~dp~~Rps~~ell~~ 303 (314)
.. ...... .+..+.+++..||..+|++|||+.++++.
T Consensus 219 ----------~~-~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 219 ----------PP-PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ----------CC-CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00 001112 55678999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=275.49 Aligned_cols=272 Identities=19% Similarity=0.274 Sum_probs=195.8
Q ss_pred hhhhhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeE
Q 043524 8 FKLWSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLI 86 (314)
Q Consensus 8 ~~~~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 86 (314)
+....+|.....+|.|+ +.|+.+.+..+|+.+|+|.+........ ..+.+.+|+.++..++|+||++++
T Consensus 12 ~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~E~~~l~~l~h~~iv~~~ 81 (353)
T cd07850 12 FTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVT----------HAKRAYRELVLMKLVNHKNIIGLL 81 (353)
T ss_pred hhhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChh----------HHHHHHHHHHHHHhcCCCCCccee
Confidence 34556677777789988 8888888888999999998753211000 114567899999999999999999
Q ss_pred eEEEeC------CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCee
Q 043524 87 GCCLET------PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHIL 160 (314)
Q Consensus 87 ~~~~~~------~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil 160 (314)
+++... ...|+|+||+. ++|.+.+.. .++...+..++.|++.||.||| +++++|+||||+||+
T Consensus 82 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil 150 (353)
T cd07850 82 NVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIV 150 (353)
T ss_pred eeeccCCCccccCcEEEEEeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEE
Confidence 998643 35799999995 588887753 2677888899999999999999 999999999999999
Q ss_pred ecCCCceEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCcccc--
Q 043524 161 FSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDL-- 238 (314)
Q Consensus 161 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~-- 238 (314)
++.++.++|+|||.++....... .....++..|+|||.+.+..++.++||||+||++|+|++|+.||.........
T Consensus 151 ~~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~ 228 (353)
T cd07850 151 VKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNK 228 (353)
T ss_pred ECCCCCEEEccCccceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 99999999999999976543221 23446788999999998888999999999999999999999999643321100
Q ss_pred -----ccchHHHH-------Hhhhcc-C-----CcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHH
Q 043524 239 -----VYPFNEYL-------KNYFED-N-----RFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDV 300 (314)
Q Consensus 239 -----~~~~~~~~-------~~~~~~-~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el 300 (314)
..+..++. ...... . .+.+..................+..+.+++..||+.||++|||+.|+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ei 308 (353)
T cd07850 229 IIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDA 308 (353)
T ss_pred HHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHH
Confidence 00000000 000000 0 00011111110000000011345678999999999999999999999
Q ss_pred HH
Q 043524 301 AR 302 (314)
Q Consensus 301 l~ 302 (314)
+.
T Consensus 309 L~ 310 (353)
T cd07850 309 LQ 310 (353)
T ss_pred hc
Confidence 86
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=259.86 Aligned_cols=278 Identities=19% Similarity=0.251 Sum_probs=202.4
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCc----ccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGK----YIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLI 86 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~----~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 86 (314)
..|+....+|.|. +.||++..+.+.. .+|+|.|.-+.- ..-++.+..+|+.+++.++|||||.+.
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd----------~tGiS~SAcREiaL~REl~h~nvi~Lv 93 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD----------GTGISMSACREIALLRELKHPNVISLV 93 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC----------CCCcCHHHHHHHHHHHHhcCCcchhHH
Confidence 3455556689999 8888886555432 688886643311 111346788999999999999999999
Q ss_pred eEEEe-CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCC-
Q 043524 87 GCCLE-TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEE- 164 (314)
Q Consensus 87 ~~~~~-~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~- 164 (314)
.++.+ +..+|+++||.+. +|..+|.-+.......++...+..++.||+.|+.||| ++-|+||||||.||++..+
T Consensus 94 ~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdg 169 (438)
T KOG0666|consen 94 KVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDG 169 (438)
T ss_pred HHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccC
Confidence 99987 8899999999976 9999998665544456889999999999999999999 9999999999999999877
Q ss_pred ---CceEEcccccceecCCCC--cccccccccccccccCcccccCC-CCcccchHHHHHHHHHHHhCCCCcccccCcccc
Q 043524 165 ---NVVKLFDFSLSISIPEGE--THITDTVMGTYGHLAPQYVTTCD-FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDL 238 (314)
Q Consensus 165 ---~~~kl~dfg~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~ 238 (314)
|.+||+|+|+++.+...- .......+-|..|.|||++++.. |+.+.|+|++||++.||++-.+.|.+.+.....
T Consensus 170 perG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~ 249 (438)
T KOG0666|consen 170 PERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKT 249 (438)
T ss_pred CccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhccc
Confidence 899999999998875432 11244567899999999999987 899999999999999999999998765543332
Q ss_pred ccchH-HHHHhhhc------cCCccccc---------Chhh-hccCCchhHH------HHHHHHHHHHhHhccCCCCCCC
Q 043524 239 VYPFN-EYLKNYFE------DNRFTEIV---------DPII-VQDLSCTEKE------QQLHASAQLTFECLNESPIDRP 295 (314)
Q Consensus 239 ~~~~~-~~~~~~~~------~~~~~~~~---------~~~~-~~~~~~~~~~------~~~~~~~~li~~cl~~dp~~Rp 295 (314)
..||- +.+...++ +..|..+. .... ..-.++.... .-++...+|+..+|.+||.+|.
T Consensus 250 ~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRI 329 (438)
T KOG0666|consen 250 KNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRI 329 (438)
T ss_pred CCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhc
Confidence 22222 22222221 11121111 0000 0011110000 0123368999999999999999
Q ss_pred CHHHHHHH
Q 043524 296 TMVDVARR 303 (314)
Q Consensus 296 s~~ell~~ 303 (314)
|+++.++.
T Consensus 330 ta~qAleh 337 (438)
T KOG0666|consen 330 TAEQALEH 337 (438)
T ss_pred cHHHHhcc
Confidence 99998873
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=266.67 Aligned_cols=243 Identities=17% Similarity=0.233 Sum_probs=185.0
Q ss_pred ccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHH---HHHhcCCCCceeeeEeEEEeCCee
Q 043524 20 IGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNV---TYAAQMSHDHILKLIGCCLETPIA 95 (314)
Q Consensus 20 ~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~niv~~~~~~~~~~~~ 95 (314)
+|+|+ +.|+.+.+..+|+.||+|.+..+........ ..+.+|. +.++...||||+++.+.+.+.+..
T Consensus 2 ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 72 (278)
T cd05606 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE---------TLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 72 (278)
T ss_pred cccCCCeEEEEEEEecCCCEEEEEEeeccccccchhH---------HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEE
Confidence 67777 7888887888899999999876432211100 1223333 445556799999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
|+|+||+++|+|.+.+... ..+++..+..++.|++.|+.||| +.+++|+||||+||+++.++.++++|||++
T Consensus 73 ~~v~e~~~g~~L~~~l~~~-----~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~ 144 (278)
T cd05606 73 SFILDLMNGGDLHYHLSQH-----GVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA 144 (278)
T ss_pred EEEEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCc
Confidence 9999999999999888654 35889999999999999999999 999999999999999999999999999998
Q ss_pred eecCCCCcccccccccccccccCcccccC-CCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCC
Q 043524 176 ISIPEGETHITDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNR 254 (314)
Q Consensus 176 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (314)
....... .....|+..|+|||++... .++.++||||+|+++|+|++|+.||........ ......
T Consensus 145 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~-----~~~~~~------ 210 (278)
T cd05606 145 CDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRM------ 210 (278)
T ss_pred cccCccC---CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch-----HHHHHH------
Confidence 7553322 2345689999999998754 588999999999999999999999975432110 000000
Q ss_pred cccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCC-----CHHHHHH
Q 043524 255 FTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRP-----TMVDVAR 302 (314)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 302 (314)
....... .+...+.++.+++.+||..||.+|| ++.++++
T Consensus 211 -------~~~~~~~--~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 211 -------TLTMAVE--LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred -------hhccCCC--CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 0000000 1112356789999999999999999 9999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=262.08 Aligned_cols=249 Identities=17% Similarity=0.196 Sum_probs=187.4
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC--C
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET--P 93 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~ 93 (314)
...+|.|+ +.|+.+.+..+|+.+|+|.+....... ......+.+.+|+.++..++||||+++++++.+. .
T Consensus 7 ~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 79 (265)
T cd06652 7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESP-------ETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMER 79 (265)
T ss_pred eeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCc-------ccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCc
Confidence 44577776 778888888899999999875321100 0000115678899999999999999999998763 5
Q ss_pred eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccc
Q 043524 94 IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFS 173 (314)
Q Consensus 94 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg 173 (314)
.+++++||+++++|.+++.... .++......++.+++.||.||| +++++|+||+|+||+++.++.++|+|||
T Consensus 80 ~~~~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg 151 (265)
T cd06652 80 TLSIFMEHMPGGSIKDQLKSYG-----ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFG 151 (265)
T ss_pred eEEEEEEecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCc
Confidence 6889999999999999887542 4677888899999999999999 9999999999999999999999999999
Q ss_pred cceecCCCCc--ccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhc
Q 043524 174 LSISIPEGET--HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFE 251 (314)
Q Consensus 174 ~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (314)
.++....... .......++..|+|||.+....++.++|+||||+++|+|++|+.||....... .. .....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-------~~-~~~~~ 223 (265)
T cd06652 152 ASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-------AI-FKIAT 223 (265)
T ss_pred cccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-------HH-HHHhc
Confidence 9875432111 11223458889999999988888999999999999999999999986332111 00 00000
Q ss_pred cCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 252 DNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
. ......+...+..+.+++.+||. +|++|||++|+++
T Consensus 224 ~-------------~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 224 Q-------------PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred C-------------CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0 00011112455678899999995 9999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=270.20 Aligned_cols=264 Identities=18% Similarity=0.246 Sum_probs=189.9
Q ss_pred ccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCe
Q 043524 16 RTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPI 94 (314)
Q Consensus 16 ~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 94 (314)
....+|.|+ +.++++....+|+.+|+|.+....... ...+.+.+|+++++.++||||+++++++.++..
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~----------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 73 (284)
T cd07860 4 KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE----------GVPSTAIREISLLKELNHPNIVKLLDVIHTENK 73 (284)
T ss_pred eeeeecCCCceEEEEEEECCCCCEEEEEEcccccccc----------ccchHHHHHHHHHHhcCCCCCcchhhhcccCCc
Confidence 344577777 888888888899999999875432110 011467899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccc
Q 043524 95 AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL 174 (314)
Q Consensus 95 ~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~ 174 (314)
.+++|||+. ++|..++..... ..++...+..++.|++.||.||| +++++|+||+|+||+++.++.++++|||.
T Consensus 74 ~~~v~e~~~-~~l~~~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~ 146 (284)
T cd07860 74 LYLVFEFLH-QDLKKFMDASPL---SGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGL 146 (284)
T ss_pred EEEEeeccc-cCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence 999999995 689888865432 35788999999999999999999 99999999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCcccccCC-CCcccchHHHHHHHHHHHhCCCCcccccCccccccchH-------HHH
Q 043524 175 SISIPEGETHITDTVMGTYGHLAPQYVTTCD-FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFN-------EYL 246 (314)
Q Consensus 175 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~-------~~~ 246 (314)
+........ ......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||.............. ...
T Consensus 147 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07860 147 ARAFGVPVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 225 (284)
T ss_pred hhhcccCcc-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Confidence 876533211 122334678899999887655 58889999999999999999999964332111000000 000
Q ss_pred Hhhhcc----CCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 247 KNYFED----NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 247 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
...... .............. ....+..+.+++.+||+.||++|||+.+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 226 PGVTSLPDYKPSFPKWARQDFSKV-----VPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhhhHHHHHHhhcccccccCHHHH-----cccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000 00000000000000 0123456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=268.36 Aligned_cols=251 Identities=20% Similarity=0.250 Sum_probs=186.8
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC-CCceeeeEeEEEeCCee
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS-HDHILKLIGCCLETPIA 95 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 95 (314)
..+|.|+ +.|+.+.+..+|+.+|+|.+........ ...+.+|+.++.++. |+||+++++++..++..
T Consensus 10 ~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~-----------~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~ 78 (288)
T cd06616 10 GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKE-----------QKRLLMDLDVVMRSSDCPYIVKFYGALFREGDC 78 (288)
T ss_pred HHhCCCCceEEEEEEECCCCCEEEEEEehhccChHH-----------HHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcE
Confidence 3578887 8888888888999999998875432211 156789999999996 99999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCC-CCceeccCCCCCeeecCCCceEEccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFP-RPIVFRDFKTSHILFSEENVVKLFDFSL 174 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~-~~i~H~dlk~~nil~~~~~~~kl~dfg~ 174 (314)
++++||+. +++.+............++...+..++.+++.||+||| + .+++||||||+||+++.++.++|+|||+
T Consensus 79 ~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 154 (288)
T cd06616 79 WICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK---EELKIIHRDVKPSNILLDRNGNIKLCDFGI 154 (288)
T ss_pred EEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hcCCeeccCCCHHHEEEccCCcEEEeecch
Confidence 99999985 46655432110000135788999999999999999999 6 5999999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCcccccC---CCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhc
Q 043524 175 SISIPEGETHITDTVMGTYGHLAPQYVTTC---DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFE 251 (314)
Q Consensus 175 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (314)
++....... .....|+..|+|||.+... .++.++||||+|+++|+|++|+.||..... ..+.......
T Consensus 155 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~ 225 (288)
T cd06616 155 SGQLVDSIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-------VFDQLTQVVK 225 (288)
T ss_pred hHHhccCCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-------HHHHHhhhcC
Confidence 876533221 2234678899999998776 588999999999999999999999864321 0010111000
Q ss_pred cCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 252 DNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
. . .+.+... .....+.++.+|+..||+.||++|||+.+++.
T Consensus 226 ~-~-----~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 226 G-D-----PPILSNS----EEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred C-C-----CCcCCCc----CCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0 0011001 00135567899999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=263.32 Aligned_cols=254 Identities=21% Similarity=0.348 Sum_probs=187.7
Q ss_pred cccCch-hHHHHHHH---hcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCC-
Q 043524 19 MIGNGA-SVLQELIA---SSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETP- 93 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~---~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~- 93 (314)
.+|.|+ +.|+.+.. ..+|..+|+|++........ -.+++.+|+++++.++||||+++++++....
T Consensus 6 ~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 75 (273)
T cd05074 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSS----------DIEEFLREAACMKEFDHPNVIKLIGVSLRSRA 75 (273)
T ss_pred cccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChH----------HHHHHHHHHHHHhcCCCCCcceEEEEEccCCC
Confidence 477777 67776653 34578899998865321111 0156789999999999999999999987532
Q ss_pred -----eeEEEEeecCCCCHHHHHhcCCC-CCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCce
Q 043524 94 -----IAILVFEYVQHGTLWDRILGAPQ-THFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVV 167 (314)
Q Consensus 94 -----~~~iv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~ 167 (314)
..++++||+.+|+|.+++..... .....++......++.|++.||.||| +++|+|+||||+||+++.++.+
T Consensus 76 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~ 152 (273)
T cd05074 76 KGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTV 152 (273)
T ss_pred CCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCE
Confidence 24788999999999887753221 11124678889999999999999999 9999999999999999999999
Q ss_pred EEcccccceecCCCCcc-cccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHH
Q 043524 168 KLFDFSLSISIPEGETH-ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEY 245 (314)
Q Consensus 168 kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~ 245 (314)
+++|||.++........ ......+++.|++||.+....++.++||||+|+++|+|++ |..||....... .
T Consensus 153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~--------~ 224 (273)
T cd05074 153 CVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE--------I 224 (273)
T ss_pred EECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH--------H
Confidence 99999998765432211 1223345678999999988888999999999999999999 888875332111 0
Q ss_pred HHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHH
Q 043524 246 LKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQI 307 (314)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~ 307 (314)
.......... ..+ ...+..+.+++.+||..+|++|||+.++++.|+++
T Consensus 225 ~~~~~~~~~~--------~~~------~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 225 YNYLIKGNRL--------KQP------PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HHHHHcCCcC--------CCC------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1100000000 000 12345689999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=269.69 Aligned_cols=247 Identities=23% Similarity=0.308 Sum_probs=190.0
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
+.....+|+|+ +.++++....+|..+|+|.+......... ..+.+.+|+++++.++|||++++++++.++
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~---------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 97 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNE---------KWQDIIKEVKFLQRIKHPNSIEYKGCYLRE 97 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchH---------HHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 44455688887 77788777788999999987643211100 125688999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~df 172 (314)
...++|+||++ |++.+.+.... .+++...+..++.+++.|+.||| +++++|+||+|+||+++.++.++++||
T Consensus 98 ~~~~lv~e~~~-g~l~~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~df 169 (317)
T cd06635 98 HTAWLVMEYCL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADF 169 (317)
T ss_pred CeEEEEEeCCC-CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecC
Confidence 99999999996 58878776543 35788999999999999999999 999999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCcccc---cCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhh
Q 043524 173 SLSISIPEGETHITDTVMGTYGHLAPQYVT---TCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNY 249 (314)
Q Consensus 173 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (314)
|++..... .....+++.|+|||.+. ...++.++|+||+|+++|+|++|..||....... .....
T Consensus 170 g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--------~~~~~ 236 (317)
T cd06635 170 GSASIASP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHI 236 (317)
T ss_pred CCccccCC-----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH--------HHHHH
Confidence 99865432 22446888999999874 3457889999999999999999999985432111 00000
Q ss_pred hccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 043524 250 FEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARR 303 (314)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 303 (314)
.. ...........+..+.+++.+||+.+|.+||++.++++.
T Consensus 237 ~~-------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 277 (317)
T cd06635 237 AQ-------------NESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKH 277 (317)
T ss_pred Hh-------------ccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhC
Confidence 00 000011111345568999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=265.88 Aligned_cols=251 Identities=20% Similarity=0.230 Sum_probs=188.4
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeEEEe
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGCCLE 91 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 91 (314)
+.....+|.|+ +.++.+....+|+.+|+|++...... .+.+.+|+.++..+ +||||+++++++..
T Consensus 24 y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~-------------~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV-------------DEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred eEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccH-------------HHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 44455678888 78888888889999999988643211 14567899999988 79999999999875
Q ss_pred C-----CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCc
Q 043524 92 T-----PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENV 166 (314)
Q Consensus 92 ~-----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~ 166 (314)
. +..|+|+||+++++|.+.+...... ...++...++.++.|++.||.||| +.+++|+||||+||+++.++.
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLIC-GQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCC
Confidence 3 4689999999999999887532111 135788899999999999999999 999999999999999999999
Q ss_pred eEEcccccceecCCCCcccccccccccccccCcccccCC-----CCcccchHHHHHHHHHHHhCCCCcccccCccccccc
Q 043524 167 VKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCD-----FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYP 241 (314)
Q Consensus 167 ~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-----~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~ 241 (314)
++++|||++........ ......++..|+|||.+.... ++.++|+||+|+++|+|++|+.||.......
T Consensus 167 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~----- 240 (291)
T cd06639 167 VKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK----- 240 (291)
T ss_pred EEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH-----
Confidence 99999999876543221 122346788999999875432 6789999999999999999999986432111
Q ss_pred hHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 242 FNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
. ....... .... . ..+...+..+.+++.+||+.||++|||+.|+++
T Consensus 241 --~-~~~~~~~-~~~~-----~------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 241 --T-LFKIPRN-PPPT-----L------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred --H-HHHHhcC-CCCC-----C------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0 0000000 0000 0 001123456889999999999999999999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=265.36 Aligned_cols=268 Identities=17% Similarity=0.226 Sum_probs=192.5
Q ss_pred ccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCe
Q 043524 16 RTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPI 94 (314)
Q Consensus 16 ~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 94 (314)
....+|.|+ +.++++.+..+|+.+|+|.+....... ..+.+.+|+.+++.++|+||+++++++.+.+.
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 72 (284)
T cd07836 4 QLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEG-----------TPSTAIREISLMKELKHENIVRLHDVIHTENK 72 (284)
T ss_pred EeeeeccCCceEEEEEEECCCCeEEEEEEeccccccc-----------chHHHHHHHHHHHhhcCCCEeeeeeeEeeCCc
Confidence 344578777 788888888889999999886542110 11456789999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccc
Q 043524 95 AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL 174 (314)
Q Consensus 95 ~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~ 174 (314)
.++|+||++ ++|.+.+...... ..++...+..++.|++.||.||| +++++|+||+|+||+++.++.++++|||.
T Consensus 73 ~~lv~e~~~-~~l~~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~ 146 (284)
T cd07836 73 LMLVFEYMD-KDLKKYMDTHGVR--GALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGL 146 (284)
T ss_pred EEEEEecCC-ccHHHHHHhcCCC--CCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecch
Confidence 999999997 4888887654321 35788999999999999999999 99999999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCcccccC-CCCcccchHHHHHHHHHHHhCCCCcccccCcccccc-------chHHHH
Q 043524 175 SISIPEGETHITDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVY-------PFNEYL 246 (314)
Q Consensus 175 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~-------~~~~~~ 246 (314)
+........ ......++..|++||.+.+. .++.++|+||+|+++|+|++|..||........... +.....
T Consensus 147 ~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07836 147 ARAFGIPVN-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTW 225 (284)
T ss_pred hhhhcCCcc-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhH
Confidence 875533221 12234568889999988664 468899999999999999999999975432211000 000000
Q ss_pred HhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 247 KNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
........+............ .......+..+.+++..||+.||.+||++.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 226 PGISQLPEYKPTFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred HHHhcCchhcccccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000000000000000000 0011134567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=267.03 Aligned_cols=245 Identities=19% Similarity=0.315 Sum_probs=191.4
Q ss_pred ccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCe
Q 043524 16 RTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPI 94 (314)
Q Consensus 16 ~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 94 (314)
....+|.|+ +.++.+....+|+.+|+|.+....... .+.+.+|+.+++.++|+||+++++.+..++.
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~------------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 91 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQR------------RELLFNEVVIMRDYQHENVVEMYNSYLVGDE 91 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhH------------HHHHHHHHHHHHhcCCcchhheeeEEEeCCE
Confidence 345688888 777777777899999999875432211 1567899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccc
Q 043524 95 AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL 174 (314)
Q Consensus 95 ~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~ 174 (314)
.+++|||+++++|.+++... .++...+..++.|++.|+.||| +++++|+||+|+||+++.++.++++|||.
T Consensus 92 ~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~ 162 (292)
T cd06657 92 LWVVMEFLEGGALTDIVTHT------RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGF 162 (292)
T ss_pred EEEEEecCCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEccccc
Confidence 99999999999998877542 3678889999999999999999 99999999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCC
Q 043524 175 SISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNR 254 (314)
Q Consensus 175 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (314)
+........ ......+++.|+|||.+....++.++|+||+|+++|+|++|..||....... ..... ..
T Consensus 163 ~~~~~~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~--------~~~~~-~~-- 230 (292)
T cd06657 163 CAQVSKEVP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--------AMKMI-RD-- 230 (292)
T ss_pred ceecccccc-cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHH-Hh--
Confidence 866543221 1233568899999999888888999999999999999999999986432111 00000 00
Q ss_pred cccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 255 FTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
........ ....+..+.+++.+||..||.+||++.++++
T Consensus 231 ---~~~~~~~~------~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 231 ---NLPPKLKN------LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred ---hCCcccCC------cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 00000000 0123445789999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=262.06 Aligned_cols=247 Identities=22% Similarity=0.304 Sum_probs=193.1
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCee
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIA 95 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (314)
...+|.|+ +.++++....+|..+|+|.+......... .+.+.+|+.+++.++|+||+++++.+..++..
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~----------~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~ 74 (257)
T cd08225 5 IKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKE----------KEASKKEVILLAKMKHPNIVTFFASFQENGRL 74 (257)
T ss_pred EEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchh----------hHHHHHHHHHHHhCCCCChhhhhheeccCCeE
Confidence 34477777 78888888889999999998765321111 14677999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCC-ceEEccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN-VVKLFDFSL 174 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~-~~kl~dfg~ 174 (314)
++++||+++++|.+++..... ..++...+..++.+++.|+.||| +.+++|+||+|+||+++.++ .++++|||.
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~ 148 (257)
T cd08225 75 FIVMEYCDGGDLMKRINRQRG---VLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGI 148 (257)
T ss_pred EEEEecCCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEeccccc
Confidence 999999999999998876432 24688899999999999999999 99999999999999998875 469999999
Q ss_pred ceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCC
Q 043524 175 SISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNR 254 (314)
Q Consensus 175 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (314)
+........ ......|++.|+|||.+....++.++|+||+|+++++|++|..||..... .......... .
T Consensus 149 ~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~-~ 218 (257)
T cd08225 149 ARQLNDSME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL--------HQLVLKICQG-Y 218 (257)
T ss_pred chhccCCcc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHhcc-c
Confidence 876543321 22334688899999999888899999999999999999999999864321 1111111110 0
Q ss_pred cccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 255 FTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
..+ . ....+..+.+++.+||..+|++|||+.+++.
T Consensus 219 ----~~~-----~----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 219 ----FAP-----I----SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred ----CCC-----C----CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 000 0 0123456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=261.59 Aligned_cols=245 Identities=20% Similarity=0.203 Sum_probs=185.8
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHH-HhcCCCCceeeeEeEEEeCCeeE
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTY-AAQMSHDHILKLIGCCLETPIAI 96 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~ 96 (314)
.+|.|+ +.|+.+....+|+.+|+|.+.......... ...+..|..+ ....+|+||+++++++..++.+|
T Consensus 3 ~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~---------~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 73 (260)
T cd05611 3 PISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQ---------VTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLY 73 (260)
T ss_pred cCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHH---------HHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEE
Confidence 367777 788888888889999999987654321110 0233445444 44568999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
+++||+++++|.+++.... +++...+..++.|++.||.||| +.+++|+||+|+||+++.++.++++|||+++
T Consensus 74 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 145 (260)
T cd05611 74 LVMEYLNGGDCASLIKTLG-----GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSR 145 (260)
T ss_pred EEEeccCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccce
Confidence 9999999999999886542 4788999999999999999999 9999999999999999999999999999986
Q ss_pred ecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcc
Q 043524 177 SIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFT 256 (314)
Q Consensus 177 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (314)
.... .....++..|+|||.+.+..++.++||||+|+++|+|++|..||....... ....... ...
T Consensus 146 ~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~-~~~- 210 (260)
T cd05611 146 NGLE-----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA--------VFDNILS-RRI- 210 (260)
T ss_pred eccc-----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHh-ccc-
Confidence 5432 223467889999999988788999999999999999999999996432111 1111100 000
Q ss_pred cccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHH
Q 043524 257 EIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRL 304 (314)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 304 (314)
..........+..+.+++.+||+.||++|||+.++.+.|
T Consensus 211 ---------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 211 ---------NWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred ---------CCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 000011113456789999999999999999876655544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=264.00 Aligned_cols=247 Identities=22% Similarity=0.300 Sum_probs=194.2
Q ss_pred cccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCC
Q 043524 15 KRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETP 93 (314)
Q Consensus 15 ~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (314)
.....+|+|+ +.++.+.+..++..+++|++..... ..+.+.+|++.++.++|+||+++++.+..++
T Consensus 22 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-------------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 88 (286)
T cd06614 22 KNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-------------NKELIINEILIMKDCKHPNIVDYYDSYLVGD 88 (286)
T ss_pred hHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-------------hHHHHHHHHHHHHHCCCCCeeEEEEEEEECC
Confidence 3334577777 7777777777889999998865432 1156789999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccc
Q 043524 94 IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFS 173 (314)
Q Consensus 94 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg 173 (314)
..|+++||+++++|.+++.... ..++...+..++.+++.||.||| +.|++|+||+|+||+++.++.++|+|||
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~ 161 (286)
T cd06614 89 ELWVVMEYMDGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFG 161 (286)
T ss_pred EEEEEEeccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccc
Confidence 9999999999999999998753 25788999999999999999999 9999999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccC
Q 043524 174 LSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDN 253 (314)
Q Consensus 174 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (314)
.+........ ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||....... . ...... .
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~-------~-~~~~~~-~ 231 (286)
T cd06614 162 FAAQLTKEKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR-------A-LFLITT-K 231 (286)
T ss_pred hhhhhccchh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-------H-HHHHHh-c
Confidence 8765432211 1234457889999999988889999999999999999999999986432211 0 000000 0
Q ss_pred CcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 254 RFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
. ..........+..+.+++..||+.+|.+|||+.++++
T Consensus 232 ~-----------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 232 G-----------IPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred C-----------CCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0 0001111134567899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=268.98 Aligned_cols=267 Identities=21% Similarity=0.322 Sum_probs=191.6
Q ss_pred ccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCe
Q 043524 16 RTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPI 94 (314)
Q Consensus 16 ~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 94 (314)
....+|.|+ +.|+.+....+|+.+|+|.+....... ...+.+.+|+++++.++||||+++++++.+++.
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~----------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 74 (286)
T cd07846 5 NLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK----------MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKR 74 (286)
T ss_pred EeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc----------hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCe
Confidence 344588887 778888777789999999875432211 012567899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccc
Q 043524 95 AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL 174 (314)
Q Consensus 95 ~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~ 174 (314)
.|+|+||++++++....... ..+.+..+..++.|++.||.||| +.+++|+||+|+||+++.++.++++|||+
T Consensus 75 ~~lv~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~ 146 (286)
T cd07846 75 LYLVFEFVDHTVLDDLEKYP-----NGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGF 146 (286)
T ss_pred EEEEEecCCccHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeee
Confidence 99999999988887766543 24788999999999999999999 99999999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCcccccC-CCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHH-------HH
Q 043524 175 SISIPEGETHITDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNE-------YL 246 (314)
Q Consensus 175 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~-------~~ 246 (314)
+....... .......++..|+|||.+.+. .++.++||||+|+++++|++|.+||........ ...... ..
T Consensus 147 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 224 (286)
T cd07846 147 ARTLAAPG-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQ-LYHIIKCLGNLIPRH 224 (286)
T ss_pred eeeccCCc-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHH-HHHHHHHhCCCchhh
Confidence 87654332 222334678899999988754 467889999999999999999999864332110 000000 00
Q ss_pred HhhhccCCc-ccccChhhhccCC-chhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 247 KNYFEDNRF-TEIVDPIIVQDLS-CTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 247 ~~~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
...+..... .....+......+ .......+..+.+|+.+||+.||++|||+.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 225 QEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000000 0000000000000 0001134567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=264.10 Aligned_cols=247 Identities=21% Similarity=0.238 Sum_probs=190.9
Q ss_pred ccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeEEE
Q 043524 20 IGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILV 98 (314)
Q Consensus 20 ~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~iv 98 (314)
+|.|+ +.++.+....+|+.+++|++......... ..+.+.+|++++..++||||+++++.+.++...|++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~---------~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 71 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKN---------QVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLV 71 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhh---------HHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEE
Confidence 35555 77777777788999999998765442211 126788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccceec
Q 043524 99 FEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISI 178 (314)
Q Consensus 99 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~ 178 (314)
+||+++++|.+++.... .++...+..++.|++.||.||| +.+++|+||+|+||+++.++.++++|||++...
T Consensus 72 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~ 143 (265)
T cd05579 72 MEYLPGGDLASLLENVG-----SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVG 143 (265)
T ss_pred EecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhc
Confidence 99999999999887643 4788999999999999999999 999999999999999999999999999998654
Q ss_pred CCCCc-------ccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhc
Q 043524 179 PEGET-------HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFE 251 (314)
Q Consensus 179 ~~~~~-------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (314)
..... .......++..|++||.......+.++|+||+|++++++++|..||...... ........
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--------~~~~~~~~ 215 (265)
T cd05579 144 LVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE--------EIFQNILN 215 (265)
T ss_pred ccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHhc
Confidence 32211 1123346788999999998888899999999999999999999998643211 11111100
Q ss_pred cCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHH
Q 043524 252 DNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRL 304 (314)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 304 (314)
+....+.....+..+.+++.+||+.+|++|||+.++.+.|
T Consensus 216 -------------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 216 -------------GKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred -------------CCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 0111111111256789999999999999999995554444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=266.94 Aligned_cols=267 Identities=18% Similarity=0.264 Sum_probs=193.1
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
+.....+|.|+ +.|+.+....+|+.+|+|.+........ ....+.+|+.++..++||||+++.+++...
T Consensus 7 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----------~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 76 (293)
T cd07843 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG----------FPITSLREINILLKLQHPNIVTVKEVVVGS 76 (293)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccccc----------chhhHHHHHHHHHhcCCCCEEEEEEEEEec
Confidence 33445578877 7888888888899999998865432211 114567899999999999999999999887
Q ss_pred --CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 93 --PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 93 --~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
...|+|+||++ ++|.+.+.... ..++...+..++.|++.||.||| +++++|+||+|+||+++.++.++|+
T Consensus 77 ~~~~~~lv~e~~~-~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~ 148 (293)
T cd07843 77 NLDKIYMVMEYVE-HDLKSLMETMK----QPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKIC 148 (293)
T ss_pred CCCcEEEEehhcC-cCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEe
Confidence 89999999996 59988887643 35789999999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCcccccCC-CCcccchHHHHHHHHHHHhCCCCcccccCcccccc-------ch
Q 043524 171 DFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCD-FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVY-------PF 242 (314)
Q Consensus 171 dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~-------~~ 242 (314)
|||.+........ ......+++.|+|||.+.+.. ++.++|+||+|+++++|++|..||........... +.
T Consensus 149 d~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~ 227 (293)
T cd07843 149 DFGLAREYGSPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPT 227 (293)
T ss_pred ecCceeeccCCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Confidence 9999876644321 123345788899999887654 68899999999999999999999975432211000 00
Q ss_pred HHHHHhhhc-----cCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 243 NEYLKNYFE-----DNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 243 ~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
......... ...........+....+.. ..+..+.+++.+||+.||++|||+.|++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 228 EKIWPGFSELPGAKKKTFTKYPYNQLRKKFPAL---SLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hHHHHHhhccchhcccccccccchhhhcccccc---CCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000000 0000000000111111100 13566889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=267.27 Aligned_cols=266 Identities=17% Similarity=0.216 Sum_probs=190.6
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeE
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAI 96 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (314)
..+|.|+ +.++++.+..+|+.+|+|++........ ..+.+.+|+++++.++||||+++++++.+++..|
T Consensus 5 ~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~----------~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~ 74 (283)
T cd07835 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEG----------VPSTAIREISLLKELNHPNIVRLLDVVHSENKLY 74 (283)
T ss_pred eEecCCCCeEEEEEEEcCCCCEEEEEEeeccccccc----------chhHHHHHHHHHHhcCCCCccCHhheeccCCeEE
Confidence 4577777 7888888888999999998865432110 1245788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
+++||++ ++|.+++..... ..++...+..++.|++.||.||| +++++|+||+|+||+++.++.++++|||.+.
T Consensus 75 iv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~ 147 (283)
T cd07835 75 LVFEFLD-LDLKKYMDSSPL---TGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLAR 147 (283)
T ss_pred EEEeccC-cCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeeccccc
Confidence 9999995 699998876442 35788999999999999999999 9999999999999999999999999999987
Q ss_pred ecCCCCcccccccccccccccCcccccC-CCCcccchHHHHHHHHHHHhCCCCcccccCccccccchH-------HHHHh
Q 043524 177 SIPEGETHITDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFN-------EYLKN 248 (314)
Q Consensus 177 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~-------~~~~~ 248 (314)
........ .....++..|+|||++.+. .++.++|+||+|+++|+|++|..||.......+....+. .....
T Consensus 148 ~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd07835 148 AFGVPVRT-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPG 226 (283)
T ss_pred ccCCCccc-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhh
Confidence 55332111 1223568889999988765 468899999999999999999999965432211000000 00000
Q ss_pred hhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 249 YFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
..........+.... ...........+..+.+++.+||+.||++|||+.|+++
T Consensus 227 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 227 VTSLPDYKPTFPKWA-RQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhchhhhhhccccc-ccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000000000000 00000011133467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=257.03 Aligned_cols=245 Identities=23% Similarity=0.367 Sum_probs=194.7
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCee
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIA 95 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (314)
...+|.|+ +.++.+....+|+.+++|.+....... .+.+.+|+..++.++|+||+++.+.+..+...
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~------------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 72 (253)
T cd05122 5 LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEK------------KEKIINEIQILKKCKHPNIVKYYGSYLKKDEL 72 (253)
T ss_pred eeeeccCCceEEEEEEECCCCcEEEEEEecccchhH------------HHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE
Confidence 34577776 778888777789999999887654311 15678999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
++++||+++++|.+++.... ..++...+..++.+++.++.+|| +++++|+||+|+||+++.++.++|+|||.+
T Consensus 73 ~l~~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~ 145 (253)
T cd05122 73 WIVMEFCSGGSLKDLLKSTN----QTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLS 145 (253)
T ss_pred EEEEecCCCCcHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccc
Confidence 99999999999999987653 35788999999999999999999 999999999999999999999999999998
Q ss_pred eecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCc
Q 043524 176 ISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRF 255 (314)
Q Consensus 176 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (314)
........ .....++..|+|||.+....++.++|+||+|+++++|++|..||....... . ... ......
T Consensus 146 ~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~-~~~-~~~~~~ 214 (253)
T cd05122 146 AQLSDTKA--RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK-------A-LFK-IATNGP 214 (253)
T ss_pred cccccccc--ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH-------H-HHH-HHhcCC
Confidence 76644321 234568889999999988888999999999999999999999986432111 0 000 000000
Q ss_pred ccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 256 TEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
... ......+..+.+++..||..||++|||+.++++
T Consensus 215 ~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 215 PGL-----------RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred CCc-----------CcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000 011123567899999999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=254.52 Aligned_cols=246 Identities=18% Similarity=0.249 Sum_probs=189.7
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC-CCceeeeEeEEEeCCee
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS-HDHILKLIGCCLETPIA 95 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 95 (314)
.-+|+|+ +.|+++....+|...|||.+....-+... ++++..++++.... .|+||+.+|+|..+...
T Consensus 98 ~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~-----------kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV 166 (391)
T KOG0983|consen 98 GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEEN-----------KRILMDLDVVLKSHDCPYIVQCFGYFITNTDV 166 (391)
T ss_pred HhhcCCCccceEEEEEcccceEEEEEeecccCCHHHH-----------HHHHHhhhHHhhccCCCeeeeeeeEEeeCchH
Confidence 3578888 99999999999999999988766544332 56677777766554 79999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
+|.||.|.. -+..++..-. .++++..+-.+...++.||.||.. .++|+|||+||+|||+|..|.+|++|||.+
T Consensus 167 ~IcMelMs~-C~ekLlkrik----~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIs 239 (391)
T KOG0983|consen 167 FICMELMST-CAEKLLKRIK----GPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGIS 239 (391)
T ss_pred HHHHHHHHH-HHHHHHHHhc----CCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeeccccc
Confidence 999999842 3434443333 457777777888899999999985 778999999999999999999999999999
Q ss_pred eecCCCCcccccccccccccccCcccccC---CCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhcc
Q 043524 176 ISIPEGETHITDTVMGTYGHLAPQYVTTC---DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFED 252 (314)
Q Consensus 176 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (314)
-.+.++.- .....|++.|||||-+.-. .|+.++||||||++++|++||+.||......-+.. ....+
T Consensus 240 GrlvdSkA--htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~l-------tkvln- 309 (391)
T KOG0983|consen 240 GRLVDSKA--HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVL-------TKVLN- 309 (391)
T ss_pred ceeecccc--cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHH-------HHHHh-
Confidence 77655432 3345799999999988643 58999999999999999999999998655332100 00110
Q ss_pred CCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 253 NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
+ .+...+....++..+++|+..||.+|+.+||...++++
T Consensus 310 -~----------ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 310 -E----------EPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred -c----------CCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 0 01111111236778999999999999999999999886
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=263.06 Aligned_cols=271 Identities=17% Similarity=0.264 Sum_probs=201.5
Q ss_pred chhhhhhhhhhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC-C
Q 043524 2 SWILRKFKLWSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS-H 79 (314)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h 79 (314)
+|+..||..... +|+|. +.|..+++..++..+|+|++..-.-. .++.+-|+++|.++. +
T Consensus 85 D~l~~Ry~i~~~------lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-------------reAa~iEi~vLqki~~~ 145 (415)
T KOG0671|consen 85 DILTNRYEIVDL------LGEGTFGKVVECWDRETKEHVALKIIKNVDKY-------------REAALIEIEVLQKINES 145 (415)
T ss_pred cccccceehhhh------hcCCcccceEEEeecCCCceehHHHHHHHHHH-------------hhHHHHHHHHHHHHHhc
Confidence 345555555554 88888 88889999999999999998754322 145678999999994 2
Q ss_pred -C----ceeeeEeEEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccC
Q 043524 80 -D----HILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDF 154 (314)
Q Consensus 80 -~----niv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dl 154 (314)
| -+|++.+||.-.++.|||+|.+ |.|+.+++..+. +.+++...++.++.|++.++++|| +.+++|.||
T Consensus 146 DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~---y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDL 218 (415)
T KOG0671|consen 146 DPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENN---YIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDL 218 (415)
T ss_pred CCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCC---ccccchHHHHHHHHHHHHHHHHHH---hcceeecCC
Confidence 3 3899999999999999999998 669999998754 367999999999999999999999 999999999
Q ss_pred CCCCeeecC--------------------CCceEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHH
Q 043524 155 KTSHILFSE--------------------ENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYS 214 (314)
Q Consensus 155 k~~nil~~~--------------------~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diws 214 (314)
||+||++.+ .-.++++|||.|+..... ..+.+.|.+|.|||++++..++.++||||
T Consensus 219 KPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLgLGwS~pCDvWS 294 (415)
T KOG0671|consen 219 KPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILGLGWSQPCDVWS 294 (415)
T ss_pred ChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccC----cceeeeccccCCchheeccCcCCccCcee
Confidence 999999832 124799999999775433 34678899999999999999999999999
Q ss_pred HHHHHHHHHhCCCCcccccCcccc------ccchHHHH------HhhhccC--CcccccChh-----hhccCCc----hh
Q 043524 215 FGAFLSELLTGRGILDLVRDAHDL------VYPFNEYL------KNYFEDN--RFTEIVDPI-----IVQDLSC----TE 271 (314)
Q Consensus 215 lG~~l~el~~g~~p~~~~~~~~~~------~~~~~~~~------~~~~~~~--~~~~~~~~~-----~~~~~~~----~~ 271 (314)
+||||.|+++|...|+..++.+.+ .+|++... ..++..+ +|.+...+. .....+. ..
T Consensus 295 iGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~ 374 (415)
T KOG0671|consen 295 IGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQ 374 (415)
T ss_pred eeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhcc
Confidence 999999999999999987754322 12222211 1111111 111111110 0000000 00
Q ss_pred HHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 272 KEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 272 ~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
......++.+|++.||.+||.+|+|+.|++.
T Consensus 375 ~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 375 DDLEHVQLFDLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred CcHHHhHHHHHHHHHHccCccccccHHHHhc
Confidence 1133456899999999999999999999885
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=268.52 Aligned_cols=271 Identities=18% Similarity=0.256 Sum_probs=192.6
Q ss_pred hhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEE
Q 043524 11 WSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCC 89 (314)
Q Consensus 11 ~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 89 (314)
...+.....+|.|+ +.|+.+....+|+.||+|.+........ ....+.+|+.++.+++|+||+++++++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~E~~~l~~l~h~~i~~~~~~~ 75 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDG----------IPISSLREITLLLNLRHPNIVELKEVV 75 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCC----------CcchhhHHHHHHHhCCCCCCcceEEEE
Confidence 44555666788888 8888888888999999998864331110 113456899999999999999999998
Q ss_pred EeC--CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCce
Q 043524 90 LET--PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVV 167 (314)
Q Consensus 90 ~~~--~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~ 167 (314)
.+. +..++|+||++ ++|.+.+.... ..++...+..++.|++.||.||| +.+++|+||||+||+++..+.+
T Consensus 76 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~ 147 (309)
T cd07845 76 VGKHLDSIFLVMEYCE-QDLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCL 147 (309)
T ss_pred ecCCCCeEEEEEecCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCE
Confidence 764 56899999996 58888876543 35788999999999999999999 9999999999999999999999
Q ss_pred EEcccccceecCCCCcccccccccccccccCcccccC-CCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHH
Q 043524 168 KLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYL 246 (314)
Q Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 246 (314)
+|+|||.+........ ......++..|+|||.+.+. .++.++|+||+|+++|+|++|..||........ ........
T Consensus 148 kL~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~-~~~~~~~~ 225 (309)
T cd07845 148 KIADFGLARTYGLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ-LDLIIQLL 225 (309)
T ss_pred EECccceeeecCCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhc
Confidence 9999999977643321 12233457889999988654 478999999999999999999999964332110 00000000
Q ss_pred HhhhccCCccccc-----Chh-hh-ccCCc--hhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 247 KNYFEDNRFTEIV-----DPI-IV-QDLSC--TEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 247 ~~~~~~~~~~~~~-----~~~-~~-~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
... ....+.... ... .. ..... ......+..+.+|+.+||+.||++|||+.|++.
T Consensus 226 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 226 GTP-NESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred CCC-ChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000 000000000 000 00 00000 000123567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=274.91 Aligned_cols=234 Identities=23% Similarity=0.286 Sum_probs=189.8
Q ss_pred ccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeEEEeCC
Q 043524 16 RTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGCCLETP 93 (314)
Q Consensus 16 ~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 93 (314)
-...+|.|+ +++..+.+..++...++|+++.+... --+|+.++... +||||+++.+++.++.
T Consensus 326 ~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~----------------~~~e~~~~~~~~~h~niv~~~~v~~~~~ 389 (612)
T KOG0603|consen 326 FREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD----------------NQDEIPISLLVRDHPNIVKSHDVYEDGK 389 (612)
T ss_pred cccccCCCCccceeeeeccccccchhheeccccccc----------------cccccchhhhhcCCCcceeecceecCCc
Confidence 334488888 89999999999999999999876211 12567555555 6999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeee-cCCCceEEccc
Q 043524 94 IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILF-SEENVVKLFDF 172 (314)
Q Consensus 94 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~-~~~~~~kl~df 172 (314)
+.|+|||.+.++.+.+.+.... ....++..|+.+|+.++.||| ++||+||||||+|||+ ++.+.++|+||
T Consensus 390 ~~~~v~e~l~g~ell~ri~~~~------~~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyF 460 (612)
T KOG0603|consen 390 EIYLVMELLDGGELLRRIRSKP------EFCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYF 460 (612)
T ss_pred eeeeeehhccccHHHHHHHhcc------hhHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEe
Confidence 9999999999999989887654 333677889999999999999 9999999999999999 68899999999
Q ss_pred ccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhcc
Q 043524 173 SLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFED 252 (314)
Q Consensus 173 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (314)
|.++..... ..+..-|..|.|||++....|+.++|+||||++||+|++|+.||....++.
T Consensus 461 G~a~~~~~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~---------------- 520 (612)
T KOG0603|consen 461 GFWSELERS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI---------------- 520 (612)
T ss_pred chhhhCchh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH----------------
Confidence 999876544 223455888999999998889999999999999999999999997544331
Q ss_pred CCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 253 NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
++...+..+. .+...+..+++|+.+||+.||.+||++.++..
T Consensus 521 ----ei~~~i~~~~----~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 521 ----EIHTRIQMPK----FSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ----HHHHhhcCCc----cccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 0000111111 11367788999999999999999999999864
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=270.51 Aligned_cols=266 Identities=17% Similarity=0.231 Sum_probs=190.1
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|.....+|.|+ +.|+.+.+..+|+.||+|.+....... ...++.+|+.+++.++|+||+++++++.
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~~~~~~~ 73 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQT-----------FCQRTLREIKILRRFKHENIIGILDIIR 73 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccch-----------hHHHHHHHHHHHHhCCCCCcCchhheee
Confidence 3455556688888 788888888899999999875321110 1256788999999999999999999876
Q ss_pred eC-----CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCC
Q 043524 91 ET-----PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN 165 (314)
Q Consensus 91 ~~-----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~ 165 (314)
.. ...|+++||++ +++.+.+.. ..++...+..++.|++.||.||| +++|+|+||||+||+++..+
T Consensus 74 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~ 143 (336)
T cd07849 74 PPSFESFNDVYIVQELME-TDLYKLIKT------QHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNC 143 (336)
T ss_pred cccccccceEEEEehhcc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCC
Confidence 54 35799999996 588887754 24788899999999999999999 99999999999999999999
Q ss_pred ceEEcccccceecCCCCcc--cccccccccccccCccccc-CCCCcccchHHHHHHHHHHHhCCCCcccccCccccccch
Q 043524 166 VVKLFDFSLSISIPEGETH--ITDTVMGTYGHLAPQYVTT-CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPF 242 (314)
Q Consensus 166 ~~kl~dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~ 242 (314)
.++|+|||++......... ......|+..|+|||.+.. ..++.++||||+|+++|+|++|+.||....... .+
T Consensus 144 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~----~~ 219 (336)
T cd07849 144 DLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH----QL 219 (336)
T ss_pred CEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HH
Confidence 9999999998765432211 1223467899999998755 458899999999999999999999996432110 00
Q ss_pred HHHHHhhhccC---CcccccChhh---------hccCCch-hHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 043524 243 NEYLKNYFEDN---RFTEIVDPII---------VQDLSCT-EKEQQLHASAQLTFECLNESPIDRPTMVDVARR 303 (314)
Q Consensus 243 ~~~~~~~~~~~---~~~~~~~~~~---------~~~~~~~-~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 303 (314)
... ....... .+..+..... ....+.. .....+..+.+++.+||+.||++|||+.|+++.
T Consensus 220 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 220 NLI-LGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHH-HHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 0000000 0000000000 0000000 001235678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=266.94 Aligned_cols=269 Identities=17% Similarity=0.228 Sum_probs=190.6
Q ss_pred hhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEE
Q 043524 11 WSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCC 89 (314)
Q Consensus 11 ~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 89 (314)
..+|.....+|.|+ +.|+.+.+..+|+.+|+|.+....... . ....+.+|+++++.++||||+++++++
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~---~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~ 80 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE---G-------FPITALREIKILQLLKHENVVNLIEIC 80 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC---C-------chhHHHHHHHHHHhCCCCCccceEEEE
Confidence 34556666788888 888888888899999999875432110 0 113456899999999999999999998
Q ss_pred EeCC--------eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeee
Q 043524 90 LETP--------IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILF 161 (314)
Q Consensus 90 ~~~~--------~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~ 161 (314)
.... ..++|+||+. +++.+.+.... ..++...+..++.|++.||.||| +++++|+||+|+||++
T Consensus 81 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~ 152 (310)
T cd07865 81 RTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKN----VKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILI 152 (310)
T ss_pred ecccccccCCCceEEEEEcCCC-cCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEE
Confidence 7654 4599999996 58888776543 35789999999999999999999 9999999999999999
Q ss_pred cCCCceEEcccccceecCCCCcc---cccccccccccccCcccccCC-CCcccchHHHHHHHHHHHhCCCCcccccCccc
Q 043524 162 SEENVVKLFDFSLSISIPEGETH---ITDTVMGTYGHLAPQYVTTCD-FSEKLDVYSFGAFLSELLTGRGILDLVRDAHD 237 (314)
Q Consensus 162 ~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~ 237 (314)
+.++.++|+|||.+......... ......++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||........
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~ 232 (310)
T cd07865 153 TKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ 232 (310)
T ss_pred CCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999998765432211 122345788899999886654 68899999999999999999999865432110
Q ss_pred cccchHHHHHhhhc---cCCccc-----ccChhh-hccCCch-----hHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 238 LVYPFNEYLKNYFE---DNRFTE-----IVDPII-VQDLSCT-----EKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 238 ~~~~~~~~~~~~~~---~~~~~~-----~~~~~~-~~~~~~~-----~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
......... ...+.. ..+... ....... .....+..+.+++.+||..||++|||+.|+++
T Consensus 233 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 233 -----LTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred -----HHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 000000000 000000 000000 0000000 00012345789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=261.70 Aligned_cols=265 Identities=18% Similarity=0.232 Sum_probs=191.1
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC--Ce
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET--PI 94 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~ 94 (314)
..+|.|+ +.++++....+|+.+|+|.+....... ...+.+.+|+.+++.++|+|++++++++... ..
T Consensus 5 ~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~----------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 74 (287)
T cd07840 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKE----------GFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGS 74 (287)
T ss_pred EEeccCCCeEEEEEEECCCCeEEEEEEEecccccc----------cchHHHHHHHHHHHhccCCCeeeheeeEecCCCCc
Confidence 3467777 888888888889999999987653100 0114678999999999999999999999987 89
Q ss_pred eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccc
Q 043524 95 AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL 174 (314)
Q Consensus 95 ~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~ 174 (314)
.++|+||++ ++|.+.+.... ..++...+..++.|++.||+||| +.+++|+||+|+||+++.++.++++|||.
T Consensus 75 ~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~ 146 (287)
T cd07840 75 IYMVFEYMD-HDLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGL 146 (287)
T ss_pred EEEEecccc-ccHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccc
Confidence 999999997 48988886543 35788999999999999999999 99999999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCcccccC-CCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccC
Q 043524 175 SISIPEGETHITDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDN 253 (314)
Q Consensus 175 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (314)
+...............++..|+|||.+.+. .++.++||||||+++|+|++|..||+.......... ....... ....
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~-~~~~~~~-~~~~ 224 (287)
T cd07840 147 ARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEK-IFELCGS-PTDE 224 (287)
T ss_pred eeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH-HHHHhCC-Cchh
Confidence 876644332112234567889999987653 578999999999999999999999975432111000 0000000 0000
Q ss_pred CcccccC----hhhhccCC------chhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 254 RFTEIVD----PIIVQDLS------CTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 254 ~~~~~~~----~~~~~~~~------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.+....+ ........ .......+..+.+++.+||..||.+|||+.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 225 NWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000 00000000 0000012567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=258.27 Aligned_cols=247 Identities=19% Similarity=0.259 Sum_probs=194.8
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCee
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIA 95 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (314)
...+|.|+ +.++.+.+..+|+.+++|.+......... ..++.+|+++++.++|+||+++.+++.++...
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~----------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd08530 5 LKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKE----------REDAVNEIRILASVNHPNIISYKEAFLDGNKL 74 (256)
T ss_pred eeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHH----------HHHHHHHHHHHHhCCCCCchhhhhhhccCCEE
Confidence 34467776 77777778888999999998765432211 15678899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
++|+||+++++|.+++...... ...++...+..++.+++.||.||| +++++|+||+|+||+++.++.++++|||.+
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~ 150 (256)
T cd08530 75 CIVMEYAPFGDLSKAISKRKKK-RKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGIS 150 (256)
T ss_pred EEEehhcCCCCHHHHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccch
Confidence 9999999999999988653211 135788889999999999999999 999999999999999999999999999998
Q ss_pred eecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCc
Q 043524 176 ISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRF 255 (314)
Q Consensus 176 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (314)
...... ......++..|+|||.+....++.++|+||+|+++++|++|+.||....... . ......
T Consensus 151 ~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~--------~-~~~~~~--- 215 (256)
T cd08530 151 KVLKKN---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD--------L-RYKVQR--- 215 (256)
T ss_pred hhhccC---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------H-HHHHhc---
Confidence 766443 1233467889999999988888999999999999999999999986433110 0 000110
Q ss_pred ccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 256 TEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
...+ ..+...+.++.+++..||..+|++|||+.++++
T Consensus 216 ---------~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 216 ---------GKYP-PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred ---------CCCC-CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0111 111245677899999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=261.08 Aligned_cols=262 Identities=19% Similarity=0.223 Sum_probs=193.8
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeE
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAI 96 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (314)
..+|.|+ +.++.+....+|+.+++|.+........ ....+.+|+.+++.++|+||+++++++..++..+
T Consensus 5 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 74 (283)
T cd05118 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEG----------IPKTALREIKLLKELNHPNIIKLLDVFRHKGDLY 74 (283)
T ss_pred eeeecCCCceEEEEEcCCCCcEEEEEEeccccccch----------hHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEE
Confidence 3577777 7888888888899999998765432210 1256788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
+++||+++ ++.+.+.... .+++...+..++.+++.||.||| +++++|+||+|+||+++.++.++++|||.+.
T Consensus 75 ~v~e~~~~-~l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~ 146 (283)
T cd05118 75 LVFEFMDT-DLYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLAR 146 (283)
T ss_pred EEEeccCC-CHHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeE
Confidence 99999964 8888886643 35788999999999999999999 9999999999999999999999999999987
Q ss_pred ecCCCCcccccccccccccccCcccccC-CCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhc--cC
Q 043524 177 SIPEGETHITDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFE--DN 253 (314)
Q Consensus 177 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~ 253 (314)
....... ......++..|+|||.+... .++.++|+||+|+++|+|++|+.||......+.. ......... ..
T Consensus 147 ~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~----~~~~~~~~~~~~~ 221 (283)
T cd05118 147 SFGSPVR-PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQL----FKIFRTLGTPDPE 221 (283)
T ss_pred ecCCCcc-cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHHHcCCCchH
Confidence 7654331 12234578889999998776 6889999999999999999999998644322110 000000000 00
Q ss_pred CcccccC------hhhhcc---CCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 254 RFTEIVD------PIIVQD---LSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 254 ~~~~~~~------~~~~~~---~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.+....+ ...... .........+.++.+++.+||+.||.+||++.+++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 222 VWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000000 000000 001112245778999999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=257.86 Aligned_cols=234 Identities=18% Similarity=0.244 Sum_probs=182.8
Q ss_pred ccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeEEEeCCeeEE
Q 043524 20 IGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGCCLETPIAIL 97 (314)
Q Consensus 20 ~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~i 97 (314)
+|+|+ +.|+.+.+..+|+.+|+|++........ |+.....+ +||||+++++.+...+..|+
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----------------e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----------------EPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----------------hHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 68888 8888888888999999999876543211 22222222 69999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCC-ceEEcccccce
Q 043524 98 VFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN-VVKLFDFSLSI 176 (314)
Q Consensus 98 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~-~~kl~dfg~~~ 176 (314)
||||+++++|.+++.... +++...+..++.|++.||.||| +.+++|+||+|+||+++.++ .++++|||.++
T Consensus 87 v~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~ 158 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKEG-----KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK 158 (267)
T ss_pred EEEcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence 999999999999987642 5789999999999999999999 99999999999999999988 99999999987
Q ss_pred ecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcc
Q 043524 177 SIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFT 256 (314)
Q Consensus 177 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (314)
..... ....++..|+|||++.+..++.++|+||+|+++|+|++|..||....... .....+....
T Consensus 159 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~------- 223 (267)
T PHA03390 159 IIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE---LDLESLLKRQ------- 223 (267)
T ss_pred ecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch---hhHHHHHHhh-------
Confidence 65332 23457889999999988889999999999999999999999997433221 0111111100
Q ss_pred cccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCC-HHHHHH
Q 043524 257 EIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPT-MVDVAR 302 (314)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps-~~ell~ 302 (314)
... .......+..+.+++.+||+.||.+||+ ++|+++
T Consensus 224 -------~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 224 -------QKK--LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred -------ccc--CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 000 0111145567899999999999999996 588874
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=264.91 Aligned_cols=242 Identities=24% Similarity=0.331 Sum_probs=187.3
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeE
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAI 96 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (314)
..+|.|+ +.++.+....+|+.+++|.+......... ..+.+.+|+.+++.++|||++++++++.++...|
T Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~---------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 97 (313)
T cd06633 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNE---------KWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAW 97 (313)
T ss_pred eeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchH---------HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 3478887 78888888888999999988653221110 1146788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
+++||+. |++.+.+.... .+++...+..++.|++.++.||| +++++|+||+|+||+++.++.++|+|||.+.
T Consensus 98 lv~e~~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~ 169 (313)
T cd06633 98 LVMEYCL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSAS 169 (313)
T ss_pred EEEecCC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCc
Confidence 9999995 58888776543 35788899999999999999999 9999999999999999999999999999985
Q ss_pred ecCCCCcccccccccccccccCcccc---cCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccC
Q 043524 177 SIPEGETHITDTVMGTYGHLAPQYVT---TCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDN 253 (314)
Q Consensus 177 ~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (314)
.... .....|+..|+|||.+. ...++.++|+||+|+++|+|++|..||....... ........
T Consensus 170 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~--------~~~~~~~~- 235 (313)
T cd06633 170 KSSP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQN- 235 (313)
T ss_pred ccCC-----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH--------HHHHHHhc-
Confidence 4321 23456888999999874 3457889999999999999999999986433211 00000000
Q ss_pred CcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 254 RFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.. +.......+..+.+|+.+||+.+|++||++.+++.
T Consensus 236 ~~------------~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 236 DS------------PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred CC------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 00001123456789999999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=276.24 Aligned_cols=247 Identities=24% Similarity=0.403 Sum_probs=195.9
Q ss_pred ccccCch-hHHHHHH-HhcCCc--ccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCC
Q 043524 18 LMIGNGA-SVLQELI-ASSNGK--YIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETP 93 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~-~~~~g~--~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (314)
..+|.|+ ++|+... ....|+ .||||.+........ +..|+.|+.+|..|+|+|+|++||+..+ .
T Consensus 116 e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~-----------mddflrEas~M~~L~H~hliRLyGvVl~-q 183 (1039)
T KOG0199|consen 116 ELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAI-----------MDDFLREASHMLKLQHPHLIRLYGVVLD-Q 183 (1039)
T ss_pred HHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchh-----------HHHHHHHHHHHHhccCcceeEEeeeecc-c
Confidence 3477777 5555444 444555 789998765544332 3789999999999999999999999987 7
Q ss_pred eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccc
Q 043524 94 IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFS 173 (314)
Q Consensus 94 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg 173 (314)
.+.+|+|+++.|+|.+++....+ ..+.....-.++.||+.|+.||- ++++|||||-..|+++.....+||+|||
T Consensus 184 p~mMV~ELaplGSLldrLrka~~---~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFG 257 (1039)
T KOG0199|consen 184 PAMMVFELAPLGSLLDRLRKAKK---AILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFG 257 (1039)
T ss_pred hhhHHhhhcccchHHHHHhhccc---cceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeeccc
Confidence 78899999999999999988433 56888889999999999999999 9999999999999999999999999999
Q ss_pred cceecCCCCccc--ccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhh
Q 043524 174 LSISIPEGETHI--TDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 174 ~~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
+.+.+..+.... .....-++.|.|||.+....|+.++|+|+|||++|||++ |.-||-+.....
T Consensus 258 LmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q-------------- 323 (1039)
T KOG0199|consen 258 LMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ-------------- 323 (1039)
T ss_pred ceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH--------------
Confidence 999886654321 122345778999999999999999999999999999999 667775544322
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHH
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRL 304 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 304 (314)
+.+.+| .....+.+..+++.+.++++.||..+|++|||+.+|.+.+
T Consensus 324 ----IL~~iD----~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 324 ----ILKNID----AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ----HHHhcc----ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 111222 1112233347778899999999999999999999997554
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=262.69 Aligned_cols=269 Identities=15% Similarity=0.168 Sum_probs=188.9
Q ss_pred cccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC-CCceeeeEeEEEeC
Q 043524 15 KRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS-HDHILKLIGCCLET 92 (314)
Q Consensus 15 ~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 92 (314)
.....+|.|+ +.|+++....+|+.||+|.+........ ....+.+|+.+++.++ ||||+++++++...
T Consensus 4 ~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~----------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~ 73 (295)
T cd07837 4 EKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEG----------IPPTALREISLLQMLSESIYIVRLLDVEHVE 73 (295)
T ss_pred eEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccC----------CchHHHHHHHHHHHccCCCCccceeeeEeec
Confidence 3444577777 7788888888999999998755321100 1146788999999995 69999999999876
Q ss_pred Ce-----eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecC-CCc
Q 043524 93 PI-----AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSE-ENV 166 (314)
Q Consensus 93 ~~-----~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~-~~~ 166 (314)
.. .|++|||+++ ++.+.+..........++...+..++.|++.||.||| +++++|+||+|+||+++. ++.
T Consensus 74 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~ 149 (295)
T cd07837 74 EKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGL 149 (295)
T ss_pred CCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCe
Confidence 65 8999999975 8988876543221135789999999999999999999 999999999999999998 889
Q ss_pred eEEcccccceecCCCCcccccccccccccccCcccccC-CCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHH
Q 043524 167 VKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEY 245 (314)
Q Consensus 167 ~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 245 (314)
++++|||.++....... ......+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||.......... ..
T Consensus 150 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~----~~ 224 (295)
T cd07837 150 LKIADLGLGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLL----HI 224 (295)
T ss_pred EEEeecccceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH----HH
Confidence 99999999876532211 11223567889999988654 47899999999999999999999996543221110 00
Q ss_pred HHhhh--ccCCcccc---cChhhhccCCc----hhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 246 LKNYF--EDNRFTEI---VDPIIVQDLSC----TEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 246 ~~~~~--~~~~~~~~---~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
..... ....+... ........... ......+.++.++|.+||..||.+|||+.|++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 225 FKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred HHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000 00000000 00000000000 000134567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=263.99 Aligned_cols=243 Identities=24% Similarity=0.317 Sum_probs=187.0
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeE
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAI 96 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (314)
..+|.|+ +.++.+....+|..+|+|.+......... ..+++.+|+++++.++|+|++++.+++..+...+
T Consensus 21 ~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (308)
T cd06634 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE---------KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 91 (308)
T ss_pred HheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChH---------HHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeE
Confidence 3477777 78888888888999999987642211100 1246788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
+|+||+. |++.+.+.... .+++...+..++.+++.|+.||| +.+++|+||+|+||+++.++.++++|||.+.
T Consensus 92 lv~e~~~-~~l~~~~~~~~----~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 163 (308)
T cd06634 92 LVMEYCL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSAS 163 (308)
T ss_pred EEEEccC-CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccce
Confidence 9999996 68877775443 35788889999999999999999 9999999999999999999999999999986
Q ss_pred ecCCCCcccccccccccccccCcccc---cCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccC
Q 043524 177 SIPEGETHITDTVMGTYGHLAPQYVT---TCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDN 253 (314)
Q Consensus 177 ~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (314)
..... ....++..|+|||.+. ...++.++||||+|+++|+|++|..||....... .......
T Consensus 164 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--------~~~~~~~-- 228 (308)
T cd06634 164 IMAPA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQ-- 228 (308)
T ss_pred eecCc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH--------HHHHHhh--
Confidence 65322 2346788999999875 3457889999999999999999999985432111 0000000
Q ss_pred CcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 043524 254 RFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARR 303 (314)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 303 (314)
...+.......+..+.+|+.+||..+|++||++.++++.
T Consensus 229 -----------~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 229 -----------NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred -----------cCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 000011111445668899999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=288.33 Aligned_cols=263 Identities=21% Similarity=0.335 Sum_probs=189.2
Q ss_pred Cchhhhhhhhh-hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC
Q 043524 1 MSWILRKFKLW-SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS 78 (314)
Q Consensus 1 ~~~~~~~~~~~-~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 78 (314)
|+|..+++.++ ........+|+|| |.|++++++-+|++||||.+.... ... .+..+.+|+++|++|+
T Consensus 467 ~s~~~r~~SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~----------~~skI~rEVk~LArLn 535 (1351)
T KOG1035|consen 467 MSPLQRQFSRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDK----------LYSKILREVKLLARLN 535 (1351)
T ss_pred cCccccchhhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHH----------HHHHHHHHHHHHhhcC
Confidence 55666654222 3344455799999 999999999999999999987664 111 1256789999999999
Q ss_pred CCceeeeEeEEEeCC-----------------------------------------------------------------
Q 043524 79 HDHILKLIGCCLETP----------------------------------------------------------------- 93 (314)
Q Consensus 79 h~niv~~~~~~~~~~----------------------------------------------------------------- 93 (314)
|||||+++..|.+..
T Consensus 536 HpNVVRYysAWVEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~ 615 (1351)
T KOG1035|consen 536 HPNVVRYYSAWVESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESS 615 (1351)
T ss_pred CcceeeeehhhhccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCcccccccccccccccc
Confidence 999999987774100
Q ss_pred ------------------------------------------------------eeEEEEeecCCCCHHHHHhcCCCCCC
Q 043524 94 ------------------------------------------------------IAILVFEYVQHGTLWDRILGAPQTHF 119 (314)
Q Consensus 94 ------------------------------------------------------~~~iv~e~~~~g~L~~~l~~~~~~~~ 119 (314)
.+||-||||+...+.+++......
T Consensus 616 ~d~e~~d~dedg~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-- 693 (1351)
T KOG1035|consen 616 TDEENDDSDEDGRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-- 693 (1351)
T ss_pred CCcccccccccccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--
Confidence 158889999887777777654310
Q ss_pred CcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccceecC------C----------CCc
Q 043524 120 EPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIP------E----------GET 183 (314)
Q Consensus 120 ~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~~------~----------~~~ 183 (314)
-.....+.++.+|+.||+|+| +.||+||||||.||+++.++.+||+|||+|+... + +..
T Consensus 694 --~~~d~~wrLFreIlEGLaYIH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~ 768 (1351)
T KOG1035|consen 694 --SQRDEAWRLFREILEGLAYIH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSN 768 (1351)
T ss_pred --hhhHHHHHHHHHHHHHHHHHH---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCC
Confidence 136788899999999999999 9999999999999999999999999999998621 0 011
Q ss_pred c-cccccccccccccCcccccCC---CCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCccccc
Q 043524 184 H-ITDTVMGTYGHLAPQYVTTCD---FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIV 259 (314)
Q Consensus 184 ~-~~~~~~g~~~y~aPE~~~~~~---~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (314)
. .....+||.-|+|||++.+.. |+.|+|+||+|++++||+. ||........ .+.. .+.+.+...
T Consensus 769 ~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~-------iL~~-LR~g~iP~~- 836 (1351)
T KOG1035|consen 769 DGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERAS-------ILTN-LRKGSIPEP- 836 (1351)
T ss_pred CcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHH-------HHHh-cccCCCCCC-
Confidence 1 133568999999999997654 9999999999999999976 3543222110 0011 111111111
Q ss_pred ChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 260 DPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
+.+ ....+ ..-.++|+.||+.||++||||.|+|.
T Consensus 837 -~~f-------~~~~~-~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 837 -ADF-------FDPEH-PEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred -ccc-------ccccc-hHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 000 00022 22368999999999999999999986
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=257.05 Aligned_cols=236 Identities=21% Similarity=0.306 Sum_probs=194.3
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeEE
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAIL 97 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i 97 (314)
.+|+|. +.|-++..+.+|+.+|+|++.+..+-..... ..-+.|-++|...+||.+..+.-.|.+.+.+|+
T Consensus 175 vLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEV---------AHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 175 VLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEV---------AHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred HhcCCccceEEEEeecccCceeehhhhhhhheeehHHh---------hhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 477777 7788888999999999999887754332211 223578899999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccccee
Q 043524 98 VFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSIS 177 (314)
Q Consensus 98 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~ 177 (314)
||||..||.|...+... ..++....+.+..+|++||.||| +++||.||||.+|.++|.+|.+||+|||+++.
T Consensus 246 VMeyanGGeLf~HLsre-----r~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE 317 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRE-----RVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKE 317 (516)
T ss_pred EEEEccCceEeeehhhh-----hcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchh
Confidence 99999999998888765 35788889999999999999999 99999999999999999999999999999976
Q ss_pred cCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCccc
Q 043524 178 IPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTE 257 (314)
Q Consensus 178 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (314)
-.... ....+++||+.|+|||++....|+..+|.|.+|+++|||++|+.||.......
T Consensus 318 ~I~~g-~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k--------------------- 375 (516)
T KOG0690|consen 318 EIKYG-DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK--------------------- 375 (516)
T ss_pred ccccc-ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH---------------------
Confidence 54332 24778999999999999999999999999999999999999999997443221
Q ss_pred ccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCC
Q 043524 258 IVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRP 295 (314)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp 295 (314)
++.-++..+...+. ..++++..|+...|..||++|.
T Consensus 376 LFeLIl~ed~kFPr--~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 376 LFELILMEDLKFPR--TLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred HHHHHHhhhccCCc--cCCHHHHHHHHHHhhcChHhhc
Confidence 12222222222221 4556788999999999999997
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=269.33 Aligned_cols=272 Identities=17% Similarity=0.213 Sum_probs=193.3
Q ss_pred hhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEE
Q 043524 11 WSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCC 89 (314)
Q Consensus 11 ~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 89 (314)
..+|+....+|.|+ +.++.+.+..+|+.+|+|.+........ ....+.+|+.+++.++|+||+++++++
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~E~~~l~~l~h~ni~~~~~~~ 73 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRI----------DAKRTLREIKLLRHLDHENVIAIKDIM 73 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccc----------hhHHHHHHHHHHHhcCCCCccchHHhe
Confidence 34556666788888 8888888888999999998764311100 014567899999999999999999988
Q ss_pred EeC-----CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCC
Q 043524 90 LET-----PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEE 164 (314)
Q Consensus 90 ~~~-----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~ 164 (314)
... ...|+++||+. ++|.+.+... ..++...+..++.|++.||.||| +++++|+||||+||+++.+
T Consensus 74 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~ 144 (337)
T cd07858 74 PPPHREAFNDVYIVYELMD-TDLHQIIRSS-----QTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNAN 144 (337)
T ss_pred ecccccccCcEEEEEeCCC-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCC
Confidence 654 35899999995 6898888654 34788999999999999999999 9999999999999999999
Q ss_pred CceEEcccccceecCCCCcccccccccccccccCccccc-CCCCcccchHHHHHHHHHHHhCCCCcccccCccccc----
Q 043524 165 NVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTT-CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLV---- 239 (314)
Q Consensus 165 ~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~---- 239 (314)
+.++|+|||+++...... .......++..|+|||.+.. ..++.++|+||+|+++|+|++|+.||..........
T Consensus 145 ~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 223 (337)
T cd07858 145 CDLKICDFGLARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITE 223 (337)
T ss_pred CCEEECcCccccccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Confidence 999999999987654332 11234467889999998765 458899999999999999999999996432110000
Q ss_pred --c-chHHHHHhhhccCCcccccChhhhcc-CC-chhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 043524 240 --Y-PFNEYLKNYFEDNRFTEIVDPIIVQD-LS-CTEKEQQLHASAQLTFECLNESPIDRPTMVDVARR 303 (314)
Q Consensus 240 --~-~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 303 (314)
. +..... ...........+....... .. .......+..+.+++.+||+.||++|||+.|+++.
T Consensus 224 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 224 LLGSPSEEDL-GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred HhCCCChHHh-hhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0 000000 0000000000000000000 00 00111356778999999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=253.71 Aligned_cols=255 Identities=24% Similarity=0.278 Sum_probs=197.6
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC-CCceeeeEeEEEeCCeeE
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS-HDHILKLIGCCLETPIAI 96 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 96 (314)
.+|+|+ ..|.-++.-.+|..||||++.+..-.. ..++.+|++++.+.+ |+||++++++|+++...|
T Consensus 85 ~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHs------------R~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FY 152 (463)
T KOG0607|consen 85 LLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHS------------RSRVFREVETFYQCQGHKNILQLIEFFEDDTRFY 152 (463)
T ss_pred HhcCccceeeeeeeeeccchhhhhhhhhcCCchH------------HHHHHHHHHHHHHhcCCccHHHHHHHhcccceEE
Confidence 577777 777778888899999999998763222 267899999999996 999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCc---eEEcccc
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENV---VKLFDFS 173 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~---~kl~dfg 173 (314)
+|+|-+.||+|...|.+.. .++..++..+..+|+.||.+|| .+||.|||+||+|||-...+. +||+||-
T Consensus 153 LVfEKm~GGplLshI~~~~-----~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfD 224 (463)
T KOG0607|consen 153 LVFEKMRGGPLLSHIQKRK-----HFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFD 224 (463)
T ss_pred EEEecccCchHHHHHHHhh-----hccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccc
Confidence 9999999999999998764 4788999999999999999999 999999999999999876654 6999998
Q ss_pred cceecCCCC------cccccccccccccccCccccc-----CCCCcccchHHHHHHHHHHHhCCCCcccccCcc---ccc
Q 043524 174 LSISIPEGE------THITDTVMGTYGHLAPQYVTT-----CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAH---DLV 239 (314)
Q Consensus 174 ~~~~~~~~~------~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~---~~~ 239 (314)
++....... +....+.+|+-.|||||+..- ..|+.++|.||+|+++|-|+.|.+||.+.=..+ +.-
T Consensus 225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrG 304 (463)
T KOG0607|consen 225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRG 304 (463)
T ss_pred cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCC
Confidence 765432221 111345678899999997742 248999999999999999999999997543321 111
Q ss_pred cchHHHHHhhhccCCcccccChhhhcc--CCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 240 YPFNEYLKNYFEDNRFTEIVDPIIVQD--LSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.+-......+ +..+..+. ++.......+.+..+|+...|..|+.+|-+|.+++.
T Consensus 305 e~Cr~CQ~~L---------FesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 305 EVCRVCQNKL---------FESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CccHHHHHHH---------HHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 1111111222 22222332 233344467888999999999999999999999876
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=254.01 Aligned_cols=246 Identities=24% Similarity=0.372 Sum_probs=194.9
Q ss_pred ccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCe
Q 043524 16 RTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPI 94 (314)
Q Consensus 16 ~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 94 (314)
....+|.|+ +.++.+.+..+|+.+++|.+........ ..+.+.+|+++++.++|+|++++.+++.+++.
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (254)
T cd06627 4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEE----------ALKSIMQEIDLLKNLKHPNIVKYIGSIETSDS 73 (254)
T ss_pred eeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHH----------HHHHHHHHHHHHHhCCCCCccEEEEEEEeCCE
Confidence 344577777 7777777788889999999876543211 12578899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccc
Q 043524 95 AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL 174 (314)
Q Consensus 95 ~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~ 174 (314)
.++++||+++++|.+.+... ..++...+..++.|++.|+.+|| +++++|+||+|+||+++.++.++|+|||.
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~ 145 (254)
T cd06627 74 LYIILEYAENGSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGV 145 (254)
T ss_pred EEEEEecCCCCcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEecccc
Confidence 99999999999999988764 35788999999999999999999 99999999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCC
Q 043524 175 SISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNR 254 (314)
Q Consensus 175 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (314)
+........ ......++..|+|||......++.++|+||+|+++++|++|..||...... ....... . ..
T Consensus 146 ~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-------~~~~~~~-~-~~ 215 (254)
T cd06627 146 ATKLNDVSK-DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-------AALFRIV-Q-DD 215 (254)
T ss_pred ceecCCCcc-cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-------HHHHHHh-c-cC
Confidence 977644332 133456788999999988777889999999999999999999998643311 1111100 0 00
Q ss_pred cccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 255 FTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
. + ..+...+..+.+++.+||..+|++|||+.+++.
T Consensus 216 ~-----~--------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 216 H-----P--------PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred C-----C--------CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 0 0 001133456889999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=263.87 Aligned_cols=263 Identities=19% Similarity=0.248 Sum_probs=187.4
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCC--
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETP-- 93 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-- 93 (314)
...+|.|+ +.|+++....+|+.+|+|.+........ ....+.+|+.+++.++||||+++++++.+..
T Consensus 12 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~----------~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 12 IGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG----------FPITAIREIKILRQLNHRNIVNLKEIVTDKQDA 81 (302)
T ss_pred eeeecccCCEEEEEEEECCCCcEEEEEEEeecccccC----------chHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence 34577776 7888888888899999998764321110 1145678999999999999999999987654
Q ss_pred --------eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCC
Q 043524 94 --------IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN 165 (314)
Q Consensus 94 --------~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~ 165 (314)
.+|+++||+++ ++.+.+.... ..++...+..++.|++.||.||| +++|+|+||+|+||+++.++
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~ 153 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDH-DLMGLLESGL----VHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKG 153 (302)
T ss_pred hhccccCCcEEEEEcccCc-cHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCC
Confidence 78999999975 7777776542 35788999999999999999999 99999999999999999999
Q ss_pred ceEEcccccceecCCCCcccccccccccccccCcccccC-CCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHH
Q 043524 166 VVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNE 244 (314)
Q Consensus 166 ~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 244 (314)
.++|+|||.+...............++..|+|||.+... .++.++||||+|+++++|++|+.||......... ..
T Consensus 154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~----~~ 229 (302)
T cd07864 154 QIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQL----EL 229 (302)
T ss_pred cEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH----HH
Confidence 999999999876543322112223467789999988654 4788999999999999999999999743321110 00
Q ss_pred HHHhhhcc---CCcccccC--------hhhhc-cCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 245 YLKNYFED---NRFTEIVD--------PIIVQ-DLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 245 ~~~~~~~~---~~~~~~~~--------~~~~~-~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
+...... ..+..+.. ..... ..........+..+.+++.+||..||.+|||+.+++.
T Consensus 230 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 230 -ISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred -HHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000000 00000000 00000 0000000123566899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=250.74 Aligned_cols=249 Identities=22% Similarity=0.295 Sum_probs=196.3
Q ss_pred ccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC--
Q 043524 16 RTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET-- 92 (314)
Q Consensus 16 ~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-- 92 (314)
....+|.|+ +.++.+....+|+.+++|++........ ..+.+.+|+.++++++||||+++++.+...
T Consensus 4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (260)
T cd06606 4 RGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEE----------ELEALEREIRILSSLQHPNIVRYYGSERDEEK 73 (260)
T ss_pred eeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchH----------HHHHHHHHHHHHHHcCCCCEeeEEEEEecCCC
Confidence 334567776 7788888888899999999876553211 126788999999999999999999999988
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~df 172 (314)
...++++||+++++|.+.+.... .++...+..++.+++.|+.||| +.+++|+|++|+||+++.++.++|+||
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~ 145 (260)
T cd06606 74 NTLNIFLEYVSGGSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADF 145 (260)
T ss_pred CeEEEEEEecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccc
Confidence 89999999999999999987643 5788999999999999999999 999999999999999999999999999
Q ss_pred ccceecCCCCcc-cccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhc
Q 043524 173 SLSISIPEGETH-ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFE 251 (314)
Q Consensus 173 g~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (314)
|.+......... ......++..|+|||.+....++.++|+||+|+++++|++|..||....... ........
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~ 218 (260)
T cd06606 146 GCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM-------AALYKIGS 218 (260)
T ss_pred ccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-------HHHHhccc
Confidence 998776544321 1234568889999999988889999999999999999999999986544110 11111000
Q ss_pred cCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 252 DNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.... ...+...+..+.+++.+||..||++||++.+++.
T Consensus 219 ~~~~-------------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 219 SGEP-------------PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cCCC-------------cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 0000 0111133567899999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=277.77 Aligned_cols=247 Identities=19% Similarity=0.233 Sum_probs=202.5
Q ss_pred ccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeEEEe--
Q 043524 16 RTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGCCLE-- 91 (314)
Q Consensus 16 ~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~-- 91 (314)
-...+|.|. +.|++....++|+..|+|+.....-. .++...|.++|+.. .|||++.++|++.-
T Consensus 23 i~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-------------deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 23 IIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-------------EEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred EEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-------------cHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 345677777 77888888899999999987765321 15667889999987 58999999999973
Q ss_pred ---CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceE
Q 043524 92 ---TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVK 168 (314)
Q Consensus 92 ---~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~k 168 (314)
++++|+|||||.+||..|++....+ ..+.+..+..++..++.|+.+|| .+.++|||+|..|||++.++.+|
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g---~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTKG---NRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhcc---cchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEE
Confidence 6789999999999999999988763 56888999999999999999999 99999999999999999999999
Q ss_pred EcccccceecCCCCcccccccccccccccCcccccC-----CCCcccchHHHHHHHHHHHhCCCCcccccCccccccchH
Q 043524 169 LFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTC-----DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFN 243 (314)
Q Consensus 169 l~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~ 243 (314)
+.|||++.++.. +.....+.+||+.|||||++.-. .|+.++|+||||++..||..|.+|+-..+...
T Consensus 164 LvDFGvSaQlds-T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr------- 235 (953)
T KOG0587|consen 164 LVDFGVSAQLDS-TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR------- 235 (953)
T ss_pred Eeeeeeeeeeec-ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh-------
Confidence 999999988754 34457889999999999998643 37899999999999999999999974333211
Q ss_pred HHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 244 EYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
-++.-...++.....+...+.++.++|..||..|-++||+..++++
T Consensus 236 -------------aLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 236 -------------ALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred -------------hhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 1111111223334456688999999999999999999999999885
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=254.11 Aligned_cols=249 Identities=24% Similarity=0.343 Sum_probs=196.0
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCee
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIA 95 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (314)
...+|.|+ +.++.+....++..+++|.+........ ..+++.+|+++++.++|+|++++.+.+..+...
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----------~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 74 (258)
T cd08215 5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEK----------EREDALNEVKILKKLNHPNIIKYYESFEEKGKL 74 (258)
T ss_pred EeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChH----------HHHHHHHHHHHHHhcCCCChhheEEEEecCCEE
Confidence 34577777 7888888888899999998865432111 115678999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
++++|++++++|.+.+...... ...++...+..++.+++.|+.+|| +++++|+||+|+||+++.++.++++|||.+
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~ 150 (258)
T cd08215 75 CIVMEYADGGDLSQKIKKQKKE-GKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGIS 150 (258)
T ss_pred EEEEEecCCCcHHHHHHHhhcc-CCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccce
Confidence 9999999999999998764210 145889999999999999999999 999999999999999999999999999998
Q ss_pred eecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCc
Q 043524 176 ISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRF 255 (314)
Q Consensus 176 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (314)
....... .......+++.|+|||......++.++|+||+|+++++|++|..||..... ......... ...
T Consensus 151 ~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~-~~~ 220 (258)
T cd08215 151 KVLSSTV-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL--------LELALKILK-GQY 220 (258)
T ss_pred eecccCc-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH--------HHHHHHHhc-CCC
Confidence 7664432 123345688899999999888899999999999999999999999864331 111111111 000
Q ss_pred ccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 256 TEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
. +. +...+..+.+++.+||..+|++|||+.++++
T Consensus 221 ~---------~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 221 P---------PI----PSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred C---------CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 00 0134466889999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=261.75 Aligned_cols=269 Identities=17% Similarity=0.211 Sum_probs=187.1
Q ss_pred cccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCC
Q 043524 15 KRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETP 93 (314)
Q Consensus 15 ~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (314)
.....+|.|+ +.++++....+|+.+|+|.+....... ...+.+.+|+++++.++||||+++++++.++.
T Consensus 5 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~----------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (294)
T PLN00009 5 EKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDE----------GVPSTAIREISLLKEMQHGNIVRLQDVVHSEK 74 (294)
T ss_pred EEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccc----------cchHHHHHHHHHHHhccCCCEeeEEEEEecCC
Confidence 3444578777 778888788889999999875432110 01246789999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecC-CCceEEccc
Q 043524 94 IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSE-ENVVKLFDF 172 (314)
Q Consensus 94 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~-~~~~kl~df 172 (314)
..|+||||++ +++.+.+..... ..++...+..++.|++.||.||| +++++|+||+|+||+++. ++.++++||
T Consensus 75 ~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~df 147 (294)
T PLN00009 75 RLYLVFEYLD-LDLKKHMDSSPD---FAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADF 147 (294)
T ss_pred eEEEEEeccc-ccHHHHHHhCCC---CCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEccc
Confidence 9999999995 588887765432 23567788889999999999999 999999999999999985 457899999
Q ss_pred ccceecCCCCcccccccccccccccCcccccC-CCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHH---Hh
Q 043524 173 SLSISIPEGETHITDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYL---KN 248 (314)
Q Consensus 173 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~---~~ 248 (314)
|++........ ......+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||............+.... ..
T Consensus 148 g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 226 (294)
T PLN00009 148 GLARAFGIPVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEE 226 (294)
T ss_pred ccccccCCCcc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 99865433211 12234568899999988654 478899999999999999999999964332111000000000 00
Q ss_pred hhcc----CCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 249 YFED----NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 249 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.+.. .+...... ..............+..+.+++.+||+.||++||++.++++
T Consensus 227 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 227 TWPGVTSLPDYKSAFP-KWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hccccccchhhhhhcc-cCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 00000000 00000000000123456889999999999999999999986
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=246.41 Aligned_cols=273 Identities=18% Similarity=0.284 Sum_probs=199.5
Q ss_pred hhhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeE
Q 043524 10 LWSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGC 88 (314)
Q Consensus 10 ~~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 88 (314)
..+++.+...+|+|. +.|+++..+.+|+.||+|.+.... .+..|. ...++|+++|..++|+|++.+++.
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen---eKeGfp-------italreikiL~~lkHenv~nliEi 84 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN---EKEGFP-------ITALREIKILQLLKHENVVNLIEI 84 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc---cccCCc-------HHHHHHHHHHHHhcchhHHHHHHH
Confidence 345667777899999 669999999999999999765433 222222 456899999999999999999988
Q ss_pred EEe--------CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCee
Q 043524 89 CLE--------TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHIL 160 (314)
Q Consensus 89 ~~~--------~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil 160 (314)
|.+ ...+|+|+.+|+. +|..++.... ..++..++..++.++..||.|+| .+.|+|||+|+.|+|
T Consensus 85 c~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~----vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvL 156 (376)
T KOG0669|consen 85 CRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNRK----VRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVL 156 (376)
T ss_pred HhhccCCcccccceeeeeHHHhhh-hHHHHhcCcc----ccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEE
Confidence 864 2348999999976 9999887654 35888999999999999999999 999999999999999
Q ss_pred ecCCCceEEcccccceecCCCCccc---ccccccccccccCcccccCC-CCcccchHHHHHHHHHHHhCCCCcccccCcc
Q 043524 161 FSEENVVKLFDFSLSISIPEGETHI---TDTVMGTYGHLAPQYVTTCD-FSEKLDVYSFGAFLSELLTGRGILDLVRDAH 236 (314)
Q Consensus 161 ~~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~~~~~ 236 (314)
|+.++.++|+|||+++.+....... -...+-|.+|++||.+.+.+ |+++.|||.-||++.||.+|.+.+++.....
T Consensus 157 It~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqq 236 (376)
T KOG0669|consen 157 ITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQ 236 (376)
T ss_pred EcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHH
Confidence 9999999999999997764332211 11235689999999998765 8999999999999999999999998665432
Q ss_pred ccccchHHHHHhhhccCCccccc-----ChhhhccCCchhHH---------HHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 237 DLVYPFNEYLKNYFEDNRFTEIV-----DPIIVQDLSCTEKE---------QQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~---------~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.. .+...+.-......|.... ..+-..+.+..... .-..++.+|+.++|..||.+|+++++++.
T Consensus 237 ql--~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 237 QL--HLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred HH--HHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 11 1111111111111111111 00000000000000 11246789999999999999999999886
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=255.41 Aligned_cols=250 Identities=21% Similarity=0.230 Sum_probs=189.0
Q ss_pred ccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC--
Q 043524 16 RTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET-- 92 (314)
Q Consensus 16 ~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-- 92 (314)
....+|+|+ +.++.+.+..+|+.+|+|.+......... ....+.+.+|+.+++.++|+||+++++.+.+.
T Consensus 6 ~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~-------~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 78 (264)
T cd06653 6 LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQET-------SKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEE 78 (264)
T ss_pred eeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchh-------hHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCC
Confidence 344578777 78888888889999999986432110000 00125678999999999999999999998764
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~df 172 (314)
..+++++||+++++|.+.+.... .++......++.|++.||.||| +.+++|+||+|+||+++.++.++++||
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~~-----~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~df 150 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAYG-----ALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDF 150 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcc
Confidence 56889999999999999887543 4678888899999999999999 999999999999999999999999999
Q ss_pred ccceecCCCCc--ccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhh
Q 043524 173 SLSISIPEGET--HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 173 g~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
|.++....... .......++..|+|||.+.+..++.++|+||+|++++++++|+.||....... ... .
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~-~-- 220 (264)
T cd06653 151 GASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA-------AIF-K-- 220 (264)
T ss_pred ccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH-------HHH-H--
Confidence 99876532111 11223468899999999988888999999999999999999999986432111 000 0
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
....+.....+...+..+.+++.+||. +|..|||+.+++.
T Consensus 221 -----------~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 221 -----------IATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -----------HHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 000111111122455678999999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=266.51 Aligned_cols=271 Identities=19% Similarity=0.266 Sum_probs=191.5
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.++.....+|.|+ +.|+.+....+|+.||+|.+....... ...+.+.+|+.++..++||||+++++++.
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~----------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 74 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVP----------TLAKRTLRELKILRHFKHDNIIAIRDILR 74 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccc----------cchHHHHHHHHHHHhcCCCCccCHHHhcc
Confidence 3444445688887 778888888899999999876432110 01256778999999999999999999876
Q ss_pred e----CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCc
Q 043524 91 E----TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENV 166 (314)
Q Consensus 91 ~----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~ 166 (314)
. +...++|+||+. ++|.+.+... ..++...+..++.|++.||.||| +++++|+||||+||+++.++.
T Consensus 75 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~ 145 (334)
T cd07855 75 PPGADFKDVYVVMDLME-SDLHHIIHSD-----QPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCE 145 (334)
T ss_pred ccCCCCceEEEEEehhh-hhHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCc
Confidence 3 457899999995 6998888654 34788999999999999999999 999999999999999999999
Q ss_pred eEEcccccceecCCCCcc---cccccccccccccCccccc-CCCCcccchHHHHHHHHHHHhCCCCcccccCccccc---
Q 043524 167 VKLFDFSLSISIPEGETH---ITDTVMGTYGHLAPQYVTT-CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLV--- 239 (314)
Q Consensus 167 ~kl~dfg~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~--- 239 (314)
++|+|||.++........ ......++..|+|||.+.. ..++.++||||+|+++|+|++|+.||..........
T Consensus 146 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~ 225 (334)
T cd07855 146 LRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLIL 225 (334)
T ss_pred EEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHH
Confidence 999999998765432211 1123468889999998866 358899999999999999999999996432211000
Q ss_pred ----cchHHHHHhhhccCCcccccChhh-hccCCch-hHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 240 ----YPFNEYLKNYFEDNRFTEIVDPII-VQDLSCT-EKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 240 ----~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.+........ .........+..- ....+.. .....+.++.+++.+||+.||++|||+.+++.
T Consensus 226 ~~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 226 SVLGSPSEEVLNRI-GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred HHhCCChhHhhhhh-chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0000000000 0000000000000 0000000 00134677899999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=258.92 Aligned_cols=255 Identities=19% Similarity=0.236 Sum_probs=190.7
Q ss_pred cccccCch-hHHHHHHH---hcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeEEEe
Q 043524 17 TLMIGNGA-SVLQELIA---SSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGCCLE 91 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~---~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 91 (314)
...+|.|+ +.++.+.. ..+++.+|+|.+.......... ..+.+.+|+.++.++ +||||+++.+.+..
T Consensus 5 ~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~--------~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~ 76 (288)
T cd05583 5 LRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAK--------TAEHTRTERQVLEAVRRCPFLVTLHYAFQT 76 (288)
T ss_pred EEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhh--------HHHHHHHHHHHHHhccCCcchhhhheeeec
Confidence 34578777 66665442 3467889999887654321110 125678999999999 59999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
+...|+||||+++|+|.+.+... ..++...+..++.|++.+|.||| +.+++|+||+|+||+++.++.++++|
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~d 148 (288)
T cd05583 77 DTKLHLILDYVNGGELFTHLYQR-----EHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTD 148 (288)
T ss_pred CCEEEEEEecCCCCcHHHHHhhc-----CCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEE
Confidence 99999999999999999988653 24778888999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCcccccCC--CCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhh
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTTCD--FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNY 249 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (314)
||+++..............++..|+|||.+.+.. .+.++|+||+|+++|+|++|..||....... .........
T Consensus 149 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----~~~~~~~~~ 224 (288)
T cd05583 149 FGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN----SQSEISRRI 224 (288)
T ss_pred CccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc----hHHHHHHHH
Confidence 9998765433322233346889999999987665 6789999999999999999999985322111 011111111
Q ss_pred hccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHH
Q 043524 250 FEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQ 306 (314)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 306 (314)
.. ... ..+...+..+.+++.+||+.||++|||+.++.+.|..
T Consensus 225 ~~-------------~~~--~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 225 LK-------------SKP--PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred Hc-------------cCC--CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 10 000 0111344567899999999999999998877766644
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=260.29 Aligned_cols=247 Identities=20% Similarity=0.261 Sum_probs=195.3
Q ss_pred ccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC-CCceeeeEeEEEeCC
Q 043524 16 RTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS-HDHILKLIGCCLETP 93 (314)
Q Consensus 16 ~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 93 (314)
-...+|.|+ +.++.+....+|..+|+|++.......... .+.+.+|+.++..++ |+||+++++++.+++
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~---------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 75 (280)
T cd05581 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKK---------VKYVKIEKEVLTRLNGHPGIIKLYYTFQDEE 75 (280)
T ss_pred EeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHH---------HHHHHHHHHHHHhcccCCCchhHHHHhcCCc
Confidence 344578887 888888888899999999988754422211 156789999999998 999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccc
Q 043524 94 IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFS 173 (314)
Q Consensus 94 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg 173 (314)
..+++||++++++|.+.+.... .++...+..++.|++.||.+|| +++++|+||+|+||+++.++.++++|||
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~ 147 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKYG-----SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFG 147 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCc
Confidence 9999999999999999997653 5889999999999999999999 9999999999999999999999999999
Q ss_pred cceecCCCCc-------------------ccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccC
Q 043524 174 LSISIPEGET-------------------HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRD 234 (314)
Q Consensus 174 ~~~~~~~~~~-------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~ 234 (314)
++........ .......++..|+|||......++.++|+||+|++++++++|..||.....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 227 (280)
T cd05581 148 TAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE 227 (280)
T ss_pred cccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH
Confidence 9876543221 122344678899999998888889999999999999999999999874431
Q ss_pred ccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCH----HHHHH
Q 043524 235 AHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTM----VDVAR 302 (314)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~----~ell~ 302 (314)
.. .+ ..... ... ..+...+..+.+++..||+.||++|||+ .+++.
T Consensus 228 ~~----~~----~~~~~-------------~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 228 YL----TF----QKILK-------------LEY--SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HH----HH----HHHHh-------------cCC--CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 11 00 00000 000 0001234568899999999999999999 77654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=256.64 Aligned_cols=262 Identities=18% Similarity=0.260 Sum_probs=189.1
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC---CCCceeeeEeEEEeC
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM---SHDHILKLIGCCLET 92 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~ 92 (314)
...+|.|+ +.++++....+|+.+|+|.+........ ....+.+|+.++.++ +||||+++++++...
T Consensus 4 ~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 73 (287)
T cd07838 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG----------IPLSTLREIALLKQLESFEHPNIVRLLDVCHGP 73 (287)
T ss_pred EEEecccCceEEEEEEECCCCCEEEEEEeccccccch----------hhhhHHHHHHHHHHhhccCCCCcceEEEEEeec
Confidence 34577777 7788888777899999998864321100 113456777776655 599999999999887
Q ss_pred Ce-----eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCce
Q 043524 93 PI-----AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVV 167 (314)
Q Consensus 93 ~~-----~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~ 167 (314)
.. .++++||++ ++|.+++..... ..+++..+..++.|++.||.||| +++++|+||+|+||+++.++.+
T Consensus 74 ~~~~~~~~~l~~e~~~-~~l~~~l~~~~~---~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~ 146 (287)
T cd07838 74 RTDRELKLTLVFEHVD-QDLATYLSKCPK---PGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQV 146 (287)
T ss_pred cCCCCceeEEEehhcc-cCHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCE
Confidence 76 999999996 589888866432 24788999999999999999999 9999999999999999999999
Q ss_pred EEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHH
Q 043524 168 KLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLK 247 (314)
Q Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (314)
+|+|||.+........ .....++..|+|||.+.+..++.++|+||+|+++|+|++|.+||......+ .+.....
T Consensus 147 ~l~dfg~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~----~~~~~~~ 220 (287)
T cd07838 147 KIADFGLARIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD----QLDKIFD 220 (287)
T ss_pred EEeccCcceeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH----HHHHHHH
Confidence 9999999877643321 223457888999999988889999999999999999999999987543221 1111111
Q ss_pred hhhcc--CCcc-------cccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 248 NYFED--NRFT-------EIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 248 ~~~~~--~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
..... ..+. ........... .......+..+.+++.+||..||++||++.|++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 221 VIGLPSEEEWPRNVSLPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred HcCCCChHhcCCCcccchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000 0000 00000000000 0111144577899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=262.08 Aligned_cols=252 Identities=20% Similarity=0.275 Sum_probs=187.5
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC-CCceeeeEeEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS-HDHILKLIGCC 89 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~ 89 (314)
..+.....+|.|+ +.++.+....+|+.+|+|.+........ ..++..|+.++.... |+||+++++++
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~-----------~~~~~~e~~~~~~~~~~~~i~~~~~~~ 83 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEE-----------NKRILMDLDVVLKSHDCPYIVKCYGYF 83 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHH-----------HHHHHHHHHHHHhccCCCchHhhheee
Confidence 3344555688887 7888888888899999999865432111 145667777676665 99999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCC-CCceeccCCCCCeeecCCCceE
Q 043524 90 LETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFP-RPIVFRDFKTSHILFSEENVVK 168 (314)
Q Consensus 90 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~-~~i~H~dlk~~nil~~~~~~~k 168 (314)
.++...|++|||++ +++.+.+.... .+++...+..++.+++.|+.||| + .+++|+||+|+||+++.++.++
T Consensus 84 ~~~~~~~~v~e~~~-~~l~~l~~~~~----~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~k 155 (296)
T cd06618 84 ITDSDVFICMELMS-TCLDKLLKRIQ----GPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVK 155 (296)
T ss_pred ecCCeEEEEeeccC-cCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEE
Confidence 99999999999985 57777765533 35788888999999999999999 7 5999999999999999999999
Q ss_pred EcccccceecCCCCcccccccccccccccCcccccCC----CCcccchHHHHHHHHHHHhCCCCcccccCccccccchHH
Q 043524 169 LFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCD----FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNE 244 (314)
Q Consensus 169 l~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 244 (314)
|+|||.+........ .....++..|+|||.+.... ++.++|+||||+++|+|++|+.||....... +
T Consensus 156 L~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------~ 226 (296)
T cd06618 156 LCDFGISGRLVDSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-------E 226 (296)
T ss_pred ECccccchhccCCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-------H
Confidence 999999866533221 22335788999999987553 7889999999999999999999986422110 0
Q ss_pred HHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 043524 245 YLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARR 303 (314)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 303 (314)
......... . +.. +.....+.++.+|+.+||+.||++|||+.++++.
T Consensus 227 ~~~~~~~~~-~-----~~~------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 227 VLTKILQEE-P-----PSL------PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred HHHHHhcCC-C-----CCC------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111111110 0 000 0000234568999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=257.14 Aligned_cols=250 Identities=19% Similarity=0.265 Sum_probs=186.3
Q ss_pred ccccCch-hHHHHHHH---hcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeEEEeC
Q 043524 18 LMIGNGA-SVLQELIA---SSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGCCLET 92 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~---~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 92 (314)
..+|.|+ +.++.+.. ..+|+.+|+|.+.......... ..+.+.+|++++..+ +|+||+++++.+..+
T Consensus 6 ~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~--------~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~ 77 (290)
T cd05613 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAK--------TTEHTRTERQVLEHIRQSPFLVTLHYAFQTD 77 (290)
T ss_pred eeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcch--------HHHHHHHHHHHHHhcccCCChhceeeEeecC
Confidence 3577777 55655443 2478999999987543321100 125677899999999 589999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~df 172 (314)
...|+|+||+++++|.+.+.... .++...+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+||
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~df 149 (290)
T cd05613 78 TKLHLILDYINGGELFTHLSQRE-----RFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDF 149 (290)
T ss_pred CeEEEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeC
Confidence 99999999999999999987643 4778888888999999999999 999999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCcccccC--CCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhh
Q 043524 173 SLSISIPEGETHITDTVMGTYGHLAPQYVTTC--DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 173 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
|++...............|+..|+|||.+... .++.++||||+|+++|+|++|..||....... ..........
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~----~~~~~~~~~~ 225 (290)
T cd05613 150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN----SQAEISRRIL 225 (290)
T ss_pred ccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc----cHHHHHHHhh
Confidence 99876544322223345688999999988753 36788999999999999999999986322111 1111111111
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCC-----CHHHHHH
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRP-----TMVDVAR 302 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 302 (314)
. ... +.+...+..+.+++.+||..||++|| ++.+++.
T Consensus 226 ~-------------~~~--~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 226 K-------------SEP--PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred c-------------cCC--CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0 000 00112345678999999999999997 6677665
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=264.01 Aligned_cols=274 Identities=17% Similarity=0.233 Sum_probs=191.3
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCC--hhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCe
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNG--FWHESCINNVTYAAQMSHDHILKLIGCCLETPI 94 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 94 (314)
..+|.|+ +.|+++.+..+|+.+|+|.+.............+... .....+.+|+++++.++|+||+++++++..++.
T Consensus 15 ~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 94 (335)
T PTZ00024 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDF 94 (335)
T ss_pred hcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCCc
Confidence 3578888 8888888888999999999865432221100000000 011357799999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccc
Q 043524 95 AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL 174 (314)
Q Consensus 95 ~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~ 174 (314)
.+++|||+. |+|.+.+... ..++......++.|++.||.||| +++++|+||+|+||+++.++.++++|||.
T Consensus 95 ~~lv~e~~~-~~l~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 95 INLVMDIMA-SDLKKVVDRK-----IRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred EEEEEeccc-cCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECCccc
Confidence 999999996 6999888653 24788899999999999999999 99999999999999999999999999999
Q ss_pred ceecCCCC-------------cccccccccccccccCcccccCC-CCcccchHHHHHHHHHHHhCCCCcccccCcccccc
Q 043524 175 SISIPEGE-------------THITDTVMGTYGHLAPQYVTTCD-FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVY 240 (314)
Q Consensus 175 ~~~~~~~~-------------~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~ 240 (314)
+....... ........++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||..........
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~- 244 (335)
T PTZ00024 166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG- 244 (335)
T ss_pred eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-
Confidence 87654110 01112234678899999887643 6899999999999999999999997544321100
Q ss_pred chHHHHHhhhccCCccccc-----Chhhhc-cCC-chhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 241 PFNEYLKNYFEDNRFTEIV-----DPIIVQ-DLS-CTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~-----~~~~~~-~~~-~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
......... ....+.... .+.... +.. .......+..+.+++..||+.||++|||+.|++.
T Consensus 245 ~i~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 245 RIFELLGTP-NEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHhCCC-chhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 000000000 000000000 000000 000 0000123567889999999999999999999986
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=257.31 Aligned_cols=264 Identities=20% Similarity=0.269 Sum_probs=189.9
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC-CCceeeeEeEEEeCCee
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS-HDHILKLIGCCLETPIA 95 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 95 (314)
..+|.|+ +.++.+....+++.+++|.+........ .....+|+..+..++ |+||+++++++.+++..
T Consensus 5 ~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~-----------~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 73 (283)
T cd07830 5 KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-----------ECMNLREVKSLRKLNEHPNIVKLKEVFRENDEL 73 (283)
T ss_pred eeeccCCceEEEEEEECCCCcEEEEEEehhhccchh-----------HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcE
Confidence 3477777 8888888888899999998764421100 023457899999999 99999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
++||||+ +|+|.+.+..... ..++...+..++.|++.+|.||| +++++|+||+|+||+++.++.++|+|||.+
T Consensus 74 ~lv~e~~-~~~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~ 146 (283)
T cd07830 74 YFVFEYM-EGNLYQLMKDRKG---KPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLA 146 (283)
T ss_pred EEEEecC-CCCHHHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccc
Confidence 9999999 7899888876532 35788999999999999999999 999999999999999999999999999999
Q ss_pred eecCCCCcccccccccccccccCccccc-CCCCcccchHHHHHHHHHHHhCCCCcccccCccccc-------cchH-HHH
Q 043524 176 ISIPEGETHITDTVMGTYGHLAPQYVTT-CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLV-------YPFN-EYL 246 (314)
Q Consensus 176 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~-------~~~~-~~~ 246 (314)
+....... .....++..|+|||.+.. ..++.++|+||||+++++|++|..||.......... .+.. .+.
T Consensus 147 ~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (283)
T cd07830 147 REIRSRPP--YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWP 224 (283)
T ss_pred eeccCCCC--cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhh
Confidence 76643322 234567889999998754 447899999999999999999999986543221100 0000 000
Q ss_pred HhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 247 KNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
............+......... ......+..+.+++..||..||++|||+.|++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 225 EGYKLASKLGFRFPQFAPTSLH-QLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred hHhhhhccccccccccccccHH-HHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000000000000000000000 000012467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=254.96 Aligned_cols=264 Identities=15% Similarity=0.108 Sum_probs=181.3
Q ss_pred cCcccccccCch-hHHHHHHHhcC---CcccccccccHHH--HHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeE
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSN---GKYIPYRIFSAQE--LKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLI 86 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~---g~~~a~k~~~~~~--~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 86 (314)
+|+....+|+|+ +.|+++....+ +..+|+|+..... ......... .........++..+..++|+||++++
T Consensus 13 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~---~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 13 EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYN---NIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred ceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHH---hhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 344455688888 88887776666 5667777532211 000000000 00012234455666778899999999
Q ss_pred eEEEeCC----eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeec
Q 043524 87 GCCLETP----IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFS 162 (314)
Q Consensus 87 ~~~~~~~----~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~ 162 (314)
+.+.... ..++++|++. .++.+.+.... ..+...+..++.|++.||.||| +++|+||||||+||+++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~ 160 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK-----CKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVD 160 (294)
T ss_pred EeeeEecCCceEEEEEEehhc-cCHHHHHHhhc-----cCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEc
Confidence 9766543 3468888774 47766665432 2467778899999999999999 99999999999999999
Q ss_pred CCCceEEcccccceecCCCCcc------cccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCcc
Q 043524 163 EENVVKLFDFSLSISIPEGETH------ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAH 236 (314)
Q Consensus 163 ~~~~~kl~dfg~~~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~ 236 (314)
.++.++|+|||+++........ ......||+.|+|||+..+..++.++||||+||++++|++|..||.......
T Consensus 161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~ 240 (294)
T PHA02882 161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG 240 (294)
T ss_pred CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence 9999999999999876432211 1223469999999999998889999999999999999999999997653322
Q ss_pred cccc-chHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHH
Q 043524 237 DLVY-PFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRL 304 (314)
Q Consensus 237 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 304 (314)
.... .-.++...... +.... ...+..+.+++..||..+|++||++.++++.+
T Consensus 241 ~~~~~~~~~~~~~~~~-------------~~~~~---~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 241 NLIHAAKCDFIKRLHE-------------GKIKI---KNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHHhHHHHHHHhhh-------------hhhcc---CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 1110 00111111110 00001 12346688999999999999999999999876
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=267.86 Aligned_cols=267 Identities=15% Similarity=0.216 Sum_probs=187.4
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.++.....+|.|+ +.|+.+.+..+|+.+|+|.+....... .+.+.+|+++++.++||||+++++++.
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~------------~~~~~~Ei~~l~~l~h~~i~~~~~~~~ 72 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQS------------VKHALREIKIIRRLDHDNIVKVYEVLG 72 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCch------------HHHHHHHHHHHHhcCCCcchhhHhhhc
Confidence 4555566688888 888888888999999999876543211 156789999999999999999998765
Q ss_pred eC--------------CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCC
Q 043524 91 ET--------------PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKT 156 (314)
Q Consensus 91 ~~--------------~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~ 156 (314)
.. ...|+++||++ ++|.+.+.. ..++...+..++.|++.||.||| +.+++|+||||
T Consensus 73 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp 142 (342)
T cd07854 73 PSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ------GPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKP 142 (342)
T ss_pred ccccccccccccccccceEEEEeeccc-ccHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCH
Confidence 43 35799999996 589887754 24788899999999999999999 99999999999
Q ss_pred CCeeecC-CCceEEcccccceecCCCCccc--ccccccccccccCccccc-CCCCcccchHHHHHHHHHHHhCCCCcccc
Q 043524 157 SHILFSE-ENVVKLFDFSLSISIPEGETHI--TDTVMGTYGHLAPQYVTT-CDFSEKLDVYSFGAFLSELLTGRGILDLV 232 (314)
Q Consensus 157 ~nil~~~-~~~~kl~dfg~~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~ 232 (314)
+||+++. ++.++++|||.++......... .....++..|+|||.+.. ..++.++||||+||++|+|++|+.||...
T Consensus 143 ~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 222 (342)
T cd07854 143 ANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGA 222 (342)
T ss_pred HHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999974 4578999999987653221111 122357889999998755 45788999999999999999999999644
Q ss_pred cCccccccchHH-------HHHhhhccCCcccccC-hhhhccCCc-hhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 233 RDAHDLVYPFNE-------YLKNYFEDNRFTEIVD-PIIVQDLSC-TEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 233 ~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
............ ....... ....... .......+. ......+.++.+|+.+||..||++|||+.|++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 223 HELEQMQLILESVPVVREEDRNELLN--VIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CHHHHHHHHHHhcCCCChHHhhhhhh--hhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 321110000000 0000000 0000000 000000000 000124466889999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=251.58 Aligned_cols=239 Identities=23% Similarity=0.340 Sum_probs=189.0
Q ss_pred ccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeEEE
Q 043524 20 IGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILV 98 (314)
Q Consensus 20 ~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~iv 98 (314)
+|.|+ +.++.+....+|+.+|+|++.......... .+.+.+|+++++.++|+||+++++.+..++..+++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 71 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKE---------VEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLV 71 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHH---------HHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEE
Confidence 46666 777777777789999999988765432211 15678999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccceec
Q 043524 99 FEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISI 178 (314)
Q Consensus 99 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~ 178 (314)
|||+++++|.+.+.... .++......++.|++.|+.|+| +.+++|+||+|+||+++.++.++++|||.+...
T Consensus 72 ~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~ 143 (250)
T cd05123 72 LEYAPGGELFSHLSKEG-----RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKEL 143 (250)
T ss_pred EecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceec
Confidence 99999999999987643 4788999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcccc
Q 043524 179 PEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEI 258 (314)
Q Consensus 179 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (314)
..... ......++..|++||...+...+.++|+||||+++|++++|..||...... ........
T Consensus 144 ~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--------~~~~~~~~------- 207 (250)
T cd05123 144 SSEGS-RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK--------EIYEKILK------- 207 (250)
T ss_pred ccCCC-cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHhc-------
Confidence 43321 233456788999999998888889999999999999999999998643321 11111110
Q ss_pred cChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHH
Q 043524 259 VDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVD 299 (314)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~e 299 (314)
...+.+ ...+..+.+++.+||..||++|||+.+
T Consensus 208 ------~~~~~~--~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 208 ------DPLRFP--EFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred ------CCCCCC--CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 000000 122466789999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=262.54 Aligned_cols=268 Identities=21% Similarity=0.265 Sum_probs=187.3
Q ss_pred cccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeEEEe-
Q 043524 15 KRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGCCLE- 91 (314)
Q Consensus 15 ~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~- 91 (314)
.....+|.|+ +.++++.+..+|+.+|+|.+....... + ....+..|+.++.++ +||||+++++++..
T Consensus 10 ~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~---------~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~ 79 (337)
T cd07852 10 EILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNA-T---------DAQRTFREIMFLQELGDHPNIVKLLNVIKAE 79 (337)
T ss_pred HHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcc-h---------hhhhhhHHHHHHHHhcCCCCccceeeeeccC
Confidence 3334478877 778888777889999999774321100 0 014567899999999 99999999999865
Q ss_pred -CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 92 -TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 92 -~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
+...|+|+||++ ++|...+... .++......++.|++.||.||| +++++|+||+|+||+++.++.++|+
T Consensus 80 ~~~~~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~ 149 (337)
T cd07852 80 NDKDIYLVFEYME-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLA 149 (337)
T ss_pred CCceEEEEecccc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEe
Confidence 346899999996 5998888653 3677788889999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCcc----cccccccccccccCccccc-CCCCcccchHHHHHHHHHHHhCCCCcccccCcccccc-----
Q 043524 171 DFSLSISIPEGETH----ITDTVMGTYGHLAPQYVTT-CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVY----- 240 (314)
Q Consensus 171 dfg~~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~----- 240 (314)
|||.++........ ......|+..|+|||.+.. ..++.++|+||+|+++|+|++|+.||...........
T Consensus 150 d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~ 229 (337)
T cd07852 150 DFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVI 229 (337)
T ss_pred eccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 99998766443221 2233468899999998765 4578899999999999999999999964332211000
Q ss_pred --chHHHHHhhhccCCcccccChhhhccCC--chhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 043524 241 --PFNEYLKNYFEDNRFTEIVDPIIVQDLS--CTEKEQQLHASAQLTFECLNESPIDRPTMVDVARR 303 (314)
Q Consensus 241 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 303 (314)
+........ .........+........ .......+.++.+++..||+.||++|||+.++++.
T Consensus 230 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 230 GPPSAEDIESI-KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred CCCCHHHHHHH-HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000000 000000000000000000 00001245678999999999999999999999973
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=254.42 Aligned_cols=265 Identities=20% Similarity=0.272 Sum_probs=192.6
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeE
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAI 96 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (314)
..+|.|+ +.++.+....+|+.+|+|.+........ ..+.+.+|+.+++.++|+||+++++++.+....+
T Consensus 5 ~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~----------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 74 (282)
T cd07829 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEG----------IPSTALREISLLKELKHPNIVKLLDVIHTERKLY 74 (282)
T ss_pred hcccccCcceEEEeeecCCCcEEEEEEecccccccc----------ccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceE
Confidence 4477777 8888888888899999999876531100 1256778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
+|+||++ ++|.+.+.... ..++...+..++.+++.||.+|| +.+++|+||+|+||+++.++.++|+|||.++
T Consensus 75 ~v~e~~~-~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~ 146 (282)
T cd07829 75 LVFEYCD-MDLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLAR 146 (282)
T ss_pred EEecCcC-cCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCccc
Confidence 9999997 59999997653 35788999999999999999999 9999999999999999999999999999987
Q ss_pred ecCCCCcccccccccccccccCcccccC-CCCcccchHHHHHHHHHHHhCCCCcccccCcccccc-------chHHHHHh
Q 043524 177 SIPEGETHITDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVY-------PFNEYLKN 248 (314)
Q Consensus 177 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~-------~~~~~~~~ 248 (314)
....... ......++..|+|||.+... .++.++|+||+|++++++++|..||........... +.......
T Consensus 147 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (282)
T cd07829 147 AFGIPLR-TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPG 225 (282)
T ss_pred ccCCCcc-ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHh
Confidence 6543321 12233457789999998766 688999999999999999999999865332110000 00000000
Q ss_pred hhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 249 YFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
...................... ....+..+.+++.+||..||++||++.+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 226 VTKLPDYKPTFPKFPPKDLEKV-LPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred hcccccccccccccCccchHHh-cccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000000110000000000 0122567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=249.36 Aligned_cols=217 Identities=19% Similarity=0.184 Sum_probs=171.7
Q ss_pred hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeEEEEeecCC
Q 043524 25 SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQH 104 (314)
Q Consensus 25 ~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~iv~e~~~~ 104 (314)
+.|+.+.+..+|+.+|+|.+..... +.+|...+....||||+++++++.++...|++|||+++
T Consensus 7 ~~v~~~~~~~~~~~~~~K~i~~~~~-----------------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 69 (237)
T cd05576 7 DKVLLVMDTRTQQTFILKGLRKSSE-----------------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEG 69 (237)
T ss_pred ceEEEEEEccCCcEEEEEeecchhh-----------------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCC
Confidence 5577778889999999998865431 12344445556799999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccceecCCCCcc
Q 043524 105 GTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETH 184 (314)
Q Consensus 105 g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~ 184 (314)
|+|.+.+.... .++...+..++.|++.||.||| +++++|+||||+||+++.++.++++|||.+......
T Consensus 70 ~~L~~~l~~~~-----~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--- 138 (237)
T cd05576 70 GKLWSHISKFL-----NIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--- 138 (237)
T ss_pred CCHHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc---
Confidence 99999887542 4788999999999999999999 999999999999999999999999999987654332
Q ss_pred cccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcccccChhhh
Q 043524 185 ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIV 264 (314)
Q Consensus 185 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (314)
.....++..|+|||......++.++|+||+|+++|+|++|..|+....... .. ..
T Consensus 139 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~--------------~~-----~~----- 193 (237)
T cd05576 139 -CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI--------------NT-----HT----- 193 (237)
T ss_pred -cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc--------------cc-----cc-----
Confidence 223345778999999988888999999999999999999998865321100 00 00
Q ss_pred ccCCchhHHHHHHHHHHHHhHhccCCCCCCCCH
Q 043524 265 QDLSCTEKEQQLHASAQLTFECLNESPIDRPTM 297 (314)
Q Consensus 265 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 297 (314)
... .+...+..+.+++.+||+.||++|||+
T Consensus 194 -~~~--~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 194 -TLN--IPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred -ccC--CcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 000 011344568899999999999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=252.09 Aligned_cols=252 Identities=17% Similarity=0.209 Sum_probs=186.8
Q ss_pred ccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCe
Q 043524 16 RTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPI 94 (314)
Q Consensus 16 ~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 94 (314)
....+|.|+ +.++.+.....+..+++|+......... ... ....+..|+.+++.++||||+++++++.+...
T Consensus 4 i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~----~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (260)
T cd08222 4 LQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGEL----NPN---ETVQANQEAQLLSKLDHPAIVKFHASFLERDA 76 (260)
T ss_pred eeeeecCCCCceEEEEEecCCCCcceEEEecccccccc----Ccc---hHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCc
Confidence 334588887 7777776666666666665443221110 000 01345678999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccc
Q 043524 95 AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL 174 (314)
Q Consensus 95 ~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~ 174 (314)
.++++||+++++|.+.+....... ..++...+..++.|++.|+.||| +++++|+||+|+||+++. +.++++|||.
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~ 151 (260)
T cd08222 77 FCIITEYCEGRDLDCKLEELKHTG-KTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGV 151 (260)
T ss_pred eEEEEEeCCCCCHHHHHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCc
Confidence 999999999999998886422111 35788999999999999999999 999999999999999975 5699999999
Q ss_pred ceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCC
Q 043524 175 SISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNR 254 (314)
Q Consensus 175 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (314)
++....... ......++..|+|||.+....++.++|+||+|+++++|++|..||..... .........
T Consensus 152 ~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--------~~~~~~~~~--- 219 (260)
T cd08222 152 SRLLMGSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF--------LSVVLRIVE--- 219 (260)
T ss_pred eeecCCCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHHc---
Confidence 876543322 23345678899999998877888999999999999999999999853221 011111000
Q ss_pred cccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 255 FTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
+.. ...+...+.++.+++..||..||++||++.|+++
T Consensus 220 ----------~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 220 ----------GPT-PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ----------CCC-CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 000 0111245567899999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=258.75 Aligned_cols=266 Identities=16% Similarity=0.202 Sum_probs=189.4
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|.....+|.|+ +.|+.+.+..+|+.+|+|.+....... ...+.+.+|+.++..++||||+++.+++.
T Consensus 10 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----------~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 79 (328)
T cd07856 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTP----------VLAKRTYRELKLLKHLRHENIISLSDIFI 79 (328)
T ss_pred cceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccccc----------chhHHHHHHHHHHHhcCCCCeeeEeeeEe
Confidence 3444555688877 888888888899999999875432110 01155778999999999999999999987
Q ss_pred e-CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEE
Q 043524 91 E-TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKL 169 (314)
Q Consensus 91 ~-~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl 169 (314)
. +...|+++||+ +++|...+... +++......++.|++.||.||| +++++|+||+|+||+++..+.+++
T Consensus 80 ~~~~~~~lv~e~~-~~~L~~~~~~~------~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l 149 (328)
T cd07856 80 SPLEDIYFVTELL-GTDLHRLLTSR------PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKI 149 (328)
T ss_pred cCCCcEEEEeehh-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEe
Confidence 5 56789999999 56998887642 4677788889999999999999 999999999999999999999999
Q ss_pred cccccceecCCCCcccccccccccccccCccccc-CCCCcccchHHHHHHHHHHHhCCCCcccccCcccc-------ccc
Q 043524 170 FDFSLSISIPEGETHITDTVMGTYGHLAPQYVTT-CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDL-------VYP 241 (314)
Q Consensus 170 ~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~-------~~~ 241 (314)
+|||.+...... .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||......... ..+
T Consensus 150 ~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~ 225 (328)
T cd07856 150 CDFGLARIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTP 225 (328)
T ss_pred CccccccccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999998654221 223467888999998765 45889999999999999999999999643321000 000
Q ss_pred hHHHHHhhhccCCcccccChhhhccCCchhH---HHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 043524 242 FNEYLKNYFEDNRFTEIVDPIIVQDLSCTEK---EQQLHASAQLTFECLNESPIDRPTMVDVARR 303 (314)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 303 (314)
..++....... ...+..... ......+.. ...+..+.+++.+||+.+|++|||+.+++..
T Consensus 226 ~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 226 PDDVINTICSE-NTLRFVQSL-PKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred CHHHHHhccch-hhHHHHhhc-cccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 01111100000 000000000 000000111 1234678999999999999999999998763
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=259.61 Aligned_cols=273 Identities=19% Similarity=0.241 Sum_probs=195.8
Q ss_pred cccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCC
Q 043524 15 KRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETP 93 (314)
Q Consensus 15 ~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (314)
.....+|.|+ +.++.+....+|+.+|+|.+....... ...+.+.+|+.+++.++|+||+++.+++....
T Consensus 3 ~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~----------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (330)
T cd07834 3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDL----------IDAKRILREIKLLRHLRHENIIGLLDILRPPS 72 (330)
T ss_pred eeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccc----------hhhhhHHHHHHHHHhcCCcchhhhhhhhcccC
Confidence 3345588877 888888888889999999876432100 01156889999999999999999999998765
Q ss_pred -----eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceE
Q 043524 94 -----IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVK 168 (314)
Q Consensus 94 -----~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~k 168 (314)
.+|+++||++ ++|.+.+.... +++...+..++.+++.||.+|| +++++|+||||+||+++.++.++
T Consensus 73 ~~~~~~~~lv~e~~~-~~l~~~l~~~~-----~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~ 143 (330)
T cd07834 73 PEDFNDVYIVTELME-TDLHKVIKSPQ-----PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLK 143 (330)
T ss_pred cccccceEEEecchh-hhHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEE
Confidence 7899999997 58988886542 5788999999999999999999 99999999999999999999999
Q ss_pred EcccccceecCCCCc--ccccccccccccccCcccccC-CCCcccchHHHHHHHHHHHhCCCCcccccCcccccc-----
Q 043524 169 LFDFSLSISIPEGET--HITDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVY----- 240 (314)
Q Consensus 169 l~dfg~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~----- 240 (314)
|+|||.+........ .......++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...........
T Consensus 144 L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 223 (330)
T cd07834 144 ICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVL 223 (330)
T ss_pred EcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhc
Confidence 999999987644321 112344678899999999887 789999999999999999999999965432110000
Q ss_pred --chHHHHHhhhccCCcccccChhhh-ccCCc-hhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH--HHHH
Q 043524 241 --PFNEYLKNYFEDNRFTEIVDPIIV-QDLSC-TEKEQQLHASAQLTFECLNESPIDRPTMVDVARR--LRQI 307 (314)
Q Consensus 241 --~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~--L~~~ 307 (314)
+..... ...........+..... ...+. ......+..+.+++..||+.||++|||+.+++.. ++.+
T Consensus 224 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 224 GTPSEEDL-KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred CCCChhHh-hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 000000 00000000000000000 00000 0001245678999999999999999999999973 4444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=261.84 Aligned_cols=264 Identities=16% Similarity=0.229 Sum_probs=187.8
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
|.....+|.|+ +.|+.+.+..+|..||+|.+....... ...+.+.+|+.+++.++||||+++++++..+
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (343)
T cd07880 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSE----------LFAKRAYRELRLLKHMKHENVIGLLDVFTPD 86 (343)
T ss_pred eEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccch----------HHHHHHHHHHHHHHhcCCCCccceeeeecCC
Confidence 44455688888 788888888899999999875321110 0125678999999999999999999998765
Q ss_pred C------eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCc
Q 043524 93 P------IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENV 166 (314)
Q Consensus 93 ~------~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~ 166 (314)
. .+++|+||+ +++|.+.+.. ..++...+..++.|++.||.||| +.+|+|+||||+||+++.++.
T Consensus 87 ~~~~~~~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~ 156 (343)
T cd07880 87 LSLDRFHDFYLVMPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCE 156 (343)
T ss_pred ccccccceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCC
Confidence 4 458999999 6799888754 24788899999999999999999 999999999999999999999
Q ss_pred eEEcccccceecCCCCcccccccccccccccCccccc-CCCCcccchHHHHHHHHHHHhCCCCcccccCccccc------
Q 043524 167 VKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTT-CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLV------ 239 (314)
Q Consensus 167 ~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~------ 239 (314)
++++|||.+...... .....+++.|+|||.+.. ..++.++|+||+|+++|++++|..||..........
T Consensus 157 ~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~ 232 (343)
T cd07880 157 LKILDFGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVT 232 (343)
T ss_pred EEEeecccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 999999998754322 223457889999998876 357889999999999999999999996433211000
Q ss_pred -cchHHHHHhhhccCCcccccCh--hhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 240 -YPFNEYLKNYFEDNRFTEIVDP--IIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 240 -~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.....+.... ........... ..............+..+.+++..||+.||++|||+.+++.
T Consensus 233 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 233 GTPSKEFVQKL-QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred CCCCHHHHHhh-cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000 00000000000 00000000000133456889999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=259.09 Aligned_cols=271 Identities=17% Similarity=0.216 Sum_probs=187.9
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.++.....+|.|+ +.++.+....+|+.+|+|.+........ ....+.+|+++++.++||||+++++++.
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG----------FPITALREIKILKKLKHPNVVPLIDMAV 77 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC----------cchhHHHHHHHHHhcCCCCccchhhhee
Confidence 3444455588888 8888888888999999998765332110 0134678999999999999999999875
Q ss_pred eCC--------eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeec
Q 043524 91 ETP--------IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFS 162 (314)
Q Consensus 91 ~~~--------~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~ 162 (314)
... .+++++||+. +++...+.... ..++...+..++.|++.||.||| +++++|+||||+||+++
T Consensus 78 ~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~~----~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~ 149 (311)
T cd07866 78 ERPDKSKRKRGSVYMVTPYMD-HDLSGLLENPS----VKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILID 149 (311)
T ss_pred cccccccccCceEEEEEecCC-cCHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEC
Confidence 433 4699999996 47877776533 35889999999999999999999 99999999999999999
Q ss_pred CCCceEEcccccceecCCCCccc----------ccccccccccccCcccccC-CCCcccchHHHHHHHHHHHhCCCCccc
Q 043524 163 EENVVKLFDFSLSISIPEGETHI----------TDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGRGILDL 231 (314)
Q Consensus 163 ~~~~~kl~dfg~~~~~~~~~~~~----------~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~ 231 (314)
.++.++++|||++.......... .....+++.|+|||.+.+. .++.++||||+|+++|+|++|..||..
T Consensus 150 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~ 229 (311)
T cd07866 150 NQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQG 229 (311)
T ss_pred CCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCC
Confidence 99999999999987653321110 1123567889999988654 478999999999999999999999864
Q ss_pred ccCccccccchHHH------HHhhhccCCcccccChhhhccCCchh---HHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 232 VRDAHDLVYPFNEY------LKNYFEDNRFTEIVDPIIVQDLSCTE---KEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 232 ~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
..........+..+ ....+. ......+.......+... .......+.+++.+||..||++|||+.|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 230 KSDIDQLHLIFKLCGTPTEETWPGWR--SLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred CCHHHHHHHHHHHhCCCChhhchhhh--hcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 33221100000000 000000 000000000000000000 0123356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=263.13 Aligned_cols=245 Identities=20% Similarity=0.256 Sum_probs=199.2
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeE
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAI 96 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (314)
..+|+|. ++||...+.++|+.||||++++-.+-.. . ...+.+|+.+|..+.||.||.+.-.|++.+.++
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k--q--------esqlR~EVaILq~l~HPGiV~le~M~ET~ervF 639 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK--Q--------ESQLRNEVAILQNLHHPGIVNLECMFETPERVF 639 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCc--h--------HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEE
Confidence 3577777 8899999999999999999987553211 1 156789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCC---ceEEcccc
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN---VVKLFDFS 173 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~---~~kl~dfg 173 (314)
+|||-+ +|++...|.+... ..++......++.||+.||.||| .++|+|+||||+|+|+.... ++||+|||
T Consensus 640 VVMEKl-~GDMLEMILSsEk---gRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFG 712 (888)
T KOG4236|consen 640 VVMEKL-HGDMLEMILSSEK---GRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFG 712 (888)
T ss_pred EEehhh-cchHHHHHHHhhc---ccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeecccc
Confidence 999999 5688777766554 56888888899999999999999 99999999999999996543 78999999
Q ss_pred cceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccC
Q 043524 174 LSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDN 253 (314)
Q Consensus 174 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (314)
.|+.+++... ..+.+||+.|+|||++....|+.+-|+||.|+++|--++|..||...++..+.+
T Consensus 713 fARiIgEksF--RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQI-------------- 776 (888)
T KOG4236|consen 713 FARIIGEKSF--RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQI-------------- 776 (888)
T ss_pred ceeecchhhh--hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHh--------------
Confidence 9999866543 667899999999999999999999999999999999999999996444332111
Q ss_pred CcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 254 RFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.++.+.-+.+ .....+..+.+||...|+..-.+|.|....+.
T Consensus 777 -----QNAaFMyPp~--PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 777 -----QNAAFMYPPN--PWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred -----hccccccCCC--chhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 1111212222 22356677899999999999999999876654
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=248.16 Aligned_cols=253 Identities=21% Similarity=0.261 Sum_probs=187.9
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeEEEeCCee
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGCCLETPIA 95 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 95 (314)
..+|.|+ ++|.+..++..|+..|||.++........ ++++.|.++..+- ..||||++||.+...+..
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq-----------~rll~e~d~~mks~~cp~IVkfyGa~F~EGdc 138 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQ-----------KRLLMEHDTVMKSSNCPNIVKFYGALFSEGDC 138 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHH-----------HHHHHHHHHHHhhcCCcHHHHHhhhhhcCCce
Confidence 3589999 99999999999999999999887663322 6788899777665 579999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
||.||+|. -||..+...-..-....+++...-.+....+.||.||.. ...|+|||+||+|||++..|.+||+|||.+
T Consensus 139 WiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIc 215 (361)
T KOG1006|consen 139 WICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGIC 215 (361)
T ss_pred eeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccch
Confidence 99999994 476443321100001346777777777788899999986 788999999999999999999999999998
Q ss_pred eecCCCCcccccccccccccccCcccccC--CCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccC
Q 043524 176 ISIPEGETHITDTVMGTYGHLAPQYVTTC--DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDN 253 (314)
Q Consensus 176 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (314)
-.+..+- ....-.|+.+|||||-+..+ .|+.++|+||+|+++||++||..|+....+.- +.+..... +
T Consensus 216 GqLv~Si--AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svf-------eql~~Vv~-g 285 (361)
T KOG1006|consen 216 GQLVDSI--AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVF-------EQLCQVVI-G 285 (361)
T ss_pred HhHHHHH--HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHH-------HHHHHHHc-C
Confidence 6653321 12233689999999988654 38899999999999999999999986433211 00111110 0
Q ss_pred CcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 254 RFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
+. |++..+ ......+..+..++--||.+|-.+||...++++
T Consensus 286 dp-----p~l~~~---~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 286 DP-----PILLFD---KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred CC-----CeecCc---ccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 11 111111 111146677899999999999999999999875
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=257.90 Aligned_cols=262 Identities=16% Similarity=0.193 Sum_probs=186.6
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.++.....+|+|+ +.++.+.+..+|+.||+|.+........ ..+.+.+|+.++..++||||+++++++.
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII----------HAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhH----------HHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 3444455688887 7778887788999999998865321111 0145778999999999999999999986
Q ss_pred eC------CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCC
Q 043524 91 ET------PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEE 164 (314)
Q Consensus 91 ~~------~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~ 164 (314)
.. ...|++++++ +++|.+.+... .++...+..++.|++.||.||| +.+++|+||||+||+++.+
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~ 156 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNED 156 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCC
Confidence 43 3468888887 78998877542 3778889999999999999999 9999999999999999999
Q ss_pred CceEEcccccceecCCCCcccccccccccccccCccccc-CCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchH
Q 043524 165 NVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTT-CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFN 243 (314)
Q Consensus 165 ~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~ 243 (314)
+.++|+|||+++..... .....++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||....... .+.
T Consensus 157 ~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~----~~~ 228 (345)
T cd07877 157 CELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID----QLK 228 (345)
T ss_pred CCEEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHH
Confidence 99999999998754322 234467889999998866 457889999999999999999999986432211 000
Q ss_pred HHHHhh----------hccCCcccccChhhhccCCchh---HHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 244 EYLKNY----------FEDNRFTEIVDPIIVQDLSCTE---KEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 244 ~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
...... ........... .......... ....+..+.+++..||+.||.+|||+.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 229 LILRLVGTPGAELLKKISSESARNYIQ-SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred HHHHHhCCCCHHHHhhcccHhHHHHHH-HhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 000000 00000000000 0000000000 0013456889999999999999999999886
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=249.63 Aligned_cols=257 Identities=22% Similarity=0.315 Sum_probs=195.0
Q ss_pred ccccccCch-hHHHHHHHhcCCcccccccccHHH-HHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE-eC
Q 043524 16 RTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQE-LKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL-ET 92 (314)
Q Consensus 16 ~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~-~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~ 92 (314)
-...+|.|| +.||++++....++||||+-.... .+..+ ...+.+-.++|.++...|.||.||++|++|. +.
T Consensus 467 lLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEK------KeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 467 LLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEK------KENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred HHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHh------hhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 344689888 999999999999999999854332 11111 1113356789999999999999999999997 55
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeec---CCCceEE
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFS---EENVVKL 169 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~---~~~~~kl 169 (314)
..+|-|+|||+|.+|.-++..+. .++.++++.++.||+.||.||... +..|+|-||||.|||+- ..|.+||
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhk-----lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHK-----LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhh-----hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEe
Confidence 67899999999999988777653 478999999999999999999844 66899999999999984 3568999
Q ss_pred cccccceecCCCCcc------cccccccccccccCcccccC----CCCcccchHHHHHHHHHHHhCCCCcccccCccccc
Q 043524 170 FDFSLSISIPEGETH------ITDTVMGTYGHLAPQYVTTC----DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLV 239 (314)
Q Consensus 170 ~dfg~~~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~----~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~ 239 (314)
+|||+++.+.+.... ..+...||.+|++||.+.-. ..+.++||||+||++|+++.|+.||.......+
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd-- 692 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD-- 692 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH--
Confidence 999999988654221 23455799999999988643 378999999999999999999999975443221
Q ss_pred cchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHH
Q 043524 240 YPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVA 301 (314)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell 301 (314)
.+..+. ++... ....+..+..+.++.+||+.||.+.-++|.+.-++.
T Consensus 693 ---------ILqeNT---IlkAt---EVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 693 ---------ILQENT---ILKAT---EVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred ---------HHhhhc---hhcce---eccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 011111 11111 111222235667789999999999999999877764
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=261.86 Aligned_cols=268 Identities=17% Similarity=0.223 Sum_probs=191.5
Q ss_pred hhhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeE
Q 043524 10 LWSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGC 88 (314)
Q Consensus 10 ~~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 88 (314)
...+|.....+|.|+ +.++.+....++..+|+|.+........ ..+.+.+|+.+++.++|+||+++.++
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~E~~~l~~l~h~~iv~~~~~ 82 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAI----------HAKRTYRELRLLKHMDHENVIGLLDV 82 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhh----------HHHHHHHHHHHHHhccCCCHHHHHHH
Confidence 344555666788888 8888888888899999998764321111 11456789999999999999999998
Q ss_pred EEeCCe------eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeec
Q 043524 89 CLETPI------AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFS 162 (314)
Q Consensus 89 ~~~~~~------~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~ 162 (314)
+..... .++|+||+ +++|.+++.. ..++...+..++.|++.||.||| +.+++|+||+|+||+++
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~ 152 (343)
T cd07851 83 FTPASSLEDFQDVYLVTHLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVN 152 (343)
T ss_pred hhccccccccccEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEC
Confidence 876554 89999999 6799998865 34788999999999999999999 99999999999999999
Q ss_pred CCCceEEcccccceecCCCCcccccccccccccccCccccc-CCCCcccchHHHHHHHHHHHhCCCCcccccCcccccc-
Q 043524 163 EENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTT-CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVY- 240 (314)
Q Consensus 163 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~- 240 (314)
.++.++|+|||.+...... .....++..|+|||.+.. ..++.++||||+|+++|+|++|+.||...........
T Consensus 153 ~~~~~kL~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i 228 (343)
T cd07851 153 EDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRI 228 (343)
T ss_pred CCCCEEEcccccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 9999999999998765332 234467888999998765 3578899999999999999999999964332110000
Q ss_pred ------chHHHHHhhhccCCcccccChhhhcc-CCc-hhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 241 ------PFNEYLKNYFEDNRFTEIVDPIIVQD-LSC-TEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 241 ------~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
+...+.... ................ ... ......+..+.+++..||..||++|||+.+++.
T Consensus 229 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 229 MNLVGTPDEELLQKI-SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHhcCCCCHHHHhhc-cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000000000 0000000000000000 000 000123567899999999999999999999975
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=271.49 Aligned_cols=257 Identities=19% Similarity=0.286 Sum_probs=207.5
Q ss_pred CcccccccCch-hHHHHHHHhcCCc----ccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeE
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGK----YIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGC 88 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~----~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 88 (314)
.++...+|.|+ +.|++...-..|+ +||+|++......+++ .+++.|+-.|..|+|||+++++++
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s-----------~e~LdeAl~masldHpnl~RLLgv 766 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKAS-----------IELLDEALRMASLDHPNLLRLLGV 766 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhh-----------HHHHHHHHHHhcCCCchHHHHhhh
Confidence 34556788888 7777777777676 5788876655443332 789999999999999999999999
Q ss_pred EEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceE
Q 043524 89 CLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVK 168 (314)
Q Consensus 89 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~k 168 (314)
|.... +.||++|++.|+|.|+++.+. .++-....+.|..||+.|+.||| +++++||||-++|+|+...+.+|
T Consensus 767 c~~s~-~qlvtq~mP~G~LlDyvr~hr----~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvk 838 (1177)
T KOG1025|consen 767 CMLST-LQLVTQLMPLGCLLDYVREHR----DNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVK 838 (1177)
T ss_pred cccch-HHHHHHhcccchHHHHHHHhh----ccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEE
Confidence 97765 889999999999999999876 56888999999999999999999 99999999999999999999999
Q ss_pred EcccccceecCCCCcc-cccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHH
Q 043524 169 LFDFSLSISIPEGETH-ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYL 246 (314)
Q Consensus 169 l~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~ 246 (314)
+.|||+++.......+ ......-.+.|||-|.+....|+.++|||||||++||++| |..|+++....+ +
T Consensus 839 itdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e---------I 909 (1177)
T KOG1025|consen 839 ITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE---------I 909 (1177)
T ss_pred EEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH---------h
Confidence 9999999887554322 2223345678999999999999999999999999999998 999987655332 1
Q ss_pred HhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhc
Q 043524 247 KNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSL 311 (314)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 311 (314)
..++ ........++.++.++--++.+||..|++.||+++++.....++.+.+
T Consensus 910 ~dll-------------e~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 910 PDLL-------------EKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred hHHH-------------hccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 1111 112222333366677888999999999999999999999998886643
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=271.42 Aligned_cols=237 Identities=23% Similarity=0.362 Sum_probs=185.7
Q ss_pred cccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeEEEeCCeeEEEEeecCCCCHHHHHhcCC
Q 043524 37 KYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAP 115 (314)
Q Consensus 37 ~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~ 115 (314)
..||||.......... .+.+..|+++|..+ +|+||+.+.|+|.+.+.+++|+|||..|+|.++++...
T Consensus 329 ~~VaVK~~k~~~~~~~-----------~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r 397 (609)
T KOG0200|consen 329 VTVAVKMLKENASSSE-----------KKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKR 397 (609)
T ss_pred EEEEEEecccccCcHH-----------HHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhcc
Confidence 4688887664433322 16789999999998 59999999999999999999999999999999998766
Q ss_pred ---------CCCCC--cccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccceecCCCCcc
Q 043524 116 ---------QTHFE--PLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETH 184 (314)
Q Consensus 116 ---------~~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~ 184 (314)
..... .+.....+.++.||+.|++||+ +++++||||-++|||+..+..+|++|||+++........
T Consensus 398 ~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y 474 (609)
T KOG0200|consen 398 VTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYY 474 (609)
T ss_pred ccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEecCCCEEEEccccceeccCCCCce
Confidence 11111 3888999999999999999999 999999999999999999999999999999865544433
Q ss_pred cccccc--cccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhccCCcccccCh
Q 043524 185 ITDTVM--GTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDP 261 (314)
Q Consensus 185 ~~~~~~--g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (314)
...... -+..|||||.+....|+.++||||||+++||+++ |..||..... ..+... ....
T Consensus 475 ~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~-------~~~l~~-~l~~--------- 537 (609)
T KOG0200|consen 475 RTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP-------TEELLE-FLKE--------- 537 (609)
T ss_pred EecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc-------HHHHHH-HHhc---------
Confidence 322222 3556999999999999999999999999999999 7888754221 111111 1111
Q ss_pred hhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHH
Q 043524 262 IIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQIC 308 (314)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~ 308 (314)
......+..++.++.++++.||+.+|++||++.++.+.+....
T Consensus 538 ----G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 538 ----GNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred ----CCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 1111222355677889999999999999999999999998854
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=258.76 Aligned_cols=263 Identities=19% Similarity=0.273 Sum_probs=184.9
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
++.....+|.|+ +.|+.+.+..+|+.+|+|.+....... ...+.+.+|+.+++.++||||+++++++..
T Consensus 16 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 85 (342)
T cd07879 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSE----------IFAKRAYRELTLLKHMQHENVIGLLDVFTS 85 (342)
T ss_pred ceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccc----------cchhHHHHHHHHHHhcCCCCccchhheecc
Confidence 444555688877 778888778889999999876432100 012457899999999999999999999875
Q ss_pred CC------eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCC
Q 043524 92 TP------IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN 165 (314)
Q Consensus 92 ~~------~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~ 165 (314)
.. .+|+++||+. .++..... ..++...+..++.|++.||.||| +++++||||||+||+++.++
T Consensus 86 ~~~~~~~~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~ 154 (342)
T cd07879 86 AVSGDEFQDFYLVMPYMQ-TDLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDC 154 (342)
T ss_pred cccCCCCceEEEEecccc-cCHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCC
Confidence 43 4699999995 47766542 24778889999999999999999 99999999999999999999
Q ss_pred ceEEcccccceecCCCCcccccccccccccccCccccc-CCCCcccchHHHHHHHHHHHhCCCCcccccCccccc-----
Q 043524 166 VVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTT-CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLV----- 239 (314)
Q Consensus 166 ~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~----- 239 (314)
.++++|||+++..... .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||..........
T Consensus 155 ~~kL~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~ 230 (342)
T cd07879 155 ELKILDFGLARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 230 (342)
T ss_pred CEEEeeCCCCcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 9999999998654322 223467888999998876 458899999999999999999999997432111000
Q ss_pred --cchHHHHHhhhccCCccccc---ChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 240 --YPFNEYLKNYFEDNRFTEIV---DPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 240 --~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.+...+. ............ ......... ...+..+..+.+|+.+||+.||++|||+.+++.
T Consensus 231 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 231 TGVPGPEFV-QKLEDKAAKSYIKSLPKYPRKDFS-TLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred cCCCCHHHH-HHhcccchHHHHhhcCCcccchHH-HHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000000 000000000000 000000000 000123456889999999999999999999985
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=275.46 Aligned_cols=251 Identities=18% Similarity=0.222 Sum_probs=202.1
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHH-HHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELK-QETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~-~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+.....||.|+ |.|..+..+.+++.||.|++++-+.. ++. + .-|..|-.+|..-+.+=||.++-.|.
T Consensus 76 DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~-t---------A~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 76 DFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAE-T---------ACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred hhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchh-H---------HHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 344556799999 88888899999999999999986543 332 1 45778889998888899999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
+.+++|+||||++||+|..++.... .+|...++.|+..|+.||.-+| +.|+|||||||+|||+|..|.+||+
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~~-----~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLA 217 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKFD-----RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLA 217 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhcC-----CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeec
Confidence 9999999999999999999997653 5899999999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCccccc-----CCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHH
Q 043524 171 DFSLSISIPEGETHITDTVMGTYGHLAPQYVTT-----CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEY 245 (314)
Q Consensus 171 dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 245 (314)
|||.+-.+...+.-.....+|||-|.+||++.. +.|+..+|.||+||++|||+.|..||....-. ..|+..
T Consensus 218 DFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslv----eTY~KI 293 (1317)
T KOG0612|consen 218 DFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLV----ETYGKI 293 (1317)
T ss_pred cchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHH----HHHHHH
Confidence 999998887666666778899999999999853 45899999999999999999999999743211 112221
Q ss_pred HHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCC---HHHHH
Q 043524 246 LKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPT---MVDVA 301 (314)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps---~~ell 301 (314)
.. . +..+..|.....++++.+||+..+. +|+.|.. ++++-
T Consensus 294 m~----h-----------k~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik 336 (1317)
T KOG0612|consen 294 MN----H-----------KESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIK 336 (1317)
T ss_pred hc----h-----------hhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence 11 1 0111122222567788999987664 6777876 76664
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=223.47 Aligned_cols=268 Identities=16% Similarity=0.193 Sum_probs=199.4
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
+.+-..||+|. ++|+++....+++.||.|.+...+-.. -+..+.++|+-+|+.++|.|||+++++...+
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrldddde----------gvpssalreicllkelkhknivrl~dvlhsd 73 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDE----------GVPSSALREICLLKELKHKNIVRLHDVLHSD 73 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCC----------CCcHHHHHHHHHHHHhhhcceeehhhhhccC
Confidence 34445599999 999999999999999999987654211 1346788999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~df 172 (314)
..+-+|+||| ..+|..+..+.. ..+..+..+..+.|++.||.+|| ++++.|||+||.|.+|+.+|.+|++||
T Consensus 74 kkltlvfe~c-dqdlkkyfdsln----g~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladf 145 (292)
T KOG0662|consen 74 KKLTLVFEFC-DQDLKKYFDSLN----GDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADF 145 (292)
T ss_pred ceeEEeHHHh-hHHHHHHHHhcC----CcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEeccc
Confidence 9999999999 459988887665 46888999999999999999999 999999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCcccccCC-CCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhh
Q 043524 173 SLSISIPEGETHITDTVMGTYGHLAPQYVTTCD-FSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 173 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
|+++.++..- .+-+..+-|..|.+|.++.+.. |+++.|+||-||++.|+.. |++.|.+..-.+....-|...- ..
T Consensus 146 glarafgipv-rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg--~p 222 (292)
T KOG0662|consen 146 GLARAFGIPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG--TP 222 (292)
T ss_pred chhhhcCCce-EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhC--CC
Confidence 9998875432 2233446789999999998876 8999999999999999997 6666654433222211111100 00
Q ss_pred ccCCcc---cccC----hhhhccCCc-hhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 251 EDNRFT---EIVD----PIIVQDLSC-TEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 251 ~~~~~~---~~~~----~~~~~~~~~-~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
....|. .+-| ++....... ..-+.....-++|+...|.-+|..|.+|++.++
T Consensus 223 ~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 223 TEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred ccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 111111 1111 000000000 001122334589999999999999999998875
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=252.49 Aligned_cols=264 Identities=17% Similarity=0.198 Sum_probs=183.0
Q ss_pred ccccCch-hHHHHHHHhcC--CcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeEEEeC-
Q 043524 18 LMIGNGA-SVLQELIASSN--GKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGCCLET- 92 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~--g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~- 92 (314)
..+|.|+ +.|+.+....+ +..+|+|.+....... ...+.+.+|+.++..+ .||||+++++.+...
T Consensus 6 ~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~----------~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 75 (332)
T cd07857 6 KELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKK----------ILAKRALRELKLLRHFRGHKNITCLYDMDIVFP 75 (332)
T ss_pred EEccccCCeEEEEEEeCCCCcCceEEEEEeccccccc----------hhHHHHHHHHHHHHHhcCCCChheeeeeeeecc
Confidence 3467777 77777777767 8899999875321110 0125678899999999 599999999876432
Q ss_pred ---CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEE
Q 043524 93 ---PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKL 169 (314)
Q Consensus 93 ---~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl 169 (314)
...++++||++ ++|.+.+... ..++...+..++.|++.||.||| +++++|+||||+||+++.++.++|
T Consensus 76 ~~~~~~~~~~e~~~-~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl 146 (332)
T cd07857 76 GNFNELYLYEELME-ADLHQIIRSG-----QPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKI 146 (332)
T ss_pred ccCCcEEEEEeccc-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEe
Confidence 45788999885 6998888654 35788999999999999999999 999999999999999999999999
Q ss_pred cccccceecCCCCcc---cccccccccccccCccccc-CCCCcccchHHHHHHHHHHHhCCCCcccccCccccc------
Q 043524 170 FDFSLSISIPEGETH---ITDTVMGTYGHLAPQYVTT-CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLV------ 239 (314)
Q Consensus 170 ~dfg~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~------ 239 (314)
+|||.++........ ......|+..|+|||.+.+ ..++.++|+||+|+++|+|++|..||..........
T Consensus 147 ~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 226 (332)
T cd07857 147 CDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVL 226 (332)
T ss_pred CcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHh
Confidence 999999765432211 1223468999999998765 458899999999999999999999986432110000
Q ss_pred -cchHHHHHhhhccCCcccccChhhhccCCchh---HHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 240 -YPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTE---KEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 240 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.+..+........ ........ ......... ....+..+.+++.+||+.||++|||+.+++.
T Consensus 227 ~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 227 GTPDEETLSRIGSP-KAQNYIRS-LPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred CCCCHHHHHhhhhh-hHHHHHHh-ccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000000 00000000 000000000 0012456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=247.06 Aligned_cols=260 Identities=23% Similarity=0.313 Sum_probs=195.3
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhc--CCCCceeeeEeEEEeCC--
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQ--MSHDHILKLIGCCLETP-- 93 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~-- 93 (314)
.+|+|. +.||++. .+++.||||+|...+. ++|.+|-++.+. ++|+||++|+++-..+.
T Consensus 217 li~~Grfg~V~Kaq--L~~~~VAVKifp~~~k---------------qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~ 279 (534)
T KOG3653|consen 217 LIGRGRFGCVWKAQ--LDNRLVAVKIFPEQEK---------------QSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD 279 (534)
T ss_pred HhhcCccceeehhh--ccCceeEEEecCHHHH---------------HHHHhHHHHHhccCccchhHHHhhchhccCCcc
Confidence 466777 7777774 3459999999998775 457788888875 47999999999987666
Q ss_pred --eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCC------CCCceeccCCCCCeeecCCC
Q 043524 94 --IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGF------PRPIVFRDFKTSHILFSEEN 165 (314)
Q Consensus 94 --~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~------~~~i~H~dlk~~nil~~~~~ 165 (314)
.+|+|+||-+.|+|.+++..+ .+++.....++..++.||+|||... ...|+|||||..|||+.+++
T Consensus 280 ~~eywLVt~fh~kGsL~dyL~~n------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl 353 (534)
T KOG3653|consen 280 RMEYWLVTEFHPKGSLCDYLKAN------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL 353 (534)
T ss_pred ccceeEEeeeccCCcHHHHHHhc------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC
Confidence 899999999999999999874 4889999999999999999999533 34699999999999999999
Q ss_pred ceEEcccccceecCCCCc-ccccccccccccccCcccccCC-CC-----cccchHHHHHHHHHHHhCCCCcccccCcccc
Q 043524 166 VVKLFDFSLSISIPEGET-HITDTVMGTYGHLAPQYVTTCD-FS-----EKLDVYSFGAFLSELLTGRGILDLVRDAHDL 238 (314)
Q Consensus 166 ~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~-~~-----~~~DiwslG~~l~el~~g~~p~~~~~~~~~~ 238 (314)
.+-|+|||+|..+..... .....-+||.+|||||++-+.. +. .+.||||+|.++|||+++-.-++. ..-.++
T Consensus 354 TccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~-~~vp~Y 432 (534)
T KOG3653|consen 354 TCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP-GPVPEY 432 (534)
T ss_pred cEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC-CCCCcc
Confidence 999999999977654322 1223368999999999997653 22 468999999999999997655433 223333
Q ss_pred ccchHHHHHhhhccCCccc---------ccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHh
Q 043524 239 VYPFNEYLKNYFEDNRFTE---------IVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICC 309 (314)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 309 (314)
..+|...+.+...-.++.+ .+...+.+. .....+.+.+..||+.||+.|.||.=+-+++.++..
T Consensus 433 qlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h-------~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 433 QLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKH-------AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred cCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcC-------ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 4444433332222111111 122222221 234557899999999999999999999998888753
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=259.59 Aligned_cols=244 Identities=20% Similarity=0.286 Sum_probs=196.5
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
..++...+|-|| +-|-+...+....-+|.|++.+..+-..... +.+..|-++|...+.|.||++|..|.+
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQq---------eHv~sEr~Im~~~~s~fIvrLYrTfrd 491 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQ---------EHVFSERNIMMECRSDFIVRLYRTFRD 491 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHH---------HHHHhHHHHHHhcCchHHHHHHHHhcc
Confidence 345556677777 5454444444444699999988876444322 567899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
...+|++||-|-||.|+..++..+ .+.......+...+++|++||| +++|+.|||||+|.+++.+|.+||.|
T Consensus 492 ~kyvYmLmEaClGGElWTiLrdRg-----~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVD 563 (732)
T KOG0614|consen 492 SKYVYMLMEACLGGELWTILRDRG-----SFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVD 563 (732)
T ss_pred chhhhhhHHhhcCchhhhhhhhcC-----CcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEee
Confidence 999999999999999999998764 4777788888899999999999 99999999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhc
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFE 251 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (314)
||+|+.+..+. +..+++||+.|.|||+++....+.++|.||+|+++||+++|.+||++...... +.-
T Consensus 564 FGFAKki~~g~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt----Yn~------- 630 (732)
T KOG0614|consen 564 FGFAKKIGSGR--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT----YNL------- 630 (732)
T ss_pred hhhHHHhccCC--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH----HHH-------
Confidence 99999886554 47899999999999999999999999999999999999999999986553321 111
Q ss_pred cCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCC
Q 043524 252 DNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPT 296 (314)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps 296 (314)
++++-.....+...+..+.+|++.....+|.+|..
T Consensus 631 ----------ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 631 ----------ILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ----------HHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 11111111122255566889999999999999974
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=272.59 Aligned_cols=146 Identities=23% Similarity=0.200 Sum_probs=125.0
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
|.....+|.|+ +.||.+.+..+|+.||+|++......... ..+.+..|+.++..++||||+++++++...
T Consensus 6 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~---------~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 76 (669)
T cd05610 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKN---------MVHQVQAERDALALSKSPFIVHLYYSLQSA 76 (669)
T ss_pred EEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHH---------HHHHHHHHHHHHHhcCCCCcCeEEEEEEEC
Confidence 33445588888 88888888889999999998764421111 125678899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~df 172 (314)
..+|+||||+.+++|.+++... ..++...++.++.||+.||.||| .++|+||||||+|||++.++.++|+||
T Consensus 77 ~~~~lVmEy~~g~~L~~li~~~-----~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DF 148 (669)
T cd05610 77 NNVYLVMEYLIGGDVKSLLHIY-----GYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDF 148 (669)
T ss_pred CEEEEEEeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeC
Confidence 9999999999999999988654 24678888999999999999999 999999999999999999999999999
Q ss_pred ccce
Q 043524 173 SLSI 176 (314)
Q Consensus 173 g~~~ 176 (314)
|+++
T Consensus 149 Gls~ 152 (669)
T cd05610 149 GLSK 152 (669)
T ss_pred CCCc
Confidence 9875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=239.31 Aligned_cols=257 Identities=22% Similarity=0.302 Sum_probs=190.0
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHh--cCCCCceeeeEeEEEeC-
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAA--QMSHDHILKLIGCCLET- 92 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~--~l~h~niv~~~~~~~~~- 92 (314)
...+|+|- +.||.. ..-|+.||||+|...+-. +..+|.++.. .|+|+||..|++.-..+
T Consensus 216 ~e~IGkGRyGEVwrG--~wrGe~VAVKiF~srdE~---------------SWfrEtEIYqTvmLRHENILgFIaaD~~~~ 278 (513)
T KOG2052|consen 216 QEIIGKGRFGEVWRG--RWRGEDVAVKIFSSRDER---------------SWFRETEIYQTVMLRHENILGFIAADNKDN 278 (513)
T ss_pred EEEecCccccceeec--cccCCceEEEEecccchh---------------hhhhHHHHHHHHHhccchhhhhhhccccCC
Confidence 34567766 677666 456889999999877643 3455555554 57999999999887654
Q ss_pred ---CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcC-----CCCCceeccCCCCCeeecCC
Q 043524 93 ---PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFG-----FPRPIVFRDFKTSHILFSEE 164 (314)
Q Consensus 93 ---~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~-----~~~~i~H~dlk~~nil~~~~ 164 (314)
.++|+|++|-+.|||.|++... ++.....+.++..++.||++||.. +...|.|||||..|||+.++
T Consensus 279 gs~TQLwLvTdYHe~GSL~DyL~r~------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn 352 (513)
T KOG2052|consen 279 GSWTQLWLVTDYHEHGSLYDYLNRN------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 352 (513)
T ss_pred CceEEEEEeeecccCCcHHHHHhhc------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC
Confidence 3689999999999999999873 588999999999999999999921 13468999999999999999
Q ss_pred CceEEcccccceecCCCCc---ccccccccccccccCcccccCC----CC--cccchHHHHHHHHHHHhC----------
Q 043524 165 NVVKLFDFSLSISIPEGET---HITDTVMGTYGHLAPQYVTTCD----FS--EKLDVYSFGAFLSELLTG---------- 225 (314)
Q Consensus 165 ~~~kl~dfg~~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~----~~--~~~DiwslG~~l~el~~g---------- 225 (314)
+.+-|+|+|+|-....... ...+..+||.+|||||++.... +. ..+||||||.++||++..
T Consensus 353 ~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey 432 (513)
T KOG2052|consen 353 GTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEY 432 (513)
T ss_pred CcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhh
Confidence 9999999999966544321 1356779999999999997543 22 569999999999999863
Q ss_pred CCCcccccCccccccchHHHHHhhhccCCcccccC-hhh-hccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 043524 226 RGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVD-PII-VQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARR 303 (314)
Q Consensus 226 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 303 (314)
+.||......+ ..-.++.+++- ..+ ....+...+...-..+.++++.||..||.-|-||-.|.+.
T Consensus 433 ~~Pyyd~Vp~D-------------Ps~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKt 499 (513)
T KOG2052|consen 433 QLPYYDVVPSD-------------PSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKT 499 (513)
T ss_pred cCCcccCCCCC-------------CCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHH
Confidence 23444333322 11122223221 111 1112222333555678899999999999999999999999
Q ss_pred HHHHHh
Q 043524 304 LRQICC 309 (314)
Q Consensus 304 L~~~~~ 309 (314)
|.++.+
T Consensus 500 l~~l~~ 505 (513)
T KOG2052|consen 500 LAKLSN 505 (513)
T ss_pred HHHHhc
Confidence 999875
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=246.79 Aligned_cols=238 Identities=20% Similarity=0.305 Sum_probs=191.6
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeEEEeCCee
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGCCLETPIA 95 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 95 (314)
..+|.|+ +.|.++-++.+.+.+|||+..+..+-+.... +--+.|-++|... +-|.++++...|.+-+.+
T Consensus 355 ~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDv---------ectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 355 MVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDV---------ECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred EEeccCccceeeeecccCcchhhhhhhhccceeeecCcc---------cceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 4689998 7777777777888999998876544322111 2235677777766 468999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
|+||||+.||+|...+++.+ .+....+..++.+|+.||-+|| ++||+.||||.+|++++.+|.+||+|||++
T Consensus 426 yFVMEyvnGGDLMyhiQQ~G-----kFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmc 497 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVG-----KFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMC 497 (683)
T ss_pred eeEEEEecCchhhhHHHHhc-----ccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccc
Confidence 99999999999999887764 4667788899999999999999 999999999999999999999999999999
Q ss_pred eecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCc
Q 043524 176 ISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRF 255 (314)
Q Consensus 176 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (314)
+.-.-... ...++.||+-|+|||++...+|+.++|.||+|++||||+.|++||++....
T Consensus 498 KEni~~~~-TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~-------------------- 556 (683)
T KOG0696|consen 498 KENIFDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-------------------- 556 (683)
T ss_pred cccccCCc-ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH--------------------
Confidence 76433322 366889999999999999999999999999999999999999999865432
Q ss_pred ccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCC
Q 043524 256 TEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPT 296 (314)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps 296 (314)
++++.+.... ...+...+.++.++.+..|...|.+|..
T Consensus 557 -elF~aI~ehn--vsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 557 -ELFQAIMEHN--VSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred -HHHHHHHHcc--CcCcccccHHHHHHHHHHhhcCCccccC
Confidence 2233333222 1222367788899999999999999963
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=234.31 Aligned_cols=244 Identities=19% Similarity=0.307 Sum_probs=194.4
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeEEEeCCee
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGCCLETPIA 95 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 95 (314)
..+|.|+ ..|..+..+++.+.+|+|++.++.+.... .+ +=+..|-.++.+- +||.+|.+...|.+...+
T Consensus 256 ~vigrgsyakvl~~~~~~t~qiyamkvvkkel~ndde-------di--dwvqtek~vfe~asn~pflvglhscfqtesrl 326 (593)
T KOG0695|consen 256 RVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDE-------DI--DWVQTEKHVFEQASNNPFLVGLHSCFQTESRL 326 (593)
T ss_pred eeecCcchhhhhheehcccceeeehhhHHHHhcCCcc-------cc--hhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence 4689999 88888889999999999998766543211 11 2234566666654 699999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
++|.||.+||+|.-.+..+. .++.+.++.+..+|+.||.||| +.||+.||||.+|+|++..|.+|++|+|+.
T Consensus 327 ffvieyv~ggdlmfhmqrqr-----klpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmc 398 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQRQR-----KLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMC 398 (593)
T ss_pred EEEEEEecCcceeeehhhhh-----cCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchh
Confidence 99999999999988887654 4899999999999999999999 999999999999999999999999999999
Q ss_pred eecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCc
Q 043524 176 ISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRF 255 (314)
Q Consensus 176 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (314)
+...... ...++++||+.|.|||++.+..|+.++|.|++|++++||+.|+.||+...... .+.+.
T Consensus 399 ke~l~~g-d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n--------------~d~nt 463 (593)
T KOG0695|consen 399 KEGLGPG-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDN--------------PDMNT 463 (593)
T ss_pred hcCCCCC-cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCC--------------cccch
Confidence 7653322 23678999999999999999999999999999999999999999998654221 01111
Q ss_pred cc-ccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCC
Q 043524 256 TE-IVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRP 295 (314)
Q Consensus 256 ~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp 295 (314)
.+ +++-++......+. ..+..+..+++.-|++||++|.
T Consensus 464 edylfqvilekqiripr--slsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 464 EDYLFQVILEKQIRIPR--SLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred hHHHHHHHhhhcccccc--eeehhhHHHHHHhhcCCcHHhc
Confidence 11 12233333433333 4556778899999999999986
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-33 Score=259.43 Aligned_cols=242 Identities=21% Similarity=0.229 Sum_probs=179.0
Q ss_pred cccccCchhHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC-CCceeeeEeEEEeCCee
Q 043524 17 TLMIGNGASVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS-HDHILKLIGCCLETPIA 95 (314)
Q Consensus 17 ~~~~G~g~~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 95 (314)
.+|-|..|++|+.. .-.|+.||||.+....... ..+|+..|..-+ |||||++++.-.+..+.
T Consensus 516 ilG~Gs~Gt~Vf~G--~ye~R~VAVKrll~e~~~~---------------A~rEi~lL~eSD~H~NviRyyc~E~d~qF~ 578 (903)
T KOG1027|consen 516 ILGYGSNGTVVFRG--VYEGREVAVKRLLEEFFDF---------------AQREIQLLQESDEHPNVIRYYCSEQDRQFL 578 (903)
T ss_pred HcccCCCCcEEEEE--eeCCceehHHHHhhHhHHH---------------HHHHHHHHHhccCCCceEEEEeeccCCceE
Confidence 33445444555544 3567899999887665433 358999999885 99999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCC-----CceEEc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEE-----NVVKLF 170 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~-----~~~kl~ 170 (314)
||..|.| ..+|.+.+.... ........-..+..+.|++.||++|| +.+||||||||.||||+.. ..++|+
T Consensus 579 YIalELC-~~sL~dlie~~~-~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iS 653 (903)
T KOG1027|consen 579 YIALELC-ACSLQDLIESSG-LDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKIS 653 (903)
T ss_pred EEEehHh-hhhHHHHHhccc-cchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEec
Confidence 9999999 579999998741 11111122345677889999999999 9999999999999999862 468999
Q ss_pred ccccceecCCCCcc--cccccccccccccCcccccCCCCcccchHHHHHHHHHHHhC-CCCcccccCccccccchHHHHH
Q 043524 171 DFSLSISIPEGETH--ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG-RGILDLVRDAHDLVYPFNEYLK 247 (314)
Q Consensus 171 dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g-~~p~~~~~~~~~~~~~~~~~~~ 247 (314)
|||+++....+..+ ......||-+|.|||++....-+.++||+|+||++|..++| ..||...-..+.
T Consensus 654 DfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~---------- 723 (903)
T KOG1027|consen 654 DFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA---------- 723 (903)
T ss_pred ccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh----------
Confidence 99999988665433 24566899999999999988888899999999999998886 778863322210
Q ss_pred hhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 248 NYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
+...+..... .+... .++ ++.+||.+|+++||..||+|.+++.
T Consensus 724 NIl~~~~~L~----~L~~~------~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 724 NILTGNYTLV----HLEPL------PDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred hhhcCcccee----eeccC------chH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 0111100000 00000 011 6889999999999999999999975
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-32 Score=232.57 Aligned_cols=236 Identities=25% Similarity=0.354 Sum_probs=184.8
Q ss_pred HHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeEEEEeecCCC
Q 043524 26 VLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHG 105 (314)
Q Consensus 26 ~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~iv~e~~~~g 105 (314)
.++.+....+|+.+++|++........ .+.+.+|++.++.++|+||+++.+.+..+...++++||++++
T Consensus 4 ~v~~~~~~~~~~~~~~k~~~~~~~~~~-----------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~ 72 (244)
T smart00220 4 KVYLARDKKTGKLVAIKVIKKEKIKKK-----------RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGG 72 (244)
T ss_pred EEEEEEECCCCcEEEEEEecccccccH-----------HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCC
Confidence 344444555788999999876543221 157889999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccceecCCCCccc
Q 043524 106 TLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHI 185 (314)
Q Consensus 106 ~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 185 (314)
+|..++.... .++...+..++.+++.++.+|| +.+++|+||+|+||+++.++.++++|||.+....... .
T Consensus 73 ~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~ 142 (244)
T smart00220 73 DLFDLLKKRG-----RLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--L 142 (244)
T ss_pred CHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--c
Confidence 9999886543 2778899999999999999999 9999999999999999999999999999987764432 2
Q ss_pred ccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcccccChhhhc
Q 043524 186 TDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQ 265 (314)
Q Consensus 186 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (314)
.....++..|++||......++.++|+||+|++++++++|..||....... .... .... .
T Consensus 143 ~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~-------~~~~-~~~~------------~ 202 (244)
T smart00220 143 LTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL-------ELFK-KIGK------------P 202 (244)
T ss_pred cccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-------HHHH-HHhc------------c
Confidence 334567889999999988888999999999999999999999986422111 0000 0000 0
Q ss_pred cCCchhHH-HHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 266 DLSCTEKE-QQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 266 ~~~~~~~~-~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
........ ..+.++.+++.+||..||++||++.++++
T Consensus 203 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 203 KPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred CCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 00000000 14467889999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-33 Score=232.50 Aligned_cols=266 Identities=19% Similarity=0.270 Sum_probs=194.5
Q ss_pred cCcccccccCchhHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 13 KGKRTLMIGNGASVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 13 ~~~~~~~~G~g~~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
+|-....+|.|...+..+.+.-.++.||+|..... ....+.. ++..+|..++..+.|+||++++.+|+-.
T Consensus 18 Ry~nL~p~~~g~~~v~~a~D~v~~~~v~ikk~~~p-f~n~~~a---------kra~rel~l~~~v~~~nii~l~n~ftP~ 87 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQIVVAAFDQVLGRPVAIKKLSRP-FQNQTHA---------KRAYRELKLMKCVNHKNIISLLNVFTPQ 87 (369)
T ss_pred eeeeecccCCCCceEEecchhhccCceehhhhcCc-cccCccc---------hhhhhhhhhhhhhcccceeeeeeccCcc
Confidence 34445567888787888888889999999977655 2221111 5567899999999999999999999743
Q ss_pred ------CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCc
Q 043524 93 ------PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENV 166 (314)
Q Consensus 93 ------~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~ 166 (314)
...|+|||++ ..+|...+.- .+.-..+..++.|++.|+.||| +.||+||||||+||++..+..
T Consensus 88 ~~l~~~~e~y~v~e~m-~~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~ 156 (369)
T KOG0665|consen 88 KTLEEFQEVYLVMELM-DANLCQVILM-------ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCT 156 (369)
T ss_pred ccHHHHHhHHHHHHhh-hhHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhh
Confidence 3579999999 4688887762 3667888999999999999999 999999999999999999999
Q ss_pred eEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccc---------
Q 043524 167 VKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHD--------- 237 (314)
Q Consensus 167 ~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--------- 237 (314)
+||.|||+++.-... -.....+.|..|.|||++.+..+...+||||+||++.||++|+..|.+....+.
T Consensus 157 lKi~dfg~ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lg 234 (369)
T KOG0665|consen 157 LKILDFGLARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLG 234 (369)
T ss_pred eeeccchhhcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhc
Confidence 999999999764332 235566789999999999999999999999999999999999988763322110
Q ss_pred -----cccchHHHHHhhhcc------CCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 238 -----LVYPFNEYLKNYFED------NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 238 -----~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
....+....+.+... -.+.+.+....-....... ......+++|+..||..||++|.|+.++|.
T Consensus 235 tpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~-~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 235 TPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGS-KLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred CCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCC-ccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 001111111222111 1112222221111111111 133455799999999999999999999985
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=215.91 Aligned_cols=262 Identities=19% Similarity=0.262 Sum_probs=194.3
Q ss_pred hhhhhhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC-CCceee
Q 043524 7 KFKLWSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS-HDHILK 84 (314)
Q Consensus 7 ~~~~~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~ 84 (314)
.++..+| +|.|- +.|+.++.-.+.+.+.||+..+-.-+ .+.+|+++|..|+ |||||+
T Consensus 39 dYeivrk------~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkk---------------KIkREikIL~nL~gg~NIi~ 97 (338)
T KOG0668|consen 39 DYEIVRK------VGRGKYSEVFEGINITNNEKCVIKILKPVKKK---------------KIKREIKILQNLRGGPNIIK 97 (338)
T ss_pred hHHHHHH------HcCccHhhHhcccccCCCceEEEeeechHHHH---------------HHHHHHHHHHhccCCCCeee
Confidence 4566655 88888 99999998889899999988765543 3569999999997 999999
Q ss_pred eEeEEEeC--CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeec
Q 043524 85 LIGCCLET--PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFS 162 (314)
Q Consensus 85 ~~~~~~~~--~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~ 162 (314)
++++..+. ....+|+||..+-+...+. +.+....++.++.+++.||.||| ++||+|||+||.|++|+
T Consensus 98 L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly--------~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmId 166 (338)
T KOG0668|consen 98 LLDIVKDPESKTPSLIFEYVNNTDFKQLY--------PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMID 166 (338)
T ss_pred hhhhhcCccccCchhHhhhhccccHHHHh--------hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeec
Confidence 99998764 4567999999888886665 45778889999999999999999 99999999999999998
Q ss_pred CCC-ceEEcccccceecCCCCcccccccccccccccCcccccCC-CCcccchHHHHHHHHHHHhCCCCcccccCcccccc
Q 043524 163 EEN-VVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCD-FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVY 240 (314)
Q Consensus 163 ~~~-~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~ 240 (314)
... .++++|+|+|.+...+.. -+..+.+..|..||++..-+ |+.+-|+|||||++..|+..+.||-.-++.-+...
T Consensus 167 h~~rkLrlIDWGLAEFYHp~~e--YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLV 244 (338)
T KOG0668|consen 167 HELRKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 244 (338)
T ss_pred hhhceeeeeecchHhhcCCCce--eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHH
Confidence 654 699999999988766543 33456788899999887655 88999999999999999999988854443322211
Q ss_pred c---------hHHHHHhhhc--cCCcccccCh----hhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 241 P---------FNEYLKNYFE--DNRFTEIVDP----IIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 241 ~---------~~~~~~~~~~--~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
. +..++..+-- ++.+..++.. .+..-.+.......++++.+|+...|.+|-.+|+||.|...
T Consensus 245 kIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 245 KIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 1 1112211110 1111111111 11111111111133577899999999999999999999865
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=243.78 Aligned_cols=269 Identities=20% Similarity=0.234 Sum_probs=203.8
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC------CCceee
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS------HDHILK 84 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~ 84 (314)
.+|......|.|. +.|+.+.+..-|..||||++...++--. .=+.|+++|..|+ --|+++
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~K-------------tGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHK-------------TGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhh-------------hhhHHHHHHHHhhccCchhhhHHHH
Confidence 3455556678888 8888888888899999999987765433 3368999999996 358999
Q ss_pred eEeEEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCC
Q 043524 85 LIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEE 164 (314)
Q Consensus 85 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~ 164 (314)
++..|...+++|+|+|.+ ..+|...+...+.. -.|....+..++.|+..||.+|- ..+|+|.||||+|||++..
T Consensus 499 l~r~F~hknHLClVFE~L-slNLRevLKKyG~n--vGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~ 572 (752)
T KOG0670|consen 499 LFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRN--VGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNES 572 (752)
T ss_pred HHHHhhhcceeEEEehhh-hchHHHHHHHhCcc--cceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccC
Confidence 999999999999999988 56999999876643 35788899999999999999999 9999999999999999754
Q ss_pred -CceEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCc------cc
Q 043524 165 -NVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDA------HD 237 (314)
Q Consensus 165 -~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~------~~ 237 (314)
+.+||||||.|-....+.. .+..-+..|.|||++++.+|+...|+||.||+|||++||+..|.+-.+. ++
T Consensus 573 k~iLKLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me 649 (752)
T KOG0670|consen 573 KNILKLCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFME 649 (752)
T ss_pred cceeeeccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHH
Confidence 5789999999977655442 2445678899999999999999999999999999999999988765442 22
Q ss_pred cccchHH-------HHHhhhccC-C-----c-----------ccccCh-------hhhccCCchhHHHHHHHHHHHHhHh
Q 043524 238 LVYPFNE-------YLKNYFEDN-R-----F-----------TEIVDP-------IIVQDLSCTEKEQQLHASAQLTFEC 286 (314)
Q Consensus 238 ~~~~~~~-------~~~~~~~~~-~-----~-----------~~~~~~-------~~~~~~~~~~~~~~~~~~~~li~~c 286 (314)
+.++|+. +..+.|... + . ...+.| .+..+-.+........++.+|+.+|
T Consensus 650 ~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkm 729 (752)
T KOG0670|consen 650 LKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKM 729 (752)
T ss_pred hcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHH
Confidence 2222222 111112110 0 0 000001 1111112223345667899999999
Q ss_pred ccCCCCCCCCHHHHHH
Q 043524 287 LNESPIDRPTMVDVAR 302 (314)
Q Consensus 287 l~~dp~~Rps~~ell~ 302 (314)
|..||++|.|..|.|.
T Consensus 730 l~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 730 LILDPEKRITVNQALK 745 (752)
T ss_pred hccChhhcCCHHHHhc
Confidence 9999999999999875
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=240.36 Aligned_cols=200 Identities=17% Similarity=0.256 Sum_probs=167.0
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeE
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAI 96 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (314)
..||-|+ +.|-++.+..+...||.|...++++...... .-+..|-.+|..-.++-||++|-.|.++..+|
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQv---------aHVKAERDILAEADn~WVVrLyySFQDkdnLY 705 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQV---------AHVKAERDILAEADNEWVVRLYYSFQDKDNLY 705 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhh---------hhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence 3466666 5565666666667999999999887654321 34668999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
+||+|++||++..++...+ .+++..++.++.++..|+++.| ..|++||||||+|||||.+|.+||+|||++.
T Consensus 706 FVMdYIPGGDmMSLLIrmg-----IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCT 777 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIRMG-----IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCT 777 (1034)
T ss_pred EEEeccCCccHHHHHHHhc-----cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccc
Confidence 9999999999999987753 5788889999999999999999 9999999999999999999999999999986
Q ss_pred ecC---C------C-----------------Cc---------------ccccccccccccccCcccccCCCCcccchHHH
Q 043524 177 SIP---E------G-----------------ET---------------HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSF 215 (314)
Q Consensus 177 ~~~---~------~-----------------~~---------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Diwsl 215 (314)
.+. + + .. ......+||+.|+|||++....|+..+|.||.
T Consensus 778 GfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~ 857 (1034)
T KOG0608|consen 778 GFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSV 857 (1034)
T ss_pred cceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHh
Confidence 531 0 0 00 00124589999999999999999999999999
Q ss_pred HHHHHHHHhCCCCcccccC
Q 043524 216 GAFLSELLTGRGILDLVRD 234 (314)
Q Consensus 216 G~~l~el~~g~~p~~~~~~ 234 (314)
|++||||+.|+.||-....
T Consensus 858 gvil~em~~g~~pf~~~tp 876 (1034)
T KOG0608|consen 858 GVILYEMLVGQPPFLADTP 876 (1034)
T ss_pred hHHHHHHhhCCCCccCCCC
Confidence 9999999999999965443
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=251.75 Aligned_cols=265 Identities=18% Similarity=0.129 Sum_probs=164.1
Q ss_pred cCcccccccCch-hHHHHHHHhcC----CcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSN----GKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIG 87 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~----g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 87 (314)
.+.....+|+|+ +.||++....+ +..+|+|.+...... +...+|. +....+.+++.+..
T Consensus 133 ~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--------------e~~~~e~--l~~~~~~~~~~~~~ 196 (566)
T PLN03225 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--------------EIWMNER--VRRACPNSCADFVY 196 (566)
T ss_pred CeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--------------HHHHHHH--HHhhchhhHHHHHH
Confidence 445556789988 88888888888 899999976532111 1111111 11112222222221
Q ss_pred E------EEeCCeeEEEEeecCCCCHHHHHhcCCCCC---------------CCcccHHHHHHHHHHHHHHHHHhhcCCC
Q 043524 88 C------CLETPIAILVFEYVQHGTLWDRILGAPQTH---------------FEPLLLKRRLKDAVDAANALAYLHFGFP 146 (314)
Q Consensus 88 ~------~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~---------------~~~l~~~~~~~~~~~i~~~l~~lH~~~~ 146 (314)
. ...+...++|+||+++++|.+++....... ........+..++.|++.||.||| +
T Consensus 197 ~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~ 273 (566)
T PLN03225 197 GFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---S 273 (566)
T ss_pred hhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---H
Confidence 1 245678999999999999999886532100 000112345678999999999999 9
Q ss_pred CCceeccCCCCCeeecC-CCceEEcccccceecCCCCcccccccccccccccCcccccC---------------------
Q 043524 147 RPIVFRDFKTSHILFSE-ENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTC--------------------- 204 (314)
Q Consensus 147 ~~i~H~dlk~~nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--------------------- 204 (314)
++|+||||||+|||++. .+.+||+|||+++.+............+++.|+|||.+...
T Consensus 274 ~gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~ 353 (566)
T PLN03225 274 TGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQ 353 (566)
T ss_pred CCEEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhcc
Confidence 99999999999999985 57899999999987654444445567889999999966422
Q ss_pred -CCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhh-hccCCcccccChhhhccCC--chhHHHHHHHHH
Q 043524 205 -DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNY-FEDNRFTEIVDPIIVQDLS--CTEKEQQLHASA 280 (314)
Q Consensus 205 -~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 280 (314)
.++.++||||+||++|||+++..+++... ..+...+... .....+.....+....... ............
T Consensus 354 ~~~~~k~DVwSlGviL~el~~~~~~~~~~~------~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 427 (566)
T PLN03225 354 LNLPDRFDIYSAGLIFLQMAFPNLRSDSNL------IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGW 427 (566)
T ss_pred ccCCCCcccHHHHHHHHHHHhCcCCCchHH------HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHH
Confidence 23446699999999999999776643110 0011000000 0000001111111000000 000001122356
Q ss_pred HHHhHhccCCCCCCCCHHHHHH
Q 043524 281 QLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 281 ~li~~cl~~dp~~Rps~~ell~ 302 (314)
+|+.+||+.||++|||+.|+++
T Consensus 428 dLi~~mL~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 428 ELLKSMMRFKGRQRISAKAALA 449 (566)
T ss_pred HHHHHHccCCcccCCCHHHHhC
Confidence 8999999999999999999986
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=210.85 Aligned_cols=200 Identities=20% Similarity=0.230 Sum_probs=159.5
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeEEEeCCe
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGCCLETPI 94 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 94 (314)
..-+|+|+ +++-+.++..+|...|+|.+...--.+. .++.++|+++.... .+|.+|+|+|.+.....
T Consensus 51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~-----------q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQE-----------QKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHH-----------HHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 34589997 8888999999999999998765532221 25678899877655 68999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccc
Q 043524 95 AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL 174 (314)
Q Consensus 95 ~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~ 174 (314)
.||.||.|. -||..+....-+.. ..+++..+-.++..++.||.|||. ...++|||+||+|||++..|++|++|||.
T Consensus 120 vwIcME~M~-tSldkfy~~v~~~g-~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGI 195 (282)
T KOG0984|consen 120 VWICMELMD-TSLDKFYRKVLKKG-GTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGI 195 (282)
T ss_pred EEEeHHHhh-hhHHHHHHHHHhcC-CcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEccccc
Confidence 999999994 47755544311100 357788888999999999999996 67899999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCccccc----CCCCcccchHHHHHHHHHHHhCCCCccccc
Q 043524 175 SISIPEGETHITDTVMGTYGHLAPQYVTT----CDFSEKLDVYSFGAFLSELLTGRGILDLVR 233 (314)
Q Consensus 175 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 233 (314)
+-.+.++-- -..-.|+..|||||.+.. ..|+.++||||+|+++.||++++.||+...
T Consensus 196 sG~L~dSiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 196 SGYLVDSIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred ceeehhhhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 876544321 112468899999998853 258999999999999999999999986443
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-32 Score=222.04 Aligned_cols=266 Identities=18% Similarity=0.256 Sum_probs=190.5
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC-----
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET----- 92 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----- 92 (314)
.||-|+ ++||..-+..+|+.+|.|.+..-.-. .. ..+++.+|+++|..++|.|+....+...-.
T Consensus 60 PIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~-L~---------s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfF 129 (449)
T KOG0664|consen 60 PIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQN-LA---------SCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFF 129 (449)
T ss_pred cccccceeEEEeccCCCCccchhHhhcchHHHH-HH---------HHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHH
Confidence 578888 88888889999999999976533211 11 237889999999999999999998887543
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~df 172 (314)
..+|+++|++. .+|..++-+. ..++...+.-.++||+.||.||| +-+|.||||||.|.|++++..+||+||
T Consensus 130 qEiYV~TELmQ-SDLHKIIVSP-----Q~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDF 200 (449)
T KOG0664|consen 130 QELYVLTELMQ-SDLHKIIVSP-----QALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDF 200 (449)
T ss_pred HHHHHHHHHHH-hhhhheeccC-----CCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEeccc
Confidence 24689999995 5888877553 46888889999999999999999 999999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCcccccCC-CCcccchHHHHHHHHHHHhCCCCcccccCccccc------c-chHH
Q 043524 173 SLSISIPEGETHITDTVMGTYGHLAPQYVTTCD-FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLV------Y-PFNE 244 (314)
Q Consensus 173 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~------~-~~~~ 244 (314)
|+++.-.......+...+-|..|.|||++.+.+ |+...||||.||++.|++-.+-.|+.......+. . |-.+
T Consensus 201 GLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~E 280 (449)
T KOG0664|consen 201 GLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQE 280 (449)
T ss_pred ccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHH
Confidence 999875443332333446688999999999876 8999999999999999999888887554432110 0 0000
Q ss_pred HHHhhhccCCccccc-----ChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHH
Q 043524 245 YLKNYFEDNRFTEIV-----DPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRL 304 (314)
Q Consensus 245 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 304 (314)
-.+..-+ +.-..++ .+..........+.....+..+++.+++..||..|.+..+.+..+
T Consensus 281 aMr~ACE-GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 281 AMKYACE-GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHHHHhh-hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 0010000 0000001 111111111112123334567899999999999999988877543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-31 Score=239.87 Aligned_cols=255 Identities=18% Similarity=0.248 Sum_probs=201.6
Q ss_pred hhhhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEe
Q 043524 9 KLWSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIG 87 (314)
Q Consensus 9 ~~~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 87 (314)
+....|.-...+|+|. +-|+++++..+|+..|+|++...- ..+| .-...|+-+++..+|||||-++|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep----~dd~--------~~iqqei~~~~dc~h~nivay~g 79 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP----GDDF--------SGIQQEIGMLRDCRHPNIVAYFG 79 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccC----Cccc--------cccccceeeeecCCCcChHHHHh
Confidence 5556666667799999 999999999999999999987642 1121 22346788899999999999999
Q ss_pred EEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCce
Q 043524 88 CCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVV 167 (314)
Q Consensus 88 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~ 167 (314)
.+.....+||.||||.+|+|.+..... .+++.-++.....+.+.|+.||| +++-+|||||..||++++.|.+
T Consensus 80 sylr~dklwicMEycgggslQdiy~~T-----gplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDv 151 (829)
T KOG0576|consen 80 SYLRRDKLWICMEYCGGGSLQDIYHVT-----GPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDV 151 (829)
T ss_pred hhhhhcCcEEEEEecCCCcccceeeec-----ccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCce
Confidence 999999999999999999999987665 46888888899999999999999 9999999999999999999999
Q ss_pred EEcccccceecCCCCcccccccccccccccCcccc---cCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHH
Q 043524 168 KLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVT---TCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNE 244 (314)
Q Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 244 (314)
|++|||.+...... .-+...+.||+.|||||+.. ...|+..+|||++|+...|+..-++|.-..+.. ..
T Consensus 152 klaDfgvsaqitat-i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm-------r~ 223 (829)
T KOG0576|consen 152 KLADFGVSAQITAT-IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM-------RA 223 (829)
T ss_pred eecccCchhhhhhh-hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH-------HH
Confidence 99999998766443 33467889999999999875 345899999999999999998877775322211 11
Q ss_pred HHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 245 YLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
......+. +++. ........++.+.+|++.||..+|++|||++.++.
T Consensus 224 --l~LmTkS~----~qpp-----~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 224 --LFLMTKSG----FQPP-----TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred --HHHhhccC----CCCC-----cccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 11111111 1111 11122256677899999999999999999988765
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=223.20 Aligned_cols=125 Identities=18% Similarity=0.271 Sum_probs=105.8
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC-----C---CceeeeEeEE
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS-----H---DHILKLIGCC 89 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~~~~~~ 89 (314)
.+|=|- ++||++++..+.++||+|++...+.-. +..+.|+++|.+++ | .+||++++.|
T Consensus 85 KLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYt-------------EaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F 151 (590)
T KOG1290|consen 85 KLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYT-------------EAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF 151 (590)
T ss_pred eccccccceeEEEeeccCCeEEEEEEEehhhHHH-------------HHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence 355555 899999999999999999987765433 44678999999885 3 3699999999
Q ss_pred Ee----CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeec
Q 043524 90 LE----TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFS 162 (314)
Q Consensus 90 ~~----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~ 162 (314)
.. +.++|+|+|++ |.+|..+|..... ..++...+..++.||+.||.|||. ..||+|.||||+|||+.
T Consensus 152 khsGpNG~HVCMVfEvL-GdnLLklI~~s~Y---rGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 152 KHSGPNGQHVCMVFEVL-GDNLLKLIKYSNY---RGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLLC 222 (590)
T ss_pred eecCCCCcEEEEEehhh-hhHHHHHHHHhCC---CCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeeee
Confidence 74 67899999999 6699898877543 568999999999999999999998 88999999999999983
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=233.25 Aligned_cols=274 Identities=16% Similarity=0.166 Sum_probs=172.8
Q ss_pred CcccccccCch-hHHHHHH----------------HhcCCcccccccccHHHHHHHhcCCcccCC---hhHHHHHHHHHH
Q 043524 14 GKRTLMIGNGA-SVLQELI----------------ASSNGKYIPYRIFSAQELKQETNNYDQKNG---FWHESCINNVTY 73 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~----------------~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~---~~~~~~~~E~~~ 73 (314)
+.....+|+|+ ++||++. ....++.||+|.+....... ..+|-.... ...+....|+.+
T Consensus 147 F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~-~~~fl~e~~~~~~~~e~~~vE~~~ 225 (507)
T PLN03224 147 FQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGV-RQDFLKTGTLAKGSAETGMVEAYM 225 (507)
T ss_pred ceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhh-HHHHHhhhhhhhcccchhHHHHHH
Confidence 34445688888 6666543 23456789999875432110 001100000 011345567888
Q ss_pred HhcCCCCce-----eeeEeEEEe--------CCeeEEEEeecCCCCHHHHHhcCCCCC-------------------CCc
Q 043524 74 AAQMSHDHI-----LKLIGCCLE--------TPIAILVFEYVQHGTLWDRILGAPQTH-------------------FEP 121 (314)
Q Consensus 74 l~~l~h~ni-----v~~~~~~~~--------~~~~~iv~e~~~~g~L~~~l~~~~~~~-------------------~~~ 121 (314)
+.+++|.++ +++.++|.. .+..|+|+||+++++|.+++....... ...
T Consensus 226 l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~ 305 (507)
T PLN03224 226 CAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDK 305 (507)
T ss_pred HHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccccc
Confidence 888876554 677777753 356899999999999999886432110 012
Q ss_pred ccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccceecCCCCcccccccccccccccCccc
Q 043524 122 LLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYV 201 (314)
Q Consensus 122 l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 201 (314)
+++..+..++.|++.+|.||| +++|+||||||+||+++.++.++|+|||++...............+++.|+|||.+
T Consensus 306 ~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 306 RDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 356678889999999999999 99999999999999999999999999999865533222112223447899999987
Q ss_pred ccCC--------------------CC--cccchHHHHHHHHHHHhCCC-CcccccCccccccchHHHHHhhhcc-CCccc
Q 043524 202 TTCD--------------------FS--EKLDVYSFGAFLSELLTGRG-ILDLVRDAHDLVYPFNEYLKNYFED-NRFTE 257 (314)
Q Consensus 202 ~~~~--------------------~~--~~~DiwslG~~l~el~~g~~-p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 257 (314)
.... ++ .+.|+||+||++++|++|.. ||........ .....-.. ..+..
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~-------~~~~~~~~~~~~r~ 455 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT-------ELRQYDNDLNRWRM 455 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh-------HHhhccchHHHHHh
Confidence 5432 12 24699999999999999874 6643221110 00000000 00000
Q ss_pred ccChhhhccCCchhHHHHHHHHHHHHhHhccCCC---CCCCCHHHHHH
Q 043524 258 IVDPIIVQDLSCTEKEQQLHASAQLTFECLNESP---IDRPTMVDVAR 302 (314)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp---~~Rps~~ell~ 302 (314)
. .............+....+|+..||..+| .+|+|+.|+|+
T Consensus 456 ~----~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 456 Y----KGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred h----cccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 0 00011111111345678999999999866 68999999985
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=203.47 Aligned_cols=211 Identities=27% Similarity=0.424 Sum_probs=177.3
Q ss_pred ccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeEEE
Q 043524 20 IGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILV 98 (314)
Q Consensus 20 ~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~iv 98 (314)
+|+|+ +.++++....+|+.+++|++....... ..+.+.+|++.+..++|++|+++++++......+++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-----------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~ 69 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-----------LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLV 69 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-----------HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEE
Confidence 35555 667777666678999999988665431 115678999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecC-CCceEEccccccee
Q 043524 99 FEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSE-ENVVKLFDFSLSIS 177 (314)
Q Consensus 99 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~-~~~~kl~dfg~~~~ 177 (314)
+|++++++|.+++.... ..++...+..++.+++.++.+|| +.+++|+||+|.||+++. .+.++++|||.+..
T Consensus 70 ~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~ 142 (215)
T cd00180 70 MEYCEGGSLKDLLKENE----GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKL 142 (215)
T ss_pred EecCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEE
Confidence 99999899999987642 24788899999999999999999 999999999999999998 89999999999876
Q ss_pred cCCCCcccccccccccccccCcccccC-CCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcc
Q 043524 178 IPEGETHITDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFT 256 (314)
Q Consensus 178 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (314)
...... ......+...|++||..... .++.++|+|++|++++++
T Consensus 143 ~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------- 187 (215)
T cd00180 143 LTSDKS-LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------- 187 (215)
T ss_pred ccCCcc-hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------
Confidence 644321 12334578889999988777 788999999999999999
Q ss_pred cccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 043524 257 EIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARR 303 (314)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 303 (314)
..+.+++..|+..||++||++.++++.
T Consensus 188 --------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 --------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred --------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 236789999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=213.85 Aligned_cols=222 Identities=18% Similarity=0.255 Sum_probs=176.6
Q ss_pred HHHHHHHHHHhcCCCCceeeeEeEEEe-CCeeEEEEeecCCCCHHHHHhcCCC---CCCCcccHHHHHHHHHHHHHHHHH
Q 043524 65 ESCINNVTYAAQMSHDHILKLIGCCLE-TPIAILVFEYVQHGTLWDRILGAPQ---THFEPLLLKRRLKDAVDAANALAY 140 (314)
Q Consensus 65 ~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~iv~e~~~~g~L~~~l~~~~~---~~~~~l~~~~~~~~~~~i~~~l~~ 140 (314)
..++.|--.+..+.|||+..+.+++.. ....++++.++.-|+|..++..... .....+...+...++.|++.|++|
T Consensus 332 ~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~h 411 (563)
T KOG1024|consen 332 NLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEH 411 (563)
T ss_pred HHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHH
Confidence 567788888888899999999999865 5678899999999999999983221 222456677788899999999999
Q ss_pred hhcCCCCCceeccCCCCCeeecCCCceEEcccccceecCCCCcccccc-cccccccccCcccccCCCCcccchHHHHHHH
Q 043524 141 LHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDT-VMGTYGHLAPQYVTTCDFSEKLDVYSFGAFL 219 (314)
Q Consensus 141 lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~-~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l 219 (314)
|| ..+|+|.||..+|++|++..++|++|=.+++.+-+.+.++... --.+..||+||.+....|+..+|+||||+++
T Consensus 412 lh---~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVll 488 (563)
T KOG1024|consen 412 LH---NHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLL 488 (563)
T ss_pred HH---hcCcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHH
Confidence 99 9999999999999999999999999999998766655544322 2357789999999999999999999999999
Q ss_pred HHHHh-CCCCcccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHH
Q 043524 220 SELLT-GRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMV 298 (314)
Q Consensus 220 ~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ 298 (314)
|||+| |+.|+-.....+ ...+.+++. ++..+. ++++++..++..||..+|++||+++
T Consensus 489 WELmtlg~~PyaeIDPfE---------m~~ylkdGy-------RlaQP~------NCPDeLf~vMacCWallpeeRPsf~ 546 (563)
T KOG1024|consen 489 WELMTLGKLPYAEIDPFE---------MEHYLKDGY-------RLAQPF------NCPDELFTVMACCWALLPEERPSFS 546 (563)
T ss_pred HHHHhcCCCCccccCHHH---------HHHHHhccc-------eecCCC------CCcHHHHHHHHHHHhcCcccCCCHH
Confidence 99998 888875333211 112222111 122233 5667899999999999999999999
Q ss_pred HHHHHHHHHHhhc
Q 043524 299 DVARRLRQICCSL 311 (314)
Q Consensus 299 ell~~L~~~~~~~ 311 (314)
|+...|++....+
T Consensus 547 Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 547 QLVICLSEFHTQL 559 (563)
T ss_pred HHHHHHHHHHHHH
Confidence 9999999987654
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-30 Score=227.99 Aligned_cols=209 Identities=21% Similarity=0.255 Sum_probs=176.3
Q ss_pred hhhhhhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC---CCce
Q 043524 7 KFKLWSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS---HDHI 82 (314)
Q Consensus 7 ~~~~~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~ni 82 (314)
.++..+.|-....+|.|+ +.|+.+.++.+...|.+|.+.++.+..-+=-.+.+. -.+-.|+.+|+.|+ |+||
T Consensus 556 ~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkL----GtVp~EIqIla~l~~~sH~NI 631 (772)
T KOG1152|consen 556 EYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKL----GTVPSEIQILATLNKHSHENI 631 (772)
T ss_pred eecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhccccc----CccchhHHHHHHhhhcCccch
Confidence 455556666777899999 999999999998899999998887754331111111 23567999999997 9999
Q ss_pred eeeEeEEEeCCeeEEEEeecC-CCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeee
Q 043524 83 LKLIGCCLETPIAILVFEYVQ-HGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILF 161 (314)
Q Consensus 83 v~~~~~~~~~~~~~iv~e~~~-~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~ 161 (314)
+|+.++|++++.+|++||--. +-+|+++|.-.+ .+.+.+...++.|++.|+++|| +.+|+|||||-+|+++
T Consensus 632 lKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp-----~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenviv 703 (772)
T KOG1152|consen 632 LKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKP-----RMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIV 703 (772)
T ss_pred hhhhheeecCCeeEEEecCCCCCcchhhhhhccC-----ccchHHHHHHHHHHHhcccccc---ccCceecccccccEEE
Confidence 999999999999999999764 559999997654 4788999999999999999999 9999999999999999
Q ss_pred cCCCceEEcccccceecCCCCcccccccccccccccCcccccCCC-CcccchHHHHHHHHHHHhCCCCcc
Q 043524 162 SEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDF-SEKLDVYSFGAFLSELLTGRGILD 230 (314)
Q Consensus 162 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p~~ 230 (314)
+.+|.+||+|||.+.....+. -..++||..|.|||++-+..| +...|||++|+++|.++....||.
T Consensus 704 d~~g~~klidfgsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 704 DSNGFVKLIDFGSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ecCCeEEEeeccchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999999999999986553332 346799999999999999987 677899999999999999988875
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-29 Score=245.67 Aligned_cols=197 Identities=16% Similarity=0.148 Sum_probs=140.4
Q ss_pred HhcCCC-CceeeeEeEE-------EeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCC
Q 043524 74 AAQMSH-DHILKLIGCC-------LETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGF 145 (314)
Q Consensus 74 l~~l~h-~niv~~~~~~-------~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~ 145 (314)
.+.++| +||++++++| .+...++.++|++ +++|.+++.... ..++...++.++.||+.||.|||
T Consensus 26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH--- 97 (793)
T PLN00181 26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD----RSVDAFECFHVFRQIVEIVNAAH--- 97 (793)
T ss_pred cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc----ccccHHHHHHHHHHHHHHHHHHH---
Confidence 345567 6888888887 2334677888887 669999997533 45889999999999999999999
Q ss_pred CCCceeccCCCCCeeecC-------------------CCceEEcccccceecCCCC--------c-------cccccccc
Q 043524 146 PRPIVFRDFKTSHILFSE-------------------ENVVKLFDFSLSISIPEGE--------T-------HITDTVMG 191 (314)
Q Consensus 146 ~~~i~H~dlk~~nil~~~-------------------~~~~kl~dfg~~~~~~~~~--------~-------~~~~~~~g 191 (314)
+++|+||||||+|||++. .+.+|++|||+++...... . .......|
T Consensus 98 ~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 177 (793)
T PLN00181 98 SQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAME 177 (793)
T ss_pred hCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCC
Confidence 999999999999999954 3456677777765421100 0 00111357
Q ss_pred ccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcccccChhhhccCCchh
Q 043524 192 TYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTE 271 (314)
Q Consensus 192 ~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (314)
|+.|+|||++.+..++.++|||||||++|||++|.+|+..... ....... ...++..
T Consensus 178 t~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----------~~~~~~~-----~~~~~~~-------- 234 (793)
T PLN00181 178 MSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----------TMSSLRH-----RVLPPQI-------- 234 (793)
T ss_pred CcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----------HHHHHHH-----hhcChhh--------
Confidence 8899999999998999999999999999999998887642110 0000000 0001000
Q ss_pred HHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 272 KEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 272 ~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
........+++..||+.||.+|||+.|+++
T Consensus 235 -~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 235 -LLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred -hhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 011233568889999999999999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=192.21 Aligned_cols=169 Identities=19% Similarity=0.147 Sum_probs=126.4
Q ss_pred CCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccceecCCCCcc
Q 043524 105 GTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETH 184 (314)
Q Consensus 105 g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~ 184 (314)
|+|.+++.... .++++..++.++.|++.||.||| +++ ||+||+++.++.+++ ||.++.....
T Consensus 1 GsL~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~--- 62 (176)
T smart00750 1 VSLADILEVRG----RPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPE--- 62 (176)
T ss_pred CcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeeccc---
Confidence 68989887643 35899999999999999999999 666 999999999999998 9998765432
Q ss_pred cccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcccccChhhh
Q 043524 185 ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIV 264 (314)
Q Consensus 185 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (314)
...||+.|+|||++.+..++.++||||+||++|||++|+.||....... .......... ....
T Consensus 63 ---~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-------~~~~~~~~~~--~~~~----- 125 (176)
T smart00750 63 ---QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-------AILEILLNGM--PADD----- 125 (176)
T ss_pred ---cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-------HHHHHHHHHh--ccCC-----
Confidence 2258899999999999999999999999999999999999986432211 1111111100 0000
Q ss_pred ccCCchhHHHHHH--HHHHHHhHhccCCCCCCCCHHHHHHHHHHHHh
Q 043524 265 QDLSCTEKEQQLH--ASAQLTFECLNESPIDRPTMVDVARRLRQICC 309 (314)
Q Consensus 265 ~~~~~~~~~~~~~--~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 309 (314)
+.........+. .+.+++..||..||++|||+.|+++.+..+..
T Consensus 126 -~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 126 -PRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred -ccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 000011112333 68999999999999999999999998876654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.4e-28 Score=208.50 Aligned_cols=263 Identities=23% Similarity=0.320 Sum_probs=187.8
Q ss_pred cccccccCch-hHHHHHHHhc---CCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC-CCceeeeEeEE
Q 043524 15 KRTLMIGNGA-SVLQELIASS---NGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS-HDHILKLIGCC 89 (314)
Q Consensus 15 ~~~~~~G~g~-~~~~~~~~~~---~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~ 89 (314)
+..-.+|.|+ ++|+.+..-. ..+.||+|-+..... ..++.+|+++|..+. +.||+++.+.+
T Consensus 39 ~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--------------p~ri~~El~~L~~~gG~~ni~~~~~~~ 104 (418)
T KOG1167|consen 39 KVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--------------PSRILNELEMLYRLGGSDNIIKLNGCF 104 (418)
T ss_pred hhhccccccchhhhhhhhHhhhccccceEeeeecccccC--------------chHHHHHHHHHHHhccchhhhcchhhh
Confidence 3444578888 7777777666 678999997654321 156789999999995 89999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCC-CceE
Q 043524 90 LETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEE-NVVK 168 (314)
Q Consensus 90 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~-~~~k 168 (314)
..+++.++|+||++..+..++.. .++...+..++..++.||+++| .+||+|||+||.|++.+.. +.-.
T Consensus 105 rnnd~v~ivlp~~~H~~f~~l~~--------~l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~ 173 (418)
T KOG1167|consen 105 RNNDQVAIVLPYFEHDRFRDLYR--------SLSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGV 173 (418)
T ss_pred ccCCeeEEEecccCccCHHHHHh--------cCCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCce
Confidence 99999999999999999988884 3678999999999999999999 9999999999999999754 5678
Q ss_pred EcccccceecC-----------------C--C---------------C---------cccccccccccccccCcccccCC
Q 043524 169 LFDFSLSISIP-----------------E--G---------------E---------THITDTVMGTYGHLAPQYVTTCD 205 (314)
Q Consensus 169 l~dfg~~~~~~-----------------~--~---------------~---------~~~~~~~~g~~~y~aPE~~~~~~ 205 (314)
|.|||+|.... . + . ....-...||++|.|||++...+
T Consensus 174 LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~ 253 (418)
T KOG1167|consen 174 LVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCP 253 (418)
T ss_pred EEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhcc
Confidence 99999987210 0 0 0 00011346899999999998876
Q ss_pred -CCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHH-----Hh---------hhccCC----------cccc-c
Q 043524 206 -FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYL-----KN---------YFEDNR----------FTEI-V 259 (314)
Q Consensus 206 -~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~-----~~---------~~~~~~----------~~~~-~ 259 (314)
.++++||||.|++++.+++++.||-...+..+......-.. +. +++..+ +..+ +
T Consensus 254 ~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~ 333 (418)
T KOG1167|consen 254 RQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHI 333 (418)
T ss_pred CcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccCh
Confidence 68899999999999999999999964444332221111000 00 000000 0011 0
Q ss_pred Chhhhcc----CCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 260 DPIIVQD----LSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 260 ~~~~~~~----~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
....+.+ .........+..+.+|+.+||+.||.+|.||++.|.
T Consensus 334 ~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 334 ESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred hhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 1111101 011111133446899999999999999999999986
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.2e-29 Score=203.63 Aligned_cols=255 Identities=18% Similarity=0.216 Sum_probs=184.0
Q ss_pred hhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC-CCceeeeEeE
Q 043524 11 WSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS-HDHILKLIGC 88 (314)
Q Consensus 11 ~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~ 88 (314)
...|.....+|+|. +.+.++.+..+...+++|.+....... ..|.+|...--.|. |.||+.-|++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~-------------~dF~rEfhY~~~Ls~H~hIi~tY~v 89 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQ-------------ADFVREFHYSFFLSPHQHIIDTYEV 89 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhH-------------HHHHHHhccceeeccchhhhHHHHH
Confidence 33344445577777 677777788888899999988776544 46888987776775 8999999876
Q ss_pred -EEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCC--C
Q 043524 89 -CLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEE--N 165 (314)
Q Consensus 89 -~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~--~ 165 (314)
|.+.+.+.+++||++.|+|..-+... .+-+.....++.|+++|+.|+| ++++||||||.+||||-.. -
T Consensus 90 aFqt~d~YvF~qE~aP~gdL~snv~~~------GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~ 160 (378)
T KOG1345|consen 90 AFQTSDAYVFVQEFAPRGDLRSNVEAA------GIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFY 160 (378)
T ss_pred HhhcCceEEEeeccCccchhhhhcCcc------cccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCcc
Confidence 66777888999999999998877653 3566777888999999999999 9999999999999998533 3
Q ss_pred ceEEcccccceecCCCCcccccccccccccccCcccccC-----CCCcccchHHHHHHHHHHHhCCCCcccccCcccccc
Q 043524 166 VVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTC-----DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVY 240 (314)
Q Consensus 166 ~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~ 240 (314)
.+|++|||..+..+.. ......+..|.+||.+... ..++.+|+|.||+++|.+++|.+||+..... ..
T Consensus 161 rvKlcDFG~t~k~g~t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~---d~ 233 (378)
T KOG1345|consen 161 RVKLCDFGLTRKVGTT----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM---DK 233 (378)
T ss_pred EEEeeecccccccCce----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc---Cc
Confidence 7999999998665322 1223346678999977532 2578899999999999999999999832222 23
Q ss_pred chHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHH
Q 043524 241 PFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQ 306 (314)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 306 (314)
++.+|.. +... ..+.....++ ..++.+..+.++-|..+|++|--..+..+...+
T Consensus 234 ~Y~~~~~--w~~r-----k~~~~P~~F~-----~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~ 287 (378)
T KOG1345|consen 234 PYWEWEQ--WLKR-----KNPALPKKFN-----PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKC 287 (378)
T ss_pred hHHHHHH--Hhcc-----cCccCchhhc-----ccCHHHHHHHHHhcCCcccccchhHHHHHHHHH
Confidence 4444432 1111 1111111111 344567889999999999999655555544433
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=195.75 Aligned_cols=196 Identities=27% Similarity=0.379 Sum_probs=163.8
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeE
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAI 96 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (314)
..+|.|+ +.++.+....+++.+|+|.+....... ..+.+.+|++.+..++|+|++++++.+......+
T Consensus 5 ~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-----------~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~ 73 (225)
T smart00221 5 KKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEK-----------QREEFLREIRILKKLKHPNIVKLYGVFEDPEPLY 73 (225)
T ss_pred eEeecCCCeEEEEEEEcCCCcEEEEEeeccccchH-----------HHHHHHHHHHHHHhCCCCChhhheeeeecCCceE
Confidence 3466666 777777777778999999987654330 1156789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
+++|++++++|.+++..... .++...+..++.+++.++.+|| +.+++|+|++|.|++++..+.++++|||.+.
T Consensus 74 ~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~ 146 (225)
T smart00221 74 LVMEYCEGGDLFDYLRKKGG----KLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLAR 146 (225)
T ss_pred EEEeccCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceee
Confidence 99999999999999876431 1678889999999999999999 9999999999999999999999999999987
Q ss_pred ecCCCCcccccccccccccccCccc-ccCCCCcccchHHHHHHHHHHHhCCCCccc
Q 043524 177 SIPEGETHITDTVMGTYGHLAPQYV-TTCDFSEKLDVYSFGAFLSELLTGRGILDL 231 (314)
Q Consensus 177 ~~~~~~~~~~~~~~g~~~y~aPE~~-~~~~~~~~~DiwslG~~l~el~~g~~p~~~ 231 (314)
..............++..|++||.+ ....++.++|+|++|+++++|++|+.||..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 147 FIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred EecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 7654321122345677889999988 666678899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.1e-26 Score=214.89 Aligned_cols=213 Identities=17% Similarity=0.230 Sum_probs=167.4
Q ss_pred HHHHHHHHhcCCCCceeeeEeEEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCC
Q 043524 67 CINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFP 146 (314)
Q Consensus 67 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~ 146 (314)
+..|+-+-..+.|||++.....+.+.....-.||||++ +|..++.... .+...++-.++.|++.|+.|+| +
T Consensus 368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~-----~~~~~e~~c~fKqL~~Gv~y~h---~ 438 (601)
T KOG0590|consen 368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNG-----KLTPLEADCFFKQLLRGVKYLH---S 438 (601)
T ss_pred hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhccc-----ccchhhhhHHHHHHHHHHHHHH---h
Confidence 66788888889999998887777665555555999999 9999997752 4677888999999999999999 9
Q ss_pred CCceeccCCCCCeeecCCCceEEcccccceecCCCCc---ccccccccccccccCcccccCCCCc-ccchHHHHHHHHHH
Q 043524 147 RPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGET---HITDTVMGTYGHLAPQYVTTCDFSE-KLDVYSFGAFLSEL 222 (314)
Q Consensus 147 ~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~-~~DiwslG~~l~el 222 (314)
.||.|||+|++|+++...+.+|++|||.+..+.-... .......|+.+|+|||++....|.+ ..||||.|++++.|
T Consensus 439 ~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m 518 (601)
T KOG0590|consen 439 MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICM 518 (601)
T ss_pred cCceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEE
Confidence 9999999999999999999999999999876543322 4456778999999999999999974 58999999999999
Q ss_pred HhCCCCcccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 223 LTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 223 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.+|+.||......+... . ..... +...............+...+.+|..||+.||.+|.|+.+|++
T Consensus 519 ~~~~~~Wk~a~~~~~~~-----~---~~~~~------~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 519 ILGRFPWKVAKKSDNSF-----K---TNNYS------DQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ecCCCccccccccccch-----h---hhccc------cccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 99999998666554321 0 00000 0000111112223366777899999999999999999999986
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.9e-23 Score=168.95 Aligned_cols=231 Identities=19% Similarity=0.247 Sum_probs=171.4
Q ss_pred CCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeEEEEeecCCCCHHHHHhcC
Q 043524 35 NGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGA 114 (314)
Q Consensus 35 ~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~ 114 (314)
.|+-+++|+...++.... .++.|.+|.-.|+.+.||||..+.+.|.+..++.++..|++.|||...+.+.
T Consensus 212 qgndivakil~vr~~t~r----------isrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~ 281 (448)
T KOG0195|consen 212 QGNDIVAKILNVREVTAR----------ISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQ 281 (448)
T ss_pred cCcchhhhhhhhhhcchh----------hcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcC
Confidence 455677777765554322 2256788999999999999999999999999999999999999999999875
Q ss_pred CCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc--ccccceecCCCCcccccccccc
Q 043524 115 PQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF--DFSLSISIPEGETHITDTVMGT 192 (314)
Q Consensus 115 ~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~--dfg~~~~~~~~~~~~~~~~~g~ 192 (314)
.. -..+..+...++.+++.|++|||++ +.-|....|....+++|.+...+|+ |--++-+ .......
T Consensus 282 t~---vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfq--------e~gr~y~ 349 (448)
T KOG0195|consen 282 TS---VVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ--------EVGRAYS 349 (448)
T ss_pred cc---EEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeee--------ccccccC
Confidence 42 2456778899999999999999964 4445556889999999988776653 3222211 1233457
Q ss_pred cccccCcccccCCC---CcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcccccChhhhccCCc
Q 043524 193 YGHLAPQYVTTCDF---SEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSC 269 (314)
Q Consensus 193 ~~y~aPE~~~~~~~---~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (314)
+.|++||.+...+- -.++|+|||++++||+.|...||......+ +-.++....+..
T Consensus 350 pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme---------------------cgmkialeglrv 408 (448)
T KOG0195|consen 350 PAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME---------------------CGMKIALEGLRV 408 (448)
T ss_pred cccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh---------------------hhhhhhhccccc
Confidence 89999999987653 267899999999999999999997554322 000111111111
Q ss_pred hhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHH
Q 043524 270 TEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQIC 308 (314)
Q Consensus 270 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~ 308 (314)
..++..+....+|+.-|+..||.+||.+..++..|+++.
T Consensus 409 ~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 409 HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 222244566789999999999999999999999998864
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.4e-22 Score=180.03 Aligned_cols=218 Identities=27% Similarity=0.367 Sum_probs=161.9
Q ss_pred HhcCCCCceeeeEeEEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCc-eec
Q 043524 74 AAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPI-VFR 152 (314)
Q Consensus 74 l~~l~h~niv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i-~H~ 152 (314)
|+.+.|.|+.+++|.+.+++..++|.+||+.|+|.|.+.... ..++.......+.+++.|+.|+| ...| .|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~----~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg 73 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED----IKLDYFFILSFIRDISKGLAYLH---NSPIGYHG 73 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc----cCccHHHHHHHHHHHHHHHHHHh---cCcceeee
Confidence 457899999999999999999999999999999999998754 35778888888999999999999 4444 899
Q ss_pred cCCCCCeeecCCCceEEcccccceecCCCCc-ccccccccccccccCcccccCC-------CCcccchHHHHHHHHHHHh
Q 043524 153 DFKTSHILFSEENVVKLFDFSLSISIPEGET-HITDTVMGTYGHLAPQYVTTCD-------FSEKLDVYSFGAFLSELLT 224 (314)
Q Consensus 153 dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~-------~~~~~DiwslG~~l~el~~ 224 (314)
.++..|++++....+|++|||+......... .......-..-|.|||++.... .+.++||||+|++++|+++
T Consensus 74 ~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~ 153 (484)
T KOG1023|consen 74 ALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF 153 (484)
T ss_pred eeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh
Confidence 9999999999999999999999866542100 0011122345689999886542 3567999999999999999
Q ss_pred CCCCcccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHH
Q 043524 225 GRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRL 304 (314)
Q Consensus 225 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 304 (314)
...||+......+ + .+......+ .....+.|.+.... ...+.+..++.+||..+|++||++.++-..+
T Consensus 154 r~~~~~~~~~~~~---~-~eii~~~~~--~~~~~~rP~i~~~~------e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~ 221 (484)
T KOG1023|consen 154 RSGPFDLRNLVED---P-DEIILRVKK--GGSNPFRPSIELLN------ELPPELLLLVARCWEEIPEKRPSIEQIRSKL 221 (484)
T ss_pred ccCccccccccCC---h-HHHHHHHHh--cCCCCcCcchhhhh------hcchHHHHHHHHhcccChhhCccHHHHHhhh
Confidence 9999975443321 1 111111111 11222222221110 2334688999999999999999999999988
Q ss_pred HHHHhh
Q 043524 305 RQICCS 310 (314)
Q Consensus 305 ~~~~~~ 310 (314)
+.+...
T Consensus 222 ~~~~~~ 227 (484)
T KOG1023|consen 222 LTINKG 227 (484)
T ss_pred hhhccc
Confidence 877553
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2e-22 Score=179.94 Aligned_cols=166 Identities=14% Similarity=0.046 Sum_probs=120.8
Q ss_pred cCcccccccCch-hHHHHHHHhc-CCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceee-eEeEE
Q 043524 13 KGKRTLMIGNGA-SVLQELIASS-NGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILK-LIGCC 89 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~-~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-~~~~~ 89 (314)
.|.....+|.|+ +.|+++.+.. +|+.+|+|.......... .....+.+.+|+++|..++|+||+. +++.
T Consensus 19 ~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~-------~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~- 90 (365)
T PRK09188 19 RFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWS-------KPLARHLAAREIRALKTVRGIGVVPQLLAT- 90 (365)
T ss_pred CceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccc-------cHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence 455566689988 8888887665 677889997642210000 0001256889999999999999985 5432
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccC-CCCCeeecCCCceE
Q 043524 90 LETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDF-KTSHILFSEENVVK 168 (314)
Q Consensus 90 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dl-k~~nil~~~~~~~k 168 (314)
+..|+||||+++++|.. +.. .. ...++.+++.+|.||| ++||+|||| ||+||+++.++.++
T Consensus 91 ---~~~~LVmE~~~G~~L~~-~~~--------~~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ik 152 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLHL-ARP--------HG---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAA 152 (365)
T ss_pred ---CCcEEEEEccCCCCHHH-hCc--------cc---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEE
Confidence 46799999999999963 211 11 1356788999999999 999999999 99999999889999
Q ss_pred EcccccceecCCCCccc-------ccccccccccccCcccccC
Q 043524 169 LFDFSLSISIPEGETHI-------TDTVMGTYGHLAPQYVTTC 204 (314)
Q Consensus 169 l~dfg~~~~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~ 204 (314)
|+|||+++......... .....+++.|+|||.+...
T Consensus 153 LiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 153 VIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred EEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99999998765432111 1345678889999988643
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.8e-20 Score=165.53 Aligned_cols=255 Identities=25% Similarity=0.347 Sum_probs=183.5
Q ss_pred ccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCC-ceeeeEeEEEeCCeeEE
Q 043524 20 IGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHD-HILKLIGCCLETPIAIL 97 (314)
Q Consensus 20 ~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~i 97 (314)
+|.|+ +.|+.+.+. ..+++|.+......... ....+.+|+.++..+.|+ +|+++.+.+......++
T Consensus 8 l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~---------~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 75 (384)
T COG0515 8 LGEGSFGEVYLARDR---KLVALKVLAKKLESKSK---------EVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYL 75 (384)
T ss_pred ecCCCCeEEEEEEec---cEEEEEeechhhccchh---------HHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEE
Confidence 44444 555555444 67788877766543220 126788999999999988 79999999987777899
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCC-ceEEcccccce
Q 043524 98 VFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN-VVKLFDFSLSI 176 (314)
Q Consensus 98 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~-~~kl~dfg~~~ 176 (314)
+++++.++++.+.+...... ..+.......++.+++.++.|+| +.+++|||+||+|++++..+ .++++|||.++
T Consensus 76 ~~~~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~ 150 (384)
T COG0515 76 VMEYVDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAK 150 (384)
T ss_pred EEecCCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcce
Confidence 99999999999776654311 14778899999999999999999 99999999999999999888 79999999997
Q ss_pred ecCCCCcc-----cccccccccccccCccccc---CCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHh
Q 043524 177 SIPEGETH-----ITDTVMGTYGHLAPQYVTT---CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKN 248 (314)
Q Consensus 177 ~~~~~~~~-----~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (314)
........ ......|+..|++||.+.. ..++...|+||+|++++++++|..||...... .........
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~----~~~~~~~~~ 226 (384)
T COG0515 151 LLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS----SATSQTLKI 226 (384)
T ss_pred ecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc----ccHHHHHHH
Confidence 65443321 2356689999999999987 56889999999999999999999997644431 000111111
Q ss_pred hhccCC--cccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 043524 249 YFEDNR--FTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARR 303 (314)
Q Consensus 249 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 303 (314)
...... .......... ......+.+++..|+..+|..|.+..+....
T Consensus 227 ~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 227 ILELPTPSLASPLSPSNP--------ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHhcCCcccccccCcccc--------chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 111000 0000000000 1233567899999999999999998776653
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.5e-21 Score=171.56 Aligned_cols=261 Identities=17% Similarity=0.133 Sum_probs=189.5
Q ss_pred cCcccccccCch-hHHHHHHHhcCC-cccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCC----CceeeeE
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNG-KYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSH----DHILKLI 86 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g-~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~~~ 86 (314)
+++....+|+|+ +.|+.+.+..++ ..+|+|+-........ ..+..|+.++..+.. +++.+++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~------------~~l~~E~~vl~~l~~~~~~~~~~~~~ 86 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP------------SVLKIEIQVLKKLEKKNGPSHFPKLL 86 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC------------ccchhHHHHHHHHhhhcCCCCCCEEE
Confidence 566667789988 888888766664 5788886554321110 134578888888862 5888888
Q ss_pred eEE-EeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCC-
Q 043524 87 GCC-LETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEE- 164 (314)
Q Consensus 87 ~~~-~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~- 164 (314)
+.. ..+...|+||+.+ |.||.++...... ..++...+..++.|++.+|.++| +.|++||||||.|+++...
T Consensus 87 ~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~---~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~ 159 (322)
T KOG1164|consen 87 DHGRSTEDFNFIVMSLL-GPSLEDLRKRNPP---GRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSS 159 (322)
T ss_pred EeccCCCceeEEEEecc-CccHHHHHHhCCC---CCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCC
Confidence 888 4777889999988 7899998865542 46889999999999999999999 9999999999999999865
Q ss_pred ----CceEEcccccce--ecCCCCc-----cc--ccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCccc
Q 043524 165 ----NVVKLFDFSLSI--SIPEGET-----HI--TDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDL 231 (314)
Q Consensus 165 ----~~~kl~dfg~~~--~~~~~~~-----~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~ 231 (314)
..+.+.|||+++ ....... .. ...+.||..|.++.+..+...+.+.|+||++-++.++..|..||..
T Consensus 160 ~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~ 239 (322)
T KOG1164|consen 160 RSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEA 239 (322)
T ss_pred CcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcc
Confidence 358999999998 3211111 10 2245699999999999999999999999999999999999999966
Q ss_pred ccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 232 VRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
.+.... ... ...... ...... .....+..+.++...+-..+..++|....+...|+++..+
T Consensus 240 ~~~~~~----~~~-~~~~~~----~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 240 LEMTDL----KSK-FEKDPR----KLLTDR---------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred ccccch----HHH-HHHHhh----hhcccc---------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 554321 000 000000 000000 0002234566677677779999999999999998887654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.9e-22 Score=160.05 Aligned_cols=268 Identities=17% Similarity=0.147 Sum_probs=196.8
Q ss_pred hhhhhhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCC-Cceee
Q 043524 7 KFKLWSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSH-DHILK 84 (314)
Q Consensus 7 ~~~~~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~ 84 (314)
++-+..+++-...||+|+ +-++.+..-.+|+.||+|+=+...- ...+..|.++...|++ ..|.+
T Consensus 10 ~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--------------hpqL~yEskvY~iL~~g~GiP~ 75 (341)
T KOG1163|consen 10 ELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--------------HPQLLYESKVYRILQGGVGIPH 75 (341)
T ss_pred hheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--------------CcchhHHHHHHHHhccCCCCch
Confidence 344556677777799999 8899999999999999996443221 1345789999999986 67888
Q ss_pred eEeEEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecC-
Q 043524 85 LIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSE- 163 (314)
Q Consensus 85 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~- 163 (314)
+..+..+.....+||+++ |.||.+...-.. ..++.+.++-++-|++..++|+| .++.+||||||+|+|+.-
T Consensus 76 i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~----R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlg 147 (341)
T KOG1163|consen 76 IRHYGTEKDYNVLVMDLL-GPSLEDLFNFCS----RRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLG 147 (341)
T ss_pred hhhhccccccceeeeecc-CccHHHHHHHHh----hhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccc
Confidence 888888888899999998 789999886544 45888999999999999999999 999999999999999864
Q ss_pred --CCceEEcccccceecCCCCccc------ccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCc
Q 043524 164 --ENVVKLFDFSLSISIPEGETHI------TDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDA 235 (314)
Q Consensus 164 --~~~~kl~dfg~~~~~~~~~~~~------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~ 235 (314)
.+++.++|||+|+...+..+.. .....||.+|.+--...+...+.+-|+=|+|-++...-.|..||++....
T Consensus 148 rh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 148 RHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred cccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence 4578999999998876543221 33457999999888777777888999999999999888999999877643
Q ss_pred cccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhc
Q 043524 236 HDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSL 311 (314)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 311 (314)
... .....+.+..+.-+. .......|.++.-.+.-|-..--++-|+-.-+-+..+-+..++
T Consensus 228 tk~--------------QKyEkI~EkK~s~~i-e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~l 288 (341)
T KOG1163|consen 228 TKK--------------QKYEKISEKKMSTPI-EVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTL 288 (341)
T ss_pred hHH--------------HHHHHHHHhhcCCCH-HHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhc
Confidence 210 011111111110000 0111134566777888888888888888666555555554433
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=160.12 Aligned_cols=260 Identities=15% Similarity=0.125 Sum_probs=197.0
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC-CCceeeeEeEEEe
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS-HDHILKLIGCCLE 91 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~ 91 (314)
++.+..||.|+ ++.+.....-+++.||||.=..+.-+ -.+.-|.+..+.|. .+.|..++-+-..
T Consensus 30 yrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A--------------PQLrdEYr~YKlL~g~~GIP~vYYFGqe 95 (449)
T KOG1165|consen 30 YRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA--------------PQLRDEYRTYKLLGGTEGIPQVYYFGQE 95 (449)
T ss_pred ceeccccccCcceeeecccccccCceEEEEeccccCCc--------------chHHHHHHHHHHHcCCCCCCceeeeccc
Confidence 34455688888 88888888889999999953322111 23457888888885 5899999888888
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCC-----Cc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEE-----NV 166 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~-----~~ 166 (314)
+-+..+|+|++ |.||.|+..-++ ..++.+.+..++.|++.-++++| ++.+|.|||||+|+||... +.
T Consensus 96 G~~NiLVidLL-GPSLEDLFD~Cg----R~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~ 167 (449)
T KOG1165|consen 96 GKYNILVIDLL-GPSLEDLFDLCG----RRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANV 167 (449)
T ss_pred cchhhhhhhhh-CcCHHHHHHHhc----CcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCce
Confidence 88889999998 789999887665 46899999999999999999999 9999999999999999743 46
Q ss_pred eEEcccccceecCCCCccc------ccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCcccccc
Q 043524 167 VKLFDFSLSISIPEGETHI------TDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVY 240 (314)
Q Consensus 167 ~kl~dfg~~~~~~~~~~~~------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~ 240 (314)
+.++|||+|+...+..+.. .....||-+||+.-...+...+.+-|.=|+|-++...+-|..||++.+....
T Consensus 168 IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn--- 244 (449)
T KOG1165|consen 168 IHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN--- 244 (449)
T ss_pred EEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcch---
Confidence 8999999999886653322 3456799999999988998899999999999999999999999998875431
Q ss_pred chHHHHHhhhcc-CCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhc
Q 043524 241 PFNEYLKNYFED-NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSL 311 (314)
Q Consensus 241 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 311 (314)
+..++. ++.+..... .......++++...++-.-+.+-.+-|+.+-+-..+..+...+
T Consensus 245 ------K~kYeKIGe~Kr~T~i-------~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~ 303 (449)
T KOG1165|consen 245 ------KEKYEKIGETKRSTPI-------EVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRL 303 (449)
T ss_pred ------HHHHHHhccccccCCH-------HHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence 111110 011100000 1112245677888888888888888999887777777766543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.5e-22 Score=188.96 Aligned_cols=239 Identities=20% Similarity=0.279 Sum_probs=164.2
Q ss_pred hHHHHHHHhcCC-cccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeEEEEeecC
Q 043524 25 SVLQELIASSNG-KYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQ 103 (314)
Q Consensus 25 ~~~~~~~~~~~g-~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~iv~e~~~ 103 (314)
+-+.+..+.++- ..+.||+|-+++....-.. +.+.+.|++ ....+|||+..+..+-.+....|+|-+|..
T Consensus 34 tRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~--------~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyvk 104 (1431)
T KOG1240|consen 34 TRFLKVARAKDREGLVVVKVFVKQDPTISLRP--------FKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYVK 104 (1431)
T ss_pred hhhhhhhhccCCCceEEEEEEeccCCCCCchH--------HHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHHh
Confidence 333444433333 2599999877652211111 133345666 566789999999999888888999999995
Q ss_pred CCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccceecCCCCc
Q 043524 104 HGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGET 183 (314)
Q Consensus 104 ~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~ 183 (314)
+ +|.|++...+ -+..-+...++.|++.||.-|| ..||+|+|||.+|||++.-+.+.|+||..-|..-....
T Consensus 105 h-nLyDRlSTRP-----FL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 105 H-NLYDRLSTRP-----FLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred h-hhhhhhccch-----HHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 4 9999997643 3567788899999999999999 99999999999999999999999999987654321111
Q ss_pred cc------ccccccccccccCcccccC----------C-CCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHH
Q 043524 184 HI------TDTVMGTYGHLAPQYVTTC----------D-FSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEY 245 (314)
Q Consensus 184 ~~------~~~~~g~~~y~aPE~~~~~----------~-~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~ 245 (314)
.. -.+...-.+|.|||-+... . .+++.||||+||++.|+++ |++||...+ .
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ-----------L 244 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ-----------L 244 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH-----------H
Confidence 00 1112233479999977541 1 4678899999999999998 688885211 1
Q ss_pred HHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 043524 246 LKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARR 303 (314)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 303 (314)
+ .+-.+ . ....+..+.. -....+++|+..|++.||++|.||++.|+.
T Consensus 245 ~-aYr~~-~-~~~~e~~Le~--------Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 245 L-AYRSG-N-ADDPEQLLEK--------IEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred H-hHhcc-C-ccCHHHHHHh--------CcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 1 11111 0 0000001100 111246899999999999999999999986
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.7e-19 Score=155.19 Aligned_cols=194 Identities=17% Similarity=0.190 Sum_probs=137.7
Q ss_pred CCCceeeeEeEEEe---------------------------CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHH
Q 043524 78 SHDHILKLIGCCLE---------------------------TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKD 130 (314)
Q Consensus 78 ~h~niv~~~~~~~~---------------------------~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~ 130 (314)
+|||||++.++|.+ +..+|+||.-.. .+|..++-... .+.....-+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~------~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH------RSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC------CchHHHHHH
Confidence 49999999998864 235789998774 58988886543 566677788
Q ss_pred HHHHHHHHHHhhcCCCCCceeccCCCCCeeec--CCC--ceEEcccccceecCCCC-----cccccccccccccccCccc
Q 043524 131 AVDAANALAYLHFGFPRPIVFRDFKTSHILFS--EEN--VVKLFDFSLSISIPEGE-----THITDTVMGTYGHLAPQYV 201 (314)
Q Consensus 131 ~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~--~~~--~~kl~dfg~~~~~~~~~-----~~~~~~~~g~~~y~aPE~~ 201 (314)
+.|+++|+.||| .+||.|||+|.+|||+. .++ .+.++|||.+-.-.... .+..-..-|.-..||||+.
T Consensus 347 laQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ 423 (598)
T KOG4158|consen 347 LAQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA 423 (598)
T ss_pred HHHHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence 899999999999 99999999999999984 333 57899999974432211 1111123466778999988
Q ss_pred ccCC-----C-CcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHH
Q 043524 202 TTCD-----F-SEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQ 275 (314)
Q Consensus 202 ~~~~-----~-~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (314)
...+ . -.++|.|+.|.+.||++....||.......-....+ ....-+..++.+
T Consensus 424 ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Y---------------------qe~qLPalp~~v 482 (598)
T KOG4158|consen 424 TAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTY---------------------QESQLPALPSRV 482 (598)
T ss_pred hcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhh---------------------hhhhCCCCcccC
Confidence 7554 2 268999999999999999999997533221000000 001111222356
Q ss_pred HHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 276 LHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 276 ~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
+..+++|+...|+.||++|+++.-...
T Consensus 483 pp~~rqlV~~lL~r~pskRvsp~iAAN 509 (598)
T KOG4158|consen 483 PPVARQLVFDLLKRDPSKRVSPNIAAN 509 (598)
T ss_pred ChHHHHHHHHHhcCCccccCCccHHHh
Confidence 677899999999999999998654443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.2e-20 Score=168.70 Aligned_cols=221 Identities=21% Similarity=0.252 Sum_probs=171.6
Q ss_pred hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC-CCceeeeEeEEEeCCeeEEEEeecC
Q 043524 25 SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS-HDHILKLIGCCLETPIAILVFEYVQ 103 (314)
Q Consensus 25 ~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~iv~e~~~ 103 (314)
.-|.++.....|..+|.|+..+........+ ....|..++..++ ||.+|++.-.+..+...++++++..
T Consensus 11 fLvrk~~g~da~~~yamkvl~k~t~~~~~~~----------~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 11 FLVRKAGGADAGHLYAMKVLKKATLKVRDRT----------HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred HHHHHhccccccchhhhhccccccccccccc----------ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 3344444455667888888776654433222 1235677788887 9999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccceecCCCCc
Q 043524 104 HGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGET 183 (314)
Q Consensus 104 ~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~ 183 (314)
+|++...+.... .+.......+...++.+++++| +.++++||+|++||+++.+|.+++.|||.++..-+...
T Consensus 81 gg~lft~l~~~~-----~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~ 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEV-----MFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI 152 (612)
T ss_pred cchhhhccccCC-----chHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence 999988887653 3566677788889999999999 99999999999999999999999999999987644322
Q ss_pred ccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcccccChhh
Q 043524 184 HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPII 263 (314)
Q Consensus 184 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (314)
.+||.-|||||++. .....+|.||+|++.+||++|..||.. +... .+.
T Consensus 153 -----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------------~~~~-------------~Il 200 (612)
T KOG0603|consen 153 -----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------------DTMK-------------RIL 200 (612)
T ss_pred -----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------------HHHH-------------HHh
Confidence 27899999999987 567889999999999999999999864 1111 111
Q ss_pred hccCCchhHHHHHHHHHHHHhHhccCCCCCCCCH
Q 043524 264 VQDLSCTEKEQQLHASAQLTFECLNESPIDRPTM 297 (314)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 297 (314)
+.. ...+...+..+.+++.+++..+|..|--+
T Consensus 201 ~~~--~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 201 KAE--LEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hhc--cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 111 12233666778999999999999999854
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.1e-19 Score=149.42 Aligned_cols=148 Identities=15% Similarity=0.183 Sum_probs=104.3
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHh--------cCCcc---cCC---hhHHHHHHHHHHHhcCCCCcee
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQET--------NNYDQ---KNG---FWHESCINNVTYAAQMSHDHIL 83 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~--------~~~~~---~~~---~~~~~~~~E~~~l~~l~h~niv 83 (314)
.+|.|+ +.|+.+.+. +|+.||+|++......... ..|.. ... .......+|++.+..+.++++.
T Consensus 4 ~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 4 CISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred ccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 578888 778888775 8999999998764321110 00100 000 0112334699999999877764
Q ss_pred eeEeEEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHh-hcCCCCCceeccCCCCCeeec
Q 043524 84 KLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYL-HFGFPRPIVFRDFKTSHILFS 162 (314)
Q Consensus 84 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~l-H~~~~~~i~H~dlk~~nil~~ 162 (314)
....... ...++||||++++++....... .+++...+..++.|++.+|.++ | +.||+||||||+||+++
T Consensus 83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~ 152 (190)
T cd05147 83 CPEPILL--KSHVLVMEFIGDDGWAAPRLKD-----APLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH 152 (190)
T ss_pred CCcEEEe--cCCEEEEEEeCCCCCcchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE
Confidence 4333222 2238999999887775543322 2477888999999999999999 7 88999999999999998
Q ss_pred CCCceEEcccccceec
Q 043524 163 EENVVKLFDFSLSISI 178 (314)
Q Consensus 163 ~~~~~kl~dfg~~~~~ 178 (314)
++.++++|||++...
T Consensus 153 -~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 -DGKLYIIDVSQSVEH 167 (190)
T ss_pred -CCcEEEEEccccccC
Confidence 478999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=9.4e-20 Score=151.96 Aligned_cols=178 Identities=13% Similarity=0.112 Sum_probs=124.0
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+++....+|+|+ +.|+. .+. +++.+|+|++..+........ .. ....+.+.+|++.+.++.|++|..+.+++.
T Consensus 31 ~~y~~~~~l~~~~f~~v~l-~~~-~~~~~iiKvf~~~~~~~~~~~-~~--f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 31 YNIKTIKVFRNIDDTKVSL-IDT-DYGKYILKVFAPKVKRTERFL-KS--FVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred CceEEEEEecCCCceEEEE-Eec-CCCcEEEEEechhcCchHHHH-Hh--hhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 4455555677777 55655 344 577899999976543221100 00 000133678999999999999999998866
Q ss_pred eC--------CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeec
Q 043524 91 ET--------PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFS 162 (314)
Q Consensus 91 ~~--------~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~ 162 (314)
.. +..+++|||++|.+|.+... ++. ....+++.++..+| +.|++|+|+||.|++++
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~ 169 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVS 169 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEe
Confidence 43 35789999999999977631 222 23558899999999 99999999999999999
Q ss_pred CCCceEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh
Q 043524 163 EENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT 224 (314)
Q Consensus 163 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~ 224 (314)
.++ ++++|||.......... . . .++....|+.++|+||||+++.....
T Consensus 170 ~~g-i~liDfg~~~~~~e~~a--~-d----------~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 170 KNG-LRIIDLSGKRCTAQRKA--K-D----------RIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred CCC-EEEEECCCcccccchhh--H-H----------HHHHHhHhcccccccceeEeehHHHH
Confidence 888 99999998765422110 0 0 12334457788999999998775543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.2e-19 Score=155.77 Aligned_cols=236 Identities=21% Similarity=0.226 Sum_probs=143.1
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC----------CCce
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS----------HDHI 82 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~----------h~ni 82 (314)
.++...+|.|+ +.|+.+.+..+|+.+|+|++..... .... ..+++.+|.-....+. |-.+
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~-~~~~--------~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~ 84 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPAD-ASAN--------EYEQLKEEQLAITLFPGVKNPKEAYRHLRF 84 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESST-THTT--------HHHHHHHHHHGGGGSTT--SHHHHHHHH-B
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccc-cchH--------HHHHHHHHHHHhhhhccCCCHHHHHHhceE
Confidence 34556777777 8888888999999999999876551 1110 1244444443333322 1122
Q ss_pred eeeEeEEE---------eC---C-----eeEEEEeecCCCCHHHHHhc---CCCCCCCcccHHHHHHHHHHHHHHHHHhh
Q 043524 83 LKLIGCCL---------ET---P-----IAILVFEYVQHGTLWDRILG---APQTHFEPLLLKRRLKDAVDAANALAYLH 142 (314)
Q Consensus 83 v~~~~~~~---------~~---~-----~~~iv~e~~~~g~L~~~l~~---~~~~~~~~l~~~~~~~~~~~i~~~l~~lH 142 (314)
+.-++... .. + ..+++|+-+ .+||.+.+.. .... ...+.....+.+..|++.-+++||
T Consensus 85 l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~-~~~l~~~arl~lT~Q~I~lvA~Lh 162 (288)
T PF14531_consen 85 LVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQT-HSPLAFAARLSLTVQMIRLVANLH 162 (288)
T ss_dssp ---SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTT-SHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EeeeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccc-cchhHHHHHHHHHHHHHHHHHHHh
Confidence 22222221 11 1 235677777 4688777642 2211 123444455666789999999999
Q ss_pred cCCCCCceeccCCCCCeeecCCCceEEcccccceecCCCCcccccccccccccccCcccccC--------CCCcccchHH
Q 043524 143 FGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTC--------DFSEKLDVYS 214 (314)
Q Consensus 143 ~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--------~~~~~~Diws 214 (314)
+.|++|+||+|+|++++.+|.+.|+||+......... . ....+..|.|||..... .++.+.|.|+
T Consensus 163 ---~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~---~-~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~ 235 (288)
T PF14531_consen 163 ---SYGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRY---R-CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQ 235 (288)
T ss_dssp ---HTTEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEE---E-GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHH
T ss_pred ---hcceEecccceeeEEEcCCCCEEEcChHHHeecCcee---e-ccCCCcccCChhhhhhhcccCcccceeeeccCHHH
Confidence 9999999999999999999999999998875543221 1 13345778999976432 3688999999
Q ss_pred HHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCC
Q 043524 215 FGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDR 294 (314)
Q Consensus 215 lG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~R 294 (314)
+|+++|.|.+|..||+.......... .-..|. +.++.++.||..+|++||.+|
T Consensus 236 LG~~ly~lWC~~lPf~~~~~~~~~~~------------------------~f~~C~---~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 236 LGITLYSLWCGRLPFGLSSPEADPEW------------------------DFSRCR---DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHHHSS-STCCCGGGSTSGG------------------------GGTTSS------HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHHHHccCCCCCCCccccccc------------------------cchhcC---CcCHHHHHHHHHHccCCcccC
Confidence 99999999999999975443221000 001122 566778999999999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=2e-18 Score=143.35 Aligned_cols=134 Identities=13% Similarity=0.080 Sum_probs=99.4
Q ss_pred ccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-----CCCceeeeEeEE
Q 043524 16 RTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-----SHDHILKLIGCC 89 (314)
Q Consensus 16 ~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~ 89 (314)
....+|+|+ +.|+. +..++.. +||++....... .+.+.+|+++++.+ +||||++++|++
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~------------~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~ 70 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGG------------DKEIRRELKYYAHLSRRLIDWSGIPRYYGTV 70 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEeccccch------------HHHHHHHHHHHHHhhccCCCCcccceeeEEE
Confidence 445688888 55553 5556555 688876532211 15678999999999 579999999999
Q ss_pred EeCC---e-eEEEEee--cCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHH-HHhhcCCCCCceeccCCCCCeeec
Q 043524 90 LETP---I-AILVFEY--VQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANAL-AYLHFGFPRPIVFRDFKTSHILFS 162 (314)
Q Consensus 90 ~~~~---~-~~iv~e~--~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l-~~lH~~~~~~i~H~dlk~~nil~~ 162 (314)
.++. . +.+|+|| +.+|+|.+++.... ++.. ..++.+++.++ .||| +++|+||||||+||+++
T Consensus 71 et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~~------~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~ 139 (210)
T PRK10345 71 ETDCGTGYVYDVIADFDGKPSITLTEFAEQCR------YEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQ 139 (210)
T ss_pred EeCCCCeEEEEEEecCCCCcchhHHHHHHccc------ccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEe
Confidence 8863 3 3478999 55799999996531 3333 35678888888 8999 99999999999999997
Q ss_pred CC----CceEEcccccc
Q 043524 163 EE----NVVKLFDFSLS 175 (314)
Q Consensus 163 ~~----~~~kl~dfg~~ 175 (314)
.. ..++|+||+.+
T Consensus 140 ~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 140 RISESEVIPVVCDNIGE 156 (210)
T ss_pred ccCCCCCcEEEEECCCC
Confidence 43 37999995443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=2e-18 Score=142.22 Aligned_cols=149 Identities=13% Similarity=0.166 Sum_probs=106.8
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHH-----HH---hcCCccc---C---ChhHHHHHHHHHHHhcCCCCcee
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELK-----QE---TNNYDQK---N---GFWHESCINNVTYAAQMSHDHIL 83 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~-----~~---~~~~~~~---~---~~~~~~~~~E~~~l~~l~h~niv 83 (314)
.+|.|+ +.|+.+.+. +|+.||+|++...... .. ...+... . ......+..|.+.+.++.|+++.
T Consensus 4 ~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 4 CISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred eeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 578888 788887766 8999999998865211 00 0011110 0 01123346899999999999875
Q ss_pred eeEeEEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCC-CCceeccCCCCCeeec
Q 043524 84 KLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFP-RPIVFRDFKTSHILFS 162 (314)
Q Consensus 84 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~-~~i~H~dlk~~nil~~ 162 (314)
....+... ..|+||||++++++....... ..++......++.+++.++.++| + .||+||||||+||+++
T Consensus 83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~ 152 (190)
T cd05145 83 VPEPILLK--KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH 152 (190)
T ss_pred CceEEEec--CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE
Confidence 54444333 248999999887554432221 23667888999999999999999 8 9999999999999998
Q ss_pred CCCceEEcccccceecC
Q 043524 163 EENVVKLFDFSLSISIP 179 (314)
Q Consensus 163 ~~~~~kl~dfg~~~~~~ 179 (314)
++.++++|||++....
T Consensus 153 -~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 -DGKPYIIDVSQAVELD 168 (190)
T ss_pred -CCCEEEEEcccceecC
Confidence 7899999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.1e-18 Score=154.80 Aligned_cols=123 Identities=28% Similarity=0.411 Sum_probs=104.5
Q ss_pred eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccc
Q 043524 94 IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFS 173 (314)
Q Consensus 94 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg 173 (314)
.+||.|++|...+|.+++...... ...+....+.++.|+..|+.| ++.+|+|+||.||....+..+||+|||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~--e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTG--EERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcc--cccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhh
Confidence 578999999999999999754432 346777888999999999987 778999999999999999999999999
Q ss_pred cceecCCCC-----cccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh
Q 043524 174 LSISIPEGE-----THITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT 224 (314)
Q Consensus 174 ~~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~ 224 (314)
+........ ........||..||+||.+.+..|+.++||||||++++|+++
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 987664433 111334589999999999999999999999999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.4e-16 Score=130.43 Aligned_cols=184 Identities=15% Similarity=0.063 Sum_probs=121.4
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHH-HHhcCCcccCChhHHHHHHHHHHHhcCC-CCceeeeEeEEEeCCee
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELK-QETNNYDQKNGFWHESCINNVTYAAQMS-HDHILKLIGCCLETPIA 95 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~-~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 95 (314)
.+|.|+ +.|+ .....+..++.+.+.....- ... ....+.+|+++|.+|+ |++|++++++ +..
T Consensus 9 ~l~~~~f~~v~--~~~~~~~k~~~~~l~~~~~~~~~~---------~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~ 73 (218)
T PRK12274 9 PLKSDTFGRIL--LVRGGERKFVRRDLSAAPWWLRGV---------AWWLARREALALRQLDGLPRTPRLLHW----DGR 73 (218)
T ss_pred eecCCCcceEE--EeecCCceeeecccccchhhhhhH---------HHHHHHHHHHHHHhcCCCCCCCEEEEE----cCE
Confidence 355555 5554 23335666665544433221 000 0135779999999996 5889999886 446
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccC-CCCCeeecCCCceEEccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDF-KTSHILFSEENVVKLFDFSL 174 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dl-k~~nil~~~~~~~kl~dfg~ 174 (314)
+++|||+.|.+|...... ....++.+++.+|.++| +.||+|||| ||+||+++.++.++|+|||+
T Consensus 74 ~lvmeyI~G~~L~~~~~~------------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~ 138 (218)
T PRK12274 74 HLDRSYLAGAAMYQRPPR------------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQL 138 (218)
T ss_pred EEEEeeecCccHHhhhhh------------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCC
Confidence 899999998888653311 11346778899999999 999999999 79999999999999999999
Q ss_pred ceecCCCCcc----c--------ccccccccccccCcccccC-CCC-cccchHHHHHHHHHHHhCCCCcccc
Q 043524 175 SISIPEGETH----I--------TDTVMGTYGHLAPQYVTTC-DFS-EKLDVYSFGAFLSELLTGRGILDLV 232 (314)
Q Consensus 175 ~~~~~~~~~~----~--------~~~~~g~~~y~aPE~~~~~-~~~-~~~DiwslG~~l~el~~g~~p~~~~ 232 (314)
+......... . ......++.++.|+--.-. ..+ ...+.++.|.-+|.++|++.|+...
T Consensus 139 A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 139 AVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred ceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 9865432210 0 0011234445555422211 234 3456669999999999999886543
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=5.2e-17 Score=137.99 Aligned_cols=257 Identities=18% Similarity=0.202 Sum_probs=170.3
Q ss_pred hhhhcCccccc--ccCchhHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeE
Q 043524 9 KLWSKGKRTLM--IGNGASVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLI 86 (314)
Q Consensus 9 ~~~~~~~~~~~--~G~g~~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 86 (314)
.+|.+.+...+ -|.|...++++.+...|..+....++....+...... +....-+.-|-++.|.|||+++
T Consensus 62 ~rw~krreqv~qrdvPgid~v~lamd~e~g~evvwneVq~~~rK~~~~qe--------ek~~~vFdnllqlvHsnlvkfH 133 (458)
T KOG1266|consen 62 GRWGKRREQVGQRDVPGIDDVYLAMDTEEGVEVVWNEVQFSERKNPKEQE--------EKRRAVFDNLLQLVHSNLVKFH 133 (458)
T ss_pred hhhhhhhhhccCCCCCchHHHHHHhhhccCchhhHHHHHHHHhcChhhCH--------HHHHHHHHHHHHHHHHHHHHHH
Confidence 34444443332 4567799999999999999888877665554433221 1112223445667799999999
Q ss_pred eEEEeC-----CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeee
Q 043524 87 GCCLET-----PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILF 161 (314)
Q Consensus 87 ~~~~~~-----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~ 161 (314)
.++.+. ....+++||+..|++..++++....+ ..+....+.+|+.||++||.|||.- +-.|+|++++.+.|++
T Consensus 134 ~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~-~a~~~~~wkkw~tqIlsal~yLhs~-~PpiihgnlTc~tifi 211 (458)
T KOG1266|consen 134 KYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQ-KALFQKAWKKWCTQILSALSYLHSC-DPPIIHGNLTCDTIFI 211 (458)
T ss_pred HhhcccccccccceEEEEecccchhHHHHHHHHHHhh-hhhhHHHHHHHHHHHHhhhhhhhcc-CCccccCCcchhheee
Confidence 999753 34789999999999999998754332 3577888899999999999999943 7789999999999999
Q ss_pred cCCCceEEcccccceecCCCCcc----cccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCc-ccccCcc
Q 043524 162 SEENVVKLFDFSLSISIPEGETH----ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGIL-DLVRDAH 236 (314)
Q Consensus 162 ~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~-~~~~~~~ 236 (314)
..++.+|+.- +........-.. ....-.+-++|.+||.-.....+.++|||+||+...+|..+..-- ......
T Consensus 212 q~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~- 289 (458)
T KOG1266|consen 212 QHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKV- 289 (458)
T ss_pred cCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCccee-
Confidence 9888777643 111111111000 011224567899999877777889999999999999998875210 000000
Q ss_pred ccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 237 DLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
...+.....+.+..+ ..-+.++..|++-.|..||+|++++-
T Consensus 290 -----------------~~ee~ia~~i~~len--------~lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 290 -----------------EVEENIANVIIGLEN--------GLQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred -----------------ehhhhhhhheeeccC--------ccccCcCcccccCCCCCCcchhhhhc
Confidence 000000001101000 01256889999999999999999874
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.1e-16 Score=153.56 Aligned_cols=142 Identities=25% Similarity=0.296 Sum_probs=106.2
Q ss_pred HHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccceecCCCCc--------------ccccccccccccccCcc
Q 043524 135 ANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGET--------------HITDTVMGTYGHLAPQY 200 (314)
Q Consensus 135 ~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~--------------~~~~~~~g~~~y~aPE~ 200 (314)
+.+++|+| +.+|+|||+||+|.+|+.-|.+|++|||+++....... -.....+||+.|.|||+
T Consensus 153 vla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV 229 (1205)
T KOG0606|consen 153 VLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV 229 (1205)
T ss_pred hHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence 67999999 99999999999999999999999999999876433211 11334589999999999
Q ss_pred cccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHH
Q 043524 201 VTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASA 280 (314)
Q Consensus 201 ~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (314)
+....|+..+|.|++|+++||.+.|..||.+....+- |...+.. ...|.+- + . -.+.+++
T Consensus 230 ilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel----fg~visd---~i~wpE~-d--------e----a~p~Ea~ 289 (1205)
T KOG0606|consen 230 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL----FGQVISD---DIEWPEE-D--------E----ALPPEAQ 289 (1205)
T ss_pred hhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH----Hhhhhhh---hcccccc-C--------c----CCCHHHH
Confidence 9999999999999999999999999999975433221 1111111 1111111 1 1 2235688
Q ss_pred HHHhHhccCCCCCCC-CHHH
Q 043524 281 QLTFECLNESPIDRP-TMVD 299 (314)
Q Consensus 281 ~li~~cl~~dp~~Rp-s~~e 299 (314)
+++.+.|+.+|..|- |..+
T Consensus 290 dli~~LL~qnp~~Rlgt~ga 309 (1205)
T KOG0606|consen 290 DLIEQLLRQNPLCRLGTGGA 309 (1205)
T ss_pred HHHHHHHHhChHhhcccchh
Confidence 999999999999998 4433
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.9e-16 Score=129.55 Aligned_cols=140 Identities=17% Similarity=0.177 Sum_probs=106.4
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeEE
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAIL 97 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i 97 (314)
.+|+|+ +.|+.+.. +|..+++|+........... ........+.+|+.++..+.|++|+....++......++
T Consensus 3 ~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~----~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l 76 (211)
T PRK14879 3 LIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPEL----DERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFII 76 (211)
T ss_pred ccccCceEEEEEEee--CCCceEEEEeCCcCCcChHH----HHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEE
Confidence 467777 66666643 67788898754321110000 000011467899999999999998887777777888899
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccccee
Q 043524 98 VFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSIS 177 (314)
Q Consensus 98 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~ 177 (314)
+|||++|++|.+.+.... . ....++.+++.+|.++| +.+++|+|++|.||+++ .+.++++|||.+..
T Consensus 77 v~e~~~G~~L~~~~~~~~--------~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 77 VMEYIEGEPLKDLINSNG--------M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEEeCCcCHHHHHHhcc--------H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999999885421 1 77788999999999999 99999999999999998 78899999998754
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.64 E-value=7.9e-17 Score=136.82 Aligned_cols=151 Identities=15% Similarity=0.145 Sum_probs=105.5
Q ss_pred cccccccCch-hHHHHHH-HhcCCcccccccccHHHHHHHh--------cCCc--c--cCChhHHHHHHHHHHHhcCCCC
Q 043524 15 KRTLMIGNGA-SVLQELI-ASSNGKYIPYRIFSAQELKQET--------NNYD--Q--KNGFWHESCINNVTYAAQMSHD 80 (314)
Q Consensus 15 ~~~~~~G~g~-~~~~~~~-~~~~g~~~a~k~~~~~~~~~~~--------~~~~--~--~~~~~~~~~~~E~~~l~~l~h~ 80 (314)
.-...+|.|+ +.|+.+. +..+|+.||+|++......... ..+. . ........+..|+..+..+.+.
T Consensus 31 ~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~ 110 (237)
T smart00090 31 AIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEA 110 (237)
T ss_pred HhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhc
Confidence 3445688888 7787877 6789999999998764321100 0000 0 0001123456899999999753
Q ss_pred --ceeeeEeEEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCC-ceeccCCCC
Q 043524 81 --HILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRP-IVFRDFKTS 157 (314)
Q Consensus 81 --niv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~-i~H~dlk~~ 157 (314)
.+.++++. ...++||||++++++....... .++.......++.|++.++.+|| +.+ ++|+|+||+
T Consensus 111 ~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~ 178 (237)
T smart00090 111 GVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-----VEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEY 178 (237)
T ss_pred CCCCCeeeEe----cCceEEEEEecCCccccccccc-----CCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChh
Confidence 23344432 2358999999988886654322 12445566788999999999999 999 999999999
Q ss_pred CeeecCCCceEEcccccceec
Q 043524 158 HILFSEENVVKLFDFSLSISI 178 (314)
Q Consensus 158 nil~~~~~~~kl~dfg~~~~~ 178 (314)
||+++ .+.++++|||.+...
T Consensus 179 NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hEEEE-CCCEEEEEChhhhcc
Confidence 99998 788999999998543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.61 E-value=6.3e-16 Score=150.56 Aligned_cols=190 Identities=17% Similarity=0.164 Sum_probs=141.3
Q ss_pred cccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC---CCceeeeEeEEE
Q 043524 15 KRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS---HDHILKLIGCCL 90 (314)
Q Consensus 15 ~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~ 90 (314)
.....+|.|+ +.||.+.... |+.+|+|+=..... + +|.-=.+++.+|+ -+-|.++...+.
T Consensus 701 ~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~-----W----------EfYI~~q~~~RLk~~~~~~~~~~~~a~~ 764 (974)
T KOG1166|consen 701 CISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP-----W----------EFYICLQVMERLKPQMLPSIMHISSAHV 764 (974)
T ss_pred EEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc-----e----------eeeehHHHHHhhchhhhcchHHHHHHHc
Confidence 3445688888 7777776666 99999997443321 0 0000012222333 245666666666
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecC-------
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSE------- 163 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~------- 163 (314)
-.+.-++|+||.+.|+|.+++... ...++..+..+.+|++.-++.|| ..+|||+||||+|+++..
T Consensus 765 ~~~~S~lv~ey~~~Gtlld~~N~~-----~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~ 836 (974)
T KOG1166|consen 765 FQNASVLVSEYSPYGTLLDLINTN-----KVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSD 836 (974)
T ss_pred cCCcceeeeeccccccHHHhhccC-----CCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCc
Confidence 677788999999999999999743 34678888899999999999999 999999999999999843
Q ss_pred CCceEEcccccceecCCC-CcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCC
Q 043524 164 ENVVKLFDFSLSISIPEG-ETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGI 228 (314)
Q Consensus 164 ~~~~kl~dfg~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p 228 (314)
...++|+|||.+--+..- ...+-....+|-.+-++|+..+.+++..+|.|.++.+++-|+.|++.
T Consensus 837 ~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 837 SKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 235899999998543211 11123455788899999999999999999999999999999999854
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.61 E-value=7.7e-17 Score=153.17 Aligned_cols=249 Identities=20% Similarity=0.233 Sum_probs=175.8
Q ss_pred cccCch-hHHHHHHHhcCC-cccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC-CCceeeeEeEEEeCCee
Q 043524 19 MIGNGA-SVLQELIASSNG-KYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS-HDHILKLIGCCLETPIA 95 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g-~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 95 (314)
-+|+|+ +.+.......+- ..+|.|.++... + . . ........|..+-..+. |.|++++++...+....
T Consensus 27 ~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~-~-~-------~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~ 96 (601)
T KOG0590|consen 27 SIGKGSFSSSALASNSRDPESSSATKPISIPP-K-S-E-------DSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSY 96 (601)
T ss_pred cccccccchhhhhhhcCCCcceeeccCCCCCC-C-c-c-------chhhhcCccccccccccccccccccCCccCCCccc
Confidence 367777 555555554433 356666555432 0 0 0 01122334565556665 99999999999999999
Q ss_pred EEEEeecCCCCHHHHH-hcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCC-ceEEcccc
Q 043524 96 ILVFEYVQHGTLWDRI-LGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN-VVKLFDFS 173 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l-~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~-~~kl~dfg 173 (314)
+++++|..++++.+.+ .... ...+......++.|+..++.|+|. ..++.|+|+||+|.+++..+ .++++|||
T Consensus 97 ~~~~~~s~g~~~f~~i~~~~~----~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~ 170 (601)
T KOG0590|consen 97 LLSLSYSDGGSLFSKISHPDS----TGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFG 170 (601)
T ss_pred ccccCcccccccccccccCCc----cCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCch
Confidence 9999999999998888 3322 124555667788999999999996 68899999999999999999 99999999
Q ss_pred cceecCC-C-Cccccccccc-ccccccCcccccCC-CCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhh
Q 043524 174 LSISIPE-G-ETHITDTVMG-TYGHLAPQYVTTCD-FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNY 249 (314)
Q Consensus 174 ~~~~~~~-~-~~~~~~~~~g-~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (314)
+|..... . .........| ++.|.|||...+.. .+...|+||.|+++.-+++|..|++......... ..|...
T Consensus 171 ~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~---~~~~~~- 246 (601)
T KOG0590|consen 171 LATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY---SSWKSN- 246 (601)
T ss_pred hhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc---eeeccc-
Confidence 9987765 2 2223445577 99999999998854 5688999999999999999999987655443111 111100
Q ss_pred hccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHH
Q 043524 250 FEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVA 301 (314)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell 301 (314)
.. ...............+++.+++..+|..|.+.+++.
T Consensus 247 ---------~~-----~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 247 ---------KG-----RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ---------cc-----ccccCccccCChhhhhcccccccCCchhcccccccc
Confidence 00 000111113344567899999999999999988764
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.9e-15 Score=124.17 Aligned_cols=136 Identities=18% Similarity=0.182 Sum_probs=100.1
Q ss_pred ccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeEEE
Q 043524 20 IGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILV 98 (314)
Q Consensus 20 ~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~iv 98 (314)
+|.|+ +.|+.+. .+|..+++|............ +.....+++.+|++++..++|+++.....++...+..+++
T Consensus 2 ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~----~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 75 (199)
T TIGR03724 2 IAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPEL----DERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIV 75 (199)
T ss_pred CCCCceEEEEEee--cCCccEEEEEecCCcCcCchH----HHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEE
Confidence 67777 6666665 567889999754221000000 0000115678999999999988766555555667778999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccccee
Q 043524 99 FEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSIS 177 (314)
Q Consensus 99 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~ 177 (314)
|||++|++|.+.+.... . .++.+++.+|.++| +.+++|+|++|.||+++ .+.++++|||.+..
T Consensus 76 ~e~~~g~~l~~~~~~~~---------~---~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 76 MEYIEGKPLKDVIEEGN---------D---ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEECCccHHHHHhhcH---------H---HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999999988774321 1 67889999999999 99999999999999998 78999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.55 E-value=6.1e-15 Score=140.10 Aligned_cols=138 Identities=17% Similarity=0.194 Sum_probs=101.9
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCee
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIA 95 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (314)
...+|+|+ +.|+++. ..++.+++|....+...... . ......+++.+|++++..++|++++....++.+....
T Consensus 338 ~~~iG~G~~g~Vy~~~--~~~~~~v~k~~~~~~~~~~~--~--~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 338 DHLIGKGAEADIKKGE--YLGRDAVIKERVPKGYRHPE--L--DERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cceeccCCcEEEEEEe--ecCccceeEEEecccccchh--H--HHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 44578887 6666643 23444555543222111000 0 0011225688999999999999999888888777888
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
++||||+++++|.+.+. ....++.+++.++.+|| +.+++|||+||+||++ .++.++++|||++
T Consensus 412 ~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred EEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCccc
Confidence 99999999999988763 34567889999999999 9999999999999999 5778999999998
Q ss_pred ee
Q 043524 176 IS 177 (314)
Q Consensus 176 ~~ 177 (314)
+.
T Consensus 475 ~~ 476 (535)
T PRK09605 475 KY 476 (535)
T ss_pred cc
Confidence 65
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.4e-14 Score=120.16 Aligned_cols=144 Identities=12% Similarity=0.098 Sum_probs=99.7
Q ss_pred ccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCC----------cccCChhHHHHHHHHHHHhcCCCC--ce
Q 043524 16 RTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNY----------DQKNGFWHESCINNVTYAAQMSHD--HI 82 (314)
Q Consensus 16 ~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~----------~~~~~~~~~~~~~E~~~l~~l~h~--ni 82 (314)
....+|.|+ +.|+.+.. .+|+.+|+|++............ ..........+..|+..+..+.|+ .+
T Consensus 19 ~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v 97 (198)
T cd05144 19 LGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPV 97 (198)
T ss_pred cCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCC
Confidence 345578887 66666644 47999999987653211000000 000001123467899999998877 44
Q ss_pred eeeEeEEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeec
Q 043524 83 LKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFS 162 (314)
Q Consensus 83 v~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~ 162 (314)
...++ ....+++|||+++++|...... .....++.+++.++.++| +.+++|+||+|+||+++
T Consensus 98 ~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nill~ 159 (198)
T cd05144 98 PKPID----WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNILVD 159 (198)
T ss_pred Cceee----cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEEEc
Confidence 44443 2455899999999998664321 223467788999999999 99999999999999999
Q ss_pred CCCceEEcccccceec
Q 043524 163 EENVVKLFDFSLSISI 178 (314)
Q Consensus 163 ~~~~~kl~dfg~~~~~ 178 (314)
.++.++|+|||.+...
T Consensus 160 ~~~~~~liDfg~~~~~ 175 (198)
T cd05144 160 DDEKIYIIDWPQMVST 175 (198)
T ss_pred CCCcEEEEECCccccC
Confidence 9999999999998554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.48 E-value=7.1e-14 Score=118.96 Aligned_cols=137 Identities=16% Similarity=0.149 Sum_probs=94.6
Q ss_pred hHHHHHHHhcCCcccccccccHHHHHHHhc--CCcccCChhHHHHHHHHHHHhcCCCCce--eeeEeEEEeC-C---eeE
Q 043524 25 SVLQELIASSNGKYIPYRIFSAQELKQETN--NYDQKNGFWHESCINNVTYAAQMSHDHI--LKLIGCCLET-P---IAI 96 (314)
Q Consensus 25 ~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~--~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~-~---~~~ 96 (314)
++++.+.. .|..+++|.+....+..... .+.. ......++.+|+.++..++|++| +..+++.... . ..+
T Consensus 46 gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~-~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~ 122 (239)
T PRK01723 46 GTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLF-TGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRAD 122 (239)
T ss_pred ccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccc-cchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeee
Confidence 55544433 36788998886433211111 0000 00112567899999999998774 6777664432 2 235
Q ss_pred EEEeecCC-CCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 97 LVFEYVQH-GTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 97 iv~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
+|+|++++ .+|.+.+... +++.. .+.+++.++.+|| ++||+|+||||.|||++.++.++++|||.+
T Consensus 123 lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 123 ILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred EEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 99999997 6898887542 23333 2567899999999 999999999999999998889999999988
Q ss_pred ee
Q 043524 176 IS 177 (314)
Q Consensus 176 ~~ 177 (314)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 55
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.6e-13 Score=111.31 Aligned_cols=145 Identities=15% Similarity=0.161 Sum_probs=92.5
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcC----------CcccC--ChhHHHHHHHHHHHhcCCCC--cee
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNN----------YDQKN--GFWHESCINNVTYAAQMSHD--HIL 83 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~----------~~~~~--~~~~~~~~~E~~~l~~l~h~--niv 83 (314)
.+|+|+ +.|+.+... +|+.||+|++........... ..... .........|...+..+.+. .+.
T Consensus 4 ~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~ 82 (187)
T cd05119 4 PIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP 82 (187)
T ss_pred ccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence 478777 667776554 789999998775321110000 00000 00001123566666666443 344
Q ss_pred eeEeEEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCC-CCceeccCCCCCeeec
Q 043524 84 KLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFP-RPIVFRDFKTSHILFS 162 (314)
Q Consensus 84 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~-~~i~H~dlk~~nil~~ 162 (314)
+.++. ...+++|||++++++........ ........++.+++.++.++| . .+++|+||||+||+++
T Consensus 83 ~~~~~----~~~~lv~e~~~g~~~~~~~l~~~------~~~~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~ 149 (187)
T cd05119 83 KPIDL----NRHVLVMEFIGGDGIPAPRLKDV------RLLEDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD 149 (187)
T ss_pred ceEec----CCCEEEEEEeCCCCccChhhhhh------hhcccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE
Confidence 44443 34689999999855422111110 011567788899999999999 7 9999999999999999
Q ss_pred CCCceEEcccccceec
Q 043524 163 EENVVKLFDFSLSISI 178 (314)
Q Consensus 163 ~~~~~kl~dfg~~~~~ 178 (314)
++.++++|||.+...
T Consensus 150 -~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 -DGKVYIIDVPQAVEI 164 (187)
T ss_pred -CCcEEEEECcccccc
Confidence 889999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.38 E-value=5.8e-13 Score=104.64 Aligned_cols=131 Identities=15% Similarity=0.138 Sum_probs=100.2
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCC--CceeeeEeEEEeCCee
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSH--DHILKLIGCCLETPIA 95 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~ 95 (314)
.+|.|+ +.++.+.. ++..+++|.+..... ...+.+|+.++..++| .++++++++...++..
T Consensus 5 ~i~~g~~~~v~~~~~--~~~~~~iK~~~~~~~--------------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~ 68 (155)
T cd05120 5 LLKGGLTNRVYLLGT--KDEDYVLKINPSREK--------------GADREREVAILQLLARKGLPVPKVLASGESDGWS 68 (155)
T ss_pred ecccccccceEEEEe--cCCeEEEEecCCCCc--------------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCcc
Confidence 366666 55555543 236788888754432 0457789999999976 5999999998888889
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
++++||++++++... +......++.+++.++.++|.....+++|+|++|+|++++..+.++++|||.+
T Consensus 69 ~~v~e~~~g~~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~ 136 (155)
T cd05120 69 YLLMEWIEGETLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYA 136 (155)
T ss_pred EEEEEecCCeecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccc
Confidence 999999988777432 33455667888999999999432357999999999999998899999999987
Q ss_pred ee
Q 043524 176 IS 177 (314)
Q Consensus 176 ~~ 177 (314)
..
T Consensus 137 ~~ 138 (155)
T cd05120 137 GY 138 (155)
T ss_pred cC
Confidence 54
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.35 E-value=8.9e-13 Score=120.81 Aligned_cols=242 Identities=17% Similarity=0.148 Sum_probs=163.9
Q ss_pred ccC--ch-hHHHHHHH--hcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC-CCceeeeEeEEEeCC
Q 043524 20 IGN--GA-SVLQELIA--SSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS-HDHILKLIGCCLETP 93 (314)
Q Consensus 20 ~G~--g~-~~~~~~~~--~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 93 (314)
+|. |+ +.++...- ..++..+|+|.-.... . ..... .+=++|+...+.++ |+|.++.+..+.+++
T Consensus 122 ~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~-s---~p~~~------~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 122 TGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF-S---PPLDS------KRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred cccCCCCCceeecccCCcccCCcccccccccCCC-C---Ccccc------ccccchhhcccccCccccccccCcccccCC
Confidence 455 55 55655555 6677788887521110 0 00001 11146777777775 999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHH----HHHHhhcCCCCCceeccCCCCCeeecCC-CceE
Q 043524 94 IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAAN----ALAYLHFGFPRPIVFRDFKTSHILFSEE-NVVK 168 (314)
Q Consensus 94 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~----~l~~lH~~~~~~i~H~dlk~~nil~~~~-~~~k 168 (314)
..++-+|+| +.++..+..... .-++.......+.+... ||.++| +.+++|-|+||.||++..+ ..++
T Consensus 192 ~lfiqtE~~-~~sl~~~~~~~~----~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~ 263 (524)
T KOG0601|consen 192 ILFIQTELC-GESLQSYCHTPC----NFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCK 263 (524)
T ss_pred cceeeeccc-cchhHHhhhccc----ccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceee
Confidence 999999999 468877765543 23567777777888888 999999 9999999999999999988 7899
Q ss_pred EcccccceecCCCCccc----ccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHH
Q 043524 169 LFDFSLSISIPEGETHI----TDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNE 244 (314)
Q Consensus 169 l~dfg~~~~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 244 (314)
++|||....+.+..... .....|...|++||+. ...++...|++++|.++.+..++..+...-. +..
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~--------~~~ 334 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGK--------NSS 334 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCC--------CCC
Confidence 99999988776654221 1122567789999955 4467889999999999999988765432110 000
Q ss_pred HHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 245 YLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
|.. .+... +-+... ...+.++...+.+|++.+|-.|+++..+..
T Consensus 335 W~~--~r~~~---ip~e~~---------~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 335 WSQ--LRQGY---IPLEFC---------EGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ccc--ccccc---Cchhhh---------cCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 000 00000 000000 012234555899999999999999887654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=9.5e-11 Score=108.93 Aligned_cols=170 Identities=16% Similarity=0.164 Sum_probs=123.2
Q ss_pred HHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeEEEEeecCCCCHH
Q 043524 29 ELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLW 108 (314)
Q Consensus 29 ~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~iv~e~~~~g~L~ 108 (314)
.+..+.+|.++.|..+....- . +.+...+.++.|+.++||||+++++.++..+..|+|+|-+. .|.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~-~-----------~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~ 95 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG-E-----------VTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLE 95 (690)
T ss_pred ccceeccCCceEEEEEeCCCc-h-----------hhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHH
Confidence 345667788888877654432 1 11345677899999999999999999999999999999873 677
Q ss_pred HHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccceecCCCCcccccc
Q 043524 109 DRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDT 188 (314)
Q Consensus 109 ~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 188 (314)
..+.+ +....+-.-+.||+.||.|||. +.+++|+++--..++++..|.-+|++|.+......... ....
T Consensus 96 ~~lk~--------l~~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~ 164 (690)
T KOG1243|consen 96 TVLKE--------LGKEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKS 164 (690)
T ss_pred HHHHH--------hHHHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-cccc
Confidence 76754 3345566668899999999986 88999999999999999999999999987643322111 0111
Q ss_pred cccccccccCcccccCCCCcccchHHHHHHHHHHHhC
Q 043524 189 VMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225 (314)
Q Consensus 189 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g 225 (314)
..--..|..|+...... -..|.|-|||++++++.|
T Consensus 165 ~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 165 LYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred chhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 11122345555332222 346999999999999998
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.16 E-value=8.1e-12 Score=114.60 Aligned_cols=239 Identities=18% Similarity=0.126 Sum_probs=159.1
Q ss_pred cccCch--hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeEEEeCCee
Q 043524 19 MIGNGA--SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGCCLETPIA 95 (314)
Q Consensus 19 ~~G~g~--~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 95 (314)
.+|.|. .++....+..++-.|++|.....-.. .+++.. -+.|+-+...+ .|.++++++..|..-.+.
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~----~~~di~------sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNGLAT----FASDIF------SLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhhccccc----hHhhhc------chhhhhHhhHhhcccccCCCCCCccccccc
Confidence 466655 33433444466677887754332211 111111 13556555555 599999999999888888
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCC-CceEEccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEE-NVVKLFDFSL 174 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~-~~~kl~dfg~ 174 (314)
|+=.|||.+++........ ..+.....+.+..+++.++.++| ++.++|+|++|+||++..+ +..++.|||.
T Consensus 342 ~ip~e~~~~~s~~l~~~~~-----~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~ 413 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTS-----QMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGC 413 (524)
T ss_pred cCchhhhcCcchhhhhHHH-----HhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhcccccc
Confidence 8999999999887766322 34667788899999999999999 9999999999999999886 7789999999
Q ss_pred ceecCCCCcccccccccccccc--cCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhcc
Q 043524 175 SISIPEGETHITDTVMGTYGHL--APQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFED 252 (314)
Q Consensus 175 ~~~~~~~~~~~~~~~~g~~~y~--aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (314)
.+.+.... ....+.-+++ ++.+.....+..++|++|||..+.+.+++...-.. .
T Consensus 414 ~t~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~--------------------~ 469 (524)
T KOG0601|consen 414 WTRLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES--------------------G 469 (524)
T ss_pred ccccceec----ccccccccccccchhhccccccccccccccccccccccccCcccCcc--------------------c
Confidence 86432211 1122233344 44444555688999999999999999887643110 0
Q ss_pred CCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHH
Q 043524 253 NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLR 305 (314)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~ 305 (314)
..+..+....+ +........+..+.+-++..|+..||++.++....+
T Consensus 470 ~~~~~i~~~~~------p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 470 VQSLTIRSGDT------PNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred ccceeeecccc------cCCCchHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 01111111111 111122256788899999999999999988876543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.11 E-value=9.4e-11 Score=95.89 Aligned_cols=98 Identities=12% Similarity=0.135 Sum_probs=72.7
Q ss_pred HHHHHHHHhcCC--CCceeeeEeEEEeCCeeEEEEeecCCCCHHH-HHhcCCCCCCCcccHHHHHHHHHHHHHHHHHh-h
Q 043524 67 CINNVTYAAQMS--HDHILKLIGCCLETPIAILVFEYVQHGTLWD-RILGAPQTHFEPLLLKRRLKDAVDAANALAYL-H 142 (314)
Q Consensus 67 ~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~iv~e~~~~g~L~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~l-H 142 (314)
..+|++.|.++. .-++.+.+++ ..-++||||+.+..+.. .+.. ..++......+..+++.++..+ |
T Consensus 73 a~kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H 142 (197)
T cd05146 73 AEKEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYK 142 (197)
T ss_pred HHHHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHH
Confidence 338999999986 3567777765 55679999997644422 2221 1233445566778999999988 8
Q ss_pred cCCCCCceeccCCCCCeeecCCCceEEcccccceec
Q 043524 143 FGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISI 178 (314)
Q Consensus 143 ~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~ 178 (314)
..+++|+||++.||++. ++.+.++|||.+...
T Consensus 143 ---~~glVHGDLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 143 ---ECNLVHADLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred ---hCCeecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence 89999999999999996 467999999988554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.2e-10 Score=105.88 Aligned_cols=151 Identities=13% Similarity=0.120 Sum_probs=94.8
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhc-------------CC-cccC--Ch------hH----H--HHH
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETN-------------NY-DQKN--GF------WH----E--SCI 68 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~-------------~~-~~~~--~~------~~----~--~~~ 68 (314)
..+|.|+ +.|+.+. ..+|+.||||+..+........ .+ .... .. +. + .|.
T Consensus 123 ~plasaSigQVh~A~-l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRAR-LVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEE-ecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 4688888 7777774 4579999999976542111110 00 0000 00 11 1 255
Q ss_pred HHHHHHhcC----CCCceeeeEeEEEe-CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHH-HHHHhh
Q 043524 69 NNVTYAAQM----SHDHILKLIGCCLE-TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAAN-ALAYLH 142 (314)
Q Consensus 69 ~E~~~l~~l----~h~niv~~~~~~~~-~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~-~l~~lH 142 (314)
+|.+.+..+ +|.+-+.+..++.+ .+..++||||++|++|.+....... ... ...++..++. .+..+|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~----~~~---~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA----GLD---RKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc----CCC---HHHHHHHHHHHHHHHHH
Confidence 566655555 34444455444432 3457899999999999877643211 112 2233444443 356788
Q ss_pred cCCCCCceeccCCCCCeeecCCCceEEcccccceecC
Q 043524 143 FGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIP 179 (314)
Q Consensus 143 ~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~~ 179 (314)
..|++|+|++|.||+++.++.++++|||++..+.
T Consensus 275 ---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 275 ---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---hCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 8999999999999999999999999999987664
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.6e-10 Score=112.05 Aligned_cols=192 Identities=20% Similarity=0.208 Sum_probs=139.1
Q ss_pred CCCceeeeEeEEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCC
Q 043524 78 SHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTS 157 (314)
Q Consensus 78 ~h~niv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~ 157 (314)
++|.++...-.+......+++++|..+++|...+...+ +.+..-.+..+..+..++.+|| ...+.|+|++|.
T Consensus 862 ~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~-----~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~ 933 (1205)
T KOG0606|consen 862 RSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSG-----CLSAEPARSPILERVQSLESLH---SSLRKHRDLKPD 933 (1205)
T ss_pred CCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCC-----CcccccccchhHHHHhhhhccc---cchhhccccccc
Confidence 45666666555666788899999999999999887754 2444555666777888999999 777899999999
Q ss_pred CeeecCCCceEEcccccceecCCC-------------------------Cc-----ccccccccccccccCcccccCCCC
Q 043524 158 HILFSEENVVKLFDFSLSISIPEG-------------------------ET-----HITDTVMGTYGHLAPQYVTTCDFS 207 (314)
Q Consensus 158 nil~~~~~~~kl~dfg~~~~~~~~-------------------------~~-----~~~~~~~g~~~y~aPE~~~~~~~~ 207 (314)
|.++...+..++++|++....... .. .......+|+.|.+||...+...+
T Consensus 934 ~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hg 1013 (1205)
T KOG0606|consen 934 SLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHG 1013 (1205)
T ss_pred chhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCC
Confidence 999999999999999843221100 00 012234789999999999999999
Q ss_pred cccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcccccChhhhccCCch-hHHHHHHHHHHHHhHh
Q 043524 208 EKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCT-EKEQQLHASAQLTFEC 286 (314)
Q Consensus 208 ~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~c 286 (314)
..+|.|+.|+++++.++|.+||....... +++.+.....+.+ .+...+....+++...
T Consensus 1014 s~ad~~~~g~~l~e~l~g~pp~na~tpq~---------------------~f~ni~~~~~~~p~g~~~~s~~aq~~~~~l 1072 (1205)
T KOG0606|consen 1014 SAADWWSSGVCLFEVLTGIPPFNAETPQQ---------------------IFENILNRDIPWPEGPEEGSYEAQDLINRL 1072 (1205)
T ss_pred CcchhhhhhhhhhhhhcCCCCCCCcchhh---------------------hhhccccCCCCCCCCccccChhhhhhhhhh
Confidence 99999999999999999999987544322 1222222221111 1124445678888889
Q ss_pred ccCCCCCCCCHH
Q 043524 287 LNESPIDRPTMV 298 (314)
Q Consensus 287 l~~dp~~Rps~~ 298 (314)
+..+|.+|-.|.
T Consensus 1073 l~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1073 LTEEPTQRLGAK 1084 (1205)
T ss_pred hccCchhccCcc
Confidence 999999998765
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.01 E-value=7.3e-11 Score=110.60 Aligned_cols=152 Identities=11% Similarity=0.103 Sum_probs=92.1
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhc-------------CCcccC-C--------hhHHH------HH
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETN-------------NYDQKN-G--------FWHES------CI 68 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~-------------~~~~~~-~--------~~~~~------~~ 68 (314)
..+|.|+ +.|+.+....+|+.||||+..+........ .+.... . .+.+. +.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 5788888 888888777779999999987653211100 000000 0 01122 33
Q ss_pred HHHHHHhcCC----CCceeeeEeEEEe-CCeeEEEEeecCCCCHHHHH--hcCCCCCCCcccHHHHHHHHHHHHHHHHHh
Q 043524 69 NNVTYAAQMS----HDHILKLIGCCLE-TPIAILVFEYVQHGTLWDRI--LGAPQTHFEPLLLKRRLKDAVDAANALAYL 141 (314)
Q Consensus 69 ~E~~~l~~l~----h~niv~~~~~~~~-~~~~~iv~e~~~~g~L~~~l--~~~~~~~~~~l~~~~~~~~~~~i~~~l~~l 141 (314)
+|...+.+++ +.+.+.+..++.+ .+..++||||+.|+++.+.- ...+. ....+....+..++.| +
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~-d~~~la~~~v~~~~~Q-------i 276 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGT-DMKLLAERGVEVFFTQ-------V 276 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCC-CHHHHHHHHHHHHHHH-------H
Confidence 4444444432 4555555555543 45677999999999997742 22110 0011222222222333 3
Q ss_pred hcCCCCCceeccCCCCCeeecCCC----ceEEcccccceecCC
Q 043524 142 HFGFPRPIVFRDFKTSHILFSEEN----VVKLFDFSLSISIPE 180 (314)
Q Consensus 142 H~~~~~~i~H~dlk~~nil~~~~~----~~kl~dfg~~~~~~~ 180 (314)
. ..|++|+|+||.||+++.++ .++++|||+...++.
T Consensus 277 f---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 F---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred H---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 4 68999999999999999887 899999999877643
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.91 E-value=4.2e-08 Score=87.18 Aligned_cols=209 Identities=17% Similarity=0.117 Sum_probs=136.0
Q ss_pred eEEEEeecCCC-CHHHHHhc-CCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccc
Q 043524 95 AILVFEYVQHG-TLWDRILG-APQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 95 ~~iv~e~~~~g-~L~~~l~~-~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~df 172 (314)
+-++|...++. .+.++... +...++....+...+..+.+++.+.+-|| ..|-+-+|+.++|+|+++++.+.+.|-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVds 161 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDS 161 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcc
Confidence 44667666543 33333322 11223345788899999999999999999 899888999999999999999998874
Q ss_pred ccceecCCCCcccccccccccccccCcccc-----cCCCCcccchHHHHHHHHHHHhC-CCCcccccCccccccchH-HH
Q 043524 173 SLSISIPEGETHITDTVMGTYGHLAPQYVT-----TCDFSEKLDVYSFGAFLSELLTG-RGILDLVRDAHDLVYPFN-EY 245 (314)
Q Consensus 173 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g-~~p~~~~~~~~~~~~~~~-~~ 245 (314)
-.-..- .++. .....+|...|.+||.-. +...+...|.|.+|+++++++.| +.||.+.....+...++- ..
T Consensus 162 Dsfqi~-~ng~-~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I 239 (637)
T COG4248 162 DSFQIN-ANGT-LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI 239 (637)
T ss_pred cceeec-cCCc-eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh
Confidence 332221 2221 123457889999999554 22346778999999999999986 889987765543333332 11
Q ss_pred HHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccC--CCCCCCCHHHHHHHHHHHHhhc
Q 043524 246 LKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNE--SPIDRPTMVDVARRLRQICCSL 311 (314)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~--dp~~Rps~~ell~~L~~~~~~~ 311 (314)
....+.. ..+--......+..++. .-.+..+..|..+|+.. ++.-|||++..+..|..+..+|
T Consensus 240 a~g~f~y--a~~~~~g~~p~P~~~P~-~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 240 AHGRFAY--ASDQRRGLKPPPRSIPL-SMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred hcceeee--chhccCCCCCCCCCCCh-hhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 1111110 00101111112222222 24556778899999986 4778999999999999887765
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.90 E-value=9.2e-10 Score=88.57 Aligned_cols=123 Identities=15% Similarity=0.129 Sum_probs=83.0
Q ss_pred ccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCc-eeeeEeEEEeCCeeEE
Q 043524 20 IGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDH-ILKLIGCCLETPIAIL 97 (314)
Q Consensus 20 ~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~i 97 (314)
+++|. +.++.+. ..|+.+++|+....... ...+.+|+.++..+.+.+ +.+++... ....++
T Consensus 6 l~~G~~~~vy~~~--~~~~~~~lK~~~~~~~~-------------~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~l 68 (170)
T cd05151 6 LKGGMTNKNYRVE--VANKKYVVRIPGNGTEL-------------LINRENEAENSKLAAEAGIGPKLYYFD--PETGVL 68 (170)
T ss_pred cCCcccCceEEEE--ECCeEEEEEeCCCCccc-------------ccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeE
Confidence 45555 4555442 24778999987543210 023457888888886544 34555543 334579
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCc-----eeccCCCCCeeecCCCceEEccc
Q 043524 98 VFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPI-----VFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 98 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i-----~H~dlk~~nil~~~~~~~kl~df 172 (314)
|||++++.++.+.- .. ....+.+++.++..|| ..++ +|+|++|.||+++ ++.++++||
T Consensus 69 v~e~i~G~~l~~~~----------~~---~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf 131 (170)
T cd05151 69 ITEFIEGSELLTED----------FS---DPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDW 131 (170)
T ss_pred EEEecCCCcccccc----------cc---CHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEec
Confidence 99999998875420 00 1234568889999999 7774 9999999999998 668999999
Q ss_pred ccce
Q 043524 173 SLSI 176 (314)
Q Consensus 173 g~~~ 176 (314)
+.+.
T Consensus 132 ~~a~ 135 (170)
T cd05151 132 EYAG 135 (170)
T ss_pred cccc
Confidence 9874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.90 E-value=7.4e-09 Score=82.44 Aligned_cols=95 Identities=22% Similarity=0.274 Sum_probs=74.0
Q ss_pred HHHHHHHHHHhcCCC--CceeeeEeEEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhh
Q 043524 65 ESCINNVTYAAQMSH--DHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLH 142 (314)
Q Consensus 65 ~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH 142 (314)
++..+|++++..++- -+..-++++ +.+...|+|||.+|..|.+.+... ...++..+-.-+.-||
T Consensus 44 ~Rt~~Earil~~a~~~GV~~P~v~dv--D~~~~~I~me~I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH 109 (204)
T COG3642 44 ERTRREARILAKAREAGVPVPIVYDV--DPDNGLIVMEYIEGELLKDALEEA------------RPDLLREVGRLVGKLH 109 (204)
T ss_pred HHHHHHHHHHHHHHHcCCCCCeEEEE--cCCCCEEEEEEeCChhHHHHHHhc------------chHHHHHHHHHHHHHH
Confidence 677899999998863 344555554 566677999999998888888543 1234556666788899
Q ss_pred cCCCCCceeccCCCCCeeecCCCceEEccccccee
Q 043524 143 FGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSIS 177 (314)
Q Consensus 143 ~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~ 177 (314)
..||+|+||+++|+++...+ +.++|||++..
T Consensus 110 ---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 110 ---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred ---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999999999997665 88999999864
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.81 E-value=3.5e-08 Score=78.40 Aligned_cols=107 Identities=21% Similarity=0.169 Sum_probs=77.0
Q ss_pred HHHHHHHHHHhcCCCCceeeeEeEEEeCCeeEEEEeecCC-CCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhc
Q 043524 65 ESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQH-GTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHF 143 (314)
Q Consensus 65 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~iv~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~ 143 (314)
++..+|.+.|.++.--.|.--.=++.+.+.-+|.|||.++ .++.+++.....+. .........+..+-..+.-||
T Consensus 55 ~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~---~~d~~~~~~~~~iG~~igklH- 130 (229)
T KOG3087|consen 55 KRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDE---SEDEGLAELARRIGELIGKLH- 130 (229)
T ss_pred HHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccCc---ccchhHHHHHHHHHHHHHHhh-
Confidence 6778999999987633332222334456666789999965 37888887655321 222233667788888999999
Q ss_pred CCCCCceeccCCCCCeeecCCC---ceEEccccccee
Q 043524 144 GFPRPIVFRDFKTSHILFSEEN---VVKLFDFSLSIS 177 (314)
Q Consensus 144 ~~~~~i~H~dlk~~nil~~~~~---~~kl~dfg~~~~ 177 (314)
+++++|+||+.+||++..++ .+.++|||++..
T Consensus 131 --~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 131 --DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred --hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99999999999999986554 347999999743
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.77 E-value=7.4e-08 Score=83.14 Aligned_cols=106 Identities=12% Similarity=0.059 Sum_probs=78.3
Q ss_pred HHHHHHHHHhcCCC--CceeeeEeEEEe-----CCeeEEEEeecCCC-CHHHHHhcCCCCCCCcccHHHHHHHHHHHHHH
Q 043524 66 SCINNVTYAAQMSH--DHILKLIGCCLE-----TPIAILVFEYVQHG-TLWDRILGAPQTHFEPLLLKRRLKDAVDAANA 137 (314)
Q Consensus 66 ~~~~E~~~l~~l~h--~niv~~~~~~~~-----~~~~~iv~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~ 137 (314)
.+.+|+..+..+.. -.+....++.+. ....++|||++++. +|.+++..... .+........++.+++..
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~---~~~~~~~~~~ll~~la~~ 150 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWAT---NPPDPRLKRMLIKRVATM 150 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcc---cCCCHHHHHHHHHHHHHH
Confidence 46788888888742 233444444432 23578999999875 78888753211 234456677888999999
Q ss_pred HHHhhcCCCCCceeccCCCCCeeecC-------CCceEEccccccee
Q 043524 138 LAYLHFGFPRPIVFRDFKTSHILFSE-------ENVVKLFDFSLSIS 177 (314)
Q Consensus 138 l~~lH~~~~~~i~H~dlk~~nil~~~-------~~~~kl~dfg~~~~ 177 (314)
+.-|| +.||+|+|+++.||+++. ...+.++||+.++.
T Consensus 151 i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 151 VRDMH---AAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHHH---HCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 99999 999999999999999975 45789999998743
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.65 E-value=4.6e-07 Score=82.59 Aligned_cols=171 Identities=15% Similarity=0.188 Sum_probs=124.4
Q ss_pred chhHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE----eCCeeEEE
Q 043524 23 GASVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL----ETPIAILV 98 (314)
Q Consensus 23 g~~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~----~~~~~~iv 98 (314)
.....|++..+-+|..|..|.+.-...+.. .....-++.++++.|+|+|++.+++. .+..+++|
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~------------nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~Slvlv 355 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST------------NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLV 355 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc------------ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEE
Confidence 557888888999999999987722222111 11134578899999999999999987 35678999
Q ss_pred EeecCC-CCHHHHHhcCCCC----------CCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCce
Q 043524 99 FEYVQH-GTLWDRILGAPQT----------HFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVV 167 (314)
Q Consensus 99 ~e~~~~-g~L~~~l~~~~~~----------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~ 167 (314)
++|.++ ++|.+..-..... ....+++..++.++.|+..||.++| +.|+.-+-|.+.+|+++...++
T Consensus 356 YDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RI 432 (655)
T KOG3741|consen 356 YDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRI 432 (655)
T ss_pred EecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceE
Confidence 999875 5776655432211 0123577889999999999999999 9999889999999999988888
Q ss_pred EEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCC
Q 043524 168 KLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226 (314)
Q Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~ 226 (314)
+|+..|.......... +| + .-..+-|.=.+|.++.-+.+|.
T Consensus 433 riS~C~i~Dvl~~d~~-------------~~--l---e~~Qq~D~~~lG~ll~aLAt~~ 473 (655)
T KOG3741|consen 433 RISGCGIMDVLQEDPT-------------EP--L---ESQQQNDLRDLGLLLLALATGT 473 (655)
T ss_pred EEecccceeeecCCCC-------------cc--h---hHHhhhhHHHHHHHHHHHhhcc
Confidence 8887777644322210 00 1 0124568889999999999985
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.63 E-value=3e-08 Score=83.17 Aligned_cols=141 Identities=22% Similarity=0.269 Sum_probs=91.0
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCC--CceeeeEeEEEeC---
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSH--DHILKLIGCCLET--- 92 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~--- 92 (314)
.+|.|. ..++++.. .+|+.+++|......... ....+.+|++++..+.+ .++.+++.+....
T Consensus 5 ~l~~G~~n~~~~v~~-~~g~~~ilK~~~~~~~~~-----------~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~ 72 (223)
T cd05154 5 QLSGGQSNLTYLLTA-GGGRRLVLRRPPPGALLP-----------SAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVL 72 (223)
T ss_pred ecCCCccceEEEEEe-cCCcceEEEeCCCcccCc-----------ccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCcc
Confidence 355555 44544433 346789999875443210 01456789999999875 4567777776553
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcC----------------------------
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFG---------------------------- 144 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---------------------------- 144 (314)
+..++||||++|.++.+.+.. ..++......++.+++..|..||..
T Consensus 73 ~~~~~v~e~i~G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (223)
T cd05154 73 GTPFYVMERVDGRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQY 146 (223)
T ss_pred CCceEEEEEeCCEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHH
Confidence 366899999998887664421 1234444445555555555555521
Q ss_pred -------------------------CCCCceeccCCCCCeeecC--CCceEEccccccee
Q 043524 145 -------------------------FPRPIVFRDFKTSHILFSE--ENVVKLFDFSLSIS 177 (314)
Q Consensus 145 -------------------------~~~~i~H~dlk~~nil~~~--~~~~kl~dfg~~~~ 177 (314)
....++|+|+.+.||+++. .+.+.++||+.+..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 147 DASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1345789999999999988 56688999988743
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.3e-08 Score=95.25 Aligned_cols=151 Identities=18% Similarity=0.239 Sum_probs=100.2
Q ss_pred HHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccceecCCCC--------cccccccccccccccCcccc
Q 043524 131 AVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGE--------THITDTVMGTYGHLAPQYVT 202 (314)
Q Consensus 131 ~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~--------~~~~~~~~g~~~y~aPE~~~ 202 (314)
+.+++.|+.|+|. +-++||+++.|++|.++..+.-|++-|+.+....... ........-..-|.|||++.
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3455589999997 8899999999999999999999999998864432211 00011112345699999999
Q ss_pred cCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHH
Q 043524 203 TCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQ 281 (314)
Q Consensus 203 ~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (314)
....+.++|++|+|+.+|.+.. |+..+.......... +.. .. .+. .....+...+.++++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~--~~~------~~------~~~-----~~~~~s~~~p~el~~ 243 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS--FSR------NL------LNA-----GAFGYSNNLPSELRE 243 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhh--hhh------cc------ccc-----ccccccccCcHHHHH
Confidence 9888899999999999999984 555443322211000 000 00 000 000111255677888
Q ss_pred HHhHhccCCCCCCCCHHHHHH
Q 043524 282 LTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 282 li~~cl~~dp~~Rps~~ell~ 302 (314)
=+..++..++..||++.+++.
T Consensus 244 ~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 244 SLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HHHHHhcCCcccCcchhhhhc
Confidence 899999999999997766653
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.53 E-value=4.4e-07 Score=74.02 Aligned_cols=100 Identities=17% Similarity=0.184 Sum_probs=64.5
Q ss_pred HHHHHHHHHHHhcCCCC--ceeeeEeEEEeCCeeEEEEeecC--CCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHH
Q 043524 64 HESCINNVTYAAQMSHD--HILKLIGCCLETPIAILVFEYVQ--HGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALA 139 (314)
Q Consensus 64 ~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~~~~iv~e~~~--~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~ 139 (314)
.....+|++.|..+..- ++.+.+++. ..+|||||++ |..+.. +.... +.......++.+++..+.
T Consensus 52 ~~~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~-l~~~~------~~~~~~~~~~~~il~~~~ 120 (188)
T PF01163_consen 52 REWAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPR-LKDVD------LSPEEPKELLEEILEEII 120 (188)
T ss_dssp HHHHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGC-HHHCG------GGGSTHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhh-HHhcc------ccchhHHHHHHHHHHHHH
Confidence 36678999999999754 677776552 3469999997 544433 33211 112334455666666554
Q ss_pred H-hhcCCCCCceeccCCCCCeeecCCCceEEcccccceec
Q 043524 140 Y-LHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISI 178 (314)
Q Consensus 140 ~-lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~ 178 (314)
. +| ..|++|+||.+.||+++.+ .+.++|||.+...
T Consensus 121 ~~~~---~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 121 KMLH---KAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp HHHH---CTTEEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred HHHH---hcCceecCCChhhEEeecc-eEEEEecCcceec
Confidence 4 68 9999999999999999877 8999999988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.52 E-value=8.2e-07 Score=73.93 Aligned_cols=106 Identities=16% Similarity=0.058 Sum_probs=81.2
Q ss_pred HHHHHHHHHHhcCC--CCceeeeEeEEEeC----CeeEEEEeecCCC-CHHHHHhcCCCCCCCcccHHHHHHHHHHHHHH
Q 043524 65 ESCINNVTYAAQMS--HDHILKLIGCCLET----PIAILVFEYVQHG-TLWDRILGAPQTHFEPLLLKRRLKDAVDAANA 137 (314)
Q Consensus 65 ~~~~~E~~~l~~l~--h~niv~~~~~~~~~----~~~~iv~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~ 137 (314)
.+..+|...+..|. .-.+.+.+++.+.. ...++|+|++++. +|.+.+.... ..+......++.+++..
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-----~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-----QLDPSQRRELLRALARL 130 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-----ccchhhHHHHHHHHHHH
Confidence 45678888887775 33455556665542 3458999999874 7888886532 14456677888899999
Q ss_pred HHHhhcCCCCCceeccCCCCCeeecCCC---ceEEcccccceec
Q 043524 138 LAYLHFGFPRPIVFRDFKTSHILFSEEN---VVKLFDFSLSISI 178 (314)
Q Consensus 138 l~~lH~~~~~~i~H~dlk~~nil~~~~~---~~kl~dfg~~~~~ 178 (314)
+.-|| +.||+|+|+++.|||++..+ .+.++||+.++..
T Consensus 131 i~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 131 IAKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999 99999999999999999887 7899999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.28 E-value=1e-06 Score=74.48 Aligned_cols=140 Identities=16% Similarity=0.190 Sum_probs=85.2
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHH-----HHHHHhcCCcccCCh-----hHHHHHHHHHHHhcCCCC--ceeee
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQ-----ELKQETNNYDQKNGF-----WHESCINNVTYAAQMSHD--HILKL 85 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~-----~~~~~~~~~~~~~~~-----~~~~~~~E~~~l~~l~h~--niv~~ 85 (314)
.+|-|- +.||.+.+ ..|+.+|+|.=... .++....-....... ......+|.++|..|... .+.+.
T Consensus 98 ~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP~P 176 (304)
T COG0478 98 KIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVPKP 176 (304)
T ss_pred ccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCCCc
Confidence 344444 44444433 36899999973322 222211111111111 225567899999998744 67777
Q ss_pred EeEEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCC
Q 043524 86 IGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN 165 (314)
Q Consensus 86 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~ 165 (314)
+++ +.-.+|||+.+|-.|...- +.....-.++..|+.-+.-.- ..|++|+|+.+=||+++.+|
T Consensus 177 ~~~----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg 239 (304)
T COG0478 177 IAW----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDG 239 (304)
T ss_pred ccc----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCC
Confidence 655 5556999999886663321 112222233334444444444 58899999999999999999
Q ss_pred ceEEcccccce
Q 043524 166 VVKLFDFSLSI 176 (314)
Q Consensus 166 ~~kl~dfg~~~ 176 (314)
.+.++||=.+.
T Consensus 240 ~~~vIDwPQ~v 250 (304)
T COG0478 240 DIVVIDWPQAV 250 (304)
T ss_pred CEEEEeCcccc
Confidence 99999996653
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.20 E-value=7.7e-06 Score=67.72 Aligned_cols=68 Identities=19% Similarity=0.156 Sum_probs=51.1
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~df 172 (314)
...+++|||++|..|.+... ++. ...-.+..++.-+| ..|+.|+|.+|.|++++.+ .++++||
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~---------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~-~i~iID~ 178 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED---------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNN-GIRIIDT 178 (229)
T ss_pred eEEEEEEEEecCeecccchh---------cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECC-cEEEEEC
Confidence 44578999999988865431 221 12345666789999 9999999999999999854 5999999
Q ss_pred cccee
Q 043524 173 SLSIS 177 (314)
Q Consensus 173 g~~~~ 177 (314)
+..+.
T Consensus 179 ~~k~~ 183 (229)
T PF06176_consen 179 QGKRM 183 (229)
T ss_pred ccccc
Confidence 87643
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.18 E-value=4.6e-07 Score=84.54 Aligned_cols=150 Identities=18% Similarity=0.131 Sum_probs=111.3
Q ss_pred HHHHHHHHhcCCCCc-eeeeEeEEEeCCeeEEEEeecCCC-CHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcC
Q 043524 67 CINNVTYAAQMSHDH-ILKLIGCCLETPIAILVFEYVQHG-TLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFG 144 (314)
Q Consensus 67 ~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~iv~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~ 144 (314)
..-++++|.+++||| .+..++-+..+...++.++++.++ +....+.... ..+...+.......-..+++++|
T Consensus 280 ~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se----~~~~~~~~~~~~r~et~~l~~l~-- 353 (829)
T KOG0576|consen 280 RRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSE----IALEQYQFAYPLRKETRPLAELH-- 353 (829)
T ss_pred hHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChhh----Hhhhhhhhhhhhhhhcccccccc--
Confidence 345788999999999 888888888888999999999876 3322221111 11233334444555567889999
Q ss_pred CCCCceeccCCCCCeeecCCCceEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh
Q 043524 145 FPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT 224 (314)
Q Consensus 145 ~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~ 224 (314)
+..-+|+| ||+.+ .+..+.++|+....+.... ..++..+++.++|||+...+.+....|.|+.|.-..+|.-
T Consensus 354 -~~~~~~~d----~~l~s-~~~~~~~~~~v~~~L~~~~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap 425 (829)
T KOG0576|consen 354 -SSYKVHRD----NILGS-EEEVKLLDFAVPPQLTRTM--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAP 425 (829)
T ss_pred -cccccCcc----ccccc-ccccccccccCCcccCccc--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCC
Confidence 55457887 66654 4678999999987765543 4667889999999999999999999999999988888888
Q ss_pred CCCCcc
Q 043524 225 GRGILD 230 (314)
Q Consensus 225 g~~p~~ 230 (314)
|.+|-.
T Consensus 426 ~~pPr~ 431 (829)
T KOG0576|consen 426 GLPPRS 431 (829)
T ss_pred CCCCCC
Confidence 877654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.17 E-value=9.1e-06 Score=66.99 Aligned_cols=107 Identities=16% Similarity=0.047 Sum_probs=80.0
Q ss_pred HHHHHHHHHHhcCCC--CceeeeEeEEEe----CCeeEEEEeecCC-CCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHH
Q 043524 65 ESCINNVTYAAQMSH--DHILKLIGCCLE----TPIAILVFEYVQH-GTLWDRILGAPQTHFEPLLLKRRLKDAVDAANA 137 (314)
Q Consensus 65 ~~~~~E~~~l~~l~h--~niv~~~~~~~~----~~~~~iv~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~ 137 (314)
..|.+|+..|..|.. -.+.+....-.. ....+||+|-+++ -||.+++..... .+.+......++.+++..
T Consensus 64 ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~---~~~~~~~k~~il~~va~~ 140 (216)
T PRK09902 64 PTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAV---SPYSDEVRQAMLKAVALA 140 (216)
T ss_pred hHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCc---CCcchHHHHHHHHHHHHH
Confidence 678999999998863 234444422111 2346899997753 588888755332 345667778889999999
Q ss_pred HHHhhcCCCCCceeccCCCCCeeecCCCc--eEEccccccee
Q 043524 138 LAYLHFGFPRPIVFRDFKTSHILFSEENV--VKLFDFSLSIS 177 (314)
Q Consensus 138 l~~lH~~~~~~i~H~dlk~~nil~~~~~~--~kl~dfg~~~~ 177 (314)
+.-|| +.|+.|+|+-+.||+++..+. +.++||..++.
T Consensus 141 ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 141 FKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred HHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 99999 999999999999999986666 89999987643
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.02 E-value=1.2e-05 Score=79.90 Aligned_cols=194 Identities=17% Similarity=0.172 Sum_probs=128.1
Q ss_pred HHHHHHhcCCCCceeeeEeEEEeCC----eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcC
Q 043524 69 NNVTYAAQMSHDHILKLIGCCLETP----IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFG 144 (314)
Q Consensus 69 ~E~~~l~~l~h~niv~~~~~~~~~~----~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~ 144 (314)
.|...+..+.|+|++.++.+-.... ...+..|+|..-++.+.+..- ...+....+.+..+...|+.++|
T Consensus 231 ~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v-----~~i~~~~~r~~~~~~~~GL~~~h-- 303 (1351)
T KOG1035|consen 231 IELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV-----GSIPLETLRILHQKLLEGLAYLH-- 303 (1351)
T ss_pred HHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc-----cccCHHHHHHHHHHHhhhHHHHH--
Confidence 4667778889999999999876432 234567888888888877654 35788899999999999999999
Q ss_pred CCCCceeccCCCC---CeeecCCCceEEc--ccccceecCCCCcccccccccccccccCcccccCCCC--cccchHHHHH
Q 043524 145 FPRPIVFRDFKTS---HILFSEENVVKLF--DFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFS--EKLDVYSFGA 217 (314)
Q Consensus 145 ~~~~i~H~dlk~~---nil~~~~~~~kl~--dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~--~~~DiwslG~ 217 (314)
+....|.-+..+ +--.+..+....+ ||+.++..+.... .....-+.-+.++|......+. ...|+|.+|.
T Consensus 304 -~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~--~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 304 -SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK--SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred -HhccceeEEecccccccccCccceeecchhhhcccccCCCccc--chhhcCccccccccccccccchhhhhhHHHHHHH
Confidence 665544444333 2222334444544 8877766544332 2233345567788877766554 4479999999
Q ss_pred HHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCH
Q 043524 218 FLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTM 297 (314)
Q Consensus 218 ~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 297 (314)
....+..|..+-.... ....+... .......++...|+..++++|+++
T Consensus 381 l~~~~~~~~~i~~~~~-------------------------~~~~~l~~-------~~~~~~~d~~~~~~~~~~~~Rl~~ 428 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKSA-------------------------VPVSLLDV-------LSTSELLDALPKCLDEDSEERLSA 428 (1351)
T ss_pred HHhhhhhcCccccccc-------------------------chhhhhcc-------ccchhhhhhhhhhcchhhhhccch
Confidence 9999988765421000 00000000 011145688899999999999999
Q ss_pred HHHHHHH
Q 043524 298 VDVARRL 304 (314)
Q Consensus 298 ~ell~~L 304 (314)
.+++...
T Consensus 429 ~~ll~~~ 435 (1351)
T KOG1035|consen 429 LELLTHP 435 (1351)
T ss_pred hhhhhch
Confidence 9998743
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.93 E-value=4.7e-05 Score=62.30 Aligned_cols=103 Identities=21% Similarity=0.265 Sum_probs=79.0
Q ss_pred HHHHHHhcCCC-CceeeeEeEEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCC
Q 043524 69 NNVTYAAQMSH-DHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPR 147 (314)
Q Consensus 69 ~E~~~l~~l~h-~niv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~ 147 (314)
+|.-++..+++ +++.+++|+|-. .+++||.+.+++......- ..+...++..+..++.+++..+.++++....
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l--~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPL--SQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccccc--ccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 68888888986 699999999932 4699999877664321000 0112357999999999999999999855446
Q ss_pred CceeccCCCCCeeecCCCceEEccccccee
Q 043524 148 PIVFRDFKTSHILFSEENVVKLFDFSLSIS 177 (314)
Q Consensus 148 ~i~H~dlk~~nil~~~~~~~kl~dfg~~~~ 177 (314)
.+.-.|++++|+.++.++.+|++|......
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 666799999999999999999999877543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.82 E-value=9.6e-05 Score=62.39 Aligned_cols=69 Identities=9% Similarity=0.004 Sum_probs=46.8
Q ss_pred ccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCC--ceeeeEeEEEeCCeeE
Q 043524 20 IGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHD--HILKLIGCCLETPIAI 96 (314)
Q Consensus 20 ~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~~~~ 96 (314)
+|+|. ..+|.. .|+.+++|........ ....+|.+++..+..- .+.+.+++...++...
T Consensus 9 i~~G~t~~~y~~----~~~~~VlR~~~~~~~~--------------~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~g 70 (226)
T TIGR02172 9 TGEGGNGESYTH----KTGKWMLKLYNPGFDK--------------ETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLG 70 (226)
T ss_pred ecCCCCcceeEe----cCCCEEEEeCCCCCCH--------------HHHHHHHHHHHHHHHcCCCCCceEEEEecCCeee
Confidence 67777 455542 3556678877532211 3457899999888632 3577788887778888
Q ss_pred EEEeecCCCC
Q 043524 97 LVFEYVQHGT 106 (314)
Q Consensus 97 iv~e~~~~g~ 106 (314)
++||+++|.+
T Consensus 71 lv~e~i~G~~ 80 (226)
T TIGR02172 71 LIYELIVGKR 80 (226)
T ss_pred eeeeecCCcc
Confidence 9999998853
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.80 E-value=4e-05 Score=71.94 Aligned_cols=153 Identities=14% Similarity=0.126 Sum_probs=90.4
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHH-------------hcCCccc-CCh--------hHHH------HH
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQE-------------TNNYDQK-NGF--------WHES------CI 68 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~-------------~~~~~~~-~~~--------~~~~------~~ 68 (314)
..++.++ +.|+.+.-.. |+.||||+..+.-.... .+.+... .+. ..+. +.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 4567777 7777765444 99999998665432221 1111111 111 1111 23
Q ss_pred HHHHHHhcC----CCCceeeeEeEEEe-CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhc
Q 043524 69 NNVTYAAQM----SHDHILKLIGCCLE-TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHF 143 (314)
Q Consensus 69 ~E~~~l~~l----~h~niv~~~~~~~~-~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~ 143 (314)
+|..-+.++ ++..=+++-.++.+ .+.-.++|||++|-.+.+...-.. ...+.+.+...+.++ -+..+-
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~----~g~d~k~ia~~~~~~--f~~q~~- 282 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS----AGIDRKELAELLVRA--FLRQLL- 282 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh----cCCCHHHHHHHHHHH--HHHHHH-
Confidence 344444444 34444555555543 455679999999988877642221 123433333333322 112222
Q ss_pred CCCCCceeccCCCCCeeecCCCceEEcccccceecCC
Q 043524 144 GFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPE 180 (314)
Q Consensus 144 ~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~~~ 180 (314)
..|+.|.|.+|.||++..++.+.+.|||+...+.+
T Consensus 283 --~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 283 --RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred --hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 57899999999999999999999999999866543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.00024 Score=59.72 Aligned_cols=140 Identities=14% Similarity=0.177 Sum_probs=84.8
Q ss_pred hHHHHHHHhcCCcccccccccHHHHHHHh--c------CCcccCC----hhHHHHHHHHHHHhcCC--CCceeeeEeEEE
Q 043524 25 SVLQELIASSNGKYIPYRIFSAQELKQET--N------NYDQKNG----FWHESCINNVTYAAQMS--HDHILKLIGCCL 90 (314)
Q Consensus 25 ~~~~~~~~~~~g~~~a~k~~~~~~~~~~~--~------~~~~~~~----~~~~~~~~E~~~l~~l~--h~niv~~~~~~~ 90 (314)
..|+++.. .++..+|+|++......-.. . -|..... .+..=...|++-|.++. +-.+.+-+++.
T Consensus 62 A~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~- 139 (268)
T COG1718 62 ANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFR- 139 (268)
T ss_pred eEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCCceeec-
Confidence 45555433 56889999998765432211 0 0111110 12222446777777664 44555555543
Q ss_pred eCCeeEEEEeecCCC-CHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEE
Q 043524 91 ETPIAILVFEYVQHG-TLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKL 169 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl 169 (314)
...+||||++.. .-...+.. -++...+...+..+++.++.-|-. ..++||+||..=|||+. ++.+.+
T Consensus 140 ---~nVLvMEfIg~~g~pAP~LkD------v~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~~~p~i 207 (268)
T COG1718 140 ---NNVLVMEFIGDDGLPAPRLKD------VPLELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH-DGEPYI 207 (268)
T ss_pred ---CCeEEEEeccCCCCCCCCccc------CCcCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE-CCeEEE
Confidence 345999998643 11222221 122333566667778888877762 48999999999999998 889999
Q ss_pred cccccceec
Q 043524 170 FDFSLSISI 178 (314)
Q Consensus 170 ~dfg~~~~~ 178 (314)
+|+|.|...
T Consensus 208 ID~~QaV~~ 216 (268)
T COG1718 208 IDVSQAVTI 216 (268)
T ss_pred EECcccccc
Confidence 999988543
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.36 E-value=3.9e-05 Score=78.44 Aligned_cols=204 Identities=12% Similarity=-0.015 Sum_probs=133.4
Q ss_pred CcccccccCch-hHHHHHHHhcCC-cccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNG-KYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g-~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
+....++|.+. ..-.....+-++ .....|....+...++.. +-.+.|+.-++...|+++...+.=...
T Consensus 1231 ~EV~l~i~~~~~~R~k~Lr~kid~Fk~~I~ke~d~e~LsePlk----------emll~e~de~~~~~h~~~~~~p~rI~p 1300 (2724)
T KOG1826|consen 1231 SEVNLGISNHFHFRNKWLRSKIDWFKFSIYKEYDFENLSEPLK----------EMLLSERDELREAKHYLTEVDPLRIPP 1300 (2724)
T ss_pred hheeeecccceeeccchHhhhhceeEEEeehhhhHHHHhhHHH----------HhhhhhhhhhhhhhceeeecccccCCC
Confidence 34556677666 444444445555 444445555554444321 344566667777889999888766543
Q ss_pred --CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhc--CCCCCceeccCCCCCeeecCCCce
Q 043524 92 --TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHF--GFPRPIVFRDFKTSHILFSEENVV 167 (314)
Q Consensus 92 --~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~--~~~~~i~H~dlk~~nil~~~~~~~ 167 (314)
....|..++|+.+|.+.+.+.+.... .+++...-+.....+.+.+..-+|. +..+-.+|+++|+-|.+|..+-.+
T Consensus 1301 s~s~ee~~r~~~~~~g~~f~iIikg~ee-~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v 1379 (2724)
T KOG1826|consen 1301 SESTEEYIRSLYVEFGKLFSIIIKGLEE-SPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNV 1379 (2724)
T ss_pred CCChHHHHHHHHHHHhHHHHHHHhcccc-CCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcc
Confidence 45568999999999999999764321 1223322222222232445544442 113345799999999999988889
Q ss_pred EEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCc
Q 043524 168 KLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGIL 229 (314)
Q Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~ 229 (314)
+++++|+.+.... .........+++.|+.|++.....++.++|+|+.|+-+|....|..+|
T Consensus 1380 ~~gk~gLdKIknp-~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1380 KLGKGGLDKIKNP-VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred cccccccccccCc-hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 9999999873211 111233456788899999888888999999999999999988877655
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.00049 Score=64.64 Aligned_cols=83 Identities=20% Similarity=0.196 Sum_probs=53.2
Q ss_pred eEeEEEe-CCeeEEEEeecCCCCHHHH--HhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeee
Q 043524 85 LIGCCLE-TPIAILVFEYVQHGTLWDR--ILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILF 161 (314)
Q Consensus 85 ~~~~~~~-~~~~~iv~e~~~~g~L~~~--l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~ 161 (314)
+..++.+ ...-.++||||+|..+.|. +.+.+ ++...+...+.+ +...+ ....|.+|+|-+|.||++
T Consensus 266 VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~g------i~~~~i~~~l~~---~~~~q--If~~GffHaDPHPGNilv 334 (538)
T KOG1235|consen 266 VPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRG------ISPHDILNKLVE---AYLEQ--IFKTGFFHADPHPGNILV 334 (538)
T ss_pred CCeehhhcCcceEEEEEecCCccCCCHHHHHHcC------CCHHHHHHHHHH---HHHHH--HHhcCCccCCCCCCcEEE
Confidence 4444432 3456799999999766443 43332 444444433333 22221 115789999999999999
Q ss_pred cC----CCceEEcccccceec
Q 043524 162 SE----ENVVKLFDFSLSISI 178 (314)
Q Consensus 162 ~~----~~~~kl~dfg~~~~~ 178 (314)
.. +..+.+.|||+....
T Consensus 335 ~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 335 RPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred ecCCCCCccEEEEcccccccc
Confidence 84 567899999997654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0028 Score=54.01 Aligned_cols=73 Identities=10% Similarity=-0.026 Sum_probs=46.7
Q ss_pred ccCchhHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC-CCceeeeEeEEEeCCeeEEE
Q 043524 20 IGNGASVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS-HDHILKLIGCCLETPIAILV 98 (314)
Q Consensus 20 ~G~g~~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~iv 98 (314)
.|.-+..|+.+.. .+..+.+|+..... . ..+..|++++..+. +.-+.+++++...++..++|
T Consensus 8 ~g~~~~~v~~~~~--~~~~~~vk~~~~~~---~------------~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 70 (244)
T cd05150 8 EGQSGATVYRLDG--KNPGLYLKIAPSGP---T------------YELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLL 70 (244)
T ss_pred CCCCcCeEEEEcC--CCCcEEEEecCCCc---c------------cchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEE
Confidence 4443355555532 23567777665432 0 23457888887774 45566778877766678899
Q ss_pred EeecCCCCHHH
Q 043524 99 FEYVQHGTLWD 109 (314)
Q Consensus 99 ~e~~~~g~L~~ 109 (314)
||+++|.++..
T Consensus 71 ~e~i~G~~l~~ 81 (244)
T cd05150 71 TSAVPGVPAAA 81 (244)
T ss_pred EEeeCCccHhH
Confidence 99998877753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0022 Score=54.43 Aligned_cols=31 Identities=16% Similarity=0.288 Sum_probs=26.3
Q ss_pred CCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 146 PRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 146 ~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
...++|+|+.+.|++++..+...++||+.+.
T Consensus 163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred CceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 5568999999999999877666799999863
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.014 Score=48.04 Aligned_cols=139 Identities=17% Similarity=0.185 Sum_probs=83.4
Q ss_pred cccccCchhHHHHHHHhcCCcccccccccHHHHHHHhcCCccc-----CChhHHHHHHHHHHHhcCC------CCceeee
Q 043524 17 TLMIGNGASVLQELIASSNGKYIPYRIFSAQELKQETNNYDQK-----NGFWHESCINNVTYAAQMS------HDHILKL 85 (314)
Q Consensus 17 ~~~~G~g~~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~-----~~~~~~~~~~E~~~l~~l~------h~niv~~ 85 (314)
...+|.|+.-. ++.........||+...... .....+..- ....+++..+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~--cy~HP~dp~~cIKV~~~~~~-~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERD--CYQHPDDPNLCIKVMRPDRG-ERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCce--EEECCCCCCeEEEEEccccc-cccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 34567766222 12334455667887776651 100000000 0002355667776666655 8899999
Q ss_pred EeEEEeCCeeEEEEeecC------CCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCe
Q 043524 86 IGCCLETPIAILVFEYVQ------HGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHI 159 (314)
Q Consensus 86 ~~~~~~~~~~~iv~e~~~------~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~ni 159 (314)
+|+.+++--.-+|+|... ..+|.+++.... ++. .....+.+.. .+|- +++|+.+|++|.||
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~------~~~-~~~~~L~~f~---~~l~---~~~Iv~~dl~~~NI 149 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG------LTE-ELRQALDEFK---RYLL---DHHIVIRDLNPHNI 149 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC------ccH-HHHHHHHHHH---HHHH---HcCCeecCCCcccE
Confidence 999999888888998753 236777775432 333 3333344433 4555 78899999999999
Q ss_pred eecCCC----ceEEcc
Q 043524 160 LFSEEN----VVKLFD 171 (314)
Q Consensus 160 l~~~~~----~~kl~d 171 (314)
++.... .+.++|
T Consensus 150 v~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 150 VVQRRDSGEFRLVLID 165 (199)
T ss_pred EEEecCCCceEEEEEe
Confidence 986432 466777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.0077 Score=60.70 Aligned_cols=42 Identities=14% Similarity=0.305 Sum_probs=32.0
Q ss_pred HHHHHHHHHHhcCC-CCce--eeeEeEEEeC---CeeEEEEeecCCCC
Q 043524 65 ESCINNVTYAAQMS-HDHI--LKLIGCCLET---PIAILVFEYVQHGT 106 (314)
Q Consensus 65 ~~~~~E~~~l~~l~-h~ni--v~~~~~~~~~---~~~~iv~e~~~~g~ 106 (314)
..+.+|+++++.+. |+++ .+++.++.+. +..|+||||++|..
T Consensus 83 ~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~ 130 (822)
T PLN02876 83 HAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRI 130 (822)
T ss_pred HHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCcc
Confidence 35678999999995 6654 7888887654 46789999998754
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.0066 Score=56.36 Aligned_cols=163 Identities=20% Similarity=0.258 Sum_probs=90.7
Q ss_pred HHHHHHHHhcCCCCceeeeEeEEEe-CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCC
Q 043524 67 CINNVTYAAQMSHDHILKLIGCCLE-TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGF 145 (314)
Q Consensus 67 ~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~ 145 (314)
++.-..+++.++|+|.-.+.++-.. .....+|+|++ +.|+.+.+.... +... + ++
T Consensus 29 ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~------l~~~-------s---~~------- 84 (725)
T KOG1093|consen 29 ILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN------LKDE-------S---LL------- 84 (725)
T ss_pred HhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc------cchh-------h---hc-------
Confidence 4555778899999999999988764 34578999999 569988876432 1000 0 00
Q ss_pred CCCceeccCCCCCeeecCCCceEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhC
Q 043524 146 PRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225 (314)
Q Consensus 146 ~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g 225 (314)
.+++.|- |+ ...+| .+.... | .+.++++||||+|.++.++.-|
T Consensus 85 ~~~~~~~-----~~-------~~~td-----~~~t~~---------------~-----~~~~pKsdVwsl~~i~~el~L~ 127 (725)
T KOG1093|consen 85 AHGVLHL-----NI-------IYITD-----HFLTKY---------------P-----SPIGPKSDVWSLGFIILELYLG 127 (725)
T ss_pred cccccee-----hh-------hhccc-----cccccC---------------C-----CCCCcchhhhhHHHHHHHHHHh
Confidence 1222221 11 22233 000000 0 0122499999999999999998
Q ss_pred CCCcccccCccccccchHHHHHhhhccCCcccc-cChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 226 RGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEI-VDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 226 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
..-+......+ ....+..++........ .... ...-.+.....++...|+-..|..||...++.+
T Consensus 128 ~~l~~~~~~s~-----~l~~i~k~~~~d~~~~~~a~e~-------~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k 193 (725)
T KOG1093|consen 128 ISLEAELTESE-----YLEILLKYYTDDQELLSTAMEH-------LIQLLADKKRLPLLKKCLWLEPIIRPLPMELSK 193 (725)
T ss_pred hHHHHHHHHHH-----HHHHHHHhccCchhHHHHHHHH-------HHHHhhhHhHHHHhccCCccccccccchhHHhc
Confidence 86654322211 11112222211110000 0000 112255667889999999999999997665543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=96.31 E-value=0.0047 Score=51.82 Aligned_cols=59 Identities=12% Similarity=0.176 Sum_probs=38.1
Q ss_pred cccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCC--CceeeeEeEEEe---CCeeEEEEeecCCCCHHH
Q 043524 37 KYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSH--DHILKLIGCCLE---TPIAILVFEYVQHGTLWD 109 (314)
Q Consensus 37 ~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~---~~~~~iv~e~~~~g~L~~ 109 (314)
+.+++|........ ..+.+|..++..+.. ..+.+++..... ....+++|+++++.++..
T Consensus 21 ~~~vlK~~~~~~~~--------------~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 21 GRYVLKFYRPPDAA--------------ERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDD 84 (239)
T ss_dssp SEEEEEEESSHHHH--------------HHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHH
T ss_pred cEEEEEEeCCCCCH--------------HHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccc
Confidence 58889987665211 345678888887752 235666664432 345789999999887766
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.78 E-value=0.0069 Score=53.21 Aligned_cols=143 Identities=15% Similarity=0.199 Sum_probs=85.8
Q ss_pred hcCcccccccCchhHHHHHHHhcCCcccccccccHHHHH--HHhc--CCcccCCh--hH----HHHHHHHHHHhcCC-CC
Q 043524 12 SKGKRTLMIGNGASVLQELIASSNGKYIPYRIFSAQELK--QETN--NYDQKNGF--WH----ESCINNVTYAAQMS-HD 80 (314)
Q Consensus 12 ~~~~~~~~~G~g~~~~~~~~~~~~g~~~a~k~~~~~~~~--~~~~--~~~~~~~~--~~----~~~~~E~~~l~~l~-h~ 80 (314)
......+|+|.-+.++.. ....|+..+.|+=...... ...+ ++-..+.. |. =+..+|+..|+.|. |.
T Consensus 94 ~svGnqIGVGKESDIY~v--~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVV--ADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhccccccccccceEEE--ecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 344555666665544433 3456788888864333221 1111 11111111 11 34568999998885 32
Q ss_pred -ceeeeEeEEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCe
Q 043524 81 -HILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHI 159 (314)
Q Consensus 81 -niv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~ni 159 (314)
-+.+.+++ +.-|+|||+..+-.|...-. ...+..+..-+..++--|+ .+|++|+|..-=||
T Consensus 172 fpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~--------v~d~~~ly~~lm~~Iv~la------~~GlIHgDFNEFNi 233 (465)
T KOG2268|consen 172 FPVPKPIDH----NRHCVVMELVDGYPLRQVRH--------VEDPPTLYDDLMGLIVRLA------NHGLIHGDFNEFNI 233 (465)
T ss_pred CCCCCcccc----cceeeHHHhhcccceeeeee--------cCChHHHHHHHHHHHHHHH------HcCceecccchhee
Confidence 34444543 55679999998877754331 1234444444555444444 79999999999999
Q ss_pred eecCCCceEEccccc
Q 043524 160 LFSEENVVKLFDFSL 174 (314)
Q Consensus 160 l~~~~~~~kl~dfg~ 174 (314)
++..++.++++||=.
T Consensus 234 mv~dd~~i~vIDFPQ 248 (465)
T KOG2268|consen 234 MVKDDDKIVVIDFPQ 248 (465)
T ss_pred EEecCCCEEEeechH
Confidence 999999999999944
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=95.30 E-value=0.048 Score=44.85 Aligned_cols=132 Identities=22% Similarity=0.340 Sum_probs=79.8
Q ss_pred ccccccCchh--HHHHHHHhcCCcccccccccHHHHHHH---hcCCcccC------ChhHHHHHHHHHHHhcCC---CCc
Q 043524 16 RTLMIGNGAS--VLQELIASSNGKYIPYRIFSAQELKQE---TNNYDQKN------GFWHESCINNVTYAAQMS---HDH 81 (314)
Q Consensus 16 ~~~~~G~g~~--~~~~~~~~~~g~~~a~k~~~~~~~~~~---~~~~~~~~------~~~~~~~~~E~~~l~~l~---h~n 81 (314)
-...+|.|+. .|++ ..-+|+.+|+|++..-..... ...+.+.. ......|.+|.+...+|+ +.+
T Consensus 41 flefLg~g~~~~~V~k--v~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e~ 118 (207)
T PF13095_consen 41 FLEFLGHGSHDGYVFK--VEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGREG 118 (207)
T ss_pred eeeecCCCCceeEEEE--EEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccccC
Confidence 3445777764 2322 345678999999332111111 01111111 123367899999999886 345
Q ss_pred e--eeeEeEEEeC------------------CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHh
Q 043524 82 I--LKLIGCCLET------------------PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYL 141 (314)
Q Consensus 82 i--v~~~~~~~~~------------------~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~l 141 (314)
+ |+.+||..-. ....||-||.+... .+. ..-+.++.+-+..+
T Consensus 119 ~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------------~~~----~~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 119 LWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------------PLQ----IRDIPQMLRDLKIL 180 (207)
T ss_pred ceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------------ccc----hhHHHHHHHHHHHH
Confidence 5 9999998421 11246777665422 011 12245667778889
Q ss_pred hcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 142 HFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 142 H~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
| ..||+-+|+++.|.. .-+|+|||.+
T Consensus 181 ~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 H---KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred H---HCCeeeccCcccccc-----CCEEEecccC
Confidence 9 999999999999986 3478999864
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.10 E-value=0.038 Score=48.14 Aligned_cols=32 Identities=25% Similarity=0.399 Sum_probs=25.6
Q ss_pred CCCceeccCCCCCeeecCCCc-eEEccccccee
Q 043524 146 PRPIVFRDFKTSHILFSEENV-VKLFDFSLSIS 177 (314)
Q Consensus 146 ~~~i~H~dlk~~nil~~~~~~-~kl~dfg~~~~ 177 (314)
...++|+|+.+.|++++.++. .-|+||+.+..
T Consensus 184 ~~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 184 HTVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CCeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 345899999999999987454 56999998743
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.01 E-value=0.11 Score=45.98 Aligned_cols=33 Identities=15% Similarity=0.381 Sum_probs=28.9
Q ss_pred CCCceeccCCCCCeeecCCCceEEcccccceec
Q 043524 146 PRPIVFRDFKTSHILFSEENVVKLFDFSLSISI 178 (314)
Q Consensus 146 ~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~ 178 (314)
...++|+|+.+.|++++..+.+-+.||+.+...
T Consensus 197 ~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 197 PPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred CceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 446899999999999999888999999998654
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.69 E-value=0.1 Score=43.56 Aligned_cols=86 Identities=16% Similarity=0.092 Sum_probs=58.5
Q ss_pred HHHHHHHHHhcCCCCceeeeEeEEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCC
Q 043524 66 SCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGF 145 (314)
Q Consensus 66 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~ 145 (314)
-|.++.+++.++. .|+++..= .+..+-++.|.|..... .+...+ .--+.+|.-.|+.
T Consensus 104 ~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i--------------~~~N~i----~agi~~L~~fH~~- 160 (308)
T PF07387_consen 104 LYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI--------------NFSNFI----TAGIKDLMDFHSE- 160 (308)
T ss_pred hhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc--------------chhHHH----HHhHHHHHHhhcc-
Confidence 4567788888765 46666622 44456699999953222 111111 1113467777854
Q ss_pred CCCceeccCCCCCeeecCCCceEEccccc
Q 043524 146 PRPIVFRDFKTSHILFSEENVVKLFDFSL 174 (314)
Q Consensus 146 ~~~i~H~dlk~~nil~~~~~~~kl~dfg~ 174 (314)
+.+.+|+|..|+||+-|..|-+|+.|-+.
T Consensus 161 ~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 161 NQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred CCCeecCCCChhheeecCCCCEEecChhh
Confidence 77899999999999999999999999765
|
The function of this family is unknown. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=94.66 E-value=0.022 Score=45.63 Aligned_cols=126 Identities=11% Similarity=0.092 Sum_probs=76.9
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCce-eeeEeEEEeCCe
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHI-LKLIGCCLETPI 94 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~ 94 (314)
...+|.|. ++|+.. ...|..+|+|+-...... ..+..|+++|..+.-.++ .+++.+-.
T Consensus 27 ~~~L~KG~~s~Vyl~--~~~~~~~a~Kvrr~ds~r--------------~~l~kEakiLeil~g~~~~p~vy~yg~---- 86 (201)
T COG2112 27 EKELAKGTTSVVYLG--EWRGGEVALKVRRRDSPR--------------RNLEKEAKILEILAGEGVTPEVYFYGE---- 86 (201)
T ss_pred hhhhhcccccEEEEe--eccCceEEEEEecCCcch--------------hhHHHHHHHHHHhhhcCCCceEEEech----
Confidence 34567777 555544 234568888865444332 456789999998875444 34454432
Q ss_pred eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCC-CCeeecCCCceEEcccc
Q 043524 95 AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKT-SHILFSEENVVKLFDFS 173 (314)
Q Consensus 95 ~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~-~nil~~~~~~~kl~dfg 173 (314)
..+.|||..|.+|.+.-... .... ...++...--|- ..||-|..+.- ...++..++.+-|+||.
T Consensus 87 ~~i~me~i~G~~L~~~~~~~--------~rk~----l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd 151 (201)
T COG2112 87 DFIRMEYIDGRPLGKLEIGG--------DRKH----LLRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFD 151 (201)
T ss_pred hhhhhhhhcCcchhhhhhcc--------cHHH----HHHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEcc
Confidence 23569999888886654321 1122 233444433344 77888888764 44444455589999999
Q ss_pred ccee
Q 043524 174 LSIS 177 (314)
Q Consensus 174 ~~~~ 177 (314)
.|+.
T Consensus 152 ~At~ 155 (201)
T COG2112 152 SATF 155 (201)
T ss_pred chhh
Confidence 8863
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.08 E-value=0.37 Score=43.35 Aligned_cols=74 Identities=24% Similarity=0.160 Sum_probs=49.7
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
+...|+++++- |+++.- +. ....++...++.+.+.-+.-+.. .-..-|||+.-.||+|+ .|.+.|+|
T Consensus 298 ~~y~yl~~kdh-gt~is~-ik--------~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLID 364 (488)
T COG5072 298 TLYLYLHFKDH-GTPISI-IK--------ADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLID 364 (488)
T ss_pred ceEEEEEEecC-Cceeee-ee--------cccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEE
Confidence 34457777765 556632 21 23467777777765443333331 22456999999999999 89999999
Q ss_pred cccceec
Q 043524 172 FSLSISI 178 (314)
Q Consensus 172 fg~~~~~ 178 (314)
|.+++..
T Consensus 365 fklsRl~ 371 (488)
T COG5072 365 FKLSRLS 371 (488)
T ss_pred eeeeecc
Confidence 9999854
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.15 E-value=0.098 Score=46.44 Aligned_cols=30 Identities=23% Similarity=0.591 Sum_probs=26.1
Q ss_pred CCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 146 PRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 146 ~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
..+++|+|+.|.||+++.+....++||+.+
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~ 215 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFA 215 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEecccc
Confidence 568999999999999987666689999886
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=91.50 E-value=0.29 Score=41.21 Aligned_cols=30 Identities=27% Similarity=0.594 Sum_probs=26.2
Q ss_pred CCCceeccCCCCCeeecC-CCceEEcccccc
Q 043524 146 PRPIVFRDFKTSHILFSE-ENVVKLFDFSLS 175 (314)
Q Consensus 146 ~~~i~H~dlk~~nil~~~-~~~~kl~dfg~~ 175 (314)
...++|+|+.+.||+++. ++.+.++||..+
T Consensus 169 ~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a 199 (235)
T cd05157 169 PIVFCHNDLLSGNIIYNEEKNSVKFIDYEYA 199 (235)
T ss_pred CEEEEcCCCCcCcEEEeCCCCCEEEEEcccC
Confidence 456899999999999997 578999999876
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=90.50 E-value=0.39 Score=42.41 Aligned_cols=30 Identities=27% Similarity=0.613 Sum_probs=27.0
Q ss_pred CCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 146 PRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 146 ~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
..+++|+|+.+.|++++.++...++||+.+
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~ 215 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFA 215 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeecccc
Confidence 578999999999999988877789999886
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=90.28 E-value=0.21 Score=43.89 Aligned_cols=30 Identities=23% Similarity=0.448 Sum_probs=26.4
Q ss_pred CCCceeccCCCCCeeecCC----CceEEcccccc
Q 043524 146 PRPIVFRDFKTSHILFSEE----NVVKLFDFSLS 175 (314)
Q Consensus 146 ~~~i~H~dlk~~nil~~~~----~~~kl~dfg~~ 175 (314)
...++|+|+.+.||+++.+ +.+.++||..+
T Consensus 178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya 211 (302)
T cd05156 178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYA 211 (302)
T ss_pred CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCC
Confidence 5578999999999999874 78999999887
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=90.16 E-value=0.22 Score=40.52 Aligned_cols=29 Identities=14% Similarity=0.289 Sum_probs=24.7
Q ss_pred CCceeccCCCCCeeecCCCceEEcccccce
Q 043524 147 RPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 147 ~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
...+|+|+.|.|++++.++ ++++||+.+.
T Consensus 77 ~~p~H~D~~~~N~~~~~~~-~~lIDwe~a~ 105 (188)
T PRK10271 77 LAPLHMDVHAGNLVHSASG-LRLIDWEYAG 105 (188)
T ss_pred eeeecCCCCCccEEEECCC-EEEEeCCccc
Confidence 3458999999999998776 8899999873
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=90.08 E-value=0.2 Score=43.89 Aligned_cols=30 Identities=23% Similarity=0.599 Sum_probs=26.5
Q ss_pred CCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 146 PRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 146 ~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
..+++|+|+.|.|++++.++.+.|+||+.+
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a 203 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFA 203 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhh
Confidence 457999999999999998777789999876
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=89.39 E-value=0.63 Score=40.34 Aligned_cols=43 Identities=14% Similarity=0.203 Sum_probs=33.0
Q ss_pred HHHHHHHHHHhhcCCC-CCceeccCCCCCeeecCCCceEEcccccc
Q 043524 131 AVDAANALAYLHFGFP-RPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 131 ~~~i~~~l~~lH~~~~-~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
+..+-.++.-.+. + .-++|+|+.|+|++.+..+.+.|+||..|
T Consensus 138 ~~~l~~~l~~~~~--~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyA 181 (269)
T COG0510 138 LKELRRALEEVPK--DDLVPCHNDLNPGNLLLTDKGGLFLIDWEYA 181 (269)
T ss_pred HHHHHHHhhhcCC--CceeeecCCCCccceEEcCCCcEEEEecccC
Confidence 3444445555552 2 45889999999999999899999999876
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=88.97 E-value=0.81 Score=40.30 Aligned_cols=29 Identities=28% Similarity=0.489 Sum_probs=25.0
Q ss_pred CCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 146 PRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 146 ~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
..+++|+|+.+.|++++. +.+.++||+.+
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~ 214 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYC 214 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECccc
Confidence 367899999999999987 66889999865
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=88.38 E-value=0.34 Score=41.53 Aligned_cols=29 Identities=14% Similarity=0.305 Sum_probs=24.9
Q ss_pred CCceeccCCCCCeeecCCCceEEcccccce
Q 043524 147 RPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 147 ~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
..++|+|+.|.||+++.++ +.++||..+.
T Consensus 146 ~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 146 LAPLHMDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred CeeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence 3579999999999998776 7899998873
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=87.56 E-value=0.34 Score=40.22 Aligned_cols=30 Identities=27% Similarity=0.432 Sum_probs=20.7
Q ss_pred CCceeccCCCCCeee-cCCCceEEcccccce
Q 043524 147 RPIVFRDFKTSHILF-SEENVVKLFDFSLSI 176 (314)
Q Consensus 147 ~~i~H~dlk~~nil~-~~~~~~kl~dfg~~~ 176 (314)
..++|.|+.+.||++ +.++.++++||..+.
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 456799999999999 888899999998874
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=86.25 E-value=1.2 Score=39.74 Aligned_cols=27 Identities=22% Similarity=0.530 Sum_probs=24.5
Q ss_pred ceeccCCCCCeeecCCCc-eEEcccccc
Q 043524 149 IVFRDFKTSHILFSEENV-VKLFDFSLS 175 (314)
Q Consensus 149 i~H~dlk~~nil~~~~~~-~kl~dfg~~ 175 (314)
++|+|+.|.||+++.+.. ..++||+-+
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa 226 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDA 226 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEcccc
Confidence 999999999999998874 889999876
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=86.23 E-value=2.7 Score=38.52 Aligned_cols=28 Identities=18% Similarity=0.229 Sum_probs=23.0
Q ss_pred CCceeccCCCCCeeecCCCceEEcccccc
Q 043524 147 RPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 147 ~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
...+|.|+-+.||+.+. +.+.++||..|
T Consensus 227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA 254 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-QGIYFIDFDFA 254 (383)
T ss_pred eeeeeccCCcccEEecC-CCEEEEEeccc
Confidence 45689999999998754 46999999776
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=85.97 E-value=1.2 Score=40.17 Aligned_cols=31 Identities=13% Similarity=0.357 Sum_probs=26.0
Q ss_pred CCCceeccCCCCCeeecC-CCceEEcccccce
Q 043524 146 PRPIVFRDFKTSHILFSE-ENVVKLFDFSLSI 176 (314)
Q Consensus 146 ~~~i~H~dlk~~nil~~~-~~~~kl~dfg~~~ 176 (314)
...++|+|+++.||+++. ++.+.++||..+.
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 446789999999999976 4679999998873
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=85.95 E-value=0.62 Score=38.27 Aligned_cols=31 Identities=29% Similarity=0.401 Sum_probs=25.2
Q ss_pred CCCceeccCCCCCeeecCCC-----ceEEcccccce
Q 043524 146 PRPIVFRDFKTSHILFSEEN-----VVKLFDFSLSI 176 (314)
Q Consensus 146 ~~~i~H~dlk~~nil~~~~~-----~~kl~dfg~~~ 176 (314)
...++|+|+.+.|+++..++ .+.++||..+.
T Consensus 119 ~~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 119 FNVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred ceEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 45788999999999997543 58899998763
|
subfamily of choline kinases |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=84.79 E-value=2.3 Score=37.24 Aligned_cols=57 Identities=14% Similarity=0.135 Sum_probs=33.6
Q ss_pred cCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC---CCceeeeEeEEEeCCeeEEEEeecCCC
Q 043524 34 SNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS---HDHILKLIGCCLETPIAILVFEYVQHG 105 (314)
Q Consensus 34 ~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~iv~e~~~~g 105 (314)
.+++.+-+|+-..... ..|..|..-|+.|. --.+.+++++...++..++++||++.+
T Consensus 38 ~~~~~~FvK~~~~~~~---------------~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 38 TDGGSYFVKVNSESGR---------------DMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp TTS-EEEEEEEEGGGC---------------CHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred CCCccEEEEecChhhH---------------HHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 5566777776652211 34667888888774 356888888888777889999998765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=83.36 E-value=4.4 Score=35.68 Aligned_cols=68 Identities=9% Similarity=0.008 Sum_probs=46.5
Q ss_pred HHHHHHHHHHhcCCC---CceeeeEeEEEe---CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHH
Q 043524 65 ESCINNVTYAAQMSH---DHILKLIGCCLE---TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANAL 138 (314)
Q Consensus 65 ~~~~~E~~~l~~l~h---~niv~~~~~~~~---~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l 138 (314)
..+.+|...|+.|.- ..+.++++++.. .+..++|||+++++++.+. . ........+..+++.++
T Consensus 52 ~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~~~~-~---------~~~~~~~~l~~~l~~~L 121 (297)
T PRK10593 52 GVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSVEAP-A---------RTPERWEQLKDQIVEGL 121 (297)
T ss_pred hHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEecCCC-C---------CCHHHHHHHHHHHHHHH
Confidence 356789999988853 367888887754 3668999999998777541 0 12233444556677788
Q ss_pred HHhh
Q 043524 139 AYLH 142 (314)
Q Consensus 139 ~~lH 142 (314)
..||
T Consensus 122 a~LH 125 (297)
T PRK10593 122 LAWH 125 (297)
T ss_pred HHHh
Confidence 8888
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=82.34 E-value=3.2 Score=37.06 Aligned_cols=42 Identities=12% Similarity=0.055 Sum_probs=26.3
Q ss_pred HHHHHHHHHHHHHHHHHh-hcCCCCCceeccCCCCCeeecCCC
Q 043524 124 LKRRLKDAVDAANALAYL-HFGFPRPIVFRDFKTSHILFSEEN 165 (314)
Q Consensus 124 ~~~~~~~~~~i~~~l~~l-H~~~~~~i~H~dlk~~nil~~~~~ 165 (314)
.+.++.++.|++.=.-.+ -..+....+|-||||+|||+-...
T Consensus 278 ~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~ 320 (444)
T PHA03111 278 VEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSD 320 (444)
T ss_pred HHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCC
Confidence 345566677874433223 222245689999999999985443
|
|
| >KOG4720 consensus Ethanolamine kinase [Lipid transport and metabolism] | Back alignment and domain information |
|---|
Probab=82.21 E-value=3 Score=36.51 Aligned_cols=35 Identities=31% Similarity=0.375 Sum_probs=29.5
Q ss_pred HHHHHHhcCC-CCceeeeEeEEEeCCeeEEEEeecCCCCH
Q 043524 69 NNVTYAAQMS-HDHILKLIGCCLETPIAILVFEYVQHGTL 107 (314)
Q Consensus 69 ~E~~~l~~l~-h~niv~~~~~~~~~~~~~iv~e~~~~g~L 107 (314)
+|+.....|+ |..-.++++.|..+ +|+||++|.+|
T Consensus 127 ~Ev~afk~L~a~G~ap~Ly~tF~NG----Lvyefi~g~tL 162 (391)
T KOG4720|consen 127 NEVIAFKLLAAYGFAPKLYGTFNNG----LVYEFIQGKTL 162 (391)
T ss_pred HHHHHHHHHHHcCcChhhhheecCc----eEEeeecCccc
Confidence 6777777775 88899999999887 99999998887
|
|
| >COG4499 Predicted membrane protein [Function unknown] | Back alignment and domain information |
|---|
Probab=81.09 E-value=22 Score=32.19 Aligned_cols=125 Identities=13% Similarity=0.103 Sum_probs=72.8
Q ss_pred HHHHHhcCCCCceeeeEeEEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCc
Q 043524 70 NVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPI 149 (314)
Q Consensus 70 E~~~l~~l~h~niv~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i 149 (314)
+..++.. ..|+++.-... +.+.+.|-++....-.-...++ .......++++.+.+..|.-+. +.-
T Consensus 41 ~~~lld~-~~~f~~~eit~--~~Ds~vIsy~i~~~~~~F~~~k--------~~~k~~Klr~a~~~I~~l~e~~----~tr 105 (434)
T COG4499 41 LAELLDK-SPPFIVAEITE--DNDSFVISYPIPEAAKSFASAK--------RKEKTRKLRLALQNIATLSELN----NTR 105 (434)
T ss_pred HHHHhcc-CCCccceeecc--cCceeEEEecCccccchHHHHH--------HHHHHHHHHHHHHHHHHHHHhh----ccc
Confidence 4555665 45566655543 2333334444322211112221 1334445555677777776543 334
Q ss_pred eeccCCCCCeeecCCCceEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchH-HHHHHHHHHHhCCCC
Q 043524 150 VFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVY-SFGAFLSELLTGRGI 228 (314)
Q Consensus 150 ~H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diw-slG~~l~el~~g~~p 228 (314)
.|.=+.|+||+++.++.+.+..+|+-..+++ .=+.|| +.| ++-+++..++.|..+
T Consensus 106 ~~~~laPeNilf~~~l~p~~vH~Glk~~lpP-------------ye~tee-----------~f~~~ykA~~~~~fn~k~~ 161 (434)
T COG4499 106 YTFFLAPENILFDGGLTPFFVHRGLKNSLPP-------------YEMTEE-----------RFLKEYKALAIYAFNGKFS 161 (434)
T ss_pred eeEEecchheEEcCCCceEEEecchhccCCC-------------CCCCHH-----------HHHHHHHHHHHHHHcCCcc
Confidence 5667889999999999999999998543322 113333 555 777888888899998
Q ss_pred ccccc
Q 043524 229 LDLVR 233 (314)
Q Consensus 229 ~~~~~ 233 (314)
|+..-
T Consensus 162 Fe~l~ 166 (434)
T COG4499 162 FESLV 166 (434)
T ss_pred HHHHh
Confidence 86433
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=81.02 E-value=0.84 Score=40.36 Aligned_cols=31 Identities=19% Similarity=0.292 Sum_probs=27.3
Q ss_pred CCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 146 PRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 146 ~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
..+++|+|+.++|++++.++.+.++||..+.
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 4579999999999999988889999998763
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=80.07 E-value=2.6 Score=43.82 Aligned_cols=31 Identities=23% Similarity=0.457 Sum_probs=25.9
Q ss_pred CCCceeccCCCCCeeecCCC--c-eEEcccccce
Q 043524 146 PRPIVFRDFKTSHILFSEEN--V-VKLFDFSLSI 176 (314)
Q Consensus 146 ~~~i~H~dlk~~nil~~~~~--~-~kl~dfg~~~ 176 (314)
..+++|.|+.+.||+++.++ . .-|+|||.+.
T Consensus 202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred CcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 57899999999999998774 3 4599999873
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 314 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-29 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-29 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-24 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-23 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-14 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-14 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-14 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-14 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-12 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-11 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-11 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-11 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-11 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-11 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-10 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-10 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-10 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-10 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-10 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-10 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-10 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-10 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-10 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-10 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-10 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 9e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 9e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 9e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-09 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-09 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-09 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-09 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-09 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-09 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-09 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-09 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-09 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-09 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-09 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-09 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-09 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-09 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-09 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-09 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-09 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-09 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-09 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-09 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-09 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-09 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-09 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-09 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-09 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-09 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-09 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-09 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-09 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-09 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 9e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-08 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-08 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-08 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-08 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-08 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-08 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-08 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-08 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-08 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-08 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-08 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-08 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-08 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-08 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-08 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-08 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-08 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-08 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-08 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-08 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-08 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-08 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-08 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-08 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-08 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-08 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-08 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-08 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-08 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-08 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-08 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-08 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-08 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-08 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-08 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-08 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-08 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-08 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-08 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 9e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-08 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-07 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-07 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-07 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-07 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-07 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-07 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-07 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-07 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-07 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-07 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-07 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-07 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-07 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-07 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-07 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-07 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-07 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-07 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-07 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-07 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-07 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-07 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-07 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-07 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-07 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-07 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-07 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-07 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-07 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-07 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-07 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-07 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-07 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-07 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-07 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-07 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-07 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-07 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-07 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-07 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-07 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 8e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 9e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 9e-07 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 9e-07 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 9e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-06 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-06 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-06 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-06 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-06 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-06 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-06 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-06 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-06 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-06 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-06 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-06 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-06 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-06 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-06 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-06 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-06 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-06 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-06 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-06 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-06 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-06 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-06 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-06 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-06 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-06 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-06 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-06 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-06 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-06 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-06 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-06 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-06 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-06 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-06 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-06 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-06 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-06 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-06 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-06 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-06 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-06 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-06 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 9e-06 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-06 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 9e-06 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 9e-06 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 9e-06 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 9e-06 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-06 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-06 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-05 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-05 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-05 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-05 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-05 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-05 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-05 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-05 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-05 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-05 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-05 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-05 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-05 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-05 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-05 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-05 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-05 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-05 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-05 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-05 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-05 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-05 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-05 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-05 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-05 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-05 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-05 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-05 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-05 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-05 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-05 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-05 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-05 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-05 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-05 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-05 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-05 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-05 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-05 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-05 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-05 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-05 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-05 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-05 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-05 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-05 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-05 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-05 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-05 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-05 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-05 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-05 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-05 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-05 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-05 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-05 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-05 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-05 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-05 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-05 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-05 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-05 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-05 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-05 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-05 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-05 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-05 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-05 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-05 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-05 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-05 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-05 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-05 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-05 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-05 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-05 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-05 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-05 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-05 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-05 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-05 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-05 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-05 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 7e-05 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-05 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-05 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-05 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-05 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-05 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 8e-05 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 8e-05 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-05 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-05 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 8e-05 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-05 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-05 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 8e-05 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 8e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-05 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 8e-05 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-05 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-05 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-05 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 8e-05 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-05 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 8e-05 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 9e-05 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 9e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 9e-05 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-05 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-05 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 9e-05 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 9e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 9e-05 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 9e-05 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 9e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 9e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 9e-05 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-05 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 9e-05 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-04 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-04 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-04 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-04 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-04 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-04 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-04 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-04 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-04 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-04 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-04 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-04 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-04 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-04 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-04 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-04 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-04 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-04 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-04 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-04 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-04 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-04 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-04 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-04 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-04 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-04 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-04 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-04 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-04 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-04 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-04 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-04 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-04 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-04 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-04 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-04 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-04 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-04 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-04 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-04 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-04 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-04 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-04 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-04 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-04 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-04 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-04 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-04 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-04 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-04 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-04 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-04 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-04 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-04 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-04 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-04 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-04 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-04 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-04 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-04 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-04 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-04 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-04 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-04 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-04 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-04 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-04 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-04 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-04 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-04 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-04 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-04 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-04 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-04 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-04 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-04 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-04 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-04 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-04 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-04 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-04 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-04 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-04 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-04 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-04 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-04 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-04 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-04 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-04 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-04 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-04 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-04 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-04 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-04 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-04 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-04 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-04 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-04 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-04 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-04 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-04 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-04 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-04 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-04 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-04 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-04 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-04 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-04 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-04 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-04 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-04 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-04 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-04 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-04 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-04 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-04 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-04 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-04 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-04 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-04 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-04 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-04 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-04 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-04 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-04 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-04 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-04 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-04 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-04 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-04 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-04 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-04 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-04 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-04 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-04 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-04 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-04 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-04 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-04 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-04 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-04 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-04 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-04 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-04 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-04 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-04 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-04 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-04 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-04 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-04 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-04 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-04 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-04 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-04 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-04 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-04 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-04 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-04 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-04 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-04 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-04 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-04 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-04 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-04 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-04 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-04 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-04 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-04 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-04 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-04 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-04 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-04 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-04 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-04 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-04 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-04 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-04 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-04 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-04 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-04 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 7e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 1e-62
Identities = 84/316 (26%), Positives = 136/316 (43%), Gaps = 45/316 (14%)
Query: 22 NGASVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKN-----GF-------------- 62
+ + + ++SS +L++ TNN+D K F
Sbjct: 7 KATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKV 66
Query: 63 -----WHESC------INNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRI 111
ES + + H H++ LIG C E IL+++Y+++G L +
Sbjct: 67 ALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL 126
Query: 112 LGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171
G+ + ++RL+ + AA L YLH I+ RD K+ +IL E V K+ D
Sbjct: 127 YGSDL-PTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITD 182
Query: 172 FSLSISIPEG-ETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILD 230
F +S E +TH++ V GT G++ P+Y +EK DVYSFG L E+L R +
Sbjct: 183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV 242
Query: 231 --LVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLN 288
L R+ +L E+ + + +IVDP + + + L +CL
Sbjct: 243 QSLPREMVNLA----EWAVESHNNGQLEQIVDPNLADKIR----PESLRKFGDTAVKCLA 294
Query: 289 ESPIDRPTMVDVARRL 304
S DRP+M DV +L
Sbjct: 295 LSSEDRPSMGDVLWKL 310
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 1e-59
Identities = 85/294 (28%), Positives = 145/294 (49%), Gaps = 36/294 (12%)
Query: 42 RIFSAQELKQETNNYDQKN-----GFW--HESCINNVTYAA--QMS-------------- 78
+ FS +EL+ ++N+ KN GF ++ + + T A ++
Sbjct: 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTE 77
Query: 79 --------HDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKD 130
H ++L+L G C+ +LV+ Y+ +G++ + P++ PL +R +
Sbjct: 78 VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ-PPLDWPKRQRI 136
Query: 131 AVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVM 190
A+ +A LAYLH I+ RD K ++IL EE + DF L+ + +TH+T V
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 196
Query: 191 GTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF 250
GT GH+AP+Y++T SEK DV+ +G L EL+TG+ DL R A+D +++K
Sbjct: 197 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256
Query: 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRL 304
++ + +VD + + E EQ + + C SP++RP M +V R L
Sbjct: 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALL----CTQSSPMERPKMSEVVRML 306
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 5e-59
Identities = 70/310 (22%), Positives = 131/310 (42%), Gaps = 56/310 (18%)
Query: 42 RIFSAQELKQETNNYDQKNGFWHESCI--------------------------------- 68
FS ELK TNN+D++ + +
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEE 72
Query: 69 ------NNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPL 122
+ A+ H+++++L+G + LV+ Y+ +G+L DR+ T PL
Sbjct: 73 LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT--PPL 130
Query: 123 LLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGE 182
R K A AAN + +LH + RD K+++IL E K+ DF L+ + +
Sbjct: 131 SWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 183 -THITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYP 241
T +T ++GT ++AP+ + + + K D+YSFG L E++TG +D R+ L+
Sbjct: 188 QTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL-- 244
Query: 242 FNEYLKNYFEDNR-FTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDV 300
+ + ++ + + +D + + A + +CL+E RP + V
Sbjct: 245 --DIKEEIEDEEKTIEDYIDKKMND---ADSTS--VEAMYSVASQCLHEKKNKRPDIKKV 297
Query: 301 ARRLRQICCS 310
+ L+++ S
Sbjct: 298 QQLLQEMTAS 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-43
Identities = 55/255 (21%), Positives = 96/255 (37%), Gaps = 33/255 (12%)
Query: 75 AQMSHDHILKLIGCCLETPIA----ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKD 130
M H++IL+ IG L+ + + G+L D + +
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL------KANVVSWNELCHI 126
Query: 131 AVDAANALAYLH------FGFPRP-IVFRDFKTSHILFSEENVVKLFDFSLSISIPEGET 183
A A LAYLH +P I RD K+ ++L + DF L++ G++
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 184 HI-TDTVMGTYGHLAPQYV-----TTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHD 237
T +GT ++AP+ + D ++D+Y+ G L EL + D D +
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 238 LVYPFNEYLKNYFEDNRFTEIV-----DPIIVQDLSCTEKEQQLHASAQLTFECLNESPI 292
L PF E + + E+V P++ +K + + EC +
Sbjct: 247 L--PFEEEIGQHPSLEDMQEVVVHKKKRPVL---RDYWQKHAGMAMLCETIEECWDHDAE 301
Query: 293 DRPTMVDVARRLRQI 307
R + V R+ Q+
Sbjct: 302 ARLSAGCVGERITQM 316
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 6e-34
Identities = 46/270 (17%), Positives = 88/270 (32%), Gaps = 53/270 (19%)
Query: 49 LKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAIL--VFEYVQHGT 106
LK + + F E SH ++L ++G C P + ++ +G+
Sbjct: 41 LKVRDWSTRKSRDFNEE-----CPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGS 95
Query: 107 LWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENV 166
L++ + + + +K A+D A +A+LH I + ++ E+
Sbjct: 96 LYNVLHEGTN---FVVDQSQAVKFALDMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMT 151
Query: 167 VKLFDFSLSISIPEGETHITDTVMGTYGHLAP---QYVTTCDFSEKLDVYSFGAFLSELL 223
++ + S M +AP Q D++SF L EL+
Sbjct: 152 ARISMADVKFSFQSP------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELV 205
Query: 224 TGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDL------SCTEKEQQLH 277
T PF + EI + ++ L +
Sbjct: 206 TRE-------------VPFADL--------SNMEIGMKVALEGLRPTIPPGISP------ 238
Query: 278 ASAQLTFECLNESPIDRPTMVDVARRLRQI 307
++L C+NE P RP + L ++
Sbjct: 239 HVSKLMKICMNEDPAKRPKFDMIVPILEKM 268
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 8e-34
Identities = 54/294 (18%), Positives = 106/294 (36%), Gaps = 48/294 (16%)
Query: 43 IFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAI----LV 98
+F E ++ E+ I M H++IL I ++ + L+
Sbjct: 67 VFFTTEEAS----------WFRETEIYQT---VLMRHENILGFIAADIKGTGSWTQLYLI 113
Query: 99 FEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPR-----PIVFRD 153
+Y ++G+L+D + L K LK A + + L +LH I RD
Sbjct: 114 TDYHENGSLYDYL------KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRD 167
Query: 154 FKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVM---GTYGHLAP------QYVTTC 204
K+ +IL + + D L++ + GT ++ P
Sbjct: 168 LKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHF 227
Query: 205 DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIV 264
D+YSFG L E+ +V + P+++ + D + ++ + + +
Sbjct: 228 QSYIMADMYSFGLILWEVARRCVSGGIVE---EYQLPYHDLV---PSDPSYEDMREIVCI 281
Query: 265 QDL-----SCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSLSC 313
+ L + ++ L +L EC +P R T + V + L ++ S
Sbjct: 282 KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDI 335
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 7e-33
Identities = 57/266 (21%), Positives = 109/266 (40%), Gaps = 40/266 (15%)
Query: 49 LKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLW 108
L Q F +E V + H +IL +G +AI V ++ + +L+
Sbjct: 54 LNVTAPTPQQLQAFKNE-----VGVLRKTRHVNILLFMGYSTAPQLAI-VTQWCEGSSLY 107
Query: 109 DRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVK 168
+ +K+ + A A + YLH + I+ RD K+++I E+N VK
Sbjct: 108 HHL----HASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVK 160
Query: 169 LFDFSLS-ISIPEGETHITDTVMGTYGHLAP---QYVTTCDFSEKLDVYSFGAFLSELLT 224
+ DF L+ +H + + G+ +AP + + +S + DVY+FG L EL+T
Sbjct: 161 IGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMT 220
Query: 225 GRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHAS---AQ 281
G+ P++ N +I++ + LS + + + +
Sbjct: 221 GQ-------------LPYSNI-------NNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKR 260
Query: 282 LTFECLNESPIDRPTMVDVARRLRQI 307
L ECL + +RP+ + + ++
Sbjct: 261 LMAECLKKKRDERPSFPRILAEIEEL 286
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 9e-33
Identities = 62/265 (23%), Positives = 103/265 (38%), Gaps = 42/265 (15%)
Query: 49 LKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLW 108
L ++ + ++ N F E V ++ H +I+ +G + P +V EY+ G+L+
Sbjct: 68 LMEQDFHAERVNEFLRE-----VAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY 122
Query: 109 DRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVK 168
+L L +RRL A D A + YLH PIV R+ K+ ++L ++ VK
Sbjct: 123 R-LLHKSGARE-QLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVK 179
Query: 169 LFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGI 228
+ DF LS + GT +AP+ + +EK DVYSFG L EL T +
Sbjct: 180 VCDFGLSRLKASTFLSSK-SAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ-- 236
Query: 229 LDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDL------SCTEKEQQLHASAQL 282
P+ ++V + + + A +
Sbjct: 237 -----------QPWGNL--------NPAQVVAAVGFKCKRLEIPRNLNP------QVAAI 271
Query: 283 TFECLNESPIDRPTMVDVARRLRQI 307
C P RP+ + LR +
Sbjct: 272 IEGCWTNEPWKRPSFATIMDLLRPL 296
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-32
Identities = 56/288 (19%), Positives = 111/288 (38%), Gaps = 48/288 (16%)
Query: 43 IFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAI----LV 98
IFS++E + ++ E+ I + H++IL I + LV
Sbjct: 72 IFSSREERS----------WFREAEIYQT---VMLRHENILGFIAADNKDNGTWTQLWLV 118
Query: 99 FEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPR-----PIVFRD 153
+Y +HG+L+D + + + ++ +K A+ A+ LA+LH I RD
Sbjct: 119 SDYHEHGSLFDYL------NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRD 172
Query: 154 FKTSHILFSEENVVKLFDFSLSISIPEGETHITD---TVMGTYGHLAP------QYVTTC 204
K+ +IL + + D L++ I +GT ++AP +
Sbjct: 173 LKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHF 232
Query: 205 DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIV 264
+ ++ D+Y+ G E+ I + D P+ + + D E+ +
Sbjct: 233 ESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ---LPYYDLVP---SDPSVEEMRKVVCE 286
Query: 265 QDL-----SCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQI 307
Q L + + + L A++ EC + R T + + + L Q+
Sbjct: 287 QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-32
Identities = 62/260 (23%), Positives = 99/260 (38%), Gaps = 55/260 (21%)
Query: 62 FWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEP 121
E A + H +I+ L G CL+ P LV E+ + G L + +
Sbjct: 53 VRQE-----AKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL------SGKR 101
Query: 122 LLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEE--------NVVKLFDFS 173
+ + AV A + YLH PI+ RD K+S+IL ++ ++K+ DF
Sbjct: 102 IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161
Query: 174 LSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVR 233
L+ + G Y +AP+ + FS+ DV+S+G L ELLTG
Sbjct: 162 LAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE------- 211
Query: 234 DAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDL------SCTEKEQQLHASAQLTFECL 287
PF + + + L +C E A+L +C
Sbjct: 212 ------VPFRGI--------DGLAVAYGVAMNKLALPIPSTCPE------PFAKLMEDCW 251
Query: 288 NESPIDRPTMVDVARRLRQI 307
N P RP+ ++ +L I
Sbjct: 252 NPDPHSRPSFTNILDQLTTI 271
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-32
Identities = 52/296 (17%), Positives = 94/296 (31%), Gaps = 53/296 (17%)
Query: 43 IFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAI-----L 97
+FS + F +E I V M HD+I + I L
Sbjct: 43 VFSFAN----------RQNFINEKNIYRV---PLMEHDNIARFIVGDERVTADGRMEYLL 89
Query: 98 VFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPR------PIVF 151
V EY +G+L + + A LAYLH PR I
Sbjct: 90 VMEYYPNGSLXKYL------SLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISH 143
Query: 152 RDFKTSHILFSEENVVKLFDFSLS-------ISIPEGETHITDTVMGTYGHLAP------ 198
RD + ++L + + DF LS + P E + + +GT ++AP
Sbjct: 144 RDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGA 203
Query: 199 -QYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTE 257
+++D+Y+ G E+ L + F + N F +
Sbjct: 204 VNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGN---HPTFED 260
Query: 258 IVDPIIVQDL------SCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQI 307
+ + + + E + + + +C ++ R T R+ ++
Sbjct: 261 MQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-31
Identities = 59/261 (22%), Positives = 111/261 (42%), Gaps = 42/261 (16%)
Query: 57 DQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQ 116
++ F E + ++++H +I+KL G CL P+ + V EY + G+L++ + GA
Sbjct: 43 SERKAFIVE-----LRQLSRVNHPNIVKLYGACLN-PVCL-VMEYAEGGSLYNVLHGAEP 95
Query: 117 THFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN-VVKLFDFSLS 175
+ + + +AYLH P+ ++ RD K ++L V+K+ DF +
Sbjct: 96 L--PYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 153
Query: 176 ISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR----GILDL 231
I +TH+T+ G+ +AP+ ++SEK DV+S+G L E++T R I
Sbjct: 154 CDI---QTHMTNNK-GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP 209
Query: 232 VRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESP 291
V R P ++++L L C ++ P
Sbjct: 210 AFRIMWAV----------HNGTR------PPLIKNLP--------KPIESLMTRCWSKDP 245
Query: 292 IDRPTMVDVARRLRQICCSLS 312
RP+M ++ + + +
Sbjct: 246 SQRPSMEEIVKIMTHLMRYFP 266
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-31
Identities = 59/288 (20%), Positives = 114/288 (39%), Gaps = 48/288 (16%)
Query: 43 IFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAI----LV 98
IFS+++ K ++ E+ + N + H++IL I + + + L+
Sbjct: 38 IFSSRDEKS----------WFRETELYNT---VMLRHENILGFIASDMTSRHSSTQLWLI 84
Query: 99 FEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLH-----FGFPRPIVFRD 153
Y + G+L+D + L L+ + A+ LA+LH I RD
Sbjct: 85 THYHEMGSLYDYL------QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRD 138
Query: 154 FKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVM---GTYGHLAP------QYVTTC 204
K+ +IL + + D L++ + + GT ++AP V
Sbjct: 139 LKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCF 198
Query: 205 DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIV 264
D +++D+++FG L E+ +V D PF + + N D F ++ + V
Sbjct: 199 DSYKRVDIWAFGLVLWEVARRMVSNGIVE---DYKPPFYDVVPN---DPSFEDMRKVVCV 252
Query: 265 QDL-----SCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQI 307
+ + L + A+L EC ++P R T + + + L +I
Sbjct: 253 DQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-31
Identities = 60/278 (21%), Positives = 107/278 (38%), Gaps = 54/278 (19%)
Query: 43 IFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYV 102
+ + ET ++ F E V + ++H +I+KL G P +V E+V
Sbjct: 51 SLILGDSEGETEMIEKFQEFQRE-----VFIMSNLNHPNIVKLYGLMHNPPR--MVMEFV 103
Query: 103 QHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFS 162
G L+ R+L P+ +L+ +D A + Y+ PIV RD ++ +I
Sbjct: 104 PCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQ 158
Query: 163 EEN-----VVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCD--FSEKLDVYSF 215
+ K+ DF LS + H ++G + +AP+ + + ++EK D YSF
Sbjct: 159 SLDENAPVCAKVADFGLS----QQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSF 214
Query: 216 GAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDL------SC 269
L +LTG PF+EY + ++ I + L C
Sbjct: 215 AMILYTILTGE-------------GPFDEY------SYGKIKFINMIREEGLRPTIPEDC 255
Query: 270 TEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQI 307
+ + C + P RP + + L ++
Sbjct: 256 PPR------LRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-29
Identities = 55/250 (22%), Positives = 94/250 (37%), Gaps = 40/250 (16%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAA 135
+ H ++LK IG + + EY++ GTL I ++ +R+ A D A
Sbjct: 63 CLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGII----KSMDSQYPWSQRVSFAKDIA 118
Query: 136 NALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITD-------- 187
+ +AYLH I+ RD + + L E V + DF L+ + + +T
Sbjct: 119 SGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPD 175
Query: 188 -----TVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPF 242
TV+G +AP+ + + EK+DV+SFG L E++ +A P
Sbjct: 176 RKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGR-------VNADPDYLPR 228
Query: 243 NEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302
D + C + +T C + P RP+ V +
Sbjct: 229 TMDFGLNVRGFL-----DRYCPPN--CPP------SFFPITVRCCDLDPEKRPSFVKLEH 275
Query: 303 RLRQICCSLS 312
L + L+
Sbjct: 276 WLETLRMHLA 285
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 6e-29
Identities = 46/280 (16%), Positives = 94/280 (33%), Gaps = 63/280 (22%)
Query: 49 LKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLW 108
+ E +N DQ F E V Q H++++ +G C+ P ++ + TL+
Sbjct: 63 IDIERDNEDQLKAFKRE-----VMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLY 117
Query: 109 DRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVK 168
+ + L + + + A + + YLH + I+ +D K+ ++ + + V
Sbjct: 118 SVV----RDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFY-DNGKVV 169
Query: 169 LFDFSLSISIPEGETHITDTVM----GTYGHLAPQYVTTCD---------FSEKLDVYSF 215
+ DF L + + + G HLAP+ + FS+ DV++
Sbjct: 170 ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFAL 229
Query: 216 GAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVD--------PIIVQDL 267
G EL +P F+ I+ + +
Sbjct: 230 GTIWYELHARE-------------WP--------FKTQPAEAIIWQMGTGMKPNLS--QI 266
Query: 268 SCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQI 307
+ + + C +RPT + L ++
Sbjct: 267 GMGK------EISDILLFCWAFEQEERPTFTKLMDMLEKL 300
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 8e-19
Identities = 59/248 (23%), Positives = 93/248 (37%), Gaps = 59/248 (23%)
Query: 76 QMSHDHILKLIG-CCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA 134
Q SH +I++LIG C + PI I V E VQ G + +T L +K L+ DA
Sbjct: 168 QYSHPNIVRLIGVCTQKQPIYI-VMELVQGGDFLTFL----RTEGARLRVKTLLQMVGDA 222
Query: 135 ANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYG 194
A + YL + + RD + L +E+NV+K+ DF +S +G G
Sbjct: 223 AAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY----AASGGLR 275
Query: 195 HL-----APQYVTTCDFSEKLDVYSFGAFLSELLT-GRG---------ILDLVRDAHDLV 239
+ AP+ + +S + DV+SFG L E + G + V L
Sbjct: 276 QVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLP 335
Query: 240 YPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVD 299
P C + + +L +C P RP+
Sbjct: 336 CPEL-------------------------CPDA---VF---RLMEQCWAYEPGQRPSFST 364
Query: 300 VARRLRQI 307
+ + L+ I
Sbjct: 365 IYQELQSI 372
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 4e-18
Identities = 59/274 (21%), Positives = 107/274 (39%), Gaps = 44/274 (16%)
Query: 49 LKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET---PIAILVFEYVQHG 105
LK E+ + E I + H++I+K G C E I + + E++ G
Sbjct: 58 LKPESGG-NHIADLKKEIEI-----LRNLYHENIVKYKGICTEDGGNGIKL-IMEFLPSG 110
Query: 106 TLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN 165
+L + + + + LK++LK AV + YL R V RD ++L E+
Sbjct: 111 SLKEYL----PKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEH 163
Query: 166 VVKLFDFSLSISIPEGETHITDTVMG------TYGHLAPQYVTTCDFSEKLDVYSFGAFL 219
VK+ DF L+ +I + + T AP+ + F DV+SFG L
Sbjct: 164 QVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY----APECLMQSKFYIASDVWSFGVTL 219
Query: 220 SELLT-GRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQD---LSCTEK-EQ 274
ELLT + ++ P + + T +V+ +++ L C
Sbjct: 220 HELLTYCDSDSSPMALFLKMIGPTHGQMTV-------TRLVN--TLKEGKRLPCPPNCPD 270
Query: 275 QLHASAQLTFECLNESPIDRPTMVDVARRLRQIC 308
+++ QL +C P +R + ++ +
Sbjct: 271 EVY---QLMRKCWEFQPSNRTSFQNLIEGFEALL 301
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-17
Identities = 51/159 (32%), Positives = 78/159 (49%), Gaps = 14/159 (8%)
Query: 74 AAQMSHDHILKL--IGC--CLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLK 129
AA ++H I+ + G P+ +V EYV TL D + T P+ KR ++
Sbjct: 66 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV----HTEG-PMTPKRAIE 120
Query: 130 DAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDT- 188
DA AL + H I+ RD K ++I+ S N VK+ DF ++ +I + +T T
Sbjct: 121 VIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 189 -VMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
V+GT +L+P+ + DVYS G L E+LTG
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 3e-17
Identities = 45/150 (30%), Positives = 69/150 (46%), Gaps = 9/150 (6%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKD-AVDA 134
++ H+ +++L E PI I V EY+ G+L D + + L +L D A
Sbjct: 318 KLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFL----KGETGKYLRLPQLVDMAAQI 372
Query: 135 ANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYG 194
A+ +AY+ V RD + ++IL E V K+ DF L+ I + E
Sbjct: 373 ASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 429
Query: 195 HLAPQYVTTCDFSEKLDVYSFGAFLSELLT 224
AP+ F+ K DV+SFG L+EL T
Sbjct: 430 WTAPEAALYGRFTIKSDVWSFGILLTELTT 459
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-17
Identities = 43/153 (28%), Positives = 73/153 (47%), Gaps = 8/153 (5%)
Query: 74 AAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVD 133
++Q+SH +I+ +I E LV EY++ TL + I ++H PL + +
Sbjct: 65 SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI----ESHG-PLSVDTAINFTNQ 119
Query: 134 AANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTY 193
+ + + H IV RD K +IL +K+FDF ++ ++ E T+ V+GT
Sbjct: 120 ILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTV 176
Query: 194 GHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
+ +P+ E D+YS G L E+L G
Sbjct: 177 QYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE 209
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 4e-17
Identities = 45/150 (30%), Positives = 69/150 (46%), Gaps = 9/150 (6%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKD-AVDA 134
++ H+ +++L E PI I V EY+ G+L D + + L +L D A
Sbjct: 235 KLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFL----KGETGKYLRLPQLVDMAAQI 289
Query: 135 ANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYG 194
A+ +AY+ V RD + ++IL E V K+ DF L+ I + E
Sbjct: 290 ASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 346
Query: 195 HLAPQYVTTCDFSEKLDVYSFGAFLSELLT 224
AP+ F+ K DV+SFG L+EL T
Sbjct: 347 WTAPEAALYGRFTIKSDVWSFGILLTELTT 376
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 79.2 bits (195), Expect = 7e-17
Identities = 28/199 (14%), Positives = 59/199 (29%), Gaps = 22/199 (11%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAA 135
+K L ++LV E +GTL + I T + + + A+
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182
Query: 136 NALAYLHFGFPRPIVFRDFKTSHILFSEENV-----------VKLFDFSLSI---SIPEG 181
+ +H I+ D K + + + + L D SI P+G
Sbjct: 183 YMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239
Query: 182 ETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYP 241
T G + ++ ++ ++D + A + +L G +
Sbjct: 240 TIFTAKC--ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKV---KNEGGECK 294
Query: 242 FNEYLKNYFEDNRFTEIVD 260
+ + + E
Sbjct: 295 PEGLFRRLPHLDMWNEFFH 313
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 8e-17
Identities = 51/258 (19%), Positives = 88/258 (34%), Gaps = 39/258 (15%)
Query: 65 ESCINNVTYAAQMSHDHILKLIGCCLETP----IAILVFEYVQHGTLWDRILGAPQTHFE 120
E +H +IL+L+ CL A L+ + + GTLW+ I
Sbjct: 71 EEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKG-N 129
Query: 121 PLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF-SLSISIP 179
L + L + L +H + RD K ++IL +E L D S++ +
Sbjct: 130 FLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI 186
Query: 180 EGETHIT-------DTVMGTYGHLAPQYVTT---CDFSEKLDVYSFGAFLSELLTGRGIL 229
E T + AP+ + C E+ DV+S G L ++ G G
Sbjct: 187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG-- 244
Query: 230 DLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNE 289
P++ + + V + LS + + A QL +
Sbjct: 245 -----------PYD-------MVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTV 286
Query: 290 SPIDRPTMVDVARRLRQI 307
P RP + + +L +
Sbjct: 287 DPHQRPHIPLLLSQLEAL 304
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 1e-16
Identities = 37/160 (23%), Positives = 63/160 (39%), Gaps = 26/160 (16%)
Query: 74 AAQMSHDHILKLI-----GCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRL 128
A++ H I+++ P+ +V EYV +L L + +
Sbjct: 133 LAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-------KLPVAEAI 185
Query: 129 KDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDT 188
++ AL+YLH +V+ D K +I+ +EE + KL D + I
Sbjct: 186 AYLLEILPALSYLH---SIGLVYNDLKPENIMLTEEQL-KLIDLGAV-------SRINSF 234
Query: 189 --VMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
+ GT G AP+ V T + D+Y+ G L+ L
Sbjct: 235 GYLYGTPGFQAPEIVRT-GPTVATDIYTVGRTLAALTLDL 273
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-16
Identities = 42/251 (16%), Positives = 84/251 (33%), Gaps = 64/251 (25%)
Query: 75 AQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA 134
A + + H+ +L+G CL + + + + + + G L D + + H + + + L V
Sbjct: 72 ASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQI 126
Query: 135 ANALAYL---HFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMG 191
A + YL V RD ++L VK+ DF L+ + E
Sbjct: 127 AKGMNYLEDRRL------VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE----KEYHA 176
Query: 192 TYGHL-----APQYVTTCDFSEKLDVYSFGAFLSELLT----------GRGILDLVRDAH 236
G + A + + ++ + DV+S+G + EL+T I ++
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 236
Query: 237 DLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPT 296
L P CT ++ + +C RP
Sbjct: 237 RLPQPPI-------------------------CTI---DVY---MIMRKCWMIDADSRPK 265
Query: 297 MVDVARRLRQI 307
++ ++
Sbjct: 266 FRELIIEFSKM 276
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-16
Identities = 50/185 (27%), Positives = 77/185 (41%), Gaps = 28/185 (15%)
Query: 49 LKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET---PIAILVFEYVQHG 105
L+ T + F E I + HD+I+K G C + + + EY+ +G
Sbjct: 47 LQHSTE--EHLRDFEREIEI-----LKSLQHDNIVKYKGVCYSAGRRNLKL-IMEYLPYG 98
Query: 106 TLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN 165
+L D + Q H E + + L+ + YL + + RD T +IL EN
Sbjct: 99 SLRDYL----QKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENEN 151
Query: 166 VVKLFDFSLSISIPEGETHITDTVMG------TYGHLAPQYVTTCDFSEKLDVYSFGAFL 219
VK+ DF L+ +P+ + G AP+ +T FS DV+SFG L
Sbjct: 152 RVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY----APESLTESKFSVASDVWSFGVVL 207
Query: 220 SELLT 224
EL T
Sbjct: 208 YELFT 212
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-16
Identities = 50/185 (27%), Positives = 78/185 (42%), Gaps = 28/185 (15%)
Query: 49 LKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET---PIAILVFEYVQHG 105
L+ T + F E I + HD+I+K G C + + + EY+ +G
Sbjct: 78 LQHSTE--EHLRDFEREIEI-----LKSLQHDNIVKYKGVCYSAGRRNLKL-IMEYLPYG 129
Query: 106 TLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN 165
+L D + Q H E + + L+ + YL + + RD T +IL EN
Sbjct: 130 SLRDYL----QKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENEN 182
Query: 166 VVKLFDFSLSISIPEGETHITDTVMG------TYGHLAPQYVTTCDFSEKLDVYSFGAFL 219
VK+ DF L+ +P+ + + G AP+ +T FS DV+SFG L
Sbjct: 183 RVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY----APESLTESKFSVASDVWSFGVVL 238
Query: 220 SELLT 224
EL T
Sbjct: 239 YELFT 243
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-16
Identities = 41/163 (25%), Positives = 72/163 (44%), Gaps = 9/163 (5%)
Query: 65 ESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHF-EPLL 123
E V A M H +I++ E +V +Y + G L+ RI F E +
Sbjct: 68 EESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI 127
Query: 124 LKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGET 183
L V AL ++H R I+ RD K+ +I +++ V+L DF ++ +
Sbjct: 128 LDW----FVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTV 179
Query: 184 HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
+ +GT +L+P+ ++ K D+++ G L EL T +
Sbjct: 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLK 222
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-16
Identities = 31/157 (19%), Positives = 58/157 (36%), Gaps = 16/157 (10%)
Query: 74 AAQMSHDHILKL--IGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDA 131
A ++ H++ + G + + L + PL R +
Sbjct: 88 AGRLQEPHVVPIHDFGE--IDGQLYVDMRLINGVDLAAML-----RRQGPLAPPRAVAIV 140
Query: 132 VDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDT--V 189
+AL H RD K +IL S ++ L DF ++ + + +T
Sbjct: 141 RQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQLGNT 195
Query: 190 MGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
+GT ++AP+ + + + D+Y+ L E LTG
Sbjct: 196 VGTLYYMAPERFSESHATYRADIYALTCVLYECLTGS 232
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-16
Identities = 51/283 (18%), Positives = 92/283 (32%), Gaps = 71/283 (25%)
Query: 49 LKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLW 108
LK E N+ K+ E+ + Q+ + +I+++IG C + V E + G L
Sbjct: 52 LKNEANDPALKDELLAEANV-----MQQLDNPYIVRMIGICEAESWML-VMEMAELGPLN 105
Query: 109 DRILGAPQTHFEPLLLKRRLKDAVDAANALAYL---HFGFPRPIVFRDFKTSHILFSEEN 165
+ + ++ + + YL +F V RD ++L ++
Sbjct: 106 KYLQQNRHVKDKNIIEL-----VHQVSMGMKYLEESNF------VHRDLAARNVLLVTQH 154
Query: 166 VVKLFDFSLSISIPEGETHITDTVMG------TYGHLAPQYVTTCDFSEKLDVYSFGAFL 219
K+ DF LS ++ E + G AP+ + FS K DV+SFG +
Sbjct: 155 YAKISDFGLSKALRADENYYKAQTHGKWPVKWY----APECINYYKFSSKSDVWSFGVLM 210
Query: 220 SELLT----------GRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSC 269
E + G + ++ + P C
Sbjct: 211 WEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAG-------------------------C 245
Query: 270 TEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSLS 312
+++ L C +RP V RLR +
Sbjct: 246 PR---EMY---DLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-15
Identities = 56/288 (19%), Positives = 114/288 (39%), Gaps = 70/288 (24%)
Query: 49 LKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET-----PIAILVFEYVQ 103
+K + ++ + F E+ SH ++++L+G C+E P +++ +++
Sbjct: 70 MKLDNSSQREIEEFLSEAAC-----MKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMK 124
Query: 104 HGTLWDRILGA-PQTHFEPLLLKRRLKDAVDAANALAYL---HFGFPRPIVFRDFKTSHI 159
+G L +L + +T + + L+ LK VD A + YL +F + RD +
Sbjct: 125 YGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNF------LHRDLAARNC 178
Query: 160 LFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHL-----APQYVTTCDFSEKLDVYS 214
+ ++ V + DF LS I G+ + G + A + + ++ K DV++
Sbjct: 179 MLRDDMTVCVADFGLSKKIYSGDYY----RQGRIAKMPVKWIAIESLADRVYTSKSDVWA 234
Query: 215 FGAFLSELLT----------GRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIV 264
FG + E+ T + D + H L P +
Sbjct: 235 FGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPED--------------------- 273
Query: 265 QDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSLS 312
C + +L+ ++ + C P+DRPT + +L ++ SL
Sbjct: 274 ----CLD---ELY---EIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-15
Identities = 55/254 (21%), Positives = 89/254 (35%), Gaps = 50/254 (19%)
Query: 75 AQMSHDHILKLIGCCLET---PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDA 131
+ D I+K G + + V EY+ G L D + Q H L R L +
Sbjct: 79 KALHSDFIVKYRGVSYGPGRQSLRL-VMEYLPSGCLRDFL----QRHRARLDASRLLLYS 133
Query: 132 VDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMG 191
+ YL R V RD +IL E VK+ DF L+ +P + + +
Sbjct: 134 SQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV---VR 187
Query: 192 TYGHL-----APQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEY 245
G AP+ ++ FS + DV+SFG L EL T +
Sbjct: 188 EPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCD-------------KSCSPS 234
Query: 246 LKNYFEDNRFTEIVDPIIVQDL-----------SCTEKEQQLHASAQLTFECLNESPIDR 294
+ ++ + +L +C ++H +L C SP DR
Sbjct: 235 AEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPA---EVH---ELMKLCWAPSPQDR 288
Query: 295 PTMVDVARRLRQIC 308
P+ + +L +
Sbjct: 289 PSFSALGPQLDMLW 302
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 59/251 (23%), Positives = 87/251 (34%), Gaps = 65/251 (25%)
Query: 75 AQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA 134
Q H HI+KLIG E P+ I + E G L + Q L L + A
Sbjct: 446 RQFDHPHIVKLIGVITENPVWI-IMELCTLGELRSFL----QVRKFSLDLASLILYAYQL 500
Query: 135 ANALAYL---HFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMG 191
+ ALAYL F V RD ++L S + VKL DF LS + + +
Sbjct: 501 STALAYLESKRF------VHRDIAARNVLVSSNDCVKLGDFGLSRYMED-----STYYKA 549
Query: 192 TYGHL-----APQYVTTCDFSEKLDVYSFGAFLSELLT----------GRGILDLVRDAH 236
+ G L AP+ + F+ DV+ FG + E+L ++ + +
Sbjct: 550 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE 609
Query: 237 DLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPT 296
L P N C L+ L +C P RP
Sbjct: 610 RLPMPPN-------------------------CPP---TLY---SLMTKCWAYDPSRRPR 638
Query: 297 MVDVARRLRQI 307
++ +L I
Sbjct: 639 FTELKAQLSTI 649
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 2e-15
Identities = 37/150 (24%), Positives = 68/150 (45%), Gaps = 8/150 (5%)
Query: 76 QMSHDHILKLIGCCLET-PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA 134
++ H ++++L+G C P I + E++ +G L D + + ++L L A
Sbjct: 272 EIKHPNLVQLLGVCTREPPFYI-ITEFMTYGNLLDYLRECNRQEVSAVVL---LYMATQI 327
Query: 135 ANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYG 194
++A+ YL + + R+ + L E ++VK+ DF LS +
Sbjct: 328 SSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 384
Query: 195 HLAPQYVTTCDFSEKLDVYSFGAFLSELLT 224
AP+ + FS K DV++FG L E+ T
Sbjct: 385 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-15
Identities = 57/289 (19%), Positives = 104/289 (35%), Gaps = 71/289 (24%)
Query: 49 LKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE------TPIAILVFEYV 102
LK + F E+ + H H+ KL+G L PI +++ ++
Sbjct: 59 LKADIIASSDIEEFLREAAC-----MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFM 113
Query: 103 QHGTLWDRILGA-PQTHFEPLLLKRRLKDAVDAANALAYL---HFGFPRPIVFRDFKTSH 158
+HG L +L + + L L+ ++ VD A + YL +F + RD +
Sbjct: 114 KHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNF------IHRDLAARN 167
Query: 159 ILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHL-----APQYVTTCDFSEKLDVY 213
+ +E+ V + DF LS I G+ + G L A + + ++ DV+
Sbjct: 168 CMLAEDMTVCVADFGLSRKIYSGDYY----RQGCASKLPVKWLALESLADNLYTVHSDVW 223
Query: 214 SFGAFLSELLT----------GRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPII 263
+FG + E++T I + + + L P
Sbjct: 224 AFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPE-------------------- 263
Query: 264 VQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSLS 312
C E +++ L ++C + P RP+ + L I LS
Sbjct: 264 -----CME---EVY---DLMYQCWSADPKQRPSFTCLRMELENILGHLS 301
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-15
Identities = 37/166 (22%), Positives = 71/166 (42%), Gaps = 6/166 (3%)
Query: 65 ESCINNVTYAAQMSHDHILKLIGCCLETPIAIL--VFEYVQHGTLWDRILGAPQTHFEPL 122
+ ++ V ++ H +I++ ++ L V EY + G L I + + L
Sbjct: 50 QMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER-QYL 108
Query: 123 LLKRRLKDAVDAANALAYLH--FGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPE 180
+ L+ AL H ++ RD K +++ + VKL DF L+ +
Sbjct: 109 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-N 167
Query: 181 GETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
+T T +GT +++P+ + ++EK D++S G L EL
Sbjct: 168 HDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM 213
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-15
Identities = 50/253 (19%), Positives = 94/253 (37%), Gaps = 60/253 (23%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWD-----RILGAPQTHFEPLLLKRRLKD 130
+ + H+++L+G + +++ E + G L R A P L + ++
Sbjct: 84 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 143
Query: 131 AVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVM 190
A + A+ +AYL+ V RD + + +E+ VK+ DF ++ I E +
Sbjct: 144 AGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY----YRK 196
Query: 191 GTYGHL-----APQYVTTCDFSEKLDVYSFGAFLSELLTGRG-----------ILDLVRD 234
G G L +P+ + F+ DV+SFG L E+ T +L V +
Sbjct: 197 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-LAEQPYQGLSNEQVLRFVME 255
Query: 235 AHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDR 294
L P N C + L +L C +P R
Sbjct: 256 GGLLDKPDN-------------------------CPD---MLF---ELMRMCWQYNPKMR 284
Query: 295 PTMVDVARRLRQI 307
P+ +++ +++
Sbjct: 285 PSFLEIISSIKEE 297
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-15
Identities = 40/157 (25%), Positives = 65/157 (41%), Gaps = 24/157 (15%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAA 135
+ H HI+KLIG E P I + E +G L + + + L + + ++
Sbjct: 69 NLDHPHIVKLIGIIEEEPTWI-IMELYPYGELGHYL----ERNKNSLKVLTLVLYSLQIC 123
Query: 136 NALAYL---HFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGT 192
A+AYL + V RD +IL + VKL DF LS I + D +
Sbjct: 124 KAMAYLESINC------VHRDIAVRNILVASPECVKLGDFGLSRYIED-----EDYYKAS 172
Query: 193 YGHL-----APQYVTTCDFSEKLDVYSFGAFLSELLT 224
L +P+ + F+ DV+ F + E+L+
Sbjct: 173 VTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS 209
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-15
Identities = 55/256 (21%), Positives = 88/256 (34%), Gaps = 62/256 (24%)
Query: 76 QMSHDHILKLIGCCLET-PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA 134
++H ++L LIG L + ++ Y+ HG L I ++ +K + +
Sbjct: 78 GLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI----RSPQRNPTVKDLISFGLQV 133
Query: 135 ANALAYL---HFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMG 191
A + YL F V RD + + E VK+ DF L+ I + E
Sbjct: 134 ARGMEYLAEQKF------VHRDLAARNCMLDESFTVKVADFGLARDILDRE--YYSVQQH 185
Query: 192 TYGHL-----APQYVTTCDFSEKLDVYSFGAFLSELLT----------GRGILDLVRDAH 236
+ L A + + T F+ K DV+SFG L ELLT + +
Sbjct: 186 RHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR 245
Query: 237 DLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPT 296
L P C + L+ Q+ +C P RPT
Sbjct: 246 RLPQPEY-------------------------CPD---SLY---QVMQQCWEADPAVRPT 274
Query: 297 MVDVARRLRQICCSLS 312
+ + QI +L
Sbjct: 275 FRVLVGEVEQIVSALL 290
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-15
Identities = 57/247 (23%), Positives = 93/247 (37%), Gaps = 40/247 (16%)
Query: 75 AQMSHDHILKLIGCCLET---PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDA 131
+ H+HI+K GCC + + + V EYV G+L D + H + L + L A
Sbjct: 88 RTLYHEHIIKYKGCCEDAGAASLQL-VMEYVPLGSLRDYL----PRH--SIGLAQLLLFA 140
Query: 132 VDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMG 191
+AYLH + + RD ++L + +VK+ DF L+ ++PEG + +
Sbjct: 141 QQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR---VR 194
Query: 192 TYGHL-----APQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLV---YP- 241
G AP+ + F DV+SFG L ELLT +L+
Sbjct: 195 EDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQ 254
Query: 242 -FNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDV 300
L E + C +++ L C RPT ++
Sbjct: 255 MTVLRLTELLERGERLP-------RPDKCPA---EVY---HLMKNCWETEASFRPTFENL 301
Query: 301 ARRLRQI 307
L+ +
Sbjct: 302 IPILKTV 308
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 4e-15
Identities = 33/158 (20%), Positives = 68/158 (43%), Gaps = 16/158 (10%)
Query: 77 MSHDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRI-----LGAPQTHFEPLLLKRRLKD 130
+ +++ L G + + +++EY+++ ++ L T F P+ + + +
Sbjct: 100 IKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI-- 156
Query: 131 AVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVM 190
N+ +Y+H + I RD K S+IL + VKL DF S + + +
Sbjct: 157 IKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK---GSR 211
Query: 191 GTYGHLAPQYVTT--CDFSEKLDVYSFGAFLSELLTGR 226
GTY + P++ + K+D++S G L +
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 4e-15
Identities = 45/158 (28%), Positives = 72/158 (45%), Gaps = 22/158 (13%)
Query: 75 AQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA 134
+ H ++++L G L P+ + V E G+L DR L Q HF L + AV
Sbjct: 76 HSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDR-LRKHQGHFLLGTL---SRYAVQV 130
Query: 135 ANALAYL---HFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMG 191
A + YL F + RD ++L + ++VK+ DF L ++P+ + H VM
Sbjct: 131 AEGMGYLESKRF------IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH---YVMQ 181
Query: 192 TYGHL-----APQYVTTCDFSEKLDVYSFGAFLSELLT 224
+ + AP+ + T FS D + FG L E+ T
Sbjct: 182 EHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 6e-15
Identities = 49/257 (19%), Positives = 90/257 (35%), Gaps = 65/257 (25%)
Query: 75 AQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA 134
Q+ + +I++LIG C + + V E G L + E + + +
Sbjct: 65 HQLDNPYIVRLIGVCQAEALML-VMEMAGGGPLHKFL----VGKREEIPVSNVAELLHQV 119
Query: 135 ANALAYL---HFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMG 191
+ + YL +F V RD ++L + K+ DF LS ++ +++ T G
Sbjct: 120 SMGMKYLEEKNF------VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 173
Query: 192 ------TYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT----------GRGILDLVRDA 235
AP+ + FS + DV+S+G + E L+ G ++ +
Sbjct: 174 KWPLKWY----APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG 229
Query: 236 HDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRP 295
+ P C +L+ L +C DRP
Sbjct: 230 KRMECPPE-------------------------CPP---ELY---ALMSDCWIYKWEDRP 258
Query: 296 TMVDVARRLRQICCSLS 312
+ V +R+R SL+
Sbjct: 259 DFLTVEQRMRACYYSLA 275
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 7e-15
Identities = 34/158 (21%), Positives = 66/158 (41%), Gaps = 23/158 (14%)
Query: 75 AQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA 134
A + + H+ +L+G CL + + + + + + G L D + + H + + + L V
Sbjct: 72 ASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQI 126
Query: 135 ANALAYL---HFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMG 191
A + YL V RD ++L VK+ DF L+ + E
Sbjct: 127 AKGMNYLEDRRL------VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE----KEYHA 176
Query: 192 TYGHL-----APQYVTTCDFSEKLDVYSFGAFLSELLT 224
G + A + + ++ + DV+S+G + EL+T
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 7e-15
Identities = 38/158 (24%), Positives = 63/158 (39%), Gaps = 25/158 (15%)
Query: 76 QMSHDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA 134
+ H +IL++ I L+ E+ G L ++ L R + A
Sbjct: 70 HLRHPNILRMYNY-FHDRKRIYLMLEFAPRGEL-----------YKELQKHGRFDEQRSA 117
Query: 135 ------ANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDT 188
A+AL Y H R ++ RD K ++L + +K+ DF S+ P T
Sbjct: 118 TFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR---T 171
Query: 189 VMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
+ GT +L P+ + EK+D++ G E L G
Sbjct: 172 MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-14
Identities = 33/158 (20%), Positives = 69/158 (43%), Gaps = 23/158 (14%)
Query: 75 AQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA 134
+ H HI++L+G C + + + V +Y+ G+L D + + H L + L V
Sbjct: 70 GSLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHV----RQHRGALGPQLLLNWGVQI 124
Query: 135 ANALAYL---HFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMG 191
A + YL V R+ ++L + V++ DF ++ +P + ++
Sbjct: 125 AKGMYYLEEHGM------VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ----LLY 174
Query: 192 TYGHL-----APQYVTTCDFSEKLDVYSFGAFLSELLT 224
+ A + + ++ + DV+S+G + EL+T
Sbjct: 175 SEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-14
Identities = 59/250 (23%), Positives = 87/250 (34%), Gaps = 65/250 (26%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAA 135
Q H HI+KLIG E P+ I + E G L + Q L L + A +
Sbjct: 72 QFDHPHIVKLIGVITENPVWI-IMELCTLGELRSFL----QVRKYSLDLASLILYAYQLS 126
Query: 136 NALAYL---HFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGT 192
ALAYL F V RD ++L S + VKL DF LS + + + +
Sbjct: 127 TALAYLESKRF------VHRDIAARNVLVSSNDCVKLGDFGLSRYMED-----STYYKAS 175
Query: 193 YGHL-----APQYVTTCDFSEKLDVYSFGAFLSELLT----------GRGILDLVRDAHD 237
G L AP+ + F+ DV+ FG + E+L ++ + +
Sbjct: 176 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER 235
Query: 238 LVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTM 297
L P N C L+ L +C P RP
Sbjct: 236 LPMPPN-------------------------CPP---TLY---SLMTKCWAYDPSRRPRF 264
Query: 298 VDVARRLRQI 307
++ +L I
Sbjct: 265 TELKAQLSTI 274
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-14
Identities = 60/262 (22%), Positives = 95/262 (36%), Gaps = 69/262 (26%)
Query: 75 AQMSHDHILKLIGCCLETPIAILVFEYVQHGTL----------WDRILGAPQTHFEPLLL 124
+ H HI++ G C E ++VFEY++HG L + G PL L
Sbjct: 98 TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157
Query: 125 KRRLKDAVDAANALAYL---HFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEG 181
+ L A A + YL HF V RD T + L + VVK+ DF +S I
Sbjct: 158 GQLLAVASQVAAGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 211
Query: 182 ETHITDTVMGTYGHL-----APQYVTTCDFSEKLDVYSFGAFLSELLT-GR----GI--- 228
+ +G L P+ + F+ + DV+SFG L E+ T G+ +
Sbjct: 212 DY----YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT 267
Query: 229 --LDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFEC 286
+D + +L P C +++ + C
Sbjct: 268 EAIDCITQGRELERPRA-------------------------CPP---EVY---AIMRGC 296
Query: 287 LNESPIDRPTMVDVARRLRQIC 308
P R ++ DV RL+ +
Sbjct: 297 WQREPQQRHSIKDVHARLQALA 318
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-14
Identities = 39/158 (24%), Positives = 66/158 (41%), Gaps = 25/158 (15%)
Query: 76 QMSHDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA 134
+ H +IL+L G + L+ EY GT+ + L + + A
Sbjct: 65 HLRHPNILRLYGY-FHDATRVYLILEYAPLGTV-----------YRELQKLSKFDEQRTA 112
Query: 135 ------ANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDT 188
ANAL+Y H + ++ RD K ++L +K+ DF S+ P +
Sbjct: 113 TYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTD 166
Query: 189 VMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
+ GT +L P+ + EK+D++S G E L G+
Sbjct: 167 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-14
Identities = 53/252 (21%), Positives = 90/252 (35%), Gaps = 64/252 (25%)
Query: 76 QMSHDHILKLIGCCL--ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVD 133
SH ++L L+G CL E + V Y++HG L + I + +K + +
Sbjct: 146 DFSHPNVLSLLGICLRSEGSPLV-VLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQ 200
Query: 134 AANALAYL---HFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVM 190
A + +L F V RD + + E+ VK+ DF L+ + + E
Sbjct: 201 VAKGMKFLASKKF------VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN-- 252
Query: 191 GTYGHL-----APQYVTTCDFSEKLDVYSFGAFLSELLT----------GRGILDLVRDA 235
T L A + + T F+ K DV+SFG L EL+T I +
Sbjct: 253 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 312
Query: 236 HDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRP 295
L+ P C + L+ ++ +C + RP
Sbjct: 313 RRLLQPEY-------------------------CPD---PLY---EVMLKCWHPKAEMRP 341
Query: 296 TMVDVARRLRQI 307
+ ++ R+ I
Sbjct: 342 SFSELVSRISAI 353
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 34/159 (21%), Positives = 65/159 (40%), Gaps = 24/159 (15%)
Query: 75 AQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA 134
Q+ + +I++LIG C + + V E G L + E + + +
Sbjct: 391 HQLDNPYIVRLIGVCQAEALML-VMEMAGGGPLHKFL----VGKREEIPVSNVAELLHQV 445
Query: 135 ANALAYL---HFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMG 191
+ + YL +F V R+ ++L + K+ DF LS ++ +++ T G
Sbjct: 446 SMGMKYLEEKNF------VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 499
Query: 192 ------TYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT 224
AP+ + FS + DV+S+G + E L+
Sbjct: 500 KWPLKWY----APECINFRKFSSRSDVWSYGVTMWEALS 534
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 4e-14
Identities = 54/256 (21%), Positives = 93/256 (36%), Gaps = 62/256 (24%)
Query: 76 QMSHDHILKLIGCCLETPIAIL-VFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA 134
SH ++L L+G CL + + L V Y++HG L + I + +K + +
Sbjct: 82 DFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQV 137
Query: 135 ANALAYL---HFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMG 191
A + YL F V RD + + E+ VK+ DF L+ + + E +
Sbjct: 138 AKGMKYLASKKF------VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHN--K 189
Query: 192 TYGHL-----APQYVTTCDFSEKLDVYSFGAFLSELLT----------GRGILDLVRDAH 236
T L A + + T F+ K DV+SFG L EL+T I +
Sbjct: 190 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 249
Query: 237 DLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPT 296
L+ P C + L+ ++ +C + RP+
Sbjct: 250 RLLQPEY-------------------------CPD---PLY---EVMLKCWHPKAEMRPS 278
Query: 297 MVDVARRLRQICCSLS 312
++ R+ I +
Sbjct: 279 FSELVSRISAIFSTFI 294
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 4e-14
Identities = 39/159 (24%), Positives = 71/159 (44%), Gaps = 27/159 (16%)
Query: 76 QMSHDHILKLIGCCL-ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA 134
++SH +++L G CL + PI + V E+++HG L D + +T + L +D
Sbjct: 59 KLSHPKLVQLYGVCLEQAPICL-VTEFMEHGCLSDYL----RTQRGLFAAETLLGMCLDV 113
Query: 135 ANALAYL---HFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMG 191
+AYL + RD + L E V+K+ DF ++ + + D
Sbjct: 114 CEGMAYLEEACV------IHRDLAARNCLVGENQVIKVSDFGMTRFVLD------DQYTS 161
Query: 192 TYGHL------APQYVTTCDFSEKLDVYSFGAFLSELLT 224
+ G +P+ + +S K DV+SFG + E+ +
Sbjct: 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 200
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 5e-14
Identities = 40/158 (25%), Positives = 74/158 (46%), Gaps = 25/158 (15%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKD-AVDA 134
Q+ H +++L + PI I + EY+++G+L D + +T L +L D A
Sbjct: 64 QLQHQRLVRLYAVVTQEPIYI-ITEYMENGSLVDFL----KTPSGIKLTINKLLDMAAQI 118
Query: 135 ANALAYL---HFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMG 191
A +A++ ++ + RD + ++IL S+ K+ DF L+ I + +
Sbjct: 119 AEGMAFIEERNY------IHRDLRAANILVSDTLSCKIADFGLARLIED-----NEYTAR 167
Query: 192 TYGHL-----APQYVTTCDFSEKLDVYSFGAFLSELLT 224
AP+ + F+ K DV+SFG L+E++T
Sbjct: 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 5e-14
Identities = 52/243 (21%), Positives = 93/243 (38%), Gaps = 38/243 (15%)
Query: 65 ESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRI--LGAPQTHF-EP 121
CI + Q++H +++K +E +V E G L I + E
Sbjct: 77 ADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPER 136
Query: 122 LLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEG 181
+ K V +AL ++H R ++ RD K +++ + VVKL D L
Sbjct: 137 TVWKY----FVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLG-RFFSS 188
Query: 182 ETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYP 241
+T +++GT +++P+ + ++ K D++S G L E+ + P
Sbjct: 189 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ-------------SP 235
Query: 242 FNEYLKNYFEDNRFTEIV----DPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTM 297
F N + +I P+ S ++L QL C+N P RP +
Sbjct: 236 FYGDKMNLYS--LCKKIEQCDYPPLPSDHYS-----EELR---QLVNMCINPDPEKRPDV 285
Query: 298 VDV 300
V
Sbjct: 286 TYV 288
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 5e-14
Identities = 51/244 (20%), Positives = 90/244 (36%), Gaps = 55/244 (22%)
Query: 75 AQMSHDHILKLIGCCLETPIAI----------------LVFEYVQHGTLWDRILGAPQTH 118
A++ H +I+ GC + E+ GTL I
Sbjct: 59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 119 F-EPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSIS 177
+ L L+ + Y+H + ++ RD K S+I + VK+ DF L S
Sbjct: 119 LDKVLALEL----FEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS 171
Query: 178 IPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHD 237
+ GT +++P+ +++ D+ +++D+Y+ G L+ELL
Sbjct: 172 LKNDGKR--TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV------------ 217
Query: 238 LVYPFNEYLKNYFE-DNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPT 296
FE FT++ D II +KE+ L L++ P DRP
Sbjct: 218 --------CDTAFETSKFFTDLRDGIISDIFD--KKEKTLLQK------LLSKKPEDRPN 261
Query: 297 MVDV 300
++
Sbjct: 262 TSEI 265
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 70.5 bits (172), Expect = 6e-14
Identities = 20/176 (11%), Positives = 41/176 (23%), Gaps = 13/176 (7%)
Query: 97 LVFEYVQHGTLWDRI--LGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDF 154
L+ L L + A L + +V F
Sbjct: 165 LLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVHGHF 220
Query: 155 KTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVT--TCDFSEKLDV 212
++ + + L D S + + +++ T F+ L+
Sbjct: 221 TPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNA 276
Query: 213 YSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVD-PIIVQDL 267
+ G + + LV + + F P V+ L
Sbjct: 277 WQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTL 332
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 6e-14
Identities = 40/150 (26%), Positives = 70/150 (46%), Gaps = 9/150 (6%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKD-AVDA 134
+ HD ++KL + PI I + E++ G+L D + ++ +L D +
Sbjct: 239 TLQHDKLVKLHAVVTKEPIYI-ITEFMAKGSLLDFL----KSDEGSKQPLPKLIDFSAQI 293
Query: 135 ANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYG 194
A +A++ R + RD + ++IL S V K+ DF L+ I + E +
Sbjct: 294 AEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK 350
Query: 195 HLAPQYVTTCDFSEKLDVYSFGAFLSELLT 224
AP+ + F+ K DV+SFG L E++T
Sbjct: 351 WTAPEAINFGSFTIKSDVWSFGILLMEIVT 380
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 7e-14
Identities = 39/159 (24%), Positives = 71/159 (44%), Gaps = 27/159 (16%)
Query: 76 QMSHDHILKLIGCCL-ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA 134
++SH ++K G C E PI I V EY+ +G L + + ++H + L + L+ D
Sbjct: 59 KLSHPKLVKFYGVCSKEYPIYI-VTEYISNGCLLNYL----RSHGKGLEPSQLLEMCYDV 113
Query: 135 ANALAYL---HFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMG 191
+A+L F + RD + L + VK+ DF ++ + + D +
Sbjct: 114 CEGMAFLESHQF------IHRDLAARNCLVDRDLCVKVSDFGMTRYVLD------DQYVS 161
Query: 192 TYGHL------APQYVTTCDFSEKLDVYSFGAFLSELLT 224
+ G AP+ +S K DV++FG + E+ +
Sbjct: 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFS 200
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-13
Identities = 38/159 (23%), Positives = 71/159 (44%), Gaps = 27/159 (16%)
Query: 76 QMSHDHILKLIGCCL-ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA 134
+SH+ +++L G C + PI I + EY+ +G L + + + ++ L+ D
Sbjct: 75 NLSHEKLVQLYGVCTKQRPIFI-ITEYMANGCLLNYL----REMRHRFQTQQLLEMCKDV 129
Query: 135 ANALAYL---HFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMG 191
A+ YL F + RD + L +++ VVK+ DF LS + + D
Sbjct: 130 CEAMEYLESKQF------LHRDLAARNCLVNDQGVVKVSDFGLSRYVLD------DEYTS 177
Query: 192 TYGHL------APQYVTTCDFSEKLDVYSFGAFLSELLT 224
+ G P+ + FS K D+++FG + E+ +
Sbjct: 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-13
Identities = 41/159 (25%), Positives = 67/159 (42%), Gaps = 23/159 (14%)
Query: 75 AQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA 134
Q H +I++L G +A++V EY+++G+L D L +TH + + +
Sbjct: 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL-DTFL---RTHDGQFTIMQLVGMLRGV 160
Query: 135 ANALAYL---HFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMG 191
+ YL + V RD ++L V K+ DF LS + + D
Sbjct: 161 GAGMRYLSDLGY------VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP----DAAYT 210
Query: 192 TYGHL------APQYVTTCDFSEKLDVYSFGAFLSELLT 224
T G AP+ + FS DV+SFG + E+L
Sbjct: 211 TTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-13
Identities = 48/255 (18%), Positives = 82/255 (32%), Gaps = 64/255 (25%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWD--RILGAPQTHFEPLLLKRRLKDAVD 133
+ +H +I++ IG L++ ++ E + G L R + L + L A D
Sbjct: 130 KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 189
Query: 134 AANALAYL---HFGFPRPIVFRDFKTSHILFS---EENVVKLFDFSLSISIPEGETHITD 187
A YL HF + RD + L + V K+ DF ++ I
Sbjct: 190 IACGCQYLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY---- 239
Query: 188 TVMGTYGHL-----APQYVTTCDFSEKLDVYSFGAFLSELLT----------GRGILDLV 232
G L P+ F+ K D +SFG L E+ + + +L+ V
Sbjct: 240 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 299
Query: 233 RDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPI 292
+ P N C ++ ++ +C P
Sbjct: 300 TSGGRMDPPKN-------------------------CPG---PVY---RIMTQCWQHQPE 328
Query: 293 DRPTMVDVARRLRQI 307
DRP + R+
Sbjct: 329 DRPNFAIILERIEYC 343
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-13
Identities = 38/156 (24%), Positives = 62/156 (39%), Gaps = 15/156 (9%)
Query: 76 QMSHDHILKLIGCCLETPIA----ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDA 131
+ H +I++ T +LV E + GTL + F+ + +K
Sbjct: 81 GLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL-----KRFKVMKIKVLRSWC 135
Query: 132 VDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN-VVKLFDFSLSISIPEGETHITDTVM 190
L +LH P PI+ RD K +I + VK+ D L+ V+
Sbjct: 136 RQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVI 191
Query: 191 GTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
GT +AP+ + E +DVY+FG + E+ T
Sbjct: 192 GTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSE 226
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-13
Identities = 55/263 (20%), Positives = 98/263 (37%), Gaps = 72/263 (27%)
Query: 75 AQMSHDHILKLIGCCLET-PIAILVFEYVQHGTL-----------WDRILGAPQTHFEPL 122
+ H+HI+K G C + P+ + VFEY++HG L + G P+ L
Sbjct: 72 TNLQHEHIVKFYGVCGDGDPLIM-VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130
Query: 123 LLKRRLKDAVDAANALAYL---HFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIP 179
L + L A A+ + YL HF V RD T + L +VK+ DF +S +
Sbjct: 131 GLSQMLHIASQIASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVY 184
Query: 180 EGETHITDTVMGTYGHL-----APQYVTTCDFSEKLDVYSFGAFLSELLT-GR----GI- 228
+ + +G + L P+ + F+ + DV+SFG L E+ T G+ +
Sbjct: 185 STDYY----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS 240
Query: 229 ----LDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTF 284
++ + L P C + +++ +
Sbjct: 241 NTEVIECITQGRVLERPRV-------------------------CPK---EVY---DVML 269
Query: 285 ECLNESPIDRPTMVDVARRLRQI 307
C P R + ++ + L +
Sbjct: 270 GCWQREPQQRLNIKEIYKILHAL 292
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-13
Identities = 48/256 (18%), Positives = 82/256 (32%), Gaps = 64/256 (25%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWD--RILGAPQTHFEPLLLKRRLKDAVD 133
+ +H +I++ IG L++ ++ E + G L R + L + L A D
Sbjct: 89 KFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 148
Query: 134 AANALAYL---HFGFPRPIVFRDFKTSHILFS---EENVVKLFDFSLSISIPEGETHITD 187
A YL HF + RD + L + V K+ DF ++ I
Sbjct: 149 IACGCQYLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY---- 198
Query: 188 TVMGTYGHL-----APQYVTTCDFSEKLDVYSFGAFLSELLT----------GRGILDLV 232
G L P+ F+ K D +SFG L E+ + + +L+ V
Sbjct: 199 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 258
Query: 233 RDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPI 292
+ P N C ++ ++ +C P
Sbjct: 259 TSGGRMDPPKN-------------------------CPG---PVY---RIMTQCWQHQPE 287
Query: 293 DRPTMVDVARRLRQIC 308
DRP + R+
Sbjct: 288 DRPNFAIILERIEYCT 303
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-13
Identities = 53/159 (33%), Positives = 81/159 (50%), Gaps = 25/159 (15%)
Query: 76 QMSHDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQTHF-EPLLLKRRLKDAVD 133
++SH +I+KL ETP I LV E V G L+DRI+ + ++ E +DA D
Sbjct: 104 RLSHPNIIKLKEIF-ETPTEISLVLELVTGGELFDRIVE--KGYYSE--------RDAAD 152
Query: 134 A----ANALAYLHFGFPRPIVFRDFKTSHILF---SEENVVKLFDFSLSISIPEGETHIT 186
A A+AYLH IV RD K ++L+ + + +K+ DF LS + +
Sbjct: 153 AVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--LM 207
Query: 187 DTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225
TV GT G+ AP+ + C + ++D++S G LL G
Sbjct: 208 KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-13
Identities = 50/187 (26%), Positives = 75/187 (40%), Gaps = 38/187 (20%)
Query: 76 QMSHDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQTHF-EPLLLKRRLKDAVD 133
+ H +I+KL E LV E + G L+D I+ + F E DA
Sbjct: 92 LLDHPNIMKLYDFF-EDKRNYYLVMECYKGGELFDEIIH--RMKFNE--------VDAAV 140
Query: 134 A----ANALAYLHFGFPRPIVFRDFKTSHILF---SEENVVKLFDFSLSISIPEGETHIT 186
+ + YLH IV RD K ++L ++ ++K+ DF LS +
Sbjct: 141 IIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM-- 195
Query: 187 DTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG---------RGILDLVRDAHD 237
+GT ++AP+ V + EK DV+S G L LL G + IL V
Sbjct: 196 KERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGK- 253
Query: 238 LVYPFNE 244
Y F+
Sbjct: 254 --YTFDS 258
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 4e-13
Identities = 38/160 (23%), Positives = 70/160 (43%), Gaps = 25/160 (15%)
Query: 75 AQMSHDHILKLIGCCLET-PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVD 133
Q H +I++L G ++ P+ I V EY+++G+L D L + H + + +
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMI-VTEYMENGSL-DSFL---RKHDAQFTVIQLVGMLRG 155
Query: 134 AANALAYL---HFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVM 190
A+ + YL + V RD +IL + V K+ DF L + + +
Sbjct: 156 IASGMKYLSDMGY------VHRDLAARNILINSNLVCKVSDFGLGRVLEDDP----EAAY 205
Query: 191 GTYGHL------APQYVTTCDFSEKLDVYSFGAFLSELLT 224
T G +P+ + F+ DV+S+G L E+++
Sbjct: 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 4e-13
Identities = 40/158 (25%), Positives = 70/158 (44%), Gaps = 24/158 (15%)
Query: 76 QMSHDHILKLIGCCL-ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA 134
++ H ++++L+G C E P I + E++ +G L D + + ++L L A
Sbjct: 65 EIKHPNLVQLLGVCTREPPFYI-ITEFMTYGNLLDYLRECNRQEVSAVVL---LYMATQI 120
Query: 135 ANALAYL---HFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMG 191
++A+ YL +F + RD + L E ++VK+ DF LS +
Sbjct: 121 SSAMEYLEKKNF------IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-----YTAH 169
Query: 192 TYGHL-----APQYVTTCDFSEKLDVYSFGAFLSELLT 224
AP+ + FS K DV++FG L E+ T
Sbjct: 170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 5e-13
Identities = 51/259 (19%), Positives = 91/259 (35%), Gaps = 70/259 (27%)
Query: 78 SHDHILKLIGCCLETPIAILVFEYVQHGTL-----------WDRILGAPQTHFEPLLLKR 126
H +I+ L+G C + ++ EY G L + + E + K
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 127 RLKDAVDAANALAYL---HFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGET 183
+ A + YL + RD ++L +E NV+K+ DF L+ I +
Sbjct: 205 LVSCTYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLARDINNIDY 258
Query: 184 HITDTVMGTYGHL-----APQYVTTCDFSEKLDVYSFGAFLSELLT----------GRGI 228
+ T G L AP+ + ++ + DV+SFG + E+ T +
Sbjct: 259 Y----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 314
Query: 229 LDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLN 288
L+++ H + P N CT +L+ + +C +
Sbjct: 315 FKLLKEGHRMDKPAN-------------------------CTN---ELY---MMMRDCWH 343
Query: 289 ESPIDRPTMVDVARRLRQI 307
P RPT + L +I
Sbjct: 344 AVPSQRPTFKQLVEDLDRI 362
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 68.2 bits (166), Expect = 5e-13
Identities = 27/222 (12%), Positives = 55/222 (24%), Gaps = 60/222 (27%)
Query: 99 FEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLH-FGFPRPIVFRDFKTS 157
T + +L TH + L+ RL+ + LA LH +G +V +
Sbjct: 186 RMQSNLQTFGEVLLSHSSTH-KSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPV 240
Query: 158 HILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVT----------TCDFS 207
I+ + V L F + +G + ++ G P+ +
Sbjct: 241 DIVLDQRGGVFLTGF--EHLVRDGASAVSPI---GRGFAPPETTAERMLPFGQHHPTLMT 295
Query: 208 EKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNE------YLKNYFEDNRFTEIVDP 261
D ++ G + + P + + + V
Sbjct: 296 FAFDTWTLGLAIYWIWCAD-------------LPNTDDAALGGSEWIFRSCKNIPQPVRA 342
Query: 262 IIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARR 303
++ L DR +
Sbjct: 343 LLEG--------------------FLRYPKEDRLLPLQAMET 364
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 5e-13
Identities = 48/179 (26%), Positives = 72/179 (40%), Gaps = 35/179 (19%)
Query: 76 QMSHDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQTHF-EPLLLKRRLKDAVD 133
Q+ H +I+KL E LV E G L+D I+ + F E DA
Sbjct: 82 QLDHPNIMKLYEFF-EDKGYFYLVGEVYTGGELFDEIIS--RKRFSE--------VDAAR 130
Query: 134 A----ANALAYLHFGFPRPIVFRDFKTSHILF---SEENVVKLFDFSLSISIPEGETHIT 186
+ + Y+H IV RD K ++L S++ +++ DF LS +
Sbjct: 131 IIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM-- 185
Query: 187 DTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG---------RGILDLVRDAH 236
+GT ++AP+ V + EK DV+S G L LL+G IL V
Sbjct: 186 KDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGK 243
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 7e-13
Identities = 31/153 (20%), Positives = 52/153 (33%), Gaps = 11/153 (7%)
Query: 74 AAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVD 133
H ++L E I L E +L + E + D
Sbjct: 111 EKVGQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGY----LRD 165
Query: 134 AANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTY 193
ALA+LH + +V D K ++I KL DF L + + + G
Sbjct: 166 TLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA--GEVQEGDP 220
Query: 194 GHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
++AP+ + + DV+S G + E+
Sbjct: 221 RYMAPE-LLQGSYGTAADVFSLGLTILEVACNM 252
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 8e-13
Identities = 51/259 (19%), Positives = 91/259 (35%), Gaps = 70/259 (27%)
Query: 78 SHDHILKLIGCCLETPIAILVFEYVQHGTL-----------WDRILGAPQTHFEPLLLKR 126
H +I+ L+G C + ++ EY G L + + E + K
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 127 RLKDAVDAANALAYL---HFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGET 183
+ A + YL + RD ++L +E NV+K+ DF L+ I +
Sbjct: 159 LVSCTYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLARDINNIDY 212
Query: 184 HITDTVMGTYGHL-----APQYVTTCDFSEKLDVYSFGAFLSELLT----------GRGI 228
+ T G L AP+ + ++ + DV+SFG + E+ T +
Sbjct: 213 Y----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268
Query: 229 LDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLN 288
L+++ H + P N CT +L+ + +C +
Sbjct: 269 FKLLKEGHRMDKPAN-------------------------CTN---ELY---MMMRDCWH 297
Query: 289 ESPIDRPTMVDVARRLRQI 307
P RPT + L +I
Sbjct: 298 AVPSQRPTFKQLVEDLDRI 316
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 9e-13
Identities = 41/265 (15%), Positives = 80/265 (30%), Gaps = 61/265 (23%)
Query: 77 MSHDHILKLIGCCLETPI-------AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLK 129
H +I++ L+ + G L + + + + L
Sbjct: 83 SGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVE--------FLKKMESRGPLS 134
Query: 130 DA------VDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGET 183
A+ ++H P PI+ RD K ++L S + +KL DF + +I
Sbjct: 135 CDTVLKIFYQTCRAVQHMHRQKP-PIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPD 193
Query: 184 HITDTVMGTYGHLAPQYVTT--------CDF------SEKLDVYSFGAFLSELLTGRGIL 229
+ TT D EK D+++ G L L +
Sbjct: 194 YSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH-- 251
Query: 230 DLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNE 289
PF + K + +++ L L
Sbjct: 252 -----------PFEDGAKLRIVNGKYSIPPHDTQYTVFH------------SLIRAMLQV 288
Query: 290 SPIDRPTMVDVARRLRQICCSLSCN 314
+P +R ++ +V +L++I + + N
Sbjct: 289 NPEERLSIAEVVHQLQEIAAARNVN 313
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 1e-12
Identities = 49/187 (26%), Positives = 75/187 (40%), Gaps = 38/187 (20%)
Query: 76 QMSHDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQTHF-EPLLLKRRLKDAVD 133
++ H +I+KL E + +V E G L+D I+ + F E DA
Sbjct: 77 KLDHPNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIK--RKRFSE--------HDAAR 125
Query: 134 A----ANALAYLHFGFPRPIVFRDFKTSHILF---SEENVVKLFDFSLSISIPEGETHIT 186
+ + Y+H IV RD K +IL ++ +K+ DF LS +
Sbjct: 126 IIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM-- 180
Query: 187 DTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG---------RGILDLVRDAHD 237
+GT ++AP+ V + EK DV+S G L LL+G IL V
Sbjct: 181 KDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK- 238
Query: 238 LVYPFNE 244
Y F+
Sbjct: 239 --YAFDL 243
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-12
Identities = 64/297 (21%), Positives = 107/297 (36%), Gaps = 84/297 (28%)
Query: 49 LKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTL- 107
LK+E + Q + F E+ + A+ + +I+KL+G C L+FEY+ +G L
Sbjct: 85 LKEEASADMQAD-FQREAAL-----MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 138
Query: 108 ------------------WDRILGAPQTHFEPLLLKRRLKDAVDAANALAYL---HFGFP 146
PL +L A A +AYL F
Sbjct: 139 EFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF--- 195
Query: 147 RPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHL-----APQYV 201
V RD T + L E VVK+ DF LS +I + + + P+ +
Sbjct: 196 ---VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY----KADGNDAIPIRWMPPESI 248
Query: 202 TTCDFSEKLDVYSFGAFLSELLT----------GRGILDLVRDAHDLVYPFNEYLKNYFE 251
++ + DV+++G L E+ + ++ VRD + L P N
Sbjct: 249 FYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPEN-------- 300
Query: 252 DNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQIC 308
C +L+ L C ++ P DRP+ + R L+++C
Sbjct: 301 -----------------CPL---ELY---NLMRLCWSKLPADRPSFCSIHRILQRMC 334
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 48/187 (25%), Positives = 77/187 (41%), Gaps = 38/187 (20%)
Query: 76 QMSHDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQTHF-EPLLLKRRLKDAVD 133
+ H +I+KL E LV E+ + G L+++I+ + F E DA +
Sbjct: 102 SLDHPNIIKLFDVF-EDKKYFYLVTEFYEGGELFEQIIN--RHKFDE--------CDAAN 150
Query: 134 A----ANALAYLHFGFPRPIVFRDFKTSHILF---SEENVVKLFDFSLSISIPEGETHIT 186
+ + YLH IV RD K +IL + +K+ DF LS +
Sbjct: 151 IMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL-- 205
Query: 187 DTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG---------RGILDLVRDAHD 237
+GT ++AP+ V ++EK DV+S G + LL G + I+ V
Sbjct: 206 RDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGK- 263
Query: 238 LVYPFNE 244
Y F+
Sbjct: 264 --YYFDF 268
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 37/165 (22%), Positives = 67/165 (40%), Gaps = 26/165 (15%)
Query: 76 QMSHDHILKLIGCCLETPIAI-------LVFEYVQHGTLWDRILGAPQTHFEPLLLK--- 125
+++H +++ + + L EY + G L + LK
Sbjct: 68 KLNHPNVVSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL----NQFENCCGLKEGP 122
Query: 126 -RRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN---VVKLFDFSLSISIPEG 181
R L D ++AL YLH I+ RD K +I+ + K+ D + + +G
Sbjct: 123 IRTL--LSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG 177
Query: 182 ETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
E + +GT +LAP+ + ++ +D +SFG E +TG
Sbjct: 178 E--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 2e-12
Identities = 34/157 (21%), Positives = 59/157 (37%), Gaps = 22/157 (14%)
Query: 77 MSHDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA- 134
+ H IL+L E + LV E +G + + + +
Sbjct: 68 LKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNR----------VKPFSENEARH 116
Query: 135 -----ANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTV 189
+ YLH I+ RD S++L + +K+ DF L+ + + T+
Sbjct: 117 FMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLA-TQLKMPHEKHYTL 172
Query: 190 MGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
GT +++P+ T + DV+S G LL GR
Sbjct: 173 CGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-12
Identities = 48/259 (18%), Positives = 95/259 (36%), Gaps = 52/259 (20%)
Query: 65 ESCINNVTYAAQMSHDHILKLIGCCLETPIAI------------LVFEYVQHGTLWDRIL 112
E + V A++ H I++ LE + + + L D +
Sbjct: 48 EKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN 107
Query: 113 GAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF 172
G + + + A A+ +LH + ++ RD K S+I F+ ++VVK+ DF
Sbjct: 108 GRCTIEERERSVCLHI--FLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDF 162
Query: 173 SLS-----------ISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSE 221
L + P +GT +++P+ + +S K+D++S G L E
Sbjct: 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222
Query: 222 LLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQ 281
LL YPF+ T++ + + +
Sbjct: 223 LL----------------YPFS---TQMERVRTLTDVRNLKFPPLFTQKYPCEY-----V 258
Query: 282 LTFECLNESPIDRPTMVDV 300
+ + L+ SP++RP +++
Sbjct: 259 MVQDMLSPSPMERPEAINI 277
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 2e-12
Identities = 46/159 (28%), Positives = 72/159 (45%), Gaps = 26/159 (16%)
Query: 76 QMSHDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQTHF-EPLLLKRRLKDAVD 133
++ H++I+ L E+ LV + V G L+DRIL + + E KDA
Sbjct: 62 KIKHENIVTLEDIY-ESTTHYYLVMQLVSGGELFDRILE--RGVYTE--------KDASL 110
Query: 134 A----ANALAYLHFGFPRPIVFRDFKTSHILF---SEENVVKLFDFSLSISIPEGETHIT 186
+A+ YLH IV RD K ++L+ E + + + DF LS G
Sbjct: 111 VIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS-- 165
Query: 187 DTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225
T GT G++AP+ + +S+ +D +S G LL G
Sbjct: 166 -TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 65.8 bits (160), Expect = 2e-12
Identities = 28/196 (14%), Positives = 55/196 (28%), Gaps = 24/196 (12%)
Query: 46 AQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEY---- 101
L+ +QK H I ++++ + + F Y
Sbjct: 124 VLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ 183
Query: 102 VQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILF 161
T + +L TH + L+ RL+ + LA LH +V + I+
Sbjct: 184 SNLQTFGEVLLSHSSTH-KSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVL 239
Query: 162 SEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTT-----------CDFSEKL 210
+ V L F + +G + G P+ +
Sbjct: 240 DQRGGVFLTGFEH--LVRDGARV---VSSVSRGFEPPELEARRATISYHRDRRTLMTFSF 294
Query: 211 DVYSFGAFLSELLTGR 226
D ++ G + +
Sbjct: 295 DAWALGLVIYWIWCAD 310
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-12
Identities = 40/166 (24%), Positives = 66/166 (39%), Gaps = 29/166 (17%)
Query: 78 SHDHILKLIGCCLETPIAILVFEYVQHGTL-----------WDRILGAPQTHFEPLLLKR 126
H +I+ L+G C + ++ EY G L + E L K
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 127 RLKDAVDAANALAYL---HFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGET 183
+ A A + YL + RD ++L +E+NV+K+ DF L+ I +
Sbjct: 193 LVSCAYQVARGMEYLASKKC------IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 246
Query: 184 HITDTVMGTYGHL-----APQYVTTCDFSEKLDVYSFGAFLSELLT 224
+ T G L AP+ + ++ + DV+SFG L E+ T
Sbjct: 247 Y----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 3e-12
Identities = 33/158 (20%), Positives = 66/158 (41%), Gaps = 23/158 (14%)
Query: 76 QMSHDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA 134
++H H++ G E + +V E + +L + ++ L +
Sbjct: 71 SLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKR-----------RKALTEPEAR 118
Query: 135 ------ANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDT 188
YLH ++ RD K ++ +E+ VK+ DF L+ + E +
Sbjct: 119 YYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKV 174
Query: 189 VMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
+ GT ++AP+ ++ S ++DV+S G + LL G+
Sbjct: 175 LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 3e-12
Identities = 46/187 (24%), Positives = 77/187 (41%), Gaps = 38/187 (20%)
Query: 76 QMSHDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQTHF-EPLLLKRRLKDAVD 133
+ H +I++L E I LV E G L++R++ + F E DA
Sbjct: 62 SLDHPNIIRLYETF-EDNTDIYLVMELCTGGELFERVVH--KRVFRE--------SDAAR 110
Query: 134 A----ANALAYLHFGFPRPIVFRDFKTSHILF---SEENVVKLFDFSLSISIPEGETHIT 186
+A+AY H + RD K + LF S ++ +KL DF L+ G+
Sbjct: 111 IMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM-- 165
Query: 187 DTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG---------RGILDLVRDAHD 237
T +GT +++PQ V + + D +S G + LL G ++ +R+
Sbjct: 166 RTKVGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGT- 223
Query: 238 LVYPFNE 244
+ F E
Sbjct: 224 --FTFPE 228
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-12
Identities = 40/160 (25%), Positives = 71/160 (44%), Gaps = 25/160 (15%)
Query: 75 AQMSHDHILKLIGCCLET-PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVD 133
Q SH +I++L G + P+ I + EY+++G L D+ L + + + +
Sbjct: 101 GQFSHHNIIRLEGVISKYKPMMI-ITEYMENGAL-DKFL---REKDGEFSVLQLVGMLRG 155
Query: 134 AANALAYL---HFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVM 190
A + YL ++ V RD +IL + V K+ DF LS + + +
Sbjct: 156 IAAGMKYLANMNY------VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP----EATY 205
Query: 191 GTYGHL------APQYVTTCDFSEKLDVYSFGAFLSELLT 224
T G AP+ ++ F+ DV+SFG + E++T
Sbjct: 206 TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-12
Identities = 46/262 (17%), Positives = 90/262 (34%), Gaps = 74/262 (28%)
Query: 78 SHDHILKLIGCCL--ETPIAILVFEYVQHGTL-----------WDRILGAPQTHFEPLLL 124
H +++ L+G C P+ + + E+ + G L + + + L L
Sbjct: 89 HHLNVVNLLGACTKPGGPLMV-IVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147
Query: 125 KRRLKDAVDAANALAYL---HFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEG 181
+ + + A + +L + RD +IL SE+NVVK+ DF L+ I +
Sbjct: 148 EHLICYSFQVAKGMEFLASRKC------IHRDLAARNILLSEKNVVKICDFGLARDIYKD 201
Query: 182 ETHITDTVMGTYGHL-----APQYVTTCDFSEKLDVYSFGAFLSELLT-----------G 225
+ V L AP+ + ++ + DV+SFG L E+ +
Sbjct: 202 PDY----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257
Query: 226 RGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFE 285
+++ + P T +++ Q +
Sbjct: 258 EEFCRRLKEGTRMRAPDY-------------------------TTP---EMY---QTMLD 286
Query: 286 CLNESPIDRPTMVDVARRLRQI 307
C + P RPT ++ L +
Sbjct: 287 CWHGEPSQRPTFSELVEHLGNL 308
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 4e-12
Identities = 44/155 (28%), Positives = 71/155 (45%), Gaps = 21/155 (13%)
Query: 76 QMSHDHILKLIGCCL-ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA 134
Q+ H ++++L+G + E +V EY+ G+L D + ++ L LK ++D
Sbjct: 242 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL---LKFSLDV 298
Query: 135 ANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYG 194
A+ YL V RD ++L SE+NV K+ DF L+ + G
Sbjct: 299 CEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---------DTG 346
Query: 195 HL-----APQYVTTCDFSEKLDVYSFGAFLSELLT 224
L AP+ + FS K DV+SFG L E+ +
Sbjct: 347 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 4e-12
Identities = 41/159 (25%), Positives = 65/159 (40%), Gaps = 28/159 (17%)
Query: 79 HDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQTHF-EPLLLKRRLKDAVDA-- 134
H +I++L ET LVF+ ++ G L+D + + E K+
Sbjct: 83 HPNIIQLKDTY-ETNTFFFLVFDLMKKGELFDYLTE--KVTLSE--------KETRKIMR 131
Query: 135 --ANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGT 192
+ LH IV RD K +IL ++ +KL DF S + GE V GT
Sbjct: 132 ALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLREVCGT 186
Query: 193 YGHLAP------QYVTTCDFSEKLDVYSFGAFLSELLTG 225
+LAP + +++D++S G + LL G
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 4e-12
Identities = 41/188 (21%), Positives = 67/188 (35%), Gaps = 35/188 (18%)
Query: 76 QMSHDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRIL--GAPQTHF-EPLLLKRRLKDA 131
+ H HI++L+ + + +VFE++ L I+ + E A
Sbjct: 82 MLKHPHIVELLETY-SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSE--------AVA 132
Query: 132 VDA----ANALAYLHFGFPRPIVFRDFKTSHILF---SEENVVKLFDFSLSISIPEGETH 184
AL Y H I+ RD K +L VKL F ++I + E
Sbjct: 133 SHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV 189
Query: 185 ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR--------GILDLVRDAH 236
V GT +AP+ V + + +DV+ G L LL+G + + +
Sbjct: 190 AGGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGK 248
Query: 237 DLVYPFNE 244
Y N
Sbjct: 249 ---YKMNP 253
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 4e-12
Identities = 48/179 (26%), Positives = 74/179 (41%), Gaps = 35/179 (19%)
Query: 76 QMSHDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQTHF-EPLLLKRRLKDAVD 133
++ H +I+KL E + +V E G L+D I+ + F E DA
Sbjct: 77 KLDHPNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIK--RKRFSE--------HDAAR 125
Query: 134 A----ANALAYLHFGFPRPIVFRDFKTSHILF---SEENVVKLFDFSLSISIPEGETHIT 186
+ + Y+H IV RD K +IL ++ +K+ DF LS + +
Sbjct: 126 IIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MK 181
Query: 187 DTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG---------RGILDLVRDAH 236
D + GT ++AP+ V + EK DV+S G L LL+G IL V
Sbjct: 182 DRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK 238
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 4e-12
Identities = 57/287 (19%), Positives = 101/287 (35%), Gaps = 78/287 (27%)
Query: 49 LKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL-ETPIAILVFEYVQHGTL 107
LK + ++ F HE+ + A++ H +++ L+G + P+++ +F Y HG L
Sbjct: 47 LKDKAEGPLREE-FRHEAML-----RARLQHPNVVCLLGVVTKDQPLSM-IFSYCSHGDL 99
Query: 108 -----------WDRILGAPQTHFEPLLLKRRLKDAVDAANALAYL---HFGFPRPIVFRD 153
+T L + A + YL H V +D
Sbjct: 100 HEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHV------VHKD 153
Query: 154 FKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHL-----APQYVTTCDFSE 208
T ++L ++ VK+ D L + + + L AP+ + FS
Sbjct: 154 LATRNVLVYDKLNVKISDLGLFREVYAADY----YKLLGNSLLPIRWMAPEAIMYGKFSI 209
Query: 209 KLDVYSFGAFLSELLT-GR----GI-----LDLVRDAHDLVYPFNEYLKNYFEDNRFTEI 258
D++S+G L E+ + G G ++++R+ L P +
Sbjct: 210 DSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPDD--------------- 254
Query: 259 VDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLR 305
C ++ L EC NE P RP D+ RLR
Sbjct: 255 ----------CPA---WVY---ALMIECWNEFPSRRPRFKDIHSRLR 285
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 5e-12
Identities = 41/159 (25%), Positives = 73/159 (45%), Gaps = 25/159 (15%)
Query: 76 QMSHDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQTHF-EPLLLKRRLKDAVD 133
++ H +I++L + LVF+ V G L++ I+ + + E DA
Sbjct: 61 KLQHPNIVRLHDSI-QEESFHYLVFDLVTGGELFEDIVA--REFYSE--------ADASH 109
Query: 134 A----ANALAYLHFGFPRPIVFRDFKTSHILF---SEENVVKLFDFSLSISIPEGETHIT 186
++AY H IV R+ K ++L ++ VKL DF L+I + + E
Sbjct: 110 CIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--W 164
Query: 187 DTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225
GT G+L+P+ + +S+ +D+++ G L LL G
Sbjct: 165 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 5e-12
Identities = 44/193 (22%), Positives = 72/193 (37%), Gaps = 38/193 (19%)
Query: 76 QMSHDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQT--HF-EPLLLKRRLKDA 131
+ H +I+K+ E + +V E + G L +RI+ A E
Sbjct: 76 SLDHPNIIKIFEVF-EDYHNMYIVMETCEGGELLERIVSAQARGKALSE--------GYV 126
Query: 132 VDA----ANALAYLHFGFPRPIVFRDFKTSHILF---SEENVVKLFDFSLSISIPEGETH 184
+ NALAY H + +V +D K +ILF S + +K+ DF L+ E
Sbjct: 127 AELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS 183
Query: 185 ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG---------RGILDLVRDA 235
GT ++AP+ V D + K D++S G + LLTG +
Sbjct: 184 --TNAAGTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYK 240
Query: 236 HDLVYPFNEYLKN 248
+ +
Sbjct: 241 E---PNYAVECRP 250
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 6e-12
Identities = 42/163 (25%), Positives = 74/163 (45%), Gaps = 31/163 (19%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAA 135
+++H I+K+ + +V E ++ G L+D+++G +RLK+A
Sbjct: 196 KLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVG-----------NKRLKEA-TCK 242
Query: 136 -------NALAYLHFGFPRPIVFRDFKTSHILF---SEENVVKLFDFSLSISIPEGETHI 185
A+ YLH I+ RD K ++L E+ ++K+ DF S + E +
Sbjct: 243 LYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--L 297
Query: 186 TDTVMGTYGHLAP---QYVTTCDFSEKLDVYSFGAFLSELLTG 225
T+ GT +LAP V T ++ +D +S G L L+G
Sbjct: 298 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 6e-12
Identities = 37/165 (22%), Positives = 67/165 (40%), Gaps = 25/165 (15%)
Query: 78 SHDHILKLIGCCLETPIAILVFEYVQHGTL-------------WDRILGAPQTHFEPLLL 124
+H +I+ L+G C +++ EY +G L + L L
Sbjct: 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 125 KRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETH 184
+ L + A +A+L + + RD +IL + + K+ DF L+ I +
Sbjct: 145 EDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 185 ITDTVMGTYGHL-----APQYVTTCDFSEKLDVYSFGAFLSELLT 224
V+ L AP+ + C ++ + DV+S+G FL EL +
Sbjct: 202 ----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 7e-12
Identities = 34/157 (21%), Positives = 59/157 (37%), Gaps = 21/157 (13%)
Query: 76 QMSHDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA 134
Q+ H ++ L E + L+ E++ G L+DRI E + ++
Sbjct: 104 QLHHPKLINLHDAF-EDKYEMVLILEFLSGGELFDRIAAEDYKMSE--------AEVINY 154
Query: 135 A----NALAYLHFGFPRPIVFRDFKTSHILFS--EENVVKLFDFSLSISIPEGETHITDT 188
L ++H IV D K +I+ + + VK+ DF L+ + E
Sbjct: 155 MRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV--KV 209
Query: 189 VMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225
T AP+ V D+++ G LL+G
Sbjct: 210 TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 8e-12
Identities = 39/160 (24%), Positives = 67/160 (41%), Gaps = 26/160 (16%)
Query: 76 QMSHDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQTHF-EPLLLKRRLKDAVD 133
Q+ H +++ L E + L+ E V G L+D + A + E ++A
Sbjct: 71 QVLHHNVITLHDVY-ENRTDVVLILELVSGGELFDFL--AQKESLSE--------EEATS 119
Query: 134 AA----NALAYLHFGFPRPIVFRDFKTSHILFSEEN----VVKLFDFSLSISIPEGETHI 185
+ + YLH + I D K +I+ ++N +KL DF L+ I +G
Sbjct: 120 FIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--E 174
Query: 186 TDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225
+ GT +AP+ V + D++S G LL+G
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 8e-12
Identities = 43/234 (18%), Positives = 76/234 (32%), Gaps = 41/234 (17%)
Query: 79 HDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANA 137
H ++++ C + + E TL + + L L+ +
Sbjct: 77 HPNVIRYF-CTEKDRQFQYIAIELCA-ATLQEYVE-QKDFAHLGLEPITLLQQTT---SG 130
Query: 138 LAYLHFGFPRPIVFRDFKTSHILFSEEN-----VVKLFDFSLSISIPEGE--THITDTVM 190
LA+LH IV RD K +IL S N + DF L + G V
Sbjct: 131 LAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP 187
Query: 191 GTYGHLAPQYVTTCDF---SEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLK 247
GT G +AP+ ++ + +D++S G +++
Sbjct: 188 GTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEG-------------SHP----- 229
Query: 248 NYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQ-LTFECLNESPIDRPTMVDV 300
F + + + L C E+ A+ L + + P RP+ V
Sbjct: 230 --FGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHV 281
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 8e-12
Identities = 43/159 (27%), Positives = 70/159 (44%), Gaps = 28/159 (17%)
Query: 79 HDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQTHF-EPLLLKRRLKDAVDA-- 134
H HI+ LI E+ + LVF+ ++ G L+D + + E K+
Sbjct: 159 HPHIITLIDSY-ESSSFMFLVFDLMRKGELFDYLTE--KVALSE--------KETRSIMR 207
Query: 135 --ANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGT 192
A+++LH IV RD K +IL + ++L DF S + GE + GT
Sbjct: 208 SLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE--KLRELCGT 262
Query: 193 YGHLAP------QYVTTCDFSEKLDVYSFGAFLSELLTG 225
G+LAP T + +++D+++ G L LL G
Sbjct: 263 PGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 8e-12
Identities = 32/157 (20%), Positives = 61/157 (38%), Gaps = 21/157 (13%)
Query: 76 QMSHDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA 134
+ H ++ L E + +++E++ G L++++ E +AV+
Sbjct: 210 VLRHPTLVNLHDAF-EDDNEMVMIYEFMSGGELFEKVADEHNKMSE--------DEAVEY 260
Query: 135 A----NALAYLHFGFPRPIVFRDFKTSHILFS--EENVVKLFDFSLSISIPEGETHITDT 188
L ++H V D K +I+F+ N +KL DF L+ + ++
Sbjct: 261 MRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--VKV 315
Query: 189 VMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225
GT AP+ D++S G LL+G
Sbjct: 316 TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 8e-12
Identities = 37/156 (23%), Positives = 67/156 (42%), Gaps = 24/156 (15%)
Query: 79 HDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQTHF-EPLLLKRRLKDAVDA-- 134
H +I+KL + LV E + G L++RI + HF E +A
Sbjct: 65 HPNIVKLHEVF-HDQLHTFLVMELLNGGELFERIKK--KKHFSE--------TEASYIMR 113
Query: 135 --ANALAYLHFGFPRPIVFRDFKTSHILF---SEENVVKLFDFSLSISIPEGETHITDTV 189
+A++++H +V RD K ++LF ++ +K+ DF + P +
Sbjct: 114 KLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC 170
Query: 190 MGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225
T + AP+ + + E D++S G L +L+G
Sbjct: 171 -FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSG 205
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 9e-12
Identities = 39/160 (24%), Positives = 64/160 (40%), Gaps = 26/160 (16%)
Query: 76 QMSHDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQTHF-EPLLLKRRLKDAVD 133
Q+ H +I+ L E + L+ E V G L+D + A + E ++A
Sbjct: 71 QVLHPNIITLHDVY-ENRTDVVLILELVSGGELFDFL--AQKESLSE--------EEATS 119
Query: 134 A----ANALAYLHFGFPRPIVFRDFKTSHILF----SEENVVKLFDFSLSISIPEGETHI 185
+ + YLH + I D K +I+ +KL DF L+ I +G
Sbjct: 120 FIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-- 174
Query: 186 TDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225
+ GT +AP+ V + D++S G LL+G
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 9e-12
Identities = 41/159 (25%), Positives = 73/159 (45%), Gaps = 25/159 (15%)
Query: 76 QMSHDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQTHF-EPLLLKRRLKDAVD 133
++ H +I++L + LVF+ V G L++ I+ + + E DA
Sbjct: 84 KLQHPNIVRLHDSI-QEESFHYLVFDLVTGGELFEDIVA--REFYSE--------ADASH 132
Query: 134 A----ANALAYLHFGFPRPIVFRDFKTSHILF---SEENVVKLFDFSLSISIPEGETHIT 186
++AY H IV R+ K ++L ++ VKL DF L+I + + E
Sbjct: 133 CIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--W 187
Query: 187 DTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225
GT G+L+P+ + +S+ +D+++ G L LL G
Sbjct: 188 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 1e-11
Identities = 33/164 (20%), Positives = 66/164 (40%), Gaps = 27/164 (16%)
Query: 78 SHDHILKLIGCCLETPIAILVFEYVQHGTLWD---------RILGAPQTHFEPLLLKRRL 128
H++I+ L+G C +++ EY +G L + A + L
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 129 KDAVDAANALAYL---HFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHI 185
+ A +A+L + + RD ++L + +V K+ DF L+ I +
Sbjct: 168 HFSSQVAQGMAFLASKNC------IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY- 220
Query: 186 TDTVMGTYGHL-----APQYVTTCDFSEKLDVYSFGAFLSELLT 224
++ L AP+ + C ++ + DV+S+G L E+ +
Sbjct: 221 ---IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-11
Identities = 33/158 (20%), Positives = 66/158 (41%), Gaps = 23/158 (14%)
Query: 76 QMSHDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA 134
++H H++ G E + +V E + +L + ++ L +
Sbjct: 97 SLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKR-----------RKALTEPEAR 144
Query: 135 ------ANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDT 188
YLH ++ RD K ++ +E+ VK+ DF L+ + E +
Sbjct: 145 YYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKV 200
Query: 189 VMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
+ GT ++AP+ ++ S ++DV+S G + LL G+
Sbjct: 201 LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 1e-11
Identities = 43/159 (27%), Positives = 71/159 (44%), Gaps = 29/159 (18%)
Query: 76 QMSHDHILKLIGCCL-ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA 134
Q+ H ++++L+G + E +V EY+ G+L D + ++ L LK ++D
Sbjct: 70 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL---LKFSLDV 126
Query: 135 ANALAYL---HFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMG 191
A+ YL +F V RD ++L SE+NV K+ DF L+ +
Sbjct: 127 CEAMEYLEGNNF------VHRDLAARNVLVSEDNVAKVSDFGLT----------KEASST 170
Query: 192 TYGHL------APQYVTTCDFSEKLDVYSFGAFLSELLT 224
AP+ + FS K DV+SFG L E+ +
Sbjct: 171 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 209
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 2e-11
Identities = 46/279 (16%), Positives = 96/279 (34%), Gaps = 44/279 (15%)
Query: 35 NGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPI 94
LK E+ ++ + ++ + S + + +
Sbjct: 76 TPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVY 135
Query: 95 AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDF 154
+ + + L D + + + + A A+ +LH + ++ RD
Sbjct: 136 LYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHI--FIQIAEAVEFLHS---KGLMHRDL 190
Query: 155 KTSHILFSEENVVKLFDFSLS------------ISIPEGETHITDTVMGTYGHLAPQYVT 202
K S+I F+ ++VVK+ DF L ++ T V GT +++P+ +
Sbjct: 191 KPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV-GTKLYMSPEQIH 249
Query: 203 TCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFE-DNRFTEIVDP 261
++S K+D++S G L ELL Y F E T++ +
Sbjct: 250 GNNYSHKVDIFSLGLILFELL----------------YSF----STQMERVRIITDVRNL 289
Query: 262 IIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDV 300
+ ++ + + L+ SP +RP D+
Sbjct: 290 KFPLLFTQKYPQE-----HMMVQDMLSPSPTERPEATDI 323
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 36/159 (22%), Positives = 68/159 (42%), Gaps = 24/159 (15%)
Query: 76 QMSHDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQTHF-EPLLLKRRLKDAVD 133
+ H +I++L L+F+ V G L++ I+ + ++ E DA
Sbjct: 66 LLKHPNIVRLHDSI-SEEGHHYLIFDLVTGGELFEDIVA--REYYSE--------ADASH 114
Query: 134 A----ANALAYLHFGFPRPIVFRDFKTSHILF---SEENVVKLFDFSLSISIPEGETHIT 186
A+ + H +V R+ K ++L + VKL DF L+I + +
Sbjct: 115 CIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF 171
Query: 187 DTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225
GT G+L+P+ + + + +D+++ G L LL G
Sbjct: 172 GFA-GTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-11
Identities = 31/166 (18%), Positives = 62/166 (37%), Gaps = 37/166 (22%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAA 135
++SH H++ G C+ ILV E+V+ G+L D L + + + + +L+ A A
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSL-DTYL---KKNKNCINILWKLEVAKQLA 123
Query: 136 NALAYL---HFGFPRPIVFRD--------FKTSHILFSEENVVKLFDFSLSISIPEGETH 184
A+ +L + + + +KL D +SI++ +
Sbjct: 124 AAMHFLEENTL------IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-- 175
Query: 185 ITDTVMGTYGHL-----APQYVTTC-DFSEKLDVYSFGAFLSELLT 224
P+ + + + D +SFG L E+ +
Sbjct: 176 --------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-11
Identities = 34/162 (20%), Positives = 64/162 (39%), Gaps = 28/162 (17%)
Query: 77 MSHDHILKLIGCCLETPIAI-----LVFEYVQHGTLWDRILGAPQTHF-EPLLLKRRLKD 130
HI+ ++ E ++ E ++ G L+ RI F E ++
Sbjct: 79 SGGPHIVCILDVY-ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTE--------RE 129
Query: 131 AVDA----ANALAYLHFGFPRPIVFRDFKTSHILF---SEENVVKLFDFSLSISIPEGET 183
A + A+ +LH I RD K ++L+ ++ V+KL DF + +
Sbjct: 130 AAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL 186
Query: 184 HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225
T T ++AP+ + + + D++S G + LL G
Sbjct: 187 Q---TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-11
Identities = 37/160 (23%), Positives = 64/160 (40%), Gaps = 26/160 (16%)
Query: 76 QMSHDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQTHF-EPLLLKRRLKDAVD 133
++ H +++ L E + L+ E V G L+D + A + E ++A +
Sbjct: 70 EIQHPNVITLHEVY-ENKTDVILILELVAGGELFDFL--AEKESLTE--------EEATE 118
Query: 134 AA----NALAYLHFGFPRPIVFRDFKTSHILFS----EENVVKLFDFSLSISIPEGETHI 185
N + YLH I D K +I+ + +K+ DF L+ I G
Sbjct: 119 FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF- 174
Query: 186 TDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225
+ GT +AP+ V + D++S G LL+G
Sbjct: 175 -KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-11
Identities = 36/157 (22%), Positives = 55/157 (35%), Gaps = 23/157 (14%)
Query: 78 SHDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQTHF-EPLLLKRRLKDAVDAA 135
S ++ L E I L+ EY G ++ L E D +
Sbjct: 87 SCPRVINLHEVY-ENTSEIILILEYAAGGEIFSLCLPELAEMVSE--------NDVIRLI 137
Query: 136 ----NALAYLHFGFPRPIVFRDFKTSHILF---SEENVVKLFDFSLSISIPEGETHITDT 188
+ YLH IV D K +IL +K+ DF +S I
Sbjct: 138 KQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC--ELRE 192
Query: 189 VMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225
+MGT +LAP+ + + D+++ G LLT
Sbjct: 193 IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 4e-11
Identities = 39/157 (24%), Positives = 69/157 (43%), Gaps = 25/157 (15%)
Query: 79 HDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQTHF-EPLLLKRRLKDAVDA-- 134
H +I+ L + + +V E ++ G L D+IL Q F E ++A
Sbjct: 75 HPNIITLKDVY-DDGKYVYVVTELMKGGELLDKILR--QKFFSE--------REASAVLF 123
Query: 135 --ANALAYLHFGFPRPIVFRDFKTSHILFSEEN----VVKLFDFSLSISIPEGETHITDT 188
+ YLH + +V RD K S+IL+ +E+ +++ DF + + E + T
Sbjct: 124 TITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL-RAENGLLMT 179
Query: 189 VMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225
T +AP+ + + D++S G L +LTG
Sbjct: 180 PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 4e-11
Identities = 52/269 (19%), Positives = 101/269 (37%), Gaps = 78/269 (28%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTL-------------------WDRILGAPQ 116
Q++H H++KL G C + +L+ EY ++G+L
Sbjct: 82 QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDH 141
Query: 117 THFEPLLLKRRLKDAVDAANALAYL---HFGFPRPIVFRDFKTSHILFSEENVVKLFDFS 173
L + + A + + YL V RD +IL +E +K+ DF
Sbjct: 142 PDERALTMGDLISFAWQISQGMQYLAEMKL------VHRDLAARNILVAEGRKMKISDFG 195
Query: 174 LSISIPEGETHITDTVMGTYGHL-----APQYVTTCDFSEKLDVYSFGAFLSELLT---- 224
LS + E +++ V + G + A + + ++ + DV+SFG L E++T
Sbjct: 196 LSRDVYEEDSY----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251
Query: 225 ------GRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHA 278
+ +L++ H + P N C+E +++
Sbjct: 252 PYPGIPPERLFNLLKTGHRMERPDN-------------------------CSE---EMY- 282
Query: 279 SAQLTFECLNESPIDRPTMVDVARRLRQI 307
+L +C + P RP D+++ L ++
Sbjct: 283 --RLMLQCWKQEPDKRPVFADISKDLEKM 309
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 5e-11
Identities = 45/194 (23%), Positives = 65/194 (33%), Gaps = 47/194 (24%)
Query: 76 QMSHDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAV-- 132
++ H +I +L E I LV E G L D++ +
Sbjct: 84 KLHHPNIARLYEV-YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142
Query: 133 --------------------------DAA-------NALAYLHFGFPRPIVFRDFKTSHI 159
+ +AL YLH + I RD K +
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENF 199
Query: 160 LFS--EENVVKLFDFSLSISIP---EGETHITDTVMGTYGHLAPQYVTTCD--FSEKLDV 212
LFS + +KL DF LS GE + T GT +AP+ + T + + K D
Sbjct: 200 LFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259
Query: 213 YSFGAFLSELLTGR 226
+S G L LL G
Sbjct: 260 WSAGVLLHLLLMGA 273
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 8e-11
Identities = 47/253 (18%), Positives = 90/253 (35%), Gaps = 55/253 (21%)
Query: 75 AQMSHDHILKLIGCCLETPIAI-------------LVFEYVQHGTLWDRILGAPQTHFEP 121
A ++H ++++ LE + + EY ++GTL+D I + + +
Sbjct: 57 ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH-SENLNQQR 115
Query: 122 LLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS------ 175
R + ++A L+Y+H + I+ RD K +I E VK+ DF L+
Sbjct: 116 DEYWRLFRQILEA---LSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRS 169
Query: 176 -------ISIPEGETHITDTVMGTYGHLAP-QYVTTCDFSEKLDVYSFGAFLSELLTGRG 227
G + + +GT ++A T ++EK+D+YS G E++
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFS 229
Query: 228 ILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECL 287
+ V + E P + EK+ + +
Sbjct: 230 ------TGMERVNILKKLRSVSIE-------FPPDFDDNKMKVEKK--------IIRLLI 268
Query: 288 NESPIDRPTMVDV 300
+ P RP +
Sbjct: 269 DHDPNKRPGARTL 281
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 8e-11
Identities = 37/160 (23%), Positives = 62/160 (38%), Gaps = 26/160 (16%)
Query: 76 QMSHDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQTHF-EPLLLKRRLKDAVD 133
++ H +I+ L E + L+ E V G L+D + A + E +A
Sbjct: 64 EIRHPNIITLHDIF-ENKTDVVLILELVSGGELFDFL--AEKESLTE--------DEATQ 112
Query: 134 A----ANALAYLHFGFPRPIVFRDFKTSHILF----SEENVVKLFDFSLSISIPEGETHI 185
+ + YLH + I D K +I+ +KL DF ++ I G
Sbjct: 113 FLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN--E 167
Query: 186 TDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225
+ GT +AP+ V + D++S G LL+G
Sbjct: 168 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 8e-11
Identities = 41/157 (26%), Positives = 63/157 (40%), Gaps = 21/157 (13%)
Query: 76 QMSHDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA 134
Q+ H ++++L E+ I LV EYV G L+DRI+ E D +
Sbjct: 142 QLDHANLIQLYDA-FESKNDIVLVMEYVDGGELFDRIIDESYNLTE--------LDTILF 192
Query: 135 A----NALAYLHFGFPRPIVFRDFKTSHILFS--EENVVKLFDFSLSISIPEGETHITDT 188
+ ++H I+ D K +IL + +K+ DF L+ E
Sbjct: 193 MKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKV 247
Query: 189 VMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225
GT LAP+ V S D++S G LL+G
Sbjct: 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-10
Identities = 53/260 (20%), Positives = 87/260 (33%), Gaps = 75/260 (28%)
Query: 79 HDHILKLIGCCLETPIAILVFEYVQHGTL-----------WDRILGAPQTHFEPLLLKRR 127
H +I+ L+G C L EY HG L D + L ++
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 128 LKDAVDAANALAYL---HFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETH 184
L A D A + YL F + RD +IL E V K+ DF LS
Sbjct: 145 LHFAADVARGMDYLSQKQF------IHRDLAARNILVGENYVAKIADFGLS--------R 190
Query: 185 ITDT-VMGTYGHL-----APQYVTTCDFSEKLDVYSFGAFLSELLT----------GRGI 228
+ V T G L A + + ++ DV+S+G L E+++ +
Sbjct: 191 GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 250
Query: 229 LDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLN 288
+ + + L P N C + +++ L +C
Sbjct: 251 YEKLPQGYRLEKPLN-------------------------CDD---EVY---DLMRQCWR 279
Query: 289 ESPIDRPTMVDVARRLRQIC 308
E P +RP+ + L ++
Sbjct: 280 EKPYERPSFAQILVSLNRML 299
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 1e-10
Identities = 30/157 (19%), Positives = 62/157 (39%), Gaps = 21/157 (13%)
Query: 76 QMSHDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA 134
H +IL L E+ + ++FE++ +++RI + E ++ V
Sbjct: 57 IARHRNILHLHESF-ESMEELVMIFEFISGLDIFERINTSAFELNE--------REIVSY 107
Query: 135 A----NALAYLHFGFPRPIVFRDFKTSHILFS--EENVVKLFDFSLSISIPEGETHITDT 188
AL +LH I D + +I++ + +K+ +F + + G+
Sbjct: 108 VHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RL 162
Query: 189 VMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225
+ + AP+ S D++S G + LL+G
Sbjct: 163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 36/160 (22%), Positives = 63/160 (39%), Gaps = 27/160 (16%)
Query: 79 HDHILKLIGCCLETPIAI-----LVFEYVQHGTLWDRILGAPQTHF-EPLLLKRRLKDAV 132
HI++++ E A +V E + G L+ RI F E ++A
Sbjct: 114 CPHIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE--------REAS 164
Query: 133 DA----ANALAYLHFGFPRPIVFRDFKTSHILF---SEENVVKLFDFSLSISIPEGETHI 185
+ A+ YLH I RD K ++L+ ++KL DF + +
Sbjct: 165 EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL- 220
Query: 186 TDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225
T T ++AP+ + + + D++S G + LL G
Sbjct: 221 -TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-10
Identities = 40/163 (24%), Positives = 75/163 (46%), Gaps = 31/163 (19%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAA 135
+++H I+K+ + +V E ++ G L+D+++G +RLK+A
Sbjct: 71 KLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVG-----------NKRLKEA-TCK 117
Query: 136 N-------ALAYLHFGFPRPIVFRDFKTSHILF---SEENVVKLFDFSLSISIPEGETHI 185
A+ YLH I+ RD K ++L E+ ++K+ DF S + E +
Sbjct: 118 LYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--L 172
Query: 186 TDTVMGTYGHLAPQYVTTCD---FSEKLDVYSFGAFLSELLTG 225
T+ GT +LAP+ + + ++ +D +S G L L+G
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 40/170 (23%), Positives = 69/170 (40%), Gaps = 30/170 (17%)
Query: 78 SHDHILKLIGCCLETPIAILVFEYVQHGTL------------------WDRILGAPQTHF 119
SH++I+ L+G C + L+FEY +G L ++ +
Sbjct: 107 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 120 EPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIP 179
L + L A A + +L F + V RD ++L + VVK+ DF L+ I
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 223
Query: 180 EGETHITDTVMGTYGHL-----APQYVTTCDFSEKLDVYSFGAFLSELLT 224
+ V+ L AP+ + ++ K DV+S+G L E+ +
Sbjct: 224 SDSNY----VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 3e-10
Identities = 37/162 (22%), Positives = 71/162 (43%), Gaps = 29/162 (17%)
Query: 77 MSHDHILKLIGCCLETPIA---ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAV- 132
+ H +++KL+ L+ P +VFE V G + + + L +
Sbjct: 93 LDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPVMEVPT------------LKPLSEDQA 139
Query: 133 -----DAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITD 187
D + YLH+ + I+ RD K S++L E+ +K+ DF +S + +G +
Sbjct: 140 RFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVS-NEFKGSDALLS 195
Query: 188 TVMGTYGHLAPQYVTTCDFS---EKLDVYSFGAFLSELLTGR 226
+GT +AP+ ++ + LDV++ G L + G+
Sbjct: 196 NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 9e-10
Identities = 32/175 (18%), Positives = 62/175 (35%), Gaps = 35/175 (20%)
Query: 79 HDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA--- 134
H ++++ C T + + E L D + + + L ++ + +
Sbjct: 68 HPNVIRYY-CSETTDRFLYIALELCN-LNLQDLVES--KNVSDENLKLQKEYNPISLLRQ 123
Query: 135 -ANALAYLHFGFPRPIVFRDFKTSHILFSEENV-------------VKLFDFSLSISIPE 180
A+ +A+LH I+ RD K +IL S + + + DF L +
Sbjct: 124 IASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 181 GE---THITDTVMGTYGHLAP-------QYVTTCDFSEKLDVYSFGAFLSELLTG 225
G+ + GT G AP T + +D++S G +L+
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-09
Identities = 19/153 (12%), Positives = 43/153 (28%), Gaps = 38/153 (24%)
Query: 74 AAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVD 133
+++ + +++ ++V E+++ G+L + +P ++
Sbjct: 85 LSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPV-------GAIRAMQS 137
Query: 134 AANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTY 193
A A H + S + S + V L
Sbjct: 138 LAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYP--------------------- 173
Query: 194 GHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
+ + + D+ GA L LL R
Sbjct: 174 ATMPDA-------NPQDDIRGIGASLYALLVNR 199
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 34/171 (19%), Positives = 66/171 (38%), Gaps = 33/171 (19%)
Query: 76 QMSHDHILKLIGCCLETPIA---ILVFEYVQHGTLWDRILGAPQTHF-----EPLLLKRR 127
+++H +I+KL E +L+ E+ G+L+ + P + E L++ R
Sbjct: 63 KLNHKNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRD 120
Query: 128 LKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFS----EENVVKLFDFSLSISIPEGET 183
+ + +L IV R+ K +I+ ++V KL DF + + + E
Sbjct: 121 V------VGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ 171
Query: 184 HITDTVMGTYGHLAPQYVTTCD--------FSEKLDVYSFGAFLSELLTGR 226
++ GT +L P + +D++S G TG
Sbjct: 172 --FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-09
Identities = 39/160 (24%), Positives = 64/160 (40%), Gaps = 19/160 (11%)
Query: 75 AQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPL---LLKRRLKDA 131
A +S I+ L G E P + E ++ G+L I L L A
Sbjct: 105 AGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI-----KQMGCLPEDRALYYLGQA 159
Query: 132 VDAANALAYLHFGFPRPIVFRDFKTSHILFSEE-NVVKLFDFSLSISIPEGETHIT---- 186
++ L YLH R I+ D K ++L S + + L DF ++ + +
Sbjct: 160 LEG---LEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG 213
Query: 187 DTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
D + GT H+AP+ V K+D++S + +L G
Sbjct: 214 DYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 2e-09
Identities = 38/149 (25%), Positives = 71/149 (47%), Gaps = 12/149 (8%)
Query: 79 HDHILKLIGCCL-ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANA 137
+I+ G + I+I E++ G+L D++L E +L K ++
Sbjct: 90 SPYIVGFYGAFYSDGEISI-CMEHMDGGSL-DQVLKKAGRIPEQILGKV----SIAVIKG 143
Query: 138 LAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLA 197
L YL I+ RD K S+IL + +KL DF +S + + + ++ +GT +++
Sbjct: 144 LTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMS 198
Query: 198 PQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
P+ + +S + D++S G L E+ GR
Sbjct: 199 PERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 2e-09
Identities = 33/166 (19%), Positives = 63/166 (37%), Gaps = 23/166 (13%)
Query: 76 QMSHDHILKLIGCCLETPIA---ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAV 132
+++H +I+KL E +L+ E+ G+L+ + ++ L L
Sbjct: 63 KLNHKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVL--EEPSNAYGLPESEFLIVLR 119
Query: 133 DAANALAYLHFGFPRPIVFRDFKTSHILFS----EENVVKLFDFSLSISIPEGETHITDT 188
D + +L IV R+ K +I+ ++V KL DF + + + E +
Sbjct: 120 DVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ--FVS 174
Query: 189 VMGTYGHLAPQYVTTCD--------FSEKLDVYSFGAFLSELLTGR 226
+ GT +L P + +D++S G TG
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-09
Identities = 40/164 (24%), Positives = 69/164 (42%), Gaps = 37/164 (22%)
Query: 77 MSHDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA- 134
++H +I+KL +ET + L+ EY G ++D ++ R+K+ +A
Sbjct: 71 LNHPNIVKLFEV-IETEKTLYLIMEYASGGEVFDYLVA-----------HGRMKEK-EAR 117
Query: 135 ------ANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDT 188
+A+ Y H + IV RD K ++L + +K+ DF S G D
Sbjct: 118 SKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG--KLDA 172
Query: 189 VMGTYGHLAP------QYVTTCDFSEKLDVYSFGAFLSELLTGR 226
G + AP +Y ++DV+S G L L++G
Sbjct: 173 FCGAPPYAAPELFQGKKYD-----GPEVDVWSLGVILYTLVSGS 211
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 3e-09
Identities = 39/140 (27%), Positives = 64/140 (45%), Gaps = 9/140 (6%)
Query: 88 CCLETPIAI-LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFP 146
ET A+ LV + G L I Q F R + A + L LH
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP---EARAVFYAAEICCGLEDLH---R 304
Query: 147 RPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDF 206
IV+RD K +IL + +++ D L++ +PEG+T +GT G++AP+ V +
Sbjct: 305 ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKNERY 362
Query: 207 SEKLDVYSFGAFLSELLTGR 226
+ D ++ G L E++ G+
Sbjct: 363 TFSPDWWALGCLLYEMIAGQ 382
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 4e-09
Identities = 45/167 (26%), Positives = 67/167 (40%), Gaps = 34/167 (20%)
Query: 79 HDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQTHF-EPLLLKRRLKDAVDA-- 134
H ++L+LI E LVFE ++ G++ I + HF E +A
Sbjct: 70 HRNVLELIEFF-EEEDRFYLVFEKMRGGSILSHIHK--RRHFNE--------LEASVVVQ 118
Query: 135 --ANALAYLHFGFPRPIVFRDFKTSHILFSEEN---VVKLFDFSLSISIPEGETHITD-- 187
A+AL +LH + I RD K +IL N VK+ DF L I
Sbjct: 119 DVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIST 175
Query: 188 ----TVMGTYGHLAPQYVTTCDFSEKL-----DVYSFGAFLSELLTG 225
T G+ ++AP+ V + D++S G L LL+G
Sbjct: 176 PELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 1e-08
Identities = 40/165 (24%), Positives = 72/165 (43%), Gaps = 31/165 (18%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQH---GTLWDRILGAPQTHFEPLLLKRRLKDAV 132
++ H++I++L LVFE++ + + R +G E L+K +
Sbjct: 59 ELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 133 DAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL--SISIPEGE-TH--IT- 186
LA+ H I+ RD K ++L ++ +KL DF L + IP + +T
Sbjct: 119 ---QGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTL 172
Query: 187 -----DTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
D +MG + Y S +D++S G L+E++TG+
Sbjct: 173 WYRAPDVLMG-----SRTY------STSIDIWSCGCILAEMITGK 206
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 1e-08
Identities = 38/179 (21%), Positives = 70/179 (39%), Gaps = 46/179 (25%)
Query: 76 QMSHDHILKLIGCCLETPIAI--------LVFEYVQHGTLWD--RILGAPQTHFEPLLLK 125
+ H++++ LI C LVF++ +H D +L F +K
Sbjct: 72 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH----DLAGLLSNVLVKFTLSEIK 127
Query: 126 RRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL----SISIPEG 181
R ++ + N L Y+H I+ RD K +++L + + V+KL DF L S++
Sbjct: 128 RVMQMLL---NGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 181
Query: 182 ETHITDTV-----------MGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGIL 229
T+ V +G Y +D++ G ++E+ T I+
Sbjct: 182 PNRYTNRVVTLWYRPPELLLG-----ERDY------GPPIDLWGAGCIMAEMWTRSPIM 229
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 1e-08
Identities = 35/161 (21%), Positives = 63/161 (39%), Gaps = 24/161 (14%)
Query: 79 HDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANA 137
D I++L T I +V E L + + +P K K+ + A
Sbjct: 87 SDKIIRLYDY-EITDQYIYMVMECGN-IDLNSWL--KKKKSIDPWERKSYWKNML---EA 139
Query: 138 LAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHIT-DTVMGTYGHL 196
+ +H IV D K ++ L + ++KL DF ++ + T + D+ +GT ++
Sbjct: 140 VHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 195
Query: 197 APQ-----------YVTTCDFSEKLDVYSFGAFLSELLTGR 226
P+ + S K DV+S G L + G+
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 39/162 (24%), Positives = 66/162 (40%), Gaps = 28/162 (17%)
Query: 75 AQMSHDHILKLIGCCLETPIAI-LVFEYVQHGTL-----WDRILGAPQTHF---EPLLLK 125
H + L +T + V EY G L +R+ + F E +
Sbjct: 203 QNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS-- 259
Query: 126 RRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS-ISIPEGETH 184
AL YLH + +V+RD K +++ ++ +K+ DF L I +G T
Sbjct: 260 -----------ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT- 305
Query: 185 ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
T GT +LAP+ + D+ +D + G + E++ GR
Sbjct: 306 -MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 3e-08
Identities = 35/161 (21%), Positives = 63/161 (39%), Gaps = 24/161 (14%)
Query: 79 HDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANA 137
D I++L T I +V E L + + +P K K+ + A
Sbjct: 68 SDKIIRLYDY-EITDQYIYMVMECGN-IDLNSWL--KKKKSIDPWERKSYWKNML---EA 120
Query: 138 LAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHIT-DTVMGTYGHL 196
+ +H IV D K ++ L + ++KL DF ++ + T + D+ +GT ++
Sbjct: 121 VHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176
Query: 197 APQ-----------YVTTCDFSEKLDVYSFGAFLSELLTGR 226
P+ + S K DV+S G L + G+
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-08
Identities = 41/164 (25%), Positives = 72/164 (43%), Gaps = 16/164 (9%)
Query: 65 ESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEP--- 121
E IN + + + +I+ + L +V EY+ G+L D + E
Sbjct: 62 ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIA 119
Query: 122 LLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEG 181
+ + L+ AL +LH ++ RD K+ +IL + VKL DF I
Sbjct: 120 AVCRECLQ-------ALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169
Query: 182 ETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225
++ T++GT +AP+ VT + K+D++S G E++ G
Sbjct: 170 QSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 4e-08
Identities = 34/161 (21%), Positives = 62/161 (38%), Gaps = 24/161 (14%)
Query: 79 HDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANA 137
D I++L T I +V E L + + +P K K+ + A
Sbjct: 115 SDKIIRLYDY-EITDQYIYMVMECGN-IDLNSWL--KKKKSIDPWERKSYWKNML---EA 167
Query: 138 LAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHIT-DTVMGTYGHL 196
+ +H IV D K ++ L + ++KL DF ++ + T + D+ +G ++
Sbjct: 168 VHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYM 223
Query: 197 APQ-----------YVTTCDFSEKLDVYSFGAFLSELLTGR 226
P+ + S K DV+S G L + G+
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 6e-08
Identities = 40/164 (24%), Positives = 65/164 (39%), Gaps = 34/164 (20%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWD--RILGAPQTHFEPLLLKRRLKDAVD 133
+ H +I+ L LVFEY+ D + L +K L +
Sbjct: 56 DLKHANIVTLHDIIHTEKSLTLVFEYLDK----DLKQYLDDCGNIINMHNVKLFLFQLL- 110
Query: 134 AANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL--SISIPEGE-TH--IT-- 186
LAY H + ++ RD K ++L +E +KL DF L + SIP + +T
Sbjct: 111 --RGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLW 165
Query: 187 ----DTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
D ++G + Y S ++D++ G E+ TGR
Sbjct: 166 YRPPDILLG-----STDY------STQIDMWGVGCIFYEMATGR 198
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 6e-08
Identities = 38/161 (23%), Positives = 67/161 (41%), Gaps = 28/161 (17%)
Query: 77 MSHDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAA 135
++H++++K G L EY G L+DRI + + A
Sbjct: 62 LNHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEP-----------DIGMPE--PDA 107
Query: 136 --------NALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS-ISIPEGETHIT 186
+ YLH I RD K ++L E + +K+ DF L+ + +
Sbjct: 108 QRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164
Query: 187 DTVMGTYGHLAPQYVTTCDFS-EKLDVYSFGAFLSELLTGR 226
+ + GT ++AP+ + +F E +DV+S G L+ +L G
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 6e-08
Identities = 44/253 (17%), Positives = 77/253 (30%), Gaps = 37/253 (14%)
Query: 75 AQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA 134
+H +I+ + +V ++ +G+ D I L + L+ +
Sbjct: 81 KLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVL-- 138
Query: 135 ANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEG------ETHITDT 188
AL Y+H V R K SHIL S + V L ++S+
Sbjct: 139 -KALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKY 194
Query: 189 VMGTYGHLAPQYVTTCD--FSEKLDVYSFGAFLSELLTG----------RGILDLVRDAH 236
+ L+P+ + + K D+YS G EL G + +L+ +
Sbjct: 195 SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV 254
Query: 237 ----DLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTF-------- 284
D E L + + + TF
Sbjct: 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFV 314
Query: 285 -ECLNESPIDRPT 296
+CL +P RP+
Sbjct: 315 EQCLQRNPDARPS 327
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 6e-08
Identities = 26/91 (28%), Positives = 46/91 (50%), Gaps = 7/91 (7%)
Query: 137 ALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHL 196
L ++H R +V+RD K ++IL E V++ D L+ + + H +GT+G++
Sbjct: 304 GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYM 357
Query: 197 APQYVTT-CDFSEKLDVYSFGAFLSELLTGR 226
AP+ + + D +S G L +LL G
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 1e-07
Identities = 41/164 (25%), Positives = 74/164 (45%), Gaps = 34/164 (20%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWD--RILGAPQTHFEPLLLKRRLKDAVD 133
++ H +I+ LI LVFE+++ D ++L +T + +K L +
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTLVFEFMEK----DLKKVLDENKTGLQDSQIKIYLYQLLR 130
Query: 134 AANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL--SISIPEGE-TH--IT-- 186
+A+ H I+ RD K ++L + + +KL DF L + IP TH +T
Sbjct: 131 G---VAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLW 184
Query: 187 ----DTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
D +MG + +Y S +D++S G +E++TG+
Sbjct: 185 YRAPDVLMG-----SKKY------STSVDIWSIGCIFAEMITGK 217
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 25/90 (27%), Positives = 48/90 (53%), Gaps = 4/90 (4%)
Query: 137 ALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHL 196
L +LH R I++RD K ++L ++ V++ D L++ + G+T T GT G +
Sbjct: 301 GLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-KTKGYAGTPGFM 356
Query: 197 APQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
AP+ + ++ +D ++ G L E++ R
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 1e-07
Identities = 42/164 (25%), Positives = 74/164 (45%), Gaps = 34/164 (20%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWD--RILGAPQTHFEPLLLKRRLKDAVD 133
++ H +I+KL +LVFE++ D ++L + E + K L +
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLDQ----DLKKLLDVCEGGLESVTAKSFLLQLL- 110
Query: 134 AANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL--SISIPEGE-TH--IT-- 186
N +AY H R ++ RD K ++L + E +K+ DF L + IP + TH +T
Sbjct: 111 --NGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLW 165
Query: 187 ----DTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
D +MG + +Y S +D++S G +E++ G
Sbjct: 166 YRAPDVLMG-----SKKY------STTIDIWSVGCIFAEMVNGT 198
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-07
Identities = 42/164 (25%), Positives = 71/164 (43%), Gaps = 14/164 (8%)
Query: 65 ESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEP--- 121
+ I ++ Q H++K G + +V EY G++ D I +T E
Sbjct: 69 QEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIA 128
Query: 122 LLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEG 181
+L+ LK L YLHF + RD K +IL + E KL DF ++ + +
Sbjct: 129 TILQSTLK-------GLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178
Query: 182 ETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225
+TV+GT +AP+ + ++ D++S G E+ G
Sbjct: 179 MAK-RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-07
Identities = 40/189 (21%), Positives = 74/189 (39%), Gaps = 44/189 (23%)
Query: 77 MSHDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAA 135
++H++++K G L EY G L+DRI + + A
Sbjct: 62 LNHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEP-----------DIGMPE--PDA 107
Query: 136 --------NALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS-ISIPEGETHIT 186
+ YLH I RD K ++L E + +K+ DF L+ + +
Sbjct: 108 QRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164
Query: 187 DTVMGTYGHLAPQYVTTCDFS-EKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPF--- 242
+ + GT ++AP+ + +F E +DV+S G L+ +L G P+
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE-------------LPWDQP 211
Query: 243 NEYLKNYFE 251
++ + Y +
Sbjct: 212 SDSCQEYSD 220
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 1e-07
Identities = 39/163 (23%), Positives = 67/163 (41%), Gaps = 27/163 (16%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWD--RILGAPQTHFEPL-------LLKR 126
+ H +I++ +G E + E V G+L R P E +L+
Sbjct: 75 HLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILE- 133
Query: 127 RLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN-VVKLFDFSLSISIPEGETHI 185
L YLH IV RD K ++L + + V+K+ DF S +
Sbjct: 134 ----------GLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC- 179
Query: 186 TDTVMGTYGHLAPQYV--TTCDFSEKLDVYSFGAFLSELLTGR 226
T+T GT ++AP+ + + + D++S G + E+ TG+
Sbjct: 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-07
Identities = 38/164 (23%), Positives = 74/164 (45%), Gaps = 16/164 (9%)
Query: 65 ESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEP--- 121
E N V H +++++ L ++ E++Q G L D + E
Sbjct: 87 ELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLN--EEQIA 144
Query: 122 LLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEG 181
+ + L+ ALAYLH + ++ RD K+ IL + + VKL DF I +
Sbjct: 145 TVCEAVLQ-------ALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD 194
Query: 182 ETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225
+++GT +AP+ ++ ++ ++D++S G + E++ G
Sbjct: 195 VPK-RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 29/93 (31%), Positives = 43/93 (46%), Gaps = 8/93 (8%)
Query: 137 ALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHL 196
AL YL + I+ RD K +IL E V + DF+++ +P T+ GT ++
Sbjct: 127 ALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ--ITTMAGTKPYM 181
Query: 197 AP---QYVTTCDFSEKLDVYSFGAFLSELLTGR 226
AP +S +D +S G ELL GR
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 2e-07
Identities = 37/162 (22%), Positives = 71/162 (43%), Gaps = 30/162 (18%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAA 135
Q+ H++++ L+ C + LVFE+V H T+ L + ++++ L +
Sbjct: 80 QLRHENLVNLLEVCKKKKRWYLVFEFVDH-TI-LDDLELFPNGLDYQVVQKYLFQII--- 134
Query: 136 NALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS--ISIPEGE-TH--IT---- 186
N + + H I+ RD K +IL S+ VVKL DF + ++ P T
Sbjct: 135 NGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYR 191
Query: 187 --DTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
+ ++G +Y + +DV++ G ++E+ G
Sbjct: 192 APELLVG-----DVKY------GKAVDVWAIGCLVTEMFMGE 222
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 2e-07
Identities = 40/162 (24%), Positives = 66/162 (40%), Gaps = 29/162 (17%)
Query: 75 AQMSHDHILKLIGCCLETPIAI-LVFEYVQHGTL-----WDRILGAPQTHF---EPLLLK 125
H + L +T + V EY G L +R+ + F E +
Sbjct: 60 QNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVS-- 116
Query: 126 RRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS-ISIPEGETH 184
AL YLH R +V+RD K +++ ++ +K+ DF L I +G T
Sbjct: 117 -----------ALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT- 161
Query: 185 ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
T GT +LAP+ + D+ +D + G + E++ GR
Sbjct: 162 -MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-07
Identities = 39/157 (24%), Positives = 65/157 (41%), Gaps = 22/157 (14%)
Query: 75 AQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA 134
+Q ++ K G L+ ++ EY+ G+ D LL L + A
Sbjct: 75 SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD------------LLEPGPLDETQIA 122
Query: 135 A------NALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDT 188
L YLH + RD K +++L SE VKL DF ++ + + + +T
Sbjct: 123 TILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RNT 178
Query: 189 VMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225
+GT +AP+ + + K D++S G EL G
Sbjct: 179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARG 215
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 3e-07
Identities = 42/167 (25%), Positives = 68/167 (40%), Gaps = 34/167 (20%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWD--RILGAPQTHFEPLLLKRRLKDAVD 133
++SH +I+ L+ LVF++++ D I+ P +K + +
Sbjct: 68 ELSHPNIIGLLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQ 123
Query: 134 AANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL--SISIPEGE-TH--IT-- 186
L YLH I+ RD K +++L E V+KL DF L S P TH +T
Sbjct: 124 G---LEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRW 177
Query: 187 ----DTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGIL 229
+ + G A Y +D+++ G L+ELL L
Sbjct: 178 YRAPELLFG-----ARMY------GVGVDMWAVGCILAELLLRVPFL 213
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 3e-07
Identities = 44/165 (26%), Positives = 63/165 (38%), Gaps = 39/165 (23%)
Query: 77 MSHDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAA 135
H HI+KL + TP +V EYV G L+D I R+++ A
Sbjct: 68 FRHPHIIKLYQV-ISTPTDFFMVMEYVSGGELFDYICK-----------HGRVEE--MEA 113
Query: 136 --------NALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITD 187
+A+ Y H +V RD K ++L K+ DF LS + +G
Sbjct: 114 RRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLR 168
Query: 188 TVMGTYGHLAPQYVTTCDFSEKL------DVYSFGAFLSELLTGR 226
T G+ P Y S +L D++S G L LL G
Sbjct: 169 TSCGS-----PNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 4e-07
Identities = 34/92 (36%), Positives = 49/92 (53%), Gaps = 8/92 (8%)
Query: 137 ALAYLH-FGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS-ISIPEGETHITDTVMGTYG 194
AL +LH G I++RD K +IL EE +KL DF LS SI + + GT
Sbjct: 138 ALDHLHSLG----IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVE 191
Query: 195 HLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
++AP+ V ++ D +SFG + E+LTG
Sbjct: 192 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 5e-07
Identities = 27/91 (29%), Positives = 49/91 (53%), Gaps = 6/91 (6%)
Query: 137 ALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS-ISIPEGETHITDTVMGTYGH 195
L +LH + IV+RD K +IL ++ +K+ DF + ++ T+T GT +
Sbjct: 130 GLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTPDY 184
Query: 196 LAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
+AP+ + ++ +D +SFG L E+L G+
Sbjct: 185 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 5e-07
Identities = 34/168 (20%), Positives = 63/168 (37%), Gaps = 38/168 (22%)
Query: 76 QMSHDHILKLIGCCLETPIAI-----LVFEYVQH--GTLWDRILGAPQTHFEPLLLKRRL 128
H ++++L C + LVFE+V T D++ P+ +K +
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMM 126
Query: 129 KDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL--SISIPEGETH-- 184
+ L +LH +V RD K +IL + +KL DF L S T
Sbjct: 127 FQLL---RGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV 180
Query: 185 IT------DTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
+T + ++ + Y + +D++S G +E+ +
Sbjct: 181 VTLWYRAPEVLLQS------SY------ATPVDLWSVGCIFAEMFRRK 216
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 7e-07
Identities = 33/179 (18%), Positives = 62/179 (34%), Gaps = 41/179 (22%)
Query: 76 QMSHDHILKLIGCCLE-TPIAI-LVFEYVQH------GTLWDRILGAPQTHFEPLLLKRR 127
++ H +++ L L + L+F+Y +H ++K
Sbjct: 74 ELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSL 133
Query: 128 LKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN----VVKLFDFSL--SISIPEG 181
L + + + YLH ++ RD K ++IL E VK+ D + P
Sbjct: 134 LYQIL---DGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP-- 185
Query: 182 ETHITDTVMGTYGHLAPQYVT-----------TCDFSEKLDVYSFGAFLSELLTGRGIL 229
+ L P VT +++ +D+++ G +ELLT I
Sbjct: 186 --------LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 236
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 7e-07
Identities = 38/162 (23%), Positives = 64/162 (39%), Gaps = 30/162 (18%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAA 135
Q+ H +++ L+ LVFEY H T+ L Q L+K +
Sbjct: 58 QLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TV-LHELDRYQRGVPEHLVKSITWQTL--- 112
Query: 136 NALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL--SISIPEGE-TH--IT---- 186
A+ + H + RD K +IL ++ +V+KL DF ++ P T
Sbjct: 113 QAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYR 169
Query: 187 --DTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
+ ++G QY +DV++ G +ELL+G
Sbjct: 170 SPELLVG-----DTQY------GPPVDVWAIGCVFAELLSGV 200
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 8e-07
Identities = 37/169 (21%), Positives = 63/169 (37%), Gaps = 40/169 (23%)
Query: 76 QMSHDHILKLIGCCLETPIAI-----LVFEYVQH--GTLWDRILGAPQTHFEPLLLKRRL 128
H ++++L+ C + LVFE+V T D+ P +K +
Sbjct: 70 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA---PPPGLPAETIKDLM 126
Query: 129 KDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL--SISIPEGETH-- 184
+ + L +LH IV RD K +IL + VKL DF L S T
Sbjct: 127 RQFL---RGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVV 180
Query: 185 IT------DTVMG-TYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
+T + ++ TY + +D++S G +E+ +
Sbjct: 181 VTLWYRAPEVLLQSTY-------------ATPVDMWSVGCIFAEMFRRK 216
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 8e-07
Identities = 35/164 (21%), Positives = 63/164 (38%), Gaps = 34/164 (20%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQHGTLWD--RILGAPQTHFEPLLLKRRLKDAVD 133
++ H +I++L LVFE+ D + + +P ++K L +
Sbjct: 57 ELKHKNIVRLHDVLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQLL- 111
Query: 134 AANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL--SISIPEGE-TH--IT-- 186
L + H R ++ RD K ++L + +KL +F L + IP + +T
Sbjct: 112 --KGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLW 166
Query: 187 ----DTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
D + G A Y S +D++S G +EL
Sbjct: 167 YRPPDVLFG-----AKLY------STSIDMWSAGCIFAELANAG 199
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 8e-07
Identities = 26/91 (28%), Positives = 49/91 (53%), Gaps = 6/91 (6%)
Query: 137 ALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS-ISIPEGETHITDTVMGTYGH 195
L +L + I++RD K +++ E +K+ DF + +I +G T T T GT +
Sbjct: 133 GLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKTFCGTPDY 187
Query: 196 LAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
+AP+ + + + +D ++FG L E+L G+
Sbjct: 188 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 9e-07
Identities = 32/92 (34%), Positives = 50/92 (54%), Gaps = 8/92 (8%)
Query: 137 ALAYLH-FGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS-ISIPEGETHITDTVMGTYG 194
AL +LH G I++RD K +I+ + + VKL DF L SI +G T T GT
Sbjct: 133 ALGHLHQKG----IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV--THTFCGTIE 186
Query: 195 HLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
++AP+ + + +D +S GA + ++LTG
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 49.3 bits (117), Expect = 9e-07
Identities = 26/91 (28%), Positives = 49/91 (53%), Gaps = 6/91 (6%)
Query: 137 ALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS-ISIPEGETHITDTVMGTYGH 195
L +L + I++RD K +++ E +K+ DF + +I +G T T T GT +
Sbjct: 454 GLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKTFCGTPDY 508
Query: 196 LAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
+AP+ + + + +D ++FG L E+L G+
Sbjct: 509 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 48.8 bits (116), Expect = 1e-06
Identities = 29/115 (25%), Positives = 52/115 (45%), Gaps = 12/115 (10%)
Query: 115 PQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL 174
+ + L L+ + + A + +L R + RD +IL SE+NVVK+ DF L
Sbjct: 183 EDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGL 239
Query: 175 SISIPEGETHITDTVMGTYGHL-----APQYVTTCDFSEKLDVYSFGAFLSELLT 224
+ I + ++ L AP+ + ++ + DV+SFG L E+ +
Sbjct: 240 ARDIYKDPDYVR----KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 1e-06
Identities = 32/165 (19%), Positives = 60/165 (36%), Gaps = 32/165 (19%)
Query: 77 MSHDHILKLIG-CCLETPIAI-LVFEYVQHGT--LWDRILGAPQTHFEPLLLKRRLKDAV 132
+ H ++++L+ E + +V EY G + D + ++R
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP------------EKRFPV-- 108
Query: 133 DAA--------NALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS-ISIPEGET 183
A + L YLH + IV +D K ++L + +K+ ++ P
Sbjct: 109 CQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD 165
Query: 184 HITDTVMGTYGHLAPQYVTTCDFSE--KLDVYSFGAFLSELLTGR 226
T G+ P+ D K+D++S G L + TG
Sbjct: 166 DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 29/91 (31%), Positives = 49/91 (53%), Gaps = 6/91 (6%)
Query: 137 ALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS-ISIPEGETHITDTVMGTYGH 195
AL YLH R I++RD K ++L E +KL D+ + + G+T T T GT +
Sbjct: 122 ALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNY 176
Query: 196 LAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
+AP+ + D+ +D ++ G + E++ GR
Sbjct: 177 IAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.5 bits (117), Expect = 1e-06
Identities = 51/323 (15%), Positives = 96/323 (29%), Gaps = 91/323 (28%)
Query: 27 LQELIASSNGKYIPYRIFSAQELKQET------NNYDQKNGFWHESCINNVTYAAQMSHD 80
+ +I S + R+F KQE + N + S I
Sbjct: 51 IDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTE--------- 101
Query: 81 HILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTH---FEPLL-LKRRLKDAVDAAN 136
+ + ++ Q L++ + + +P L L++ L + A N
Sbjct: 102 --------QRQPSMMTRMYIE-QRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKN 152
Query: 137 ALAYLH--FGFPRPI----VFRDFKTSHILFSEENVVKLFDFSLS-ISIPEGETHITDTV 189
L + G + V +K V DF + +++ + +TV
Sbjct: 153 VL--IDGVLGSGKTWVALDVCLSYK----------VQCKMDFKIFWLNL--KNCNSPETV 198
Query: 190 M----GTYGHLAPQYVTTCDFSE--KLDVYSFGAFLSELLTGRG------ILDLVRDAHD 237
+ + P + + D S KL ++S A L LL + +L V++A
Sbjct: 199 LEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKA 258
Query: 238 LVYPFNEYLKNYFE----------DNRFTEIVDPIIVQDLSCTEKEQQLHA--SAQLTFE 285
N F + T+ + +S L L +
Sbjct: 259 W---------NAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLK 309
Query: 286 CLNESPIDRPTMVDVARRLRQIC 308
L+ P D P R++
Sbjct: 310 YLDCRPQDLP---------REVL 323
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.2 bits (111), Expect = 5e-06
Identities = 41/301 (13%), Positives = 86/301 (28%), Gaps = 64/301 (21%)
Query: 19 MIGNGASVLQELIASSNG--KYIPYRIF---------SAQELKQETNNYDQKNGFWHESC 67
++G+G + + + S + ++IF L+ Q + W
Sbjct: 158 VLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRS 217
Query: 68 --INNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFE---PL 122
+N+ + +L+ +LV VQ+ W+ F +
Sbjct: 218 DHSSNIKLRIHSIQAELRRLL-KSKPYENCLLVLLNVQNAKAWN--------AFNLSCKI 268
Query: 123 LLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISI---P 179
LL R K D +A H I + + + V L L P
Sbjct: 269 LLTTRFKQVTDFLSAATTTH------ISLDHHSMT---LTPDEVKSLLLKYLDCRPQDLP 319
Query: 180 EGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLV 239
+ + T D + ++ + L +L+
Sbjct: 320 REVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLN---VLE--------- 367
Query: 240 YPFNEYLKNY-----FEDN-RFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPID 293
P EY K + F + I+ +I D+ ++ ++ + S ++
Sbjct: 368 -P-AEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVN-------KLHKYSLVE 418
Query: 294 R 294
+
Sbjct: 419 K 419
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 1e-06
Identities = 24/91 (26%), Positives = 50/91 (54%), Gaps = 4/91 (4%)
Query: 137 ALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS-ISIPEGETHITDTVMGTYGH 195
AL YLH + I+ RD K +IL +E+ +++ DF + + PE + ++ +GT +
Sbjct: 142 ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 198
Query: 196 LAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
++P+ +T + D+++ G + +L+ G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 29/91 (31%), Positives = 49/91 (53%), Gaps = 6/91 (6%)
Query: 137 ALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS-ISIPEGETHITDTVMGTYGH 195
AL YLH R I++RD K ++L E +KL D+ + + G+T T T GT +
Sbjct: 165 ALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNY 219
Query: 196 LAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
+AP+ + D+ +D ++ G + E++ GR
Sbjct: 220 IAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 29/91 (31%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 137 ALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS-ISIPEGETHITDTVMGTYGH 195
AL +LH + I++RD K ++L E KL DF + I G T T T GT +
Sbjct: 136 ALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT--TATFCGTPDY 190
Query: 196 LAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
+AP+ + + +D ++ G L E+L G
Sbjct: 191 IAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 3e-06
Identities = 35/160 (21%), Positives = 57/160 (35%), Gaps = 48/160 (30%)
Query: 79 HDHILKLIGCCLETPIAI-----LVFEYVQHGTLWDRILGAPQTHF-EPLLLKRRLKDAV 132
HI++++ E A +V E + G L+ RI F E ++A
Sbjct: 70 CPHIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE--------REAS 120
Query: 133 DA----ANALAYLHFGFPRPIVFRDFKTSHILF---SEENVVKLFDFSLSISIPEGETHI 185
+ A+ YLH I RD K ++L+ ++KL DF G
Sbjct: 121 EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDF--------G---- 165
Query: 186 TDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG 225
A + T + + D++S G + LL G
Sbjct: 166 ----------FAKE-TTGEKYDKSCDMWSLGVIMYILLCG 194
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 24/101 (23%), Positives = 41/101 (40%), Gaps = 20/101 (19%)
Query: 137 ALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHL 196
A+ +H V RD K +IL ++L DF + + E T + +GT ++
Sbjct: 187 AIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI 243
Query: 197 AP-----------QYVTTCDFSEKLDVYSFGAFLSELLTGR 226
+P +Y CD+ +S G + E+L G
Sbjct: 244 SPEILQAMEGGKGRYGPECDW------WSLGVCMYEMLYGE 278
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 3e-06
Identities = 32/91 (35%), Positives = 44/91 (48%), Gaps = 6/91 (6%)
Query: 137 ALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS-ISIPEGETHITDTVMGTYGH 195
AL YLH IV+RD K +IL + + L DF L +I T T T GT +
Sbjct: 151 ALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST--TSTFCGTPEY 205
Query: 196 LAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
LAP+ + + +D + GA L E+L G
Sbjct: 206 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 3e-06
Identities = 31/175 (17%), Positives = 53/175 (30%), Gaps = 33/175 (18%)
Query: 74 AAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRIL--GAPQTHFEPLLLKRRLKDA 131
A H H+++ E ++ EY G+L D I ++F+ LK L
Sbjct: 65 AVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL--- 121
Query: 132 VDAANALAYLHFGFPRPIVFRDFKTSHILFSEENV-------------------VKLFDF 172
+ L Y+H +V D K S+I S ++ K+ D
Sbjct: 122 LQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDL 178
Query: 173 SLSISIPEGETHITDTVMGTYGHLAPQYVT-TCDFSEKLDVYSFGAFLSELLTGR 226
I G LA + + K D+++ +
Sbjct: 179 GHVTRISS-----PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 6e-06
Identities = 23/90 (25%), Positives = 45/90 (50%), Gaps = 5/90 (5%)
Query: 137 ALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHL 196
+ +LH I+ RD K S+I+ + +K+ DF L+ + +T V+ T +
Sbjct: 139 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVV-TRYYR 193
Query: 197 APQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
AP+ + + E +D++S G + E++ G
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 7e-06
Identities = 38/159 (23%), Positives = 70/159 (44%), Gaps = 19/159 (11%)
Query: 75 AQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEP---LLLKRRLKDA 131
A H +I+KL+G ++ E+ G + +L + EP ++ ++ L+
Sbjct: 71 ATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLE-- 128
Query: 132 VDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMG 191
AL +LH + I+ RD K ++L + E ++L DF +S + D+ +G
Sbjct: 129 -----ALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK-RDSFIG 179
Query: 192 TYGHLAPQYVTTCDFSE-----KLDVYSFGAFLSELLTG 225
T +AP+ V + K D++S G L E+
Sbjct: 180 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 8e-06
Identities = 26/100 (26%), Positives = 42/100 (42%), Gaps = 19/100 (19%)
Query: 137 ALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHL 196
AL +H + RD K ++L + +KL DF + + + DT +GT ++
Sbjct: 180 ALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 236
Query: 197 AP----------QYVTTCDFSEKLDVYSFGAFLSELLTGR 226
+P Y CD+ +S G FL E+L G
Sbjct: 237 SPEVLKSQGGDGYYGRECDW------WSVGVFLYEMLVGD 270
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 8e-06
Identities = 44/165 (26%), Positives = 62/165 (37%), Gaps = 39/165 (23%)
Query: 77 MSHDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAA 135
H HI+KL + TP I +V EYV G L+D I RL + +
Sbjct: 73 FRHPHIIKLYQV-ISTPSDIFMVMEYVSGGELFDYICK-----------NGRLDE--KES 118
Query: 136 --------NALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITD 187
+ + Y H +V RD K ++L K+ DF LS + +G
Sbjct: 119 RRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLR 173
Query: 188 TVMGTYGHLAPQYVTTCDFSEKL------DVYSFGAFLSELLTGR 226
T G+ P Y S +L D++S G L LL G
Sbjct: 174 TSCGS-----PNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 32/106 (30%), Positives = 44/106 (41%), Gaps = 19/106 (17%)
Query: 131 AVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTV- 189
V AL YL ++ RD K S+IL E +KL DF +S + D
Sbjct: 130 TVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGIS-------GRLVDDKA 180
Query: 190 ----MGTYGHLAP-----QYVTTCDFSEKLDVYSFGAFLSELLTGR 226
G ++AP T D+ + DV+S G L EL TG+
Sbjct: 181 KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 1e-05
Identities = 27/98 (27%), Positives = 42/98 (42%), Gaps = 14/98 (14%)
Query: 136 NALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGE---THITDTVMGT 192
AL +LH ++ RD K S++L + VK+ DF +S G D G
Sbjct: 120 KALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGIS-----GYLVDDVAKDIDAGC 172
Query: 193 YGHLAP----QYVTTCDFSEKLDVYSFGAFLSELLTGR 226
++AP + +S K D++S G + EL R
Sbjct: 173 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 1e-05
Identities = 22/98 (22%), Positives = 38/98 (38%), Gaps = 12/98 (12%)
Query: 137 ALAYLH-FGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGH 195
A+ +H G V RD K +IL ++L DF + + T + +GT +
Sbjct: 174 AIDSVHRLG----YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDY 229
Query: 196 LAPQYVTTCDFSEKLDVY-------SFGAFLSELLTGR 226
L+P+ + Y + G F E+ G+
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 1e-05
Identities = 22/90 (24%), Positives = 45/90 (50%), Gaps = 5/90 (5%)
Query: 137 ALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHL 196
+ +LH I+ RD K S+I+ + +K+ DF L+ + +T V+ T +
Sbjct: 176 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVV-TRYYR 230
Query: 197 APQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
AP+ + + E +D++S G + E++ +
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 37/165 (22%), Positives = 64/165 (38%), Gaps = 38/165 (23%)
Query: 77 MSHDHILKLIGCCLETPIAI-LVFE-YVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA 134
+ H +I+K++ E LV E + L+ I RL + A
Sbjct: 86 VEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFID-----------RHPRLDEP-LA 132
Query: 135 -------ANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITD 187
+A+ YL + I+ RD K +I+ +E+ +KL DF + + G+ +
Sbjct: 133 SYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK--LFY 187
Query: 188 TVMGTYGHLAP------QYVTTCDFSEKLDVYSFGAFLSELLTGR 226
T GT + AP Y +L+++S G L L+
Sbjct: 188 TFCGTIEYCAPEVLMGNPYR-----GPELEMWSLGVTLYTLVFEE 227
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 33/93 (35%), Positives = 43/93 (46%), Gaps = 7/93 (7%)
Query: 137 ALAYLH-FGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGH 195
AL +LH G I++RD K +IL V L DF LS ET GT +
Sbjct: 171 ALEHLHKLG----IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 226
Query: 196 LAPQYVTTCD--FSEKLDVYSFGAFLSELLTGR 226
+AP V D + +D +S G + ELLTG
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 2e-05
Identities = 36/169 (21%), Positives = 67/169 (39%), Gaps = 40/169 (23%)
Query: 76 QMSHDHILKLIGCCLETPIAILVFEYVQH--GTLWDRILGAPQTHFEPLLLKRRLKDAVD 133
++ H +I++L L+FEY ++ D+ ++K L +
Sbjct: 89 ELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDK-----NPDVSMRVIKSFLYQLI- 142
Query: 134 AANALAYLHFGFPRPIVFRDFKTSHILFSEEN-----VVKLFDFSL--SISIPEGE-TH- 184
N + + H R + RD K ++L S + V+K+ DF L + IP + TH
Sbjct: 143 --NGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHE 197
Query: 185 -IT------DTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
IT + ++G + Y S +D++S +E+L
Sbjct: 198 IITLWYRPPEILLG-----SRHY------STSVDIWSIACIWAEMLMKT 235
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 3e-05
Identities = 29/105 (27%), Positives = 44/105 (41%), Gaps = 18/105 (17%)
Query: 131 AVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTV- 189
+ AL +L I+ RD K S+IL +KL DF +S + D++
Sbjct: 131 TLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGIS-------GQLVDSIA 181
Query: 190 ----MGTYGHLAP----QYVTTCDFSEKLDVYSFGAFLSELLTGR 226
G ++AP + + + DV+S G L EL TGR
Sbjct: 182 KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 3e-05
Identities = 20/90 (22%), Positives = 44/90 (48%), Gaps = 7/90 (7%)
Query: 137 ALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHL 196
YLH +++RD K ++L ++ +++ DF + + T T+ GT L
Sbjct: 153 TFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWTLCGTPEAL 205
Query: 197 APQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
AP+ + + +++ +D ++ G + E+ G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 3e-05
Identities = 38/163 (23%), Positives = 63/163 (38%), Gaps = 17/163 (10%)
Query: 75 AQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA 134
+Q H +I+ + LV + + G++ D I + L ++ A
Sbjct: 68 SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIK---HIVAKGEHKSGVLDESTIA 124
Query: 135 A------NALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF----SLSISIPEGETH 184
L YLH + RD K +IL E+ V++ DF L+
Sbjct: 125 TILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNK 181
Query: 185 ITDTVMGTYGHLAPQYVTTCD-FSEKLDVYSFGAFLSELLTGR 226
+ T +GT +AP+ + + K D++SFG EL TG
Sbjct: 182 VRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 40/185 (21%), Positives = 66/185 (35%), Gaps = 54/185 (29%)
Query: 77 MSHDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAA 135
+ H +I++ + TP + ++ EY G L++RI R + D A
Sbjct: 73 LRHPNIVRFKEV-ILTPTHLAIIMEYASGGELYERICN-----------AGRFSE--DEA 118
Query: 136 --------NALAYLHFGFPRPIVFRDFKTSHILF--SEENVVKLFDFSLSISIPEGETHI 185
+ ++Y H I RD K + L S +K+ DF S S
Sbjct: 119 RFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQ 173
Query: 186 TDTVMGTYGHLAPQYVTTCDFSEKL------DVYSFGAFLSELLTGRGILDLVRDAHDLV 239
+ +GT ++AP+ + DV+S G L +L G
Sbjct: 174 PKSTVGTPAYIAPEV-----LLRQEYDGKIADVWSCGVTLYVMLVGA------------- 215
Query: 240 YPFNE 244
YPF +
Sbjct: 216 YPFED 220
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 5e-05
Identities = 34/166 (20%), Positives = 54/166 (32%), Gaps = 42/166 (25%)
Query: 78 SHDHILKLIGCCLETPIAI-LVFEYVQHGT-LWDRILGAPQTHFEPLLLKRRLKDAVDAA 135
H +++L+ ET LV E L+D I K L + +
Sbjct: 96 GHPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYIT-----------EKGPLGE--GPS 141
Query: 136 --------NALAYLHFGFPRPIVFRDFKTSHILF-SEENVVKLFDFSLSISIPEGETHIT 186
A+ + H R +V RD K +IL KL DF + +
Sbjct: 142 RCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYT-- 196
Query: 187 DTVMGTYGHLAPQYVTTCDFSEKL------DVYSFGAFLSELLTGR 226
GT + P++ S V+S G L +++ G
Sbjct: 197 -DFDGTRVYSPPEW-----ISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 5e-05
Identities = 48/165 (29%), Positives = 69/165 (41%), Gaps = 40/165 (24%)
Query: 77 MSHDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAA 135
+ H HI+KL + TP I +V EY G L+D I+ K+R+ + D
Sbjct: 66 LRHPHIIKLYDV-ITTPTDIVMVIEYAG-GELFDYIVE-----------KKRMTE--DEG 110
Query: 136 --------NALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITD 187
A+ Y H IV RD K ++L + VK+ DF LS + +G +
Sbjct: 111 RRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--NFLK 165
Query: 188 TVMGTYGHLAPQYVTTCDFSEKL------DVYSFGAFLSELLTGR 226
T G+ P Y + KL DV+S G L +L GR
Sbjct: 166 TSCGS-----PNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 3e-04
Identities = 42/157 (26%), Positives = 67/157 (42%), Gaps = 22/157 (14%)
Query: 75 AQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEP---LLLKRRLKDA 131
++ H + ++ GC L A LV EY G+ D + + E + L+
Sbjct: 109 QKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQ-- 165
Query: 132 VDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMG 191
LAYLH ++ RD K +IL SE +VKL DF + + ++ +G
Sbjct: 166 -----GLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVG 212
Query: 192 TYGHLAPQYVTTCDFSE---KLDVYSFGAFLSELLTG 225
T +AP+ + D + K+DV+S G EL
Sbjct: 213 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 5e-04
Identities = 37/165 (22%), Positives = 63/165 (38%), Gaps = 30/165 (18%)
Query: 78 SHDHILKLIGCCLETPIAI------LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDA 131
H +I G ++ LV E+ G++ D I LK+
Sbjct: 79 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN---------TKGNTLKEE 129
Query: 132 VDAA------NALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHI 185
A L++LH ++ RD K ++L +E VKL DF +S +
Sbjct: 130 WIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR- 185
Query: 186 TDTVMGTYGHLAPQYVTTCDFSE-----KLDVYSFGAFLSELLTG 225
+T +GT +AP+ + + + K D++S G E+ G
Sbjct: 186 RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 39.8 bits (94), Expect = 7e-04
Identities = 30/90 (33%), Positives = 53/90 (58%), Gaps = 7/90 (7%)
Query: 137 ALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHL 196
AL YLH + I++RD K +IL + +K+ DF + +P+ +T T+ GT ++
Sbjct: 118 ALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYTLCGTPDYI 170
Query: 197 APQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
AP+ V+T +++ +D +SFG + E+L G
Sbjct: 171 APEVVSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 39.6 bits (93), Expect = 7e-04
Identities = 29/163 (17%), Positives = 56/163 (34%), Gaps = 42/163 (25%)
Query: 81 HILKLIGCCLETPIAI-LVFEYVQ-HGTLWDRILGAPQTHFEPLLLKRRLKDAVDAA--- 135
+++L+ E P + L+ E + L+D I + L++ + A
Sbjct: 109 GVIRLLDW-FERPDSFVLILERPEPVQDLFDFIT-----------ERGALQE--ELARSF 154
Query: 136 -----NALAYLHFGFPRPIVFRDFKTSHILFSEENV-VKLFDFSLSISIPEGETHITDTV 189
A+ + H ++ RD K +IL +KL DF + +
Sbjct: 155 FWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT---DF 208
Query: 190 MGTYGHLAPQYVTTCDFSEKL------DVYSFGAFLSELLTGR 226
GT + P++ V+S G L +++ G
Sbjct: 209 DGTRVYSPPEW-----IRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 314 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.82 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.64 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.43 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.99 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.81 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.81 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.49 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.37 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.2 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.88 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.21 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.14 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 96.96 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.93 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 96.44 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 95.93 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 95.03 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 93.85 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 93.18 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 92.25 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 88.67 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 88.58 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 87.53 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 84.07 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 83.52 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 82.31 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 81.18 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-57 Score=400.74 Aligned_cols=252 Identities=20% Similarity=0.273 Sum_probs=201.3
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|.....+|+|+ +.|+++.+..+|+.||+|++........ ..+.+.+|+++|+.|+|||||++++++.
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~----------~~~~~~~E~~il~~l~HpnIV~~~~~~~ 93 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK----------EREESRREVAVLANMKHPNIVQYRESFE 93 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHH----------HHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHH----------HHHHHHHHHHHHHHCCCCCCCcEEEEEE
Confidence 4566677799999 9999999999999999999875432211 1267899999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
+++.+|||||||++|+|.+++..... ..+++..++.++.||+.||.||| +++|+||||||+|||++.++.+||+
T Consensus 94 ~~~~~yiVmEy~~gg~L~~~i~~~~~---~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~ 167 (350)
T 4b9d_A 94 ENGSLYIVMDYCEGGDLFKRINAQKG---VLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLG 167 (350)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEEC
T ss_pred ECCEEEEEEeCCCCCcHHHHHHHcCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEc
Confidence 99999999999999999999976542 34688899999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhh
Q 043524 171 DFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 171 dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
|||+|+...... ......+||+.|||||++.+..|+.++||||+||++|||++|+.||...... +......
T Consensus 168 DFGla~~~~~~~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~--------~~~~~i~ 238 (350)
T 4b9d_A 168 DFGIARVLNSTV-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK--------NLVLKII 238 (350)
T ss_dssp STTEESCCCHHH-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHH
T ss_pred ccccceeecCCc-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--------HHHHHHH
Confidence 999998753321 1234567999999999999999999999999999999999999999743311 1111111
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
. +..+. .+...+.++.+||.+||+.||++|||+.|+++
T Consensus 239 ~-------------~~~~~-~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 239 S-------------GSFPP-VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp H-------------TCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c-------------CCCCC-CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 11110 11134567899999999999999999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-56 Score=392.17 Aligned_cols=249 Identities=16% Similarity=0.233 Sum_probs=207.9
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
.|+....+|+|+ +.|+++.+..+|+.||+|++.+........ .+.+.+|+++|+.++|||||++++++.+
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~---------~~~~~~E~~il~~l~HpnIv~l~~~~~~ 103 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK---------VPYVTRERDVMSRLDHPFFVKLYFTFQD 103 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTC---------HHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHH---------HHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence 455666799999 999999999999999999999876644321 2678999999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
++.+|+|||||++|+|.+++...+ .++...+..++.||+.||.||| +++|+||||||+|||++.++.+||+|
T Consensus 104 ~~~~yivmEy~~gG~L~~~i~~~~-----~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~D 175 (311)
T 4aw0_A 104 DEKLYFGLSYAKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITD 175 (311)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECC
T ss_pred CCEEEEEEecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEE
Confidence 999999999999999999997653 5899999999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCC-cccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhh
Q 043524 172 FSLSISIPEGE-THITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 172 fg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
||+|+.+.... .....+.+||+.|||||++.+..|+.++||||+||++|+|++|+.||...... .....
T Consensus 176 FGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--------~~~~~-- 245 (311)
T 4aw0_A 176 FGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG--------LIFAK-- 245 (311)
T ss_dssp CTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHH--
T ss_pred cCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHH--
Confidence 99998875432 22355678999999999999999999999999999999999999999643211 11111
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHH
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVA 301 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell 301 (314)
+.......+ ...+.++.+||.+||+.||++|||+.|++
T Consensus 246 -----------i~~~~~~~p--~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 246 -----------IIKLEYDFP--EKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp -----------HHHTCCCCC--TTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred -----------HHcCCCCCC--cccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 111111111 13456789999999999999999999874
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-56 Score=394.96 Aligned_cols=248 Identities=18% Similarity=0.294 Sum_probs=204.0
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
.|.....||+|+ +.|+++.+..+|+.||+|++....... .+.+.+|+++|+.++|||||++++++.+
T Consensus 75 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~------------~~~~~~Ei~il~~l~HpnIV~l~~~~~~ 142 (346)
T 4fih_A 75 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR------------RELLFNEVVIMRDYQHENVVEMYNSYLV 142 (346)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS------------GGGGHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH------------HHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 355556699999 999999999999999999987543111 1567899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
++.+|||||||++|+|.+++... .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|
T Consensus 143 ~~~~~ivmEy~~gg~L~~~l~~~------~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~D 213 (346)
T 4fih_A 143 GDELWVVMEFLEGGALTDIVTHT------RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSD 213 (346)
T ss_dssp TTEEEEEECCCTTEEHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECC
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEec
Confidence 99999999999999999998753 4889999999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhc
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFE 251 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (314)
||+|+...... ....+.+||+.|||||++.+..|+.++||||+||++|||++|..||....... .......
T Consensus 214 FGla~~~~~~~-~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~--------~~~~i~~ 284 (346)
T 4fih_A 214 FGFCAQVSKEV-PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--------AMKMIRD 284 (346)
T ss_dssp CTTCEECCSSS-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHHHH
T ss_pred CcCceecCCCC-CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--------HHHHHHc
Confidence 99998764432 23456789999999999999899999999999999999999999996432211 1111111
Q ss_pred cCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 252 DNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
. . .+ ........+.++.+||.+||..||++|||+.|+++
T Consensus 285 ~-~-----~~------~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 285 N-L-----PP------RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp S-S-----CC------CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C-C-----CC------CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 0 00 01111144567899999999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-55 Score=390.45 Aligned_cols=249 Identities=20% Similarity=0.255 Sum_probs=202.0
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCee
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIA 95 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (314)
...+|+|+ +.|+++.+..+|+.||+|++..+.. ..+|+.+++.++|||||++++++.+++.+
T Consensus 63 ~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----------------~~~E~~il~~l~HpnIV~l~~~~~~~~~~ 125 (336)
T 4g3f_A 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----------------RVEELVACAGLSSPRIVPLYGAVREGPWV 125 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----------------CTHHHHTTTTCCCTTBCCEEEEEEETTEE
T ss_pred CcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----------------HHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 34589988 8999999999999999999864321 13799999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCC-ceEEccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN-VVKLFDFSL 174 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~-~~kl~dfg~ 174 (314)
|||||||++|+|.+++... .++++..+..++.|++.||.||| +++|+||||||+|||++.++ .+||+|||+
T Consensus 126 ~ivmEy~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGl 197 (336)
T 4g3f_A 126 NIFMELLEGGSLGQLIKQM-----GCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGH 197 (336)
T ss_dssp EEEECCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTT
T ss_pred EEEEeccCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCC
Confidence 9999999999999999764 35899999999999999999999 99999999999999999887 699999999
Q ss_pred ceecCCCCcc----cccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhh
Q 043524 175 SISIPEGETH----ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 175 ~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
|+........ ......||+.|||||++.+..|+.++||||+||++|||++|+.||........ +... .
T Consensus 198 a~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~----~~~i----~ 269 (336)
T 4g3f_A 198 ALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL----CLKI----A 269 (336)
T ss_dssp CEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC----HHHH----H
T ss_pred CeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH----HHHH----H
Confidence 9876543211 13345799999999999999999999999999999999999999975433221 0010 0
Q ss_pred ccCCcccccChhhhccCCc-hhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhc
Q 043524 251 EDNRFTEIVDPIIVQDLSC-TEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSL 311 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 311 (314)
. .+.+. ..+..++..+.+||.+||+.||++|||+.|+++.|.+.....
T Consensus 270 ~-------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 270 S-------------EPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp H-------------SCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred c-------------CCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 0 00000 011144567899999999999999999999999998876654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-55 Score=379.77 Aligned_cols=248 Identities=22% Similarity=0.301 Sum_probs=190.7
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|+....+|+|+ +.|+++.+..+|+.||+|++.+....... ..+.+.+|+++++.++|||||++++++.
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~---------~~~~~~~Ei~il~~l~HpnIv~~~~~~~ 83 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSD---------MQGRIEREISYLRLLRHPHIIKLYDVIK 83 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC---------------CHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHH---------HHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence 3566667799999 89999999999999999999765443221 1267899999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
+++.+|+||||| +|+|.+.+.... .++...+..++.|++.||.||| +++|+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~ivmEy~-~g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~ 154 (275)
T 3hyh_A 84 SKDEIIMVIEYA-GNELFDYIVQRD-----KMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIA 154 (275)
T ss_dssp CSSEEEEEEECC-CEEHHHHHHHSC-----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEEC
T ss_pred ECCEEEEEEeCC-CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEe
Confidence 999999999999 689999997653 5899999999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCcccccCCC-CcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhh
Q 043524 171 DFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDF-SEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNY 249 (314)
Q Consensus 171 dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (314)
|||+|+...... ...+..||+.|+|||++.+..+ +.++||||+||++|+|++|+.||..... .......
T Consensus 155 DFGla~~~~~~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~--------~~~~~~i 224 (275)
T 3hyh_A 155 DFGLSNIMTDGN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI--------PVLFKNI 224 (275)
T ss_dssp CSSCC-----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHH
T ss_pred ecCCCeecCCCC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHH
Confidence 999998764432 2446789999999999998876 5799999999999999999999964321 1111111
Q ss_pred hccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 250 FEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
. .+....+ ...+.++.+|+.+||+.||++|||+.|+++
T Consensus 225 ~-------------~~~~~~p--~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 225 S-------------NGVYTLP--KFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp H-------------HTCCCCC--TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred H-------------cCCCCCC--CCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1 1111111 134567899999999999999999999986
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-55 Score=385.38 Aligned_cols=256 Identities=20% Similarity=0.309 Sum_probs=201.1
Q ss_pred ccccCch-hHHHHHHH-----hcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 18 LMIGNGA-SVLQELIA-----SSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~-----~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
..+|+|+ +.|+++.. ..+|..||||.+....... .++|.+|+++|++++|||||+++|+|.+
T Consensus 19 ~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~------------~~~f~~E~~il~~l~HpnIV~l~g~~~~ 86 (299)
T 4asz_A 19 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNA------------RKDFHREAELLTNLQHEHIVKFYGVCVE 86 (299)
T ss_dssp EEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHH------------HHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred eEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHH------------HHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 3588888 77777643 3467899999986433221 2679999999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCC--------CCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecC
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAP--------QTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSE 163 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~--------~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~ 163 (314)
++.+|+|||||++|||.+++.... ......+++..++.++.|++.||.||| +++|+||||||+|||++.
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~ 163 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGE 163 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECC
Confidence 999999999999999999997542 111146899999999999999999999 999999999999999999
Q ss_pred CCceEEcccccceecCCCCcc-cccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccc
Q 043524 164 ENVVKLFDFSLSISIPEGETH-ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYP 241 (314)
Q Consensus 164 ~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~ 241 (314)
++.+||+|||+|+........ ......||+.|||||++.+..|+.++|||||||++|||+| |+.||......+
T Consensus 164 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~----- 238 (299)
T 4asz_A 164 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE----- 238 (299)
T ss_dssp GGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-----
T ss_pred CCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-----
Confidence 999999999999876443322 2234568999999999999999999999999999999998 899997543211
Q ss_pred hHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 242 FNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
........ .. .+.+..++.++.+|+.+||+.||++|||+.||++.|+++.+.
T Consensus 239 ---~~~~i~~~-------------~~-~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 239 ---VIECITQG-------------RV-LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp ---HHHHHHHT-------------CC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---HHHHHHcC-------------CC-CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 11111111 00 001114556789999999999999999999999999998764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-55 Score=379.81 Aligned_cols=242 Identities=18% Similarity=0.284 Sum_probs=193.6
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe----CC
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE----TP 93 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~ 93 (314)
.+|+|+ +.|+++.+..+|..||+|.+......... .++|.+|+++|+.++|||||+++++|.+ +.
T Consensus 33 ~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~----------~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~ 102 (290)
T 3fpq_A 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE----------RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHH----------HHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEE
T ss_pred EEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHH----------HHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCc
Confidence 588888 89999999999999999998765432211 2678999999999999999999999975 35
Q ss_pred eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCC--ceeccCCCCCeeecC-CCceEEc
Q 043524 94 IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRP--IVFRDFKTSHILFSE-ENVVKLF 170 (314)
Q Consensus 94 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~--i~H~dlk~~nil~~~-~~~~kl~ 170 (314)
.+|||||||++|+|.+++... ..+++..+..++.|++.||.||| +++ |+||||||+|||++. ++.+||+
T Consensus 103 ~~~lvmEy~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~ 174 (290)
T 3fpq_A 103 CIVLVTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIG 174 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEEC
T ss_pred EEEEEEeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEE
Confidence 689999999999999999764 35889999999999999999999 888 999999999999975 7899999
Q ss_pred ccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhh
Q 043524 171 DFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 171 dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
|||+|+..... ...+..||+.|||||++.+ .|+.++|||||||++|||++|+.||....... .......
T Consensus 175 DFGla~~~~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~-------~~~~~i~ 243 (290)
T 3fpq_A 175 DLGLATLKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-------QIYRRVT 243 (290)
T ss_dssp CTTGGGGCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-------HHHHHHT
T ss_pred eCcCCEeCCCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH-------HHHHHHH
Confidence 99999764332 2456789999999998864 69999999999999999999999996433211 1111111
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
. +..+...+...++++.+|+.+||+.||++|||+.|+++
T Consensus 244 ~-------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 244 S-------------GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp T-------------TCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c-------------CCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00001111123456889999999999999999999985
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-55 Score=387.30 Aligned_cols=255 Identities=22% Similarity=0.322 Sum_probs=195.7
Q ss_pred cccCch-hHHHHHH-----HhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 19 MIGNGA-SVLQELI-----ASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 19 ~~G~g~-~~~~~~~-----~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
.+|+|+ +.||++. ...+|..||||++....... .++|.+|+++|++++|||||+++|+|.++
T Consensus 48 ~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~------------~~~f~~E~~il~~l~HpnIV~l~g~~~~~ 115 (329)
T 4aoj_A 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA------------RQDFQREAELLTMLQHQHIVRFFGVCTEG 115 (329)
T ss_dssp EEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHH------------HHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred EEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHH------------HHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 488888 7777764 33568899999986433221 26799999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCC----------CCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeec
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQT----------HFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFS 162 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~----------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~ 162 (314)
+.+|||||||++|+|.+++...... ...++++..++.++.|++.||.||| +++|+||||||+|||++
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVG 192 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEEC
Confidence 9999999999999999999764321 1145899999999999999999999 99999999999999999
Q ss_pred CCCceEEcccccceecCCCCc-ccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCcccccc
Q 043524 163 EENVVKLFDFSLSISIPEGET-HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVY 240 (314)
Q Consensus 163 ~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~ 240 (314)
.++.+||+|||+++....... .......||+.|||||++.+..|+.++|||||||++|||+| |+.||......+
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~---- 268 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE---- 268 (329)
T ss_dssp TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH----
T ss_pred CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH----
Confidence 999999999999987644322 22344679999999999999999999999999999999999 899997543211
Q ss_pred chHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 241 PFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
......... .++.+..+++++.+|+..||+.||++|||+.||++.|+.+.+.
T Consensus 269 ----~~~~i~~g~--------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 269 ----AIDCITQGR--------------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp ----HHHHHHHTC--------------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----HHHHHHcCC--------------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 111111110 0011114556789999999999999999999999999998765
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-55 Score=382.39 Aligned_cols=257 Identities=20% Similarity=0.288 Sum_probs=193.8
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCee
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIA 95 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (314)
...+|+|+ +.||++.. ...||||++....... ...++|.+|+.++++++|||||+++|++.+ +.+
T Consensus 41 ~~~iG~G~fG~Vy~~~~---~~~vAvK~~~~~~~~~----------~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~ 106 (307)
T 3omv_A 41 STRIGSGSFGTVYKGKW---HGDVAVKILKVVDPTP----------EQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNL 106 (307)
T ss_dssp EEECCCCSSSEEEEEES---SSEEEEEECCCSSCCH----------HHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred eeEEeeCCCcEEEEEEE---CCcEEEEEEEecCCCH----------HHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeE
Confidence 34588888 77777643 3358999875322111 012679999999999999999999998854 568
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
|||||||++|+|.+++.... .++++..++.++.|++.||.||| +++|+||||||+|||++.++.+||+|||+|
T Consensus 107 ~iVmEy~~gGsL~~~l~~~~----~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 179 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHVQE----TKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLA 179 (307)
T ss_dssp EEEEECCSSCBHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSC
T ss_pred EEEEEcCCCCCHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCc
Confidence 99999999999999997654 35899999999999999999999 999999999999999999999999999999
Q ss_pred eecCCCC-cccccccccccccccCccccc---CCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhc
Q 043524 176 ISIPEGE-THITDTVMGTYGHLAPQYVTT---CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFE 251 (314)
Q Consensus 176 ~~~~~~~-~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (314)
+...... ........||+.|||||++.. ..|+.++|||||||++|||++|+.||....... .......
T Consensus 180 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~--------~~~~~~~ 251 (307)
T 3omv_A 180 TVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD--------QIIFMVG 251 (307)
T ss_dssp BC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--------HHHHHHH
T ss_pred eecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH--------HHHHHHh
Confidence 8764322 223445689999999999864 358999999999999999999999997544321 0111111
Q ss_pred cCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhc
Q 043524 252 DNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSL 311 (314)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 311 (314)
... ..+... .....++..+.+|+.+||+.||++|||+.||++.|+.+..++
T Consensus 252 ~~~----~~p~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 252 RGY----ASPDLS-----KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp TTC----CCCCST-----TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred cCC----CCCCcc-----cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 110 011000 011134567899999999999999999999999999887654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-55 Score=396.29 Aligned_cols=249 Identities=18% Similarity=0.295 Sum_probs=204.6
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|.....||+|+ +.|+++.+..+|+.||+|++...... ..+.+.+|+.+|+.++|||||+++++|.
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~------------~~~~~~~Ei~il~~l~HpnIV~l~~~~~ 218 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ------------RRELLFNEVVIMRDYQHENVVEMYNSYL 218 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS------------SGGGHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh------------HHHHHHHHHHHHHhCCCCCCCceEEEEE
Confidence 4456666799999 99999999999999999998643211 1256889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
+++.+|||||||++|+|.+++... .++...+..++.||+.||.||| +++|+||||||+|||++.++.+||+
T Consensus 219 ~~~~~~iVmEy~~gG~L~~~i~~~------~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~ 289 (423)
T 4fie_A 219 VGDELWVVMEFLEGGALTDIVTHT------RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLS 289 (423)
T ss_dssp ETTEEEEEEECCTTEEHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEEC
T ss_pred ECCEEEEEEeCCCCCcHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEe
Confidence 999999999999999999998753 4889999999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhh
Q 043524 171 DFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 171 dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
|||+|+...... ....+.+||+.|||||++.+..|+.++||||+||++|||++|..||....... ......
T Consensus 290 DFGla~~~~~~~-~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~--------~~~~i~ 360 (423)
T 4fie_A 290 DFGFCAQVSKEV-PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--------AMKMIR 360 (423)
T ss_dssp CCTTCEECCSSC-CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHHH
T ss_pred cCccceECCCCC-ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--------HHHHHH
Confidence 999998764432 23556789999999999999999999999999999999999999996433211 111111
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.. . .+.. ......+.++.+||..||..||++||||.|+++
T Consensus 361 ~~-~-----~~~~------~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 361 DN-L-----PPRL------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp HS-C-----CCCC------SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cC-C-----CCCC------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 10 0 0000 111134567899999999999999999999986
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-55 Score=383.11 Aligned_cols=253 Identities=19% Similarity=0.271 Sum_probs=197.9
Q ss_pred cccCch-hHHHHHH-----HhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 19 MIGNGA-SVLQELI-----ASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 19 ~~G~g~-~~~~~~~-----~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
.+|+|+ +.||++. ...+++.||||.+..... ....++|.+|+.++++++|||||+++|+|.++
T Consensus 33 ~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~-----------~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~ 101 (308)
T 4gt4_A 33 ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE-----------GPLREEFRHEAMLRARLQHPNVVCLLGVVTKD 101 (308)
T ss_dssp EEEECSSCEEEEEEEC-------CEEEEEEECCC-CC-----------C-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred EeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC-----------hHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence 488888 7777654 345778999999863210 11236799999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCC-----------CCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeee
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQ-----------THFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILF 161 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~ 161 (314)
+.+++|||||++|||.+++..... .....+++..++.++.||+.||.||| +++|+||||||+|||+
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLV 178 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEE
Confidence 999999999999999999965321 11135889999999999999999999 9999999999999999
Q ss_pred cCCCceEEcccccceecCCCCc-ccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccc
Q 043524 162 SEENVVKLFDFSLSISIPEGET-HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLV 239 (314)
Q Consensus 162 ~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~ 239 (314)
+.++.+||+|||+++....... .......||+.|||||++.+..|+.++|||||||++|||+| |..||......+
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~--- 255 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD--- 255 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---
Confidence 9999999999999987643322 22345679999999999999999999999999999999998 899997543211
Q ss_pred cchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHH
Q 043524 240 YPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQI 307 (314)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~ 307 (314)
...... .... .+.+..++..+.+|+.+||+.||++|||+.||++.|+..
T Consensus 256 -----~~~~i~-~~~~-------------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 256 -----VVEMIR-NRQV-------------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp -----HHHHHH-TTCC-------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred -----HHHHHH-cCCC-------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111111 1110 011114556789999999999999999999999999753
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-54 Score=377.54 Aligned_cols=248 Identities=21% Similarity=0.259 Sum_probs=191.7
Q ss_pred cCcccccccCch-hHHHHHHH---hcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeE
Q 043524 13 KGKRTLMIGNGA-SVLQELIA---SSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGC 88 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~---~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 88 (314)
.|+....+|+|+ +.|+++.+ ..+++.||+|++.+...... . ..++.+|+++|+.++|||||+++++
T Consensus 25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-------~---~~~~~~E~~il~~l~HpnIv~l~~~ 94 (304)
T 3ubd_A 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-------D---RVRTKMERDILVEVNHPFIVKLHYA 94 (304)
T ss_dssp GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-------E---CC------CCCCCCCCTTEECEEEE
T ss_pred ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-------H---HHHHHHHHHHHHHCCCCCCCeEEEE
Confidence 456666799999 77777654 34678999999875432110 0 0356789999999999999999999
Q ss_pred EEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceE
Q 043524 89 CLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVK 168 (314)
Q Consensus 89 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~k 168 (314)
+.+++.+|+|||||+||+|.+++.... .++...+..++.|++.||.||| +++|+||||||+|||++.++.+|
T Consensus 95 ~~~~~~~~ivmEy~~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vK 166 (304)
T 3ubd_A 95 FQTEGKLYLILDFLRGGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIK 166 (304)
T ss_dssp EEETTEEEEEECCCTTCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEE
T ss_pred EEECCEEEEEEEcCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEE
Confidence 999999999999999999999997653 5889999999999999999999 99999999999999999999999
Q ss_pred EcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHh
Q 043524 169 LFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKN 248 (314)
Q Consensus 169 l~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (314)
|+|||+|+....... ...+..||+.|||||++.+..|+.++||||+||++|||++|+.||....... ....
T Consensus 167 l~DFGla~~~~~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~--------~~~~ 237 (304)
T 3ubd_A 167 LTDFGLSKESIDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE--------TMTM 237 (304)
T ss_dssp EESSEEEEC-----C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHH
T ss_pred ecccccceeccCCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH--------HHHH
Confidence 999999986543322 2456789999999999999999999999999999999999999997433211 1111
Q ss_pred hhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCH-----HHHHH
Q 043524 249 YFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTM-----VDVAR 302 (314)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~-----~ell~ 302 (314)
. .......+ ...+.++.+|+.+||+.||++|||+ +|+++
T Consensus 238 i-------------~~~~~~~p--~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 238 I-------------LKAKLGMP--QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp H-------------HHCCCCCC--TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred H-------------HcCCCCCC--CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 1 11111111 1345678999999999999999985 56653
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-52 Score=364.29 Aligned_cols=262 Identities=21% Similarity=0.279 Sum_probs=192.9
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCC---
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETP--- 93 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--- 93 (314)
..+|+|+ +.||++. .+|+.||||++........ .+..|+..+..++|||||++++++.+++
T Consensus 9 ~~iG~G~fG~Vy~~~--~~g~~VAvK~l~~~~~~~~-------------~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~ 73 (303)
T 3hmm_A 9 ESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSW-------------FREAEIYQTVMLRHENILGFIAADNKDNGTW 73 (303)
T ss_dssp EEEEECSSSEEEEEE--ETTEEEEEEEECGGGHHHH-------------HHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred EEEeeCCCeEEEEEE--ECCEEEEEEEECccchhhH-------------HHHHHHHHHhcCCCCCCCcEEEEEEecCCCc
Confidence 3578888 7777764 4689999999976543221 2235667777899999999999998754
Q ss_pred -eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCC--------CceeccCCCCCeeecCC
Q 043524 94 -IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPR--------PIVFRDFKTSHILFSEE 164 (314)
Q Consensus 94 -~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~--------~i~H~dlk~~nil~~~~ 164 (314)
.+|||||||++|+|.+++... ++++..+..++.|++.||+||| ++ +|+||||||+|||++.+
T Consensus 74 ~~~~lV~Ey~~~gsL~~~l~~~------~l~~~~~~~i~~~ia~gl~ylH---~~~~~~~~~~~IiHRDlKp~NILl~~~ 144 (303)
T 3hmm_A 74 TQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLH---MEIVGTQGKPAIAHRDLKSKNILVKKN 144 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHH---CCBCSTTCBCCEECSCCCGGGEEECTT
T ss_pred eEEEEEecCCCCCcHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHH---HhhhhccCCCCEeeccCCcccEEECCC
Confidence 579999999999999999763 4789999999999999999999 66 99999999999999999
Q ss_pred CceEEcccccceecCCCCcc---cccccccccccccCcccccC------CCCcccchHHHHHHHHHHHhCCCCcccccCc
Q 043524 165 NVVKLFDFSLSISIPEGETH---ITDTVMGTYGHLAPQYVTTC------DFSEKLDVYSFGAFLSELLTGRGILDLVRDA 235 (314)
Q Consensus 165 ~~~kl~dfg~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~------~~~~~~DiwslG~~l~el~~g~~p~~~~~~~ 235 (314)
+.+||+|||+|+........ ......||+.|||||++.+. .++.++|||||||++|||++|.+||......
T Consensus 145 ~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~ 224 (303)
T 3hmm_A 145 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224 (303)
T ss_dssp SCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCC
T ss_pred CCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccc
Confidence 99999999999876543321 12345799999999998754 3567999999999999999999887644332
Q ss_pred cccc------cchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHh
Q 043524 236 HDLV------YPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICC 309 (314)
Q Consensus 236 ~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 309 (314)
..-. .+.................++.. ......+..+.+|+.+||+.||++||||.||++.|+++.+
T Consensus 225 ~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~-------~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 225 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNR-------WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGG-------GGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccchhcccccchHHHHHHHHhcccCCCCCCcc-------ccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 2100 00011111111111111111111 1112456678999999999999999999999999999976
Q ss_pred h
Q 043524 310 S 310 (314)
Q Consensus 310 ~ 310 (314)
.
T Consensus 298 ~ 298 (303)
T 3hmm_A 298 Q 298 (303)
T ss_dssp C
T ss_pred H
Confidence 5
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=366.88 Aligned_cols=249 Identities=20% Similarity=0.300 Sum_probs=186.7
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
|.....+|+|+ +.|+++.+..+|+.||+|++........ .+++.+|+++|+.++|||||++++++.+.
T Consensus 7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~-----------~~~~~~E~~il~~l~HpnIV~~~~~~~~~ 75 (299)
T 4g31_A 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA-----------REKVMREVKALAKLEHPGIVRYFNAWLEK 75 (299)
T ss_dssp EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHH-----------HHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHH-----------HHHHHHHHHHHHhCCCCCCCeEEEEEEec
Confidence 44556789998 8899999999999999999865432111 25788999999999999999999999765
Q ss_pred C------------eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCee
Q 043524 93 P------------IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHIL 160 (314)
Q Consensus 93 ~------------~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil 160 (314)
+ .+|+|||||++|+|.+++..... ........++.++.|++.||.||| +++|+||||||+|||
T Consensus 76 ~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NIL 150 (299)
T 4g31_A 76 NTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCT--IEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIF 150 (299)
T ss_dssp C----------CEEEEEEEECCCSCCHHHHHHTCCS--GGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEE
T ss_pred CccccccccCCCcEEEEEEecCCCCcHHHHHHhcCC--CChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeE
Confidence 4 37999999999999999986542 134556678899999999999999 999999999999999
Q ss_pred ecCCCceEEcccccceecCCCCcc-----------cccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCc
Q 043524 161 FSEENVVKLFDFSLSISIPEGETH-----------ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGIL 229 (314)
Q Consensus 161 ~~~~~~~kl~dfg~~~~~~~~~~~-----------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~ 229 (314)
++.++.+||+|||+|+........ ...+.+||+.|||||++.+..|+.++||||+||++|||++ ||
T Consensus 151 l~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf 227 (299)
T 4g31_A 151 FTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PF 227 (299)
T ss_dssp ECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CC
T ss_pred ECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CC
Confidence 999999999999999876443211 1234579999999999999999999999999999999996 66
Q ss_pred ccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 230 DLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
..... ...... ....... ++.....++.+.+|+..||+.||++|||+.|+++
T Consensus 228 ~~~~~----------~~~~~~----------~~~~~~~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 228 STQME----------RVRTLT----------DVRNLKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp SSHHH----------HHHHHH----------HHHTTCC-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCccH----------HHHHHH----------HHhcCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 42110 000000 0001111 1222244556789999999999999999999986
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-53 Score=377.19 Aligned_cols=264 Identities=20% Similarity=0.331 Sum_probs=204.5
Q ss_pred cCcccccccCch-hHHHHHHHhc-----CCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCC-Cceeee
Q 043524 13 KGKRTLMIGNGA-SVLQELIASS-----NGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSH-DHILKL 85 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~-----~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~ 85 (314)
+++-...+|+|+ +.|+++.... +++.||+|.+........ .++|.+|+++|..++| ||||++
T Consensus 65 ~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~-----------~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 65 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-----------HRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp GEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHH-----------HHHHHHHHHHHHHHCCCTTBCCE
T ss_pred HeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHH-----------HHHHHHHHHHHHHcCCCCcEEEE
Confidence 444455688888 7787775444 345789998765432221 1578999999999975 999999
Q ss_pred EeEEEe-CCeeEEEEeecCCCCHHHHHhcCCCC-----------CCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceecc
Q 043524 86 IGCCLE-TPIAILVFEYVQHGTLWDRILGAPQT-----------HFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRD 153 (314)
Q Consensus 86 ~~~~~~-~~~~~iv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~d 153 (314)
+|+|.+ ++.+|||||||++|+|.+++...... ....+++..++.++.||+.||.||| +++|+|||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCc
Confidence 999976 46789999999999999999753210 1134789999999999999999999 99999999
Q ss_pred CCCCCeeecCCCceEEcccccceecCCCCcc-cccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCccc
Q 043524 154 FKTSHILFSEENVVKLFDFSLSISIPEGETH-ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDL 231 (314)
Q Consensus 154 lk~~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~ 231 (314)
|||+|||++.++.+||+|||+|+........ ......||+.|||||++.+..|+.++|||||||++|||+| |..||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876543322 2345678999999999999999999999999999999998 8999975
Q ss_pred ccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhc
Q 043524 232 VRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSL 311 (314)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 311 (314)
...... +.. ....+. ....+..+++++.+|+.+||+.||++|||+.||++.|+++.++-
T Consensus 291 ~~~~~~----~~~----~i~~g~-------------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 291 VKIDEE----FCR----RLKEGT-------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp CCCSHH----HHH----HHHHTC-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCHHHH----HHH----HHHcCC-------------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 443221 111 111100 01111134567899999999999999999999999999987653
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-50 Score=364.14 Aligned_cols=267 Identities=16% Similarity=0.207 Sum_probs=198.0
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
+|.....+|.|+ ++|+++.+..+|+.||||++........ ..+.+.+|+++|+.++|||||++++++..
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~----------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 124 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVT----------NAKRTLRELKILKHFKHDNIIAIKDILRP 124 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHH----------HHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchH----------HHHHHHHHHHHHHhcCCCCcceEeeeeec
Confidence 466667799999 9999999999999999999864321111 11567899999999999999999999864
Q ss_pred ------CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCC
Q 043524 92 ------TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN 165 (314)
Q Consensus 92 ------~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~ 165 (314)
.+.+|||||||+ |+|.+.+... .+++...+..++.||+.||.||| +++|+||||||+|||++.++
T Consensus 125 ~~~~~~~~~~~ivmE~~~-g~L~~~i~~~-----~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~ 195 (398)
T 4b99_A 125 TVPYGEFKSVYVVLDLME-SDLHQIIHSS-----QPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENC 195 (398)
T ss_dssp SSCTTTCCCEEEEEECCS-EEHHHHHTSS-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTC
T ss_pred ccccccCCEEEEEEeCCC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCC
Confidence 367899999995 7899999764 35899999999999999999999 99999999999999999999
Q ss_pred ceEEcccccceecCCCC---cccccccccccccccCcccccCC-CCcccchHHHHHHHHHHHhCCCCcccccCccccccc
Q 043524 166 VVKLFDFSLSISIPEGE---THITDTVMGTYGHLAPQYVTTCD-FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYP 241 (314)
Q Consensus 166 ~~kl~dfg~~~~~~~~~---~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~ 241 (314)
.+||+|||+|+.+.... .....+.+||+.|+|||++.+.. ++.++||||+||++|||++|++||.+....+..
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l--- 272 (398)
T 4b99_A 196 ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQL--- 272 (398)
T ss_dssp CEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHH---
T ss_pred CEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHH---
Confidence 99999999998764321 22244678999999999988764 689999999999999999999999754322110
Q ss_pred hHHHHHhhhc--cCCccccc----Chh---hhccCCchhH---HHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 242 FNEYLKNYFE--DNRFTEIV----DPI---IVQDLSCTEK---EQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 242 ~~~~~~~~~~--~~~~~~~~----~~~---~~~~~~~~~~---~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
......... ...+.... ... .....+.+.. ...+.++.+||.+||..||++||||.|+++
T Consensus 273 -~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 273 -QLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp -HHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -HHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000000 00000000 000 0000000000 123567899999999999999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=355.12 Aligned_cols=197 Identities=21% Similarity=0.291 Sum_probs=164.0
Q ss_pred hcCcccccccCch-hHHHHHHHh---cCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIAS---SNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLI 86 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~---~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~ 86 (314)
.+|+....+|+|+ +.|+++.+. .+++.||+|.+..... ..++.+|+++|..+ +|||||+++
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--------------~~~~~~E~~~l~~~~~h~nIv~l~ 86 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--------------PIRIAAELQCLTVAGGQDNVMGVK 86 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--------------HHHHHHHHHHHHHTCSBTTBCCCS
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--------------HHHHHHHHHHHHHhcCCCCCceEE
Confidence 4466667799998 888877543 4678999998754321 14577999999988 699999999
Q ss_pred eEEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCC-C
Q 043524 87 GCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEE-N 165 (314)
Q Consensus 87 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~-~ 165 (314)
+++.+.+.+|+|||||++|+|.+++. .++...++.++.|++.||.||| ++||+||||||+|||++.+ +
T Consensus 87 ~~~~~~~~~~lvmE~~~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~ 155 (361)
T 4f9c_A 87 YCFRKNDHVVIAMPYLEHESFLDILN--------SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLK 155 (361)
T ss_dssp EEEEETTEEEEEEECCCCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTT
T ss_pred EEEEECCEEEEEEeCCCcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCC
Confidence 99999999999999999999999983 3788999999999999999999 9999999999999999876 7
Q ss_pred ceEEcccccceecCCCCc---------------------------ccccccccccccccCcccccCC-CCcccchHHHHH
Q 043524 166 VVKLFDFSLSISIPEGET---------------------------HITDTVMGTYGHLAPQYVTTCD-FSEKLDVYSFGA 217 (314)
Q Consensus 166 ~~kl~dfg~~~~~~~~~~---------------------------~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~ 217 (314)
.+||+|||+|+....... ....+.+||+.|+|||++.+.. |+.++||||+||
T Consensus 156 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~ 235 (361)
T 4f9c_A 156 KYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGV 235 (361)
T ss_dssp EEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHH
T ss_pred eEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHH
Confidence 999999999986543211 1123457999999999998764 899999999999
Q ss_pred HHHHHHhCCCCccccc
Q 043524 218 FLSELLTGRGILDLVR 233 (314)
Q Consensus 218 ~l~el~~g~~p~~~~~ 233 (314)
++|||++|+.||....
T Consensus 236 il~ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 236 IFLSLLSGRYPFYKAS 251 (361)
T ss_dssp HHHHHHHTCSSSSCCS
T ss_pred HHHHHHHCCCCCCCCC
Confidence 9999999999996443
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-49 Score=372.41 Aligned_cols=249 Identities=16% Similarity=0.223 Sum_probs=200.5
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHH---HHHHHhcCCCCceeeeEeEE
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCIN---NVTYAAQMSHDHILKLIGCC 89 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~---E~~~l~~l~h~niv~~~~~~ 89 (314)
+.....||.|+ +.|+++.+..+|+.||+|++.+..+...... ..+.+ ++.+++.++|||||+++++|
T Consensus 191 f~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~---------~~~~~E~~~l~ll~~~~HP~IV~l~~~f 261 (689)
T 3v5w_A 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE---------TLALNERIMLSLVSTGDCPFIVCMSYAF 261 (689)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCH---------HHHHHHHHHHHHHSSSCCTTBCCEEEEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhH---------HHHHHHHHHHHHHhhCCCCCEeEEEEEE
Confidence 44556799999 9999999999999999999998776543211 22333 46677788999999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEE
Q 043524 90 LETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKL 169 (314)
Q Consensus 90 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl 169 (314)
.+.+.+|+|||||+||+|.+++...+ .++...++.++.||+.||.||| ++||+||||||+|||++.+|.+||
T Consensus 262 ~~~~~lylVmEy~~GGdL~~~l~~~~-----~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL 333 (689)
T 3v5w_A 262 HTPDKLSFILDLMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRI 333 (689)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEE
T ss_pred EECCEEEEEEecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEe
Confidence 99999999999999999999997653 5899999999999999999999 999999999999999999999999
Q ss_pred cccccceecCCCCcccccccccccccccCccccc-CCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHh
Q 043524 170 FDFSLSISIPEGETHITDTVMGTYGHLAPQYVTT-CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKN 248 (314)
Q Consensus 170 ~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (314)
+|||+|+...... ..+.+||+.|||||++.. ..|+.++|+||+||++|||++|.+||........ ......
T Consensus 334 ~DFGlA~~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~-----~~i~~~ 405 (689)
T 3v5w_A 334 SDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRM 405 (689)
T ss_dssp CCCTTCEECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH-----HHHHHH
T ss_pred cccceeeecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHh
Confidence 9999998765432 456789999999999975 5799999999999999999999999975432220 011111
Q ss_pred hhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCC-----HHHHHH
Q 043524 249 YFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPT-----MVDVAR 302 (314)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps-----~~ell~ 302 (314)
........+ ...+.++.+||..||..||++|++ |.||++
T Consensus 406 -------------i~~~~~~~p--~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 406 -------------TLTMAVELP--DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp -------------HHHCCCCCC--TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred -------------hcCCCCCCC--ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 111111111 134567899999999999999998 677764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-49 Score=373.30 Aligned_cols=250 Identities=16% Similarity=0.264 Sum_probs=204.3
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
+|.....||.|+ +.|+++.+..+|+.||+|++........ +.+.+|+++|+.++|||||++++++.+
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~------------~~~~~Ei~il~~l~hpnIv~l~~~~~~ 225 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK------------ETVRKEIQTMSVLRHPTLVNLHDAFED 225 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHH------------HHHHHHHHHHHHTCCTTBCCEEEEEEC
T ss_pred ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhH------------HHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 445556789988 8899999999999999999865443222 567899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCC--CceEE
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEE--NVVKL 169 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~--~~~kl 169 (314)
.+.+|+|||||+||+|.+++.... ..++...+..++.||+.||.||| +++|+||||||+|||++.+ +.+||
T Consensus 226 ~~~~~iv~E~~~gg~L~~~i~~~~----~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl 298 (573)
T 3uto_A 226 DNEMVMIYEFMSGGELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKL 298 (573)
T ss_dssp SSEEEEEEECCCCCBHHHHHTCTT----SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEE
T ss_pred CCEEEEEEeecCCCcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEE
Confidence 999999999999999999997543 45899999999999999999999 9999999999999999854 78999
Q ss_pred cccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhh
Q 043524 170 FDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNY 249 (314)
Q Consensus 170 ~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (314)
+|||+++.+..... .....||+.|+|||++.+..|+.++||||+||++|+|++|..||....... .....
T Consensus 299 ~DFG~a~~~~~~~~--~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~--------~~~~i 368 (573)
T 3uto_A 299 IDFGLTAHLDPKQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE--------TLRNV 368 (573)
T ss_dssp CCCSSCEECCTTSE--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--------HHHHH
T ss_pred eeccceeEccCCCc--eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--------HHHHH
Confidence 99999988754432 446689999999999999999999999999999999999999997543211 11111
Q ss_pred hccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 250 FEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
... .. ..+.......+.++.+||.+||+.||++|||+.|+++
T Consensus 369 ~~~-~~----------~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 369 KSC-DW----------NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp HTT-CC----------CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HhC-CC----------CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 110 00 0011111134567899999999999999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-46 Score=329.22 Aligned_cols=276 Identities=28% Similarity=0.474 Sum_probs=220.1
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.++.....+|.|+ +.|+.+. ..+|+.||+|++......... ..+.+|++++..++||||+++++++.
T Consensus 30 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~-----------~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 30 DNFSNKNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGE-----------LQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp TSSCSTTEEECCSSSEEEEEC-CSSSCCEEEEECCC-----CC-----------CHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred hccccceeEecCCCcEEEEEE-ecCCCEEEEEEeccccCchHH-----------HHHHHHHHHHHhccCCCccceEEEEe
Confidence 4556666788888 7777664 457899999998754422111 35789999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCC---CceeccCCCCCeeecCCCce
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPR---PIVFRDFKTSHILFSEENVV 167 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~---~i~H~dlk~~nil~~~~~~~ 167 (314)
+++..++||||+++|+|.+.+...... ..++++..+..++.|++.||.||| ++ +|+||||||+||+++.++.+
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~ivH~Dlkp~Nil~~~~~~~ 173 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPES-QPPLDWPKRQRIALGSARGLAYLH---DHCDPKIIHRDVKAANILLDEEFEA 173 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTT-CCCCCHHHHHHHHHHHHHHHHHHH---HSSSSCEECCCCSGGGEEECTTCCE
T ss_pred cCCceEEEEEeccCCCHHHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCeEeCCCchhhEEECCCCCE
Confidence 999999999999999999999875432 145889999999999999999999 78 99999999999999999999
Q ss_pred EEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHH
Q 043524 168 KLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLK 247 (314)
Q Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (314)
+|+|||+++..............||+.|+|||++....++.++||||+|+++|+|++|..||+..............+..
T Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 174 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp EECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred EeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 99999999877554444455567999999999998888999999999999999999999999754433333344555655
Q ss_pred hhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHH
Q 043524 248 NYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQI 307 (314)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~ 307 (314)
............+........ ...+..+.+++..||+.||++|||+.|+++.|+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 254 GLLKEKKLEALVDVDLQGNYK----DEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TTTSSCCSTTSSCTTCTTSCC----HHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HHhhchhhhhhcChhhccccC----HHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 555555555555544433322 35677899999999999999999999999999753
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=325.07 Aligned_cols=261 Identities=22% Similarity=0.309 Sum_probs=208.0
Q ss_pred hhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEE
Q 043524 11 WSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCC 89 (314)
Q Consensus 11 ~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 89 (314)
..++.....+|.|+ +.|+.+.+..+|+.+|+|.+....... .+.+.+|++++..++||||+++++++
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~------------~~~~~~E~~~l~~l~hp~iv~~~~~~ 76 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEET------------QRTFLKEVKVMRCLEHPNVLKFIGVL 76 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHH------------HHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHH------------HHHHHHHHHHHHhCCCcCcccEEEEE
Confidence 34555666799988 888888888999999999875432221 25788999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEE
Q 043524 90 LETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKL 169 (314)
Q Consensus 90 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl 169 (314)
.+++..++||||+++|+|.+++.... ..+++..+..++.|++.||.||| +++|+|+||||+||+++.++.++|
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl 149 (310)
T 3s95_A 77 YKDKRLNFITEYIKGGTLRGIIKSMD----SQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVV 149 (310)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHCC----TTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEE
T ss_pred ecCCeeEEEEEecCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEE
Confidence 99999999999999999999998754 35889999999999999999999 999999999999999999999999
Q ss_pred cccccceecCCCCccc-------------ccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCcc
Q 043524 170 FDFSLSISIPEGETHI-------------TDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAH 236 (314)
Q Consensus 170 ~dfg~~~~~~~~~~~~-------------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~ 236 (314)
+|||+++......... .....||+.|+|||++.+..++.++||||+|+++|+|++|..||.......
T Consensus 150 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~ 229 (310)
T 3s95_A 150 ADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT 229 (310)
T ss_dssp CCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBC
T ss_pred eecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhH
Confidence 9999998764332211 114579999999999999899999999999999999999999986433221
Q ss_pred c-cccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhc
Q 043524 237 D-LVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSL 311 (314)
Q Consensus 237 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 311 (314)
. ........... ..+ ..++..+.+++..||+.||++|||+.++++.|+++...+
T Consensus 230 ~~~~~~~~~~~~~-----------------~~~----~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 230 MDFGLNVRGFLDR-----------------YCP----PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp TTSSBCHHHHHHH-----------------TCC----TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHhhhhhccccc-----------------cCC----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 1 11111111100 000 123345789999999999999999999999999987654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=325.83 Aligned_cols=250 Identities=21% Similarity=0.280 Sum_probs=202.9
Q ss_pred hhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEE
Q 043524 11 WSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCC 89 (314)
Q Consensus 11 ~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 89 (314)
..+|.....+|.|+ +.|+.+.+..+|+.||+|++....... .+.+.+|+.+++.++||||+++++++
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------------~~~~~~E~~~l~~l~hp~iv~~~~~~ 86 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK------------KELIINEILVMRENKNPNIVNYLDSY 86 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC------------HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH------------HHHHHHHHHHHhcCCCCCCCeEeEEE
Confidence 34566677799988 888888888999999999986543111 25688999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEE
Q 043524 90 LETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKL 169 (314)
Q Consensus 90 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl 169 (314)
..++..|+||||+++|+|.+++... .++...+..++.|++.||.||| +++|+||||||+||+++.++.++|
T Consensus 87 ~~~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl 157 (297)
T 3fxz_A 87 LVGDELWVVMEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKL 157 (297)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEE
T ss_pred EECCEEEEEEECCCCCCHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEE
Confidence 9999999999999999999999763 3788999999999999999999 999999999999999999999999
Q ss_pred cccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhh
Q 043524 170 FDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNY 249 (314)
Q Consensus 170 ~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (314)
+|||++........ ......||+.|+|||++.+..++.++||||+|+++|+|++|..||....... .....
T Consensus 158 ~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--------~~~~~ 228 (297)
T 3fxz_A 158 TDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--------ALYLI 228 (297)
T ss_dssp CCCTTCEECCSTTC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHH
T ss_pred eeCCCceecCCccc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHH
Confidence 99999977644332 2445679999999999999899999999999999999999999996433211 00000
Q ss_pred hccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 250 FEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.... ......+...+..+.+|+..||+.||++|||+.|+++
T Consensus 229 ~~~~------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 229 ATNG------------TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp HHHC------------SCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HhCC------------CCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0000 0000111134566889999999999999999999986
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=329.13 Aligned_cols=248 Identities=20% Similarity=0.281 Sum_probs=201.8
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
..|.....+|.|+ +.|+.+.+..+|+.||+|++........ ..+++.+|+++++.++||||+++++++.
T Consensus 15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 84 (328)
T 3fe3_A 15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPT----------SLQKLFREVRIMKILNHPNIVKLFEVIE 84 (328)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH----------HHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHH----------HHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 4556666789988 8888888889999999999876532111 1256789999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
+.+..|+||||+++|+|.+++.... .++...+..++.|++.||.||| +++|+||||||+||+++.++.+||+
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~ 156 (328)
T 3fe3_A 85 TEKTLYLIMEYASGGEVFDYLVAHG-----RMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIA 156 (328)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred ECCEEEEEEECCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEe
Confidence 9999999999999999999987643 4788999999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCcccccCCCC-cccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhh
Q 043524 171 DFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFS-EKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNY 249 (314)
Q Consensus 171 dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (314)
|||+++...... ......||+.|+|||++.+..+. .++||||+||++|+|++|+.||...... ......
T Consensus 157 DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~~~~i 226 (328)
T 3fe3_A 157 DFGFSNEFTVGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK--------ELRERV 226 (328)
T ss_dssp STTCCGGGSSSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHH
T ss_pred eccCceecCCCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHH
Confidence 999997664432 24566899999999999888765 7899999999999999999999643311 111111
Q ss_pred hccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 250 FEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
. .+....+ ...+..+.+|+.+||..||++|||+.|+++
T Consensus 227 ~-------------~~~~~~p--~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 227 L-------------RGKYRIP--FYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp H-------------HCCCCCC--TTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred H-------------hCCCCCC--CCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1 1111111 123456889999999999999999999975
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=320.87 Aligned_cols=276 Identities=28% Similarity=0.447 Sum_probs=215.4
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.++.....+|.|+ +.|+.+.. .+|+.||+|.+...... ..+.+.+|+.++..++||||+++++++.
T Consensus 39 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------------~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 105 (321)
T 2qkw_B 39 NNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQ------------GIEEFETEIETLSFCRHPHLVSLIGFCD 105 (321)
T ss_dssp CCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSS------------HHHHHHHHHHGGGSCCCTTBCCEEEECC
T ss_pred hccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChH------------HHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 4455666788888 77777654 56899999987543211 1257889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
+++..++||||+++|+|.+++...... ...+++..++.++.|++.||.||| +++|+||||||+||+++.++.++|+
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~ 181 (321)
T 2qkw_B 106 ERNEMILIYKYMENGNLKRHLYGSDLP-TMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKIT 181 (321)
T ss_dssp CTTCCEEEEECCTTCBTGGGSSSSCCC-SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEEC
T ss_pred CCCeEEEEEEcCCCCcHHHHHhccCCC-ccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEe
Confidence 999999999999999999988654321 135889999999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCC-cccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhh
Q 043524 171 DFSLSISIPEGE-THITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNY 249 (314)
Q Consensus 171 dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (314)
|||+++...... ........||+.|+|||++.+..++.++||||+|+++|+|++|+.||....... ......+....
T Consensus 182 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~ 259 (321)
T 2qkw_B 182 DFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE--MVNLAEWAVES 259 (321)
T ss_dssp CCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSS--CCCHHHHTHHH
T ss_pred ecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHH--HHHHHHHhhhc
Confidence 999997654322 112334568999999999988889999999999999999999999997544332 12233333333
Q ss_pred hccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 250 FEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
.........+++...... ....+..+.+++.+||+.||++|||+.|+++.|+.+.+-
T Consensus 260 ~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 260 HNNGQLEQIVDPNLADKI----RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp HTTTCCCSSSSSSCTTCS----CHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred cccccHHHhcChhhcccc----CHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 333334444443332222 236678899999999999999999999999999988764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=319.96 Aligned_cols=266 Identities=21% Similarity=0.259 Sum_probs=202.1
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
++.....+|.|+ +.|+++. ..|+.||+|++....... ..+..|+.++..++||||+++++++..
T Consensus 25 ~y~~~~~lg~G~~g~Vy~~~--~~~~~vavK~~~~~~~~~-------------~~~~~E~~~l~~l~hpniv~~~~~~~~ 89 (322)
T 3soc_A 25 PLQLLEVKARGRFGCVWKAQ--LLNEYVAVKIFPIQDKQS-------------WQNEYEVYSLPGMKHENILQFIGAEKR 89 (322)
T ss_dssp EEEEEEEEECSTTCEEEEEE--ETTEEEEEEEECGGGHHH-------------HHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred hchhhheecccCceEEEEEE--ECCCEEEEEEeecCchHH-------------HHHHHHHHHHhcCCCCCchhhcceecc
Confidence 445555688888 7777764 347899999987654322 234568999999999999999999987
Q ss_pred CC----eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCC----------CceeccCCCC
Q 043524 92 TP----IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPR----------PIVFRDFKTS 157 (314)
Q Consensus 92 ~~----~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~----------~i~H~dlk~~ 157 (314)
+. .+|+|||||++|+|.+++... .+++..+..++.|++.||.||| +. +|+||||||+
T Consensus 90 ~~~~~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~ 160 (322)
T 3soc_A 90 GTSVDVDLWLITAFHEKGSLSDFLKAN------VVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSK 160 (322)
T ss_dssp ECSSSEEEEEEEECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGG
T ss_pred CCCCCceEEEEEecCCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChH
Confidence 54 369999999999999999763 4889999999999999999999 88 9999999999
Q ss_pred CeeecCCCceEEcccccceecCCCCcc-cccccccccccccCcccccC-----CCCcccchHHHHHHHHHHHhCCCCccc
Q 043524 158 HILFSEENVVKLFDFSLSISIPEGETH-ITDTVMGTYGHLAPQYVTTC-----DFSEKLDVYSFGAFLSELLTGRGILDL 231 (314)
Q Consensus 158 nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~-----~~~~~~DiwslG~~l~el~~g~~p~~~ 231 (314)
||+++.++.+||+|||+++........ ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||..
T Consensus 161 Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~ 240 (322)
T 3soc_A 161 NVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240 (322)
T ss_dssp GEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSS
T ss_pred hEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999876543322 23345799999999998763 355788999999999999999999976
Q ss_pred ccCccccccchHHHH---------HhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 232 VRDAHDLVYPFNEYL---------KNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 232 ~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
...... .++.... ................. .....+..+.+|+..||+.||++|||+.|+++
T Consensus 241 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 241 PVDEYM--LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYW-------QKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp CCCCCC--CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGG-------GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Ccchhc--cchhhhhccCCchhhhhhhhhcccCCCCccccc-------cccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 543321 1222111 11111111111111111 11145667999999999999999999999999
Q ss_pred HHHHHHhhc
Q 043524 303 RLRQICCSL 311 (314)
Q Consensus 303 ~L~~~~~~~ 311 (314)
.|+++.+..
T Consensus 312 ~L~~l~~~~ 320 (322)
T 3soc_A 312 RITQMQRLT 320 (322)
T ss_dssp HHHHHHHHC
T ss_pred HHHHHHHHh
Confidence 999998754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=323.27 Aligned_cols=249 Identities=18% Similarity=0.276 Sum_probs=201.8
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
.+.....+|.|+ +.|+++.+..+|+.||+|++.......... .+.+.+|++++..++||||+++++++.+
T Consensus 6 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~---------~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 76 (337)
T 1o6l_A 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE---------VAHTVTESRVLQNTRHPFLTALKYAFQT 76 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTC---------HHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred HeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhH---------HHHHHHHHHHHHhCCCCcCcceEEEEEe
Confidence 344555688888 888888888899999999998765433221 2568899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
.+.+|+||||+++|+|.+.+... ..++...+..++.|++.||.||| +++|+||||||+||+++.++.+||+|
T Consensus 77 ~~~~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~D 148 (337)
T 1o6l_A 77 HDRLCFVMEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITD 148 (337)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECC
T ss_pred CCEEEEEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEee
Confidence 99999999999999999988754 24788999999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhc
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFE 251 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (314)
||+++...... .......||+.|+|||++.+..++.++|+||+||++|||++|..||...... ........
T Consensus 149 FG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--------~~~~~i~~ 219 (337)
T 1o6l_A 149 FGLCKEGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------RLFELILM 219 (337)
T ss_dssp CTTCBCSCCTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHH
T ss_pred ccchhhcccCC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH--------HHHHHHHc
Confidence 99997643222 1244668999999999999989999999999999999999999999643211 11111111
Q ss_pred cCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCC-----CHHHHHH
Q 043524 252 DNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRP-----TMVDVAR 302 (314)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 302 (314)
.....+ ...+.++.+|+.+||+.||++|| ++.|+++
T Consensus 220 -------------~~~~~p--~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 220 -------------EEIRFP--RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -------------CCCCCC--TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -------------CCCCCC--CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 111111 13446789999999999999999 8999875
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=328.48 Aligned_cols=257 Identities=21% Similarity=0.259 Sum_probs=204.5
Q ss_pred hhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEE
Q 043524 11 WSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCC 89 (314)
Q Consensus 11 ~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 89 (314)
...|.....+|.|+ +.|+++.+..+|+.+|+|++........ ......+.+.+|+.++..++||||+++++++
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~------~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~ 84 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRAS------RRGVCREEIEREVSILRQVLHPNIITLHDVY 84 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTC------SSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccc------cchhHHHHHHHHHHHHHhCCCcCCCcEEEEE
Confidence 34566666789888 8888998899999999999875432111 1111236788999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCC----
Q 043524 90 LETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN---- 165 (314)
Q Consensus 90 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~---- 165 (314)
.++..+|+||||+++|+|.+++... ..++...+..++.|++.||.||| +++|+||||||+||+++..+
T Consensus 85 ~~~~~~~lv~e~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~ 156 (361)
T 2yab_A 85 ENRTDVVLILELVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIP 156 (361)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHTTC-----SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSC
T ss_pred EeCCEEEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCcc
Confidence 9999999999999999999999654 35889999999999999999999 99999999999999998776
Q ss_pred ceEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHH
Q 043524 166 VVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEY 245 (314)
Q Consensus 166 ~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 245 (314)
.++|+|||+++....... .....||+.|+|||++....++.++||||+|+++|+|++|..||....... .
T Consensus 157 ~vkl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~--------~ 226 (361)
T 2yab_A 157 HIKLIDFGLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--------T 226 (361)
T ss_dssp CEEECCCSSCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--------H
T ss_pred CEEEEecCCceEcCCCCc--cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH--------H
Confidence 799999999987654322 345679999999999998889999999999999999999999996533211 1
Q ss_pred HHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 246 LKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
....... . ...+.......+..+.+||..||..||++|||+.|+++
T Consensus 227 ~~~i~~~-~----------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 227 LANITAV-S----------YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHHHHTT-C----------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHhc-C----------CCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1111100 0 01111111234567899999999999999999999985
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=324.10 Aligned_cols=272 Identities=22% Similarity=0.303 Sum_probs=200.6
Q ss_pred cCcccccccCch-hHHHHHH----HhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEe
Q 043524 13 KGKRTLMIGNGA-SVLQELI----ASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIG 87 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~----~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 87 (314)
+++....+|.|+ +.|+.+. +..+|+.||+|++....... .+.+.+|++++..++||||+++++
T Consensus 11 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~------------~~~~~~E~~~l~~l~h~~iv~~~~ 78 (295)
T 3ugc_A 11 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH------------LRDFEREIEILKSLQHDNIVKYKG 78 (295)
T ss_dssp GEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHH------------HHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred HhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHH------------HHHHHHHHHHHHhCCCCCEeeEEE
Confidence 344445688888 7777765 66789999999986543222 156889999999999999999999
Q ss_pred EEEe--CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCC
Q 043524 88 CCLE--TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN 165 (314)
Q Consensus 88 ~~~~--~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~ 165 (314)
++.. ....++||||+++|+|.+++.... ..++...+..++.|++.||.||| +++|+||||||+||+++.++
T Consensus 79 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~ 151 (295)
T 3ugc_A 79 VCYSAGRRNLKLIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENEN 151 (295)
T ss_dssp EECHHHHTSCEEEEECCTTCBHHHHHHHCG----GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETT
T ss_pred EEecCCCCceEEEEEeCCCCCHHHHHHhcc----cccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCC
Confidence 9865 456899999999999999997754 35889999999999999999999 99999999999999999999
Q ss_pred ceEEcccccceecCCCCc--ccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchH
Q 043524 166 VVKLFDFSLSISIPEGET--HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFN 243 (314)
Q Consensus 166 ~~kl~dfg~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~ 243 (314)
.++|+|||+++....... .......++..|+|||++.+..++.++||||+|+++|+|++|..|+.....
T Consensus 152 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~--------- 222 (295)
T 3ugc_A 152 RVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA--------- 222 (295)
T ss_dssp EEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH---------
T ss_pred eEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChH---------
Confidence 999999999977643321 112334577889999999988999999999999999999999998853321
Q ss_pred HHHHhhhccCCccc---ccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhcc
Q 043524 244 EYLKNYFEDNRFTE---IVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSLS 312 (314)
Q Consensus 244 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~ 312 (314)
.+............ .....+......+.+..++.++.+|+..||+.||++|||+.|+++.|+++.++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~ 294 (295)
T 3ugc_A 223 EFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294 (295)
T ss_dssp HHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred HHHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence 11000000000000 0000011111111112455678999999999999999999999999999988764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=324.35 Aligned_cols=248 Identities=21% Similarity=0.291 Sum_probs=201.3
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|.....+|.|+ +.|+++.+..+|+.||+|++........... +.+.+|+.++..++||||+++++++.
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~---------~~~~~E~~~l~~l~hpnIv~l~~~~~ 79 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMH---------MRVEREISYLKLLRHPHIIKLYDVIT 79 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCS---------HHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHH---------HHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 4455566789888 8888898889999999999987655433221 57889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
+++..++||||+ +|+|.+.+.... .++...+..++.|++.||.||| +++|+||||||+||+++.++.+||+
T Consensus 80 ~~~~~~lv~E~~-~g~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~ 150 (336)
T 3h4j_B 80 TPTDIVMVIEYA-GGELFDYIVEKK-----RMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIA 150 (336)
T ss_dssp CSSEEEEEECCC-CEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEEC
T ss_pred eCCEEEEEEECC-CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEE
Confidence 999999999999 689999887643 4889999999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCcccccCCC-CcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhh
Q 043524 171 DFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDF-SEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNY 249 (314)
Q Consensus 171 dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (314)
|||++....... ......||+.|+|||++.+..+ +.++||||+|+++|+|++|..||+......
T Consensus 151 DFG~s~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~------------- 215 (336)
T 3h4j_B 151 DFGLSNIMTDGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN------------- 215 (336)
T ss_dssp CSSCTBTTTTSB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT-------------
T ss_pred EeccceeccCCc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH-------------
Confidence 999997654432 2345679999999999988776 689999999999999999999996433211
Q ss_pred hccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 250 FEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
............+ ...+..+.+|+.+||+.||++|||+.|+++
T Consensus 216 --------~~~~i~~~~~~~p--~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 216 --------LFKKVNSCVYVMP--DFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp --------CBCCCCSSCCCCC--TTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred --------HHHHHHcCCCCCc--ccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 0000000000000 133466889999999999999999999976
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=323.57 Aligned_cols=261 Identities=25% Similarity=0.337 Sum_probs=194.5
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+++....+|.|+ +.|+.+. .+|+.||+|++........ ..+++.+|++++..++||||+++++++.
T Consensus 37 ~~y~i~~~lG~G~~g~V~~~~--~~~~~vavK~~~~~~~~~~----------~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 104 (309)
T 3p86_A 37 CDLNIKEKIGAGSFGTVHRAE--WHGSDVAVKILMEQDFHAE----------RVNEFLREVAIMKRLRHPNIVLFMGAVT 104 (309)
T ss_dssp GGEEEEEEEEECSSEEEEEEE--ETTEEEEEEEECCCCCSHH----------HHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hHceeeeEeecCCCeEEEEEE--ECCCcEEEEEecCCCCCHH----------HHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 4455556688888 7777663 4688999999864432111 1256889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCC--ceeccCCCCCeeecCCCceE
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRP--IVFRDFKTSHILFSEENVVK 168 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~--i~H~dlk~~nil~~~~~~~k 168 (314)
+.+..++||||+++|+|.+++...... ..++...++.++.|++.||.||| +++ |+||||||+||+++.++.++
T Consensus 105 ~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~k 179 (309)
T 3p86_A 105 QPPNLSIVTEYLSRGSLYRLLHKSGAR--EQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVK 179 (309)
T ss_dssp STTCCEEEEECCTTCBHHHHHHSTTHH--HHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEE
T ss_pred ECCceEEEEecCCCCcHHHHHhhcCCC--CCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEE
Confidence 999999999999999999999764311 24788999999999999999999 999 99999999999999999999
Q ss_pred EcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHh
Q 043524 169 LFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKN 248 (314)
Q Consensus 169 l~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (314)
|+|||+++...... .......||+.|+|||++.+..++.++||||+|+++|+|++|..||....... ....
T Consensus 180 L~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~--------~~~~ 250 (309)
T 3p86_A 180 VCDFGLSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ--------VVAA 250 (309)
T ss_dssp ECCCC------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH--------HHHH
T ss_pred ECCCCCCccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHH
Confidence 99999997543322 12345678999999999999889999999999999999999999996443211 1110
Q ss_pred hhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhc
Q 043524 249 YFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSL 311 (314)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 311 (314)
...... . ...+...+..+.+|+..||+.||++|||+.++++.|+.+.++.
T Consensus 251 ~~~~~~-----------~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 251 VGFKCK-----------R--LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp HHHSCC-----------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred HHhcCC-----------C--CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 000000 0 0001134456889999999999999999999999999987653
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=324.73 Aligned_cols=260 Identities=20% Similarity=0.264 Sum_probs=202.6
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCc---ccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEe
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGK---YIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIG 87 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~---~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 87 (314)
.++.....+|.|+ +.|+++....+|+ .||+|++........ .+.+.+|+.++..++||||+++++
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~E~~~l~~l~h~~iv~~~~ 117 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ-----------RRDFLSEASIMGQFDHPNIIRLEG 117 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHH-----------HHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHH-----------HHHHHHHHHHHHhCCCCCCCcEEE
Confidence 3445556789888 7788777765554 499999875321111 156889999999999999999999
Q ss_pred EEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCce
Q 043524 88 CCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVV 167 (314)
Q Consensus 88 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~ 167 (314)
++.+++..|+||||+++|+|.+++.... ..++...+..++.|++.||.||| +++|+||||||+||+++.++.+
T Consensus 118 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~ 190 (325)
T 3kul_A 118 VVTRGRLAMIVTEYMENGSLDTFLRTHD----GQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVC 190 (325)
T ss_dssp EECGGGCCEEEEECCTTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCE
T ss_pred EEEeCCccEEEeeCCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCE
Confidence 9999999999999999999999997654 35889999999999999999999 9999999999999999999999
Q ss_pred EEcccccceecCCCCcc--cccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHH
Q 043524 168 KLFDFSLSISIPEGETH--ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNE 244 (314)
Q Consensus 168 kl~dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~ 244 (314)
+|+|||+++........ ......+|+.|+|||++....++.++||||+|+++|+|++ |..||.......
T Consensus 191 kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------- 262 (325)
T 3kul_A 191 KVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD-------- 262 (325)
T ss_dssp EECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--------
T ss_pred EECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH--------
Confidence 99999999876443211 1223346778999999988889999999999999999999 999986433211
Q ss_pred HHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhc
Q 043524 245 YLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSL 311 (314)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 311 (314)
........ ...+.+..++..+.+|+..||..||++|||+.|+++.|+++.+..
T Consensus 263 ~~~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 263 VISSVEEG--------------YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp HHHHHHTT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred HHHHHHcC--------------CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 11111110 000011134567899999999999999999999999999997654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=321.96 Aligned_cols=250 Identities=15% Similarity=0.212 Sum_probs=202.0
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|.....+|.|+ +.|+.+.+..+|+.+|+|++...... .+.+.+|+.++..++||||+++++++.
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-------------~~~~~~E~~~l~~l~hpnIv~~~~~~~ 71 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-------------QVLVKKEISILNIARHRNILHLHESFE 71 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-------------HHHHHHHHHHHHHSCCTTBCCEEEEEE
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCccc-------------HHHHHHHHHHHHhCCCCCCCeEeEEEe
Confidence 4455566689888 88899988999999999988644321 145789999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecC--CCceE
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSE--ENVVK 168 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~--~~~~k 168 (314)
+.+.+++|||||++|+|.+++.... ..++...+..++.|++.||.||| +++|+||||||+||+++. ++.++
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~k 144 (321)
T 1tki_A 72 SMEELVMIFEFISGLDIFERINTSA----FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIK 144 (321)
T ss_dssp ETTEEEEEECCCCCCBHHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEE
T ss_pred cCCEEEEEEEeCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEE
Confidence 9999999999999999999997643 35889999999999999999999 999999999999999987 78999
Q ss_pred EcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHh
Q 043524 169 LFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKN 248 (314)
Q Consensus 169 l~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (314)
|+|||+++....... .....||+.|+|||++.+..++.++||||+|+++|+|++|..||...... .....
T Consensus 145 l~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~ 214 (321)
T 1tki_A 145 IIEFGQARQLKPGDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--------QIIEN 214 (321)
T ss_dssp ECCCTTCEECCTTCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHH
T ss_pred EEECCCCeECCCCCc--cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH--------HHHHH
Confidence 999999987654332 34567899999999998888899999999999999999999999643321 11111
Q ss_pred hhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 249 YFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
..... ...+.......+.++.+|+..||..||++|||+.|+++
T Consensus 215 i~~~~-----------~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 215 IMNAE-----------YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHTC-----------CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHcCC-----------CCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11100 00111111234567899999999999999999999987
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=334.05 Aligned_cols=257 Identities=22% Similarity=0.285 Sum_probs=203.3
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
+.....+|.|+ +.|+.+....+|+.||+|++........ .+++.+|+++++.++||||+++++++.++
T Consensus 116 ~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 184 (377)
T 3cbl_A 116 LVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDL-----------KAKFLQEARILKQYSHPNIVRLIGVCTQK 184 (377)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHH-----------HTTTTHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred eEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHH-----------HHHHHHHHHHHHhCCCCCEEEEEEEEecC
Confidence 33445688888 8888888888899999998864321111 14577999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~df 172 (314)
+..|+||||+++|+|.+++.... ..++...+..++.|++.||.||| +++|+||||||+||+++.++.+||+||
T Consensus 185 ~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~Df 257 (377)
T 3cbl_A 185 QPIYIVMELVQGGDFLTFLRTEG----ARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDF 257 (377)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCG
T ss_pred CCcEEEEEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcC
Confidence 99999999999999999997643 35788999999999999999999 999999999999999999999999999
Q ss_pred ccceecCCCCcccc-cccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhh
Q 043524 173 SLSISIPEGETHIT-DTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 173 g~~~~~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
|+++.......... ....++..|+|||++....++.++||||||+++|||++ |..||....... .....
T Consensus 258 G~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~---------~~~~~ 328 (377)
T 3cbl_A 258 GMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ---------TREFV 328 (377)
T ss_dssp GGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH---------HHHHH
T ss_pred CCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---------HHHHH
Confidence 99986543321111 12235778999999988889999999999999999998 999986543211 11111
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
.... ..+.+..++..+.+|+.+||+.||++|||+.++++.|+++.+.
T Consensus 329 ~~~~-------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 329 EKGG-------------RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp HTTC-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HcCC-------------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 1100 0000113445688999999999999999999999999998764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=317.16 Aligned_cols=246 Identities=20% Similarity=0.327 Sum_probs=201.3
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
.+.....+|.|+ +.|+.+.+..+|+.||+|++.......... .+.+.+|+.++..++||||+++++++.+
T Consensus 7 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~---------~~~~~~E~~~l~~l~hp~Iv~~~~~~~~ 77 (318)
T 1fot_A 7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ---------VEHTNDERLMLSIVTHPFIIRMWGTFQD 77 (318)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTC---------HHHHHHHHHHHHSCCBTTBCCEEEEEEC
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhH---------HHHHHHHHHHHhhCCCCCCceEeEEEEe
Confidence 344555688888 888888888899999999998765543221 2567899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
...+|+||||+++|+|.+++.... .++...+..++.|++.||.||| +++|+||||||+||+++.++.+||+|
T Consensus 78 ~~~~~lv~e~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~D 149 (318)
T 1fot_A 78 AQQIFMIMDYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITD 149 (318)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECC
T ss_pred CCEEEEEEeCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEee
Confidence 999999999999999999997643 4788999999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhc
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFE 251 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (314)
||+++..... .....||+.|+|||++.+..++.++|+||+||++|+|++|..||...... ........
T Consensus 150 fg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~~~~i~~ 217 (318)
T 1fot_A 150 FGFAKYVPDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--------KTYEKILN 217 (318)
T ss_dssp CSSCEECSSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHH
T ss_pred cCcceecCCc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHh
Confidence 9999875432 33567999999999999888999999999999999999999999643211 11111111
Q ss_pred cCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCC-----CHHHHHH
Q 043524 252 DNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRP-----TMVDVAR 302 (314)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 302 (314)
.....+ ...+.++.+|+.+||..||++|| ++.|+++
T Consensus 218 -------------~~~~~p--~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 218 -------------AELRFP--PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp -------------CCCCCC--TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -------------CCCCCC--CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 111111 13346689999999999999999 8888874
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=332.92 Aligned_cols=253 Identities=20% Similarity=0.267 Sum_probs=201.1
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|.....+|.|+ +.|+++.+..+|+.+|+|++......... .+.+.+|+++++.++||||+++++++.
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~----------~~~~~~E~~il~~l~hpnIv~l~~~~~ 80 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD----------HQKLEREARICRLLKHPNIVRLHDSIS 80 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHH----------HHHHHHHHHHHHHCCBTTBCCEEEEEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHH----------HHHHHHHHHHHHhCCCcCCCeEEEEEE
Confidence 4455566689888 88888888999999999998765432211 156889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeec---CCCce
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFS---EENVV 167 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~---~~~~~ 167 (314)
+++..|+|||||++|+|.+.+.... .++...+..++.|++.||.||| +++|+||||||+||+++ .++.+
T Consensus 81 ~~~~~~lv~E~~~gg~L~~~i~~~~-----~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~v 152 (444)
T 3soa_A 81 EEGHHYLIFDLVTGGELFEDIVARE-----YYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAV 152 (444)
T ss_dssp CSSEEEEEECCCBCCBHHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCE
T ss_pred ECCEEEEEEEeCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcE
Confidence 9999999999999999999987653 4889999999999999999999 99999999999999998 45789
Q ss_pred EEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHH
Q 043524 168 KLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLK 247 (314)
Q Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (314)
||+|||+++....... ......||+.|+|||++.+..++.++||||+||++|+|++|..||....... ...
T Consensus 153 kL~DFG~a~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~--------~~~ 223 (444)
T 3soa_A 153 KLADFGLAIEVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR--------LYQ 223 (444)
T ss_dssp EECCCSSCBCCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHH
T ss_pred EEccCceeEEecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH--------HHH
Confidence 9999999976644322 2345679999999999998899999999999999999999999996433111 111
Q ss_pred hhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 248 NYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
..... .. ..+.+.....+.++.+|+..||+.||++|||+.|+++
T Consensus 224 ~i~~~-~~----------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 224 QIKAG-AY----------DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp HHHHT-CC----------CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhC-CC----------CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 11110 00 0001111134567899999999999999999999987
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=316.27 Aligned_cols=277 Identities=16% Similarity=0.173 Sum_probs=208.3
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
+|.....+|.|+ +.|+.+.+..+|+.||+|++........ .+.+.+|++++..++||||+++++++..
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 78 (319)
T 4euu_A 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-----------VDVQMREFEVLKKLNHKNIVKLFAIEEE 78 (319)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC-----------HHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccch-----------HHHHHHHHHHHHhcCCCCcceEEEEeec
Confidence 444555688888 8899998889999999999875432111 2567899999999999999999999987
Q ss_pred CC--eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeee----cCCC
Q 043524 92 TP--IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILF----SEEN 165 (314)
Q Consensus 92 ~~--~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~----~~~~ 165 (314)
.. ..|+||||+++++|.+++...... ..++...++.++.|++.||.||| +++|+||||||+||++ +..+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~ 153 (319)
T 4euu_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQS 153 (319)
T ss_dssp TTTCCEEEEEECCTTCBHHHHHHSGGGT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCE
T ss_pred CCCceEEEEEeCCCCCCHHHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCc
Confidence 55 789999999999999999764321 23889999999999999999999 9999999999999998 7778
Q ss_pred ceEEcccccceecCCCCcccccccccccccccCcccc--------cCCCCcccchHHHHHHHHHHHhCCCCcccccCccc
Q 043524 166 VVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVT--------TCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHD 237 (314)
Q Consensus 166 ~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--------~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~ 237 (314)
.+||+|||+++....... .....||+.|+|||++. ...++.++||||+||++|+|++|..||........
T Consensus 154 ~~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 231 (319)
T 4euu_A 154 VYKLTDFGAARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231 (319)
T ss_dssp EEEECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG
T ss_pred eEEEccCCCceecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch
Confidence 899999999987654432 33557999999999886 45688999999999999999999999975443322
Q ss_pred cccchHHHHHhhhccCCcccc---cChh--h--hccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHH
Q 043524 238 LVYPFNEYLKNYFEDNRFTEI---VDPI--I--VQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQIC 308 (314)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~---~~~~--~--~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~ 308 (314)
.............. ..+... .... . .-+.........+..+.+|+..||+.||++|||+.|+++...+..
T Consensus 232 ~~~~~~~~~~~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 232 NKEVMYKIITGKPS-GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp CHHHHHHHHHHCCT-TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred hHHHHHHHhcCCCc-ccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 22112221111110 000000 0000 0 001112223467788999999999999999999999999887643
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=325.15 Aligned_cols=263 Identities=18% Similarity=0.297 Sum_probs=204.0
Q ss_pred cCcccccccCch-hHHHHHHHh-------cCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCcee
Q 043524 13 KGKRTLMIGNGA-SVLQELIAS-------SNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHIL 83 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~-------~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 83 (314)
++.....+|.|+ +.|+.+.+. .++..||+|++........ .+.+.+|+.++..+ +||||+
T Consensus 82 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~E~~~l~~l~~hpnIv 150 (370)
T 2psq_A 82 KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD-----------LSDLVSEMEMMKMIGKHKNII 150 (370)
T ss_dssp GEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHH-----------HHHHHHHHHHHHHSCCCTTBC
T ss_pred HCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHH-----------HHHHHHHHHHHHHhcCCCCEe
Confidence 444555688888 777776532 3556799999865421111 25688999999999 899999
Q ss_pred eeEeEEEeCCeeEEEEeecCCCCHHHHHhcCCCC-----------CCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceec
Q 043524 84 KLIGCCLETPIAILVFEYVQHGTLWDRILGAPQT-----------HFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFR 152 (314)
Q Consensus 84 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~ 152 (314)
++++++.+.+.+|+||||+++|+|.+++...... ....++...++.++.|++.||.||| +++|+||
T Consensus 151 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHr 227 (370)
T 2psq_A 151 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHR 227 (370)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred eEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeecc
Confidence 9999999999999999999999999999865321 1134788999999999999999999 9999999
Q ss_pred cCCCCCeeecCCCceEEcccccceecCCCCc-ccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcc
Q 043524 153 DFKTSHILFSEENVVKLFDFSLSISIPEGET-HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILD 230 (314)
Q Consensus 153 dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~ 230 (314)
||||+||+++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 228 Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~ 307 (370)
T 2psq_A 228 DLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 307 (370)
T ss_dssp CCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999999999987644322 12233457889999999998899999999999999999999 999986
Q ss_pred cccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 231 LVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
...... ...... ... ....+..++..+.+|+..||+.||++|||+.|+++.|+++...
T Consensus 308 ~~~~~~--------~~~~~~-~~~-------------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 308 GIPVEE--------LFKLLK-EGH-------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp TCCGGG--------HHHHHH-TTC-------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCHHH--------HHHHHh-cCC-------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 533211 001100 000 0000113446789999999999999999999999999998764
Q ss_pred c
Q 043524 311 L 311 (314)
Q Consensus 311 ~ 311 (314)
.
T Consensus 366 ~ 366 (370)
T 2psq_A 366 T 366 (370)
T ss_dssp H
T ss_pred h
Confidence 3
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=315.88 Aligned_cols=255 Identities=22% Similarity=0.339 Sum_probs=202.6
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
++.....+|.|+ +.|+.+.+. +++.||+|++...... .+.+.+|+++++.++||||+++++++.+
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-------------~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 76 (269)
T 4hcu_A 11 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS-------------EEDFIEEAEVMMKLSHPKLVQLYGVCLE 76 (269)
T ss_dssp GEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC-------------HHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred hceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC-------------HHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 344455688888 777766544 5778999998743211 1568899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
++..++||||+++++|.+++.... ..++...+..++.|++.||.||| +++++|+||||+||+++.++.++|+|
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~D 149 (269)
T 4hcu_A 77 QAPICLVFEFMEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSD 149 (269)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECC
T ss_pred CCceEEEEEeCCCCcHHHHHHhcC----cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEecc
Confidence 999999999999999999997654 35889999999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhh
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
||+++..............+|+.|+|||++....++.++||||+|+++|+|++ |..||...... .......
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~--------~~~~~~~ 221 (269)
T 4hcu_A 150 FGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--------EVVEDIS 221 (269)
T ss_dssp TTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHH
T ss_pred ccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH--------HHHHHHh
Confidence 99997664433222334567888999999988899999999999999999999 99998643321 1111111
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
... ....+...+..+.+++..||+.||++|||+.|+++.|+++.++
T Consensus 222 ~~~--------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 222 TGF--------------RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp TTC--------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cCc--------------cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 100 0000012345688999999999999999999999999999764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=323.20 Aligned_cols=252 Identities=18% Similarity=0.250 Sum_probs=202.4
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
..+.....+|.|+ +.|+.+.+..+|+.||+|++.......... .+.+.+|++++..++|||||++++++.
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~---------~~~~~~E~~il~~l~hp~Iv~l~~~~~ 85 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNE---------VRNVFKELQIMQGLEHPFLVNLWYSFQ 85 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTC---------HHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHH---------HHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 3455566799998 888888889999999999998776543221 267889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
+....|+||||+.+|+|.+.+.... .++...+..++.|++.||.||| ++||+||||||+||+++.++.++|+
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~ 157 (384)
T 4fr4_A 86 DEEDMFMVVDLLLGGDLRYHLQQNV-----HFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHIT 157 (384)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred eCCEEEEEEecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEe
Confidence 9999999999999999999997643 5889999999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCccccc---CCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHH
Q 043524 171 DFSLSISIPEGETHITDTVMGTYGHLAPQYVTT---CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLK 247 (314)
Q Consensus 171 dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (314)
|||+++...... ......||+.|+|||++.. ..++.++||||+||++|+|++|..||....... ......
T Consensus 158 DFG~a~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~-----~~~~~~ 230 (384)
T 4fr4_A 158 DFNIAAMLPRET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS-----SKEIVH 230 (384)
T ss_dssp CCTTCEECCTTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC-----HHHHHH
T ss_pred ccceeeeccCCC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc-----HHHHHH
Confidence 999998764432 2456689999999999874 348899999999999999999999997443221 111111
Q ss_pred hhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCC-HHHHHH
Q 043524 248 NYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPT-MVDVAR 302 (314)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps-~~ell~ 302 (314)
.... .....+ ...+..+.+|+..||+.||++||+ +.++++
T Consensus 231 ~~~~-------------~~~~~p--~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 231 TFET-------------TVVTYP--SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHHH-------------CCCCCC--TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred HHhh-------------cccCCC--CcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 1100 000000 134467899999999999999998 776654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=322.37 Aligned_cols=260 Identities=20% Similarity=0.286 Sum_probs=203.1
Q ss_pred hhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEE
Q 043524 11 WSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCC 89 (314)
Q Consensus 11 ~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 89 (314)
..+|.....+|.|+ +.|+++.+..+|+.||+|++......... ....+.+.+|+.++..++||||+++++++
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 95 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSP-------GLSTEDLKREASICHMLKHPHIVELLETY 95 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSS-------SCCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccc-------cchHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 34556666789888 88999988999999999999876543211 01126788999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCc---
Q 043524 90 LETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENV--- 166 (314)
Q Consensus 90 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~--- 166 (314)
.+++.+|+|||||++|+|.+.+....... ..++...+..++.|++.||.||| +++|+||||||+||+++.++.
T Consensus 96 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~ 171 (351)
T 3c0i_A 96 SSDGMLYMVFEFMDGADLCFEIVKRADAG-FVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAP 171 (351)
T ss_dssp EETTEEEEEEECCSSCBHHHHHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCC
T ss_pred EeCCEEEEEEeCCCCCCHHHHHHHhcccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCc
Confidence 99999999999999999988776432110 24788999999999999999999 999999999999999976554
Q ss_pred eEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHH
Q 043524 167 VKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYL 246 (314)
Q Consensus 167 ~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 246 (314)
+||+|||+++....... ......||+.|+|||++.+..++.++||||+||++|+|++|..||..... ...
T Consensus 172 vkl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~ 241 (351)
T 3c0i_A 172 VKLGGFGVAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE---------RLF 241 (351)
T ss_dssp EEECCCTTCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH---------HHH
T ss_pred EEEecCcceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH---------HHH
Confidence 99999999987654322 23456799999999999988899999999999999999999999964221 111
Q ss_pred HhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 247 KNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
...... .. ..........+..+.+|+.+||..||++|||+.|+++
T Consensus 242 ~~i~~~-~~----------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 242 EGIIKG-KY----------KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHHHT-CC----------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHcC-CC----------CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111110 00 0011111134567899999999999999999999986
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=325.73 Aligned_cols=250 Identities=18% Similarity=0.274 Sum_probs=198.3
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGCC 89 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 89 (314)
.++.....+|.|+ +.|+++.+..+|+.||+|++.......... .+.+.+|.+++..+ +||||+++++++
T Consensus 23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~---------~~~~~~E~~il~~~~~hp~Iv~l~~~~ 93 (353)
T 3txo_A 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDD---------VECTMTEKRILSLARNHPFLTQLFCCF 93 (353)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTT---------HHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhH---------HHHHHHHHHHHHhccCCCceeeEEEEE
Confidence 3455566799988 888888888999999999998775543321 25678999999988 699999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEE
Q 043524 90 LETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKL 169 (314)
Q Consensus 90 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl 169 (314)
.+.+.+|+|||||++|+|.+.+.... .++...++.++.|++.||.||| +++|+||||||+||+++.++.+||
T Consensus 94 ~~~~~~~lv~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL 165 (353)
T 3txo_A 94 QTPDRLFFVMEFVNGGDLMFHIQKSR-----RFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKL 165 (353)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEE
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEE
Confidence 99999999999999999999987643 4889999999999999999999 999999999999999999999999
Q ss_pred cccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhh
Q 043524 170 FDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNY 249 (314)
Q Consensus 170 ~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (314)
+|||+++...... .......||+.|+|||++.+..++.++||||+||++|+|++|..||....... .....
T Consensus 166 ~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~--------~~~~i 236 (353)
T 3txo_A 166 ADFGMCKEGICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD--------LFEAI 236 (353)
T ss_dssp CCCTTCBCSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHH
T ss_pred ccccceeecccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH--------HHHHH
Confidence 9999997543222 22445679999999999988889999999999999999999999996433211 11111
Q ss_pred hccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCH------HHHHH
Q 043524 250 FEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTM------VDVAR 302 (314)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~------~ell~ 302 (314)
. ......+ ...+..+.+|+..||..||++||++ .|+++
T Consensus 237 ~-------------~~~~~~p--~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 237 L-------------NDEVVYP--TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp H-------------HCCCCCC--TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred H-------------cCCCCCC--CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1 1111111 1244568899999999999999998 67664
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=320.41 Aligned_cols=264 Identities=20% Similarity=0.264 Sum_probs=201.0
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|+....+|.|+ +.|+.+.+..+|+.+|+|.+...... .....+.+.+|+.++..++||||+++++++.
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~ 81 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPRE---------KEETLKRFEREVHNSSQLSHQNIVSMIDVDE 81 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSC---------CHHHHHHHHHHHHHHTTCCBTTBCCEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccc---------cHHHHHHHHHHHHHHhcCCCCCCceEEEeee
Confidence 3455556688888 88888888889999999987432110 0012267889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
+++..|+||||+++++|.+++.... +++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+
T Consensus 82 ~~~~~~lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~ 153 (294)
T 4eqm_A 82 EDDCYYLVMEYIEGPTLSEYIESHG-----PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIF 153 (294)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEEC
T ss_pred eCCeEEEEEeCCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEE
Confidence 9999999999999999999987643 5889999999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhh
Q 043524 171 DFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 171 dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
|||+++..............||+.|+|||++.+..++.++||||+|+++|+|++|+.||....... ......
T Consensus 154 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~--------~~~~~~ 225 (294)
T 4eqm_A 154 DFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS--------IAIKHI 225 (294)
T ss_dssp CCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH--------HHHHHH
T ss_pred eCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH--------HHHHHh
Confidence 999997664443333445679999999999999889999999999999999999999996543211 000011
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCC-CHHHHHHHHHHHHhh
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRP-TMVDVARRLRQICCS 310 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-s~~ell~~L~~~~~~ 310 (314)
.. ..... .... ....+..+.+++.+||+.||++|| ++.++.+.|+++..+
T Consensus 226 ~~-----~~~~~-~~~~----~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 226 QD-----SVPNV-TTDV----RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp SS-----CCCCH-HHHS----CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred hc-----cCCCc-chhc----ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 10 00000 0000 013346688999999999999999 899999999887544
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=319.83 Aligned_cols=256 Identities=21% Similarity=0.260 Sum_probs=202.8
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
..|.....+|.|+ +.|+.+.+..+|+.+|+|++........ ......+.+.+|+.++..++||||+++++++.
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 84 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSS------RRGVSREDIEREVSILKEIQHPNVITLHEVYE 84 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTC------SSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccc------cchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 4455666789888 8888898889999999999875432111 01112367889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCC----c
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN----V 166 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~----~ 166 (314)
++...++||||+++|+|.+++... ..++...+..++.|++.||.||| +++|+||||||+||+++.++ .
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~ 156 (326)
T 2y0a_A 85 NKTDVILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPR 156 (326)
T ss_dssp CSSEEEEEEECCCSCBHHHHHTTS-----SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCC
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCC
Confidence 999999999999999999999654 35889999999999999999999 99999999999999998877 7
Q ss_pred eEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHH
Q 043524 167 VKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYL 246 (314)
Q Consensus 167 ~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 246 (314)
++|+|||+++....... .....||+.|+|||++....++.++||||+|+++|+|++|..||....... ..
T Consensus 157 ~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------~~ 226 (326)
T 2y0a_A 157 IKIIDFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--------TL 226 (326)
T ss_dssp EEECCCTTCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--------HH
T ss_pred EEEEECCCCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH--------HH
Confidence 99999999987643322 335579999999999988889999999999999999999999996432111 11
Q ss_pred HhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 247 KNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
...... . ...........+..+.+|+..||..||++|||+.|+++
T Consensus 227 ~~~~~~-~----------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 227 ANVSAV-N----------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHHHHT-C----------CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhc-C----------CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111100 0 00111111234567899999999999999999999986
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=326.78 Aligned_cols=253 Identities=21% Similarity=0.311 Sum_probs=197.0
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeEEE
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGCCL 90 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 90 (314)
.+.....+|.|+ +.|+++.+..+|+.+|+|++.+........ .+.+.+|..++..+ +|||||++++++.
T Consensus 53 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~---------~~~~~~E~~il~~~~~hp~Iv~l~~~~~ 123 (396)
T 4dc2_A 53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDED---------IDWVQTEKHVFEQASNHPFLVGLHSCFQ 123 (396)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC-------------CCHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred HcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHH---------HHHHHHHHHHHHhcCCCCCcCeeEEEEE
Confidence 445556799988 889999889999999999998654322111 14577899999877 8999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
+.+.+|+||||+++|+|.+.+.... .++...+..++.|++.||.||| +++|+||||||+||+++.++.+||+
T Consensus 124 ~~~~~~lV~E~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~ 195 (396)
T 4dc2_A 124 TESRLFFVIEYVNGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLT 195 (396)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEEC
T ss_pred ECCEEEEEEEcCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEe
Confidence 9999999999999999999887643 4889999999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhh
Q 043524 171 DFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 171 dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
|||+++...... .......||+.|+|||++.+..++.++|+||+||++|||++|+.||.................
T Consensus 196 DFGla~~~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~---- 270 (396)
T 4dc2_A 196 DYGMCKEGLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL---- 270 (396)
T ss_dssp CCTTCBCCCCTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHH----
T ss_pred ecceeeecccCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHH----
Confidence 999997632222 224567899999999999999999999999999999999999999975432221110001111
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCH
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTM 297 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 297 (314)
...+.......+ ...+.++.+||.+||+.||++||++
T Consensus 271 --------~~~i~~~~~~~p--~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 271 --------FQVILEKQIRIP--RSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp --------HHHHHHCCCCCC--TTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred --------HHHHhccccCCC--CcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 111111111111 1345678999999999999999986
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=321.38 Aligned_cols=252 Identities=22% Similarity=0.334 Sum_probs=198.7
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|.....+|.|+ +.|+++.+..+|+.||+|++........ .+.+.+|+.+++.++||||+++++++.
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~E~~~l~~l~hpnIv~~~~~~~ 75 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC-----------PENIKKEICINKMLNHENVVKFYGHRR 75 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC------------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccch-----------HHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 4555666799988 8888888888999999999865433221 145789999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
+++..|+|||||++|+|.+++... ..++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~ 147 (323)
T 3tki_A 76 EGNIQYLFLEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKIS 147 (323)
T ss_dssp CSSEEEEEEECCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred cCCeEEEEEEcCCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEE
Confidence 999999999999999999988654 35889999999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCC-cccccccccccccccCcccccCCC-CcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHh
Q 043524 171 DFSLSISIPEGE-THITDTVMGTYGHLAPQYVTTCDF-SEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKN 248 (314)
Q Consensus 171 dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (314)
|||+++...... ........||+.|+|||++.+..+ +.++||||+|+++|+|++|..||........ .+..+..
T Consensus 148 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~~~~~- 223 (323)
T 3tki_A 148 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ---EYSDWKE- 223 (323)
T ss_dssp CCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH---HHHHHHT-
T ss_pred EeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH---HHHHHhc-
Confidence 999997653322 112345679999999999987775 6789999999999999999999975443221 1111110
Q ss_pred hhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 249 YFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
... .. ......+..+.+|+.+||+.||++|||+.|+++
T Consensus 224 ---~~~---~~----------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 224 ---KKT---YL----------NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp ---TCT---TS----------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---ccc---cC----------CccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 000 00 001134456789999999999999999999975
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=330.30 Aligned_cols=253 Identities=18% Similarity=0.246 Sum_probs=203.2
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
.+.....+|.|+ +.|+++.+..+|+.||+|++.+......... +.+.+|+.++..++|||||++++++.+
T Consensus 70 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~---------~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 70 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDS---------AFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCC---------STHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred ccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHH---------HHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 455556789988 8899898889999999999987655433221 457899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
+..+|+|||||++|+|.+++... .++...+..++.|++.||.||| +++|+||||||+||+++.++.+||+|
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~------~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~D 211 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLAD 211 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECC
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEec
Confidence 99999999999999999998753 3788999999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCcccccCC----CCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHH
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTTCD----FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLK 247 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (314)
||+++..............||+.|+|||++.... ++.++||||+||++|||++|+.||....... ...
T Consensus 212 FG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--------~~~ 283 (410)
T 3v8s_A 212 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG--------TYS 283 (410)
T ss_dssp CTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHH
T ss_pred cceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh--------HHH
Confidence 9999877554433345678999999999997655 7889999999999999999999996433211 111
Q ss_pred hhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCC--CCCHHHHHH
Q 043524 248 NYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPID--RPTMVDVAR 302 (314)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~--Rps~~ell~ 302 (314)
..... .. ....+.....+.++.+||..||..+|++ ||++.||++
T Consensus 284 ~i~~~---------~~--~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 284 KIMNH---------KN--SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp HHHTH---------HH--HCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred HHHhc---------cc--cccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 11100 00 0001111134467899999999999998 999999985
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=330.33 Aligned_cols=249 Identities=21% Similarity=0.268 Sum_probs=203.4
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
..|.....+|.|+ +.|+.+.+..+|+.||+|++......... ..+.+.+|+.+++.++||||+++++++.
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~---------~~~~~~~Ei~~l~~l~HpnIv~l~~~~~ 86 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLD---------VVGKIRREIQNLKLFRHPHIIKLYQVIS 86 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTT---------THHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHH---------HHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 4455666789988 88888888889999999999876554321 1257889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
+.+.+|+||||+++|+|.+++... ..++...+..++.|++.||.||| +++|+||||||+||+++.++.+||+
T Consensus 87 ~~~~~~lv~E~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~ 158 (476)
T 2y94_A 87 TPSDIFMVMEYVSGGELFDYICKN-----GRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIA 158 (476)
T ss_dssp CSSEEEEEEECCSSEEHHHHTTSS-----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEEC
T ss_pred ECCEEEEEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEE
Confidence 999999999999999999998754 35889999999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCcccccCCC-CcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhh
Q 043524 171 DFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDF-SEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNY 249 (314)
Q Consensus 171 dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (314)
|||+++...... ......||+.|+|||++.+..+ +.++||||+||++|+|++|..||+..... ......
T Consensus 159 DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--------~~~~~i 228 (476)
T 2y94_A 159 DFGLSNMMSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP--------TLFKKI 228 (476)
T ss_dssp CCSSCEECCTTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH--------HHHHHH
T ss_pred eccchhhccccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH--------HHHHHH
Confidence 999998765432 2345679999999999988775 68999999999999999999999743321 111111
Q ss_pred hccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 250 FEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
... ....+ ...+..+.+|+..||..||++|||+.|+++
T Consensus 229 ~~~-------------~~~~p--~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 229 CDG-------------IFYTP--QYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp HTT-------------CCCCC--TTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcC-------------CcCCC--ccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 110 00000 123456889999999999999999999986
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=320.18 Aligned_cols=247 Identities=16% Similarity=0.245 Sum_probs=203.0
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.++.....+|.|+ +.|+.+.+..+|+.||+|++.......... .+.+.+|++++..++||||+++++++.
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~---------~~~~~~E~~~l~~l~hp~iv~~~~~~~ 111 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ---------IEHTLNEKRILQAVNFPFLVKLEFSFK 111 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTC---------HHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHH---------HHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 4555666789988 888888888899999999998776543221 267889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
++..+|+||||+++|+|.+++.... .++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+
T Consensus 112 ~~~~~~lv~e~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~ 183 (350)
T 1rdq_E 112 DNSNLYMVMEYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVT 183 (350)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEc
Confidence 9999999999999999999997643 4788999999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhh
Q 043524 171 DFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 171 dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
|||+++..... .....||+.|+|||++.+..++.++|+||+||++|+|++|..||...... .......
T Consensus 184 DFg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--------~~~~~i~ 251 (350)
T 1rdq_E 184 DFGFAKRVKGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI--------QIYEKIV 251 (350)
T ss_dssp CCTTCEECSSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHH
T ss_pred ccccceeccCC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH--------HHHHHHH
Confidence 99999876433 33567999999999999988999999999999999999999999643211 1111111
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCC-----HHHHHH
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPT-----MVDVAR 302 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps-----~~ell~ 302 (314)
. +....+ ...+..+.+|+.+||+.||++||+ +.|+++
T Consensus 252 ~-------------~~~~~p--~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 252 S-------------GKVRFP--SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp H-------------CCCCCC--TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred c-------------CCCCCC--CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 1 111111 134566899999999999999998 788764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=324.00 Aligned_cols=252 Identities=22% Similarity=0.311 Sum_probs=200.4
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|.....+|.|+ +.|+.+.+..+|+.||+|++........ ..+.+.+|+.+++.++||||+++++++.
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~----------~~~~~~~E~~il~~l~hpnIv~~~~~~~ 98 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR----------DFQKLEREARICRKLQHPNIVRLHDSIQ 98 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHH----------HHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHH----------HHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 4566666789888 8888888889999999999875432111 1256889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCC---ce
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN---VV 167 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~---~~ 167 (314)
+++..|+||||+++|+|.+.+... ..++...+..++.|++.||.||| +++|+||||||+||+++..+ .+
T Consensus 99 ~~~~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~ 170 (362)
T 2bdw_A 99 EESFHYLVFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAV 170 (362)
T ss_dssp CSSEEEEEECCCCSCBHHHHHTTC-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCE
T ss_pred eCCEEEEEEecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCE
Confidence 999999999999999999988754 35789999999999999999999 99999999999999998654 59
Q ss_pred EEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHH
Q 043524 168 KLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLK 247 (314)
Q Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (314)
||+|||+++....... .....||+.|+|||++.+..++.++||||+||++|+|++|..||...... ....
T Consensus 171 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~--------~~~~ 240 (362)
T 2bdw_A 171 KLADFGLAIEVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--------RLYA 240 (362)
T ss_dssp EECCCTTCBCCTTCCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHH
T ss_pred EEeecCcceEecCCcc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--------HHHH
Confidence 9999999977643322 34567999999999999888999999999999999999999999643311 1111
Q ss_pred hhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 248 NYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
..... .. ..+.+.....+.++.+|+..||+.||++|||+.|+++
T Consensus 241 ~i~~~-~~----------~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 241 QIKAG-AY----------DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp HHHHT-CC----------CCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHhC-CC----------CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11110 00 0001111134567899999999999999999999876
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=315.33 Aligned_cols=258 Identities=20% Similarity=0.305 Sum_probs=208.8
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
.+.....+|.|+ +.|+.+.+..++..+|+|++...... .+.+.+|+++++.++||||+++++++.+
T Consensus 14 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 80 (288)
T 3kfa_A 14 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-------------VEEFLKEAAVMKEIKHPNLVQLLGVCTR 80 (288)
T ss_dssp GEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTH-------------HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHH-------------HHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 344455689888 88999888889999999998643221 2568899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
++..|+||||+++++|.+++..... ..++...+..++.|++.||.||| +++|+|+||||+||+++.++.++|+|
T Consensus 81 ~~~~~~v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~D 154 (288)
T 3kfa_A 81 EPPFYIITEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVAD 154 (288)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCCT---TTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECC
T ss_pred CCCEEEEEEcCCCCcHHHHHHhccc---CCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEcc
Confidence 9999999999999999999976543 45788999999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhh
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
||.+...............+|+.|+|||++....++.++||||+|+++|+|++ |..||....... .......
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~-----~~~~~~~-- 227 (288)
T 3kfa_A 155 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----VYELLEK-- 227 (288)
T ss_dssp CCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-----HHHHHHT--
T ss_pred CccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHhc--
Confidence 99997765444333444567889999999998899999999999999999999 999986543211 1111100
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhc
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSL 311 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 311 (314)
......+...+..+.+|+..||+.||++|||+.|+++.|+++....
T Consensus 228 ---------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 228 ---------------DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp ---------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---------------cCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 0000001134467899999999999999999999999999987653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=325.24 Aligned_cols=259 Identities=17% Similarity=0.234 Sum_probs=192.4
Q ss_pred hcCcccccccCch-hHHHHHHHh---cCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEe
Q 043524 12 SKGKRTLMIGNGA-SVLQELIAS---SNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIG 87 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~---~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 87 (314)
..+.....+|.|+ +.|+.+... .++..||+|.+........ .+.+.+|+.++..++||||+++++
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~~~~ 113 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-----------RRDFLGEASIMGQFDHPNIIRLEG 113 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHH-----------HHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHH-----------HHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3455566788888 777777655 4677899999865321111 157899999999999999999999
Q ss_pred EEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCce
Q 043524 88 CCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVV 167 (314)
Q Consensus 88 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~ 167 (314)
++.+++..++||||+++|+|.+++.... ..++...++.++.|++.||.||| +++|+||||||+||+++.++.+
T Consensus 114 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~ 186 (373)
T 2qol_A 114 VVTKSKPVMIVTEYMENGSLDSFLRKHD----AQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVC 186 (373)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCE
T ss_pred EEeeCCceEEEEeCCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCE
Confidence 9999999999999999999999997654 35889999999999999999999 9999999999999999999999
Q ss_pred EEcccccceecCCCCccc--ccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHH
Q 043524 168 KLFDFSLSISIPEGETHI--TDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNE 244 (314)
Q Consensus 168 kl~dfg~~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~ 244 (314)
||+|||+++......... .....+++.|+|||++....++.++||||||+++|||++ |..||.......
T Consensus 187 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~-------- 258 (373)
T 2qol_A 187 KVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD-------- 258 (373)
T ss_dssp EECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH--------
T ss_pred EECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--------
Confidence 999999997764432111 122245678999999998899999999999999999998 999986433211
Q ss_pred HHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 245 YLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
........ ...+ .+..++..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 259 ~~~~i~~~----------~~~~----~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 259 VIKAVDEG----------YRLP----PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp HHHHHHTT----------EECC----CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHcC----------CCCC----CCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 11111000 0000 0013445689999999999999999999999999998764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=317.02 Aligned_cols=261 Identities=15% Similarity=0.133 Sum_probs=206.0
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGCC 89 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 89 (314)
.++.....+|.|+ +.|+.+.+..+|+.||+|++..... .+.+.+|+.++..+ +||||+++++++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------------~~~~~~E~~~l~~l~~h~~i~~~~~~~ 74 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--------------APQLHLEYRFYKQLGSGDGIPQVYYFG 74 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--------------SCCHHHHHHHHHHHCSCTTSCCEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--------------hHHHHHHHHHHHHhhCCCCCCEEEEEE
Confidence 3455556689888 8888888889999999998764311 13578999999999 899999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCc---
Q 043524 90 LETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENV--- 166 (314)
Q Consensus 90 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~--- 166 (314)
..+...++||||+ +++|.+++.... ..++...++.++.|++.||.||| +++|+||||||+||+++.++.
T Consensus 75 ~~~~~~~lv~e~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~ 146 (330)
T 2izr_A 75 PCGKYNAMVLELL-GPSLEDLFDLCD----RTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQ 146 (330)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCT
T ss_pred ecCCccEEEEEeC-CCCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCC
Confidence 9999999999999 899999998653 35889999999999999999999 999999999999999998887
Q ss_pred --eEEcccccceecCCCCcc------cccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCcccc
Q 043524 167 --VKLFDFSLSISIPEGETH------ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDL 238 (314)
Q Consensus 167 --~kl~dfg~~~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~ 238 (314)
++|+|||+++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus 147 ~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~-- 224 (330)
T 2izr_A 147 QVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT-- 224 (330)
T ss_dssp TSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS--
T ss_pred ceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc--
Confidence 999999999876443221 1245679999999999999899999999999999999999999997654222
Q ss_pred ccchHHHHHhhhccCCcccccChhhhccCCchh-HHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhc
Q 043524 239 VYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTE-KEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSL 311 (314)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 311 (314)
.......... .. ...+... ....+ ++.+++..||+.||.+||++.+|++.|+++.+..
T Consensus 225 ---~~~~~~~i~~---------~~--~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 225 ---LKERYQKIGD---------TK--RATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp ---HHHHHHHHHH---------HH--HHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ---HHHHHHHHHh---------hh--ccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 0110000000 00 0000000 00123 7899999999999999999999999999987764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=316.34 Aligned_cols=251 Identities=21% Similarity=0.289 Sum_probs=194.2
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|.....+|.|+ +.|+++.+..+|+.||+|++...... ...+.+.+|+++++.++||||+++++++.
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-----------~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 74 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE-----------LAREKVMREVKALAKLEHPGIVRYFNAWL 74 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTT-----------THHHHHHHHHHHHTSCCCTTBCCEEEEEE
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCch-----------hHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 3444555699988 88999988889999999998643211 12267889999999999999999999986
Q ss_pred eCC---------------------------------------------------------eeEEEEeecCCCCHHHHHhc
Q 043524 91 ETP---------------------------------------------------------IAILVFEYVQHGTLWDRILG 113 (314)
Q Consensus 91 ~~~---------------------------------------------------------~~~iv~e~~~~g~L~~~l~~ 113 (314)
+.. ..++|||||++|+|.+++..
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 154 (332)
T 3qd2_B 75 ETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNR 154 (332)
T ss_dssp ECCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHT
T ss_pred EeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhc
Confidence 644 37999999999999999987
Q ss_pred CCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccceecCCCCc----------
Q 043524 114 APQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGET---------- 183 (314)
Q Consensus 114 ~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~---------- 183 (314)
.... .......++.++.|++.||.||| +++|+||||||+||+++.++.++|+|||+++.......
T Consensus 155 ~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~ 229 (332)
T 3qd2_B 155 RCSL--EDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 229 (332)
T ss_dssp CCSG--GGSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC------------
T ss_pred ccCc--cchhhHHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccc
Confidence 5432 34566678899999999999999 99999999999999999999999999999987654321
Q ss_pred -ccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcccccChh
Q 043524 184 -HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPI 262 (314)
Q Consensus 184 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (314)
.......||+.|+|||++.+..++.++||||+|+++|+|++|..|+.... ..... .
T Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~----------~~~~~-------------~ 286 (332)
T 3qd2_B 230 YATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV----------RIITD-------------V 286 (332)
T ss_dssp --CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH----------HHHHH-------------H
T ss_pred cccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH----------HHHHH-------------h
Confidence 11234579999999999999899999999999999999999877642111 00000 0
Q ss_pred hhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 263 IVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
..... +......+..+.+|+..||+.||++|||+.|+++
T Consensus 287 ~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 287 RNLKF-PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HTTCC-CHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred hccCC-CcccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 00111 1222245567799999999999999999999986
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=312.99 Aligned_cols=264 Identities=14% Similarity=0.070 Sum_probs=207.1
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGCC 89 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 89 (314)
.+|.....+|.|+ +.|+.+.+..+|+.||+|++..... .+.+.+|+.++..+ +|+||+++++++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------------~~~~~~e~~~~~~l~~~~~i~~~~~~~ 75 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--------------APQLRDEYRTYKLLAGCTGIPNVYYFG 75 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--------------SCCHHHHHHHHHHTTTCTTCCCEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--------------cHHHHHHHHHHHHHhcCCCCCeEEeec
Confidence 3455556688888 8888888888999999998753210 13577899999999 799999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCc---
Q 043524 90 LETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENV--- 166 (314)
Q Consensus 90 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~--- 166 (314)
..+...++||||+ +++|.+++.... .+++...+..++.|++.||.||| +++|+||||||+||+++.++.
T Consensus 76 ~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~ 147 (298)
T 1csn_A 76 QEGLHNVLVIDLL-GPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNA 147 (298)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTT
T ss_pred CCCceeEEEEEec-CCCHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCC
Confidence 9999999999999 899999998654 35889999999999999999999 999999999999999987765
Q ss_pred --eEEcccccceecCCCCcc------cccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCcccc
Q 043524 167 --VKLFDFSLSISIPEGETH------ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDL 238 (314)
Q Consensus 167 --~kl~dfg~~~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~ 238 (314)
++|+|||+++........ ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||........
T Consensus 148 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~- 226 (298)
T 1csn_A 148 NMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN- 226 (298)
T ss_dssp TCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH-
T ss_pred CeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcccc-
Confidence 999999999876543221 13455799999999999988899999999999999999999999976443221
Q ss_pred ccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhcc
Q 043524 239 VYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSLS 312 (314)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~ 312 (314)
.......... .. ...........+..+.+++..||+.||++|||+.+|++.|+++.+.+.
T Consensus 227 ----~~~~~~~~~~---------~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 227 ----KQKYERIGEK---------KQ-STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp ----HHHHHHHHHH---------HH-HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ----HHHHHHHHhh---------cc-CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 0000000000 00 000000001345678999999999999999999999999999987654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=324.90 Aligned_cols=251 Identities=18% Similarity=0.256 Sum_probs=189.0
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|.....+|.|+ +.|+++.+..+|+.||+|++..... ..+.+.+|+.+++.++||||+++++++.
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~E~~~l~~l~hpniv~~~~~~~ 86 (361)
T 3uc3_A 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-------------IDENVQREIINHRSLRHPNIVRFKEVIL 86 (361)
T ss_dssp TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-------------SCHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-------------ccHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 3455566799988 8888998889999999999864221 1156789999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCc--eE
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENV--VK 168 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~--~k 168 (314)
++...|+||||+++|+|.+++.... .++...+..++.|++.||.||| +++|+||||||+||+++.++. +|
T Consensus 87 ~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~k 158 (361)
T 3uc3_A 87 TPTHLAIIMEYASGGELYERICNAG-----RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLK 158 (361)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEE
T ss_pred eCCEEEEEEEeCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEE
Confidence 9999999999999999999986543 4889999999999999999999 999999999999999987665 99
Q ss_pred EcccccceecCCCCcccccccccccccccCcccccCCCCcc-cchHHHHHHHHHHHhCCCCcccccCccccccchHHHHH
Q 043524 169 LFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEK-LDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLK 247 (314)
Q Consensus 169 l~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (314)
|+|||+++...... ......||+.|+|||++.+..++.+ +||||+||++|+|++|+.||........ +.....
T Consensus 159 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~----~~~~~~ 232 (361)
T 3uc3_A 159 ICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD----YRKTIQ 232 (361)
T ss_dssp ECCCCCC-----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC----HHHHHH
T ss_pred EeecCccccccccC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH----HHHHHH
Confidence 99999987543222 2345579999999999988887655 8999999999999999999975443321 111111
Q ss_pred hhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 248 NYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.... .....+.....+..+.+|+.+||..||++|||+.|+++
T Consensus 233 ~~~~-------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 233 RILS-------------VKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp HHHT-------------TCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHhc-------------CCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 1111 11111111123456889999999999999999999986
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=324.46 Aligned_cols=264 Identities=20% Similarity=0.342 Sum_probs=204.0
Q ss_pred hcCcccccccCch-hHHHHHH-----HhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceee
Q 043524 12 SKGKRTLMIGNGA-SVLQELI-----ASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILK 84 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~-----~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 84 (314)
.++.....+|.|+ +.|+++. +..+|+.||+|++........ .+.+.+|++++..+ +||||++
T Consensus 22 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-----------HRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHH-----------HHHHHHHHHHHHHHCCCTTBCC
T ss_pred cceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHH-----------HHHHHHHHHHHHhhcCCcceee
Confidence 3445556688888 7787776 667788999999865432221 15688999999999 7899999
Q ss_pred eEeEEEeCC-eeEEEEeecCCCCHHHHHhcCCCCC---------------------------------------------
Q 043524 85 LIGCCLETP-IAILVFEYVQHGTLWDRILGAPQTH--------------------------------------------- 118 (314)
Q Consensus 85 ~~~~~~~~~-~~~iv~e~~~~g~L~~~l~~~~~~~--------------------------------------------- 118 (314)
+++++.+.+ ..++|||||++|+|.+++.......
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 999998754 4899999999999999997653210
Q ss_pred ----------------CCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccceecCCCC
Q 043524 119 ----------------FEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGE 182 (314)
Q Consensus 119 ----------------~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~ 182 (314)
...++...++.++.|++.||.||| +++|+||||||+||+++.++.++|+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 012788999999999999999999 9999999999999999999999999999997654332
Q ss_pred c-ccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhccCCcccccC
Q 043524 183 T-HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVD 260 (314)
Q Consensus 183 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (314)
. .......||+.|+|||++.+..++.++||||+|+++|+|++ |..||........ ... ......
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~----~~~----~~~~~~------ 313 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE----FCR----RLKEGT------ 313 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH----HHH----HHHHTC------
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH----HHH----HHHcCC------
Confidence 2 22334568899999999998899999999999999999998 9999975443221 000 010000
Q ss_pred hhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 261 PIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
....+...+.++.+++..||+.||++|||+.|+++.|+++.++
T Consensus 314 -------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 314 -------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 0000012345688999999999999999999999999999875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=312.47 Aligned_cols=258 Identities=21% Similarity=0.249 Sum_probs=189.9
Q ss_pred hcCcccccccCch-hHHHHHHHhc---CCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEe
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASS---NGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIG 87 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~---~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 87 (314)
.++.....+|.|+ +.|+.+.... .+..+|+|.+....... ..+.+.+|+.++..++||||+++++
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~iv~~~~ 83 (281)
T 1mp8_A 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS-----------VREKFLQEALTMRQFDHPHIVKLIG 83 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHH-----------HHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHH-----------HHHHHHHHHHHHHhCCCCccceEEE
Confidence 3444555688888 7777776544 34579999876432111 1257889999999999999999999
Q ss_pred EEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCce
Q 043524 88 CCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVV 167 (314)
Q Consensus 88 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~ 167 (314)
++ .++..|+||||+++|+|.+++.... ..++...+..++.|++.||.||| +++++||||||+||+++.++.+
T Consensus 84 ~~-~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~ 155 (281)
T 1mp8_A 84 VI-TENPVWIIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCV 155 (281)
T ss_dssp EE-CSSSCEEEEECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEE
T ss_pred EE-ccCccEEEEecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCE
Confidence 98 4567899999999999999997654 35789999999999999999999 9999999999999999999999
Q ss_pred EEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHH
Q 043524 168 KLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYL 246 (314)
Q Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~ 246 (314)
+|+|||+++..............+|+.|+|||++....++.++||||+|+++|+|++ |..||....... . .
T Consensus 156 kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~-----~---~ 227 (281)
T 1mp8_A 156 KLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-----V---I 227 (281)
T ss_dssp EECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----H---H
T ss_pred EECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH-----H---H
Confidence 999999998765443323334457789999999988889999999999999999996 999997543221 0 0
Q ss_pred HhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 247 KNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
...... ... +.+...+..+.+++..||+.||++|||+.|+++.|+++.+.
T Consensus 228 ~~i~~~-~~~-------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 228 GRIENG-ERL-------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp HHHHTT-CCC-------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHcC-CCC-------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 111100 000 00113446688999999999999999999999999998764
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=322.93 Aligned_cols=275 Identities=17% Similarity=0.190 Sum_probs=200.0
Q ss_pred hcCcccccccCc--h-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeE
Q 043524 12 SKGKRTLMIGNG--A-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGC 88 (314)
Q Consensus 12 ~~~~~~~~~G~g--~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 88 (314)
.+|.....+|.| + +.|+.+.+..+|+.||+|++........ ..+.+.+|+.+++.++|||||+++++
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~~E~~~l~~l~h~niv~~~~~ 94 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNE----------MVTFLQGELHVSKLFNHPNIVPYRAT 94 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHH----------HHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChH----------HHHHHHHHHHHHHhCCCCCCCcEeEE
Confidence 345555668888 7 7899999999999999999876532111 12567889999999999999999999
Q ss_pred EEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceE
Q 043524 89 CLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVK 168 (314)
Q Consensus 89 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~k 168 (314)
+.+++..|+|||||++|+|.+++..... ..++...+..++.|++.||.||| +++|+||||||+||+++.++.++
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~k 168 (389)
T 3gni_B 95 FIADNELWVVTSFMAYGSAKDLICTHFM---DGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVY 168 (389)
T ss_dssp EEETTEEEEEEECCTTCBHHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEE
T ss_pred EEECCEEEEEEEccCCCCHHHHHhhhcc---cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEE
Confidence 9999999999999999999999976532 34789999999999999999999 99999999999999999999999
Q ss_pred EcccccceecCCCC------cccccccccccccccCccccc--CCCCcccchHHHHHHHHHHHhCCCCcccccCcccccc
Q 043524 169 LFDFSLSISIPEGE------THITDTVMGTYGHLAPQYVTT--CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVY 240 (314)
Q Consensus 169 l~dfg~~~~~~~~~------~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~ 240 (314)
|+|||.+....... ........||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...........
T Consensus 169 l~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 248 (389)
T 3gni_B 169 LSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE 248 (389)
T ss_dssp ECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHH
T ss_pred EcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 99999986542211 111233478999999999987 5689999999999999999999999975443321111
Q ss_pred chHHHHHhhhcc------------------CCcccccC---h--hhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCH
Q 043524 241 PFNEYLKNYFED------------------NRFTEIVD---P--IIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTM 297 (314)
Q Consensus 241 ~~~~~~~~~~~~------------------~~~~~~~~---~--~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 297 (314)
............ ....+... + ........+.....+..+.+|+..||+.||++|||+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta 328 (389)
T 3gni_B 249 KLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSA 328 (389)
T ss_dssp C--------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCH
T ss_pred HhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCH
Confidence 111000000000 00000000 0 000000111223456779999999999999999999
Q ss_pred HHHHH
Q 043524 298 VDVAR 302 (314)
Q Consensus 298 ~ell~ 302 (314)
.|+++
T Consensus 329 ~ell~ 333 (389)
T 3gni_B 329 STLLN 333 (389)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 99985
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=338.75 Aligned_cols=256 Identities=20% Similarity=0.298 Sum_probs=205.7
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
+.....+|.|+ +.|+++....++..||+|.+..... ..++|.+|+.+++.++||||+++++++.++
T Consensus 222 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 288 (495)
T 1opk_A 222 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-------------EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 288 (495)
T ss_dssp EEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-------------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-------------chHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 33445688888 8888888888899999998864221 126789999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~df 172 (314)
..+|+||||+++|+|.+++..... ..++...++.++.|++.||.||| +++|+||||||+||+++.++.+||+||
T Consensus 289 ~~~~lv~E~~~~g~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DF 362 (495)
T 1opk_A 289 PPFYIITEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADF 362 (495)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCT---TTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCT
T ss_pred CcEEEEEEccCCCCHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeec
Confidence 999999999999999999986442 35788999999999999999999 999999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhc
Q 043524 173 SLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFE 251 (314)
Q Consensus 173 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (314)
|+++..............++..|+|||++....++.++||||||+++|||++ |..||....... ....+.
T Consensus 363 G~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~-----~~~~~~---- 433 (495)
T 1opk_A 363 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----VYELLE---- 433 (495)
T ss_dssp TCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-----HHHHHH----
T ss_pred ccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHH----
Confidence 9998765433322334456789999999988889999999999999999999 999986543221 111110
Q ss_pred cCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 252 DNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
. ......+..++..+.+|+..||+.||++|||+.+|++.|+.+...
T Consensus 434 ~-------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 434 K-------------DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp T-------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred c-------------CCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 0 000001113456789999999999999999999999999887543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=312.75 Aligned_cols=254 Identities=17% Similarity=0.291 Sum_probs=201.3
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
+++....+|.|+ +.|+.+ ...++..||+|++...... .+++.+|++++..++||||+++++++.+
T Consensus 9 ~y~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~-------------~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 74 (268)
T 3sxs_A 9 EITLLKELGSGQFGVVKLG-KWKGQYDVAVKMIKEGSMS-------------EDEFFQEAQTMMKLSHPKLVKFYGVCSK 74 (268)
T ss_dssp GEEEEEEEEEETTEEEEEE-EETTTEEEEEEEECBTTBC-------------HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred heeeeeeeccCCCceEEEE-EecCceeEEEEEeccCCCc-------------HHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 344455688888 666665 4456778999998643211 1568899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
++..++||||+++++|.+++.... ..++...+..++.|++.||.||| +++++|+||||+||+++.++.++|+|
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~D 147 (268)
T 3sxs_A 75 EYPIYIVTEYISNGCLLNYLRSHG----KGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSD 147 (268)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECC
T ss_pred CCceEEEEEccCCCcHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEcc
Confidence 999999999999999999997653 35889999999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhh
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
||.++..............+|+.|+|||++.+..++.++||||+|+++|+|++ |..||....... ......
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------~~~~~~ 219 (268)
T 3sxs_A 148 FGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE--------VVLKVS 219 (268)
T ss_dssp TTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH--------HHHHHH
T ss_pred CccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH--------HHHHHH
Confidence 99998765544333344556788999999988889999999999999999999 999986433211 111111
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHh
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICC 309 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 309 (314)
... .... +...+..+.+++..||+.||++|||+.|+++.|+++.+
T Consensus 220 ~~~---~~~~-----------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 220 QGH---RLYR-----------PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp TTC---CCCC-----------CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred cCC---CCCC-----------CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 000 0000 01234568899999999999999999999999988764
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=317.24 Aligned_cols=248 Identities=21% Similarity=0.272 Sum_probs=178.9
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC-CCceeeeEeEEEeCCe
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS-HDHILKLIGCCLETPI 94 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 94 (314)
...+|.|+ +.|+++.+..+|+.||+|++..... ..+.+|+.++..+. ||||+++++++.++..
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------------~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~ 80 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME---------------ANTQKEITALKLCEGHPNIVKLHEVFHDQLH 80 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGH---------------HHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChhhh---------------hhHHHHHHHHHHhcCCCCeeEEEEEEEcCCE
Confidence 45688888 8888888999999999999875432 34568999999997 9999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCC---ceEEcc
Q 043524 95 AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN---VVKLFD 171 (314)
Q Consensus 95 ~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~---~~kl~d 171 (314)
.|+||||+++|+|.+.+... ..++...+..++.|++.||.||| +++|+||||||+||+++.++ .++|+|
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~D 152 (325)
T 3kn6_A 81 TFLVMELLNGGELFERIKKK-----KHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIID 152 (325)
T ss_dssp EEEEECCCCSCBHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECC
T ss_pred EEEEEEccCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEec
Confidence 99999999999999999765 35889999999999999999999 99999999999999997765 799999
Q ss_pred cccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhc
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFE 251 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (314)
||+++....... ......||+.|+|||++.+..++.++||||+|+++|+|++|..||......... ....+....
T Consensus 153 fg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~~~--- 227 (325)
T 3kn6_A 153 FGFARLKPPDNQ-PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC-TSAVEIMKK--- 227 (325)
T ss_dssp CTTCEECCC-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C-CCHHHHHHH---
T ss_pred cccceecCCCCC-cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc-ccHHHHHHH---
Confidence 999986644322 234557899999999999889999999999999999999999999754432110 011111111
Q ss_pred cCCcccccChhhhccC--CchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 252 DNRFTEIVDPIIVQDL--SCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 252 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
...+.. ........+.++.+|+..||+.||++|||+.|+++
T Consensus 228 ----------i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 228 ----------IKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp ----------HTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred ----------HHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 111111 11122245677899999999999999999998873
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=315.61 Aligned_cols=244 Identities=19% Similarity=0.306 Sum_probs=196.9
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCee
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIA 95 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (314)
...+|.|+ +.|+.+....+|+.||+|++...... ..+.+.+|+.+++.++||||+++++++..++..
T Consensus 50 ~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~------------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (321)
T 2c30_A 50 YVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ------------RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEEL 117 (321)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC------------SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred cEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh------------HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEE
Confidence 34688888 88888888889999999998643211 125688999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
++||||+++++|.+++... .++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+|||++
T Consensus 118 ~lv~e~~~~~~L~~~l~~~------~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~ 188 (321)
T 2c30_A 118 WVLMEFLQGGALTDIVSQV------RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFC 188 (321)
T ss_dssp EEEECCCCSCBHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecCCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCcEEEeeeeee
Confidence 9999999999999988642 4789999999999999999999 999999999999999999999999999999
Q ss_pred eecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCc
Q 043524 176 ISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRF 255 (314)
Q Consensus 176 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (314)
........ ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||....... ........ .
T Consensus 189 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~--------~~~~~~~~-~- 257 (321)
T 2c30_A 189 AQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--------AMKRLRDS-P- 257 (321)
T ss_dssp EECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHHHHS-S-
T ss_pred eecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHhcC-C-
Confidence 77644322 2345679999999999998889999999999999999999999996432111 11111110 0
Q ss_pred ccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 256 TEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.+.. ......+..+.+|+..||+.||++|||+.|+++
T Consensus 258 ----~~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 258 ----PPKL------KNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp ----CCCC------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----CCCc------CccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 011133456889999999999999999999986
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=320.80 Aligned_cols=249 Identities=19% Similarity=0.273 Sum_probs=200.4
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGCC 89 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 89 (314)
..+.....+|.|+ +.|+.+.+..+|+.||+|++.......... .+.+..|..++..+ +||||+++++++
T Consensus 17 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~---------~~~~~~E~~il~~~~~hp~iv~l~~~~ 87 (345)
T 1xjd_A 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD---------VECTMVEKRVLSLAWEHPFLTHMFCTF 87 (345)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTC---------HHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhh---------HHHHHHHHHHHHhcCCCCCCCcEEEEE
Confidence 3455556789888 889999888999999999998765433211 25678899999876 899999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEE
Q 043524 90 LETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKL 169 (314)
Q Consensus 90 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl 169 (314)
.+...+|+||||+++|+|.+++.... .++...+..++.|++.||.||| +++|+||||||+||+++.++.++|
T Consensus 88 ~~~~~~~lv~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL 159 (345)
T 1xjd_A 88 QTKENLFFVMEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKI 159 (345)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEE
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEE
Confidence 99999999999999999999987642 4788999999999999999999 999999999999999999999999
Q ss_pred cccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhh
Q 043524 170 FDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNY 249 (314)
Q Consensus 170 ~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (314)
+|||+++...... .......||+.|+|||++.+..++.++|+||+||++|+|++|..||...... ......
T Consensus 160 ~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--------~~~~~i 230 (345)
T 1xjd_A 160 ADFGMCKENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--------ELFHSI 230 (345)
T ss_dssp CCCTTCBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHH
T ss_pred eEChhhhhcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHH
Confidence 9999997643222 1245668999999999999988999999999999999999999999643321 111111
Q ss_pred hccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHH-HHH
Q 043524 250 FEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMV-DVA 301 (314)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~-ell 301 (314)
.. .....+ ...+.++.+|+.+||..||++||++. +++
T Consensus 231 ~~-------------~~~~~p--~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 231 RM-------------DNPFYP--RWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp HH-------------CCCCCC--TTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred Hh-------------CCCCCC--cccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 11 010000 12446789999999999999999987 654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=315.70 Aligned_cols=269 Identities=22% Similarity=0.282 Sum_probs=201.5
Q ss_pred cCcccccccCch-hHHHHHH----HhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEe
Q 043524 13 KGKRTLMIGNGA-SVLQELI----ASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIG 87 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~----~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 87 (314)
.++....+|.|+ +.|+.+. +..+|+.||+|++....... ..+.+.+|++++..++||||+++++
T Consensus 22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~i~~~~~ 90 (302)
T 4e5w_A 22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN-----------HIADLKKEIEILRNLYHENIVKYKG 90 (302)
T ss_dssp GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----C-----------CHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccch-----------hHHHHHHHHHHHHhCCCCCeeeeee
Confidence 345556688888 7777765 57789999999987543111 1266889999999999999999999
Q ss_pred EEEeC--CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCC
Q 043524 88 CCLET--PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN 165 (314)
Q Consensus 88 ~~~~~--~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~ 165 (314)
++... ...++||||+++|+|.+++.... ..++...+..++.|++.||.||| +++|+|+||||+||+++.++
T Consensus 91 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~ 163 (302)
T 4e5w_A 91 ICTEDGGNGIKLIMEFLPSGSLKEYLPKNK----NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEH 163 (302)
T ss_dssp EEEC---CCEEEEEECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETT
T ss_pred EEecCCCceEEEEEEeCCCCcHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCC
Confidence 99876 67899999999999999996543 35889999999999999999999 99999999999999999999
Q ss_pred ceEEcccccceecCCCCc--ccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchH
Q 043524 166 VVKLFDFSLSISIPEGET--HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFN 243 (314)
Q Consensus 166 ~~kl~dfg~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~ 243 (314)
.++|+|||++........ .......+|..|+|||++.+..++.++||||+|+++|+|++|..|+.....
T Consensus 164 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------- 234 (302)
T 4e5w_A 164 QVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA--------- 234 (302)
T ss_dssp EEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH---------
T ss_pred CEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh---------
Confidence 999999999987654332 123345688889999999888899999999999999999999998642211
Q ss_pred HHHHhh---hccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHh
Q 043524 244 EYLKNY---FEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICC 309 (314)
Q Consensus 244 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 309 (314)
...... .......... ...........+...+..+.+|+.+||+.||++|||+.++++.|+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 235 LFLKMIGPTHGQMTVTRLV-NTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp HHHHHHCSCCGGGHHHHHH-HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHhhccCCcccccCHHHHH-HHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 000000 0000000000 0011111111111445678999999999999999999999999998863
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=325.07 Aligned_cols=263 Identities=18% Similarity=0.227 Sum_probs=200.7
Q ss_pred hcCcccccccCch-hHHHHHH-----HhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeee
Q 043524 12 SKGKRTLMIGNGA-SVLQELI-----ASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKL 85 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~-----~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 85 (314)
.++.....+|.|+ +.|+++. +..+++.||+|.+........ ...+.+|+.++..++||||+++
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~E~~~l~~l~hpnIv~~ 139 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD-----------ELDFLMEALIISKFNHQNIVRC 139 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHH-----------HHHHHHHHHHHHHCCCTTBCCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhh-----------HHHHHHHHHHHHhCCCCCCCeE
Confidence 3444555689888 7787776 556788999999853211111 1467899999999999999999
Q ss_pred EeEEEeCCeeEEEEeecCCCCHHHHHhcCCC--CCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecC
Q 043524 86 IGCCLETPIAILVFEYVQHGTLWDRILGAPQ--THFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSE 163 (314)
Q Consensus 86 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~ 163 (314)
++++.++...++|||||++|+|.+++..... .....++...++.++.|++.||.||| +++|+||||||+||+++.
T Consensus 140 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~ 216 (367)
T 3l9p_A 140 IGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTC 216 (367)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESC
T ss_pred EEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEec
Confidence 9999999999999999999999999976432 11134788999999999999999999 999999999999999985
Q ss_pred CC---ceEEcccccceecCCC-CcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCcccc
Q 043524 164 EN---VVKLFDFSLSISIPEG-ETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDL 238 (314)
Q Consensus 164 ~~---~~kl~dfg~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~ 238 (314)
++ .+||+|||+++..... .........+|+.|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 217 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~-- 294 (367)
T 3l9p_A 217 PGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-- 294 (367)
T ss_dssp SSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--
T ss_pred CCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--
Confidence 54 5999999999754222 1122334567899999999998899999999999999999998 999986433211
Q ss_pred ccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 239 VYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
.......... ...+..++..+.+|+..||+.||++|||+.++++.|+.+.+.
T Consensus 295 ------~~~~i~~~~~--------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 295 ------VLEFVTSGGR--------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp ------HHHHHHTTCC--------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ------HHHHHHcCCC--------------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 1111111100 000013345688999999999999999999999999988654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=329.90 Aligned_cols=256 Identities=15% Similarity=0.159 Sum_probs=203.7
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
.+.....+|.|+ +.|+++....+|+.||+|++........... +.+.+|+.++..++||||+++++++.+
T Consensus 75 ~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~---------~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 75 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAET---------ACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTT---------CCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred heEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHH---------HHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 455566799988 8888988888999999999987655433211 347899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
++.+|+|||||++|+|.+++.... ..++...++.++.|++.||.||| +++|+||||||+|||++.++.+||+|
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~~----~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKFE----DRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECC
T ss_pred CCEEEEEEecCCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcc
Confidence 999999999999999999997643 35889999999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCcccc-----cCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHH
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVT-----TCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYL 246 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 246 (314)
||+++..............||+.|+|||++. ...++.++||||+||++|||++|+.||....... ..
T Consensus 219 FGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~--------~~ 290 (437)
T 4aw2_A 219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE--------TY 290 (437)
T ss_dssp CTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HH
T ss_pred hhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH--------HH
Confidence 9999876554443344568999999999987 4568999999999999999999999997533211 11
Q ss_pred HhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCC--CCCHHHHHH
Q 043524 247 KNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPID--RPTMVDVAR 302 (314)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~--Rps~~ell~ 302 (314)
...... ......+.. ....+.++.+||.+||..+|++ ||++.|+++
T Consensus 291 ~~i~~~---------~~~~~~p~~-~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 291 GKIMNH---------KERFQFPTQ-VTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHHHTH---------HHHCCCCSS-CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred Hhhhhc---------cccccCCcc-cccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 111100 000000000 0024467899999999998888 999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=317.87 Aligned_cols=259 Identities=18% Similarity=0.274 Sum_probs=196.2
Q ss_pred hhcCcccccccCch-hHHHHHHHhcCCccc----ccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeee
Q 043524 11 WSKGKRTLMIGNGA-SVLQELIASSNGKYI----PYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKL 85 (314)
Q Consensus 11 ~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~----a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 85 (314)
..+++....+|.|+ +.|+++.+..+|+.+ |+|.+....... ..+++.+|+.++..++||||+++
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~iv~~ 82 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-----------ANKEILDEAYVMASVDNPHVCRL 82 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC------------------CHHHHHHHHHHHHHCCBTTBCCE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHH-----------HHHHHHHHHHHHHhCCCCCEeEE
Confidence 44566666799988 888888877777766 566554322111 12678999999999999999999
Q ss_pred EeEEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCC
Q 043524 86 IGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN 165 (314)
Q Consensus 86 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~ 165 (314)
++++.++. .++++||+++|+|.+.+.... ..++...++.++.|++.||.||| +++|+||||||+||+++.++
T Consensus 83 ~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~ 154 (327)
T 3poz_A 83 LGICLTST-VQLITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQ 154 (327)
T ss_dssp EEEEESSS-EEEEEECCTTCBHHHHHHHST----TSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETT
T ss_pred EEEEecCC-eEEEEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCC
Confidence 99998754 779999999999999998754 35889999999999999999999 99999999999999999999
Q ss_pred ceEEcccccceecCCCCcc-cccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchH
Q 043524 166 VVKLFDFSLSISIPEGETH-ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFN 243 (314)
Q Consensus 166 ~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~ 243 (314)
.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||....... ..
T Consensus 155 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-----~~ 229 (327)
T 3poz_A 155 HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----IS 229 (327)
T ss_dssp EEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----HH
T ss_pred CEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH-----HH
Confidence 9999999999876443221 1233456889999999999999999999999999999999 999997543221 11
Q ss_pred HHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 244 EYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
... .... ..+.+...+..+.+++..||+.||++|||+.|+++.|+++...
T Consensus 230 ~~~----~~~~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 230 SIL----EKGE-------------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHH----HTTC-------------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred HHH----HcCC-------------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 111 0000 0000113345688999999999999999999999999988653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=312.72 Aligned_cols=257 Identities=18% Similarity=0.293 Sum_probs=200.0
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
++.....+|.|+ +.|+.+ ...++..||+|++...... .+++.+|++++..++||||+++++++.+
T Consensus 25 ~y~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~-------------~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 90 (283)
T 3gen_A 25 DLTFLKELGTGQFGVVKYG-KWRGQYDVAIKMIKEGSMS-------------EDEFIEEAKVMMNLSHEKLVQLYGVCTK 90 (283)
T ss_dssp GEEEEEECC---CEEEEEE-EETTTEEEEEEEECTTSBC-------------HHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred HHHhHhhcCCCCCceEEEE-EEcCCCeEEEEEecCCCCC-------------HHHHHHHHHHHhcCCCCCEeeEEEEEec
Confidence 344455688888 666665 4446778999998743211 1568899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
++..++||||+++++|.+++.... ..++...+..++.|++.||.||| +++|+|+||||+||+++.++.++|+|
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~D 163 (283)
T 3gen_A 91 QRPIFIITEYMANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSD 163 (283)
T ss_dssp SSSEEEEECCCTTCBHHHHHHCGG----GCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECS
T ss_pred CCCeEEEEeccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEcc
Confidence 999999999999999999997643 35889999999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhh
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
||.++..............+|+.|+|||++....++.++||||+|+++|+|++ |+.||....... ......
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~--------~~~~~~ 235 (283)
T 3gen_A 164 FGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--------TAEHIA 235 (283)
T ss_dssp TTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--------HHHHHH
T ss_pred ccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH--------HHHHHh
Confidence 99997664432222334456788999999998889999999999999999998 999986443211 111111
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhcc
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSLS 312 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~ 312 (314)
.... ...+...+..+.+++..||+.||++|||+.|+++.|.++.+.-|
T Consensus 236 ~~~~--------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~es 283 (283)
T 3gen_A 236 QGLR--------------LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES 283 (283)
T ss_dssp TTCC--------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred cccC--------------CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhccC
Confidence 1000 00001234568899999999999999999999999999987643
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=312.63 Aligned_cols=259 Identities=19% Similarity=0.284 Sum_probs=193.2
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcc---------------cCChhHHHHHHHHHHHh
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQ---------------KNGFWHESCINNVTYAA 75 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~E~~~l~ 75 (314)
.+|.....+|.|+ +.|+.+.+..+|+.||+|++.......... +.. ......+.+.+|+++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAG-FPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC--------------------------------CHHHHHHHHHH
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcc-cccccccccccccccccccccchHHHHHHHHHHHH
Confidence 4455566799988 889998888999999999987654322110 000 00011256889999999
Q ss_pred cCCCCceeeeEeEEEe--CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceecc
Q 043524 76 QMSHDHILKLIGCCLE--TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRD 153 (314)
Q Consensus 76 ~l~h~niv~~~~~~~~--~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~d 153 (314)
.++||||+++++++.+ +...|+||||+++++|.+.+.. .+++...+..++.|++.||.||| +++|+|||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~D 162 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLH---YQKIIHRD 162 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccC
Confidence 9999999999999986 6789999999999999775432 35889999999999999999999 99999999
Q ss_pred CCCCCeeecCCCceEEcccccceecCCCCcccccccccccccccCcccccCC---CCcccchHHHHHHHHHHHhCCCCcc
Q 043524 154 FKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCD---FSEKLDVYSFGAFLSELLTGRGILD 230 (314)
Q Consensus 154 lk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~DiwslG~~l~el~~g~~p~~ 230 (314)
|||+||+++.++.++|+|||+++....... ......||+.|+|||++.... ++.++||||+|+++|+|++|..||.
T Consensus 163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 163 IKPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 999999999999999999999987644322 234567999999999997765 3778999999999999999999996
Q ss_pred cccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 231 LVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
..... ......... . ...+.....+..+.+|+.+||+.||++|||+.|+++
T Consensus 242 ~~~~~--------~~~~~~~~~-~------------~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 242 DERIM--------CLHSKIKSQ-A------------LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp CSSHH--------HHHHHHHHC-C------------CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CccHH--------HHHHHHhcc-c------------CCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 43211 111111100 0 000000123456899999999999999999999875
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=334.45 Aligned_cols=255 Identities=20% Similarity=0.294 Sum_probs=205.7
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
..+.....+|.|+ +.|+.+.+..+|+.||+|++.......... .+.+.+|+++|..++|||||++++++.
T Consensus 184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~---------~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 254 (576)
T 2acx_A 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG---------EAMALNEKQILEKVNSRFVVSLAYAYE 254 (576)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTC---------HHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHH---------HHHHHHHHHHHHHcCCCCEeeEEEEEe
Confidence 3455566789988 888888888899999999998876544321 256789999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
+.+.+|+||||+++|+|.+.+..... ..++...++.++.||+.||.||| +++|+||||||+||+++.++.+||+
T Consensus 255 ~~~~l~lVmEy~~gg~L~~~l~~~~~---~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~ 328 (576)
T 2acx_A 255 TKDALCLVLTLMNGGDLKFHIYHMGQ---AGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRIS 328 (576)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHSSSS---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEEC
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEE
Confidence 99999999999999999999876542 34889999999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhh
Q 043524 171 DFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 171 dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
|||+++....... .....||+.|+|||++.+..++.++||||+||++|+|++|..||........ .........
T Consensus 329 DFGla~~~~~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~----~~~i~~~i~ 402 (576)
T 2acx_A 329 DLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK----REEVERLVK 402 (576)
T ss_dssp CCTTCEECCTTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC----HHHHHHHHH
T ss_pred ecccceecccCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh----HHHHHHHhh
Confidence 9999987654332 3456899999999999988899999999999999999999999975432210 001111100
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCC-----CHHHHHH
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRP-----TMVDVAR 302 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 302 (314)
. .+...+ ...+.++.+|+.+||+.||++|| ++.|+++
T Consensus 403 ~-------------~~~~~p--~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 403 E-------------VPEEYS--ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp H-------------CCCCCC--TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred c-------------ccccCC--ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 0 000000 13456789999999999999999 7888875
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=320.90 Aligned_cols=247 Identities=22% Similarity=0.288 Sum_probs=195.6
Q ss_pred ccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCe
Q 043524 16 RTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPI 94 (314)
Q Consensus 16 ~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 94 (314)
....+|.|+ +.|+++.+..+|+.||+|++........ +.+.+|++++..++||||+++++++.+.+.
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~------------~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 160 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK------------EEVKNEISVMNQLDHANLIQLYDAFESKND 160 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHH------------HHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccH------------HHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 344689988 8888888888999999999876443222 568899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeee--cCCCceEEccc
Q 043524 95 AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILF--SEENVVKLFDF 172 (314)
Q Consensus 95 ~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~--~~~~~~kl~df 172 (314)
.++||||+++++|.+.+.... ..++...+..++.|++.||.||| +++|+||||||+||++ +..+.++|+||
T Consensus 161 ~~lv~E~~~~~~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DF 233 (373)
T 2x4f_A 161 IVLVMEYVDGGELFDRIIDES----YNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDF 233 (373)
T ss_dssp EEEEEECCTTCEEHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCC
T ss_pred EEEEEeCCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeC
Confidence 999999999999999887543 35788999999999999999999 9999999999999999 56678999999
Q ss_pred ccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhcc
Q 043524 173 SLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFED 252 (314)
Q Consensus 173 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (314)
|+++....... .....||+.|+|||++....++.++|||||||++|+|++|..||....... ........
T Consensus 234 G~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--------~~~~i~~~ 303 (373)
T 2x4f_A 234 GLARRYKPREK--LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE--------TLNNILAC 303 (373)
T ss_dssp SSCEECCTTCB--CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHHT
T ss_pred CCceecCCccc--cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhc
Confidence 99987644332 334579999999999988889999999999999999999999996543211 11111111
Q ss_pred CCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 253 NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.. ..........+.++.+|+.+||+.||++|||+.|+++
T Consensus 304 ~~-----------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 304 RW-----------DLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp CC-----------CSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cC-----------CCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 0000111134567899999999999999999999987
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=322.16 Aligned_cols=251 Identities=19% Similarity=0.254 Sum_probs=200.8
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
..|.....+|.|+ +.|+.+.+..+|+.+|+|++........ ..+.+|+.++..++||||+++++++.
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~------------~~~~~E~~il~~l~hpnIv~~~~~~~ 118 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK------------YTVKNEISIMNQLHHPKLINLHDAFE 118 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHH------------HHHHHHHHHHTTCCSTTBCCEEEEEE
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhH------------HHHHHHHHHHHhCCCcCCCeEEEEEE
Confidence 3455566789988 8888888889999999999865432211 46789999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecC--CCceE
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSE--ENVVK 168 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~--~~~~k 168 (314)
++...++||||+++|+|.+.+.... ..++...+..++.|++.||.||| +++|+||||||+||+++. .+.++
T Consensus 119 ~~~~~~lv~E~~~gg~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vk 191 (387)
T 1kob_A 119 DKYEMVLILEFLSGGELFDRIAAED----YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVK 191 (387)
T ss_dssp CSSEEEEEEECCCCCBHHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEE
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceE
Confidence 9999999999999999999987643 35889999999999999999999 999999999999999974 46799
Q ss_pred EcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHh
Q 043524 169 LFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKN 248 (314)
Q Consensus 169 l~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (314)
|+|||+++....... .....||+.|+|||++.+..++.++||||+||++|+|++|..||....... ....
T Consensus 192 L~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~--------~~~~ 261 (387)
T 1kob_A 192 IIDFGLATKLNPDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE--------TLQN 261 (387)
T ss_dssp ECCCTTCEECCTTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--------HHHH
T ss_pred EEecccceecCCCcc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH--------HHHH
Confidence 999999987644322 334579999999999998889999999999999999999999997533211 1111
Q ss_pred hhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 249 YFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.... .+. .+ .......+.++.+|+..||..||++|||+.|+++
T Consensus 262 i~~~-~~~--~~--------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 262 VKRC-DWE--FD--------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp HHHC-CCC--CC--------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHhC-CCC--CC--------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 1110 000 00 0001134467899999999999999999999986
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=313.82 Aligned_cols=263 Identities=19% Similarity=0.300 Sum_probs=204.1
Q ss_pred hcCcccccccCch-hHHHHHHH-----hcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeee
Q 043524 12 SKGKRTLMIGNGA-SVLQELIA-----SSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKL 85 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~-----~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 85 (314)
.++.....+|.|+ +.|+.+.+ ..+|+.||+|++........ .+.+.+|++++..++||||+++
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~E~~~l~~l~hp~iv~~ 91 (314)
T 2ivs_A 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE-----------LRDLLSEFNVLKQVNHPHVIKL 91 (314)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHH-----------HHHHHHHHHHHTTCCCTTBCCE
T ss_pred hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHH-----------HHHHHHHHHHHhhCCCCceeeE
Confidence 3444455688888 77777654 34568999999865321111 2568899999999999999999
Q ss_pred EeEEEeCCeeEEEEeecCCCCHHHHHhcCCCC-------------------CCCcccHHHHHHHHHHHHHHHHHhhcCCC
Q 043524 86 IGCCLETPIAILVFEYVQHGTLWDRILGAPQT-------------------HFEPLLLKRRLKDAVDAANALAYLHFGFP 146 (314)
Q Consensus 86 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~-------------------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~ 146 (314)
++++.+++..++||||+++|+|.+++...... ....++...++.++.|++.||.||| +
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~ 168 (314)
T 2ivs_A 92 YGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---E 168 (314)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---H
T ss_pred EEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---H
Confidence 99999999999999999999999999765321 1124788999999999999999999 9
Q ss_pred CCceeccCCCCCeeecCCCceEEcccccceecCCCCcc-cccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-
Q 043524 147 RPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETH-ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT- 224 (314)
Q Consensus 147 ~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~- 224 (314)
++|+|+||||+||+++.++.++|+|||+++........ ......+|+.|+|||++.+..++.++||||+|+++|+|++
T Consensus 169 ~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 248 (314)
T 2ivs_A 169 MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 248 (314)
T ss_dssp TTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred CCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhC
Confidence 99999999999999999999999999999876443221 2234457888999999988889999999999999999999
Q ss_pred CCCCcccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHH
Q 043524 225 GRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRL 304 (314)
Q Consensus 225 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 304 (314)
|..||....... .... ...... ...+...+..+.+++.+||+.||++|||+.|+++.|
T Consensus 249 g~~p~~~~~~~~-----~~~~----~~~~~~-------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l 306 (314)
T 2ivs_A 249 GGNPYPGIPPER-----LFNL----LKTGHR-------------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDL 306 (314)
T ss_dssp SCCSSTTCCGGG-----HHHH----HHTTCC-------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCCCCHHH-----HHHH----hhcCCc-------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 999996543221 0111 111000 000013446789999999999999999999999999
Q ss_pred HHHHhh
Q 043524 305 RQICCS 310 (314)
Q Consensus 305 ~~~~~~ 310 (314)
+++...
T Consensus 307 ~~~~~~ 312 (314)
T 2ivs_A 307 EKMMVK 312 (314)
T ss_dssp HHHHHT
T ss_pred HHHHhh
Confidence 998764
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=325.54 Aligned_cols=256 Identities=18% Similarity=0.169 Sum_probs=202.0
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
..+.....+|.|+ +.|+.+.+..+|+.||+|++.+......... +.+.+|..++..++||||+++++++.
T Consensus 61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~---------~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEV---------SCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGG---------CCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHH---------HHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 3455566799988 8888888889999999999987665433211 45789999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
+.+.+|+||||+++|+|.+++.... ..++...++.++.|++.||.||| +++|+||||||+||+++.++.+||+
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~ 204 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFG----ERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLA 204 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEe
Confidence 9999999999999999999997643 35888999999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCcccc-------cCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchH
Q 043524 171 DFSLSISIPEGETHITDTVMGTYGHLAPQYVT-------TCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFN 243 (314)
Q Consensus 171 dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-------~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~ 243 (314)
|||+++..............||+.|+|||++. ...++.++|+||+||++|||++|+.||.......
T Consensus 205 DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------- 277 (412)
T 2vd5_A 205 DFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE------- 277 (412)
T ss_dssp CCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------
T ss_pred echhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH-------
Confidence 99999877554433344568999999999987 3468999999999999999999999996533211
Q ss_pred HHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCC---CCHHHHHH
Q 043524 244 EYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDR---PTMVDVAR 302 (314)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~R---ps~~ell~ 302 (314)
........ ......+ ......+.++.+||.+||. +|++| |++.|+++
T Consensus 278 -~~~~i~~~---------~~~~~~p-~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 278 -TYGKIVHY---------KEHLSLP-LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp -HHHHHHTH---------HHHCCCC-----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred -HHHHHHhc---------ccCcCCC-ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 01111100 0000000 0112345678999999999 99998 58998864
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=306.29 Aligned_cols=262 Identities=21% Similarity=0.300 Sum_probs=193.1
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhc--CCCCceeeeEeE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQ--MSHDHILKLIGC 88 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~ 88 (314)
.++.....+|.|+ +.|+.+. .+|+.||+|++..... +.+..|.+++.. ++||||++++++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~--~~~~~vavK~~~~~~~---------------~~~~~e~~~~~~~~l~h~niv~~~~~ 70 (301)
T 3q4u_A 8 RDITLLECVGKGRYGEVWRGS--WQGENVAVKIFSSRDE---------------KSWFRETELYNTVMLRHENILGFIAS 70 (301)
T ss_dssp GGCEEEEEEEECSSEEEEEEE--ETTEEEEEEEECGGGH---------------HHHHHHHHHHHHTCCCCTTBCCEEEE
T ss_pred CcEEEEEeeccCCCcEEEEEE--ECCEEEEEEEeccccc---------------hhhHHHHHHHHHhhccCcCeeeEEEe
Confidence 4455556688888 7777653 3789999999876543 234556666665 789999999999
Q ss_pred EEe----CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCC-----CCCceeccCCCCCe
Q 043524 89 CLE----TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGF-----PRPIVFRDFKTSHI 159 (314)
Q Consensus 89 ~~~----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~-----~~~i~H~dlk~~ni 159 (314)
+.. ....|+||||+++|+|.+++.. ..++...+..++.|++.||.|||... +++|+||||||+||
T Consensus 71 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Ni 144 (301)
T 3q4u_A 71 DMTSRHSSTQLWLITHYHEMGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNI 144 (301)
T ss_dssp EEEEETTEEEEEEEECCCTTCBHHHHHTT------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGE
T ss_pred eccccCCCceeEEehhhccCCCHHHHHhh------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhE
Confidence 765 3568999999999999999954 34889999999999999999999321 57899999999999
Q ss_pred eecCCCceEEcccccceecCCCCccc---ccccccccccccCcccccC------CCCcccchHHHHHHHHHHHhC-----
Q 043524 160 LFSEENVVKLFDFSLSISIPEGETHI---TDTVMGTYGHLAPQYVTTC------DFSEKLDVYSFGAFLSELLTG----- 225 (314)
Q Consensus 160 l~~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~------~~~~~~DiwslG~~l~el~~g----- 225 (314)
+++.++.+||+|||+++......... .....||+.|+|||++... .++.++||||+|+++|+|++|
T Consensus 145 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~ 224 (301)
T 3q4u_A 145 LVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG 224 (301)
T ss_dssp EECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred EEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcc
Confidence 99999999999999997764433221 2334799999999999876 344789999999999999999
Q ss_pred -----CCCcccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHH
Q 043524 226 -----RGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDV 300 (314)
Q Consensus 226 -----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el 300 (314)
..||........ .+.......... ........ .......+..+.+|+..||+.||++|||+.|+
T Consensus 225 ~~~~~~~pf~~~~~~~~---~~~~~~~~~~~~-~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i 293 (301)
T 3q4u_A 225 IVEDYKPPFYDVVPNDP---SFEDMRKVVCVD-QQRPNIPN-------RWFSDPTLTSLAKLMKECWYQNPSARLTALRI 293 (301)
T ss_dssp BCCCCCCTTTTTSCSSC---CHHHHHHHHTTS-CCCCCCCG-------GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred ccccccccccccCCCCc---chhhhhHHHhcc-CCCCCCCh-------hhccCccHHHHHHHHHHHhhcChhhCCCHHHH
Confidence 667654332221 111111111111 00000110 01112567789999999999999999999999
Q ss_pred HHHHHHH
Q 043524 301 ARRLRQI 307 (314)
Q Consensus 301 l~~L~~~ 307 (314)
++.|+++
T Consensus 294 ~~~L~~i 300 (301)
T 3q4u_A 294 KKTLTKI 300 (301)
T ss_dssp HHHHHHH
T ss_pred HHHHhcc
Confidence 9999986
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=317.43 Aligned_cols=250 Identities=18% Similarity=0.279 Sum_probs=201.0
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGCC 89 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 89 (314)
..+.....+|.|+ +.|+++.+..+|+.||+|++.......... .+.+.+|..++..+ +||||+++++++
T Consensus 20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~---------~~~~~~E~~~l~~~~~hp~iv~l~~~~ 90 (353)
T 2i0e_A 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD---------VECTMVEKRVLALPGKPPFLTQLHSCF 90 (353)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTC---------HHHHHHHHHHHTCTTCCTTBCCEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchH---------HHHHHHHHHHHHhcCCCCEEeeEEEEE
Confidence 3455566789988 888888888889999999998776543221 25678999999988 799999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEE
Q 043524 90 LETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKL 169 (314)
Q Consensus 90 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl 169 (314)
.+.+.+|+||||+++|+|.+++.... .++...++.++.|++.||.||| +++|+||||||+||+++.++.++|
T Consensus 91 ~~~~~~~lv~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL 162 (353)
T 2i0e_A 91 QTMDRLYFVMEYVNGGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKI 162 (353)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEE
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEE
Confidence 99999999999999999999987643 4789999999999999999999 999999999999999999999999
Q ss_pred cccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhh
Q 043524 170 FDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNY 249 (314)
Q Consensus 170 ~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (314)
+|||+++...... .......||+.|+|||++.+..++.++|+||+||++|||++|..||...... ......
T Consensus 163 ~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--------~~~~~i 233 (353)
T 2i0e_A 163 ADFGMCKENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--------ELFQSI 233 (353)
T ss_dssp CCCTTCBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHH
T ss_pred EeCCcccccccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH--------HHHHHH
Confidence 9999997643222 1244668999999999999889999999999999999999999999643211 111111
Q ss_pred hccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCC-----HHHHHH
Q 043524 250 FEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPT-----MVDVAR 302 (314)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps-----~~ell~ 302 (314)
.. .....+ ...+.++.+|+..||..||++||+ +.++++
T Consensus 234 ~~-------------~~~~~p--~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 234 ME-------------HNVAYP--KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp HH-------------CCCCCC--TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred Hh-------------CCCCCC--CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 11 111111 134567899999999999999995 566654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=314.14 Aligned_cols=266 Identities=20% Similarity=0.333 Sum_probs=207.1
Q ss_pred hcCcccccccCch-hHHHHHH-----HhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceee
Q 043524 12 SKGKRTLMIGNGA-SVLQELI-----ASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILK 84 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~-----~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 84 (314)
.++.....+|.|+ +.|+.+. +..+++.||+|++........ .+.+.+|++++..+ +||||++
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~E~~~l~~l~~h~~i~~ 91 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE-----------REALMSELKVLSYLGNHMNIVN 91 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHH-----------HHHHHHHHHHHHHHCCCTTBCC
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHH-----------HHHHHHHHHHHhhcccCCCeee
Confidence 3455566788888 7777665 456778999999875432111 15688999999999 8999999
Q ss_pred eEeEEEeCCeeEEEEeecCCCCHHHHHhcCCCC-------------CCCcccHHHHHHHHHHHHHHHHHhhcCCCCCcee
Q 043524 85 LIGCCLETPIAILVFEYVQHGTLWDRILGAPQT-------------HFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVF 151 (314)
Q Consensus 85 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~-------------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H 151 (314)
+++++.+++..++||||+++|+|.+++...... ....++...++.++.|++.||.||| +++++|
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H 168 (313)
T 1t46_A 92 LLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIH 168 (313)
T ss_dssp EEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeec
Confidence 999999999999999999999999999765421 0124789999999999999999999 999999
Q ss_pred ccCCCCCeeecCCCceEEcccccceecCCCCcc-cccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCc
Q 043524 152 RDFKTSHILFSEENVVKLFDFSLSISIPEGETH-ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGIL 229 (314)
Q Consensus 152 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~ 229 (314)
+||||+||+++.++.++|+|||+++........ ......+|+.|+|||++.+..++.++||||+|+++|+|++ |..||
T Consensus 169 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~ 248 (313)
T 1t46_A 169 RDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248 (313)
T ss_dssp SCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred CCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999999776443221 1234457889999999988889999999999999999999 99998
Q ss_pred ccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHh
Q 043524 230 DLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICC 309 (314)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 309 (314)
........ ......... . ...+...+..+.+++..||+.||++|||+.|+++.|+++..
T Consensus 249 ~~~~~~~~----~~~~~~~~~-----~------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 249 PGMPVDSK----FYKMIKEGF-----R------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp TTCCSSHH----HHHHHHHTC-----C------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcccchhH----HHHHhccCC-----C------------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 65432210 111111000 0 00001334568999999999999999999999999999987
Q ss_pred hcc
Q 043524 310 SLS 312 (314)
Q Consensus 310 ~~~ 312 (314)
+..
T Consensus 308 ~~~ 310 (313)
T 1t46_A 308 EST 310 (313)
T ss_dssp HTC
T ss_pred Hhh
Confidence 654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=304.88 Aligned_cols=250 Identities=20% Similarity=0.290 Sum_probs=180.8
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
+++....+|.|+ +.|+.+.+..+|+.||+|++......... ..+.+.+|++++..++||||+++++++.+
T Consensus 12 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 82 (278)
T 3cok_A 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAG---------MVQRVQNEVKIHCQLKHPSILELYNYFED 82 (278)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTT---------CHHHHHHHHHHHTTBCCTTBCCEEEEEEC
T ss_pred cceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhh---------HHHHHHHHHHHHHhCCCCCeEeEEEEEcc
Confidence 345556688888 88888888889999999999876543321 12678899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
++..++||||+++++|.+++.... .+++...+..++.|++.||.||| +++++|+||||+||+++.++.++|+|
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~d 155 (278)
T 3cok_A 83 SNYVYLVLEMCHNGEMNRYLKNRV----KPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIAD 155 (278)
T ss_dssp SSEEEEEEECCTTEEHHHHHHTCS----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECC
T ss_pred CCeEEEEEecCCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEe
Confidence 999999999999999999997654 45889999999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhc
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFE 251 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (314)
||.+........ ......||+.|+|||++.+..++.++||||+|+++|+|++|..||.........
T Consensus 156 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------------- 221 (278)
T 3cok_A 156 FGLATQLKMPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL------------- 221 (278)
T ss_dssp CTTCEECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------------
T ss_pred ecceeeccCCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-------------
Confidence 999977643221 123457899999999998888999999999999999999999999653322100
Q ss_pred cCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 252 DNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
..... .....+ ...+.++.+|+.+||+.||++|||+.++++
T Consensus 222 ----~~~~~----~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 222 ----NKVVL----ADYEMP--SFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ------CCS----SCCCCC--TTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ----HHHhh----cccCCc--cccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 00000 000000 123456889999999999999999999986
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=317.96 Aligned_cols=253 Identities=20% Similarity=0.294 Sum_probs=195.9
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeEEE
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGCCL 90 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 90 (314)
.+.....+|.|+ +.|+++.+..+|+.||+|++......... ..+.+.+|+.++..+ +||||+++++++.
T Consensus 10 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~---------~~~~~~~E~~~l~~~~~hp~iv~l~~~~~ 80 (345)
T 3a8x_A 10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDE---------DIDWVQTEKHVFEQASNHPFLVGLHSCFQ 80 (345)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHH---------HHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchH---------HHHHHHHHHHHHHhcCCCCccCeEEEEEE
Confidence 344555688888 88888888889999999998765321110 115578899999987 8999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
+.+.+|+||||+++|+|.+.+.... .++...++.++.|++.||.||| +++|+||||||+||+++.++.+||+
T Consensus 81 ~~~~~~lv~e~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~ 152 (345)
T 3a8x_A 81 TESRLFFVIEYVNGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLT 152 (345)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEEC
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEE
Confidence 9999999999999999999987642 4889999999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhh
Q 043524 171 DFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 171 dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
|||+++...... .......||+.|+|||++.+..++.++|+||+||++|+|++|..||...................
T Consensus 153 DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-- 229 (345)
T 3a8x_A 153 DYGMCKEGLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ-- 229 (345)
T ss_dssp CGGGCBCSCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHH--
T ss_pred eccccccccCCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHH--
Confidence 999997643222 12446689999999999999889999999999999999999999997543221100000011100
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCH
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTM 297 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 297 (314)
.........+ ...+..+.+|+.+||+.||++||++
T Consensus 230 ----------~i~~~~~~~p--~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 230 ----------VILEKQIRIP--RSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ----------HHHHCCCCCC--TTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ----------HHHcCCCCCC--CCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 0111111111 1345678999999999999999996
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=310.28 Aligned_cols=258 Identities=22% Similarity=0.364 Sum_probs=197.2
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
++.....+|.|+ +.|+.+.+..+++.||+|++.......... .....+.+.+|+.++..++||||+++++++.+
T Consensus 20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (287)
T 4f0f_A 20 EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETE-----MIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN 94 (287)
T ss_dssp TEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHH-----HHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred cceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchh-----HHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence 444555689888 888888888899999999885432110000 00011578899999999999999999999866
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCC--ceeccCCCCCeeecCCCc---
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRP--IVFRDFKTSHILFSEENV--- 166 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~--i~H~dlk~~nil~~~~~~--- 166 (314)
.. ++||||+++|+|.+.+.... ..++...+..++.|++.||.||| +++ |+|+||||+||+++..+.
T Consensus 95 ~~--~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~ 165 (287)
T 4f0f_A 95 PP--RMVMEFVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAP 165 (287)
T ss_dssp TT--EEEEECCTTCBHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCS
T ss_pred CC--eEEEEecCCCCHHHHHhccc----CCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCc
Confidence 54 69999999999999887654 46889999999999999999999 999 999999999999987776
Q ss_pred --eEEcccccceecCCCCcccccccccccccccCcccc--cCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccch
Q 043524 167 --VKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVT--TCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPF 242 (314)
Q Consensus 167 --~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~ 242 (314)
++|+|||+++..... .....||+.|+|||++. ...++.++||||+|+++|+|++|..||.......
T Consensus 166 ~~~kl~Dfg~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------ 235 (287)
T 4f0f_A 166 VCAKVADFGLSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK------ 235 (287)
T ss_dssp CCEEECCCTTCBCCSSC----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH------
T ss_pred eeEEeCCCCcccccccc----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH------
Confidence 999999999754322 34567899999999984 4457899999999999999999999996543221
Q ss_pred HHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHH
Q 043524 243 NEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQI 307 (314)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~ 307 (314)
.......... ... ...+...+..+.+|+..||+.||++|||+.|+++.|+++
T Consensus 236 ~~~~~~~~~~-~~~------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 236 IKFINMIREE-GLR------------PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHHHHHHHS-CCC------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HHHHHHHhcc-CCC------------CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 0001111100 000 001113446789999999999999999999999999863
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=313.06 Aligned_cols=266 Identities=18% Similarity=0.243 Sum_probs=195.2
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|.....+|.|+ +.|+++.+ .+|+.||+|++........ ..+.+.+|+++++.++||||+++++++.
T Consensus 21 ~~y~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~----------~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 89 (311)
T 3niz_A 21 EKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEG----------IPSTAIREISLLKELHHPNIVSLIDVIH 89 (311)
T ss_dssp CEEEEEEEEEECSSCEEEEEEE-TTSCEEEEEEEC------C----------HHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhhHhhhhccCCCCeEEEEEEE-CCCCEEEEEEEecccccch----------hhHHHHHHHHHHHHcCCCCEeeeeeEEc
Confidence 4555566689888 77777765 4689999999875432111 2256889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
++...++||||++ |+|.+.+.... ..++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~ 161 (311)
T 3niz_A 90 SERCLTLVFEFME-KDLKKVLDENK----TGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLA 161 (311)
T ss_dssp CSSCEEEEEECCS-EEHHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEEC
T ss_pred cCCEEEEEEcCCC-CCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEc
Confidence 9999999999997 58888887654 35889999999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCccccc-CCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhh
Q 043524 171 DFSLSISIPEGETHITDTVMGTYGHLAPQYVTT-CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNY 249 (314)
Q Consensus 171 dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (314)
|||+++....... ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||......... ..... .
T Consensus 162 Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~----~~i~~-~ 235 (311)
T 3niz_A 162 DFGLARAFGIPVR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL----PKIFS-I 235 (311)
T ss_dssp CCTTCEETTSCCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH----HHHHH-H
T ss_pred cCcCceecCCCcc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH----HHHHH-H
Confidence 9999987643322 2334578999999999876 45899999999999999999999999765443311 11111 0
Q ss_pred hcc---CCcccccCh---------hhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 250 FED---NRFTEIVDP---------IIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 250 ~~~---~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
... ..+....+. ..............+.++.+|+.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 236 LGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000 000000000 00000000001123467889999999999999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=321.17 Aligned_cols=264 Identities=21% Similarity=0.304 Sum_probs=204.8
Q ss_pred cCcccccccCch-hHHHHHHHh-------cCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCcee
Q 043524 13 KGKRTLMIGNGA-SVLQELIAS-------SNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHIL 83 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~-------~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 83 (314)
++.....+|.|+ +.|+++... ..+..||+|++........ .+++.+|++++..+ +||||+
T Consensus 70 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~E~~~l~~l~~hpnIv 138 (382)
T 3tt0_A 70 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-----------LSDLISEMEMMKMIGKHKNII 138 (382)
T ss_dssp GEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHH-----------HHHHHHHHHHHHHHCCCTTBC
T ss_pred heEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHH-----------HHHHHHHHHHHHHhcCCchhh
Confidence 444455688888 777777643 3345799999865422211 15688999999999 899999
Q ss_pred eeEeEEEeCCeeEEEEeecCCCCHHHHHhcCCCCC-----------CCcccHHHHHHHHHHHHHHHHHhhcCCCCCceec
Q 043524 84 KLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTH-----------FEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFR 152 (314)
Q Consensus 84 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~-----------~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~ 152 (314)
++++++.+++..|+||||+++|+|.+++....... ...++...++.++.|++.||.||| +++|+||
T Consensus 139 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~ 215 (382)
T 3tt0_A 139 NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHR 215 (382)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred hheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecC
Confidence 99999999999999999999999999998654211 135889999999999999999999 9999999
Q ss_pred cCCCCCeeecCCCceEEcccccceecCCCCc-ccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcc
Q 043524 153 DFKTSHILFSEENVVKLFDFSLSISIPEGET-HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILD 230 (314)
Q Consensus 153 dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~ 230 (314)
||||+||+++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 216 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~ 295 (382)
T 3tt0_A 216 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 295 (382)
T ss_dssp CCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999986644322 12334467889999999999889999999999999999999 999986
Q ss_pred cccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 231 LVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
..... ......... ... ..+..++.++.+|+..||+.||++|||+.|+++.|+++...
T Consensus 296 ~~~~~--------~~~~~~~~~-~~~-------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 353 (382)
T 3tt0_A 296 GVPVE--------ELFKLLKEG-HRM-------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353 (382)
T ss_dssp TCCHH--------HHHHHHHTT-CCC-------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCHH--------HHHHHHHcC-CCC-------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 43311 111111111 000 00013345689999999999999999999999999999765
Q ss_pred cc
Q 043524 311 LS 312 (314)
Q Consensus 311 ~~ 312 (314)
.+
T Consensus 354 ~~ 355 (382)
T 3tt0_A 354 TS 355 (382)
T ss_dssp SC
T ss_pred Hh
Confidence 43
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=328.61 Aligned_cols=250 Identities=17% Similarity=0.273 Sum_probs=192.9
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
..+.....+|.|+ +.|+++.+..+|+.||+|++.......... .+.+.+|+.++..++||||+++++++.
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~---------~~~~~~e~~~l~~l~h~~iv~l~~~~~ 218 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE---------VAHTLTENRVLQNSRHPFLTALKYSFQ 218 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC----------------------CCCCCSCTTSCCEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHH---------HHHHHHHHHHHHhCCCCeEeeEEEEEe
Confidence 3455566789988 888888888999999999998654322111 145678999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCC-CCceeccCCCCCeeecCCCceEE
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFP-RPIVFRDFKTSHILFSEENVVKL 169 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~-~~i~H~dlk~~nil~~~~~~~kl 169 (314)
+.+.+|+||||+++|+|.+.+... ..++...+..++.|++.||.||| + ++|+||||||+||+++.++.+||
T Consensus 219 ~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl 290 (446)
T 4ejn_A 219 THDRLCFVMEYANGGELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKI 290 (446)
T ss_dssp ETTEEEEEECCCSSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEE
T ss_pred eCCEEEEEEeeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEE
Confidence 999999999999999999988764 35789999999999999999999 8 99999999999999999999999
Q ss_pred cccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhh
Q 043524 170 FDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNY 249 (314)
Q Consensus 170 ~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (314)
+|||+++....... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||....... .....
T Consensus 291 ~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--------~~~~i 361 (446)
T 4ejn_A 291 TDFGLCKEGIKDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--------LFELI 361 (446)
T ss_dssp CCCCCCCTTCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHH
T ss_pred ccCCCceeccCCCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH--------HHHHH
Confidence 99999975433221 2445689999999999999899999999999999999999999996433211 11111
Q ss_pred hccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCC-----CHHHHHH
Q 043524 250 FEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRP-----TMVDVAR 302 (314)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 302 (314)
.. .....+ ...+..+.+|+..||+.||++|| |+.|+++
T Consensus 362 ~~-------------~~~~~p--~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 362 LM-------------EEIRFP--RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp HH-------------CCCCCC--TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred Hh-------------CCCCCC--ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 11 111111 12345689999999999999999 9999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=317.12 Aligned_cols=264 Identities=19% Similarity=0.294 Sum_probs=201.5
Q ss_pred hcCcccccccCch-hHHHHHHH-----hcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceee
Q 043524 12 SKGKRTLMIGNGA-SVLQELIA-----SSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILK 84 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~-----~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 84 (314)
..+.....+|.|+ +.|+.+.. ..++..||+|++........ .+.+.+|+.++..+ +||||++
T Consensus 45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~E~~~l~~l~~hp~iv~ 113 (344)
T 1rjb_A 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE-----------REALMSELKMMTQLGSHENIVN 113 (344)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-----------------CHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHH-----------HHHHHHHHHHHHhhcCCCCeee
Confidence 3445556788888 77777664 34567899999875432111 16789999999999 8999999
Q ss_pred eEeEEEeCCeeEEEEeecCCCCHHHHHhcCCCC------------------CCCcccHHHHHHHHHHHHHHHHHhhcCCC
Q 043524 85 LIGCCLETPIAILVFEYVQHGTLWDRILGAPQT------------------HFEPLLLKRRLKDAVDAANALAYLHFGFP 146 (314)
Q Consensus 85 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~------------------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~ 146 (314)
+++++..++..++||||+++|+|.+++...... ....++...++.++.|++.||.||| +
T Consensus 114 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~ 190 (344)
T 1rjb_A 114 LLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---F 190 (344)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---H
T ss_pred EEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---h
Confidence 999999999999999999999999999765421 0123788999999999999999999 9
Q ss_pred CCceeccCCCCCeeecCCCceEEcccccceecCCCCc-ccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-
Q 043524 147 RPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGET-HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT- 224 (314)
Q Consensus 147 ~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~- 224 (314)
++|+||||||+||+++.++.++|+|||++........ .......+|+.|+|||++.+..++.++||||||+++|+|++
T Consensus 191 ~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 270 (344)
T 1rjb_A 191 KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 270 (344)
T ss_dssp TTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred CCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcC
Confidence 9999999999999999999999999999976543322 12334567889999999988889999999999999999998
Q ss_pred CCCCcccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHH
Q 043524 225 GRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRL 304 (314)
Q Consensus 225 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 304 (314)
|..||........ +... ..... ....+...+..+.+|+..||+.||++|||+.|+++.|
T Consensus 271 g~~p~~~~~~~~~----~~~~----~~~~~-------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 271 GVNPYPGIPVDAN----FYKL----IQNGF-------------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp SCCSSTTCCCSHH----HHHH----HHTTC-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCcccCCcHHH----HHHH----HhcCC-------------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 9999975442210 1111 11100 0000012346689999999999999999999999999
Q ss_pred HHHHhh
Q 043524 305 RQICCS 310 (314)
Q Consensus 305 ~~~~~~ 310 (314)
+++...
T Consensus 330 ~~~~~~ 335 (344)
T 1rjb_A 330 GCQLAD 335 (344)
T ss_dssp HHHC--
T ss_pred HHHHHH
Confidence 998664
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=319.04 Aligned_cols=263 Identities=22% Similarity=0.305 Sum_probs=202.5
Q ss_pred cCcccccccCch-hHHHHHHHh-----cCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeE
Q 043524 13 KGKRTLMIGNGA-SVLQELIAS-----SNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLI 86 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~-----~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 86 (314)
++.....+|.|+ +.|+.+.+. .+++.||+|++....... ..+.+.+|+.++..++||||++++
T Consensus 48 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~~E~~~l~~l~hp~iv~~~ 116 (343)
T 1luf_A 48 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD-----------MQADFQREAALMAEFDNPNIVKLL 116 (343)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHH-----------HHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred HCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHH-----------HHHHHHHHHHHHHhCCCCCEEEEE
Confidence 444555688888 777777665 455889999987542211 126788999999999999999999
Q ss_pred eEEEeCCeeEEEEeecCCCCHHHHHhcCCCCC-------------------CCcccHHHHHHHHHHHHHHHHHhhcCCCC
Q 043524 87 GCCLETPIAILVFEYVQHGTLWDRILGAPQTH-------------------FEPLLLKRRLKDAVDAANALAYLHFGFPR 147 (314)
Q Consensus 87 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~-------------------~~~l~~~~~~~~~~~i~~~l~~lH~~~~~ 147 (314)
+++.+++..|+||||+++|+|.+++....... ...++...++.++.|++.||.||| ++
T Consensus 117 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~ 193 (343)
T 1luf_A 117 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ER 193 (343)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HT
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hC
Confidence 99999999999999999999999997642110 135888999999999999999999 99
Q ss_pred CceeccCCCCCeeecCCCceEEcccccceecCCCCc-ccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-C
Q 043524 148 PIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGET-HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-G 225 (314)
Q Consensus 148 ~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g 225 (314)
+|+||||||+||+++.++.++|+|||+++....... .......+|+.|+|||++....++.++||||||+++|+|++ |
T Consensus 194 ~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 273 (343)
T 1luf_A 194 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 273 (343)
T ss_dssp TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred CeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcC
Confidence 999999999999999999999999999876533221 12234567899999999998889999999999999999999 9
Q ss_pred CCCcccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHH
Q 043524 226 RGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLR 305 (314)
Q Consensus 226 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~ 305 (314)
..||...... +...... ...... .+..++..+.+|+..||+.||++|||+.++++.|+
T Consensus 274 ~~p~~~~~~~--------~~~~~~~-~~~~~~-------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~ 331 (343)
T 1luf_A 274 LQPYYGMAHE--------EVIYYVR-DGNILA-------------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 331 (343)
T ss_dssp CCTTTTSCHH--------HHHHHHH-TTCCCC-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCcCCCCChH--------HHHHHHh-CCCcCC-------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHH
Confidence 9998643321 1111111 111000 00133456899999999999999999999999999
Q ss_pred HHHhhc
Q 043524 306 QICCSL 311 (314)
Q Consensus 306 ~~~~~~ 311 (314)
++.+.+
T Consensus 332 ~~~~~~ 337 (343)
T 1luf_A 332 RMCERA 337 (343)
T ss_dssp HTTC--
T ss_pred HHHhhh
Confidence 987654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=305.65 Aligned_cols=264 Identities=16% Similarity=0.149 Sum_probs=203.1
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEE-
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCC- 89 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~- 89 (314)
.+|.....+|.|+ +.|+.+.+..+|+.||+|++...... +.+.+|+.++..++|++++..+..+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------------~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--------------PQLHIESKIYKMMQGGVGIPTIRWCG 74 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--------------CCHHHHHHHHHHHTTSTTCCCEEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--------------hHHHHHHHHHHHhcCCCCCCeeeeec
Confidence 4566666789888 88888888899999999986543211 3467899999999988776666555
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeee---cCCCc
Q 043524 90 LETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILF---SEENV 166 (314)
Q Consensus 90 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~---~~~~~ 166 (314)
..+...++||||+ +++|.+++.... ..++...+..++.|++.||.||| +++|+||||||+||++ +..+.
T Consensus 75 ~~~~~~~lv~e~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~ 146 (296)
T 4hgt_A 75 AEGDYNVMVMELL-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNL 146 (296)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTC
T ss_pred CCCCceEEEEEcc-CCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCe
Confidence 6778889999999 899999997544 35889999999999999999999 9999999999999999 78889
Q ss_pred eEEcccccceecCCCCcc------cccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCcccccc
Q 043524 167 VKLFDFSLSISIPEGETH------ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVY 240 (314)
Q Consensus 167 ~kl~dfg~~~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~ 240 (314)
++|+|||+++........ ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||..........
T Consensus 147 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~- 225 (296)
T 4hgt_A 147 VYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ- 225 (296)
T ss_dssp EEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS-
T ss_pred EEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhh-
Confidence 999999999876543221 1235578999999999999899999999999999999999999997654332111
Q ss_pred chHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhcc
Q 043524 241 PFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSLS 312 (314)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~ 312 (314)
.+....... ...+. .......+..+.+|+..||+.||++|||+.++++.|+++..+.+
T Consensus 226 ~~~~~~~~~-------------~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 226 KYERISEKK-------------MSTPI-EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp HHHHHHHHH-------------HHSCH-HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred hhhhhhccc-------------ccchh-hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 011100000 00000 00001235678999999999999999999999999999987654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=305.55 Aligned_cols=263 Identities=20% Similarity=0.294 Sum_probs=194.4
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC--CCCceeeeEeE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM--SHDHILKLIGC 88 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~ 88 (314)
.+++....+|.|+ +.|+.+.. +|+.||+|++..... ..+..|.+++..+ +||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~---------------~~~~~e~~~~~~~~~~h~~i~~~~~~ 99 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEE---------------ASWFRETEIYQTVLMRHENILGFIAA 99 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGGH---------------HHHHHHHHHHTSTTCCCTTBCCEEEE
T ss_pred cceEEEeEeecCCCeEEEEEEE--CCceEEEEEEecccc---------------chhhhHHHHHHHHhhcCCCeeeEEEE
Confidence 4556666788888 67776643 489999999865432 2234555555554 89999999999
Q ss_pred EEeC----CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCC--------CceeccCCC
Q 043524 89 CLET----PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPR--------PIVFRDFKT 156 (314)
Q Consensus 89 ~~~~----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~--------~i~H~dlk~ 156 (314)
+... ...++||||+++|+|.+++... .++...+..++.|++.||.||| ++ +|+||||||
T Consensus 100 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp 170 (337)
T 3mdy_A 100 DIKGTGSWTQLYLITDYHENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKS 170 (337)
T ss_dssp EEESCGGGCEEEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCG
T ss_pred EccCCCCCCceEEEEeccCCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccch
Confidence 9887 7899999999999999999753 4788999999999999999999 88 999999999
Q ss_pred CCeeecCCCceEEcccccceecCCCCccc---ccccccccccccCcccccCCCCcc------cchHHHHHHHHHHHhCCC
Q 043524 157 SHILFSEENVVKLFDFSLSISIPEGETHI---TDTVMGTYGHLAPQYVTTCDFSEK------LDVYSFGAFLSELLTGRG 227 (314)
Q Consensus 157 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~------~DiwslG~~l~el~~g~~ 227 (314)
+||+++.++.+||+|||+++......... .....||+.|+|||++.....+.. +|||||||++|||++|..
T Consensus 171 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~ 250 (337)
T 3mdy_A 171 KNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCV 250 (337)
T ss_dssp GGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBC
T ss_pred HHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccC
Confidence 99999999999999999997664432211 234579999999999987766654 999999999999999944
Q ss_pred ----------CcccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCH
Q 043524 228 ----------ILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTM 297 (314)
Q Consensus 228 ----------p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 297 (314)
||........ .+.. ................. .....++..+.+|+.+||+.||++|||+
T Consensus 251 ~~~~~~~~~~p~~~~~~~~~---~~~~-~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dP~~Rps~ 319 (337)
T 3mdy_A 251 SGGIVEEYQLPYHDLVPSDP---SYED-MREIVCIKKLRPSFPNR-------WSSDECLRQMGKLMTECWAHNPASRLTA 319 (337)
T ss_dssp BTTBCCCCCCTTTTTSCSSC---CHHH-HHHHHTTSCCCCCCCGG-------GGGSHHHHHHHHHHHHHSCSSGGGSCCH
T ss_pred cccccccccccHhhhcCCCC---chhh-hHHHHhhhccCcccccc-------chhhHHHHHHHHHHHHhhhhChhhCCCH
Confidence 4432222111 1111 11111111111111111 1112667889999999999999999999
Q ss_pred HHHHHHHHHHHhhc
Q 043524 298 VDVARRLRQICCSL 311 (314)
Q Consensus 298 ~ell~~L~~~~~~~ 311 (314)
.|+++.|+++.++.
T Consensus 320 ~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 320 LRVKKTLAKMSESQ 333 (337)
T ss_dssp HHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhhc
Confidence 99999999998764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=309.93 Aligned_cols=268 Identities=15% Similarity=0.200 Sum_probs=197.0
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
+|+....+|.|+ +.|+++.+..+|+.||+|++..... .....+.+.+|+.++..++||||+++++++.+
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 72 (292)
T 3o0g_A 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD----------DEGVPSSALREICLLKELKHKNIVRLHDVLHS 72 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS----------STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC----------cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe
Confidence 344555689888 8899998889999999999864321 11123567899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
++..++||||+++ ++.+.+.... ..++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+|
T Consensus 73 ~~~~~lv~e~~~~-~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~D 144 (292)
T 3o0g_A 73 DKKLTLVFEFCDQ-DLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLAN 144 (292)
T ss_dssp TTEEEEEEECCSE-EHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECC
T ss_pred CCEEEEEEecCCC-CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEee
Confidence 9999999999965 6766665543 35889999999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCcccccCC-CCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhh
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTTCD-FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
||+++...... .......||+.|+|||++.+.. ++.++||||+||++|+|++|..||.......+.. ........
T Consensus 145 fg~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~---~~i~~~~~ 220 (292)
T 3o0g_A 145 FGLARAFGIPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL---KRIFRLLG 220 (292)
T ss_dssp CTTCEECCSCC-SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHH---HHHHHHHC
T ss_pred cccceecCCcc-ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHH---HHHHHHhC
Confidence 99998764332 2234567899999999998766 7999999999999999999888864322211111 11111000
Q ss_pred --ccCCcccccC-----h--hh-hccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 251 --EDNRFTEIVD-----P--II-VQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 251 --~~~~~~~~~~-----~--~~-~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
....+..... + .. ............+..+.+|+.+||+.||++|||+.|+++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 221 TPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0000000000 0 00 000000011134567889999999999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=321.97 Aligned_cols=278 Identities=15% Similarity=0.169 Sum_probs=208.6
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
+|.....+|.|+ +.|+.+.+..+|+.||+|++........ .+.+.+|+++++.++||||+++++++..
T Consensus 10 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 78 (396)
T 4eut_A 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-----------VDVQMREFEVLKKLNHKNIVKLFAIEEE 78 (396)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC-----------HHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred ceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccch-----------HHHHHHHHHHHHhcCCCCCCeEEEeecc
Confidence 445556689888 8899998999999999999875432111 2567899999999999999999999987
Q ss_pred CC--eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeee----cCCC
Q 043524 92 TP--IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILF----SEEN 165 (314)
Q Consensus 92 ~~--~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~----~~~~ 165 (314)
.+ ..|+|||||++|+|.+++...... ..++...++.++.|++.||.||| +++|+||||||+||++ +..+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~ 153 (396)
T 4eut_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQS 153 (396)
T ss_dssp TTTCCEEEEECCCTTEEHHHHTTSGGGT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCE
T ss_pred CCCCeeEEEEecCCCCCHHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCce
Confidence 55 789999999999999998764321 23889999999999999999999 9999999999999998 7777
Q ss_pred ceEEcccccceecCCCCcccccccccccccccCccccc--------CCCCcccchHHHHHHHHHHHhCCCCcccccCccc
Q 043524 166 VVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTT--------CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHD 237 (314)
Q Consensus 166 ~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~ 237 (314)
.+||+|||+++...... ......||+.|+|||++.. ..++.++||||+||++|+|++|+.||........
T Consensus 154 ~~kL~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~ 231 (396)
T 4eut_A 154 VYKLTDFGAARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231 (396)
T ss_dssp EEEECCGGGCEECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT
T ss_pred eEEEecCCCceEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc
Confidence 89999999998764432 2335679999999998865 3567899999999999999999999975443322
Q ss_pred cccchHHHHHhhhccCCcccc---cChh--h--hccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHh
Q 043524 238 LVYPFNEYLKNYFEDNRFTEI---VDPI--I--VQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICC 309 (314)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~---~~~~--~--~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 309 (314)
.............. ..+... .... . .-+..+......+..+.+++..||+.||++|||+.|+++.++++..
T Consensus 232 ~~~~~~~~~~~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 232 NKEVMYKIITGKPS-GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp CHHHHHHHHHSCCT-TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred hHHHHHHHhcCCCc-ccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 11111111111000 000000 0000 0 0011122234677889999999999999999999999999998865
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=314.80 Aligned_cols=277 Identities=15% Similarity=0.108 Sum_probs=203.5
Q ss_pred cCcccccccCch-hHHHHHHHhcC-----CcccccccccHHHHHH--HhcCCcccCChhHHHHHHHHHHHhcCCCCceee
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSN-----GKYIPYRIFSAQELKQ--ETNNYDQKNGFWHESCINNVTYAAQMSHDHILK 84 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~-----g~~~a~k~~~~~~~~~--~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 84 (314)
+|.....+|.|+ +.|+++.+..+ ++.||+|++....... ...-+... ....++.|+..+..++||||++
T Consensus 36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~---~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRA---AKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHH---CCHHHHHHHHHHTTCSCCCSCC
T ss_pred eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhh---hhhHHHHHHHHHhhccCCCCCe
Confidence 455556799998 88888866554 5789999876543110 00000000 1145677888899999999999
Q ss_pred eEeEEEeC----CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCee
Q 043524 85 LIGCCLET----PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHIL 160 (314)
Q Consensus 85 ~~~~~~~~----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil 160 (314)
+++++... ...|+||||+ +++|.+++.... ..++...++.++.|++.||.||| +++|+||||||+||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nil 184 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA----KRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLL 184 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEE
Confidence 99999874 4589999999 999999998754 45899999999999999999999 999999999999999
Q ss_pred ec--CCCceEEcccccceecCCCCcc------cccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccc
Q 043524 161 FS--EENVVKLFDFSLSISIPEGETH------ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLV 232 (314)
Q Consensus 161 ~~--~~~~~kl~dfg~~~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 232 (314)
++ .++.++|+|||+++........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 185 l~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~ 264 (364)
T 3op5_A 185 LNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN 264 (364)
T ss_dssp EESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 98 8899999999999876432211 113345999999999999988999999999999999999999999754
Q ss_pred cCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhcc
Q 043524 233 RDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSLS 312 (314)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~ 312 (314)
...... ......... ....+..++.+.. ...+.++.+++..||+.||++|||+.+|++.|+++.+...
T Consensus 265 ~~~~~~----~~~~~~~~~-~~~~~~~~~~~~~-------~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~ 332 (364)
T 3op5_A 265 LKDPKY----VRDSKIRYR-ENIASLMDKCFPA-------ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG 332 (364)
T ss_dssp TTCHHH----HHHHHHHHH-HCHHHHHHHHSCT-------TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ccCHHH----HHHHHHHhh-hhHHHHHHHhccc-------ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 332211 111110000 0111111111100 1235678999999999999999999999999999987654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=307.54 Aligned_cols=255 Identities=22% Similarity=0.326 Sum_probs=200.8
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
.+.....+|.|+ +.|+.+... +++.+|+|++...... .+.+.+|++++..++||||+++++++.+
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~-------------~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 74 (267)
T 3t9t_A 9 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS-------------EEDFIEEAEVMMKLSHPKLVQLYGVCLE 74 (267)
T ss_dssp GEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC-------------HHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred heeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC-------------HHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 344445688888 666666543 6788999998754321 1568899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
++..++||||+++++|.+++.... ..++...+..++.|++.||.||| +++++|+||||+||+++.++.++|+|
T Consensus 75 ~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~d 147 (267)
T 3t9t_A 75 QAPICLVTEFMEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSD 147 (267)
T ss_dssp SSSCEEEECCCTTCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECC
T ss_pred CCCeEEEEeCCCCCcHHHHHhhCc----ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEcc
Confidence 999999999999999999997654 35788999999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhh
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
||.++..............++..|+|||++....++.++||||+|+++|+|++ |..||...... .......
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~i~ 219 (267)
T 3t9t_A 148 FGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--------EVVEDIS 219 (267)
T ss_dssp TTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHH
T ss_pred cccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH--------HHHHHHh
Confidence 99997654332222234457788999999988889999999999999999999 89998643211 1111111
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
... .. ..+...+..+.+++..||+.||++|||+.++++.|+++.++
T Consensus 220 ~~~--~~------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 220 TGF--RL------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp TTC--CC------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cCC--cC------------CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 100 00 00012345688999999999999999999999999998763
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=328.63 Aligned_cols=257 Identities=18% Similarity=0.275 Sum_probs=204.0
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
.+.....+|.|+ +.|+.+.+..+|+.||+|++.......... .+.+.+|++++..++||||+++++++.+
T Consensus 186 ~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~---------~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 256 (543)
T 3c4z_A 186 WFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKG---------YQGAMVEKKILAKVHSRFIVSLAYAFET 256 (543)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTC---------HHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred heEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHH---------HHHHHHHHHHHHhcCCCCEeeEEEEEee
Confidence 344445689888 888888888899999999998776543321 2568899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
...+|+||||+++|+|.+++...... ...++...++.++.|++.||.||| +++|+||||||+||+++.++.+||+|
T Consensus 257 ~~~l~lVmE~~~gg~L~~~l~~~~~~-~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~D 332 (543)
T 3c4z_A 257 KTDLCLVMTIMNGGDIRYHIYNVDED-NPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISD 332 (543)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTSSTT-SCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECC
T ss_pred CCEEEEEEEeccCCCHHHHHHHhhcc-cccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEee
Confidence 99999999999999999998764321 135889999999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhc
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFE 251 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (314)
||+++....... ......||+.|+|||++.+..++.++|+||+||++|||++|..||........ .........
T Consensus 333 FGla~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~----~~~~~~~i~- 406 (543)
T 3c4z_A 333 LGLAVELKAGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE----NKELKQRVL- 406 (543)
T ss_dssp CTTCEECCTTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC----HHHHHHHHH-
T ss_pred cceeeeccCCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh----HHHHHHHHh-
Confidence 999987654332 23445899999999999998999999999999999999999999975432210 111111111
Q ss_pred cCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCH-----HHHHH
Q 043524 252 DNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTM-----VDVAR 302 (314)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~-----~ell~ 302 (314)
......+ ...+..+.+|+..||..||++||++ .++++
T Consensus 407 ------------~~~~~~p--~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 407 ------------EQAVTYP--DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp ------------HCCCCCC--TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred ------------hcccCCC--cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 1111111 1345678999999999999999964 66653
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=312.91 Aligned_cols=264 Identities=23% Similarity=0.211 Sum_probs=198.6
Q ss_pred hhhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeE
Q 043524 10 LWSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGC 88 (314)
Q Consensus 10 ~~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 88 (314)
...+|.....+|.|+ +.|+.+.+..+++.+|+|++........... ..+.+.+|++++..++||||++++++
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~-------~~~~~~~E~~~l~~l~hpniv~~~~~ 96 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPK-------DVERIKTEVRLMKKLHHPNIARLYEV 96 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---C-------HHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHH-------HHHHHHHHHHHHHhCCCCCcceeehh
Confidence 345566666788888 8888888889999999999987654321111 12678899999999999999999999
Q ss_pred EEeCCeeEEEEeecCCCCHHHHHhcCCCC-----------------------------------CCCcccHHHHHHHHHH
Q 043524 89 CLETPIAILVFEYVQHGTLWDRILGAPQT-----------------------------------HFEPLLLKRRLKDAVD 133 (314)
Q Consensus 89 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~-----------------------------------~~~~l~~~~~~~~~~~ 133 (314)
+.+++..++|||||++|+|.+.+...... ....++...+..++.|
T Consensus 97 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~q 176 (345)
T 3hko_A 97 YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQ 176 (345)
T ss_dssp EECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHH
T ss_pred hccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHH
Confidence 99999999999999999999988521000 0023467778889999
Q ss_pred HHHHHHHhhcCCCCCceeccCCCCCeeecCCC--ceEEcccccceecCCCC---cccccccccccccccCccccc--CCC
Q 043524 134 AANALAYLHFGFPRPIVFRDFKTSHILFSEEN--VVKLFDFSLSISIPEGE---THITDTVMGTYGHLAPQYVTT--CDF 206 (314)
Q Consensus 134 i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~--~~kl~dfg~~~~~~~~~---~~~~~~~~g~~~y~aPE~~~~--~~~ 206 (314)
++.||.||| +++|+|+||||+||+++.++ .++|+|||+++...... ........||+.|+|||++.. ..+
T Consensus 177 i~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 253 (345)
T 3hko_A 177 IFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY 253 (345)
T ss_dssp HHHHHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCC
T ss_pred HHHHHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCC
Confidence 999999999 99999999999999998766 89999999998654321 112345679999999999875 568
Q ss_pred CcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHh
Q 043524 207 SEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFEC 286 (314)
Q Consensus 207 ~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 286 (314)
+.++||||||+++|+|++|..||....... .......... ....+.....+..+.+|+..|
T Consensus 254 ~~~~DiwslG~il~el~~g~~pf~~~~~~~--------~~~~~~~~~~-----------~~~~~~~~~~~~~~~~li~~~ 314 (345)
T 3hko_A 254 GPKCDAWSAGVLLHLLLMGAVPFPGVNDAD--------TISQVLNKKL-----------CFENPNYNVLSPLARDLLSNL 314 (345)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCC-----------CTTSGGGGGSCHHHHHHHHHH
T ss_pred CcHHHHHHHHHHHHHHHHCCCCCCCCChHH--------HHHHHHhccc-----------ccCCcccccCCHHHHHHHHHH
Confidence 999999999999999999999996543221 1111111100 000011113456789999999
Q ss_pred ccCCCCCCCCHHHHHH
Q 043524 287 LNESPIDRPTMVDVAR 302 (314)
Q Consensus 287 l~~dp~~Rps~~ell~ 302 (314)
|+.||++|||+.|+++
T Consensus 315 l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 315 LNRNVDERFDAMRALQ 330 (345)
T ss_dssp SCSCTTTSCCHHHHHH
T ss_pred cCCChhHCCCHHHHhc
Confidence 9999999999999987
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=303.06 Aligned_cols=248 Identities=20% Similarity=0.335 Sum_probs=198.5
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|.....+|.|+ +.|+.+.+..++..+|+|++.......... .+.+.+|+.+++.++||||+++++++.
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~ 79 (279)
T 3fdn_A 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV---------EHQLRREVEIQSHLRHPNILRLYGYFH 79 (279)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTC---------HHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhH---------HHHHHHHHHHHHcCCCCCCcchhheEe
Confidence 3445555688888 888888889999999999998766544321 267889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
+....++||||+++|+|.+.+.... .++...+..++.|++.||.||| +++|+|+||||+||+++.++.++|+
T Consensus 80 ~~~~~~lv~e~~~~~~l~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~ 151 (279)
T 3fdn_A 80 DATRVYLILEYAPLGTVYRELQKLS-----KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIA 151 (279)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEEC
T ss_pred cCCEEEEEEecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEE
Confidence 9999999999999999999887643 4788999999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhh
Q 043524 171 DFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 171 dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
|||++....... .....|++.|+|||++.+..++.++||||+|+++|+|++|..||...... .......
T Consensus 152 Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~ 220 (279)
T 3fdn_A 152 DFGWSVHAPSSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--------ETYKRIS 220 (279)
T ss_dssp SCCEESCC-----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHH
T ss_pred eccccccCCccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH--------HHHHHHH
Confidence 999985543322 33457899999999999888999999999999999999999999643211 1111111
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
. .....+ ...+..+.+|+..||+.||++|||+.|+++
T Consensus 221 ~-------------~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 221 R-------------VEFTFP--DFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp H-------------TCCCCC--TTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred h-------------CCCCCC--CcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0 000000 123456789999999999999999999997
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=312.54 Aligned_cols=268 Identities=22% Similarity=0.328 Sum_probs=200.1
Q ss_pred cccccccCch-hHH----HHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEE
Q 043524 15 KRTLMIGNGA-SVL----QELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCC 89 (314)
Q Consensus 15 ~~~~~~G~g~-~~~----~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 89 (314)
+....+|.|+ +.| +.+.+..+|+.||+|++....... ..+.+.+|+++++.++||||+++++++
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~iv~~~~~~ 102 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQ-----------HRSGWKQEIDILRTLYHEHIIKYKGCC 102 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHH-----------HHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChH-----------HHHHHHHHHHHHHhCCCcchhhEEEEE
Confidence 4445688777 666 445566789999999987542111 125688999999999999999999999
Q ss_pred Ee--CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCce
Q 043524 90 LE--TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVV 167 (314)
Q Consensus 90 ~~--~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~ 167 (314)
.+ ...+++||||+++|+|.+++... .++...++.++.|++.||.||| +++|+|+||||+||+++.++.+
T Consensus 103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~ 173 (318)
T 3lxp_A 103 EDAGAASLQLVMEYVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLV 173 (318)
T ss_dssp EETTTTEEEEEECCCTTCBHHHHGGGS------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCE
T ss_pred ecCCCceEEEEEecccCCcHHHHHhhC------CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCE
Confidence 87 46789999999999999999764 3788999999999999999999 9999999999999999999999
Q ss_pred EEcccccceecCCCCc--ccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccc--cchH
Q 043524 168 KLFDFSLSISIPEGET--HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLV--YPFN 243 (314)
Q Consensus 168 kl~dfg~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~--~~~~ 243 (314)
+|+|||.++....... .......+|..|+|||++.+..++.++||||+|+++|+|++|..||.......... ....
T Consensus 174 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~ 253 (318)
T 3lxp_A 174 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQG 253 (318)
T ss_dssp EECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCH
T ss_pred EECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhccccc
Confidence 9999999987654322 12334467888999999988889999999999999999999999986432110000 0000
Q ss_pred HHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhc
Q 043524 244 EYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSL 311 (314)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 311 (314)
.... .. ....+......+.+..++..+.+|+..||+.||++|||+.|+++.|+++.+.+
T Consensus 254 ~~~~--------~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 254 QMTV--------LR-LTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp HHHH--------HH-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred chhH--------HH-HHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 0000 00 00000011111111244567899999999999999999999999999997765
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=301.48 Aligned_cols=268 Identities=24% Similarity=0.384 Sum_probs=202.4
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCee
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIA 95 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (314)
...+|.|+ +.|+.+.. +++.+|+|.+..... .......+.+.+|+.+++.++||||+++++++.+++..
T Consensus 36 ~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--------~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 105 (307)
T 2nru_A 36 GNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVD--------ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDL 105 (307)
T ss_dssp CCEEEECSSEEEEEEES--SSCEEEEEEECCCTT--------SCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred CCccccCCCeEEEEEEE--CCceEEEEEEecccC--------cchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCce
Confidence 35688888 67776643 678999998753210 00111236788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
++||||+++|+|.+++...... .+++...+..++.|++.||.||| +++++|+||||+||+++.++.++|+|||++
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~ 180 (307)
T 2nru_A 106 CLVYVYMPNGSLLDRLSCLDGT--PPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLA 180 (307)
T ss_dssp EEEEECCTTCBHHHHHHTGGGC--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCCCcHHHHHHhccCC--CCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEcCCCcEEEeecccc
Confidence 9999999999999998753221 35889999999999999999999 999999999999999999999999999999
Q ss_pred eecCCCCcc-cccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhc-cC
Q 043524 176 ISIPEGETH-ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFE-DN 253 (314)
Q Consensus 176 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~ 253 (314)
+........ ......||+.|+|||++.+ .++.++||||+|+++|+|++|..||.......... .+...... ..
T Consensus 181 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~ 255 (307)
T 2nru_A 181 RASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL----DIKEEIEDEEK 255 (307)
T ss_dssp EECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT----HHHHHHHTTSC
T ss_pred cccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH----HHHHHhhhhhh
Confidence 876443221 2334578999999998765 57899999999999999999999997654332111 11111111 11
Q ss_pred CcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHh
Q 043524 254 RFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICC 309 (314)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 309 (314)
...+.+++.. . ......+..+.+++.+||+.||++|||+.++++.|+++..
T Consensus 256 ~~~~~~~~~~----~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 256 TIEDYIDKKM----N-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp CHHHHSCSSC----S-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred hhhhhccccc----c-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 1112222211 1 1122567789999999999999999999999999999865
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=309.77 Aligned_cols=268 Identities=19% Similarity=0.256 Sum_probs=197.2
Q ss_pred hhhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeE
Q 043524 10 LWSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGC 88 (314)
Q Consensus 10 ~~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 88 (314)
...+|+....+|.|+ +.|+.+....+|+.+|+|++........ ...+.+.+|+.++..++||||++++++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---------~~~~~~~~E~~~l~~l~h~~i~~~~~~ 100 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDA---------KARADCIKEIDLLKQLNHPNVIKYYAS 100 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCH---------HHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCH---------HHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 345566667799988 8888888888999999998864221000 012568899999999999999999999
Q ss_pred EEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceE
Q 043524 89 CLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVK 168 (314)
Q Consensus 89 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~k 168 (314)
+..++..++||||+++++|.+++...... ...++...++.++.|++.||.||| +++++|+||||+||+++.++.++
T Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~k 176 (310)
T 2wqm_A 101 FIEDNELNIVLELADAGDLSRMIKHFKKQ-KRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVK 176 (310)
T ss_dssp EEETTEEEEEEECCCSCBHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEE
T ss_pred EEcCCcEEEEEecCCCCCHHHHHHHhccc-ccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEE
Confidence 99999999999999999999988642100 035788999999999999999999 99999999999999999999999
Q ss_pred EcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHh
Q 043524 169 LFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKN 248 (314)
Q Consensus 169 l~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (314)
|+|||++........ ......|++.|+|||++....++.++||||||+++|+|++|..||....... ......
T Consensus 177 l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~ 249 (310)
T 2wqm_A 177 LGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL------YSLCKK 249 (310)
T ss_dssp ECCC-------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH------HHHHHH
T ss_pred EEeccceeeecCCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH------HHHHHH
Confidence 999999876543321 2334568999999999998889999999999999999999999986432111 111111
Q ss_pred hhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 249 YFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
. ....... ......+..+.+|+..||+.||++|||+.++++.|+++...
T Consensus 250 ~-~~~~~~~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~ 298 (310)
T 2wqm_A 250 I-EQCDYPP------------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC 298 (310)
T ss_dssp H-HTTCSCC------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred h-hcccCCC------------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 1 1111100 00013446789999999999999999999999999999764
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=307.14 Aligned_cols=256 Identities=20% Similarity=0.269 Sum_probs=194.9
Q ss_pred cCcccccccCch-hHHHHHHHh---cCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeE
Q 043524 13 KGKRTLMIGNGA-SVLQELIAS---SNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGC 88 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~---~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 88 (314)
++.....+|.|+ +.|+.+... .++..||+|.+........ .+.+.+|+.++..++||||++++++
T Consensus 13 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~E~~~l~~l~h~~i~~~~~~ 81 (281)
T 3cc6_A 13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDN-----------KEKFMSEAVIMKNLDHPHIVKLIGI 81 (281)
T ss_dssp GEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHH-----------HHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred ceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchH-----------HHHHHHHHHHHHhCCCCCcceEEEE
Confidence 344455688888 777776533 2344699998875421111 1568899999999999999999999
Q ss_pred EEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceE
Q 043524 89 CLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVK 168 (314)
Q Consensus 89 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~k 168 (314)
+.+ +..|+||||+++++|.+++.... ..++...+..++.|++.||.||| +++++|+||||+||+++.++.++
T Consensus 82 ~~~-~~~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~k 153 (281)
T 3cc6_A 82 IEE-EPTWIIMELYPYGELGHYLERNK----NSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVK 153 (281)
T ss_dssp ECS-SSCEEEEECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEE
T ss_pred EcC-CCCEEEEecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEE
Confidence 865 45789999999999999997643 34788999999999999999999 99999999999999999999999
Q ss_pred EcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHH
Q 043524 169 LFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLK 247 (314)
Q Consensus 169 l~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~ 247 (314)
|+|||.+...............+++.|+|||++....++.++||||+|+++|+|++ |+.||....... ......
T Consensus 154 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~-----~~~~~~ 228 (281)
T 3cc6_A 154 LGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD-----VIGVLE 228 (281)
T ss_dssp ECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG-----HHHHHH
T ss_pred eCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH-----HHHHHh
Confidence 99999997664433323344567889999999988889999999999999999998 999996433221 011000
Q ss_pred hhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHh
Q 043524 248 NYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICC 309 (314)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 309 (314)
.... .+.+...+..+.+++..||+.||++|||+.|+++.|+++..
T Consensus 229 ---~~~~--------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 229 ---KGDR--------------LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp ---HTCC--------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---cCCC--------------CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 0000 00001234568899999999999999999999999998865
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=325.13 Aligned_cols=249 Identities=23% Similarity=0.292 Sum_probs=195.9
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
+.....+|.|+ +.|+.+. ..|+.||+|++.... ..+.|.+|+++++.++||||+++++++.+.
T Consensus 195 ~~~~~~lG~G~fg~V~~~~--~~~~~vavK~~~~~~--------------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 258 (450)
T 1k9a_A 195 LKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKNDA--------------TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 258 (450)
T ss_dssp EEEEEEEEECSSEEEEEEE--ETTEEEEEEEESSCT--------------TSHHHHHHHHHHHTCCCTTBCCEEEEEECT
T ss_pred eEEEeeecCcCCeeEEEEE--ecCCeEEEEEeCCch--------------HHHHHHHHHHHHHhccCCCEEEEEEEEEcC
Confidence 34445688887 6666553 357899999986432 116789999999999999999999998776
Q ss_pred C-eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 93 P-IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 93 ~-~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
. ..|+||||+++|+|.+++..... ..++...++.++.|++.||.||| +++|+||||||+||+++.++.+||+|
T Consensus 259 ~~~~~iv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~D 332 (450)
T 1k9a_A 259 KGGLYIVTEYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSD 332 (450)
T ss_dssp TSCEEEEEECCTTCBHHHHHHHHCT---TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECC
T ss_pred CCceEEEEEecCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEee
Confidence 5 79999999999999999986542 23688899999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhh
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
||+++..... .....++..|+|||++....++.++||||||+++|||++ |..||....... ... ...
T Consensus 333 fG~a~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-----~~~---~i~ 400 (450)
T 1k9a_A 333 FGLTKEASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----VVP---RVE 400 (450)
T ss_dssp CTTCEECC----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT-----HHH---HHH
T ss_pred CCCccccccc----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHH---HHH
Confidence 9999764322 223357889999999999899999999999999999998 999997544322 001 110
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
.. . ....+..++..+.+|+.+||+.||++|||+.++++.|+++...
T Consensus 401 ~~-~-------------~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 401 KG-Y-------------KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp TT-C-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cC-C-------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 00 0 0001113456789999999999999999999999999998653
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=313.15 Aligned_cols=270 Identities=19% Similarity=0.250 Sum_probs=189.4
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
+|+....+|.|+ +.|+.+.+..+|+.||+|++...... . ..+.+.+|+++++.++||||+++++++.+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 74 (317)
T 2pmi_A 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE--------G---TPSTAIREISLMKELKHENIVRLYDVIHT 74 (317)
T ss_dssp -------------CEEEEEECSSSCCEEEEEEEECCSTT--------C---SCHHHHHHHHHHTTCCBTTBCCEEEEECC
T ss_pred ceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc--------c---cHHHHHHHHHHHHhcCCCCcceEEEEEEE
Confidence 444555689988 88888888889999999988643210 0 11567899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCC-CCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQ-THFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
++..|+||||++ |+|.+++..... .....++...+..++.|++.||.||| +++|+||||||+||+++.++.+||+
T Consensus 75 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~ 150 (317)
T 2pmi_A 75 ENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLG 150 (317)
T ss_dssp TTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEEC
T ss_pred CCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEEC
Confidence 999999999997 699888865321 11134788999999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCcccccC-CCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhh
Q 043524 171 DFSLSISIPEGETHITDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNY 249 (314)
Q Consensus 171 dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (314)
|||+++....... ......||+.|+|||++.+. .++.++||||+||++|+|++|+.||........ ........
T Consensus 151 Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----~~~i~~~~ 225 (317)
T 2pmi_A 151 DFGLARAFGIPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ----LKLIFDIM 225 (317)
T ss_dssp CCSSCEETTSCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHH
T ss_pred cCccceecCCCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHHHh
Confidence 9999987643321 23345789999999998764 589999999999999999999999975432211 00000000
Q ss_pred h--ccCCcccc-----cChhhhcc--------CCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 250 F--EDNRFTEI-----VDPIIVQD--------LSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 250 ~--~~~~~~~~-----~~~~~~~~--------~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
- ....+... ..+.+... .........+..+.+|+.+||+.||++|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 226 GTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp CSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0 00000000 00000000 000000123457899999999999999999999985
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=313.05 Aligned_cols=265 Identities=20% Similarity=0.325 Sum_probs=189.1
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCc---ccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEe
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGK---YIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIG 87 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~---~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 87 (314)
.++.....+|.|+ +.|+.+....+++ .||+|++........ ..+++.+|+++++.++||||+++++
T Consensus 23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~~E~~~l~~l~h~~iv~~~~ 92 (323)
T 3qup_A 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASS----------DIEEFLREAACMKEFDHPHVAKLVG 92 (323)
T ss_dssp --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CH----------HHHHHHHHHHHHTTCCCTTBCCCCE
T ss_pred hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHH----------HHHHHHHHHHHHHHCCCCceehhhc
Confidence 4455666789888 8888877666665 799999865432211 1267889999999999999999999
Q ss_pred EEEeCCee------EEEEeecCCCCHHHHHhcCCCC-CCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCee
Q 043524 88 CCLETPIA------ILVFEYVQHGTLWDRILGAPQT-HFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHIL 160 (314)
Q Consensus 88 ~~~~~~~~------~iv~e~~~~g~L~~~l~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil 160 (314)
++...... ++|+||+++|+|.+++...... ....++...+..++.|++.||.||| +++|+||||||+||+
T Consensus 93 ~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIl 169 (323)
T 3qup_A 93 VSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCM 169 (323)
T ss_dssp EEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred eeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEE
Confidence 99876655 9999999999999988643211 1125889999999999999999999 999999999999999
Q ss_pred ecCCCceEEcccccceecCCCCcc-cccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCcccc
Q 043524 161 FSEENVVKLFDFSLSISIPEGETH-ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDL 238 (314)
Q Consensus 161 ~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~ 238 (314)
++.++.++|+|||+++........ ......+++.|+|||.+.+..++.++||||+|+++|+|++ |..||.......
T Consensus 170 i~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-- 247 (323)
T 3qup_A 170 LAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-- 247 (323)
T ss_dssp ECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--
T ss_pred EcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH--
Confidence 999999999999999765443221 1223456788999999999899999999999999999999 899987544322
Q ss_pred ccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhc
Q 043524 239 VYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSL 311 (314)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 311 (314)
.......... ...+...+..+.+|+.+||+.||++|||+.++++.|+++...+
T Consensus 248 ------~~~~~~~~~~--------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 248 ------IYNYLIGGNR--------------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp ------HHHHHHTTCC--------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred ------HHHHHhcCCC--------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 0011111000 0001134456899999999999999999999999999997654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=310.28 Aligned_cols=256 Identities=20% Similarity=0.266 Sum_probs=202.5
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
..|.....+|.|+ +.|+.+.+..+|+.+|+|++....... .......+.+.+|+.++..++||||+++++++.
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 85 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRA------SRRGVSREEIEREVSILRQVLHHNVITLHDVYE 85 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSS------CSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccc------cccchhHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 4455566788888 888888888899999999986543211 111112367889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCC----c
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN----V 166 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~----~ 166 (314)
++...++||||+++++|.+++... ..++...+..++.|++.||.||| +++|+|+||||+||+++.++ .
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~ 157 (321)
T 2a2a_A 86 NRTDVVLILELVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPH 157 (321)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTC-----SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCC
T ss_pred cCCEEEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCC
Confidence 999999999999999999999764 35889999999999999999999 99999999999999999887 7
Q ss_pred eEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHH
Q 043524 167 VKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYL 246 (314)
Q Consensus 167 ~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 246 (314)
++|+|||+++....... .....||+.|+|||++.+..++.++||||+|+++|+|++|..||...... +..
T Consensus 158 ~kl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~ 227 (321)
T 2a2a_A 158 IKLIDFGLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETL 227 (321)
T ss_dssp EEECCCTTCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHH
T ss_pred EEEccCccceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH--------HHH
Confidence 99999999987654322 33457899999999999888999999999999999999999999643211 111
Q ss_pred HhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 247 KNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
...... . ...+.......+..+.+|+..||+.||++|||+.|+++
T Consensus 228 ~~i~~~-~----------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 228 ANITSV-S----------YDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HHHHTT-C----------CCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred HHHHhc-c----------cccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 111100 0 00111111234567899999999999999999999986
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=315.95 Aligned_cols=248 Identities=22% Similarity=0.288 Sum_probs=184.3
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
++.....+|.|+ +.|+.+.+..+++.||+|++...... +.+.+|+.++..++||||+++++++.+
T Consensus 54 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------------~~~~~E~~~l~~l~h~niv~~~~~~~~ 119 (349)
T 2w4o_A 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--------------KIVRTEIGVLLRLSHPNIIKLKEIFET 119 (349)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------------------CHHHHHCCCTTBCCEEEEEEC
T ss_pred cEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhH--------------HHHHHHHHHHHhCCCCCCcceeeeEec
Confidence 355556788888 88888888889999999998754311 456789999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecC---CCceE
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSE---ENVVK 168 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~---~~~~k 168 (314)
++..++||||+++|+|.+.+... ..++...+..++.|++.||.||| +++|+||||||+||+++. ++.++
T Consensus 120 ~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~k 191 (349)
T 2w4o_A 120 PTEISLVLELVTGGELFDRIVEK-----GYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLK 191 (349)
T ss_dssp SSEEEEEECCCCSCBHHHHHTTC-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEE
T ss_pred CCeEEEEEEeCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEE
Confidence 99999999999999999998764 34789999999999999999999 999999999999999975 78999
Q ss_pred EcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHh
Q 043524 169 LFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKN 248 (314)
Q Consensus 169 l~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (314)
|+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ....
T Consensus 192 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-------~~~~ 262 (349)
T 2w4o_A 192 IADFGLSKIVEHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF-------MFRR 262 (349)
T ss_dssp ECCCC------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH-------HHHH
T ss_pred EccCccccccCccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH-------HHHH
Confidence 99999997654322 23456789999999999988899999999999999999999999964332210 0111
Q ss_pred hhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 249 YFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.... ... .. .+.....+..+.+|+.+||+.||++|||+.|+++
T Consensus 263 i~~~-~~~-~~---------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 263 ILNC-EYY-FI---------SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp HHTT-CCC-CC---------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHhC-CCc-cC---------CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1110 000 00 0001134467889999999999999999999986
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=317.10 Aligned_cols=245 Identities=16% Similarity=0.248 Sum_probs=185.7
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHh-cCCCCceeeeEeEEEe----
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAA-QMSHDHILKLIGCCLE---- 91 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~---- 91 (314)
..+|.|+ +.|+.+.+..+|+.||+|++... ..+.+|+.++. ..+||||+++++++..
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----------------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~ 130 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----------------PKARREVELHWRASQCPHIVRIVDVYENLYAG 130 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----------------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----------------hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence 3578888 88888888899999999998532 34567888774 4589999999999876
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecC---CCceE
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSE---ENVVK 168 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~---~~~~k 168 (314)
...+|+|||||++|+|.+++..... ..++...+..++.|++.||.||| +++|+||||||+||+++. ++.+|
T Consensus 131 ~~~~~lv~E~~~gg~L~~~l~~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~k 204 (400)
T 1nxk_A 131 RKCLLIVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILK 204 (400)
T ss_dssp EEEEEEEEECCCSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEE
T ss_pred CcEEEEEEEeCCCCcHHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEE
Confidence 6678999999999999999986532 35889999999999999999999 999999999999999987 78899
Q ss_pred EcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHh
Q 043524 169 LFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKN 248 (314)
Q Consensus 169 l~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (314)
|+|||+++...... ......||+.|+|||++....++.++|||||||++|+|++|..||........... ......
T Consensus 205 l~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-~~~~i~- 280 (400)
T 1nxk_A 205 LTDFGFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-MKTRIR- 280 (400)
T ss_dssp ECCCTTCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS-HHHHHH-
T ss_pred EEecccccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH-HHHHHH-
Confidence 99999998754332 23456789999999999888999999999999999999999999975443221110 000000
Q ss_pred hhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 249 YFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.... ..+.+.....+.++.+||..||+.||++|||+.|+++
T Consensus 281 ---~~~~----------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 281 ---MGQY----------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp ---HTCC----------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---cCcc----------cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000 0000011134567899999999999999999999987
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=306.52 Aligned_cols=263 Identities=16% Similarity=0.180 Sum_probs=196.3
Q ss_pred hhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEE
Q 043524 11 WSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCC 89 (314)
Q Consensus 11 ~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 89 (314)
..+|+....+|.|+ +.|+.+.+..+|+.||+|++........ ...+.+.+|+.++..++||||+++++++
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~---------~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 103 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDP---------VFRTRMQREARTAGRLQEPHVVPIHDFG 103 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSH---------HHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCH---------HHHHHHHHHHHHHhhcCCCCeeEEEEEE
Confidence 35566667788888 8888888888999999999875432111 0226688999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEE
Q 043524 90 LETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKL 169 (314)
Q Consensus 90 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl 169 (314)
..++..|+|+||+++++|.+++... .+++...+..++.|++.||.||| +++|+|+||||+||+++.++.++|
T Consensus 104 ~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl 175 (309)
T 2h34_A 104 EIDGQLYVDMRLINGVDLAAMLRRQ-----GPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYL 175 (309)
T ss_dssp EETTEEEEEEECCCCEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEE
T ss_pred eeCCeEEEEEEecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEE
Confidence 9999999999999999999998764 24788999999999999999999 999999999999999999999999
Q ss_pred cccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhh
Q 043524 170 FDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNY 249 (314)
Q Consensus 170 ~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (314)
+|||++...............|++.|+|||++.+..++.++||||+|+++|+|++|..||...... .....
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---------~~~~~ 246 (309)
T 2h34_A 176 VDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS---------VMGAH 246 (309)
T ss_dssp CSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH---------HHHHH
T ss_pred ecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH---------HHHHH
Confidence 999998766444333334557899999999999888999999999999999999999999643211 11111
Q ss_pred hccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCC-CHHHHHHHHHHHHhh
Q 043524 250 FEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRP-TMVDVARRLRQICCS 310 (314)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-s~~ell~~L~~~~~~ 310 (314)
..... ..+. ......+..+.+++..||+.||++|| |+.++++.|+++...
T Consensus 247 ~~~~~----~~~~-------~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 247 INQAI----PRPS-------TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp HHSCC----CCGG-------GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred hccCC----CCcc-------ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 11100 0000 00013345688999999999999999 999999999887554
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=302.16 Aligned_cols=247 Identities=19% Similarity=0.248 Sum_probs=198.5
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|.....+|.|+ +.|+.+.+..++..+|+|.+....... .+.+.+|+++++.++||||+++++++.
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~------------~~~~~~E~~~l~~l~h~~i~~~~~~~~ 76 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED------------VDRFKQEIEIMKSLDHPNIIRLYETFE 76 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC------------HHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch------------HHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 4455566688888 888888888899999999886543211 256889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeee---cCCCce
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILF---SEENVV 167 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~---~~~~~~ 167 (314)
++...++||||+++++|.+.+.... .++...+..++.|++.||.||| +++++|+||||+||++ +.++.+
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~ 148 (277)
T 3f3z_A 77 DNTDIYLVMELCTGGELFERVVHKR-----VFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPL 148 (277)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCE
T ss_pred cCCeEEEEEeccCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcE
Confidence 9999999999999999999887643 4789999999999999999999 9999999999999999 778899
Q ss_pred EEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHH
Q 043524 168 KLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLK 247 (314)
Q Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (314)
+|+|||.+....... ......||+.|+|||++.+ .++.++||||+|+++|+|++|..||....... ...
T Consensus 149 ~l~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------~~~ 217 (277)
T 3f3z_A 149 KLIDFGLAARFKPGK--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE--------VML 217 (277)
T ss_dssp EECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHH
T ss_pred EEEecccceeccCcc--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHH--------HHH
Confidence 999999998764433 2345679999999998865 48999999999999999999999996433211 111
Q ss_pred hhhccCCcccccChhhhccCCchh--HHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 248 NYFEDNRFTEIVDPIIVQDLSCTE--KEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
... .+....+. ....+..+.+|+.+||+.||++|||+.|+++
T Consensus 218 ~~~-------------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 218 KIR-------------EGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHH-------------HCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHH-------------hCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111 11111111 1134567899999999999999999999986
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=304.74 Aligned_cols=253 Identities=24% Similarity=0.357 Sum_probs=185.7
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.++.....+|.|+ +.|+.+.+ +|+.+|+|++......... ...+.+.+|+++++.++||||+++++++.
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 76 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDIS--------QTIENVRQEAKLFAMLKHPNIIALRGVCL 76 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC------------------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHH--------HHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 3444555688888 77776653 4889999998754322111 12267889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCC---ceeccCCCCCeeecC----
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRP---IVFRDFKTSHILFSE---- 163 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~---i~H~dlk~~nil~~~---- 163 (314)
+++..++||||+++++|.+++.. ..++...+..++.|++.||.||| +++ |+|+||||+||+++.
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~ 147 (271)
T 3dtc_A 77 KEPNLCLVMEFARGGPLNRVLSG------KRIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVEN 147 (271)
T ss_dssp CC--CEEEEECCTTEEHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSS
T ss_pred cCCceEEEEEcCCCCCHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEeccccc
Confidence 99999999999999999998854 34788999999999999999999 888 899999999999986
Q ss_pred ----CCceEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccc
Q 043524 164 ----ENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLV 239 (314)
Q Consensus 164 ----~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~ 239 (314)
.+.++|+|||.++...... .....||+.|+|||++.+..++.++||||+|+++|+|++|+.||.......
T Consensus 148 ~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--- 221 (271)
T 3dtc_A 148 GDLSNKILKITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA--- 221 (271)
T ss_dssp SCCSSCCEEECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH---
T ss_pred ccccCcceEEccCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---
Confidence 6789999999997654332 224578999999999998889999999999999999999999996433211
Q ss_pred cchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHH
Q 043524 240 YPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQI 307 (314)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~ 307 (314)
........ .. ....+...+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 222 -----~~~~~~~~-~~------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 222 -----VAYGVAMN-KL------------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp -----HHHHHHTS-CC------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred -----HHHhhhcC-CC------------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 00000000 00 0000113345689999999999999999999999999864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=319.91 Aligned_cols=249 Identities=21% Similarity=0.272 Sum_probs=190.6
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHH-HhcCCCCceeeeEeEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTY-AAQMSHDHILKLIGCC 89 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~~~~~~ 89 (314)
..+.....+|.|+ +.|+++.+..+++.||+|++.+........ .+.+.+|..+ +..++||||+++++++
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~---------~~~~~~e~~~ll~~~~hp~Iv~l~~~~ 108 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKE---------EKHIMSERNVLLKNVKHPFLVGLHFSF 108 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC----------------------CCBCCCCCTTBCCEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHH---------HHHHHHHHHHHHHhCCCCCCCCEEEEE
Confidence 3455566799998 889999888999999999997664322111 1345677776 4678999999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEE
Q 043524 90 LETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKL 169 (314)
Q Consensus 90 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl 169 (314)
.+.+.+|+||||+++|+|.+.+.... .++...++.++.|++.||.||| +++|+||||||+||+++.++.+||
T Consensus 109 ~~~~~~~lv~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL 180 (373)
T 2r5t_A 109 QTADKLYFVLDYINGGELFYHLQRER-----CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVL 180 (373)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEE
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEE
Confidence 99999999999999999999987642 4788899999999999999999 999999999999999999999999
Q ss_pred cccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhh
Q 043524 170 FDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNY 249 (314)
Q Consensus 170 ~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (314)
+|||+++...... .......||+.|+|||++.+..++.++|+||+||++|||++|..||...... +.....
T Consensus 181 ~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--------~~~~~i 251 (373)
T 2r5t_A 181 TDFGLCKENIEHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--------EMYDNI 251 (373)
T ss_dssp CCCCBCGGGBCCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH--------HHHHHH
T ss_pred eeCccccccccCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHH
Confidence 9999997643322 2245668999999999999989999999999999999999999999643311 111111
Q ss_pred hccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHH
Q 043524 250 FEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVA 301 (314)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell 301 (314)
.. .....+ ...+..+.+|+.+||+.||++||++.+.+
T Consensus 252 ~~-------------~~~~~~--~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 252 LN-------------KPLQLK--PNITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp HH-------------SCCCCC--SSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred Hh-------------cccCCC--CCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 11 111100 12345688999999999999999985433
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=316.94 Aligned_cols=263 Identities=18% Similarity=0.283 Sum_probs=197.7
Q ss_pred hhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEE
Q 043524 11 WSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCC 89 (314)
Q Consensus 11 ~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 89 (314)
..+++....+|.|+ +.||++.+..+|+.+++|+..+...... .. ...+.+.+|+.++..++||||+++++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~----~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 84 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS----GR---QSFQAVTDHMLAIGSLDHAHIVRLLGLC 84 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT----SC---SCBCSCCHHHHHHHTCCCTTBCCEEEEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc----cH---HHHHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence 34566667799988 8898888888888754443322110000 00 0113466899999999999999999998
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEE
Q 043524 90 LETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKL 169 (314)
Q Consensus 90 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl 169 (314)
. +...++|+||+++|+|.+.+.... ..++...+..++.|++.||.||| +++|+||||||+||+++.++.++|
T Consensus 85 ~-~~~~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl 156 (325)
T 3kex_A 85 P-GSSLQLVTQYLPLGSLLDHVRQHR----GALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQV 156 (325)
T ss_dssp C-BSSEEEEEECCTTCBSHHHHHSSG----GGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEE
T ss_pred c-CCccEEEEEeCCCCCHHHHHHHcc----ccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEE
Confidence 6 567889999999999999997653 45788899999999999999999 999999999999999999999999
Q ss_pred cccccceecCCCCcc-cccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHH
Q 043524 170 FDFSLSISIPEGETH-ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLK 247 (314)
Q Consensus 170 ~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~ 247 (314)
+|||+++........ ......+|..|+|||++....++.++||||+|+++|+|++ |..||....... .....
T Consensus 157 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~- 230 (325)
T 3kex_A 157 ADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE-----VPDLL- 230 (325)
T ss_dssp CSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH-----HHHHH-
T ss_pred CCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH-----HHHHH-
Confidence 999999876443322 2334567889999999998899999999999999999999 999997543221 11111
Q ss_pred hhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 248 NYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
..... . ..+...+..+.+++..||..||++|||+.|+++.|+++...
T Consensus 231 ---~~~~~--~-----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 231 ---EKGER--L-----------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp ---HTTCB--C-----------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred ---HcCCC--C-----------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00000 0 00001233567899999999999999999999999998653
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=308.79 Aligned_cols=245 Identities=17% Similarity=0.131 Sum_probs=188.3
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeEEE
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGCCL 90 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 90 (314)
++.....+|.|+ +.||++.+..+|+.||+|++........ ...++..|+..+..+ +||||+++++++.
T Consensus 58 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~~e~~~~~~~~~h~~iv~l~~~~~ 127 (311)
T 3p1a_A 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPK----------DRARKLAEVGSHEKVGQHPCCVRLEQAWE 127 (311)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHH----------HHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred heeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChH----------HHHHHHHHHHHHHHhcCCCcEEEEEEEEE
Confidence 344555699988 8899988888999999998653211000 013445666666555 8999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
+++..|+||||+ +++|.+.+.... ..+++..+..++.|++.||.||| +++|+||||||+||+++.++.+||+
T Consensus 128 ~~~~~~lv~e~~-~~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~ 199 (311)
T 3p1a_A 128 EGGILYLQTELC-GPSLQQHCEAWG----ASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLG 199 (311)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEEC
T ss_pred eCCEEEEEEecc-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEc
Confidence 999999999999 679988887654 35889999999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhh
Q 043524 171 DFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 171 dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
|||++....... ......||+.|+|||++.+ .++.++||||+|+++|+|++|..|+..... .....
T Consensus 200 DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~-----------~~~~~ 265 (311)
T 3p1a_A 200 DFGLLVELGTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG-----------WQQLR 265 (311)
T ss_dssp CCTTCEECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-----------HHHHT
T ss_pred cceeeeecccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH-----------HHHHh
Confidence 999997764332 2334569999999998876 789999999999999999999766532111 00000
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
. +..+.......+..+.+|+..||+.||++|||+.|+++
T Consensus 266 -~------------~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 266 -Q------------GYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp -T------------TCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -c------------cCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 0 01111112234567899999999999999999999985
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=312.52 Aligned_cols=270 Identities=21% Similarity=0.272 Sum_probs=203.5
Q ss_pred hcCcccccccCch-hHHHHHH----HhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeE
Q 043524 12 SKGKRTLMIGNGA-SVLQELI----ASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLI 86 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~----~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 86 (314)
.+++....+|.|+ +.|+++. +..+|+.||+|++........ +.+.+|++++..++||||++++
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~------------~~~~~E~~~l~~l~h~~i~~~~ 90 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ------------RDFQREIQILKALHSDFIVKYR 90 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHH------------HHHHHHHHHHHTCCCTTBCCEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHH------------HHHHHHHHHHHhcCCCceeEEE
Confidence 4455556688888 7777765 577889999999875433222 5688999999999999999999
Q ss_pred eEEE--eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCC
Q 043524 87 GCCL--ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEE 164 (314)
Q Consensus 87 ~~~~--~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~ 164 (314)
+++. +....++||||+++++|.+++.... ..++...++.++.|++.||.||| +++|+|+||||+||+++.+
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~ 163 (327)
T 3lxl_A 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR----ARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESE 163 (327)
T ss_dssp EEEECSSSCEEEEEEECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEET
T ss_pred EEEecCCCceEEEEEeecCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCC
Confidence 9987 4567899999999999999997643 35889999999999999999999 9999999999999999999
Q ss_pred CceEEcccccceecCCCCcc--cccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccch
Q 043524 165 NVVKLFDFSLSISIPEGETH--ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPF 242 (314)
Q Consensus 165 ~~~kl~dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~ 242 (314)
+.++|+|||+++........ ......+|..|+|||++.+..++.++||||+|+++|+|++|..||.......
T Consensus 164 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~------ 237 (327)
T 3lxl_A 164 AHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF------ 237 (327)
T ss_dssp TEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH------
T ss_pred CCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchh------
Confidence 99999999999876443221 2334467888999999988889999999999999999999999986432210
Q ss_pred HHHHHhhhccCC---cccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 243 NEYLKNYFEDNR---FTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 243 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
......... ...... .+........+...+..+.+|+..||+.||++|||+.|+++.|+++...
T Consensus 238 ---~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 238 ---LRMMGCERDVPALSRLLE-LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp ---HHHCC----CCHHHHHHH-HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred ---hhhcccccccccHHHHHH-HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 000000000 000000 0011111111124456789999999999999999999999999988654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=303.54 Aligned_cols=252 Identities=21% Similarity=0.303 Sum_probs=199.6
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|.....+|.|+ +.|+.+.+..+|+.+|+|++........ ..+.+.+|+.+++.++||||+++++++.
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (284)
T 3kk8_A 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR----------DFQKLEREARICRKLQHPNIVRLHDSIQ 75 (284)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHH----------HHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHH----------HHHHHHHHHHHHHHcCCCCcCeEEEEEE
Confidence 4455566688888 8888888889999999999876542211 1256789999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCc---e
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENV---V 167 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~---~ 167 (314)
+++..++||||+++++|.+.+... ..++...+..++.|++.||.||| +++|+|+||||+||+++.++. +
T Consensus 76 ~~~~~~~v~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~ 147 (284)
T 3kk8_A 76 EESFHYLVFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAV 147 (284)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCE
T ss_pred cCCEEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcE
Confidence 999999999999999998888754 34788999999999999999999 999999999999999976654 9
Q ss_pred EEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHH
Q 043524 168 KLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLK 247 (314)
Q Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (314)
+|+|||.+........ .....||+.|+|||++.+..++.++||||+|+++|+|++|..||....... ...
T Consensus 148 kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--------~~~ 217 (284)
T 3kk8_A 148 KLADFGLAIEVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--------LYA 217 (284)
T ss_dssp EECCCTTCEECCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHH
T ss_pred EEeeceeeEEcccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH--------HHH
Confidence 9999999977644322 345678999999999999889999999999999999999999996433211 111
Q ss_pred hhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 248 NYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
..... ... .+.+.....+..+.+|+..||+.||++|||+.|+++
T Consensus 218 ~~~~~-~~~----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 218 QIKAG-AYD----------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp HHHHT-CCC----------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHhc-ccc----------CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 11100 000 000011133456889999999999999999999987
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=305.06 Aligned_cols=257 Identities=24% Similarity=0.297 Sum_probs=196.6
Q ss_pred cccccCch-hHHHHHHHhcCCc---ccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 17 TLMIGNGA-SVLQELIASSNGK---YIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~---~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
...+|.|+ +.|+.+....+++ .+|+|.+........ .+.+.+|+.+++.++||||+++++++.+.
T Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~-----------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 94 (298)
T 3pls_A 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQ-----------VEAFLREGLLMRGLNHPNVLALIGIMLPP 94 (298)
T ss_dssp EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHH-----------HHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHH-----------HHHHHHHHHHHHhCCCCCeeeEEEEEecC
Confidence 34588888 7777776444443 799998764321111 25788999999999999999999999876
Q ss_pred Cee-EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 93 PIA-ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 93 ~~~-~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
+.. ++++||+.+|+|.+.+.... ..++...+..++.|++.||.||| +++++|+||||+||+++.++.++|+|
T Consensus 95 ~~~~~~v~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~D 167 (298)
T 3pls_A 95 EGLPHVLLPYMCHGDLLQFIRSPQ----RNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVAD 167 (298)
T ss_dssp SSCCEEEECCCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECC
T ss_pred CCCcEEEEecccCCCHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCc
Confidence 655 99999999999999997744 45788999999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCC---cccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHh
Q 043524 172 FSLSISIPEGE---THITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKN 248 (314)
Q Consensus 172 fg~~~~~~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (314)
||+++...... ........+|+.|+|||.+.+..++.++||||+|+++|+|++|..|+.......+ ......
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~----~~~~~~- 242 (298)
T 3pls_A 168 FGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD----LTHFLA- 242 (298)
T ss_dssp TTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG----HHHHHH-
T ss_pred CCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH----HHHHhh-
Confidence 99997553321 1112345678899999999998999999999999999999996555432221110 111100
Q ss_pred hhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhcc
Q 043524 249 YFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSLS 312 (314)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~ 312 (314)
.. . ....+...+..+.+++..||+.||++|||+.++++.|+++.+.+.
T Consensus 243 --~~-~-------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 243 --QG-R-------------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp --TT-C-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred --cC-C-------------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 00 0 000011334568999999999999999999999999999987763
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=314.39 Aligned_cols=248 Identities=19% Similarity=0.234 Sum_probs=199.0
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|.....+|.|+ +.|+.+.+..+|+.||+|++.......... .+.. ..+.+.+|+.++..++||||+++++++.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~-~~~~---~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 99 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCW-IEDP---KLGKVTLEIAILSRVEHANIIKVLDIFE 99 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSE-EEET---TTEEEEHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccc-cchH---HHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 4555666789988 889999889999999999987643211100 0000 1135678999999999999999999999
Q ss_pred eCCeeEEEEeecCCC-CHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEE
Q 043524 91 ETPIAILVFEYVQHG-TLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKL 169 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl 169 (314)
+.+..++||||+.+| +|.+++.... .++...+..++.|++.||.||| +++|+||||||+||+++.++.++|
T Consensus 100 ~~~~~~lv~e~~~~g~~l~~~~~~~~-----~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL 171 (335)
T 3dls_A 100 NQGFFQLVMEKHGSGLDLFAFIDRHP-----RLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKL 171 (335)
T ss_dssp CSSEEEEEEECCTTSCBHHHHHHTCC-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEE
T ss_pred eCCEEEEEEEeCCCCccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEE
Confidence 999999999999776 9999987653 4889999999999999999999 999999999999999999999999
Q ss_pred cccccceecCCCCcccccccccccccccCcccccCCC-CcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHh
Q 043524 170 FDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDF-SEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKN 248 (314)
Q Consensus 170 ~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (314)
+|||+++....... .....||+.|+|||++.+..+ +.++||||+|+++|+|++|..||.......
T Consensus 172 ~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------------ 237 (335)
T 3dls_A 172 IDFGSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV------------ 237 (335)
T ss_dssp CCCTTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT------------
T ss_pred eecccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH------------
Confidence 99999987654332 345679999999999988776 788999999999999999999996432111
Q ss_pred hhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 249 YFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
......+. ..+.++.+|+..||+.||++|||+.|+++
T Consensus 238 -----------~~~~~~~~------~~~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 238 -----------EAAIHPPY------LVSKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp -----------TTCCCCSS------CCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------hhccCCCc------ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000011 13456889999999999999999999987
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=325.30 Aligned_cols=253 Identities=20% Similarity=0.270 Sum_probs=199.9
Q ss_pred hhhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeE
Q 043524 10 LWSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGC 88 (314)
Q Consensus 10 ~~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 88 (314)
+..+|.....+|.|+ +.|+++.+..+|+.||+|++........ ..+.+.+|+++++.++||||++++++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~~E~~~l~~l~hpniv~~~~~ 89 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK----------DTSTILREVELLKKLDHPNIMKLFEI 89 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCS----------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccch----------HHHHHHHHHHHHHhCCCCCcCeEEEE
Confidence 345566667799988 8899998888999999999976542110 12578899999999999999999999
Q ss_pred EEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeec---CCC
Q 043524 89 CLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFS---EEN 165 (314)
Q Consensus 89 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~---~~~ 165 (314)
+.+...+|+|||||++|+|.+.+.... .++...+..++.|++.||.||| +++|+||||||+||+++ ..+
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~ 161 (486)
T 3mwu_A 90 LEDSSSFYIVGELYTGGELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDC 161 (486)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTC
T ss_pred EEcCCEEEEEEEcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCC
Confidence 999999999999999999999887643 4789999999999999999999 99999999999999995 455
Q ss_pred ceEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHH
Q 043524 166 VVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEY 245 (314)
Q Consensus 166 ~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 245 (314)
.+||+|||+++...... ......||+.|+|||++.+ .++.++||||+||++|+|++|..||...... +.
T Consensus 162 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~ 230 (486)
T 3mwu_A 162 DIKIIDFGLSTCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--------DI 230 (486)
T ss_dssp CEEECSCSCTTTBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HH
T ss_pred CEEEEECCcCeECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HH
Confidence 79999999997654332 2345679999999998875 5899999999999999999999999643321 11
Q ss_pred HHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 246 LKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
....... .. ..+.+.....+..+.+|+..||+.||++|||+.|+++
T Consensus 231 ~~~i~~~-~~----------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 231 LKRVETG-KY----------AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp HHHHHHT-CC----------CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHhC-CC----------CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1111110 00 0111111244567899999999999999999999987
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=321.76 Aligned_cols=203 Identities=23% Similarity=0.316 Sum_probs=159.9
Q ss_pred hhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC-CCceeeeEeE
Q 043524 11 WSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS-HDHILKLIGC 88 (314)
Q Consensus 11 ~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~ 88 (314)
..+|.....+|.|+ +.|+.+.+..+|+.||+|.+........ ..+++.+|+.++..+. ||||++++++
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~----------~~~~~~~E~~~l~~l~~h~niv~l~~~ 77 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNST----------DAQRTFREIMILTELSGHENIVNLLNV 77 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHH----------HHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChH----------HHHHHHHHHHHHHhccCCCCCCeeeeE
Confidence 34556666799999 8899998899999999998753311110 1156789999999997 9999999999
Q ss_pred EEeCC--eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCc
Q 043524 89 CLETP--IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENV 166 (314)
Q Consensus 89 ~~~~~--~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~ 166 (314)
+...+ .+|+|||||+ ++|.+.+... .++...+..++.|++.||.||| +.+|+||||||+||+++.++.
T Consensus 78 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~ 147 (388)
T 3oz6_A 78 LRADNDRDVYLVFDYME-TDLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECH 147 (388)
T ss_dssp EECTTSSCEEEEEECCS-EEHHHHHHHT------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCC
T ss_pred EecCCCCEEEEEecccC-cCHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCC
Confidence 97544 7899999996 6999988763 4788889999999999999999 999999999999999999999
Q ss_pred eEEcccccceecCCCC--------------------cccccccccccccccCccccc-CCCCcccchHHHHHHHHHHHhC
Q 043524 167 VKLFDFSLSISIPEGE--------------------THITDTVMGTYGHLAPQYVTT-CDFSEKLDVYSFGAFLSELLTG 225 (314)
Q Consensus 167 ~kl~dfg~~~~~~~~~--------------------~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g 225 (314)
+||+|||+++...... ........||+.|+|||++.+ ..++.++||||+||++|+|++|
T Consensus 148 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g 227 (388)
T 3oz6_A 148 VKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG 227 (388)
T ss_dssp EEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHS
T ss_pred EEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhC
Confidence 9999999998653211 111234579999999999986 5689999999999999999999
Q ss_pred CCCccccc
Q 043524 226 RGILDLVR 233 (314)
Q Consensus 226 ~~p~~~~~ 233 (314)
++||....
T Consensus 228 ~~pf~~~~ 235 (388)
T 3oz6_A 228 KPIFPGSS 235 (388)
T ss_dssp SCSCCCSS
T ss_pred CCCCCCCC
Confidence 99997543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=305.60 Aligned_cols=252 Identities=19% Similarity=0.300 Sum_probs=197.1
Q ss_pred cccCch-hHHHHHH--HhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCee
Q 043524 19 MIGNGA-SVLQELI--ASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIA 95 (314)
Q Consensus 19 ~~G~g~-~~~~~~~--~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (314)
.+|.|+ +.|+.+. ...++..||+|++....... ..+++.+|++++..++||||+++++++ ..+..
T Consensus 17 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~ 84 (287)
T 1u59_A 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA-----------DTEEMMREAQIMHQLDNPYIVRLIGVC-QAEAL 84 (287)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHH-----------HHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSE
T ss_pred cccccCceeEEEeEeccCCCcceEEEEecCCccchh-----------HHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCc
Confidence 588888 7777664 34567889999987532111 126688999999999999999999999 56678
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
++||||+++++|.+++.... ..++...+..++.|++.||.||| +++++|+||||+||+++.++.++|+|||++
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~ 157 (287)
T 1u59_A 85 MLVMEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLS 157 (287)
T ss_dssp EEEEECCTTEEHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEEeCCCCCHHHHHHhCC----ccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccce
Confidence 99999999999999987543 45889999999999999999999 999999999999999999999999999999
Q ss_pred eecCCCCcc--cccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhcc
Q 043524 176 ISIPEGETH--ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFED 252 (314)
Q Consensus 176 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (314)
......... ......+|+.|+|||++....++.++||||+|+++|+|++ |..||....... ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--------~~~~i~~~ 229 (287)
T 1u59_A 158 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--------VMAFIEQG 229 (287)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--------HHHHHHTT
T ss_pred eeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--------HHHHHhcC
Confidence 876443221 1223356889999999988889999999999999999998 999996543211 11111110
Q ss_pred CCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhc
Q 043524 253 NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSL 311 (314)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 311 (314)
... . .+...+..+.+++..||+.||++|||+.++++.|+++..+.
T Consensus 230 -~~~---------~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 274 (287)
T 1u59_A 230 -KRM---------E----CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 274 (287)
T ss_dssp -CCC---------C----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -CcC---------C----CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 000 0 00134467899999999999999999999999999997653
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=303.88 Aligned_cols=253 Identities=16% Similarity=0.199 Sum_probs=196.9
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.++.....+|.|+ +.|+.+.. +|+.+|+|++........ ..+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~----------~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 77 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTR----------KSRDFNEECPRLRIFSHPNVLPVLGACQ 77 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHH----------HHHHHHHHGGGGCCCSCTTEECEEEEEC
T ss_pred HHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHH----------HHHHHHHHHHHHHhcCCCchhheEEEEc
Confidence 4555566788888 77776654 488999999875421111 1156889999999999999999999998
Q ss_pred eC--CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCC--ceeccCCCCCeeecCCCc
Q 043524 91 ET--PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRP--IVFRDFKTSHILFSEENV 166 (314)
Q Consensus 91 ~~--~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~--i~H~dlk~~nil~~~~~~ 166 (314)
+. +..++||||+++|+|.+++..... ..++...+..++.|++.||.||| +++ ++|+||||+||+++.++.
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~ 151 (271)
T 3kmu_A 78 SPPAPHPTLITHWMPYGSLYNVLHEGTN---FVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMT 151 (271)
T ss_dssp TTTSSSCEEEEECCTTCBHHHHHHSCSS---CCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSC
T ss_pred cCCCCCeEeeecccCCCcHHHHHhhccc---CCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcc
Confidence 76 788999999999999999987542 35889999999999999999999 899 999999999999999999
Q ss_pred eEEcccccceecCCCCcccccccccccccccCcccccCCCCc---ccchHHHHHHHHHHHhCCCCcccccCccccccchH
Q 043524 167 VKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSE---KLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFN 243 (314)
Q Consensus 167 ~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~---~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~ 243 (314)
++++|||++.... .....||+.|+|||++.+..++. ++||||+|+++|+|++|..||.......
T Consensus 152 ~~l~~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------- 218 (271)
T 3kmu_A 152 ARISMADVKFSFQ------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME------- 218 (271)
T ss_dssp EEEEGGGSCCTTS------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH-------
T ss_pred eeEEeccceeeec------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH-------
Confidence 9999888864422 22446899999999998765443 7999999999999999999996433211
Q ss_pred HHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHh
Q 043524 244 EYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICC 309 (314)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 309 (314)
.......... ....+...+..+.+++..||+.||++|||+.|+++.|+++.+
T Consensus 219 -~~~~~~~~~~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 219 -IGMKVALEGL-------------RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp -HHHHHHHSCC-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred -HHHHHHhcCC-------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1111111100 000011344568999999999999999999999999999864
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=313.74 Aligned_cols=270 Identities=22% Similarity=0.297 Sum_probs=202.0
Q ss_pred CcccccccCch-hHHHHHH----HhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeE
Q 043524 14 GKRTLMIGNGA-SVLQELI----ASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGC 88 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~----~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 88 (314)
++....+|.|+ +.|+.+. +..+|+.||+|++...... ..+.+.+|+++++.++||||++++++
T Consensus 43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~------------~~~~~~~E~~~l~~l~h~~iv~~~~~ 110 (326)
T 2w1i_A 43 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE------------HLRDFEREIEILKSLQHDNIVKYKGV 110 (326)
T ss_dssp EEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSH------------HHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHH------------HHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 44455688888 7776665 5678999999998653211 12568899999999999999999999
Q ss_pred EEeC--CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCc
Q 043524 89 CLET--PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENV 166 (314)
Q Consensus 89 ~~~~--~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~ 166 (314)
+... ...++||||+++++|.+++.... ..++...++.++.|++.||.||| +++|+|+||||+||+++.++.
T Consensus 111 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~ 183 (326)
T 2w1i_A 111 CYSAGRRNLKLIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENR 183 (326)
T ss_dssp ECC----CCEEEECCCTTCBHHHHHHHST----TSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTE
T ss_pred EEecCCCceEEEEECCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCc
Confidence 8764 37899999999999999998754 35788999999999999999999 999999999999999999999
Q ss_pred eEEcccccceecCCCCcc--cccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHH
Q 043524 167 VKLFDFSLSISIPEGETH--ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNE 244 (314)
Q Consensus 167 ~kl~dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 244 (314)
++|+|||+++........ ......++..|+|||++.+..++.++||||+|+++|+|++|..|+..... .
T Consensus 184 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~---------~ 254 (326)
T 2w1i_A 184 VKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA---------E 254 (326)
T ss_dssp EEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH---------H
T ss_pred EEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH---------H
Confidence 999999999876543221 12234567889999999888889999999999999999999998753210 1
Q ss_pred HHHhhhccCCccc---ccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhc
Q 043524 245 YLKNYFEDNRFTE---IVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSL 311 (314)
Q Consensus 245 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 311 (314)
+............ .+...+......+.+..++.++.+|+.+||+.||++|||+.|+++.|+++.+.+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 255 FMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp HHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 0000000000000 000000000011111234567899999999999999999999999999998765
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=304.43 Aligned_cols=264 Identities=17% Similarity=0.156 Sum_probs=203.6
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEE-
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCC- 89 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~- 89 (314)
.+|.....+|.|+ +.|+.+.+..+|+.||+|++..... .+.+.+|+.++..++|++++..+..+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------------~~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--------------HPQLHIESKIYKMMQGGVGIPTIRWCG 74 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--------------CCHHHHHHHHHHHHTTSTTCCCEEEEE
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--------------hhHHHHHHHHHHHhhcCCCCCcccccc
Confidence 4455566788888 8888888889999999998754221 14578999999999988766665554
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeec---CCCc
Q 043524 90 LETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFS---EENV 166 (314)
Q Consensus 90 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~---~~~~ 166 (314)
..+...++||||+ +++|.+++.... ..++...+..++.|++.||.||| +++|+||||||+||+++ .++.
T Consensus 75 ~~~~~~~lv~e~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~ 146 (296)
T 3uzp_A 75 AEGDYNVMVMELL-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNL 146 (296)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTC
T ss_pred CCCCceEEEEEec-CCCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCe
Confidence 5678889999999 899999997543 35889999999999999999999 99999999999999994 7889
Q ss_pred eEEcccccceecCCCCcc------cccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCcccccc
Q 043524 167 VKLFDFSLSISIPEGETH------ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVY 240 (314)
Q Consensus 167 ~kl~dfg~~~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~ 240 (314)
++|+|||+++........ ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||......... .
T Consensus 147 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~ 225 (296)
T 3uzp_A 147 VYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR-Q 225 (296)
T ss_dssp EEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS-S
T ss_pred EEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhh-h
Confidence 999999999876544321 124557999999999999989999999999999999999999999764432211 0
Q ss_pred chHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhcc
Q 043524 241 PFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSLS 312 (314)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~ 312 (314)
.+......... .+. .......+..+.+++..||+.||++|||+.++++.|+++.....
T Consensus 226 ~~~~~~~~~~~-------------~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 283 (296)
T 3uzp_A 226 KYERISEKKMS-------------TPI-EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp HHHHHHHHHHH-------------SCH-HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred hhhhhcccccC-------------Cch-HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence 11111100000 000 00001335678999999999999999999999999999977653
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=311.34 Aligned_cols=258 Identities=20% Similarity=0.265 Sum_probs=194.1
Q ss_pred CcccccccCch-hHHHHHHHhcCC----cccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeE
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNG----KYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGC 88 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g----~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 88 (314)
+.....+|.|+ +.|+.+....++ ..||+|++........ ...+.+|+.++..++||||++++++
T Consensus 46 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~E~~~l~~l~h~~iv~~~~~ 114 (333)
T 1mqb_A 46 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ-----------RVDFLGEAGIMGQFSHHNIIRLEGV 114 (333)
T ss_dssp EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHH-----------HHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHH-----------HHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 33445688888 777777655443 3599999865321111 1568899999999999999999999
Q ss_pred EEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceE
Q 043524 89 CLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVK 168 (314)
Q Consensus 89 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~k 168 (314)
+.+.+..++||||+++|+|.+++.... ..++...++.++.|++.||.||| +++|+|+||||+||+++.++.++
T Consensus 115 ~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~k 187 (333)
T 1mqb_A 115 ISKYKPMMIITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCK 187 (333)
T ss_dssp ECSSSSEEEEEECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEE
T ss_pred EecCCCcEEEEeCCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEE
Confidence 999999999999999999999997654 35889999999999999999999 99999999999999999999999
Q ss_pred EcccccceecCCCCcc--cccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHH
Q 043524 169 LFDFSLSISIPEGETH--ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEY 245 (314)
Q Consensus 169 l~dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~ 245 (314)
|+|||+++........ ......+|+.|+|||++....++.++||||+|+++|+|++ |..||...... +.
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--------~~ 259 (333)
T 1mqb_A 188 VSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--------EV 259 (333)
T ss_dssp ECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HH
T ss_pred ECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH--------HH
Confidence 9999999776433211 1222346788999999988889999999999999999998 99998643321 11
Q ss_pred HHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhc
Q 043524 246 LKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSL 311 (314)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 311 (314)
......... .+.+...+..+.+++.+||+.||++|||+.++++.|+++....
T Consensus 260 ~~~~~~~~~--------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 260 MKAINDGFR--------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp HHHHHTTCC--------------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred HHHHHCCCc--------------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 111111000 0001134456889999999999999999999999999987654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=324.71 Aligned_cols=263 Identities=19% Similarity=0.252 Sum_probs=200.3
Q ss_pred hhhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhc-CCcccCChhHHHHHHHHHHHhcCCCCceeeeEe
Q 043524 10 LWSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETN-NYDQKNGFWHESCINNVTYAAQMSHDHILKLIG 87 (314)
Q Consensus 10 ~~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~-~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 87 (314)
+..+|.....+|.|+ +.|+++.+..+|+.+|+|++.......... ..........+.+.+|+.+++.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 345666677899999 889999888999999999987655332110 000011113477899999999999999999999
Q ss_pred EEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCC--
Q 043524 88 CCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN-- 165 (314)
Q Consensus 88 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~-- 165 (314)
++.++..+|+|||||++|+|.+.+.... .++...+..++.|++.||.||| +++|+||||||+||+++..+
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~ 185 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH-----KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSL 185 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCC
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCC
Confidence 9999999999999999999999887643 4889999999999999999999 99999999999999998776
Q ss_pred -ceEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHH
Q 043524 166 -VVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNE 244 (314)
Q Consensus 166 -~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 244 (314)
.++|+|||+++...... ......||+.|+|||++. ..++.++||||+||++|+|++|..||...... +
T Consensus 186 ~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~ 254 (504)
T 3q5i_A 186 LNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ--------D 254 (504)
T ss_dssp SSEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------H
T ss_pred ccEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--------H
Confidence 69999999998765432 244567999999999876 46899999999999999999999999753321 1
Q ss_pred HHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 245 YLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
........ . ...+.......+.++.+|+..||..||++|||+.|+++
T Consensus 255 ~~~~i~~~-~----------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 255 IIKKVEKG-K----------YYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHHHHHC-C----------CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHcC-C----------CCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 11111110 0 00111111234567899999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=311.17 Aligned_cols=264 Identities=21% Similarity=0.308 Sum_probs=202.9
Q ss_pred hhcCcccccccCch-hHHHHHHHhcCCccc--ccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeE
Q 043524 11 WSKGKRTLMIGNGA-SVLQELIASSNGKYI--PYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLI 86 (314)
Q Consensus 11 ~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~--a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~ 86 (314)
+..++....+|.|+ +.|+.+....+|..+ |+|.+........ .+.+.+|++++..+ +||||++++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~-----------~~~~~~E~~~l~~l~~hp~iv~~~ 92 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD-----------HRDFAGELEVLCKLGHHPNIINLL 92 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-----------------CHHHHHHHHHTTCCCCTTBCCEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHH-----------HHHHHHHHHHHHhccCCCchhhhc
Confidence 34566667799988 888888888888855 8888764221111 15688999999999 899999999
Q ss_pred eEEEeCCeeEEEEeecCCCCHHHHHhcCCC-----------CCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCC
Q 043524 87 GCCLETPIAILVFEYVQHGTLWDRILGAPQ-----------THFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFK 155 (314)
Q Consensus 87 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk 155 (314)
+++.+.+..|+||||+++|+|.+++..... .....++...++.++.|++.||.||| +++|+|||||
T Consensus 93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlk 169 (327)
T 1fvr_A 93 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLA 169 (327)
T ss_dssp EEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCS
T ss_pred eeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCc
Confidence 999999999999999999999999976430 11135889999999999999999999 9999999999
Q ss_pred CCCeeecCCCceEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccC
Q 043524 156 TSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRD 234 (314)
Q Consensus 156 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~ 234 (314)
|+||+++.++.++|+|||+++...... ......+++.|+|||++....++.++||||+|+++|+|++ |..||.....
T Consensus 170 p~NIl~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~ 247 (327)
T 1fvr_A 170 ARNILVGENYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 247 (327)
T ss_dssp GGGEEECGGGCEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred cceEEEcCCCeEEEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH
Confidence 999999999999999999986432211 1223456889999999988889999999999999999998 9999964332
Q ss_pred ccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhcc
Q 043524 235 AHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSLS 312 (314)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~ 312 (314)
. ........... ...+...+..+.+|+.+||+.||++|||+.|+++.|+++.....
T Consensus 248 ~--------~~~~~~~~~~~--------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 248 A--------ELYEKLPQGYR--------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp H--------HHHHHGGGTCC--------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred H--------HHHHHhhcCCC--------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 1 11111111000 00001334568999999999999999999999999999877543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=316.04 Aligned_cols=253 Identities=21% Similarity=0.277 Sum_probs=197.1
Q ss_pred hhhhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeE
Q 043524 9 KLWSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLI 86 (314)
Q Consensus 9 ~~~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~ 86 (314)
.+..+|.....+|.|+ +.|+.+.+..+|+.||+|++.... ....+|++++..+ +||||++++
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----------------~~~~~E~~~l~~~~~hp~iv~~~ 82 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----------------RDPTEEIEILLRYGQHPNIITLK 82 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT----------------CCCHHHHHHHHHHTTSTTBCCEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc----------------CChHHHHHHHHHhcCCCCcCeEE
Confidence 3445566666789888 888899899999999999986432 1234788888887 799999999
Q ss_pred eEEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCC--
Q 043524 87 GCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEE-- 164 (314)
Q Consensus 87 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~-- 164 (314)
+++.++...|+|||||++|+|.+.+.... .++...+..++.|++.||.||| +++|+||||||+||++...
T Consensus 83 ~~~~~~~~~~lv~E~~~gg~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~ 154 (342)
T 2qr7_A 83 DVYDDGKYVYVVTELMKGGELLDKILRQK-----FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESG 154 (342)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHTCT-----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSC
T ss_pred EEEEcCCEEEEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCC
Confidence 99999999999999999999999997653 4889999999999999999999 9999999999999998543
Q ss_pred --CceEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccch
Q 043524 165 --NVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPF 242 (314)
Q Consensus 165 --~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~ 242 (314)
+.+||+|||+++....... ......||+.|+|||++.+..++.++||||+||++|+|++|..||....... .
T Consensus 155 ~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-----~ 228 (342)
T 2qr7_A 155 NPESIRICDFGFAKQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT-----P 228 (342)
T ss_dssp SGGGEEECCCTTCEECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC-----H
T ss_pred CcCeEEEEECCCcccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC-----H
Confidence 3599999999987644322 2345678999999999988778999999999999999999999997432211 1
Q ss_pred HHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 243 NEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.+........ ... .........+..+.+|+..||..||++|||+.|+++
T Consensus 229 ~~~~~~i~~~-~~~----------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 229 EEILARIGSG-KFS----------LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp HHHHHHHHHC-CCC----------CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHccC-Ccc----------cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1111111110 000 000001134567899999999999999999999886
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=324.25 Aligned_cols=268 Identities=18% Similarity=0.244 Sum_probs=193.8
Q ss_pred hhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEE
Q 043524 11 WSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCC 89 (314)
Q Consensus 11 ~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 89 (314)
..+|.....+|.|+ +.|+.+.+..+|+.||+|++........ ..+++.+|+.+++.++|||||++++++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~----------~~~~~~~E~~~l~~l~hpnIv~l~~~~ 130 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT----------HAKRAYRELVLMKCVNHKNIISLLNVF 130 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHH----------HHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChH----------HHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 34566667799988 8899998999999999999865321111 115678999999999999999999999
Q ss_pred EeC------CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecC
Q 043524 90 LET------PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSE 163 (314)
Q Consensus 90 ~~~------~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~ 163 (314)
... ..+|+||||+++ ++.+.+.. .++...+..++.|++.||.||| +++|+||||||+||+++.
T Consensus 131 ~~~~~~~~~~~~~lv~E~~~~-~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~ 199 (464)
T 3ttj_A 131 TPQKTLEEFQDVYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKS 199 (464)
T ss_dssp CSCCSTTTCCEEEEEEECCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECT
T ss_pred ccCCccccCCeEEEEEeCCCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeC
Confidence 754 457999999965 67676642 3778899999999999999999 999999999999999999
Q ss_pred CCceEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCcccccc---
Q 043524 164 ENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVY--- 240 (314)
Q Consensus 164 ~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~--- 240 (314)
++.+||+|||+++...... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+....+....
T Consensus 200 ~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~ 277 (464)
T 3ttj_A 200 DCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 277 (464)
T ss_dssp TSCEEECCCCCC-----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCEEEEEEEeeeecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999999997764332 23456899999999999999999999999999999999999999975432111000
Q ss_pred ----chHHH-------HHhhhcc-C-----CcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 241 ----PFNEY-------LKNYFED-N-----RFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 241 ----~~~~~-------~~~~~~~-~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
+...+ ...+... . .+...+..... +.........+.++.+|+.+||..||++|||+.|+++
T Consensus 278 ~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 278 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLF-PADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGS-CCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCccccc-ccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000 0111100 0 00111111110 1111222244678999999999999999999999986
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=329.55 Aligned_cols=254 Identities=19% Similarity=0.292 Sum_probs=198.4
Q ss_pred cccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCC
Q 043524 15 KRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETP 93 (314)
Q Consensus 15 ~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (314)
.....+|.|+ +.|+.+.. .++..||+|.+..... ..+.|.+|+++++.++||||+++++++. ..
T Consensus 191 ~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~-------------~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~ 255 (454)
T 1qcf_A 191 KLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGSM-------------SVEAFLAEANVMKTLQHDKLVKLHAVVT-KE 255 (454)
T ss_dssp EEEEEEECCSSEEEEEEEE-TTTEEEEEEEECTTSB-------------CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred EEEEEcccCCceEEEEEEE-CCccEEEEEEecCCCc-------------cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence 3344688888 67766644 3467899998864321 1267899999999999999999999986 67
Q ss_pred eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccc
Q 043524 94 IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFS 173 (314)
Q Consensus 94 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg 173 (314)
..|+||||+++|+|.+++..... ..++...++.++.|++.||.||| +++|+||||||+||+++.++.+||+|||
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG 329 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFG 329 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHHH---HTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTT
T ss_pred ccEEEEeecCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCC
Confidence 78999999999999999975321 24678889999999999999999 9999999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhcc
Q 043524 174 LSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFED 252 (314)
Q Consensus 174 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (314)
+++..............+|..|+|||++....++.++||||||+++|||++ |..||....... ........
T Consensus 330 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~--------~~~~i~~~ 401 (454)
T 1qcf_A 330 LARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--------VIRALERG 401 (454)
T ss_dssp GGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--------HHHHHHHT
T ss_pred CceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcC
Confidence 998764332222233456788999999998889999999999999999999 999996433211 11111111
Q ss_pred CCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhc
Q 043524 253 NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSL 311 (314)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 311 (314)
. ..+.+..++..+.+|+.+||+.||++|||+.+|++.|+++....
T Consensus 402 ~--------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 402 Y--------------RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp C--------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred C--------------CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 0 00011134567899999999999999999999999999886543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=324.76 Aligned_cols=251 Identities=21% Similarity=0.272 Sum_probs=196.5
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|.....+|.|+ +.|+++.+..+|..+|+|++......... .+.+.+|+.+++.++||||+++++++.
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~----------~~~~~~E~~~l~~l~hpniv~~~~~~~ 106 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS----------NSKLLEEVAVLKLLDHPNIMKLYDFFE 106 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CT----------THHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchH----------HHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 4566667799999 88888888889999999998765432211 157889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCC---Cce
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEE---NVV 167 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~---~~~ 167 (314)
++..+|+|||||++|+|.+.+.... .++...+..++.|++.||.||| +++|+||||||+||+++.. +.+
T Consensus 107 ~~~~~~lv~e~~~~g~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~ 178 (494)
T 3lij_A 107 DKRNYYLVMECYKGGELFDEIIHRM-----KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALI 178 (494)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCE
T ss_pred eCCEEEEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcE
Confidence 9999999999999999999887643 4788999999999999999999 9999999999999999764 459
Q ss_pred EEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHH
Q 043524 168 KLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLK 247 (314)
Q Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (314)
||+|||+++...... ......||+.|+|||++. ..++.++||||+||++|+|++|..||...... +...
T Consensus 179 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~ 247 (494)
T 3lij_A 179 KIVDFGLSAVFENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ--------EILR 247 (494)
T ss_dssp EECCCTTCEECBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHH
T ss_pred EEEECCCCeECCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHH
Confidence 999999998765432 244567999999999876 46899999999999999999999999753321 1111
Q ss_pred hhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 248 NYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
..... .. ....+.....+..+.+|+.+||+.||++|||+.|+++
T Consensus 248 ~i~~~-~~----------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 248 KVEKG-KY----------TFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp HHHHT-CC----------CCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhC-CC----------CCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 11111 00 0001111134567899999999999999999999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=300.98 Aligned_cols=252 Identities=22% Similarity=0.339 Sum_probs=198.9
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|.....+|.|+ +.|+.+.+..+|+.||+|++....... ..+.+.+|+.++..++||||+++++++.
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-----------CPENIKKEICINKMLNHENVVKFYGHRR 75 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTT-----------HHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchh-----------hhHHHHHHHHHHHhcCCCCceeeeeEEE
Confidence 3445555688888 888888888899999999987543211 1256889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
+++..|+|+||+++++|.+.+... ..++...+..++.|++.||.||| +++++|+||||+||+++.++.++|+
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~ 147 (276)
T 2yex_A 76 EGNIQYLFLEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKIS 147 (276)
T ss_dssp ETTEEEEEEECCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred cCCEEEEEEEecCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEe
Confidence 999999999999999999988653 35889999999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCc-ccccccccccccccCcccccCCC-CcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHh
Q 043524 171 DFSLSISIPEGET-HITDTVMGTYGHLAPQYVTTCDF-SEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKN 248 (314)
Q Consensus 171 dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (314)
|||.+........ .......|++.|+|||++.+..+ +.++||||+|+++|+|++|..||........ .+..+.
T Consensus 148 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~-- 222 (276)
T 2yex_A 148 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ---EYSDWK-- 222 (276)
T ss_dssp CCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH---HHHHHH--
T ss_pred eCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH---HHHHhh--
Confidence 9999976533221 12345578999999999987765 6789999999999999999999975443221 111110
Q ss_pred hhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 249 YFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.... .. ......+..+.+|+..||+.||++|||+.|+++
T Consensus 223 --~~~~---~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 223 --EKKT---YL----------NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp --TTCT---TS----------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --hccc---cc----------CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 0000 00 000133456889999999999999999999975
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=316.04 Aligned_cols=247 Identities=23% Similarity=0.307 Sum_probs=194.3
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
.+.....+|.|+ +.|+++.+..+|+.||+|++......... ..+++.+|++++..++||||+++++++.+
T Consensus 55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~---------~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 125 (348)
T 1u5q_A 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE---------KWQDIIKEVRFLQKLRHPNTIQYRGCYLR 125 (348)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHH---------HHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchH---------HHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 344555689888 88888888889999999998643211100 12568899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
++..|+||||+. |++.+.+.... .+++...+..++.|++.||.||| +++|+||||||+||+++.++.+||+|
T Consensus 126 ~~~~~lv~e~~~-g~l~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~D 197 (348)
T 1u5q_A 126 EHTAWLVMEYCL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGD 197 (348)
T ss_dssp TTEEEEEEECCS-EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECC
T ss_pred CCeEEEEEecCC-CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEee
Confidence 999999999996 68888876443 35889999999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCcccc---cCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHh
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVT---TCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKN 248 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (314)
||+++.... .....||+.|+|||++. ...++.++|||||||++|+|++|..||....... ....
T Consensus 198 fG~a~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~--------~~~~ 264 (348)
T 1u5q_A 198 FGSASIMAP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYH 264 (348)
T ss_dssp CTTCBSSSS-----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHH
T ss_pred ccCceecCC-----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--------HHHH
Confidence 999976532 23457999999999885 4568999999999999999999999986433111 1111
Q ss_pred hhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 249 YFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
...... .. ......+..+.+|+..||+.||++|||+.++++
T Consensus 265 ~~~~~~-~~------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 265 IAQNES-PA------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp HHHSCC-CC------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHhcCC-CC------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 111100 00 000133456889999999999999999999985
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=309.45 Aligned_cols=251 Identities=19% Similarity=0.264 Sum_probs=187.7
Q ss_pred hcCcccccccCch-hHHHHHHHh---cCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEe
Q 043524 12 SKGKRTLMIGNGA-SVLQELIAS---SNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIG 87 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~---~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 87 (314)
..+.....+|.|+ +.|+.+.+. .+|+.+|+|++.......... ....+.+|+.+++.++||||+++++
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~--------~~~~~~~E~~~l~~l~hp~iv~~~~ 88 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAK--------DTAHTKAERNILEEVKHPFIVDLIY 88 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC----------------------HHHHHHHCCCTTBCCEEE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhh--------HHHHHHHHHHHHHhCCCCCccceeE
Confidence 3455556788888 777766553 688999999987654321110 0145678999999999999999999
Q ss_pred EEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCce
Q 043524 88 CCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVV 167 (314)
Q Consensus 88 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~ 167 (314)
++.+++.+|+||||+++|+|.+.+.... .++...+..++.|++.||.||| +++|+||||||+||+++.++.+
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~ 160 (327)
T 3a62_A 89 AFQTGGKLYLILEYLSGGELFMQLEREG-----IFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHV 160 (327)
T ss_dssp EEECSSCEEEEEECCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCE
T ss_pred EEEcCCEEEEEEeCCCCCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcE
Confidence 9999999999999999999999987542 4788899999999999999999 9999999999999999999999
Q ss_pred EEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHH
Q 043524 168 KLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLK 247 (314)
Q Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (314)
||+|||+++....... ......||+.|+|||++.+..++.++||||+|+++|+|++|..||....... ...
T Consensus 161 kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--------~~~ 231 (327)
T 3a62_A 161 KLTDFGLCKESIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK--------TID 231 (327)
T ss_dssp EECCCSCC-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHH
T ss_pred EEEeCCcccccccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH--------HHH
Confidence 9999999875432221 2345679999999999998889999999999999999999999996433211 111
Q ss_pred hhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCC-----CHHHHHH
Q 043524 248 NYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRP-----TMVDVAR 302 (314)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 302 (314)
.... .....+ ...+..+.+|+.+||..||++|| ++.|+++
T Consensus 232 ~i~~-------------~~~~~p--~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 232 KILK-------------CKLNLP--PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp HHHH-------------TCCCCC--TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred HHHh-------------CCCCCC--CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 1111 111111 12346689999999999999999 7778775
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=304.58 Aligned_cols=271 Identities=20% Similarity=0.249 Sum_probs=197.0
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC---CCCceeeeEe
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM---SHDHILKLIG 87 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~ 87 (314)
.+|+....+|.|+ +.|+++.+..+|+.||+|++....... ........+.+|+.+++.+ +||||+++++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~ 81 (308)
T 3g33_A 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGG-------GGGGLPISTVREVALLRRLEAFEHPNVVRLMD 81 (308)
T ss_dssp -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCT-------TSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccc-------cccccchhHHHHHHHHHHHhhcCCCCeEEeee
Confidence 4556666799998 889999888999999999986432110 0001113456777777666 4999999999
Q ss_pred EEEeCC-----eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeec
Q 043524 88 CCLETP-----IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFS 162 (314)
Q Consensus 88 ~~~~~~-----~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~ 162 (314)
++.... ..+++|||+. |+|.+++..... ..++...+..++.|++.||.||| +++|+||||||+||+++
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~ 154 (308)
T 3g33_A 82 VCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPP---PGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVT 154 (308)
T ss_dssp EEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCT---TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEEC
T ss_pred eeeccCCCCceeEEEEehhhh-cCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEc
Confidence 998765 5899999996 699999987543 34889999999999999999999 99999999999999999
Q ss_pred CCCceEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccch
Q 043524 163 EENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPF 242 (314)
Q Consensus 163 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~ 242 (314)
.++.++|+|||+++...... ......||+.|+|||++.+..++.++||||+||++|+|++|..||........ .
T Consensus 155 ~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~----~ 228 (308)
T 3g33_A 155 SGGTVKLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ----L 228 (308)
T ss_dssp TTSCEEECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH----H
T ss_pred CCCCEEEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH----H
Confidence 99999999999997654332 23456789999999999998999999999999999999999999975432211 1
Q ss_pred HHHHHhh--hccCCccccc---ChhhhccCCch---hHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 243 NEYLKNY--FEDNRFTEIV---DPIIVQDLSCT---EKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 243 ~~~~~~~--~~~~~~~~~~---~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
....... .....+.... ........... .....+..+.+|+.+||+.||++|||+.|+++
T Consensus 229 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 229 GKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 1111100 0000111000 00000000000 00134567899999999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=309.01 Aligned_cols=265 Identities=20% Similarity=0.329 Sum_probs=203.7
Q ss_pred hcCcccccccCch-hHHHHHH-----HhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceee
Q 043524 12 SKGKRTLMIGNGA-SVLQELI-----ASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILK 84 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~-----~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 84 (314)
.+++....+|.|+ +.|+.+. ...+++.||+|++........ .+.+.+|++++..+ +||||++
T Consensus 27 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-----------HRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHH-----------HHHHHHHHHHHHHHCCCTTBCC
T ss_pred hheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHH-----------HHHHHHHHHHHHhcccCCCeee
Confidence 3455566788888 7777765 346778999999875422111 15688999999999 6899999
Q ss_pred eEeEEEeCC-eeEEEEeecCCCCHHHHHhcCCCCC-----------CCcccHHHHHHHHHHHHHHHHHhhcCCCCCceec
Q 043524 85 LIGCCLETP-IAILVFEYVQHGTLWDRILGAPQTH-----------FEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFR 152 (314)
Q Consensus 85 ~~~~~~~~~-~~~iv~e~~~~g~L~~~l~~~~~~~-----------~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~ 152 (314)
+++++...+ .+++||||+++|+|.+++....... ...++...+..++.|++.||.||| +++|+|+
T Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~ 172 (316)
T 2xir_A 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHR 172 (316)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccc
Confidence 999998754 5899999999999999998754210 012788999999999999999999 9999999
Q ss_pred cCCCCCeeecCCCceEEcccccceecCCCCc-ccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcc
Q 043524 153 DFKTSHILFSEENVVKLFDFSLSISIPEGET-HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILD 230 (314)
Q Consensus 153 dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~ 230 (314)
||||+||+++.++.++|+|||+++....... .......+|+.|+|||++.+..++.++||||+|+++|+|++ |..||.
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 9999999999999999999999976544322 22334567889999999998889999999999999999998 999996
Q ss_pred cccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 231 LVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
....... ........ .. ...+...+..+.+++..||+.||++|||+.|+++.|+++..+
T Consensus 253 ~~~~~~~-------~~~~~~~~-~~-------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 253 GVKIDEE-------FCRRLKEG-TR-------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp TCCCSHH-------HHHHHHHT-CC-------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccchhHH-------HHHHhccC-cc-------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 5432211 00111000 00 000012345688999999999999999999999999998765
Q ss_pred c
Q 043524 311 L 311 (314)
Q Consensus 311 ~ 311 (314)
.
T Consensus 312 ~ 312 (316)
T 2xir_A 312 N 312 (316)
T ss_dssp H
T ss_pred h
Confidence 3
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=312.96 Aligned_cols=263 Identities=17% Similarity=0.245 Sum_probs=196.6
Q ss_pred hhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEE
Q 043524 11 WSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCC 89 (314)
Q Consensus 11 ~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 89 (314)
..+|+....+|.|+ +.|+++.+..+|+.+++|+..+.... .. .....+++.+|+.++..++||||+++++++
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~----~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 86 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----AT---SPKANKEILDEAYVMASVDNPHVCRLLGIC 86 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECC----CS---SCCCHHHHHHHHHHHTTCCBTTBCCCCEEE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecc----cc---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEE
Confidence 34556666799988 88888888888888765543321100 00 011236788999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEE
Q 043524 90 LETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKL 169 (314)
Q Consensus 90 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl 169 (314)
.++. .++++||+.+|+|.+.+.... ..++...++.++.|++.||.||| +++|+||||||+||+++.++.++|
T Consensus 87 ~~~~-~~~v~~~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL 158 (327)
T 3lzb_A 87 LTST-VQLITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKI 158 (327)
T ss_dssp ESSS-EEEEECCCSSCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEE
T ss_pred ecCC-ceEEEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEE
Confidence 8754 789999999999999998754 35889999999999999999999 999999999999999999999999
Q ss_pred cccccceecCCCCc-ccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHH
Q 043524 170 FDFSLSISIPEGET-HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLK 247 (314)
Q Consensus 170 ~dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~ 247 (314)
+|||+++....... .......+|+.|+|||++.+..++.++||||+|+++|+|++ |..||....... ....
T Consensus 159 ~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-----~~~~-- 231 (327)
T 3lzb_A 159 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----ISSI-- 231 (327)
T ss_dssp CCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----HHHH--
T ss_pred ccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-----HHHH--
Confidence 99999977643321 11233456888999999999899999999999999999999 999997543222 1111
Q ss_pred hhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 248 NYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
..... ..+.+...+..+.+++..||+.||++|||+.|+++.|+++...
T Consensus 232 --~~~~~-------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 232 --LEKGE-------------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp --HHTTC-------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred --HHcCC-------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 00000 0000113345688999999999999999999999999998753
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=328.90 Aligned_cols=252 Identities=22% Similarity=0.310 Sum_probs=200.9
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|+....+|.|+ +.|+.+.+..+|+.||+|++........ ...+.+.+|+.+++.++||||+++++++.
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~---------~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 96 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQK---------TDKESLLREVQLLKQLDHPNIMKLYEFFE 96 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBS---------SCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccc---------hHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 4566666789988 8888888888999999999865432110 01267889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeee---cCCCce
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILF---SEENVV 167 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~---~~~~~~ 167 (314)
+.+..|+|||||.+|+|.+.+.... .++...+..++.|++.||.||| +++|+||||||+||++ +.++.+
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~ 168 (484)
T 3nyv_A 97 DKGYFYLVGEVYTGGELFDEIISRK-----RFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANI 168 (484)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTCS-----CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCE
T ss_pred eCCEEEEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcE
Confidence 9999999999999999999987653 5889999999999999999999 9999999999999999 467889
Q ss_pred EEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHH
Q 043524 168 KLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLK 247 (314)
Q Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (314)
+|+|||+++....... .....||+.|+|||++.+ .++.++||||+||++|+|++|..||....... ...
T Consensus 169 kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------~~~ 237 (484)
T 3nyv_A 169 RIIDFGLSTHFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD--------ILK 237 (484)
T ss_dssp EECCTTHHHHBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHH
T ss_pred EEEeeeeeEEcccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH--------HHH
Confidence 9999999977644332 345579999999998865 68999999999999999999999997533211 111
Q ss_pred hhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 248 NYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
..... .. ....+.....+..+.+|+..||+.||++|||+.|+++
T Consensus 238 ~i~~~-~~----------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 238 KVEKG-KY----------TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp HHHHC-CC----------CCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHcC-CC----------CCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 11111 00 0111111244567899999999999999999999986
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=304.22 Aligned_cols=265 Identities=18% Similarity=0.243 Sum_probs=191.0
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
|.....+|.|+ +.|+++.+ .+|+.+|+|.+....... . ..+.+.+|+.+++.++||||+++++++.++
T Consensus 4 y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~-------~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 72 (288)
T 1ob3_A 4 YHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDE-------G---IPSTTIREISILKELKHSNIVKLYDVIHTK 72 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGG-------C---CCHHHHHHHHGGGGCCCTTBCCEEEEEECS
T ss_pred chhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccccc-------c---cchhHHHHHHHHHhcCCCCEeeeeeEEccC
Confidence 44455688888 77777765 678999999886432110 0 115678999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~df 172 (314)
+..++||||+++ +|.+.+.... ..++...+..++.|++.||.||| +++|+||||||+||+++.++.+||+||
T Consensus 73 ~~~~lv~e~~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Df 144 (288)
T 1ob3_A 73 KRLVLVFEHLDQ-DLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADF 144 (288)
T ss_dssp SCEEEEEECCSE-EHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCT
T ss_pred CeEEEEEEecCC-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeEC
Confidence 999999999974 9999887654 35788999999999999999999 999999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCcccccC-CCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhc
Q 043524 173 SLSISIPEGETHITDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFE 251 (314)
Q Consensus 173 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (314)
|+++....... ......||+.|+|||++.+. .++.++||||+||++|+|++|..||........ ........-.
T Consensus 145 g~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~~~ 219 (288)
T 1ob3_A 145 GLARAFGIPVR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ----LMRIFRILGT 219 (288)
T ss_dssp THHHHHCC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHCC
T ss_pred ccccccCcccc-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHHCC
Confidence 99976543221 23345689999999998764 489999999999999999999999975432211 0011100000
Q ss_pred --cCCcccc-----cChhhhc--cCCc-hhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 252 --DNRFTEI-----VDPIIVQ--DLSC-TEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 252 --~~~~~~~-----~~~~~~~--~~~~-~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
...+... .++.... +.+. ......+..+.+|+.+||+.||++|||+.|+++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 220 PNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000 0000000 0000 000123466889999999999999999999985
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=307.80 Aligned_cols=198 Identities=19% Similarity=0.264 Sum_probs=169.7
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC-----CCceeee
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS-----HDHILKL 85 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~~ 85 (314)
.+|.....+|.|+ +.|+++.+..+|+.||+|++...... .+.+..|+.++..++ ||||+++
T Consensus 35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKY-------------TRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHH-------------HHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhh-------------hhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 3455556689888 88998888889999999998642211 144668999999886 9999999
Q ss_pred EeEEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecC--
Q 043524 86 IGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSE-- 163 (314)
Q Consensus 86 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~-- 163 (314)
++++...+..|+||||+ +++|.+++..... ..++...+..++.|++.||.||| +++|+||||||+||+++.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~ 174 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNY---NGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPY 174 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTT
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEcccc
Confidence 99999999999999999 8899999987543 34788999999999999999999 999999999999999975
Q ss_pred -----------------------CCceEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHH
Q 043524 164 -----------------------ENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLS 220 (314)
Q Consensus 164 -----------------------~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~ 220 (314)
.+.++|+|||+++..... .....||+.|+|||++.+..++.++||||+||++|
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 250 (360)
T 3llt_A 175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA 250 (360)
T ss_dssp CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred ccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHH
Confidence 778999999999765432 23567899999999999999999999999999999
Q ss_pred HHHhCCCCccccc
Q 043524 221 ELLTGRGILDLVR 233 (314)
Q Consensus 221 el~~g~~p~~~~~ 233 (314)
+|++|+.||....
T Consensus 251 ell~g~~pf~~~~ 263 (360)
T 3llt_A 251 ELYTGSLLFRTHE 263 (360)
T ss_dssp HHHHSSCSCCCSS
T ss_pred HHHHCCCCCCCCc
Confidence 9999999997543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=316.41 Aligned_cols=269 Identities=17% Similarity=0.245 Sum_probs=199.8
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.++.....+|.|+ +.|+++.+..+|+.+|+|++....... ..+.+.+|+.++..++||||+++++++.
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 101 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA-----------IRNQIIRELQVLHECNSPYIVGFYGAFY 101 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHH-----------HHHHHHHHHGGGGGCCCTTBCCEEEEEE
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHH-----------HHHHHHHHHHHHHHCCCCCEEEEeEEEE
Confidence 3455566789888 889888888899999999986532111 1256889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCC-CceeccCCCCCeeecCCCceEE
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPR-PIVFRDFKTSHILFSEENVVKL 169 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~-~i~H~dlk~~nil~~~~~~~kl 169 (314)
+++..|+||||+++++|.+++.... .++...+..++.+++.||.||| ++ +|+|+||||+||+++.++.++|
T Consensus 102 ~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl 173 (360)
T 3eqc_A 102 SDGEISICMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKL 173 (360)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEE
T ss_pred ECCEEEEEEECCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEE
Confidence 9999999999999999999997643 4788999999999999999999 75 9999999999999999999999
Q ss_pred cccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCcccccc---------
Q 043524 170 FDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVY--------- 240 (314)
Q Consensus 170 ~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~--------- 240 (314)
+|||++...... ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||...........
T Consensus 174 ~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 250 (360)
T 3eqc_A 174 CDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA 250 (360)
T ss_dssp CCCCCCHHHHHH---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------
T ss_pred EECCCCcccccc---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccC
Confidence 999998654322 13345789999999999998999999999999999999999999975332110000
Q ss_pred ------------chHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 241 ------------PFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 241 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.+..+...........+..+...............+.++.+|+..||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 251 AETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp -----------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 00000000000000011111111111111111134567899999999999999999999987
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=305.69 Aligned_cols=256 Identities=21% Similarity=0.374 Sum_probs=190.0
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
..+.....+|.|+ +.|+.+. ..++.||+|.+..... .+.+.+|+++++.++||||+++++++.
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~--~~~~~vavK~~~~~~~--------------~~~~~~E~~~l~~l~hp~iv~~~~~~~ 71 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAK--WRAKDVAIKQIESESE--------------RKAFIVELRQLSRVNHPNIVKLYGACL 71 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEE--ETTEEEEEEECSSTTH--------------HHHHHHHHHHHHHCCCTTBCCEEEBCT
T ss_pred hHeeeeeEeecCCCceEEEEE--ECCeeEEEEEecChhH--------------HHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence 3444555688888 6666653 3578899998864321 256889999999999999999999886
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCc-eEE
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENV-VKL 169 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~-~kl 169 (314)
+..++||||+++|+|.+++..... ...++...++.++.|++.||.|||..+.++|+||||||+||+++.++. +||
T Consensus 72 --~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl 147 (307)
T 2eva_A 72 --NPVCLVMEYAEGGSLYNVLHGAEP--LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKI 147 (307)
T ss_dssp --TTTEEEEECCTTCBHHHHHHCSSS--EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEE
T ss_pred --CCcEEEEEcCCCCCHHHHHhccCC--CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEE
Confidence 458999999999999999976532 124678889999999999999999211189999999999999988876 799
Q ss_pred cccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhh
Q 043524 170 FDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNY 249 (314)
Q Consensus 170 ~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (314)
+|||++...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||....... .......
T Consensus 148 ~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~ 217 (307)
T 2eva_A 148 CDFGTACDIQTH----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA------FRIMWAV 217 (307)
T ss_dssp CCCCC----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH------HHHHHHH
T ss_pred cccccccccccc----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH------HHHHHHH
Confidence 999998755332 223468999999999998889999999999999999999999997443211 0111110
Q ss_pred hccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhc
Q 043524 250 FEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSL 311 (314)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 311 (314)
.. ..... .....+..+.+++.+||+.||++|||+.++++.|+++.+.+
T Consensus 218 ~~-~~~~~-------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 218 HN-GTRPP-------------LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp HT-TCCCC-------------CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred hc-CCCCC-------------cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 00 00000 00133456889999999999999999999999999997654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=312.57 Aligned_cols=262 Identities=19% Similarity=0.323 Sum_probs=200.9
Q ss_pred CcccccccCch-hHHHHHHHhcCCc-----ccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeE
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGK-----YIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLI 86 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~-----~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~ 86 (314)
+.....+|.|+ +.|+.+.+..+|+ .+|+|.+........ .+.+.+|+.++..+ +||||++++
T Consensus 48 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~E~~~l~~l~~h~~iv~~~ 116 (333)
T 2i1m_A 48 LQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADE-----------KEALMSELKIMSHLGQHENIVNLL 116 (333)
T ss_dssp EEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHH-----------HHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHH-----------HHHHHHHHHHHHhhcCCCCeeeEE
Confidence 44455688888 7888877666554 689998765421111 15688999999999 899999999
Q ss_pred eEEEeCCeeEEEEeecCCCCHHHHHhcCCCC---------CCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCC
Q 043524 87 GCCLETPIAILVFEYVQHGTLWDRILGAPQT---------HFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTS 157 (314)
Q Consensus 87 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~---------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~ 157 (314)
+++.+++..++||||+++|+|.+++...... ....++...++.++.|++.||.||| +++|+|+||||+
T Consensus 117 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~ 193 (333)
T 2i1m_A 117 GACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAAR 193 (333)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGG
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccc
Confidence 9999999999999999999999998753100 0134788999999999999999999 999999999999
Q ss_pred CeeecCCCceEEcccccceecCCCCc-ccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCc
Q 043524 158 HILFSEENVVKLFDFSLSISIPEGET-HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDA 235 (314)
Q Consensus 158 nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~ 235 (314)
||+++.++.++|+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 194 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 273 (333)
T 2i1m_A 194 NVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN 273 (333)
T ss_dssp GCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS
T ss_pred eEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh
Confidence 99999999999999999976543322 12234457889999999988889999999999999999998 99998654322
Q ss_pred cccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 236 HDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
.. +........ ....+...+..+.+++..||+.||++|||+.|+++.|+++...
T Consensus 274 ~~----~~~~~~~~~-----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 274 SK----FYKLVKDGY-----------------QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp HH----HHHHHHHTC-----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH----HHHHHhcCC-----------------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 10 111111000 0000012345688999999999999999999999999988653
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=309.57 Aligned_cols=269 Identities=18% Similarity=0.240 Sum_probs=193.7
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHH--HHhcCCCCceeeeEeE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVT--YAAQMSHDHILKLIGC 88 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~--~l~~l~h~niv~~~~~ 88 (314)
.+++....+|.|+ +.|+++ ..+|+.||+|++...... .+..|.+ .+..++||||+++++.
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~--~~~~~~vavK~~~~~~~~---------------~~~~e~~~~~~~~~~h~~i~~~~~~ 75 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKG--SLDERPVAVKVFSFANRQ---------------NFINEKNIYRVPLMEHDNIARFIVG 75 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEE--EETTEEEEEEEEEGGGHH---------------HHHHHHHHHTSTTCCCTTBCCEEEE
T ss_pred HHhheeeecccCCCeEEEEE--EECCeEEEEEEeeccchh---------------hHHHHHHHHHHHhccCcchhhheec
Confidence 3445556688888 677765 447899999998755432 2333444 4456899999999986
Q ss_pred EEe-----CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCC---------CceeccC
Q 043524 89 CLE-----TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPR---------PIVFRDF 154 (314)
Q Consensus 89 ~~~-----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~---------~i~H~dl 154 (314)
+.. ...+++|||||++|+|.+++.... .+...+..++.|++.||.||| ++ +|+||||
T Consensus 76 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Di 146 (336)
T 3g2f_A 76 DERVTADGRMEYLLVMEYYPNGSLXKYLSLHT------SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDL 146 (336)
T ss_dssp EEEECTTSCEEEEEEECCCTTCBHHHHHHHCC------BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSC
T ss_pred ccccccCCCceEEEEEecCCCCcHHHHHhhcc------cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeeccc
Confidence 653 336789999999999999997643 577888999999999999999 88 9999999
Q ss_pred CCCCeeecCCCceEEcccccceecCCCCc-------ccccccccccccccCccccc-------CCCCcccchHHHHHHHH
Q 043524 155 KTSHILFSEENVVKLFDFSLSISIPEGET-------HITDTVMGTYGHLAPQYVTT-------CDFSEKLDVYSFGAFLS 220 (314)
Q Consensus 155 k~~nil~~~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~g~~~y~aPE~~~~-------~~~~~~~DiwslG~~l~ 220 (314)
||+||+++.++.+||+|||+++....... .......||+.|+|||++.+ ..++.++|||||||++|
T Consensus 147 kp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ 226 (336)
T 3g2f_A 147 NSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYW 226 (336)
T ss_dssp SGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHH
T ss_pred ccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHH
Confidence 99999999999999999999987643221 11224569999999999876 34567899999999999
Q ss_pred HHHhCCCCcccccCccccccchHH---------HHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCC
Q 043524 221 ELLTGRGILDLVRDAHDLVYPFNE---------YLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESP 291 (314)
Q Consensus 221 el~~g~~p~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp 291 (314)
||++|..||............+.. ..............+... .......+..+.+|+.+||+.||
T Consensus 227 ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP 300 (336)
T 3g2f_A 227 EIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA------WKENSLAVRSLKETIEDCWDQDA 300 (336)
T ss_dssp HHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT------CCCCSHHHHHHHHHHHHHSCSSG
T ss_pred HHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcc------cccccchHHHHHHHHHHHhcCCh
Confidence 999998777543332222111111 111111111111111111 11112466789999999999999
Q ss_pred CCCCCHHHHHHHHHHHHhhcc
Q 043524 292 IDRPTMVDVARRLRQICCSLS 312 (314)
Q Consensus 292 ~~Rps~~ell~~L~~~~~~~~ 312 (314)
++|||+.|+++.|+++...+.
T Consensus 301 ~~Rps~~e~l~~L~~ll~~~~ 321 (336)
T 3g2f_A 301 EARLTAQXAEERMAELMMIWE 321 (336)
T ss_dssp GGSCCHHHHHHHHHHHHHCCC
T ss_pred hhCcchHHHHHHHHHHHHHHH
Confidence 999999999999999987553
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=299.77 Aligned_cols=248 Identities=20% Similarity=0.281 Sum_probs=201.9
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.++.....+|.|+ +.|+.+.+..+++.+|+|++......... ..+.+.+|+.++..++||||+++++++.
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 84 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEG---------VEHQLRREIEIQSHLRHPNILRMYNYFH 84 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTT---------CHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHH---------HHHHHHHHHHHHhcCCCCCEeeEEEEEE
Confidence 4455566788888 88888888889999999999876554321 1256889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
+++..|+||||+++|+|.+.+.... .++...+..++.|++.||.||| +++++|+||||+||+++.++.++|+
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~ 156 (284)
T 2vgo_A 85 DRKRIYLMLEFAPRGELYKELQKHG-----RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIA 156 (284)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEEC
T ss_pred cCCEEEEEEEeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEe
Confidence 9999999999999999999987643 4788999999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhh
Q 043524 171 DFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 171 dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
|||.+....... .....|++.|+|||++.+..++.++||||+|+++|+|++|..||....... ......
T Consensus 157 Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~~~~~~ 225 (284)
T 2vgo_A 157 DFGWSVHAPSLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE--------THRRIV 225 (284)
T ss_dssp CCTTCEECSSSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHH
T ss_pred cccccccCcccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH--------HHHHHh
Confidence 999987654322 335578999999999998889999999999999999999999996433211 111111
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.. ....+ ...+..+.+++..||+.||++|||+.|+++
T Consensus 226 ~~-------------~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 226 NV-------------DLKFP--PFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp TT-------------CCCCC--TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cc-------------ccCCC--CcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 10 00000 123456889999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=318.12 Aligned_cols=258 Identities=20% Similarity=0.276 Sum_probs=189.9
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|.....+|.|+ +.|+++.+..+|+.||+|++.............. ....+.+|+.+|..++||||+++++++.
T Consensus 135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREAD----PALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC------------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccch----hHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 4555666789988 8899999999999999999886543211100000 1135789999999999999999999974
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCC---ce
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN---VV 167 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~---~~ 167 (314)
.+..|+||||+++|+|.+.+... ..++...+..++.|++.||.||| +++|+||||||+||+++..+ .+
T Consensus 211 -~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~ 281 (419)
T 3i6u_A 211 -AEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLI 281 (419)
T ss_dssp -SSEEEEEEECCTTCBGGGGTSSS-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCE
T ss_pred -cCceEEEEEcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceE
Confidence 55689999999999999988654 35889999999999999999999 99999999999999997544 59
Q ss_pred EEcccccceecCCCCcccccccccccccccCccccc---CCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHH
Q 043524 168 KLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTT---CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNE 244 (314)
Q Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 244 (314)
||+|||+++...... ......||+.|+|||++.. ..++.++||||+||++|+|++|..||........ ...
T Consensus 282 kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~----~~~ 355 (419)
T 3i6u_A 282 KITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS----LKD 355 (419)
T ss_dssp EECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC----HHH
T ss_pred EEeecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH----HHH
Confidence 999999997764332 2345679999999999864 4578899999999999999999999975433221 111
Q ss_pred HHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 245 YLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
... .... ..........+..+.+|+..||+.||++|||+.|+++
T Consensus 356 ~i~----~~~~----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 356 QIT----SGKY----------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHH----TTCC----------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHh----cCCC----------CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 000 0000 0001111134567899999999999999999999987
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=304.63 Aligned_cols=251 Identities=20% Similarity=0.271 Sum_probs=195.4
Q ss_pred cccCch-hHHHHH--HHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCee
Q 043524 19 MIGNGA-SVLQEL--IASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIA 95 (314)
Q Consensus 19 ~~G~g~-~~~~~~--~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (314)
.+|.|+ +.|+.+ ....+++.+|+|++........ ..+++.+|++++..++||||+++++++ ..+..
T Consensus 24 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA----------LKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CH----------HHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred ccccccCeeeEeeeecCCCceeeEEEEeecccccCHH----------HHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 678877 777776 3456678999999875432111 126788999999999999999999999 66788
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
++||||+++++|.+++.... .++...+..++.|++.||.||| +++++|+||||+||+++.++.++|+|||++
T Consensus 93 ~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 164 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLS 164 (291)
T ss_dssp EEEEECCTTEEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEEeCCCCCHHHHHHhCc-----CCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcc
Confidence 99999999999999997643 4788999999999999999999 999999999999999999999999999999
Q ss_pred eecCCCCccc--ccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhcc
Q 043524 176 ISIPEGETHI--TDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFED 252 (314)
Q Consensus 176 ~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (314)
.......... .....+++.|+|||++....++.++||||+|+++|+|++ |..||....... .... ...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------~~~~-~~~ 235 (291)
T 1xbb_A 165 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--------VTAM-LEK 235 (291)
T ss_dssp EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--------HHHH-HHT
T ss_pred eeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--------HHHH-HHc
Confidence 8764433211 122346788999999988888999999999999999999 999996533211 1111 111
Q ss_pred CCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 253 NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
.... ..+...+..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 236 ~~~~-------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 236 GERM-------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp TCCC-------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCC-------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 0000 00013446789999999999999999999999999998764
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=303.85 Aligned_cols=258 Identities=21% Similarity=0.290 Sum_probs=193.9
Q ss_pred CcccccccCch-hHHHHHHHhc---CCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEE
Q 043524 14 GKRTLMIGNGA-SVLQELIASS---NGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCC 89 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~---~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 89 (314)
+.....+|.|+ +.|+.+.... .+..+|+|.+........ .+.+.+|+.+++.++||||+++++++
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~-----------~~~~~~E~~~l~~l~h~~iv~~~~~~ 95 (298)
T 3f66_A 27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE-----------VSQFLTEGIIMKDFSHPNVLSLLGIC 95 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHH-----------HHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHH-----------HHHHHHHHHHHHhCCCCCEeeeeeEE
Confidence 33445688888 7777665332 333688888764221111 25688999999999999999999996
Q ss_pred E-eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceE
Q 043524 90 L-ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVK 168 (314)
Q Consensus 90 ~-~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~k 168 (314)
. .++..++||||+++|+|.+++.... ..++...+..++.|++.||.||| +++|+||||||+||+++.++.++
T Consensus 96 ~~~~~~~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~k 168 (298)
T 3f66_A 96 LRSEGSPLVVLPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVK 168 (298)
T ss_dssp CCSSSCCEEEEECCTTCBHHHHHHCTT----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEE
T ss_pred EcCCCceEEEEeCCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEE
Confidence 5 4568899999999999999997644 35788999999999999999999 99999999999999999999999
Q ss_pred EcccccceecCCCCc---ccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHH
Q 043524 169 LFDFSLSISIPEGET---HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNE 244 (314)
Q Consensus 169 l~dfg~~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~ 244 (314)
|+|||.++....... .......+|+.|+|||.+.+..++.++||||+|+++|+|++ |.+||....... ...
T Consensus 169 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~-----~~~ 243 (298)
T 3f66_A 169 VADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-----ITV 243 (298)
T ss_dssp ECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT-----HHH
T ss_pred ECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH-----HHH
Confidence 999999976543221 11234467889999999998899999999999999999999 555654333221 000
Q ss_pred HHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhc
Q 043524 245 YLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSL 311 (314)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 311 (314)
..... .. ...+...+..+.+++..||+.||++|||+.|+++.|+++...+
T Consensus 244 ---~~~~~-------------~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 244 ---YLLQG-------------RR-LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp ---HHHTT-------------CC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred ---HHhcC-------------CC-CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 00000 00 0000123456889999999999999999999999999998765
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=309.51 Aligned_cols=263 Identities=19% Similarity=0.299 Sum_probs=201.8
Q ss_pred hcCcccccccCch-hHHHHHHHh-------cCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCce
Q 043524 12 SKGKRTLMIGNGA-SVLQELIAS-------SNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHI 82 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~-------~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni 82 (314)
.++.....+|.|+ +.|+.+... .++..||+|++........ .+.+.+|++++..+ +||||
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~E~~~l~~l~~hp~i 103 (334)
T 2pvf_A 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD-----------LSDLVSEMEMMKMIGKHKNI 103 (334)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHH-----------HHHHHHHHHHHHHHCCCTTB
T ss_pred hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHH-----------HHHHHHHHHHHHHhhcCCCE
Confidence 4455566788888 777776543 4667899999865422111 25688999999999 89999
Q ss_pred eeeEeEEEeCCeeEEEEeecCCCCHHHHHhcCCCCC-----------CCcccHHHHHHHHHHHHHHHHHhhcCCCCCcee
Q 043524 83 LKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTH-----------FEPLLLKRRLKDAVDAANALAYLHFGFPRPIVF 151 (314)
Q Consensus 83 v~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~-----------~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H 151 (314)
+++++++.+++..|+||||+++|+|.+++....... ...++...++.++.|++.||.||| +++|+|
T Consensus 104 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH 180 (334)
T 2pvf_A 104 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIH 180 (334)
T ss_dssp CCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEEC
T ss_pred eeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeC
Confidence 999999999999999999999999999998654210 124788999999999999999999 999999
Q ss_pred ccCCCCCeeecCCCceEEcccccceecCCCCcc-cccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCc
Q 043524 152 RDFKTSHILFSEENVVKLFDFSLSISIPEGETH-ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGIL 229 (314)
Q Consensus 152 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~ 229 (314)
+||||+||+++.++.++|+|||+++........ ......+|+.|+|||++.+..++.++||||+|+++|+|++ |..||
T Consensus 181 ~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~ 260 (334)
T 2pvf_A 181 RDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260 (334)
T ss_dssp SCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCc
Confidence 999999999999999999999999876543221 1233456788999999988889999999999999999999 99998
Q ss_pred ccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHh
Q 043524 230 DLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICC 309 (314)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 309 (314)
...... +........ ... ..+...+..+.+++..||+.||++|||+.|+++.|+++..
T Consensus 261 ~~~~~~--------~~~~~~~~~-~~~-------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 261 PGIPVE--------ELFKLLKEG-HRM-------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp TTCCHH--------HHHHHHHHT-CCC-------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcCCHH--------HHHHHHhcC-CCC-------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 643211 111111111 000 0001334568899999999999999999999999999865
Q ss_pred h
Q 043524 310 S 310 (314)
Q Consensus 310 ~ 310 (314)
.
T Consensus 319 ~ 319 (334)
T 2pvf_A 319 L 319 (334)
T ss_dssp H
T ss_pred c
Confidence 4
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=304.55 Aligned_cols=270 Identities=20% Similarity=0.281 Sum_probs=193.7
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
+|.....+|.|+ +.|+.+.+..+|+.||+|++........ ..+.+.+|++++..++||||+++++++.+
T Consensus 4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 73 (311)
T 4agu_A 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPV----------IKKIALREIRMLKQLKHPNLVNLLEVFRR 73 (311)
T ss_dssp CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HH----------HHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchH----------HHHHHHHHHHHHHhCCCCCccchhheeec
Confidence 445556688888 8888888888999999998754321111 12567899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
++..++||||+++++|.+++... ..++...+..++.|++.||.||| +++|+|+||||+||+++.++.++|+|
T Consensus 74 ~~~~~lv~e~~~~~~l~~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~D 145 (311)
T 4agu_A 74 KRRLHLVFEYCDHTVLHELDRYQ-----RGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCD 145 (311)
T ss_dssp TTEEEEEEECCSEEHHHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECC
T ss_pred CCeEEEEEEeCCCchHHHHHhhh-----cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEee
Confidence 99999999999999998887654 34789999999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccc-CCCCcccchHHHHHHHHHHHhCCCCcccccCcccccc------chHH
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTT-CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVY------PFNE 244 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~------~~~~ 244 (314)
||.+........ ......||+.|+|||++.+ ..++.++||||+|+++|+|++|..||........... ....
T Consensus 146 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 224 (311)
T 4agu_A 146 FGFARLLTGPSD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIP 224 (311)
T ss_dssp CTTCEECC-------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred CCCchhccCccc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccc
Confidence 999987643322 2335578999999999876 5689999999999999999999999975443221000 0000
Q ss_pred HHHhhhccCC-ccc--ccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 245 YLKNYFEDNR-FTE--IVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 245 ~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.....+.... ... ..++....+. .......+..+.+|+..||+.||++|||+.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 225 RHQQVFSTNQYFSGVKIPDPEDMEPL-ELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp HHHHHHHTCGGGTTCCCCCCSSCCCH-HHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccccccccccccCcCCCccccchh-hhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000010000 000 0000000000 0000134566899999999999999999999985
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=316.04 Aligned_cols=265 Identities=17% Similarity=0.215 Sum_probs=190.8
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
+|.....+|.|+ +.|+.+.+..+|+.||+|++......... ..+.+|++++..++||||+++++++.+
T Consensus 3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-----------~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (324)
T 3mtl_A 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAP-----------CTAIREVSLLKDLKHANIVTLHDIIHT 71 (324)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------C-----------CCCCCCHHHHSCCCCTTBCCEEEEEEC
T ss_pred ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccc-----------hhHHHHHHHHHhcCCCCCCeeeeEEee
Confidence 345556689888 88888888889999999998755432221 123478999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
++..++||||++ |+|.+.+.... ..++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+|
T Consensus 72 ~~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~D 143 (324)
T 3mtl_A 72 EKSLTLVFEYLD-KDLKQYLDDCG----NIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLAD 143 (324)
T ss_dssp SSCEEEEEECCS-EEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECS
T ss_pred CCEEEEEecccc-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEcc
Confidence 999999999996 69999887654 35788999999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCccccc-CCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhh
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTT-CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
||+++....... ......||+.|+|||++.+ ..++.++||||+|+++|+|++|+.||........ ........
T Consensus 144 fg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-----~~~i~~~~ 217 (324)
T 3mtl_A 144 FGLARAKSIPTK-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ-----LHFIFRIL 217 (324)
T ss_dssp SSEEECC-------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-----HHHHHHHH
T ss_pred CcccccccCCcc-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHHHh
Confidence 999976543221 2334578999999999876 4589999999999999999999999975432210 00000000
Q ss_pred c---cCCcccccChh---------hhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 251 E---DNRFTEIVDPI---------IVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 251 ~---~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
. ...+....... .............+..+.+|+.+||+.||++|||+.|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 218 GTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0 00111110000 0000000001133467899999999999999999999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=311.95 Aligned_cols=267 Identities=16% Similarity=0.216 Sum_probs=191.0
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|.....+|.|+ +.|+.+.+..+|+.||+|++........ ..+.+.+|+++++.++||||+++++++.
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (329)
T 3gbz_A 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEG----------VPGTAIREVSLLKELQHRNIIELKSVIH 103 (329)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC------------------CHHHHHHGGGCCCTTBCCEEEEEE
T ss_pred hhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccc----------cchhHHHHHHHHHHcCCCCcceEEEEEe
Confidence 4556666799888 8899988889999999999865432211 1145679999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeec-----CCC
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFS-----EEN 165 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~-----~~~ 165 (314)
++...|+||||++ |+|.+++.... .++...+..++.|++.||.||| +++|+||||||+||+++ ..+
T Consensus 104 ~~~~~~lv~e~~~-~~L~~~~~~~~-----~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~ 174 (329)
T 3gbz_A 104 HNHRLHLIFEYAE-NDLKKYMDKNP-----DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETP 174 (329)
T ss_dssp ETTEEEEEEECCS-EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CC
T ss_pred cCCEEEEEEecCC-CCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccc
Confidence 9999999999997 59999997653 4788999999999999999999 99999999999999994 455
Q ss_pred ceEEcccccceecCCCCcccccccccccccccCcccccCC-CCcccchHHHHHHHHHHHhCCCCcccccCccccccchHH
Q 043524 166 VVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCD-FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNE 244 (314)
Q Consensus 166 ~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 244 (314)
.++|+|||+++....... ......||+.|+|||++.+.. ++.++||||+||++|+|++|..||......... ..
T Consensus 175 ~~kl~Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~----~~ 249 (329)
T 3gbz_A 175 VLKIGDFGLARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQL----FK 249 (329)
T ss_dssp EEEECCTTHHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HH
T ss_pred eEEECcCCCccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHH----HH
Confidence 699999999976643221 233456899999999998754 899999999999999999999999754322110 00
Q ss_pred HHHhh--hcc---------CCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 245 YLKNY--FED---------NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 245 ~~~~~--~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
..... ... ..+....................+.++.+|+..||+.||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 250 IFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp HHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00000 000 00000000000000000011124567899999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=299.08 Aligned_cols=249 Identities=22% Similarity=0.314 Sum_probs=200.2
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.++.....+|.|+ +.|+.+.+..+|+.||+|.+.... +.+.+|++++..++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------------~~~~~e~~~l~~l~h~~i~~~~~~~~ 74 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----------------EKAEREVKALAKLDHVNIVHYNGCWD 74 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----------------GGGHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----------------HHHHHHHHHHHhCCCCCEEEEeeeEe
Confidence 4455566788888 888888888899999999886432 34578999999999999999999986
Q ss_pred e----------------CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccC
Q 043524 91 E----------------TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDF 154 (314)
Q Consensus 91 ~----------------~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dl 154 (314)
. ...+++||||+++++|.+++..... ..++...+..++.|++.||.||| +++|+|+||
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl 148 (284)
T 2a19_B 75 GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG---EKLDKVLALELFEQITKGVDYIH---SKKLINRDL 148 (284)
T ss_dssp EEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCC
T ss_pred ccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccC
Confidence 4 4558999999999999999975432 35788999999999999999999 999999999
Q ss_pred CCCCeeecCCCceEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccC
Q 043524 155 KTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRD 234 (314)
Q Consensus 155 k~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~ 234 (314)
||+||+++.++.++|+|||+++....... .....||+.|+|||++.+..++.++||||+|+++|+|++|..|+....
T Consensus 149 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~- 225 (284)
T 2a19_B 149 KPSNIFLVDTKQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS- 225 (284)
T ss_dssp SGGGEEEEETTEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-
T ss_pred CHHHEEEcCCCCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-
Confidence 99999999999999999999987654322 334568999999999998889999999999999999999998864211
Q ss_pred ccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhc
Q 043524 235 AHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSL 311 (314)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 311 (314)
...... ...... ...+..+.+++.+||+.||++|||+.|+++.|..+.++.
T Consensus 226 ---------~~~~~~-~~~~~~----------------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 226 ---------KFFTDL-RDGIIS----------------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp ---------HHHHHH-HTTCCC----------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred ---------HHHHHh-hccccc----------------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 111111 010000 023345789999999999999999999999999987654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=308.06 Aligned_cols=262 Identities=21% Similarity=0.272 Sum_probs=198.3
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
+|.....+|.|+ +.|+.+.+..+|+.||+|++....... .+.+.+|+.++..++||||+++++++..
T Consensus 30 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------------~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 97 (317)
T 2buj_A 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQD------------REEAQREADMHRLFNHPNILRLVAYCLR 97 (317)
T ss_dssp EEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHH------------HHHHHHHHHHHHTCCCTTBCCCCEEEEE
T ss_pred EEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHH------------HHHHHHHHHHHhhcCCCCeeeEEEEEEe
Confidence 455566789988 888888888899999999885433222 1567899999999999999999999973
Q ss_pred ----CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCce
Q 043524 92 ----TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVV 167 (314)
Q Consensus 92 ----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~ 167 (314)
....|+|+||+++|+|.+.+...... ...++...++.++.|++.||.||| +++|+|+||||+||+++.++.+
T Consensus 98 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~ 173 (317)
T 2buj_A 98 ERGAKHEAWLLLPFFKRGTLWNEIERLKDK-GNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQP 173 (317)
T ss_dssp EETTEEEEEEEEECCTTCBHHHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCE
T ss_pred ccCCCceeEEEEEeCCCCcHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCE
Confidence 45789999999999999988752110 145889999999999999999999 9999999999999999999999
Q ss_pred EEcccccceecCCCCcc--------cccccccccccccCcccccCC---CCcccchHHHHHHHHHHHhCCCCcccccCcc
Q 043524 168 KLFDFSLSISIPEGETH--------ITDTVMGTYGHLAPQYVTTCD---FSEKLDVYSFGAFLSELLTGRGILDLVRDAH 236 (314)
Q Consensus 168 kl~dfg~~~~~~~~~~~--------~~~~~~g~~~y~aPE~~~~~~---~~~~~DiwslG~~l~el~~g~~p~~~~~~~~ 236 (314)
+|+|||.+......... ......||+.|+|||++.... ++.++||||||+++|+|++|..||+......
T Consensus 174 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 253 (317)
T 2buj_A 174 VLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG 253 (317)
T ss_dssp EECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT
T ss_pred EEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc
Confidence 99999998764321100 012335799999999987554 6889999999999999999999986422111
Q ss_pred ccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 237 DLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
.. ...... . ....+.....+..+.+++..||+.||++|||+.++++.|+++...
T Consensus 254 ~~---~~~~~~----~-------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 254 DS---VALAVQ----N-------------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp SC---HHHHHH----C-------------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred ch---hhHHhh----c-------------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 00 000000 0 000000113346789999999999999999999999999987654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=306.62 Aligned_cols=259 Identities=20% Similarity=0.338 Sum_probs=185.9
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
++.....+|.|+ +.||++. ....+|+|++........ ..+.+.+|+++++.++||||+++++++ .
T Consensus 25 ~y~~~~~lG~G~~g~Vy~~~---~~~~vavK~~~~~~~~~~----------~~~~~~~E~~~l~~l~h~~iv~~~~~~-~ 90 (289)
T 3og7_A 25 QITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQ----------QLQAFKNEVGVLRKTRHVNILLFMGYS-T 90 (289)
T ss_dssp SCEEEEEEEECSSEEEEEEE---SSSEEEEEEESCSSCCHH----------HHHHHHHHHHHHTTCCCTTBCCEEEEE-C
T ss_pred ceeeeeEecCCCCeEEEEEE---EcCceEEEEEeccCCCHH----------HHHHHHHHHHHHHhCCCCcEEEEEeec-c
Confidence 444555688888 7776653 344599998754321110 125688999999999999999999965 5
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
....++||||+++++|.+.+.... ..++...+..++.|++.||.||| +++|+|+||||+||+++.++.++|+|
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~D 163 (289)
T 3og7_A 91 APQLAIVTQWCEGSSLYHHLHASE----TKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGD 163 (289)
T ss_dssp SSSCEEEEECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECC
T ss_pred CCccEEEEEecCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEcc
Confidence 667899999999999999986554 45888999999999999999999 99999999999999999999999999
Q ss_pred cccceecCCC-CcccccccccccccccCcccc---cCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHH
Q 043524 172 FSLSISIPEG-ETHITDTVMGTYGHLAPQYVT---TCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLK 247 (314)
Q Consensus 172 fg~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (314)
||+++..... .........||+.|+|||++. ...++.++||||+|+++|+|++|..||........ ..
T Consensus 164 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--------~~ 235 (289)
T 3og7_A 164 FGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--------II 235 (289)
T ss_dssp CC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--------HH
T ss_pred ceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--------HH
Confidence 9998765332 112233457899999999886 55688899999999999999999999975443211 11
Q ss_pred hhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHh
Q 043524 248 NYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICC 309 (314)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 309 (314)
.............. ....++..+.+|+.+||+.||++|||+.++++.|+++.+
T Consensus 236 ~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 236 EMVGRGSLSPDLSK---------VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp HHHHHTSCCCCTTS---------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HHhcccccCcchhh---------ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 11111111000000 001344678999999999999999999999999998865
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=303.32 Aligned_cols=257 Identities=21% Similarity=0.294 Sum_probs=200.6
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+++....+|.|+ +.|+.+. ..+++.+|+|.+..... ..+.+.+|++++..++||||+++++++.
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-------------~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 78 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSM-------------SPDAFLAEANLMKQLQHQRLVRLYAVVT 78 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEE-ETTTEEEEEEEECTTSS-------------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HhhhheeeecCCCCeEEEEEE-EcCCcEEEEEEecCCcc-------------cHHHHHHHHHHHHhCCCcCcceEEEEEc
Confidence 4455566788888 6676664 34567899998864321 1256889999999999999999999986
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
.+..++||||+++++|.+++..... ..++...+..++.|++.||.||| +++++|+||||+||+++.++.++|+
T Consensus 79 -~~~~~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~ 151 (279)
T 1qpc_A 79 -QEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIA 151 (279)
T ss_dssp -SSSCEEEEECCTTCBHHHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEEC
T ss_pred -CCCcEEEEecCCCCCHHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEEC
Confidence 4568999999999999999865321 24788999999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhh
Q 043524 171 DFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNY 249 (314)
Q Consensus 171 dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (314)
|||.+...............++..|+|||++....++.++||||+|+++|+|++ |..||...... +.....
T Consensus 152 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--------~~~~~~ 223 (279)
T 1qpc_A 152 DFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--------EVIQNL 223 (279)
T ss_dssp CCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHHHHH
T ss_pred CCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH--------HHHHHH
Confidence 999998775543333344567889999999988889999999999999999999 89998643321 111111
Q ss_pred hccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhc
Q 043524 250 FEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSL 311 (314)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 311 (314)
.... . ...+...+..+.+++..||+.||++|||+.++++.|+++....
T Consensus 224 ~~~~--~------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 224 ERGY--R------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp HTTC--C------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred hccc--C------------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 1100 0 0000133467899999999999999999999999999987654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=300.06 Aligned_cols=245 Identities=18% Similarity=0.272 Sum_probs=191.8
Q ss_pred ccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe---
Q 043524 16 RTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE--- 91 (314)
Q Consensus 16 ~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--- 91 (314)
-...+|.|+ +.|+.+.+..++..||+|++......... .+.+.+|+.+++.++||||+++++++..
T Consensus 30 ~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~----------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (290)
T 1t4h_A 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE----------RQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 99 (290)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHH----------HHHHHHHHHHHTTCCCTTBCCEEEEEEEESS
T ss_pred eeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHH----------HHHHHHHHHHHHhCCCCCeeeeeeeeccccC
Confidence 334588888 88888888899999999998754322111 2568899999999999999999999875
Q ss_pred -CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCC--ceeccCCCCCeeec-CCCce
Q 043524 92 -TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRP--IVFRDFKTSHILFS-EENVV 167 (314)
Q Consensus 92 -~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~--i~H~dlk~~nil~~-~~~~~ 167 (314)
+..+++||||+++++|.+++... ..++...+..++.|++.||.||| +++ ++|+||||+||+++ .++.+
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~ 171 (290)
T 1t4h_A 100 GKKCIVLVTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSV 171 (290)
T ss_dssp SCEEEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCE
T ss_pred CCceEEEEEEecCCCCHHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCE
Confidence 45689999999999999999764 24788999999999999999999 888 99999999999997 78899
Q ss_pred EEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHH
Q 043524 168 KLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLK 247 (314)
Q Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (314)
+|+|||++....... .....||+.|+|||++. ..++.++||||+|+++|+|++|..||....... ....
T Consensus 172 kl~Dfg~~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-------~~~~ 240 (290)
T 1t4h_A 172 KIGDLGLATLKRASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA-------QIYR 240 (290)
T ss_dssp EECCTTGGGGCCTTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-------HHHH
T ss_pred EEeeCCCcccccccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH-------HHHH
Confidence 999999996543322 33457899999999876 458999999999999999999999996533221 1111
Q ss_pred hhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 248 NYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
..... . .+.......+..+.+|+..||+.||++|||+.|+++
T Consensus 241 ~~~~~-~------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 241 RVTSG-V------------KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHTTT-C------------CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhcc-C------------CccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11100 0 000011122356889999999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=304.03 Aligned_cols=266 Identities=21% Similarity=0.318 Sum_probs=192.6
Q ss_pred hcCcccccccCch-hHHHHHHHhc---CCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEe
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASS---NGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIG 87 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~---~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 87 (314)
.++.....+|.|+ +.|+.+.... ++..||+|.+........ ..+.+.+|+.++..++||||+++++
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~~e~~~l~~l~h~~iv~~~~ 103 (313)
T 3brb_A 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQR----------EIEEFLSEAACMKDFSHPNVIRLLG 103 (313)
T ss_dssp GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHH----------HHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchh----------HHHHHHHHHHHHhcCCCCCeeeeeE
Confidence 4455556688888 7777664443 556899999865421111 1256889999999999999999999
Q ss_pred EEEeCC-----eeEEEEeecCCCCHHHHHhcCCC-CCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeee
Q 043524 88 CCLETP-----IAILVFEYVQHGTLWDRILGAPQ-THFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILF 161 (314)
Q Consensus 88 ~~~~~~-----~~~iv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~ 161 (314)
++.+.. ..++||||+++|+|.+++..... .....++...++.++.|++.||.||| +++|+|+||||+||++
T Consensus 104 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli 180 (313)
T 3brb_A 104 VCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCML 180 (313)
T ss_dssp EEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEE
T ss_pred EEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEE
Confidence 998754 35999999999999999853211 11145889999999999999999999 9999999999999999
Q ss_pred cCCCceEEcccccceecCCCCcc-cccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccc
Q 043524 162 SEENVVKLFDFSLSISIPEGETH-ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLV 239 (314)
Q Consensus 162 ~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~ 239 (314)
+.++.++|+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 181 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--- 257 (313)
T 3brb_A 181 RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE--- 257 (313)
T ss_dssp CTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---
T ss_pred cCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---
Confidence 99999999999999765433211 1234457889999999998889999999999999999999 888986543221
Q ss_pred cchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhcc
Q 043524 240 YPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSLS 312 (314)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~ 312 (314)
.. ........ ...+...+..+.+++..||..||++|||+.++++.|+++.+.+.
T Consensus 258 --~~---~~~~~~~~--------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 258 --MY---DYLLHGHR--------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp --HH---HHHHTTCC--------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred --HH---HHHHcCCC--------------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 00 11111000 00001344568999999999999999999999999999988764
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=311.10 Aligned_cols=271 Identities=16% Similarity=0.220 Sum_probs=195.7
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|.....+|.|+ +.|+.+.+..+|+.||+|++........... ..+.+.+|++++..++||||+++++++.
T Consensus 10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 82 (346)
T 1ua2_A 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDG-------INRTALREIKLLQELSHPNIIGLLDAFG 82 (346)
T ss_dssp ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC-------------------CTHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhh-------hhHHHHHHHHHHhhCCCCCCCeEEEEEe
Confidence 4566667789888 8888888888999999999876543222111 1146789999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
+.+..++||||+++ +|.+.+.... ..++...+..++.|++.||.||| +++|+||||||+||+++.++.++|+
T Consensus 83 ~~~~~~lv~e~~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~ 154 (346)
T 1ua2_A 83 HKSNISLVFDFMET-DLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLA 154 (346)
T ss_dssp CTTCCEEEEECCSE-EHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred eCCceEEEEEcCCC-CHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEE
Confidence 99999999999975 8988887644 35778889999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCcccccC-CCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhh
Q 043524 171 DFSLSISIPEGETHITDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNY 249 (314)
Q Consensus 171 dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (314)
|||+++....... ......||+.|+|||++.+. .++.++||||+||++|+|++|.+||........ +.......
T Consensus 155 Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~----~~~i~~~~ 229 (346)
T 1ua2_A 155 DFGLAKSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ----LTRIFETL 229 (346)
T ss_dssp CCGGGSTTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHHH
T ss_pred ecccceeccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH----HHHHHHHc
Confidence 9999976643321 23355789999999998764 488999999999999999999999875432211 11111100
Q ss_pred h--ccCCcccccC---hhhhccC-Cch---hHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 250 F--EDNRFTEIVD---PIIVQDL-SCT---EKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 250 ~--~~~~~~~~~~---~~~~~~~-~~~---~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
. ....+..... ....... ..+ .....+..+.+|+..||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 230 GTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp CCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0 0001111000 0000000 000 00133567899999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=300.75 Aligned_cols=250 Identities=20% Similarity=0.326 Sum_probs=194.7
Q ss_pred cCcccccccCch-hHHHHHHHhcCCc-------ccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceee
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGK-------YIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILK 84 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~-------~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 84 (314)
++.....+|.|+ +.|+++.+..+|+ .+|+|++...... ..+.+.+|+.+++.++||||++
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~------------~~~~~~~E~~~l~~l~h~~iv~ 76 (289)
T 4fvq_A 9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRN------------YSESFFEAASMMSKLSHKHLVL 76 (289)
T ss_dssp GEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGG------------GHHHHHHHHHHHHTSCCTTBCC
T ss_pred HeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHH------------HHHHHHHHHHHHHhCCCCCEeE
Confidence 444555688888 8888888777774 5999988653321 1267889999999999999999
Q ss_pred eEeEEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCC
Q 043524 85 LIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEE 164 (314)
Q Consensus 85 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~ 164 (314)
+++++.+++..++||||+++|+|.+++.... ..++...+..++.|++.||.||| +++|+||||||+||+++.+
T Consensus 77 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~ 149 (289)
T 4fvq_A 77 NYGVCVCGDENILVQEFVKFGSLDTYLKKNK----NCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIRE 149 (289)
T ss_dssp EEEEECCTTCCEEEEECCTTCBHHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEEC
T ss_pred EEEEEEeCCCCEEEEECCCCCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecC
Confidence 9999999999999999999999999998754 34888999999999999999999 9999999999999999888
Q ss_pred Cc--------eEEcccccceecCCCCcccccccccccccccCccccc-CCCCcccchHHHHHHHHHHHhCCCC-cccccC
Q 043524 165 NV--------VKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTT-CDFSEKLDVYSFGAFLSELLTGRGI-LDLVRD 234 (314)
Q Consensus 165 ~~--------~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p-~~~~~~ 234 (314)
+. ++|+|||.+..... .....+|+.|+|||++.+ ..++.++||||+|+++|+|++|..| |.....
T Consensus 150 ~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~ 224 (289)
T 4fvq_A 150 EDRKTGNPPFIKLSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS 224 (289)
T ss_dssp CBGGGTBCCEEEECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred CcccccccceeeeccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch
Confidence 76 99999999855422 223457889999999987 6689999999999999999996544 432211
Q ss_pred ccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 235 AHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
.. ............ . ..+.++.+|+..||+.||++|||+.|+++.|+++..+
T Consensus 225 ~~--------~~~~~~~~~~~~--------~--------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 225 QR--------KLQFYEDRHQLP--------A--------PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp HH--------HHHHHHTTCCCC--------C--------CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred HH--------HHHHhhccCCCC--------C--------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 10 000000000000 0 1123478999999999999999999999999988664
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=330.52 Aligned_cols=249 Identities=18% Similarity=0.282 Sum_probs=202.4
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeEEE
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGCCL 90 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 90 (314)
.+.....+|.|+ +.|+++.+..+|+.||+|++.+......... +.+..|..++..+ +||||+++++++.
T Consensus 342 ~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~---------~~~~~E~~~l~~~~~~~~i~~l~~~~~ 412 (674)
T 3pfq_A 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDV---------ECTMVEKRVLALPGKPPFLTQLHSCFQ 412 (674)
T ss_dssp TEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTT---------HHHHHHHHHHTCTTCCTTBCCEEEECB
T ss_pred ceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHH---------HHHHHHHHHHHhccCCCeEEEEEEEEE
Confidence 344556799999 8899898889999999999987655433221 6678999999988 6999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
+.+.+|+||||+++|+|.+++.... .++...++.++.||+.||.||| +++|+||||||+|||++.++.+||+
T Consensus 413 ~~~~~~lV~E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~ 484 (674)
T 3pfq_A 413 TMDRLYFVMEYVNGGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIA 484 (674)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEEC
T ss_pred eCCEEEEEEeCcCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEe
Confidence 9999999999999999999997643 4889999999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhh
Q 043524 171 DFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 171 dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
|||+++....... ......||+.|+|||++....++.++|+||||+++|||++|..||...... +......
T Consensus 485 DFGla~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~--------~~~~~i~ 555 (674)
T 3pfq_A 485 DFGMCKENIWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--------ELFQSIM 555 (674)
T ss_dssp CCTTCEECCCTTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHH
T ss_pred ecceeeccccCCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH--------HHHHHHH
Confidence 9999986433222 245678999999999999999999999999999999999999999753321 1111111
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCH-----HHHHH
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTM-----VDVAR 302 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~-----~ell~ 302 (314)
. .....+ ...+.++.+||..||+.||++||++ .||++
T Consensus 556 ~-------------~~~~~p--~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 556 E-------------HNVAYP--KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp S-------------SCCCCC--TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred h-------------CCCCCC--ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1 111111 1345678999999999999999987 66653
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=297.01 Aligned_cols=249 Identities=22% Similarity=0.266 Sum_probs=191.8
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|.....+|.|+ +.|+.+.+..+|+.||+|++......... ..+.+.+|+.++..++||||+++++++.
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 81 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLD---------VVGKIKREIQNLKLFRHPHIIKLYQVIS 81 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTT---------CHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchh---------HHHHHHHHHHHHhcCCCCCEeEEEEEEe
Confidence 3455556688888 88888888889999999999876543321 1267889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
+++..++||||+++++|.+++.... .++...+..++.|++.||.||| +++++|+||||+||+++.++.++|+
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~ 153 (276)
T 2h6d_A 82 TPTDFFMVMEYVSGGELFDYICKHG-----RVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIA 153 (276)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEEC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEe
Confidence 9999999999999999999987643 4788999999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCcccccCCC-CcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhh
Q 043524 171 DFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDF-SEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNY 249 (314)
Q Consensus 171 dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (314)
|||.+........ .....+++.|+|||++.+..+ +.++||||+|+++|+|++|..||...... ......
T Consensus 154 dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~ 223 (276)
T 2h6d_A 154 DFGLSNMMSDGEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP--------TLFKKI 223 (276)
T ss_dssp CCCGGGCCCC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHH
T ss_pred ecccccccCCCcc--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--------HHHHHh
Confidence 9999976543321 334568999999999987765 58999999999999999999999643211 111111
Q ss_pred hccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 250 FEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
... ....+ ...+..+.+++..||+.||++|||+.|+++
T Consensus 224 ~~~-------------~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 224 RGG-------------VFYIP--EYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp HHC-------------CCCCC--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hcC-------------cccCc--hhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 100 00000 123456889999999999999999999987
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=310.23 Aligned_cols=262 Identities=22% Similarity=0.303 Sum_probs=193.3
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|.....+|.|+ +.|+++.+..+|+.||+|++........ ...+.+.+|+.++..++||||+++++++.
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 82 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDP---------SFYLRFRREAQNAAALNHPAIVAVYDTGE 82 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSH---------HHHHHHHHHHTTCCCCCCTTBCCEEEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCH---------HHHHHHHHHHHHHHcCCCCCcceEEEeee
Confidence 3455556688888 8888888889999999999865321111 12256889999999999999999999988
Q ss_pred eCCe----eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCc
Q 043524 91 ETPI----AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENV 166 (314)
Q Consensus 91 ~~~~----~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~ 166 (314)
.... .|+||||+++++|.+++.... +++...++.++.|++.||.||| +++|+||||||+||+++.++.
T Consensus 83 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~ 154 (311)
T 3ork_A 83 AETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNA 154 (311)
T ss_dssp EEETTEEEEEEEEECCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSC
T ss_pred ccCCCCcccEEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCC
Confidence 6543 499999999999999987543 4789999999999999999999 999999999999999999999
Q ss_pred eEEcccccceecCCCCc--ccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHH
Q 043524 167 VKLFDFSLSISIPEGET--HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNE 244 (314)
Q Consensus 167 ~kl~dfg~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 244 (314)
++|+|||+++....... .......||+.|+|||++.+..++.++||||+|+++|+|++|..||.......
T Consensus 155 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-------- 226 (311)
T 3ork_A 155 VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-------- 226 (311)
T ss_dssp EEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------
T ss_pred EEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH--------
Confidence 99999999976544322 12334568999999999998899999999999999999999999996433211
Q ss_pred HHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCC-HHHHHHHHHHHHh
Q 043524 245 YLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPT-MVDVARRLRQICC 309 (314)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps-~~ell~~L~~~~~ 309 (314)
.......... ..+. ......+..+.+++..||+.||++||+ +.++...+.++..
T Consensus 227 ~~~~~~~~~~----~~~~-------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 227 VAYQHVREDP----IPPS-------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp HHHHHHHCCC----CCHH-------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred HHHHHhcCCC----CCcc-------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 1111111000 0000 000124567899999999999999996 5556666666543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=313.50 Aligned_cols=256 Identities=21% Similarity=0.307 Sum_probs=187.6
Q ss_pred cccccCch-hHHHHHHHhcC---CcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe-
Q 043524 17 TLMIGNGA-SVLQELIASSN---GKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE- 91 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~---g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~- 91 (314)
...+|.|+ +.|+++....+ +..+|+|.+...... ...+++.+|+.+++.++||||+++++++..
T Consensus 94 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 162 (373)
T 3c1x_A 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-----------GEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 162 (373)
T ss_dssp EEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCS-----------HHHHHHHHHHTTSTTCCCTTBCCCCEEECCC
T ss_pred CcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCH-----------HHHHHHHHHHHHHHhCCCCCcceEEEEEEcC
Confidence 34688888 77776654332 236899987532110 112678899999999999999999999754
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
++..++||||+++|+|.+++.... ..++...+..++.|++.||.||| +++|+||||||+||+++.++.+||+|
T Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~D 235 (373)
T 3c1x_A 163 EGSPLVVLPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVAD 235 (373)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECC
T ss_pred CCCeEEEEECCCCCCHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEee
Confidence 567899999999999999997654 34788899999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCcc---cccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHH
Q 043524 172 FSLSISIPEGETH---ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLK 247 (314)
Q Consensus 172 fg~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~ 247 (314)
||+++........ ......+|+.|+|||++....++.++||||||+++|+|++ |.+||....... .....
T Consensus 236 FG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~-----~~~~~- 309 (373)
T 3c1x_A 236 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-----ITVYL- 309 (373)
T ss_dssp C---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC-----HHHHH-
T ss_pred ccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH-----HHHHH-
Confidence 9999765432211 1223457788999999998899999999999999999999 677776443222 11110
Q ss_pred hhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhcc
Q 043524 248 NYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSLS 312 (314)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~ 312 (314)
... . .. ..+..++..+.+++.+||+.||++|||+.|+++.|+++...+.
T Consensus 310 --~~~-~--~~-----------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 310 --LQG-R--RL-----------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp --HTT-C--CC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred --HcC-C--CC-----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 000 0 00 0001334568899999999999999999999999999987654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=307.87 Aligned_cols=256 Identities=22% Similarity=0.226 Sum_probs=189.9
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeEEEeCCee
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGCCLETPIA 95 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 95 (314)
..+|.|+ +.|+.+.+..+|+.||+|++..... ...+.+.+|++++.++ +||||+++++++.+++..
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------------~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~ 86 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPG------------HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRF 86 (316)
T ss_dssp CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS------------CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc------------hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 3578888 8888888888999999999864310 0126788999999885 799999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCc---eEEccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENV---VKLFDF 172 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~---~kl~df 172 (314)
|+||||+++|+|.+.+.... .++...+..++.|++.||.||| +++|+||||||+||+++.++. ++|+||
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Df 158 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHKRR-----HFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDF 158 (316)
T ss_dssp EEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCT
T ss_pred EEEEEcCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEc
Confidence 99999999999999997642 4788999999999999999999 999999999999999987765 999999
Q ss_pred ccceecCCCCc------ccccccccccccccCccccc-----CCCCcccchHHHHHHHHHHHhCCCCcccccCcccccc-
Q 043524 173 SLSISIPEGET------HITDTVMGTYGHLAPQYVTT-----CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVY- 240 (314)
Q Consensus 173 g~~~~~~~~~~------~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~- 240 (314)
|++........ .......||+.|+|||++.. ..++.++||||+||++|+|++|..||...........
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~ 238 (316)
T 2ac3_A 159 DLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR 238 (316)
T ss_dssp TCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC--
T ss_pred cCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccc
Confidence 99876532211 11223468999999999875 4578999999999999999999999975443221000
Q ss_pred --chHHHHHhhhccCCcccccChhhhccCCch--hHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 241 --PFNEYLKNYFEDNRFTEIVDPIIVQDLSCT--EKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 241 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
....... .+......+....+ .....+..+.+|+.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~---------~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 239 GEACPACQN---------MLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp --CCHHHHH---------HHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cccchhHHH---------HHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 0000000 00011111111111 11134567899999999999999999999987
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=302.59 Aligned_cols=251 Identities=23% Similarity=0.296 Sum_probs=197.7
Q ss_pred hhhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeE
Q 043524 10 LWSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGC 88 (314)
Q Consensus 10 ~~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 88 (314)
...+|.....+|.|+ +.|+.+.+..+|+.+|+|++....... .+.+.+|+.++..++||||++++++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------------~~~~~~e~~~l~~l~h~~i~~~~~~ 74 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR------------DSSLENEIAVLKKIKHENIVTLEDI 74 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------------------HHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccc------------hHHHHHHHHHHHhCCCCCeeehhhh
Confidence 345556666789888 888888888899999999987543211 1467899999999999999999999
Q ss_pred EEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeee---cCCC
Q 043524 89 CLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILF---SEEN 165 (314)
Q Consensus 89 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~---~~~~ 165 (314)
+.+++..|+||||+++++|.+.+.... .++...+..++.|++.||.||| +++++|+||||+||++ +.++
T Consensus 75 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~ 146 (304)
T 2jam_A 75 YESTTHYYLVMQLVSGGELFDRILERG-----VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENS 146 (304)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTC
T ss_pred cccCCEEEEEEEcCCCccHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCC
Confidence 999999999999999999999886542 4788999999999999999999 9999999999999999 7788
Q ss_pred ceEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHH
Q 043524 166 VVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEY 245 (314)
Q Consensus 166 ~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 245 (314)
.++|+|||.++..... ......||+.|+|||++.+..++.++||||+|+++|+|++|..||...... ..
T Consensus 147 ~~kl~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~ 215 (304)
T 2jam_A 147 KIMITDFGLSKMEQNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES--------KL 215 (304)
T ss_dssp CEEBCSCSTTCCCCCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HH
T ss_pred CEEEccCCcceecCCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--------HH
Confidence 9999999998654322 133456899999999999888999999999999999999999999643211 11
Q ss_pred HHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 246 LKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
....... .. ....+.....+..+.+|+..||..||++|||+.|+++
T Consensus 216 ~~~i~~~-~~----------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 216 FEKIKEG-YY----------EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp HHHHHHC-CC----------CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHHHHcC-CC----------CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111111 00 0000001134467899999999999999999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=332.36 Aligned_cols=252 Identities=19% Similarity=0.281 Sum_probs=193.7
Q ss_pred cccCch-hHHHHHHHh--cCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCee
Q 043524 19 MIGNGA-SVLQELIAS--SNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIA 95 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~--~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (314)
.+|.|+ +.|+++... .++..||+|++..... ....+++.+|++++..++|||||++++++.. +.+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-----------~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~ 410 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-----------KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 410 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS-----------STTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSE
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC-----------hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCe
Confidence 478888 777766443 3556799998864310 0112678999999999999999999999976 568
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
++|||||++|+|.+++.... ..++...+..++.|++.||.||| +++|+||||||+||+++.++.+||+|||++
T Consensus 411 ~lv~E~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla 483 (613)
T 2ozo_A 411 MLVMEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLS 483 (613)
T ss_dssp EEEEECCTTCBHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTT
T ss_pred EEEEEeCCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCc
Confidence 99999999999999997543 45889999999999999999999 999999999999999999999999999999
Q ss_pred eecCCCCcc--cccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhcc
Q 043524 176 ISIPEGETH--ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFED 252 (314)
Q Consensus 176 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (314)
+........ ......+|+.|+|||++....++.++|||||||++|||++ |..||....... ........
T Consensus 484 ~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--------~~~~i~~~ 555 (613)
T 2ozo_A 484 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--------VMAFIEQG 555 (613)
T ss_dssp TTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH--------HHHHHHTT
T ss_pred ccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--------HHHHHHcC
Confidence 765432211 1122345688999999998899999999999999999998 999997544321 11111110
Q ss_pred CCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhc
Q 043524 253 NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSL 311 (314)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 311 (314)
. ....+..++.++.+|+.+||+.||++|||+.++++.|+++....
T Consensus 556 -~-------------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 556 -K-------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp -C-------------CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred -C-------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 0 00001134567899999999999999999999999999987654
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=325.27 Aligned_cols=253 Identities=22% Similarity=0.294 Sum_probs=191.9
Q ss_pred cccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCC
Q 043524 15 KRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETP 93 (314)
Q Consensus 15 ~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (314)
.....+|.|+ +.|+++... .+..||+|++..... ..++|.+|+++++.++||||+++++++.+ +
T Consensus 187 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~ 251 (452)
T 1fmk_A 187 RLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM-------------SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 251 (452)
T ss_dssp EEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTSS-------------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred eeeeeecCCCCeEEEEEEEC-CCceEEEEEeccCCC-------------CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-C
Confidence 3344688888 777766544 356799998864321 12578999999999999999999999866 7
Q ss_pred eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccc
Q 043524 94 IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFS 173 (314)
Q Consensus 94 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg 173 (314)
..|+||||+++|+|.+++..... ..++...+..++.|++.||.||| +++|+||||||+||+++.++.+||+|||
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG 325 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFG 325 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred ceEEEehhhcCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCc
Confidence 78999999999999999964321 24788999999999999999999 9999999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhcc
Q 043524 174 LSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFED 252 (314)
Q Consensus 174 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (314)
+++..............++..|+|||++....++.++||||||+++|||++ |..||....... ........
T Consensus 326 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--------~~~~i~~~ 397 (452)
T 1fmk_A 326 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--------VLDQVERG 397 (452)
T ss_dssp TTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--------HHHHHHTT
T ss_pred cceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcC
Confidence 998764433222334457889999999998899999999999999999999 999986433211 11111110
Q ss_pred CCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 253 NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
. ..+.+..++..+.+|+.+||+.||++|||+.++++.|+++..+
T Consensus 398 ~--------------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 398 Y--------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp C--------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred C--------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 0 0001113456789999999999999999999999999988654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=309.07 Aligned_cols=273 Identities=15% Similarity=0.112 Sum_probs=197.5
Q ss_pred cCcccccccCch-hHHHHHHHhc---CCcccccccccHHHH--HHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeE
Q 043524 13 KGKRTLMIGNGA-SVLQELIASS---NGKYIPYRIFSAQEL--KQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLI 86 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~---~g~~~a~k~~~~~~~--~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 86 (314)
+|.....+|.|+ +.|+.+.... ++..+|+|++..... ......+... ..+.+.+|+..+..++||||++++
T Consensus 38 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~---~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRV---AKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp EEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHH---CCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred eEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHH---hhhHHHHHHHhhccccccCcceee
Confidence 455566789988 8888887776 778999998765321 1100000000 115678899999999999999999
Q ss_pred eEEEe----CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeec
Q 043524 87 GCCLE----TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFS 162 (314)
Q Consensus 87 ~~~~~----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~ 162 (314)
+++.. +...|+||||+ +++|.+++.... .++...++.++.|++.||.||| +++|+||||||+||+++
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~ 185 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-----TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLG 185 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-----BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEE
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEc
Confidence 99988 78899999999 999999987542 5889999999999999999999 99999999999999998
Q ss_pred CCC--ceEEcccccceecCCCCc------ccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccC
Q 043524 163 EEN--VVKLFDFSLSISIPEGET------HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRD 234 (314)
Q Consensus 163 ~~~--~~kl~dfg~~~~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~ 234 (314)
.++ .++|+|||+++....... .......||+.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 186 ~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~ 265 (345)
T 2v62_A 186 YKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK 265 (345)
T ss_dssp SSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT
T ss_pred cCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 877 999999999987643211 112455799999999999988899999999999999999999999964322
Q ss_pred ccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHh
Q 043524 235 AHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICC 309 (314)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 309 (314)
..... ........ ...........+ ....+.++.+++..||..||++|||+.++++.|+++..
T Consensus 266 ~~~~~---~~~~~~~~------~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 266 DPVAV---QTAKTNLL------DELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp CHHHH---HHHHHHHH------HTTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred ccHHH---HHHHHhhc------ccccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 11100 00000000 000111000000 00334578999999999999999999999999987643
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=307.02 Aligned_cols=256 Identities=19% Similarity=0.252 Sum_probs=182.6
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC-CCceeeeEeEEE
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS-HDHILKLIGCCL 90 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 90 (314)
+++....+|.|+ +.|+++.+..+|+.||+|.+........ +.+.+|+.++..+. ||||+++++++.
T Consensus 29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------------~~~~~e~~~l~~l~~h~~iv~~~~~~~ 96 (337)
T 3ll6_A 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN------------RAIIQEVCFMKKLSGHPNIVQFCSAAS 96 (337)
T ss_dssp EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHH------------HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHH------------HHHHHHHHHHHHhccCCChhhcccccc
Confidence 445556789888 8888888888999999998754432221 56789999999996 999999999995
Q ss_pred --------eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCC--ceeccCCCCCee
Q 043524 91 --------ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRP--IVFRDFKTSHIL 160 (314)
Q Consensus 91 --------~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~--i~H~dlk~~nil 160 (314)
....+++++||+. |+|.+++...... .+++...++.++.|++.||.||| +++ |+|+||||+||+
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl 170 (337)
T 3ll6_A 97 IGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESR--GPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLL 170 (337)
T ss_dssp ECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTT--CSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCE
T ss_pred ccccccccCCceEEEEEEecC-CCHHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEE
Confidence 3445899999995 7998888652111 35889999999999999999999 898 999999999999
Q ss_pred ecCCCceEEcccccceecCCCCcc-----------cccccccccccccCccc---ccCCCCcccchHHHHHHHHHHHhCC
Q 043524 161 FSEENVVKLFDFSLSISIPEGETH-----------ITDTVMGTYGHLAPQYV---TTCDFSEKLDVYSFGAFLSELLTGR 226 (314)
Q Consensus 161 ~~~~~~~kl~dfg~~~~~~~~~~~-----------~~~~~~g~~~y~aPE~~---~~~~~~~~~DiwslG~~l~el~~g~ 226 (314)
++.++.++|+|||+++........ ......||+.|+|||++ ....++.++||||||+++|+|++|.
T Consensus 171 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~ 250 (337)
T 3ll6_A 171 LSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250 (337)
T ss_dssp ECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSS
T ss_pred ECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCC
Confidence 999999999999999776433211 11144689999999998 4566889999999999999999999
Q ss_pred CCcccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHH
Q 043524 227 GILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQ 306 (314)
Q Consensus 227 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 306 (314)
.||........ .......+. ....+..+.+|+..||+.||++|||+.|+++.|++
T Consensus 251 ~p~~~~~~~~~---------------------~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 305 (337)
T 3ll6_A 251 HPFEDGAKLRI---------------------VNGKYSIPP----HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQE 305 (337)
T ss_dssp CCC---------------------------------CCCCT----TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred CCCcchhHHHh---------------------hcCcccCCc----ccccchHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 99864322110 000000000 00122346789999999999999999999999999
Q ss_pred HHhhc
Q 043524 307 ICCSL 311 (314)
Q Consensus 307 ~~~~~ 311 (314)
+....
T Consensus 306 ~~~~~ 310 (337)
T 3ll6_A 306 IAAAR 310 (337)
T ss_dssp HHHHT
T ss_pred HHhcc
Confidence 97654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=301.87 Aligned_cols=251 Identities=22% Similarity=0.252 Sum_probs=189.8
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
++.....+|.|+ +.|+++.+..+|..+|+|.+...... ...+.+.+|++++..++||||+++++++.+
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 91 (285)
T 3is5_A 23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-----------VPMEQIEAEIEVLKSLDHPNIIKIFEVFED 91 (285)
T ss_dssp HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC-----------SCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred heeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc-----------hhHHHHHHHHHHHHhCCCchHHhHHHheec
Confidence 344455688888 88888888889999999998754311 012678899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeee---cCCCceE
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILF---SEENVVK 168 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~---~~~~~~k 168 (314)
....++||||+++|+|.+.+...... ...++...+..++.|++.||.||| +++|+|+||||+||++ +..+.++
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~k 167 (285)
T 3is5_A 92 YHNMYIVMETCEGGELLERIVSAQAR-GKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIK 167 (285)
T ss_dssp SSEEEEEECCCSCCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEE
T ss_pred CCeEEEEEEeCCCCcHHHHHHhhhhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEE
Confidence 99999999999999999988542100 034788999999999999999999 9999999999999999 4567899
Q ss_pred EcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHh
Q 043524 169 LFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKN 248 (314)
Q Consensus 169 l~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (314)
|+|||+++...... ......||+.|+|||++. ..++.++||||+|+++|+|++|..||....... ....
T Consensus 168 l~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~--------~~~~ 236 (285)
T 3is5_A 168 IIDFGLAELFKSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE--------VQQK 236 (285)
T ss_dssp ECCCCCCCC------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHH
T ss_pred EEeeecceecCCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH--------HHhh
Confidence 99999997654332 134557899999999875 468899999999999999999999996433111 1111
Q ss_pred hh-ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 249 YF-EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 249 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.. ...... ......+..+.+|+.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~-------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 237 ATYKEPNYA-------------VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp HHHCCCCCC-------------C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred hccCCcccc-------------cccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 000000 000012356789999999999999999999985
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=305.39 Aligned_cols=252 Identities=14% Similarity=0.112 Sum_probs=196.2
Q ss_pred CcccccccCch-hHHHHH-----HHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC---CCceee
Q 043524 14 GKRTLMIGNGA-SVLQEL-----IASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS---HDHILK 84 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~-----~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~ 84 (314)
|.....+|.|+ +.|+++ .+..+++.||+|++..... .++..|++++..++ |+||++
T Consensus 67 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---------------~~~~~e~~~~~~l~~~~~~~iv~ 131 (365)
T 3e7e_A 67 VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---------------WEFYIGTQLMERLKPSMQHMFMK 131 (365)
T ss_dssp EEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---------------HHHHHHHHHHHHSCGGGGGGBCC
T ss_pred EEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---------------hHHHHHHHHHHHhhhhhhhhhhh
Confidence 33444688888 788887 5778899999999875432 35667788888776 999999
Q ss_pred eEeEEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecC-
Q 043524 85 LIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSE- 163 (314)
Q Consensus 85 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~- 163 (314)
+++++..++..|+|||||++|+|.+++..........+++..++.++.|++.||.||| +++|+||||||+||+++.
T Consensus 132 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~ 208 (365)
T 3e7e_A 132 FYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNG 208 (365)
T ss_dssp EEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGG
T ss_pred hheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEeccc
Confidence 9999999999999999999999999997522111145899999999999999999999 999999999999999988
Q ss_pred ----------CCceEEcccccceecCCC-CcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccc
Q 043524 164 ----------ENVVKLFDFSLSISIPEG-ETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLV 232 (314)
Q Consensus 164 ----------~~~~kl~dfg~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 232 (314)
.+.+||+|||+++..... .........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 209 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 288 (365)
T 3e7e_A 209 FLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKN 288 (365)
T ss_dssp GTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred ccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccC
Confidence 889999999999765321 222344567999999999999988999999999999999999999998643
Q ss_pred cCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCC-CHHHHHHHHHHHHhh
Q 043524 233 RDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRP-TMVDVARRLRQICCS 310 (314)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-s~~ell~~L~~~~~~ 310 (314)
...... ........ ..++.+.+++..||+.+|.+|+ ++.++.+.|+++...
T Consensus 289 ~~~~~~--------------------~~~~~~~~-------~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 289 EGGECK--------------------PEGLFRRL-------PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp ETTEEE--------------------ECSCCTTC-------SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CCCcee--------------------echhcccc-------CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 322100 00000000 1134577899999999999995 788998888887654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=308.56 Aligned_cols=275 Identities=20% Similarity=0.327 Sum_probs=198.1
Q ss_pred hhhhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEe
Q 043524 9 KLWSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIG 87 (314)
Q Consensus 9 ~~~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 87 (314)
....+|+....+|.|+ +.|+.+.+..+|+.||+|++....... ...+.+.+|++++..++||||+++++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----------~~~~~~~~E~~~l~~l~h~~iv~~~~ 91 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDK----------MVKKIAMREIKLLKQLRHENLVNLLE 91 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCH----------HHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCch----------HHHHHHHHHHHHHhhCCCCCEeeEEE
Confidence 3455666777899998 889888888999999999875332111 12256789999999999999999999
Q ss_pred EEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCce
Q 043524 88 CCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVV 167 (314)
Q Consensus 88 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~ 167 (314)
++.+++..|+||||+++++|.++.... ..++...+..++.|++.||.||| +++|+|+||||+||+++.++.+
T Consensus 92 ~~~~~~~~~lv~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~ 163 (331)
T 4aaa_A 92 VCKKKKRWYLVFEFVDHTILDDLELFP-----NGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVV 163 (331)
T ss_dssp EEEETTEEEEEEECCSEEHHHHHHHST-----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCE
T ss_pred EeecCCEEEEEEecCCcchHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcE
Confidence 999999999999999988888776543 34889999999999999999999 9999999999999999999999
Q ss_pred EEcccccceecCCCCcccccccccccccccCcccccC-CCCcccchHHHHHHHHHHHhCCCCcccccCccccccc-----
Q 043524 168 KLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYP----- 241 (314)
Q Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~----- 241 (314)
+|+|||.++....... ......||+.|+|||++.+. .++.++||||+|+++|+|++|..||............
T Consensus 164 kl~Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 242 (331)
T 4aaa_A 164 KLCDFGFARTLAAPGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLG 242 (331)
T ss_dssp EECCCTTC-------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred EEEeCCCceeecCCcc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence 9999999976543221 23345789999999998775 6899999999999999999999999754432211000
Q ss_pred -hHHHHHhhhc-cCCcccccChhhhccCC-chhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 242 -FNEYLKNYFE-DNRFTEIVDPIIVQDLS-CTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 242 -~~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
........+. .........+....... .......+..+.+|+..||+.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 243 NLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp SCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000000 00001110010000000 0011134567899999999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=317.56 Aligned_cols=195 Identities=18% Similarity=0.236 Sum_probs=151.0
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|.....+|.|+ +.|+++.+..+|+.||+|++........ ..+++.+|+++|..++|||||++++++.
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~----------~~~~~~~E~~~l~~l~h~niv~l~~~~~ 122 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLI----------DCKRILREIAILNRLNHDHVVKVLDIVI 122 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHH----------HHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHH----------HHHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence 4566667799999 8898898899999999998754211000 1256889999999999999999999995
Q ss_pred eC-----CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCC
Q 043524 91 ET-----PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN 165 (314)
Q Consensus 91 ~~-----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~ 165 (314)
.. ..+|+||||+ +++|.+.+... ..++...+..++.||+.||.||| +++|+||||||+|||++.++
T Consensus 123 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~ 193 (458)
T 3rp9_A 123 PKDVEKFDELYVVLEIA-DSDFKKLFRTP-----VYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDC 193 (458)
T ss_dssp CSCTTTCCCEEEEECCC-SEEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTC
T ss_pred cCCcccCceEEEEEecc-ccchhhhcccC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCC
Confidence 43 5789999998 57999988764 35889999999999999999999 99999999999999999999
Q ss_pred ceEEcccccceecCCCCc--------------------------ccccccccccccccCcccc-cCCCCcccchHHHHHH
Q 043524 166 VVKLFDFSLSISIPEGET--------------------------HITDTVMGTYGHLAPQYVT-TCDFSEKLDVYSFGAF 218 (314)
Q Consensus 166 ~~kl~dfg~~~~~~~~~~--------------------------~~~~~~~g~~~y~aPE~~~-~~~~~~~~DiwslG~~ 218 (314)
.+||+|||+++....... .......||+.|+|||++. ...++.++||||+||+
T Consensus 194 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~i 273 (458)
T 3rp9_A 194 SVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCI 273 (458)
T ss_dssp CEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHH
T ss_pred CEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHH
Confidence 999999999987542211 1123457899999999764 5569999999999999
Q ss_pred HHHHHhC
Q 043524 219 LSELLTG 225 (314)
Q Consensus 219 l~el~~g 225 (314)
+|||++|
T Consensus 274 l~elltg 280 (458)
T 3rp9_A 274 FAELLNM 280 (458)
T ss_dssp HHHHHTT
T ss_pred HHHHHHh
Confidence 9999994
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=307.49 Aligned_cols=267 Identities=15% Similarity=0.236 Sum_probs=192.7
Q ss_pred hhhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeE
Q 043524 10 LWSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGC 88 (314)
Q Consensus 10 ~~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 88 (314)
...+|.....+|.|+ +.|+.+.+..+|+.||+|.+....... ...+++.+|+++++.++||||++++++
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~----------~~~~~~~~E~~~l~~l~hpnIv~l~~~ 92 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE----------LFAKRAYRELRLLKHMRHENVIGLLDV 92 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSH----------HHHHHHHHHHHHHHHCCBTTBCCCSEE
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCH----------HHHHHHHHHHHHHHhCCCcCCCCceee
Confidence 345566667799999 888888888999999999875421100 012568899999999999999999999
Q ss_pred EEeC------CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeec
Q 043524 89 CLET------PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFS 162 (314)
Q Consensus 89 ~~~~------~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~ 162 (314)
+... ..+|+||||+ +++|.+++... .++...+..++.|++.||.||| +++|+||||||+||+++
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~------~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~ 162 (367)
T 1cm8_A 93 FTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVN 162 (367)
T ss_dssp ECSCSSTTTCCCCEEEEECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEC
T ss_pred EecCCccccCceEEEEEecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEc
Confidence 9865 3469999999 78999998763 4788999999999999999999 99999999999999999
Q ss_pred CCCceEEcccccceecCCCCcccccccccccccccCccccc-CCCCcccchHHHHHHHHHHHhCCCCcccccCcccccc-
Q 043524 163 EENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTT-CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVY- 240 (314)
Q Consensus 163 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~- 240 (314)
.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||...........
T Consensus 163 ~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i 238 (367)
T 1cm8_A 163 EDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI 238 (367)
T ss_dssp TTCCEEECCCTTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCCCEEEEeeecccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9999999999999875432 334578999999999877 6799999999999999999999999975432211000
Q ss_pred ------chHHHHHhhhccCCcccc---cChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 241 ------PFNEYLKNYFEDNRFTEI---VDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 241 ------~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
+..+..... ........ .......... ......+..+.+|+.+||..||++|||+.|+++
T Consensus 239 ~~~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 239 MKVTGTPPAEFVQRL-QSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHHHCCCCHHHHHTC-SCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhcCCCCHHHHHHh-hhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 000000000 00000000 0000000000 000133567899999999999999999999987
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=303.37 Aligned_cols=250 Identities=22% Similarity=0.299 Sum_probs=201.0
Q ss_pred hhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEE
Q 043524 11 WSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCC 89 (314)
Q Consensus 11 ~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 89 (314)
...+.....+|.|+ +.|+.+.+..+|+.||+|++....... ..+.+.+|+.++..++||||+++++++
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~i~~~~~~~ 89 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED-----------EIEDIQQEITVLSQCDSPYVTKYYGSY 89 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCST-----------THHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHH-----------HHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 34455666788888 888888888899999999986543110 126788999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEE
Q 043524 90 LETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKL 169 (314)
Q Consensus 90 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl 169 (314)
.+....|+||||+++++|.+++.. .+++...+..++.|++.||.||| +++++|+||||+||+++.++.++|
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl 160 (303)
T 3a7i_A 90 LKDTKLWIIMEYLGGGSALDLLEP------GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKL 160 (303)
T ss_dssp EETTEEEEEEECCTTEEHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEE
T ss_pred ecCCeEEEEEEeCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEE
Confidence 999999999999999999998864 34789999999999999999999 999999999999999999999999
Q ss_pred cccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhh
Q 043524 170 FDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNY 249 (314)
Q Consensus 170 ~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (314)
+|||.+........ ......|++.|+|||++....++.++||||||+++|+|++|..||....... .....
T Consensus 161 ~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~ 231 (303)
T 3a7i_A 161 ADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK--------VLFLI 231 (303)
T ss_dssp CCCTTCEECBTTBC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHH
T ss_pred eecccceecCcccc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH--------HHHHh
Confidence 99999977644322 2345678999999999998889999999999999999999999986433211 01100
Q ss_pred hccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 043524 250 FEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARR 303 (314)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~ 303 (314)
.. .. .+... ...+..+.+|+..||+.||++|||+.|+++.
T Consensus 232 ~~-~~-----~~~~~--------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 232 PK-NN-----PPTLE--------GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp HH-SC-----CCCCC--------SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred hc-CC-----CCCCc--------cccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00 00 00000 1234568899999999999999999999873
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=300.52 Aligned_cols=251 Identities=19% Similarity=0.295 Sum_probs=194.2
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
+.....+|.|+ +.|+.+.+..+++.||+|.+...... ..+.+.+|+.++..++||||+++++++...
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 91 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSR------------YSQPLHEEIALHKHLKHKNIVQYLGSFSEN 91 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---------------HHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchH------------HHHHHHHHHHHHHhCCCCCEeeEeeEEEeC
Confidence 34445688888 88888888889999999988643211 126688999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecC-CCceEEcc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSE-ENVVKLFD 171 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~-~~~~kl~d 171 (314)
+..++||||+++++|.+++...... ..++...+..++.|++.||.||| +++++|+||||+||+++. ++.++|+|
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~D 166 (295)
T 2clq_A 92 GFIKIFMEQVPGGSLSALLRSKWGP--LKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISD 166 (295)
T ss_dssp TEEEEEEECCSEEEHHHHHHHTTCC--CTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECC
T ss_pred CcEEEEEEeCCCCCHHHHHHhhccC--CCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEee
Confidence 9999999999999999999765321 24568888899999999999999 999999999999999987 88999999
Q ss_pred cccceecCCCCcccccccccccccccCcccccCC--CCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhh
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTTCD--FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNY 249 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (314)
||.++....... ......|++.|+|||++.... ++.++||||||+++|+|++|..||........ ......
T Consensus 167 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~ 239 (295)
T 2clq_A 167 FGTSKRLAGINP-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA------AMFKVG 239 (295)
T ss_dssp TTTCEESCC------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH------HHHHHH
T ss_pred cccccccCCCCC-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH------HHHhhc
Confidence 999987643321 234557899999999987654 78999999999999999999999964332110 000000
Q ss_pred hccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 250 FEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
... ..+ .. +...+.++.+|+.+||+.||++|||+.|+++
T Consensus 240 ~~~------~~~----~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 240 MFK------VHP----EI----PESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp HHC------CCC----CC----CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ccc------ccc----cc----cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000 000 00 0133456889999999999999999999985
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=332.09 Aligned_cols=252 Identities=19% Similarity=0.267 Sum_probs=195.0
Q ss_pred cccCch-hHHHHH--HHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCee
Q 043524 19 MIGNGA-SVLQEL--IASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIA 95 (314)
Q Consensus 19 ~~G~g~-~~~~~~--~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (314)
.+|.|+ +.|+++ ....+++.||+|++....... ...+++.+|++++..++|||||++++++. ....
T Consensus 376 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~----------~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~ 444 (635)
T 4fl3_A 376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP----------ALKDELLAEANVMQQLDNPYIVRMIGICE-AESW 444 (635)
T ss_dssp EEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCG----------GGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSE
T ss_pred EeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCH----------HHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCE
Confidence 478888 777766 344567899999986542111 12267899999999999999999999996 4568
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
++|||||++|+|.+++.... .++...++.++.|++.||.||| +++|+||||||+||+++.++.+||+|||++
T Consensus 445 ~lv~E~~~~g~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla 516 (635)
T 4fl3_A 445 MLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLS 516 (635)
T ss_dssp EEEEECCTTEEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHH
T ss_pred EEEEEccCCCCHHHHHhhCC-----CCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCc
Confidence 89999999999999997643 4788999999999999999999 999999999999999999999999999999
Q ss_pred eecCCCCc--ccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhcc
Q 043524 176 ISIPEGET--HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFED 252 (314)
Q Consensus 176 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (314)
+....... .......+|+.|+|||++....++.++|||||||++|||++ |+.||....... ... ....
T Consensus 517 ~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--------~~~-~i~~ 587 (635)
T 4fl3_A 517 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--------VTA-MLEK 587 (635)
T ss_dssp HHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--------HHH-HHHT
T ss_pred cccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHH-HHHc
Confidence 87644321 11223356788999999998899999999999999999998 999996543211 111 1111
Q ss_pred CCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhc
Q 043524 253 NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSL 311 (314)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 311 (314)
... ...+..++.++.+|+..||+.||++|||+.++++.|+++...+
T Consensus 588 ~~~-------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 588 GER-------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp TCC-------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCC-------------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 000 0001134567899999999999999999999999999998765
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=305.49 Aligned_cols=264 Identities=18% Similarity=0.218 Sum_probs=197.3
Q ss_pred hhcCcccccccCch-hHHHHHH-----HhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceee
Q 043524 11 WSKGKRTLMIGNGA-SVLQELI-----ASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILK 84 (314)
Q Consensus 11 ~~~~~~~~~~G~g~-~~~~~~~-----~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 84 (314)
..++.....+|.|+ +.|+.+. +..+|+.||+|.+........ ..++.+|+.++..++||||++
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~E~~~l~~l~h~~iv~ 97 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD-----------ELDFLMEALIISKFNHQNIVR 97 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHH-----------HHHHHHHHHHHHHCCCTTBCC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhh-----------HHHHHHHHHHHhhCCCCCCCe
Confidence 34555666788888 7777766 556788999999853321111 156789999999999999999
Q ss_pred eEeEEEeCCeeEEEEeecCCCCHHHHHhcCCCC--CCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeec
Q 043524 85 LIGCCLETPIAILVFEYVQHGTLWDRILGAPQT--HFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFS 162 (314)
Q Consensus 85 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~ 162 (314)
+++++.++...|+||||+++|+|.+++...... ....++...++.++.|++.||.||| +++|+|+||||+||+++
T Consensus 98 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~ 174 (327)
T 2yfx_A 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLT 174 (327)
T ss_dssp EEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEES
T ss_pred EEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEe
Confidence 999999999999999999999999999865321 1134788999999999999999999 99999999999999998
Q ss_pred C---CCceEEcccccceecCCCCc-ccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccc
Q 043524 163 E---ENVVKLFDFSLSISIPEGET-HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHD 237 (314)
Q Consensus 163 ~---~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~ 237 (314)
. ...++|+|||++........ .......+|+.|+|||++....++.++||||||+++|+|++ |..||......
T Consensus 175 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-- 252 (327)
T 2yfx_A 175 CPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-- 252 (327)
T ss_dssp CSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--
T ss_pred cCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH--
Confidence 4 44699999999875533221 12334567899999999988889999999999999999998 99998643211
Q ss_pred cccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 238 LVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
......... ... ..+...+..+.+++..||+.||++|||+.++++.|..+...
T Consensus 253 ------~~~~~~~~~-~~~-------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 253 ------EVLEFVTSG-GRM-------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp ------HHHHHHHTT-CCC-------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ------HHHHHHhcC-CCC-------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 111111111 000 00013345688999999999999999999999999988653
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=304.07 Aligned_cols=258 Identities=24% Similarity=0.351 Sum_probs=198.7
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGCC 89 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 89 (314)
.+|.....+|.|+ +.|+.+....+|+.||+|++....... .........+.+.+|+.++..+ +||||+++++++
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~----~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERL----SPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCC----CHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc----CHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 4556667789888 888888888899999999876432000 0000001226688999999999 799999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEE
Q 043524 90 LETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKL 169 (314)
Q Consensus 90 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl 169 (314)
...+..|+||||+++++|.+++... ..++...+..++.|++.||.||| ++|++|+||||+||+++.++.++|
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEK-----VALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEE
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEE
Confidence 9999999999999999999998753 34789999999999999999999 999999999999999999999999
Q ss_pred cccccceecCCCCcccccccccccccccCccccc------CCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchH
Q 043524 170 FDFSLSISIPEGETHITDTVMGTYGHLAPQYVTT------CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFN 243 (314)
Q Consensus 170 ~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~ 243 (314)
+|||++........ .....||+.|+|||++.. ..++.++||||||+++|+|++|..||.......
T Consensus 242 ~DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~------- 312 (365)
T 2y7j_A 242 SDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL------- 312 (365)
T ss_dssp CCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------
T ss_pred EecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH-------
Confidence 99999987654322 345679999999998863 357889999999999999999999996432111
Q ss_pred HHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 244 EYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
........ .. ....+.....+..+.+|+..||+.||++|||+.|+++
T Consensus 313 -~~~~i~~~-~~----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 313 -MLRMIMEG-QY----------QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp -HHHHHHHT-CC----------CCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -HHHHHHhC-CC----------CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111100 00 0001111133466899999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=301.96 Aligned_cols=249 Identities=20% Similarity=0.265 Sum_probs=196.9
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
..+.....+|.|+ +.|+.+.+..+|+.||+|.+.... ..+.+.+|+.++..++||||+++++++.
T Consensus 29 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (314)
T 3com_A 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--------------DLQEIIKEISIMQQCDSPHVVKYYGSYF 94 (314)
T ss_dssp -CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--------------CCHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--------------HHHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence 3445556789888 888888888899999999886432 0156889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
..+..|+||||+++++|.+++.... ..++...+..++.+++.||.||| +++++|+||||+||+++.++.++|+
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~ 167 (314)
T 3com_A 95 KNTDLWIVMEYCGAGSVSDIIRLRN----KTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLA 167 (314)
T ss_dssp ETTEEEEEEECCTTEEHHHHHHHHT----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEEC
T ss_pred eCCEEEEEeecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEe
Confidence 9999999999999999999986433 35889999999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhh
Q 043524 171 DFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 171 dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
|||.+........ ......|++.|+|||++....++.++||||+|+++|+|++|..||....... ......
T Consensus 168 dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~ 238 (314)
T 3com_A 168 DFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR--------AIFMIP 238 (314)
T ss_dssp CCTTCEECBTTBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHHH
T ss_pred ecccchhhhhhcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH--------HHHHHh
Confidence 9999977644322 2345578999999999998889999999999999999999999996433211 000000
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.. . .+. ...+...+..+.+|+.+||..||++|||+.++++
T Consensus 239 ~~-~-----~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 239 TN-P-----PPT------FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp HS-C-----CCC------CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cC-C-----Ccc------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00 0 000 0001133466889999999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=301.37 Aligned_cols=251 Identities=23% Similarity=0.292 Sum_probs=190.5
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+++....+|.|+ +.|+.+. .+|+.+|+|++..... .+.+.+|++++..++||||+++++++.
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~--~~~~~vavK~~~~~~~--------------~~~~~~E~~~l~~l~h~~iv~~~~~~~ 84 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKNDAT--------------AQAFLAEASVMTQLRHSNLVQLLGVIV 84 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEE--ETTEEEEEEECCCCC----------------HHHHHTHHHHTTCCCTTBCCEEEEEC
T ss_pred hhceEEeEEecCCCceEEEEE--EcCCEEEEEEecchhH--------------HHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 4455566688888 6666553 3588999999864321 156889999999999999999999976
Q ss_pred eC-CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEE
Q 043524 91 ET-PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKL 169 (314)
Q Consensus 91 ~~-~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl 169 (314)
+. +..++||||+++++|.+++..... ..++...+..++.|++.||.||| +++++|+||||+||+++.++.++|
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l 158 (278)
T 1byg_A 85 EEKGGLYIVTEYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKV 158 (278)
T ss_dssp CC--CCEEEECCCTTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEE
T ss_pred cCCCceEEEEecCCCCCHHHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEE
Confidence 54 578999999999999999875421 23678889999999999999999 999999999999999999999999
Q ss_pred cccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHh
Q 043524 170 FDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKN 248 (314)
Q Consensus 170 ~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 248 (314)
+|||.+...... .....+++.|+|||++.+..++.++||||+|+++|+|++ |..||....... ....
T Consensus 159 ~Dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--------~~~~ 226 (278)
T 1byg_A 159 SDFGLTKEASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPR 226 (278)
T ss_dssp CCCCC----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--------HHHH
T ss_pred eecccccccccc----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHH
Confidence 999998754332 223457889999999988889999999999999999998 999986433211 0111
Q ss_pred hhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 249 YFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
.... . ....+...+..+.+++..||+.||++|||+.|+++.|+++...
T Consensus 227 ~~~~-~-------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 227 VEKG-Y-------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp HTTT-C-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HhcC-C-------------CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 1000 0 0000113446688999999999999999999999999998754
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=303.39 Aligned_cols=258 Identities=20% Similarity=0.267 Sum_probs=192.8
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|.....+|.|+ +.|+.+.+..+|+.||+|++............. .....+.+|+.++..++||||+++++++.
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 85 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREA----DPALNVETEIEILKKLNHPCIIKIKNFFD 85 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC-------------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccc----hhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence 4455566688888 888888888999999999987654321111000 01145789999999999999999999987
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCc---e
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENV---V 167 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~---~ 167 (314)
.+. .|+||||+++++|.+.+... ..++...+..++.|++.||.||| +++|+|+||||+||+++..+. +
T Consensus 86 ~~~-~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~ 156 (322)
T 2ycf_A 86 AED-YYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLI 156 (322)
T ss_dssp SSS-EEEEEECCTTEETHHHHSTT-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCE
T ss_pred CCc-eEEEEecCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeE
Confidence 654 89999999999999988654 35788999999999999999999 999999999999999987654 9
Q ss_pred EEcccccceecCCCCcccccccccccccccCcccc---cCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHH
Q 043524 168 KLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVT---TCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNE 244 (314)
Q Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 244 (314)
+|+|||+++...... ......||+.|+|||++. ...++.++||||+|+++|+|++|..||........ ...
T Consensus 157 kl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~ 230 (322)
T 2ycf_A 157 KITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS----LKD 230 (322)
T ss_dssp EECCCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC----HHH
T ss_pred EEccCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH----HHH
Confidence 999999998764332 233456899999999874 45688999999999999999999999975443221 111
Q ss_pred HHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 245 YLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
... .... ..........+..+.+|+.+||+.||++|||+.|+++
T Consensus 231 ~~~----~~~~----------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 231 QIT----SGKY----------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHH----HTCC----------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHH----hCcc----------ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 100 0000 0001111134567899999999999999999999985
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=300.90 Aligned_cols=250 Identities=18% Similarity=0.261 Sum_probs=200.5
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|.....+|.|+ +.|+.+.+..+|+.+|+|++......... ..+.+.+|+.+++.++||||+++++++.
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~---------~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 85 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPH---------QREKMSMEISIHRSLAHQHVVGFHGFFE 85 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHH---------HHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHH---------HHHHHHHHHHHHHhCCCCCEeeeeeeec
Confidence 4556667789888 88888888889999999998754321100 1256889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
+++..++||||+++++|.+.+... ..++...+..++.|++.||.||| +++++|+||||+||+++.++.++|+
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~ 157 (294)
T 2rku_A 86 DNDFVFVVLELCRRRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIG 157 (294)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEEC
T ss_pred cCCEEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEE
Confidence 999999999999999999988654 24788999999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhh
Q 043524 171 DFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 171 dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
|||.+........ ......||+.|+|||++.+..++.++||||+|+++|+|++|..||....... ......
T Consensus 158 dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~ 228 (294)
T 2rku_A 158 DFGLATKVEYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE--------TYLRIK 228 (294)
T ss_dssp CCTTCEECCSTTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHH
T ss_pred eccCceecccCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHh
Confidence 9999987643322 2334578999999999988889999999999999999999999996433211 111111
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.. . ...+ ...+..+.+++.+||+.||++|||+.|+++
T Consensus 229 ~~-~------------~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 229 KN-E------------YSIP--KHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp TT-C------------CCCC--TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hc-c------------CCCc--cccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 00 0 0000 023356789999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=308.79 Aligned_cols=264 Identities=14% Similarity=0.147 Sum_probs=200.3
Q ss_pred cCcccccccCch-hHHHHHHHhc--------CCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCcee
Q 043524 13 KGKRTLMIGNGA-SVLQELIASS--------NGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHIL 83 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~--------~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 83 (314)
+|.....+|.|+ +.|+.+.+.. +++.||+|++... +.+.+|++++..++||||+
T Consensus 43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----------------~~~~~E~~~l~~l~h~niv 105 (352)
T 2jii_A 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----------------GRLFNEQNFFQRAAKPLQV 105 (352)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----------------STHHHHHHHHHHHCCHHHH
T ss_pred eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----------------chHHHHHHHHHHhcccchh
Confidence 455556788888 7888887766 4889999988643 2467899999999999998
Q ss_pred e---------------eEeEEEe-CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCC
Q 043524 84 K---------------LIGCCLE-TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPR 147 (314)
Q Consensus 84 ~---------------~~~~~~~-~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~ 147 (314)
+ +++++.. +...|+||||+ +++|.+++..... ..++...++.++.|++.||.||| ++
T Consensus 106 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH---~~ 178 (352)
T 2jii_A 106 NKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK---HVLSERSVLQVACRLLDALEFLH---EN 178 (352)
T ss_dssp HHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHH---HT
T ss_pred hhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc---CCCCHHHHHHHHHHHHHHHHHHH---hC
Confidence 8 6777776 78899999999 9999999986521 35889999999999999999999 99
Q ss_pred CceeccCCCCCeeecCCC--ceEEcccccceecCCCCcc------cccccccccccccCcccccCCCCcccchHHHHHHH
Q 043524 148 PIVFRDFKTSHILFSEEN--VVKLFDFSLSISIPEGETH------ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFL 219 (314)
Q Consensus 148 ~i~H~dlk~~nil~~~~~--~~kl~dfg~~~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l 219 (314)
+|+||||||+||+++.++ .++|+|||+++........ ......||+.|+|||++.+..++.++||||||+++
T Consensus 179 ~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 258 (352)
T 2jii_A 179 EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCM 258 (352)
T ss_dssp TCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred CccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHH
Confidence 999999999999999988 8999999999765432211 12344799999999999988899999999999999
Q ss_pred HHHHhCCCCcccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHH
Q 043524 220 SELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVD 299 (314)
Q Consensus 220 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~e 299 (314)
|+|++|+.||......... ........... .....+..... ...+..+.+|+..||+.||++|||+.+
T Consensus 259 ~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~--~~~~~~~~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~ 326 (352)
T 2jii_A 259 LKWLYGFLPWTNCLPNTED---IMKQKQKFVDK--PGPFVGPCGHW-------IRPSETLQKYLKVVMALTYEEKPPYAM 326 (352)
T ss_dssp HHHHHSCCTTGGGTTCHHH---HHHHHHHHHHS--CCCEECTTSCE-------ECCCHHHHHHHHHHHTCCTTCCCCHHH
T ss_pred HHHHhCCCCcccCCcCHHH---HHHHHHhccCC--hhhhhhhcccc-------CCCcHHHHHHHHHHHhCChhhCCCHHH
Confidence 9999999999755422110 11111111100 00111100000 022456899999999999999999999
Q ss_pred HHHHHHHHHhhcc
Q 043524 300 VARRLRQICCSLS 312 (314)
Q Consensus 300 ll~~L~~~~~~~~ 312 (314)
+++.|+++.+...
T Consensus 327 l~~~L~~~~~~~~ 339 (352)
T 2jii_A 327 LRNNLEALLQDLR 339 (352)
T ss_dssp HHHHHHHHHHHTT
T ss_pred HHHHHHHHHHhcC
Confidence 9999999987654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=299.13 Aligned_cols=266 Identities=20% Similarity=0.258 Sum_probs=198.9
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhc--CCCCceeeeEeE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQ--MSHDHILKLIGC 88 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~ 88 (314)
.++.....+|.|+ +.|+.+.. +|+.||+|++..... +.+.+|++++.. ++||||++++++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~---------------~~~~~e~~~~~~~~l~h~ni~~~~~~ 104 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE---------------RSWFREAEIYQTVMLRHENILGFIAA 104 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGH---------------HHHHHHHHHHHHSCCCCTTBCCEEEE
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhH---------------HHHHHHHHHHHHhhcCCCcEEEEEee
Confidence 4555666788887 66766543 589999999875432 346788888877 789999999999
Q ss_pred EEeCC----eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCC-----CCCceeccCCCCCe
Q 043524 89 CLETP----IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGF-----PRPIVFRDFKTSHI 159 (314)
Q Consensus 89 ~~~~~----~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~-----~~~i~H~dlk~~ni 159 (314)
+.... ..++||||+++|+|.+++... .++...++.++.|++.||.|||... +++|+|+||||+||
T Consensus 105 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NI 178 (342)
T 1b6c_B 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 178 (342)
T ss_dssp EECCCSSCCCEEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGE
T ss_pred ecccCCccceeEEEEeecCCCcHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHE
Confidence 98776 789999999999999999753 4788999999999999999999211 37899999999999
Q ss_pred eecCCCceEEcccccceecCCCCcc---cccccccccccccCcccccCC------CCcccchHHHHHHHHHHHhC-----
Q 043524 160 LFSEENVVKLFDFSLSISIPEGETH---ITDTVMGTYGHLAPQYVTTCD------FSEKLDVYSFGAFLSELLTG----- 225 (314)
Q Consensus 160 l~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~------~~~~~DiwslG~~l~el~~g----- 225 (314)
+++.++.++|+|||++......... ......||+.|+|||++.... ++.++||||||+++|+|++|
T Consensus 179 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 258 (342)
T 1b6c_B 179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258 (342)
T ss_dssp EECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred EECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCC
Confidence 9999999999999999776544321 123457999999999987653 23689999999999999999
Q ss_pred -----CCCcccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHH
Q 043524 226 -----RGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDV 300 (314)
Q Consensus 226 -----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~el 300 (314)
..||........ .......... .......+.... .....+..+.+|+.+||+.||++|||+.|+
T Consensus 259 ~~~~~~~p~~~~~~~~~---~~~~~~~~~~-~~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~dp~~Rps~~~i 327 (342)
T 1b6c_B 259 IHEDYQLPYYDLVPSDP---SVEEMRKVVC-EQKLRPNIPNRW-------QSCEALRVMAKIMRECWYANGAARLTALRI 327 (342)
T ss_dssp BCCCCCCTTTTTSCSSC---CHHHHHHHHT-TSCCCCCCCGGG-------GTSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred cccccccCccccCcCcc---cHHHHHHHHH-HHHhCCCCcccc-------cchhHHHHHHHHHHHHhccChhhCCCHHHH
Confidence 556643322211 1111111111 111111111111 112566789999999999999999999999
Q ss_pred HHHHHHHHhhc
Q 043524 301 ARRLRQICCSL 311 (314)
Q Consensus 301 l~~L~~~~~~~ 311 (314)
++.|+++.+..
T Consensus 328 ~~~L~~i~~~~ 338 (342)
T 1b6c_B 328 KKTLSQLSQQE 338 (342)
T ss_dssp HHHHHHHHHTT
T ss_pred HHHHHHHHHHh
Confidence 99999998754
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=312.13 Aligned_cols=206 Identities=16% Similarity=0.177 Sum_probs=167.4
Q ss_pred hhhhhhhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceee
Q 043524 6 RKFKLWSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILK 84 (314)
Q Consensus 6 ~~~~~~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 84 (314)
..+.+-.+|.....+|.|+ +.|+.+.+..+|+.||+|++........ ..+++.+|+++|+.++||||++
T Consensus 20 ~~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~----------~~~~~~~E~~~l~~l~h~nIv~ 89 (432)
T 3n9x_A 20 KNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLI----------DCKRILREITILNRLKSDYIIR 89 (432)
T ss_dssp GGCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHH----------HHHHHHHHHHHHHHCCCTTBCC
T ss_pred CcceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChH----------HHHHHHHHHHHHHHcCCCCcce
Confidence 3455566777777899999 8899999999999999999864211000 1256889999999999999999
Q ss_pred eEeEEEeC-----CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCe
Q 043524 85 LIGCCLET-----PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHI 159 (314)
Q Consensus 85 ~~~~~~~~-----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~ni 159 (314)
+++++... ..+|+||||++ |+|.+.+... ..++...+..++.|++.||.||| +++|+||||||+||
T Consensus 90 l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NI 160 (432)
T 3n9x_A 90 LYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTP-----IFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANC 160 (432)
T ss_dssp EEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGE
T ss_pred EEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHe
Confidence 99999876 57899999995 6999999764 34889999999999999999999 99999999999999
Q ss_pred eecCCCceEEcccccceecCCCCc---------------------ccccccccccccccCccc-ccCCCCcccchHHHHH
Q 043524 160 LFSEENVVKLFDFSLSISIPEGET---------------------HITDTVMGTYGHLAPQYV-TTCDFSEKLDVYSFGA 217 (314)
Q Consensus 160 l~~~~~~~kl~dfg~~~~~~~~~~---------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~~DiwslG~ 217 (314)
+++.++.+||+|||+++....... .......||+.|+|||++ ....++.++||||+||
T Consensus 161 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~ 240 (432)
T 3n9x_A 161 LLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGC 240 (432)
T ss_dssp EECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHH
T ss_pred EECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHH
Confidence 999999999999999987643321 113456789999999986 4556999999999999
Q ss_pred HHHHHHhCCCCcc
Q 043524 218 FLSELLTGRGILD 230 (314)
Q Consensus 218 ~l~el~~g~~p~~ 230 (314)
++|||++|..||.
T Consensus 241 il~ell~g~~p~~ 253 (432)
T 3n9x_A 241 IFAELLNMLQSHI 253 (432)
T ss_dssp HHHHHHTTCTTTC
T ss_pred HHHHHHhcccccc
Confidence 9999998665554
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=305.20 Aligned_cols=270 Identities=17% Similarity=0.237 Sum_probs=198.2
Q ss_pred hhhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeE
Q 043524 10 LWSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGC 88 (314)
Q Consensus 10 ~~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 88 (314)
...+|.....+|.|+ +.|+.+.+..+|+.||+|++...... . .....+.+|++++..++||||++++++
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~---~~~~~~~~E~~~l~~l~h~~iv~~~~~ 84 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-------E---GFPITALREIKILQLLKHENVVNLIEI 84 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS-------S---SSCHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc-------c---cchHHHHHHHHHHHhccCCCcccHhhe
Confidence 345666777899998 88999988899999999988543211 0 112567899999999999999999999
Q ss_pred EEe--------CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCee
Q 043524 89 CLE--------TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHIL 160 (314)
Q Consensus 89 ~~~--------~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil 160 (314)
+.. ++..|+||||++ |++.+.+.... ..++...+..++.|++.||.||| +++|+||||||+||+
T Consensus 85 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl 156 (351)
T 3mi9_A 85 CRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVL 156 (351)
T ss_dssp EEEC--------CEEEEEEECCS-EEHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEE
T ss_pred eeccccccccCCceEEEEEeccC-CCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEE
Confidence 987 456899999996 58888887654 35889999999999999999999 999999999999999
Q ss_pred ecCCCceEEcccccceecCCCC---cccccccccccccccCcccccC-CCCcccchHHHHHHHHHHHhCCCCcccccCcc
Q 043524 161 FSEENVVKLFDFSLSISIPEGE---THITDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGRGILDLVRDAH 236 (314)
Q Consensus 161 ~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~ 236 (314)
++.++.++|+|||+++...... ........||+.|+|||++.+. .++.++||||+||++|+|++|..||.......
T Consensus 157 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 236 (351)
T 3mi9_A 157 ITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH 236 (351)
T ss_dssp ECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred EcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 9999999999999998764322 1123345789999999988764 48999999999999999999999997543221
Q ss_pred ccccchHHHHHhhhc---cCCcccc-----cChh--hhccCCchh----HHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 237 DLVYPFNEYLKNYFE---DNRFTEI-----VDPI--IVQDLSCTE----KEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 237 ~~~~~~~~~~~~~~~---~~~~~~~-----~~~~--~~~~~~~~~----~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
. ......... ...+... .+.. ......... ....+..+.+|+.+||+.||++|||+.|+++
T Consensus 237 ~-----~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 237 Q-----LALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp H-----HHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred H-----HHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 0 000000000 0000000 0000 000000000 0012456889999999999999999999986
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=313.06 Aligned_cols=248 Identities=17% Similarity=0.260 Sum_probs=186.2
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC--CCceeeeEeEEE
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS--HDHILKLIGCCL 90 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~ 90 (314)
|.....+|.|+ +.|+++.+. +|+.||+|++........ ..+.+.+|+.++..++ ||||+++++++.
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~-~~~~vaiK~~~~~~~~~~----------~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~ 126 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQ----------TLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 126 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECTTCCHH----------HHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred eEEEEEEccCCCeEEEEEEcC-CCCEEEEEEEecccccHH----------HHHHHHHHHHHHHHcccCCCeEEEEEEEEe
Confidence 55556788888 777776554 488999999865432111 1267889999999997 599999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
.++.+|+||| +.+++|.+++.... .++...+..++.|++.||.||| +++|+||||||+||+++ ++.+||+
T Consensus 127 ~~~~~~lv~E-~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~ 196 (390)
T 2zmd_A 127 TDQYIYMVME-CGNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLI 196 (390)
T ss_dssp CSSEEEEEEE-CCSEEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEEC
T ss_pred cCCEEEEEEe-cCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEE
Confidence 9999999999 56889999997653 4778889999999999999999 99999999999999995 5789999
Q ss_pred ccccceecCCCCcc-cccccccccccccCccccc-----------CCCCcccchHHHHHHHHHHHhCCCCcccccCcccc
Q 043524 171 DFSLSISIPEGETH-ITDTVMGTYGHLAPQYVTT-----------CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDL 238 (314)
Q Consensus 171 dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~-----------~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~ 238 (314)
|||+++........ ......||+.|+|||++.. ..++.++|||||||++|+|++|..||.......
T Consensus 197 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-- 274 (390)
T 2zmd_A 197 DFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-- 274 (390)
T ss_dssp CCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--
T ss_pred ecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH--
Confidence 99999876443221 2345679999999999865 358899999999999999999999996432211
Q ss_pred ccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 239 VYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
......... ......+. ..+..+.+|+..||..||++|||+.|+++
T Consensus 275 -----~~~~~~~~~---------~~~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 275 -----SKLHAIIDP---------NHEIEFPD----IPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp -----HHHHHHHCT---------TSCCCCCC----CSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----HHHHHHhCc---------cccCCCCc----cchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 111111111 00000000 11346789999999999999999999985
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=308.05 Aligned_cols=268 Identities=16% Similarity=0.241 Sum_probs=191.1
Q ss_pred hhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEE
Q 043524 11 WSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCC 89 (314)
Q Consensus 11 ~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 89 (314)
..+|.....+|.|+ +.|+.+.+..+|+.||+|++........ ..+.+.+|+.+++.++||||+++++++
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~~E~~~l~~l~hpniv~~~~~~ 93 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT----------HAKRAYRELVLMKCVNHKNIIGLLNVF 93 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHH----------HHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChH----------HHHHHHHHHHHHHhcCCCCccceEEee
Confidence 34566667799988 8888888888999999999864321100 125678999999999999999999999
Q ss_pred EeCC------eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecC
Q 043524 90 LETP------IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSE 163 (314)
Q Consensus 90 ~~~~------~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~ 163 (314)
.... ..|+||||++ |+|.+.+.. .++...+..++.|++.||.||| +++|+||||||+||+++.
T Consensus 94 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~ 162 (371)
T 2xrw_A 94 TPQKSLEEFQDVYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKS 162 (371)
T ss_dssp CSCCSTTTCCEEEEEEECCS-EEHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECT
T ss_pred ccccccccccceEEEEEcCC-CCHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcC
Confidence 8654 7899999996 588888753 3778899999999999999999 999999999999999999
Q ss_pred CCceEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCcccc-----
Q 043524 164 ENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDL----- 238 (314)
Q Consensus 164 ~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~----- 238 (314)
++.+||+|||+++...... ......||+.|+|||++.+..++.++||||+||++|+|++|..||.........
T Consensus 163 ~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 240 (371)
T 2xrw_A 163 DCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 240 (371)
T ss_dssp TSCEEECCCCC------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC
T ss_pred CCCEEEEEeeccccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999999997654322 233567899999999999988999999999999999999999999754321100
Q ss_pred --ccchHHHH-------Hhhhcc-C-----CcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 239 --VYPFNEYL-------KNYFED-N-----RFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 239 --~~~~~~~~-------~~~~~~-~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
..+...+. ...... . .+........ .+.........+..+.+|+.+||..||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 241 QLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVL-FPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp -CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGG-SCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhccccc-CcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 00001110 000000 0 0001111111 11112223345778999999999999999999999987
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=297.59 Aligned_cols=259 Identities=20% Similarity=0.284 Sum_probs=199.2
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
|.....+|.|+ +.|+.+.+..+|+.+|+|++........ ......+.+.+|+.++..++||||+++++++.++
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T 3bhy_A 7 YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSS------RRGVSREEIEREVNILREIRHPNIITLHDIFENK 80 (283)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTC------SSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhcccccc------ccchHHHHHHHHHHHHHhCCCCCeeehhheecCC
Confidence 34445588888 8888888888999999998865432111 1111236788999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCC----ceE
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN----VVK 168 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~----~~k 168 (314)
...++||||+++++|.+++... ..++...+..++.|++.||.||| +++++|+||||+||+++.++ .++
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~k 152 (283)
T 3bhy_A 81 TDVVLILELVSGGELFDFLAEK-----ESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIK 152 (283)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEE
T ss_pred CeEEEEEeecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceE
Confidence 9999999999999999998753 34789999999999999999999 99999999999999998877 799
Q ss_pred EcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHh
Q 043524 169 LFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKN 248 (314)
Q Consensus 169 l~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (314)
|+|||.+........ .....|++.|+|||++....++.++||||+|+++|+|++|..||....... ....
T Consensus 153 l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~ 222 (283)
T 3bhy_A 153 LIDFGIAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE--------TLTN 222 (283)
T ss_dssp ECCCTTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHH
T ss_pred EEecccceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH--------HHHH
Confidence 999999987644322 334568999999999988889999999999999999999999996433211 1111
Q ss_pred hhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH--HHHHH
Q 043524 249 YFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR--RLRQI 307 (314)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~--~L~~~ 307 (314)
.... . ...+.......+..+.+|+.+||..||++|||+.|+++ .++++
T Consensus 223 ~~~~-~----------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 223 ISAV-N----------YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp HHTT-C----------CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred hHhc-c----------cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 1000 0 00111111234567899999999999999999999997 44544
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=306.80 Aligned_cols=250 Identities=19% Similarity=0.269 Sum_probs=200.6
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|.....+|.|+ +.|+.+.+..+++.+|+|++......... ..+.+.+|+.+++.++||||+++++++.
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~---------~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 111 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPH---------QREKMSMEISIHRSLAHQHVVGFHGFFE 111 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHH---------HHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHH---------HHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 4556667789888 88888888889999999998754321100 1256889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
+.+..|+||||+++++|.+++... ..++...+..++.|++.||.||| +++|+|+||||+||+++.++.++|+
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~ 183 (335)
T 2owb_A 112 DNDFVFVVLELCRRRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIG 183 (335)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEEC
T ss_pred cCCeEEEEEecCCCCCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEe
Confidence 999999999999999999988754 24788999999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhh
Q 043524 171 DFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 171 dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
|||+++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...... +......
T Consensus 184 Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~~~ 254 (335)
T 2owb_A 184 DFGLATKVEYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--------ETYLRIK 254 (335)
T ss_dssp CCTTCEECCSTTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHH
T ss_pred eccCceecccCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH--------HHHHHHh
Confidence 9999987643322 234557899999999998888999999999999999999999999643211 1111111
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.. ....+ ...+..+.+|+.+||+.||++|||+.|+++
T Consensus 255 ~~-------------~~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 255 KN-------------EYSIP--KHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp HT-------------CCCCC--TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cC-------------CCCCC--ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00000 023356789999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=303.65 Aligned_cols=255 Identities=18% Similarity=0.218 Sum_probs=195.7
Q ss_pred hhhhhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeE
Q 043524 8 FKLWSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLI 86 (314)
Q Consensus 8 ~~~~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 86 (314)
+....+|.....+|.|+ +.|+.+.+..+|+.+|+|++...... ..+.+.+|++++..++||||++++
T Consensus 15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~------------~~~~~~~e~~~l~~l~h~~i~~~~ 82 (302)
T 2j7t_A 15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE------------ELEDYIVEIEILATCDHPYIVKLL 82 (302)
T ss_dssp SCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----C------------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHH------------HHHHHHHHHHHHhcCCCCCEeeee
Confidence 44556666777799988 88898888889999999998754321 126788999999999999999999
Q ss_pred eEEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCc
Q 043524 87 GCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENV 166 (314)
Q Consensus 87 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~ 166 (314)
+++..++..++||||+++++|.+++.... ..++...+..++.|++.||.||| +++++|+||||+||+++.++.
T Consensus 83 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~ 155 (302)
T 2j7t_A 83 GAYYHDGKLWIMIEFCPGGAVDAIMLELD----RGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGD 155 (302)
T ss_dssp EEEECC-CEEEEEECCTTEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSC
T ss_pred eeeeeCCeEEEEEEeCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCC
Confidence 99999999999999999999999887543 35889999999999999999999 999999999999999999999
Q ss_pred eEEcccccceecCCCCcccccccccccccccCcccc-----cCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccc
Q 043524 167 VKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVT-----TCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYP 241 (314)
Q Consensus 167 ~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~ 241 (314)
++|+|||++....... .......||+.|+|||++. ...++.++||||+|+++|+|++|..||.......
T Consensus 156 ~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----- 229 (302)
T 2j7t_A 156 IRLADFGVSAKNLKTL-QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR----- 229 (302)
T ss_dssp EEECCCHHHHHHHHHH-HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----
T ss_pred EEEEECCCCccccccc-cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-----
Confidence 9999999875432111 1123456899999999883 5668899999999999999999999986433211
Q ss_pred hHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 242 FNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
........ .... ...+...+..+.+++..||+.||++|||+.|+++
T Consensus 230 ---~~~~~~~~-~~~~-----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 230 ---VLLKIAKS-DPPT-----------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp ---HHHHHHHS-CCCC-----------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ---HHHHHhcc-CCcc-----------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 11111111 0000 0011134567899999999999999999999986
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=309.02 Aligned_cols=248 Identities=18% Similarity=0.264 Sum_probs=184.5
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCC--CceeeeEeEEE
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSH--DHILKLIGCCL 90 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~ 90 (314)
|.....+|.|+ +.|+++.+ .+++.||+|++........ ..+.+.+|+.++..++| |||+++++++.
T Consensus 11 y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~----------~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~ 79 (343)
T 3dbq_A 11 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQ----------TLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 79 (343)
T ss_dssp EEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHH----------HHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred EEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchH----------HHHHHHHHHHHHHhhhhcCCceEEEeeeEe
Confidence 44555688888 77776655 5688999998864421111 12568899999999986 99999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
++...|+||| +.+++|.+++.... .++...+..++.|++.||.||| +++|+||||||+||+++ ++.+||+
T Consensus 80 ~~~~~~lv~e-~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~ 149 (343)
T 3dbq_A 80 TDQYIYMVME-CGNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLI 149 (343)
T ss_dssp CSSEEEEEEC-CCSEEHHHHHHHSC-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEEC
T ss_pred eCCEEEEEEe-CCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEe
Confidence 9999999999 55789999998653 5788999999999999999999 99999999999999997 5789999
Q ss_pred ccccceecCCCCcc-cccccccccccccCccccc-----------CCCCcccchHHHHHHHHHHHhCCCCcccccCcccc
Q 043524 171 DFSLSISIPEGETH-ITDTVMGTYGHLAPQYVTT-----------CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDL 238 (314)
Q Consensus 171 dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~-----------~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~ 238 (314)
|||+++........ ......||+.|+|||++.. ..++.++||||+||++|+|++|+.||.......
T Consensus 150 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-- 227 (343)
T 3dbq_A 150 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-- 227 (343)
T ss_dssp CCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH--
T ss_pred ecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH--
Confidence 99999776443221 2335579999999999864 568899999999999999999999996432211
Q ss_pred ccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 239 VYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
......... ......+. ..+..+.+|+..||+.||++|||+.|+++
T Consensus 228 -----~~~~~~~~~---------~~~~~~~~----~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 228 -----SKLHAIIDP---------NHEIEFPD----IPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp -----HHHHHHHCT---------TSCCCCCC----CSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----HHHHHHhcC---------CcccCCcc----cCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 011111110 00000000 12345789999999999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=302.40 Aligned_cols=263 Identities=16% Similarity=0.186 Sum_probs=196.2
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC-CCceeeeEeEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS-HDHILKLIGCC 89 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~ 89 (314)
.+|.....+|.|+ +.|+.+.+..+|+.||+|++..... +.+.+|+.++..++ ||||+++++++
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------------~~~~~E~~~l~~l~~~~~i~~~~~~~ 100 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---------------KKIKREIKILENLRGGPNIITLADIV 100 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCH---------------HHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccch---------------HHHHHHHHHHHHcCCCCCEEEeeeee
Confidence 4555666789888 8888888889999999999864321 45789999999997 99999999999
Q ss_pred Ee--CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCC-c
Q 043524 90 LE--TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN-V 166 (314)
Q Consensus 90 ~~--~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~-~ 166 (314)
.+ ....++||||+++++|.+.+. .++...+..++.|++.||.||| +++|+||||||+||+++.++ .
T Consensus 101 ~~~~~~~~~lv~e~~~~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~ 169 (330)
T 3nsz_A 101 KDPVSRTPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRK 169 (330)
T ss_dssp ECTTTCCEEEEEECCCCCCHHHHGG--------GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTE
T ss_pred ccCCCCceEEEEeccCchhHHHHHH--------hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCE
Confidence 87 677899999999999998873 3778899999999999999999 99999999999999999776 8
Q ss_pred eEEcccccceecCCCCcccccccccccccccCccccc-CCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHH
Q 043524 167 VKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTT-CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEY 245 (314)
Q Consensus 167 ~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 245 (314)
++|+|||+++....... .....++..|+|||++.. ..++.++||||+||++|+|++|..||.......+........
T Consensus 170 ~kl~Dfg~a~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~ 247 (330)
T 3nsz_A 170 LRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 247 (330)
T ss_dssp EEECCCTTCEECCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHH
T ss_pred EEEEeCCCceEcCCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHh
Confidence 99999999987644332 345578999999999877 568999999999999999999999995433221111000000
Q ss_pred H-----HhhhccCC--ccccc--------ChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 246 L-----KNYFEDNR--FTEIV--------DPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 246 ~-----~~~~~~~~--~~~~~--------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
. ........ ..... ................+.++.+|+..||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 248 LGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 00000000 00000 0000000011111134567899999999999999999999986
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=307.29 Aligned_cols=248 Identities=20% Similarity=0.238 Sum_probs=192.6
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC-CCceeeeEeEEEeCCee
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS-HDHILKLIGCCLETPIA 95 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 95 (314)
..+|.|+ +.|+++.+..+|+.||+|++....... ....++.+|+.++..++ ||||+++++++.++...
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----------~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~ 104 (327)
T 3lm5_A 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ----------DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI 104 (327)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE----------ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred ceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch----------HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence 4588888 888888888899999999886532110 11256889999999995 69999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecC---CCceEEccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSE---ENVVKLFDF 172 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~---~~~~kl~df 172 (314)
++||||+++|+|.+++..... ..++...++.++.|++.||.||| +++|+||||||+||+++. .+.++|+||
T Consensus 105 ~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPELA---EMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp EEEEECCTTEEGGGGGSSCC----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred EEEEEecCCCcHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEeeC
Confidence 999999999999998865432 45889999999999999999999 999999999999999987 789999999
Q ss_pred ccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhcc
Q 043524 173 SLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFED 252 (314)
Q Consensus 173 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (314)
|+++....... .....||+.|+|||++....++.++||||+|+++|+|++|..||....... ........
T Consensus 179 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------~~~~i~~~ 248 (327)
T 3lm5_A 179 GMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE--------TYLNISQV 248 (327)
T ss_dssp GGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHT
T ss_pred ccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--------HHHHHHhc
Confidence 99987643322 334579999999999998899999999999999999999999996533211 01110000
Q ss_pred CCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 253 NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
. ...........+..+.+|+..||+.||++|||+.|+++
T Consensus 249 -~----------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 249 -N----------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp -C----------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -c----------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 0 00000111134466889999999999999999999975
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=300.23 Aligned_cols=261 Identities=23% Similarity=0.366 Sum_probs=191.1
Q ss_pred hcCcccccccCch-hHHHHHHHh-cCCc--ccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEe
Q 043524 12 SKGKRTLMIGNGA-SVLQELIAS-SNGK--YIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIG 87 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~-~~g~--~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 87 (314)
.+++....+|.|+ +.|+.+... .+++ .||+|++......... ..+.+.+|++++..++||||+++++
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~ 88 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE---------AMDDFIREVNAMHSLDHRNLIRLYG 88 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CH---------HHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHH---------HHHHHHHHHHHHHhCCCCCcccEEE
Confidence 3455556688888 777776533 2333 6899998765332111 2267889999999999999999999
Q ss_pred EEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCce
Q 043524 88 CCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVV 167 (314)
Q Consensus 88 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~ 167 (314)
++.++. .++|+||+++++|.+.+.... ..++...+..++.|++.||.||| +++++|+||||+||+++.++.+
T Consensus 89 ~~~~~~-~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~ 160 (291)
T 1u46_A 89 VVLTPP-MKMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLV 160 (291)
T ss_dssp EECSSS-CEEEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEE
T ss_pred EEccCC-ceeeEecccCCCHHHHHHhcc----CCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCE
Confidence 998765 889999999999999987643 35788999999999999999999 9999999999999999999999
Q ss_pred EEcccccceecCCCCcc--cccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHH
Q 043524 168 KLFDFSLSISIPEGETH--ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNE 244 (314)
Q Consensus 168 kl~dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~ 244 (314)
+|+|||++......... ......+|..|+|||++....++.++||||+|+++|+|++ |..||...... .
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~ 232 (291)
T 1u46_A 161 KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--------Q 232 (291)
T ss_dssp EECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------H
T ss_pred EEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH--------H
Confidence 99999999876543221 1223457888999999988888999999999999999999 99998644321 1
Q ss_pred HHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 245 YLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
.......... ..+.....+..+.+++..||+.||++|||+.++++.|+++...
T Consensus 233 ~~~~~~~~~~-------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 233 ILHKIDKEGE-------------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp HHHHHHTSCC-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred HHHHHHccCC-------------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 1111111100 0001113456789999999999999999999999999988653
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=304.49 Aligned_cols=262 Identities=18% Similarity=0.294 Sum_probs=200.6
Q ss_pred hcCcccccccCch-hHHHHHHHh-----cCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeee
Q 043524 12 SKGKRTLMIGNGA-SVLQELIAS-----SNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKL 85 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~-----~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 85 (314)
.++.....+|.|+ +.|+.+... .+++.||+|.+........ ..++.+|++++..++||||+++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~~E~~~l~~l~h~~i~~~ 93 (322)
T 1p4o_A 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE-----------RIEFLNEASVMKEFNCHHVVRL 93 (322)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHH-----------HHHHHHHHHHGGGCCCTTBCCE
T ss_pred hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHH-----------HHHHHHHHHHHHhcCCCCEeee
Confidence 3445556688888 777776544 4678899999864422111 1568899999999999999999
Q ss_pred EeEEEeCCeeEEEEeecCCCCHHHHHhcCCC-----CCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCee
Q 043524 86 IGCCLETPIAILVFEYVQHGTLWDRILGAPQ-----THFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHIL 160 (314)
Q Consensus 86 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~-----~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil 160 (314)
++++.+++..++||||+++|+|.+++..... ....+++...++.++.|++.||.||| +++|+||||||+||+
T Consensus 94 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIl 170 (322)
T 1p4o_A 94 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCM 170 (322)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEE
T ss_pred EEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEE
Confidence 9999999999999999999999999865210 11134688899999999999999999 999999999999999
Q ss_pred ecCCCceEEcccccceecCCCCc-ccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCcccc
Q 043524 161 FSEENVVKLFDFSLSISIPEGET-HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDL 238 (314)
Q Consensus 161 ~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~ 238 (314)
++.++.++|+|||+++....... .......+|+.|+|||++.+..++.++||||+|+++|+|++ |..||.......
T Consensus 171 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-- 248 (322)
T 1p4o_A 171 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-- 248 (322)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH--
T ss_pred EcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH--
Confidence 99999999999999876533221 11233456889999999988889999999999999999999 888986433211
Q ss_pred ccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHh
Q 043524 239 VYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICC 309 (314)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 309 (314)
........ .... .+...+..+.+|+..||+.||++|||+.|+++.|+++..
T Consensus 249 ------~~~~~~~~-~~~~-------------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 249 ------VLRFVMEG-GLLD-------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp ------HHHHHHTT-CCCC-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ------HHHHHHcC-CcCC-------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11111111 0000 001344568899999999999999999999999987643
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=303.64 Aligned_cols=264 Identities=19% Similarity=0.284 Sum_probs=180.3
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.++.....+|.|+ +.|+.+.+..+|+.||+|++........ .+++.+|+.++..++||||+++++++.
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~~~~~~~ 83 (303)
T 2vwi_A 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS-----------MDELLKEIQAMSQCHHPNIVSYYTSFV 83 (303)
T ss_dssp CCCEEEEECC---CCCEEEEEC----CEEEEECCC---------------------------CCCCCCCTTBCCEEEEEE
T ss_pred hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchh-----------HHHHHHHHHHHhhcCCCCEeeEEEEEe
Confidence 3455566789988 8888888888999999999876543221 156789999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcC---CCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCce
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGA---PQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVV 167 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~---~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~ 167 (314)
.++..++||||+++++|.+++... .......++...+..++.|++.||.||| +++++|+||||+||+++.++.+
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~ 160 (303)
T 2vwi_A 84 VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSV 160 (303)
T ss_dssp SSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCE
T ss_pred ecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCE
Confidence 999999999999999999988641 0011135889999999999999999999 9999999999999999999999
Q ss_pred EEcccccceecCCCC----cccccccccccccccCccccc-CCCCcccchHHHHHHHHHHHhCCCCcccccCccccccch
Q 043524 168 KLFDFSLSISIPEGE----THITDTVMGTYGHLAPQYVTT-CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPF 242 (314)
Q Consensus 168 kl~dfg~~~~~~~~~----~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~ 242 (314)
+|+|||.+....... ........||+.|+|||++.. ..++.++||||+|+++|+|++|..||........
T Consensus 161 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----- 235 (303)
T 2vwi_A 161 QIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV----- 235 (303)
T ss_dssp EECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-----
T ss_pred EEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH-----
Confidence 999999987653321 111234578999999998876 4689999999999999999999999975432210
Q ss_pred HHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 243 NEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
... .... .............. ....+..+.+|+..||+.||++|||+.|+++
T Consensus 236 --~~~-~~~~-~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 236 --LML-TLQN-DPPSLETGVQDKEM----LKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp --HHH-HHTS-SCCCTTC-----CC----CCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --HHH-Hhcc-CCCccccccccchh----hhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 000 0000 00000000000000 0023456889999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=294.68 Aligned_cols=253 Identities=17% Similarity=0.236 Sum_probs=195.4
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|.....+|.|+ +.|+.+.+..+|+.+|+|++.......... ..+.+.+|++++..++||||+++++++.
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~--------~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 76 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPN--------GEANVKKEIQLLRRLRHKNVIQLVDVLY 76 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTT--------HHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccch--------hHHHHHHHHHHHHhcCCCCeeEEEEEEE
Confidence 4566667789888 888888888899999999998776543110 1267889999999999999999999984
Q ss_pred --eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceE
Q 043524 91 --ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVK 168 (314)
Q Consensus 91 --~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~k 168 (314)
++...|+||||++++ +.+.+..... ..++...+..++.|++.||.||| +++++|+||||+||+++.++.++
T Consensus 77 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~k 149 (305)
T 2wtk_C 77 NEEKQKMYMVMEYCVCG-MQEMLDSVPE---KRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLK 149 (305)
T ss_dssp CC---CEEEEEECCSEE-HHHHHHHSTT---CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEE
T ss_pred cCCCCeEEEEehhccCC-HHHHHHhCcc---cccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEE
Confidence 556889999999765 7777765432 35888999999999999999999 99999999999999999999999
Q ss_pred EcccccceecCCCC-cccccccccccccccCcccccCC--CCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHH
Q 043524 169 LFDFSLSISIPEGE-THITDTVMGTYGHLAPQYVTTCD--FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEY 245 (314)
Q Consensus 169 l~dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 245 (314)
|+|||.+....... ........||+.|+|||++.+.. ++.++||||+|+++|+|++|..||..... ...
T Consensus 150 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~ 221 (305)
T 2wtk_C 150 ISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI--------YKL 221 (305)
T ss_dssp ECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHH
T ss_pred eeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH--------HHH
Confidence 99999998764321 12234556899999999987654 37799999999999999999999964321 111
Q ss_pred HHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 246 LKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
....... ....+ ...+..+.+|+.+||+.||++|||+.|+++
T Consensus 222 ~~~i~~~-------------~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 222 FENIGKG-------------SYAIP--GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp HHHHHHC-------------CCCCC--SSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHhcC-------------CCCCC--CccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111110 00000 123456789999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=312.49 Aligned_cols=254 Identities=11% Similarity=0.009 Sum_probs=175.6
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC--CCCceeeeE----
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM--SHDHILKLI---- 86 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~---- 86 (314)
+.....+|.|+ +.|+++.+..+|+.||+|++......... ..+.+.+|+.++..+ +||||++++
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---------~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~ 134 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRS---------ELERLHEATFAAARLLGESPEEARDRRRLL 134 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHH---------HHHHHHHHHHHHHHHHC----------CBC
T ss_pred eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccccccc---------HHHHHHHHHHHHHHhcccChhhhhhceeEE
Confidence 45566789888 88889888889999999998874321111 114567775444444 699988755
Q ss_pred ---eEEEeC-----------------CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHH------HHHHHHHHHHHHH
Q 043524 87 ---GCCLET-----------------PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRR------LKDAVDAANALAY 140 (314)
Q Consensus 87 ---~~~~~~-----------------~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~------~~~~~~i~~~l~~ 140 (314)
+++... ..+|+|||||+ |+|.+++..... .+....+ ..++.|++.||.|
T Consensus 135 ~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~~vk~~i~~qi~~aL~~ 209 (371)
T 3q60_A 135 LPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF----VYVFRGDEGILALHILTAQLIRLAAN 209 (371)
T ss_dssp CCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred eeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc----ccchhhhhhhhhHHHHHHHHHHHHHH
Confidence 555543 33899999998 899999976421 1233333 5666999999999
Q ss_pred hhcCCCCCceeccCCCCCeeecCCCceEEcccccceecCCCCcccccccccccccccCccccc--CCCCcccchHHHHHH
Q 043524 141 LHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTT--CDFSEKLDVYSFGAF 218 (314)
Q Consensus 141 lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~~ 218 (314)
|| +++|+||||||+||+++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++||||+||+
T Consensus 210 LH---~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~i 282 (371)
T 3q60_A 210 LQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLS 282 (371)
T ss_dssp HH---HTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHH
T ss_pred HH---HCCCccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHH
Confidence 99 999999999999999999999999999999875332 224457799999999987 679999999999999
Q ss_pred HHHHHhCCCCcccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHH
Q 043524 219 LSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMV 298 (314)
Q Consensus 219 l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ 298 (314)
+|+|++|+.||.......... +....... ........+.....+..+.+|+.+||+.||++|||+.
T Consensus 283 l~elltg~~Pf~~~~~~~~~~----------~~~~~~~~----~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 348 (371)
T 3q60_A 283 IYRVWCLFLPFGLVTPGIKGS----------WKRPSLRV----PGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPL 348 (371)
T ss_dssp HHHHHHSSCSTTBCCTTCTTC----------CCBCCTTS----CCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHH
T ss_pred HHHHHhCCCCCCCcCcccccc----------hhhhhhhh----ccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHH
Confidence 999999999997553321000 00000000 0000111111113456789999999999999999999
Q ss_pred HHHH
Q 043524 299 DVAR 302 (314)
Q Consensus 299 ell~ 302 (314)
|+++
T Consensus 349 e~l~ 352 (371)
T 3q60_A 349 EAME 352 (371)
T ss_dssp HHTT
T ss_pred HHhc
Confidence 9975
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=305.84 Aligned_cols=268 Identities=16% Similarity=0.221 Sum_probs=198.1
Q ss_pred hhhhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEe
Q 043524 9 KLWSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIG 87 (314)
Q Consensus 9 ~~~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 87 (314)
..-.+|.....+|.|+ +.|+.+.+..+|+.||+|++....... ..+.+.+|++++..++||||+++++
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~~~~ 92 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQT-----------YCQRTLREIKILLRFRHENIIGIND 92 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHH-----------HHHHHHHHHHHHHHCCCTTBCCCCE
T ss_pred cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcH-----------HHHHHHHHHHHHHhcCCCCCcccee
Confidence 3345677777899998 888888888899999999986432111 1256889999999999999999999
Q ss_pred EEEeC-----CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeec
Q 043524 88 CCLET-----PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFS 162 (314)
Q Consensus 88 ~~~~~-----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~ 162 (314)
++... ...|+|+||++ |+|.+.+... .++...+..++.|++.||.||| +++|+||||||+||+++
T Consensus 93 ~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~ 162 (364)
T 3qyz_A 93 IIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQ------HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLN 162 (364)
T ss_dssp EECCSSTTTCCCEEEEEECCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEC
T ss_pred EEecCCccccceEEEEEcccC-cCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEEC
Confidence 99765 46899999996 6999988753 4788999999999999999999 99999999999999999
Q ss_pred CCCceEEcccccceecCCCCcc--cccccccccccccCcccccC-CCCcccchHHHHHHHHHHHhCCCCcccccCccccc
Q 043524 163 EENVVKLFDFSLSISIPEGETH--ITDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLV 239 (314)
Q Consensus 163 ~~~~~kl~dfg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~ 239 (314)
.++.++|+|||+++........ ......||+.|+|||++... .++.++||||+||++|+|++|+.||.........
T Consensus 163 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~- 241 (364)
T 3qyz_A 163 TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL- 241 (364)
T ss_dssp TTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHH-
T ss_pred CCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHH-
Confidence 9999999999999876433211 12345799999999987654 4899999999999999999999999754432211
Q ss_pred cchHHHHHhhhccCC---cccccCh-------hhhccCCch---hHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 240 YPFNEYLKNYFEDNR---FTEIVDP-------IIVQDLSCT---EKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 240 ~~~~~~~~~~~~~~~---~~~~~~~-------~~~~~~~~~---~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
..... ...... +....+. ........+ .....+..+.+|+.+||+.||++|||+.|+++
T Consensus 242 ---~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 242 ---NHILG-ILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp ---HHHHH-HHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---HHHHH-HhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000 000000 0000000 000000000 00123467899999999999999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=294.94 Aligned_cols=260 Identities=22% Similarity=0.314 Sum_probs=200.1
Q ss_pred hhhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcc-cCChhHHHHHHHHHHHhcCC-CCceeeeE
Q 043524 10 LWSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQ-KNGFWHESCINNVTYAAQMS-HDHILKLI 86 (314)
Q Consensus 10 ~~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~ 86 (314)
...+|.....+|.|+ +.|+.+.+..+|+.||+|++...... .+.. ......+.+.+|++++..+. ||||++++
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~ 90 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGG----SFSAEEVQELREATLKEVDILRKVSGHPNIIQLK 90 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCST----TCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEeccccc----ccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeee
Confidence 345566667789888 88888888889999999998643200 0000 00001266889999999996 99999999
Q ss_pred eEEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCc
Q 043524 87 GCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENV 166 (314)
Q Consensus 87 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~ 166 (314)
+++.+++..++||||+++++|.+++... ..++...+..++.|++.||.||| +++++|+||||+||+++.++.
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~ 162 (298)
T 1phk_A 91 DTYETNTFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMN 162 (298)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCC
T ss_pred eeeccCCeEEEEEeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCc
Confidence 9999999999999999999999999764 35788999999999999999999 999999999999999999999
Q ss_pred eEEcccccceecCCCCcccccccccccccccCcccc------cCCCCcccchHHHHHHHHHHHhCCCCcccccCcccccc
Q 043524 167 VKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVT------TCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVY 240 (314)
Q Consensus 167 ~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~ 240 (314)
++|+|||.+........ .....|++.|+|||++. ...++.++||||+|+++|+|++|..||......
T Consensus 163 ~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----- 235 (298)
T 1phk_A 163 IKLTDFGFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM----- 235 (298)
T ss_dssp EEECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----
T ss_pred EEEecccchhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH-----
Confidence 99999999987644322 34557899999999885 345788999999999999999999999643311
Q ss_pred chHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 241 PFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
......... ... ...+.....+..+.+|+.+||+.||++|||+.|+++
T Consensus 236 ---~~~~~~~~~-~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 236 ---LMLRMIMSG-NYQ----------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp ---HHHHHHHHT-CCC----------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ---HHHHHHhcC-Ccc----------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 111111110 000 000111134567899999999999999999999985
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=308.17 Aligned_cols=197 Identities=18% Similarity=0.246 Sum_probs=167.7
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC------CCCceeee
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM------SHDHILKL 85 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~ 85 (314)
+|.....+|.|+ +.|+++.+..+|+.||+|++...... .+.+.+|++++..+ .|+||+++
T Consensus 98 ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~-------------~~~~~~E~~~l~~l~~~~~~~~~~iv~~ 164 (429)
T 3kvw_A 98 RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRF-------------HRQAAEEIRILEHLRKQDKDNTMNVIHM 164 (429)
T ss_dssp TEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHH-------------HHHHHHHHHHHHHHHTTCTTSCSCBCCE
T ss_pred cEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccch-------------HHHHHHHHHHHHHHhhccccCCcCEEEE
Confidence 455566789988 88999988999999999998754321 14456777777766 57799999
Q ss_pred EeEEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCC
Q 043524 86 IGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN 165 (314)
Q Consensus 86 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~ 165 (314)
++++...+.+|+||||+. ++|.+.+..... ..++...+..++.|++.||.||| +++|+||||||+||+++.++
T Consensus 165 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~ 237 (429)
T 3kvw_A 165 LENFTFRNHICMTFELLS-MNLYELIKKNKF---QGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQG 237 (429)
T ss_dssp EEEEEETTEEEEEECCCC-CBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTT
T ss_pred EeecccCCeEEEEEeccC-CCHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCC
Confidence 999999999999999995 699999877543 34788999999999999999999 99999999999999999988
Q ss_pred c--eEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCccccc
Q 043524 166 V--VKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVR 233 (314)
Q Consensus 166 ~--~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 233 (314)
. +||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 238 ~~~vkL~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 238 RSGIKVIDFGSSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp SCCEEECCCTTCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CcceEEeecccceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 7 999999999765332 335678999999999999999999999999999999999999997544
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=297.30 Aligned_cols=253 Identities=20% Similarity=0.240 Sum_probs=180.7
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
++.....+|.|+ +.|+++.+..+|+.||+|++......... .+.+.++...++.++||||+++++++.+
T Consensus 8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----------~~~~~~~~~~~~~~~h~~iv~~~~~~~~ 77 (290)
T 3fme_A 8 DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQ----------KRLLMDLDISMRTVDCPFTVTFYGALFR 77 (290)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHH----------HHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred hhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHH----------HHHHHHHHHHHHhCCCCeEEEEeeeeec
Confidence 344455688888 88888888889999999998754322111 1334455566888899999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCC-CceeccCCCCCeeecCCCceEEc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPR-PIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~-~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
++..++||||++ |+|.+.+...... ...++...+..++.|++.||.||| ++ +++|+||||+||+++.++.++|+
T Consensus 78 ~~~~~lv~e~~~-~~l~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~ 152 (290)
T 3fme_A 78 EGDVWICMELMD-TSLDKFYKQVIDK-GQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMC 152 (290)
T ss_dssp SSSEEEEEECCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBC
T ss_pred cCCEEEEEehhc-cchHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEe
Confidence 999999999996 5887776541100 035889999999999999999999 88 99999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCccc----ccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHH
Q 043524 171 DFSLSISIPEGETHITDTVMGTYGHLAPQYV----TTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYL 246 (314)
Q Consensus 171 dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 246 (314)
|||+++....... .....||+.|+|||++ ....++.++||||+|+++|+|++|..||....... .. .
T Consensus 153 Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~-~ 223 (290)
T 3fme_A 153 DFGISGYLVDDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF------QQ-L 223 (290)
T ss_dssp CC-----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH------HH-H
T ss_pred ecCCccccccccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH------HH-H
Confidence 9999976544322 3344789999999996 45568899999999999999999999996432211 11 1
Q ss_pred HhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 247 KNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
........ ........+..+.+|+..||+.||++|||+.|+++
T Consensus 224 ~~~~~~~~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 224 KQVVEEPS-------------PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHHHHSCC-------------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHhccCC-------------CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 11111100 00000133456899999999999999999999987
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=314.58 Aligned_cols=251 Identities=12% Similarity=0.054 Sum_probs=186.5
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHH---HHHhcCCCCceeeeE--
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNV---TYAAQMSHDHILKLI-- 86 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~niv~~~-- 86 (314)
++.....+|.|+ +.|+++.+..+|+.||+|++........ ...+.+.+|+ +.++.++|||||+++
T Consensus 74 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~---------~~~~~~~~E~~~l~~l~~l~hpniv~~~~~ 144 (377)
T 3byv_A 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPS---------NAIKQMKEEVLRLRLLRGIKNQKQAKVHLR 144 (377)
T ss_dssp EEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCT---------THHHHHHHHHHGGGGSTTCCSHHHHHHHHC
T ss_pred eEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccch---------HHHHHHHHHHHHHHhccccCCHHHHHHHhh
Confidence 344456789888 8888888888999999999874311100 0125688999 555566799999998
Q ss_pred -----eEEEeCCe-----------------eEEEEeecCCCCHHHHHhcCCCC--CCCcccHHHHHHHHHHHHHHHHHhh
Q 043524 87 -----GCCLETPI-----------------AILVFEYVQHGTLWDRILGAPQT--HFEPLLLKRRLKDAVDAANALAYLH 142 (314)
Q Consensus 87 -----~~~~~~~~-----------------~~iv~e~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lH 142 (314)
+++.+.+. .|++|||+ +|+|.+++...... ....++...++.++.|++.||.|||
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 223 (377)
T 3byv_A 145 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH 223 (377)
T ss_dssp BCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 77665542 78999999 68999999753210 0023456788889999999999999
Q ss_pred cCCCCCceeccCCCCCeeecCCCceEEcccccceecCCCCcccccccccccccccCcccccC-----------CCCcccc
Q 043524 143 FGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTC-----------DFSEKLD 211 (314)
Q Consensus 143 ~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~~D 211 (314)
+++|+||||||+||+++.++.+||+|||+++.... ......| +.|+|||++... .++.++|
T Consensus 224 ---~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~D 295 (377)
T 3byv_A 224 ---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFD 295 (377)
T ss_dssp ---HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHH
T ss_pred ---hCCeecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhh
Confidence 99999999999999999999999999999986432 2335567 999999999887 7999999
Q ss_pred hHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCC
Q 043524 212 VYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESP 291 (314)
Q Consensus 212 iwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp 291 (314)
||||||++|+|++|+.||........ ......... ..+..+.+|+..||+.||
T Consensus 296 vwSlG~il~elltg~~Pf~~~~~~~~---------------------~~~~~~~~~------~~~~~~~~li~~~L~~dp 348 (377)
T 3byv_A 296 AWALGLVIYWIWCADLPITKDAALGG---------------------SEWIFRSCK------NIPQPVRALLEGFLRYPK 348 (377)
T ss_dssp HHHHHHHHHHHHHSSCCC------CC---------------------SGGGGSSCC------CCCHHHHHHHHHHTCSSG
T ss_pred HHHHHHHHHHHHHCCCCCcccccccc---------------------hhhhhhhcc------CCCHHHHHHHHHHcCCCc
Confidence 99999999999999999964332211 000111011 234568899999999999
Q ss_pred CCCCCHHHHHH--HHHHHH
Q 043524 292 IDRPTMVDVAR--RLRQIC 308 (314)
Q Consensus 292 ~~Rps~~ell~--~L~~~~ 308 (314)
++|||+.|+++ .++++.
T Consensus 349 ~~Rpt~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 349 EDRLLPLQAMETPEYEQLR 367 (377)
T ss_dssp GGCCCHHHHHTSHHHHHHH
T ss_pred hhCCCHHHHhhChHHHHHH
Confidence 99999999986 444443
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=298.96 Aligned_cols=255 Identities=20% Similarity=0.289 Sum_probs=195.5
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
+|+....+|.|+ +.|+.+.+..+|+.+|+|.+........ ..+.+.+|+.+++.++||||+++++++..
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (279)
T 2w5a_A 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA----------EKQMLVSEVNLLRELKHPNIVRYYDRIID 76 (279)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHH----------HHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred heeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHH----------HHHHHHHHHHHHHhcCCCCCCeEEEEEec
Confidence 444555688888 8888888888999999999865321111 12568899999999999999999998854
Q ss_pred --CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCC-----ceeccCCCCCeeecCC
Q 043524 92 --TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRP-----IVFRDFKTSHILFSEE 164 (314)
Q Consensus 92 --~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~-----i~H~dlk~~nil~~~~ 164 (314)
+...++||||+++++|.+++...... ...++...++.++.|++.||.||| +++ ++|+||||+||+++.+
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~ 152 (279)
T 2w5a_A 77 RTNTTLYIVMEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGK 152 (279)
T ss_dssp GGGTEEEEEEECCTTEEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSS
T ss_pred CCCceEEEEEeCCCCCCHHHHHHhhccc-CCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCC
Confidence 67899999999999999998753211 134789999999999999999999 888 9999999999999999
Q ss_pred CceEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHH
Q 043524 165 NVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNE 244 (314)
Q Consensus 165 ~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 244 (314)
+.++|+|||.++...... .......|++.|+|||++.+..++.++||||+|+++|+|++|..||...... .
T Consensus 153 ~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~ 223 (279)
T 2w5a_A 153 QNVKLGDFGLARILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--------E 223 (279)
T ss_dssp SCEEECCCCHHHHC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------H
T ss_pred CCEEEecCchheeecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH--------H
Confidence 999999999987654322 1223456899999999999888999999999999999999999999654311 1
Q ss_pred HHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHH
Q 043524 245 YLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRL 304 (314)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L 304 (314)
....... ..... . +...+.++.+++.+||+.||++|||+.|+++.+
T Consensus 224 ~~~~i~~-~~~~~---------~----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 224 LAGKIRE-GKFRR---------I----PYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp HHHHHHH-TCCCC---------C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred HHHHHhh-ccccc---------C----CcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 1111111 11000 0 013446789999999999999999999999754
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=305.76 Aligned_cols=265 Identities=16% Similarity=0.204 Sum_probs=196.6
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC--------CCce
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS--------HDHI 82 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~ni 82 (314)
.+|.....+|.|+ +.|+++.+..+|+.||+|++...... .+.+.+|++++..++ |+||
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~E~~~l~~l~~~~~~~~~~~~i 103 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHY-------------TETALDEIRLLKSVRNSDPNDPNREMV 103 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH-------------HHHHHHHHHHHHHHHHSCTTCGGGGGB
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcc-------------hHHHHHHHHHHHHHhhcCCCCCCccee
Confidence 4455666789888 88999888899999999998754321 156789999999886 7889
Q ss_pred eeeEeEEE----eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCC-CceeccCCCC
Q 043524 83 LKLIGCCL----ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPR-PIVFRDFKTS 157 (314)
Q Consensus 83 v~~~~~~~----~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~-~i~H~dlk~~ 157 (314)
+++++++. .+..+|+||||+ ++++.+.+..... ..++...++.++.|++.||.||| ++ +|+||||||+
T Consensus 104 v~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~ 176 (397)
T 1wak_A 104 VQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNY---QGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPE 176 (397)
T ss_dssp CCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGG
T ss_pred eeeecceeecCCCCceEEEEEecc-CccHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHH
Confidence 99999998 566899999999 5677777665432 35889999999999999999999 88 9999999999
Q ss_pred CeeecCCC-------------------------------------------------ceEEcccccceecCCCCcccccc
Q 043524 158 HILFSEEN-------------------------------------------------VVKLFDFSLSISIPEGETHITDT 188 (314)
Q Consensus 158 nil~~~~~-------------------------------------------------~~kl~dfg~~~~~~~~~~~~~~~ 188 (314)
||+++.++ .++|+|||.+...... ...
T Consensus 177 NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~ 252 (397)
T 1wak_A 177 NILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTE 252 (397)
T ss_dssp GEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCS
T ss_pred HeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----Ccc
Confidence 99998765 7999999999876432 234
Q ss_pred cccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccc-cchHHHHHhhh-----------------
Q 043524 189 VMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLV-YPFNEYLKNYF----------------- 250 (314)
Q Consensus 189 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~----------------- 250 (314)
..||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... ...........
T Consensus 253 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 332 (397)
T 1wak_A 253 DIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEF 332 (397)
T ss_dssp CCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGT
T ss_pred CCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccc
Confidence 578999999999999899999999999999999999999997544322100 00000000000
Q ss_pred -cc-CCcccccC-------hhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 251 -ED-NRFTEIVD-------PIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 251 -~~-~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.. .....+.. ..+.... ......+..+.+|+.+||+.||++|||+.|+++
T Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 333 FTKKGDLKHITKLKPWGLFEVLVEKY--EWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp BCTTSSBSSCCCCCCCCHHHHHHHTS--CCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cCCccccccccccCCcchhHhhhhhc--ccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00 00000000 0000000 112356778999999999999999999999985
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=308.71 Aligned_cols=256 Identities=19% Similarity=0.247 Sum_probs=195.0
Q ss_pred hcCcccccccCch-hHHHHHHH---hcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIA---SSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLI 86 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~---~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~ 86 (314)
.+|.....+|.|+ +.|+++.+ ..+|+.||+|++.......... ..+.+.+|++++..+ +||||++++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~--------~~~~~~~E~~~l~~l~~h~~iv~~~ 125 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAK--------TTEHTRTERQVLEHIRQSPFLVTLH 125 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEES--------SGGGCCCHHHHHHHHHTCTTBCCEE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhh--------HHHHHHHHHHHHHHccCCCceeEEE
Confidence 3455556788888 77776655 3588999999986432110000 113456799999999 699999999
Q ss_pred eEEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCc
Q 043524 87 GCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENV 166 (314)
Q Consensus 87 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~ 166 (314)
+++...+..++||||+++|+|.+++.... .++...+..++.|++.||.||| +++|+||||||+||+++.++.
T Consensus 126 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~ 197 (355)
T 1vzo_A 126 YAFQTETKLHLILDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGH 197 (355)
T ss_dssp EEEEETTEEEEEECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSC
T ss_pred EEEeeCceEEEEeecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCc
Confidence 99999999999999999999999987642 4788999999999999999999 999999999999999999999
Q ss_pred eEEcccccceecCCCCcccccccccccccccCcccccC--CCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHH
Q 043524 167 VKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTC--DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNE 244 (314)
Q Consensus 167 ~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 244 (314)
++|+|||+++..............||+.|+|||++.+. .++.++|||||||++|+|++|..||........ ...
T Consensus 198 ~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~----~~~ 273 (355)
T 1vzo_A 198 VVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS----QAE 273 (355)
T ss_dssp EEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC----HHH
T ss_pred EEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch----HHH
Confidence 99999999987644333334456799999999999853 478999999999999999999999974432211 111
Q ss_pred HHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCC-----CHHHHHH
Q 043524 245 YLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRP-----TMVDVAR 302 (314)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 302 (314)
....... ..... +...+..+.+|+..||..||++|| |+.|+++
T Consensus 274 ~~~~~~~-------------~~~~~--~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~ 321 (355)
T 1vzo_A 274 ISRRILK-------------SEPPY--PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 321 (355)
T ss_dssp HHHHHHH-------------CCCCC--CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred HHHHHhc-------------cCCCC--CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence 1111111 00000 013345688999999999999999 9999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=326.33 Aligned_cols=256 Identities=21% Similarity=0.243 Sum_probs=195.5
Q ss_pred CcccccccCch-hHHHHHHHhc---CCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEE
Q 043524 14 GKRTLMIGNGA-SVLQELIASS---NGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCC 89 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~---~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 89 (314)
+.....+|.|+ +.|+.+.... .+..+|+|.+....... ..+.+.+|+.+++.++||||+++++++
T Consensus 392 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~~E~~~l~~l~HpnIv~l~~~~ 460 (656)
T 2j0j_A 392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDS-----------VREKFLQEALTMRQFDHPHIVKLIGVI 460 (656)
T ss_dssp EEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHH-----------HHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred EEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHH-----------HHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 34455688888 7777765543 34579999875432111 126788999999999999999999998
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEE
Q 043524 90 LETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKL 169 (314)
Q Consensus 90 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl 169 (314)
. ++..|+||||+++|+|.+++.... ..++...++.++.|++.||.||| +++|+||||||+||+++.++.+||
T Consensus 461 ~-~~~~~lv~E~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL 532 (656)
T 2j0j_A 461 T-ENPVWIIMELCTLGELRSFLQVRK----FSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKL 532 (656)
T ss_dssp C-SSSCEEEEECCTTCBHHHHHHHTT----TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEE
T ss_pred e-cCceEEEEEcCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEE
Confidence 4 567899999999999999997654 35788999999999999999999 999999999999999999999999
Q ss_pred cccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHh
Q 043524 170 FDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKN 248 (314)
Q Consensus 170 ~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 248 (314)
+|||+++..............+|+.|+|||++....++.++||||+|+++|||++ |..||....... ....
T Consensus 533 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--------~~~~ 604 (656)
T 2j0j_A 533 GDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--------VIGR 604 (656)
T ss_dssp CCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHH
T ss_pred EecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH--------HHHH
Confidence 9999998765443333334457789999999988889999999999999999997 999986543211 1111
Q ss_pred hhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 249 YFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
.... .. .+.+..++..+.+|+.+||+.||++|||+.|+++.|+++.+.
T Consensus 605 i~~~-~~-------------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 605 IENG-ER-------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp HHHT-CC-------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHcC-CC-------------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 1110 00 000113446788999999999999999999999999998654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=312.07 Aligned_cols=262 Identities=17% Similarity=0.149 Sum_probs=203.4
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCC-CceeeeEeEEE
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSH-DHILKLIGCCL 90 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~ 90 (314)
+|+....+|.|+ +.|+++.+..+|+.||+|++..... .+.+.+|++++..++| ++|..+..++.
T Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--------------~~~~~~E~~il~~L~~~~~i~~i~~~~~ 73 (483)
T 3sv0_A 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--------------HPQLLYESKIYRILQGGTGIPNVRWFGV 73 (483)
T ss_dssp TEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--------------SCCHHHHHHHHHHTTTSTTCCCEEEEEE
T ss_pred cEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--------------cHHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 444555688888 8888888888999999997654321 1357899999999987 66667777777
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeee---cCCCce
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILF---SEENVV 167 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~---~~~~~~ 167 (314)
.+...++||||+ +++|.+++.... ..+++..++.++.||+.||.||| +++|+||||||+|||+ +..+.+
T Consensus 74 ~~~~~~lvme~~-g~sL~~ll~~~~----~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~v 145 (483)
T 3sv0_A 74 EGDYNVLVMDLL-GPSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQV 145 (483)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCE
T ss_pred eCCEEEEEEECC-CCCHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeE
Confidence 889999999999 899999997544 35889999999999999999999 9999999999999999 578899
Q ss_pred EEcccccceecCCCCcc------cccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccc
Q 043524 168 KLFDFSLSISIPEGETH------ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYP 241 (314)
Q Consensus 168 kl~dfg~~~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~ 241 (314)
+|+|||+++........ ......||..|+|||++.+..++.++|||||||++|+|++|..||.......... .
T Consensus 146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~-~ 224 (483)
T 3sv0_A 146 YIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ-K 224 (483)
T ss_dssp EECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHH-H
T ss_pred EEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHH-H
Confidence 99999999876543321 1235679999999999999999999999999999999999999997654322100 0
Q ss_pred hHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhc
Q 043524 242 FNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSL 311 (314)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 311 (314)
+......... ... ......++.++.+|+..||+.||++||++.+|++.|+++....
T Consensus 225 ~~~i~~~~~~-----~~~---------~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 225 YEKISEKKVA-----TSI---------EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp HHHHHHHHHH-----SCH---------HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHHhhcccc-----ccH---------HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 0110000000 000 0011133567899999999999999999999999999997644
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=297.42 Aligned_cols=247 Identities=15% Similarity=0.181 Sum_probs=191.0
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGCC 89 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 89 (314)
.+|.....+|.|+ +.|+.+.+..+|+.||+|++........ ...++.+|+..+..+ +||||+++++++
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~e~~~~~~l~~h~~iv~~~~~~ 80 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSV----------DEQNALREVYAHAVLGQHSHVVRYFSAW 80 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSH----------HHHHHHHHHHHHHHSCSCTTBCCEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccH----------HHHHHHHHHHHHHHhCCCCCeeeeeeee
Confidence 4555566788888 8888888888999999998764311100 125678999999999 899999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCC-----
Q 043524 90 LETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEE----- 164 (314)
Q Consensus 90 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~----- 164 (314)
.+++..++||||+++++|.+++...... ...++...+..++.|++.||.||| +++|+||||||+||+++.+
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~ 156 (289)
T 1x8b_A 81 AEDDHMLIQNEYCNGGSLADAISENYRI-MSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNA 156 (289)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC-------
T ss_pred ecCCeEEEEEEecCCCcHHHHHHhhccc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCcc
Confidence 9999999999999999999998753210 024788999999999999999999 9999999999999999843
Q ss_pred --------------CceEEcccccceecCCCCcccccccccccccccCcccccC-CCCcccchHHHHHHHHHHHhCCCCc
Q 043524 165 --------------NVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGRGIL 229 (314)
Q Consensus 165 --------------~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~ 229 (314)
..++|+|||.+....... ...||+.|+|||++.+. .++.++||||+|+++|+|++|.+|+
T Consensus 157 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~ 231 (289)
T 1x8b_A 157 ASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP 231 (289)
T ss_dssp -------------CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred cccccccccccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCC
Confidence 478999999998764432 34589999999999876 4668999999999999999998775
Q ss_pred ccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 230 DLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
..... ..... ...... .+ ...+..+.+|+..||+.||++|||+.|+++
T Consensus 232 ~~~~~-----------~~~~~-~~~~~~---------~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 232 RNGDQ-----------WHEIR-QGRLPR---------IP----QVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp SSSHH-----------HHHHH-TTCCCC---------CS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cchhH-----------HHHHH-cCCCCC---------CC----cccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 32110 00010 001000 00 123456889999999999999999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=327.00 Aligned_cols=253 Identities=23% Similarity=0.300 Sum_probs=196.5
Q ss_pred cccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCC
Q 043524 15 KRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETP 93 (314)
Q Consensus 15 ~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (314)
.....+|.|+ +.|+++... .+..||+|++..... ..++|.+|+++|+.++||||+++++++.+ .
T Consensus 270 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~ 334 (535)
T 2h8h_A 270 RLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM-------------SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 334 (535)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTEEEEEEEECTTSS-------------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred hhheecccCCCeEEEEEEEC-CCceEEEEEeCCCCC-------------CHHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence 3444688888 677766544 356799998864321 12578999999999999999999999866 7
Q ss_pred eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccc
Q 043524 94 IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFS 173 (314)
Q Consensus 94 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg 173 (314)
..|+||||+++|+|.+++..... ..++...++.++.|++.||.||| +++|+||||||+|||++.++.+||+|||
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG 408 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFG 408 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTT
T ss_pred cceEeeehhcCCcHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccc
Confidence 78999999999999999964321 24788999999999999999999 9999999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhcc
Q 043524 174 LSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFED 252 (314)
Q Consensus 174 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (314)
+++..............++..|+|||++....++.++||||||+++|||++ |..||......+ ........
T Consensus 409 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~--------~~~~i~~~ 480 (535)
T 2h8h_A 409 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--------VLDQVERG 480 (535)
T ss_dssp STTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH--------HHHHHHTT
T ss_pred cceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcC
Confidence 997654322212233456788999999998899999999999999999999 899986433211 11111110
Q ss_pred CCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 253 NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
.. .+.+..++..+.+||.+||+.||++|||+.+|++.|+++..+
T Consensus 481 ~~--------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 481 YR--------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp CC--------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred CC--------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 00 000113456788999999999999999999999999988654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=306.48 Aligned_cols=263 Identities=18% Similarity=0.249 Sum_probs=189.8
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
+|.....+|.|+ +.|+.+.+..+|+.||+|.+.... +...+|+++++.++||||+++++++..
T Consensus 8 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----------------~~~~~E~~il~~l~hpnIv~l~~~~~~ 71 (383)
T 3eb0_A 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----------------RYKNRELDIMKVLDHVNIIKLVDYFYT 71 (383)
T ss_dssp TEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----------------TSCCHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred eEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----------------chHHHHHHHHHHcCCCCccchhheeee
Confidence 455556799999 889898888999999999875321 112379999999999999999999854
Q ss_pred --------------------------------------CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHH
Q 043524 92 --------------------------------------TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVD 133 (314)
Q Consensus 92 --------------------------------------~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~ 133 (314)
...+++||||++ |+|.+.+...... ...++...+..++.|
T Consensus 72 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~l~~~~~~~i~~q 149 (383)
T 3eb0_A 72 TGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS-GRSIPMNLISIYIYQ 149 (383)
T ss_dssp C-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHHH
T ss_pred cCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc-CCCCCHHHHHHHHHH
Confidence 334889999997 5877766531100 035889999999999
Q ss_pred HHHHHHHhhcCCCCCceeccCCCCCeeec-CCCceEEcccccceecCCCCcccccccccccccccCcccccCC-CCcccc
Q 043524 134 AANALAYLHFGFPRPIVFRDFKTSHILFS-EENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCD-FSEKLD 211 (314)
Q Consensus 134 i~~~l~~lH~~~~~~i~H~dlk~~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~D 211 (314)
++.||.||| +++|+||||||+||+++ .++.+||+|||+++....... .....+|+.|+|||++.+.. ++.++|
T Consensus 150 i~~aL~~LH---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~D 224 (383)
T 3eb0_A 150 LFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSID 224 (383)
T ss_dssp HHHHHHHHH---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHH
T ss_pred HHHHHHHHH---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchh
Confidence 999999999 99999999999999997 678999999999987644332 33557899999999887654 899999
Q ss_pred hHHHHHHHHHHHhCCCCcccccCcccccc-------chHHHHHhh---hccCCcccccChhhhccCCchhHHHHHHHHHH
Q 043524 212 VYSFGAFLSELLTGRGILDLVRDAHDLVY-------PFNEYLKNY---FEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQ 281 (314)
Q Consensus 212 iwslG~~l~el~~g~~p~~~~~~~~~~~~-------~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (314)
|||+||++|+|++|+.||......+.... +..+..... +....+.......+....+ ...+..+.+
T Consensus 225 iwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ 300 (383)
T 3eb0_A 225 LWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILP----EGTPSLAID 300 (383)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSC----TTCCHHHHH
T ss_pred hhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCC----CCCCHHHHH
Confidence 99999999999999999975443221000 000000000 0000001100111111011 124466899
Q ss_pred HHhHhccCCCCCCCCHHHHHH
Q 043524 282 LTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 282 li~~cl~~dp~~Rps~~ell~ 302 (314)
|+.+||+.||++|||+.|+++
T Consensus 301 li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 301 LLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp HHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHccCChhhCCCHHHHhc
Confidence 999999999999999999985
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=304.61 Aligned_cols=263 Identities=17% Similarity=0.205 Sum_probs=180.2
Q ss_pred hhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEE
Q 043524 11 WSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCC 89 (314)
Q Consensus 11 ~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 89 (314)
-.+|.....+|.|+ +.|+.+.+..+|+.||+|++....... ...+++.+|+++++.++||||+++++++
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~----------~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 97 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI----------IHAKRTYRELRLLKHMKHENVIGLLDVF 97 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSH----------HHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCH----------HHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 35566667799999 888888888999999999986431100 0125678999999999999999999999
Q ss_pred EeC------CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecC
Q 043524 90 LET------PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSE 163 (314)
Q Consensus 90 ~~~------~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~ 163 (314)
... ...|+++|++ +++|.+++.. ..++...+..++.|++.||.||| +++|+||||||+||+++.
T Consensus 98 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~ 167 (367)
T 2fst_X 98 TPARSLEEFNDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 167 (367)
T ss_dssp CSCSSGGGCCCCEEEEECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECT
T ss_pred ecCCccccCCeEEEEeccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECC
Confidence 754 5689999999 6899888864 24888999999999999999999 999999999999999999
Q ss_pred CCceEEcccccceecCCCCcccccccccccccccCccccc-CCCCcccchHHHHHHHHHHHhCCCCcccccCccccccch
Q 043524 164 ENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTT-CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPF 242 (314)
Q Consensus 164 ~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~ 242 (314)
++.+||+|||+++..... .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||........ +
T Consensus 168 ~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----l 239 (367)
T 2fst_X 168 DCELKILDFGLARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ----L 239 (367)
T ss_dssp TCCEEECC-------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH----H
T ss_pred CCCEEEeecccccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----H
Confidence 999999999999765332 234578999999999887 5689999999999999999999999975442211 0
Q ss_pred HHHHHhhhccCC---cccccCh----h---hhccCCchhH---HHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 243 NEYLKNYFEDNR---FTEIVDP----I---IVQDLSCTEK---EQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 243 ~~~~~~~~~~~~---~~~~~~~----~---~~~~~~~~~~---~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
..... ...... +..+... . +......... ...+..+.+|+.+||..||++|||+.|+++
T Consensus 240 ~~i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 240 KLILR-LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHHHH-HHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHH-HhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 00000 000000 0000000 0 0000000000 123466899999999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=299.09 Aligned_cols=272 Identities=17% Similarity=0.237 Sum_probs=200.4
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccC-----ChhHHHHHHHHHHHhcCCCCceeee
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKN-----GFWHESCINNVTYAAQMSHDHILKL 85 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~ 85 (314)
.+|.....+|.|+ +.|+.+.+ +|+.||+|++................ ....+.+.+|+.++..++||||+++
T Consensus 31 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp TTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred CceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 4556666789888 77777766 89999999998765432111000000 0022678999999999999999999
Q ss_pred EeEEEeCCeeEEEEeecCCCCHHHH------HhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCC-CCceeccCCCCC
Q 043524 86 IGCCLETPIAILVFEYVQHGTLWDR------ILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFP-RPIVFRDFKTSH 158 (314)
Q Consensus 86 ~~~~~~~~~~~iv~e~~~~g~L~~~------l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~-~~i~H~dlk~~n 158 (314)
++++.+.+..++||||+++|+|.++ +..... ..++...+..++.|++.||.||| + ++++|+||||+|
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~N 182 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYT---CFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSN 182 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSC---CCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGG
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccc---cCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHh
Confidence 9999999999999999999999988 543211 46889999999999999999999 8 999999999999
Q ss_pred eeecCCCceEEcccccceecCCCCcccccccccccccccCcccccC-CCCc-ccchHHHHHHHHHHHhCCCCcccccCcc
Q 043524 159 ILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTC-DFSE-KLDVYSFGAFLSELLTGRGILDLVRDAH 236 (314)
Q Consensus 159 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~-~~DiwslG~~l~el~~g~~p~~~~~~~~ 236 (314)
|+++.++.++|+|||.+...... ......|+..|+|||++.+. .++. ++||||+|+++|+|++|..||.......
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 259 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV 259 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred EEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence 99999999999999999876433 23456789999999999877 5666 9999999999999999999997544311
Q ss_pred ccccchHHHHHhhhccC-Ccc----cccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 237 DLVYPFNEYLKNYFEDN-RFT----EIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 237 ~~~~~~~~~~~~~~~~~-~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.......... ... ....+..... ........+..+.+|+..||+.||++|||+.|+++
T Consensus 260 -------~~~~~i~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 260 -------ELFNNIRTKNIEYPLDRNHFLYPLTNKK-STCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp -------HHHHHHTSCCCCCCCSSSSSTTTTCC---------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -------HHHHHHhccCcCCccchhhhhccccccc-cccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111111110 000 0000000000 00011234567899999999999999999999987
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=298.09 Aligned_cols=254 Identities=18% Similarity=0.232 Sum_probs=171.8
Q ss_pred hhhhhcCcccc-cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHH-HHHhcCCCCceee
Q 043524 8 FKLWSKGKRTL-MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNV-TYAAQMSHDHILK 84 (314)
Q Consensus 8 ~~~~~~~~~~~-~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~ 84 (314)
+.+..+|.... .+|.|+ +.|+.+.+..+|+.||+|++..... ..+|+ ..+..++||||++
T Consensus 24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------------~~~e~~~~~~~~~h~~i~~ 86 (336)
T 3fhr_A 24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-----------------ARQEVDHHWQASGGPHIVC 86 (336)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH-----------------HHHHHHHHHHHTTSTTBCC
T ss_pred ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH-----------------HHHHHHHHHHhcCCCChHH
Confidence 44455555533 588888 8889998999999999999864321 12233 3456678999999
Q ss_pred eEeEEEe----CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCee
Q 043524 85 LIGCCLE----TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHIL 160 (314)
Q Consensus 85 ~~~~~~~----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil 160 (314)
+++++.. +...++||||+++|+|.+++..... ..++...++.++.|++.||.||| +++|+||||||+||+
T Consensus 87 ~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~---~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIl 160 (336)
T 3fhr_A 87 ILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGD---QAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLL 160 (336)
T ss_dssp EEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-C---CCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEE
T ss_pred HHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEE
Confidence 9999976 5568999999999999999987542 35889999999999999999999 999999999999999
Q ss_pred ecC---CCceEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccc
Q 043524 161 FSE---ENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHD 237 (314)
Q Consensus 161 ~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~ 237 (314)
++. .+.++|+|||+++...... .....+|+.|+|||++....++.++||||+|+++|+|++|..||........
T Consensus 161 l~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 237 (336)
T 3fhr_A 161 YTSKEKDAVLKLTDFGFAKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI 237 (336)
T ss_dssp ESCSSTTCCEEECCCTTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred EEecCCCceEEEeccccceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh
Confidence 976 4459999999997654322 3355789999999999888889999999999999999999999965433211
Q ss_pred cccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 238 LVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
... .. ..+.... ...+.+.....+..+.+|+..||+.||++|||+.|+++
T Consensus 238 ~~~-----~~--------~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 238 SPG-----MK--------RRIRLGQ--YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ----------------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhh-----HH--------Hhhhccc--cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000 00 0000000 00000111134567899999999999999999999997
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=299.33 Aligned_cols=250 Identities=18% Similarity=0.242 Sum_probs=188.5
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGCC 89 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 89 (314)
.+|.....+|.|+ +.|+.+.+..+|+.||+|++..... ..+.+.+|+.++..+ +||||+++++++
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 90 (326)
T 2x7f_A 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-------------EEEEIKQEINMLKKYSHHRNIATYYGAF 90 (326)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------------TTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-------------cHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence 3445556788888 8888888888999999999853211 015678999999999 799999999999
Q ss_pred Ee------CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecC
Q 043524 90 LE------TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSE 163 (314)
Q Consensus 90 ~~------~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~ 163 (314)
.. ....|+||||+++|+|.+++..... ..++...+..++.|++.||.||| +++|+|+||||+||+++.
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~ 164 (326)
T 2x7f_A 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTE 164 (326)
T ss_dssp EECC--CCCCEEEEEEECCTTEEHHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECT
T ss_pred eeccCccccceEEEEEEcCCCCcHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcC
Confidence 87 5688999999999999999976432 35788899999999999999999 999999999999999999
Q ss_pred CCceEEcccccceecCCCCcccccccccccccccCcccc-----cCCCCcccchHHHHHHHHHHHhCCCCcccccCcccc
Q 043524 164 ENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVT-----TCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDL 238 (314)
Q Consensus 164 ~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~ 238 (314)
++.++|+|||++........ ......||+.|+|||++. ...++.++||||+|+++|+|++|..||.......
T Consensus 165 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-- 241 (326)
T 2x7f_A 165 NAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-- 241 (326)
T ss_dssp TCCEEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--
T ss_pred CCCEEEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH--
Confidence 99999999999876543221 233457899999999987 4568899999999999999999999986433211
Q ss_pred ccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 239 VYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
......... .... .....+..+.+|+.+||..||++|||+.++++
T Consensus 242 ------~~~~~~~~~-~~~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 242 ------ALFLIPRNP-APRL------------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp ------HHHHHHHSC-CCCC------------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ------HHHHhhcCc-cccC------------CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 001111100 0000 00123456889999999999999999999987
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=292.64 Aligned_cols=264 Identities=19% Similarity=0.261 Sum_probs=195.3
Q ss_pred hcCcccccccCch-hHHHHHHH-hcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCC------cee
Q 043524 12 SKGKRTLMIGNGA-SVLQELIA-SSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHD------HIL 83 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~-~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~------niv 83 (314)
.+|.....+|.|+ +.|+.+.+ ..+|+.||+|++...... .+.+.+|++++..++|+ +|+
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~e~~~l~~l~~~~~~~~~~i~ 80 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRY-------------CEAARSEIQVLEHLNTTDPNSTFRCV 80 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHH-------------HHHHHHHHHHHHHHHHHCTTCTTCBC
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCch-------------hHHHHHHHHHHHHhhhcCCCCceeeE
Confidence 4556666788888 77777766 567899999998643321 14577899998888765 499
Q ss_pred eeEeEEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecC
Q 043524 84 KLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSE 163 (314)
Q Consensus 84 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~ 163 (314)
++++++.+.+..|+||||+ +++|.+.+..... .+++...+..++.|++.||.||| +++|+||||||+||+++.
T Consensus 81 ~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~ 153 (339)
T 1z57_A 81 QMLEWFEHHGHICIVFELL-GLSTYDFIKENGF---LPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQ 153 (339)
T ss_dssp CEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESC
T ss_pred eeecccccCCcEEEEEcCC-CCCHHHHHHhcCC---CCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEec
Confidence 9999999999999999999 8899999976542 35788999999999999999999 999999999999999987
Q ss_pred -------------------CCceEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh
Q 043524 164 -------------------ENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT 224 (314)
Q Consensus 164 -------------------~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~ 224 (314)
++.++|+|||.++..... .....||+.|+|||++.+..++.++||||+|+++|+|++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 229 (339)
T 1z57_A 154 SDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL 229 (339)
T ss_dssp CCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHH
T ss_pred cccccccCCccccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHh
Confidence 567999999999765332 235578999999999999899999999999999999999
Q ss_pred CCCCcccccCccccc------cchHHHHHhhhccC--------Ccccc----------cChhhhccCCchhHHHHHHHHH
Q 043524 225 GRGILDLVRDAHDLV------YPFNEYLKNYFEDN--------RFTEI----------VDPIIVQDLSCTEKEQQLHASA 280 (314)
Q Consensus 225 g~~p~~~~~~~~~~~------~~~~~~~~~~~~~~--------~~~~~----------~~~~~~~~~~~~~~~~~~~~~~ 280 (314)
|..||.......... .+............ .+... ..+.. .. .......+..+.
T Consensus 230 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~l~ 306 (339)
T 1z57_A 230 GFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLK-EF--MLSQDVEHERLF 306 (339)
T ss_dssp SSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGG-GG--CSCCSHHHHHHH
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchh-hh--cccchhhHHHHH
Confidence 999997543221000 00000000000000 00000 00000 00 001114567889
Q ss_pred HHHhHhccCCCCCCCCHHHHHH
Q 043524 281 QLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 281 ~li~~cl~~dp~~Rps~~ell~ 302 (314)
+|+..||+.||++|||+.|+++
T Consensus 307 ~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 307 DLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHhCcCcccccCHHHHhc
Confidence 9999999999999999999985
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=305.52 Aligned_cols=266 Identities=18% Similarity=0.278 Sum_probs=177.5
Q ss_pred cccCch-hHHHHHHHh--cCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe--CC
Q 043524 19 MIGNGA-SVLQELIAS--SNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE--TP 93 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~--~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~ 93 (314)
.+|.|+ +.|+++... .+++.||+|++..... .+.+.+|+.+|+.++||||+++++++.. +.
T Consensus 28 ~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--------------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--------------SMSACREIALLRELKHPNVISLQKVFLSHADR 93 (405)
T ss_dssp CCC-----EEEEEEESSSSCCCCEEEEECSSSSC--------------CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred EeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--------------CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence 588888 888887743 5788999998863221 1467899999999999999999999965 77
Q ss_pred eeEEEEeecCCCCHHHHHhcCC----CCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeee----cCCC
Q 043524 94 IAILVFEYVQHGTLWDRILGAP----QTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILF----SEEN 165 (314)
Q Consensus 94 ~~~iv~e~~~~g~L~~~l~~~~----~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~----~~~~ 165 (314)
..|+||||++ |+|.+.+.... ......++...++.++.|++.||.||| +++|+||||||+||++ +..+
T Consensus 94 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 94 KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTT
T ss_pred eEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCC
Confidence 8999999996 58888775321 011124888999999999999999999 9999999999999999 6778
Q ss_pred ceEEcccccceecCCCCc--ccccccccccccccCcccccCC-CCcccchHHHHHHHHHHHhCCCCcccccCcccccc-c
Q 043524 166 VVKLFDFSLSISIPEGET--HITDTVMGTYGHLAPQYVTTCD-FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVY-P 241 (314)
Q Consensus 166 ~~kl~dfg~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~-~ 241 (314)
.+||+|||+++....... .......||+.|+|||++.+.. ++.++||||+||++|+|++|..||........... .
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~ 249 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 249 (405)
T ss_dssp CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCC
T ss_pred cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccc
Confidence 999999999977643211 1234567899999999998754 89999999999999999999999975443211000 0
Q ss_pred hHHHHHhhhc------cCCcccccC---------hhhhccC-CchhHH-------HHHHHHHHHHhHhccCCCCCCCCHH
Q 043524 242 FNEYLKNYFE------DNRFTEIVD---------PIIVQDL-SCTEKE-------QQLHASAQLTFECLNESPIDRPTMV 298 (314)
Q Consensus 242 ~~~~~~~~~~------~~~~~~~~~---------~~~~~~~-~~~~~~-------~~~~~~~~li~~cl~~dp~~Rps~~ 298 (314)
..+.+...+. ...+..+.. ....... .+.... ..+..+.+||..||+.||++|||+.
T Consensus 250 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~ 329 (405)
T 3rgf_A 250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE 329 (405)
T ss_dssp CHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHH
T ss_pred hHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence 0111111110 001111000 0000000 000000 0145678999999999999999999
Q ss_pred HHHH
Q 043524 299 DVAR 302 (314)
Q Consensus 299 ell~ 302 (314)
|+++
T Consensus 330 e~L~ 333 (405)
T 3rgf_A 330 QAMQ 333 (405)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=292.18 Aligned_cols=251 Identities=20% Similarity=0.271 Sum_probs=196.4
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|+....+|.|+ +.|+.+.+..+|+.||+|++....... ...+.+.+|+++++.++||||+++++++.
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~----------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 91 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN----------KDTSTILREVELLKKLDHPNIMKLFEILE 91 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS----------SCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch----------HHHHHHHHHHHHHHhccCCCccEEEEEEe
Confidence 4556666788888 888888888899999999986543110 01267889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCC---Cce
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEE---NVV 167 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~---~~~ 167 (314)
+.+..++|+||+++++|.+.+... ..++...+..++.|++.||.||| +++++|+||||+||+++.. +.+
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~ 163 (287)
T 2wei_A 92 DSSSFYIVGELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDI 163 (287)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCeEEEEEEccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccE
Confidence 999999999999999999888654 24788999999999999999999 9999999999999999754 469
Q ss_pred EEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHH
Q 043524 168 KLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLK 247 (314)
Q Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (314)
+|+|||.+........ .....+++.|+|||++.+ .++.++||||+|+++|+|++|..||...... ....
T Consensus 164 kL~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~ 232 (287)
T 2wei_A 164 KIIDFGLSTCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--------DILK 232 (287)
T ss_dssp EECSTTGGGTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHH
T ss_pred EEeccCcceeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH--------HHHH
Confidence 9999999876543322 234468999999998865 4889999999999999999999999643311 1111
Q ss_pred hhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 248 NYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
..... ... .+.+.....+..+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~-~~~----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 233 RVETG-KYA----------FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp HHHHC-CCC----------CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHcC-CCC----------CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 11111 000 001111134567899999999999999999999997
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=293.19 Aligned_cols=267 Identities=16% Similarity=0.234 Sum_probs=190.5
Q ss_pred hhhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeE
Q 043524 10 LWSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGC 88 (314)
Q Consensus 10 ~~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 88 (314)
+..+|.....+|.|+ +.|+.+.+..+|+.||+|.+....... .+++.+|+++++.++||||++++++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------------~~~~~~e~~~l~~l~h~~iv~~~~~ 76 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQS------------VKHALREIKIIRRLDHDNIVKVFEI 76 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHH------------HHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHH------------HHHHHHHHHHHHhcCCCCeeEEEEe
Confidence 345666677799988 888999888899999999886543222 1568899999999999999999998
Q ss_pred EE--------------eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccC
Q 043524 89 CL--------------ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDF 154 (314)
Q Consensus 89 ~~--------------~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dl 154 (314)
+. +....|+||||++ |+|.+.+.. .+++...+..++.|++.||.||| +++|+|+||
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl 146 (320)
T 2i6l_A 77 LGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIH---SANVLHRDL 146 (320)
T ss_dssp ECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCC
T ss_pred ccccccccccccccccccCceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHH---hCCEecCCC
Confidence 73 4467899999997 699998864 34788999999999999999999 999999999
Q ss_pred CCCCeeec-CCCceEEcccccceecCCCCc--ccccccccccccccCccccc-CCCCcccchHHHHHHHHHHHhCCCCcc
Q 043524 155 KTSHILFS-EENVVKLFDFSLSISIPEGET--HITDTVMGTYGHLAPQYVTT-CDFSEKLDVYSFGAFLSELLTGRGILD 230 (314)
Q Consensus 155 k~~nil~~-~~~~~kl~dfg~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~ 230 (314)
||+||+++ .++.++|+|||.++....... .......++..|+|||++.. ..++.++||||+|+++|+|++|+.||.
T Consensus 147 kp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 226 (320)
T 2i6l_A 147 KPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFA 226 (320)
T ss_dssp SGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCC
Confidence 99999997 567899999999976543211 11234467899999998865 568999999999999999999999997
Q ss_pred cccCccccccchHHHHHhhhc--c-------CCcccccChhhhccCCc--hhHHHHHHHHHHHHhHhccCCCCCCCCHHH
Q 043524 231 LVRDAHDLVYPFNEYLKNYFE--D-------NRFTEIVDPIIVQDLSC--TEKEQQLHASAQLTFECLNESPIDRPTMVD 299 (314)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~--~-------~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rps~~e 299 (314)
....... .......... . .............+... ......+..+.+|+.+||+.||++|||+.|
T Consensus 227 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 302 (320)
T 2i6l_A 227 GAHELEQ----MQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEE 302 (320)
T ss_dssp CSSHHHH----HHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred CCCHHHH----HHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHH
Confidence 5432110 0000000000 0 00000000000000000 000134567899999999999999999999
Q ss_pred HHH
Q 043524 300 VAR 302 (314)
Q Consensus 300 ll~ 302 (314)
+++
T Consensus 303 ll~ 305 (320)
T 2i6l_A 303 ALS 305 (320)
T ss_dssp HHT
T ss_pred HhC
Confidence 986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=297.29 Aligned_cols=267 Identities=19% Similarity=0.202 Sum_probs=194.8
Q ss_pred hhhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeE
Q 043524 10 LWSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGC 88 (314)
Q Consensus 10 ~~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 88 (314)
...++.....+|.|+ +.|+.+.+..+|+.||+|++....... ...++.+|++++..++||||++++++
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~iv~~~~~ 77 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPL-----------FALRTLREIKILKHFKHENIITIFNI 77 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHH-----------HHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccch-----------HHHHHHHHHHHHHhCcCCCcCCeeee
Confidence 345566666789888 888888888899999999885322111 12567899999999999999999999
Q ss_pred EEeC-----CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecC
Q 043524 89 CLET-----PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSE 163 (314)
Q Consensus 89 ~~~~-----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~ 163 (314)
+... ...|+||||++ ++|.+.+... .++...+..++.|++.||.||| +++|+||||||+||+++.
T Consensus 78 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~ 147 (353)
T 2b9h_A 78 QRPDSFENFNEVYIIQELMQ-TDLHRVISTQ------MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINS 147 (353)
T ss_dssp CCCSCSTTCCCEEEEECCCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECT
T ss_pred ecccccCccceEEEEEeccC-ccHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcC
Confidence 8764 67899999996 6999988753 4788999999999999999999 999999999999999999
Q ss_pred CCceEEcccccceecCCCCcc---------cccccccccccccCccccc-CCCCcccchHHHHHHHHHHHhCCCCccccc
Q 043524 164 ENVVKLFDFSLSISIPEGETH---------ITDTVMGTYGHLAPQYVTT-CDFSEKLDVYSFGAFLSELLTGRGILDLVR 233 (314)
Q Consensus 164 ~~~~kl~dfg~~~~~~~~~~~---------~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 233 (314)
++.++|+|||+++........ ......||+.|+|||++.. ..++.++||||+|+++|+|++|..||....
T Consensus 148 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 227 (353)
T 2b9h_A 148 NCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227 (353)
T ss_dssp TCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999876432211 1223478999999998765 568999999999999999999999997543
Q ss_pred CccccccchHHHHHhhhcc----CCcccccChh----hh----ccCCc--hhHHHHHHHHHHHHhHhccCCCCCCCCHHH
Q 043524 234 DAHDLVYPFNEYLKNYFED----NRFTEIVDPI----IV----QDLSC--TEKEQQLHASAQLTFECLNESPIDRPTMVD 299 (314)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~----~~----~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rps~~e 299 (314)
.... ..... ..... .......... .. .+... ......+..+.+|+.+||+.||++|||+.|
T Consensus 228 ~~~~----~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 302 (353)
T 2b9h_A 228 YRHQ----LLLIF-GIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKE 302 (353)
T ss_dssp HHHH----HHHHH-HHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred cHHH----HHHHH-HHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHH
Confidence 2110 00000 00000 0000000000 00 00000 000134567899999999999999999999
Q ss_pred HHH
Q 043524 300 VAR 302 (314)
Q Consensus 300 ll~ 302 (314)
+++
T Consensus 303 ll~ 305 (353)
T 2b9h_A 303 ALE 305 (353)
T ss_dssp HHT
T ss_pred Hhc
Confidence 986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=292.35 Aligned_cols=250 Identities=20% Similarity=0.312 Sum_probs=185.8
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|.....+|.|+ +.|+.+.+..+|+.||+|++...... .+.+.+|+.++..++||||+++++++.
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~E~~~l~~l~h~~i~~~~~~~~ 72 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-------------LSTILSEVMLLASLNHQYVVRYYAAWL 72 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHH-------------HHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHH-------------HHHHHHHHHHHHhcCchHHHHHHHHHH
Confidence 4455566788888 88888888889999999998643211 156789999999999999999999986
Q ss_pred e-------------CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCC
Q 043524 91 E-------------TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTS 157 (314)
Q Consensus 91 ~-------------~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~ 157 (314)
+ ....|+||||+++|+|.+++.... ..++...++.++.|++.||.||| +++++|+||||+
T Consensus 73 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~ 145 (303)
T 1zy4_A 73 ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN----LNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPM 145 (303)
T ss_dssp ECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSC----GGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGG
T ss_pred hhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccc----cccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHH
Confidence 5 456899999999999999997644 35778889999999999999999 999999999999
Q ss_pred CeeecCCCceEEcccccceecCCCC-------------cccccccccccccccCcccccC-CCCcccchHHHHHHHHHHH
Q 043524 158 HILFSEENVVKLFDFSLSISIPEGE-------------THITDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELL 223 (314)
Q Consensus 158 nil~~~~~~~kl~dfg~~~~~~~~~-------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~ 223 (314)
||+++.++.++|+|||.++...... ........||+.|+|||++.+. .++.++||||+|+++|+|+
T Consensus 146 Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 225 (303)
T 1zy4_A 146 NIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225 (303)
T ss_dssp GEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHH
T ss_pred hEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHH
Confidence 9999999999999999987653221 1112345689999999998765 6899999999999999999
Q ss_pred hCCCCcccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 224 TGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 224 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
+ ||...... ......... .. ....+ ......+..+.+++..||+.||++|||+.|+++
T Consensus 226 ~---p~~~~~~~-------~~~~~~~~~-~~--~~~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 226 Y---PFSTGMER-------VNILKKLRS-VS--IEFPP--------DFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp S---CCSSHHHH-------HHHHHHHHS-TT--CCCCT--------TCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred h---ccCCchhH-------HHHHHhccc-cc--cccCc--------cccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 8 43211100 011111110 00 00000 011133456789999999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=308.94 Aligned_cols=265 Identities=22% Similarity=0.290 Sum_probs=188.0
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
+|.....+|.|+ +.|+++.+..+|+.||+|.+.... +...+|+++++.++|||||++++++..
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----------------~~~~~E~~il~~l~hpniv~l~~~~~~ 118 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----------------RFKNRELQIMRKLDHCNIVRLRYFFYS 118 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----------------TSCCHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----------------hhHHHHHHHHHHcCCCCccceeeEEec
Confidence 345556789888 889998888899999999875321 112379999999999999999999864
Q ss_pred C------CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCC-
Q 043524 92 T------PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEE- 164 (314)
Q Consensus 92 ~------~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~- 164 (314)
. ..+++||||+++ ++.+.+...... ...++...+..++.|++.||.||| +++|+||||||+|||++.+
T Consensus 119 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~ 193 (420)
T 1j1b_A 119 SGEKKDEVYLNLVLDYVPE-TVYRVARHYSRA-KQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDT 193 (420)
T ss_dssp EETTTTEEEEEEEEECCCE-EHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTT
T ss_pred cCCCCcceeEEeehhcccc-cHHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCC
Confidence 2 236799999975 676655421000 035888999999999999999999 9999999999999999955
Q ss_pred CceEEcccccceecCCCCcccccccccccccccCcccccC-CCCcccchHHHHHHHHHHHhCCCCcccccCcccccc---
Q 043524 165 NVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVY--- 240 (314)
Q Consensus 165 ~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~--- 240 (314)
+.+||+|||+++....... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||......+....
T Consensus 194 ~~~kl~DFG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~ 271 (420)
T 1j1b_A 194 AVLKLCDFGSAKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 271 (420)
T ss_dssp TEEEECCCTTCEECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CeEEeccchhhhhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 5789999999987644322 3345789999999998765 689999999999999999999999975442211100
Q ss_pred ----chHHHHHhhhccCCcccccChhhhc-cCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 241 ----PFNEYLKNYFEDNRFTEIVDPIIVQ-DLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 241 ----~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
+..+.+... .....+..-+.+.. +.........+.++.+|+.+||..||++|||+.|+++
T Consensus 272 ~lg~p~~~~~~~~--~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 272 VLGTPTREQIREM--NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHCSCCHHHHHHH--CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhCCCCHHHHHhh--ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 000000000 01111110010000 0000000123467899999999999999999999985
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=299.09 Aligned_cols=265 Identities=17% Similarity=0.244 Sum_probs=191.3
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|.....+|.|+ +.|+.+.+..+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++.
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 111 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE----------IFAKRAYRELLLLKHMQHENVIGLLDVFT 111 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSH----------HHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccch----------hHHHHHHHHHHHHHhcCCCCchhhhhhee
Confidence 4555566799988 889999889999999999986432111 11256789999999999999999999998
Q ss_pred eCCee------EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCC
Q 043524 91 ETPIA------ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEE 164 (314)
Q Consensus 91 ~~~~~------~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~ 164 (314)
..+.. |+||||+. ++|.+.+. ..++...+..++.|++.||.||| +++|+||||||+||+++.+
T Consensus 112 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~ 180 (371)
T 4exu_A 112 PASSLRNFYDFYLVMPFMQ-TDLQKIMG-------MEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNED 180 (371)
T ss_dssp SCSSSTTCCCCEEEEECCC-EEHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTT
T ss_pred ccCCcccceeEEEEEcccc-ccHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCC
Confidence 77655 99999996 68888773 24789999999999999999999 9999999999999999999
Q ss_pred CceEEcccccceecCCCCcccccccccccccccCccccc-CCCCcccchHHHHHHHHHHHhCCCCcccccCcccccc---
Q 043524 165 NVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTT-CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVY--- 240 (314)
Q Consensus 165 ~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~--- 240 (314)
+.++|+|||+++..... .....||+.|+|||++.+ ..++.++||||+|+++|+|++|..||......+....
T Consensus 181 ~~~kL~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 256 (371)
T 4exu_A 181 CELKILDFGLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 256 (371)
T ss_dssp CCEEECSTTCC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCEEEEecCcccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 99999999999765332 335578999999999887 6789999999999999999999999975432110000
Q ss_pred ----chHHHHHhhhccCCcccccChhhhccCC--chhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 241 ----PFNEYLKNYFEDNRFTEIVDPIIVQDLS--CTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 241 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
+...+... ................... .......+..+.+|+..||+.||++|||+.|+++
T Consensus 257 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 257 VTGVPGTEFVQK-LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHCCCCHHHHTT-CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HhCCCcHHHHHH-hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 00000000 0000000000000000000 0000123567899999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=298.34 Aligned_cols=265 Identities=15% Similarity=0.196 Sum_probs=194.0
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC-----------C
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS-----------H 79 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h 79 (314)
.+|.....+|.|+ +.|+.+.+..+|+.||+|++....... +.+.+|++++..++ |
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------------~~~~~e~~~l~~l~~~~~~~~~~~~~ 85 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-------------EAAEDEIKLLQRVNDADNTKEDSMGA 85 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHH-------------HHHHHHHHHHHHHHHTCCSHHHHHHH
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccch-------------hhhhHHHHHHHHhhcccccchhcccc
Confidence 3455566789888 888888888899999999987543221 45678999988876 8
Q ss_pred CceeeeEeEEEeCC----eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCC-CceeccC
Q 043524 80 DHILKLIGCCLETP----IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPR-PIVFRDF 154 (314)
Q Consensus 80 ~niv~~~~~~~~~~----~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~-~i~H~dl 154 (314)
|||+++++++...+ ..+++||++ +++|.+++..... ..++...+..++.|++.||.||| ++ +|+||||
T Consensus 86 ~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Di 158 (373)
T 1q8y_A 86 NHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEH---RGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDI 158 (373)
T ss_dssp TTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCC
T ss_pred chHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhc---cCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCC
Confidence 99999999998654 789999999 8899999976543 34788999999999999999999 88 9999999
Q ss_pred CCCCeeec------CCCceEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCC
Q 043524 155 KTSHILFS------EENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGI 228 (314)
Q Consensus 155 k~~nil~~------~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p 228 (314)
||+||+++ ..+.++|+|||+++..... .....||+.|+|||++.+..++.++||||+|+++|+|++|..|
T Consensus 159 kp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 234 (373)
T 1q8y_A 159 KPENVLMEIVDSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 234 (373)
T ss_dssp SGGGEEEEEEETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCC
T ss_pred ChHHeEEeccCCCcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCC
Confidence 99999994 3447999999999776432 2345789999999999998899999999999999999999999
Q ss_pred cccccCcccc--ccchHHHHH-----------------hhhccCCcccccC--------hhhhccCCchhHHHHHHHHHH
Q 043524 229 LDLVRDAHDL--VYPFNEYLK-----------------NYFEDNRFTEIVD--------PIIVQDLSCTEKEQQLHASAQ 281 (314)
Q Consensus 229 ~~~~~~~~~~--~~~~~~~~~-----------------~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~ 281 (314)
|......... ......... ..+........+. ........ .+...+..+.+
T Consensus 235 f~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 312 (373)
T 1q8y_A 235 FEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYK--FSKDEAKEISD 312 (373)
T ss_dssp C---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTC--CCHHHHHHHHH
T ss_pred CCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhccc--CCcchHHHHHH
Confidence 9754321100 000000000 0000000000000 00111111 12356788999
Q ss_pred HHhHhccCCCCCCCCHHHHHH
Q 043524 282 LTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 282 li~~cl~~dp~~Rps~~ell~ 302 (314)
||..||+.||++|||+.|+++
T Consensus 313 li~~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 313 FLSPMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp HHGGGGCSSTTTCBCHHHHHT
T ss_pred HHHHHhccCccccCCHHHHhh
Confidence 999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=297.10 Aligned_cols=256 Identities=18% Similarity=0.221 Sum_probs=171.6
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHH-HHhcCCCCceeeeEeEEE
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVT-YAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~ 90 (314)
+++....+|.|+ +.|+.+.+..+|+.||+|++........ ..++..|+. +++.++||||+++++++.
T Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~~e~~~~~~~~~h~niv~~~~~~~ 91 (327)
T 3aln_A 23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE-----------QKQLLMDLDVVMRSSDCPYIVQFYGALF 91 (327)
T ss_dssp SEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHH-----------HHHHHHHHHHHHSSCCCTTBCCEEEEEE
T ss_pred HhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchH-----------HHHHHHHHHHHHHcCCCCcEeeeeeEEE
Confidence 444555688888 8888888888999999999864321111 134556665 677789999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCC-CceeccCCCCCeeecCCCceEE
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPR-PIVFRDFKTSHILFSEENVVKL 169 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~-~i~H~dlk~~nil~~~~~~~kl 169 (314)
+++..++||||++ |+|.+.+..........++...+..++.|++.||.||| ++ +++|+||||+||+++.++.+||
T Consensus 92 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl 167 (327)
T 3aln_A 92 REGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKL 167 (327)
T ss_dssp CSSEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEE
T ss_pred eCCceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEE
Confidence 9999999999997 48877775311000145788999999999999999999 88 9999999999999999999999
Q ss_pred cccccceecCCCCcccccccccccccccCccc----ccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHH
Q 043524 170 FDFSLSISIPEGETHITDTVMGTYGHLAPQYV----TTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEY 245 (314)
Q Consensus 170 ~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 245 (314)
+|||+++....... .....||+.|+|||++ ....++.++||||||+++|+|++|..||.......+..
T Consensus 168 ~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------ 239 (327)
T 3aln_A 168 CDFGISGQLVDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL------ 239 (327)
T ss_dssp CCCSSSCC--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------
T ss_pred ccCCCceecccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHH------
Confidence 99999976543321 2334689999999998 45568899999999999999999999996433211000
Q ss_pred HHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 246 LKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
..... ...+.+... .....+..+.+|+..||+.||++|||+.|+++
T Consensus 240 -~~~~~------~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 240 -TQVVK------GDPPQLSNS----EEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp -CCCCC------SCCCCCCCC----SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -HHHhc------CCCCCCCCc----ccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 00000 000000000 00123456899999999999999999999976
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=306.65 Aligned_cols=262 Identities=19% Similarity=0.271 Sum_probs=184.1
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
+|.....+|.|+ +.|+.+....+++ +|+|.+.... +...+|+++++.++||||+++++++..
T Consensus 41 ~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~----------------~~~~~E~~il~~l~h~niv~l~~~~~~ 103 (394)
T 4e7w_A 41 AYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK----------------RFKNRELQIMRIVKHPNVVDLKAFFYS 103 (394)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCT----------------TSCCHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCc----------------chHHHHHHHHHhCCCCCcceEEEEEEe
Confidence 455566789988 7777776666555 8888764321 011269999999999999999999975
Q ss_pred CCe------eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeec-CC
Q 043524 92 TPI------AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFS-EE 164 (314)
Q Consensus 92 ~~~------~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~-~~ 164 (314)
... +++||||+++ ++...+..... ....++...+..++.|++.||.||| +++|+||||||+||+++ .+
T Consensus 104 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~ 178 (394)
T 4e7w_A 104 NGDKKDEVFLNLVLEYVPE-TVYRASRHYAK-LKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPS 178 (394)
T ss_dssp ESSSSSCEEEEEEEECCSE-EHHHHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTT
T ss_pred cCCCCCceEEEEEeeccCc-cHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCC
Confidence 443 8899999976 44443331100 0035788999999999999999999 99999999999999998 78
Q ss_pred CceEEcccccceecCCCCcccccccccccccccCcccccC-CCCcccchHHHHHHHHHHHhCCCCcccccCcccccc---
Q 043524 165 NVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVY--- 240 (314)
Q Consensus 165 ~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~--- 240 (314)
+.+||+|||+++....... .....||+.|+|||++.+. .++.++||||+||++|+|++|+.||......+....
T Consensus 179 ~~~kL~DFG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~ 256 (394)
T 4e7w_A 179 GVLKLIDFGSAKILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIK 256 (394)
T ss_dssp TEEEECCCTTCEECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CcEEEeeCCCcccccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999999987644332 3356789999999998765 489999999999999999999999975443221100
Q ss_pred ----chHHHHHhh---hccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 241 ----PFNEYLKNY---FEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 241 ----~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
+........ +................. ....+.++.+|+.+||+.||++|||+.|+++
T Consensus 257 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 257 VLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVF----RPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHS----CTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HhCCCCHHHHHhhChhhhhhccccccCCcHHHhc----cccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 000000000 000000000000000000 0124567899999999999999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=292.01 Aligned_cols=264 Identities=16% Similarity=0.217 Sum_probs=193.4
Q ss_pred hcCcccccccCch-hHHHHHHHhcCC-cccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCc------ee
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNG-KYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDH------IL 83 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g-~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv 83 (314)
.+|.....+|.|+ +.|+.+.+..++ +.||+|++...... .+.+.+|+.++..++|++ ++
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~E~~~l~~l~~~~~~~~~~~~ 85 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKY-------------REAARLEINVLKKIKEKDKENKFLCV 85 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHH-------------HHHHHHHHHHHHHHHHHCTTSCSCBC
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccc-------------hhHHHHHHHHHHHHhhcCCCCceeEE
Confidence 3445555688888 788888777766 68999998643221 145778999999887665 99
Q ss_pred eeEeEEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeee--
Q 043524 84 KLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILF-- 161 (314)
Q Consensus 84 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~-- 161 (314)
.+.+++...+..|+||||+ ++++.+.+..... .+++...+..++.|++.||.||| +++|+||||||+||++
T Consensus 86 ~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~---~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~ 158 (355)
T 2eu9_A 86 LMSDWFNFHGHMCIAFELL-GKNTFEFLKENNF---QPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVN 158 (355)
T ss_dssp CEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESC
T ss_pred EeeeeeeeCCeEEEEEecc-CCChHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEec
Confidence 9999999999999999999 6677777765432 35889999999999999999999 9999999999999999
Q ss_pred -----------------cCCCceEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh
Q 043524 162 -----------------SEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT 224 (314)
Q Consensus 162 -----------------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~ 224 (314)
+..+.++|+|||+++..... .....||+.|+|||++.+..++.++||||+|+++|+|++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 234 (355)
T 2eu9_A 159 SEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234 (355)
T ss_dssp CCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHh
Confidence 56788999999999765332 234578999999999999899999999999999999999
Q ss_pred CCCCcccccCccccc------cchHHHHHhhhccC--------Cccc----------ccChhhhccCCchhHHHHHHHHH
Q 043524 225 GRGILDLVRDAHDLV------YPFNEYLKNYFEDN--------RFTE----------IVDPIIVQDLSCTEKEQQLHASA 280 (314)
Q Consensus 225 g~~p~~~~~~~~~~~------~~~~~~~~~~~~~~--------~~~~----------~~~~~~~~~~~~~~~~~~~~~~~ 280 (314)
|..||.......... .+............ .+.. ...+.... .......+..+.
T Consensus 235 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~ 311 (355)
T 2eu9_A 235 GFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSY---MLQDSLEHVQLF 311 (355)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGG---CSCCSHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCccccc---ccccchhHHHHH
Confidence 999997543221000 00000000000000 0000 00000000 001114456789
Q ss_pred HHHhHhccCCCCCCCCHHHHHH
Q 043524 281 QLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 281 ~li~~cl~~dp~~Rps~~ell~ 302 (314)
+|+..||+.||++|||+.|+++
T Consensus 312 ~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 312 DLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHhcCChhhCcCHHHHhc
Confidence 9999999999999999999985
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=295.16 Aligned_cols=280 Identities=16% Similarity=0.160 Sum_probs=187.5
Q ss_pred hhhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeE
Q 043524 10 LWSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGC 88 (314)
Q Consensus 10 ~~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 88 (314)
...+|.....+|.|+ +.|+.+.+. +|+.||+|.+............ .......+.+.+|++++..++||||++++++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNI-LSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEG-GGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred hccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhh-hhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 345666677799988 777766554 4899999988543211000000 0000123678999999999999999999999
Q ss_pred EEe-----CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecC
Q 043524 89 CLE-----TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSE 163 (314)
Q Consensus 89 ~~~-----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~ 163 (314)
+.. ....|+||||++ |+|.+.+.... ..++...+..++.|++.||.||| +++|+|+||||+||+++.
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~ 169 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR----IVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLAD 169 (362)
T ss_dssp EEECCTTTCCEEEEEEECCS-EEHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECT
T ss_pred EEeccCCCcceEEEEEccCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEEcC
Confidence 954 346899999997 69988887654 35889999999999999999999 999999999999999999
Q ss_pred CCceEEcccccceecCCCCcccccccccccccccCccccc-CCCCcccchHHHHHHHHHHHhCCCCcccccCcccccc--
Q 043524 164 ENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTT-CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVY-- 240 (314)
Q Consensus 164 ~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~-- 240 (314)
++.++|+|||+++...... ......+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||...........
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~ 247 (362)
T 3pg1_A 170 NNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV 247 (362)
T ss_dssp TCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999999997543322 1334578999999999877 5689999999999999999999999975432110000
Q ss_pred -----chHHHHHhhhccCCcccccChhhhccCC---chhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 241 -----PFNEYLKNYFEDNRFTEIVDPIIVQDLS---CTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 241 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
+...... .+......+........... .......+..+.+|+.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 248 EVVGTPKIEDVV-MFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHCCCCHHHHH-HTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHcCCCChHHhh-hccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 0000000 00000000000000000000 0001123466899999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=293.52 Aligned_cols=200 Identities=20% Similarity=0.266 Sum_probs=166.1
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC-CC-----ceee
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS-HD-----HILK 84 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~ 84 (314)
.+|.....+|.|+ +.|+++.+..+|+.||+|++...... .+++..|++++..++ |+ +|++
T Consensus 54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~e~~~l~~l~~~~~~~~~~iv~ 120 (382)
T 2vx3_A 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAF-------------LNQAQIEVRLLELMNKHDTEMKYYIVH 120 (382)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHH-------------HHHHHHHHHHHHHHHHCSSGGGGGBCC
T ss_pred eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHH-------------HHHHHHHHHHHHHHHhcccccceeEEE
Confidence 4455566789988 88999988889999999998744321 145667888888775 44 5999
Q ss_pred eEeEEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeec--
Q 043524 85 LIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFS-- 162 (314)
Q Consensus 85 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~-- 162 (314)
+.+++...+..|+||||++ |+|.+.+..... ..++...+..++.|++.||.|||.. +.+|+||||||+||+++
T Consensus 121 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~ 195 (382)
T 2vx3_A 121 LKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNF---RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNP 195 (382)
T ss_dssp EEEEEEETTEEEEEEECCC-CBHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESST
T ss_pred eeeeeccCCceEEEEecCC-CCHHHHHhhcCc---CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecC
Confidence 9999999999999999995 599999986542 3478999999999999999999921 36899999999999995
Q ss_pred CCCceEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCccccc
Q 043524 163 EENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVR 233 (314)
Q Consensus 163 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 233 (314)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++||||+||++|+|++|+.||....
T Consensus 196 ~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 196 KRSAIKIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp TSCCEEECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCcEEEEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 4678999999999876432 235678999999999999899999999999999999999999997543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=299.53 Aligned_cols=245 Identities=16% Similarity=0.209 Sum_probs=177.7
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeEEEe
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGCCLE 91 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 91 (314)
+.....+|.|+ +.|+ .....+|+.||||.+..... +.+.+|+++|..+ +|||||++++++.+
T Consensus 26 y~~~~~LG~G~~G~V~-~~~~~~~~~vAvK~~~~~~~---------------~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 89 (432)
T 3p23_A 26 FCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILPECF---------------SFADREVQLLRESDEHPNVIRYFCTEKD 89 (432)
T ss_dssp EEEEEEEEECGGGCEE-EEEESSSSEEEEEEECTTTE---------------EECHHHHHHHHHSCCCTTBCCEEEEEEE
T ss_pred EecCCeeecCcCEEEE-EEEEeCCeEEEEEEECHHHH---------------HHHHHHHHHHHhccCCCCcCeEEEEEec
Confidence 34445688888 4443 35567889999998864321 2245899999999 79999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecC-----CCc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSE-----ENV 166 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~-----~~~ 166 (314)
....|+|||||+ |+|.+++..... ......+..++.|++.||.||| +++|+||||||+||+++. ...
T Consensus 90 ~~~~~lv~E~~~-g~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~ 161 (432)
T 3p23_A 90 RQFQYIAIELCA-ATLQEYVEQKDF----AHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIK 161 (432)
T ss_dssp TTEEEEEEECCS-EEHHHHHHSSSC----CCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCC
T ss_pred CCEEEEEEECCC-CCHHHHHHhcCC----CccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCcee
Confidence 999999999995 699999986542 2333455688999999999999 999999999999999953 235
Q ss_pred eEEcccccceecCCCCc--ccccccccccccccCccccc---CCCCcccchHHHHHHHHHHHh-CCCCcccccCcccccc
Q 043524 167 VKLFDFSLSISIPEGET--HITDTVMGTYGHLAPQYVTT---CDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVY 240 (314)
Q Consensus 167 ~kl~dfg~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~ 240 (314)
++|+|||+++....... .......||+.|+|||++.. ..++.++||||+||++|+|++ |..||.......
T Consensus 162 ~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~---- 237 (432)
T 3p23_A 162 AMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ---- 237 (432)
T ss_dssp EEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH----
T ss_pred EEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH----
Confidence 78999999987643321 12345679999999999973 457789999999999999999 888885322111
Q ss_pred chHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 241 PFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
........... ... .....+..+.+|+..||+.||++|||+.|+++
T Consensus 238 -----~~~~~~~~~~~-~~~----------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 238 -----ANILLGACSLD-CLH----------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp -----HHHHTTCCCCT-TSC----------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----HHHHhccCCcc-ccC----------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 00011000000 000 01144566889999999999999999999984
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=311.57 Aligned_cols=277 Identities=17% Similarity=0.166 Sum_probs=197.9
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|.....+|.|+ +.|+.+.+..+|+.||+|++....... ..+++.+|++++..++||||+++++++.
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~-----------~~~~~~~Ei~iL~~L~HpnIV~l~~v~~ 82 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK-----------NRERWCLEIQIMKKLNHPNVVSAREVPD 82 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHH-----------HHHHHHHHHHHHHHCCBTTBCCEEECCT
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHH-----------HHHHHHHHHHHHHhCCCCCCCceeeeec
Confidence 4566666789888 888888888999999999886431111 1256889999999999999999999976
Q ss_pred e------CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCC
Q 043524 91 E------TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEE 164 (314)
Q Consensus 91 ~------~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~ 164 (314)
. ++..|+|||||++|+|.+++...... ..++...++.++.+++.||.||| +++|+|+||||+||+++.+
T Consensus 83 ~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~--~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~ 157 (676)
T 3qa8_A 83 GLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENC--CGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPG 157 (676)
T ss_dssp TTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCT--TCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECC
T ss_pred ccccccCCCeEEEEEEeCCCCCHHHHHHhcccC--CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecC
Confidence 5 67789999999999999999865422 24778889999999999999999 9999999999999999876
Q ss_pred Cc---eEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccc
Q 043524 165 NV---VKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYP 241 (314)
Q Consensus 165 ~~---~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~ 241 (314)
+. ++|+|||.+........ .....||+.|+|||++.+..++.++||||+|+++|+|++|..||............
T Consensus 158 g~~~~vKL~DFG~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~ 235 (676)
T 3qa8_A 158 PQRLIHKIIDLGYAKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK 235 (676)
T ss_dssp SSSCEEEECSCCCCCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTT
T ss_pred CCceeEEEcccccccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhh
Confidence 64 89999999987644332 34567999999999999889999999999999999999999999643211000000
Q ss_pred hHHH-HHhhhccCCccc--ccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHH-----HHHHHHHHH
Q 043524 242 FNEY-LKNYFEDNRFTE--IVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVD-----VARRLRQIC 308 (314)
Q Consensus 242 ~~~~-~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~e-----ll~~L~~~~ 308 (314)
.... ............ .+.... +.+.......+..+.+|+..||..||++|||+.| .++.++++.
T Consensus 236 i~~~~~~~~~~~~~l~g~~~~~~~l--p~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL 308 (676)
T 3qa8_A 236 VREKSNEHIVVYDDLTGAVKFSSVL--PTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL 308 (676)
T ss_dssp CC------CCSCCCCSSSCCCCSSS--CCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred hhcccchhhhhhhhhcccccccccc--CCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence 0000 000000000000 000000 0111112245678999999999999999999988 445665554
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=293.14 Aligned_cols=268 Identities=18% Similarity=0.254 Sum_probs=193.4
Q ss_pred hcCcccccccCch-hHHHHHHHh-cCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC---CCCceeeeE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIAS-SNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM---SHDHILKLI 86 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~-~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~ 86 (314)
.+|.....+|.|+ +.|+.+.+. .+|+.||+|++....... . ....+.+|+.++..+ +||||++++
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-------~---~~~~~~~e~~~l~~l~~~~h~~i~~~~ 80 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-------G---MPLSTIREVAVLRHLETFEHPNVVRLF 80 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-------S---CBCTHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-------c---CCchhhHHHHHHHhhhccCCCCeEeee
Confidence 4556666788888 778877764 678899999886432110 0 012456777777665 899999999
Q ss_pred eEEE-----eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeee
Q 043524 87 GCCL-----ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILF 161 (314)
Q Consensus 87 ~~~~-----~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~ 161 (314)
+++. .....++||||++ |+|.+++..... ..++...+..++.|++.||.||| ++||+|+||||+||++
T Consensus 81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili 153 (326)
T 1blx_A 81 DVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILV 153 (326)
T ss_dssp EEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEE
T ss_pred eeeeecccCCCceEEEEEecCC-CCHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEE
Confidence 9997 5677899999997 699999876543 34788999999999999999999 9999999999999999
Q ss_pred cCCCceEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccc
Q 043524 162 SEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYP 241 (314)
Q Consensus 162 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~ 241 (314)
+.++.++|+|||.++...... ......||+.|+|||++.+..++.++||||+|+++|+|++|..||........
T Consensus 154 ~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---- 227 (326)
T 1blx_A 154 TSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---- 227 (326)
T ss_dssp CTTCCEEECSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----
T ss_pred cCCCCEEEecCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH----
Confidence 999999999999987653221 23456789999999999988899999999999999999999999975432210
Q ss_pred hHHHHHhhh--ccCCccccc---Chhhh---ccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 242 FNEYLKNYF--EDNRFTEIV---DPIIV---QDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 242 ~~~~~~~~~--~~~~~~~~~---~~~~~---~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
........- ....+.... ..... ...........+..+.+|+.+||+.||++|||+.|+++
T Consensus 228 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 228 LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp HHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 011110000 000000000 00000 00000000134566889999999999999999999985
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=298.69 Aligned_cols=257 Identities=17% Similarity=0.234 Sum_probs=188.3
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.++.....+|.|+ +.|+.+.. +..+|+|++..... +.. ..+.+.+|+.++..++||||+++++++.
T Consensus 33 ~~~~~~~~lg~G~~g~V~~~~~---~~~~avk~~~~~~~-----~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 99 (319)
T 2y4i_B 33 EQLEIGELIGKGRFGQVYHGRW---HGEVAIRLIDIERD-----NED-----QLKAFKREVMAYRQTRHENVVLFMGACM 99 (319)
T ss_dssp SCEECCCBCCCSSSSEEEEEEE---SSSEEEEECCCCSC-----CCC-----CCCCCCTTGGGGTTCCCTTBCCCCEEEE
T ss_pred HHeEEeeEeccCCceEEEEEEE---cCeEEEEEeecCCC-----CHH-----HHHHHHHHHHHHhcCCCCCEeEEEEEEe
Confidence 4455666788888 67766533 34589998864321 000 0134568899999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
+.+..++|+||+++++|.+++.... ..++...+..++.|++.||.||| +++++|+||||+||+++ ++.++|+
T Consensus 100 ~~~~~~iv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~ 171 (319)
T 2y4i_B 100 SPPHLAIITSLCKGRTLYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVIT 171 (319)
T ss_dssp CSSCEEEECBCCCSEEHHHHTTSSC----CCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEEC
T ss_pred cCCceEEEeecccCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEe
Confidence 9999999999999999999997644 35788999999999999999999 99999999999999998 6789999
Q ss_pred ccccceecCCCC----cccccccccccccccCccccc---------CCCCcccchHHHHHHHHHHHhCCCCcccccCccc
Q 043524 171 DFSLSISIPEGE----THITDTVMGTYGHLAPQYVTT---------CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHD 237 (314)
Q Consensus 171 dfg~~~~~~~~~----~~~~~~~~g~~~y~aPE~~~~---------~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~ 237 (314)
|||+++...... ........|++.|+|||++.. ..++.++||||||+++|+|++|..||.......
T Consensus 172 Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~- 250 (319)
T 2y4i_B 172 DFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA- 250 (319)
T ss_dssp CCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH-
T ss_pred ecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence 999976543211 111234468999999998864 347889999999999999999999996433211
Q ss_pred cccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 238 LVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
........ ....... . ..+..+.+++..||..||++|||+.++++.|+++.+.
T Consensus 251 -------~~~~~~~~-~~~~~~~------~------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 251 -------IIWQMGTG-MKPNLSQ------I------GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp -------HHHHHHTT-CCCCCCC------S------SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred -------HHHHhccC-CCCCCCc------C------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 11111110 0000000 0 1234578999999999999999999999999887654
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=298.50 Aligned_cols=247 Identities=17% Similarity=0.295 Sum_probs=176.3
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeEEEeCCee
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGCCLETPIA 95 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 95 (314)
..+|.|+ +.|+. ....+|+.||+|.+..... +.+.+|++++..+ +|||||++++++.+++..
T Consensus 21 ~~LG~G~~g~V~~-~~~~~g~~vAvK~~~~~~~---------------~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~ 84 (434)
T 2rio_A 21 KILGYGSSGTVVF-QGSFQGRPVAVKRMLIDFC---------------DIALMEIKLLTESDDHPNVIRYYCSETTDRFL 84 (434)
T ss_dssp EEEEECSTTCEEE-EEESSSSEEEEEEEEGGGH---------------HHHHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred CeEeeCCCeEEEE-EEEECCeEEEEEEEcHHHH---------------HHHHHHHHHHHhccCCCCcCeEEEEEecCCeE
Confidence 4567777 44443 4567899999998865432 3457899999876 899999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCC--cccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCC---------
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFE--PLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEE--------- 164 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~--------- 164 (314)
|+|||||+ |+|.+++......... ......++.++.|++.||.||| +++|+||||||+||+++..
T Consensus 85 ~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~ 160 (434)
T 2rio_A 85 YIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQT 160 (434)
T ss_dssp EEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTT
T ss_pred EEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCccccccccc
Confidence 99999995 6999999765421100 0122235678999999999999 9999999999999999754
Q ss_pred ----CceEEcccccceecCCCCcc---cccccccccccccCccccc-------CCCCcccchHHHHHHHHHHHh-CCCCc
Q 043524 165 ----NVVKLFDFSLSISIPEGETH---ITDTVMGTYGHLAPQYVTT-------CDFSEKLDVYSFGAFLSELLT-GRGIL 229 (314)
Q Consensus 165 ----~~~kl~dfg~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~-------~~~~~~~DiwslG~~l~el~~-g~~p~ 229 (314)
+.++|+|||+++........ ......||+.|+|||++.+ ..++.++||||+||++|+|++ |..||
T Consensus 161 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf 240 (434)
T 2rio_A 161 GAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240 (434)
T ss_dssp CCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCC
Confidence 47999999999876543221 1234579999999999865 558899999999999999999 99998
Q ss_pred ccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 230 DLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
....... ......... .. ..........+.++.+|+.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~------~~i~~~~~~---~~---------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 241 GDKYSRE------SNIIRGIFS---LD---------EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp CSTTTHH------HHHHHTCCC---CC---------CCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCchhhH------HHHhcCCCC---cc---------cccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 6432111 111111000 00 0011111256678999999999999999999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=291.51 Aligned_cols=273 Identities=17% Similarity=0.174 Sum_probs=183.7
Q ss_pred hhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEE
Q 043524 11 WSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCC 89 (314)
Q Consensus 11 ~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 89 (314)
..+|.....+|.|+ +.|+++.+..+|+.||+|++..... ..+.+.+|++.+..++||||+++++++
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~~~l~~l~h~niv~~~~~~ 88 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-------------FRNRELQIMQDLAVLHHPNIVQLQSYF 88 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-------------CCCHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-------------ccHHHHHHHHHHHhcCCCCcccHHHhh
Confidence 34556666799998 8888888888999999998743210 114567888889999999999999999
Q ss_pred EeCCe-------eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeec
Q 043524 90 LETPI-------AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFS 162 (314)
Q Consensus 90 ~~~~~-------~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~ 162 (314)
..... .++||||+++ ++...+...... ...++...+..++.|++.||.|||. ++++|+||||||+||+++
T Consensus 89 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~-~~~~ivH~Dlkp~NIll~ 165 (360)
T 3e3p_A 89 YTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRR-QVAPPPILIKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVLVN 165 (360)
T ss_dssp EEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHTS-TTTCCBCSCCCGGGEEEE
T ss_pred hccccccccceeEEEEeecccc-cHHHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHhC-CCCCeecCcCCHHHEEEe
Confidence 76443 8899999975 665544321000 1357888899999999999999993 268999999999999999
Q ss_pred C-CCceEEcccccceecCCCCcccccccccccccccCcccccCC-CCcccchHHHHHHHHHHHhCCCCcccccCcccccc
Q 043524 163 E-ENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCD-FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVY 240 (314)
Q Consensus 163 ~-~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~ 240 (314)
. ++.++|+|||+++....... .....||+.|+|||++.+.. ++.++||||+||++|+|++|..||...........
T Consensus 166 ~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 243 (360)
T 3e3p_A 166 EADGTLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHE 243 (360)
T ss_dssp TTTTEEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred CCCCcEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHH
Confidence 6 88999999999987644332 33557899999999987655 89999999999999999999999975432211000
Q ss_pred -------chHHHHHhhhccCCcccccCh---hhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 241 -------PFNEYLKNYFEDNRFTEIVDP---IIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 241 -------~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
+..................+. ....... ......+..+.+|+.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 244 IVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFS-DHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTT-TCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHcCCCCHHHHHhcccchhhccccccccCCcccccc-hhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000000000000000000 0000000 000024567899999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=289.12 Aligned_cols=252 Identities=19% Similarity=0.262 Sum_probs=177.0
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.++.....+|.|+ +.|+.+.+..+|+.||+|++......... .+.+.++..++..++||||+++++++.
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----------~~~~~~~~~~~~~~~h~~i~~~~~~~~ 94 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEEN----------KRILMDLDVVLKSHDCPYIVQCFGTFI 94 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHH----------HHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHH----------HHHHHHHHHHHHhcCCCceeeEEEEEe
Confidence 3445556789888 88888888889999999998754322111 133445556788889999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCC-CceeccCCCCCeeecCCCceEE
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPR-PIVFRDFKTSHILFSEENVVKL 169 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~-~i~H~dlk~~nil~~~~~~~kl 169 (314)
+++..++||||+ ++.+........ ..++...+..++.|++.||.||| ++ +++|+||||+||+++.++.++|
T Consensus 95 ~~~~~~lv~e~~-~~~~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl 166 (318)
T 2dyl_A 95 TNTDVFIAMELM-GTCAEKLKKRMQ----GPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKL 166 (318)
T ss_dssp CSSEEEEEECCC-SEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEE
T ss_pred cCCcEEEEEecc-CCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEE
Confidence 999999999999 556655554322 35788999999999999999999 85 9999999999999999999999
Q ss_pred cccccceecCCCCcccccccccccccccCcccc-----cCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHH
Q 043524 170 FDFSLSISIPEGETHITDTVMGTYGHLAPQYVT-----TCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNE 244 (314)
Q Consensus 170 ~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 244 (314)
+|||++........ .....+|+.|+|||++. ...++.++||||+|+++|+|++|..||....... .
T Consensus 167 ~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~ 237 (318)
T 2dyl_A 167 CDFGISGRLVDDKA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF-------E 237 (318)
T ss_dssp CCCTTC----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH-------H
T ss_pred EECCCchhccCCcc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH-------H
Confidence 99999876543321 33456899999999985 4458899999999999999999999997433211 1
Q ss_pred HHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 245 YLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.......... +..... ...+..+.+|+..||+.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~------~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 238 VLTKVLQEEP------PLLPGH------MGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp HHHHHHHSCC------CCCCSS------SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHhccCC------CCCCcc------CCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1111111100 000000 023456889999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=295.34 Aligned_cols=246 Identities=17% Similarity=0.214 Sum_probs=195.1
Q ss_pred hhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC--CCceeeeEe
Q 043524 11 WSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS--HDHILKLIG 87 (314)
Q Consensus 11 ~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~ 87 (314)
..+|.....+|.|+ +.|+.+.+..+|+.||+|++.......... .. ..+.+.+|+.++..++ |+||+++++
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~-~~-----~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE-LP-----NGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEE-CT-----TCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhh-hh-----hhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 34566667799988 888888888899999999987654221100 00 0134568999999996 599999999
Q ss_pred EEEeCCeeEEEEeecCC-CCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeec-CCC
Q 043524 88 CCLETPIAILVFEYVQH-GTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFS-EEN 165 (314)
Q Consensus 88 ~~~~~~~~~iv~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~-~~~ 165 (314)
++..++..++|+|++.+ ++|.+++... ..++...+..++.|++.||.||| +++|+||||||+||+++ .++
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~ 187 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRG 187 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTT
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCC
Confidence 99999999999999975 8999998764 34788999999999999999999 99999999999999998 778
Q ss_pred ceEEcccccceecCCCCcccccccccccccccCcccccCCC-CcccchHHHHHHHHHHHhCCCCcccccCccccccchHH
Q 043524 166 VVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDF-SEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNE 244 (314)
Q Consensus 166 ~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 244 (314)
.++|+|||+++...... .....||+.|+|||++....+ +.++||||||+++|+|++|..||......
T Consensus 188 ~~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--------- 255 (320)
T 3a99_A 188 ELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--------- 255 (320)
T ss_dssp EEEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH---------
T ss_pred CEEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh---------
Confidence 99999999998764332 334568999999999887765 67899999999999999999998632210
Q ss_pred HHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 245 YLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
..... ... ...+..+.+|+..||+.||++|||+.|+++
T Consensus 256 -----~~~~~---~~~------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 256 -----IRGQV---FFR------------QRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp -----HHCCC---CCS------------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----hcccc---ccc------------ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 000 023356889999999999999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=293.37 Aligned_cols=261 Identities=17% Similarity=0.230 Sum_probs=189.9
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|.....+|.|+ +.|+.+.+..+|+.||+|++....... ...+++.+|+.++..++||||+++++++.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 93 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE----------IFAKRAYRELLLLKHMQHENVIGLLDVFT 93 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSH----------HHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccch----------HHHHHHHHHHHHHHhcCCCCcccHhheEe
Confidence 3455566789888 888888888999999999986432111 01256789999999999999999999998
Q ss_pred eCCe------eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCC
Q 043524 91 ETPI------AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEE 164 (314)
Q Consensus 91 ~~~~------~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~ 164 (314)
.... .|+||||++ ++|.+.+. ..++...+..++.|++.||.||| +++|+|+||||+||+++.+
T Consensus 94 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~ 162 (353)
T 3coi_A 94 PASSLRNFYDFYLVMPFMQ-TDLQKIMG-------LKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNED 162 (353)
T ss_dssp SCSSGGGCCCCEEEEECCS-EEGGGTTT-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTT
T ss_pred cccccccceeEEEEecccc-CCHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCC
Confidence 7654 499999996 68877763 24788999999999999999999 9999999999999999999
Q ss_pred CceEEcccccceecCCCCcccccccccccccccCccccc-CCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchH
Q 043524 165 NVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTT-CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFN 243 (314)
Q Consensus 165 ~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~ 243 (314)
+.++|+|||+++..... .....+|+.|+|||++.+ ..++.++||||+|+++|+|++|..||........ +.
T Consensus 163 ~~~kl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~----~~ 234 (353)
T 3coi_A 163 CELKILDFGLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ----LT 234 (353)
T ss_dssp CCEEECSTTCTTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH----HH
T ss_pred CcEEEeecccccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HH
Confidence 99999999999764322 234578999999999877 5689999999999999999999999975432110 00
Q ss_pred HHHHhhhcc-CC-cccccC-----------hhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 244 EYLKNYFED-NR-FTEIVD-----------PIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 244 ~~~~~~~~~-~~-~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
......-.. .. ...+.+ ........ ......+..+.+|+.+||+.||++|||+.|+++
T Consensus 235 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 235 QILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000000 00 000000 00000000 000134567899999999999999999999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=292.52 Aligned_cols=245 Identities=17% Similarity=0.245 Sum_probs=187.8
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC----CCCceeeeE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM----SHDHILKLI 86 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l----~h~niv~~~ 86 (314)
.+|.....+|.|+ +.|+.+.+..+|+.||+|++........... . ....+.+|+.++..+ +||||++++
T Consensus 31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~-~-----~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPL-S-----DSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccc-h-----hhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 4566666788888 8888888888999999999875432111000 0 012345788888888 899999999
Q ss_pred eEEEeCCeeEEEEee-cCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeec-CC
Q 043524 87 GCCLETPIAILVFEY-VQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFS-EE 164 (314)
Q Consensus 87 ~~~~~~~~~~iv~e~-~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~-~~ 164 (314)
+++...+..++|+|+ +.+++|.+++.... .++...+..++.|++.||.||| +++|+|+||||+||+++ .+
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~ 176 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKG-----PLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRR 176 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTT
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCC
Confidence 999999999999999 78899999997642 4789999999999999999999 99999999999999998 78
Q ss_pred CceEEcccccceecCCCCcccccccccccccccCcccccCCCC-cccchHHHHHHHHHHHhCCCCcccccCccccccchH
Q 043524 165 NVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFS-EKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFN 243 (314)
Q Consensus 165 ~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~ 243 (314)
+.++|+|||+++...... .....|+..|+|||++....+. .++||||+|+++|+|++|+.||......
T Consensus 177 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------- 245 (312)
T 2iwi_A 177 GCAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI-------- 245 (312)
T ss_dssp TEEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH--------
T ss_pred CeEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH--------
Confidence 899999999998764432 3355689999999998877764 5899999999999999999998632210
Q ss_pred HHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 244 EYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.. .... .+ ...+..+.+|+.+||+.||++|||+.|+++
T Consensus 246 --~~---~~~~------------~~----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 246 --LE---AELH------------FP----AHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp --HH---TCCC------------CC----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --hh---hccC------------Cc----ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 0000 00 123456789999999999999999999987
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=288.94 Aligned_cols=249 Identities=18% Similarity=0.258 Sum_probs=183.5
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC--CCceeeeEeEE
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS--HDHILKLIGCC 89 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~ 89 (314)
+|+....+|.|+ +.|+.+.+ .+|+.+|+|++........ ..+.+.+|+.++..++ ||||+++++++
T Consensus 29 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~----------~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 29 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQ----------TLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp EEEEEEEEECCSSEEEEEEEC-TTCCEEEEEEEECSSCCHH----------HHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred eEEEEEEecCCCCEEEEEEEc-CCCcEEEEEEecccccccc----------chHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 345555688888 77776655 4588999999864321111 1256889999999997 59999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEE
Q 043524 90 LETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKL 169 (314)
Q Consensus 90 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl 169 (314)
.+++..++||| +.+++|.+++.... .++...+..++.|++.||.||| +++|+|+||||+||+++. +.++|
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL 167 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKL 167 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEE
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEE
Confidence 99999999999 55789999997653 5788899999999999999999 999999999999999964 88999
Q ss_pred cccccceecCCCCcc-cccccccccccccCccccc-----------CCCCcccchHHHHHHHHHHHhCCCCcccccCccc
Q 043524 170 FDFSLSISIPEGETH-ITDTVMGTYGHLAPQYVTT-----------CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHD 237 (314)
Q Consensus 170 ~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~-----------~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~ 237 (314)
+|||+++........ ......||+.|+|||++.. ..++.++||||+|+++|+|++|..||.......
T Consensus 168 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~- 246 (313)
T 3cek_A 168 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI- 246 (313)
T ss_dssp CCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-
T ss_pred eeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-
Confidence 999999765433221 1234578999999999865 367889999999999999999999996432211
Q ss_pred cccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 238 LVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
......... ......+. ..+..+.+++..||+.||++|||+.|+++
T Consensus 247 ------~~~~~~~~~---------~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 247 ------SKLHAIIDP---------NHEIEFPD----IPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp ------HHHHHHHCT---------TSCCCCCC----CSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ------HHHHHHHhc---------ccccCCcc----cchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 111111111 00000000 12356889999999999999999999986
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=274.91 Aligned_cols=233 Identities=11% Similarity=0.049 Sum_probs=179.8
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|+....+|.|+ +.||++.+..+|+.||+|++....... ....+.+.+|+..+..++||||+++++++.
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~---------~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~ 101 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLP---------DDVLQETLSRTLRLSRIDKPGVARVLDVVH 101 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSC---------HHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccC---------HHHHHHHHHHHHHHhcCCCCCcceeeEEEE
Confidence 3455566789888 888999888899999999987542110 001267889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
+++..|+||||+++++|.+++... .....+..++.|++.||.||| ++||+||||||+||+++.++.++|+
T Consensus 102 ~~~~~~lv~e~~~g~~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~ 171 (286)
T 3uqc_A 102 TRAGGLVVAEWIRGGSLQEVADTS-------PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLA 171 (286)
T ss_dssp ETTEEEEEEECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEEC
T ss_pred ECCcEEEEEEecCCCCHHHHHhcC-------CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEE
Confidence 999999999999999999998542 244567889999999999999 9999999999999999999999988
Q ss_pred ccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhh
Q 043524 171 DFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 171 dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
+++. ++ .++.++||||||+++|+|++|+.||..........
T Consensus 172 ~~~~---------------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~----------- 212 (286)
T 3uqc_A 172 YPAT---------------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA----------- 212 (286)
T ss_dssp SCCC---------------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE-----------
T ss_pred eccc---------------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH-----------
Confidence 5432 22 36889999999999999999999997544322100
Q ss_pred ccCCcccccChhhhccCCc--hhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 251 EDNRFTEIVDPIIVQDLSC--TEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
............ ......+..+.+++.+||+.||++| |+.|+++.|+++...
T Consensus 213 -------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 213 -------PAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp -------ECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred -------HHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 000000000000 0011345678999999999999999 999999999988653
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=305.58 Aligned_cols=240 Identities=19% Similarity=0.230 Sum_probs=188.0
Q ss_pred hcCcccccccCch-hHHHHHHHhc-CCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASS-NGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCC 89 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~-~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 89 (314)
.+|.....+|.|+ +.||.+.+.. +|+.||+|++....... ..+.+.+|++++..++||||+++++++
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~~E~~~l~~l~hp~iv~~~~~~ 148 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAE-----------AQAMAMAERQFLAEVVHPSIVQIFNFV 148 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHH-----------HHHHHHHHHGGGGGCCCTTBCCEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHH-----------HHHHHHHHHHHHHhcCCCCcCeEeeeE
Confidence 4555666788888 7888877665 78999999876432111 125678999999999999999999999
Q ss_pred EeCCe-----eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCC
Q 043524 90 LETPI-----AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEE 164 (314)
Q Consensus 90 ~~~~~-----~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~ 164 (314)
...+. .|+||||+++++|.+.+.. .+++..++.++.|++.||.||| +++|+||||||+||+++.+
T Consensus 149 ~~~~~~~~~~~~lv~E~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~ 218 (681)
T 2pzi_A 149 EHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE 218 (681)
T ss_dssp EEECTTSCEEEEEEEECCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS
T ss_pred eecCCCCCceeEEEEEeCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC
Confidence 87665 7999999999999887643 4789999999999999999999 9999999999999999875
Q ss_pred CceEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHH
Q 043524 165 NVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNE 244 (314)
Q Consensus 165 ~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 244 (314)
.+||+|||+++..... ....||+.|+|||++.+. ++.++|||||||++|+|++|..||.......
T Consensus 219 -~~kl~DFG~a~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-------- 283 (681)
T 2pzi_A 219 -QLKLIDLGAVSRINSF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG-------- 283 (681)
T ss_dssp -CEEECCCTTCEETTCC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS--------
T ss_pred -cEEEEecccchhcccC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc--------
Confidence 8999999999876433 345799999999988664 4889999999999999999998875321100
Q ss_pred HHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCC-CHHHHHHHHHHHH
Q 043524 245 YLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRP-TMVDVARRLRQIC 308 (314)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-s~~ell~~L~~~~ 308 (314)
.. ........+..+.+|+.+||+.||++|| ++.++...|..+.
T Consensus 284 --------------~~-------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 284 --------------LP-------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp --------------CC-------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred --------------cc-------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 00 0001113446788999999999999999 5777877777664
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=273.85 Aligned_cols=222 Identities=17% Similarity=0.274 Sum_probs=173.2
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHH-hcCCCCceeeeEeEEEe----
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYA-AQMSHDHILKLIGCCLE---- 91 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~---- 91 (314)
..+|.|+ +.|+.+.+..+|+.||+|++... ..+.+|+.++ +.++||||+++++++..
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 86 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----------------PKARREVELHWRASQCPHIVRIVDVYENLYAG 86 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----------------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEeccc-----------------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence 4588888 88888888899999999998532 3456788887 56689999999999987
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecC---CCceE
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSE---ENVVK 168 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~---~~~~k 168 (314)
+...++||||+++|+|.+++..... ..++...+..++.|++.||.||| +++|+||||||+||+++. ++.++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~k 160 (299)
T 3m2w_A 87 RKCLLIVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILK 160 (299)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEE
T ss_pred CceEEEEEeecCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEE
Confidence 7789999999999999999987542 35889999999999999999999 999999999999999998 78899
Q ss_pred EcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHh
Q 043524 169 LFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKN 248 (314)
Q Consensus 169 l~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (314)
|+|||++.... +..++.++||||+|+++|+|++|..||.........
T Consensus 161 l~Dfg~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~---------- 207 (299)
T 3m2w_A 161 LTDFGFAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---------- 207 (299)
T ss_dssp ECCCTTCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-----------------
T ss_pred Eeccccccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh----------
Confidence 99999986532 124677899999999999999999999644322100
Q ss_pred hhccCCcccccChhhhc--cCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 249 YFEDNRFTEIVDPIIVQ--DLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 249 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.......... ..+.......+.++.+|+..||+.||++|||+.|+++
T Consensus 208 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 208 -------PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp -------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -------HHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0000000011 1111111245677899999999999999999999987
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=284.05 Aligned_cols=244 Identities=13% Similarity=0.057 Sum_probs=175.4
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCC-Ccee--------
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSH-DHIL-------- 83 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv-------- 83 (314)
++....+|.|+ +.||++.+..+|+.||||++......... ..+.+.+|+.++..++| +|..
T Consensus 80 ~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~---------~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~ 150 (413)
T 3dzo_A 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSN---------AIKQMKEEVLRLRLLRGIKNQKQAKVHLRF 150 (413)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC-------------CCHHHHHHHHGGGGSTTCCSHHHHHHHTCB
T ss_pred EEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHH---------HHHHHHHHHHHHHhhccCCCHHHHHHhccc
Confidence 34445689988 88999988999999999988733211111 12668899999999987 2211
Q ss_pred -------e------eEeEEEe-----CCeeEEEEeecCCCCHHHHHhcCC--CCCCCcccHHHHHHHHHHHHHHHHHhhc
Q 043524 84 -------K------LIGCCLE-----TPIAILVFEYVQHGTLWDRILGAP--QTHFEPLLLKRRLKDAVDAANALAYLHF 143 (314)
Q Consensus 84 -------~------~~~~~~~-----~~~~~iv~e~~~~g~L~~~l~~~~--~~~~~~l~~~~~~~~~~~i~~~l~~lH~ 143 (314)
. +..++.. ...++++|+++ +++|.+++.... ......++...++.++.|++.||.|||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH- 228 (413)
T 3dzo_A 151 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH- 228 (413)
T ss_dssp CCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH-
T ss_pred ccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH-
Confidence 1 1111111 23467777766 689998884110 000145778888999999999999999
Q ss_pred CCCCCceeccCCCCCeeecCCCceEEcccccceecCCCCcccccccccccccccCccc----------ccCCCCcccchH
Q 043524 144 GFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYV----------TTCDFSEKLDVY 213 (314)
Q Consensus 144 ~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~----------~~~~~~~~~Diw 213 (314)
+++|+||||||+||+++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||
T Consensus 229 --~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dvw 301 (413)
T 3dzo_A 229 --HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTW 301 (413)
T ss_dssp --HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHH
T ss_pred --hCCcccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHH
Confidence 999999999999999999999999999998765332 334567 999999998 455588899999
Q ss_pred HHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCC
Q 043524 214 SFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPID 293 (314)
Q Consensus 214 slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~ 293 (314)
||||++|+|++|+.||....... .......... ..+..+.+|+..||+.||++
T Consensus 302 SlGvil~elltg~~Pf~~~~~~~---------------------~~~~~~~~~~------~~~~~~~~li~~~l~~dP~~ 354 (413)
T 3dzo_A 302 TLGLAIYWIWCADLPNTDDAALG---------------------GSEWIFRSCK------NIPQPVRALLEGFLRYPKED 354 (413)
T ss_dssp HHHHHHHHHHHSSCCCCTTGGGS---------------------CSGGGGSSCC------CCCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHHHHHHHCCCCCCCcchhh---------------------hHHHHHhhcc------cCCHHHHHHHHHHccCChhh
Confidence 99999999999999996443221 0111111111 22356899999999999999
Q ss_pred CCCHHHHHH
Q 043524 294 RPTMVDVAR 302 (314)
Q Consensus 294 Rps~~ell~ 302 (314)
|||+.|+++
T Consensus 355 Rpt~~~~l~ 363 (413)
T 3dzo_A 355 RLLPLQAME 363 (413)
T ss_dssp SCCHHHHTT
T ss_pred CcCHHHHHh
Confidence 999888854
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=274.57 Aligned_cols=249 Identities=14% Similarity=0.112 Sum_probs=178.3
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC---------CCc
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS---------HDH 81 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---------h~n 81 (314)
.+|.....+|.|+ +.|+++.+ +|+.||+|++........ ........+.+.+|+.+++.++ |||
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~----~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~n 93 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLV----NGSHQKTFEEILPEIIISKELSLLSGEVCNRTEG 93 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCB----TTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCC
T ss_pred ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCcccc----ccccchhHHHHHHHHHHHHHHHHhhccccccCCc
Confidence 3444555688888 77777755 789999999875431100 0011112356788998888885 777
Q ss_pred eeeeEeEEE-----------------e-------------CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHH
Q 043524 82 ILKLIGCCL-----------------E-------------TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDA 131 (314)
Q Consensus 82 iv~~~~~~~-----------------~-------------~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~ 131 (314)
||++.+++. + +..+|+|||||++|++.+.+.. ..++...++.++
T Consensus 94 iv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~ 167 (336)
T 2vuw_A 94 FIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSIL 167 (336)
T ss_dssp BCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHH
T ss_pred hhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHH
Confidence 777776643 2 6789999999999977676643 247889999999
Q ss_pred HHHHHHHHHhhcCCCCCceeccCCCCCeeecCCC--------------------ceEEcccccceecCCCCccccccccc
Q 043524 132 VDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN--------------------VVKLFDFSLSISIPEGETHITDTVMG 191 (314)
Q Consensus 132 ~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~--------------------~~kl~dfg~~~~~~~~~~~~~~~~~g 191 (314)
.|++.||.|||. +++|+||||||+|||++.++ .+||+|||+++..... ...|
T Consensus 168 ~qi~~aL~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~g 239 (336)
T 2vuw_A 168 HQLTASLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVF 239 (336)
T ss_dssp HHHHHHHHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEEC
T ss_pred HHHHHHHHHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEE
Confidence 999999999993 48999999999999999887 8999999999876432 3479
Q ss_pred ccccccCcccccCCCCcccchHHHHHH-HHHHHhCCCCcccccCccccccchHHHHHhhhccCCcccccChhhhccCCch
Q 043524 192 TYGHLAPQYVTTCDFSEKLDVYSFGAF-LSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCT 270 (314)
Q Consensus 192 ~~~y~aPE~~~~~~~~~~~DiwslG~~-l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (314)
|+.|+|||++.+.. +.++||||++++ .++++.|..||..... ............. ........
T Consensus 240 t~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~-------~~~~~~~~~~~~~--------~~~~~~~~ 303 (336)
T 2vuw_A 240 CDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW-------LHYLTDKMLKQMT--------FKTKCNTP 303 (336)
T ss_dssp CCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH-------HHHHHHHHHHTCC--------CSSCCCSH
T ss_pred eecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh-------hhHHHHhhhhhhc--------cCcccchh
Confidence 99999999998766 889999998777 7778889988742100 0000001110000 01111222
Q ss_pred hHHHHHHHHHHHHhHhccCCCCCCCCHHHHH
Q 043524 271 EKEQQLHASAQLTFECLNESPIDRPTMVDVA 301 (314)
Q Consensus 271 ~~~~~~~~~~~li~~cl~~dp~~Rps~~ell 301 (314)
.....+.++.+|+.+||++| ||.|++
T Consensus 304 ~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 304 AMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred hhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 34467889999999999987 999988
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-32 Score=260.71 Aligned_cols=190 Identities=11% Similarity=0.011 Sum_probs=132.6
Q ss_pred hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeEEEeCCeeEEEEeecC
Q 043524 25 SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGCCLETPIAILVFEYVQ 103 (314)
Q Consensus 25 ~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~iv~e~~~ 103 (314)
+.+..+++...|+.+|+|++......... ...+...-.++|.+|+++|+++ .|+||+++++++++++.+||||||++
T Consensus 248 ~~h~~~rr~~fg~~~~~K~~~~~~~~~~~--~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~ 325 (569)
T 4azs_A 248 LAHKRSRRYFFGEDYVCKFFYYDMPHGIL--TAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLP 325 (569)
T ss_dssp ----CCEEEEECSSEEEEEEESSCSTTCS--CHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCC
T ss_pred ccccccccccccceeEEEEEecccccccc--hhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCC
Confidence 45556677778999999998643110000 0000000126799999999999 69999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccceecCCCCc
Q 043524 104 HGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGET 183 (314)
Q Consensus 104 ~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~ 183 (314)
|++|.+++...+ +++.. .++.||+.||.|+| ++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 326 G~~L~d~i~~~~-----~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~ 394 (569)
T 4azs_A 326 GRLLSDMLAAGE-----EIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS 394 (569)
T ss_dssp SEEHHHHHHTTC-----CCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---C
T ss_pred CCcHHHHHHhCC-----CCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCc
Confidence 999999998753 45544 47889999999999 99999999999999999999999999999987644322
Q ss_pred ccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCc
Q 043524 184 HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGIL 229 (314)
Q Consensus 184 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~ 229 (314)
...+.+||+.|+|||++.+ .+...+|+||+|++++++.++..++
T Consensus 395 -~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 395 -WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp -CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred -cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 2446689999999998865 4667899999999988877665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-26 Score=218.24 Aligned_cols=183 Identities=16% Similarity=0.136 Sum_probs=140.9
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHH-----HHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQE-----LKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~-----~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
..+|+|+ +.|+++ ...++.+++|....+. ..... ..+++.+|+++++.++||||+++..++..
T Consensus 342 ~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~---------~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 410 (540)
T 3en9_A 342 HLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENI---------RKSRTAREARYLALVKDFGIPAPYIFDVD 410 (540)
T ss_dssp ------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHH---------HHHHHHHHHHHHHHGGGGTCCCCCEEEEE
T ss_pred CEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHH---------HHHHHHHHHHHHHhcCCCCcCceEEEEEe
Confidence 3578877 667666 5567788888643321 11110 12568999999999999999976666667
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
.+..|+||||+++++|.+++.. ...++.|++.||.||| +++|+||||||+||+++. .+||+|
T Consensus 411 ~~~~~lVmE~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~D 472 (540)
T 3en9_A 411 LDNKRIMMSYINGKLAKDVIED-------------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIID 472 (540)
T ss_dssp TTTTEEEEECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECC
T ss_pred CCccEEEEECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEE
Confidence 8888999999999999998853 4578999999999999 999999999999999998 999999
Q ss_pred cccceecCCCCccc------ccccccccccccCccccc--CCCCcccchHHHHHHHHHHHhCCCCc
Q 043524 172 FSLSISIPEGETHI------TDTVMGTYGHLAPQYVTT--CDFSEKLDVYSFGAFLSELLTGRGIL 229 (314)
Q Consensus 172 fg~~~~~~~~~~~~------~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~p~ 229 (314)
||+++......... .....||+.|+|||++.. ..|+..+|+||..+-..+.+.++.+|
T Consensus 473 FGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 473 FGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 99998875432211 235679999999999976 45788899999999888888777665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=9.9e-22 Score=170.66 Aligned_cols=148 Identities=14% Similarity=0.099 Sum_probs=108.8
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCC--------hhHHHHHHHHHHHhcCCCCceeeeEeE
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNG--------FWHESCINNVTYAAQMSHDHILKLIGC 88 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~ 88 (314)
..+|.|+ +.|+.+.. .+|+.+|+|++........... .... ....++.+|+.++..++ | +++.++
T Consensus 96 ~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~--~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~ 169 (282)
T 1zar_A 96 KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVK--EKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKV 169 (282)
T ss_dssp EEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCC--C-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCE
T ss_pred CEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhh--hhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeE
Confidence 5688888 77777777 7899999999875432211100 0000 01256889999999999 5 667665
Q ss_pred EEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceE
Q 043524 89 CLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVK 168 (314)
Q Consensus 89 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~k 168 (314)
+.. +..|+||||+++++|.+ +.. .....++.|++.||.||| +++|+||||||+||+++ ++.++
T Consensus 170 ~~~-~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-~~~vk 232 (282)
T 1zar_A 170 YAW-EGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-EEGIW 232 (282)
T ss_dssp EEE-ETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-TTEEE
T ss_pred Eec-cceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-CCcEE
Confidence 543 56699999999999988 421 123368899999999999 99999999999999999 99999
Q ss_pred EcccccceecCCCCcccccccccccccccCcccc
Q 043524 169 LFDFSLSISIPEGETHITDTVMGTYGHLAPQYVT 202 (314)
Q Consensus 169 l~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 202 (314)
|+|||+++.. ..+.|||++.
T Consensus 233 l~DFG~a~~~--------------~~~~a~e~l~ 252 (282)
T 1zar_A 233 IIDFPQSVEV--------------GEEGWREILE 252 (282)
T ss_dssp ECCCTTCEET--------------TSTTHHHHHH
T ss_pred EEECCCCeEC--------------CCCCHHHHHH
Confidence 9999998643 3467777664
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=2.4e-17 Score=141.15 Aligned_cols=146 Identities=12% Similarity=0.111 Sum_probs=101.2
Q ss_pred cccccCch-hHHHHHHHhcCCcc--cccccccHHHH--HHHhc------CCccc----CChhHHHHHHHHHHHhcCCCCc
Q 043524 17 TLMIGNGA-SVLQELIASSNGKY--IPYRIFSAQEL--KQETN------NYDQK----NGFWHESCINNVTYAAQMSHDH 81 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~--~a~k~~~~~~~--~~~~~------~~~~~----~~~~~~~~~~E~~~l~~l~h~n 81 (314)
...+|.|+ +.|+.+....+|+. ||+|++..... ..... .+... .......+.+|+..|..+.|++
T Consensus 52 ~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 131 (258)
T 1zth_A 52 GGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAG 131 (258)
T ss_dssp EEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCC
Confidence 34688888 78888877678999 99998754321 11000 00000 0012246789999999998875
Q ss_pred e--eeeEeEEEeCCeeEEEEeecCC-C----CHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccC
Q 043524 82 I--LKLIGCCLETPIAILVFEYVQH-G----TLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDF 154 (314)
Q Consensus 82 i--v~~~~~~~~~~~~~iv~e~~~~-g----~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dl 154 (314)
+ ..+++. +..++||||+++ | +|.+.... .+...+..++.|++.++.|||. +.+|+||||
T Consensus 132 i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~--~~givHrDl 197 (258)
T 1zth_A 132 VSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQ--EAELVHADL 197 (258)
T ss_dssp CCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSC
T ss_pred CCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCC
Confidence 4 444432 357899999942 3 66665422 2234567889999999999995 589999999
Q ss_pred CCCCeeecCCCceEEcccccceec
Q 043524 155 KTSHILFSEENVVKLFDFSLSISI 178 (314)
Q Consensus 155 k~~nil~~~~~~~kl~dfg~~~~~ 178 (314)
||+|||++. .++|+|||++...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999988 8999999999654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.43 E-value=5.8e-16 Score=138.60 Aligned_cols=147 Identities=14% Similarity=0.128 Sum_probs=92.8
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHH--HHhc--CCcccCCh------hHHHHHHHHHHHhcCCCCce
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELK--QETN--NYDQKNGF------WHESCINNVTYAAQMSHDHI 82 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~--~~~~--~~~~~~~~------~~~~~~~E~~~l~~l~h~ni 82 (314)
|.....||.|+ +.||.+.+ .+|+.||+|++...... .... .+...... ..-....|...|.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 44556788888 77777655 57999999987643210 0000 00000000 00112356677777654333
Q ss_pred eeeEeEEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeec
Q 043524 83 LKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFS 162 (314)
Q Consensus 83 v~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~ 162 (314)
. ....+.. ...++||||++|++|...... .....++.|++.++.+|| ..||+||||||.|||++
T Consensus 176 ~-vp~p~~~-~~~~LVME~i~G~~L~~l~~~-----------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~ 239 (397)
T 4gyi_A 176 P-VPEPIAQ-SRHTIVMSLVDALPMRQVSSV-----------PDPASLYADLIALILRLA---KHGLIHGDFNEFNILIR 239 (397)
T ss_dssp S-CCCEEEE-ETTEEEEECCSCEEGGGCCCC-----------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE
T ss_pred C-CCeeeec-cCceEEEEecCCccHhhhccc-----------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEe
Confidence 2 2211111 234799999998888554311 123456789999999999 99999999999999998
Q ss_pred CCC----------ceEEccccccee
Q 043524 163 EEN----------VVKLFDFSLSIS 177 (314)
Q Consensus 163 ~~~----------~~kl~dfg~~~~ 177 (314)
.++ .+.|+||+.+..
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCCcccccccccceEEEEeCCccc
Confidence 766 378999998754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.99 E-value=9.9e-11 Score=99.88 Aligned_cols=134 Identities=9% Similarity=-0.015 Sum_probs=94.1
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC-CCceeeeEeEEEeCCeeE
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS-HDHILKLIGCCLETPIAI 96 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 96 (314)
..|.|+ +.|+.+. ..|+.+++|+........ . ..+.+|+.++..+. +.++.++++++.+++..|
T Consensus 21 ~~~g~s~~~v~~~~--~~~~~~vlK~~~~~~~~~---~---------~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 21 DTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT---T---------YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp CCSCCSSSEEEEEE--CSSCEEEEEEECGGGTTS---T---------TCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred eccCCCCCeEEEEE--CCCCcEEEEeCCcccCCC---H---------HHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence 344444 4455442 236789999876432100 0 34678999999885 678889999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcC--------------------------------
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFG-------------------------------- 144 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~-------------------------------- 144 (314)
+|||+++|.++.+.+... .....++.++..++..||..
T Consensus 87 lv~e~i~G~~l~~~~~~~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYEDE----------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEECCSSEEHHHHCCTT----------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGG
T ss_pred EEEEecCCeehhhccCCc----------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccc
Confidence 999999999987753211 11235567777888888841
Q ss_pred ------------------------CCCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 145 ------------------------FPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 145 ------------------------~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
....++|+|++|.||+++....+.|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01458899999999999876566799998763
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.81 E-value=2e-09 Score=96.10 Aligned_cols=143 Identities=17% Similarity=0.251 Sum_probs=96.2
Q ss_pred ccccccCch-hHHHHHHHhcCCccccccccc--HHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC--CCceeeeEeEEE
Q 043524 16 RTLMIGNGA-SVLQELIASSNGKYIPYRIFS--AQELKQETNNYDQKNGFWHESCINNVTYAAQMS--HDHILKLIGCCL 90 (314)
Q Consensus 16 ~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~--~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~ 90 (314)
....++.|. ..+|.+ ... +..+++|... ........ +.+.+|+.++..+. +..+.+++.++.
T Consensus 42 ~~~~l~~G~sn~~y~v-~~~-~~~~vlr~~~~p~~~~~~~~-----------~~~~~E~~~l~~L~~~~vpvP~~~~~~~ 108 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKL-VTP-GQTYVMRAKPGPKSKLLPSA-----------HAIEREYRVMDALAGTDVPVAKMYALCE 108 (359)
T ss_dssp EEEECCC-CCSCEEEE-ECS-SCEEEEECCCC---------------------CHHHHHHHHHHHTTSSSCCCCEEEEEC
T ss_pred eEEEcCCcccceEEEE-EEC-CceEEEEeCCCCCCCCCCcH-----------HHHHHHHHHHHHhhcCCCCCCcEEEECC
Confidence 344556665 444443 222 4567788765 43221111 35678999999987 456889999887
Q ss_pred eC---CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCC----------------------
Q 043524 91 ET---PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGF---------------------- 145 (314)
Q Consensus 91 ~~---~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---------------------- 145 (314)
+. +..|+||||++|.++.+... ..++......++.++...|..||...
T Consensus 109 ~~~~~g~~~~vme~v~G~~l~~~~~-------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (359)
T 3dxp_A 109 DESVIGRAFYIMEFVSGRVLWDQSL-------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIER 181 (359)
T ss_dssp CTTTTSSCEEEEECCCCBCCCCTTC-------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHH
T ss_pred CCCccCCeEEEEEecCCeecCCCcc-------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHH
Confidence 76 45889999999877744211 23567777788889999999999410
Q ss_pred ---------------------------------CCCceeccCCCCCeeecCCC--ceEEcccccceec
Q 043524 146 ---------------------------------PRPIVFRDFKTSHILFSEEN--VVKLFDFSLSISI 178 (314)
Q Consensus 146 ---------------------------------~~~i~H~dlk~~nil~~~~~--~~kl~dfg~~~~~ 178 (314)
...++|+|+++.||+++.++ .+.++||+.+...
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 182 WTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 25689999999999998765 3689999998653
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.81 E-value=7.1e-10 Score=94.09 Aligned_cols=124 Identities=10% Similarity=0.001 Sum_probs=84.7
Q ss_pred hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCc--eeeeEeEEEeCCeeEEEEeec
Q 043524 25 SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDH--ILKLIGCCLETPIAILVFEYV 102 (314)
Q Consensus 25 ~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~iv~e~~ 102 (314)
..++.+ ...+|+.+++|+..... ...+.+|+.++..+.+.+ +.+++++...++..++||||+
T Consensus 34 ~~v~~~-~~~~g~~~vlK~~~~~~---------------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 34 AAVFRL-SAQGRPVLFVKTDLSGA---------------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp CEEEEE-ECTTSCCEEEEEECSCT---------------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred ceEEEE-ecCCCCeEEEEeCCccc---------------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 455544 34567789999865320 034678899998886433 667888888888899999999
Q ss_pred CCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCC-------------------------------------
Q 043524 103 QHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGF------------------------------------- 145 (314)
Q Consensus 103 ~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~------------------------------------- 145 (314)
+|.++. ... ... ..++.++...+..||...
T Consensus 98 ~G~~l~--~~~--------~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 98 PGQDLL--SSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp SSEETT--TSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred CCcccC--cCc--------CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 998873 211 111 134556666677777210
Q ss_pred ------------------CCCceeccCCCCCeeecCCCceEEccccccee
Q 043524 146 ------------------PRPIVFRDFKTSHILFSEENVVKLFDFSLSIS 177 (314)
Q Consensus 146 ------------------~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~ 177 (314)
...++|+|++|.||+++.++.+.++||+.+..
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11289999999999998766667999998743
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.49 E-value=1.7e-08 Score=87.95 Aligned_cols=170 Identities=16% Similarity=0.197 Sum_probs=98.1
Q ss_pred cccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC-CCc--eeeeEeEEEeCC---eeEEEEeecCCCCHHHH
Q 043524 37 KYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS-HDH--ILKLIGCCLETP---IAILVFEYVQHGTLWDR 110 (314)
Q Consensus 37 ~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~~~~~~~~~~---~~~iv~e~~~~g~L~~~ 110 (314)
+.+++|+....... ..+.+|++++..+. +.. +.+++.....+. ..|+|||+++|.++.+.
T Consensus 41 ~~~vlR~~~~~~~~--------------~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~ 106 (304)
T 3sg8_A 41 RDFIFKFPKHSRGS--------------TNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPL 106 (304)
T ss_dssp TSEEEEEESSHHHH--------------HHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHH
T ss_pred CEEEEEecCCcchH--------------HHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcc
Confidence 56788876543211 45678999998874 332 444544433333 34789999998887643
Q ss_pred HhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhc-----------------------------------------------
Q 043524 111 ILGAPQTHFEPLLLKRRLKDAVDAANALAYLHF----------------------------------------------- 143 (314)
Q Consensus 111 l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~----------------------------------------------- 143 (314)
... .++..+...++.+++..+..||.
T Consensus 107 ~~~-------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 179 (304)
T 3sg8_A 107 LLN-------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRD 179 (304)
T ss_dssp HHH-------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHH
T ss_pred ccc-------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHH
Confidence 221 23444445555555555555552
Q ss_pred --------CCCCCceeccCCCCCeeecC--CCceEEcccccceecCCCCcccccccccccccccCccccc-----C----
Q 043524 144 --------GFPRPIVFRDFKTSHILFSE--ENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTT-----C---- 204 (314)
Q Consensus 144 --------~~~~~i~H~dlk~~nil~~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~---- 204 (314)
.....++|+|++|.||+++. ...+.++||+.+........ .. .......-..|+.... .
T Consensus 180 ~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D-l~-~~~~~~~~~~~~~~~~~l~~Y~~~~~ 257 (304)
T 3sg8_A 180 ILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND-FI-SLMEDDEEYGMEFVSKILNHYKHKDI 257 (304)
T ss_dssp HHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH-HH-TTCCTTTSCCHHHHHHHHHHHTCSCH
T ss_pred HHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH-HH-HHHhhccccCHHHHHHHHHHcCCCCc
Confidence 01245799999999999987 45678999999865432100 00 0000000011111100 0
Q ss_pred -----CCCcccchHHHHHHHHHHHhCCCCc
Q 043524 205 -----DFSEKLDVYSFGAFLSELLTGRGIL 229 (314)
Q Consensus 205 -----~~~~~~DiwslG~~l~el~~g~~p~ 229 (314)
......+.|++|.+++.+.+|..+|
T Consensus 258 ~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 258 PTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0112258899999999999998775
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.20 E-value=1.7e-06 Score=73.74 Aligned_cols=72 Identities=7% Similarity=0.001 Sum_probs=52.0
Q ss_pred hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC-CCceeeeEeEEEeCCeeEEEEeecC
Q 043524 25 SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS-HDHILKLIGCCLETPIAILVFEYVQ 103 (314)
Q Consensus 25 ~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~iv~e~~~ 103 (314)
..++......++..+.+|+...... ..+..|...|+.+. +--+.+++.++.+++..|+|||+++
T Consensus 39 ~~v~rl~~~~~~~~~~lk~~~~~~~---------------~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~ 103 (272)
T 4gkh_A 39 ATIYRLYGKPNAPELFLKHGKGSVA---------------NDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIP 103 (272)
T ss_dssp CEEEEEECCTTCCCEEEEEEETHHH---------------HHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCC
T ss_pred CeEEEEEecCCCeEEEEEECCCCCH---------------hHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeC
Confidence 3455444455667788887664431 34668888888875 4457888899999999999999999
Q ss_pred CCCHHHHH
Q 043524 104 HGTLWDRI 111 (314)
Q Consensus 104 ~g~L~~~l 111 (314)
|.++.+..
T Consensus 104 G~~~~~~~ 111 (272)
T 4gkh_A 104 GKTAFQVL 111 (272)
T ss_dssp SEEHHHHH
T ss_pred Cccccccc
Confidence 87776544
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.88 E-value=7.5e-05 Score=64.84 Aligned_cols=60 Identities=10% Similarity=0.013 Sum_probs=41.4
Q ss_pred CcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCC---ceeeeEeEEE-eCCeeEEEEeecCCCCHHH
Q 043524 36 GKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHD---HILKLIGCCL-ETPIAILVFEYVQHGTLWD 109 (314)
Q Consensus 36 g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~-~~~~~~iv~e~~~~g~L~~ 109 (314)
|+.+++|+....... ..+.+|+++|..+.+. .+.+.+.+.. ..+..+++||+++|.++.+
T Consensus 39 g~~~VlR~~~~~~~~--------------~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~ 102 (306)
T 3tdw_A 39 NGDWVFRFPKSQQGA--------------DELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGE 102 (306)
T ss_dssp TTTEEEEEESSHHHH--------------HHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHH
T ss_pred CCEEEEEecCCchHH--------------HHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECch
Confidence 567888875433211 4577999999999742 3556666654 3455789999999887765
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0024 Score=51.97 Aligned_cols=101 Identities=14% Similarity=0.016 Sum_probs=62.3
Q ss_pred CCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccceecCCCCcc
Q 043524 105 GTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETH 184 (314)
Q Consensus 105 g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~ 184 (314)
-||.+++...+ .|++.++++.++.|.+.+|.-+-. ...-..+=..|..|++..+|.+.+.+ ..+.
T Consensus 33 vSL~eIL~~~~----~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------- 97 (229)
T 2yle_A 33 LSLEEILRLYN----QPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------- 97 (229)
T ss_dssp EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred ccHHHHHHHcC----CCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc--------
Confidence 37889998776 689999999999999988876621 11101223345777777777776553 1110
Q ss_pred cccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCC
Q 043524 185 ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226 (314)
Q Consensus 185 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~ 226 (314)
.....+.|||... ...+.+.=|||+|+++|.-+.-.
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg 133 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG 133 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence 0122456787653 34467788999999999988743
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=96.96 E-value=0.001 Score=58.72 Aligned_cols=32 Identities=13% Similarity=0.362 Sum_probs=26.3
Q ss_pred CCCceeccCCCCCeeecCCCceEEccccccee
Q 043524 146 PRPIVFRDFKTSHILFSEENVVKLFDFSLSIS 177 (314)
Q Consensus 146 ~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~ 177 (314)
...++|+|+.+.||+++....+.|+||+.+..
T Consensus 221 ~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 221 EPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp CCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred CceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 45789999999999998644578999998744
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=96.44 E-value=0.0018 Score=58.09 Aligned_cols=80 Identities=11% Similarity=0.100 Sum_probs=42.8
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHH-HHHhcCCcccCChhHHHHHHHHHHHhcCCC--C-ceeeeEeEEEeC
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQEL-KQETNNYDQKNGFWHESCINNVTYAAQMSH--D-HILKLIGCCLET 92 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~-~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~-niv~~~~~~~~~ 92 (314)
..+|.|. +.++.+....+++.+++|....... ...... ...+++..|.+++..+.. + .+.+++.+ +.
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~------~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~ 107 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWP------LTIDRARIESSALIRQGEHVPHLVPRVFYS--DT 107 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CC------CCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ET
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCc------CcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cC
Confidence 3566666 5555543334567889997653211 110000 011456788888887742 3 44566644 45
Q ss_pred CeeEEEEeecCCC
Q 043524 93 PIAILVFEYVQHG 105 (314)
Q Consensus 93 ~~~~iv~e~~~~g 105 (314)
...++|||++++.
T Consensus 108 ~~~~lvmE~l~g~ 120 (397)
T 2olc_A 108 EMAVTVMEDLSHL 120 (397)
T ss_dssp TTTEEEECCCTTS
T ss_pred CccEEEEEeCCCc
Confidence 5678999999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=95.93 E-value=0.0054 Score=53.20 Aligned_cols=74 Identities=8% Similarity=-0.015 Sum_probs=51.1
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC---CCceeeeEeEEEeC
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS---HDHILKLIGCCLET 92 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~ 92 (314)
...++.|. ..++.+.. +++.+.+|+...... ..+..|...|+.|. ...+.+++.+....
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~---------------~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~ 103 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERSYR---------------SMFRAEADQLALLAKTNSINVPLVYGIGNSQ 103 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGGGH---------------HHHHHHHHHHHHHHHTTSSBCCCEEEEEECS
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcccH---------------HHHHHHHHHHHHHHhhCCCCcceEEEEeecC
Confidence 34566665 44444422 456778887764321 45678888888874 36788888888878
Q ss_pred CeeEEEEeecCCCCH
Q 043524 93 PIAILVFEYVQHGTL 107 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L 107 (314)
+..++|||++++.++
T Consensus 104 g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 104 GHSFLLLEALNKSKN 118 (312)
T ss_dssp SEEEEEEECCCCCCC
T ss_pred CceEEEEEeccCCCC
Confidence 889999999988754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=95.03 E-value=0.055 Score=46.26 Aligned_cols=31 Identities=16% Similarity=0.127 Sum_probs=25.4
Q ss_pred CCCceeccCCCCCeeecCCCceEEccccccee
Q 043524 146 PRPIVFRDFKTSHILFSEENVVKLFDFSLSIS 177 (314)
Q Consensus 146 ~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~ 177 (314)
...++|+|+.+.|++ ..++.+.++||..+..
T Consensus 172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 455799999999999 5566789999988754
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=93.85 E-value=0.073 Score=46.07 Aligned_cols=31 Identities=16% Similarity=0.333 Sum_probs=27.6
Q ss_pred CCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 146 PRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 146 ~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
...++|+|+++.||+++.++.+.++||+.+.
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 5789999999999999877889999999763
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=93.18 E-value=0.012 Score=50.22 Aligned_cols=72 Identities=10% Similarity=0.052 Sum_probs=42.2
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCC---ceeeeEeEEEeCCe
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHD---HILKLIGCCLETPI 94 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~~~ 94 (314)
.+|.|. ..+|.+ ...+|+.+.+|+....... ....|..|+..|+.|.-. .+.+++.+. .
T Consensus 22 ~~g~G~~~~vyrv-~l~DG~~~~vK~~~~~~~~------------~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~ 84 (288)
T 3f7w_A 22 ERGHSHRWHLYRV-ELADGTPLFVKALPDDAPA------------LDGLFRAEALGLDWLGRSFGSPVPQVAGWD----D 84 (288)
T ss_dssp EEEEETTEEEEEE-EETTSCEEEEEECCTTCCC------------CTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----T
T ss_pred ecCCCCCeEEEEE-EECCCCEEEEEEeCCCCcc------------hhhHHHHHHHHHHHHHhhCCCCcceEEecc----C
Confidence 455555 444443 4567888999975432110 013466899888888532 344555442 2
Q ss_pred eEEEEeecCCCCH
Q 043524 95 AILVFEYVQHGTL 107 (314)
Q Consensus 95 ~~iv~e~~~~g~L 107 (314)
-++|||++.++..
T Consensus 85 ~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 85 RTLAMEWVDERPP 97 (288)
T ss_dssp TEEEEECCCCCCC
T ss_pred ceEEEEeecccCC
Confidence 4689999876543
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=92.25 E-value=0.15 Score=45.80 Aligned_cols=32 Identities=13% Similarity=0.354 Sum_probs=28.2
Q ss_pred CCCceeccCCCCCeeecCCCceEEcccccceec
Q 043524 146 PRPIVFRDFKTSHILFSEENVVKLFDFSLSISI 178 (314)
Q Consensus 146 ~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~ 178 (314)
...++|+|+++.||+++.++ +.++||+.+...
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 78899999999999998766 999999988654
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=88.67 E-value=0.61 Score=40.19 Aligned_cols=33 Identities=27% Similarity=0.341 Sum_probs=28.0
Q ss_pred CCCceeccCCCCCeeecCC----CceEEcccccceec
Q 043524 146 PRPIVFRDFKTSHILFSEE----NVVKLFDFSLSISI 178 (314)
Q Consensus 146 ~~~i~H~dlk~~nil~~~~----~~~kl~dfg~~~~~ 178 (314)
...++|+|+.+.||+++.+ +.+.++||+.+...
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 5679999999999999864 67899999988654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=88.58 E-value=0.12 Score=44.33 Aligned_cols=31 Identities=19% Similarity=0.488 Sum_probs=26.0
Q ss_pred CCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 146 PRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 146 ~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
..+++|+|+.+.||+++.+..+.++||+.+.
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 4578999999999999876656899998763
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=87.53 E-value=0.61 Score=39.98 Aligned_cols=30 Identities=13% Similarity=0.150 Sum_probs=25.6
Q ss_pred CCCceeccCCCCCeeecCCCceEEccccccee
Q 043524 146 PRPIVFRDFKTSHILFSEENVVKLFDFSLSIS 177 (314)
Q Consensus 146 ~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~ 177 (314)
...++|+|+++.||+++ + .+.++||+.+..
T Consensus 194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 56688999999999998 4 789999988754
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=84.07 E-value=5.1 Score=32.24 Aligned_cols=115 Identities=8% Similarity=0.069 Sum_probs=75.9
Q ss_pred CCCceeeeEeEEEeCCeeEEEEeecCCC-CHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCC
Q 043524 78 SHDHILKLIGCCLETPIAILVFEYVQHG-TLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKT 156 (314)
Q Consensus 78 ~h~niv~~~~~~~~~~~~~iv~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~ 156 (314)
.||+.+.. .+-.+.+.+.+.++.-+.+ ++.. + ...+....+.++.+|+.-..+++ .-+|--+.|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i--------k~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P 107 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I--------KSFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAP 107 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G--------GGSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H--------HhcCHHHHHHHHHHHHHHHHHhc-----CceEEEEec
Confidence 57888866 4656667766666654322 3322 3 34667888888888876664444 236889999
Q ss_pred CCeeecCCCceEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchH-HHHHHHHHHHhCCCCccc
Q 043524 157 SHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVY-SFGAFLSELLTGRGILDL 231 (314)
Q Consensus 157 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Diw-slG~~l~el~~g~~p~~~ 231 (314)
+|++++.++.+++.--|+...+ +|. ..+ ..|.| .+=+++..+++++..|+.
T Consensus 108 ~NL~f~~~~~p~i~~RGik~~l------------------~P~-----~~~-ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 108 DELFFTRDGLPIAKTRGLQNVV------------------DPL-----PVS-EAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp GGEEECTTSCEEESCCEETTTB------------------SCC-----CCC-HHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred ceEEEcCCCCEEEEEccCccCC------------------CCC-----CCC-HHHHHHHHHHHHHHHHcCCCCHHH
Confidence 9999999999999987764222 111 111 12333 677888889999888753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=83.52 E-value=1.1 Score=40.80 Aligned_cols=36 Identities=8% Similarity=-0.000 Sum_probs=24.2
Q ss_pred HHHHHHHhcCCCCc-eeeeEeEEEeCCeeEEEEeecCCCCH
Q 043524 68 INNVTYAAQMSHDH-ILKLIGCCLETPIAILVFEYVQHGTL 107 (314)
Q Consensus 68 ~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~iv~e~~~~g~L 107 (314)
.+|..++..|...+ ..++++.+.. .+|+||++|.++
T Consensus 152 ~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~l 188 (458)
T 2qg7_A 152 EREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYAL 188 (458)
T ss_dssp HHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEEC
T ss_pred HHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCccC
Confidence 47888888886433 4677777632 259999986443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=82.31 E-value=0.56 Score=41.17 Aligned_cols=30 Identities=20% Similarity=0.356 Sum_probs=24.4
Q ss_pred CCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 146 PRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 146 ~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
...++|+|+.+.||+++.+. +.++||..+.
T Consensus 211 ~~~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 211 TIVFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp CEEEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred CeEEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 45689999999999997554 8999998764
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=81.18 E-value=0.6 Score=40.58 Aligned_cols=33 Identities=12% Similarity=0.300 Sum_probs=27.8
Q ss_pred CCCceeccCCCCCeeecCCCceEEcccccceec
Q 043524 146 PRPIVFRDFKTSHILFSEENVVKLFDFSLSISI 178 (314)
Q Consensus 146 ~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~ 178 (314)
...++|+|+.+.|++++.++.+.++||+.+...
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 356899999999999987778999999877543
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 314 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-38 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-36 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-35 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-33 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-33 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-33 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-33 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-33 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-32 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-31 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-31 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-31 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-30 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-30 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-29 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-29 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-29 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-28 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-28 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-28 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-28 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-28 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-27 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-27 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-27 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-27 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-27 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 9e-26 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-26 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-25 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-25 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-25 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-24 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-23 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-23 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-23 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-22 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-22 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-22 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-22 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-21 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-21 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-20 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-20 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-19 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-19 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-19 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-19 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-19 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-18 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 9e-18 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-17 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-17 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-17 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-16 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-15 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-14 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-14 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-12 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-11 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-11 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-10 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 2e-38
Identities = 57/268 (21%), Positives = 105/268 (39%), Gaps = 36/268 (13%)
Query: 49 LKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLW 108
L Q F +E V + H +IL +G +AI V ++ + +L+
Sbjct: 38 LNVTAPTPQQLQAFKNE-----VGVLRKTRHVNILLFMGYSTAPQLAI-VTQWCEGSSLY 91
Query: 109 DRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVK 168
+ + + + A A + YLH + I+ RD K+++I E+ VK
Sbjct: 92 HHL----HIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVK 144
Query: 169 LFDFSLSISIPEGE-THITDTVMGTYGHLAPQYVTTCD---FSEKLDVYSFGAFLSELLT 224
+ DF L+ +H + + G+ +AP+ + D +S + DVY+FG L EL+T
Sbjct: 145 IGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT 204
Query: 225 GRGILDLVRDAHDLVYPFNEY-LKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLT 283
G+ P++ ++ + P + + S K +L
Sbjct: 205 GQ-------------LPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA-----MKRLM 246
Query: 284 FECLNESPIDRPTMVDVARRLRQICCSL 311
ECL + +RP + + + SL
Sbjct: 247 AECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 9e-36
Identities = 49/243 (20%), Positives = 92/243 (37%), Gaps = 28/243 (11%)
Query: 65 ESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLL 124
++ + Q+ H +++L + PI ++ EY+++G+L D +
Sbjct: 53 DAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTI--- 108
Query: 125 KRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETH 184
+ L A A +A++ R + RD + ++IL S+ K+ DF L+ I + E
Sbjct: 109 NKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165
Query: 185 ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNE 244
+ AP+ + F+ K DV+SFG L+E++T
Sbjct: 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHG------------------ 207
Query: 245 YLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRL 304
+ + E++ + + + QL C E P DRPT + L
Sbjct: 208 --RIPYPGMTNPEVIQ-NLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
Query: 305 RQI 307
Sbjct: 265 EDF 267
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 6e-35
Identities = 53/250 (21%), Positives = 94/250 (37%), Gaps = 28/250 (11%)
Query: 59 KNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTH 118
+ E I ++SH +++L G CLE LVFE+++HG L D +
Sbjct: 39 EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF 98
Query: 119 FEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISI 178
+ L +D +AYL ++ RD + L E V+K+ DF ++ +
Sbjct: 99 AA----ETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFV 151
Query: 179 PEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDL 238
+ + + +P+ + +S K DV+SFG + E+ + I R ++
Sbjct: 152 LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV 211
Query: 239 VYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMV 298
V + + Y T + + C E P DRP
Sbjct: 212 VEDISTGFRLYKPRLASTHVYQ---------------------IMNHCWKERPEDRPAFS 250
Query: 299 DVARRLRQIC 308
+ R+L +I
Sbjct: 251 RLLRQLAEIA 260
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 2e-33
Identities = 52/250 (20%), Positives = 98/250 (39%), Gaps = 32/250 (12%)
Query: 59 KNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAI-LVFEYVQHGTLWDRILGAPQT 117
KN ++ + + Q+ H ++++L+G +E + +V EY+ G+L D + ++
Sbjct: 39 KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS 98
Query: 118 HFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSIS 177
LK ++D A+ YL V RD ++L SE+NV K+ DF L+
Sbjct: 99 VLGG---DCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE 152
Query: 178 IPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHD 237
+ T AP+ + FS K DV+SFG L E+ +
Sbjct: 153 ASSTQD----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG----------- 197
Query: 238 LVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTM 297
+ + ++V P + + + A ++ C + RP+
Sbjct: 198 ---------RVPYPRIPLKDVV-PRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSF 247
Query: 298 VDVARRLRQI 307
+ + +L I
Sbjct: 248 LQLREQLEHI 257
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 2e-33
Identities = 49/253 (19%), Positives = 97/253 (38%), Gaps = 29/253 (11%)
Query: 75 AQMSHDHILKLIGCCLETPIAI----LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKD 130
+ H++IL I + LV +Y +HG+L+D + + + ++ +K
Sbjct: 52 VMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL------NRYTVTVEGMIKL 105
Query: 131 AVDAANALAYLH-----FGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHI 185
A+ A+ LA+LH I RD K+ +IL + + D L++ I
Sbjct: 106 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 165
Query: 186 ---TDTVMGTYGHLAPQYVTTC------DFSEKLDVYSFGAFLSELLTGRGILDLVRDAH 236
+ +GT ++AP+ + + ++ D+Y+ G E+ I + D
Sbjct: 166 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 225
Query: 237 DLVYPFNEYLKNYFE--DNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDR 294
Y + E + + P I E + + A++ EC + R
Sbjct: 226 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVM---AKIMRECWYANGAAR 282
Query: 295 PTMVDVARRLRQI 307
T + + + L Q+
Sbjct: 283 LTALRIKKTLSQL 295
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 3e-33
Identities = 55/253 (21%), Positives = 94/253 (37%), Gaps = 28/253 (11%)
Query: 59 KNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTH 118
E+ + ++ H+ +++L E PI I V EY+ G+L D + G +
Sbjct: 51 PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETGKY 109
Query: 119 FEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISI 178
L + + A A+ +AY+ V RD + ++IL E V K+ DF L+ I
Sbjct: 110 LR---LPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI 163
Query: 179 PEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDL 238
+ E AP+ F+ K DV+SFG L+EL T
Sbjct: 164 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG------------ 211
Query: 239 VYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMV 298
+ + E++D + + + + L +C + P +RPT
Sbjct: 212 --------RVPYPGMVNREVLD-QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFE 262
Query: 299 DVARRLRQICCSL 311
+ L S
Sbjct: 263 YLQAFLEDYFTST 275
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 6e-33
Identities = 45/249 (18%), Positives = 92/249 (36%), Gaps = 28/249 (11%)
Query: 59 KNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTH 118
+ + I +SH+ +++L G C + ++ EY+ +G L + + +
Sbjct: 38 EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL----REM 93
Query: 119 FEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISI 178
++ L+ D A+ YL + + RD + L +++ VVK+ DF LS +
Sbjct: 94 RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 150
Query: 179 PEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDL 238
+ E + P+ + FS K D+++FG + E+ +
Sbjct: 151 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLG------------ 198
Query: 239 VYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMV 298
K +E +E + I Q L + + C +E +RPT
Sbjct: 199 --------KMPYERFTNSETAE-HIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFK 249
Query: 299 DVARRLRQI 307
+ + +
Sbjct: 250 ILLSNILDV 258
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 8e-33
Identities = 49/252 (19%), Positives = 93/252 (36%), Gaps = 31/252 (12%)
Query: 65 ESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLL 124
E + Q+ + +I++LIG C + +LV E G L ++G E + +
Sbjct: 54 EEMMREAQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVG----KREEIPV 108
Query: 125 KRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETH 184
+ + + YL + V RD ++L + K+ DF LS ++ +++
Sbjct: 109 SNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 165
Query: 185 IT--DTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPF 242
T AP+ + FS + DV+S+G + E L+
Sbjct: 166 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYG---------------- 209
Query: 243 NEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302
+ ++ + E++ I Q + L +C DRP + V +
Sbjct: 210 ----QKPYKKMKGPEVMA-FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 264
Query: 303 RLRQICCSLSCN 314
R+R SL+
Sbjct: 265 RMRACYYSLASK 276
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 2e-32
Identities = 42/258 (16%), Positives = 89/258 (34%), Gaps = 31/258 (12%)
Query: 64 HESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLL 123
I + + + +I+ G + E++ G+L + +
Sbjct: 48 RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-----KKAGRIP 102
Query: 124 LKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGET 183
+ K ++ L YL I+ RD K S+IL + +KL DF +S + +
Sbjct: 103 EQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 160
Query: 184 HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR----------------- 226
+ + +GT +++P+ + +S + D++S G L E+ GR
Sbjct: 161 N---SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGC 217
Query: 227 ----GILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQL 282
+ P + Y + E++D I+ +
Sbjct: 218 QVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDF 277
Query: 283 TFECLNESPIDRPTMVDV 300
+CL ++P +R + +
Sbjct: 278 VNKCLIKNPAERADLKQL 295
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 118 bits (295), Expect = 1e-31
Identities = 52/261 (19%), Positives = 93/261 (35%), Gaps = 44/261 (16%)
Query: 68 INNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRI---------------- 111
A+ + +I+KL+G C L+FEY+ +G L + +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 112 ---LGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVK 168
PL +L A A +AYL R V RD T + L E VVK
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVK 180
Query: 169 LFDFSLSISIPEGE-THITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRG 227
+ DF LS +I + + P+ + ++ + DV+++G L E+ +
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG- 239
Query: 228 ILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECL 287
+ E++ + ++ + L L C
Sbjct: 240 -------------------LQPYYGMAHEEVIYYVRDGNILACPENCPLEL-YNLMRLCW 279
Query: 288 NESPIDRPTMVDVARRLRQIC 308
++ P DRP+ + R L+++C
Sbjct: 280 SKLPADRPSFCSIHRILQRMC 300
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 1e-31
Identities = 50/268 (18%), Positives = 91/268 (33%), Gaps = 37/268 (13%)
Query: 42 RIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEY 101
+ + + LK E N+ K+ E Q+ + +I+++IG C E +LV E
Sbjct: 35 KTVAVKILKNEANDPALKDELLAE-----ANVMQQLDNPYIVRMIGIC-EAESWMLVMEM 88
Query: 102 VQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILF 161
+ G L + + K ++ + + YL V RD ++L
Sbjct: 89 AELGPLNKYL-----QQNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLL 140
Query: 162 SEENVVKLFDFSLSISIPEGETHIT--DTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFL 219
++ K+ DF LS ++ E + AP+ + FS K DV+SFG +
Sbjct: 141 VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLM 200
Query: 220 SELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHAS 279
E + + + + +E+ ++ +
Sbjct: 201 WEAFSYG--------------------QKPYRGMKGSEVTA-MLEKGERMGCPAGCPREM 239
Query: 280 AQLTFECLNESPIDRPTMVDVARRLRQI 307
L C +RP V RLR
Sbjct: 240 YDLMNLCWTYDVENRPGFAAVELRLRNY 267
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 6e-31
Identities = 53/246 (21%), Positives = 94/246 (38%), Gaps = 30/246 (12%)
Query: 64 HESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLL 123
+ I V + H ++++L G L P+ +V E G+L DR + H L
Sbjct: 55 MDDFIREVNAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDR----LRKHQGHFL 109
Query: 124 LKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGET 183
L + AV A + YL + + RD ++L + ++VK+ DF L ++P+ +
Sbjct: 110 LGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 166
Query: 184 H--ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYP 241
H + + + AP+ + T FS D + FG L E+ T
Sbjct: 167 HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYG--------------- 211
Query: 242 FNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVA 301
+ + ++I+ I + E + +C P DRPT V +
Sbjct: 212 -----QEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266
Query: 302 RRLRQI 307
L +
Sbjct: 267 DFLLEA 272
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 1e-30
Identities = 53/251 (21%), Positives = 93/251 (37%), Gaps = 39/251 (15%)
Query: 50 KQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWD 109
K + ++ E I + + H +IL+L G + L+ EY GT++
Sbjct: 41 KAQLEKAGVEHQLRREVEI-----QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYR 95
Query: 110 RILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKL 169
+ +R + ANAL+Y H + ++ RD K ++L +K+
Sbjct: 96 EL-----QKLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKI 147
Query: 170 FDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGIL 229
DF S+ P T+ GT +L P+ + EK+D++S G E L G+
Sbjct: 148 ADFGWSVHAPSSRRT---TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK--- 201
Query: 230 DLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNE 289
FE N + E I + + + + + L L
Sbjct: 202 ------------------PPFEANTYQETYKRISRVEFTFPDFVTE--GARDLISRLLKH 241
Query: 290 SPIDRPTMVDV 300
+P RP + +V
Sbjct: 242 NPSQRPMLREV 252
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 114 bits (287), Expect = 1e-30
Identities = 45/249 (18%), Positives = 96/249 (38%), Gaps = 27/249 (10%)
Query: 59 KNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTH 118
++ E + ++ H ++++L+G C P ++ E++ +G L D + + +
Sbjct: 52 EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECN 108
Query: 119 FEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISI 178
+ + L A ++A+ YL + + RD + L E ++VK+ DF LS +
Sbjct: 109 RQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 165
Query: 179 PEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDL 238
AP+ + FS K DV++FG L E+ T
Sbjct: 166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG------------ 213
Query: 239 VYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMV 298
+ + +++ + ++ +D E +L C +P DRP+
Sbjct: 214 --------MSPYPGIDLSQVYE-LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFA 264
Query: 299 DVARRLRQI 307
++ + +
Sbjct: 265 EIHQAFETM 273
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 112 bits (280), Expect = 1e-29
Identities = 51/295 (17%), Positives = 104/295 (35%), Gaps = 43/295 (14%)
Query: 19 MIGNGA--SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQ 76
+IG G V + + I I K + Y +K ++ + Q
Sbjct: 33 VIGAGEFGEVCSGHLKLPGKREIFVAI------KTLKSGYTEKQ---RRDFLSEASIMGQ 83
Query: 77 MSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAAN 136
H +++ L G ++ +++ E++++G+L + + + + + A
Sbjct: 84 FDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF----LRQNDGQFTVIQLVGMLRGIAA 139
Query: 137 ALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDT----VMGT 192
+ YL V RD +IL + V K+ DF LS + + + T T
Sbjct: 140 GMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIP 196
Query: 193 YGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFED 252
AP+ + F+ DV+S+G + E+++ + + D
Sbjct: 197 IRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG--------------------ERPYWD 236
Query: 253 NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQI 307
++++ I QD A QL +C + RP + L ++
Sbjct: 237 MTNQDVIN-AIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 6e-29
Identities = 60/299 (20%), Positives = 112/299 (37%), Gaps = 43/299 (14%)
Query: 19 MIGNGA--SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQ 76
+IG G V + ++GK I + + L + T+ + F E I
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAV---KSLNRITDIGEVSQ-FLTEGII-----MKD 84
Query: 77 MSHDHILKLIGCCLETP-IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAA 135
SH ++L L+G CL + ++V Y++HG L + + +K + + A
Sbjct: 85 FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF----IRNETHNPTVKDLIGFGLQVA 140
Query: 136 NALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGE---THITDTVMGT 192
+ +L + V RD + + E+ VK+ DF L+ + + E H
Sbjct: 141 KGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 197
Query: 193 YGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFED 252
+A + + T F+ K DV+SFG L EL+T + D
Sbjct: 198 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG--------------------APPYPD 237
Query: 253 NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSL 311
+I ++ Q + E ++ +C + RP+ ++ R+ I +
Sbjct: 238 VNTFDITVYLL-QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 7e-29
Identities = 49/238 (20%), Positives = 89/238 (37%), Gaps = 30/238 (12%)
Query: 65 ESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLL 124
E+ + ++H++++K G E I L EY G L+DRI +
Sbjct: 48 ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPE 102
Query: 125 KRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISI-PEGET 183
+ + YLH I RD K ++L E + +K+ DF L+
Sbjct: 103 PDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159
Query: 184 HITDTVMGTYGHLAPQYVTTCDF-SEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPF 242
+ + + GT ++AP+ + +F +E +DV+S G L+ +L G D D+ +
Sbjct: 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 219
Query: 243 NEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDV 300
E + ++ + L E+P R T+ D+
Sbjct: 220 KEKKTYLNPWKKIDSAPLALLHK--------------------ILVENPSARITIPDI 257
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 1e-28
Identities = 45/247 (18%), Positives = 82/247 (33%), Gaps = 42/247 (17%)
Query: 77 MSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFE---------------- 120
SH++I+ L+G C + L+FEY +G L + + + E
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 121 --PLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISI 178
L + L A A + +L F + V RD ++L + VVK+ DF L+ I
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDI 214
Query: 179 PEGETHITD-TVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHD 237
++ +AP+ + ++ K DV+S+G L E+ +
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG----------- 263
Query: 238 LVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTM 297
N + +I + + C RP+
Sbjct: 264 ---------VNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSF 314
Query: 298 VDVARRL 304
++ L
Sbjct: 315 PNLTSFL 321
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 109 bits (274), Expect = 1e-28
Identities = 52/239 (21%), Positives = 83/239 (34%), Gaps = 37/239 (15%)
Query: 65 ESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLL 124
+ I V + ++ H + ++ GC L A LV EY + H +PL
Sbjct: 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV-----HKKPLQE 114
Query: 125 KRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETH 184
A LAYLH ++ RD K +IL SE +VKL DF + +
Sbjct: 115 VEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167
Query: 185 ITDTVMGTYGHLAPQYVTTCD---FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYP 241
++ +GT +AP+ + D + K+DV+S G EL +
Sbjct: 168 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP------------- 213
Query: 242 FNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDV 300
+ + I + + CL + P DRPT +
Sbjct: 214 --------LFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 264
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 2e-28
Identities = 42/244 (17%), Positives = 86/244 (35%), Gaps = 37/244 (15%)
Query: 78 SHDHILKLIGCCLETPIAILVFEYVQHGTLWDRI-------------LGAPQTHFEPLLL 124
+H +I+ L+G C +++ EY +G L + + + L L
Sbjct: 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 125 KRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETH 184
+ L + A +A+L + + RD +IL + + K+ DF L+ I +
Sbjct: 145 EDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 185 ITDT-VMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFN 243
+ +AP+ + C ++ + DV+S+G FL EL +
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG----------------- 244
Query: 244 EYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARR 303
+ + +I + E + C + P+ RPT + +
Sbjct: 245 ---SSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301
Query: 304 LRQI 307
+ +
Sbjct: 302 IEKQ 305
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 3e-28
Identities = 45/264 (17%), Positives = 90/264 (34%), Gaps = 35/264 (13%)
Query: 42 RIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETP--IAILVF 99
+I +EL + +K E + ++ H +I++ ++ +V
Sbjct: 30 KILVWKELDYGSMTEAEKQMLVSEVNL-----LRELKHPNIVRYYDRIIDRTNTTLYIVM 84
Query: 100 EYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLH--FGFPRPIVFRDFKTS 157
EY + G L I + + L + L+ AL H ++ RD K +
Sbjct: 85 EYCEGGDLASVITKGTKER-QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPA 143
Query: 158 HILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGA 217
++ + VKL DF L+ + + +GT +++P+ + ++EK D++S G
Sbjct: 144 NVFLDGKQNVKLGDFGLARILNHDTSF-AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGC 202
Query: 218 FLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLH 277
L EL F E+ I +
Sbjct: 203 LLYELCALM---------------------PPFTAFSQKELAGKIREGKFR--RIPYRYS 239
Query: 278 ASA-QLTFECLNESPIDRPTMVDV 300
++ LN RP++ ++
Sbjct: 240 DELNEIITRMLNLKDYHRPSVEEI 263
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 5e-28
Identities = 47/240 (19%), Positives = 81/240 (33%), Gaps = 37/240 (15%)
Query: 79 HDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEP-----------LLLKRR 127
H +I+ L+G C L EY HG L D + + +P L ++
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 128 LKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITD 187
L A D A + YL + + RD +IL E V K+ DF LS
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KT 184
Query: 188 TVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLK 247
+A + + ++ DV+S+G L E+++
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG--------------------G 224
Query: 248 NYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQI 307
+ E+ + + Q + L +C E P +RP+ + L ++
Sbjct: 225 TPYCGMTCAELYE-KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 1e-27
Identities = 40/245 (16%), Positives = 87/245 (35%), Gaps = 30/245 (12%)
Query: 64 HESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLL 123
++ ++ A + + H+ +L+G CL + + L+ + + G L D +
Sbjct: 55 NKEILDEAYVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGS--- 110
Query: 124 LKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGET 183
+ L V A + YL R +V RD ++L VK+ DF L+ + E
Sbjct: 111 -QYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 166
Query: 184 -HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPF 242
+ + +A + + ++ + DV+S+G + EL+T
Sbjct: 167 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG---------------- 210
Query: 243 NEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302
++ +EI I+ + + + +C RP ++
Sbjct: 211 ----SKPYDGIPASEISS-ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELII 265
Query: 303 RLRQI 307
++
Sbjct: 266 EFSKM 270
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 1e-27
Identities = 55/244 (22%), Positives = 83/244 (34%), Gaps = 29/244 (11%)
Query: 64 HESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLL 123
E + Q H HI+KLIG E P+ I + E G L Q L
Sbjct: 52 REKFLQEALTMRQFDHPHIVKLIGVITENPVWI-IMELCTLGELRSF----LQVRKYSLD 106
Query: 124 LKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGET 183
L + A + ALAYL + V RD ++L S + VKL DF LS + +
Sbjct: 107 LASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 163
Query: 184 HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFN 243
+ +AP+ + F+ DV+ FG + E+L
Sbjct: 164 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG-------------VKPF 210
Query: 244 EYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARR 303
+ +KN R + + L +C P RP ++ +
Sbjct: 211 QGVKNNDVIGRIENGERLPMPPNCP--------PTLYSLMTKCWAYDPSRRPRFTELKAQ 262
Query: 304 LRQI 307
L I
Sbjct: 263 LSTI 266
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 1e-27
Identities = 46/237 (19%), Positives = 88/237 (37%), Gaps = 32/237 (13%)
Query: 65 ESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLL 124
E IN + + + +I+ + L +V EY+ G+L D +
Sbjct: 62 ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD------E 115
Query: 125 KRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETH 184
+ + AL +LH ++ RD K+ +IL + VKL DF I ++
Sbjct: 116 GQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172
Query: 185 ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNE 244
+ T++GT +AP+ VT + K+D++S G E++ G P
Sbjct: 173 RS-TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE-------------PP--- 215
Query: 245 YLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQ-LTFECLNESPIDRPTMVDV 300
+ + + I + ++L A + CL+ R + ++
Sbjct: 216 -----YLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (264), Expect = 2e-27
Identities = 53/264 (20%), Positives = 94/264 (35%), Gaps = 40/264 (15%)
Query: 42 RIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIA----IL 97
+ EL+ ++ F E + H +I++ T +L
Sbjct: 35 VEVAWCELQDRKLTKSERQRFKEE-----AEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89
Query: 98 VFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTS 157
V E + GTL + F+ + +K L +LH P PI+ RD K
Sbjct: 90 VTELMTSGTLKTYL-----KRFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCD 143
Query: 158 HILFSEEN-VVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFG 216
+I + VK+ D L+ V+GT +AP+ + E +DVY+FG
Sbjct: 144 NIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFG 199
Query: 217 AFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQL 276
+ E+ T YP++E R T V P ++ E
Sbjct: 200 MCMLEMATSE-------------YPYSECQNAAQIYRRVTSGVKPASFDKVAIPE----- 241
Query: 277 HASAQLTFECLNESPIDRPTMVDV 300
++ C+ ++ +R ++ D+
Sbjct: 242 --VKEIIEGCIRQNKDERYSIKDL 263
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 4e-27
Identities = 48/250 (19%), Positives = 87/250 (34%), Gaps = 35/250 (14%)
Query: 57 DQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQ 116
D K+ E + + A H +I+KL+ ++ E+ G + +
Sbjct: 46 DTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVM----L 101
Query: 117 THFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176
PL + +AL YLH I+ RD K +ILF+ + +KL DF +S
Sbjct: 102 ELERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSA 158
Query: 177 SIPEGETHITDTVMGTYGHLAPQYVTTCD-----FSEKLDVYSFGAFLSELLTGRGILDL 231
D+ +GT +AP+ V + K DV+S G L E+
Sbjct: 159 KNTRTIQR-RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE----- 212
Query: 232 VRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQ-LTFECLNES 290
P + ++ I + + + ++ + +CL ++
Sbjct: 213 --------PP--------HHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKN 256
Query: 291 PIDRPTMVDV 300
R T +
Sbjct: 257 VDARWTTSQL 266
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 9e-26
Identities = 46/242 (19%), Positives = 88/242 (36%), Gaps = 36/242 (14%)
Query: 78 SHDHILKLIGCCLETPIAILVFEYVQHGTLWDRI-----------LGAPQTHFEPLLLKR 126
H +I+ L+G C + ++ EY G L + + E L K
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 127 RLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHI- 185
+ A A + YL + + RD ++L +E+NV+K+ DF L+ I + +
Sbjct: 137 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 186 TDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEY 245
T +AP+ + ++ + DV+SFG L E+ T
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG------------------- 234
Query: 246 LKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLR 305
+ + E+ ++ + + + + +C + P RPT + L
Sbjct: 235 -GSPYPGVPVEELFK-LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
Query: 306 QI 307
+I
Sbjct: 293 RI 294
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 9e-26
Identities = 46/279 (16%), Positives = 100/279 (35%), Gaps = 41/279 (14%)
Query: 42 RIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAI-LVFE 100
R + + LK+ + + + + H +++ L+G C + + ++ E
Sbjct: 44 RTVAVKMLKEGATHSEHRALMSELKIL-----IHIGHHLNVVNLLGACTKPGGPLMVIVE 98
Query: 101 YVQHGTLWDRI-----------LGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPI 149
+ + G L + + + + L L+ + + A + +L R
Sbjct: 99 FCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKC 155
Query: 150 VFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHI-TDTVMGTYGHLAPQYVTTCDFSE 208
+ RD +IL SE+NVVK+ DF L+ I + ++ +AP+ + ++
Sbjct: 156 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 215
Query: 209 KLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLS 268
+ DV+SFG L E+ + + + + E + +
Sbjct: 216 QSDVWSFGVLLWEIFSLG--------------------ASPYPGVKIDEEFCRRLKEGTR 255
Query: 269 CTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQI 307
+ Q +C + P RPT ++ L +
Sbjct: 256 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 1e-25
Identities = 33/178 (18%), Positives = 72/178 (40%), Gaps = 14/178 (7%)
Query: 50 KQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWD 109
K+ ++ E + +++ H +KL + Y ++G L
Sbjct: 43 KRHIIKENKVPYVTRERDV-----MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 97
Query: 110 RILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKL 169
I + +AL YLH + I+ RD K +IL +E+ +++
Sbjct: 98 YI-----RKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQI 149
Query: 170 FDFSLS-ISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
DF + + PE + ++ +GT +++P+ +T + D+++ G + +L+ G
Sbjct: 150 TDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 207
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (251), Expect = 2e-25
Identities = 58/293 (19%), Positives = 106/293 (36%), Gaps = 40/293 (13%)
Query: 19 MIGNGA--SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQ 76
+IG G V + ++ +S+GK + + LK Q+ F E+ I Q
Sbjct: 14 VIGAGEFGEVYKGMLKTSSGKK--EVPVAIKTLKAGYTE-KQRVDFLGEAGI-----MGQ 65
Query: 77 MSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAAN 136
SH +I++L G + +++ EY+++G L + L+
Sbjct: 66 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGM-------LRG 118
Query: 137 ALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGE--THITDTVMGTYG 194
A + + V RD +IL + V K+ DF LS + + T+ T
Sbjct: 119 IAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 195 HLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNR 254
AP+ ++ F+ DV+SFG + E++T + + +
Sbjct: 179 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYG--------------------ERPYWELS 218
Query: 255 FTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQI 307
E++ I A QL +C + RP D+ L ++
Sbjct: 219 NHEVMK-AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.5 bits (247), Expect = 8e-25
Identities = 40/246 (16%), Positives = 97/246 (39%), Gaps = 30/246 (12%)
Query: 68 INNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRI-----LGAPQTHFEPL 122
+N + + + H+++L+G + +++ E + G L + A P
Sbjct: 71 LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 130
Query: 123 LLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGE 182
L + ++ A + A+ +AYL+ V RD + + +E+ VK+ DF ++ I E +
Sbjct: 131 SLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 187
Query: 183 -THITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYP 241
+ ++P+ + F+ DV+SFG L E+ T
Sbjct: 188 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA--------------- 232
Query: 242 FNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVA 301
+ ++ +++ +++ + + +L C +P RP+ +++
Sbjct: 233 -----EQPYQGLSNEQVLR-FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 286
Query: 302 RRLRQI 307
+++
Sbjct: 287 SSIKEE 292
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 98.6 bits (245), Expect = 4e-24
Identities = 39/244 (15%), Positives = 81/244 (33%), Gaps = 42/244 (17%)
Query: 65 ESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLL 124
E+ + + + H ++ L + ++++E++ G L++++ +
Sbjct: 68 ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV----ADEHNKMSE 123
Query: 125 KRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFS--EENVVKLFDFSLSISIPEGE 182
++ L ++H V D K +I+F+ N +KL DF L+ + +
Sbjct: 124 DEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180
Query: 183 THITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPF 242
+ T + AP+ D++S G LL+G PF
Sbjct: 181 SVKVTTGTAEF--AAPEVAEGKPVGYYTDMWSVGVLSYILLSGL-------------SPF 225
Query: 243 -----NEYLKNYFEDN-RFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPT 296
+E L+N + + I +D + L P R T
Sbjct: 226 GGENDDETLRNVKSCDWNMDDSAFSGISEDG------------KDFIRKLLLADPNTRMT 273
Query: 297 MVDV 300
+
Sbjct: 274 IHQA 277
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.6 bits (240), Expect = 1e-23
Identities = 39/247 (15%), Positives = 84/247 (34%), Gaps = 34/247 (13%)
Query: 58 QKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQT 117
+ G ++ H +IL L +++FE++ +++RI T
Sbjct: 39 KVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERI----NT 94
Query: 118 HFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFS--EENVVKLFDFSLS 175
L + + AL +LH I D + +I++ + +K+ +F +
Sbjct: 95 SAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQA 151
Query: 176 ISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDA 235
+ G+ + + AP+ S D++S G + LL+G
Sbjct: 152 RQLKPGDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI--------- 200
Query: 236 HDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKE-QQLHASAQ-LTFECLNESPID 293
P F +I++ I+ + + E+ +++ A L +
Sbjct: 201 ----NP--------FLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKS 248
Query: 294 RPTMVDV 300
R T +
Sbjct: 249 RMTASEA 255
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 95.9 bits (238), Expect = 3e-23
Identities = 42/228 (18%), Positives = 74/228 (32%), Gaps = 30/228 (13%)
Query: 75 AQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA 134
Q+ H ++ L + +L+ E++ G L+DRI + + A
Sbjct: 81 NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI----AAEDYKMSEAEVINYMRQA 136
Query: 135 ANALAYLHFGFPRPIVFRDFKTSHILFS--EENVVKLFDFSLSISIPEGETHITDTVMGT 192
L ++H IV D K +I+ + + VK+ DF L+ + E T
Sbjct: 137 CEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--VKVTTAT 191
Query: 193 YGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFED 252
AP+ V D+++ G LL+G PF
Sbjct: 192 AEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL-------------SPFAGEDDLETLQ 238
Query: 253 NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDV 300
N + S + + + + L + P R T+ D
Sbjct: 239 NVKRCDWEFDEDAFSSVSPEAKDFIKN------LLQKEPRKRLTVHDA 280
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 94.0 bits (233), Expect = 6e-23
Identities = 59/257 (22%), Positives = 99/257 (38%), Gaps = 46/257 (17%)
Query: 64 HESCINNVTYAAQMSHDHILKLIGCCLET----PIAILVFEYVQHGTLWDRILGAPQTHF 119
+ AA ++H I+ + P+ +V EYV TL D +
Sbjct: 51 YLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-----HTE 105
Query: 120 EPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIP 179
P+ KR ++ DA AL + H I+ RD K ++I+ S N VK+ DF ++ +I
Sbjct: 106 GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 162
Query: 180 EGETHI--TDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHD 237
+ + T V+GT +L+P+ + DVYS G L E+LTG
Sbjct: 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE----------- 211
Query: 238 LVYPFNE------YLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESP 291
PF ++ ED + DL + + L ++P
Sbjct: 212 --PPFTGDSPVSVAYQHVREDPIPPSARHEGLSADL------------DAVVLKALAKNP 257
Query: 292 IDRP-TMVDVARRLRQI 307
+R T ++ L ++
Sbjct: 258 ENRYQTAAEMRADLVRV 274
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.6 bits (232), Expect = 1e-22
Identities = 46/230 (20%), Positives = 81/230 (35%), Gaps = 32/230 (13%)
Query: 74 AAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVD 133
+ H + + V EY+ G L I L R A +
Sbjct: 57 SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI-----QSCHKFDLSRATFYAAE 111
Query: 134 AANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTY 193
L +LH + IV+RD K +IL ++ +K+ DF + G+ T GT
Sbjct: 112 IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN-TFCGTP 167
Query: 194 GHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDN 253
++AP+ + ++ +D +SFG L E+L G+ PF+ ++ E
Sbjct: 168 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ-------------SPFHG--QDEEELF 212
Query: 254 RFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARR 303
+ +P + L + L + P R + R+
Sbjct: 213 HSIRMDNPFYPRWLE--------KEAKDLLVKLFVREPEKRLGVRGDIRQ 254
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.4 bits (231), Expect = 1e-22
Identities = 44/260 (16%), Positives = 83/260 (31%), Gaps = 29/260 (11%)
Query: 54 NNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILG 113
+ + + + + + ++SH +I+ L+ LVF++++
Sbjct: 34 GHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVII--- 90
Query: 114 APQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFS 173
+ + L + L YLH I+ RD K +++L E V+KL DF
Sbjct: 91 --KDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFG 145
Query: 174 LSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRG------ 227
L+ S T V+ + + +D+++ G L+ELL
Sbjct: 146 LAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS 205
Query: 228 -------ILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASA 280
I + + + +P L +Y F I I +
Sbjct: 206 DLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLD------- 258
Query: 281 QLTFECLNESPIDRPTMVDV 300
L +P R T
Sbjct: 259 -LIQGLFLFNPCARITATQA 277
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 92.8 bits (230), Expect = 2e-22
Identities = 38/226 (16%), Positives = 72/226 (31%), Gaps = 26/226 (11%)
Query: 75 AQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA 134
++ H +I+ L L+ + V G L+DRI+ + +
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV-----EKGFYTERDASRLIFQV 116
Query: 135 ANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYG 194
+A+ YLH + + E++ + + DF LS G T GT G
Sbjct: 117 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV--LSTACGTPG 174
Query: 195 HLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNR 254
++AP+ + +S+ +D +S G LL G PF + +
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY-------------PPFYDENDAKLFEQI 221
Query: 255 FTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDV 300
+ ++ + + + P R T
Sbjct: 222 LKAEYEFDSPYWDDISDSAKDFIRH------LMEKDPEKRFTCEQA 261
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 91.3 bits (226), Expect = 5e-22
Identities = 48/229 (20%), Positives = 80/229 (34%), Gaps = 35/229 (15%)
Query: 78 SHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANA 137
H +I++L LVF+ ++ G L+D + T L K K
Sbjct: 68 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-----TEKVTLSEKETRKIMRALLEV 122
Query: 138 LAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLA 197
+ LH IV RD K +IL ++ +KL DF S + GE V GT +LA
Sbjct: 123 ICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPSYLA 177
Query: 198 PQYVTTCD------FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFE 251
P+ + + +++D++S G + LL G PF +
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS-------------PPFWHRKQMLML 224
Query: 252 DNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDV 300
+ + ++ + L + L P R T +
Sbjct: 225 RMIMSGNYQFGSPEWDDYSDTVKDLVSR------FLVVQPQKRYTAEEA 267
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 89.2 bits (220), Expect = 3e-21
Identities = 41/265 (15%), Positives = 88/265 (33%), Gaps = 19/265 (7%)
Query: 42 RIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEY 101
F+ ++++ E + + E I ++ H +I+KL +LVFE+
Sbjct: 27 ETFALKKIRLEKEDEGIPSTTIREISI-----LKELKHSNIVKLYDVIHTKKRLVLVFEH 81
Query: 102 VQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILF 161
+ L + N +AY H R ++ RD K ++L
Sbjct: 82 LDQDLKKLLD-----VCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLI 133
Query: 162 SEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSE 221
+ E +K+ DF L+ + T ++ + + + +S +D++S G +E
Sbjct: 134 NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAE 193
Query: 222 LLTGR------GILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQ 275
++ G D + ++ N + + + + +
Sbjct: 194 MVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGL 253
Query: 276 LHASAQLTFECLNESPIDRPTMVDV 300
+ L + L P R T
Sbjct: 254 DESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.6 bits (221), Expect = 3e-21
Identities = 43/264 (16%), Positives = 89/264 (33%), Gaps = 12/264 (4%)
Query: 42 RIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEY 101
R + + ++ +T E + + + H ++++L C +
Sbjct: 34 RFVALKRVRVQTGEEGMPLSTIRE--VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 91
Query: 102 VQHGTLWDRILGAPQTHFEPLLLKRRLKD-AVDAANALAYLHFGFPRPIVFRDFKTSHIL 160
+ + + EP + +KD L +LH +V RD K +IL
Sbjct: 92 LVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNIL 148
Query: 161 FSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLS 220
+ +KL DF L+ +V+ T + AP+ + ++ +D++S G +
Sbjct: 149 VTSSGQIKLADFGLARIYSFQMAL--TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFA 206
Query: 221 ELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASA 280
E+ + + D L + ED + S E+ +
Sbjct: 207 EMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDID 266
Query: 281 QLTFE----CLNESPIDRPTMVDV 300
+L + CL +P R +
Sbjct: 267 ELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.8 bits (214), Expect = 3e-20
Identities = 44/266 (16%), Positives = 87/266 (32%), Gaps = 20/266 (7%)
Query: 42 RIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEY 101
+ + ++++ +T + E + +++H +I+KL+ LVFE+
Sbjct: 28 EVVALKKIRLDTETEGVPSTAIREISL-----LKELNHPNIVKLLDVIHTENKLYLVFEF 82
Query: 102 VQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILF 161
+ + + L LA+ H ++ RD K ++L
Sbjct: 83 LHQDLKKFMDA----SALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLI 135
Query: 162 SEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSE 221
+ E +KL DF L+ + T V+ + + +S +D++S G +E
Sbjct: 136 NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAE 195
Query: 222 LLTGRGILD-------LVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQ 274
++T R + L R L P + QD S
Sbjct: 196 MVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPL 255
Query: 275 QLHASAQLTFECLNESPIDRPTMVDV 300
L + L+ P R +
Sbjct: 256 DEDG-RSLLSQMLHYDPNKRISAKAA 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.2 bits (215), Expect = 4e-20
Identities = 44/239 (18%), Positives = 84/239 (35%), Gaps = 19/239 (7%)
Query: 75 AQMSHDHILKLIGCCLET------PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRL 128
++ H +I++L + LV +YV R+ + L +
Sbjct: 68 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET--VYRVARHYSRAKQTLPVIYVK 125
Query: 129 KDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN-VVKLFDFSLSISIPEGETHITD 187
+LAY+H I RD K ++L + V+KL DF + + GE +++
Sbjct: 126 LYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS- 181
Query: 188 TVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR------GILDLVRDAHDLVYP 241
+ Y D++ +DV+S G L+ELL G+ +D + + ++
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 242 FNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDV 300
N I + + + + L L +P R T ++
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 85.9 bits (212), Expect = 1e-19
Identities = 29/153 (18%), Positives = 57/153 (37%), Gaps = 12/153 (7%)
Query: 75 AQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA 134
+ I+ + + + + G L + + A +
Sbjct: 62 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-----SQHGVFSEADMRFYAAEI 116
Query: 135 ANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYG 194
L ++H R +V+RD K ++IL E V++ D L+ + + H + +GT+G
Sbjct: 117 ILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHG 170
Query: 195 HLA-PQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
++A + D +S G L +LL G
Sbjct: 171 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 203
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.0 bits (209), Expect = 1e-19
Identities = 39/266 (14%), Positives = 84/266 (31%), Gaps = 20/266 (7%)
Query: 42 RIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEY 101
I + + ++ + ++ + E C+ ++ H +I++L LVFE+
Sbjct: 28 EIVALKRVRLDDDDEGVPSSALREICL-----LKELKHKNIVRLHDVLHSDKKLTLVFEF 82
Query: 102 VQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILF 161
+ L + L + H R ++ RD K ++L
Sbjct: 83 CDQDLKKY-----FDSCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLI 134
Query: 162 SEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSE 221
+ +KL +F L+ + + V+ + +S +D++S G +E
Sbjct: 135 NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAE 194
Query: 222 LLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQ 281
L L D D + L E+ + P ++ +
Sbjct: 195 LANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPK 254
Query: 282 LTFE-------CLNESPIDRPTMVDV 300
L L +P+ R + +
Sbjct: 255 LNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.8 bits (209), Expect = 1e-19
Identities = 50/250 (20%), Positives = 85/250 (34%), Gaps = 37/250 (14%)
Query: 57 DQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQ 116
+ G E V+ ++ H +++ L IL+ E V G L+D
Sbjct: 50 SSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD-----FL 104
Query: 117 THFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENV----VKLFDF 172
E L + + N + YLH I D K +I+ + NV +K+ DF
Sbjct: 105 AEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 161
Query: 173 SLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLV 232
L+ I G + GT +AP+ V + D++S G LL+G
Sbjct: 162 GLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA------ 213
Query: 233 RDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKE-QQLHASAQ-LTFECLNES 290
+ F + E + + + ++ A A+ L +
Sbjct: 214 ---------------SPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKD 258
Query: 291 PIDRPTMVDV 300
P R T+ D
Sbjct: 259 PKKRMTIQDS 268
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.8 bits (209), Expect = 2e-19
Identities = 39/231 (16%), Positives = 76/231 (32%), Gaps = 30/231 (12%)
Query: 77 MSHDHILKLIGCC----LETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAV 132
HI++++ ++V E + G L+ RI + + +
Sbjct: 62 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ---DRGDQAFTEREASEIMK 118
Query: 133 DAANALAYLHFGFPRPIVFRDFKTSHILFSEEN---VVKLFDFSLSISIPEGETHITDTV 189
A+ YLH I RD K ++L++ + ++KL DF + + T
Sbjct: 119 SIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL--TTP 173
Query: 190 MGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNY 249
T ++AP+ + + + D++S G + LL G H L +
Sbjct: 174 CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY---PPFYSNHGLAISPGMKTRIR 230
Query: 250 FEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDV 300
F + +++ L L P R T+ +
Sbjct: 231 MGQYEFPNPEWSEVSEEV------------KMLIRNLLKTEPTQRMTITEF 269
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 83.0 bits (204), Expect = 6e-19
Identities = 39/243 (16%), Positives = 69/243 (28%), Gaps = 33/243 (13%)
Query: 75 AQMSHDHILKLIG-CCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVD 133
M + I C E ++V E + LK L A
Sbjct: 57 KMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFN-----FCSRKFSLKTVLLLADQ 111
Query: 134 AANALAYLHFGFPRPIVFRDFKTSHILFSEE---NVVKLFDFSLSISIPEGETHI----- 185
+ + Y+H + + RD K + L N+V + DF L+ + TH
Sbjct: 112 MISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYR 168
Query: 186 -TDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNE 244
+ GT + + + S + D+ S G L G
Sbjct: 169 ENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGS---------LPWQGLKAA 219
Query: 245 YLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRL 304
+ +E ++ PI V + C + D+P + +
Sbjct: 220 TKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNF------CRSLRFDDKPDYSYLRQLF 273
Query: 305 RQI 307
R +
Sbjct: 274 RNL 276
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 82.4 bits (203), Expect = 1e-18
Identities = 37/177 (20%), Positives = 80/177 (45%), Gaps = 17/177 (9%)
Query: 50 KQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWD 109
K+ Q E + + ++H I+++ G + ++ +Y++ G L+
Sbjct: 39 KEIVVRLKQVEHTNDERLM-----LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFS 93
Query: 110 RILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKL 169
+ ++ P + + AA L + + I++RD K +IL + +K+
Sbjct: 94 LL---RKSQRFPNPVAKFY-----AAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKI 145
Query: 170 FDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
DF + +P+ T+ GT ++AP+ V+T +++ +D +SFG + E+L G
Sbjct: 146 TDFGFAKYVPDVTY----TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 198
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.3 bits (197), Expect = 9e-18
Identities = 40/253 (15%), Positives = 88/253 (34%), Gaps = 24/253 (9%)
Query: 63 WHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQ---HGTLWDRILGAPQTHF 119
+ + + + + H++I+ + I + Y+ G ++L
Sbjct: 49 YCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-----KT 103
Query: 120 EPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIP 179
+ L L Y+H ++ RD K S++L + +K+ DF L+
Sbjct: 104 QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160
Query: 180 EGETHIT--DTVMGTYGHLAPQYVTT-CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAH 236
H + T + AP+ + +++ +D++S G L+E+L+ R + +
Sbjct: 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYL 219
Query: 237 DLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQL---------HASAQLTFECL 287
D + L + +++ I LS K + + L + L
Sbjct: 220 DQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKML 279
Query: 288 NESPIDRPTMVDV 300
+P R +
Sbjct: 280 TFNPHKRIEVEQA 292
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 78.7 bits (193), Expect = 2e-17
Identities = 30/242 (12%), Positives = 67/242 (27%), Gaps = 34/242 (14%)
Query: 78 SHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANA 137
I + E +LV + + +K A
Sbjct: 59 GCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLL-----DLCGRKFSVKTVAMAAKQMLAR 113
Query: 138 LAYLHFGFPRPIVFRDFKTSHILFSE-----ENVVKLFDFSLSISIPEGETHI------T 186
+ +H + +V+RD K + L N++ + DF + + T
Sbjct: 114 VQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 170
Query: 187 DTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYL 246
+ GT +++ + S + D+ + G L G + +
Sbjct: 171 KNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP-----------WQGLKAA 219
Query: 247 KNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQ 306
N + R E +++L C ++ + N + P + +
Sbjct: 220 TNKQKYERIGEKKQSTPLREL-CAGFPEEF---YKYMHYARNLAFDATPDYDYLQGLFSK 275
Query: 307 IC 308
+
Sbjct: 276 VL 277
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.0 bits (191), Expect = 5e-17
Identities = 39/258 (15%), Positives = 87/258 (33%), Gaps = 29/258 (11%)
Query: 64 HESCINNVTYAAQMSHDHILKLIGCCLETPIAI--------LVFEYVQHGTLWDRILGAP 115
+ + + + H++++ LI C LVF++ +H
Sbjct: 53 PITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS--NV 110
Query: 116 QTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175
F +KR ++ L L++ I+ RD K +++L + + V+KL DF L+
Sbjct: 111 LVKFTLSEIKRVMQML------LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA 164
Query: 176 ISIPEGET---HITDTVMGTYGHLA-PQYVTTCDFSEKLDVYSFGAFLSELLTGRGI--- 228
+ + + + T + + D+ +D++ G ++E+ T I
Sbjct: 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG 224
Query: 229 ---LDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQ---L 282
+ L + ++ E ++ + Q ++ + L
Sbjct: 225 NTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDL 284
Query: 283 TFECLNESPIDRPTMVDV 300
+ L P R D
Sbjct: 285 IDKLLVLDPAQRIDSDDA 302
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.5 bits (190), Expect = 7e-17
Identities = 38/177 (21%), Positives = 66/177 (37%), Gaps = 14/177 (7%)
Query: 50 KQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWD 109
K+ D+ ES + H + L V EY G L+
Sbjct: 40 KEVIIAKDEVAHTVTESRV-----LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFF 94
Query: 110 RILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKL 169
+ + +R + +AL YLH R +V+RD K +++ ++ +K+
Sbjct: 95 HL-----SRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKI 146
Query: 170 FDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
DF L T GT +LAP+ + D+ +D + G + E++ GR
Sbjct: 147 TDFGLCKEGISDGAT-MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.3 bits (187), Expect = 1e-16
Identities = 37/224 (16%), Positives = 69/224 (30%), Gaps = 41/224 (18%)
Query: 79 HDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANAL 138
+++L+ +L+ E + + T L + A+
Sbjct: 68 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI----TERGALQEELARSFFWQVLEAV 123
Query: 139 AYLHFGFPRPIVFRDFKTSHILFSEEN-VVKLFDFSLSISIPEGETHITDTVMGTYGHLA 197
+ H ++ RD K +IL +KL DF + + GT +
Sbjct: 124 RHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT---DFDGTRVYSP 177
Query: 198 PQYVTTCDF-SEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFT 256
P+++ + V+S G L +++ G PF
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGD-------------IPFEHD----------E 214
Query: 257 EIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDV 300
EI+ + + + Q L CL P DRPT ++
Sbjct: 215 EIIRGQVFFRQRVSSECQHLIRW------CLALRPSDRPTFEEI 252
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 72.6 bits (177), Expect = 3e-15
Identities = 41/242 (16%), Positives = 77/242 (31%), Gaps = 30/242 (12%)
Query: 77 MSHDHILKLIGCCLE--TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDA 134
+I+ L + + LVFE+V + + L +
Sbjct: 87 RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--------QTLTDYDIRFYMYEI 138
Query: 135 ANALAYLHFGFPRPIVFRDFKTSHILFSEEN-VVKLFDFSLSISIPEGETHITDTVMGTY 193
AL Y H I+ RD K +++ E+ ++L D+ L+ G+ + V Y
Sbjct: 139 LKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVASRY 194
Query: 194 GHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYL------- 246
V + LD++S G L+ ++ + D +D + + L
Sbjct: 195 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 254
Query: 247 ----KNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFE----CLNESPIDRPTMV 298
N D RF +I+ + + H + + L R T
Sbjct: 255 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 314
Query: 299 DV 300
+
Sbjct: 315 EA 316
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.6 bits (172), Expect = 2e-14
Identities = 45/221 (20%), Positives = 70/221 (31%), Gaps = 29/221 (13%)
Query: 79 HDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANAL 138
++ L L+ +Y+ G L+ + + E + AL
Sbjct: 88 SPFLVTLHYAFQTETKLHLILDYINGGELFTHL-----SQRERFTEHEVQIYVGEIVLAL 142
Query: 139 AYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAP 198
+LH I++RD K +IL V L DF LS ET GT ++AP
Sbjct: 143 EHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199
Query: 199 QYVTTCD--FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNRFT 256
V D + +D +S G + ELLTG PF + +
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGA-------------SPFTVDGEKNSQAEISR 246
Query: 257 EIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTM 297
I+ + + L L + P R
Sbjct: 247 RILKSEPPYPQEMSALAKDLIQR------LLMKDPKKRLGC 281
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.1 bits (168), Expect = 7e-14
Identities = 37/251 (14%), Positives = 87/251 (34%), Gaps = 27/251 (10%)
Query: 64 HESCINNVTYAAQMSHDHILKLIGCCLETPIA------ILVFEYVQHGTLWDRILGAPQT 117
+ + M H++++ L+ LV ++ GT +++
Sbjct: 61 AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLM----- 113
Query: 118 HFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSIS 177
E L R L Y+H I+ RD K ++ +E+ +K+ DF L+
Sbjct: 114 KHEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 170
Query: 178 IPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR------GILDL 231
++ +T V+ + + +++ +D++S G ++E++TG+ LD
Sbjct: 171 A---DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ 227
Query: 232 VRDAHDLVYPFNEYLKNYFEDNRFTEIVDPII-VQDLSCTEKEQQLHASAQ-LTFECLNE 289
+++ + + + + + ++ A L + L
Sbjct: 228 LKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVL 287
Query: 290 SPIDRPTMVDV 300
R T +
Sbjct: 288 DAEQRVTAGEA 298
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 65.6 bits (159), Expect = 1e-12
Identities = 32/177 (18%), Positives = 67/177 (37%), Gaps = 17/177 (9%)
Query: 50 KQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWD 109
KQ+ Q +E I ++ ++KL + +V EYV G ++
Sbjct: 76 KQKVVKLKQIEHTLNEKRI-----LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS 130
Query: 110 RILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKL 169
+ A YLH +++RD K ++L ++ +++
Sbjct: 131 HL-----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 170 FDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
DF + + T+ GT LAP+ + + +++ +D ++ G + E+ G
Sbjct: 183 TDFGFAKRVKGRTW----TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.4 bits (148), Expect = 2e-11
Identities = 46/272 (16%), Positives = 95/272 (34%), Gaps = 30/272 (11%)
Query: 42 RIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCC-----LETPIAI 96
+ ++L + + + E + M H++++ L+ LE +
Sbjct: 44 LRVAVKKLSRPFQSIIHAKRTYRELRL-----LKHMKHENVIGLLDVFTPARSLEEFNDV 98
Query: 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKT 156
+ ++ L + + T L ++ L Y+H I+ RD K
Sbjct: 99 YLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI------LRGLKYIHS---ADIIHRDLKP 149
Query: 157 SHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFG 216
S++ +E+ +K+ DF L+ + +T V + + +++ +D++S G
Sbjct: 150 SNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 206
Query: 217 AFLSELLTGR-------GILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSC 269
++ELLTGR I L + P E LK ++ I + ++
Sbjct: 207 CIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNF 266
Query: 270 TEKEQQLHASAQ-LTFECLNESPIDRPTMVDV 300
+ A L + L R T
Sbjct: 267 ANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.6 bits (143), Expect = 9e-11
Identities = 47/284 (16%), Positives = 95/284 (33%), Gaps = 43/284 (15%)
Query: 42 RIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIA------ 95
R + ++L + N + E + ++H +I+ L+
Sbjct: 43 RNVAIKKLSRPFQNQTHAKRAYRELVL-----MKCVNHKNIISLLNVFTPQKTLEEFQDV 97
Query: 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFK 155
LV E + + +R + +LH I+ RD K
Sbjct: 98 YLVMELMDANLCQVIQMELDH--------ERMSYLLYQMLCGIKHLHS---AGIIHRDLK 146
Query: 156 TSHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSF 215
S+I+ + +K+ DF L+ + G + + + T + AP+ + + E +D++S
Sbjct: 147 PSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 204
Query: 216 GAFLSELLTGR-------GILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDP------- 261
G + E++ + I + L P E++K R P
Sbjct: 205 GCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTF 264
Query: 262 --IIVQDLSCTEKEQQLHASAQ---LTFECLNESPIDRPTMVDV 300
+ L + E ++Q L + L P R ++ D
Sbjct: 265 PKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 59.3 bits (142), Expect = 1e-10
Identities = 28/163 (17%), Positives = 57/163 (34%), Gaps = 12/163 (7%)
Query: 70 NVTYAAQMSHDHILKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLK 129
+ T M +HILKL+ + V + + + + L +
Sbjct: 70 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129
Query: 130 DAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENV------VKLFDFSLSISIPEGET 183
+ L Y+H I+ D K ++L + +K+ D + E T
Sbjct: 130 ISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 187
Query: 184 HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR 226
+ + T + +P+ + + D++S + EL+TG
Sbjct: 188 N----SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 314 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.8 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.72 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 96.91 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 95.65 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 92.63 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 91.84 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-55 Score=373.15 Aligned_cols=246 Identities=21% Similarity=0.340 Sum_probs=204.4
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
|.....+|+|+ +.|+++.+..+|+.||+|++.+....... ..+.+.+|+++++.++|||||++++++.++
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~---------~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 78 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG---------VEHQLRREVEIQSHLRHPNILRLYGYFHDA 78 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTT---------CHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChH---------HHHHHHHHHHHHHhcCCCCCCeEEEEEEEC
Confidence 34445689988 88999999999999999999877654432 126788999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~df 172 (314)
+.+|+|||||++|+|.+.+... ..++...+..++.|++.||.||| +++|+||||||+||+++.++.+||+||
T Consensus 79 ~~~~ivmEy~~~g~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DF 150 (263)
T d2j4za1 79 TRVYLILEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADF 150 (263)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred CEEEEEEeecCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeeccc
Confidence 9999999999999999998764 35889999999999999999999 999999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhcc
Q 043524 173 SLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFED 252 (314)
Q Consensus 173 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (314)
|+++...... .....||+.|+|||++.+..++.++||||+||++|+|++|+.||...... +.......
T Consensus 151 G~a~~~~~~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--------~~~~~i~~- 218 (263)
T d2j4za1 151 GWSVHAPSSR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--------ETYKRISR- 218 (263)
T ss_dssp CSCSCCCCCC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHT-
T ss_pred ceeeecCCCc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH--------HHHHHHHc-
Confidence 9997664432 34567999999999999989999999999999999999999999643211 11111111
Q ss_pred CCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 253 NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.....+ ...++++.+|+.+||+.||++|||+.|+++
T Consensus 219 ------------~~~~~p--~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 219 ------------VEFTFP--DFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ------------TCCCCC--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------------CCCCCC--ccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 111111 134567899999999999999999999986
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-55 Score=374.91 Aligned_cols=250 Identities=22% Similarity=0.331 Sum_probs=199.1
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
|+....+|+|+ +.|+++.+..+|+.||+|++......... +.+.+|+++++.++|||||++++++.++
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~-----------~~~~~Ei~~l~~l~HpnIv~~~~~~~~~ 75 (271)
T d1nvra_ 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-----------ENIKKEICINKMLNHENVVKFYGHRREG 75 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC------------------CHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHH-----------HHHHHHHHHHHhCCCCCEeeEeeeeccC
Confidence 34445689888 88999999999999999998765432221 4688999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~df 172 (314)
+.+|+|||||++|+|.+++... ..++...++.++.|++.||.||| +++|+||||||+|||++.++.+||+||
T Consensus 76 ~~~~ivmEy~~gg~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DF 147 (271)
T d1nvra_ 76 NIQYLFLEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDF 147 (271)
T ss_dssp TEEEEEEECCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCC
T ss_pred ceeEEEEeccCCCcHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccc
Confidence 9999999999999999998654 35899999999999999999999 999999999999999999999999999
Q ss_pred ccceecCCCCc-ccccccccccccccCcccccCCC-CcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhh
Q 043524 173 SLSISIPEGET-HITDTVMGTYGHLAPQYVTTCDF-SEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 173 g~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
|+|+....... .......||+.|+|||++.+..+ +.++||||+||++|+|++|+.||........ .+... .
T Consensus 148 G~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~---~~~~~----~ 220 (271)
T d1nvra_ 148 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ---EYSDW----K 220 (271)
T ss_dssp TTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH---HHHHH----H
T ss_pred hhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH---HHHHH----h
Confidence 99987644322 22445689999999999988776 5789999999999999999999975443221 00110 0
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.. ..........+.++.+|+.+||+.||++|||+.|+++
T Consensus 221 ~~-------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 221 EK-------------KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TT-------------CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cC-------------CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00 0000011134567889999999999999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-54 Score=375.67 Aligned_cols=249 Identities=21% Similarity=0.280 Sum_probs=204.9
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|.....+|+|+ +.|+++.+..+|+.||+|++...... ..+.+.+|+.+++.++|||||++++++.
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~------------~~~~~~~E~~il~~l~HpnIv~~~~~~~ 87 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP------------KKELIINEILVMRENKNPNIVNYLDSYL 87 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS------------CHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh------------HHHHHHHHHHHHHhCCCCCEeeEeEEEE
Confidence 3567777899999 99999999999999999998754311 1257889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
+++.+|+|||||++|+|.+++... .++...++.++.|++.||.||| ++||+||||||+|||++.++.+||+
T Consensus 88 ~~~~~~ivmEy~~gg~L~~~~~~~------~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~ 158 (293)
T d1yhwa1 88 VGDELWVVMEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLT 158 (293)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEEC
T ss_pred ECCEEEEEEEecCCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeec
Confidence 999999999999999999988653 4889999999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhh
Q 043524 171 DFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 171 dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
|||+++....... ......||+.|+|||++.+..++.++||||+||++|+|++|..||....... ......
T Consensus 159 DFG~a~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--------~~~~~~ 229 (293)
T d1yhwa1 159 DFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--------ALYLIA 229 (293)
T ss_dssp CCTTCEECCSTTC-CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHHH
T ss_pred cchhheeeccccc-cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH--------HHHHHH
Confidence 9999987644332 2446679999999999999899999999999999999999999996433211 111111
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
... ......+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 230 ~~~------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 230 TNG------------TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp HHC------------SCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hCC------------CCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 100 0011111244567899999999999999999999975
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.8e-54 Score=372.91 Aligned_cols=257 Identities=19% Similarity=0.276 Sum_probs=207.0
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
+.-...+|.|+ +.|+++.+..+|+.||||++..... -.++|.+|+++|+.++|||||++++++.++
T Consensus 19 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-------------~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 85 (287)
T d1opja_ 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-------------EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 85 (287)
T ss_dssp EEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-------------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred eEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-------------hHHHHHHHHHHHHhCCCCCEecCCccEeeC
Confidence 33345689998 8999998889999999998864221 126789999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~df 172 (314)
+..|+|||||++|+|.+.+..... ..+++..++.++.|++.||.||| +++|+||||||+|||++.++.+||+||
T Consensus 86 ~~~~iv~E~~~~g~l~~~l~~~~~---~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DF 159 (287)
T d1opja_ 86 PPFYIITEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADF 159 (287)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCT---TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred CeeEEEeecccCcchHHHhhhccc---cchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccc
Confidence 999999999999999999876433 46889999999999999999999 999999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhcc
Q 043524 173 SLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFED 252 (314)
Q Consensus 173 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (314)
|+++..............|++.|+|||++.+..++.++|||||||++|||++|..||....+.. .... ....
T Consensus 160 G~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~-------~~~~-~i~~ 231 (287)
T d1opja_ 160 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------QVYE-LLEK 231 (287)
T ss_dssp CCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-------HHHH-HHHT
T ss_pred cceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH-------HHHH-HHhc
Confidence 9998765544433444568999999999999999999999999999999999776653222111 1111 1111
Q ss_pred CCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 253 NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
...+..+..++.++.+|+..||+.||++|||+.|+++.|+.+.+.
T Consensus 232 -------------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 232 -------------DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp -------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred -------------CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 001111113456789999999999999999999999999987654
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=366.78 Aligned_cols=251 Identities=22% Similarity=0.346 Sum_probs=189.9
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCee
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIA 95 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (314)
...+|+|+ +.|+++.. .+++.||||.+..... ..++|.+|+++++.++|||||+++|++.+++..
T Consensus 10 ~~~iG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~-------------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~ 75 (263)
T d1sm2a_ 10 VQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAM-------------SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 75 (263)
T ss_dssp EEEEECCSSCCEEEEEE-TTTEEEEEEECCSSSS-------------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred EEEEeeCCCeEEEEEEE-CCCCEEEEEEECCCcC-------------cHHHHHHHHHHHHhcCCCCcccccceeccCCce
Confidence 34588888 77777754 4678899998864211 126789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
|+|||||++|+|.+++.... ..+++..++.++.|++.||.||| +++|+||||||+||+++.++.+||+|||++
T Consensus 76 ~lv~E~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla 148 (263)
T d1sm2a_ 76 CLVFEFMEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMT 148 (263)
T ss_dssp EEEEECCTTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC--
T ss_pred EEEEEecCCCcHHHHhhccc----cCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchh
Confidence 99999999999999987654 45788999999999999999999 999999999999999999999999999999
Q ss_pred eecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhC-CCCcccccCccccccchHHHHHhhhccCC
Q 043524 176 ISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTG-RGILDLVRDAHDLVYPFNEYLKNYFEDNR 254 (314)
Q Consensus 176 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (314)
+..............||+.|+|||++....++.++|||||||++|||+++ .+||..... .+..........
T Consensus 149 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~--------~~~~~~i~~~~~ 220 (263)
T d1sm2a_ 149 RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SEVVEDISTGFR 220 (263)
T ss_dssp ----------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH--------HHHHHHHHHTCC
T ss_pred eeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH--------HHHHHHHHhcCC
Confidence 87755444334456789999999999999999999999999999999995 555432211 111111111100
Q ss_pred cccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 255 FTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
...+..++.++.+|+..||+.||++|||++||++.|+++.++
T Consensus 221 --------------~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 221 --------------LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp --------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------------CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 000113346789999999999999999999999999999875
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.8e-53 Score=370.22 Aligned_cols=251 Identities=21% Similarity=0.286 Sum_probs=187.7
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|.-...+|+|+ +.|+++.+..+|+.||+|++......... +.+.+|+++|+.++|||||++++++.
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~-----------~~~~~Ei~il~~l~HpnIv~l~~~~~ 77 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE-----------GSMENEIAVLHKIKHPNIVALDDIYE 77 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC---------------------CHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHH-----------HHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 3455566799999 89999988899999999999865543221 45679999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeec---CCCce
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFS---EENVV 167 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~---~~~~~ 167 (314)
+++.+|+|||||++|+|.+++... ..++...+..++.|++.||.||| +++|+||||||+||++. .++.+
T Consensus 78 ~~~~~~lvmE~~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~v 149 (307)
T d1a06a_ 78 SGGHLYLIMQLVSGGELFDRIVEK-----GFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKI 149 (307)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTC-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCE
T ss_pred ECCEEEEEEeccCCCcHHHhhhcc-----cCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceE
Confidence 999999999999999999999764 35899999999999999999999 99999999999999995 46789
Q ss_pred EEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHH
Q 043524 168 KLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLK 247 (314)
Q Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (314)
||+|||+++...... ...+..||+.|+|||++.+..|+.++||||+||++|+|++|..||....... ...
T Consensus 150 kl~DFG~a~~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--------~~~ 219 (307)
T d1a06a_ 150 MISDFGLSKMEDPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK--------LFE 219 (307)
T ss_dssp EECCC--------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHH
T ss_pred EEeccceeEEccCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH--------HHH
Confidence 999999998664332 2445689999999999999999999999999999999999999996433211 111
Q ss_pred hhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 248 NYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
..... .. ..+.+.....++++.+|+..||+.||++|||+.|+++
T Consensus 220 ~i~~~-~~----------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 220 QILKA-EY----------EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp HHHTT-CC----------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHhcc-CC----------CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 11111 00 0111111244567899999999999999999999987
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=370.42 Aligned_cols=251 Identities=16% Similarity=0.220 Sum_probs=203.1
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
..|.....+|+|+ +.|+++.+..+|+.||+|++.......... .+.+.+|++++++++|||||++++++.
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~---------~~~~~~E~~il~~l~HpnIv~l~~~~~ 78 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK---------VPYVTRERDVMSRLDHPFFVKLYFTFQ 78 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTC---------HHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHH---------HHHHHHHHHHHHHcCCCCeeEEEEEEE
Confidence 3456666789988 889999999999999999998766543321 267899999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
+++.+|+|||||++|+|.+++.... .++...++.++.|++.||.||| +++|+||||||+||+++.++.+||+
T Consensus 79 ~~~~~~ivmEy~~gg~L~~~~~~~~-----~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~ 150 (288)
T d1uu3a_ 79 DDEKLYFGLSYAKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQIT 150 (288)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEEC
T ss_pred ECCEEEEEEEccCCCCHHHhhhccC-----CCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEec
Confidence 9999999999999999999887653 5889999999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCC-cccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhh
Q 043524 171 DFSLSISIPEGE-THITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNY 249 (314)
Q Consensus 171 dfg~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (314)
|||+|+...... ........||+.|+|||++.+..++.++||||+||++|+|++|..||....... .....
T Consensus 151 DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--------~~~~i 222 (288)
T d1uu3a_ 151 DFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKI 222 (288)
T ss_dssp CCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHH
T ss_pred ccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH--------HHHHH
Confidence 999998765332 222345679999999999999999999999999999999999999997432111 11111
Q ss_pred hccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 250 FEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
. ......+ ...++++.+||.+||+.||++|||++|++.
T Consensus 223 ~-------------~~~~~~p--~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 223 I-------------KLEYDFP--EKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp H-------------TTCCCCC--TTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred H-------------cCCCCCC--ccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 1 1111111 134567899999999999999999999754
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-54 Score=372.10 Aligned_cols=251 Identities=20% Similarity=0.222 Sum_probs=201.0
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
..|+....+|+|+ +.|+++.+..+|+.||+|++...... ..+++.+|+++|+.++|||||++++++.
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~------------~~~~~~~E~~il~~l~HpnIv~l~~~~~ 79 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE------------ELEDYMVEIDILASCDHPNIVKLLDAFY 79 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG------------GGGGTHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH------------HHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 3455556789998 89999999999999999998643211 1256889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
+++.+|+|||||++|+|.+++.... .+++...+..++.|++.||.||| +++|+||||||+|||++.++.+||+
T Consensus 80 ~~~~~~lvmEy~~~g~L~~~~~~~~----~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~ 152 (288)
T d2jfla1 80 YENNLWILIEFCAGGAVDAVMLELE----RPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLA 152 (288)
T ss_dssp ETTEEEEEEECCTTEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred eCCeEEEEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEE
Confidence 9999999999999999999876543 35899999999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCcccc-----cCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHH
Q 043524 171 DFSLSISIPEGETHITDTVMGTYGHLAPQYVT-----TCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEY 245 (314)
Q Consensus 171 dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 245 (314)
|||+|+...... .......||+.|+|||++. ...|+.++||||+||++|+|++|+.||........
T Consensus 153 DFG~a~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~-------- 223 (288)
T d2jfla1 153 DFGVSAKNTRTI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-------- 223 (288)
T ss_dssp CCTTCEECHHHH-HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--------
T ss_pred echhhhccCCCc-ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH--------
Confidence 999997653221 1234568999999999884 34588999999999999999999999975432220
Q ss_pred HHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 246 LKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
....... .. .....+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 224 ~~~i~~~-~~-----------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 224 LLKIAKS-EP-----------PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp HHHHHHS-CC-----------CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHcC-CC-----------CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111110 00 001111245567899999999999999999999986
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.5e-53 Score=370.05 Aligned_cols=257 Identities=17% Similarity=0.255 Sum_probs=192.6
Q ss_pred cccccccCch-hHHHHHHHhcCCc---ccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 15 KRTLMIGNGA-SVLQELIASSNGK---YIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 15 ~~~~~~G~g~-~~~~~~~~~~~g~---~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
+....+|+|+ +.||++....+|+ .||||.+........ .++|.+|+++|++++|||||+++|++.
T Consensus 29 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~E~~~l~~l~HpnIv~l~g~~~ 97 (299)
T d1jpaa_ 29 KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ-----------RRDFLSEASIMGQFDHPNVIHLEGVVT 97 (299)
T ss_dssp EEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHH-----------HHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred EEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHH-----------HHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence 3345688888 8888887766664 588887754322221 157899999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
+++.+++|||||++|+|.+++.... ..+++..++.++.|++.||.||| +++|+||||||+|||++.++.+||+
T Consensus 98 ~~~~~~iv~Ey~~~g~L~~~~~~~~----~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~ 170 (299)
T d1jpaa_ 98 KSTPVMIITEFMENGSLDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVS 170 (299)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEEC
T ss_pred eCCEEEEEEEecCCCcceeeecccc----CCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEEC
Confidence 9999999999999999999887654 35889999999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCcc----cccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHH
Q 043524 171 DFSLSISIPEGETH----ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEY 245 (314)
Q Consensus 171 dfg~~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~ 245 (314)
|||+++........ ......||+.|+|||++....++.++|||||||++|||++ |..||....... .
T Consensus 171 DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~--------~ 242 (299)
T d1jpaa_ 171 DFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD--------V 242 (299)
T ss_dssp CC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------H
T ss_pred CcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH--------H
Confidence 99999876443211 1122457899999999998899999999999999999998 899986433211 1
Q ss_pred HHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhc
Q 043524 246 LKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSL 311 (314)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 311 (314)
....... ...+.+..++..+.+|+.+||+.||++|||+.||++.|+++.++.
T Consensus 243 ~~~i~~~--------------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p 294 (299)
T d1jpaa_ 243 INAIEQD--------------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294 (299)
T ss_dssp HHHHHTT--------------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred HHHHHcC--------------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence 1111110 000111134567899999999999999999999999999987654
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-53 Score=362.02 Aligned_cols=242 Identities=18% Similarity=0.284 Sum_probs=192.5
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe----CC
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE----TP 93 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~ 93 (314)
.+|+|+ +.|+++.+..+|+.||+|.+......... .+.+.+|+++|++++|||||++++++.+ +.
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~----------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 85 (270)
T d1t4ha_ 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE----------RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 85 (270)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHH----------HHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred EEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHH----------HHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCC
Confidence 588888 88999999999999999998765422111 1568899999999999999999999875 45
Q ss_pred eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCC--ceeccCCCCCeeec-CCCceEEc
Q 043524 94 IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRP--IVFRDFKTSHILFS-EENVVKLF 170 (314)
Q Consensus 94 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~--i~H~dlk~~nil~~-~~~~~kl~ 170 (314)
.+|+|||||++|+|.+++... ..++...++.++.|++.||.||| +++ |+||||||+|||++ .++.+||+
T Consensus 86 ~~~ivmE~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~ 157 (270)
T d1t4ha_ 86 CIVLVTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIG 157 (270)
T ss_dssp EEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred EEEEEEeCCCCCcHHHHHhcc-----ccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEe
Confidence 689999999999999999764 35889999999999999999999 888 99999999999996 47899999
Q ss_pred ccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhh
Q 043524 171 DFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 171 dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
|||+++..... ......||+.|+|||++.+ .++.++||||+||++|||++|+.||....... .......
T Consensus 158 DFGla~~~~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~-------~~~~~i~ 226 (270)
T d1t4ha_ 158 DLGLATLKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-------QIYRRVT 226 (270)
T ss_dssp CTTGGGGCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-------HHHHHHT
T ss_pred ecCcceeccCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH-------HHHHHHH
Confidence 99999764332 2346689999999998865 69999999999999999999999996433221 1111111
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
. +..+...+...++++.+|+.+||+.||++|||+.|+++
T Consensus 227 ~-------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 227 S-------------GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp T-------------TCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c-------------CCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1 00111111123456889999999999999999999985
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-54 Score=378.04 Aligned_cols=272 Identities=18% Similarity=0.230 Sum_probs=201.4
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
|.....+|+|+ +.|+++.+..+|+.||+|++...... ...+.+.+|+.+|+.++|||||+++++|.++
T Consensus 8 y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-----------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 76 (322)
T d1s9ja_ 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-----------AIRNQIIRELQVLHECNSPYIVGFYGAFYSD 76 (322)
T ss_dssp EEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCT-----------THHHHHHHHGGGGGGCCCTTBCCEEEEEECS
T ss_pred CEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCH-----------HHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 33445689988 88999999999999999998643110 1225788999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCC-CceeccCCCCCeeecCCCceEEcc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPR-PIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~-~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
+.+|+|||||++|+|.+++.... .++...+..++.|++.||.||| ++ +|+||||||+|||++.++.+||+|
T Consensus 77 ~~~~iVmEy~~gg~L~~~l~~~~-----~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~D 148 (322)
T d1s9ja_ 77 GEISICMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCD 148 (322)
T ss_dssp SEEEEEEECCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECC
T ss_pred CEEEEEEEcCCCCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEee
Confidence 99999999999999999997643 4889999999999999999999 74 899999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccc-------hHH
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYP-------FNE 244 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~-------~~~ 244 (314)
||+|+..... ...+..||+.|+|||++.+..|+.++||||+||++|||++|+.||............ ...
T Consensus 149 FGla~~~~~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 225 (322)
T d1s9ja_ 149 FGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225 (322)
T ss_dssp CCCCHHHHHH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------
T ss_pred CCCccccCCC---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCccc
Confidence 9999865332 234568999999999999999999999999999999999999999754322100000 000
Q ss_pred H----------HHhhhc----cCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH--HHHHH
Q 043524 245 Y----------LKNYFE----DNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR--RLRQI 307 (314)
Q Consensus 245 ~----------~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~--~L~~~ 307 (314)
. ...... .....+..+.......+.......+.++.+|+.+||+.||++||||+|+++ .+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 226 TPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp --------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred CCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 0 000000 000000000000011000011123567899999999999999999999987 45443
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-53 Score=365.54 Aligned_cols=260 Identities=20% Similarity=0.306 Sum_probs=194.5
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
+.....+|+|+ +.|+++. ....||||++...... ....+.|.+|+.++..++|||||++++++. .
T Consensus 10 ~~~~~~lG~G~fg~Vy~~~---~~~~vAvK~~~~~~~~----------~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~ 75 (276)
T d1uwha_ 10 ITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPT----------PQQLQAFKNEVGVLRKTRHVNILLFMGYST-A 75 (276)
T ss_dssp CCCCSEEEECSSCEEEEEE---SSSEEEEEECCCSSCC----------TTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred EEEEEEEeeCCCcEEEEEE---ECCEEEEEEEEcccCC----------HHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-c
Confidence 33344588888 7777663 3346999987643211 012367899999999999999999999875 4
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~df 172 (314)
+.+++|||||++|+|.+++.... ..+++..++.++.|++.||+||| +++|+||||||+|||++.++.+||+||
T Consensus 76 ~~~~lv~Ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DF 148 (276)
T d1uwha_ 76 PQLAIVTQWCEGSSLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDF 148 (276)
T ss_dssp SSCEEEEECCCEEEHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCC
T ss_pred cEEEEEEecCCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccc
Confidence 67899999999999999997654 35889999999999999999999 999999999999999999999999999
Q ss_pred ccceecCCCC-cccccccccccccccCccccc---CCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHh
Q 043524 173 SLSISIPEGE-THITDTVMGTYGHLAPQYVTT---CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKN 248 (314)
Q Consensus 173 g~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (314)
|+|+...... ........||+.|+|||++.. ..|+.++|||||||++|||++|+.||........ ...
T Consensus 149 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~--------~~~ 220 (276)
T d1uwha_ 149 GLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--------IIF 220 (276)
T ss_dssp CCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--------HHH
T ss_pred cceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH--------HHH
Confidence 9997764432 222445679999999999864 3488999999999999999999999975433211 011
Q ss_pred hhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhc
Q 043524 249 YFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSL 311 (314)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 311 (314)
...... ..+... .....+++++.+|+.+||+.||++|||+.||++.|+.+.+++
T Consensus 221 ~~~~~~----~~p~~~-----~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 221 MVGRGY----LSPDLS-----KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp HHHHTS----CCCCGG-----GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred HHhcCC----CCCcch-----hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 111100 001000 001134567899999999999999999999999999998764
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-54 Score=368.61 Aligned_cols=253 Identities=19% Similarity=0.291 Sum_probs=188.8
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
.|.....+|+|+ +.|+++.+..+|+.||+|++......... .+.+.+|++++++++|||||++++++.+
T Consensus 5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~----------~~~~~~E~~il~~l~HpnIv~~~~~~~~ 74 (269)
T d2java1 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE----------KQMLVSEVNLLRELKHPNIVRYYDRIID 74 (269)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHH----------HHHHHHHHHHTTSCCCTTBCCEEEEEEC
T ss_pred hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHH----------HHHHHHHHHHHHHCCCCCEeeEEEEEEe
Confidence 344455689888 88999999999999999998755322211 1568899999999999999999999864
Q ss_pred --CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCC-----ceeccCCCCCeeecCC
Q 043524 92 --TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRP-----IVFRDFKTSHILFSEE 164 (314)
Q Consensus 92 --~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~-----i~H~dlk~~nil~~~~ 164 (314)
++.+|+|||||++|+|.+++...... ...+++..++.++.|++.||.||| +++ |+||||||+||+++.+
T Consensus 75 ~~~~~~~ivmEy~~~g~L~~~i~~~~~~-~~~l~e~~~~~i~~qi~~al~ylH---~~~~~~~~IiHrDiKp~NIll~~~ 150 (269)
T d2java1 75 RTNTTLYIVMEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGK 150 (269)
T ss_dssp ----CEEEEEECCTTEEHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHH---HHCC---------CCGGGEEECTT
T ss_pred CCCCEEEEEEecCCCCcHHHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHH---HhcCCCCCEEeCcCchhhcCcCCC
Confidence 56789999999999999988642110 035889999999999999999999 655 9999999999999999
Q ss_pred CceEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHH
Q 043524 165 NVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNE 244 (314)
Q Consensus 165 ~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 244 (314)
+.+||+|||+++....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... +
T Consensus 151 ~~vkl~DFG~a~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~--------~ 221 (269)
T d2java1 151 QNVKLGDFGLARILNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--------E 221 (269)
T ss_dssp SCEEECCHHHHHHC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--------H
T ss_pred CcEEEeeccceeecccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH--------H
Confidence 9999999999987644322 244568999999999999989999999999999999999999999643321 1
Q ss_pred HHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 245 YLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
....... ..... .+...++++.+|+.+||+.||++|||+.|+++
T Consensus 222 ~~~~i~~-~~~~~-------------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 222 LAGKIRE-GKFRR-------------IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHHHHHH-TCCCC-------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHc-CCCCC-------------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1111111 11100 01134567899999999999999999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-52 Score=364.37 Aligned_cols=253 Identities=20% Similarity=0.309 Sum_probs=199.5
Q ss_pred cccCch-hHHHHHHHh--cCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCee
Q 043524 19 MIGNGA-SVLQELIAS--SNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIA 95 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~--~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (314)
.||.|+ +.|+++... .++..||||++........ .++|.+|+++|++++|||||+++|++.+ +.+
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~-----------~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~ 83 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD-----------TEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 83 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHH-----------HHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHH-----------HHHHHHHHHHHHhCCCCCEeeEeeeecc-CeE
Confidence 388888 778777443 3455799998864321111 2678999999999999999999999864 568
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
|+|||||++|+|.+++.... ..+++..++.++.|++.||.||| +++|+||||||+||+++.++.+||+|||++
T Consensus 84 ~lvmE~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla 156 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLS 156 (285)
T ss_dssp EEEEECCTTEEHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEEeCCCCcHHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhh
Confidence 99999999999999886554 45899999999999999999999 999999999999999999999999999999
Q ss_pred eecCCCCcc--cccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhcc
Q 043524 176 ISIPEGETH--ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFED 252 (314)
Q Consensus 176 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (314)
+........ ......||+.|+|||++....++.++|||||||++|||++ |+.||......+ ..... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~--------~~~~i-~~ 227 (285)
T d1u59a_ 157 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--------VMAFI-EQ 227 (285)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--------HHHHH-HT
T ss_pred hcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH--------HHHHH-Hc
Confidence 887554322 1234468999999999998899999999999999999998 899997543221 11111 11
Q ss_pred CCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhcc
Q 043524 253 NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSLS 312 (314)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~ 312 (314)
+.. +..+..++.++.+|+.+||+.||++|||+.+|++.|+++..++.
T Consensus 228 ~~~-------------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~ 274 (285)
T d1u59a_ 228 GKR-------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274 (285)
T ss_dssp TCC-------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCC-------------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence 100 00111345678999999999999999999999999998876543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-53 Score=363.56 Aligned_cols=256 Identities=21% Similarity=0.277 Sum_probs=200.0
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
.++-...+|+|+ +.|+++.. .+++.||||++..... ..++|.+|++++++++|||||+++|++.
T Consensus 14 ~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~~~~~~~-------------~~~~~~~E~~~l~~l~HpnIv~~~g~~~- 78 (272)
T d1qpca_ 14 TLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSM-------------SPDAFLAEANLMKQLQHQRLVRLYAVVT- 78 (272)
T ss_dssp GEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTSS-------------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred HeEEeEEEecCCCcEEEEEEE-CCCCEEEEEEEccCcC-------------CHHHHHHHHHHHHhCCCCCEeEEEeeec-
Confidence 344445588888 77777754 4678899998864221 1267899999999999999999999875
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
++..|+|||||++|+|.+.+..... ..+++..++.++.|++.||.||| +++|+||||||+||+++.++.+||+|
T Consensus 79 ~~~~~iv~Ey~~~g~L~~~~~~~~~---~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~D 152 (272)
T d1qpca_ 79 QEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIAD 152 (272)
T ss_dssp SSSCEEEEECCTTCBHHHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECC
T ss_pred cCCeEEEEEeCCCCcHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeecc
Confidence 4567999999999999987754321 24789999999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhc
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFE 251 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (314)
||+|+..............||+.|+|||++....++.++|||||||++|||+||..|+...... .+.......
T Consensus 153 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-------~~~~~~i~~ 225 (272)
T d1qpca_ 153 FGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-------PEVIQNLER 225 (272)
T ss_dssp CTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHT
T ss_pred ccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHh
Confidence 9999987655444445567899999999998888999999999999999999965554322211 111111111
Q ss_pred cCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 252 DNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
. .....+..++.++.+|+.+||+.||++|||+.||++.|+++..+
T Consensus 226 ~--------------~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 226 G--------------YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp T--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred c--------------CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 0 00011113456789999999999999999999999999998764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=364.57 Aligned_cols=248 Identities=18% Similarity=0.289 Sum_probs=205.0
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
|.....+|+|+ +.|+++.+..+|+.||+|++.+........ .+.+.+|+.+|+.++|||||++++++.++
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~---------~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 77 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE---------VAHTVTESRVLQNTRHPFLTALKYAFQTH 77 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTC---------HHHHHHHHHHHHSCCCTTBCCEEEEEECS
T ss_pred cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHH---------HHHHHHHHHHHHhCCCCCEEEEEeeeccc
Confidence 44455689988 889999999999999999998776543321 26688999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~df 172 (314)
+.+|+|||||++|+|.+.+.... .++...++.++.|++.||.||| +++|+||||||+|||++.++.+||+||
T Consensus 78 ~~~~iv~ey~~gg~L~~~~~~~~-----~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DF 149 (337)
T d1o6la_ 78 DRLCFVMEYANGGELFFHLSRER-----VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDF 149 (337)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred cccccceeccCCCchhhhhhccc-----CCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeec
Confidence 99999999999999999987653 5788999999999999999999 999999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhcc
Q 043524 173 SLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFED 252 (314)
Q Consensus 173 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (314)
|+|+....... ......||+.|+|||++.+..|+.++||||+||++|||++|++||....... ...
T Consensus 150 G~a~~~~~~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~--------~~~----- 215 (337)
T d1o6la_ 150 GLCKEGISDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--------LFE----- 215 (337)
T ss_dssp TTCBCSCCTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHH-----
T ss_pred ccccccccCCc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH--------HHH-----
Confidence 99987643322 3456789999999999999999999999999999999999999997533211 111
Q ss_pred CCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCC-----HHHHHH
Q 043524 253 NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPT-----MVDVAR 302 (314)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps-----~~ell~ 302 (314)
.........+ ...+.++.+||.+||+.||++||+ +.|+++
T Consensus 216 --------~i~~~~~~~p--~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 216 --------LILMEEIRFP--RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --------HHHHCCCCCC--TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --------HHhcCCCCCC--ccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 1111111111 134567899999999999999994 888875
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.5e-53 Score=369.14 Aligned_cols=246 Identities=23% Similarity=0.287 Sum_probs=196.8
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
|.....+|+|+ +.|+++.+..+|+.||||++......... ..+.+.+|+++|+.++|||||++++++.++
T Consensus 17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~---------~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~ 87 (309)
T d1u5ra_ 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE---------KWQDIIKEVRFLQKLRHPNTIQYRGCYLRE 87 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHH---------HHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred cEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHH---------HHHHHHHHHHHHHHCCCCCEeeEEEEEEEC
Confidence 44555689988 89999999999999999998654321111 125688999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~df 172 (314)
+.+|+|||||++|++...+... .++++..++.++.|++.||.||| +++|+||||||+|||++.++.+||+||
T Consensus 88 ~~~~iv~E~~~~g~l~~~~~~~-----~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DF 159 (309)
T d1u5ra_ 88 HTAWLVMEYCLGSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDF 159 (309)
T ss_dssp TEEEEEEECCSEEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCC
T ss_pred CEEEEEEEecCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeec
Confidence 9999999999999887666543 35899999999999999999999 999999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCccccc---CCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhh
Q 043524 173 SLSISIPEGETHITDTVMGTYGHLAPQYVTT---CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNY 249 (314)
Q Consensus 173 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (314)
|+++.... .....||+.|+|||++.+ ..|+.++||||+||++|||++|..||....... .....
T Consensus 160 G~a~~~~~-----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~--------~~~~i 226 (309)
T d1u5ra_ 160 GSASIMAP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHI 226 (309)
T ss_dssp TTCBSSSS-----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHH
T ss_pred ccccccCC-----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH--------HHHHH
Confidence 99976533 335679999999999864 358899999999999999999999996432211 11111
Q ss_pred hccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 250 FEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.. +..+.......++.+.+|+.+||+.||++||||.|+++
T Consensus 227 ~~-------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 227 AQ-------------NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HH-------------SCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred Hh-------------CCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 11 11111111134567899999999999999999999975
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.1e-52 Score=369.25 Aligned_cols=251 Identities=17% Similarity=0.267 Sum_probs=203.9
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|.....+|+|+ +.|+++.+..+|+.||+|++........ +.+.+|+++|+.++|||||++++++.
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~------------~~~~~E~~il~~l~HpnIv~~~~~~~ 93 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK------------ETVRKEIQTMSVLRHPTLVNLHDAFE 93 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHH------------HHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhH------------HHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 3455566799999 8899998999999999999876543322 56889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecC--CCceE
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSE--ENVVK 168 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~--~~~~k 168 (314)
+++.+|+|||||++|+|.+.+.... ..++...+..++.||+.||.||| +++|+||||||+|||++. ++.+|
T Consensus 94 ~~~~~~ivmE~~~gg~L~~~l~~~~----~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vk 166 (350)
T d1koaa2 94 DDNEMVMIYEFMSGGELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELK 166 (350)
T ss_dssp ETTEEEEEECCCCSCBHHHHHTCTT----SCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEE
T ss_pred ECCEEEEEEEcCCCCCHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEE
Confidence 9999999999999999999986543 45899999999999999999999 999999999999999964 57899
Q ss_pred EcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHh
Q 043524 169 LFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKN 248 (314)
Q Consensus 169 l~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (314)
|+|||+++....... .....||+.|+|||++.+..++.++||||+||++|+|++|+.||...... +....
T Consensus 167 L~DFG~a~~~~~~~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--------~~~~~ 236 (350)
T d1koaa2 167 LIDFGLTAHLDPKQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--------ETLRN 236 (350)
T ss_dssp ECCCTTCEECCTTSC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHH
T ss_pred Eeecchheecccccc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH--------HHHHH
Confidence 999999987654432 44568999999999999989999999999999999999999999643211 11111
Q ss_pred hhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 249 YFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.... .. ..+.......++++.+||.+||+.||++|||+.|+++
T Consensus 237 i~~~-~~----------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 237 VKSC-DW----------NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp HHHT-CC----------CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred HHhC-CC----------CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111 00 0011111134567899999999999999999999986
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.6e-52 Score=369.74 Aligned_cols=251 Identities=19% Similarity=0.256 Sum_probs=204.6
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
..|+....+|+|+ +.|+++.+..+|+.||+|++........ +.+.+|+++|++++|||||++++++.
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~------------~~~~~Ei~il~~l~HpnIv~~~~~~~ 96 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK------------YTVKNEISIMNQLHHPKLINLHDAFE 96 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHH------------HHHHHHHHHHTTCCSTTBCCEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHH------------HHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 3456666799999 8999999999999999999876543222 46789999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeec--CCCceE
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFS--EENVVK 168 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~--~~~~~k 168 (314)
+++.+|+|||||++|+|.+.+.... .+++..+++.++.||+.||.||| ++||+||||||+|||++ ..+.+|
T Consensus 97 ~~~~~~ivmE~~~gg~L~~~~~~~~----~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vk 169 (352)
T d1koba_ 97 DKYEMVLILEFLSGGELFDRIAAED----YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVK 169 (352)
T ss_dssp CSSEEEEEEECCCCCBHHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEE
T ss_pred ECCEEEEEEEcCCCChHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEE
Confidence 9999999999999999999886654 45899999999999999999999 99999999999999997 568899
Q ss_pred EcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHh
Q 043524 169 LFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKN 248 (314)
Q Consensus 169 l~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (314)
|+|||+|+....... .....||+.|+|||++.+..++.++||||+||++|+|++|+.||....... ....
T Consensus 170 L~DFGla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--------~~~~ 239 (352)
T d1koba_ 170 IIDFGLATKLNPDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE--------TLQN 239 (352)
T ss_dssp ECCCTTCEECCTTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--------HHHH
T ss_pred EeecccceecCCCCc--eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--------HHHH
Confidence 999999988754432 445679999999999999999999999999999999999999996433211 1111
Q ss_pred hhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 249 YFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.... .. ..+.......+.++.+||..||+.||++|||+.|+++
T Consensus 240 i~~~-~~----------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 240 VKRC-DW----------EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp HHHC-CC----------CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHhC-CC----------CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1110 00 0011111134567899999999999999999999986
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-52 Score=362.90 Aligned_cols=261 Identities=20% Similarity=0.249 Sum_probs=208.3
Q ss_pred hhhhhhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeee
Q 043524 7 KFKLWSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKL 85 (314)
Q Consensus 7 ~~~~~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 85 (314)
+-++..+|.....+|+|+ +.|+++.+..+|+.||+|++.+...... ......+.+.+|+++|+.++|||||++
T Consensus 5 ~~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~------~~~~~~~~~~~E~~il~~l~HpnIv~~ 78 (293)
T d1jksa_ 5 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSS------RRGVSREDIEREVSILKEIQHPNVITL 78 (293)
T ss_dssp CSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTC------SSSBCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchh------hhhHHHHHHHHHHHHHHhCCCCCCCcE
Confidence 334445566677799988 8999999999999999999875432211 111234778999999999999999999
Q ss_pred EeEEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCC
Q 043524 86 IGCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN 165 (314)
Q Consensus 86 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~ 165 (314)
++++.+++.+|+|||||++|+|.+++... ..++...++.++.|++.||.||| +++|+||||||+||+++..+
T Consensus 79 ~~~~~~~~~~~iv~E~~~gg~L~~~i~~~-----~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~ 150 (293)
T d1jksa_ 79 HEVYENKTDVILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRN 150 (293)
T ss_dssp EEEEECSSEEEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSS
T ss_pred EEEEEECCEEEEEEEcCCCccccchhccc-----cccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCC
Confidence 99999999999999999999999998764 35899999999999999999999 99999999999999998776
Q ss_pred ----ceEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccc
Q 043524 166 ----VVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYP 241 (314)
Q Consensus 166 ----~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~ 241 (314)
.+|++|||+++....... .....||+.|+|||++.+..++.++||||+||++|+|++|..||.......
T Consensus 151 ~~~~~vkl~DfG~a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~----- 223 (293)
T d1jksa_ 151 VPKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE----- 223 (293)
T ss_dssp SSSCCEEECCCTTCEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----
T ss_pred CcccceEecchhhhhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH-----
Confidence 489999999987654332 345678999999999999889999999999999999999999997433211
Q ss_pred hHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 242 FNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
........ . ...+.......+..+.+||.+||+.||++|||+.|+++
T Consensus 224 ---~~~~i~~~-~----------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 224 ---TLANVSAV-N----------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp ---HHHHHHTT-C----------CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---HHHHHHhc-C----------CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111110 0 01111122245567899999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-52 Score=359.10 Aligned_cols=250 Identities=19% Similarity=0.265 Sum_probs=194.3
Q ss_pred cccCch-hHHHHHHH--hcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCee
Q 043524 19 MIGNGA-SVLQELIA--SSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIA 95 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~--~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (314)
.+|+|+ +.|+++.. ..+++.||||++........ ..++|.+|+++|++++|||||+++++|.+ +..
T Consensus 14 ~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~----------~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~ 82 (277)
T d1xbba_ 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA----------LKDELLAEANVMQQLDNPYIVRMIGICEA-ESW 82 (277)
T ss_dssp EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CH----------HHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSE
T ss_pred CcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHH----------HHHHHHHHHHHHHhCCCCCCceEEEEecc-CCE
Confidence 478888 77777653 34567899999865432111 12679999999999999999999999864 567
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 96 ILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 96 ~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
++|||||++|+|.+++.... ++++..++.++.|++.||.||| +++|+||||||+||+++.++.+|++|||++
T Consensus 83 ~lvmE~~~~g~L~~~l~~~~-----~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla 154 (277)
T d1xbba_ 83 MLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLS 154 (277)
T ss_dssp EEEEECCTTEEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEEcCCCCcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhh
Confidence 89999999999999987653 5889999999999999999999 999999999999999999999999999999
Q ss_pred eecCCCCcc--cccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhcc
Q 043524 176 ISIPEGETH--ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFED 252 (314)
Q Consensus 176 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (314)
+........ ......||+.|+|||++....++.++|||||||++|||++ |+.||....... .... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~--------~~~~-i~~ 225 (277)
T d1xbba_ 155 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--------VTAM-LEK 225 (277)
T ss_dssp EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--------HHHH-HHT
T ss_pred hhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH--------HHHH-HHc
Confidence 876544322 1234578999999999999889999999999999999997 899997533211 1111 111
Q ss_pred CCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHh
Q 043524 253 NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICC 309 (314)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 309 (314)
.. .++.+..++.++.+|+.+||+.||++|||+++|++.|++...
T Consensus 226 ~~-------------~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 226 GE-------------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp TC-------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CC-------------CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 10 001111345678999999999999999999999999988653
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.6e-51 Score=357.62 Aligned_cols=245 Identities=20% Similarity=0.324 Sum_probs=202.1
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
|+....+|+|+ +.|+++.+..+|+.||+|++.......... .+.+.+|+.+++.++|||||++++++.++
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~---------~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 76 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ---------VEHTNDERLMLSIVTHPFIIRMWGTFQDA 76 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTC---------HHHHHHHHHHHHSCCBTTBCCEEEEEECS
T ss_pred eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHH---------HHHHHHHHHHHHhccCcChhheeeeEeeC
Confidence 33445689888 889999999999999999998766543321 26788999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~df 172 (314)
+.+|+|||||++|++...+.... .++...+..++.|++.||.||| +++|+||||||+|||++.++.+||+||
T Consensus 77 ~~~~ivmE~~~gg~l~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DF 148 (316)
T d1fota_ 77 QQIFMIMDYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDF 148 (316)
T ss_dssp SEEEEEECCCCSCBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred CeeeeEeeecCCccccccccccc-----cccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecC
Confidence 99999999999999999887654 4678888899999999999999 999999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhcc
Q 043524 173 SLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFED 252 (314)
Q Consensus 173 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (314)
|+|+..... .....||+.|+|||++.+..|+.++||||+||++|+|++|+.||...... +.....
T Consensus 149 G~a~~~~~~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~--------~~~~~i--- 213 (316)
T d1fota_ 149 GFAKYVPDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--------KTYEKI--- 213 (316)
T ss_dssp SSCEECSSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHH---
T ss_pred ccceEeccc----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH--------HHHHHH---
Confidence 999886543 33568999999999999989999999999999999999999999643211 111111
Q ss_pred CCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCC-----CHHHHHH
Q 043524 253 NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRP-----TMVDVAR 302 (314)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 302 (314)
..+....+ ...+.++.+++.+||..||++|| |++|+++
T Consensus 214 ----------~~~~~~~p--~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 214 ----------LNAELRFP--PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ----------HHCCCCCC--TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ----------HcCCCCCC--CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 11111111 13446689999999999999996 8999875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=364.31 Aligned_cols=258 Identities=20% Similarity=0.310 Sum_probs=199.3
Q ss_pred CcccccccCch-hHHHHHHHhcCCc-----ccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeE
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGK-----YIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLI 86 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~-----~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~ 86 (314)
+.-...+|.|+ +.|+++....+++ .||+|.+........ .+.+.+|+.++.++ +|||||+++
T Consensus 39 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~E~~~l~~l~~HpnIv~l~ 107 (325)
T d1rjba_ 39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE-----------REALMSELKMMTQLGSHENIVNLL 107 (325)
T ss_dssp EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-----------------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred eEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHH-----------HHHHHHHHHHHHHhcCCCcEeEEE
Confidence 34445688888 8888877655544 588988764432211 16789999999998 899999999
Q ss_pred eEEEeCCeeEEEEeecCCCCHHHHHhcCCCC------------------CCCcccHHHHHHHHHHHHHHHHHhhcCCCCC
Q 043524 87 GCCLETPIAILVFEYVQHGTLWDRILGAPQT------------------HFEPLLLKRRLKDAVDAANALAYLHFGFPRP 148 (314)
Q Consensus 87 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~------------------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~ 148 (314)
+++.+.+.+|+|||||++|+|.+++...... ....+++..++.++.|++.||.||| +++
T Consensus 108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~ 184 (325)
T d1rjba_ 108 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKS 184 (325)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred EEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCC
Confidence 9999999999999999999999999764321 1134788999999999999999999 999
Q ss_pred ceeccCCCCCeeecCCCceEEcccccceecCCCCcc-cccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CC
Q 043524 149 IVFRDFKTSHILFSEENVVKLFDFSLSISIPEGETH-ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GR 226 (314)
Q Consensus 149 i~H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~ 226 (314)
|+||||||+||+++.++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||++ |.
T Consensus 185 IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~ 264 (325)
T d1rjba_ 185 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 264 (325)
T ss_dssp EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCC
Confidence 999999999999999999999999999876544322 2335568999999999999999999999999999999997 89
Q ss_pred CCcccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHH
Q 043524 227 GILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQ 306 (314)
Q Consensus 227 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 306 (314)
.||........ +... ... ...++.+..+++++.+||..||+.||++|||++||++.|.+
T Consensus 265 ~Pf~~~~~~~~----~~~~----~~~-------------~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 265 NPYPGIPVDAN----FYKL----IQN-------------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp CSSTTCCCSHH----HHHH----HHT-------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCCHHHH----HHHH----Hhc-------------CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 99975443221 1111 111 11111111345678999999999999999999999999864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-52 Score=354.26 Aligned_cols=246 Identities=17% Similarity=0.310 Sum_probs=199.4
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeE
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAI 96 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (314)
..+|+|+ +.|+++.. .+++.||||.+...... .++|.+|+++++.++||||++++|++.+++.++
T Consensus 10 ~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~-------------~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~ 75 (258)
T d1k2pa_ 10 KELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMS-------------EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF 75 (258)
T ss_dssp CCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSC-------------HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEE
T ss_pred EEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCC-------------HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceE
Confidence 3488888 77777765 57789999998643211 267899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
+||||+++|++.+.+.... ..++...+..++.|++.||.||| +++|+||||||+||+++.++.+||+|||+++
T Consensus 76 iv~Ey~~~g~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~ 148 (258)
T d1k2pa_ 76 IITEYMANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 148 (258)
T ss_dssp EEEECCTTEEHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCC
T ss_pred EEEEccCCCcHHHhhhccc----cCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhhe
Confidence 9999999999999876654 45788899999999999999999 9999999999999999999999999999998
Q ss_pred ecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhccCCc
Q 043524 177 SIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFEDNRF 255 (314)
Q Consensus 177 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (314)
..............||+.|+|||++....++.++|||||||++|||++ |+.||+.....+ ........ .
T Consensus 149 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~--------~~~~i~~~-~- 218 (258)
T d1k2pa_ 149 YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--------TAEHIAQG-L- 218 (258)
T ss_dssp BCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--------HHHHHHTT-C-
T ss_pred eccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH--------HHHHHHhC-C-
Confidence 765544433445678999999999999999999999999999999998 899987543221 11111110 0
Q ss_pred ccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHH
Q 043524 256 TEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQ 306 (314)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~ 306 (314)
....+...+.++.+|+.+||+.||++|||++||++.|.+
T Consensus 219 ------------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 219 ------------RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp ------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ------------CCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 001111344678999999999999999999999999864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-51 Score=355.05 Aligned_cols=256 Identities=20% Similarity=0.261 Sum_probs=192.6
Q ss_pred ccccccCch-hHHHHHHHhcCC----cccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 16 RTLMIGNGA-SVLQELIASSNG----KYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 16 ~~~~~G~g~-~~~~~~~~~~~g----~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
....+|+|+ +.||++....++ ..||||.+........ .++|.+|+++++.++|||||+++|++.
T Consensus 11 ~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~-----------~~~~~~E~~il~~l~H~nIv~~~g~~~ 79 (283)
T d1mqba_ 11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ-----------RVDFLGEAGIMGQFSHHNIIRLEGVIS 79 (283)
T ss_dssp EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHH-----------HHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHH-----------HHHHHHHHHHHHhcCCCCEeeeeEEEe
Confidence 444688888 778877655444 3699998864432221 156899999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
+.+..++|||||.+|++.+.+.... ..+++..++.++.|++.||.||| +++|+||||||+|||++.++.+||+
T Consensus 80 ~~~~~~~v~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~ 152 (283)
T d1mqba_ 80 KYKPMMIITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVS 152 (283)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEEC
T ss_pred cCCceEEEEEecccCcchhhhhccc----ccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEc
Confidence 9999999999999999999887654 45889999999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCc--ccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHh
Q 043524 171 DFSLSISIPEGET--HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKN 248 (314)
Q Consensus 171 dfg~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (314)
|||+++....... .......||+.|+|||++....++.++|||||||++|||++|..|+....... +....
T Consensus 153 DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~-------~~~~~ 225 (283)
T d1mqba_ 153 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-------EVMKA 225 (283)
T ss_dssp CCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHH
T ss_pred ccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH-------HHHHH
Confidence 9999987644321 12233468999999999999999999999999999999999766553222111 11111
Q ss_pred hhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 249 YFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
. .... .++.+..++..+.+|+..||+.||++|||+.||++.|+++.+.
T Consensus 226 i-~~~~-------------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 226 I-NDGF-------------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp H-HTTC-------------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred H-hccC-------------CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 1 1100 0011113446689999999999999999999999999988654
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-51 Score=353.89 Aligned_cols=256 Identities=21% Similarity=0.245 Sum_probs=189.7
Q ss_pred CcccccccCch-hHHHHHHHhcC---CcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEE
Q 043524 14 GKRTLMIGNGA-SVLQELIASSN---GKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCC 89 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~---g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 89 (314)
+.-...+|+|+ +.|+++.+..+ +..||+|.+........ .+.|.+|++++++++|||||+++|++
T Consensus 9 ~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~-----------~~~~~~E~~~l~~l~HpnIv~l~~~~ 77 (273)
T d1mp8a_ 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV-----------REKFLQEALTMRQFDHPHIVKLIGVI 77 (273)
T ss_dssp EEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHH-----------HHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHH-----------HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 33445688888 77877765443 34688887754322211 26789999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEE
Q 043524 90 LETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKL 169 (314)
Q Consensus 90 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl 169 (314)
. .+.+|+|||||++|++.+++.... .+++...++.++.|++.||.||| +++|+||||||+||+++.++.+||
T Consensus 78 ~-~~~~~iv~E~~~~g~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl 149 (273)
T d1mp8a_ 78 T-ENPVWIIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKL 149 (273)
T ss_dssp C-SSSCEEEEECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEE
T ss_pred e-cCeEEEEEEeccCCcHHhhhhccC----CCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEE
Confidence 5 567899999999999999877654 45889999999999999999999 999999999999999999999999
Q ss_pred cccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHh
Q 043524 170 FDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKN 248 (314)
Q Consensus 170 ~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 248 (314)
+|||+++..............||+.|+|||++....++.++|||||||++|||++ |.+||....... ....
T Consensus 150 ~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~--------~~~~ 221 (273)
T d1mp8a_ 150 GDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--------VIGR 221 (273)
T ss_dssp CC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HHHH
T ss_pred ccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH--------HHHH
Confidence 9999998765544433445678999999999999999999999999999999998 888987544322 0111
Q ss_pred hhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 249 YFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
.... .. .+.+..++.++.+||.+||+.||++|||+.||++.|+++.+.
T Consensus 222 i~~~-~~-------------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 222 IENG-ER-------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp HHTT-CC-------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHcC-CC-------------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 1111 00 011113456789999999999999999999999999988654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=356.90 Aligned_cols=248 Identities=16% Similarity=0.221 Sum_probs=203.2
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|.-...+|+|+ +.|+++.+..+|+.||+|++....... ..+.+|+++|..++|||||++++++.
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~-------------~~~~~Ei~il~~l~HpnIv~~~~~~~ 71 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-------------VLVKKEISILNIARHRNILHLHESFE 71 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHH-------------HHHHHHHHHHHHSCCTTBCCEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccH-------------HHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 4455556789988 899999999999999999997654322 35779999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCC--CceE
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEE--NVVK 168 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~--~~~k 168 (314)
+++.+|+|||||++|+|.+.+.... ..++..+++.++.||+.||.||| +++|+||||||+||+++.+ ..++
T Consensus 72 ~~~~~~lvmE~~~gg~L~~~i~~~~----~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ik 144 (321)
T d1tkia_ 72 SMEELVMIFEFISGLDIFERINTSA----FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIK 144 (321)
T ss_dssp ETTEEEEEECCCCCCBHHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEE
T ss_pred ECCEEEEEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEE
Confidence 9999999999999999999997654 35899999999999999999999 9999999999999999854 4799
Q ss_pred EcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHh
Q 043524 169 LFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKN 248 (314)
Q Consensus 169 l~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (314)
++|||+++...... ......+|+.|+|||.+.+..++.++||||+||++|+|++|..||....... ....
T Consensus 145 l~DFG~~~~~~~~~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~--------~~~~ 214 (321)
T d1tkia_ 145 IIEFGQARQLKPGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ--------IIEN 214 (321)
T ss_dssp ECCCTTCEECCTTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHH
T ss_pred EcccchhhccccCC--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH--------HHHH
Confidence 99999998764433 2445678999999999999899999999999999999999999996433211 1111
Q ss_pred hhccCCcccccChhhhccCCc--hhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 249 YFEDNRFTEIVDPIIVQDLSC--TEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
+....... ......+.++.+|+..||..||++|||+.|+++
T Consensus 215 -------------i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 215 -------------IMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp -------------HHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -------------HHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111111 111234567899999999999999999999987
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.2e-50 Score=358.26 Aligned_cols=246 Identities=16% Similarity=0.248 Sum_probs=204.4
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
+|.....+|+|+ +.|+++.+..+|+.||+|++.+........ .+.+.+|+++|+.++|||||++++++.+
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~---------~~~~~~E~~il~~l~hpnIv~~~~~~~~ 112 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ---------IEHTLNEKRILQAVNFPFLVKLEFSFKD 112 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTC---------HHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHH---------HHHHHHHHHHHHHcCCCcEeeccccccc
Confidence 455566799999 899999999999999999998766544321 2678999999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
....++|+||+.+|+|.+.+.... .++...++.++.||+.||.||| +++|+||||||+|||++.++.+||+|
T Consensus 113 ~~~~~~v~e~~~~g~l~~~l~~~~-----~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~D 184 (350)
T d1rdqe_ 113 NSNLYMVMEYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTD 184 (350)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECC
T ss_pred ccccccccccccccchhhhHhhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeee
Confidence 999999999999999999987653 4889999999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhc
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFE 251 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (314)
||+++..... .....||+.|+|||++.+..++.++||||+||++|+|++|+.||...... ......
T Consensus 185 FG~a~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--------~~~~~i-- 250 (350)
T d1rdqe_ 185 FGFAKRVKGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI--------QIYEKI-- 250 (350)
T ss_dssp CTTCEECSSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHH--
T ss_pred ceeeeecccc----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH--------HHHHHH--
Confidence 9999876433 33568999999999999999999999999999999999999999643211 111111
Q ss_pred cCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCC-----CHHHHHH
Q 043524 252 DNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRP-----TMVDVAR 302 (314)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 302 (314)
..+....+ ...+.++.+|+.+||+.||++|+ |++|+++
T Consensus 251 -----------~~~~~~~p--~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 251 -----------VSGKVRFP--SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -----------HHCCCCCC--TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -----------hcCCCCCC--ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 11111111 13456789999999999999994 8999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=352.97 Aligned_cols=250 Identities=17% Similarity=0.242 Sum_probs=198.3
Q ss_pred hhcCcccc-cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhc-CCCCceeeeEe
Q 043524 11 WSKGKRTL-MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQ-MSHDHILKLIG 87 (314)
Q Consensus 11 ~~~~~~~~-~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~ 87 (314)
..+|.... .+|+|+ +.|+++.+..+|+.||+|++... ..+.+|+.++.+ .+|||||++++
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----------------~~~~~E~~~~~~~~~hpnIv~l~~ 72 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----------------PKARREVELHWRASQCPHIVRIVD 72 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----------------HHHHHHHHHHHHHTTSTTBCCEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----------------HHHHHHHHHHHHhcCCCCCCeEEE
Confidence 34454432 589888 88999999999999999998532 345689988765 48999999999
Q ss_pred EEEe----CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecC
Q 043524 88 CCLE----TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSE 163 (314)
Q Consensus 88 ~~~~----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~ 163 (314)
+|.+ ...+|+|||||++|+|.+++...+. ..+++..++.++.|++.||.||| +++|+||||||+||+++.
T Consensus 73 ~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~---~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~ 146 (335)
T d2ozaa1 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTS 146 (335)
T ss_dssp EEEEEETTEEEEEEEEECCCSEEHHHHHHSCSC---CCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESC
T ss_pred EEeecccCCCEEEEEEECCCCCcHHHHHHhcCC---CCcCHHHHHHHHHHHHHHHHHHH---HcCCcccccccccccccc
Confidence 9976 4678999999999999999986532 46899999999999999999999 999999999999999985
Q ss_pred ---CCceEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCcccccc
Q 043524 164 ---ENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVY 240 (314)
Q Consensus 164 ---~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~ 240 (314)
.+.+||+|||+++....... .....||+.|+|||++.+..|+.++||||+||++|+|++|+.||..........
T Consensus 147 ~~~~~~~Kl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~- 223 (335)
T d2ozaa1 147 KRPNAILKLTDFGFAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP- 223 (335)
T ss_dssp SSTTCCEEECCCTTCEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----
T ss_pred ccccccccccccceeeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH-
Confidence 45799999999987654432 446689999999999999899999999999999999999999997544322000
Q ss_pred chHHHHHhhhccCCcccccChhhhc--cCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 241 PFNEYLKNYFEDNRFTEIVDPIIVQ--DLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.+....... ..+.+.....++++.+||.+||+.||++|||+.|+++
T Consensus 224 ----------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 224 ----------------GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp --------------------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ----------------HHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 000001111 1122233356788999999999999999999999986
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.4e-50 Score=350.31 Aligned_cols=260 Identities=22% Similarity=0.310 Sum_probs=198.8
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
|.....+|+|+ +.||++.+..+|+.||+|++......... ..+++.+|+++++.++|||||++++++...
T Consensus 9 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~---------~~~~~~~E~~~l~~~~hpniv~~~~~~~~~ 79 (277)
T d1o6ya_ 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPS---------FYLRFRREAQNAAALNHPAIVAVYDTGEAE 79 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHH---------HHHHHHHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred eEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHH---------HHHHHHHHHHHHHhcCCCCCCcccceeeec
Confidence 44455689888 89999999999999999998654321111 225788999999999999999999999865
Q ss_pred C----eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceE
Q 043524 93 P----IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVK 168 (314)
Q Consensus 93 ~----~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~k 168 (314)
+ .+|+|||||++++|.+.+.... ++++..++.++.|++.||.||| +++|+||||||+||+++.++..+
T Consensus 80 ~~~~~~~~lvmE~~~g~~L~~~~~~~~-----~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~ 151 (277)
T d1o6ya_ 80 TPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVK 151 (277)
T ss_dssp CSSSEEEEEEEECCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEE
T ss_pred cCCCceEEEEEECCCCCEehhhhcccC-----CCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccce
Confidence 4 3899999999999998887643 5889999999999999999999 99999999999999999999999
Q ss_pred EcccccceecCCCCc--ccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHH
Q 043524 169 LFDFSLSISIPEGET--HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYL 246 (314)
Q Consensus 169 l~dfg~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 246 (314)
++|||.++....... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||......+ ..
T Consensus 152 l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--------~~ 223 (277)
T d1o6ya_ 152 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS--------VA 223 (277)
T ss_dssp ECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HH
T ss_pred eehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH--------HH
Confidence 999999876543321 22345679999999999998889999999999999999999999997433211 11
Q ss_pred HhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCC-CHHHHHHHHHHHHh
Q 043524 247 KNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRP-TMVDVARRLRQICC 309 (314)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-s~~ell~~L~~~~~ 309 (314)
........ ..+. ......++++.+|+.+||+.||++|| |+++++..|.++..
T Consensus 224 ~~~~~~~~----~~~~-------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 224 YQHVREDP----IPPS-------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp HHHHHCCC----CCGG-------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred HHHHhcCC----CCCc-------hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 11111100 0000 00113456789999999999999999 89999999998864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1e-49 Score=356.87 Aligned_cols=251 Identities=16% Similarity=0.195 Sum_probs=197.2
Q ss_pred cccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCC
Q 043524 15 KRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETP 93 (314)
Q Consensus 15 ~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (314)
.....+|.|+ +.|+++.+..+|+.||+|++.+......... .......+|+++++.++|||||++++++.+++
T Consensus 7 ~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~------~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~ 80 (364)
T d1omwa3 7 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE------TLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 80 (364)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCH------HHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred eeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHH------HHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC
Confidence 3344688888 8899999999999999999987765433211 00112234577778888999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccc
Q 043524 94 IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFS 173 (314)
Q Consensus 94 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg 173 (314)
.+|+|||||++|+|.+++.... .++...+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFG 152 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLG 152 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCT
T ss_pred EEEEEEEecCCCcHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeec
Confidence 9999999999999999997643 4788999999999999999999 9999999999999999999999999999
Q ss_pred cceecCCCCcccccccccccccccCccccc-CCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhcc
Q 043524 174 LSISIPEGETHITDTVMGTYGHLAPQYVTT-CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFED 252 (314)
Q Consensus 174 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (314)
+|+...... .....||+.|+|||++.. ..|+.++||||+||++|+|++|+.||....... ........
T Consensus 153 la~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----~~~~~~~~--- 221 (364)
T d1omwa3 153 LACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KHEIDRMT--- 221 (364)
T ss_dssp TCEECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC-----HHHHHHHS---
T ss_pred eeeecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhc---
Confidence 998765432 345689999999999875 458999999999999999999999997543322 00111000
Q ss_pred CCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCC-----HHHHHH
Q 043524 253 NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPT-----MVDVAR 302 (314)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps-----~~ell~ 302 (314)
...+... +...++++.+||..||+.||++||| |+|+++
T Consensus 222 ----------~~~~~~~--~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 222 ----------LTMAVEL--PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp ----------SSCCCCC--CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ----------ccCCCCC--CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 0000000 1134567899999999999999999 788875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.8e-50 Score=345.19 Aligned_cols=258 Identities=22% Similarity=0.296 Sum_probs=201.7
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC-CCceeeeEeEEE
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS-HDHILKLIGCCL 90 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 90 (314)
+|.....||+|+ +.|+++.+..+|+.||+|++.+...... .........+.+.+|+.+++.++ |||||++++++.
T Consensus 4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~---~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 80 (277)
T d1phka_ 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSF---SAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 80 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTC---CHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccch---hHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence 444556689888 8899998889999999999865421000 00000012367899999999997 999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
+++.+|+|||||++|+|.+++... .++++..++.++.||+.||.||| +++|+||||||+||+++.++.+||+
T Consensus 81 ~~~~~~ivmE~~~~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~ 152 (277)
T d1phka_ 81 TNTFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLT 152 (277)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred cCcceEEEEEcCCCchHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEc
Confidence 999999999999999999999764 35899999999999999999999 9999999999999999999999999
Q ss_pred ccccceecCCCCcccccccccccccccCccccc------CCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHH
Q 043524 171 DFSLSISIPEGETHITDTVMGTYGHLAPQYVTT------CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNE 244 (314)
Q Consensus 171 dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 244 (314)
|||+++....... .....||+.|+|||.+.. ..++.++||||+||++|+|++|+.||.......
T Consensus 153 DFG~a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-------- 222 (277)
T d1phka_ 153 DFGFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-------- 222 (277)
T ss_dssp CCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------
T ss_pred cchheeEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH--------
Confidence 9999988754332 345679999999998853 346889999999999999999999997543211
Q ss_pred HHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 245 YLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
........ ... .+.+.....++++.+|+.+||+.||++|||+.|+++
T Consensus 223 ~~~~i~~~-~~~----------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 223 MLRMIMSG-NYQ----------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHHHHHT-CCC----------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHhC-CCC----------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11111111 000 011111245677999999999999999999999875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-50 Score=350.38 Aligned_cols=265 Identities=16% Similarity=0.192 Sum_probs=193.2
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCCeeE
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETPIAI 96 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (314)
..+|+|+ +.|+++.+..+|+.||+|++........... ..+.+.+|+.+++.++|||||++++++.+++.+|
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~-------~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ 76 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDG-------INRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 76 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC-------------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHH-------HHHHHHHHHHHHHhCCCCCEeEEEeeeccCCcee
Confidence 4688888 8899999999999999999876543322211 1256889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
+|||||.++++....... ..++...+..++.|++.||.||| +++|+||||||+||+++.++.+||+|||.++
T Consensus 77 ivmE~~~~~~~~~~~~~~-----~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~ 148 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAK 148 (299)
T ss_dssp EEEECCSEEHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred ehhhhhcchHHhhhhhcc-----cCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCcccc
Confidence 999999887776555432 35788899999999999999999 9999999999999999999999999999997
Q ss_pred ecCCCCcccccccccccccccCcccccC-CCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhh--ccC
Q 043524 177 SIPEGETHITDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF--EDN 253 (314)
Q Consensus 177 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~ 253 (314)
....... ......||+.|+|||++... .++.++||||+||++|||++|..||......+. +........ ...
T Consensus 149 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~----l~~i~~~~~~~~~~ 223 (299)
T d1ua2a_ 149 SFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ----LTRIFETLGTPTEE 223 (299)
T ss_dssp TTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHHHCCCCTT
T ss_pred ccCCCcc-cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH----HHHHHHhcCCCChh
Confidence 7644322 23456799999999988755 579999999999999999999999975433221 011110000 000
Q ss_pred CcccccC---hh-hhccCCchh---HHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 254 RFTEIVD---PI-IVQDLSCTE---KEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 254 ~~~~~~~---~~-~~~~~~~~~---~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.+..... .. .......+. ....++++.+|+.+||+.||++||||+|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 224 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0000000 00 000000000 0123567899999999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-50 Score=352.89 Aligned_cols=257 Identities=18% Similarity=0.273 Sum_probs=195.8
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcc----cccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKY----IPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLI 86 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~----~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 86 (314)
..|+....+|+|+ +.|+++....+|+. ||+|.+....... ..++|.+|++++++++|||||+++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~~E~~~l~~l~HpnIv~l~ 77 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-----------ANKEILDEAYVMASVDNPHVCRLL 77 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----C-----------THHHHHHHHHHHHHCCCTTBCCEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHH-----------HHHHHHHHHHHHHhCCCCCEeeEE
Confidence 3466667899998 88888888878875 5666554221111 126789999999999999999999
Q ss_pred eEEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCc
Q 043524 87 GCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENV 166 (314)
Q Consensus 87 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~ 166 (314)
|+|.++ ..++++||+.+|+|.+.+.... ..++...++.++.|++.||.||| +++|+||||||+||+++.++.
T Consensus 78 g~~~~~-~~~~v~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~ 149 (317)
T d1xkka_ 78 GICLTS-TVQLITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 149 (317)
T ss_dssp EEEESS-SEEEEEECCTTCBHHHHHHHTS----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTE
T ss_pred EEEecC-CeeEEEEeccCCcccccccccc----cCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCC
Confidence 999765 5678889999999999887754 46889999999999999999999 999999999999999999999
Q ss_pred eEEcccccceecCCCCcc-cccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHH
Q 043524 167 VKLFDFSLSISIPEGETH-ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNE 244 (314)
Q Consensus 167 ~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~ 244 (314)
+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+| |..||+...... ...
T Consensus 150 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~-----~~~ 224 (317)
T d1xkka_ 150 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----ISS 224 (317)
T ss_dssp EEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG-----HHH
T ss_pred eEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH-----HHH
Confidence 999999999876543322 2334468999999999999999999999999999999998 788886543221 111
Q ss_pred HHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHh
Q 043524 245 YLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICC 309 (314)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 309 (314)
.+. . ...++.+..++..+.+|+.+||+.||++|||+.||++.|.++.+
T Consensus 225 ~i~----~-------------~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 225 ILE----K-------------GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp HHH----H-------------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHH----c-------------CCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 111 0 00011111445678999999999999999999999999988754
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=351.01 Aligned_cols=245 Identities=19% Similarity=0.295 Sum_probs=198.3
Q ss_pred cccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHh-cCCCCceeeeEeEEEeCCe
Q 043524 17 TLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAA-QMSHDHILKLIGCCLETPI 94 (314)
Q Consensus 17 ~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~ 94 (314)
...+|+|+ ++|+++.+..+|+.||+|++.+........ .+.+..|+.++. .++|||||++++++.+++.
T Consensus 7 ~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~---------~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~ 77 (320)
T d1xjda_ 7 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD---------VECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 77 (320)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTC---------HHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred eeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHH---------HHHHHHHHHHHHHhCCCCcEEEEEEEEccCCc
Confidence 34588888 889999999999999999998765433221 155677777765 6899999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccccc
Q 043524 95 AILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSL 174 (314)
Q Consensus 95 ~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~ 174 (314)
+|+|||||++|+|.+++.... .++...+..++.||+.||.||| +++|+||||||+|||++..+.+||+|||+
T Consensus 78 ~yivmEy~~~g~L~~~i~~~~-----~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~ 149 (320)
T d1xjda_ 78 LFFVMEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGM 149 (320)
T ss_dssp EEEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred eeEEEeecCCCcHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccch
Confidence 999999999999999997653 4788999999999999999999 99999999999999999999999999999
Q ss_pred ceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhccCC
Q 043524 175 SISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFEDNR 254 (314)
Q Consensus 175 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (314)
++...... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+..... .....
T Consensus 150 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~--------~~~~i----- 215 (320)
T d1xjda_ 150 CKENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--------LFHSI----- 215 (320)
T ss_dssp CBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHH-----
T ss_pred hhhccccc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH--------HHHHH-----
Confidence 98654332 22445689999999999999999999999999999999999999997433211 11111
Q ss_pred cccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHH-HHHH
Q 043524 255 FTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMV-DVAR 302 (314)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~-ell~ 302 (314)
..+....+ ...+.++.+|+.+||+.||++|||+. |+++
T Consensus 216 --------~~~~~~~p--~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 216 --------RMDNPFYP--RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp --------HHCCCCCC--TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --------HcCCCCCC--ccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11111111 13456789999999999999999985 6753
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-50 Score=344.58 Aligned_cols=254 Identities=23% Similarity=0.368 Sum_probs=189.1
Q ss_pred ccccccCch-hHHHHHHHh-cCC--cccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 16 RTLMIGNGA-SVLQELIAS-SNG--KYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 16 ~~~~~G~g~-~~~~~~~~~-~~g--~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
-...+|+|+ +.|+++... .++ ..||+|++......... ..++|.+|+++|+.++|||||+++|++.+
T Consensus 12 ~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~---------~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~ 82 (273)
T d1u46a_ 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE---------AMDDFIREVNAMHSLDHRNLIRLYGVVLT 82 (273)
T ss_dssp EEEECC----CCCEEEEEECTTSCEEEEEEEC--------CH---------HHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred EEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHH---------HHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 344588888 777777543 333 36899988765432221 22679999999999999999999999965
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
+..++|||||++|++.+.+.... .+++...++.++.|++.||.||| +++|+||||||+||+++.++.+||+|
T Consensus 83 -~~~~lv~e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~D 154 (273)
T d1u46a_ 83 -PPMKMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGD 154 (273)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECC
T ss_pred -cchheeeeeecCcchhhhhhccc----CCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeecc
Confidence 56789999999999998887644 46899999999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCcc--cccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHh
Q 043524 172 FSLSISIPEGETH--ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKN 248 (314)
Q Consensus 172 fg~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 248 (314)
||+++........ ......||..|+|||++.+..++.++||||||+++|||++ |..||......+ ....
T Consensus 155 fGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~--------~~~~ 226 (273)
T d1u46a_ 155 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--------ILHK 226 (273)
T ss_dssp CTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHH
T ss_pred chhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH--------HHHH
Confidence 9999887554322 1233467889999999999889999999999999999998 899986433211 1111
Q ss_pred hhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHH
Q 043524 249 YFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQI 307 (314)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~ 307 (314)
..... ..++.+...+..+.+|+.+||+.||++||||.||++.|+++
T Consensus 227 i~~~~-------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 227 IDKEG-------------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHTSC-------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhCC-------------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11111 11111113446789999999999999999999999999875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-50 Score=348.71 Aligned_cols=256 Identities=21% Similarity=0.267 Sum_probs=192.4
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
+++....+|+|+ +.|+++... +++.||+|++...... .+.|.+|+.++.+++|||||+++|++.
T Consensus 18 ~~~i~~~iG~G~fg~Vy~~~~~-~~~~vAiK~l~~~~~~-------------~~~~~~E~~~l~~l~h~nIv~~~g~~~- 82 (285)
T d1fmka3 18 SLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMS-------------PEAFLQEAQVMKKLRHEKLVQLYAVVS- 82 (285)
T ss_dssp GEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTSSC-------------HHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred HEEEeeEEeeCCCeEEEEEEEC-CCCEEEEEEECcccCC-------------HHHHHHHHHHHHhcccCCEeEEEEEEe-
Confidence 344555688888 778877654 4567999998643211 157899999999999999999999985
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
.+..|+|||||++|+|...+..... ..+++..++.++.|++.||.||| +++|+||||||+||+++.++.+||+|
T Consensus 83 ~~~~~lv~Ey~~~g~l~~~~~~~~~---~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~D 156 (285)
T d1fmka3 83 EEPIYIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVAD 156 (285)
T ss_dssp SSSCEEEECCCTTCBHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECC
T ss_pred cCCeEEEEEecCCCchhhhhhhccc---ccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcc
Confidence 5668999999999999888865321 34789999999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhc
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFE 251 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (314)
||+++..............||+.|+|||++....++.++|||||||++|||++|..|+....... +.......
T Consensus 157 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~-------~~~~~i~~ 229 (285)
T d1fmka3 157 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-------EVLDQVER 229 (285)
T ss_dssp CCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHT
T ss_pred cchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH-------HHHHHHHh
Confidence 99998765444333445678999999999999999999999999999999999766653322111 11111111
Q ss_pred cCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 252 DNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
. . ..+.+..+++++.+|+.+||+.||++|||+.+|++.|++...+
T Consensus 230 ~-~-------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 230 G-Y-------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp T-C-------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred c-C-------------CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 0 0 0011113456789999999999999999999999999876644
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-50 Score=343.51 Aligned_cols=243 Identities=23% Similarity=0.311 Sum_probs=186.5
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe-CCeeE
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE-TPIAI 96 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~ 96 (314)
.+|+|+ +.|+++.. .|+.||||++..... .+++.+|++++++++||||++++|++.+ .+.+|
T Consensus 14 ~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~--------------~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 77 (262)
T d1byga_ 14 TIGKGEFGDVMLGDY--RGNKVAVKCIKNDAT--------------AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 77 (262)
T ss_dssp EEEECSSCEEEEEEE--TTEEEEEEECCCCC----------------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred EEecCCCeEEEEEEE--CCeEEEEEEECcHHH--------------HHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEE
Confidence 377777 67777654 578999999864321 2678999999999999999999999865 46789
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccccce
Q 043524 97 LVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFSLSI 176 (314)
Q Consensus 97 iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~ 176 (314)
+||||+++|+|.+++..... ..+++..++.++.|++.||.||| +++|+||||||+||+++.++.++++|||+++
T Consensus 78 lv~ey~~~g~L~~~l~~~~~---~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~ 151 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 151 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred EEEeccCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccce
Confidence 99999999999999865431 35789999999999999999999 9999999999999999999999999999997
Q ss_pred ecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCcccccCccccccchHHHHHhhhccCCc
Q 043524 177 SIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVRDAHDLVYPFNEYLKNYFEDNRF 255 (314)
Q Consensus 177 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (314)
..... .....+|..|+|||++.+..++.++|||||||++|||++ |+.||....... ........ .
T Consensus 152 ~~~~~----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~--------~~~~i~~~-~- 217 (262)
T d1byga_ 152 EASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPRVEKG-Y- 217 (262)
T ss_dssp --------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--------HHHHHTTT-C-
T ss_pred ecCCC----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH--------HHHHHHcC-C-
Confidence 65432 234567899999999998899999999999999999998 687876433221 11111100 0
Q ss_pred ccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHh
Q 043524 256 TEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICC 309 (314)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 309 (314)
..+. +...+.++.+|+.+||+.||++||||.++++.|+++..
T Consensus 218 --------~~~~----~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 218 --------KMDA----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp --------CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------CCCC----CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 0011 11334568899999999999999999999999999865
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=347.07 Aligned_cols=262 Identities=20% Similarity=0.279 Sum_probs=200.2
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcc--cccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEe
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKY--IPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIG 87 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~--~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~ 87 (314)
..++-...+|+|+ +.|+++....+|.. ||||.+........ .++|.+|+++|..+ +|||||++++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~~E~~~l~~l~~HpnIv~~~~ 78 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD-----------HRDFAGELEVLCKLGHHPNIINLLG 78 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-----------------CHHHHHHHHHTTCCCCTTBCCEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHH-----------HHHHHHHHHHHHhccCCCCEeeEEE
Confidence 3444455699998 88888888888874 66666543222111 15789999999998 7999999999
Q ss_pred EEEeCCeeEEEEeecCCCCHHHHHhcCC-----------CCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCC
Q 043524 88 CCLETPIAILVFEYVQHGTLWDRILGAP-----------QTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKT 156 (314)
Q Consensus 88 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~-----------~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~ 156 (314)
++.+++.+++|||||++|+|.+++.... ......+++..+..++.|++.||.|+| +++|+||||||
T Consensus 79 ~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp 155 (309)
T d1fvra_ 79 ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAA 155 (309)
T ss_dssp EEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSG
T ss_pred EEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCcccccccc
Confidence 9999999999999999999999986541 011245889999999999999999999 99999999999
Q ss_pred CCeeecCCCceEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCC-CcccccCc
Q 043524 157 SHILFSEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRG-ILDLVRDA 235 (314)
Q Consensus 157 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~-p~~~~~~~ 235 (314)
+|||++.++.+||+|||+++....... .....||..|+|||.+....++.++|||||||++|||++|.. ||.....
T Consensus 156 ~NIL~~~~~~~kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~- 232 (309)
T d1fvra_ 156 RNILVGENYVAKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC- 232 (309)
T ss_dssp GGEEECGGGCEEECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-
T ss_pred ceEEEcCCCceEEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH-
Confidence 999999999999999999976533221 334568999999999999899999999999999999999764 5643221
Q ss_pred cccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhc
Q 043524 236 HDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSL 311 (314)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 311 (314)
.+......... .+..+...++++.+||.+||+.||++|||++||++.|+++.+..
T Consensus 233 -------~~~~~~i~~~~--------------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 233 -------AELYEKLPQGY--------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp -------HHHHHHGGGTC--------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred -------HHHHHHHHhcC--------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 11111111100 00111134567899999999999999999999999999987654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-49 Score=346.15 Aligned_cols=264 Identities=20% Similarity=0.323 Sum_probs=192.6
Q ss_pred hcCcccccccCch-hHHHHHHHh-----cCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceee
Q 043524 12 SKGKRTLMIGNGA-SVLQELIAS-----SNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILK 84 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~-----~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 84 (314)
.++.-...+|+|+ +.|+++... .+++.||+|.+........ .+.+.+|+..+.++ +|+|||.
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~-----------~~~~~~e~~~l~~~~~h~~iv~ 81 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-----------HRALMSELKILIHIGHHLNVVN 81 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHH-----------HHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHH-----------HHHHHHHHHHHHhhcCCCeEEE
Confidence 3455556788888 777776543 3556899998865432222 15678888888877 5899999
Q ss_pred eEeEEEeC-CeeEEEEeecCCCCHHHHHhcCCCC-----------CCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceec
Q 043524 85 LIGCCLET-PIAILVFEYVQHGTLWDRILGAPQT-----------HFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFR 152 (314)
Q Consensus 85 ~~~~~~~~-~~~~iv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~ 152 (314)
+++++... ..+++|||||++|+|.+++...... ....+++..++.++.|++.||.||| +++|+||
T Consensus 82 ~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHr 158 (299)
T d1ywna1 82 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHR 158 (299)
T ss_dssp EEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred eeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCC
Confidence 99998764 5689999999999999999754210 1134788999999999999999999 9999999
Q ss_pred cCCCCCeeecCCCceEEcccccceecCCCCcc-cccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCC-CCcc
Q 043524 153 DFKTSHILFSEENVVKLFDFSLSISIPEGETH-ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR-GILD 230 (314)
Q Consensus 153 dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~-~p~~ 230 (314)
||||+|||++.++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||++|. +||.
T Consensus 159 DlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~ 238 (299)
T d1ywna1 159 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 238 (299)
T ss_dssp CCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999876443222 234567999999999999999999999999999999999864 5775
Q ss_pred cccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 231 LVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
....... +... ..... .+..+...++++.+|+.+||+.||++|||+.|+++.|+++.++
T Consensus 239 ~~~~~~~----~~~~----~~~~~-------------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 239 GVKIDEE----FCRR----LKEGT-------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp TCCCSHH----HHHH----HHHTC-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCHHHH----HHHH----HhcCC-------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 4332211 1111 11100 0011113445689999999999999999999999999998764
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-49 Score=346.83 Aligned_cols=259 Identities=22% Similarity=0.305 Sum_probs=199.4
Q ss_pred cccccccCch-hHHHHHHHh-----cCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeE
Q 043524 15 KRTLMIGNGA-SVLQELIAS-----SNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGC 88 (314)
Q Consensus 15 ~~~~~~G~g~-~~~~~~~~~-----~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 88 (314)
.-...+|+|+ +.||++... .+++.||||++........ .++|.+|+.+++.++||||++++++
T Consensus 16 ~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~-----------~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 16 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM-----------QADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp EEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHH-----------HHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred EEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHH-----------HHHHHHHHHHHHhcCCCCcccceee
Confidence 3344588888 778777543 4567899999865432221 2678999999999999999999999
Q ss_pred EEeCCeeEEEEeecCCCCHHHHHhcCCC-------------------CCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCc
Q 043524 89 CLETPIAILVFEYVQHGTLWDRILGAPQ-------------------THFEPLLLKRRLKDAVDAANALAYLHFGFPRPI 149 (314)
Q Consensus 89 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~-------------------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i 149 (314)
+.+++..+++|||+++|+|.+++..... .....++...++.++.|++.||+||| +++|
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCe
Confidence 9999999999999999999999864321 11134788899999999999999999 9999
Q ss_pred eeccCCCCCeeecCCCceEEcccccceecCCCCc-ccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCC-C
Q 043524 150 VFRDFKTSHILFSEENVVKLFDFSLSISIPEGET-HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR-G 227 (314)
Q Consensus 150 ~H~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~-~ 227 (314)
+||||||+|||++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||++|. +
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 9999999999999999999999999986643322 2233457889999999999999999999999999999999985 5
Q ss_pred CcccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHH
Q 043524 228 ILDLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQI 307 (314)
Q Consensus 228 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~ 307 (314)
||......+ .... ....... ..+...+.++.+|+..||+.||++||||.||++.|+++
T Consensus 242 p~~~~~~~e--------~~~~-v~~~~~~-------------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 242 PYYGMAHEE--------VIYY-VRDGNIL-------------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TTTTSCHHH--------HHHH-HHTTCCC-------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCCCHHH--------HHHH-HHcCCCC-------------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 665433211 1111 1111110 01113445688999999999999999999999999988
Q ss_pred Hh
Q 043524 308 CC 309 (314)
Q Consensus 308 ~~ 309 (314)
.+
T Consensus 300 ~~ 301 (301)
T d1lufa_ 300 CE 301 (301)
T ss_dssp TC
T ss_pred cC
Confidence 63
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-49 Score=343.70 Aligned_cols=267 Identities=17% Similarity=0.247 Sum_probs=195.8
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
|+....+|+|+ +.|+++.+..+|+.||+|++........ ..+++.+|+++|++++|||||++++++.++
T Consensus 4 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~----------~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~ 73 (298)
T d1gz8a_ 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG----------VPSTAIREISLLKELNHPNIVKLLDVIHTE 73 (298)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-----------------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred CEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChH----------HHHHHHHHHHHHHhCCCCcEEEeccccccc
Confidence 44455689888 9999999999999999999975432211 126789999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~df 172 (314)
+.+|+|||||.+ ++.+.+..... ..+++..+..++.|++.||.||| +++|+||||||+||+++.++.+|++||
T Consensus 74 ~~~~iv~e~~~~-~~~~~~~~~~~---~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DF 146 (298)
T d1gz8a_ 74 NKLYLVFEFLHQ-DLKKFMDASAL---TGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 146 (298)
T ss_dssp TEEEEEEECCSE-EHHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECST
T ss_pred cceeEEEeecCC-chhhhhhhhcc---cCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccC
Confidence 999999999965 44444433321 45899999999999999999999 999999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCcccccCC-CCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhc
Q 043524 173 SLSISIPEGETHITDTVMGTYGHLAPQYVTTCD-FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFE 251 (314)
Q Consensus 173 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (314)
|.|+...... .......||+.|+|||++.... ++.++||||+||++|+|++|+.||........ +.........
T Consensus 147 G~a~~~~~~~-~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~----~~~i~~~~~~ 221 (298)
T d1gz8a_ 147 GLARAFGVPV-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ----LFRIFRTLGT 221 (298)
T ss_dssp THHHHHCCCS-BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHCC
T ss_pred CcceeccCCc-ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH----HHHHHHhcCC
Confidence 9998764432 2345568999999999887766 57899999999999999999999975432110 0111100000
Q ss_pred --cCCccccc---C--hhhhccCCc---hhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 252 --DNRFTEIV---D--PIIVQDLSC---TEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 252 --~~~~~~~~---~--~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
...+.... + ......... ......+.++.+|+.+||..||++|||+.|+++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 222 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp CCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 00000000 0 000000000 000133467899999999999999999999987
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=342.61 Aligned_cols=254 Identities=20% Similarity=0.289 Sum_probs=195.9
Q ss_pred cccCch-hHHHHHHHhcCC---cccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe-CC
Q 043524 19 MIGNGA-SVLQELIASSNG---KYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE-TP 93 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g---~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~ 93 (314)
.+|+|+ +.||++....++ ..||||.+....... ..++|.+|+++|++++|||||+++|++.+ ++
T Consensus 34 ~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~-----------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 102 (311)
T d1r0pa_ 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-----------EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 102 (311)
T ss_dssp EEEEETTEEEEEEEECC----CEEEEEEEECCCCCHH-----------HHHHHHHHHHHHHTCCCTTBCCCCEEEEETTT
T ss_pred EEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHH-----------HHHHHHHHHHHHHhCCCCCEeEEeEEEEecCC
Confidence 478888 777776554432 368999875321111 12679999999999999999999999876 56
Q ss_pred eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcccc
Q 043524 94 IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDFS 173 (314)
Q Consensus 94 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~dfg 173 (314)
..++|||||++|+|.+++.... ...+...++.++.|++.||.|+| +++|+||||||+|||++.++.+||+|||
T Consensus 103 ~~~lv~E~~~~g~l~~~~~~~~----~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG 175 (311)
T d1r0pa_ 103 SPLVVLPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFG 175 (311)
T ss_dssp EEEEEEECCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSG
T ss_pred ceEEEEEEeecCchhhhhcccc----ccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEeccc
Confidence 8999999999999999887654 35678889999999999999999 9999999999999999999999999999
Q ss_pred cceecCCCCcc---cccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhh
Q 043524 174 LSISIPEGETH---ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 174 ~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
+++........ ......||+.|+|||.+....++.++||||||+++|||++|+.||.......+. .....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~-------~~~i~ 248 (311)
T d1r0pa_ 176 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-------TVYLL 248 (311)
T ss_dssp GGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------C-------HHHHH
T ss_pred chhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHH-------HHHHH
Confidence 99876543221 123356899999999999999999999999999999999988887543322211 11111
Q ss_pred ccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhc
Q 043524 251 EDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSL 311 (314)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 311 (314)
.+.. +..+..+++++.+|+.+||+.||++|||+.||++.|+++.++.
T Consensus 249 ~g~~--------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 249 QGRR--------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp TTCC--------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred cCCC--------------CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence 1100 0001134456889999999999999999999999999998753
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=335.43 Aligned_cols=264 Identities=21% Similarity=0.281 Sum_probs=193.2
Q ss_pred cccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeCC----
Q 043524 19 MIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLETP---- 93 (314)
Q Consensus 19 ~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 93 (314)
.+|+|+ +.||++. .+|+.||||+++....... ....|+..+..++|||||++++++.+.+
T Consensus 10 ~iG~G~fg~Vy~~~--~~g~~vAvK~~~~~~~~~~-------------~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~ 74 (303)
T d1vjya_ 10 SIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSW-------------FREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp EEECCSSSEEEEEE--ETTEEEEEEEECGGGHHHH-------------HHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred EEeeCCCeEEEEEE--ECCEEEEEEEECccchhHH-------------HHHHHHHHHhhCCCCcCcceEEEEEeCCCcce
Confidence 478888 7777664 5789999999876543221 1224566667789999999999998654
Q ss_pred eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcC-----CCCCceeccCCCCCeeecCCCceE
Q 043524 94 IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFG-----FPRPIVFRDFKTSHILFSEENVVK 168 (314)
Q Consensus 94 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~-----~~~~i~H~dlk~~nil~~~~~~~k 168 (314)
.+|+|||||++|+|.+++.+. .+++..++.++.|++.|+.|+|.. .+++|+||||||+|||++.++.+|
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~K 148 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 148 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred EEEEEEecccCCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeE
Confidence 589999999999999999763 478899999999999999999921 126999999999999999999999
Q ss_pred EcccccceecCCCCcc---cccccccccccccCcccccCC------CCcccchHHHHHHHHHHHhCCCCcccccCccccc
Q 043524 169 LFDFSLSISIPEGETH---ITDTVMGTYGHLAPQYVTTCD------FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLV 239 (314)
Q Consensus 169 l~dfg~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~------~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~ 239 (314)
|+|||+++........ ......||+.|+|||++.... ++.++|||||||++|||++|..||..........
T Consensus 149 l~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~ 228 (303)
T d1vjya_ 149 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228 (303)
T ss_dssp ECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred EEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccch
Confidence 9999999877554322 133467999999999987643 5678999999999999999998886443322111
Q ss_pred c------chHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 240 Y------PFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 240 ~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
. +.................+.. ..........+.+|+.+||+.||++|||+.||++.|+++.+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~-------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 229 YDLVPSDPSVEEMRKVVCEQKLRPNIPN-------RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCG-------GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhcccccchHHHHHHHHhccccCCCCCc-------ccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 0 111111111111111111111 111124556789999999999999999999999999998764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-49 Score=344.24 Aligned_cols=260 Identities=19% Similarity=0.338 Sum_probs=201.9
Q ss_pred ccccccCch-hHHHHHH-----HhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCceeeeEeE
Q 043524 16 RTLMIGNGA-SVLQELI-----ASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHILKLIGC 88 (314)
Q Consensus 16 ~~~~~G~g~-~~~~~~~-----~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~ 88 (314)
-...+|+|+ +.|+++. +..+++.||||.+........ ..++.+|+.++..+ +|||||+++++
T Consensus 27 l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~-----------~~~~~~E~~~~~~l~~HpnIv~~~g~ 95 (311)
T d1t46a_ 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE-----------REALMSELKVLSYLGNHMNIVNLLGA 95 (311)
T ss_dssp EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHH-----------HHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred EeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHH-----------HHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 344688888 7777664 345677999999875432211 15688999999999 69999999999
Q ss_pred EEeCCeeEEEEeecCCCCHHHHHhcCCCC-------------CCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCC
Q 043524 89 CLETPIAILVFEYVQHGTLWDRILGAPQT-------------HFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFK 155 (314)
Q Consensus 89 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~-------------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk 155 (314)
+.++...|+|||||++|+|.+++...... ....+++..++.++.||+.|+.||| +++++|||||
T Consensus 96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLK 172 (311)
T d1t46a_ 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLA 172 (311)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccc
Confidence 99999999999999999999998764321 1135888999999999999999999 9999999999
Q ss_pred CCCeeecCCCceEEcccccceecCCCCcc-cccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCccccc
Q 043524 156 TSHILFSEENVVKLFDFSLSISIPEGETH-ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGILDLVR 233 (314)
Q Consensus 156 ~~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~ 233 (314)
|+||+++..+.++++|||.++........ ......||+.|+|||++....++.++|||||||++|||++ |.+||....
T Consensus 173 p~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999877554322 2344678999999999998899999999999999999999 555554332
Q ss_pred CccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhh
Q 043524 234 DAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCS 310 (314)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~ 310 (314)
.... +... .. ....+..+...+..+.+||..||+.||++||||.||++.|++...+
T Consensus 253 ~~~~----~~~~----i~-------------~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 253 VDSK----FYKM----IK-------------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp SSHH----HHHH----HH-------------HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHH----HHHH----Hh-------------cCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 2110 0111 11 1111111113456789999999999999999999999999887665
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=340.33 Aligned_cols=262 Identities=20% Similarity=0.319 Sum_probs=200.0
Q ss_pred hcCcccccccCch-hHHHHHHHhcCC-------cccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC-CCCce
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNG-------KYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM-SHDHI 82 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g-------~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni 82 (314)
.++.....+|+|+ +.|+++....++ ..||+|.+........ ..++.+|+..+.++ +||||
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~-----------~~~~~~e~~~l~~~~~HpnI 81 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-----------LSDLISEMEMMKMIGKHKNI 81 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHH-----------HHHHHHHHHHHHHHCCCTTB
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHH-----------HHHHHHHHHHHHHhcCCCeE
Confidence 3444445689988 777777544433 4799999865432222 15688999999888 79999
Q ss_pred eeeEeEEEeCCeeEEEEeecCCCCHHHHHhcCCCC-----------CCCcccHHHHHHHHHHHHHHHHHhhcCCCCCcee
Q 043524 83 LKLIGCCLETPIAILVFEYVQHGTLWDRILGAPQT-----------HFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVF 151 (314)
Q Consensus 83 v~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H 151 (314)
|+++++|.+++..++|||||++|+|.+++...... ....++...++.++.|++.||.||| +++|+|
T Consensus 82 v~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivH 158 (299)
T d1fgka_ 82 INLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIH 158 (299)
T ss_dssp CCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred EecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEe
Confidence 99999999999999999999999999999754321 1235899999999999999999999 999999
Q ss_pred ccCCCCCeeecCCCceEEcccccceecCCCCc-ccccccccccccccCcccccCCCCcccchHHHHHHHHHHHh-CCCCc
Q 043524 152 RDFKTSHILFSEENVVKLFDFSLSISIPEGET-HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLT-GRGIL 229 (314)
Q Consensus 152 ~dlk~~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p~ 229 (314)
|||||+|||++.++.+||+|||+++....... .......+|+.|+|||.+....|+.++||||||+++|||++ |.+||
T Consensus 159 rDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~ 238 (299)
T d1fgka_ 159 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 238 (299)
T ss_dssp SCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred eeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCC
Confidence 99999999999999999999999987654322 22345578999999999999999999999999999999998 68888
Q ss_pred ccccCccccccchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHh
Q 043524 230 DLVRDAHDLVYPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICC 309 (314)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 309 (314)
....... ... ...... .+..+...+..+.+|+.+||+.||++||||.||++.|+++.+
T Consensus 239 ~~~~~~~--------~~~-~i~~~~-------------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 239 PGVPVEE--------LFK-LLKEGH-------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp TTCCHHH--------HHH-HHHTTC-------------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCHHH--------HHH-HHHcCC-------------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 6433211 111 111110 000111344678999999999999999999999999999865
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=342.92 Aligned_cols=244 Identities=16% Similarity=0.221 Sum_probs=193.7
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC--CCceeeeEeEE
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS--HDHILKLIGCC 89 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~ 89 (314)
+|.....+|+|+ +.|+++.+..+|+.||+|++............. ..++.+|+.+++.++ |||||++++++
T Consensus 5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~------~~~~~~E~~il~~l~~~h~nIv~~~~~~ 78 (273)
T d1xwsa_ 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN------GTRVPMEVVLLKKVSSGFSGVIRLLDWF 78 (273)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTT------CCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhH------HHHHHHHHHHHHHhccCCCCccEEEEEE
Confidence 455556789988 899999999999999999987654321111000 133568999999987 89999999999
Q ss_pred EeCCeeEEEEeecCC-CCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecC-CCce
Q 043524 90 LETPIAILVFEYVQH-GTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSE-ENVV 167 (314)
Q Consensus 90 ~~~~~~~iv~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~-~~~~ 167 (314)
.+++..|+||||+.+ +++.+.+... ..++...++.++.|++.||.||| +++|+||||||+||+++. .+.+
T Consensus 79 ~~~~~~~lv~e~~~~~~~l~~~~~~~-----~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~v 150 (273)
T d1xwsa_ 79 ERPDSFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGEL 150 (273)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEE
T ss_pred eeCCeEEEEEEeccCcchHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeE
Confidence 999999999999975 5787777654 35889999999999999999999 999999999999999985 4789
Q ss_pred EEcccccceecCCCCcccccccccccccccCcccccCCC-CcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHH
Q 043524 168 KLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDF-SEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYL 246 (314)
Q Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 246 (314)
||+|||+|+..... ......||+.|+|||++.+..+ +.++||||+||++|+|++|+.||......
T Consensus 151 kl~DFG~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i----------- 216 (273)
T d1xwsa_ 151 KLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI----------- 216 (273)
T ss_dssp EECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-----------
T ss_pred EECccccceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH-----------
Confidence 99999999875433 2346689999999999987775 57789999999999999999999643210
Q ss_pred HhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 247 KNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
..... .++ ...++++.+|+.+||+.||++|||++|+++
T Consensus 217 ---~~~~~---~~~------------~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 217 ---IRGQV---FFR------------QRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ---HHCCC---CCS------------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---hhccc---CCC------------CCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 00000 000 023466899999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-48 Score=337.63 Aligned_cols=268 Identities=18% Similarity=0.210 Sum_probs=191.5
Q ss_pred hcCcccccccCch-hHHHHHHHhcC-CcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcC---CCCceeeeE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSN-GKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQM---SHDHILKLI 86 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~-g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~ 86 (314)
.+|+....+|+|+ ++|+++.+..+ ++.||+|++........ . ...+.+|+.+++.+ +||||++++
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~-------~---~~~~~~E~~~l~~l~~~~HpnIv~~~ 76 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-------M---PLSTIREVAVLRHLETFEHPNVVRLF 76 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-------C---BCTHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch-------H---HHHHHHHHHHHHHHhhcCCCCcceee
Confidence 4555666799998 88888877655 56899999865321110 0 13455677766655 799999999
Q ss_pred eEEEe-----CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeee
Q 043524 87 GCCLE-----TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILF 161 (314)
Q Consensus 87 ~~~~~-----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~ 161 (314)
++|.. ...+++++|||.++++........ ..++...++.++.|++.||+||| +++|+||||||+|||+
T Consensus 77 ~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~----~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi 149 (305)
T d1blxa_ 77 DVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILV 149 (305)
T ss_dssp EEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCT----TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEE
T ss_pred eeecccccccCceEEEEEEeccCCchhhhhhccC----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEE
Confidence 99864 356899999998877655544433 45788999999999999999999 9999999999999999
Q ss_pred cCCCceEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccc
Q 043524 162 SEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYP 241 (314)
Q Consensus 162 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~ 241 (314)
+..+.+||+|||+++..... .......||+.|+|||++.+..|+.++||||+||++|||++|+.||......+.
T Consensus 150 ~~~~~~kl~dfg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---- 223 (305)
T d1blxa_ 150 TSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---- 223 (305)
T ss_dssp CTTCCEEECSCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----
T ss_pred cCCCCeeecchhhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH----
Confidence 99999999999998765332 234567899999999999999999999999999999999999999975432210
Q ss_pred hHHHHHhhhc--cCCccc------ccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 242 FNEYLKNYFE--DNRFTE------IVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 242 ~~~~~~~~~~--~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
+......... ...+.. ..................++.+.+|+.+||+.||++||||.|+++
T Consensus 224 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 224 LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp HHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 1111100000 000000 000000000000011134466889999999999999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=335.81 Aligned_cols=261 Identities=18% Similarity=0.284 Sum_probs=200.5
Q ss_pred cCcccccccCch-hHHHHHHHh-----cCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeE
Q 043524 13 KGKRTLMIGNGA-SVLQELIAS-----SNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLI 86 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~-----~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 86 (314)
++.....+|+|+ +.|+++... .++..||||.+......... ..|.+|++++++++|||||+++
T Consensus 21 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~-----------~~~~~E~~il~~l~h~nIv~~~ 89 (308)
T d1p4oa_ 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER-----------IEFLNEASVMKEFNCHHVVRLL 89 (308)
T ss_dssp GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHH-----------HHHHHHHHHGGGCCCTTBCCEE
T ss_pred HeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHH-----------HHHHHHHHHHHHcCCCCEeeee
Confidence 334445588888 778776554 34578999988644322221 5688999999999999999999
Q ss_pred eEEEeCCeeEEEEeecCCCCHHHHHhcCC-----CCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeee
Q 043524 87 GCCLETPIAILVFEYVQHGTLWDRILGAP-----QTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILF 161 (314)
Q Consensus 87 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~-----~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~ 161 (314)
+++...+..++|||||++|+|.+++.... ......++...+..++.|++.||.||| +++|+||||||+|||+
T Consensus 90 ~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLl 166 (308)
T d1p4oa_ 90 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMV 166 (308)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEE
T ss_pred eEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceee
Confidence 99999999999999999999999886421 111234678899999999999999999 9999999999999999
Q ss_pred cCCCceEEcccccceecCCCCc-ccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCC-CCcccccCccccc
Q 043524 162 SEENVVKLFDFSLSISIPEGET-HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGR-GILDLVRDAHDLV 239 (314)
Q Consensus 162 ~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~-~p~~~~~~~~~~~ 239 (314)
+.++.+||+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||++|. .||......
T Consensus 167 d~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~---- 242 (308)
T d1p4oa_ 167 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---- 242 (308)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH----
T ss_pred cCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH----
Confidence 9999999999999986644322 2233447899999999999999999999999999999999985 666433211
Q ss_pred cchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHh
Q 043524 240 YPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICC 309 (314)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 309 (314)
+......+ ... +..+..++..+.+|+..||+.||++|||+.||++.|++..+
T Consensus 243 ----~~~~~i~~-~~~-------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 243 ----QVLRFVME-GGL-------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp ----HHHHHHHT-TCC-------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ----HHHHHHHh-CCC-------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11111111 110 00111344678999999999999999999999999987543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.1e-47 Score=331.82 Aligned_cols=264 Identities=17% Similarity=0.191 Sum_probs=190.3
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
|.....+|+|+ +.|+++.+ .+|+.||+|++....... . ..+++.+|+.+|+.++|||||++++++.++
T Consensus 4 Y~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~-------~---~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 72 (286)
T d1ob3a_ 4 YHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDE-------G---IPSTTIREISILKELKHSNIVKLYDVIHTK 72 (286)
T ss_dssp EEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGG-------C---CCHHHHHHHHGGGGCCCTTBCCEEEEEECS
T ss_pred ceeccEEecCCCcEEEEEEe-CCCCEEEEEEEehhhcCh-------H---HHHHHHHHHHHHHhCCCCcEEeeeeecccC
Confidence 44455688888 77877755 578999999986543211 0 126789999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEccc
Q 043524 93 PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFDF 172 (314)
Q Consensus 93 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~df 172 (314)
+..++++|++.++.+....... ..++...+..++.|++.||.||| +++|+||||||+||+++.++.+|++||
T Consensus 73 ~~~~i~~e~~~~~~~~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~Df 144 (286)
T d1ob3a_ 73 KRLVLVFEHLDQDLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADF 144 (286)
T ss_dssp SCEEEEEECCSEEHHHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCT
T ss_pred CceeEEEEeehhhhHHHHHhhc-----CCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEeccc
Confidence 9999999999776665554433 45899999999999999999999 999999999999999999999999999
Q ss_pred ccceecCCCCcccccccccccccccCcccccCC-CCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhhc
Q 043524 173 SLSISIPEGETHITDTVMGTYGHLAPQYVTTCD-FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYFE 251 (314)
Q Consensus 173 g~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (314)
|.+........ ......+++.|+|||.+.... ++.++||||+||++|||++|+.||......+. +.........
T Consensus 145 G~a~~~~~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~----~~~i~~~~~~ 219 (286)
T d1ob3a_ 145 GLARAFGIPVR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ----LMRIFRILGT 219 (286)
T ss_dssp THHHHHCC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHCC
T ss_pred ccceecccCcc-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH----HHHHHHhhCC
Confidence 99977644322 234557899999999987654 68999999999999999999999975432211 0110000000
Q ss_pred --cCCcc---------cccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 252 --DNRFT---------EIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 252 --~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
...+. .........+. .......+..+.+|+.+||+.||++||||+|+++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 220 PNSKNWPNVTELPKYDPNFTVYEPLPW-ESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCTTTSTTGGGSTTCCTTCCCCCCCCG-GGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CChhhccchhhhhhcccccccccCcch-hhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 00000000000 0001133467899999999999999999999984
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-46 Score=331.15 Aligned_cols=270 Identities=15% Similarity=0.183 Sum_probs=194.7
Q ss_pred hhhhhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeE
Q 043524 8 FKLWSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLI 86 (314)
Q Consensus 8 ~~~~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 86 (314)
|.+-.+|.....+|+|+ +.|+++.+..+|+.||||++........ .+++++|+.+|.+++|||||+++
T Consensus 4 ~~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~-----------~~~~~~Ei~il~~l~hp~iv~~~ 72 (345)
T d1pmea_ 4 FDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTY-----------CQRTLREIKILLRFRHENIIGIN 72 (345)
T ss_dssp CCCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHH-----------HHHHHHHHHHHHHCCCTTBCCCC
T ss_pred cCcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHH-----------HHHHHHHHHHHHHcCCCCCCcEE
Confidence 34445677777899999 8999999999999999999875432221 15688999999999999999999
Q ss_pred eEEEeCC----eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeec
Q 043524 87 GCCLETP----IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFS 162 (314)
Q Consensus 87 ~~~~~~~----~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~ 162 (314)
+++.... ..+++++|+.+|+|.+++... .++...++.++.|++.||.||| ++||+||||||+|||++
T Consensus 73 ~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~ 143 (345)
T d1pmea_ 73 DIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLN 143 (345)
T ss_dssp EEECCSSTTTCCCEEEEEECCCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEC
T ss_pred EEEeeccccccceEEEEEeecCCchhhhhhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEEC
Confidence 9997643 234455666789999999753 4889999999999999999999 99999999999999999
Q ss_pred CCCceEEcccccceecCCCCc--ccccccccccccccCcccccC-CCCcccchHHHHHHHHHHHhCCCCcccccCccccc
Q 043524 163 EENVVKLFDFSLSISIPEGET--HITDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLV 239 (314)
Q Consensus 163 ~~~~~kl~dfg~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~ 239 (314)
.++.+||+|||+++....... .......||+.|+|||++... .++.++||||+||++|+|++|+.||..........
T Consensus 144 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~ 223 (345)
T d1pmea_ 144 TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 223 (345)
T ss_dssp TTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred CCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHH
Confidence 999999999999987644322 123456799999999998554 57899999999999999999999996543211000
Q ss_pred cchHHHHHhhhccCCcc--------cccCh--hhhccCCch---hHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 240 YPFNEYLKNYFEDNRFT--------EIVDP--IIVQDLSCT---EKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 240 ~~~~~~~~~~~~~~~~~--------~~~~~--~~~~~~~~~---~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
..... ....... ..... ........+ .....+.++.+|+.+||+.||++||||.|+++
T Consensus 224 ----~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 224 ----HILGI-LGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp ----HHHHH-HCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----HHhhh-ccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 0000000 00000 000000000 00123456899999999999999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-46 Score=332.03 Aligned_cols=269 Identities=16% Similarity=0.234 Sum_probs=194.0
Q ss_pred hhhhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEe
Q 043524 9 KLWSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIG 87 (314)
Q Consensus 9 ~~~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 87 (314)
++..+|+....+|.|+ ++|+++.+..+|+.||+|++........ ..+.+.+|+++|+.++|||||++++
T Consensus 15 ~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~----------~~~~~~~Ei~il~~l~hpniv~l~~ 84 (346)
T d1cm8a_ 15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL----------FAKRAYRELRLLKHMRHENVIGLLD 84 (346)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHH----------HHHHHHHHHHHHHHCCBTTBCCCSE
T ss_pred ecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChH----------HHHHHHHHHHHHHhcCCCCeeEEEE
Confidence 3456677777899999 9999999999999999999874321111 1257889999999999999999999
Q ss_pred EEEeCC------eeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeee
Q 043524 88 CCLETP------IAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILF 161 (314)
Q Consensus 88 ~~~~~~------~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~ 161 (314)
+|...+ .+|+||||| +++|...+.. ..++...++.++.|++.||.||| ++||+||||||+|||+
T Consensus 85 ~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~ 154 (346)
T d1cm8a_ 85 VFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAV 154 (346)
T ss_dssp EECSCSSTTTCCCCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEE
T ss_pred EeccCccccccceEEEEEecc-cccHHHHHHh------ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhc
Confidence 998654 579999999 5688777754 34899999999999999999999 9999999999999999
Q ss_pred cCCCceEEcccccceecCCCCcccccccccccccccCcccccC-CCCcccchHHHHHHHHHHHhCCCCcccccCcccccc
Q 043524 162 SEENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVY 240 (314)
Q Consensus 162 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~ 240 (314)
+.++.+|++|||.++..... .....||+.|+|||++.+. .++.++||||+||++|+|++|++||...........
T Consensus 155 ~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~ 230 (346)
T d1cm8a_ 155 NEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE 230 (346)
T ss_dssp CTTCCEEECCCTTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred ccccccccccccceeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHH
Confidence 99999999999999876433 3356799999999998765 468999999999999999999999975432211000
Q ss_pred -------chHHHHHhhhcc--CCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 241 -------PFNEYLKNYFED--NRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 241 -------~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
+...+....... ............... .......+..+.+|+.+||..||++||||.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 231 IMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp HHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhccCCCcHHHHhhhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000000000 000000000000000 0000133456889999999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-47 Score=337.25 Aligned_cols=263 Identities=21% Similarity=0.250 Sum_probs=189.0
Q ss_pred CcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEeC
Q 043524 14 GKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLET 92 (314)
Q Consensus 14 ~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 92 (314)
|.....+|.|+ ++|+++.+..+|+.||+|++.... ....+|+++|++++|||||+++++|...
T Consensus 22 Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----------------~~~~~Ei~il~~l~h~niv~~~~~~~~~ 85 (350)
T d1q5ka_ 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----------------RFKNRELQIMRKLDHCNIVRLRYFFYSS 85 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----------------SSCCHHHHHHHHCCCTTBCCEEEEEEEC
T ss_pred cEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc----------------hHHHHHHHHHHhcCCCCCCcEEEEEEec
Confidence 44555699988 899999999999999999985421 1123799999999999999999998643
Q ss_pred ------CeeEEEEeecCCCCHHHHHh--cCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCC
Q 043524 93 ------PIAILVFEYVQHGTLWDRIL--GAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEE 164 (314)
Q Consensus 93 ------~~~~iv~e~~~~g~L~~~l~--~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~ 164 (314)
..+|+|||||+++.+..... ... ..+++..++.++.|++.||+||| ++||+||||||+|||++.+
T Consensus 86 ~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~----~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~ 158 (350)
T d1q5ka_ 86 GEKKDEVYLNLVLDYVPETVYRVARHYSRAK----QTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPD 158 (350)
T ss_dssp --CCSCCEEEEEEECCSEEHHHHHHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTT
T ss_pred CccCCceEEEEEEeccCCccHHHHHhhhhcc----CCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecC
Confidence 35789999997654333221 111 45889999999999999999999 9999999999999999877
Q ss_pred C-ceEEcccccceecCCCCcccccccccccccccCccccc-CCCCcccchHHHHHHHHHHHhCCCCcccccCcccccc--
Q 043524 165 N-VVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTT-CDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVY-- 240 (314)
Q Consensus 165 ~-~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~-- 240 (314)
+ .+||+|||+++....... ..+..||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+....
T Consensus 159 ~~~~kl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~ 236 (350)
T d1q5ka_ 159 TAVLKLCDFGSAKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 236 (350)
T ss_dssp TCCEEECCCTTCEECCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHH
T ss_pred CCceeEecccchhhccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHH
Confidence 5 899999999987644332 445689999999998775 4689999999999999999999999975443221100
Q ss_pred -----chHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 241 -----PFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 241 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
+..+........ .....+......+.........++++.+|+.+||..||++||||.|+++
T Consensus 237 ~~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 237 KVLGTPTREQIREMNPN-YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHHCCCCHHHHHHHCC----CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhCCChHHhhhhhccc-hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011111111000 0000000000000000001134566899999999999999999999985
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-46 Score=328.19 Aligned_cols=272 Identities=17% Similarity=0.252 Sum_probs=193.1
Q ss_pred hhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEE
Q 043524 11 WSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCC 89 (314)
Q Consensus 11 ~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 89 (314)
..+|+....+|+|+ ++|+++.+..+|+.||||++....... . ..+++.+|+++|+.++||||+++++++
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~---~-------~~~~~~~E~~il~~l~h~nii~~~~~~ 78 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE---G-------FPITALREIKILQLLKHENVVNLIEIC 78 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT---S-------SCHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch---H-------HHHHHHHHHHHHHHhcCCCccceEeee
Confidence 46667777799998 999999999999999999986543211 0 126788999999999999999999998
Q ss_pred Ee--------CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeee
Q 043524 90 LE--------TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILF 161 (314)
Q Consensus 90 ~~--------~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~ 161 (314)
.. .+..|++||||+++.+.. ..... ..++...++.++.|++.||.||| +++|+||||||+||++
T Consensus 79 ~~~~~~~~~~~~~~~iv~e~~~~~~~~~-~~~~~----~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl 150 (318)
T d3blha1 79 RTKASPYNRCKGSIYLVFDFCEHDLAGL-LSNVL----VKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLI 150 (318)
T ss_dssp EC----------CEEEEEECCCEEHHHH-HTCTT----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEE
T ss_pred ecccccccccCceEEEEEeccCCCccch-hhhcc----cccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheee
Confidence 65 456899999997765544 43332 35788899999999999999999 9999999999999999
Q ss_pred cCCCceEEcccccceecCCCCc---ccccccccccccccCcccccC-CCCcccchHHHHHHHHHHHhCCCCcccccCccc
Q 043524 162 SEENVVKLFDFSLSISIPEGET---HITDTVMGTYGHLAPQYVTTC-DFSEKLDVYSFGAFLSELLTGRGILDLVRDAHD 237 (314)
Q Consensus 162 ~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~ 237 (314)
+.++.+|++|||+++....... .......||+.|+|||++... .++.++||||+||++|||++|+.||+.......
T Consensus 151 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~ 230 (318)
T d3blha1 151 TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ 230 (318)
T ss_dssp CTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHH
Confidence 9999999999999987654321 123345799999999998765 589999999999999999999999975332111
Q ss_pred cccchHHHHHhhhccCCcccc-----cChhhh-ccCCch-----hHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 238 LVYPFNEYLKNYFEDNRFTEI-----VDPIIV-QDLSCT-----EKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~-~~~~~~-----~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.. ........ ......... ...... ...... .....+..+.+|+.+||+.||++||||+|+++
T Consensus 231 ~~-~i~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 231 LA-LISQLCGS-ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp HH-HHHHHHCC-CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HH-HHHHhcCC-CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 00 00000000 000000000 000000 000000 11122456789999999999999999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.4e-46 Score=328.52 Aligned_cols=264 Identities=17% Similarity=0.221 Sum_probs=196.9
Q ss_pred hhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC-CCceeeeEeE
Q 043524 11 WSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS-HDHILKLIGC 88 (314)
Q Consensus 11 ~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~ 88 (314)
..+|+....+|+|+ +.|+++.+..+|+.||+|++..... +++.+|+.+|..++ ||||++++++
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---------------~~~~~Ei~il~~l~~hpnIv~~~~~ 98 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---------------KKIKREIKILENLRGGPNIITLADI 98 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCH---------------HHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHH---------------HHHHHHHHHHHhccCCCCCcEEEEE
Confidence 34566667799998 9999999999999999999864332 45779999999996 9999999999
Q ss_pred EEe--CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCC-
Q 043524 89 CLE--TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN- 165 (314)
Q Consensus 89 ~~~--~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~- 165 (314)
+.. ...+++|||||++++|.... ..++...++.++.||+.||.||| ++||+||||||+|||++.++
T Consensus 99 ~~~~~~~~~~~v~e~~~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~ 167 (328)
T d3bqca1 99 VKDPVSRTPALVFEHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHR 167 (328)
T ss_dssp EECTTTCSEEEEEECCCSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTT
T ss_pred EEecCCCceeEEEeecCCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCC
Confidence 974 45689999999999997654 35889999999999999999999 99999999999999998655
Q ss_pred ceEEcccccceecCCCCcccccccccccccccCcccccCC-CCcccchHHHHHHHHHHHhCCCCcccccCccccccchHH
Q 043524 166 VVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCD-FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNE 244 (314)
Q Consensus 166 ~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 244 (314)
.++++|||+|+....... .....+|+.|+|||.+.+.. ++.++||||+||++|+|++|+.||.......+.......
T Consensus 168 ~vkl~DFG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~ 245 (328)
T d3bqca1 168 KLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 245 (328)
T ss_dssp EEEECCGGGCEECCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHH
T ss_pred eeeecccccceeccCCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHH
Confidence 689999999987654432 44567899999999987754 799999999999999999999999654432211110000
Q ss_pred HH-----Hhhhc--cC----CcccccC----hhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 245 YL-----KNYFE--DN----RFTEIVD----PIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 245 ~~-----~~~~~--~~----~~~~~~~----~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
.. ..... .. ....... ...............+.++.+||.+||+.||++||||+|+++
T Consensus 246 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 246 VLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00000 00 0000000 000111111111244567899999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-45 Score=322.10 Aligned_cols=260 Identities=17% Similarity=0.143 Sum_probs=196.2
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCc-eeeeEeEEE
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDH-ILKLIGCCL 90 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~ 90 (314)
+|+....+|+|+ +.|+++.+..+|+.||+|++..... .+++..|+++++.++|+| |+.+.+++.
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--------------~~~~~~E~~i~~~l~~~~~i~~~~~~~~ 73 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--------------HPQLHIESKIYKMMQGGVGIPTIRWCGA 73 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--------------SCCHHHHHHHHHHSTTSTTCCCEEEEEE
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--------------CHHHHHHHHHHHHccCCCcccEEEEEEe
Confidence 455556689998 8899998889999999998764210 135778999999998766 555566667
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecC---CCce
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSE---ENVV 167 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~---~~~~ 167 (314)
+++..++||||+ ++++.+.+.... ..++...+..++.|++.||+||| +++|+||||||+||+++. +..+
T Consensus 74 ~~~~~~ivme~~-~~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~v 145 (299)
T d1ckia_ 74 EGDYNVMVMELL-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLV 145 (299)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCE
T ss_pred cCCEEEEEEEEc-CCchhhhhhhcc----CCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCcee
Confidence 888999999999 567777766544 45889999999999999999999 999999999999998764 4579
Q ss_pred EEcccccceecCCCCcc------cccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccccc
Q 043524 168 KLFDFSLSISIPEGETH------ITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYP 241 (314)
Q Consensus 168 kl~dfg~~~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~ 241 (314)
+++|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||++|..||...........
T Consensus 146 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~- 224 (299)
T d1ckia_ 146 YIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK- 224 (299)
T ss_dssp EECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------
T ss_pred eeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHH-
Confidence 99999999887543221 23456799999999999999999999999999999999999999976543321110
Q ss_pred hHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHh
Q 043524 242 FNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICC 309 (314)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~ 309 (314)
....... ....+ .......++.++.+++..||+.||++||+++++.+.|+++..
T Consensus 225 ~~~~~~~-------------~~~~~-~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 225 YERISEK-------------KMSTP-IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HHHHHHH-------------HHHSC-HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHhhcc-------------cCCCC-hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 0000000 00000 000011345678999999999999999999999999988754
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-46 Score=323.29 Aligned_cols=270 Identities=15% Similarity=0.156 Sum_probs=199.8
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEEe
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCLE 91 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (314)
+|+....+|+|+ +.|+++.+..+|+.||||++...... ....+++.+|+.+|+.++|||||++++++.+
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~----------~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 72 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD----------EGVPSSALREICLLKELKHKNIVRLHDVLHS 72 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS----------TTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCC----------hHHHHHHHHHHHHHHhcCcCCEEeecccccc
Confidence 445556689888 99999999999999999998543211 1123678899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEcc
Q 043524 92 TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLFD 171 (314)
Q Consensus 92 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~d 171 (314)
....++++|++.++++...+... ..++...+..++.|++.||+||| +++|+||||||+||+++.++.+|++|
T Consensus 73 ~~~~~iv~~~~~~~~l~~~~~~~-----~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~D 144 (292)
T d1unla_ 73 DKKLTLVFEFCDQDLKKYFDSCN-----GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLAN 144 (292)
T ss_dssp SSEEEEEEECCSEEHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECC
T ss_pred ccceeEEeeeccccccccccccc-----cccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeee
Confidence 99999999999998888877654 35788999999999999999999 99999999999999999999999999
Q ss_pred cccceecCCCCcccccccccccccccCcccccCC-CCcccchHHHHHHHHHHHhCCCCcccccCccccccchHHHHHhhh
Q 043524 172 FSLSISIPEGETHITDTVMGTYGHLAPQYVTTCD-FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNEYLKNYF 250 (314)
Q Consensus 172 fg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
||.++....... ......+++.|+|||++.... ++.++||||+||++|||++|+.||....+..+.............
T Consensus 145 FG~a~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 223 (292)
T d1unla_ 145 FGLARAFGIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT 223 (292)
T ss_dssp CTTCEECCSCCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cchhhcccCCCc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCC
Confidence 999987654332 233446788899999887765 689999999999999999999997543332211111111100000
Q ss_pred ccCCcc---cccC-----hhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 251 EDNRFT---EIVD-----PIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 251 ~~~~~~---~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
...+. ...+ ...............+..+.+|+.+||+.||++||||+|+++
T Consensus 224 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 224 -EEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp -TTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -hhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 0000 000000001111134567899999999999999999999975
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-46 Score=328.98 Aligned_cols=256 Identities=19% Similarity=0.251 Sum_probs=199.2
Q ss_pred hcCcccccccCch-hHHHHHHH---hcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCC-CceeeeE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIA---SSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSH-DHILKLI 86 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~---~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~ 86 (314)
.+|+....||+|+ +.|+++.+ ..+|+.||+|++.+....... . ..+.+.+|++++++++| |||++++
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~-~-------~~~~~~~E~~il~~l~h~pnIv~~~ 95 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA-K-------TTEHTRTERQVLEHIRQSPFLVTLH 95 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEE-S-------SGGGCCCHHHHHHHHHTCTTBCCEE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccch-H-------HHHHHHHHHHHHHhccCCCeEEEee
Confidence 3455566799998 88877754 457899999998754321100 0 12456799999999976 8999999
Q ss_pred eEEEeCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCc
Q 043524 87 GCCLETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENV 166 (314)
Q Consensus 87 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~ 166 (314)
+++.+....++++||+.+|+|.+.+.... .++...+..++.|++.||.|+| +++|+||||||+||+++.++.
T Consensus 96 ~~~~~~~~~~~v~e~~~~~~L~~~i~~~~-----~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~ 167 (322)
T d1vzoa_ 96 YAFQTETKLHLILDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGH 167 (322)
T ss_dssp EEEEETTEEEEEECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSC
T ss_pred eeeccCCceeeeeecccccHHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCC
Confidence 99999999999999999999999987654 4678889999999999999999 999999999999999999999
Q ss_pred eEEcccccceecCCCCcccccccccccccccCcccccCC--CCcccchHHHHHHHHHHHhCCCCcccccCccccccchHH
Q 043524 167 VKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCD--FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNE 244 (314)
Q Consensus 167 ~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 244 (314)
++|+|||+++.+............|++.|+|||.+.... ++.++||||+||++|+|++|..||........ ...
T Consensus 168 vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~----~~~ 243 (322)
T d1vzoa_ 168 VVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS----QAE 243 (322)
T ss_dssp EEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC----HHH
T ss_pred EEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH----HHH
Confidence 999999999887555444455678999999999997654 67899999999999999999999976543321 111
Q ss_pred HHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCC-----CHHHHHH
Q 043524 245 YLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRP-----TMVDVAR 302 (314)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-----s~~ell~ 302 (314)
..... .....+. +...+.++.+|+.+||++||++|| ||+|+++
T Consensus 244 i~~~~-------------~~~~~~~--~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 244 ISRRI-------------LKSEPPY--PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HHHHH-------------HHCCCCC--CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred HHHhc-------------ccCCCCC--cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 11111 0111111 114557789999999999999999 4888875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-45 Score=325.87 Aligned_cols=269 Identities=17% Similarity=0.243 Sum_probs=192.6
Q ss_pred hhhcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeE
Q 043524 10 LWSKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGC 88 (314)
Q Consensus 10 ~~~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 88 (314)
...+|+....+|.|+ ++|+++.+..+|+.||||++........ ..+++.+|+.+++.++|||||+++++
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~----------~~~~~~~Ei~il~~l~hpnIv~~~~~ 84 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT----------HAKRAYRELVLMKCVNHKNIISLLNV 84 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHH----------HHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHH----------HHHHHHHHHHHHHhcCCCCeeEEEEE
Confidence 345667777799999 8999999999999999999864322111 11467899999999999999999999
Q ss_pred EEe------CCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeec
Q 043524 89 CLE------TPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFS 162 (314)
Q Consensus 89 ~~~------~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~ 162 (314)
+.. ...+|+|||||.+ ++.+.+. ..++...++.++.|++.||.||| ++||+||||||+||+++
T Consensus 85 f~~~~~~~~~~~~~iv~Ey~~~-~l~~~~~-------~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~ 153 (355)
T d2b1pa1 85 FTPQKTLEEFQDVYLVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVK 153 (355)
T ss_dssp ECSCCSTTTCCEEEEEEECCSE-EHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEC
T ss_pred EecccccccCceeEEEEeccch-HHHHhhh-------cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccc
Confidence 964 4688999999965 4545553 34788999999999999999999 99999999999999999
Q ss_pred CCCceEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCcccc----
Q 043524 163 EENVVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDL---- 238 (314)
Q Consensus 163 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~---- 238 (314)
.++.++++|||.++...... ......+|+.|+|||++.+..++.++||||+||++++|++|+.||.........
T Consensus 154 ~~~~~kl~df~~~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~ 231 (355)
T d2b1pa1 154 SDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 231 (355)
T ss_dssp TTCCEEECCCCC-----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cccceeeechhhhhcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHH
Confidence 99999999999987654432 244567899999999999989999999999999999999999999644321100
Q ss_pred ---ccchHHHH-------HhhhccC------CcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 239 ---VYPFNEYL-------KNYFEDN------RFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 239 ---~~~~~~~~-------~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
..+..++. ....... .....+.... ...........+.++.+|+.+||..||++||||+|+|+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 232 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSL-FPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGG-SCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhccCCCHHHHHHhhhhHHHHhhcCcccccccccccccccc-ccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00011111 1111110 0111111111 11222334466788999999999999999999999985
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.9e-45 Score=317.60 Aligned_cols=262 Identities=14% Similarity=0.074 Sum_probs=203.1
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCC-CceeeeEeEEE
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSH-DHILKLIGCCL 90 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~ 90 (314)
+|+....+|+|+ +.|+++.+..+|+.||+|++..... .+.+.+|++.+..++| +|++.+++++.
T Consensus 6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--------------~~~~~~e~~~~~~l~~~~~i~~~~~~~~ 71 (293)
T d1csna_ 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--------------APQLRDEYRTYKLLAGCTGIPNVYYFGQ 71 (293)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--------------SCCHHHHHHHHHHTTTCTTCCCEEEEEE
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--------------cHHHHHHHHHHHHhcCCCCCCEEEEEee
Confidence 344455689988 9999999999999999998753210 0346788999999975 89999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecC-----CC
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSE-----EN 165 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~-----~~ 165 (314)
++...|+||||+ +++|.+.+.... ..++...+..++.|++.||.||| ++||+||||||+||+++. .+
T Consensus 72 ~~~~~~~vme~~-~~~l~~~~~~~~----~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~ 143 (293)
T d1csna_ 72 EGLHNVLVIDLL-GPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNAN 143 (293)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTT
T ss_pred cCCccEEEEEec-CCCHHHHHHhhc----cchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCC
Confidence 999999999999 689999887654 35889999999999999999999 999999999999999964 56
Q ss_pred ceEEcccccceecCCCCc------ccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcccccCccccc
Q 043524 166 VVKLFDFSLSISIPEGET------HITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLV 239 (314)
Q Consensus 166 ~~kl~dfg~~~~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~ 239 (314)
.++|+|||+|+....... .......||+.|+|||++.+..++.++||||+|+++|||++|..||..........
T Consensus 144 ~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~ 223 (293)
T d1csna_ 144 MIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ 223 (293)
T ss_dssp CEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH
T ss_pred ceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH
Confidence 799999999987644321 12335579999999999999899999999999999999999999997544332100
Q ss_pred cchHHHHHhhhccCCcccccChhhhccCCchhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHHHHhhc
Q 043524 240 YPFNEYLKNYFEDNRFTEIVDPIIVQDLSCTEKEQQLHASAQLTFECLNESPIDRPTMVDVARRLRQICCSL 311 (314)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~ 311 (314)
........ ...... ......+++++.+++..|+..+|++||+++.+.+.|+++.+..
T Consensus 224 -----~~~~i~~~---~~~~~~-------~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 224 -----KYERIGEK---KQSTPL-------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp -----HHHHHHHH---HHHSCH-------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -----HHHHHHhc---cCCCCh-------HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 00000000 000000 0000134467899999999999999999999999998887654
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-44 Score=320.23 Aligned_cols=264 Identities=15% Similarity=0.182 Sum_probs=190.9
Q ss_pred hcCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 12 SKGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 12 ~~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
.+|+....+|.|+ ++|+++.+..+|+.||+|++........ ..+++.+|+++|+.++|||||++++++.
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~----------~~~~~~~Ei~il~~l~h~~iv~~~~~~~ 87 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII----------HAKRTYRELRLLKHMKHENVIGLLDVFT 87 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHH----------HHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChH----------HHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 3566667799999 9999999999999999999875321111 1156789999999999999999999996
Q ss_pred eC-----CeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCC
Q 043524 91 ET-----PIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEEN 165 (314)
Q Consensus 91 ~~-----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~ 165 (314)
.. ...+++++|+.+|+|.+++.. ..++...++.++.|++.||.||| ++||+||||||+||+++.++
T Consensus 88 ~~~~~~~~~~~~i~~~~~gg~L~~~~~~------~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~ 158 (348)
T d2gfsa1 88 PARSLEEFNDVYLVTHLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDC 158 (348)
T ss_dssp SCSSTTTCCCCEEEEECCSEEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTC
T ss_pred eccccccCceEEEEEeecCCchhhhccc------ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccc
Confidence 43 334666777889999998854 34899999999999999999999 99999999999999999999
Q ss_pred ceEEcccccceecCCCCcccccccccccccccCcccccCC-CCcccchHHHHHHHHHHHhCCCCcccccCccccccchHH
Q 043524 166 VVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCD-FSEKLDVYSFGAFLSELLTGRGILDLVRDAHDLVYPFNE 244 (314)
Q Consensus 166 ~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 244 (314)
.++++|||.+..... ......||+.|+|||...... ++.++||||+||++|+|++|+.||........ ...
T Consensus 159 ~~kl~dfg~a~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~----~~~ 230 (348)
T d2gfsa1 159 ELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ----LKL 230 (348)
T ss_dssp CEEECCC----CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHH
T ss_pred cccccccchhcccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH----HHH
Confidence 999999999865422 244567999999999877665 68899999999999999999999975432110 000
Q ss_pred HHHhhhccC-------C---cccccChhhh-ccCCc-hhHHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 043524 245 YLKNYFEDN-------R---FTEIVDPIIV-QDLSC-TEKEQQLHASAQLTFECLNESPIDRPTMVDVAR 302 (314)
Q Consensus 245 ~~~~~~~~~-------~---~~~~~~~~~~-~~~~~-~~~~~~~~~~~~li~~cl~~dp~~Rps~~ell~ 302 (314)
......... . .......... ..... ......+..+.+||.+||+.||++||||.|+++
T Consensus 231 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 231 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 000000000 0 0000000000 00000 000123567899999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.2e-39 Score=288.96 Aligned_cols=267 Identities=14% Similarity=0.151 Sum_probs=185.3
Q ss_pred cCcccccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC-----------CC
Q 043524 13 KGKRTLMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS-----------HD 80 (314)
Q Consensus 13 ~~~~~~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~ 80 (314)
||+....+|.|+ ++|+++.+..+|+.||||++....... +.+.+|+++++.++ |+
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~-------------~~~~~Ei~~l~~l~~~~~~~~~~~~~~ 80 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-------------EAAEDEIKLLQRVNDADNTKEDSMGAN 80 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHH-------------HHHHHHHHHHHHHHHTCCSHHHHHHHT
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccch-------------HHHHHHHHHHHHhcchhhhhhhhcCcC
Confidence 466677799988 899999999999999999987654321 45678888887765 57
Q ss_pred ceeeeEeEEEe--CCeeEEEEeecCCCCH-HHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCC-CCceeccCCC
Q 043524 81 HILKLIGCCLE--TPIAILVFEYVQHGTL-WDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFP-RPIVFRDFKT 156 (314)
Q Consensus 81 niv~~~~~~~~--~~~~~iv~e~~~~g~L-~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~-~~i~H~dlk~ 156 (314)
||+++++++.. ....+++++++..+.. ......... ..++...+..++.|++.||.||| + .||+||||||
T Consensus 81 ~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~i~~i~~qil~al~~lh---~~~~IvHrDlKp 154 (362)
T d1q8ya_ 81 HILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEH---RGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKP 154 (362)
T ss_dssp TBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSG
T ss_pred ceEEEEEEeeeccccceeeeeeecccccccccccccccc---cCCcHHHHHHHHHHHHHHHHHHh---hhcCcccccCCh
Confidence 89999998864 4566677777655433 222222221 45788899999999999999999 6 8999999999
Q ss_pred CCeeecCCC------ceEEcccccceecCCCCcccccccccccccccCcccccCCCCcccchHHHHHHHHHHHhCCCCcc
Q 043524 157 SHILFSEEN------VVKLFDFSLSISIPEGETHITDTVMGTYGHLAPQYVTTCDFSEKLDVYSFGAFLSELLTGRGILD 230 (314)
Q Consensus 157 ~nil~~~~~------~~kl~dfg~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p~~ 230 (314)
+|||++..+ .++++|||.+...... .....||+.|+|||++....++.++||||+||++++|++|+.||.
T Consensus 155 ~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~ 230 (362)
T d1q8ya_ 155 ENVLMEIVDSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230 (362)
T ss_dssp GGEEEEEEETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred hHeeeeccCcccccceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCC
Confidence 999997654 4899999999765432 345679999999999998889999999999999999999999997
Q ss_pred cccCccccc--cchHHHHH-----------------hhhccCCcccccChhhh------ccCCchhHHHHHHHHHHHHhH
Q 043524 231 LVRDAHDLV--YPFNEYLK-----------------NYFEDNRFTEIVDPIIV------QDLSCTEKEQQLHASAQLTFE 285 (314)
Q Consensus 231 ~~~~~~~~~--~~~~~~~~-----------------~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~ 285 (314)
......... ........ ..+.............. ...........+.++.+|+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~ 310 (362)
T d1q8ya_ 231 PDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 310 (362)
T ss_dssp --------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGG
T ss_pred CCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHH
Confidence 543321100 00000000 00000000000000000 000111123567789999999
Q ss_pred hccCCCCCCCCHHHHHH
Q 043524 286 CLNESPIDRPTMVDVAR 302 (314)
Q Consensus 286 cl~~dp~~Rps~~ell~ 302 (314)
||..||.+||||+|+|+
T Consensus 311 mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 311 MLQLDPRKRADAGGLVN 327 (362)
T ss_dssp GGCSSTTTCBCHHHHHT
T ss_pred HCCCChhHCcCHHHHhc
Confidence 99999999999999986
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.80 E-value=1.3e-21 Score=158.29 Aligned_cols=169 Identities=14% Similarity=0.102 Sum_probs=111.6
Q ss_pred ccccCch-hHHHHHHHhcCCcccccccccHHHHHHHhcCCcc--cC-C---hhHHHHHHHHHHHhcCCCCceeeeEeEEE
Q 043524 18 LMIGNGA-SVLQELIASSNGKYIPYRIFSAQELKQETNNYDQ--KN-G---FWHESCINNVTYAAQMSHDHILKLIGCCL 90 (314)
Q Consensus 18 ~~~G~g~-~~~~~~~~~~~g~~~a~k~~~~~~~~~~~~~~~~--~~-~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 90 (314)
..||+|+ +.||.+.+ .+|+.||+|++.............. .. . ........|+..+..+.|++++..+++.
T Consensus 6 ~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~- 83 (191)
T d1zara2 6 KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE- 83 (191)
T ss_dssp EEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE-
T ss_pred CEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec-
Confidence 3578888 77777654 5789999998765432211110000 00 0 0124456789999999999999988663
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcCCCCCCCcccHHHHHHHHHHHHHHHHHhhcCCCCCceeccCCCCCeeecCCCceEEc
Q 043524 91 ETPIAILVFEYVQHGTLWDRILGAPQTHFEPLLLKRRLKDAVDAANALAYLHFGFPRPIVFRDFKTSHILFSEENVVKLF 170 (314)
Q Consensus 91 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~i~H~dlk~~nil~~~~~~~kl~ 170 (314)
..+++|||+++..+.+ ++......++.|++.++.||| +++|+||||||+|||++.. .++++
T Consensus 84 ---~~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 84 ---GNAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp ---TTEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEEC
T ss_pred ---CCEEEEEeeccccccc------------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEE
Confidence 2379999998765532 223344577899999999999 9999999999999999865 58899
Q ss_pred ccccceecCCCCccccccccccccccc------CcccccCCCCcccchHHHHH
Q 043524 171 DFSLSISIPEGETHITDTVMGTYGHLA------PQYVTTCDFSEKLDVYSFGA 217 (314)
Q Consensus 171 dfg~~~~~~~~~~~~~~~~~g~~~y~a------PE~~~~~~~~~~~DiwslG~ 217 (314)
|||.|+....... ..|+. .+ +....|+.++|+||..-
T Consensus 145 DFG~a~~~~~~~~---------~~~l~rd~~~~~~-~f~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 145 DFPQSVEVGEEGW---------REILERDVRNIIT-YFSRTYRTEKDINSAID 187 (191)
T ss_dssp CCTTCEETTSTTH---------HHHHHHHHHHHHH-HHHHHHCCCCCHHHHHH
T ss_pred ECCCcccCCCCCc---------HHHHHHHHHHHHH-HHcCCCCCcccHHHHHH
Confidence 9999976532211 00110 01 11235788899999753
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.72 E-value=2.2e-05 Score=64.25 Aligned_cols=46 Identities=4% Similarity=-0.106 Sum_probs=35.3
Q ss_pred HHHHHHHHHhcCC-CCceeeeEeEEEeCCeeEEEEeecCCCCHHHHH
Q 043524 66 SCINNVTYAAQMS-HDHILKLIGCCLETPIAILVFEYVQHGTLWDRI 111 (314)
Q Consensus 66 ~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~iv~e~~~~g~L~~~l 111 (314)
.+..|...+..+. +--+.+++.+..+++..++||++.+|.++.+..
T Consensus 55 ~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~ 101 (263)
T d1j7la_ 55 DVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEY 101 (263)
T ss_dssp CHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHT
T ss_pred hHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccc
Confidence 3567888887774 445778888888889999999999887775443
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=96.91 E-value=0.0012 Score=53.13 Aligned_cols=60 Identities=8% Similarity=0.001 Sum_probs=40.6
Q ss_pred hcCCcccccccccHHHHHHHhcCCcccCChhHHHHHHHHHHHhcCC--CCceeeeEeEEEeCCeeEEEEeecCCCCH
Q 043524 33 SSNGKYIPYRIFSAQELKQETNNYDQKNGFWHESCINNVTYAAQMS--HDHILKLIGCCLETPIAILVFEYVQHGTL 107 (314)
Q Consensus 33 ~~~g~~~a~k~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~iv~e~~~~g~L 107 (314)
..+|..+.+|....... ..+..|...++.+. .-.+.+++.+..+++..++||++++|.++
T Consensus 32 ~~~~~~~vlK~~~~~~~---------------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 32 AQGRPVLFVKTDLSGAL---------------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CTTSCCEEEEEECSCTT---------------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred eCCCCEEEEEeCCccCH---------------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 34556677776543221 23557777777664 33467788888888889999999987554
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=95.65 E-value=0.0026 Score=54.94 Aligned_cols=32 Identities=22% Similarity=0.297 Sum_probs=26.2
Q ss_pred CCCceeccCCCCCeeecCCCceEEcccccceec
Q 043524 146 PRPIVFRDFKTSHILFSEENVVKLFDFSLSISI 178 (314)
Q Consensus 146 ~~~i~H~dlk~~nil~~~~~~~kl~dfg~~~~~ 178 (314)
...++|+|+.|.||+++.+ .++++||..+...
T Consensus 222 ~~~LiHGDl~~gNIlv~~~-~~~vID~E~a~~G 253 (392)
T d2pula1 222 AETLIHGDLHTGSIFASEH-ETKVIDPEFAFYG 253 (392)
T ss_dssp CCEEECSCCCGGGEEECSS-CEEECCCTTCEEE
T ss_pred CcceeccCCcCCceeEcCC-ceEEechhhcccC
Confidence 3468999999999999765 5899999887543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=92.63 E-value=0.014 Score=48.35 Aligned_cols=30 Identities=20% Similarity=0.516 Sum_probs=27.3
Q ss_pred CCCceeccCCCCCeeecCCCceEEcccccc
Q 043524 146 PRPIVFRDFKTSHILFSEENVVKLFDFSLS 175 (314)
Q Consensus 146 ~~~i~H~dlk~~nil~~~~~~~kl~dfg~~ 175 (314)
..|++|+|+.++|++++.+...-++||+.+
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~ 211 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFA 211 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred ccccccCCcchhhhhcccccceeEeccccc
Confidence 678999999999999998877789999987
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=91.84 E-value=0.057 Score=46.09 Aligned_cols=36 Identities=19% Similarity=0.120 Sum_probs=24.7
Q ss_pred HHHHHHHhcCC-CCceeeeEeEEEeCCeeEEEEeecCCCCH
Q 043524 68 INNVTYAAQMS-HDHILKLIGCCLETPIAILVFEYVQHGTL 107 (314)
Q Consensus 68 ~~E~~~l~~l~-h~niv~~~~~~~~~~~~~iv~e~~~~g~L 107 (314)
.+|..+++.+. +.-..++++++.+ .+|+||++|.++
T Consensus 92 ~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 92 VAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 128 (395)
T ss_dssp HHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred HHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence 46788887774 4445678887743 489999876444
|